PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cui, Y; Wei, HY; Lu, FG; Liu, XW; Liu, DL; Gu, L; Ouyang, CH				Cui, Yi; Wei, Hongyun; Lu, Fanggen; Liu, Xiaowei; Liu, Deliang; Gu, Li; Ouyang, Chunhui			Different Effects of Three Selected Lactobacillus Strains in Dextran Sulfate Sodium-Induced Colitis in BALB/c Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDUCED ULCERATIVE-COLITIS; MURINE COLITIS; DSS; MICROFLORA; PROBIOTICS; PREBIOTICS; MICROBIOTA; INDUCTION; REMISSION	Aim To analyze the changes of different Lactobacillus species in ulcerative colitis patients and to further assess the therapeutic effects of selected Lactobacillus strains on dextran sulfate sodium (DSS)-induced experimental colitis in BALB/c mice. Methods Forty-five active ulcerative colitis (UC) patients and 45 population-based healthy controls were enrolled. Polymerase chain reaction (PCR) amplification and real-time PCR were performed for qualitative and quantitative analyses, respectively, of the Lactobacillus species in UC patients. Three Lactobacillus strains from three species were selected to assess the therapeutic effects on experimental colitis. Sixty 8-week-old BALB/c mice were divided into six groups. The five groups that had received DSS were administered normal saline, mesalazine, L. fermentum CCTCC M206110 strain, L. crispatus CCTCC M206119 strain, or L. plantarum NCIMB8826 strain. We assessed the severity of colitis based on disease activity index (DAI), body weight loss, colon length, and histologic damage. Results The detection rate of four of the 11 Lactobacillus species decreased significantly (P < 0.05), and the detection rate of two of the 11 Lactobacillus species increased significantly (P < 0.05) in UC patients. Relative quantitative analysis revealed that eight Lactobacillus species declined significantly in UC patients (P < 0.05), while three Lactobacillus species increased significantly (P < 0.05). The CCTCC M206110 treatment group had less weight loss and colon length shortening, lower DAI scores, and lower histologic scores (P < 0.05), while the CCTCC M206119 treatment group had greater weight loss and colon length shortening, higher histologic scores, and more severe inflammatory infiltration (P < 0.05). NCIMB8826 improved weight loss and colon length shortening (P < 0.05) with no significant influence on DAI and histologic damage in the colitis model. Conclusions Administration of an L. crispatus CCTCC M206119 supplement aggravated DSS-induced colitis. L. fermentum CCTCC M206110 proved to be effective at attenuating DSS-induced colitis. The potential probiotic effect of L. plantarum NCIMB8826 on UC has yet to be assessed.	[Cui, Yi; Wei, Hongyun; Lu, Fanggen; Liu, Xiaowei; Liu, Deliang; Gu, Li; Ouyang, Chunhui] Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Cui, Yi] Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO USA	Central South University; University of Missouri System; Missouri University of Science & Technology	Gu, L; Ouyang, CH (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China.	liguxy2yy@gmail.com; ouyangchxy2yy@gmail.com			National Natural Science Foundation of China [81470801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NO. 81470801), received by F. Lu.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Cammarota G, 2015, PHARMACOL THERAPEUT, V149, P191, DOI 10.1016/j.pharmthera.2014.12.006; Castagliuolo I, 2005, FEMS IMMUNOL MED MIC, V43, P197, DOI 10.1016/j.femsim.2004.08.011; Chen LL, 2013, WORLD J GASTROENTERO, V19, P5347, DOI 10.3748/wjg.v19.i32.5347; COOPER HS, 1993, LAB INVEST, V69, P238; Dijkstra G, 2002, SCAND J GASTROENTERO, V37, P37, DOI 10.1080/003655202320621436; Feng YN, 2010, VET MICROBIOL, V140, P116, DOI 10.1016/j.vetmic.2009.07.001; Geier MS, 2007, INT J FOOD MICROBIOL, V114, P267, DOI 10.1016/j.ijfoodmicro.2006.09.018; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Herias MV, 2005, INT J FOOD MICROBIOL, V103, P143, DOI 10.1016/j.ijfoodmicro.2004.11.032; Jang SE, 2014, INT IMMUNOPHARMACOL, V21, P186, DOI 10.1016/j.intimp.2014.04.021; Koido S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086702; Kokesova A, 2006, FOLIA MICROBIOL, V51, P478, DOI 10.1007/BF02931595; Kumar CSVS, 2015, INT IMMUNOPHARMACOL, V25, P504, DOI 10.1016/j.intimp.2015.02.026; Liu YW, 2011, INT IMMUNOPHARMACOL, V11, P2159, DOI 10.1016/j.intimp.2011.09.013; Macfarlane GT, 2009, CURR PHARM DESIGN, V15, P1528, DOI 10.2174/138161209788168146; Martin R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0400-1; Miele E, 2009, AM J GASTROENTEROL, V104, P437, DOI 10.1038/ajg.2008.118; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Navidshad B, 2012, INT J MOL SCI, V13, P2119, DOI 10.3390/ijms13022119; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Oliva S, 2012, ALIMENT PHARM THER, V35, P327, DOI 10.1111/j.1365-2036.2011.04939.x; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Sanchez B, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/159094; Sanchez-Fidalgo S, 2015, J NUTR BIOCHEM, V26, P513, DOI 10.1016/j.jnutbio.2014.12.001; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Ulinski T, 2010, CURR MED CHEM, V17, P847, DOI 10.2174/092986710790712174; Wasilewski A, 2015, INFLAMM BOWEL DIS, V21, P1674, DOI 10.1097/MIB.0000000000000364; Zhang J, 2013, WORLD J MICROB BIOT, V29, P2293, DOI 10.1007/s11274-013-1395-0; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x; Zuo FL, 2014, APPL MICROBIOL BIOT, V98, P7523, DOI 10.1007/s00253-014-5851-z	35	23	23	14	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148241	10.1371/journal.pone.0148241	http://dx.doi.org/10.1371/journal.pone.0148241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840426	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200108
J	Jirschitzka, J; Kimmerle, J; Cress, U				Jirschitzka, Jens; Kimmerle, Joachim; Cress, Ulrike			A New Method for Re-Analyzing Evaluation Bias: Piecewise Growth Curve Modeling Reveals an Asymmetry in the Evaluation of Pro and Con Arguments	PLOS ONE			English	Article							PREFERENCE-INCONSISTENT RECOMMENDATIONS; RIGHT-WING AUTHORITARIANISM; REDUCING CONFIRMATION BIAS; SELECTIVE EXPOSURE; MYSIDE BIAS; INFORMATION; POLARIZATION; ASSIMILATION; CONSISTENCY; DECISIONS	In four studies we tested a new methodological approach to the investigation of evaluation bias. The usage of piecewise growth curve modeling allowed for investigation into the impact of people's attitudes on their persuasiveness ratings of pro-and con-arguments, measured over the whole range of the arguments' polarity from an extreme con to an extreme pro position. Moreover, this method provided the opportunity to test specific hypotheses about the course of the evaluation bias within certain polarity ranges. We conducted two field studies with users of an existing online information portal (Studies 1a and 2a) as participants, and two Internet laboratory studies with mostly student participants (Studies 1b and 2b). In each of these studies we presented pro-and con-arguments, either for the topic of MOOCs (massive open online courses, Studies 1a and 1b) or for the topic of M-learning (mobile learning, Studies 2a and 2b). Our results indicate that using piecewise growth curve models is more appropriate than simpler approaches. An important finding of our studies was an asymmetry of the evaluation bias toward pro-or con-arguments: the evaluation bias appeared over the whole polarity range of pro-arguments and increased with more and more extreme polarity. This clear-cut result pattern appeared only on the pro-argument side. For the con-arguments, in contrast, the evaluation bias did not feature such a systematic picture.	[Jirschitzka, Jens; Kimmerle, Joachim; Cress, Ulrike] Leibniz Inst Wissensmed, Tubingen, Germany; [Kimmerle, Joachim; Cress, Ulrike] Univ Tubingen, Dept Psychol, Tubingen, Germany	Leibniz Institut fur Wissensmedien; Eberhard Karls University of Tubingen	Kimmerle, J (corresponding author), Leibniz Inst Wissensmed, Tubingen, Germany.; Kimmerle, J (corresponding author), Univ Tubingen, Dept Psychol, Tubingen, Germany.	j.kimmerle@iwm-tuebingen.de	Cress, Ulrike/AAB-4264-2020; Cress, Ulrike/A-5615-2013; Kimmerle, Joachim/ABE-8803-2020	Cress, Ulrike/0000-0002-8996-8303; Cress, Ulrike/0000-0002-8996-8303; 	Deutsche Forschungsgemeinschaft; Eberhard Karls University of Tuebingen; Leibniz-Institut fur Wissensmedien, Tuebingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Eberhard Karls University of Tuebingen; Leibniz-Institut fur Wissensmedien, Tuebingen	The authors acknowledge support by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), Open Access Publishing Fund (JK) of Eberhard Karls University of Tuebingen (http://www.uni-tuebingen.de/einrichtungen/universitaetsbibliothek/publizieren/open-access-publikationsfonds.html), and the Leibniz-Institut fur Wissensmedien, Tuebingen (http://www.iwm-kmrc.de/www/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], 2014, CONTR HIGH ED POL 2; Asparouhov T., 2010, MPLUS TECHNICAL REPO; Asparouhov T., 2010, BAYESIAN ANAL USING; Bartels LM, 2002, POLIT BEHAV, V24, P117, DOI 10.1023/A:1021226224601; Bientzle M, 2015, PSYCHOL HEALTH MED, V20, P670, DOI 10.1080/13548506.2015.1005017; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Bortz J., 2006, FORSCHUNGSMETHODEN E; Bretz F., 2010, MULTIPLE COMP USING; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cohen J., 2003, APPL MULTIPLE REGRES; Cohrs JC, 2005, PERS SOC PSYCHOL B, V31, P1425, DOI 10.1177/0146167205275614; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Dallago F, 2008, BASIC APPL SOC PSYCH, V30, P362, DOI 10.1080/01973530802502333; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Druckman JN, 2011, J COMMUN, V61, P659, DOI 10.1111/j.1460-2466.2011.01562.x; DUNCAN T, 2006, INTRO LATENT GROWTH; Edwards K, 1996, J PERS SOC PSYCHOL, V71, P5, DOI 10.1037/0022-3514.71.1.5; Enders C. K., 2010, APPL MISSING DATA AN; Entman RM, 2009, INT COMMUN ASSOC HAN, P175; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Garrett RK, 2014, J COMMUN, V64, P680, DOI 10.1111/jcom.12105; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gwet K. L., 2012, HDB INTERRATER RELIA; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; Hart W, 2009, PSYCHOL BULL, V135, P555, DOI 10.1037/a0015701; HASSEBRAUCK M, 1983, Z SOZIALPSYCHOL, V14, P152; Hassebrauck M, 1993, PHYS ATTRAKTIVITAT, P29; Hergovich A, 2010, CURR PSYCHOL, V29, P188, DOI 10.1007/s12144-010-9087-5; Holt JK, 2008, QUANT METH EDUC BEHA, P111; Honekopp J, 2006, J EXP PSYCHOL HUMAN, V32, P199, DOI 10.1037/0096-1523.32.2.199; Honekopp J, 2006, PSYCHOL METHODS, V11, P72, DOI 10.1037/1082-989X.11.1.72; Jonas E, 2001, J PERS SOC PSYCHOL, V80, P557, DOI 10.1037/0022-3514.80.4.557; Kaplan D., 2012, HDB STRUCTURAL EQUAT, P650; Kaplan D., 2013, OXFORD HDB QUANTITAT, P407, DOI DOI 10.1093/OXFORDHB/9780199934874.013.0020; Kassin SM, 2013, J APPL RES MEM COGN, V2, P42, DOI 10.1016/j.jarmac.2013.01.001; Kimmerle J, 2013, COMPUT HUM BEHAV, V29, P1078, DOI 10.1016/j.chb.2012.09.010; Knobloch-Westerwick S, 2009, COMMUN RES, V36, P426, DOI 10.1177/0093650209333030; Kruschke J. K., 2015, DOING BAYESIAN DATA, V2nd, DOI 10.1016/B978-0-12-405888-0.00010-6; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Masyn K., 2013, ENCY CRIMINOLOGY CRI, P2013, DOI DOI 10.1007/978-1-4614-5690-2_404; Matthes J, 2013, COMMUN RES, V40, P360, DOI 10.1177/0093650211420255; McClelland D. C., 1992, MOTIV PERS, P87, DOI [10.1017/CBO9780511527937.006, DOI 10.1017/CBO9780511527937.006]; Mendel R, 2011, PSYCHOL MED, V41, P2651, DOI 10.1017/S0033291711000808; Mirisola A, 2007, PERS INDIV DIFFER, V43, P1851, DOI 10.1016/j.paid.2007.06.006; Mojzisch A, 2010, EUR J SOC PSYCHOL, V40, P946, DOI 10.1002/ejsp.660; Muthen B, 2014, GEN RANDOM EFF UNPUB; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; OConnell AA, 2008, QUANT METH EDUC BEHA, P1; Perrissol S, 2008, APPL PSYCHOL RES TRE, P1, DOI DOI 10.5465/AMBPP.2008.33636328; Peterson RA, 2014, J BUS RES, V67, P1035, DOI 10.1016/j.jbusres.2013.08.010; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rhemtulla M, 2012, PSYCHOL METHODS, V17, P354, DOI 10.1037/a0029315; Richardson JD, 2008, J APPL SOC PSYCHOL, V38, P1255, DOI 10.1111/j.1559-1816.2008.00347.x; Schwind C, 2012, COMPUT HUM BEHAV, V28, P2280, DOI 10.1016/j.chb.2012.06.035; Schwind C, 2012, COMPUT EDUC, V58, P787, DOI 10.1016/j.compedu.2011.10.003; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sherif M., 1961, SOCIAL JUDGMENT ASSI, V4; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stanovich KE, 2007, THINK REASONING, V13, P225, DOI 10.1080/13546780600780796; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; Thiel S., 2012, CONFLICT COMMUNICATI, V11; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; van Strien JLH, 2014, COMPUT HUM BEHAV, V32, P101, DOI 10.1016/j.chb.2013.11.021; Wolfe CR, 2008, THINK REASONING, V14, P1, DOI 10.1080/13546780701527674; Zyphur MJ, 2015, J MANAGE, V41, P390, DOI 10.1177/0149206313501200	73	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148283	10.1371/journal.pone.0148283	http://dx.doi.org/10.1371/journal.pone.0148283			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840219	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200119
J	Rallos, LEE; Baudoin, AB				Rallos, Lynn Esther E.; Baudoin, Anton B.			Co-Occurrence of Two Allelic Variants of CYP51 in Erysiphe necator and Their Correlation with Over-Expression for DMI Resistance	PLOS ONE			English	Article							POWDERY MILDEW FUNGUS; DEMETHYLATION INHIBITOR FUNGICIDES; 14-ALPHA-DEMETHYLASE GENE CYP51; UNCINULA-NECATOR; STEROL DEMETHYLATION; DIFFERENTIAL SENSITIVITY; ASPERGILLUS-FUMIGATUS; MONILINIA-FRUCTICOLA; FUSARIUM-GRAMINEARUM; AZOLE FUNGICIDE	Demethylation inhibitors (DMIs) have been an important tool in the management of grapevine powdery mildew caused by Erysiphe necator. Long-term, intensive use of DMIs has resulted in reduced sensitivity in field populations. To further characterize DMI resistance and understand resistance mechanisms in this pathogen, we investigated the cyp51 sequence of 24 single-spored isolates from Virginia and surrounding states and analyzed gene expression in isolates representing a wide range of sensitivity. Two cyp51 alleles were found with respect to the 136th codon of the predicted EnCYP51 sequence: the wildtype (TAT) and the mutant (TTT), which results in the known Y136F amino acid change. Some isolates possessed both alleles, demonstrating gene duplication or increased gene copy number and possibly a requirement for at least one mutant copy of CYP51 for resistance. Cyp51 was over-expressed 1.4- to 19-fold in Y136F-mutant isolates. However, the Y136F mutation was absent in one isolate with moderate to high resistance factor. Two additional synonymous mutations were detected as well, one of which, A1119C was present only in isolates with high cyp51 expression. Overall, our results indicate that at least two mechanisms, cyp51 over-expression and the known target-site mutation in CYP51, contribute to resistance in E. necator, and may be working in conjunction with each other.	[Rallos, Lynn Esther E.; Baudoin, Anton B.] Virginia Tech, Coll Agr & Life Sci, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Rallos, LEE (corresponding author), Virginia Tech, Coll Agr & Life Sci, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA.	lynn.e.rallos@dupont.com			Virginia Wine Board; Viticulture Consortium-East; North Carolina Wine Grape Council	Virginia Wine Board; Viticulture Consortium-East; North Carolina Wine Grape Council	This work was supported by Virginia Wine Board (http://www.virginiawine.org/industry/wine-board), Viticulture Consortium-East (http://portal.nifa.usda.gov/web/crisprojectpages/0218903-viticulture-consortium-east.html), and North Carolina Wine & Grape Council (no current website, referenced at http://www.ncagr.gov/markets/ncwine/about-us/ncwine-history.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini C, 2003, EUR J PLANT PATHOL, V109, P117, DOI 10.1023/A:1022584822191; Amrani L, 2006, PLANT PATHOL, V55, P505, DOI 10.1111/j.1365-3059.2006.01390.x; Aoyama Y, 2005, FRONT BIOSCI, V10, P1546, DOI 10.2741/1639; Aoyama Y, 1996, J BIOCHEM-TOKYO, V119, P926; Araya C, 2014, VITIS, V53, P163; Becher R, 2012, APPL MICROBIOL BIOT, V95, P825, DOI 10.1007/s00253-012-4195-9; Becher R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-52; Bellamine A, 2004, J LIPID RES, V45, P2000, DOI 10.1194/jlr.M400239-JLR200; Blatter RHE, 1998, PLANT PATHOL, V47, P570, DOI 10.1046/j.1365-3059.1998.00276.x; Bolton MD, 2012, PHYTOPATHOLOGY, V102, P298, DOI 10.1094/PHYTO-07-11-0212; Boudon-Padieu E., 2015, COMPENDIUM GRAPE DIS, V2nd ed., P103; Brent K.J., 2007, FRAC MONOGRAPH, V2; Brewer MT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-268; Butters JA, 2000, PEST MANAG SCI, V56, P257, DOI 10.1002/(SICI)1526-4998(200003)56:3<257::AID-PS131>3.3.CO;2-2; Canas-Gutierrez GP, 2009, PEST MANAG SCI, V65, P892, DOI 10.1002/ps.1770; Chen FP, 2012, PLANT DIS, V96, P416, DOI 10.1094/PDIS-06-11-0495; Colcol JF, 2012, PLANT DIS, V96, P111, DOI 10.1094/PDIS-12-10-0883; DEBIEU D, 1995, PHYTOCHEMISTRY, V39, P293, DOI 10.1016/0031-9422(95)00015-Y; Delye C, 1998, CURR GENET, V34, P399, DOI 10.1007/s002940050413; Delye C, 1997, GENE, V195, P29, DOI 10.1016/S0378-1119(97)00141-8; Delye C, 1999, APPL ENVIRON MICROB, V65, P3950; Delye C, 1997, APPL ENVIRON MICROB, V63, P2966; Donald TM, 2002, THEOR APPL GENET, V104, P610, DOI 10.1007/s00122-001-0768-1; DOSTER MA, 1985, AM J ENOL VITICULT, V36, P101; Dufour MC, 2011, PEST MANAG SCI, V67, P60, DOI 10.1002/ps.2032; Erickson EO, 1997, PHYTOPATHOLOGY, V87, P784, DOI 10.1094/PHYTO.1997.87.8.784; Ferreira MED, 2005, MED MYCOL, V43, pS313, DOI 10.1080/13693780400029114; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; FRAC, 2012, FRAC COD LIST 2012 F; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; Frenkel O, 2015, PHYTOPATHOLOGY, V105, P370, DOI 10.1094/PHYTO-07-14-0202-R; GADHER P, 1983, PESTIC BIOCHEM PHYS, V19, P1, DOI 10.1016/0048-3575(83)90034-2; Gubler WD, 1996, PLANT DIS, V80, P902, DOI 10.1094/PD-80-0902; Gubler WD, 1992, GRAPE PEST MANAGEMEN, P57; Hamamoto H, 2000, APPL ENVIRON MICROB, V66, P3421, DOI 10.1128/AEM.66.8.3421-3426.2000; Hayashi K, 2002, PESTIC BIOCHEM PHYS, V73, P110, DOI 10.1016/S0048-3575(02)00015-9; Hoffman LE, 2003, PLANT DIS, V87, P273, DOI 10.1094/PDIS.2003.87.3.273; Jones L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1081; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Leroux P, 2007, PEST MANAG SCI, V63, P688, DOI 10.1002/ps.1390; Liu X, 2011, FUNGAL GENET BIOL, V48, P113, DOI 10.1016/j.fgb.2010.10.004; Luo CX, 2008, APPL ENVIRON MICROB, V74, P359, DOI 10.1128/AEM.02159-07; Ma ZH, 2006, APPL ENVIRON MICROB, V72, P2581, DOI 10.1128/AEM.72.4.2581-2585.2006; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Marichal P, 1997, ANTIMICROB AGENTS CH, V41, P2229, DOI 10.1128/AAC.41.10.2229; Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001; Miazzi M, 2011, J PLANT PATHOL, V93, P729; Miller TC, 2004, PLANT DIS, V88, P1205, DOI 10.1094/PDIS.2004.88.11.1205; Mullins JGL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020973; Nikou D, 2009, PESTIC BIOCHEM PHYS, V95, P18, DOI 10.1016/j.pestbp.2009.04.014; Northover J, 2001, CAN J PLANT PATHOL, V23, P337, DOI 10.1080/07060660109506954; Osherov N, 2001, J ANTIMICROB CHEMOTH, V48, P75, DOI 10.1093/jac/48.1.75; Rallos LEE, 2013, THESIS; Rallos LEE, 2014, PLANT DIS, V98, P1494, DOI 10.1094/PDIS-12-13-1202-RE; Reimann S, 2005, APPL ENVIRON MICROB, V71, P3269, DOI 10.1128/AEM.71.6.3269-3275.2005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Savocchia S, 2004, AUSTRALAS PLANT PATH, V33, P465, DOI 10.1071/AP04066; Schnabel G, 2003, PEST MANAG SCI, V59, P1143, DOI 10.1002/ps.744; Schnabel G, 2001, PHYTOPATHOLOGY, V91, P102, DOI 10.1094/PHYTO.2001.91.1.102; Stammler G, 2009, CROP PROT, V28, P891, DOI 10.1016/j.cropro.2009.05.007; Steinkellner S., 2001, Bodenkultur, V52, P213; STEVA H, 1990, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V55, P983; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wong FP, 2002, PLANT DIS, V86, P394, DOI 10.1094/PDIS.2002.86.4.394; Wyand RA, 2005, FUNGAL GENET BIOL, V42, P726, DOI 10.1016/j.fgb.2005.04.007; Ypema HL, 1997, PLANT DIS, V81, P293, DOI 10.1094/PDIS.1997.81.3.293; Ziogas BN, 2015, FUNGICIDE RESISTANCE; Zwiers LH, 2002, ANTIMICROB AGENTS CH, V46, P3900, DOI 10.1128/AAC.46.12.3900-3906.2002	69	23	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148025	10.1371/journal.pone.0148025	http://dx.doi.org/10.1371/journal.pone.0148025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839970	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200078
J	Scharf, AK; LaPoint, S; Wikelski, M; Safi, K				Scharf, Anne K.; LaPoint, Scott; Wikelski, Martin; Safi, Kamran			Acceleration Data Reveal Highly Individually Structured Energetic Landscapes in Free-Ranging Fishers (Pekania pennanti)	PLOS ONE			English	Article							HABITAT FRAGMENTATION; BODY ACCELERATION; MOVEMENT; SHAPE	Investigating animal energy expenditure across space and time may provide more detailed insight into how animals interact with their environment. This insight should improve our understanding of how changes in the environment affect animal energy budgets and is particularly relevant for animals living near or within human altered environments where habitat change can occur rapidly. We modeled fisher (Pekania pennanti) energy expenditure within their home ranges and investigated the potential environmental and spatial drivers of the predicted spatial patterns. As a proxy for energy expenditure we used overall dynamic body acceleration (ODBA) that we quantified from tri-axial accelerometer data during the active phases of 12 individuals. We used a generalized additive model (GAM) to investigate the spatial distribution of ODBA by associating the acceleration data to the animals' GPS-recorded locations. We related the spatial patterns of ODBA to the utilization distributions and habitat suitability estimates across individuals. The ODBA of fishers appears highly structured in space and was related to individual utilization distribution and habitat suitability estimates. However, we were not able to predict ODBA using the environmental data we selected. Our results suggest an unexpected complexity in the space use of animals that was only captured partially by re-location data-based concepts of home range and habitat suitability. We suggest future studies recognize the limits of ODBA that arise from the fact that acceleration is often collected at much finer spatio-temporal scales than the environmental data and that ODBA lacks a behavioral correspondence. Overcoming these limits would improve the interpretation of energy expenditure in relation to the environment.	[Scharf, Anne K.; LaPoint, Scott; Wikelski, Martin; Safi, Kamran] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Scharf, Anne K.; LaPoint, Scott; Wikelski, Martin; Safi, Kamran] Univ Konstanz, Dept Biol, Constance, Germany	Max Planck Society; University of Konstanz	Scharf, AK (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.; Scharf, AK (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	annekscharf@gmail.com	Safi, Kamran/B-2079-2008; Scharf, Anne K./P-6348-2019	Safi, Kamran/0000-0002-8418-6759; Scharf, Anne K./0000-0002-3357-8533	NSF [0756920]; New York State Museum; Max-Planck-Institute for Ornithology; International Max Planck Research School for Organismal Biology; North Carolina Museum of Natural Sciences; National Geographic Society Waitt Grant Program [W157-11]; Max-Planck-Poland Biodiversity Fund	NSF(National Science Foundation (NSF)); New York State Museum; Max-Planck-Institute for Ornithology; International Max Planck Research School for Organismal Biology; North Carolina Museum of Natural Sciences; National Geographic Society Waitt Grant Program(National Geographic Society); Max-Planck-Poland Biodiversity Fund	This work was supported in part by NSF (Grant 0756920 to Roland Kays), the New York State Museum, the Max-Planck-Institute for Ornithology, the International Max Planck Research School for Organismal Biology (AKS), the North Carolina Museum of Natural Sciences, and the National Geographic Society Waitt Grant Program (Grant W157-11 to SL). SL was supported by the Max-Planck-Poland Biodiversity Fund.	Amelineau F, 2014, J EXP BIOL, V217, P876, DOI 10.1242/jeb.097915; [Anonymous], 2014, MCLOGIT MIXED CONDIT; Barton K, 2014, MUMIN MULTIMODEL INF; Brown DD, 2012, WILDLIFE SOC B, V36, P139, DOI 10.1002/wsb.111; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Genz A., 2014, MVTNORM MULTIVARIATE; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Jin SM, 2013, REMOTE SENS ENVIRON, V132, P159, DOI 10.1016/j.rse.2013.01.012; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; LaPoint SD, 2013, LANDSCAPE ECOL, V28, P1645; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; McElroy B, 2012, ECOLOGY, V93, P29, DOI 10.1890/11-1082.1; Mosser AA, 2014, J ANIM ECOL, V83, P916, DOI 10.1111/1365-2656.12187; New York State Office of Cyber Security, 2006, NEW YORK STAT STREET; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Okuyama J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0040; Poessel SA, 2014, BIOL CONSERV, V180, P224, DOI 10.1016/j.biocon.2014.10.010; Powell R.A., 1993, FISHER LIFE HIST ECO, V2nd ed.; R Core Team, 2021, R LANGUAGE ENV STAT; Rees WG, 2004, COMPUT GEOSCI-UK, V30, P203, DOI 10.1016/j.cageo.2003.11.001; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Shepard ELC, 2013, AM NAT, V182, P298, DOI 10.1086/671257; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Smolla M, 2014, MOVE VISUALIZING ANA; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; United States Census Bureau, 2008, AM FACT FIND; United States Census Bureau, 2011, TIGER LIN SHAP TIGER; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Wang Y, 2014, THESIS UC SANTA CRUZ; Weir RD, 2003, J WILDLIFE MANAGE, V67, P73, DOI 10.2307/3803063; White G.C., 1990, ANAL WILDLIFE RADIO; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; WOODS SN, 2006, GEN ADDITIVE MODELS	44	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0145732	10.1371/journal.pone.0145732	http://dx.doi.org/10.1371/journal.pone.0145732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840399	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200003
J	Minelli, C; Dean, CH; Hind, M; Alves, AC; Amaral, AFS; Siroux, V; Huikari, V; Artigas, MS; Evans, DM; Loth, DW; Bosse, Y; Postma, DS; Sin, D; Thompson, J; Demenais, F; Henderson, J; Bouzigon, E; Jarvis, D; Jarvelin, MR; Burney, P				Minelli, Cosetta; Dean, Charlotte H.; Hind, Matthew; Alves, Alexessander Couto; Amaral, Andre F. S.; Siroux, Valerie; Huikari, Ville; Artigas, Maria Soler; Evans, David M.; Loth, Daan W.; Bosse, Yohan; Postma, Dirkje S.; Sin, Don; Thompson, John; Demenais, Florence; Henderson, John; Bouzigon, Emmanuelle; Jarvis, Deborah; Jarvelin, Marjo-Riitta; Burney, Peter		SpiroMeta Consortium; CHARGE Consortium	Association of Forced Vital Capacity with the Developmental Gene NCOR2	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-FUNCTION; HERITABILITY; REGENERATION; MECHANISMS; EXPRESSION; SERPINE2	Background Forced Vital Capacity (FVC) is an important predictor of all-cause mortality in the absence of chronic respiratory conditions. Epidemiological evidence highlights the role of early life factors on adult FVC, pointing to environmental exposures and genes affecting lung development as risk factors for low FVC later in life. Although highly heritable, a small number of genes have been found associated with FVC, and we aimed at identifying further genetic variants by focusing on lung development genes. Methods Per-allele effects of 24,728 SNPs in 403 genes involved in lung development were tested in 7,749 adults from three studies (NFBC1966, ECRHS, EGEA). The most significant SNP for the top 25 genes was followed-up in 46,103 adults (CHARGE and SpiroMeta consortia) and 5,062 children (ALSPAC). Associations were considered replicated if the replication p-value survived Bonferroni correction (p < 0.002; 0.05/25), with a nominal p-value considered as suggestive evidence. For SNPs with evidence of replication, effects on the expression levels of nearby genes in lung tissue were tested in 1,111 lung samples (Lung eQTL consortium), with further functional investigation performed using public epigenomic profiling data (ENCODE). Results NCOR2-rs12708369 showed strong replication in children (p = 0.0002), with replication unavailable in adults due to low imputation quality. This intronic variant is in a strong transcriptional enhancer element in lung fibroblasts, but its eQTL effects could not be tested due to low imputation quality in the eQTL dataset. SERPINE2-rs6754561 replicated at nominal level in both adults (p = 0.036) and children (p = 0.045), while WNT16-rs2707469 replicated at nominal level only in adults (p = 0.026). The eQTL analyses showed association of WNT16-rs2707469 with expression levels of the nearby gene CPED1. We found no statistically significant eQTL effects for SERPINE2-rs6754561. Conclusions We have identified a new gene, NCOR2, in the retinoic acid signalling pathway pointing to a role of vitamin A metabolism in the regulation of FVC. Our findings also support SERPINE2, a COPD gene with weak previous evidence of association with FVC, and suggest WNT16 as a further promising candidate.	[Minelli, Cosetta; Amaral, Andre F. S.; Jarvis, Deborah; Burney, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England; [Dean, Charlotte H.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol, London, England; [Dean, Charlotte H.] MRC Harwell, Mammalian Genet Unit, Didcot, Oxon, England; [Hind, Matthew] Royal Brompton & Harefield NHS Fdn Trust, Resp Dept, London, England; [Alves, Alexessander Couto; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Amaral, Andre F. S.; Jarvis, Deborah; Jarvelin, Marjo-Riitta; Burney, Peter] MRC PHE Ctr Environm & Hlth, London, England; [Siroux, Valerie] Univ Grenoble Alpes, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, F-38000 Grenoble, France; [Siroux, Valerie] INSERM, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, F-38000 Grenoble, France; [Siroux, Valerie] CHU Grenoble, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, F-38000 Grenoble, France; [Huikari, Ville; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Artigas, Maria Soler] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester, Leics, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Evans, David M.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Loth, Daan W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Bosse, Yohan] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Dept Mol Med, Quebec City, PQ, Canada; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Sin, Don] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada; [Thompson, John] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Demenais, Florence; Bouzigon, Emmanuelle] INSERM, Genet Variat Human Dis Unit, UMRS 946, Paris, France; [Henderson, John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [SpiroMeta Consortium] Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, SpiroMeta Consortium, Leicester, Leics, England; [CHARGE Consortium] CHARGE Consortium, Inst Hlth, Dept Hlth & Human Serv, Res Triangle Pk, NC USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Epidemiol, FI-90014 Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, FI-90220 Oulu, Finland	Imperial College London; Imperial College London; MRC Harwell; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Oulu; University of Leicester; University of Queensland; University of Bristol; Erasmus University Rotterdam; Erasmus MC; Laval University; University of Groningen; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Leicester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Bristol; University of Leicester; University of Oulu; University of Oulu	Minelli, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England.	cosetta.minelli1@imperial.ac.uk	Amaral, Andre F. S./M-4202-2019; Lederer, David/W-7957-2018; Amaral, Andre FS/A-7662-2008; siroux, valerie/N-1865-2013; Artigas, María Soler/L-6529-2013; Schulz, Holger/J-5643-2015; Viñuela, Ana/L-5015-2019; Hind, Matthew/AAC-4384-2021; Polasek, Ozren/B-6002-2011; Sin, Don/AAC-2219-2021; Evans, David M/H-6325-2013; London, Stephanie/C-3734-2019; Demenais, Florence/G-3298-2013; Bouzigon, Emmanuelle/L-2766-2017; Lee, Mikyeong/C-3046-2017; Aspelund, Thor/C-5983-2008; Heinrich, Joachim/N-1720-2013; Rantanen, Taina/O-6579-2016; Smith, Albert Vernon/K-5150-2015; Scott, Rodney/B-2827-2013; Kolcic, Ivana/E-2713-2017; Smith, Blair/G-2834-2012	Amaral, Andre F. S./0000-0002-0369-9449; Lederer, David/0000-0001-5258-0228; Amaral, Andre FS/0000-0002-0369-9449; siroux, valerie/0000-0001-7329-7237; Artigas, María Soler/0000-0002-3213-1107; Schulz, Holger/0000-0002-1157-200X; Viñuela, Ana/0000-0003-3771-8537; Polasek, Ozren/0000-0002-5765-1862; Evans, David M/0000-0003-0663-4621; London, Stephanie/0000-0003-4911-5290; Demenais, Florence/0000-0001-8361-0936; Bouzigon, Emmanuelle/0000-0001-5756-4286; GHARIB, SINA A./0000-0002-2480-4367; Rich, Stephen/0000-0003-3872-7793; Kahonen, Mika/0000-0002-4510-7341; Hui, Jennie/0000-0002-1653-2496; Bracke, Ken/0000-0001-5906-4605; Hall, Ian/0000-0001-9933-3216; Morrison, Alanna/0000-0001-6381-4296; Pottinger, Tess/0000-0003-0647-5712; Smith, Lewis J/0000-0002-4728-1562; Tobin, Martin/0000-0002-3596-7874; Lee, Mikyeong/0000-0002-3036-3684; Gieger, Christian/0000-0001-6986-9554; Aspelund, Thor/0000-0002-7998-5433; Heinrich, Joachim/0000-0002-9620-1629; Wain, Louise/0000-0003-4951-1867; Couto Alves, Alex/0000-0001-8519-7356; Burney, Peter/0000-0001-8635-5678; Rantanen, Taina/0000-0002-1604-1945; Smith, Albert Vernon/0000-0003-1942-5845; Zemunik, Tatijana/0000-0001-8120-2891; Sayers, Ian/0000-0001-5601-5410; Scott, Rodney/0000-0001-7724-3404; Kolcic, Ivana/0000-0001-7918-6052; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Loth, Daan/0000-0003-1260-9326; Hysi, Pirro/0000-0001-5752-2510; Cassano, Patricia A./0000-0003-4827-5073; Loehr, Laura/0000-0002-9054-1825; de Jong, Kim/0000-0002-3948-1046; Jarvis, Deborah/0000-0002-1753-3896; Pietilainen, Kirsi/0000-0002-8522-1288; Smith, Blair/0000-0002-5362-9430; Kumar, Rajesh/0000-0002-1962-7108; Hind, Matthew/0000-0002-9966-9446; Oldmeadow, Christopher/0000-0001-6104-1322	Academy of Finland [104781, 120315, 129269, 1114194, 24300796]; University Hospital Oulu; Biocenter, University of Oulu, Finland [75617]; NHLBI through the STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706: 02]; ENGAGE project; EU FP7 EurHEALTHAgeing [277849]; Medical Research Council, UK [G0500539, G0600705, G1002319]; MRC, Centenary Early Career Award; Dyna-HEALTH action [H2020-633595]; academy of Finland EGEA-project;  [HEALTH-F4-2007-201413]; MRC [G0600705, MR/M022501/1, G1002319, MC_UU_12013/4, G0901214, G1000861, MC_UU_12015/1] Funding Source: UKRI; Medical Research Council [MC_PC_13048, G1002319, G1000861, MC_PC_15018, G9815508, MC_U106179471, G0901214, MR/M022501/1, MC_UU_12015/1, MC_UU_12013/4, G0600705] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062633, R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); University Hospital Oulu; Biocenter, University of Oulu, Finland; NHLBI through the STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); EU FP7 EurHEALTHAgeing; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC, Centenary Early Career Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dyna-HEALTH action; academy of Finland EGEA-project(Academy of Finland); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NFBC1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, 24300796, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706: 02), ENGAGE project and grant agreement HEALTH-F4-2007-201413, EU FP7 EurHEALTHAgeing -277849, the Medical Research Council, UK (G0500539, G0600705, G1002319, PrevMetSyn/SALVE) and the MRC, Centenary Early Career Award. The program is currently being funded by the H2020-633595 Dyna-HEALTH action and academy of Finland EGEA-project.	Bartley M, 2012, AM J EPIDEMIOL, V175, P33, DOI 10.1093/aje/kwr284; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Collins SA, 2013, EUR RESPIR J, V41, P756, DOI 10.1183/09031936.00171712; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Hallberg J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-92; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Hegewald MJ, 2007, CHEST, V132, P1608, DOI 10.1378/chest.07-1405; Himes BE, 2011, CHEST, V140, P667, DOI 10.1378/chest.10-2973; Hind M, 2009, THORAX, V64, P451, DOI 10.1136/thx.2008.105437; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kauffmann F, 1999, CLIN EXP ALLERGY, V29, P17; Kerkhof M, 2014, J ALLERGY CLIN IMMUN, V133, P68, DOI 10.1016/j.jaci.2013.06.004; Kho AT, 2009, AM J RESP CELL MOL, V40, P47, DOI 10.1165/rcmb.2008-0048OC; Klimentidis Yann C., 2013, Frontiers in Genetics, V4, P174, DOI 10.3389/fgene.2013.00174; Krauss-Etschmann S, 2013, THORAX, V68, P380, DOI 10.1136/thoraxjnl-2012-201902; Kreiner-Moller E, 2014, J ALLERGY CLIN IMMUN, V134, P1036, DOI 10.1016/j.jaci.2014.04.003; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Loth DW, 2014, NAT GENET, V46, P669, DOI 10.1038/ng.3011; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Massaro D, 2010, NEW ENGL J MED, V362, P1829, DOI 10.1056/NEJMe1002366; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Palmer LJ, 2001, EUR RESPIR J, V17, P696, DOI 10.1183/09031936.01.17406960; Rai MF, 2013, G3-GENES GENOM GENET, V3, P1881, DOI 10.1534/g3.113.007302; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Shi W, 2007, CHEST, V132, P651, DOI 10.1378/chest.06-2663; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Thomas DC, 2009, STAT SCI, V24, P414, DOI 10.1214/09-STS288; Twisk JWR, 1998, EUR RESPIR J, V12, P627, DOI 10.1183/09031936.98.12030627; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yates LL, 2011, ORGANOGENESIS, V7, P209, DOI 10.4161/org.7.3.18462; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0147388	10.1371/journal.pone.0147388	http://dx.doi.org/10.1371/journal.pone.0147388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836265	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548500002
J	Ahmed, S; Hoque, ME; Sarker, AR; Sultana, M; Islam, Z; Gazi, R; Khan, JAM				Ahmed, Sayem; Hoque, Mohammad Enamul; Sarker, Abdur Razzaque; Sultana, Marufa; Islam, Ziaul; Gazi, Rukhsana; Khan, Jahangir A. M.			Willingness-to-Pay for Community-Based Health Insurance among Informal Workers in Urban Bangladesh	PLOS ONE			English	Article							CONTINGENT VALUATION; SECTOR WORKERS; COUNTRIES; PAYMENTS; INDIA; CARE; PARTICIPATION; DEMAND; STATE; POOR	Introduction Reliance on out-of-pocket payment for healthcare may lead poor households to undertake catastrophic health expenditure, and risk-pooling mechanisms have been recommended to mitigate such burdens for households in Bangladesh. About 88% of the population of Bangladesh depends on work in the informal sector. We aimed to estimate willingness-to-pay (WTP) for CBHI and identify its determinants among three categories of urban informal workers rickshaw-pullers, shopkeepers and restaurant workers. Methods The bidding game version of contingent valuation method was used to estimate weekly WTP. In three urban locations 557 workers were interviewed using a structured questionnaire during 2010 and 2011. Multiple-regression analysis was used to predict WTP by demographic and household characteristics, occupation, education level and past illness. Results WTP for a CBHI scheme was expressed by 86.7% of informal workers. Weekly average WTP was 22.8 BDT [Bangladeshi Taka; 95% confidence interval (CI) 20.9-24.8] or 0.32 USD and varied significantly across occupational groups (p = 0.000) and locations (p = 0.003). WTP was highest among rickshaw-pullers (28.2 BDT or 0.40 USD; 95% CI: 24.7-31.7), followed by restaurant workers (20.4 BDT 0.29 USD; 95% CI: 17.0-23.8) and shopkeepers (19.2 BDT or 0.27 USD; 95% CI: 16.1-22.4). Multiple regression analysis identified monthly income, occupation, geographical location and educational level as the key determinants of WTP. WTP increased 0.196% with each 1% increase in monthly income, and was 26.9% lower among workers with up to a primary level of education versus those with higher than primary, but less than one year of education. Conclusion Informal workers in urban areas thus are willing to pay for CBHI and socioeconomic differences explain the magnitude of WTP. The policy maker might think introducing community-based model including public-community partnership model for healthcare financing of informal workers. Decision making regarding the implementation of such schemes should consider worker location and occupation.	[Ahmed, Sayem; Sarker, Abdur Razzaque; Sultana, Marufa; Islam, Ziaul; Gazi, Rukhsana; Khan, Jahangir A. M.] Int Ctr Diarrhoeal Dis Res, Hlth Econ & Financing Res Grp, Ctr Equ & Hlth Syst, GPO Box 128, Dhaka 1000, Bangladesh; [Ahmed, Sayem; Khan, Jahangir A. M.] Karolinska Inst, Hlth Econ & Policy Res Grp, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Hoque, Mohammad Enamul] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Khan, Jahangir A. M.] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Khan, Jahangir A. M.] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh; [Khan, Jahangir A. M.] Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England	International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet; University of Queensland; Bangladesh Rural Advancement Committee BRAC; BRAC University; International Centre for Diarrhoeal Disease Research (ICDDR); Liverpool School of Tropical Medicine; University of Liverpool	Ahmed, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Hlth Econ & Financing Res Grp, Ctr Equ & Hlth Syst, GPO Box 128, Dhaka 1000, Bangladesh.; Ahmed, S (corresponding author), Karolinska Inst, Hlth Econ & Policy Res Grp, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden.	sayemahmed@icddrb.org	Khan, Jahangir/AAG-4014-2019; Ahmed, Sayem/AAI-6500-2021; Ahmed, Sayem/G-1439-2015	Ahmed, Sayem/0000-0001-9499-1500; Ahmed, Sayem/0000-0001-9499-1500; KHAN, JAHANGIR/0000-0002-6151-764X	International Labor Organization and Microinsurance Innovation Facility	International Labor Organization and Microinsurance Innovation Facility	This work was supported by the International Labor Organization and Microinsurance Innovation Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2013, POLICY RES WORK PAP; Adams R, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0806-3; Akazili J., 2010, EQUITY HLTH CARE FIN; Lara JLA, 2011, INT J HEALTH CARE FI, V11, P83, DOI 10.1007/s10754-011-9089-3; [Anonymous], EXPLAINING INC UNPUB; Asenso-Okyere WK, 1997, HEALTH POLICY, V42, P223, DOI 10.1016/S0168-8510(97)00069-9; Asgary Ali, 2004, Eur J Health Econ, V5, P209, DOI 10.1007/s10198-004-0233-6; Barnighausen T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-114; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Basaza R, 2008, HEALTH POLICY, V87, P172, DOI 10.1016/j.healthpol.2007.12.008; Bawa SK, 2011, INT J HUMANIT SOC SC, V1, P100; Binnendijk E, 2013, SOC SCI MED, V76, P67, DOI 10.1016/j.socscimed.2012.10.006; Cavaniol C., 2020, UNIVERSAL HLTH COVER; Churchill C., 2006, PROTECTING POOR MICR; Cohen M, 2006, PROTECTING POOR MICR; Cole S, 2013, AM ECON J-APPL ECON, V5, P104, DOI 10.1257/app.5.1.104; Danis M., 2007, Economic and Political Weekly, V42, P3331; Das J, 2011, EC POLIT WKLY, Vxlvi; Donfouet HPP, 2011, INT J HEALTH CARE FI, V11, P209, DOI 10.1007/s10754-011-9097-3; Dong HJ, 2003, HEALTH ECON, V12, P849, DOI 10.1002/hec.771; Dror DM, 2012, INDIAN J MED RES, V135, P56, DOI 10.4103/0971-5916.93425; Dror DM, 2007, HEALTH POLICY, V82, P12, DOI 10.1016/j.healthpol.2006.07.011; Dror DM, 2007, SOC SCI MED, V64, P884, DOI 10.1016/j.socscimed.2006.10.032; Dror DM., 2002, SOCIAL REINSURANCE N; Drummond MF, 2008, METHODS EC EVALUATIO; Dupas P, 2014, AM ECON REV, V104, P291; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; Engel E., 1895, INT STATISTICAL I B, V9, P1; Folland S, 2007, EC HLTH HLTH CARE; Gujarati D., 2008, MCGRAW HILL ED; Gustafsson-Wright E, 2009, SOC SCI MED, V69, P1351, DOI 10.1016/j.socscimed.2009.08.011; HADI AS, 1994, J ROY STAT SOC B MET, V56, P393; Haile M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-591; Hussmanns R, 1998, DEV DESIGN IMPLEMENT; Jain A, 2014, J EPIDEMIOL GLOB HEA, V4, P159, DOI 10.1016/j.jegh.2013.12.004; JPGSPH, 2015, BANGL HLTH WATCH 201; Jutting J, 2004, WORLD DEV; Kartman B, 1996, MED DECIS MAKING, V16, P248, DOI 10.1177/0272989X9601600309; Khan JAM, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-12; Kobelt G, 2002, HLTH EC INTRO EC EVA; Leftley R, 2006, EFFECTIVE MICROINSUR; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Maligalig DS, 2009, SSRN ELECT J MAN APR, DOI [10.2139/ssrn.1611402, DOI 10.2139/SSRN.1611402]; Mathauer I, 2008, INT J HEALTH PLAN M, V23, P51, DOI 10.1002/hpm.914; Mathiyazhagan K, 1998, INT J HEALTH PLAN M, V13, P47, DOI 10.1002/(SICI)1099-1751(199801/03)13:1&lt;47::AID-HPM495&gt;3.0.CO;2-I; McCord MJ, 2008, VISIONS FUTURE MICRO; MoHFW, 2015, BANGL NAT HLTH ACC 1; Muhit AMA, 2013, 4 YEARS PROGR BANGLA; Musango L, 2009, MUTUALISATION RISQUE; Nguyen H, 2010, SOC SCI MED, V71, P2074, DOI 10.1016/j.socscimed.2010.09.033; Nosratnejad Shirin, 2014, Glob J Health Sci, V6, P154, DOI 10.5539/gjhs.v6n5p154; O'Brien BJ, 1998, MED CARE, V36, P370, DOI 10.1097/00005650-199803000-00013; OBRIEN B, 1994, MED DECIS MAKING, V14, P289, DOI 10.1177/0272989X9401400311; OECD, 1982, OECD LIST SOC IND; Onwujekwe O, 2010, HEALTH POLICY PLANN, V25, P155, DOI 10.1093/heapol/czp046; Panda P, 2015, TROP MED INT HEALTH, V20, P1093, DOI 10.1111/tmi.12524; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; PERTHEL D, 1975, INT STAT REV, V43, P211, DOI 10.2307/1402900; Radermacher R, 2009, WHAT DO WE KNOW ABOU; Rahman MM, 2013, B WORLD HEALTH ORGAN, V91, P449, DOI 10.2471/BLT.12.115428; Roth J, 2007, LANDSCAPE MICROINSUR; Shafie AA, 2013, SOC SCI MED, V96, P272, DOI 10.1016/j.socscimed.2013.02.045; Twahirwa A, 2008, B WORLD HEALTH ORGAN, V86, P823, DOI 10.2471/BLT.08.021108; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, WOR HEALT REP, P1; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Ying XH, 2007, HEALTH ECON, V16, P1041, DOI 10.1002/hec.1206	69	47	47	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148211	10.1371/journal.pone.0148211	http://dx.doi.org/10.1371/journal.pone.0148211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828935	Green Accepted, Green Published, gold			2022-12-27	WOS:000369548200084
J	Kinoshita-Kikuta, E; Kinoshita, E; Eguchi, Y; Koike, T				Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Eguchi, Yoko; Koike, Tohru			Validation of Cis and Trans Modes in Multistep Phosphotransfer Signaling of Bacterial Tripartite Sensor Kinases by Using Phos-Tag SDS-PAGE	PLOS ONE			English	Article							PHOSPHORELAY; PHOSPHORYLATION; ELECTROPHORESIS; PROTEIN	Tripartite sensor kinases (TSKs) have three phosphorylation sites on His, Asp, and His residues, which are conserved in a histidine kinase (HK) domain, a receiver domain, and a histidine-containing phosphotransmitter (HPt) domain, respectively. By means of a three-step phosphorelay, TSKs convey a phosphoryl group from the.-phosphate group of ATP to the first His residue in the HK domain, then to the Asp residue in the receiver domain, and finally to the second His residue in the HPt domain. Although TSKs generally form homodimers, it was unknown whether the mode of phosphorylation in each step was intramolecular (cis) or intermolecular (trans). To examine this mode, we performed in vitro complementation analyses using Ala-substituted mutants of the ATP-binding region and three phosphorylation sites of recombinant ArcB, EvgS, and BarA TSKs derived from Escherichia coli. Phosphorylation profiles of these kinases, determined by using Phos-tag SDS-PAGE, showed that the sequential modes of the three-step phosphoryl-transfer reactions of ArcB, EvgS, and BarA are all different: cis-trans-trans, cis-cis-cis, and trans-trans-trans, respectively. The inclusion of a trans mode is consistent with the need to form a homodimer; the fact that all the steps for EvgS have cis modes is particularly interesting. Phos-tag SDS-PAGE therefore provides a simple method for identifying the unique and specific phosphotransfer mode for a given kinase, without taking complicated intracellular elements into consideration.	[Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Koike, Tohru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan; [Eguchi, Yoko] Kinki Univ, Fac Biol Oriented Sci & Technol, Dept Sci & Technol Food Safety, Kinokawa, Japan	Hiroshima University; Kindai University (Kinki University)	Kinoshita, E (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan.	kinoeiji@hiroshima-u.ac.jp	Kinoshita, Eiji/H-2284-2019	Emiko, Kinoshita/0000-0001-7355-1784	KAKENHI [25293005, 25560417, 15K07887, 26460036]; Takeda Science Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by KAKENHI Grant no. 25293005 to EK, no. 25560417 to EK, no. 15K07887 to EK-K, and no. 26460036 to TK, and by research grants from the Takeda Science Foundation to EK and EK-K.	Ashenberg O, 2013, J MOL BIOL, V425, P1198, DOI 10.1016/j.jmb.2013.01.011; Bantscheff M, 2000, INT J MED MICROBIOL, V290, P317; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Jovanovic G, 2015, MOL BIOSYST, V11, P1348, DOI 10.1039/c4mb00720d; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita E, 2014, PROTEOMICS, V14, P668, DOI 10.1002/pmic.201300533; Kinoshita E, 2009, ELECTROPHORESIS, V30, P550, DOI 10.1002/elps.200800386; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kinoshita-Kikuta E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132598; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Mizuno T, 1998, J BIOCHEM, V123, P555; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Sommer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077708; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; UTSUMI R, 1994, GENE, V140, P73, DOI 10.1016/0378-1119(94)90733-1; Wagner PD, 1997, P NATL ACAD SCI USA, V94, P9000, DOI 10.1073/pnas.94.17.9000; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057	25	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148294	10.1371/journal.pone.0148294	http://dx.doi.org/10.1371/journal.pone.0148294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828204	Green Published, gold			2022-12-27	WOS:000369548200094
J	Kotkowiak, W; Pasternak, A; Kierzek, R				Kotkowiak, Weronika; Pasternak, Anna; Kierzek, Ryszard			Studies on Transcriptional Incorporation of 5 '-N-Triphosphates of 5 '-Amino-5 '-Deoxyribonucleosides	PLOS ONE			English	Article							T7 RNA-POLYMERASE; PHOSPHORAMIDATE BONDS; NUCLEOTIDE CHEMISTRY; ENZYMATIC-SYNTHESIS; SINGLE MISMATCHES; DNA-POLYMERASE; PHIX174 DNA; TEMPLATE; CLEAVAGE; PURIFICATION	In this study, several RNA polymerases were used for the first time to examine the possibility of transcriptional incorporation of 5'-N-triphosphates of 5'-amino-5'-deoxyribonucleosides (5'NH NTPs). The T3, T7, Sp6 and T7 Y639F RNA polymerases were employed to show that the full-length transcript cannot be synthesized. The results suggest that the application of 5'NH NTPs could decrease transcription reaction rates. What is more, the modification of transcription conditions had no influence on the rate of 5'NH NTPs incorporation. Based on experimental data it is postulated that 5'NH NTPs can be used as potential transcription inhibitors. Our findings expand the knowledge on suitable uses of the 5'-N-triphosphates of 5'-amino-5'-deoxyribonucleoside and the exact mechanism of transcriptional inhibition.	[Kotkowiak, Weronika; Pasternak, Anna; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Kierzek, R (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	rkierzek@ibch.poznan.pl	Pasternak, Anna/H-9411-2013	Kierzek, Ryszard/0000-0002-7644-0016; Pasternak, Anna/0000-0002-9666-4148; Kotkowiak, Weronika/0000-0002-9776-0924	National Science Center grant [UMO-2011/03/B/NZ1/00576]; Polish Ministry of Science and Higher Education grant [Mlod-WK 500-8051]; Polish Ministry of Science and Higher Education under KNOW program	National Science Center grant; Polish Ministry of Science and Higher Education grant(Ministry of Science and Higher Education, Poland); Polish Ministry of Science and Higher Education under KNOW program	This work has been financed by the National Science Center grant (UMO-2011/03/B/NZ1/00576 to R.K.) and by the Polish Ministry of Science and Higher Education grant (Mlod-WK 500-8051 to W.K.). This publication was also supported by the Polish Ministry of Science and Higher Education, under the KNOW program.	AURUP H, 1992, BIOCHEMISTRY-US, V31, P9636, DOI 10.1021/bi00155a016; BANNWARTH W, 1988, HELV CHIM ACTA, V71, P1517, DOI 10.1002/hlca.19880710618; Baranowski DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137674; Beckmann BM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq437; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; CHEN MS, 1976, J BIOL CHEM, V251, P4833; CHEN MS, 1976, J BIOL CHEM, V251, P4839; Davis AR, 2008, BIOCHEMISTRY-US, V47, P10178, DOI 10.1021/bi800471z; Gopalakrishna S, 2004, RNA, V10, P1820, DOI 10.1261/rna.5222504; Huang Y, 1997, BIOCHEMISTRY-US, V36, P13718, DOI 10.1021/bi971609o; Imashimizu M, 2013, NUCLEIC ACIDS RES, V41, P9090, DOI 10.1093/nar/gkt698; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4461, DOI 10.1093/nar/gkg632; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kotkowiak W, 2014, BIOCHEM J, V464, P203, DOI 10.1042/BJ20141023; LETSINGER RL, 1976, BIOCHEMISTRY-US, V15, P2810, DOI 10.1021/bi00658a017; LETSINGER RL, 1976, NUCLEIC ACIDS RES, V3, P1053, DOI 10.1093/nar/3.4.1053; LETSINGER RL, 1972, J AM CHEM SOC, V94, P292, DOI 10.1021/ja00756a060; Lin LN, 2011, RNA, V17, P1932, DOI 10.1261/rna.2719311; MAG M, 1989, NUCLEIC ACIDS RES, V17, P5973, DOI 10.1093/nar/17.15.5973; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MCBRIDE LJ, 1983, TETRAHEDRON LETT, V24, P245, DOI 10.1016/S0040-4039(00)81376-3; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; Olejnik J, 1996, NUCLEIC ACIDS RES, V24, P361, DOI 10.1093/nar/24.2.361; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Padilla R, 1999, NUCLEIC ACIDS RES, V27, P1561, DOI 10.1093/nar/27.6.1561; Pal S, 2013, J BIOMOL STRUCT DYN, V31, P288, DOI 10.1080/07391102.2012.698237; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Shchepinov MS, 2001, NUCLEIC ACIDS RES, V29, P3864, DOI 10.1093/nar/29.18.3864; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Suga H, 1998, BIOCHEMISTRY-US, V37, P10118, DOI 10.1021/bi980432a; Ueno Y, 2008, TETRAHEDRON, V64, P11328, DOI 10.1016/j.tet.2008.08.117; Williamson D, 2008, ORG BIOMOL CHEM, V6, P1056, DOI 10.1039/b717896d; Wolfe JL, 2003, J AM CHEM SOC, V125, P10500, DOI 10.1021/ja035646g; Wolfe JL, 2002, NUCLEIC ACIDS RES, V30, P3739, DOI 10.1093/nar/gkf502; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zhu B, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv367	38	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148282	10.1371/journal.pone.0148282	http://dx.doi.org/10.1371/journal.pone.0148282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829482	Green Published, gold			2022-12-27	WOS:000369548200091
J	Kuismin, M; Sillanpaa, MJ				Kuismin, Markku; Sillanpaa, Mikko J.			Use of Wishart Prior and Simple Extensions for Sparse Precision Matrix Estimation	PLOS ONE			English	Article							COVARIANCE ESTIMATION; PRIOR DISTRIBUTIONS; SELECTION	A conjugate Wishart prior is used to present a simple and rapid procedure for computing the analytic posterior (mode and uncertainty) of the precision matrix elements of a Gaussian distribution. An interpretation of covariance estimates in terms of eigenvalues is presented, along with a simple decision-rule step to improve the performance of the estimation of sparse precision matrices and associated graphs. In this, elements of the estimated precision matrix that are zero or near zero can be detected and shrunk to zero. Simulated data sets are used to compare posterior estimation with decision-rule with two other Wishart-based approaches and with graphical lasso. Furthermore, an empirical Bayes procedure is used to select prior hyperparameters in high dimensional cases with extension to sparsity.	[Kuismin, Markku; Sillanpaa, Mikko J.] Univ Oulu, Dept Math Sci, Oulu, Finland; [Sillanpaa, Mikko J.] Bioctr, Oulu, Finland	University of Oulu	Sillanpaa, MJ (corresponding author), Univ Oulu, Dept Math Sci, Oulu, Finland.; Sillanpaa, MJ (corresponding author), Bioctr, Oulu, Finland.	mikko.sillanpaa@oulu.fi		Sillanpaa, Mikko J./0000-0003-2808-2768; Kuismin, Markku/0000-0001-9074-7420	Biocenter Oulu	Biocenter Oulu	This work was supported by Biocenter Oulu (http://www.oulu.fi/biocenter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien J, 2011, BIOMETRIKA, V98, P807, DOI 10.1093/biomet/asr054; Bouriga M, 2013, J STAT PLAN INFER, V143, P795, DOI 10.1016/j.jspi.2012.09.006; Buhlmann P, 2014, ANNU REV STAT APPL, V1, P255, DOI 10.1146/annurev-statistics-022513-115545; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Edwards D., 2000, INTRO GRAPHICAL MODE; FOYGEL R., 2010, P ADV NEURAL INFORM, P604; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Hsu CW, 2012, ANN I STAT MATH, V64, P319, DOI 10.1007/s10463-010-0314-5; Huang A, 2013, BAYESIAN ANAL, V8, P439, DOI 10.1214/13-BA815; Khondker ZS, 2013, STAT INTERFACE, V6, P243; Kubokawa T, 2008, J MULTIVARIATE ANAL, V99, P1906, DOI 10.1016/j.jmva.2008.01.016; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; LEONARD T, 1992, ANN STAT, V20, P1669, DOI 10.1214/aos/1176348885; Lessmann K, 2002, THESIS U OSNABRUCK; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Liu Han, 2010, Adv Neural Inf Process Syst, V24, P1432; Mazumder R., 2012, J MACHINE LEARNING R, V13, P723; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Pourahmadi M., 2013, HIGH DIMENSIONAL COV, VVolume 882; Rowe D. B., 2003, MULTIVARIATE BAYESIA; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang H, 2012, BAYESIAN ANAL, V7, P867, DOI 10.1214/12-BA729; Witten DM, 2011, J COMPUT GRAPH STAT, V20, P892, DOI 10.1198/jcgs.2011.11051a; Won J. H., 2009, TECHNICAL REPORT; YANG RY, 1994, ANN STAT, V22, P1195, DOI 10.1214/aos/1176325625; Yuan T, 2013, STAT ANAL DATA MIN, V6, P431, DOI 10.1002/sam.11185	29	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148171	10.1371/journal.pone.0148171	http://dx.doi.org/10.1371/journal.pone.0148171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828427	Green Published, gold			2022-12-27	WOS:000369548200077
J	Phiri, SN; Fylkesnes, K; Moland, KM; Byskov, J; Kiserud, T				Phiri, Selia Ng'anjo; Fylkesnes, Knut; Moland, Karen Marie; Byskov, Jens; Kiserud, Torvid			Rural-Urban Inequity in Unmet Obstetric Needs and Functionality of Emergency Obstetric Care Services in a Zambian District	PLOS ONE			English	Article							KAPIRI-MPOSHI DISTRICT; MATERNAL MORTALITY; LEVEL; CHILDBIRTH; PREGNANCY; REGION; RATES; DEATH	Background Zambia has a high maternal mortality ratio, 398/100,000 live births. Few pregnant women access emergency obstetric care services to handle complications at childbirth. We aimed to assess the deficit in life-saving obstetric services in the rural and urban areas of Kapiri Mposhi district. Method A cross-sectional survey was conducted in 2011 as part of the 'Response to Accountable priority setting for Trust in health systems' (REACT) project. Data on all childbirths that occurred in emergency obstetric care facilities in 2010 were obtained retrospectively. Sources of information included registers from maternity ward admission, delivery and operation theatre, and case records. Data included age, parity, mode of delivery, obstetric complications, and outcome of mother and the newborn. An approach using estimated major obstetric interventions expected but not done in health facilities was used to assess deficit of life-saving interventions in urban and rural areas. Results A total of 2114 urban and 1226 rural childbirths occurring in emergency obstetric care facilities (excluding abortions) were analysed. Facility childbirth constituted 81% of expected births in urban and 16% in rural areas. Based on the reference estimate that 1.4% of childbearing women were expected to need major obstetric intervention, unmet obstetric need was 77 of 106 women, thus 73% (95% CI 71-75%) in rural areas whereas urban areas had no deficit. Major obstetric interventions for absolute maternal indications were higher in urban 2.1% (95% CI 1.60-2.71%) than in rural areas 0.4% (95% CI 0.27-0.55%), with an urban to rural rate ratio of 5.5 (95% CI 3.55-8.76). Conclusions Women in rural areas had deficient obstetric care. The likelihood of under-going a life-saving intervention was 5.5 times higher for women in urban than rural areas. Targeting rural women with life-saving services could substantially reduce this inequity and preventable deaths.	[Phiri, Selia Ng'anjo; Fylkesnes, Knut; Moland, Karen Marie] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Phiri, Selia Ng'anjo; Fylkesnes, Knut] Univ Zambia, Sch Med, Dept Publ Hlth, Lusaka, Zambia; [Byskov, Jens] Univ Copenhagen, Fac Hlth & Med Sci, Res Unit Human Parasitol & Environm, Dyrlaegevej 100, DK-1870 Copenhagen C, Denmark; [Kiserud, Torvid] Haukeland Hosp, Dept Obstet & Gynaecol, N-5021 Bergen, Norway; [Kiserud, Torvid] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; University of Zambia; University of Copenhagen; University of Bergen; Haukeland University Hospital; University of Bergen	Phiri, SN (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway.; Phiri, SN (corresponding author), Univ Zambia, Sch Med, Dept Publ Hlth, Lusaka, Zambia.	Selia.Nganjo@student.uib.no		Kiserud, Torvid/0000-0003-1825-1660	European Union Sixth Framework Programme [PL517709, INCO-2003-A.1.2]; Norwegian government through its Quota Scheme; Centre for International Health, University of Bergen, Norway	European Union Sixth Framework Programme(European Commission); Norwegian government through its Quota Scheme; Centre for International Health, University of Bergen, Norway	This study was made possible through funding and support from the European Union Sixth Framework Programme (INCO-2003-A.1.2, contract PL517709) for the Specific Targeted Research and Innovation Project REACT - Response to ACcountable priority setting for Trust in health systems. Funding was also received from the Norwegian government through its Quota Scheme and the Centre for International Health, University of Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Belghiti A, 1998, TROP MED INT HEALTH, V3, P584; Byskov Jens, 2009, Health Res Policy Syst, V7, P23, DOI 10.1186/1478-4505-7-23; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Central Statistical Office (CSO) MoHM and ICF International, 2014, ZAMB DEM HLTH SURV 2; Dubourg D, UNMET OBSTET NEEDS N; Echoka E, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0112-4; Echoka E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-113; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gebremedhin S, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-14; GRZ MoH, 2013, 2012 LIST HLTH FAC Z; Guindo G, 2004, HEALTH POLICY PLANN, V19, pI87, DOI 10.1093/heapol/czh049; Hunger C, 2007, TROP MED INT HEALTH, V12, P1239, DOI 10.1111/j.1365-3156.2007.01909.x; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Mayor S, 2004, BRIT MED J, V328, P1152, DOI 10.1136/bmj.328.7449.1152-a; Mirkuzie AH, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-354; Ng SK, 2014, BMC PREGNANCY CHILDB, V14, DOI [10.1186/1471-2393-14-314, 10.1186/1471-2393-14-323]; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Phiri SN, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-219; Prytherch Helen, 2007, BMC Pregnancy Childbirth, V7, P16, DOI 10.1186/1471-2393-7-16; Republic of Zambia Central Statistical Office, 2012, 2010 CENS POP HOUS P; Ronsmans C, 2002, B WORLD HEALTH ORGAN, V80, P317; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Saleem S, 2014, B WORLD HEALTH ORGAN, V92, P605, DOI 10.2471/BLT.13.127464; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Treffers PE, 2001, INT J GYNECOL OBSTET, V75, P111, DOI 10.1016/S0020-7292(01)00368-X; UNICEF WHO UN Population Fund, 1997, GUID MON AV US OBST; United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 2009, HDB MON EM OBST CAR; World Health Organization, 2005, WORLD HLTH REP 2005; Zulu JM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-75	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0145196	10.1371/journal.pone.0145196	http://dx.doi.org/10.1371/journal.pone.0145196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824599	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600005
J	Zundler, S; Caioni, M; Muller, M; Strauch, U; Kunst, C; Woelfel, G				Zundler, Sebastian; Caioni, Massimiliano; Mueller, Martina; Strauch, Ulrike; Kunst, Claudia; Woelfel, Gisela			K+ Channel Inhibition Differentially Regulates Migration of Intestinal Epithelial Cells in Inflamed vs. Non-Inflamed Conditions in a PI3K/Akt-Mediated Manner	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACTIVATED POTASSIUM CHANNEL; INTERFERON-GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE; BARRIER DYSFUNCTION; CHLORIDE SECRETION; POTENTIAL ROLE; ION-TRANSPORT; MOUSE MODEL; EXPRESSION	Background Potassium channels have been shown to determine wound healing in different tissues, but their role in intestinal epithelial restitution-the rapid closure of superficial wounds by intestinal epithelial cells (IEC)-remains unclear. Methods In this study, the regulation of IEC migration by potassium channel modulation was explored with and without additional epidermal growth factor (EGF) under baseline and interferon-gamma (IFN-gamma)-pretreated conditions in scratch assays and Boyden chamber assays using the intestinal epithelial cell lines IEC-18 and HT-29. To identify possibly involved subcellular pathways, Western Blot (WB)-analysis of ERK and Akt phosphorylation was conducted and PI3K and ERK inhibitors were used in scratch assays. Furthermore, mRNA-levels of the potassium channel KCNN4 were determined in IEC from patients suffering from inflammatory bowel diseases (IBD). Results Inhibition of Ca2+-dependent potassium channels significantly increased intestinal epithelial restitution, which could not be further promoted by additional EGF. In contrast, inhibition of KCNN4 after pretreatment with IFN-gamma led to decreased or unaffected migration. This effect was abolished by EGF. Changes in Akt, but not in ERK phosphorylation strongly correlated with these findings and PI3K but not ERK inhibition abrogated the effect of KCNN4 inhibition. Levels of KCNN4 mRNA were higher in samples from IBD patients compared with controls. Conclusions Taken together, we demonstrate that inhibition of KCNN4 differentially regulates IEC migration in IFN-gamma-pretreated vs. non pretreated conditions. Moreover, our data propose that the PI3K signaling cascade is responsible for this differential regulation. Therefore, we present a cellular model that contributes new aspects to epithelial barrier dysfunction in chronic intestinal inflammation, resulting in propagation of inflammation and symptoms like ulcers or diarrhea.	[Zundler, Sebastian; Caioni, Massimiliano; Mueller, Martina; Strauch, Ulrike; Kunst, Claudia; Woelfel, Gisela] Univ Regensburg, Med Ctr, Dept Internal Med 1, D-93053 Regensburg, Germany; [Zundler, Sebastian] Univ Erlangen Nurnberg, Kussmaul Campus Med Res & Translat Res Ctr, Dept Med 1, D-91054 Erlangen, Germany	University of Regensburg; University of Erlangen Nuremberg	Woelfel, G (corresponding author), Univ Regensburg, Med Ctr, Dept Internal Med 1, D-93053 Regensburg, Germany.	gisela.woelfel@ukr.de			ReForM A (Regensburger Forschungsforderung in der Medizin Baustein A) grant of the University of Regensburg; German Research Foundation (DFG) within the funding programme Open Access Publishing	ReForM A (Regensburger Forschungsforderung in der Medizin Baustein A) grant of the University of Regensburg; German Research Foundation (DFG) within the funding programme Open Access Publishing(German Research Foundation (DFG))	This study was supported by a ReForM A (Regensburger Forschungsforderung in der Medizin Baustein A) grant of the University of Regensburg to GW and by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Thomas Karrasch and Dr. Rocio Lopez-Posadas for generously providing IEC-18 and HT-29 cells, respectively. This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing.	Agarwal JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063028; Al-Hazza A, 2012, J PATHOL, V226, P463, DOI 10.1002/path.2994; Arcangeli A, 2006, TRENDS CELL BIOL, V16, P631, DOI 10.1016/j.tcb.2006.10.003; Artym VV, 2002, J GEN PHYSIOL, V120, P29, DOI 10.1085/jgp.20028607; Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Basalingappa KM, 2011, AM J PHYSIOL-GASTR L, V301, pG905, DOI 10.1152/ajpgi.00558.2010; Basavappa S, 2005, J CELL PHYSIOL, V202, P21, DOI 10.1002/jcp.20085; Baumgart DC, 2002, CURR OPIN CLIN NUTR, V5, P685, DOI 10.1097/00075197-200211000-00012; Bertelsen LS, 2004, J BIOL CHEM, V279, P6271, DOI 10.1074/jbc.M311612200; Bertelsen LS, 2004, AM J PHYSIOL-GASTR L, V286, pG157, DOI 10.1152/ajpgi.00227.2003; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Cao L, 2011, INVEST OPHTH VIS SCI, V52, P2272, DOI 10.1167/iovs.10-5972; Chen Hong-Chen, 2004, V294, P15; Chiu T, 2005, AM J PHYSIOL-GASTR L, V288, pG182, DOI 10.1152/ajpgi.00200.2004; CIACCI C, 1993, GASTROENTEROLOGY, V105, P93, DOI 10.1016/0016-5085(93)90014-4; Dieckgraefe BK, 1997, BIOCHEM BIOPH RES CO, V233, P389, DOI 10.1006/bbrc.1997.6469; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254, DOI 10.1016/0016-5085(94)90017-5; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Dong H, 2006, AM J PHYSIOL-GASTR L, V291, pG1120, DOI 10.1152/ajpgi.00566.2005; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Felderbauer P, 2007, INT J COLORECTAL DIS, V22, P1475, DOI 10.1007/s00384-007-0321-z; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Girault A, 2014, AM J PHYSIOL-CELL PH, V306, pC307, DOI 10.1152/ajpcell.00226.2013; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Karrasch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026340; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotz MM, 2004, WOUND REPAIR REGEN, V12, P565, DOI 10.1111/j.1067-1927.2004.012509.x; MacVinish LJ, 2001, PFLUG ARCH EUR J PHY, V443, pS127; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Ohya S, 2014, AM J PHYSIOL-GASTR L, V306, pG873, DOI 10.1152/ajpgi.00156.2013; Paul G, 2012, J BIOL CHEM, V287, P2144, DOI 10.1074/jbc.M111.318139; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Riegler M, 1996, GASTROENTEROLOGY, V111, P28, DOI 10.1053/gast.1996.v111.pm8698221; Roderick C, 2003, J MEMBRANE BIOL, V196, P41, DOI 10.1007/s00232-003-0623-1; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515; SASAKI T, 1992, GASTROENTEROL JPN, V27, P29; Schneider SW, 2000, PFLUG ARCH EUR J PHY, V439, P297, DOI 10.1007/s004240050943; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Sciaccaluga M, 2010, AM J PHYSIOL-CELL PH, V299, pC175, DOI 10.1152/ajpcell.00344.2009; Shao ZF, 2011, AM J RESP CELL MOL, V45, P962, DOI 10.1165/rcmb.2010-0514OC; Simms LA, 2010, AM J GASTROENTEROL, V105, P2209, DOI 10.1038/ajg.2010.161; Sones WR, 2009, BRIT J PHARMACOL, V158, P521, DOI 10.1111/j.1476-5381.2009.00332.x; Strobaek D, 2013, BRIT J PHARMACOL, V168, P432, DOI 10.1111/j.1476-5381.2012.02143.x; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilson AJ, 1999, EXP CELL RES, V250, P187, DOI 10.1006/excr.1999.4496; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314; Zimmerman NP, 2011, LAB INVEST, V91, P1040, DOI 10.1038/labinvest.2011.77	71	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147736	10.1371/journal.pone.0147736	http://dx.doi.org/10.1371/journal.pone.0147736			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824610	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600053
J	Bishop, JH; Fox, JR; Maple, R; Loretan, C; Badger, GJ; Henry, SM; Vizzard, MA; Langevin, HM				Bishop, James H.; Fox, James R.; Maple, Rhonda; Loretan, Caitlin; Badger, Gary J.; Henry, Sharon M.; Vizzard, Margaret A.; Langevin, Helene M.			Ultrasound Evaluation of the Combined Effects of Thoracolumbar Fascia Injury and Movement Restriction in a Porcine Model	PLOS ONE			English	Article							LOW-BACK-PAIN; SENSORY INNERVATION; PIG; ANATOMY; SKIN; RATS	The persistence of back pain following acute back "sprains" is a serious public health problem with poorly understood pathophysiology. The recent finding that human subjects with chronic low back pain (LBP) have increased thickness and decreased mobility of the thoracolumbar fascia measured with ultrasound suggest that the fasciae of the back may be involved in LBP pathophysiology. This study used a porcine model to test the hypothesis that similar ultrasound findings can be produced experimentally in a porcine model by combining a local injury of fascia with movement restriction using a "hobble" device linking one foot to a chest harness for 8 weeks. Ultrasound measurements of thoracolumbar fascia thickness and shear plane mobility (shear strain) during passive hip flexion were made at the 8 week time point on the non-intervention side (injury and/or hobble). Injury alone caused both an increase in fascia thickness (p =.007) and a decrease in fascia shear strain on the non-injured side (p =.027). Movement restriction alone did not change fascia thickness but did decrease shear strain on the non-hobble side (p =.024). The combination of injury plus movement restriction had additive effects on reducing fascia mobility with a 52% reduction in shear strain compared with controls and a 28% reduction compared to movement restriction alone. These results suggest that a back injury involving fascia, even when healed, can affect the relative mobility of fascia layers away from the injured area, especially when movement is also restricted.	[Bishop, James H.; Fox, James R.; Maple, Rhonda; Loretan, Caitlin; Vizzard, Margaret A.; Langevin, Helene M.] Univ Vermont, Dept Neurol Sci, Burlington, VT USA; [Badger, Gary J.] Univ Vermont, Dept Med Biostat, Burlington, VT USA; [Henry, Sharon M.] Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT USA; [Langevin, Helene M.] Harvard Univ, Sch Med, Div Prevent Med, Brigham & Womens Hosp, Boston, MA 02115 USA	University of Vermont; University of Vermont; University of Vermont; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Langevin, HM (corresponding author), Univ Vermont, Dept Neurol Sci, Burlington, VT USA.; Langevin, HM (corresponding author), Harvard Univ, Sch Med, Div Prevent Med, Brigham & Womens Hosp, Boston, MA 02115 USA.	hlangevin@partners.org			National Center for Complementary and Alternative Medicine [RO1AT004400]; National Center for Complementary and Integrative Health [RO1 AT004400]; National Center for Complementary & Integrative Health [R01AT004400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051369, R01DK060481] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary and Integrative Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work came from National Center for Complementary and Alternative Medicine RO1AT004400. The funding entity had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors thank Dr. Ruth Blauwiekel, Mr. Stephen Bell and the University of Vermont animal care staff for invaluable assistance with the care of the animals. This project was supported by Research Grants RO1 AT004400 from the National Center for Complementary and Integrative Health. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Complementary and Integrative Health, National Institutes of Health.	Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Benetazzo L, 2011, SURG RADIOL ANAT, V33, P855, DOI 10.1007/s00276-010-0757-7; Corey SM, 2011, CELLS TISSUES ORGANS; Crick SJ, 1998, J ANAT, V193, P105, DOI 10.1046/j.1469-7580.1998.19310105.x; DOUGLAS WR, 1972, SPACE LIFE SCI, V3, P226, DOI 10.1007/BF00928167; Eakin CL, 2001, PHYSICIAN SPORTSMED, V29, P31, DOI 10.3810/psm.2001.03.668; Johanson E, 2011, EUR SPINE J, V20, P2152, DOI 10.1007/s00586-011-1825-3; KERRIGAN CL, 1986, LAB ANIM SCI, V36, P408; Langevin HM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-203; Langevin HM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-151; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Malanga GA, 2010, PHYS MED REH CLIN N, V21, P711, DOI 10.1016/j.pmr.2010.07.003; MARCARIAN HQ, 1966, AM J VET RES, V27, P765; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; MEYER W, 1981, ARCH DERMATOL RES, V270, P391, DOI 10.1007/BF00403783; Meyer W, 1978, Curr Probl Dermatol, V7, P39; Rose E H, 1978, Ann Plast Surg, V1, P252, DOI 10.1097/00000637-197805000-00002; Schilling Nadja, 2005, Pathophysiology, V12, P233, DOI 10.1016/j.pathophys.2005.09.005; Solomonow M, 2012, J ELECTROMYOGR KINES, V22, P155, DOI 10.1016/j.jelekin.2011.11.008; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Taguchi T, 2008, PAIN, V138, P119, DOI 10.1016/j.pain.2007.11.015; Tesarz J, 2011, NEUROSCIENCE, V194, P302, DOI 10.1016/j.neuroscience.2011.07.066; Tillman L.J., 1992, DYNAMICS HUMAN BIOL; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; VLEEMING A, 1995, SPINE, V20, P753, DOI 10.1097/00007632-199504000-00001; Weinstein Stuart MHS, 2005, PHYS MED REHABILITAI; Willard FH, 2012, J ANAT, V221, P507, DOI 10.1111/j.1469-7580.2012.01511.x; YAHIA LH, 1992, ACTA ORTHOP SCAND, V63, P195, DOI 10.3109/17453679209154822	30	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147393	10.1371/journal.pone.0147393	http://dx.doi.org/10.1371/journal.pone.0147393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820883	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400023
J	de Kretser, DM; Bensley, JG; Phillips, DJ; Levvey, BJ; Snell, GI; Lin, E; Hedger, MP; O'Hehir, RE				de Kretser, David M.; Bensley, Jonathan G.; Phillips, David J.; Levvey, Bronwyn J.; Snell, Greg I.; Lin, Enjarn; Hedger, Mark P.; O'Hehir, Robyn E.			Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation	PLOS ONE			English	Article							BINDING-PROTEIN; REPERFUSION INJURY; INFLAMMATION; ISCHEMIA; FIBROSIS; HEPARIN; KIDNEY; ACTIVATION; RELEASE; DEATH	Background Lung transplantation exposes the donated lung to a period of anoxia. Re-establishing the circulation after ischemia stimulates inflammation causing organ damage. Since our published data established that activin A is a key pro-inflammatory cytokine, we assessed the roles of activin A and B, and their binding protein, follistatin, in patients undergoing lung transplantation. Methods Sera from 46 patients participating in a published study of remote ischemia conditioning in lung transplantation were used. Serum activin A and B, follistatin and 11 other cytokines were measured in samples taken immediately after anaesthesia induction, after remote ischemia conditioning or sham treatment undertaken just prior to allograft reperfusion and during the subsequent 24 hours. Results Substantial increases in serum activin A, B and follistatin occurred after the baseline sample, taken before anaesthesia induction and peaked immediately after the remote ischemia conditioning/sham treatment. The levels remained elevated 15 minutes after lung transplantation declining thereafter reaching baseline 2 hours post-transplant. Activin B and follistatin concentrations were lower in patients receiving remote ischemia conditioning compared to sham treated patients but the magnitude of the decrease did not correlate with early transplant outcomes. Conclusions We propose that the increases in the serum activin A, B and follistatin result from a combination of factors; the acute phase response, the reperfusion response and the use of heparin- based anti-coagulants.	[de Kretser, David M.; Bensley, Jonathan G.] Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia; [de Kretser, David M.; Phillips, David J.; Hedger, Mark P.] Hudson Inst Med Res, Clayton, Vic, Australia; [Levvey, Bronwyn J.; Snell, Greg I.; O'Hehir, Robyn E.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Levvey, Bronwyn J.; Snell, Greg I.; O'Hehir, Robyn E.] Alfred Hosp, Lung Transplant Serv, Melbourne, Vic, Australia; [Snell, Greg I.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Lin, Enjarn] Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic, Australia; [Phillips, David J.] Epworth HealthCare, Epworth Res Inst, Richmond, Vic, Australia	Monash University; Hudson Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health	de Kretser, DM (corresponding author), Monash Univ, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia.; de Kretser, DM (corresponding author), Hudson Inst Med Res, Clayton, Vic, Australia.	david.de.kretser@monash.edu	Hedger, Mark P/C-3495-2008; O'Hehir, Robyn E/H-3627-2011	O'Hehir, Robyn E/0000-0002-3489-7595; Levvey, Bronwyn/0000-0002-1954-4249; Bensley, Jonathan/0000-0003-2926-1856; Hedger, Mark/0000-0003-0602-3724	National Health and Medical Research Council of Australia (NHMRC) [APP1048094]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	The study was supported in part by a grant (APP1048094) from the National Health and Medical Research Council of Australia (NHMRC) and by the Victorian Government's Operational Infrastructure Support Program.	Aoki F, 2007, ENDOCR J, V54, P849, DOI 10.1507/endocrj.KR07E-001; Chen Y, 2014, CYTOKINE, V69, P255, DOI 10.1016/j.cyto.2014.06.017; Chen Y, 2011, CYTOKINE, V54, P154, DOI 10.1016/j.cyto.2011.01.001; COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; de Kretser DM, 2013, CRIT CARE, V17, DOI 10.1186/cc13093; de Kretser DM, 1999, J ENDOCRINOL, V161, P195, DOI 10.1677/joe.0.1610195; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; de Vries DK, 2011, AM J TRANSPLANT, V11, P1064, DOI 10.1111/j.1600-6143.2011.03466.x; Dohi T, 2005, GASTROENTEROLOGY, V128, P411, DOI 10.1053/j.gastro.2004.11.063; Dorgan DJ, 2014, EXPERT REV RESP MED, V8, P315, DOI 10.1586/17476348.2014.899906; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Hardy CL, 2015, IMMUNOL CELL BIOL, V93, P567, DOI 10.1038/icb.2015.7; Hardy CL, 2006, CLIN EXP ALLERGY, V36, P941, DOI 10.1111/j.1365-2222.2006.02523.x; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Hedger MP, 2011, VITAM HORM, V85, P255, DOI 10.1016/B978-0-12-385961-7.00013-5; Hirche TO, 2014, PULM MED, V2014, DOI 10.1155/2014/621342; Jones KL, 2004, J ENDOCRINOL, V181, P307, DOI 10.1677/joe.0.1810307; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; King RC, 2000, ANN THORAC SURG, V69, P1681, DOI 10.1016/S0003-4975(00)01425-9; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Lin E, 2014, J HEART LUNG TRANSPL, V33, P1139, DOI 10.1016/j.healun.2014.04.022; Ludlow H, 2009, CLIN ENDOCRINOL, V71, P867, DOI 10.1111/j.1365-2265.2009.03567.x; Michel U, 2003, EUR J ENDOCRINOL, V148, P559, DOI 10.1530/eje.0.1480559; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Oto T, 2008, AM J TRANSPLANT, V8, P2132, DOI 10.1111/j.1600-6143.2008.02357.x; Patella S, 2001, J HEPATOL, V34, P576, DOI 10.1016/S0168-8278(00)00029-5; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Phillips DJ, 2000, J CLIN ENDOCR METAB, V85, P2411, DOI 10.1210/jc.85.7.2411; Phillips DJ, 1996, J ENDOCRINOL, V151, P119, DOI 10.1677/joe.0.1510119; Russell CE, 1999, MOL CELL ENDOCRINOL, V148, P129, DOI 10.1016/S0303-7207(98)00226-3; SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yamashita S, 2004, J AM SOC NEPHROL, V15, P91, DOI 10.1097/01.ASN.0000103225.68136.E6; Zipori D, 2001, J LEUKOCYTE BIOL, V69, P867	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0140948	10.1371/journal.pone.0140948	http://dx.doi.org/10.1371/journal.pone.0140948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820896	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400001
J	Pchelintsev, NA; Adams, PD; Nelson, DM				Pchelintsev, Nikolay A.; Adams, Peter D.; Nelson, David M.			Critical Parameters for Efficient Sonication and Improved Chromatin Immunoprecipitation of High Molecular Weight Proteins	PLOS ONE			English	Article							DNA INTERACTIONS INVIVO; CROSS-LINKING; FORMALDEHYDE	Solubilization of cross-linked cells followed by chromatin shearing is essential for successful chromatin immunoprecipitation (ChIP). However, this task, typically accomplished by ultrasound treatment, may often become a pitfall of the process, due to inconsistent results obtained between different experiments under seemingly identical conditions. To address this issue we systematically studied ultrasound-mediated cell lysis and chromatin shearing, identified critical parameters of the process and formulated a generic strategy for rational optimization of ultrasound treatment. We also demonstrated that whereas ultrasound treatment required to shear chromatin to within a range of 100-400 bp typically degrades large proteins, a combination of brief sonication and benzonase digestion allows for the generation of similarly sized chromatin fragments while preserving the integrity of associated proteins. This approach should drastically improve ChIP efficiency for this class of proteins.	[Pchelintsev, Nikolay A.; Adams, Peter D.; Nelson, David M.] Univ Glasgow, Inst Canc Sci, CR UK Beatson Labs, Glasgow, Lanark, Scotland; [Pchelintsev, Nikolay A.] Abcam Plc, 204 Cambridge Sci Pk, Cambridge, England	University of Glasgow	Pchelintsev, NA (corresponding author), Univ Glasgow, Inst Canc Sci, CR UK Beatson Labs, Glasgow, Lanark, Scotland.; Pchelintsev, NA (corresponding author), Abcam Plc, 204 Cambridge Sci Pk, Cambridge, England.	nikolay.pchelintsev@abcam.com		Adams, Peter/0000-0002-0684-1770	CR-UK program project [C10652/A10250]; program project NIA [AG031862-02]; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER; Cancer Research UK [16566] Funding Source: researchfish	CR-UK program project; program project NIA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cancer Research UK(Cancer Research UK)	Work in the Adams laboratory was funded by CR-UK program project, C10652/A10250, and program project NIA AG031862-02.	ELSNER HI, 1989, DNA-J MOLEC CELL BIO, V8, P697, DOI 10.1089/dna.1989.8.697; GILMOUR DS, 1984, P NATL ACAD SCI-BIOL, V81, P4275, DOI 10.1073/pnas.81.14.4275; Ginsburg E, 1998, Adm Radiol J, V17, P17; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297	10	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148023	10.1371/journal.pone.0148023	http://dx.doi.org/10.1371/journal.pone.0148023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821228	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000369528400059
J	Zhou, SF; Gopalakrishnan, S; Xu, YH; Yang, J; Lam, YW; Pang, SW				Zhou, Shu Fan; Gopalakrishnan, Singaram; Xu, Yuan Hao; Yang, Jie; Lam, Yun Wah; Pang, Stella W.			A Unidirectional Cell Switching Gate by Engineering Grating Length and Bending Angle	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; SUBSTRATE TOPOGRAPHY; SHEAR-STRESS; ENDOTHELIAL-CELLS; STEM-CELLS; IN-VITRO; MIGRATION; GUIDANCE; BEHAVIOR; MORPHOLOGY	On a microgrooved substrate, cells migrate along the pattern, and at random positions, reverse their directions. Here, we demonstrate that these reversals can be controlled by introducing discontinuities to the pattern. On "V-shaped grating patterns", mouse osteogenic progenitor MC3T3-E1 cells reversed predominately at the bends and the ends. The patterns were engineered in a way that the combined effects of angle-and length-dependence could be examined in addition to their individual effects. Results show that when the bend was placed closer to one end, migration behaviour of cells depends on their direction of approach. At an obtuse bend (135 degrees), more cells reversed when approaching from the long segment than from the short segment. But at an acute bend (45 degrees), this relationship was reversed. Based on this anisotropic behaviour, the designed patterns effectively allowed cells to move in one direction but blocked migrations in the opposing direction. This study demonstrates that by the strategic placement of bends and ends on grating patterns, we can engineer effective unidirectional switching gates that can control the movement of adherent cells. The knowledge developed in this study could be utilised in future cell sorting or filtering platforms without the need for chemotaxis or microfluidic control.	[Zhou, Shu Fan; Xu, Yuan Hao; Pang, Stella W.] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China; [Zhou, Shu Fan; Gopalakrishnan, Singaram; Xu, Yuan Hao; Yang, Jie; Lam, Yun Wah; Pang, Stella W.] City Univ Hong Kong, Ctr Biosyst Neurosci & Nanotechnol, Kowloon, Hong Kong, Peoples R China; [Gopalakrishnan, Singaram; Yang, Jie; Lam, Yun Wah] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong; City University of Hong Kong	Pang, SW (corresponding author), City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China.; Lam, YW; Pang, SW (corresponding author), City Univ Hong Kong, Ctr Biosyst Neurosci & Nanotechnol, Kowloon, Hong Kong, Peoples R China.; Lam, YW (corresponding author), City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China.	yunwlam@cityu.edu.hk; pang@cityu.edu.hk	Gopalakrishnan, Singaram/AEB-6454-2022; Pang, Stella/A-7770-2012	Xu, Yuanhao/0000-0001-5529-5078; Pang, Stella/0000-0002-4330-0877; Lam, Yun Wah/0000-0001-8929-5965	Centre for Biosystems, Neuroscience, and Nanotechnology of City University of Hong Kong [9360148]; University Grants Council of Hong Kong [GRF 120413, 11210814]; City University of Hong Kong [9380062]	Centre for Biosystems, Neuroscience, and Nanotechnology of City University of Hong Kong; University Grants Council of Hong Kong; City University of Hong Kong(City University of Hong Kong)	This project received the financial support from the Centre for Biosystems, Neuroscience, and Nanotechnology of City University of Hong Kong under project number 9360148, the University Grants Council of Hong Kong (GRF 120413 and 11210814) and grant from the City University of Hong Kong (9380062).	Ankam S, 2013, ACTA BIOMATER, V9, P4535, DOI 10.1016/j.actbio.2012.08.018; Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Boneschansker L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5787; Cardozo BL, 2008, J VAC SCI TECHNOL B, V26, P2578, DOI 10.1116/1.2991859; Chen P, 2008, FRONT BIOSCI-LANDMRK, V13, P2464, DOI 10.2741/2859; Chen P, 2010, ANAL CHIM ACTA, V663, P1, DOI 10.1016/j.aca.2010.01.046; Choi MJ, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/045006; Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033; CLARK P, 1991, J CELL SCI, V99, P73; Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; DAVIES PF, 1984, J CLIN INVEST, V73, P1121, DOI 10.1172/JCI111298; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Diao JP, 2006, LAB CHIP, V6, P381, DOI 10.1039/b511958h; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dukkipati VR, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/46/465102; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001; Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Guvakova MA, 2007, INT J BIOCHEM CELL B, V39, P890, DOI 10.1016/j.biocel.2006.10.013; Hamilton DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015129; Hu W, 2005, J VAC SCI TECHNOL B, V23, P2984, DOI 10.1116/1.2121729; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Jana S, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035012; Jeffries EM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035015; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Kemkemer R, 2006, BIOPHYS J, V90, P4701, DOI 10.1529/biophysj.105.067967; Kidoaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078067; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070; Koufaki N, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045004; Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629; Kurosaka Satoshi, 2008, Birth Defects Research, V84, P102, DOI 10.1002/bdrc.20125; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lawrence BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050190; Li JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035003; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mandal K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6749; McKee CT, 2012, BIOPHYS J, V102, P1224, DOI 10.1016/j.bpj.2012.01.053; Mitchel JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024316; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; Palm D, 2005, SEMIN CANCER BIOL, V15, P396, DOI 10.1016/j.semcancer.2005.06.008; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raghavan V, 2014, P NATL ACAD SCI USA, V111, P8506, DOI 10.1073/pnas.1402195111; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Song S, 2015, LAB CHIP, V15, P1250, DOI 10.1039/c4lc01417k; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Tang QY, 2015, J BIOMED MATER RES A, V103, P2383, DOI 10.1002/jbm.a.35378; Tang QY, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015011; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Veith M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035001; Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687; Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z; Wang L, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035013; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	66	45	46	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147801	10.1371/journal.pone.0147801	http://dx.doi.org/10.1371/journal.pone.0147801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821058	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400046
J	MacDonald, K; Thomas, ML; Sciolla, AF; Schneider, B; Pappas, K; Bleijenberg, G; Bohus, M; Bekh, B; Carpenter, L; Carr, A; Dannlowski, U; Dorahy, M; Fahlke, C; Finzi-Dottan, R; Karu, T; Gerdner, A; Glaesmer, H; Grabe, HJ; Heins, M; Kenny, DT; Kim, D; Knoop, H; Lobbestael, J; Lochner, C; Lauritzen, G; Ravndal, E; Riggs, S; Sar, V; Schafer, I; Schlosser, N; Schwandt, ML; Stein, MB; Subic-Wrana, C; Vogel, M; Wingenfeld, K				MacDonald, Kai; Thomas, Michael L.; Sciolla, Andres F.; Schneider, Beacher; Pappas, Katherine; Bleijenberg, Gijs; Bohus, Martin; Bekh, Bradley; Carpenter, Linda; Carr, Alan; Dannlowski, Udo; Dorahy, Martin; Fahlke, Claudia; Finzi-Dottan, Ricky; Karu, Tobi; Gerdner, Arne; Glaesmer, Heide; Grabe, Hans Joergen; Heins, Marianne; Kenny, Dianna T.; Kim, Daeho; Knoop, Hans; Lobbestael, Jill; Lochner, Christine; Lauritzen, Grethe; Ravndal, Edle; Riggs, Shelley; Sar, Vedat; Schaefer, Ingo; Schlosser, Nicole; Schwandt, Melanie L.; Stein, Murray B.; Subic-Wrana, Claudia; Vogel, Mark; Wingenfeld, Katja			Minimization of Childhood Maltreatment Is Common and Consequential: Results from a Large, Multinational Sample Using the Childhood Trauma Questionnaire	PLOS ONE			English	Article							ADULT PSYCHIATRIC-DISORDERS; PSYCHOMETRIC PROPERTIES; HOUSEHOLD DYSFUNCTION; GERMAN VERSION; SHORT FORM; ABUSE; RELIABILITY; VALIDITY; CTQ; ADVERSITY	Childhood maltreatment has diverse, lifelong impact on morbidity and mortality. The Childhood Trauma Questionnaire (CTQ) is one of the most commonly used scales to assess and quantify these experiences and their impact. Curiously, despite very widespread use of the CTQ, scores on its Minimization-Denial (MD) subscale-originally designed to assess a positive response bias-are rarely reported. Hence, little is known about this measure. If response biases are either common or consequential, current practices of ignoring the MD scale deserve revision. Therewith, we designed a study to investigate 3 aspects of minimization, as defined by the CTQ's MD scale: 1) its prevalence; 2) its latent structure; and finally 3) whether minimization moderates the CTQ's discriminative validity in terms of distinguishing between psychiatric patients and community volunteers. Archival, item-level CTQ data from 24 multinational samples were combined for a total of 19,652 participants. Analyses indicated: 1) minimization is common; 2) minimization functions as a continuous construct; and 3) high MD scores attenuate the ability of the CTQ to distinguish between psychiatric patients and community volunteers. Overall, results suggest that a minimizing response bias-as detected by the MD subscale-has a small but significant moderating effect on the CTQ's discriminative validity. Results also may suggest that some prior analyses of maltreatment rates or the effects of early maltreatment that have used the CTQ may have underestimated its incidence and impact. We caution researchers and clinicians about the widespread practice of using the CTQ without the MD or collecting MD data but failing to assess and control for its effects on outcomes or dependent variables.	[MacDonald, Kai; Thomas, Michael L.; Schneider, Beacher; Pappas, Katherine; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Sciolla, Andres F.] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Bleijenberg, Gijs; Heins, Marianne; Knoop, Hans] Radboud Univ Nijmegen, Med Ctr, Expert Ctr Chron Fatigue, NL-6525 ED Nijmegen, Netherlands; [Bohus, Martin] Heidelberg Univ, Cent Inst Mental Hlth, Heidelberg, Germany; [Bekh, Bradley] Atlanta VA Med Ctr, Atlanta, GA USA; [Bekh, Bradley] Emory Univ, Dept Psychiat, Atlanta, GA 30322 USA; [Carpenter, Linda] Brown Univ, Providence, RI 02912 USA; [Carr, Alan] Univ Coll Dublin, Dublin 2, Ireland; [Dannlowski, Udo] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Dorahy, Martin] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [Fahlke, Claudia] Univ Gothenburg, Dept Psychol, Box 14158, S-40020 Gothenburg, Sweden; [Finzi-Dottan, Ricky; Karu, Tobi] Bar Ilan Univ, Ramat Gan, Israel; [Gerdner, Arne] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Glaesmer, Heide] Univ Leipzig, Dept Med Psychol & Med, D-04109 Leipzig, Germany; [Grabe, Hans Joergen] Helios Hosp Stralsund, Dept Psychiat & Psychotherapy, Stralsund, Germany; [Grabe, Hans Joergen] Univ Med Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany; [Kenny, Dianna T.] Univ Sydney, Sydney, NSW 2006, Australia; [Kim, Daeho] Hanyang Univ, Sch Med, Dept Psychiat, Seoul 133791, South Korea; [Lobbestael, Jill] Maastricht Univ, Fac Psychol & Neurosci, Dept Clin Psychol, NL-6200 MD Maastricht, Netherlands; [Lochner, Christine] Univ Stellenbosch, Dept Psychiat, MRC Unit Anxiety & Stress Disorders, ZA-7600 Stellenbosch, South Africa; [Lauritzen, Grethe; Ravndal, Edle] Univ Oslo, Norwegian Inst Alcohol & Drug Res SIRUS, Oslo, Norway; [Lauritzen, Grethe; Ravndal, Edle] Univ Oslo, Norwegian Ctr Addict Res SERAF, Oslo, Norway; [Riggs, Shelley] Univ N Texas, Denton, TX 76203 USA; [Sar, Vedat] Koc Univ, Sch Med, Istanbul, Turkey; [Schaefer, Ingo] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany; [Schlosser, Nicole] Evangel Hosp Bielefeld, Res Dept, Bielefeld, Germany; [Schwandt, Melanie L.] NIAAA, Bethesda, MD USA; [Subic-Wrana, Claudia] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Vogel, Mark] Univ Basel, Hosp Psychiat, Div Subst Use Disorders, Basel, Switzerland; [Wingenfeld, Katja] Charite, Dept Psychiat, Campus Benjamin Franklin, Berlin, Germany	University of California System; University of California San Diego; University of California System; University of California Davis; Radboud University Nijmegen; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Brown University; University College Dublin; University of Munster; University of Canterbury; University of Gothenburg; Bar Ilan University; Jonkoping University; Leipzig University; Greifswald Medical School; University of Sydney; Hanyang University; Maastricht University; Stellenbosch University; University of Oslo; University of Oslo; University of North Texas System; University of North Texas Denton; Koc University; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Johannes Gutenberg University of Mainz; University of Basel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	MacDonald, K (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.	kai@kaimacdonald.com	Sar, Vedat/B-9832-2009; Schwandt, Melanie L/L-9866-2016; Vogel, Marc/CAG-0220-2022; Knoop, Hans/D-3264-2009; Schäfer, Ingo/B-7514-2017; Şar, Vedat/AAH-6284-2019; Gerdner, Arne/HDL-7517-2022; /AAD-2172-2020	Sar, Vedat/0000-0002-5392-9644; Vogel, Marc/0000-0002-3088-0331; Knoop, Hans/0000-0001-7763-3517; Schäfer, Ingo/0000-0002-9711-3559; Şar, Vedat/0000-0002-5392-9644; Gerdner, Arne/0000-0002-8158-0486; Carr, Alan/0000-0003-4563-8852; Dannlowski, Udo/0000-0002-0623-3759; Lobbestael, Jill/0000-0001-9205-3115; Kenny, Dianna/0000-0003-1934-0163; Wingenfeld, Katja/0000-0001-7457-0370; Fahlke, Claudia/0000-0002-8059-5491	National Institutes Health [MH071537, HD071982]; Australia Research Council; New South Wales Dept of Juvenile Justice, Australia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071537, R56MH071537] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australia Research Council(Australian Research Council); New South Wales Dept of Juvenile Justice, Australia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work from BB's lab was supported by National Institutes Health Grants MH071537 and HD071982. The work from DK's lab was supported by the Australia Research Council and New South Wales Dept of Juvenile Justice, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Author, 2014, LME4 LINEAR MIXED EF; Baker AJL, 2010, CHILD YOUTH SERV REV, V32, P740, DOI 10.1016/j.childyouth.2010.01.011; Barrios YV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116609; Berglund KJ, 2013, ALCOHOL CLIN EXP RES, V37, P757, DOI 10.1111/acer.12023; Bernet C Z, 1999, Depress Anxiety, V9, P169, DOI 10.1002/(SICI)1520-6394(1999)9:4<169::AID-DA4>3.3.CO;2-U; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bradley B, 2011, J CLIN PSYCHIAT, V72, P685, DOI 10.4088/JCP.10m06409blu; Carr CP, 2013, J NERV MENT DIS, V201, P1007, DOI 10.1097/NMD.0000000000000049; CLAUSSEN AH, 1991, CHILD ABUSE NEGLECT, V15, P5, DOI 10.1016/0145-2134(91)90085-R; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Dalenberg CJ, 2012, PSYCHOL BULL, V138, P550, DOI 10.1037/a0027447; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Dovran A, 2013, SCAND J PSYCHOL, V54, P286, DOI 10.1111/sjop.12052; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fergusson D., 1999, CHILDHOOD SEXUAL ABU; Garrusi B, 2009, PSYCHOL REP, V104, P509, DOI 10.2466/PR0.104.2.509-516; Gerdner A, 2009, NORD J PSYCHIAT, V63, P160, DOI 10.1080/08039480802514366; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Grant MM, 2015, NEUROPSYCHOPHARMACOL; Grassi-Oliveira R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087118; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Haynes S.N., 2011, SCI FDN CLIN ASSESSM, DOI 10.4324/9780203829172; Heim C, 2010, DEV PSYCHOBIOL, V52, P671, DOI 10.1002/dev.20494; Hoertel N, 2015, J CLIN PSYCHIAT, V76, P916, DOI 10.4088/JCP.14m09420; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Kenny DT, 2007, J OFFENDER REHABIL, V45, P123, DOI 10.1300/J076v45n01_10; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Keyes KM, 2012, BRIT J PSYCHIAT, V200, P107, DOI 10.1192/bjp.bp.111.093062; Kim D, 2013, SCHIZOPHR RES, V144, P93, DOI 10.1016/j.schres.2012.12.020; Kim D, 2011, PSYCHIAT INVEST, V8, P305, DOI 10.4306/pi.2011.8.4.305; Klein DN, 2009, DEPRESS ANXIETY, V26, P701, DOI 10.1002/da.20577; Klinitzke G, 2012, PSYCHOTHER PSYCH MED, V62, P47, DOI 10.1055/s-0031-1295495; Lewis DO, 1997, AM J PSYCHIAT, V154, P1703, DOI 10.1176/ajp.154.12.1703; Li XB, 2014, J AFFECT DISORDERS, V168, P58, DOI 10.1016/j.jad.2014.06.017; MacDonald K, 2014, J INTERPERS VIOLENCE; Maughan B, 1997, J PERS DISORD, V11, P19, DOI 10.1521/pedi.1997.11.1.19; MEEHL PE, 1994, PSYCHOL REP, V74, P1059; MEEHL PE, 1995, AM PSYCHOL, V50, P266, DOI 10.1037/0003-066X.50.4.266; Millsap RE, 2011, STAT APPROACHES MEAS; Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Paivio SC, 2004, CHILD ABUSE NEGLECT, V28, P889, DOI 10.1016/j.chiabu.2004.01.011; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reckase MD, 2009, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-89976-3_1; Rogers R., 1997, CLIN ASSESSMENT MALI; Rossiter A, 2015, CHILD ABUSE NEGL; Ruscio J., 2006, INTRO TAXOMETRIC MET; Ruscio J, 2010, PSYCHOL ASSESSMENT, V22, P5, DOI 10.1037/a0018259; Sar V, 2012, TURK KLIN TIP BILIM, V32, P1054, DOI 10.5336/medsci.2011-26947; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; SCHMIDT NB, 2004, TAXOMETRICS NEW DIAG; Scott KM, 2010, ARCH GEN PSYCHIAT, V67, P712, DOI 10.1001/archgenpsychiatry.2010.71; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Shenk CE, 2010, CHILD ABUSE NEGLECT, V34, P752, DOI 10.1016/j.chiabu.2010.02.010; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Spinhoven P, 2014, PSYCHOL ASSESSMENT, V26, P717, DOI 10.1037/pas0000002; Sudbrack R, 2015, J PSYCHIAT RES; Swartz JR, 2015, NEURON, V85, P505, DOI 10.1016/j.neuron.2014.12.055; Teicher MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117423; Teicher MH, 2014, BIOL PSYCHIAT, V76, P297, DOI 10.1016/j.biopsych.2013.09.016; Thombs BD, 2009, CHILD ABUSE NEGLECT, V33, P518, DOI 10.1016/j.chiabu.2009.03.001; Uziel L, 2010, PERSPECT PSYCHOL SCI, V5, P243, DOI 10.1177/1745691610369465; van Zelst C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117386; Varia R, 1996, CHILD ABUSE NEGLECT, V20, P511, DOI 10.1016/0145-2134(96)00033-6; Waller NG, 2006, J ABNORM PSYCHOL, V115, P210, DOI 10.1037/0021-843X.115.2.210; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Wingenfeld K, 2010, PSYCHOTHER PSYCH MED, V60, P442, DOI 10.1055/s-0030-1247564; Wright MO, 2009, CHILD ABUSE NEGLECT, V33, P59, DOI 10.1016/j.chiabu.2008.12.007	75	95	95	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146058	10.1371/journal.pone.0146058	http://dx.doi.org/10.1371/journal.pone.0146058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26815788	gold, Green Published			2022-12-27	WOS:000369528200007
J	Clouse, BJ; Jadcherla, SR; Slaughter, JL				Clouse, Brian J.; Jadcherla, Sudarshan R.; Slaughter, Jonathan L.			Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions	PLOS ONE			English	Review							METERED-DOSE INHALER; CHRONIC LUNG-DISEASE; IN-VITRO EVALUATION; RANDOMIZED CONTROLLED-TRIAL; PRETERM INFANTS; PULMONARY-FUNCTION; PREMATURE-INFANTS; AEROSOL DELIVERY; JET NEBULIZER; BECLOMETHASONE DIPROPIONATE	Background There is much debate surrounding the use of inhaled bronchodilators and corticosteroids for infants with bronchopulmonary dysplasia (BPD). Objective The objective of this systematic review was to identify strengths and knowledge gaps in the literature regarding inhaled therapies in BPD and guide future research to improve long-termoutcomes. Methods The databases of Academic Search Complete, CINAHL, PUBMED/MEDLINE, and Scopus were searched for studies that evaluated both acute and long-term clinical outcomes related to the delivery and therapeutic efficacy of inhaled beta-agonists, anticholinergics and corticosteroids in infants with developing and/or established BPD. Results Of 181 articles, 22 met inclusion criteria for review. Five evaluated beta-agonist therapies (n = 84, weighted gestational age (GA) of 27.1(26-30) weeks, weighted birth weight (BW) of 974(843-1310) grams, weighted post menstrual age (PMA) of 34.8(28-39) weeks, and weighted age of 53(15-86) days old at the time of evaluation). Fourteen evaluated inhaled corticosteroids (n = 2383, GA 26.2(26-29) weeks, weighted BW of 853(760-1114) grams, weighted PMA of 27.0(26-31) weeks, and weighted age of 6(0-45) days old at time of evaluation). Three evaluated combination therapies (n = 198, weighted GA of 27.8(27-29) weeks, weighted BW of 1057(898-1247) grams, weighted PMA of 30.7(29-45) weeks, and age 20(10-111) days old at time of evaluation). Conclusion Whether inhaled bronchodilators and inhaled corticosteroids improve long-term outcomes in BPD remains unclear. Literature regarding these therapies mostly addresses evolving BPD. There appears to be heterogeneity in treatment responses, and may be related to varying modes of administration. Further research is needed to evaluate inhaled therapies in infants with severe BPD. Such investigations should focus on appropriate definitions of disease and subject selection, timing of therapies, and new drugs, devices and delivery methods as compared to traditional methods across all modalities of respiratory support, in addition to the assessment of long-term outcomes of initial responders.	[Clouse, Brian J.; Jadcherla, Sudarshan R.; Slaughter, Jonathan L.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Jadcherla, Sudarshan R.; Slaughter, Jonathan L.] Nationwide Childrens Hosp, Dept Pediat, Div Neonatol, Columbus, OH USA; [Jadcherla, Sudarshan R.; Slaughter, Jonathan L.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Clouse, BJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA.	Brian.Clouse@nationwidechildrens.org	Slaughter, Jonathan L/E-4102-2011; Jadcherla, Sudarshan/AAE-5178-2020	Slaughter, Jonathan L/0000-0001-6831-7520; 				Allen J, 2003, AM J RESP CRIT CARE, V168, P356, DOI 10.1164/rccm.168.3.356; Amirav I, 2014, J AEROSOL MED PULM D, V27, P272, DOI 10.1089/jamp.2013.1069; Ari A, 2012, RESP CARE, V57, P1066, DOI 10.4187/respcare.01167; Ari A, 2010, RESP CARE, V55, P845; Ballard Julie, 2002, Respir Care, V47, P31; Bancalari E, 2005, EARLY HUM DEV, V81, P171, DOI 10.1016/j.earlhumdev.2004.12.005; Bar-Yishay E, 2011, ISR MED ASSOC J, V13, P39; Bassler D, 2015, NEW ENGL J MED, V373, P1497, DOI 10.1056/NEJMoa1501917; Bassler D, 2015, NEONATOLOGY, V107, P358, DOI 10.1159/000381132; Bassler D, 2010, NEONATOLOGY, V97, P52, DOI 10.1159/000227294; Bekhof J, ARCH DIS CHILD; Bekhof J, 2014, PAEDIATR RESPIR REV, V15, P98, DOI 10.1016/j.prrv.2013.08.004; BRUNDAGE KL, 1990, AM REV RESPIR DIS, V142, P1137, DOI 10.1164/ajrccm/142.5.1137; Castile R, 2000, PEDIATR PULM, V30, P215, DOI 10.1002/1099-0496(200009)30:3<215::AID-PPUL6>3.0.CO;2-V; Cheng YS, 2001, J AEROSOL MED, V14, P255, DOI 10.1089/08942680152484180; Clearie KL, 2011, BRIT J CLIN PHARMACO, V71, P504, DOI 10.1111/j.1365-2125.2010.03857.x; Cole CH, 1999, NEW ENGL J MED, V340, P1005, DOI 10.1056/NEJM199904013401304; Cole CH, 1999, J PEDIATR-US, V135, P65, DOI 10.1016/S0022-3476(99)70329-X; Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Cuevas Guaman M, 2015, AM J PERINATOL; De Boeck K, 1998, EUR J PEDIATR, V157, P75, DOI 10.1007/s004310050771; DENJEAN A, 1992, J PEDIATR-US, V120, P974, DOI 10.1016/S0022-3476(05)81973-0; Denjean A, 1998, EUR J PEDIATR, V157, P926, DOI 10.1007/s004310050969; Di Fiore JM, 2007, J PERINATOL, V27, P766, DOI 10.1038/sj.jp.7211830; DiBlasi RM, 2010, RESP CARE, V55, P419; Dimitriou G, 1997, EUR J PEDIATR, V156, P51; Dugas MA, 2005, PEDIATRICS, V115, pE566, DOI 10.1542/peds.2004-0951; Fakhoury KF, 2010, PEDIATRICS, V125, pE1441, DOI 10.1542/peds.2009-0668; Farney KD, 2014, RESP CARE, V59, P340, DOI 10.4187/respcare.01904; Fok TF, 2009, SEMIN FETAL NEONAT M, V14, P49, DOI 10.1016/j.siny.2008.08.002; Fok TF, 1999, ARCH DIS CHILD-FETAL, V80, pF203, DOI 10.1136/fn.80.3.F203; Fok TF, 1998, ARCH DIS CHILD-FETAL, V79, pF100, DOI 10.1136/fn.79.2.F100; Fok TF, 1996, PEDIATR PULM, V21, P301, DOI 10.1002/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P; Gappa M, 1997, PEDIATR PULM, V23, P442, DOI 10.1002/(SICI)1099-0496(199706)23:6<442::AID-PPUL8>3.0.CO;2-K; Garrard J, 2011, HLTH SCI LIT REV MAD, pxi; Giep T, 1996, AM J PERINAT, V13, P5, DOI 10.1055/s-2007-994193; Goldstein AB, 2001, AM J RESP CRIT CARE, V164, P447, DOI 10.1164/ajrccm.164.3.2005080; Gupta GK, 2000, PEDIATR PULM, V30, P275, DOI 10.1002/1099-0496(200010)30:4<275::AID-PPUL1>3.0.CO;2-G; Halliday HL, 2001, PEDIATRICS, V107, P232, DOI 10.1542/peds.107.2.232; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jones M, 2000, AM J RESP CRIT CARE, V161, P353, DOI 10.1164/ajrccm.161.2.9903026; KAO LC, 1989, PEDIATR PULM, V6, P74, DOI 10.1002/ppul.1950060204; KAO LC, 1984, PEDIATRICS, V73, P509; Kovacs L, 1998, ACTA PAEDIATR, V87, P792, DOI 10.1080/080352598750013905; Kugelman A, 2006, J PERINATOL, V26, P31, DOI 10.1038/sj.jp.7211434; Kugelman A, 1997, PEDIATRICS, V99, P71, DOI 10.1542/peds.99.1.71; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x; LAFORCE WR, 1993, J PEDIATR-US, V122, P285, DOI 10.1016/S0022-3476(06)80134-4; Lauterbach R, 2006, J MATERN-FETAL NEO M, V19, P433, DOI 10.1080/14767050600736754; Leach C, 2009, J ALLERGY CLIN IMMUN, V124, pS88, DOI 10.1016/j.jaci.2009.09.050; Longest PW, 2015, PHARM RES-DORDR, V32, P321, DOI 10.1007/s11095-014-1466-4; Maas C, 2010, NEONATOLOGY, V98, P404, DOI 10.1159/000316978; Mavunda K, 1989, Pediatr Pulmonol, V7, P284, DOI 10.1002/ppul.1950070415; Mazela J, 2014, J AEROSOL MED PULM D, V27, P58, DOI 10.1089/jamp.2012.0992; Merz U, 1999, BIOL NEONATE, V75, P46, DOI 10.1159/000014076; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; MOTOYAMA EK, 1987, AM REV RESPIR DIS, V136, P50, DOI 10.1164/ajrccm/136.1.50; Nguyen P., 1997, MCGILL J MED, V3, P19; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Onland W, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002311.pub3; PFENNINGER J, 1993, INTENS CARE MED, V19, P251, DOI 10.1007/BF01690544; Robin B, 2004, PEDIATR PULM, V37, P236, DOI 10.1002/ppul.10424; ROTSCHILD A, 1989, J PEDIATR-US, V115, P984, DOI 10.1016/S0022-3476(89)80755-3; Rozycki HJ, 2003, PEDIATR PULM, V35, P375, DOI 10.1002/ppul.10269; Sidler-Moix AL, 2015, RESP CARE, V60, P38, DOI 10.4187/respcare.02490; Sivakumar D, 1999, PEDIATR PULM, V27, P208, DOI 10.1002/(SICI)1099-0496(199903)27:3<208::AID-PPUL10>3.0.CO;2-A; Slaughter JL, 2015, J PERINATOL, V35, P61, DOI 10.1038/jp.2014.141; Slaughter JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106838; Suchomski Sandra J, 2002, J Perinatol, V22, P196, DOI 10.1038/sj.jp.7210705; Sunbul FS, PEDIAT PULMONOL; Tin W, 2008, SEMIN FETAL NEONAT M, V13, P44, DOI 10.1016/j.siny.2007.09.008; Tin W, 2009, SEMIN FETAL NEONAT M, V14, P383, DOI 10.1016/j.siny.2009.08.003; United Nations Environment Programme, 1987, MONTR PROT SUBST DEP; WILKIE RA, 1987, J PEDIATR-US, V111, P278, DOI 10.1016/S0022-3476(87)80087-2; Xi JX, 2014, RESP CARE, V59, P263, DOI 10.4187/respcare.02568	75	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148188	10.1371/journal.pone.0148188	http://dx.doi.org/10.1371/journal.pone.0148188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840339	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200094
J	Darshan, A; Kachari, A; Dutta, R; Ganguly, A; Das, DN				Darshan, Achom; Kachari, Akash; Dutta, Rashmi; Ganguly, Arijit; Das, Debangshu Narayan			Amblyceps waikhomi, a New Species of Catfish (Siluriformes: Amblycipitidae) from the Brahmaputra Drainage of Arunachal Pradesh, India	PLOS ONE			English	Article							TELEOSTEI; GENUS	Amblyceps waikhomi sp. nov. is described from the Nongkon stream which drains into the Noa Dehing River, a tributary of the Brahmaputra River, in Arunachal Pradesh, India. The new species can be distinguished from congeners (except A. torrentis) in having a deeper body depth at anus. It further differs from congeners (except A. mangois and A. serratum) in having fewer vertebrae, from A. mangois in lacking (vs. having) strongly-developed projections on the proximal lepidotrichia of the median caudal-fin rays, and in having a longer, wider, and deeper head; and from A. serratum in having a posteriorly smooth (vs. with 4-5 serrations) pectoral spine, and unequal jaw length (lower jaw longer and weakly-projecting anteriorly vs. equal upper and lower jaws). It additionally differs from A. murraystuarti, A. torrentis, A. apangi, A. laticeps, and A. cerinum in having a deeply forked (vs. emarginate or truncate) caudal fin. This species is the seventh amblycipitid species known to occur in the Ganga-Brahmaputra River system.	[Darshan, Achom; Dutta, Rashmi; Das, Debangshu Narayan] Rajiv Gandhi Univ, Ctr Potential Excellence Biodivers, Rono Hills, Doimukh, India; [Kachari, Akash; Dutta, Rashmi; Ganguly, Arijit; Das, Debangshu Narayan] Rajiv Gandhi Univ, Dept Zool, Fishery & Aquat Ecol Lab, Rono Hills, Doimukh, India; [Ganguly, Arijit] Achhruram Mem Coll, Dept Zool, Jhalda, Purulia, India	Rajiv Gandhi University, Itanagar; Rajiv Gandhi University, Itanagar	Darshan, A (corresponding author), Rajiv Gandhi Univ, Ctr Potential Excellence Biodivers, Rono Hills, Doimukh, India.	achom_darshan@yahoo.com	Das, Debangshu/AAU-1538-2020	Das, Debangshu/0000-0001-5164-4322; Singh, Achom/0000-0001-7679-3519; Das, Debangshu/0000-0002-8747-2267	University Grants Commission (UGC), New Delhi [1-15/2002/2011, F1.17.1/2013-14/RGNF.2013-14-ST-ASS-41715]	University Grants Commission (UGC), New Delhi(University Grants Commission, India)	This work has been supported by University Grants Commission (UGC), New Delhi, through the Centre with Potential for Excellence in Biodiversity (CPEB) scheme [F.No. 1-15/2002/2011 (NS/PE), dated 20th March, 2012] to carry out the research work, and also through Rajiv Gandhi National Fellowship scheme (F1.17.1/2013-14/RGNF.2013-14-ST-ASS-41715, dated 6th February, 2014) as fellowship to the second author. However no fund has been allotted for publication under the mentioned schemes.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Chen XP, 1995, COPEIA, P780; Eschmeyer WN, CATALOG FISHES GENER; HOLLISTER GLORIA, 1934, ZOOLOGICA [NEW YORK], V12, P89; Linthoingambi I, 2008, ICHTHYOL EXPLOR FRES, V19, P167; Ng H.H., 2001, Ichthyological Exploration of Freshwaters, V12, P201; Ng H.H., 2000, Ichthyological Exploration of Freshwaters, V11, P335; Ng HH, 2010, ZOOTAXA, P50; Ng HH, 2009, COPEIA, P369, DOI 10.1643/CI-08-113; Ng HH, 2005, RAFFLES B ZOOL, V53, P243; Roberts T.R., 1992, Ichthyological Exploration of Freshwaters, V3, P77; Roberts Tyson R., 1994, Ichthyological Exploration of Freshwaters, V5, P241	12	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147283	10.1371/journal.pone.0147283	http://dx.doi.org/10.1371/journal.pone.0147283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840400	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200030
J	Glass, JR; Davis, M; Walsh, TJ; Sargis, EJ; Caccone, A				Glass, Jessica R.; Davis, Matt; Walsh, Timothy J.; Sargis, Eric J.; Caccone, Adalgisa			Was Frozen Mammoth or Giant Ground Sloth Served for Dinner at The Explorers Club?	PLOS ONE			English	Article							EXPLOITATION; MEGALONYX	Accounts of woolly mammoths (Mammuthus primigenius) preserved so well in ice that their meat is still edible have a long history of intriguing the public and influencing paleontological thought on Quaternary extinctions and climate, with some scientists resorting to catastrophism to explain the instantaneous freezing necessary to preserve edible meat. Famously, members of The Explorers Club purportedly dined on frozen mammoth from Alaska, USA, in 1951. This event, well received by the press and general public, became an enduring legend for the Club and popularized the notorious annual tradition of serving rare and exotic food at Club dinners that continues to this day. The Yale Peabody Museum holds a sample of meat preserved from the 1951 meal, interestingly labeled as a South American giant ground sloth (Megatherium), not mammoth. We sequenced a fragment of the mitochondrial cytochrome-b gene and studied archival material to verify its identity, which if genuine, would extend the range of Megatherium over 600% and alter our views on ground sloth evolution. Our results indicate that the meat was not mammoth or Megatherium but green sea turtle (Chelonia mydas). The prehistoric dinner was likely an elaborate publicity stunt. Our study emphasizes the value of museums collecting and curating voucher specimens, particularly those used for evidence of extraordinary claims.	[Glass, Jessica R.; Sargis, Eric J.; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Glass, Jessica R.; Sargis, Eric J.] Yale Univ, Div Vertebrate Zool, Yale Peabody Museum Nat Hist, New Haven, CT USA; [Davis, Matt] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Walsh, Timothy J.] Bruce Museum, Greenwich, CT USA; [Sargis, Eric J.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Caccone, Adalgisa] Yale Univ, Inst Biospher Studies, Mol Systemat & Conservat Genet Ctr, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Glass, JR (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.; Glass, JR (corresponding author), Yale Univ, Div Vertebrate Zool, Yale Peabody Museum Nat Hist, New Haven, CT USA.	jessica.glass@yale.edu	Caccone, Adalgisa/AAE-4238-2021	Caccone, Adalgisa/0000-0002-8949-9260; Glass, Jessica/0000-0002-9843-1786	Explorers Club Exploration Fund; Yale Institute for Biospheric Studies	Explorers Club Exploration Fund; Yale Institute for Biospheric Studies	Funding was received by JRG from The Explorers Club Exploration Fund (https://explorers.org/expeditions/funding/expedition_grants) and by AC from the Yale Institute for Biospheric Studies (http://yibs.yale.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2007, THE STRAIGHT DOPE; Adelman L, 1957, HARTFORD COURAN 0118, P17; Adelman L, 1957, THE HARTFORD COURANT, p1B; [Anonymous], 1951, NEW YORK HERALD TRIB, P40; [Anonymous], 1950, NY TIMES, P10; [Anonymous], 1962, NY TIMES, P27; [Anonymous], 1951, W AUSTR         0219, P4; Cartelle C, 2006, J SYST PALAEONTOL, V4, P199, DOI 10.1017/S1477201905001781; Cowen RC, 1983, CHRISTIAN SCI MONITO, P24; Darwin C., 1887, LIFE LETT C DARWIN; Darwin C, 1839, J AND REMARKS; Dodge WP, 1950, EXPLOR J, V28, P17; Dodge WP, 1951, EXPLOR J, V29, P45; FARRAND WR, 1961, SCIENCE, V133, P729, DOI 10.1126/science.133.3455.729; Graham R.W., 2010, FAUNMAP 2 NEW DATA N; Grayson DK, 2015, J ARCHAEOL SCI, V56, P177, DOI 10.1016/j.jas.2015.02.009; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Haverlee AH, 1971, EXPLORERS COOKBOOK, P103; Howland JA, 1912, CHICAGO DAILY TRIBUN, pD2; Hubbard BR, 1932, MUSH YOU MALEMUTES; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keyser H, 2014, MENTAL FLOSS; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kosco WG, 2010, FOX 10 NEWS     0902; Lee PY, 2013, GAME; Louie E, 2013, NY TIMES; Lucas FA, 1901, ANN REP BOARD REGENT, P353; McDonald HG, 2000, ARCTIC, V53, P213; Murphy T, 1957, HARTFORD COURAN 0117, P12; Nichols HB, 1951, CHRISTIAN SCI MONITO, P3; Pfizenmayer EW, 1939, SIBERIAN MAN MAMMOTH; Ramde D, 2008, US TODAY; Rasmussen Pamela C., 2003, Bulletin of the British Ornithologists' Club, V123A, P66; Ray CE, 1979, NOTULAE NATURAE ACAD, V455, P1; Redmond BG, 2012, WORLD ARCHAEOL, V44, P75, DOI 10.1080/00438243.2012.647576; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schoch RM, 2002, HORNS TUSKS HOOVES A; Seminoff J.A., 2004, 2004 IUCN RED LIST T, DOI [https://dx.doi.org/10.2305/IUCN.UK.2004.RLTS.T4615A11037468.en, DOI 10.2305/IUCN.UK.2004.RLTS.T4615A11037468.EN]; Shapiro Beth, 2015, CLONE MAMMOTH; Sparks F, 1946, DAILY BOSTON GL 1205, P16; Stein FW, 1842, SCHRIFTEN ST PETERSB, V1, P199; Stone R, 2001, MAMMOTH; Tait J, 1954, NEW YORK HERALD TRIB, P13; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TIKHOMIROV BA, 1962, GEOGR J, V128, P443, DOI 10.2307/1792040; Tolmachoff IP., 1929, T AM PHILOS SOC, V23, pi, DOI [10.2307/1005437, DOI 10.2307/1005437]; Veltre DW, 2008, QUATERNARY RES, V70, P40, DOI 10.1016/j.yqres.2008.03.006; Whiton LC, 1980, EXPLOR J, V58, P110; Williams CS, 1971, THE EXPLORERS COOKBO, P219	51	4	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146825	10.1371/journal.pone.0146825	http://dx.doi.org/10.1371/journal.pone.0146825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840445	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200018
J	Lee, SH; Kwak, SW; Kang, EM; Kim, GA; Lee, SY; Bae, HW; Seong, GJ; Kim, CY				Lee, Si Hyung; Kwak, Seung Woo; Kang, Eun Min; Kim, Gyu Ah; Lee, Sang Yeop; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun			Estimated Trans-Lamina Cribrosa Pressure Differences in Low-Teen and High-Teen Intraocular Pressure Normal Tension Glaucoma: The Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CEREBROSPINAL-FLUID PRESSURE; OPTIC-NERVE HEAD; NOCTURNAL ARTERIAL-HYPOTENSION; INTRACRANIAL-PRESSURE; FIBER LAYER; RISK-FACTOR; SPACE; EYE; PREVALENCE	Background To investigate the association between estimated trans-lamina cribrosa pressure difference (TLCPD) and prevalence of normal tension glaucoma (NTG) with low-teen and high-teen intraocular pressure (IOP) using a population-based study design. Methods A total of 12,743 adults (>= 40 years of age) who participated in the Korean National Health and Nutrition Examination Survey (KNHANES) from 2009 to 2012 were included. Using a previously developed formula, cerebrospinal fluid pressure (CSFP) in mmHg was estimated as 0.55 x body mass index (kg/m(2)) + 0.16 x diastolic blood pressure (mmHg)-0.18 x age (years)-1.91. TLCPD was calculated as IOP-CSFP. The NTG subjects were divided into two groups according to IOP level: low-teen NTG (IOP <= 15 mmHg) and high-teen NTG (15 mmHg < IOP <= 21 mmHg) groups. The association between TLCPD and the prevalence of NTG was assessed in the low-and high-teen IOP groups. Results In the normal population (n = 12,069), the weighted mean estimated CSFP was 11.69 +/- 0.04 mmHg and the weighted mean TLCPD 2.31 +/- 0.06 mmHg. Significantly higher TLCPD (p < 0.001; 6.48 +/- 0.27 mmHg) was found in the high-teen NTG compared with the normal group. On the other hand, there was no significant difference in TLCPD between normal and low-teen NTG subjects (p = 0.395; 2.31 +/- 0.06 vs. 2.11 +/- 0.24 mmHg). Multivariate logistic regression analysis revealed that TLCPD was significantly associated with the prevalence of NTG in the high-teen IOP group (p = 0.006; OR: 1.09; 95% CI: 1.02, 1.15), but not the low-teen IOP group (p = 0.636). Instead, the presence of hypertension was significantly associated with the prevalence of NTGin the low-teen IOP group (p < 0.001; OR: 1.65; 95% CI: 1.26, 2.16). Conclusions TLCPD was significantly associated with the prevalence of NTG in high-teen IOP subjects, but not low-teen IOP subjects, in whom hypertension may be more closely associated. This study suggests that the underlying mechanisms may differ between low-teen and high-teen NTG patients.	[Lee, Si Hyung; Kang, Eun Min; Kim, Gyu Ah; Lee, Sang Yeop; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun] Yonsei Univ, Coll Med, Severance Hosp, Inst Vis Res,Dept Ophthalmol, Seoul 120749, South Korea; [Kwak, Seung Woo] Univ Georgia, Dept Stat, Athens, GA 30602 USA	Yonsei University; Yonsei University Health System; University System of Georgia; University of Georgia	Kim, CY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Inst Vis Res,Dept Ophthalmol, Seoul 120749, South Korea.	kcyeye@yuhs.ac	Lee, Sang Yeop/M-4685-2015	Lee, Sang Yeop/0000-0002-3834-7953; Kim, Chan Yun/0000-0002-8373-9999; Bae, Hyoung Won/0000-0002-8421-5636; Seong, Gong Je/0000-0002-5456-4296	SMBA, Republic of Korea [10031270]; World Class 300 Project of the SMBA, Republic of Korea [10031270]	SMBA, Republic of Korea; World Class 300 Project of the SMBA, Republic of Korea	This work was supported by the World Class 300 Project (10031270) of the SMBA, Republic of Korea. The sponsor or funding organization had no role in the design or conduct of this research.; This work was supported by the World Class 300 Project (10031270) of the SMBA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108226; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bonovas S, 2004, DIABETIC MED, V21, P609, DOI 10.1111/j.1464-5491.2004.01173.x; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; Fleischman D, 2015, ACTA OPHTHALMOL, V93, pe234, DOI 10.1111/aos.12551; Hayreh SS, 1999, OPHTHALMOLOGICA, V213, P76, DOI 10.1159/000027399; HAYREH SS, 1994, AM J OPHTHALMOL, V117, P603, DOI 10.1016/S0002-9394(14)70067-4; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jaggi GP, 2012, BRIT J OPHTHALMOL, V96, P53, DOI 10.1136/bjo.2010.199224; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Jonas JB, 1999, J GLAUCOMA, V8, P227; Jonas JB, 2015, ACTA OPHTHALMOL, V93, pE7, DOI 10.1111/aos.12480; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100533; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Killer HE, 2008, CLIN EXP OPHTHALMOL, V36, P308, DOI 10.1111/j.1442-9071.2008.01735.x; Killer HE, 2012, BRIT J OPHTHALMOL, V96, P544, DOI 10.1136/bjophthalmol-2011-300663; Killer Hanspeter Esriel, 2013, J Glaucoma, V22 Suppl 5, pS19, DOI 10.1097/IJG.0b013e3182934a0f; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim DM, 2007, J GLAUCOMA, V16, P293, DOI 10.1097/IJG.0b013e31803bda3d; Kim Jee Hyun, 2014, Korean J Ophthalmol, V28, P473, DOI 10.3341/kjo.2014.28.6.473; Kim M, 2014, ACTA OPHTHALMOL, V92, pe637, DOI 10.1111/aos.12434; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Morgan WH, 2008, J GLAUCOMA, V17, P408, DOI 10.1097/IJG.0b013e31815c5f7c; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; OGDEN TE, 1988, EXP EYE RES, V46, P559, DOI 10.1016/S0014-4835(88)80012-5; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; Ramdas WD, 2011, INVEST OPHTH VIS SCI, V52, P6875, DOI 10.1167/iovs.11-7376; Ren RJ, 2011, GRAEF ARCH CLIN EXP, V249, P1057, DOI 10.1007/s00417-011-1657-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007; Shirakashi M, 1999, BRIT J OPHTHALMOL, V83, P353, DOI 10.1136/bjo.83.3.353; Suh W, 2012, AM J OPHTHALMOL, V154, P99, DOI 10.1016/j.ajo.2012.01.009; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Wang XH, 1996, ACTA OPHTHALMOL SCAN, V74, P364; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; YAMAGAMI J, 1990, Nippon Ganka Gakkai Zasshi, V94, P514; Yamamoto S, 2014, OPHTHALMOLOGY, V121, P1558, DOI 10.1016/j.ophtha.2014.03.003; Yoo TK, 2014, PUBLIC HEALTH NUTR, V17, P833, DOI 10.1017/S1368980013003492; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	46	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148412	10.1371/journal.pone.0148412	http://dx.doi.org/10.1371/journal.pone.0148412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840184	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200132
J	Rulifson, IC; Cao, P; Miao, L; Kopecky, D; Huang, LD; White, RD; Samayoa, K; Gardner, J; Wu, XS; Chen, K; Tsuruda, T; Homann, O; Baribault, H; Yamane, H; Carlson, T; Wiltzius, J; Li, Y				Rulifson, Ingrid C.; Cao, Ping; Miao, Li; Kopecky, David; Huang, Linda; White, Ryan D.; Samayoa, Kim; Gardner, Jonitha; Wu, Xiaosu; Chen, Kui; Tsuruda, Trace; Homann, Oliver; Baribault, Helene; Yamane, Harvey; Carlson, Tim; Wiltzius, Jed; Li, Yang			Identification of Human Islet Amyloid Polypeptide as a BACE2 Substrate	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PRECURSOR PROTEIN; FIBRIL FORMATION; ALZHEIMERS-DISEASE; HUMAN AMYLIN; FULL-LENGTH; SECRETASE; INSULIN; LANGERHANS; IAPP	Pancreatic amyloid formation by islet amyloid polypeptide ( IAPP) is a hallmark pathological feature of type 2 diabetes. IAPP is stored in the secretory granules of pancreatic beta-cells and co-secreted with insulin to maintain glucose homeostasis. IAPP is innocuous under homeostatic conditions but imbalances in production or processing of IAPP may result in homodimer formation leading to the rapid production of cytotoxic oligomers and amyloid fibrils. The consequence is beta-cell dysfunction and the accumulation of proteinaceous plaques in and around pancreatic islets. Beta-site APP-cleaving enzyme 2, BACE2, is an aspartyl protease commonly associated with BACE1, a related homolog responsible for amyloid processing in the brain and strongly implicated in Alzheimer's disease. Herein, we identify two distinct sites of the mature human IAPP sequence that are susceptible to BACE2-mediated proteolytic activity. The result of proteolysis is modulation of human IAPP fibrillation and human IAPP protein degradation. These results suggest a potential therapeutic role for BACE2 in type 2 diabetes-associated hyperamylinaemia.	[Rulifson, Ingrid C.; Miao, Li; Gardner, Jonitha; Wu, Xiaosu; Baribault, Helene; Li, Yang] Amgen Inc, Cardiometab Disorders, San Francisco, CA USA; [Cao, Ping; Huang, Linda] Amgen Inc, Mol Struct & Characterizat, San Francisco, CA USA; [Kopecky, David] Amgen Inc, Med Chem, Thousand Oaks, CA USA; [White, Ryan D.] Amgen Inc, Med Chem, Cambridge, MA USA; [Samayoa, Kim] Amgen Inc, Pathol, San Francisco, CA USA; [Chen, Kui] Amgen Inc, Discovery Technol, Thousand Oaks, CA USA; [Tsuruda, Trace; Yamane, Harvey] Amgen Inc, Biol, Thousand Oaks, CA USA; [Homann, Oliver; Wiltzius, Jed] Amgen Inc, Genome Anal Unit, San Francisco, CA USA; [Carlson, Tim] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Rulifson, IC (corresponding author), Amgen Inc, Cardiometab Disorders, San Francisco, CA USA.	ingridr@amgen.com						Abdul-Hay SO, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-46; Alcarraz-Vizan G, 2015, FASEB J, V29, P95, DOI 10.1096/fj.14-255489; Altirriba J, 2010, DIABETOLOGIA, V53, P1406, DOI 10.1007/s00125-010-1728-6; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Azkona G, 2010, AMINO ACIDS, V39, P1571, DOI 10.1007/s00726-010-0662-8; Badman MK, 1996, FEBS LETT, V378, P227, DOI 10.1016/0014-5793(95)01460-8; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bolder SG, 2007, LANGMUIR, V23, P4144, DOI 10.1021/la063048k; Casas S, 2010, AM J PHYSIOL-ENDOC M, V299, pE1087, DOI 10.1152/ajpendo.00420.2010; Cheng Y, 2015, ACS MED CHEM LETT, V6, P210, DOI 10.1021/ml500458t; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; EHRLICH JC, 1961, AM J PATHOL, V38, P49; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Exley C, 2010, J INORG BIOCHEM, V104, P1125, DOI 10.1016/j.jinorgbio.2010.05.012; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Finzi G, 2008, ULTRASTRUCT PATHOL, V32, P246, DOI 10.1080/01913120802486217; Gebre-Medhin S, 2000, DIABETOLOGIA, V43, P687, DOI 10.1007/s001250051364; Gilead S, 2006, ANGEW CHEM INT EDIT, V45, P6476, DOI 10.1002/anie.200602034; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Green J, 2003, J MOL BIOL, V326, P1147, DOI 10.1016/S0022-2836(02)01377-3; Gregory L, 2007, JOVE-J VIS EXP, V7, P255, DOI [10.3791/255, DOI 10.3791/255]; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; Jackson K, 2013, ANN NEUROL, V74, P517, DOI 10.1002/ana.23956; Jaikaran ETAS, 2004, BIOCHEM J, V377, P709, DOI 10.1042/bj20030852; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Kahn SE, 1998, DIABETES, V47, P640, DOI 10.2337/diabetes.47.4.640; Kim YT, 2002, EUR J BIOCHEM, V269, P5668, DOI 10.1046/j.1432-1033.2002.03277.x; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Krampert M, 2000, CHEM BIOL, V7, P855, DOI 10.1016/S1074-5521(00)00034-X; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; National Research Council, 2011, GUID CAR US LAB AN, P8; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; NISHI M, 1990, J BIOL CHEM, V265, P4173; Opie Eugene L, 1900, J Boston Soc Med Sci, V4, P251; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Peter ODonnell UN, 2014, ALZHEIMERS AND DEMEN, V10, pP491; Pillay K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826706; Rondas D, 2013, DIABETES OBES METAB, V15, P185, DOI 10.1111/dom.12165; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Vignini A, 2013, CURR DIABETES REV, V9, P218, DOI 10.2174/1573399811309030003; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145; Wright AW, 1927, AM J PATHOL, V3, P461; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X	56	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147254	10.1371/journal.pone.0147254	http://dx.doi.org/10.1371/journal.pone.0147254			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840340	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200029
J	Zetsche, EM; Baussant, T; Meysman, FJR; van Oevelen, D				Zetsche, Eva-Maria; Baussant, Thierry; Meysman, Filip J. R.; van Oevelen, Dick			Direct Visualization of Mucus Production by the Cold-Water Coral Lophelia pertusa with Digital Holographic Microscopy	PLOS ONE			English	Article							ROCKALL BANK; NE ATLANTIC; SCLERACTINIA; SEDIMENT; COMMUNITY; IMPACT	Lophelia pertusa is the dominant reef-building organism of cold-water coral reefs, and is known to produce significant amounts of mucus, which could involve an important metabolic cost. Mucus is involved in particle removal and feeding processes, yet the triggers and dynamics of mucus production are currently still poorly described because the existing tools to study these processes are not appropriate. Using a novel microscopic technique-digital holographic microscopy (DHM)-we studied the mucus release of L. pertusa under various experimental conditions. DHM technology permits mu m-scale observations and allows the visualization of transparent mucoid substances in real time without staining. Fragments of L. pertusa were first maintained in flow-through chambers without stressors and imaged with DHM, then exposed to various stressors (suspended particles, particulate food and air exposure) and re-imaged. Under non-stressed conditions no release of mucus was observed, whilst mucus strings and sheaths were produced in response to suspended particles (activated charcoal and drill cuttings sediment) i.e. in a stressed condition. Mucus strings and so-called 'string balls' were also observed in response to exposure to particulate food (brine shrimp Artemia salina). Upon air-exposure, mucus production was clearly visible once the fragments were returned to the flow chamber. Distinct optical properties such as optical path length difference (OPD) were measured with DHM in response to the various stimuli suggesting that different mucus types are produced by L. pertusa. Mucus produced to reject particles is similar in refractive index to the surrounding seawater, suggesting that the energy content of this mucus is low. In contrast, mucus produced in response to either food particle addition or air exposure had a higher refractive index, suggesting a higher metabolic investment in the production of these mucoid substances. This paper shows for the first time the potential of DHM technology for the detection, characterization and quantification of mucus production through OPD measurements in L. pertusa.	[Zetsche, Eva-Maria; Meysman, Filip J. R.] Vrije Univ Brussel, Analyt Environm & Geochem, Brussels, Belgium; [Zetsche, Eva-Maria; Meysman, Filip J. R.; van Oevelen, Dick] Royal Netherlands Inst Sea Res NIOZ Yerseke, Dept Ecosyst Studies, Yerseke, Netherlands; [Baussant, Thierry] Int Res Inst Stavanger IRIS, Randaberg, Norway; [Zetsche, Eva-Maria] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden	Vrije Universiteit Brussel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Gothenburg	Zetsche, EM (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	eva-maria.zetsche@nioz.nl	Meysman, Filip JR/C-9585-2009; Zetsche, Eva-Maria/J-5790-2012	Meysman, Filip JR/0000-0001-5334-7655; Zetsche, Eva-Maria/0000-0001-5460-5134	Brussels Institute for Research and Innovation (INNOVIRIS - Impulse-Environment grant); Netherlands Organization for Scientific Research (NWO-VIDI); Statoil [4502229690]; Research Council of Norway's programme HavKyst [204025]	Brussels Institute for Research and Innovation (INNOVIRIS - Impulse-Environment grant)(Innoviris); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Statoil; Research Council of Norway's programme HavKyst(Research Council of Norway)	This work was financially supported by the Brussels Institute for Research and Innovation (INNOVIRIS - Impulse-Environment grant to FJRM) in the framework of the HoloFlow Impulse-Environment Project and by the Netherlands Organization for Scientific Research (NWO-VIDI grant to DvO). Funding for travel and subsistence for the laboratory work in Norway was provided by Statoil (contract 4502229690). The Research Council of Norway's programme HavKyst (Project number 204025) provided access to specimens of Lophelia pertusa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2013, MAR POLLUT BULL, V74, P132, DOI 10.1016/j.marpolbul.2013.07.016; Alm K., 2013, HOLOGRAPHY BASIC PRI, P335, DOI DOI 10.5772/54505; Beckmann A, 2012, INT J DEV BIOL, V56, P577, DOI 10.1387/ijdb.113472ab; Brooke SD, 2009, MAR ECOL PROG SER, V390, P137, DOI 10.3354/meps08191; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Cathalot C, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00037; COFFROTH MA, 1990, MAR BIOL, V105, P39, DOI 10.1007/BF01344269; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Duerden JE, 1906, Q J MICROSC SCI, V49, P591; Duineveld GCA, 2007, B MAR SCI, V81, P449; EDMUNDS PJ, 1989, CORAL REEFS, V8, P37, DOI 10.1007/BF00304690; Freiwald A., 2004, COLD WATER CORAL REE; Freiwald Andre, 1998, Historical Biology, V13, P37; Gass SE, 2006, THESIS OPEN U; Godo OR, 2014, MAR POLLUT BULL, V84, P236, DOI 10.1016/j.marpolbul.2014.05.007; Jatkar AA, 2010, MAR BIOL, V157, P261, DOI 10.1007/s00227-009-1313-z; Kemper B, 2008, APPL OPTICS, V47, pA52, DOI 10.1364/AO.47.000A52; Larsson AI, 2013, MAR POLLUT BULL, V70, P176, DOI 10.1016/j.marpolbul.2013.02.033; Larsson AI, 2011, MAR POLLUT BULL, V62, P1159, DOI 10.1016/j.marpolbul.2011.03.041; LEWIS JB, 1976, J ZOOL, V178, P77; LEWIS JB, 1975, J ZOOL, V176, P527, DOI 10.1111/j.1469-7998.1975.tb03219.x; McClain CR, 2012, P NATL ACAD SCI USA, V109, P15366, DOI 10.1073/pnas.1208976109; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Minetti C, 2008, APPL OPTICS, V47, P5305, DOI 10.1364/AO.47.005305; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Mueller CE, 2014, BIOGEOSCIENCES, V11, P123, DOI 10.5194/bg-11-123-2014; Mueller CE, 2014, THESIS U UTRECHT; Naumann MS, 2011, J EXP BIOL, V214, P3570, DOI 10.1242/jeb.061390; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; Neulinger SC, 2009, APPL ENVIRON MICROB, V75, P1437, DOI 10.1128/AEM.01781-08; Nevalainen TJ, 2004, COMP BIOCHEM PHYS B, V139, P731, DOI 10.1016/j.cbpc.2004.09.006; Ostman C, 1758, ACTA ZOOLOG IN PRESS; Palanques A, 2001, LIMNOL OCEANOGR, V46, P1100, DOI 10.4319/lo.2001.46.5.1100; Purser A, 2010, J EXP MAR BIOL ECOL, V395, P55, DOI 10.1016/j.jembe.2010.08.013; Qurban MA, 2014, DEEP-SEA RES PT I, V89, P35, DOI 10.1016/j.dsr.2014.04.002; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Roberts JM, 2009, MAR ECOL PROG SER, V397, P139, DOI 10.3354/meps08112; Roder C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02802; Shapiro OH, 2014, P NATL ACAD SCI USA, V111, P13391, DOI 10.1073/pnas.1323094111; SHELTON GAB, 1980, J MAR BIOL ASSOC UK, V60, P517, DOI 10.1017/S0025315400028538; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wijgerde T, 2011, J EXP BIOL, V214, P3351, DOI 10.1242/jeb.058354; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wild C, 2010, AQUAT BIOL, V10, P41, DOI 10.3354/ab00269; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Zetsche EM, 2014, LIMNOL OCEANOGR-METH, V12, P757, DOI 10.4319/lom.2014.12.757	49	20	20	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146766	10.1371/journal.pone.0146766	http://dx.doi.org/10.1371/journal.pone.0146766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840074	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200014
J	Chiang, JY; Huang, JW; Lin, LY; Chang, CH; Chu, FY; Lin, YH; Wu, CK; Lee, JK; Hwang, JJ; Lin, JL; Chiang, FT				Chiang, Jiun-Yang; Huang, Jenq-Wen; Lin, Lian-Yu; Chang, Chin-Hao; Chu, Fang-Ying; Lin, Yen-Hung; Wu, Cho-Kai; Lee, Jen-Kuang; Hwang, Juei-Jen; Lin, Jiunn-Lee; Chiang, Fu-Tien			Detrended Fluctuation Analysis of Heart Rate Dynamics Is an Important Prognostic Factor in Patients with End-Stage Renal Disease Receiving Peritoneal Dialysis	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; R INTERVAL DYNAMICS; RATE-VARIABILITY; SYMPATHETIC OVERACTIVITY; MORTALITY; SURVIVAL	Background and Objectives Patients with severe kidney function impairment often have autonomic dysfunction, which could be evaluated noninvasively by heart rate variability (HRV) analysis. Nonlinear HRV parameters such as detrended fluctuation analysis (DFA) has been demonstrated to be an important outcome predictor in patients with cardiovascular diseases. Whether cardiac autonomic dysfunction measured by DFA is also a useful prognostic factor in patients with end-stage renal disease (ESRD) receiving peritoneal dialysis (PD) remains unclear. The purpose of the present study was designed to test the hypothesis. Materials and Methods Patients with ESRD receiving PD were included for the study. Twenty-four hour Holter monitor was obtained from each patient together with other important traditional prognostic makers such as underlying diseases, left ventricular ejection fraction (LVEF) and serum biochemistry profiles. Short-term (DFA alpha 1) and long-term (DFA alpha 2) DFA as well as other linear HRV parameters were calculated. Results A total of 132 patients (62 men, 72 women) with a mean age of 53.7+/-12.5 years were recruited from July 2007 to March 2009. During a median follow-up period of around 34 months, eight cardiac and six non-cardiac deaths were observed. Competing risk analysis demonstrated that decreased DFA alpha 1 was a strong prognostic predictor for increased cardiac and total mortality. ROC analysis showed that the AUC of DFAa1 (< 0.95) to predict mortality was 0.761 (95% confidence interval (CI). = 0.617-0.905). DFA alpha 1 >=. 0.95 was associated with lower cardiac mortality (Hazard ratio (HR) 0.062, 95% CI = 0.007-0.571, P = 0.014) and total mortality (HR = 0.109, 95% CI = 0.033-0.362, P = 0.0003). Conclusion Cardiac autonomic dysfunction evaluated by DFAa1 is an independent predictor for cardiac and total mortality in patients with ESRD receiving PD.	[Chiang, Jiun-Yang] Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Huang, Jenq-Wen] Natl Taiwan Univ, Coll Med & Hosp, Div Nephrol, Dept Internal Med, Taipei 10764, Taiwan; [Lin, Lian-Yu; Lin, Yen-Hung; Wu, Cho-Kai; Lee, Jen-Kuang; Hwang, Juei-Jen; Lin, Jiunn-Lee; Chiang, Fu-Tien] Natl Taiwan Univ, Coll Med & Hosp, Div Cardiol, Dept Internal Med, Taipei 10764, Taiwan; [Chang, Chin-Hao] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chu, Fang-Ying] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chiang, Fu-Tien] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chiang, FT (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Div Cardiol, Dept Internal Med, Taipei 10764, Taiwan.; Chiang, FT (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.	futienc@ntuh.gov.tw	Lin, Yen-Hung/AAQ-1242-2020	Lin, Yen-Hung/0000-0001-8153-1441; HUANG, JENQ-WEN/0000-0001-8011-2317; LIN, LIAN-YU/0000-0001-7505-6429; WU, CHO-KAI/0000-0002-3867-150X; CHIANG, FU-TIEN/0000-0003-4936-8968	Taiwan's Ministry of Science and Technology [MOST 103-2220-E-002 -011]	Taiwan's Ministry of Science and Technology	This study was partially supported by Taiwan's Ministry of Science and Technology on data analysis, MOST 103-2220-E-002 -011, http://www.most.gov.tw/mp.aspx?mp=7. There was no other financial support, and the remaining data collection and analysis were performed by the authors.	CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Ho KKL, 1997, CIRCULATION, V96, P842; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Lim HJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-97; Makikallio TH, 2001, J AM COLL CARDIOL, V37, P1395, DOI 10.1016/S0735-1097(01)01171-8; Mylonopoulou M, 2010, NEPHROL DIAL TRANSPL, V25, P3749, DOI 10.1093/ndt/gfq226; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Oikawa K, 2009, INT J CARDIOL, V131, P370, DOI 10.1016/j.ijcard.2007.10.033; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Tulppo MP, 2005, CIRCULATION, V112, P314, DOI 10.1161/CIRCULATIONAHA.104.523712; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH810, DOI 10.1152/ajpheart.1998.274.3.H810; Vikman S, 1999, CIRCULATION, V100, P2079, DOI 10.1161/01.CIR.100.20.2079; Vonend O, 2008, SEMIN DIALYSIS, V21, P326, DOI 10.1111/j.1525-139X.2008.00456.x; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; WOO MA, 1994, J AM COLL CARDIOL, V23, P565, DOI 10.1016/0735-1097(94)90737-4; Ye SH, 2006, HYPERTENSION, V48, P309, DOI 10.1161/01.HYP.0000231307.69761.2e	21	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147282	10.1371/journal.pone.0147282	http://dx.doi.org/10.1371/journal.pone.0147282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828209	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200018
J	Govindan, J; Tun, KM; Iovine, MK				Govindan, Jayalakshmi; Tun, Kyaw Min; Iovine, M. Kathryn			Cx43-Dependent Skeletal Phenotypes Are Mediated by Interactions between the Hapln1a-ECM and Sema3d during Fin Regeneration	PLOS ONE			English	Article							HUMAN HYALURONAN SYNTHASE; EXTRACELLULAR-MATRIX; LINK-PROTEIN; GAP-JUNCTIONS; OCULODENTODIGITAL DYSPLASIA; INTERCELLULAR COMMUNICATION; CRANIOFACIAL ABNORMALITIES; CONNEXIN43 GJA1; CARCINOMA-CELLS; ZEBRAFISH FINS	Skeletal development is a tightly regulated process and requires proper communication between the cells for efficient exchange of information. Analysis of fin length mutants has revealed that the gap junction protein Connexin43 (Cx43) coordinates cell proliferation (growth) and joint formation (patterning) during zebrafish caudal fin regeneration. Previous studies have shown that the extra cellular matrix (ECM) protein Hyaluronan and Proteoglycan Link Protein1a (Hapln1a) is molecularly and functionally downstream of Cx43, and that hapln1a knockdown leads to reduction of the glycosaminoglycan hyaluronan. Here we find that the proteoglycan aggrecan is similarly reduced following Hapln1a knockdown. Notably, we demonstrate that both hyaluronan and aggrecan are required for growth and patterning. Moreover, we provide evidence that the Hapln1a-ECM stabilizes the secreted growth factor Semaphorin3d (Sema3d), which has been independently shown to mediate Cx43 dependent phenotypes during regeneration. Double knockdown of hapln1a and sema3d reveal synergistic interactions. Further, hapln1a knockdown phenotypes were rescued by Sema3d overexpression. Therefore, Hapln1a maintains the composition of specific components of the ECM, which appears to be required for the stabilization of at least one growth factor, Sema3d. We propose that the Hapln1a dependent ECM provides the required conditions for Sema3d stabilization and function. Interactions between the ECM and signaling molecules are complex and our study demonstrates the requirement for components of the Hapln1a-ECM for Sema3d signal transduction.	[Govindan, Jayalakshmi; Tun, Kyaw Min; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, 111 Res Dr,Iacocca B217, Bethlehem, PA 18015 USA	Lehigh University	Iovine, MK (corresponding author), Lehigh Univ, Dept Biol Sci, 111 Res Dr,Iacocca B217, Bethlehem, PA 18015 USA.	mki3@lehigh.edu			National Science Foundation [IOS 1145582]; Direct For Biological Sciences [1145582] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation: IOS 1145582. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Batra N, 2012, BBA-BIOMEMBRANES, V1818, P1909, DOI 10.1016/j.bbamem.2011.09.018; Bhadra J, 2015, MECH DEVELOP, V138, P364, DOI 10.1016/j.mod.2015.06.004; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Casini P, 2012, DEV DYNAM, V241, P294, DOI 10.1002/dvdy.23715; Contreras EG, 2009, DEVELOPMENT, V136, P2987, DOI 10.1242/dev.035501; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghokale JRPaB, 2001, BIOCH BONE OSTEOPORO, P82; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Govindan J, 2015, GENE EXPR PATTERNS; Govindan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088574; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Hoptak-Solga AD, 2007, FEBS LETT, V581, P3297, DOI 10.1016/j.febslet.2007.06.030; Hynes RO, 2014, NAT REV MOL CELL BIO, V15, P761, DOI 10.1038/nrm3908; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Iovine MK, 2000, GENETICS, V155, P1321; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; JONES SJ, 1993, ANAT EMBRYOL, V187, P343; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; KOSHER RA, 1981, J EMBRYOL EXP MORPH, V63, P85; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Law LY, 2002, DEV GROWTH DIFFER, V44, P537; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; LI H, 1993, J BIOL CHEM, V268, P23504; Li Xiao-ying, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P941; Liu Y, 2004, J NEUROSCI, V24, P310, DOI 10.1523/JNEUROSCI.4287-03.2004; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; McGonnell IM, 2001, DEV DYNAM, V222, P420, DOI 10.1002/dvdy.1208; MELCHING LI, 1985, J BIOL CHEM, V260, P6279; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Moffatt P, 2011, DEV DYNAM, V240, P404, DOI 10.1002/dvdy.22529; Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; NEAME PJ, 1993, EXPERIENTIA, V49, P393, DOI 10.1007/BF01923584; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; PERIN JP, 1987, J BIOL CHEM, V262, P13269; Rodriguez E, 2006, J BIOL CHEM, V281, P18444, DOI 10.1074/jbc.M512531200; Roughley PJ, 2013, THE ROLE OF HA AND H, P219; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; SINGLEY CT, 1981, DEV BIOL, V84, P102, DOI 10.1016/0012-1606(81)90375-4; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Sztrolovics R, 2002, BIOCHEM J, V362, P465, DOI 10.1042/0264-6021:3620465; THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Ton QV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081240; Ton QV, 2012, DEV BIOL, V366, P195, DOI 10.1016/j.ydbio.2012.03.020; TOOLE BP, 1971, DEV BIOL, V25, P57, DOI 10.1016/0012-1606(71)90019-4; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Torronen K, 2014, HISTOCHEM CELL BIOL, V141, P17, DOI 10.1007/s00418-013-1143-4; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wai AWK, 1998, DEV GENET, V22, P349, DOI 10.1002/(SICI)1520-6408(1998)22:4<349::AID-DVG5>3.0.CO;2-6; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	73	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148202	10.1371/journal.pone.0148202	http://dx.doi.org/10.1371/journal.pone.0148202			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828861	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200082
J	Averett, JP; McCune, B; Parks, CG; Naylor, BJ; DelCurto, T; Mata-Gonzalez, R				Averett, Joshua P.; McCune, Bruce; Parks, Catherine G.; Naylor, Bridgett J.; DelCurto, Tim; Mata-Gonzalez, Ricardo			Non-Native Plant Invasion along Elevation and Canopy Closure Gradients in a Middle Rocky Mountain Ecosystem	PLOS ONE			English	Article							WESTERN NORTH-AMERICA; LAND-USE; PATTERNS; RESTORATION; FORESTS; CLIMATE; ROADS	Mountain environments are currently among the ecosystems least invaded by non-native species; however, mountains are increasingly under threat of non-native plant invasion. The slow pace of exotic plant invasions in mountain ecosystems is likely due to a combination of low anthropogenic disturbances, low propagule supply, and extreme/steep environmental gradients. The importance of any one of these factors is debated and likely ecosystem dependent. We evaluated the importance of various correlates of plant invasions in the Wallowa Mountain Range of northeastern Oregon and explored whether non-native species distributions differed from native species along an elevation gradient. Vascular plant communities were sampled in summer 2012 along three mountain roads. Transects (n = 20) were evenly stratified by elevation (similar to 70 m intervals) along each road. Vascular plant species abundances and environmental parameters were measured. We used indicator species analysis to identify habitat affinities for non-native species. Plots were ordinated in species space, joint plots and non-parametric multiplicative regression were used to relate species and community variation to environmental variables. Non-native species richness decreased continuously with increasing elevation. In contrast, native species richness displayed a unimodal distribution with maximum richness occurring at mid-elevations. Species composition was strongly related to elevation and canopy openness. Overlays of trait and environmental factors onto non-metric multidimensional ordinations identified the montane-subalpine community transition and over-story canopy closure exceeding 60% as potential barriers to non-native species establishment. Unlike native species, non-native species showed little evidence for high-elevation or closed-canopy specialization. These data suggest that non-native plants currently found in the Wallowa Mountains are dependent on open canopies and disturbance for establishment in low and mid elevations. Current management objectives including restoration to more open canopies in dry Rocky Mountain forests, may increase immigration pressure of non-native plants from lower elevations into the montane and subalpine zones.	[Averett, Joshua P.; DelCurto, Tim] Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, La Grande, OR USA; [McCune, Bruce] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Parks, Catherine G.; Naylor, Bridgett J.] USDA Forest Serv, Pacific Northwest Res Stn, La Grande, OR USA; [Mata-Gonzalez, Ricardo] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Averett, JP (corresponding author), Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, La Grande, OR USA.	averettj@onid.oregonstate.edu			U.S.D.A. Forest Service Pacific Northwest Research Station [11-JV-11261967-064]; Oregon State University	U.S.D.A. Forest Service Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Oregon State University	This project was funded by U.S.D.A. Forest Service Pacific Northwest Research Station, URL: http://www.fs.fed.us/pnw/, Contract (Joint Ventura Agreement with Oregon State University): 11-JV-11261967-064. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2002, ECOL APPL, V12, P1418; Andersen KM, 2015, APPL VEG SCI, V18, P683, DOI 10.1111/avsc.12185; Anderson E.W., 1998, ECOLOGICAL PROVINCES; [Anonymous], [No title captured]; [Anonymous], 2013, MEASUREMENTS TERREST; Averett JP, 2014, THESIS OREGON STATE; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Daehler CC, 2005, PERSPECT PLANT ECOL, V7, P203, DOI 10.1016/j.ppees.2005.08.002; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Dufrene M, 1989, ECOL MONOGR, V67, P345; Dukes JS, 2004, REV CHIL HIST NAT, V77, P411; Federal Geographic Data Committee, 1997, FGDCSTD005 US GEOL S; Fitzgerald SA, 2005, PSWGTR198 USDA FOR S; Franklin JF, 2012, J FOREST, V110, P429, DOI 10.5849/jof.10-006; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Johnson C. G., 1994, PNWGTR339 USDA FOR S; Johnson CG, 2004, TECHNICAL PUBLICATIO, VR6-NR-ECOL-TP-03-04; Johnson CG, 2005, PNWGTR641 USDA FOR S, P119; Jovan S, 2005, ECOL APPL, V15, P1712, DOI 10.1890/03-5368; Kalwij JM, 2008, APPL VEG SCI, V11, P491, DOI 10.3170/2008-7-18555; Klenner W, 2008, FOREST ECOL MANAG, V256, P1711, DOI 10.1016/j.foreco.2008.02.047; Lembrechts JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089664; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lichthardt J., 1997, STATUS CONSERVATION; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; MACK RN, 1982, AM NAT, V119, P757, DOI 10.1086/283953; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; Mallen-Cooper J., 2008, VICTORIAN NAT, V125, P64; Martin PH, 2009, FRONT ECOL ENVIRON, V7, P142, DOI 10.1890/070096; McCune B., 2011, PC ORD VERSION 6 06; McCune B., 2009, HYPERNICHE V 2 1 3 N; McCune B., 2011, NONPARAMETRIC MULTIP; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McCune B, 2006, J VEG SCI, V17, P819, DOI 10.1111/j.1654-1103.2006.tb02505.x; Milbau A, 2013, NEW PHYTOL, V197, P1002, DOI 10.1111/nph.12054; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; Northam FE, 1994, INT313 USDA FOR SERV; Parks CG, 2005, PERSPECT PLANT ECOL, V7, P137, DOI 10.1016/j.ppees.2005.09.007; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; Pauchard A, 2009, FRONT ECOL ENVIRON, V7, P479, DOI 10.1890/080072; Petryna L, 2002, APPL VEG SCI, V5, P195, DOI 10.1111/j.1654-109X.2002.tb00549.x; Pickering C, 2007, MT RES DEV, V27, P359, DOI 10.1659/mrd.0805; Pollnac F, 2012, BIOL INVASIONS, V14, P1753, DOI 10.1007/s10530-012-0188-y; Pysek Petr, 2007, V193, P97; Pysek P, 2011, P NATL ACAD SCI USA, V108, P439, DOI 10.1073/pnas.1017682108; Quigley TM, 1997, PNWGTR405 USDA FOR S, V2; Quiroz CL, 2011, BIOL INVASIONS, V13, P2889, DOI 10.1007/s10530-011-9971-4; Roberts DW, 1989, LAND CLASSIFICATIONS, P90; Ross LC, 2008, PERSPECT PLANT ECOL, V10, P251, DOI 10.1016/j.ppees.2008.06.001; del Rio CMR, 2006, CAN J FOREST RES, V36, P2943, DOI 10.1139/X06-169; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; US Department of Agriculture Forest Service, 2014, BLUE MOUNT NAT FOR P; Wallace JM, 2015, INVAS PLANT SCI MANA, V8, P57, DOI 10.1614/IPSM-D-14-00034.1; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wisdom MJ, 2009, RESTOR ECOL, V17, P740, DOI 10.1111/j.1526-100X.2009.00591.x	58	36	36	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147826	10.1371/journal.pone.0147826	http://dx.doi.org/10.1371/journal.pone.0147826			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824750	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600063
J	Hu, MM; Hu, Y; He, JB; Li, BL				Hu, Mingming; Hu, Ying; He, Jiabei; Li, Baolan			Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							UP-REGULATION; SERUM LEVELS; EXPRESSION; VEGF; ANGIOGENESIS; BEVACIZUMAB; RECEPTOR; CHEMOTHERAPY; PREDICTOR; APOPTOSIS	Background Basic fibroblast growth factor (bFGF) is known to stimulate angiogenesis and thus to influence the proliferation, migration and survival of tumor cells. Many studies examined the relationship between human bFGF overexpression and survival in lung cancer patients, but the results have been mixed. To systematically summarize the clinical prognostic function of bFGF in lung cancer, we performed this systematic review with meta-analysis. Method Studies were identified by an electronic search of PubMed, EMBASE, China National Knowledge Infrastructure and Wanfang databases, including publications prior toAugust 2014. Pooled hazard ratios (HR) for overall survival (OS) were aggregated and quantitatively analyzed by meta-analysis. Results Twenty-two studies (n = 2154) were evaluated in the meta-analysis. Combined HR suggested that bFGF overexpression had an adverse impact on survival of patients with lung cancer(HR = 1.202,95% CI, 1.022-1.382). Our subgroup analysis revealed that the combined HR evaluating bFGF expression on OS in operable non-small cell lung cancer (NSCLC) was 1.553 (95% CI, 1.120-1.986); the combined HR in small cell lung cancer (SCLC) was 1.667 (95% CI, 1.035-2.299). There was no significant impact of bFGF expression on survival in advanced NSCLC. Conclusion This meta-analysis showed that bFGF overexpression is a potential indicator of worse prognosis for patients with operable NSCLC and SCLC, but is not associated with outcome in advanced NSCLC. The data suggests that high bFGF expression is highly related to poor prognosis. Nevertheless, more high-quality studies should be performed in order to provide additional evidence for the prognostic value of bFGF in lung cancer.	[Hu, Mingming; Hu, Ying; He, Jiabei; Li, Baolan] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Gen Med, Beijing 101149, Peoples R China	Capital Medical University	Li, BL (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Gen Med, Beijing 101149, Peoples R China.	libaolan1109@163.com						Alessi P, 2009, EUR CYTOKINE NETW, V20, P225, DOI 10.1684/ecn.2009.0175; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Behrens C, 2008, CLIN CANCER RES, V14, P6014, DOI 10.1158/1078-0432.CCR-08-0167; Brattstrom D, 1998, ANTICANCER RES, V18, P1123; Brattstrom D, 2002, LUNG CANCER, V37, P57, DOI 10.1016/S0169-5002(02)00027-2; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Colman RW, 2010, THROMB HAEMOSTASIS, V104, P875, DOI 10.1160/TH10-01-0017; Donnem T, 2009, J THORAC ONCOL, V4, P578, DOI 10.1097/JTO.0b013e31819f2e38; Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; Dyduch G, 2012, POL J PATHOL, V63, P1; Eto H, 2012, LAB INVEST, V92, P214, DOI 10.1038/labinvest.2011.127; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Garpenstrand H, 2004, MED ONCOL, V21, P241, DOI 10.1385/MO:21:3:241; Gyanchandani R, 2013, MOL CANCER RES, V11, P1585, DOI 10.1158/1541-7786.MCR-13-0358; Horn L, 2009, J CLIN ONCOL, V27, P6006, DOI 10.1200/JCO.2009.23.7545; Ito H, 2002, ONCOL REP, V9, P119; Iwasaki A, 2004, EUR J CARDIO-THORAC, V25, P443, DOI 10.1016/j.ejcts.2003.11.031; [姜伟 Jiang Wei], 2013, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V40, P638; Joensuu H, 2002, CANCER RES, V62, P5210; Kelly RJ, 2011, CLIN CANCER RES, V17, P1190, DOI 10.1158/1078-0432.CCR-10-2331; Kim HR, 2012, BMB REP, V45, P287, DOI 10.5483/BMBRep.2012.45.5.287; Kojima H, 2002, CANCER, V94, P1083, DOI 10.1002/cncr.10352; McMillen E, 2010, EXP LUNG RES, V36, P531, DOI 10.3109/01902148.2010.482176; Middleton Kellie K, 2012, Iowa Orthop J, V32, P150; Mok T, 2014, J THORAC ONCOL, V9, P848, DOI 10.1097/JTO.0000000000000160; Nishida T, 2011, ENDOCRINOLOGY, V152, P4232, DOI 10.1210/en.2011-0234; Okada-Ban M, 2000, INT J BIOCHEM CELL B, V32, P263, DOI 10.1016/S1357-2725(99)00133-8; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Rades D, 2012, INT J RADIAT ONCOL, V82, P442, DOI 10.1016/j.ijrobp.2010.08.048; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Ruotsalainen T, 2002, CANCER EPIDEM BIOMAR, V11, P1492; Semrad TJ, 2012, CLIN LUNG CANCER, V13, P90, DOI 10.1016/j.cllc.2011.08.001; Shou Y, 2001, BRIT J CANCER, V85, P1706, DOI 10.1054/bjoc.2001.2137; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Takanami I, 1996, EUR J CANCER, V32A, P1504, DOI 10.1016/0959-8049(95)00620-6; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Ueno K, 2001, LUNG CANCER-J IASLC, V31, P213, DOI 10.1016/S0169-5002(00)00187-2; Wao H, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-10; Xiao DS, 2008, ACTA BIOCH BIOPH SIN, V40, P297, DOI 10.1111/j.1745-7270.2008.00401.x; Yu Min, 2005, Zhonghua Bing Li Xue Za Zhi, V34, P36; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002; Zhou T, 2004, THESIS	44	28	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147374	10.1371/journal.pone.0147374	http://dx.doi.org/10.1371/journal.pone.0147374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824699	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528600030
J	Lee, J; Jang, S; Son, H				Lee, Jongseok; Jang, Sungok; Son, Heejeong			Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Korean Adults: Findings from the Korea National Health and Nutrition Examination Survey, 2009-2011	PLOS ONE			English	Article							LDL-CHOLESTEROL; FRIEDEWALD EQUATION; HOMOGENEOUS ASSAYS; FORMULA; SERUM; TRIGLYCERIDE; POPULATION; ACCURACY; PLASMA; VALUES	Despite the importance of accurate assessment for low-density lipoprotein cholesterol (LDL-C), the Friedewald formula has primarily been used as a cost-effective method to estimate LDL-C when triglycerides are less than 400 mg/dL. In a recent study, an alternative to the formula was proposed to improve estimation of LDL-C. We evaluated the performance of the novel method versus the Friedewald formula using a sample of 5,642 Korean adults with LDL-C measured by an enzymatic homogeneous assay (LDL-C-D). Friedewald LDL-C (LDL-C-F) was estimated using a fixed factor of 5 for the ratio of triglycerides to very-low-density lipoprotein cholesterol (TG:VLDL-C ratio). However, the novel LDL-C (LDL-C-N) estimates were calculated using the N-strata-specific median TG:VLDL-C ratios, LDL-C-5 and LDL-C-25 from respective ratios derived from our data set, and LDL-C-180 from the 180-cell table reported by the original study. Compared with LDL-C-F, each LDL-C-N estimate exhibited a significantly higher overall concordance in the NCEP-ATP III guideline classification with LDL-C-D (p < 0.001 for each comparison). Overall concordance was 78.2% for LDL-C-F, 81.6% for LDL-C-5, 82.3% for LDL-C-25, and 82.0% for LDL-C-180. Compared to LDL-C-5, LDL-C-25 significantly but slightly improved overall concordance (p = 0.008). LDL-C-25 and LDL-C-180 provided almost the same overall concordance; however, LDL-C-180 achieved superior improvement in classifying LDL-C < 70 mg/dL compared to the other estimates. In subjects with triglycerides of 200 to 399 mg/dL, each LDL-C-N estimate showed a significantly higher concordance than that of LDL-C-F (p < 0.001 for each comparison). The novel method offers a significant improvement in LDL-C estimation when compared with the Friedewald formula. However, it requires further modification and validation considering the racial differences as well as the specific character of the applied measuring method.	[Lee, Jongseok; Jang, Sungok] Hallym Univ, Sch Business Adm, Chunchon, South Korea; [Jang, Sungok] Korea Assoc Hlth Promot Gwangju, Jeonnam Branch, Gwangju, South Korea; [Son, Heejeong] Kangwon Natl Univ, Sch Med, Dept Anesthesiol, Chunchon, South Korea	Hallym University; Kangwon National University	Son, H (corresponding author), Kangwon Natl Univ, Sch Med, Dept Anesthesiol, Chunchon, South Korea.	shjane@kangwon.ac.kr			Hallym University Research Fund [HRF-201407-007]	Hallym University Research Fund	This research was supported by the 2014 Hallym University Research Fund (HRF-201407-007). The fund provided support in salaries for one author (J. Lee). The University had no additional role regarding the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DELONG DM, 1986, JAMA-J AM MED ASSOC, V256, P2372, DOI 10.1001/jama.256.17.2372; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; HATA Y, 1986, JPN CIRC J, V50, P1191, DOI 10.1253/jcj.50.1191; Korea Centers for Disease Control and Prevention, 4 KOR NAT HLTH NUTR; Korea Centers for Disease Control and Prevention, 5 KOR NAT HLTH NUTR; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; Martin SS, 2013, J AM COLL CARDIOL, V62, P732, DOI 10.1016/j.jacc.2013.01.079; MCNAMARA JR, 1990, CLIN CHEM, V36, P36; Meeusen JW, 2014, CLIN CHEM, V60, P1519, DOI 10.1373/clinchem.2014.227710; Miida T, 2012, ATHEROSCLEROSIS, V225, P208, DOI 10.1016/j.atherosclerosis.2012.08.022; Miller WG, 2010, CLIN CHEM, V56, P977, DOI 10.1373/clinchem.2009.142810; National Health Insurance Service, 2014, 2013 NAT HLTH SCREEN; National Health Insurance Service, 2013, 2012 NAT HLTH SCREEN; Nauck M, 2002, CLIN CHEM, V48, P236; Oliveira MJA, 2013, CLIN CHIM ACTA, V423, P135, DOI 10.1016/j.cca.2013.04.009; Puavilai Wilai, 2009, Journal of the Medical Association of Thailand, V92, P182; Scharnagl H, 2001, CLIN CHEM LAB MED, V39, P426, DOI 10.1515/CCLM.2001.068; Stein EA, 2014, CLIN CHEM, V60, P1466, DOI 10.1373/clinchem.2014.232793; Tanno K, 2010, CLIN CHIM ACTA, V411, P1774, DOI 10.1016/j.cca.2010.07.034; Wang TY, 2001, ARCH PATHOL LAB MED, V125, P404; Yamada K, 2010, CLIN LAB, V56, P327; Yamashita S, 2009, CLIN CHIM ACTA, V410, P31, DOI 10.1016/j.cca.2009.09.010; Zhang B, 2012, CIRC J, V76, P2241, DOI 10.1253/circj.CJ-12-0381	24	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148147	10.1371/journal.pone.0148147	http://dx.doi.org/10.1371/journal.pone.0148147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824910	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600105
J	Morgan, WH; House, PH; Hazelton, ML; Betz-Stablein, BD; Chauhan, BC; Viswanathan, A; Yu, DY				Morgan, William H.; House, Philip H.; Hazelton, Martin L.; Betz-Stablein, Brigid D.; Chauhan, Balwantray C.; Viswanathan, Ananth; Yu, Dao-Yi			Intraocular Pressure Reduction Is Associated with Reduced Venous Pulsation Pressure	PLOS ONE			English	Article							CENTRAL RETINAL VEIN; OPTIC-NERVE HEAD; INTRACRANIAL-PRESSURE; LAMINA-CRIBROSA	Purpose To explore whether alterations in intraocular pressure (IOP) affect vein pulsation properties using ophthalmodynamometric measures of vein pulsation pressure. Patients and Methods Glaucoma patients had two retinal vein pulsation pressure (VPP) measurements from upper and lower hemiveins performed by ophthalmodynamometry at least 3 months apart. All subjects had VPP and IOP recorded at two visits, with standard automated perimetry, central corneal thickness (CCT) recorded at the initial visit. Where venous pulsation was spontaneous ophthalmodynamometry could not be performed and VPP was considered equal to IOP. Change in VPP was calculated and binarized with reduction in pressure scored 1 and no change or increase scored as 0. Data analysis used a mixed logistic regression model with change in VPP as response variable and change in IOP, visual field loss (mean deviation), CCT and time interval as explanatory variables. Results 31 subjects (20 females) with mean age 60 years (sd 11) were examined with change in VPP being significantly associated with change in IOP (odds ratio 1.6/mmHg, 95% CI 1.2 to 2.1 in the glaucoma patients but not suspect patients (p = 0.0005). Conclusion Change in VPP is strongly associated with change in IOP such that a reduced intraocular pressure is associated with a subsequent reduction in VPP. This indicates that reduced IOP alters some retinal vein properties however the nature and time course of these changes is not known.	[Morgan, William H.; House, Philip H.; Yu, Dao-Yi] Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia; [Hazelton, Martin L.; Betz-Stablein, Brigid D.] Massey Univ, Stat & Bioinformat Grp, Inst Fundamental Sci, Palmerston North, New Zealand; [Chauhan, Balwantray C.] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Viswanathan, Ananth] City Univ London, Moorfields Eye Hosp, London EC1V 0HB, England	Lions Eye Institute; University of Western Australia; Massey University; Dalhousie University; City University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Morgan, WH (corresponding author), Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia.	billmorgan@lei.org.au	Betz-Stablein, Brigid/S-6925-2018; Hazelton, Martin/AAB-9373-2019	Betz-Stablein, Brigid/0000-0003-3876-501X; Hazelton, Martin/0000-0001-7831-725X; Chauhan, Balwantray/0000-0002-7936-6907; Yu, Dao-Yi/0000-0002-9490-534X	National Health and Medical Research Council, Australia (NHMRC) [1020367]	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by The National Health and Medical Research Council, Australia (NHMRC Project Grant 1020367) (https://www.nhmrc.gov.au/) (WHM D-YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ARCH OPHTHALMOL-CHIC, V111, P545; Balaratnasingam C, 2007, BRIT J OPHTHALMOL, V91, P441, DOI 10.1136/bjo.2006.105338; BEAUMONT PE, 1994, AUST NZ J OPHTHALMOL, V22, P271, DOI 10.1111/j.1442-9071.1994.tb00796.x; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Fatehee N, 2011, INVEST OPHTH VIS SCI, V52, P6192, DOI 10.1167/iovs.10-7137; FRY DL, 1968, CIRC RES, V22, P165, DOI 10.1161/01.RES.22.2.165; Joshua SP, 2011, CLIN NEUROL NEUROSUR, V113, P635, DOI 10.1016/j.clineuro.2011.05.012; Kang MH, 2013, EXP EYE RES, V111, P50, DOI 10.1016/j.exer.2013.03.005; Kang MH, 2011, INVEST OPHTH VIS SCI, V52, P1359, DOI 10.1167/iovs.10-6366; Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2; Leske M Cristina, 2004, Curr Opin Ophthalmol, V15, P102; McCulley TJ, 2003, AM J OPHTHALMOL, V135, P706, DOI 10.1016/S0002-9394(03)00122-3; MEYERSCHWICKERATH R, 1995, GRAEF ARCH CLIN EXP, V233, P783, DOI 10.1007/BF00184090; Morgan WH, 2009, BRIT J OPHTHALMOL, V93, P594, DOI 10.1136/bjo.2008.149963; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan WH, 2002, INVEST OPHTH VIS SCI, V43, P3236; Morgan WH, 2010, GRAEF ARCH CLIN EXP, V248, P401, DOI 10.1007/s00417-009-1288-y; R Core Team, 2018, R LANG ENV STAT COMP; RIOSMONTENEGRO EN, 1973, ARCH OPHTHALMOL-CHIC, V89, P52; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; ROSNER B, 1984, BIOMETRICS, V40, P1025, DOI 10.2307/2531153; Seo JH KT, 2013, OPHTHALMOLOGY, V119, P2254; Stodtmeister R, 2013, INVEST OPHTH VIS SCI, V54, P4698, DOI 10.1167/iovs.12-10607	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147915	10.1371/journal.pone.0147915	http://dx.doi.org/10.1371/journal.pone.0147915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824849	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600072
J	Mortlock, SA; Khatkar, MS; Williamson, P				Mortlock, Sally-Anne; Khatkar, Mehar S.; Williamson, Peter			Comparative Analysis of Genome Diversity in Bullmastiff Dogs	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; GENETIC DIVERSITY; PEDIGREE ANALYSIS; HOMOZYGOSITY; VARIABILITY; BREEDS; RUNS; DISORDERS; RETRIEVER; SOFTWARE	Management and preservation of genomic diversity in dog breeds is a major objective for maintaining health. The present study was undertaken to characterise genomic diversity in Bullmastiff dogs using both genealogical and molecular analysis. Genealogical analysis of diversity was conducted using a database consisting of 16,378 Bullmastiff pedigrees from year 1980 to 2013. Additionally, a total of 188 Bullmastiff dogs were genotyped using the 170,000 SNP Illumina CanineHD Beadchip. Genealogical parameters revealed a mean inbreeding coefficient of 0.047; 142 total founders (f); an effective number of founders (f(e)) of 79; an effective number of ancestors (fa) of 62; and an effective population size of the reference population of 41. Genetic diversity and the degree of genome-wide homogeneity within the breed were also investigated using molecular data. Multiple-locus heterozygosity (MLH) was equal to 0.206; runs of homozygosity (ROH) as proportion of the genome, averaged 16.44%; effective population size was 29.1, with an average inbreeding coefficient of 0.035, all estimated using SNP Data. Fine-scale population structure was analysed using NETVIEW, a population analysis pipeline. Visualisation of the high definition network captured relationships among individuals within and between subpopulations. Effects of unequal founder use, and ancestral inbreeding and selection, were evident. While current levels of Bullmastiff heterozygosity, inbreeding and homozygosity are not unusual, a relatively small effective population size indicates that a breeding strategy to reduce the inbreeding rate may be beneficial.	[Mortlock, Sally-Anne; Khatkar, Mehar S.; Williamson, Peter] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Williamson, P (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	p.williamson@sydney.edu.au	Mortlock, Sally/AAH-1584-2021	Mortlock, Sally-Anne/0000-0003-2327-9465	bequests of Sarah Ann Payton; Australian Postgraduate Award; Maple Simmons; STFC [ST/K001051/1] Funding Source: UKRI	bequests of Sarah Ann Payton; Australian Postgraduate Award(Australian Government); Maple Simmons; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by funds from the bequests of Sarah & Ann Payton, and Maple Simmons (PW); and an Australian Postgraduate Award (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell J., 2012, VET MED GUIDE DOG CA, V1st; Bijma P., 2000, LONG TERM GENETIC CO; Boichard D, 1997, GENET SEL EVOL, V29, P5, DOI 10.1051/gse:19970101; Boichard D, 2002, P 7 WORLD C GEN APPL; Brohee S, 2008, NAT PROTOC, V3, P1616, DOI 10.1038/nprot.2008.100; Calboli FCF, 2008, GENETICS, V179, P593, DOI 10.1534/genetics.107.084954; Coile C., 2005, ENCY DOG BREEDS; Coster A., 2014, PACKAGE PEDIGREE R P; Curik I, 2014, LIVEST SCI, V166, P26, DOI 10.1016/j.livsci.2014.05.034; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dobson JM, 2012, ISRN VET SCI; Edwards D S, 2003, Vet Comp Oncol, V1, P200, DOI 10.1111/j.1476-5810.2003.00025.x; Ferencakovic Maja, 2011, Agriculturae Conspectus Scientificus, V76, P325; Fernandez J, 2005, GENETICS, V170, P1313, DOI 10.1534/genetics.104.037325; Fletcher JL, 2011, BBA-MOL BASIS DIS, V1812, P1418, DOI 10.1016/j.bbadis.2011.06.001; Fletcher JL, 2010, JAVMA-J AM VET MED A, V237, P682, DOI 10.2460/javma.237.6.682; Gutierrez JP, 2005, J ANIM BREED GENET, V122, P172, DOI 10.1111/j.1439-0388.2005.00512.x; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Jansson M, 2014, J ANIM BREED GENET, V131, P153, DOI 10.1111/jbg.12060; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kijas James W, 2013, Methods Mol Biol, V1019, P331, DOI 10.1007/978-1-62703-447-0_14; Koechl Silvano, 2005, V297, P13; LACY RC, 1989, ZOO BIOL, V8, P111, DOI 10.1002/zoo.1430080203; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Leroy G, 2006, J ANIM BREED GENET, V123, P1, DOI 10.1111/j.1439-0388.2006.00565.x; Leroy G, 2011, ANIM GENET, V42, P66, DOI 10.1111/j.1365-2052.2010.02079.x; Leroy G, 2009, ANIM GENET, V40, P323, DOI 10.1111/j.1365-2052.2008.01842.x; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Lewis T W, 2015, Canine Genet Epidemiol, V2, P13, DOI 10.1186/s40575-015-0027-4; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Maki K, 2010, J ANIM BREED GENET, V127, P318, DOI 10.1111/j.1439-0388.2010.00851.x; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Morrissey J., 1999, BULLMASTIFF AUSTR HI; Mortlock SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121169; Neuditschko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048375; Nicholas FW, 2010, VET J, V183, P8, DOI 10.1016/j.tvjl.2009.11.008; Oliehoek PA, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-9; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pedersen Niels C, 2015, Canine Genet Epidemiol, V2, P14, DOI 10.1186/s40575-015-0026-5; Pertoldi C, 2013, J ANIM SCI, V91, P5122, DOI 10.2527/jas.2013-6617; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; R Core Team, 2014, LANG ENV STAT COMP V; Schoenebeck JJ, 2014, ANNU REV CELL DEV BI, V30, P535, DOI 10.1146/annurev-cellbio-100913-012927; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shariflou MR, 2011, VET J, V189, P203, DOI 10.1016/j.tvjl.2011.06.020; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Therneau Terry, R PACKAGE VERSION; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Voges S, 2009, J ANIM BREED GENET, V126, P357, DOI 10.1111/j.1439-0388.2009.00800.x; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Walkey B., 1992, THE BULLMASTIFF FANC; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Windig JJ, 2015, J ANIM BREED GENET, V132, P428, DOI 10.1111/jbg.12149; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x	58	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147941	10.1371/journal.pone.0147941	http://dx.doi.org/10.1371/journal.pone.0147941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824579	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600077
J	Kuhne, M; Knecht, S; Muhl, A; Reichlin, T; Pavlovic, N; Kessel-Schaefer, A; Kaufmann, BA; Schaer, B; Sticherling, C; Osswald, S				Kuehne, Michael; Knecht, Sven; Muehl, Aline; Reichlin, Tobias; Pavlovic, Nikola; Kessel-Schaefer, Arnheid; Kaufmann, Beat A.; Schaer, Beat; Sticherling, Christian; Osswald, Stefan			Fluoroscopy-Free Pulmonary Vein Isolation in Patients with Atrial Fibrillation and a Patent Foramen Ovale Using Solely an Electroanatomic Mapping System	PLOS ONE			English	Article							CATHETER ABLATION PROCEDURES; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; FOLLOW-UP; RISK; MANAGEMENT	Introduction The advent of electroanatomical mapping (EAM) systems for pulmonary vein isolation (PVI) has dramatically decreased radiation exposure. However, the need for some fluoroscopy remains for obtaining left atrial (LA) access. The aim was to test the feasibility of fluoroscopy-free PVI in patients with atrial fibrillation (AF) and a patent for a men ovale (PFO) guided solely by an EAM system. Methods Consecutive patients with AF undergoing PVI and documented PFO were studied. An EAM-guided approach without fluoroscopy and ultrasound was used. After completing the map of the right atrium, the superior vena cava and the coronary sinus, a catheter pull-down to the PFO was performed allowing LA access. The map of the LA and subsequent PVI was also performed without fluoroscopy. Results 30 patients [age 61 +/- 12 years, 73% male, ejection fraction 0.64 (0.53-0.65), LA size in parasternal long axis 38 +/- 7 mm] undergoing PVI were included. The time required for right atrial mapping including transseptal crossing was 9 +/- 4 minutes. Total procedure time was 127 +/- 37 minutes. Fluoroscopy-free PVI was feasible in 26/30 (87%) patients. In four patients, fluoroscopy was needed to access (n = 3) or to re-access (n = 1) the LA. In these four patients, total fluoroscopy time was 5 +/- 3 min and the DAP was 14.9 +/- 13.4 Gy*cm(2). Single-procedure success rate was 80% (24/30) after a median follow-up of 12 months. Conclusion In patients with a documented PFO, completely fluoroscopy-free PVI is feasible in the vast majority of cases.	[Kuehne, Michael; Knecht, Sven; Muehl, Aline; Reichlin, Tobias; Kessel-Schaefer, Arnheid; Kaufmann, Beat A.; Schaer, Beat; Sticherling, Christian; Osswald, Stefan] Univ Basel Hosp, Cardiol Electrophysiol, CH-4031 Basel, Switzerland; [Pavlovic, Nikola] Univ Hosp Ctr Sisters Mercy, Zagreb, Croatia	University of Basel	Kuhne, M (corresponding author), Univ Basel Hosp, Cardiol Electrophysiol, CH-4031 Basel, Switzerland.	michael.kuehne@usb.ch	Knecht, Sven/AAP-6941-2020; Sticherling, Christian/AAY-4435-2021; Kühne, Michael/AAB-5202-2022; Kaufmann, Beat/AAB-7805-2022; Osswald, Stefan/A-6904-2018	Sticherling, Christian/0000-0001-8428-7050; Kühne, Michael/0000-0002-2937-3711; Osswald, Stefan/0000-0002-9240-6731; Knecht, Sven/0000-0001-7122-021X; Pavlovic, Nikola/0000-0001-9187-7681; Kaufmann, Beat/0000-0001-6295-3630				Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Fernandez-Gomez JM, 2014, J CARDIOVASC ELECTR, V25, P638, DOI 10.1111/jce.12385; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Klein LW, 2009, HEART RHYTHM, V6, P439, DOI 10.1016/j.hrthm.2009.01.030; Knecht S, 2015, EUROPACE, V17, P1694, DOI 10.1093/europace/euv006; Kuhne M, 2013, J INTERV CARD ELECTR, V36, P47, DOI 10.1007/s10840-012-9740-z; Kuhl HP, 1999, J AM COLL CARDIOL, V34, P1823, DOI 10.1016/S0735-1097(99)00412-X; Lehrmann H, 2014, J CARDIOVASC ELECTR, V25, P479, DOI 10.1111/jce.12356; Lickfett L, 2004, CIRCULATION, V110, P3003, DOI 10.1161/01.CIR.0000146952.49223.11; Macias R, 2014, PACE, V37, P1029, DOI 10.1111/pace.12376; Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862; Pavlovic N, 2014, J INTERV CARD ELECTR, V41, P261, DOI 10.1007/s10840-014-9952-5; Perisinakis K, 2001, CIRCULATION, V104, P58, DOI 10.1161/hc2601.091710; Sorgente A, 2012, AM J CARDIOL, V109, P1179, DOI 10.1016/j.amjcard.2011.11.058	15	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148059	10.1371/journal.pone.0148059	http://dx.doi.org/10.1371/journal.pone.0148059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820309	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528400062
J	Rodriguez-Escudero, M; Cid, VJ; Molina, M; Schulze-Luehrmann, J; Luhrmann, A; Rodriguez-Escudero, I				Rodriguez-Escudero, Maria; Cid, Victor J.; Molina, Maria; Schulze-Luehrmann, Jan; Luehrmann, Anja; Rodriguez-Escudero, Isabel			Studying Coxiella burnetii Type IV Substrates in the Yeast Saccharomyces cerevisiae: Focus on Subcellular Localization and Protein Aggregation	PLOS ONE			English	Article							INTRACELLULAR REPLICATION; EFFECTOR PROTEIN; APOPTOSIS; PATHWAY; SYSTEM; IDENTIFICATION; EXPRESSION; SECRETION; ANKYRIN; KINASE	Coxiella burnetii is a Gram-negative obligate parasitic bacterium that causes the disease Q-fever in humans. To establish its intracellular niche, it utilizes the Icm/Dot type IVB secretion system (T4BSS) to inject protein effectors into the host cell cytoplasm. The host targets of most cognate and candidate T4BSS-translocated effectors remain obscure. We used the yeast Saccharomyces cerevisiae as a model to express and study six C. burnetii effectors, namely AnkA, AnkB, AnkF, CBU0077, CaeA and CaeB, in search for clues about their role in C. burnetii virulence. When ectopically expressed in HeLa cells, these effectors displayed distinct subcellular localizations. Accordingly, GFP fusions of these proteins produced in yeast also decorated distinct compartments, and most of them altered cell growth. CaeA was ubiquitinated both in yeast and mammalian cells and, in S. cerevisiae, accumulated at juxtanuclear quality-control compartments (JUNQs) and insoluble protein deposits (IPODs), characteristic of aggregative or misfolded proteins. AnkA, which was not ubiquitinated, accumulated exclusively at the IPOD. CaeA, but not AnkA or the other effectors, caused oxidative damage in yeast. We discuss that CaeA and AnkA behavior in yeast may rather reflect misfolding than recognition of conserved targets in the heterologous system. In contrast, CBU0077 accumulated at vacuolar membranes and abnormal ER extensions, suggesting that it interferes with vesicular traffic, whereas AnkB associated with the yeast nucleolus. Both effectors shared common localization features in HeLa and yeast cells. Our results support the idea that C. burnetii T4BSS effectors manipulate multiple host cell targets, which can be conserved in higher and lower eukaryotic cells. However, the behavior of CaeA and AnkA prompt us to conclude that heterologous protein aggregation and proteostatic stress can be a limitation to be considered when using the yeast model to assess the function of bacterial effectors.	[Rodriguez-Escudero, Maria; Cid, Victor J.; Molina, Maria; Rodriguez-Escudero, Isabel] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain; [Rodriguez-Escudero, Maria; Cid, Victor J.; Molina, Maria; Rodriguez-Escudero, Isabel] IRyCIS, Madrid, Spain; [Schulze-Luehrmann, Jan; Luehrmann, Anja] Univ Erlangen Nurnberg, Mikrobiol Inst Klin Mikrobiol Immunol & Hyg, Univ Klinikum Erlangen, D-91054 Erlangen, Germany	Complutense University of Madrid; University of Erlangen Nuremberg	Cid, VJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.; Cid, VJ (corresponding author), IRyCIS, Madrid, Spain.	vicjcid@ucm.es	Molina, Maria/ABE-7186-2021; CID, VICTOR JIMENEZ/I-1240-2015; Rodríguez, Isabel/I-5955-2017; JIMENEZ CID, VICTOR/ABC-4858-2021	Molina, Maria/0000-0003-0074-3309; CID, VICTOR JIMENEZ/0000-0002-3933-2016; Rodríguez, Isabel/0000-0002-1792-1143; JIMENEZ CID, VICTOR/0000-0002-3933-2016	ERA-NET Pathogenomics "CellPath" Project; Ministerio de Ciencia e Innovacion (Spain) [PIM2010EPA-00664]; ERA-NET PathoGenoMics "Cellpath" Project [0315903]	ERA-NET Pathogenomics "CellPath" Project; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ERA-NET PathoGenoMics "Cellpath" Project	This work was supported by the ERA-NET Pathogenomics "CellPath" Project, grant PIM2010EPA-00664 from Ministerio de Ciencia e Innovacion (Spain) to IRE, and ERA-NET PathoGenoMics "Cellpath" Project, grant 0315903, to AL.	Aleman A, 2005, CELL MICROBIOL, V7, P1432, DOI 10.1111/j.1462-5822.2005.00568.x; Beare PA, 2012, ADV EXP MED BIOL, V984, P249, DOI 10.1007/978-94-007-4315-1_13; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Berens C, 2015, JOVE-J VIS EXP, DOI 10.3791/52903; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Greenwood MT, 2010, CELL DEATH DIFFER, V17, P737, DOI 10.1038/cdd.2009.177; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Klingenbeck L, 2013, CELL MICROBIOL, V15, P675, DOI 10.1111/cmi.12066; Lifshitz Z, 2014, INFECT IMMUN, V82, P3740, DOI 10.1128/IAI.01729-14; Luhrmann A, 2010, P NATL ACAD SCI USA, V107, P18997, DOI 10.1073/pnas.1004380107; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Campoy EM, 2011, INFECT IMMUN, V79, P402, DOI 10.1128/IAI.00688-10; Martin H, 1997, MOL MICROBIOL, V23, P431, DOI 10.1046/j.1365-2958.1997.d01-1870.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Rennoll-Bankert KE, 2015, CELL MICROBIOL, V17, P1640, DOI 10.1111/cmi.12461; Rodiguez-Escudero I, 2006, MICROBIOL-SGM, V152, P3437, DOI 10.1099/mic.0.29186-0; Rodriguez-Escudero I, 2011, MOL MICROBIOL, V80, P1220, DOI 10.1111/j.1365-2958.2011.07639.x; Rodriguez-Escudero I, 2009, J BIOL CHEM, V284, P13373, DOI 10.1074/jbc.M807867200; ROMAN MJ, 1991, ACTA VIROL, V35, P503; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Valdivia RH, 2004, EUKARYOT CELL, V3, P827, DOI 10.1128/EC.3.4.827-834.2004; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Voth DE, 2009, CURR OPIN MICROBIOL, V12, P74, DOI 10.1016/j.mib.2008.11.005; Weber MM, 2013, J BACTERIOL, V195, P3914, DOI 10.1128/JB.00071-13; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973	42	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148032	10.1371/journal.pone.0148032	http://dx.doi.org/10.1371/journal.pone.0148032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821324	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400060
J	Xi, QY; Liu, ZH; Zhao, ZH; Luo, Q; Huang, ZW				Xi, Qunying; Liu, Zhihong; Zhao, Zhihui; Luo, Qin; Huang, Zhiwei			High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; ARTERIAL-HYPERTENSION; EMBOLISM; LESIONS; LYSIS	The pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) is unknown. Histopathologic studies revealed that pulmonary vasculature lesions similar to idiopathic pulmonary arterial hypertension (PAH) existed in CTEPH patients as well. It's well-known that genetic predisposition plays an important role in the mechanism of PAH. So we hypothesized that PAH-causing gene mutation might exist in some CTEPH patients and act as a background to facilitate the development of CTEPH. In this study, we analyzed 7 PAH-causing genes including BMPR2, ACVRL1, ENG, SMAD9, CAV1, KCNK3, and CBLN2 in 49 CTEPH patients and 17 patients recovered from pulmonary embolism (PE) but without pulmonary hypertension(PH). The results showed that the nonsynonymous mutation rate in CTEPH patients is significantly higher than that in PE without PH patients (25 out of 49 (51%) CTEPH patients vs. 3 out of 17 PE without PH patients (18%); p = 0.022). Four CTEPH patients had the same point mutation in ACVRL1 exon 10 (c. 1450C>G), a mutation approved to be associated with PH in a previous study. In addition, we identified two CTEPH associated SNPs (rs3739817 and rs55805125). Our results suggest that PAH-causing gene mutation might play an important role in the development of CTEPH.	[Xi, Qunying; Huang, Zhiwei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, Beijing 100730, Peoples R China; [Xi, Qunying; Liu, Zhihong; Zhao, Zhihui; Luo, Qin; Huang, Zhiwei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xi, Qunying; Liu, Zhihong; Zhao, Zhihui; Luo, Qin; Huang, Zhiwei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Ctr Pulm Vasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Liu, ZH (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.; Liu, ZH (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Ctr Pulm Vasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China.	fuwaipumc@163.com	Xi, Qunying/GWR-3728-2022	Liu, Zhihong/0000-0001-8639-6306; Huang, Zhiwei/0000-0002-6312-7434	National Key Technology R&D Program in the 12th Five year Plan of China [2011BA11B17]	National Key Technology R&D Program in the 12th Five year Plan of China(National Key Technology R&D Program)	This study was supported by a grant from National Key Technology R&D Program in the 12th Five year Plan of China (2011BA11B17). ZHL recieved the funding.	Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Becattini C, 2006, CHEST, V130, P172, DOI 10.1378/chest.130.1.172; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Delcroix M, 2013, EUR RESPIR J, V41, P224, DOI 10.1183/09031936.00047712; Germain M, 2013, NAT GENET, V45, P518, DOI 10.1038/ng.2581; Gurney AM, 2003, CIRC RES, V93, P957, DOI 10.1161/01.RES.0000099883.68414.61; Haythe J, 2012, PROG CARDIOVASC DIS, V55, P134, DOI 10.1016/j.pcad.2012.07.005; Huang Z, 2009, HUM MOL GENET, V18, P2791, DOI 10.1093/hmg/ddp214; Lang I, 2010, BRIT J HAEMATOL, V149, P478, DOI 10.1111/j.1365-2141.2010.08142.x; Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312; Ma LJ, 2014, HUM GENET, V133, P471, DOI 10.1007/s00439-014-1419-3; Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097; Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23; Miniati M, 2010, AM J RESP CRIT CARE, V181, P992, DOI 10.1164/rccm.200907-1135OC; Morris TA, 2006, AM J RESP CRIT CARE, V173, P1270, DOI 10.1164/rccm.200506-916OC; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Nijkeuter M, 2006, CHEST, V129, P192, DOI 10.1378/chest.129.1.192; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Ribeiro A, 1999, CIRCULATION, V99, P1325, DOI 10.1161/01.CIR.99.10.1325; Soubrier F, 2013, J AM COLL CARDIOL, V62, pD13, DOI 10.1016/j.jacc.2013.10.035; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Yi ES, 2000, AM J RESP CRIT CARE, V162, P1577, DOI 10.1164/ajrccm.162.4.9912131	23	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147396	10.1371/journal.pone.0147396	http://dx.doi.org/10.1371/journal.pone.0147396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820968	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400024
J	Teixeira, MBCG; Martins, GM; Miranda-Rodrigues, M; De Araujo, IF; Oliveira, R; Brum, PC; Gouveia, CHA				Cruz Grecco Teixeira, Marilia Bianca; Martins, Gisele Miyamura; Miranda-Rodrigues, Manuela; De Araujo, Iasmin Ferreira; Oliveira, Ricardo; Brum, Patricia Chakur; Azevedo Gouveia, Cecilia Helena			Lack of alpha(2C)-Adrenoceptor Results in Contrasting Phenotypes of Long Bones and Vertebra and Prevents the Thyrotoxicosis-Induced Osteopenia	PLOS ONE			English	Article							ALPHA(2)-ADRENERGIC RECEPTOR SUBTYPES; SYMPATHETIC-NERVOUS-SYSTEM; THYROID-HORMONE; TRABECULAR BONE; L-THYROXINE; LEPTIN; HYPERTHYROIDISM; MASS; METABOLISM; RELEASE	A series of studies have demonstrated that activation of the sympathetic nervous system (SNS) causes osteopenia via beta(2)-adrenoceptor (beta(2)-AR) signaling. However, in a recent study, we found an unexpected and generalized phenotype of high bone mass in female mice with chronic sympathetic hyperactivity, due to double gene inactivation of adrenoceptors that negatively regulate norepinephrine release, alpha(2A)-and alpha(2C)-AR (alpha(2A/2C)-AR(-/-)). These findings suggest that beta(2)-AR is not the single adrenoceptor involved in bone turnover regulation and show that alpha(2)-AR signaling may also mediate the SNS actions in the skeleton. In addition, we found that alpha(2A/2C)-AR(-/-) animals are resistant to the thyrotoxicosis-induced osteopenia, suggesting that thyroid hormone (TH), when in supraphysiological levels, interacts with the SNS to control bone mass and structure, and that this interaction may also involve alpha(2)-AR signaling. In the present study, to further investigate these hypotheses and to discriminate the roles of alpha(2)-AR subtypes, we have evaluated the bone phenotype of mice with the single gene inactivation of alpha(2C)-AR subtype, which mRNA expression was previously shown to be down regulated by triiodothyronine (T3). A cohort of 30 day-old female alpha(2C)AR(-/-) mice and their wild-type (WT) controls were treated with a supraphysiological dose of T3 for 30 or 90 days, which induced a thyrotoxic state in both mouse lineages. The microcomputed tomographic (mu CT) analysis showed that alpha(2C)-AR(-/-) mice present lower trabecular bone volume (BV/TV) and number (Tb.N), and increased trabecular separation (Tb.Sp) in the femur compared with WT mice; which was accompanied by decreased bone strength (determined by the three-point bending test) in the femur and tibia. The opposite was observed in the vertebra, where alpha(2C)-AR(-/-) mice show increased BV/TV, Tb.N and trabecular thickness (Tb.Th), and decreased Tb.Sp, compared with WT animals. In spite of the contrasting bone phenotypes of the femur and L5, thyrotoxicosis negatively regulated most of the micro architectural features of the trabecular bone in both skeletal sites of WT, but not of alpha(2C)-AR-/- mice. T3 treatment also decreased biomechanical properties (maximum load and ultimate load) in the femur and tibia of WT, but not of knockout mice. The mRNA expression of osteocalcin, a marker of mature osteoblasts, and tartrate-resistant acid phosphatase, which is expressed by osteoclasts and is involved in collagen degradation, was increased by T3 treatment only in WT, and not in alpha(2C)-AR(-/-) mice. Altogether, these findings suggest that alpha(2C)-AR subtype mediates the effects of the SNS in the bone in a skeletal site-dependent manner, and that thyrotoxicosis depends on alpha(2C)-AR signaling to promote bone loss, which sustains the hypothesis of a TH-SNS interaction to modulate bone remodeling and structure.	[Cruz Grecco Teixeira, Marilia Bianca; Martins, Gisele Miyamura; Miranda-Rodrigues, Manuela; De Araujo, Iasmin Ferreira; Azevedo Gouveia, Cecilia Helena] Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil; [Oliveira, Ricardo] RDODiagnost Med, Sao Paulo, Brazil; [Brum, Patricia Chakur] Univ Sao Paulo, Dept Biodinam Human Body Moviment, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Martins, Gisele Miyamura] Univ Fed Juiz de Fora, Hlth Basic Dept, Juiz De Fora, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Juiz de Fora	Gouveia, CHA (corresponding author), Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil.	cgouveia@usp.br	Gouveia, Cecilia H A/E-3444-2012; Brum, Patricia C/E-6605-2011; Oliveira, Ricardo/GVS-4393-2022	Gouveia, Cecilia H A/0000-0001-8662-943X; Brum, Patricia C/0000-0002-4750-6506; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/06409-0, 2010/50068-2]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) Grants: 2010/06409-0 and 2010/50068-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Bassett JHD, 2007, MOL ENDOCRINOL, V21, P1095, DOI 10.1210/me.2007-0033; Bassett JHD, 2003, TRENDS ENDOCRIN MET, V14, P356, DOI 10.1016/S1043-2760(03)00144-90; Beber EH, 2009, CALCIFIED TISSUE INT, V84, P324, DOI 10.1007/s00223-009-9230-1; BEYLOT M, 1982, NOUV PRESSE MED, V11, P989; BJURHOLM A, 1988, J AUTONOM NERV SYST, V25, P119, DOI 10.1016/0165-1838(88)90016-1; Bonnet N, 2005, MED SCI SPORT EXER, V37, P1493, DOI 10.1249/01.mss.0000177592.82507.95; Bonnet N., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P94; Bonnet N, 2007, J BONE MINER RES, V22, P578, DOI 10.1359/JBMR.070117; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Brede M, 2004, BIOL CELL, V96, P343, DOI 10.1016/j.biolcel.2004.03.006; Bucheler MM, 2002, NEUROSCIENCE, V109, P819, DOI 10.1016/S0306-4522(01)00531-0; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; COINDRE JM, 1986, ARCH INTERN MED, V146, P48, DOI 10.1001/archinte.146.1.48; Cray JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069067; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elefteriou F, 2014, CALCIFIED TISSUE INT, V94, P140, DOI 10.1007/s00223-013-9752-4; ERIKSEN EF, 1985, BONE, V6, P421, DOI 10.1016/8756-3282(85)90218-2; Fonseca TL, 2014, AM J PHYSIOL-ENDOC M, V307, pE408, DOI 10.1152/ajpendo.00643.2013; Fonseca TL, 2011, J BONE MINER RES, V26, P591, DOI 10.1002/jbmr.243; FOX KM, 1995, ANAT RECORD, V241, P284, DOI 10.1002/ar.1092410215; GARNERO P, 1994, J CLIN ENDOCR METAB, V78, P955, DOI 10.1210/jc.78.4.955; Gorka J, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/638727; Gouveia CHA, 1997, J BONE MINER RES, V12, P2098, DOI 10.1359/jbmr.1997.12.12.2098; Gribble FM, 2010, NEW ENGL J MED, V362, P361, DOI 10.1056/NEJMcibr0911499; Hamrick MW, 2004, J BONE MINER RES, V19, P1607, DOI 10.1359/JBMR.040712; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Kanbur Nuray O, 2002, Int J Adolesc Med Health, V14, P235; Kondo A, 2013, INT J MOL MED, V31, P1457, DOI 10.3892/ijmm.2013.1349; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; KRAGSTRUP J, 1981, METAB BONE DIS RELAT, V3, P181, DOI 10.1016/0221-8747(81)90006-0; KRANE SM, 1956, J CLIN INVEST, V35, P874, DOI 10.1172/JCI103340; Livak K, 1997, SEQUENCE DETECTION S; LU PW, 1994, BONE, V15, P199, DOI 10.1016/8756-3282(94)90708-0; MELSEN F, 1977, ACTA PATH MICRO IM A, V85, P141; Mlakar V, 2015, J CELL MOL MED; MOSEKILDE L, 1977, ACTA ENDOCRINOL-COP, V85, P515, DOI 10.1530/acta.0.0850515; MOSEKILDE L, 1978, ACTA PATH MICRO IM A, V86, P56; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Philbin KE, 2010, BRAIN RES, V1347, P65, DOI 10.1016/j.brainres.2010.06.001; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Rozanski A, 2013, MOL ENDOCRINOL, V27, P2055, DOI 10.1210/me.2013-1018; RUDE RK, 1976, NEW ENGL J MED, V294, P431, DOI 10.1056/NEJM197602192940807; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Scheibner J, 2001, BRIT J PHARMACOL, V132, P925, DOI 10.1038/sj.bjp.0703882; Senese R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00475; Suwanwalaikorn S, 1996, EUR J ENDOCRINOL, V134, P655, DOI 10.1530/eje.0.1340655; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TOH SH, 1985, ARCH INTERN MED, V145, P883, DOI 10.1001/archinte.145.5.883; Trost Z, 2010, BONE, V46, P72, DOI 10.1016/j.bone.2009.09.015; Warren JT, 2015, J CELL BIOCH; Waung JA, 2012, TRENDS ENDOCRIN MET, V23, P155, DOI 10.1016/j.tem.2011.11.002; Williams GR, 2014, ENDOCRINOLOGY, V155, P2747, DOI 10.1210/en.2014-1527; Williams GR, 2013, EUR THYROID J, V2, P3, DOI 10.1159/000345548	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146795	10.1371/journal.pone.0146795	http://dx.doi.org/10.1371/journal.pone.0146795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815679	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200020
J	Scholten, H; Malmberg, M; Lobel, A; Engels, RCME; Granic, I				Scholten, Hanneke; Malmberg, Monique; Lobel, Adam; Engels, Rutger C. M. E.; Granic, Isabela			A Randomized Controlled Trial to Test the Effectiveness of an Immersive 3D Video Game for Anxiety Prevention among Adolescents	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; CHILDHOOD ANXIETY; SOCIAL PHOBIA; WAITING-LIST; DEPRESSION; DISORDERS; CHILDREN; INTERVENTION; OUTCOMES; RISK	Adolescent anxiety is debilitating, the most frequently diagnosed adolescent mental health problem, and leads to substantial long-term problems. A randomized controlled trial (n = 138) was conducted to test the effectiveness of a biofeedback video game (Dojo) for adolescents with elevated levels of anxiety. Adolescents (11-15 years old) were randomly assigned to play Dojo or a control game (Rayman 2: The Great Escape). Initial screening for anxiety was done on 1,347 adolescents in five high schools; only adolescents who scored above the "at-risk" cut-off on the Spence Children Anxiety Survey were eligible. Adolescents' anxiety levels were assessed at pre-test, post-test, and at three month follow-up to examine the extent to which playing Dojo decreased adolescents' anxiety. The present study revealed equal improvements in anxiety symptoms in both conditions at follow-up and no differences between Dojo and the closely matched control game condition. Latent growth curve models did reveal a steeper decrease of personalized anxiety symptoms (not of total anxiety symptoms) in the Dojo condition compared to the control condition. Moderation analyses did not show any differences in outcomes between boys and girls nor did age differentiate outcomes. The present results are of importance for prevention science, as this was the first full-scale randomized controlled trial testing indicated prevention effects of a video game aimed at reducing anxiety. Future research should carefully consider the choice of control condition and outcome measurements, address the potentially high impact of participants' expectations, and take critical design issues into consideration, such as individual-versus group-based intervention and contamination issues.	[Scholten, Hanneke; Malmberg, Monique; Lobel, Adam; Engels, Rutger C. M. E.; Granic, Isabela] Radboud Univ Nijmegen, Inst Behav Sci, Dept Dev Psychopathol, NL-6525 ED Nijmegen, Netherlands; [Engels, Rutger C. M. E.] Trimbos Inst Netherlands Inst Mental Hlth & Add, Utrecht, Netherlands	Radboud University Nijmegen; Trimbos Institute	Scholten, H (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, Dept Dev Psychopathol, NL-6525 ED Nijmegen, Netherlands.	h.scholten@bsi.ru.nl		Engels, Rutger/0000-0003-1944-9126; Scholten, Hanneke/0000-0002-5471-6093				Albano AM, 2002, INT REV PSYCHIATR, V14, P129, DOI 10.1080/09540260220132644; Allart-van Dam E, 2003, BEHAV THER, V34, P381, DOI 10.1016/S0005-7894(03)80007-2; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; [Anonymous], 2008, PEW INTERNET AM LIFE; [Anonymous], 2011, ANXIETY DISORDERS CH; [Anonymous], 2004, PSYCHOPHYSIOLOGY TOD; Arrindell WA, 2001, BEHAV RES THER, V39, P1227, DOI 10.1016/S0005-7967(00)00104-2; Asparouhov T., 2010, WEIGHTED LEAST SQUAR; Baranowski T, 2008, AM J PREV MED, V34, P74, DOI 10.1016/j.amepre.2007.09.027; Barrett PM, 1998, J CLIN CHILD PSYCHOL, V27, P459, DOI 10.1207/s15374424jccp2704_10; Barrett PM, 1996, J CONSULT CLIN PSYCH, V64, P333, DOI 10.1037/0022-006X.64.2.333; Beale IL, 2007, J ADOLESCENT HEALTH, V41, P263, DOI 10.1016/j.jadohealth.2007.04.006; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Booth ML, 2004, J ADOLESCENT HEALTH, V34, P97, DOI 10.1016/j.jadohealth.2003.06.011; Bradley RT, 2010, APPL PSYCHOPHYS BIOF, V35, P261, DOI 10.1007/s10484-010-9134-x; Cartwright-Hatton S, 2004, BRIT J CLIN PSYCHOL, V43, P421, DOI 10.1348/0144665042388928; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Cole SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033909; Connolly TM, 2012, COMPUT EDUC, V59, P661, DOI 10.1016/j.compedu.2012.03.004; Crenshaw D. A., 2008, THERAPEUTIC ENGAGEME; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Donovan CL, 2000, CLIN PSYCHOL REV, V20, P509, DOI 10.1016/S0272-7358(99)00040-9; Duchesne S, 2008, J YOUTH ADOLESCENCE, V37, P1134, DOI 10.1007/s10964-007-9224-0; Duncan T, 2006, INTRO LATENT VARIABL; Fagundo AB, 2013, EUR EAT DISORD REV, V21, P493, DOI 10.1002/erv.2259; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feldner MT, 2004, CLIN PSYCHOL-SCI PR, V11, P405, DOI 10.1093/clipsy/bph098; Fernandez-Aranda F, 2012, J MENT HEALTH, V21, P364, DOI 10.3109/09638237.2012.664302; Fisak BJ, 2011, PREV SCI, V12, P255, DOI 10.1007/s11121-011-0210-0; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Furukawa TA, 2014, ACTA PSYCHIAT SCAND, V130, P181, DOI 10.1111/acps.12275; Gega L, 2004, J CLIN PSYCHOL, V60, P147, DOI 10.1002/jclp.10241; Girard C, 2013, J COMPUT ASSIST LEAR, V29, P207, DOI 10.1111/j.1365-2729.2012.00489.x; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Granic I, 2014, AM PSYCHOL, V69, P66, DOI 10.1037/a0034857; Greenberg BS, 2010, SIMULAT GAMING, V41, P238, DOI 10.1177/1046878108319930; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; Henderson S, 1981, NEUROSIS AND THE SOC; Henriques G, 2011, APPL PSYCHOPHYS BIOF, V36, P101, DOI 10.1007/s10484-011-9151-4; Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P87, DOI 10.1093/jpepsy/27.1.87; Homer BD, 2012, COMPUT HUM BEHAV, V28, P1782, DOI 10.1016/j.chb.2012.04.018; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Kendall P. C., 2011, CHILD ADOLESCENT THE; Kendall PC, 2004, J CONSULT CLIN PSYCH, V72, P276, DOI 10.1037/0022-006X.72.2.276; Klimes-Dougan B, 2001, DEV PSYCHOPATHOL, V13, P695, DOI 10.1017/S0954579401003157; Knox M, 2011, Ment Health Fam Med, V8, P195; Kuhn S, 2014, MOL PSYCHIATR, V19, P265, DOI 10.1038/mp.2013.120; Lock S, 2003, BEHAV CHANGE, V20, P183, DOI 10.1375/bech.20.4.183.29383; Manassis K, 2002, J AM ACAD CHILD PSY, V41, P1423, DOI 10.1097/00004583-200212000-00013; Marmorstein NR, 2007, J ANXIETY DISORD, V21, P420, DOI 10.1016/j.janxdis.2006.06.004; Mazzone L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-347; McGonigal J., 2011, REALITY IS BROKEN WH; Monk C, 2001, INT J NEUROPSYCHOPH, V4, P199, DOI 10.1017/S146114570100236X; Muris P, 2002, BEHAV RES THER, V40, P753, DOI 10.1016/S0005-7967(01)00056-0; Muris P, 2009, CHILD PSYCHIAT HUM D, V40, P139, DOI 10.1007/s10578-008-0116-7; Muthen B., 2010, MPLUS USERS GUIDE; Mychailyszyn MP, 2012, CLIN PSYCHOL-SCI PR, V19, P129, DOI 10.1111/j.1468-2850.2012.01279.x; Neil AL, 2009, CLIN PSYCHOL REV, V29, P208, DOI 10.1016/j.cpr.2009.01.002; Newman M. G., 2006, CLIN PSYCHOL, V10, P43, DOI DOI 10.1080/13284200500378779; Olson CK, 2010, REV GEN PSYCHOL, V14, P180, DOI 10.1037/a0018984; Primack BA, 2012, AM J PREV MED, V42, P630, DOI 10.1016/j.amepre.2012.02.023; Puffer S, 2005, J EVAL CLIN PRACT, V11, P479, DOI 10.1111/j.1365-2753.2005.00568.x; Rapee R. M., 2000, TREATING ANXIOUS CHI; Rapee RM, 2002, BIOL PSYCHIAT, V52, P947, DOI 10.1016/S0006-3223(02)01572-X; Reardon S, 2014, NATURE, V507, P288, DOI 10.1038/507288a; Reivich K., 2001, PREVENTION TREATMENT, V4, P1, DOI DOI 10.1037/1522-3736.4.1.49C; Schuller B, 2013, P IEEE INT C MAY 26, DOI [10.1109/ICASSP.2013.6639064, DOI 10.1109/ICASSP.2013.6639064]; Shaffer F., 2006, TXB COMPLEMENTARY AL, P291; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Spence, 1999, SPENCE CHILDRENS ANX; Spence SH, 2000, J CHILD PSYCHOL PSYC, V41, P713, DOI 10.1017/S0021963099005934; Stangier U, 2003, BEHAV RES THER, V41, P991, DOI 10.1016/S0005-7967(02)00176-6; Stice E, 2004, PSYCHOL BULL, V130, P206, DOI 10.1037/0033-2909.130.2.206; Stice E, 2010, J CONSULT CLIN PSYCH, V78, P273, DOI 10.1037/a0018396; Stice E, 2009, J CONSULT CLIN PSYCH, V77, P486, DOI 10.1037/a0015168; Terlecki M, 2011, CURR PSYCHOL, V30, P22, DOI 10.1007/s12144-010-9095-5; Teubert D, 2011, J ANXIETY DISORD, V25, P1046, DOI 10.1016/j.janxdis.2011.07.001; Thurber M. R., 2010, BIOFEEDBACK, V38, P28, DOI [DOI 10.5298/1081-5937-38.1.28, 10.5298/1081-5937-38.1.28]; van Rooij AJ, 2011, ADDICTION, V106, P205, DOI 10.1111/j.1360-0443.2010.03104.x; Ventura M, 2013, COMPUT EDUC, V60, P52, DOI 10.1016/j.compedu.2012.07.003; White KS, 2013, J CONSULT CLIN PSYCH, V81, P47, DOI 10.1037/a0030666; Wijnhoven LAMW, 2014, J ABNORM CHILD PSYCH, V42, P217, DOI 10.1007/s10802-013-9773-5; Woodward LJ, 2001, J AM ACAD CHILD PSY, V40, P1086, DOI 10.1097/00004583-200109000-00018; Wright JH, 2005, AM J PSYCHIAT, V162, P1158, DOI 10.1176/appi.ajp.162.6.1158; Yucha C., 2008, EVIDENCE BASED PRACT	89	46	48	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147763	10.1371/journal.pone.0147763	http://dx.doi.org/10.1371/journal.pone.0147763			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26816292	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200049
J	Wong, SM; Liu, FH; Lee, YL; Huang, HM				Wong, Shuit-Mun; Liu, Fu-Hwa; Lee, Yueh-Lun; Huang, Huei-Mei			MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CYCLE PROGRESSION; CANCER-CELLS; K562 CELLS; MESYLATE; KINASE; BCL-2; PHOSPHORYLATION; INDUCTION; ARREST	Chronic myeloid leukemia (CML) is a clonal disorder of hematopoietic stem/progenitor cells that is caused by the Bcr-Abl oncoprotein. Clinical resistance to the Bcr-Abl inhibitor imatinib is a critical problem in treating CML. This study investigated the antitumor effect and mechanism of MPT0B169, a new antitubulin agent, in K562 CML cells and their derived imatinib-resistant cells, IMR2 and IMR3. IMR2 and IMR3 cells showed complete resistance to imatinib-induced growth inhibition and apoptosis. Resistance involved ERK1/2 overactivation and MDR1 overexpression. MPT0B169 inhibited the growth of K562, IMR2, and IMR3 cells in a dose-and time-dependent manner. MPT0B169 substantially inhibited the mRNA and protein levels of Bcr-Abl, followed by its downstream pathways including Akt, ERK1/2, and STAT3 in these cells. MPT0B169 treatment resulted in a decrease in the polymer form of tubulin according to Western blot analysis. It triggered cell cycle arrest at the G2/M phase before apoptosis, which was related to the upregulation of the mitotic marker MPM2 and the cyclin B1 level, and a change in the phosphorylation of Cdk1. MPT0B169 induced apoptosis in nonresistant and imatinib-resistant cells via a mitochondrion-mediated caspase pathway. Further study showed that the agent led to a decrease in the antiapoptotic proteins Bcl-2, Bcl-xL, and Mcl-1 and an increase in the apoptotic protein Bax. Taken together, our results suggest that MPT0B169 might be a promising agent for overcoming imatinib resistance in CML cells.	[Wong, Shuit-Mun; Huang, Huei-Mei] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Liu, Fu-Hwa] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Lee, Yueh-Lun] Taipei Med Univ, Coll Med, Dept Microbiol & Immunol, Taipei, Taiwan	Taipei Medical University; Academia Sinica - Taiwan; Taipei Medical University	Huang, HM (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	cmbhhm@tmu.edu.tw			Ministry of Science and Technology, Taiwan, ROC [MOST 104-2320-B-038-028]	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology (MOST 104-2320-B-038-028), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves-Luquero CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006124; Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Baccarani M, 2015, ANN HEMATOL, V94, pS141, DOI 10.1007/s00277-015-2322-2; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Chen JG, 2002, CANCER RES, V62, P1935; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; CLARKE PR, 1991, J CELL SCI, V100, P409; Cory S, 2005, CANCER CELL, V8, P5, DOI 10.1016/j.ccr.2005.06.012; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Fava C, 2015, ANN HEMATOL, V94, pS123, DOI 10.1007/s00277-015-2321-3; Goldman JM, 2008, ACTA HAEMATOL-BASEL, V119, P212, DOI 10.1159/000140633; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Handa H, 1997, LEUKEMIA RES, V21, P479, DOI 10.1016/S0145-2126(97)00006-4; Holyoake TL, 2001, BRIT J HAEMATOL, V113, P11, DOI 10.1046/j.1365-2141.2001.02558.x; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Huang HM, 2004, BIOCHEM BIOPH RES CO, V320, P1247, DOI 10.1016/j.bbrc.2004.06.083; Hutchins JRA, 2004, CELL CYCLE, V3, P41; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kang CD, 2000, LEUKEMIA RES, V24, P527, DOI 10.1016/S0145-2126(00)00010-2; Kimura S, 2014, INT J CLIN ONCOL, V19, P3, DOI 10.1007/s10147-013-0641-7; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Lee J, 2013, BIOMED PHARMACOTHER, V67, P157, DOI 10.1016/j.biopha.2012.10.017; Lee WH, 2014, AM J PHYSIOL-CELL PH, V306, pC407, DOI 10.1152/ajpcell.00312.2013; Lee WH, 2013, PHARMACOLOGY, V92, P90, DOI 10.1159/000351852; Lee YL, 2013, PLOS ONE, V17; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Roy MJ, 2014, BRIT J PHARMACOL, V171, P1973, DOI 10.1111/bph.12431; Savitskaya MA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1393, DOI 10.1134/S0006297915110012; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Shi XP, 2009, CLIN CANCER RES, V15, P1686, DOI 10.1158/1078-0432.CCR-08-2141; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Wei GQ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-47	43	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148093	10.1371/journal.pone.0148093	http://dx.doi.org/10.1371/journal.pone.0148093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815740	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200073
J	Guseman, AJ; Miller, K; Kunkle, G; Dively, GP; Pettis, JS; Evans, JD; vanEngelsdorp, D; Hawthorne, DJ				Guseman, Alex J.; Miller, Kaliah; Kunkle, Grace; Dively, Galen P.; Pettis, Jeffrey S.; Evans, Jay D.; vanEngelsdorp, Dennis; Hawthorne, David J.			Multi-Drug Resistance Transporters and a Mechanism-Based Strategy for Assessing Risks of Pesticide Combinations to Honey Bees	PLOS ONE			English	Article							GLYCOPROTEIN-MEDIATED TRANSPORT; P-GLYCOPROTEIN; MALPIGHIAN TUBULES; ABC TRANSPORTERS; TRANSEPITHELIAL TRANSPORT; INSECTICIDE TOXICITY; DRUG INTERACTIONS; APIS-MELLIFERA; EXPRESSION; IVERMECTIN	Annual losses of honey bee colonies remain high and pesticide exposure is one possible cause. Dangerous combinations of pesticides, plant-produced compounds and antibiotics added to hives may cause or contribute to losses, but it is very difficult to test the many combinations of those compounds that bees encounter. We propose a mechanism-based strategy for simplifying the assessment of combinations of compounds, focusing here on compounds that interact with xenobiotic handling ABC transporters. We evaluate the use of ivermectin as a model substrate for these transporters. Compounds that increase sensitivity of bees to ivermectin may be inhibiting key transporters. We show that several compounds commonly encountered by honey bees (fumagillin, Pristine, quercetin) significantly increased honey bee mortality due to ivermectin and significantly reduced the LC50 of ivermectin suggesting that they may interfere with transporter function. These inhibitors also significantly increased honey bees sensitivity to the neonicotinoid insecticide acetamiprid. This mechanism-based strategy may dramatically reduce the number of tests needed to assess the possibility of adverse combinations among pesticides. We also demonstrate an in vivo transporter assay that provides physical evidence of transporter inhibition by tracking the dynamics of a fluorescent substrate of these transporters (Rhodamine B) in bee tissues. Significantly more Rhodamine B remains in the head and hemolymph of bees pretreated with higher concentrations of the transporter inhibitor verapamil. Mechanism-based strategies for simplifying the assessment of adverse chemical interactions such as described here could improve our ability to identify those combinations that pose significantly greater risk to bees and perhaps improve the risk assessment protocols for honey bees and similar sensitive species.	[Guseman, Alex J.; Miller, Kaliah; Kunkle, Grace; Dively, Galen P.; vanEngelsdorp, Dennis; Hawthorne, David J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Guseman, Alex J.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Pettis, Jeffrey S.; Evans, Jay D.] ARS, Bee Res Lab, USDA, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Agriculture (USDA)	Hawthorne, DJ (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	djh@umd.edu	vanEngelsdorp, Dennis/E-7934-2010; Evans, Jay/C-8408-2012	Evans, Jay/0000-0002-0036-4651; Guseman, Alex/0000-0002-9796-5719	USDA-ARS Bee Research Laboratory; Maryland Agricultural Experiment Station; UMD Libraries Open Access Publishing Fund; National Socio-Environmental Synthesis Center (SESYNC)-National Science Foundation (NSF) [DBI-1052875]; Direct For Biological Sciences [1052875] Funding Source: National Science Foundation; ARS [ARS-0425645] Funding Source: Federal RePORTER	USDA-ARS Bee Research Laboratory; Maryland Agricultural Experiment Station; UMD Libraries Open Access Publishing Fund; National Socio-Environmental Synthesis Center (SESYNC)-National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded primarily by a Cooperative Agreement with the USDA-ARS Bee Research Laboratory, and received partial funding by the Maryland Agricultural Experiment Station. Funding for Open Access was provided by the UMD Libraries Open Access Publishing Fund. D.J.H. received support from the National Socio-Environmental Synthesis Center (SESYNC)-National Science Foundation (NSF) award DBI-1052875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson O, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.50; Andersson O, 2013, J PHARMACOL EXP THER, V346, P211, DOI 10.1124/jpet.113.205476; Bain LJ, 1997, ENVIRON HEALTH PERSP, V105, P812, DOI 10.1289/ehp.97105812; Bain LJ, 1996, TOXICOL APPL PHARM, V141, P288, DOI 10.1016/S0041-008X(96)80035-4; Bartley DJ, 2009, PARASITOLOGY, V136, P1081, DOI 10.1017/S0031182009990345; Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Buss DS, 2002, MED VET ENTOMOL, V16, P218, DOI 10.1046/j.1365-2915.2002.00365.x; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chiu LY, 2010, TOXICOL LETT, V192, P408, DOI 10.1016/j.toxlet.2009.11.018; CLARK JM, 1995, ANNU REV ENTOMOL, V40, P1, DOI 10.1146/annurev.en.40.010195.000245; CORNWALL R, 1995, AQUAT TOXICOL, V31, P277, DOI 10.1016/0166-445X(94)00070-7; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Dunn ST, 2011, DRUG METAB DISPOS, V39, P789, DOI 10.1124/dmd.110.034827; Dupuy J, 2006, J VET PHARMACOL THER, V29, P489, DOI 10.1111/j.1365-2885.2006.00780.x; Dupuy J, 2003, VET PARASITOL, V112, P337, DOI 10.1016/S0304-4017(03)00008-6; FISHER MH, 1992, ANNU REV PHARMACOL, V32, P537, DOI 10.1146/annurev.pa.32.040192.002541; Frazier M, 2008, AM BEE J, V148, P521; Gaertner LS, 1998, J EXP BIOL, V201, P2637; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2013, J APPL ENTOMOL, V137, P35, DOI 10.1111/j.1439-0418.2012.01718.x; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Hull JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113046; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kerboeuf D, 2011, ANTIMICROB AGENTS CH, V55, P2224, DOI 10.1128/AAC.01477-10; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Labbe R, 2011, J EXP BIOL, V214, P937, DOI 10.1242/jeb.051060; Leader JP, 2005, J EXP BIOL, V208, P4363, DOI 10.1242/jeb.01911; Lee KV, 2015, NATL SURVEY MANAGED; Leroux P, 2013, EUR J PLANT PATHOL, V135, P683, DOI 10.1007/s10658-012-0105-3; Lespine A, 2009, CURR DRUG METAB, V10, P272, DOI 10.2174/138920009787846297; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P58, DOI 10.1016/j.ijpddr.2011.10.001; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Luo L, 2013, INSECT BIOCHEM MOLEC, V43, P627, DOI 10.1016/j.ibmb.2013.04.006; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; McFadzen I, 2000, MAR ENVIRON RES, V50, P319, DOI 10.1016/S0141-1136(00)00057-X; Merzendorfer H, 2014, ADV INSECT PHYSIOL, V46, P1, DOI 10.1016/B978-0-12-417010-0.00001-X; Morris ME, 2006, LIFE SCI, V78, P2116, DOI 10.1016/j.lfs.2005.12.003; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Pal D, 2006, J NEUROIMMUNE PHARM, V1, P323, DOI 10.1007/s11481-006-9034-2; Pang KS, 2009, MOL PHARMACEUT, V6, P1734, DOI 10.1021/mp900258z; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Podsiadlowski L, 1998, COMP BIOCHEM PHYS B, V121, P443, DOI 10.1016/S0305-0491(98)10137-2; Pohl PC, 2014, VET PARASITOL, V204, P316, DOI 10.1016/j.vetpar.2014.05.042; Pohl PC, 2011, INT J PARASITOL, V41, P1323, DOI 10.1016/j.ijpara.2011.08.004; Reybroeck W, 2012, VET MICROBIOL, V158, P1, DOI 10.1016/j.vetmic.2012.01.012; Schrickx J, 2007, J VET PHARMACOL THER, V30, P25, DOI 10.1111/j.1365-2885.2007.00808.x; Smital T, 2000, COMP BIOCHEM PHYS C, V126, P175, DOI 10.1016/S0742-8413(00)00110-9; Spurgeon DJ, 2010, SCI TOTAL ENVIRON, V408, P3725, DOI 10.1016/j.scitotenv.2010.02.038; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; TOMASBARBERAN FA, 1993, Z LEBENSM UNTERS FOR, V196, P38, DOI 10.1007/BF01192982; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; WEBSTER TC, 1994, J ECON ENTOMOL, V87, P601, DOI 10.1093/jee/87.3.601; Wolstenholme AJ, 2010, INVERTEBR NEUROSCI, V10, P5, DOI 10.1007/s10158-010-0105-y; Yoon KS, 2011, INSECT MOL BIOL, V20, P687, DOI 10.1111/j.1365-2583.2011.01097.x; Yoshida N, 2006, FOOD CHEM TOXICOL, V44, P2033, DOI 10.1016/j.fct.2006.07.003	68	21	22	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148242	10.1371/journal.pone.0148242	http://dx.doi.org/10.1371/journal.pone.0148242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840460	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200109
J	Teraguchi, M; Yoshimura, N; Hashizume, H; Muraki, S; Yamada, H; Oka, H; Minamide, A; Ishimoto, Y; Nagata, K; Kagotani, R; Tanaka, S; Kawaguchi, H; Nakamura, K; Akune, T; Yoshida, M				Teraguchi, Masatoshi; Yoshimura, Noriko; Hashizume, Hiroshi; Muraki, Shigeyuki; Yamada, Hiroshi; Oka, Hiroyuki; Minamide, Akihito; Ishimoto, Yuyu; Nagata, Keiji; Kagotani, Ryohei; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Akune, Toru; Yoshida, Munehito			Metabolic Syndrome Components Are Associated with Intervertebral Disc Degeneration: The Wakayama Spine Study	PLOS ONE			English	Article							LOW-BACK-PAIN; FOLLOW-UP; LUMBAR SPINE; KNEE OSTEOARTHRITIS; NUCLEUS PULPOSUS; EXPRESSION; LEPTIN; CLASSIFICATION; CALCIFICATION; HYPERTENSION	Objective The objective of the present study was to examine the associations between metabolic syndrome (MS) components, such as overweight (OW), hypertension (HT), dyslipidemia (DL), and impaired glucose tolerance (IGT), and intervertebral disc degeneration (DD). Design The present study included 928 participants (308 men, 620 women) of the 1,011 participants in the Wakayama Spine Study. DD on magnetic resonance imaging was classified according to the Pfirrmann system. OW, HT, DL, and IGT were assessed using the criteria of the Examination Committee of Criteria for MS in Japan. Results Multivariable logistic regression analysis revealed that OW was significantly associated with cervical, thoracic, and lumbar DD (cervical: odds ratio [OR], 1.28; 95% confidence interval [CI], 0.92-1.78; thoracic: OR, 1.75; 95% CI, 1.24-2.51; lumbar: OR, 1.87; 95% CI, 1.06-3.48). HT and IGT were significantly associated with thoracic DD (HT: OR, 1.54; 95% CI, 1.09-2.18; IGT: OR, 1.65; 95% CI, 1.12-2.48). Furthermore, subjects with 1 or more MS components had a higher OR for thoracic DD compared with those without MS components (vs. no component; 1 component: OR, 1.58; 95% CI, 1.03-2.42; 2 components: OR, 2.60; 95% CI, 1.62-4.20; >= 3 components: OR, 2.62; 95% CI, 1.42-5.00). Conclusion MS components were significantly associated with thoracic DD. Furthermore, accumulation of MS components significantly increased the OR for thoracic DD. These findings support the need for further studies of the effects of metabolic abnormality on DD.	[Teraguchi, Masatoshi; Hashizume, Hiroshi; Yamada, Hiroshi; Minamide, Akihito; Ishimoto, Yuyu; Nagata, Keiji; Kagotani, Ryohei; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan; [Yoshimura, Noriko; Muraki, Shigeyuki] Univ Tokyo, Dept Joint Dis, Century Med & Res Ctr 22, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Oka, Hiroyuki] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, Century Med & Res Ctr 22, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Kawaguchi, Hiroshi] Japan Community Healthcare Org, Tokyo Shinjuku Med Ctr, Shinjuku Ku, 5-1 Tsukudo Chome, Tokyo 1628543, Japan; [Nakamura, Kozo; Akune, Toru] Natl Rehabil Ctr Persons Disabil, Rehabil Serv Bur, 1 Namiki 4 Chome, Tokorozawa, Saitama 3598555, Japan	Wakayama Medical University; University of Tokyo; University of Tokyo; University of Tokyo	Hashizume, H (corresponding author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.	hashizum@wakayama-med.ac.jp	Tanaka, Sakae/Y-3061-2019; Hashizume, Hiroshi/V-6888-2019	Tanaka, Sakae/0000-0001-9210-9414; Hashizume, Hiroshi/0000-0002-9064-0284; Nagata, Keiji/0000-0002-9251-672X	Ministry of Health, Labour and Welfare [H23-Choujyu-002, H-25-Choujyu-007, H25-Nanchitou (Men)-005, 201417014A, H22-Choujyu-Wakate-007]; JSPS KAKENHI [B26293139, B23390172, B2629333, C20591774, C26462249, C25462305, B25860448, B26861286, B26860419, B15K20013, 15K15219, 26670307, 24659666, 25670293]; Japanese Orthopaedics and Traumatology Foundation, Inc. [287]; NSF from the Ministry of Education, Culture, Sports, Science and Technology in Japan [08033011-00262]; Japan Osteoporosis Society; JA Kyosai Research Institute; Mitsui Sumitomo Insurance Welfare Foundation; Japanese Orthopaedic Association (JOA) [2006-1, 2010-2]; Grants-in-Aid for Scientific Research [26462249] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Orthopaedics and Traumatology Foundation, Inc.; NSF from the Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Osteoporosis Society(Japan Osteoporosis Society); JA Kyosai Research Institute; Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Japanese Orthopaedic Association (JOA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by H23-Choujyu-002 (Director, Toru Akune), H-25-Choujyu-007 (Director, Noriko Yoshimura), H25-Nanchitou (Men)-005 (Director, Sakae Tanaka), 201417014A (Director, Noriko Yoshimura), and H22-Choujyu-Wakate-007 (Director, Shigeyuki Muraki) from the Ministry of Health, Labour and Welfare; a Grant-in-Aid for Scientific Research (B26293139, B23390172 to Noriko Yoshimura, B2629333, C20591774 to Shigeyuki Muraki, C26462249 to Hiroshi Hashizume, C25462305 to Hiroshi Yamada) and a Grant-in-Aid for Young Researcher (B25860448 to Yuyu Ishimoto, B26861286 to Masatoshi Teraguchi, B26860419 to Ryohei Kagotani, B15K20013 to Hiroki Iwahashi), and Grant-in-Aid for Challenging Exploratory Research (15K15219 to Noriko Yoshimura, 26670307 to Shigeyuki Muraki, 24659666 to Hiroyuki Oka, 25670293 to Toru Akune) of JSPS KAKENHI grant; a Grant from the Japanese Orthopaedics and Traumatology Foundation, Inc. (No. 287) to Masatoshi Teraguchi; and Collaborating Research with NSF 08033011-00262 (Director, Noriko Yoshimura) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. This study was also supported by grants from the Japan Osteoporosis Society (Noriko Yoshimura, Shigeyuki Muraki, Hiroyuki Oka, and Toru Akune), a grant from JA Kyosai Research Institute (Hiroyuki Oka), a grant from Mitsui Sumitomo Insurance Welfare Foundation (Shigeyuki Muraki), and research aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2006-1 & 2010-2; Director, Hiroshi Kawaguchi).	ALEXANDER RW, 1995, HYPERTENSION, V25, P155, DOI 10.1161/01.HYP.25.2.155; Anekstein Y, 2010, ISR MED ASSOC J, V12, P16; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Benneker LM, 2005, EUR SPINE J, V14, P27, DOI 10.1007/s00586-004-0759-4; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Borenstein DG, 2001, J BONE JOINT SURG AM, V83A, P1306, DOI 10.2106/00004623-200109000-00002; de Schepper EIT, 2010, SPINE, V35, P531, DOI 10.1097/BRS.0b013e3181aa5b33; Gruber HE, 2007, SPINE J, V7, P437, DOI 10.1016/j.spinee.2006.08.001; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hangai M, 2008, SPINE J, V8, P732, DOI 10.1016/j.spinee.2007.07.392; HART DJ, 1995, J RHEUMATOL, V22, P1118; Jhawar Balraj S, 2006, Spine J, V6, P684, DOI 10.1016/j.spinee.2006.04.016; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; Kauppila LI, 1997, SPINE, V22, P1642, DOI 10.1097/00007632-199707150-00023; Kauppila LI, 2004, SPINE, V29, P2147, DOI 10.1097/01.brs.0000141168.77393.b8; Kauppila LI, 1997, ANN RHEUM DIS, V56, P591, DOI 10.1136/ard.56.10.591; Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08; Li Z, 2013, J ORTHOP RES, V31, P847, DOI 10.1002/jor.22308; Liuke M, 2005, INT J OBESITY, V29, P903, DOI 10.1038/sj.ijo.0802974; Lotan R, 2008, J SPINAL DISORD TECH, V21, P247, DOI 10.1097/BSD.0b013e31813707af; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Ministry of Health Labour and Welfare, 2008, OUTL RES NAT HLTH NU; Okada E, 2009, SPINE, V34, P706, DOI 10.1097/BRS.0b013e31819c2003; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Samartzis D, 2012, ARTHRITIS RHEUM-US, V64, P1488, DOI 10.1002/art.33462; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Shibata Kiyoshi, 2010, Environmental Health and Preventive Medicine, V15, P229, DOI 10.1007/s12199-009-0132-7; Suri P, 2012, SPINE J, V12, P315, DOI 10.1016/j.spinee.2012.03.033; Takatalo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056244; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; The Examination Committee of Criteria for Metabolic Syndrome, 2005, J JPN SOC INT MED, V94, P794; Tsai TT, 2014, J ORTHOP RES, V32, P238, DOI 10.1002/jor.22508; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Videman T, 2000, J ORTHOPAED RES, V18, P768, DOI 10.1002/jor.1100180514; Vitale C, 2006, Minerva Med, V97, P219; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006; Yoshimura N, 2000, J RHEUMATOL, V27, P429; Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Zhao CQ, 2008, SPINE, V33, pE858, DOI 10.1097/BRS.0b013e31818338e5; ZIV I, 1992, J ORTHOPAED RES, V10, P205, DOI 10.1002/jor.1100100207	46	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147565	10.1371/journal.pone.0147565	http://dx.doi.org/10.1371/journal.pone.0147565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840834	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200047
J	Wang, LL; Dumoulin, A; Renner, M; Triller, A; Specht, CG				Wang, Lili; Dumoulin, Andrea; Renner, Marianne; Triller, Antoine; Specht, Christian G.			The Role of Synaptopodin in Membrane Protein Diffusion in the Dendritic Spine Neck	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; ACTIN-ASSOCIATED PROTEIN; SYNAPTIC PLASTICITY; ENDOPLASMIC-RETICULUM; AMPA RECEPTORS; APPARATUS; DYNAMICS; NEURONS; RAT; COMPARTMENTALIZATION	The dynamic exchange of neurotransmitter receptors at synapses relies on their lateral diffusion in the plasma membrane. At synapses located on dendritic spines this process is limited by the geometry of the spine neck that restricts the passage of membrane proteins. Biochemical compartmentalisation of the spine is believed to underlie the input-specificity of excitatory synapses and to set the scale on which functional changes can occur. Synaptopodin is located predominantly in the neck of dendritic spines, and is thus ideally placed to regulate the exchange of synaptic membrane proteins. The central aim of our study was to assess whether the presence of synaptopodin influences the mobility of membrane proteins in the spine neck and to characterise whether this was due to direct molecular interactions or to spatial constraints that are related to the structural organisation of the neck. Using single particle tracking we have identified a specific effect of synaptopodin on the diffusion of metabotropic mGluR5 receptors in the spine neck. However, super-resolution STORM/PALM imaging showed that this was not due to direct interactions between the two proteins, but that the presence of synaptopodin is associated with an altered local organisation of the F-actin cytoskeleton, that in turn could restrict the diffusion of membrane proteins with large intracellular domains through the spine neck. This study contributes new data on the way in which the spine neck compartmentalises excitatory synapses. Our data complement models that consider the impact of the spine neck as a function of its shape, by showing that the internal organisation of the neck imposes additional physical barriers to membrane protein diffusion.	[Wang, Lili; Dumoulin, Andrea; Renner, Marianne; Triller, Antoine; Specht, Christian G.] Ecole Normale Super, CNRS 8197, INSERM, Biol Cellulaire Synapse,U1024,Inst Biol, 24 Rue Lhomond, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Triller, A (corresponding author), Ecole Normale Super, CNRS 8197, INSERM, Biol Cellulaire Synapse,U1024,Inst Biol, 24 Rue Lhomond, F-75231 Paris, France.	triller@biologie.ens.fr	wang, lili/HDL-7210-2022; Renner, Marianne/H-5315-2011	TRILLER, Antoine/0000-0002-7530-1233; Specht, Christian G/0000-0001-6038-7735; Dumoulin, Andrea/0000-0003-1309-3448; Renner, Marianne/0000-0002-8727-6581	Agence Nationale de la Recherche (ANR, Synaptune); European Research Council (ERC); Labex (Memolife); France-BioImaging (FBI); China Scholarship Council (CSC) [2011614094]	Agence Nationale de la Recherche (ANR, Synaptune)(French National Research Agency (ANR)); European Research Council (ERC)(European Research Council (ERC)); Labex (Memolife); France-BioImaging (FBI)(French National Research Agency (ANR)); China Scholarship Council (CSC)(China Scholarship Council)	This research was funded by the Agence Nationale de la Recherche (ANR, Synaptune), European Research Council (ERC), Labex (Memolife), and France-BioImaging (FBI). LW was supported by the China Scholarship Council (CSC, fellowship No. 2011614094). The funding organisations had no influence in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00142; Araya R, 2014, P NATL ACAD SCI USA, V111, pE2895, DOI 10.1073/pnas.1321869111; Arizono M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002498; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BUCKLE PJ, 1982, J PHYSIOL-LONDON, V326, P109, DOI 10.1113/jphysiol.1982.sp014180; Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100; Deller T, 2000, J COMP NEUROL, V418, P164, DOI 10.1002/(SICI)1096-9861(20000306)418:2<164::AID-CNE4>3.0.CO;2-0; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Enz R, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00052; Ewers H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113916; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hennekinne L, 2013, J NEUROSCI, V33, P11432, DOI 10.1523/JNEUROSCI.5247-12.2013; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Kalinowska M, 2015, J BIOL CHEM; Korkotian E, 2014, J NEUROSCI, V34, P11641, DOI 10.1523/JNEUROSCI.0381-14.2014; Kusters R, 2013, BIOPHYS J, V105, P2743, DOI [10.1016/j.bpj.2013.41.016, 10.1016/j.bpj.2013.11.016]; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Orth CB, 2005, J COMP NEUROL, V487, P227, DOI 10.1002/cne.20539; Ouyang Y, 2007, BRAIN RES, V1143, P238, DOI 10.1016/j.brainres.2007.01.077; Perroy J, 2008, J BIOL CHEM, V283, P6799, DOI 10.1074/jbc.M705661200; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Renner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025731; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Ribrault C, 2011, J NEUROSCI, V31, P17590, DOI 10.1523/JNEUROSCI.4065-11.2011; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Segal M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00064; Simon CM, 2014, J COMPUT NEUROSCI, V36, P483, DOI 10.1007/s10827-013-0482-4; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takasaki K, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00029; Tonnesen J, 2014, NAT NEUROSCI, V17, P678, DOI 10.1038/nn.3682; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vlachos A, 2013, P NATL ACAD SCI USA, V110, P8242, DOI 10.1073/pnas.1213677110; Vlachos A, 2012, ANN ANAT, V194, P317, DOI 10.1016/j.aanat.2011.10.014; Vlachos A, 2009, J NEUROSCI, V29, P1017, DOI 10.1523/JNEUROSCI.5528-08.2009; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009	49	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148310	10.1371/journal.pone.0148310	http://dx.doi.org/10.1371/journal.pone.0148310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840625	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200124
J	Liu, CB; Tsow, F; Zou, Y; Tao, NJ				Liu, Chenbin; Tsow, Francis; Zou, Yi; Tao, Nongjian			Particle Pollution Estimation Based on Image Analysis	PLOS ONE			English	Article							AIR-POLLUTION; VISIBILITY	Exposure to fine particles can cause various diseases, and an easily accessible method to monitor the particles can help raise public awareness and reduce harmful exposures. Here we report a method to estimate PM air pollution based on analysis of a large number of outdoor images available for Beijing, Shanghai (China) and Phoenix (US). Six image features were extracted from the images, which were used, together with other relevant data, such as the position of the sun, date, time, geographic information and weather conditions, to predict PM2.5 index. The results demonstrate that the image analysis method provides good prediction of PM2.5 indexes, and different features have different significance levels in the prediction.	[Liu, Chenbin; Tao, Nongjian] Nanjing Univ, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China; [Tsow, Francis; Tao, Nongjian] Arizona State Univ, Biodesign Inst, Ctr Bioelect & Biosensors, Tempe, AZ USA; [Zou, Yi] Beijing Kinto Investment Management Co Ltd, Beijing, Peoples R China	Nanjing University; Arizona State University; Arizona State University-Tempe	Tao, NJ (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China.; Tao, NJ (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Bioelect & Biosensors, Tempe, AZ USA.	njtao@asu.edu	Liu, Chenbin/J-4691-2019	Liu, Chenbin/0000-0002-2037-5630	National Natural Science Foundation of China [21575062, 21327902]; Beijing Kinto Investment Management Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Kinto Investment Management Co., Ltd	This study was supported by the National Natural Science Foundation of China, grant numbers 21575062, 21327902, http://isisn.nsfc.gov.cn/egrantweb/, Nongjian Tao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beijing Kinto Investment Management Co., Ltd provided support in the form of salaries for an author [YZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the author contributions section.	Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Anderson TL, 1998, AEROSOL SCI TECH, V29, P57, DOI 10.1080/02786829808965551; Byun H, 2002, LECT NOTES COMPUT SC, V2388, P213; Carr P, 2009, 2009 DIGITAL IMAGE COMPUTING: TECHNIQUES AND APPLICATIONS (DICTA 2009), P103, DOI 10.1109/DICTA.2009.25; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Day DE, 2001, ATMOS ENVIRON, V35, P5169, DOI 10.1016/S1352-2310(01)00320-X; dos Santos EM, 2001, XIV BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P399, DOI 10.1109/SIBGRAPI.2001.963105; Fattal R, 2014, ACM T GRAPHIC, V34, DOI 10.1145/2651362; Fattal R, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360671; Hauck H, 2004, J AEROSOL SCI, V35, P1135, DOI 10.1016/j.jaerosci.2004.04.004; Huang W, 2009, SCI TOTAL ENVIRON, V407, P3295, DOI 10.1016/j.scitotenv.2009.02.019; Hyslop NP, 2009, ATMOS ENVIRON, V43, P182, DOI 10.1016/j.atmosenv.2008.09.067; Jacobs N, 2007, IEEE I CONF COMP VIS, P1305; Jolliffe I., 2014, PRINCIPAL COMPONENT; KOSCHMIEDER H., 1924, BEITR PHYS FREIEN AT, V12, P171; MACIAS ES, 1976, ENVIRON SCI TECHNOL, V10, P904, DOI 10.1021/es60120a015; MALM WC, 1980, JAPCA J AIR WASTE MA, V30, P122, DOI 10.1080/00022470.1980.10465927; McCartney EJ, 1975, OPTICS ATMOSPHERE SC; MUIR D, 1995, ATMOS ENVIRON, V29, P959, DOI 10.1016/1352-2310(94)00370-Z; Narasimhan SG, 2002, INT J COMPUT VISION, V48, P233, DOI 10.1023/A:1016328200723; Ni KS, 2007, IEEE T IMAGE PROCESS, V16, P1596, DOI 10.1109/TIP.2007.896644; Noble CA, 2001, AEROSOL SCI TECH, V34, P457, DOI 10.1080/027868201750172914; Olman CA, 2004, VISION RES, V44, P669, DOI 10.1016/j.visres.2003.10.022; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Reda I, 2004, SOL ENERGY, V76, P577, DOI 10.1016/j.solener.2003.12.003; Ruppecht E, 1992, J AEROSOL SCI, V23, P635, DOI [DOI 10.1016/0021-8502(92)90492-E, 10.1016/0021-8502(92)90492-E]; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Smith JD, 2001, ANALYST, V126, P1216, DOI 10.1039/b101491i; Swietlicki E, 1999, ATMOS RES, V50, P205, DOI 10.1016/S0169-8095(98)00105-7; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wang HQ, 2014, 2014 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING CONFERENCE, P326, DOI 10.1109/VCIP.2014.7051572	33	43	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0145955	10.1371/journal.pone.0145955	http://dx.doi.org/10.1371/journal.pone.0145955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828757	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200004
J	DebRoy, C; Fratamico, PM; Yan, XH; Baranzoni, GM; Liu, YH; Needleman, DS; Tebbs, R; O'Connell, CD; Allred, A; Swimley, M; Mwangi, M; Kapur, V; Garay, JAR; Roberts, EL; Katani, R				DebRoy, Chitrita; Fratamico, Pina M.; Yan, Xianghe; Baranzoni, GianMarco; Liu, Yanhong; Needleman, David S.; Tebbs, Robert; O'Connell, Catherine D.; Allred, Adam; Swimley, Michelle; Mwangi, Michael; Kapur, Vivek; Garay, Juan A. Raygoza; Roberts, Elisabeth L.; Katani, Robab			Comparison of O-Antigen Gene Clusters of All O-Serogroups of Escherichia coli and Proposal for Adopting a New Nomenclature for O-Typing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ABC TRANSPORTER; DNA MICROARRAY; IDENTIFICATION; SEQUENCE; STRAINS; O145; BIOSYNTHESIS; DIVERSITY; PATHWAYS	Escherichia coli strains are classified based on O-antigens that are components of the lipopolysaccharide (LPS) in the cell envelope. O-antigens are important virulence factors, targets of both the innate and adaptive immune system, and play a role in host-pathogen interactions. Because they are highly immunogenic and display antigenic specificity unique for each strain, O-antigens are the biomarkers for designating O-types. Immunologically, 185 O-serogroups and 11 OX-groups exist for classification. Conventional serotyping for O-typing entails agglutination reactions between the O-antigen and antisera generated against each O-group. The procedure is labor intensive, not always accurate, and exhibits equivocal results. In this report, we present the sequences of 71 O-antigen gene clusters (O-AGC) and a comparison of all 196 O- and OX-groups. Many of the designated O-types, applied for classification over several decades, exhibited similar nucleotide sequences of the O-AGCs and cross-reacted serologically. Some O-AGCs carried insertion sequences and others had only a few nucleotide differences between them. Thus, based on these findings, it is proposed that several of the E. coli O-groups may be merged. Knowledge of the O-AGC sequences facilitates the development of molecular diagnostic platforms that are rapid, accurate, and reliable that can replace conventional serotyping. Additionally, with the scientific knowledge presented, new frontiers in the discovery of biomarkers, understanding the roles of O-antigens in the innate and adaptive immune system and pathogenesis, the development of glycoconjugate vaccines, and other investigations, can be explored.	[DebRoy, Chitrita; Mwangi, Michael; Kapur, Vivek; Garay, Juan A. Raygoza; Roberts, Elisabeth L.; Katani, Robab] Penn State Univ, Dept Vet & Biomed Sci, E Coli Reference Ctr, Univ Pk, Pennsauken, NJ USA; [Fratamico, Pina M.; Yan, Xianghe; Baranzoni, GianMarco; Liu, Yanhong; Needleman, David S.] ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA USA; [Tebbs, Robert; O'Connell, Catherine D.; Allred, Adam; Swimley, Michelle] Thermo Fisher Sci, Anim Hlth & Food Safety Life Sci Solut, Austin, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; United States Department of Agriculture (USDA); Thermo Fisher Scientific	DebRoy, C (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, E Coli Reference Ctr, Univ Pk, Pennsauken, NJ USA.	rcd3@psu.edu	Garay, Juan Antonio Raygoza/AAM-9568-2021; Katani, Robab/AAS-1292-2020; Liu, Yanhong/L-7093-2019	Liu, Yanhong/0000-0002-0759-7597	Thermo Fisher Scientific	Thermo Fisher Scientific	Thermo Fisher Scientific partially supported sequencing of the O-antigen gene clusters and purchased some of the reference standard strains. Robert Tebbs and Michelle Swimley contributed on a technical level through generating whole genome sequencing results for some of the strains. Adam Aldred was involved in genome assembly.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; Bugarel M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/j.ijfoodmicro.2010.07.010; Cheng JS, 2006, CURR MICROBIOL, V53, P470, DOI 10.1007/s00284-006-0032-7; Coimbra RS, 2000, RES MICROBIOL, V151, P639, DOI 10.1016/S0923-2508(00)00134-0; DebRoy Chitrita, 2011, Animal Health Research Reviews, V12, P169, DOI 10.1017/S1466252311000193; DebRoy C, 2011, FOODBORNE PATHOG DIS, V8, P651, DOI 10.1089/fpd.2010.0769; DebRoy C, 2010, FOODBORNE PATHOG DIS, V7, P1407, DOI 10.1089/fpd.2010.0614; Duda KA, 2011, MICROBIOL-SGM, V157, P1750, DOI 10.1099/mic.0.046912-0; Ewing W., 1972, GENUS ESCHERICHIA; Ewing WH, 1956, STUD SER ESCH COL GR; Feng L, 2004, J BACTERIOL, V186, P4510, DOI 10.1128/JB.186.14.4510-4519.2004; Fratamico PM, 2010, CAN J MICROBIOL, V56, P308, DOI [10.1139/W10-010, 10.1139/w10-010]; Fratamico PM, 2009, FOODBORNE PATHOG DIS, V6, P605, DOI 10.1089/fpd.2008.0254; Gehring A, 2013, SENSORS-BASEL, V13, P5737, DOI 10.3390/s130505737; Geue L, 2014, MICROBIOL IMMUNOL, V58, P77, DOI 10.1111/1348-0421.12120; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Han WQ, 2007, APPL ENVIRON MICROB, V73, P4082, DOI 10.1128/AEM.01820-06; Hegde NV, 2013, J MICROBIOL METH, V93, P273, DOI 10.1016/j.mimet.2013.03.024; Hegde NV, 2012, FOODBORNE PATHOG DIS, V9, P1044, DOI 10.1089/fpd.2012.1231; Hegde NV, 2012, J CLIN MICROBIOL, V50, P2137, DOI 10.1128/JCM.00137-12; HOBBS M, 1994, MOL MICROBIOL, V12, P855, DOI 10.1111/j.1365-2958.1994.tb01071.x; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Jensen SO, 2004, CAN J MICROBIOL, V50, P299, DOI 10.1139/W04-010; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Kauffmann F., 1943, ACTA PATH ET MICROBIOL SCAND, V20, P21; Kauffmann F., 1944, ADA PATH ET MICROBIOL SCAND, V21, P20; KAUFFMANN F, 1947, J IMMUNOL, V57, P71; Lacher DW, 2014, APPL ENVIRON MICROB, V80, P4677, DOI 10.1128/AEM.01049-14; Lin A, 2011, J MICROBIOL METH, V87, P105, DOI 10.1016/j.mimet.2011.07.019; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Liu B, 2010, VET MICROBIOL, V142, P373, DOI 10.1016/j.vetmic.2009.10.019; Liu YH, 2008, FOODBORNE PATHOG DIS, V5, P449, DOI 10.1089/fpd.2008.0096; Liu YH, 2006, MOL CELL PROBE, V20, P239, DOI 10.1016/j.mcp.2006.01.001; Liu YH, 2015, BIOSENSORS-BASEL, V5, P51, DOI 10.3390/bios5010051; Medina MB, 2012, J FOOD PROTECT, V75, P819, DOI 10.4315/0362-028X.JFP-11-430; ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Perepelov AV, 2010, CARBOHYD RES, V345, P1594, DOI 10.1016/j.carres.2010.04.023; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sanchez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117660; Scheutz F, 2004, APMIS, V112, P569, DOI 10.1111/j.1600-0463.2004.apm1120903.x; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Wang W, 2007, MICROBIOL-SGM, V153, P2159, DOI 10.1099/mic.0.2007/004192-0; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001	51	67	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147434	10.1371/journal.pone.0147434	http://dx.doi.org/10.1371/journal.pone.0147434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824864	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600032
J	Ash, GI; Kostek, MA; Lee, H; Angelopoulos, TJ; Clarkson, PM; Gordon, PM; Moyna, NM; Visich, PS; Zoeller, RF; Price, TB; Devaney, JM; Gordish-Dressman, H; Thompson, PD; Hoffman, EP; Pescatello, LS				Ash, Garrett I.; Kostek, Matthew A.; Lee, Harold; Angelopoulos, Theodore J.; Clarkson, Priscilla M.; Gordon, Paul M.; Moyna, Niall M.; Visich, Paul S.; Zoeller, Robert F.; Price, Thomas B.; Devaney, Joseph M.; Gordish-Dressman, Heather; Thompson, Paul D.; Hoffman, Eric P.; Pescatello, Linda S.			Glucocorticoid Receptor (NR3C1) Variants Associate with the Muscle Strength and Size Response to Resistance Training	PLOS ONE			English	Article							IN-VIVO; CARDIOVASCULAR-DISEASE; MAJOR DEPRESSION; N363S VARIANT; 1ST EXONS; GENE; POLYMORPHISM; SENSITIVITY; CORTISOL; WOMEN	Glucocorticoid receptor (NR3C1) polymorphisms associate with obesity, muscle strength, and cortisol sensitivity. We examined associations among four NR3C1 polymorphisms and the muscle response to resistance training (RT). European-American adults (n = 602, 23.8 +/- 0.4yr) completed a 12 week unilateral arm RT program. Maximum voluntary contraction (MVC) assessed isometric strength (kg) and MRI assessed biceps size (cm(2)) pre-and post-resistance training. Subjects were genotyped for NR3C1 -2722G> A, -1887G> A, -1017T>C, and +363A>G. Men carrying the -2722G allele gained less relative MVC (17.3 +/- 1.2vs33.5 +/- 6.1%) (p = 0.010) than AA homozygotes; men with -1887GG gained greater relative MVC than A allele carriers (19.6 +/- 1.4vs13.2 +/- 2.3%) (p = 0.016). Women carrying the -1017T allele gained greater relative size (18.7 +/- 0.5 vs 16.1 +/- 0.9%) (p = 0.016) than CC homozygotes. We found sex-specific NR3C1 associations with the muscle strength and size response to RT. Future studies should investigate whether these associations are partially explained by cortisol's actions in muscle tissue as they interact with sex differences in cortisol production.	[Ash, Garrett I.; Kostek, Matthew A.; Pescatello, Linda S.] Univ Connecticut, Dept Kinesiol, Storrs, CT USA; [Ash, Garrett I.; Kostek, Matthew A.; Pescatello, Linda S.] Univ Connecticut, Human Performance Lab, Storrs, CT USA; [Lee, Harold] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Angelopoulos, Theodore J.] Emory & Henry Coll, Sch Hlth Sci, Emory, VA USA; [Clarkson, Priscilla M.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Gordon, Paul M.] Baylor Univ, Dept Hlth Human Performance & Recreat, Waco, TX 76798 USA; [Moyna, Niall M.] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Visich, Paul S.] Univ New England, Exercise & Sport Performance Dept, Biddeford, ME USA; [Zoeller, Robert F.] Florida Atlantic Univ, Dept Exercise Sci & Hlth Promot, Boca Raton, FL 33431 USA; [Price, Thomas B.] Univ Bridgeport, Dept Hlth Sci, Bridgeport, CT USA; [Devaney, Joseph M.; Gordish-Dressman, Heather; Hoffman, Eric P.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Thompson, Paul D.] Hartford Hosp, Henry Low Heart Ctr, Div Cardiol, Hartford, CT 06115 USA; [Pescatello, Linda S.] Univ Connecticut, Inst Syst Genom, Storrs, CT USA	University of Connecticut; University of Connecticut; Brown University; University of Massachusetts System; University of Massachusetts Amherst; Baylor University; Dublin City University; University of New England - Maine; State University System of Florida; Florida Atlantic University; University of Bridgeport; Children's National Health System; Hartford Hospital; University of Connecticut	Ash, GI (corresponding author), Univ Connecticut, Dept Kinesiol, Storrs, CT USA.; Ash, GI (corresponding author), Univ Connecticut, Human Performance Lab, Storrs, CT USA.	garrett.ash@uconn.edu	Ash, Garrett I./H-2874-2019	Ash, Garrett I./0000-0002-8655-7525; Hoffman, Eric/0000-0001-6470-5139; Lee, Harold/0000-0001-5778-3227	National Institutes of Health National Institute of Neurological Disorders and Stroke [R01 NS40606-02]; University of Connecticut Center for Health, Intervention, and Prevention; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040606] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Connecticut Center for Health, Intervention, and Prevention; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institutes of Health National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) R01 NS40606-02 and the University of Connecticut Center for Health, Intervention, and Prevention (http://www.chip.uconn.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Hoffman EP, 2013, MED SCI SPORT EXER, V45, P1060, DOI 10.1249/MSS.0b013e31828093c1; Hubal MJ, 2005, MED SCI SPORT EXER, V37, P964, DOI 10.1249/01.mss.0000170469.90461.5f; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Larsson CA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-16; Lin RCY, 2003, OBES RES, V11, P802, DOI 10.1038/oby.2003.111; Lin RCY, 2003, HYPERTENSION, V41, P404, DOI 10.1161/01.HYP.0000055342.40301.DC; Marti A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-50; PAFFENBARGER RS, 1993, MED SCI SPORT EXER, V25, P60, DOI 10.1249/00005768-199301000-00010; Peeters GMEE, 2008, CLIN ENDOCRINOL, V69, P673, DOI 10.1111/j.1365-2265.2008.03212.x; Pescatello LS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/643575; Pistilli EE, 2008, CYTOKINE, V43, P45, DOI 10.1016/j.cyto.2008.04.008; Presul E, 2007, J MOL ENDOCRINOL, V38, P79, DOI 10.1677/jme.1.02183; Rosmond R, 2001, BRIT MED J, V322, P652, DOI 10.1136/bmj.322.7287.652; Schatzberg AF, 2014, MOL PSYCHIATR, V19, P220, DOI 10.1038/mp.2013.129; Sinclair D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031720; Spijker AT, 2009, ANN NY ACAD SCI, V1179, P199, DOI 10.1111/j.1749-6632.2009.04985.x; STARON RS, 1994, J APPL PHYSIOL, V76, P1247, DOI 10.1152/jappl.1994.76.3.1247; Thompson PD, 2004, MED SCI SPORT EXER, V36, P1132, DOI 10.1249/01.MSS.0000132274.26612.23; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; van den Akker ELT, 2008, ARCH INTERN MED, V168, P33, DOI 10.1001/archinternmed.2007.41; van Raalte DH, 2012, DIABETIC MED, V29, pE211, DOI 10.1111/j.1464-5491.2012.03690.x; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; van Rossum EFC, 2004, J CLIN ENDOCR METAB, V89, P4004, DOI 10.1210/jc.2003-031422; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; Viau V, 1996, J NEUROSCI, V16, P1866; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204	30	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148112	10.1371/journal.pone.0148112	http://dx.doi.org/10.1371/journal.pone.0148112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821164	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400068
J	Catry, B; Dewulf, J; Maes, D; Pardon, B; Callens, B; Vanrobaeys, M; Opsomer, G; de Kruif, A; Haesebrouck, F				Catry, Boudewijn; Dewulf, Jeroen; Maes, Dominiek; Pardon, Bart; Callens, Benedicte; Vanrobaeys, Mia; Opsomer, Geert; de Kruif, Aart; Haesebrouck, Freddy			Effect of Antimicrobial Consumption and Production Type on Antibacterial Resistance in the Bovine Respiratory and Digestive Tract	PLOS ONE			English	Article							FECAL ESCHERICHIA-COLI; VEAL CALVES; ANTIBIOTIC-RESISTANCE; FATTENING PIGS; DAIRY CALVES; DRUG-USE; FARMS; SUSCEPTIBILITY; BACTERIA; PASTEURELLA	The aim of this study was to investigate the relationship between antimicrobial use and the occurrence of antimicrobial resistance in the digestive and respiratory tract in three different production systems of food producing animals. A longitudinal study was set up in 25 Belgian bovine herds (10 dairy, 10 beef, and 5 veal herds) for a 2 year monitoring of antimicrobial susceptibilities in E. coli and Pasteurellaceae retrieved from the rectum and the nasal cavity, respectively. During the first year of observation, the antimicrobial use was prospectively recorded on 15 of these farms (5 of each production type) and transformed into the treatment incidences according to the (animal) defined daily dose (TIADD) and (actually) used daily dose (TIUDD). Antimicrobial resistance rates of 4,174 E. coli (all herds) and 474 Pasteurellaceae (beef and veal herds only) isolates for 12 antimicrobial agents demonstrated large differences between intensively reared veal calves (abundant and inconstant) and more extensively reared dairy and beef cattle (sparse and relatively stable). Using linear mixed effect models, a strong relation was found between antimicrobial treatment incidences and resistance profiles of 1,639 E. coli strains (p< 0.0001) and 309 Pasteurellaceae (p <= 0.012). These results indicate that a high antimicrobial selection pressure, here found to be represented by low dosages of oral prophylactic and therapeutic group medication, converts not only the commensal microbiota from the digestive tract but also the opportunistic pathogenic bacteria in the respiratory tract into reservoirs of multi-resistance.	[Catry, Boudewijn] Sci Inst Publ Hlth WIV ISP, Healthcare Associated Infect & Antimicrobial Resi, Brussels, Belgium; [Catry, Boudewijn; Dewulf, Jeroen; Maes, Dominiek; Pardon, Bart; Callens, Benedicte; Opsomer, Geert; de Kruif, Aart; Haesebrouck, Freddy] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Vanrobaeys, Mia] Anim Hlth Care Flanders DGZ, Torhout, Belgium	Ghent University	Catry, B (corresponding author), Sci Inst Publ Hlth WIV ISP, Healthcare Associated Infect & Antimicrobial Resi, Brussels, Belgium.; Catry, B (corresponding author), Univ Ghent, Fac Vet Med, Merelbeke, Belgium.	Boudewijn.Catry@wiv-isp.be	Haesebrouck, Freddy/M-3857-2014; Dewulf, jeroen/AAJ-1580-2020	Haesebrouck, Freddy/0000-0002-1709-933X; Dewulf, jeroen/0000-0001-9843-5990; Pardon, Bart/0000-0003-1026-8433	Belgian Federal Public Service of Public Health, Food Chain Security and Environment [S-6166]	Belgian Federal Public Service of Public Health, Food Chain Security and Environment	This study was supported by the Belgian Federal Public Service of Public Health, Food Chain Security and Environment (Grant S-6166).	Berge ACB, 2006, APPL ENVIRON MICROB, V72, P3872, DOI 10.1128/AEM.02239-05; Busato A, 1997, DEUT TIERARZTL WOCH, V104, P131; Bywater R, 2004, J ANTIMICROB CHEMOTH, V54, P744, DOI 10.1093/jac/dkh422; Catry B, 2005, MICROB DRUG RESIST, V11, P387, DOI 10.1089/mdr.2005.11.387; Catry B, 2007, ANTIMICROBIAL USE RE; Catry B, 2007, MICROB DRUG RESIST, V13, P204, DOI 10.1089/mdr.2007.721; Catry B, 2007, MICROB DRUG RESIST, V13, P147, DOI 10.1089/mdr.2007.744; Checkley SL, 2010, CAN VET J, V51, P853; *DANMAP, 2005, US ANT AG OCC ANT RE; Dewulf J, 2007, PREV VET MED, V78, P339, DOI 10.1016/j.prevetmed.2006.11.001; Di Labio E, 2007, ZOONOSES PUBLIC HLTH, V54, P344, DOI 10.1111/j.1863-2378.2007.01071.x; Donaldson SC, 2006, APPL ENVIRON MICROB, V72, P3940, DOI 10.1128/AEM.02770-05; Gould CV, 2006, INFECT CONT HOSP EP, V27, P920, DOI 10.1086/507280; Heuer OE, 2002, MICROB DRUG RESIST, V8, P355, DOI 10.1089/10766290260469624; HINTON M, 1985, J APPL BACTERIOL, V58, P131, DOI 10.1111/j.1365-2672.1985.tb01439.x; HINTON M, 1985, J HYG-CAMBRIDGE, V95, P595, DOI 10.1017/S0022172400060691; Hoyle DV, 2004, APPL ENVIRON MICROB, V70, P6927, DOI 10.1128/AEM.70.11.6927-6930.2004; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Jordan D, 2005, AUST VET J, V83, P688, DOI 10.1111/j.1751-0813.2005.tb13051.x; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Khachatryan AR, 2006, APPL ENVIRON MICROB, V72, P4583, DOI 10.1128/AEM.02584-05; Kolkman I, 2007, REPROD DOMEST ANIM, V42, P583, DOI 10.1111/j.1439-0531.2006.00825.x; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; MARAN, 2005, MON ANT RES ANT US A; MEEK AH, 1986, CAN J VET RES, V50, P7; Nicholls T, 2001, REV SCI TECH OIE, V20, P841, DOI 10.20506/rst.20.3.1317; Pardon B, 2012, J ANTIMICROB CHEMOTH, V67, P1027, DOI 10.1093/jac/dkr570; SARGEANT JM, 1994, CAN J VET RES, V58, P189; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; Walk ST, 2007, APPL ENVIRON MICROB, V73, P5982, DOI 10.1128/AEM.00709-07; WHOCC, 2020, GUID AN THER CHEM AT; World Health Organization, 2002, GUID ATCVET CLASS DD; Zhang L, 2013, ANTIMICROB AGENTS CH, V57, P3659, DOI 10.1128/AAC.00670-13	34	63	63	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146488	10.1371/journal.pone.0146488	http://dx.doi.org/10.1371/journal.pone.0146488			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820134	Green Published, gold			2022-12-27	WOS:000369528400006
J	Devadas, K; Biswas, S; Haleyurgirisetty, M; Wood, O; Ragupathy, V; Lee, S; Hewlett, I				Devadas, Krishnakumar; Biswas, Santanu; Haleyurgirisetty, Mohan; Wood, Owen; Ragupathy, Viswanath; Lee, Sherwin; Hewlett, Indira			Analysis of Host Gene Expression Profile in HIV-1 and HIV-2 Infected T-Cells	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; CD4+T CELLS; VIRAL LOAD; JURKAT CELLS; IDENTIFICATION; CANCER; REPLICATION; METABOLISM; CD4(+); DIFFERENTIATION	HIV replication is closely regulated by a complex pathway of host factors, many of them being determinants of cell tropism and host susceptibility to HIV infection. These host factors are known to exert a positive or negative influence on the replication of the two major types of HIV, HIV-1 and HIV-2, thereby modulating virus infectivity, host response to infection and ultimately disease progression profiles characteristic of these two types. Understanding the differential regulation of host cellular factors in response to HIV-1 and HIV-2 infections will help us to understand the apparent differences in rates of disease progression and pathogenesis. This knowledge would aid in the discovery of new biomarkers that may serve as novel targets for therapy and diagnosis. The objective of this study was to determine the differential expression of host genes in response to HIV-1/HIV-2 infection. To achieve this, we analyzed the effects of HIV-1 (MN) and HIV-2 (ROD) infection on the expression of host factors in PBMC at the RNA level using the Agilent Whole Human Genome Oligo Microarray. Differentially expressed genes were identified and their biological functions determined. Host gene expression profiles were significantly changed. Gene expression profiling analysis identified a subset of differentially expressed genes in HIV-1 and HIV-2 infected cells. Genes involved in cellular metabolism, apoptosis, immune cell proliferation and activation, cytokines, chemokines, and transcription factors were differentially expressed in HIV-1 infected cells. Relatively few genes were differentially expressed in cells infected with HIV-2.	[Devadas, Krishnakumar; Biswas, Santanu; Haleyurgirisetty, Mohan; Wood, Owen; Ragupathy, Viswanath; Lee, Sherwin; Hewlett, Indira] US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Devadas, K; Hewlett, I (corresponding author), US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	Krishnakumar.devadas@fda.hhs.gov; Indira.hewlett@fda.hhs.gov	Ragupathy, Viswanath/ABA-3444-2021	Biswas, Santanu/0000-0003-4056-4305	Intramural CBER Modernizing Grant; Food and Drug Administration	Intramural CBER Modernizing Grant; Food and Drug Administration(United States Department of Health & Human Services)	This work was funded by an Intramural CBER Modernizing Grant and the Food and Drug Administration.	Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; GILLIS S, 1980, J IMMUNOL, V125, P2570; HILFINGER JM, 1993, J VIROL, V67, P4448, DOI 10.1128/JVI.67.7.4448-4453.1993; Hollenbaugh JA, 2011, VIROLOGY, V415, P153, DOI 10.1016/j.virol.2011.04.007; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Imbeault M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002861; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jones NP, 2012, DRUG DISCOV TODAY, V17, P232, DOI 10.1016/j.drudis.2011.12.017; Kameoka M, 2007, BIOCHEM BIOPH RES CO, V359, P729, DOI 10.1016/j.bbrc.2007.05.173; Koblavi-Deme S, 2004, AIDS, V18, P413, DOI 10.1097/01.aids.0000104327.15729.cb; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lee YS, 2015, CANCER GENOM PROTEOM, V12, P153; Machuca A, 2004, AIDS RES HUM RETROV, V20, P507, DOI 10.1089/088922204323087750; Molina L, 2007, PROTEOMICS, V7, P3116, DOI 10.1002/pmic.200700306; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Palmer CS, 2014, AIDS, V28, P297, DOI 10.1097/QAD.0000000000000128; Pincini A, 2013, CELL CYCLE, V12, P2409, DOI 10.4161/cc.25415; Popper SJ, 2000, J VIROL, V74, P1554, DOI 10.1128/JVI.74.3.1554-1557.2000; Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rhoads MP, 2011, JAIDS-J ACQ IMM DEF, V57, P404, DOI 10.1097/QAI.0b013e31821d33be; Salgado M, 2011, VIROLOGY, V411, P103, DOI 10.1016/j.virol.2010.12.037; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sievers M, 2009, J INFECT DIS, V200, P252, DOI 10.1086/599986; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Tan JY, 2013, J CELL PHYSIOL, V228, P2305, DOI 10.1002/jcp.24397; van't Wout AB, 2003, J VIROL, V77, P1392, DOI 10.1128/JVI.77.2.1392-1402.2003; van 't Wout AB, 2005, J VIROL, V79, P10053, DOI 10.1128/JVI.79.15.10053-10058.2005; Wang X, 2012, CELL SIGNAL, V24, P1414, DOI 10.1016/j.cellsig.2012.02.016; Wang X, 2010, MOL CELL BIOCHEM, V337, P175, DOI 10.1007/s11010-009-0297-9; Wang X, 2009, MOL CELL BIOCHEM, V330, P23, DOI 10.1007/s11010-009-0096-3; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu WW, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-15; Ye YF, 2013, BIOCHEM BIOPH RES CO, V436, P19, DOI 10.1016/j.bbrc.2013.05.008	42	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147421	10.1371/journal.pone.0147421	http://dx.doi.org/10.1371/journal.pone.0147421			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821323	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400027
J	Hasegawa, J; Toyokawa, S; Ikenoue, T; Asano, Y; Satoh, S; Ikeda, T; Ichizuka, K; Tamiya, N; Nakai, A; Fujimori, K; Maeda, T; Masuzaki, H; Suzuki, H; Ueda, S				Hasegawa, Junichi; Toyokawa, Satoshi; Ikenoue, Tsuyomu; Asano, Yuri; Satoh, Shoji; Ikeda, Tomoaki; Ichizuka, Kiyotake; Tamiya, Nanako; Nakai, Akihito; Fujimori, Keiya; Maeda, Tsugio; Masuzaki, Hideaki; Suzuki, Hideaki; Ueda, Shigeru		Prevention Recurrence Committee; Japan Obstet Compensation System	Relevant Obstetric Factors for Cerebral Palsy: From the Nationwide Obstetric Compensation System in Japan	PLOS ONE			English	Article							UMBILICAL-CORD PROLAPSE; PRETERM BIRTH; RISK-FACTORS; INTRAUTERINE GROWTH; PLACENTAL ABRUPTION; BREECH PRESENTATION; PERINATAL OUTCOMES; CASE-COHORT; TERM; PREGNANCIES	Objective The aim of this study was to identify the relevant obstetric factors for cerebral palsy (CP) after 33 weeks' gestation in Japan. Study design This retrospective case cohort study (1: 100 cases and controls) used a Japanese national CP registry. Obstetric characteristics and clinical course were compared between CP cases in the Japan Obstetric Compensation System for Cerebral Palsy database and controls in the perinatal database of the Japan Society of Obstetrics and Gynecology born as live singleton infants between 2009 and 2011 with a birth weight >= 2,000 g and gestation >= 33 weeks. Results One hundred and seventy-five CP cases and 17,475 controls were assessed. Major relevant single factors for CP were placental abnormalities (31%), umbilical cord abnormalities (15%), maternal complications (10%), and neonatal complications (1%). A multivariate regression model demonstrated that obstetric variables associated with CP were acute delivery due to non-reassuring fetal status (relative risk [RR]: 37.182, 95% confidence interval [CI]: 20.028-69.032), uterine rupture (RR: 24.770, 95% CI: 6.006-102.160), placental abruption (RR: 20.891, 95% CI: 11.817-36.934), and preterm labor (RR: 3.153, 95% CI: 2.024-4.911), whereas protective factors were head presentation (RR: 0.199, 95% CI: 0.088-0.450) and elective cesarean section (RR: 0.236, 95% CI: 0.067-0.828). Conclusion CP after 33 weeks' gestation in the recently reported cases in Japan was strongly associated with acute delivery due to non-reassuring fetal status, uterine rupture, and placental abruption.	[Hasegawa, Junichi] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kanagawa, Japan; [Toyokawa, Satoshi] Univ Tokyo, Dept Publ Hlth, Tokyo, Japan; [Ikenoue, Tsuyomu] Miyazaki Univ, Miyazaki, Japan; [Asano, Yuri; Suzuki, Hideaki; Ueda, Shigeru] Japan Council Qual Hlth Care, Dept Japan Obstetr Compensat Syst Cerebral Palsy, Publ Interest Inc Fdn, Tokyo, Japan; [Satoh, Shoji] Oita Prefectural Hosp, Maternal & Perinatal Care Ctr, Oita, Japan; [Ikeda, Tomoaki] Mie Univ, Sch Med, Dept Obstet & Gynecol, Tsu, Mie, Japan; [Ichizuka, Kiyotake] Showa Univ, Northern Yokohama Hosp, Kanagawa, Japan; [Tamiya, Nanako] Univ Tsukuba, Fac Med, Dept Hlth Serv Res, Ibaraki, Japan; [Nakai, Akihito] Nippon Med Sch, Dept Obstet & Gynecol, 1-1-5 Sendagi, Tokyo 113, Japan; [Fujimori, Keiya] Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Japan; [Fujimori, Keiya] Inc Assoc Anzu Kai, Maeda Clin, Shizuoka, Japan; [Masuzaki, Hideaki] Nagasaki Univ, Dept Obstet & Gynecol, Nagasaki 852, Japan	Saint Marianna University; University of Tokyo; University of Miyazaki; Mie University; Showa University; University of Tsukuba; Nippon Medical School; Fukushima Medical University; Nagasaki University	Hasegawa, J (corresponding author), St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kanagawa, Japan.	hasejun@oak.dti.ne.jp	Hasegawa, Junichi/AAO-5291-2020	Hasegawa, Junichi/0000-0002-5789-1022				Andersen GL, 2009, DEV MED CHILD NEUROL, V51, P860, DOI 10.1111/j.1469-8749.2009.03338.x; EDDLEMAN KA, 1992, AM J PERINAT, V9, P123, DOI 10.1055/s-2007-994684; Hasegawa J, ARCH GYNECO IN PRESS; Hasegawa J, J MATERN FE IN PRESS; Hasegawa J, J PERINATAL MED; Hasegawa J, 2016, J MATERN-FETAL NEO M, V29, P1652, DOI 10.3109/14767058.2015.1058772; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Heinonen S, 1996, OBSTET GYNECOL, V87, P112, DOI 10.1016/0029-7844(95)00339-8; Holbrook BD, 2013, OBSTET GYN CLIN N AM, V40, P1, DOI 10.1016/j.ogc.2012.11.002; Jacobsson B, 2004, BEST PRACT RES CL OB, V18, P425, DOI 10.1016/j.bpobgyn.2004.02.011; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Jarvis S, 2006, CLIN PERINATOL, V33, P285, DOI 10.1016/j.clp.2006.03.009; Kahana B, 2004, INT J GYNECOL OBSTET, V84, P127, DOI 10.1016/S0020-7292(03)00333-3; KATZ Z, 1982, AM J OBSTET GYNECOL, V142, P239, DOI 10.1016/S0002-9378(16)32344-4; KOONINGS PP, 1990, J REPROD MED, V35, P690; Krebs L, 1999, BRIT J OBSTET GYNAEC, V106, P943, DOI 10.1111/j.1471-0528.1999.tb08434.x; MacLennan AH, 2002, MED J AUSTRALIA, V176, P425, DOI 10.5694/j.1326-5377.2002.tb04484.x; Mann JR, 2011, PAEDIATR PERINAT EP, V25, P100, DOI 10.1111/j.1365-3016.2010.01157.x; Matsuda Y, 2011, J OBSTET GYNAECOL RE, V37, P538, DOI 10.1111/j.1447-0756.2010.01408.x; McIntyre S, 2013, OBSTET GYNECOL, V122, P869, DOI 10.1097/AOG.0b013e3182a265ab; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; MURPHY DJ, 1995, BRIT J OBSTET GYNAEC, V102, P826, DOI 10.1111/j.1471-0528.1995.tb10850.x; Nelson KB, 2015, NEW ENGL J MED, V373, P946, DOI 10.1056/NEJMra1505261; O'Callaghan M, 2013, OBSTET GYNECOL, V122, P1169, DOI 10.1097/AOG.0000000000000020; O'Callaghan ME, 2011, OBSTET GYNECOL, V118, P576, DOI 10.1097/AOG.0b013e31822ad2dc; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Parkes J, 2001, PAEDIATR PERINAT EP, V15, P278, DOI 10.1046/j.1365-3016.2001.00349.x; Ray JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102275; Redline RW, 2004, HUM PATHOL, V35, P1494, DOI 10.1016/j.humpath.2004.08.003; Reid SM, 2011, DEV MED CHILD NEUROL, V53, P907, DOI 10.1111/j.1469-8749.2011.04039.x; Sameshima H, 2004, AM J OBSTET GYNECOL, V190, P118, DOI 10.1016/j.ajog.2003.07.014; Shiozaki A, 2011, J OBSTET GYNAECOL RE, V37, P1447, DOI 10.1111/j.1447-0756.2011.01565.x; Streja E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126743; Sukhov A, 2012, J MATERN-FETAL NEO M, V25, P53, DOI 10.3109/14767058.2011.564689; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Tronnes H, 2014, DEV MED CHILD NEUROL, V56, P779, DOI 10.1111/dmcn.12430; Yamada T, 2013, J OBSTET GYNAECOL RE, V39, P1159, DOI 10.1111/jog.12036; Yamada T, 2012, EARLY HUM DEV, V88, P861, DOI 10.1016/j.earlhumdev.2012.06.008; Yang YT, 2009, MED CARE, V47, P234, DOI 10.1097/MLR.0b013e31818475de	39	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148122	10.1371/journal.pone.0148122	http://dx.doi.org/10.1371/journal.pone.0148122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821386	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528400071
J	Zhou, TT; Tao, Y; Jin, H; Song, B; Jing, T; Luo, D; Zhou, YS; Zhou, YK; Lee, YI; Mei, SR				Zhou, Tingting; Tao, Yun; Jin, Hua; Song, Bin; Jing, Tao; Luo, Dan; Zhou, Yusun; Zhou, Yikai; Lee, Yong-Ill; Mei, Surong			Fabrication of a Selective and Sensitive Sensor Based on Molecularly Imprinted Polymer/Acetylene Black for the Determination of Azithromycin in Pharmaceuticals and Biological Samples	PLOS ONE			English	Article							CARBON-PASTE ELECTRODE; ELECTROCHEMICAL SENSOR; COMPOSITE FILM; WATER SAMPLES; HUMAN PLASMA; POLYMER; NANOPARTICLES; GRAPHENE; ASSAY; TETRABROMOBISPHENOL	A new selective and sensitive sensor based on molecularly imprinted polymer/acetylene black (MIP/AB) was developed for the determination of azithromycin (AZM) in pharmaceuticals and biological samples. The MIP of AZM was synthesized by precipitation polymerization. MIP and AB were then respectively introduced as selective and sensitive elements for the preparation of MIP/AB-modified carbon paste (MIP/ABP) electrode. The performance of the obtained sensor was estimated by cyclic voltammetry (CV) and differential pulse voltammetry (DPV) techniques. Compared with non-molecularly imprinted polymer (NIP) electrodes, NIP/ABP electrodes, and MIP-modified carbon paste electrodes, MIP/ABP electrode exhibited excellent current response toward AZM. The prepared sensor also exhibited good selectivity for AZM in comparison with structurally similar compounds. The effect of electrode composition, extraction parameters, and electrolyte conditions on the current response of the sensor was investigated. Under the optimized conditions, the prepared sensor showed two dynamic linear ranges of 1.0 x 10(-7) mol L-1 to 2.0 x 10(-6) mol L-1 and 2.0 x 10(-6) mol L-1 to 2.0 x 10(-5) mol L-1, with a limit of detection of 1.1 x 10(-8) mol L-1. These predominant properties ensured that the sensor exhibits excellent reliability for detecting AZM in pharmaceuticals and biological fluids without the assistance of any separation techniques. The results were validated by the high-performance liquid chromatography-tandem mass spectrometry method.	[Zhou, Tingting; Tao, Yun; Song, Bin; Jing, Tao; Luo, Dan; Zhou, Yusun; Zhou, Yikai; Mei, Surong] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat,Key Lab Envir, Minist Educ,Key Lab Environm & Hlth Wuhan, Minist Environm Protect,Sch Publ Hlth,Tongji Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China; [Jin, Hua; Lee, Yong-Ill] Changwon Natl Univ, Dept Chem, Chang Won 641773, South Korea; [Jin, Hua] Yanbian Univ Hosp, Cent Lab, Yanji 133000, Jilin, Peoples R China	Huazhong University of Science & Technology; Changwon National University; Yanbian University	Mei, SR (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat,Key Lab Envir, Minist Educ,Key Lab Environm & Hlth Wuhan, Minist Environm Protect,Sch Publ Hlth,Tongji Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.	surongmei@hust.edu.cn	Tao, Jing/H-3931-2014; Zhou, Tingting/AIA-2242-2022	Tao, Jing/0000-0002-1755-9578; Lee, Yong-Ill/0000-0001-5383-9801	National Basic Research Grant (973) of China [2015CB352100]; National Natural Science Foundation of China [21577043]	National Basic Research Grant (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Grant (973) of China (Grant No. 2015CB352100), and the National Natural Science Foundation of China (No. 21577043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh T, 2011, J ELECTROANAL CHEM, V657, P98, DOI 10.1016/j.jelechem.2011.03.029; Alreja Gaurav, 2012, J Cardiovasc Dis Res, V3, P319, DOI 10.4103/0975-3583.102720; Arvand M, 2013, SENSOR ACTUAT B-CHEM, V188, P797, DOI 10.1016/j.snb.2013.07.092; Ashour S, 2012, SPECTROCHIM ACTA A, V99, P74, DOI 10.1016/j.saa.2012.08.024; Bahrami BG, 2005, J CHROMATOGR B, V820, P277, DOI 10.1016/j.jchromb.2005.03.042; Breier AR, 2002, J PHARMACEUT BIOMED, V29, P957, DOI 10.1016/S0731-7085(02)00213-3; Chen HJ, 2013, ANALYST, V138, P2769, DOI 10.1039/c3an00146f; Chen LY, 2007, J CHROMATOGR B, V855, P255, DOI 10.1016/j.jchromb.2007.05.016; Ensafi AA, 2013, COLLOID SURFACE B, V103, P468, DOI 10.1016/j.colsurfb.2012.11.021; Filist M, 2014, J PHARMACEUT BIOMED, V100, P184, DOI 10.1016/j.jpba.2014.07.015; Gandhi R, 2000, J PHARMACEUT BIOMED, V23, P1073, DOI 10.1016/S0731-7085(00)00406-4; Gholivand MB, 2011, TALANTA, V84, P905, DOI 10.1016/j.talanta.2011.02.022; Hu XZ, 2010, COLLOID SURFACE B, V81, P27, DOI 10.1016/j.colsurfb.2010.06.018; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Li M, 2012, SENSOR ACTUAT B-CHEM, V168, P329, DOI 10.1016/j.snb.2012.04.030; Lin FY, 2001, J CHROMATOGR A, V912, P281, DOI 10.1016/S0021-9673(01)00584-2; Liu B, 2013, ANAL BIOCHEM, V440, P220, DOI 10.1016/j.ab.2013.05.030; Mandic Z, 2003, J PHARMACEUT BIOMED, V33, P647, DOI 10.1016/S0731-7085(03)00315-7; Mazloum-Ardakani M, 2014, ANAL BIOCHEM, V455, P60, DOI 10.1016/j.ab.2014.03.006; Miguel L, 2003, J PHARMACEUT BIOMED, V33, P211, DOI 10.1016/S0731-7085(03)00258-9; Muniz FWMG, 2013, EUR J PHARMACOL, V705, P135, DOI 10.1016/j.ejphar.2013.02.044; Nichols DP, 2013, J SURG RES, V183, P767, DOI 10.1016/j.jss.2013.02.003; Nigovic B, 2003, J PHARMACEUT BIOMED, V32, P197, DOI 10.1016/S0731-7085(03)00060-8; Parnham MJ, 2014, PHARMACOL THERAPEUT, V143, P225, DOI 10.1016/j.pharmthera.2014.03.003; Peng JY, 2011, TALANTA, V86, P227, DOI 10.1016/j.talanta.2011.09.005; Rafique S, 2015, BIOELECTROCHEMISTRY, V101, P75, DOI 10.1016/j.bioelechem.2014.08.001; Song B, 2014, MICROCHEM J, V116, P183, DOI 10.1016/j.microc.2014.05.010; Tong YJ, 2013, BIOSENS BIOELECTRON, V47, P553, DOI 10.1016/j.bios.2013.03.072; Turcinov T, 1998, J PHARMACEUT BIOMED, V17, P903, DOI 10.1016/S0731-7085(97)00275-6; Wan K, 2015, APPL CATAL B-ENVIRON, V165, P566, DOI 10.1016/j.apcatb.2014.10.054; Wang XJ, 2008, J MEMBRANE SCI, V313, P97, DOI 10.1016/j.memsci.2007.12.067; Wu NQ, 2005, NANOTECHNOLOGY, V16, P2878, DOI 10.1088/0957-4484/16/12/024; Xu W, 2013, MICROCHIM ACTA, V180, P1005, DOI 10.1007/s00604-013-1020-9; Yin YM, 2012, J CHROMATOGR A, V1220, P7, DOI 10.1016/j.chroma.2011.11.065; Yuan BQ, 2013, ELECTROCHIM ACTA, V88, P708, DOI 10.1016/j.electacta.2012.10.102; Zhang HJ, 2011, COLLOID SURFACE B, V87, P378, DOI 10.1016/j.colsurfb.2011.05.045; Zhang KX, 2013, ANAL CHIM ACTA, V787, P50, DOI 10.1016/j.aca.2013.05.037; Zhang XY, 2014, SENSOR ACTUAT B-CHEM, V200, P69, DOI 10.1016/j.snb.2014.04.028; Zhang YY, 2013, COLLOID SURFACE B, V103, P94, DOI 10.1016/j.colsurfb.2012.10.015; Zhang ZA, 2015, J POWER SOURCES, V284, P95, DOI 10.1016/j.jpowsour.2015.03.019; Zubata P, 2002, J PHARMACEUT BIOMED, V27, P833, DOI 10.1016/S0731-7085(01)00554-4	41	18	18	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147002	10.1371/journal.pone.0147002	http://dx.doi.org/10.1371/journal.pone.0147002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820753	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528400011
J	Han, XB; Yang, JC; Li, LQ; Huang, JS; King, G; Quarles, LD				Han, Xiaobin; Yang, Jiancheng; Li, Linqiang; Huang, Jinsong; King, Gwendalyn; Quarles, L. Darryl			Conditional Deletion of Fgfr1 in the Proximal and Distal Tubule Identifies Distinct Roles in Phosphate and Calcium Transport	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BLOOD-PRESSURE; KLOTHO; FGF23; RECEPTOR; EXPRESSION; KIDNEY; MICE; BONE; HOMEOSTASIS	A postnatal role of fibroblast growth factor receptor-1 (FGFR1) in the kidney is suggested by its binding to a-Klotho to form an obligate receptor for the hormone fibroblast growth factor-23 (FGF-23). FGFR1 is expressed in both the proximal and distal renal tubular segments, but its tubular specific functions are unclear. In this study, we crossed Fgfr1(flox/flox) mice with either gamma-glutamyltransferase-Cre (gamma GT-Cre) or kidney specific-Cre (Ksp-Cre) mice to selectively create proximal tubule (PT) and distal tubule (DT) Fgfr1 conditional knockout mice (designated Fgfr1(PT-cKO) and Fgfr1(DT-cKO), respectively). Fgfr1(PT-cKO) mice exhibited an increase in sodium-dependent phosphate co-transporter expression, hyperphosphatemia, and refractoriness to the phosphaturic actions of FGF-23, consistent with a direct role of FGFR1 in mediating the proximal tubular phosphate responses to FGF-23. In contrast, Fgfr1(DT-cKO) mice unexpectedly developed hypercalciuria, secondary elevations of parathyroid hormone (PTH), hypophosphatemia and enhanced urinary phosphate excretion. Fgfr1(PT-cKO) mice also developed a curly tail/spina bifida-like skeletal phenotype, whereas Fgfr1(DT-cKO) mice developed renal tubular micro-calcifications and reductions in cortical bone thickness. Thus, FGFR1 has dual functions to directly regulate proximal and distal tubule phosphate and calcium reabsorption, indicating a physiological role of FGFR1 signaling in both phosphate and calcium homeostasis.	[Han, Xiaobin; Yang, Jiancheng; Li, Linqiang; Huang, Jinsong; Quarles, L. Darryl] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [King, Gwendalyn] Univ Alabama Birmingham, Birmingham, AL USA	University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.	dquarles@uthsc.edu	yang, jian/HIK-0188-2022	Quarles, L. Darryl/0000-0002-5082-7896	NIAMS of the National Institutes of Health [R01-AR045955]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045955] Funding Source: NIH RePORTER	NIAMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the NIAMS of the National Institutes of Health under award number R01-AR045955, www.NIH.gov.	Andrukhova O, 2014, EMBO MOL MED, V6, P744, DOI 10.1002/emmm.201303716; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Baum M, 2005, KIDNEY INT, V68, P1148, DOI 10.1111/j.1523-1755.2005.00506.x; Cancilla B, 2001, KIDNEY INT, V60, P147, DOI 10.1046/j.1523-1755.2001.00781.x; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Dai B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044161; David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627; Deng CX, 1997, DEV BIOL, V185, P42, DOI 10.1006/dbio.1997.8553; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Gattineni J, 2010, PEDIATR NEPHROL, V25, P591, DOI 10.1007/s00467-009-1273-z; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Pi M, 2011, J BONE MINER RES; Pond AC, 2010, CANCER RES, V70, P4868, DOI 10.1158/0008-5472.CAN-09-4404; PROIA AD, 1985, ARCH PATHOL LAB MED, V109, P186; Quabius ES, 1996, AM J PHYSIOL-RENAL, V270, pF220, DOI 10.1152/ajprenal.1996.270.1.F220; Quarles LD, 2011, NAT MED, V17, P428, DOI 10.1038/nm0411-428; Quarles LD, 2003, J CLIN INVEST, V112, P642, DOI 10.1172/JC1200319687; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Riazi S, 2006, AM J PHYSIOL-RENAL, V291, pF597, DOI 10.1152/ajprenal.00508.2005; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Worcester E, 2006, AM J PHYSIOL-RENAL, V291, pF1061, DOI 10.1152/ajprenal.00033.2006; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101251; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamazaki Y, 2008, J BONE MINER RES, V23, P1509, DOI 10.1359/JBMR.080417; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	46	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147845	10.1371/journal.pone.0147845	http://dx.doi.org/10.1371/journal.pone.0147845			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839958	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200065
J	Kawaguchi, H; Koike, S				Kawaguchi, Hideaki; Koike, Soichi			Association between the Density of Physicians and Suicide Rates in Japan: Nationwide Ecological Study Using a Spatial Bayesian Model	PLOS ONE			English	Article							MENTAL-HEALTH; RISK; MORTALITY; DIVORCE; AREAS	Background Regional disparity in suicide rates is a serious problem worldwide. One possible cause is unequal distribution of the health workforce, especially psychiatrists. Research about the association between regional physician numbers and suicide rates is therefore important but studies are rare. The objective of this study was to evaluate the association between physician numbers and suicide rates in Japan, by municipality. Methods The study included all the municipalities in Japan (n = 1,896). We estimated smoothed standardized mortality ratios of suicide rates for each municipality and evaluated the association between health workforce and suicide rates using a hierarchical Bayesian model accounting for spatially correlated random effects, a conditional autoregressive model. We assumed a Poisson distribution for the observed number of suicides and set the expected number of suicides as the offset variable. The explanatory variables were numbers of physicians, a binary variable for the presence of psychiatrists, and social covariates. Results After adjustment for socioeconomic factors, suicide rates in municipalities that had at least one psychiatrist were lower than those in the other municipalities. There was, however, a positive and statistically significant association between the number of physicians and suicide rates. Conclusions Suicide rates in municipalities that had at least one psychiatrist were lower than those in other municipalities, but the number of physicians was positively and significantly related with suicide rates. To improve the regional disparity in suicide rates, the government should encourage psychiatrists to participate in community-based suicide prevention programs and to settle in municipalities that currently have no psychiatrists. The government and other stakeholders should also construct better networks between psychiatrists and non-psychiatrists to support sharing of information for suicide prevention.	[Kawaguchi, Hideaki] Univ Tokyo, Dept Med Informat & Econ, Tokyo, Japan; [Koike, Soichi] Jichi Med Univ, Ctr Community Med, Div Hlth Policy & Management, Shimotsuke, Tochigi, Japan; [Koike, Soichi] Univ Tokyo, Grad Sch Med, Dept Hlth Management & Policy, Tokyo, Japan	University of Tokyo; Jichi Medical University; University of Tokyo	Kawaguchi, H (corresponding author), Univ Tokyo, Dept Med Informat & Econ, Tokyo, Japan.	hikawaguchi-tky@umin.ac.jp						Aihara Hirokuni, 2002, J Epidemiol, V12, P439; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allison P. D., 1999, MULTIPLE REGRESSION; [Anonymous], NAT MUN BOUND DAT JA; [Anonymous], 2015, ETHICAL GUIDELINES M; [Anonymous], 2010, DATA INVESTIGATION D; [Anonymous], 2014, R LANG ENV STAT COMP; Cabinet Office, STAT SUIC; Caldwell TM, 2004, MED J AUSTRALIA, V181, pS10; Chang SS, 2011, HEALTH PLACE, V17, P641, DOI 10.1016/j.healthplace.2011.01.003; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Helbich M, 2015, BRIT J PSYCHIAT, V207, P64, DOI 10.1192/bjp.bp.114.152991; Hirsch JK, 2006, CRISIS, V27, P189, DOI 10.1027/0227-5910.27.4.189; Kapusta ND, 2010, PSYCHIAT SERV, V61, P1198, DOI 10.1176/ps.2010.61.12.1198; Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001; Middleton N, 2006, J EPIDEMIOL COMMUN H, V60, P1040, DOI 10.1136/jech.2005.045302; Ministry of Health Labour and Welfare, ABSTR PROJ TEAM PREV; MOTOHASHI Y, 1991, J BIOSOC SCI, V23, P221, DOI 10.1017/S0021932000019234; Ono Y, 2013, PLOS ONE, V8; Pirkola S, 2009, LANCET, V373, P147, DOI 10.1016/S0140-6736(08)61848-6; Reardon DC, 2002, LANCET, V359, P2274, DOI 10.1016/S0140-6736(02)09267-X; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; RIHMER Z, 1993, ACTA PSYCHIAT SCAND, V88, P391, DOI 10.1111/j.1600-0447.1993.tb03479.x; Saini P, 2016, HEALTH SOC CARE COMM, V24, P260, DOI 10.1111/hsc.12198; Saini P, 2014, CRISIS, V35, P415, DOI 10.1027/0227-5910/a000277; Santana P, 2015, HEALTH PLACE, V35, P85, DOI 10.1016/j.healthplace.2015.07.001; Singh GK, 2002, AM J PUBLIC HEALTH, V92, P1161, DOI 10.2105/AJPH.92.7.1161; STACK S, 1992, J MARRIAGE FAM, V54, P327, DOI 10.2307/353064; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Suzuki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063443; Tondo L, 2006, J CLIN PSYCHIAT, V67, P517, DOI 10.4088/JCP.v67n0402; World Health Organization (WHO), 2015, SUICIDE PREVENTION; Ying YH, 2009, SUICIDE LIFE-THREAT, V39, P214, DOI 10.1521/suli.2009.39.2.214; Yip PSF, 2015, SOC SCI MED, V128, P87, DOI 10.1016/j.socscimed.2014.12.034; Yoshioka E, 2014, EPIDEMIOL PSYCHIAT S, P1	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148288	10.1371/journal.pone.0148288	http://dx.doi.org/10.1371/journal.pone.0148288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840389	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200120
J	Rodriguez-Centeno, J; Sastre, L				Rodriguez-Centeno, Javier; Sastre, Leandro			Biological Activity of the Alternative Promoters of the Dictyostelium discoideum Adenylyl Cyclase A Gene	PLOS ONE			English	Article							STALK CELL-DIFFERENTIATION; DEPENDENT PROTEIN-KINASE; SOCIAL AMEBAS; TRANSCRIPTIONAL REGULATION; PRESPORE DIFFERENTIATION; EXTRACELLULAR CAMP; CYCLIC-AMP; EXPRESSION; AGGREGATION; EVOLUTION	Amoebae of the Dictyostelium discoideum species form multicellular fruiting bodies upon starvation. Cyclic adenosine monophosphate (cAMP) is used as intercellular signalling molecule in cell-aggregation, cell differentiation and morphogenesis. This molecule is synthesized by three adenylyl cyclases, one of which, ACA, is required for cell aggregation. The gene coding for ACA (acaA) is transcribed from three different promoters that are active at different developmental stages. Promoter 1 is active during cell-aggregation, promoters 2 and 3 are active in prespore and prestalk tip cells at subsequent developmental stages. The biological relevance of acaA expression from each of the promoters has been studied in this article. The acaA gene was expressed in acaA-mutant cells, that do not aggregate, under control of each of the three acaA promoters. acaA expression under promoter 1 control induced cell aggregation although subsequent development was delayed, very small fruiting bodies were formed and cell differentiation genes were expressed at very low levels. Promoter 2-driven acaA expression induced the formation of small aggregates and small fruiting bodies were formed at the same time as in wild-type strains and differentiation genes were also expressed at lower levels. Expression of acaA from promoter 3 induced aggregates and fruiting bodies formation and their size and the expression of differentiation genes were more similar to that of wild-type cells. Expression of acaA from promoters 1 and 2 in AX4 cells also produced smaller structures. In conclusion, the expression of acaA under control of the aggregation-specific Promoter 1 is able to induce cell aggregation in acaA-mutant strains. Expression from promoters 2 and 3 also recovered aggregation and development although promoter 3 induced a more complete recovery of fruiting body formation.	[Rodriguez-Centeno, Javier; Sastre, Leandro] Inst Investi Biomed CSIC UAM, C Arturo Duperier 4, Madrid 28029, Spain; [Sastre, Leandro] CIBERER, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sastre, L (corresponding author), Inst Investi Biomed CSIC UAM, C Arturo Duperier 4, Madrid 28029, Spain.; Sastre, L (corresponding author), CIBERER, Valencia, Spain.	lsastre@iib.uam.es		Sastre, Leandro/0000-0003-3613-5938; Rodriguez-Centeno, Javier/0000-0001-8137-2225	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2008-02249]; Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad) - FEDER funds [PI11/00949]; Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad) - FEDER (Federacion Espanola de Asociaciones de Enfermedades Raras) funds [PI11/00949]	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad) - FEDER funds; Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad) - FEDER (Federacion Espanola de Asociaciones de Enfermedades Raras) funds	The authors are indebted to Zhi-Hui Chen and Pauline Schaap (University of Dundee, Dundee, UK) for the plasmid vector used to generate the acaA-mutant strain by homologous recombination. This work was supported by grants BFU2008-02249 from the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) and PI11/00949 from the Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad), supported by FEDER funds.; This work was supported by grants BFU2008-02249 from the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) and PI11/00949 from the Ministry of Health (Ministerio de Sanidad, Servicios Sociales e Igualdad), supported by FEDER (Federacion Espanola de Asociaciones de Enfermedades Raras) funds.	Alvarez-Curto E, 2005, P NATL ACAD SCI USA, V102, P6385, DOI 10.1073/pnas.0502238102; Alvarez-Curto E, 2007, DEVELOPMENT, V134, P959, DOI 10.1242/dev.02775; Bader S, 2007, BIOCHEM J, V402, P153, DOI 10.1042/BJ20061153; BARKLIS E, 1983, CELL, V32, P1139, DOI 10.1016/0092-8674(83)90297-0; BERKS M, 1988, DEV BIOL, V126, P108, DOI 10.1016/0012-1606(88)90244-8; Chen ZH, 2014, J BIOTECHNOL, V191, P246, DOI 10.1016/j.jbiotec.2014.08.008; Dormann D, 2000, PHILOS T R SOC B, V355, P983, DOI 10.1098/rstb.2000.0634; Dubin M, 2010, GENE, V465, P1, DOI 10.1016/j.gene.2010.06.010; FAURE M, 1990, MOL CELL BIOL, V10, P1921, DOI 10.1128/MCB.10.5.1921; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Galardi-Castilla M, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-12; Galardi-Castilla M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013286; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; HOPPER NA, 1993, DEVELOPMENT, V119, P147; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Iranfar N, 2001, MOL BIOL CELL, V12, P2590, DOI 10.1091/mbc.12.9.2590; Kim HJ, 1998, J BIOL CHEM, V273, P30859, DOI 10.1074/jbc.273.47.30859; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; Loomis WF, 2014, DEV BIOL, V391, P1, DOI 10.1016/j.ydbio.2014.04.001; Loomis WF, 2011, DEV GROWTH DIFFER, V53, P567, DOI 10.1111/j.1440-169X.2010.01241.x; LOUIS JM, 1993, P NATL ACAD SCI USA, V90, P5969, DOI 10.1073/pnas.90.13.5969; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Maeda M, 2003, EUKARYOT CELL, V2, P627, DOI 10.1128/EC.2.3.627-637.2003; MANN SKO, 1993, DEVELOPMENT, V119, P135; MEHDY MC, 1983, CELL, V32, P763, DOI 10.1016/0092-8674(83)90062-4; Miranda ER, 2015, DEV BIOL, V397, P203, DOI 10.1016/j.ydbio.2014.11.006; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; Ritchie AV, 2008, MOL BIOL EVOL, V25, P2109, DOI 10.1093/molbev/msn156; Rosengarten RD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1491-7; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Schaap P, 2011, DEV GROWTH DIFFER, V53, P452, DOI 10.1111/j.1440-169X.2011.01263.x; Schaap P, 2011, DEVELOPMENT, V138, P387, DOI 10.1242/dev.048934; Siol O, 2006, EUKARYOT CELL, V5, P658, DOI 10.1128/EC.5.4.658-664.2006; SMITH E, 1980, J EMBRYOL EXP MORPH, V57, P233; Soderbom F, 1999, DEVELOPMENT, V126, P5463; vanEs S, 1996, J BIOL CHEM, V271, P23623, DOI 10.1074/jbc.271.39.23623; Verkerke-van Wijk I, 2001, DEV BIOL, V234, P151, DOI 10.1006/dbio.2001.0232; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714	44	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148533	10.1371/journal.pone.0148533	http://dx.doi.org/10.1371/journal.pone.0148533			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840347	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200146
J	Tholen, ATR; Schinkel, J; Molenkamp, R; Ang, CW				Tholen, Aletta T. R.; Schinkel, Janke; Molenkamp, Richard; Ang, C. Wim			Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands	PLOS ONE			English	Article							INFECTION; RECIPIENTS; REVERSE; HEV	Background Recent studies indicate that 27% of Dutch blood donors have evidence of past infection with HEV. However, the low number of diagnosed HEV infections indicates either an asymptomatic course or under diagnosis. Objectives We investigated whether HEV is a cause of acute hepatitis in Dutch patients and which diagnostic modality (serology or PCR) should be used for optimal detection. Study design Serum samples were retrospectively selected from non-severely immuno-compromised patients from a university hospital population, suspected of having an infectious hepatitis. Criteria were: elevated alanine aminotransferase (ALT> 34 U/l) and request for antibody testing for CMV, EBV or Hepatitis A (HAV). Results All samples were tested for HEV using ELISA and PCR. Ninety patients/sera were tested, of which 22% were HEV IgG positive. Only one serum was IgM positive. HEV PCR was positive in two patients: one patient was both HEV IgM and IgG positive, the other patient was only IgG positive. Both HEV RNA positive samples belonged to genotype 3. Evidence of recent infection with CMV, EBV and HAV was found in 13%, 10% and 3% respectively. Conclusions Although our study is limited by small numbers, we conclude that HEV is a cause of acute hepatitis in hospital associated patients in The Netherlands. Moreover, in our study population the prevalence of acute HAV (3%) was almost similar to acute HEV (2%). We propose to incorporate HEV testing in panels for acute infectious hepatitis. Negative results obtained for HEV IgM in a HEV PCR positive patient, indicates that antibody testing alone may not be sufficient and argues for PCR as a primary diagnostic tool in hospital associated patients. The high percentage of HEV IgG seropositivity confirms earlier epidemiological studies.	[Tholen, Aletta T. R.; Ang, C. Wim] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Schinkel, Janke; Molenkamp, Richard] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Sect Clin Virol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Ang, CW (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	w.ang@vumc.nl	Schinkel, Janke/I-3099-2012	Schinkel, Janke/0000-0002-1112-0644				Ahmed A, 2015, INT J HEPATOL, V2015, DOI 10.1155/2015/872431; Ahn JM, 2006, DIAGN MICR INFEC DIS, V56, P269, DOI 10.1016/j.diagmicrobio.2006.04.010; Andriesse Gunnar I, 2010, Ned Tijdschr Geneeskd, V154, pA1865; Dalton HR, 2007, J VIRAL HEPATITIS, V14, P304, DOI 10.1111/j.1365-2893.2006.00800.x; Echevarria JM, 2011, J CLIN VIROL, V50, P69, DOI 10.1016/j.jcv.2010.09.016; Haagsman A, 2007, J MED VIROL, V79, P927, DOI 10.1002/jmv.20869; Harvala H, 2014, J CLIN VIROL, V59, P184, DOI 10.1016/j.jcv.2014.01.001; Hogema BM, 2015, TRANSFUSION; Hogema BM, 2014, TRANSFUSION, V54, P3092, DOI 10.1111/trf.12733; Kantala T, 2009, J CLIN VIROL, V45, P109, DOI 10.1016/j.jcv.2009.03.006; Koot H, 2015, J CLIN VIROL, V62, P38, DOI 10.1016/j.jcv.2014.11.020; Manka P, 2015, CLIN GASTROENTEROL H, V13, P1836, DOI 10.1016/j.cgh.2015.04.014; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pas SD, 2012, EMERG INFECT DIS, V18, P869, DOI 10.3201/eid1805.111712; Petrik J, 2015, VOX SANG; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Riezebos-Brilman A, 2013, J CLIN VIROL, V58, P509, DOI 10.1016/j.jcv.2013.08.022; Slot E, 2012, EUROSURVEILLANCE, V2013, P18, DOI DOI 10.2807/1560-7917.ES2013.18.31.20550; Waar K, 2005, J CLIN VIROL, V33, P145, DOI 10.1016/j.jcv.2004.10.015; Xu CY, 2013, TRANSFUSION, V53, P2505, DOI 10.1111/trf.12326; Zaki ME, 2006, FEMS IMMUNOL MED MIC, V48, P16, DOI 10.1111/j.1574-695X.2006.00111.x; Zanetti AR, 1999, J MED VIROL, V57, P356, DOI 10.1002/(SICI)1096-9071(199904)57:4&lt;356::AID-JMV5&gt;3.0.CO;2-D	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146906	10.1371/journal.pone.0146906	http://dx.doi.org/10.1371/journal.pone.0146906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840767	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200021
J	Vehmeijer, WB; Magnusdottir, V; Eliasdottir, TS; Hardarson, SH; Schalij-Delfos, NE; Stefansson, E				Vehmeijer, Wouter B.; Magnusdottir, Vigdis; Eliasdottir, Thorunn S.; Hardarson, Sveinn Hakon; Schalij-Delfos, Nicoline E.; Stefansson, Einar			Retinal Oximetry with Scanning Laser Ophthalmoscope in Infants	PLOS ONE			English	Article							EXTREMELY PRETERM INFANTS; OXYGEN-SATURATION; PREMATURITY; RETINOPATHY; VESSELS; FETAL; DISEASE	Purpose Dual wavelength retinal oximetry has been developed for adults, but is not available for infants. Retinal oximetry may provide insight into the pathophysiology of oxygen-mediated diseases like retinopathy of prematurity. More insight in the oxygen metabolism of the retina in infants may provide valuable clues for better understanding and subsequent prevention or treatment of the disease. The measurements of oxygen saturation are obtained with two fundus images simultaneously captured in two different wavelengths of light. The comparison in light absorption of oxygenated and deoxygenated hemoglobin can be used to estimate the oxygen saturation within the retinal vessels by means of a software algorithm. This study aims to make retinal oximetry available for neonates. The first step towards estimating retinal oxygen saturation is determining the optical density ratio. Therefore, the purpose of this study is to image healthy newborn infants with a scanning laser ophthalmoscope and determine the optical density ratio for retinal oximetry analysis. Methods Images of the retina of full-term healthy infants were obtained with an SLO, Optomap 200Tx (Optos), with two laser wavelengths (532nm and 633nm). The infant lay face down on the lower arm of the parent, while the parent supported the chest and chin with one hand, and stabilized the back with the other hand. No mydriatics or eyelid specula were used during this study. The images were analyzed with modified Oxymap Analyzer software for calculation of the Optical Density Ratio (ODR) and vessel width. The ODR is inversely and approximately linearly related to the oxygen saturation. Measurements were included from the superotemporal vessel pair. A paired t-test was used for statistical analysis. Results Fifty-nine infants, (58% female), were included with mean gestational age of 40 +/- 1.3 weeks (mean +/- SD) and mean post-natal age of 16 +/- 4.8 days. A total of 28 images were selected for retinal oximetry analysis. The ODR was 0.256 +/- 0.041 for the arterioles and 0.421 +/- 0.089 for the venules (n = 28, p < 0.001). The measured vessel-width for the arterioles was 14.1 +/- 2.7 pixels and for the venules 19.7 +/- 3.7 pixels (n = 28, p < 0.001). Conclusions Retinal oximetry can be performed in newborn infants by combining an SLO and a dual-wavelength algorithm software. Sensitivity of the approach is indicated by the fact that the ODR measurements are significantly different between the arterioles and the venules. However, more variability in ODR is seen with the SLO approach in babies than is seen with conventional oximetry in adults. This approach is completely non-invasive, non-contact and even avoids the use of mydriatics or eyelid specula.	[Vehmeijer, Wouter B.; Schalij-Delfos, Nicoline E.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [Magnusdottir, Vigdis] Oslo Univ Hosp, Dept Ophthalmol, Oslo, Norway; [Eliasdottir, Thorunn S.; Hardarson, Sveinn Hakon; Stefansson, Einar] Univ Iceland, Landspitali Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oslo; Landspitali National University Hospital; University of Iceland	Stefansson, E (corresponding author), Univ Iceland, Landspitali Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland.	einarste@landspitali.is		Eliasdottir, Thorunn/0000-0003-4217-7050; Hardarson, Sveinn Hakon/0000-0001-5865-6756	ODAS foundation (Den Hoorn, The Netherlands); Icelandic Center for Research (Rannis) [141425-052]; University of Iceland; Landspitali-University Hospital [A-2015-011]; Helga Jonsdottir and Sigurlioi Kristjansson Memorial Fund; Icelandic Center for Research (Rannis); Landspitali-University Hospital	ODAS foundation (Den Hoorn, The Netherlands); Icelandic Center for Research (Rannis); University of Iceland; Landspitali-University Hospital; Helga Jonsdottir and Sigurlioi Kristjansson Memorial Fund; Icelandic Center for Research (Rannis); Landspitali-University Hospital	This study was supported by the ODAS foundation (http://www.odasstichting.nl/) (Den Hoorn, The Netherlands) to NES; The Icelandic Center for Research (Rannis), Award nr.: 141425-052, to ES; The University of Iceland Research Fund, to SHH; The Landspitali-University Hospital Research Fund, Award nr.: A-2015-011, to SHH; and the Helga Jonsdottir and Sigurlioi Kristjansson Memorial Fund, to ES.; This study was supported by the ODAS foundation (Den Hoorn, The Netherlands), The Icelandic Center for Research (Rannis), The University of Iceland Research Fund, The Landspitali-University Hospital Research Fund, Helga Jonsdottir and Sigurlioi Kristjansson Memorial Fund. We would like to thank Martine J. Jager for her contribution to the research.	Al Hazzani F, 2013, J CLIN NEONATOL, V2, P70, DOI 10.4103/2249-4847.116403; Ashman Ross A., 2001, International Ophthalmology, V23, P343, DOI 10.1023/A:1014406831412; Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Denninghoff KR, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3638134; Dhaliwal CA, 2009, ARCH DIS CHILD-FETAL, V94, pF193, DOI 10.1136/adc.2008.143552; Dickinson JL, 2006, CLIN EXP OPHTHALMOL, V34, P682, DOI 10.1111/j.1442-9071.2006.01314.x; FAGAN DG, 1995, ARCH DIS CHILD-FETAL, V72, pF111, DOI 10.1136/fn.72.2.F111; Fledelius HC, 1996, BRIT J OPHTHALMOL, V80, P918, DOI 10.1136/bjo.80.10.918; Geirsdottir A, 2012, INVEST OPHTH VIS SCI, V53, P5433, DOI 10.1167/iovs.12-9912; Gilmour DF, 2015, EYE, V29, P1, DOI 10.1038/eye.2014.70; Hardarson SH, 2006, INVEST OPHTH VIS SCI, V47, P5011, DOI 10.1167/iovs.06-0039; Harris A, 2003, OPHTHAL SURG LAS IM, V34, P152, DOI 10.3928/1542-8877-20030301-16; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; HICKAM J B, 1959, Trans Am Clin Climatol Assoc, V71, P34; Holmstrom G, 2013, CLIN PERINATOL, V40, P311, DOI 10.1016/j.clp.2013.02.008; Hoyt C.S., 2012, PEDIAT OPHTHALMOLOGY, V4th ed.; Khadawardi E, 2013, J CLIN NEONATOL, V2, P73, DOI 10.4103/2249-4847.116404; Kristjansdottir JV, 2014, INVEST OPHTH VIS SCI, V55, P3120, DOI 10.1167/iovs.13-13255; Mordant DJ, 2011, EYE, V25, P309, DOI 10.1038/eye.2010.222; Olafsdottir OB, 2014, BRIT J OPHTHALMOL, V98, P329, DOI 10.1136/bjophthalmol-2013-303162; Palsson O, 2012, INVEST OPHTH VIS SCI, V53, P1729, DOI 10.1167/iovs.11-8621; Patel CK, 2013, EYE, V27, P589, DOI 10.1038/eye.2013.45; PATZ A, 1952, AM J OPHTHALMOL, V35, P1248, DOI 10.1016/0002-9394(52)91140-9; Schweitzer D, 1999, IEEE T BIO-MED ENG, V46, P1454, DOI 10.1109/10.804573; Sigler EJ, 2014, SURV OPHTHALMOL, V59, P30, DOI 10.1016/j.survophthal.2013.03.007; Slidsborg C, 2008, PEDIATRICS, V121, P97, DOI 10.1542/peds.2007-0644; Smith MH, 1998, J BIOMED OPT, V3, P296, DOI 10.1117/1.429856; Termote JUM, 2005, BIOL NEONATE, V88, P92, DOI 10.1159/000085295; Zijlstra W. G., 2000, VISIBLE NEAR INFRARE; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633	32	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148077	10.1371/journal.pone.0148077	http://dx.doi.org/10.1371/journal.pone.0148077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840073	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200079
J	Cross, PJ; Heyes, LC; Zhang, SW; Nazmi, AR; Parker, EJ				Cross, Penelope J.; Heyes, Logan C.; Zhang, Shiwen; Nazmi, Ali Reza; Parker, Emily J.			The Functional Unit of Neisseria meningitidis 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase Is Dimeric	PLOS ONE			English	Article							AMINO-ACID BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; MACROMOLECULAR CRYSTALLOGRAPHY; SYNERGISTIC ALLOSTERY; SHIKIMATE PATHWAY; DATA QUALITY; ULTRACENTRIFUGATION; PHENYLALANINE; REFINEMENT; SOFTWARE	Neisseria meningitidis 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (Nme-DAH7PS) adopts a homotetrameric structure consisting of an extensive and a less extensive interface. Perturbation of the less extensive interface through a single mutation of a salt bridge (Arg126-Glu27) formed at the tetramer interface of all chains resulted in a dimeric DAH7PS in solution, as determined by small angle X-ray scattering, analytical ultracentrifugation and analytical size-exclusion chromatography. The dimeric NmeDAH7PS(R126S) variant was shown to be catalytically active in the aldol-like condensation reaction between D-erythrose 4-phosphate and phosphoenolpyruvate, and allosterically inhibited by L-phenylalanine to the same extent as the wild-type enzyme. The dimeric NmeDAH7PS(R126S) variant exhibited a slight reduction in thermal stability by differential scanning calorimetry experiments and a slow loss of activity over time compared to the wild-type enzyme. Although NmeDAH7PS(R126S) crystallised as a tetramer, like the wild-type enzyme, structural asymmetry at the less extensive interface was observed consistent with its destabilisation. The tetrameric association enabled by this Arg126-Glu27 salt-bridge appears to contribute solely to the stability of the protein, ultimately revealing that the functional unit of NmeDAH7PS is dimeric.	[Parker, Emily J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; Univ Canterbury, Dept Chem, Christchurch 1, New Zealand	University of Canterbury; University of Canterbury	Parker, EJ (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.	emily.parker@canterbury.ac.nz		Parker, Emily/0000-0002-9571-9987; Nazmi, Ali Reza/0000-0003-1262-5078	New Zealand Marsden fund [UoC1105]; New Zealand Synchrotron Group; Australian Synchrotron; Marsden	New Zealand Marsden fund(Royal Society of New ZealandMarsden Fund (NZ)); New Zealand Synchrotron Group; Australian Synchrotron; Marsden(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by the New Zealand Marsden fund (UoC1105). This work was also supported by the New Zealand Synchrotron Group and the Australian Synchrotron. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; Part of this research was undertaken on the MX and SAXS/WAXS beamlines at the Australian Synchrotron, Victoria, Australia with access administered by the New Zealand Synchrotron Group. L.C.H is grateful for a BIC administered Marsden funded PhD Doctoral scholarship. This research was funded, in part, by the New Zealand Marsden Fund (UOC1105).	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2013, P NATL ACAD SCI USA, V110, P2111, DOI 10.1073/pnas.1217923110; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Lynch M, 2013, P NATL ACAD SCI USA, V110, pE2821, DOI 10.1073/pnas.1310980110; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nazmi AR, 2014, J MOL BIOL, V426, P656, DOI 10.1016/j.jmb.2013.11.008; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Wilkins MR, 1999, METH MOL B, V112, P531; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200	32	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0145187	10.1371/journal.pone.0145187	http://dx.doi.org/10.1371/journal.pone.0145187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828675	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200003
J	Jiang, LN; Luo, DH				Jiang, Lina; Luo, Dahua			Legal Professionals' Knowledge of Eyewitness Testimony in China: A Cross-Sectional Survey	PLOS ONE			English	Article							US JUDGES; PERCEPTIONS; ACCURACY; BELIEFS	Purpose To examine legal professionals' knowledge of a wide range of factors that affect eyewitness accuracy in China. Methods A total of 812 participants, including 210 judges, 244 prosecutors, 202 police officers, and 156 defense attorneys, were asked to respond to 12 statements about eyewitness testimony and 3 basic demographic questions (i.e., gender, age, and prior experience). Results Although the judges and the defense attorneys had a somewhat higher number of correct responses than the other two groups, all groups showed limited knowledge of eyewitness testimony. In addition, the participants' responses to only four items (i.e., weapon focus, attitude and expectations, child suggestibility, and the impact of stress) were roughly unanimous within the four legal professional groups. Legal professionals' gender showed no significant correlations with their knowledge of eyewitness testimony. Prior experiences were significantly and negatively correlated with the item on the knowledge of forgetting curve among judges but positively correlated with two items (i.e., attitudes and exposure time) among defense attorneys and with 4 statements (i.e., the knowledge of attitudes and expectations, impact of stress, child witness accuracy, and exposure time) among prosecutors. Conclusions The findings suggest that knowledge of the factors that influence eyewitness accuracy must be more effectively communicated to legal professionals in the future.	[Jiang, Lina] Hangzhou Dianzi Univ, Coll Humanities & Law, Hangzhou, Zhejiang, Peoples R China; [Luo, Dahua] China Univ Polit Sci & Law, Inst Evidence Law & Forens Sci, Beijing, Peoples R China	Hangzhou Dianzi University; China University of Political Science & Law	Jiang, LN (corresponding author), Hangzhou Dianzi Univ, Coll Humanities & Law, Hangzhou, Zhejiang, Peoples R China.	jln@hdu.edu.cn			National Social Science Foundation of China [12CFX055]; Foundation of Humanity and Social Science, Ministry of Education, China [12YJCZH085]	National Social Science Foundation of China; Foundation of Humanity and Social Science, Ministry of Education, China	The study was supported by a grant from National Social Science Foundation of China (Grant number: 12CFX055) and the Foundation of Humanity and Social Science, Ministry of Education, China (Grant number: 12YJCZH085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton TR, 2006, APPL COGNITIVE PSYCH, V20, P1115; BRIGHAM JC, 1983, LAW HUMAN BEHAV, V7, P337, DOI 10.1007/BF01044736; Deffenbacher KA, 2004, LAW HUMAN BEHAV, V28, P687, DOI 10.1007/s10979-004-0565-x; Einhorn H., 1982, JUDGMENT UNCERTAINTY, P268; Finsher RP, 1989, J APPL PSYCHOL, V74, P722; Granhag PA, 2005, BEHAV SCI LAW, V23, P709, DOI 10.1002/bsl.670; Kassin SM, 2001, AM PSYCHOL, V56, P405, DOI 10.1037//0003-066X.56.5.405; Kebbell MR, 1998, J SOC PSYCHOL, V138, P323, DOI 10.1080/00224549809600384; Liu PX., 2009, CAUSES COUNTERMEASUR, P78; Magnussen S, 2008, PSYCHOL CRIME LAW, V14, P177, DOI 10.1080/10683160701580099; Magnussen S, 2010, APPL COGNITIVE PSYCH, V24, P122, DOI 10.1002/acp.1550; Saks MJ, 2005, SCIENCE, V309, P892, DOI 10.1126/science.1111565; Scheck B., 2000, ACTUAL INNOCENCE 5 D; Steblay N, 2003, LAW HUMAN BEHAV, V27, P523, DOI 10.1023/A:1025438223608; Stinson V, 1996, J APPL PSYCHOL, V81, P64, DOI 10.1037/0021-9010.81.1.64; Wells G., 2005, PSYCHOL LAW EMPIRICA, P483; Wells GL, 1998, LAW HUMAN BEHAV, V22, P603, DOI 10.1023/A:1025750605807; Wells GL, 2006, PSYCHOL SCI PUBLIC I, V7, P43; Wise RA, 2004, APPL COGNITIVE PSYCH, V18, P427, DOI 10.1002/acp.993; Wise RA, 2007, J CRIM LAW CRIM, V97, P807; Wise RA, 2010, PSYCHOL CRIME LAW, V16, P695, DOI 10.1080/10683160903153893; Wise RA, 2010, J APPL SOC PSYCHOL, V40, P1400, DOI 10.1111/j.1559-1816.2010.00623.x; Wise RA, 2009, APPL COGNITIVE PSYCH, V23, P1266, DOI 10.1002/acp.1530; Yu P., 2002, VANDERBILT J TRANSNA, V35, P827	24	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148116	10.1371/journal.pone.0148116	http://dx.doi.org/10.1371/journal.pone.0148116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828933	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200065
J	Xu, YB; Guo, N; Dou, DQ; Ran, XK; Ma, XD; Kuang, HX				Xu, Yubin; Guo, Na; Dou, Deqiang; Ran, Xiaoku; Ma, Xiande; Kuang, Haixue			Proteomics Study on Nonallergic Hypersensitivity Induced by Compound 4880 and Ovalbumin	PLOS ONE			English	Article							COMPLEMENT ACTIVATION; MAST-CELL; G-PROTEINS; IN-VITRO; ANAPHYLAXIS; INJECTION; DERMCIDIN; BINDING; ROLES; MODEL	Nonallergic hypersensitivity reaction (NHR) accounts for more than 77% of all immune-mediated immediate hypersensitivity reactions and has become a serious threat to public health. Here, proteomics was used to study the NHR mechanism of two typical substances, the compound 4880 and ovalbumin. Twelve different proteins were suggested as potential biomarkers for examining the NHR mechanism, and our results revealed that the mechanism mainly encompassed 2 processes, i.e., generation and effect processes. The generation process could be classified as direct stimulation, complement (classical and alternative), coagulation, kallikrein-kinin, and integrated pathways. Thus glutathione peroxidase 1, terminal complement complex (complement factor 4d and Bb), coagulation 13, kininogen-1, and IgE could be used as candidate biomarkers for the indication of the corresponding pathways respectively, the proteins were further confirmed by ELISA. And the effect process was mainly composed of histamine as well as proteins such as DCD and MYLPF, which could be used as important indices for the symptoms of NHR. Our study differs from previous studies in that C4880 was found to not only be involved in the direct stimulation pathway, but also in the activated complement and kallikrein-kinin pathways through the coagulation pathway. We also report for the first time that ovalbumin-induced NHR could be a combination of the coagulation, classical complement, and integrated pathways.	[Xu, Yubin; Dou, Deqiang; Ran, Xiaoku; Ma, Xiande] Liaoning Univ Tradit Chinese Med, Coll Pharm, Dalian, Liaoning, Peoples R China; [Kuang, Haixue] Heilongjiang Univ Chinese Med, Coll Pharm, Harbin, Heilongjiang, Peoples R China; [Guo, Na] China Acad Chinese Med Sci, Expt Res Ctr, Beijing, Peoples R China	Liaoning University of Traditional Chinese Medicine; Heilongjiang University of Chinese Medicine; China Academy of Chinese Medical Sciences; Experimental Research Center, CACMS	Dou, DQ (corresponding author), Liaoning Univ Tradit Chinese Med, Coll Pharm, Dalian, Liaoning, Peoples R China.; Kuang, HX (corresponding author), Heilongjiang Univ Chinese Med, Coll Pharm, Harbin, Heilongjiang, Peoples R China.	deqiangdou@126.com; hxkuang@hotmail.com	ma, xiande/AAK-5895-2020; Dou, Deqiang/GLR-4592-2022; Xu, Yubin/O-3562-2019; Xu, Yubin/F-4017-2015	Xu, Yubin/0000-0003-0340-4425; Xu, Yubin/0000-0003-0340-4425	Natural Science Foundation of China [81373939, 81370095]; Innovation Team Project of Colleges and Universities in Liaoning Province [LT2013020]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Project of Colleges and Universities in Liaoning Province	The authors gratefully acknowledge the support of this work by the funding of the Natural Science Foundation of China (81373939, 81370095) and Innovation Team Project of Colleges and Universities in Liaoning Province of 2013 (LT2013020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2012, J BIOL CHEM, V287, P10210, DOI 10.1074/jbc.M111.327809; Asano E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114452; Chanan-Khan A, 2003, ANN ONCOL, V14, P1430, DOI 10.1093/annonc/mdg374; Choi YH, 2010, ANAT CELL BIOL, V43, P36, DOI 10.5115/acb.2010.43.1.36; Coors EA, 2005, ANN ALLERG ASTHMA IM, V95, P593, DOI 10.1016/S1081-1206(10)61024-1; Doroszko A, 2010, SHOCK, V34, P592, DOI 10.1097/SHK.0b013e3181e14f1d; Ferry X, 2002, PEPTIDES, V23, P1507, DOI 10.1016/S0196-9781(02)00090-6; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; Giles TD, 2012, J CLIN HYPERTENS, V14, P198, DOI 10.1111/j.1751-7176.2012.00606.x; Golias Ch, 2007, Hippokratia, V11, P124; Gomez E, 2013, CURR OPIN ALLERGY CL, V13, P345, DOI 10.1097/ACI.0b013e328362b926; GROSSMANN A, 1983, EUR J BIOCHEM, V135, P549, DOI 10.1111/j.1432-1033.1983.tb07687.x; Gueant-Rodriguez RM, 2006, CURR PHARM DESIGN, V12, P3359, DOI 10.2174/138161206778193999; Hanzlik PJ, 1920, J PHARMACOL EXP THER, V14, P379; Hashimoto T, 2006, J PHARMACOL SCI, V100, P82, DOI 10.1254/jphs.FPJ05030X; Hobson DJ, 2007, FOOD CHEM TOXICOL, V45, P2372, DOI 10.1016/j.fct.2007.06.039; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; Ishii T, 2012, J CLIN BIOCHEM NUTR, V50, P91, DOI 10.3164/jcbn.11-109; JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876; Kilis-Pstrusinska K, 2012, POSTEP HIG MED DOSW, V66, P215, DOI 10.5604/17322693.991600; Kim HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095332; Kobek M, 2014, Arch Med Sadowej Kryminol, V64, P102; Krishnan V, 2009, ACTA CRYSTALLOGR D, V65, P266, DOI 10.1107/S0907444909000389; Li XM, 2003, J ALLERGY CLIN IMMUN, V112, P159, DOI 10.1067/mai.2003.1622; Li YH, 2011, CLIN CARDIOL, V34, P30, DOI 10.1002/clc.20832; Li ZG, 2010, ASIAN PAC J ALLERGY, V28, P185; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; Mi YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090199; MOUSLI M, 1990, FEBS LETT, V259, P260, DOI 10.1016/0014-5793(90)80023-C; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; Nie JZ, 2013, J PROTEOME RES, V12, P3843, DOI 10.1021/pr301044b; Palomaki VAB, 2006, BRIT J PHARMACOL, V147, P596, DOI 10.1038/sj.bjp.0706671; Rieg S, 2004, BRIT J DERMATOL, V151, P534, DOI 10.1111/j.1365-2133.2004.06081.x; Sala-Cunill A, 2015, J ALLERGY CLIN IMMUN, V135, P1031, DOI 10.1016/j.jaci.2014.07.057; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Szabo K.E., 2009, REDOX SIGNALING REGU, P143; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 1998, JNCI-J NATL CANCER I, V90, P300, DOI 10.1093/jnci/90.4.300; Szebeni J, 2003, METHOD ENZYMOL, V373, P136; Tarr J, 2005, CRIT REV IMMUNOL, V25, P305, DOI 10.1615/CritRevImmunol.v25.i4.40; TOMAN M, 1992, VET MED-CZECH, V37, P417; Toncic RJ, 2009, ACTA DERMATOVENER CR, V17, P54; Wang ZG, 2012, J TRADIT CHIN MED, V32, P641, DOI 10.1016/S0254-6272(13)60085-0; Xiang Z, 2013, PLANTA MED, V79, P1043, DOI 10.1055/s-0032-1328746; Xu CP, 2015, J PROTEOMICS, V114, P234, DOI 10.1016/j.jprot.2014.11.002; Yang CS, 2007, J EXP MED, V204, P583, DOI 10.1084/jem.20061849; Yang R, 2015, J APPL TOXICOL, V35, P295, DOI 10.1002/jat.3069	48	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148262	10.1371/journal.pone.0148262	http://dx.doi.org/10.1371/journal.pone.0148262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829397	Green Submitted, gold, Green Published			2022-12-27	WOS:000369548200090
J	Amor, R; McDonald, A; Tragardh, J; Robb, G; Wilson, L; Rahman, NZA; Dempster, J; Amos, WB; Bushell, TJ; McConnell, G				Amor, Rumelo; McDonald, Alison; Traegardh, Johanna; Robb, Gillian; Wilson, Louise; Rahman, Nor Zaihana Abdul; Dempster, John; Amos, William Bradshaw; Bushell, Trevor J.; McConnell, Gail			Widefield Two-Photon Excitation without Scanning: Live Cell Microscopy with High Time Resolution and Low Photo-Bleaching	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; MULTIPHOTON; SINGLE; TRANSIENTS; INDICATOR; SPINES; DEEP	We demonstrate fluorescence imaging by two-photon excitation without scanning in biological specimens as previously described by Hwang and co-workers, but with an increased field size and with framing rates of up to 100 Hz. During recordings of synaptically-driven Ca2+ events in primary rat hippocampal neurone cultures loaded with the fluorescent Ca2+ indicator Fluo-4 AM, we have observed greatly reduced photo-bleaching in comparison with single-photon excitation. This method, which requires no costly additions to the microscope, promises to be useful for work where high time-resolution is required.	[Amor, Rumelo; McDonald, Alison; Traegardh, Johanna; Robb, Gillian; Amos, William Bradshaw; McConnell, Gail] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Ctr Biophoton, Glasgow, Lanark, Scotland; [Wilson, Louise; Rahman, Nor Zaihana Abdul; Dempster, John; Bushell, Trevor J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Amos, William Bradshaw] MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England	University of Strathclyde; University of Strathclyde; MRC Laboratory Molecular Biology	Amor, R (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Ctr Biophoton, Glasgow, Lanark, Scotland.	rumelo.amor@gmail.com	RAHMAN, NOR ZAIHANA ABDUL/AAP-6207-2020; Trägårdh, Johanna/N-2761-2014	RAHMAN, NOR ZAIHANA ABDUL/0000-0002-7497-7637; Trägårdh, Johanna/0000-0002-8662-9509; Amor, Rumelo/0000-0001-9206-8878; Dempster, John/0000-0003-2199-2945; Bushell, Trevor/0000-0003-4145-9670; McConnell, Gail/0000-0002-7213-0686	Medical Research Council [MR/K015583/1]; Engineering and Physical Sciences Research Council [EP/I006826/1]; Biotechnology and Biological Sciences Research Council [BB/M018903/1]; Scottish Universities Physics Alliance INSPIRE studentship; BBSRC [BB/M018903/1] Funding Source: UKRI; EPSRC [EP/I006826/1] Funding Source: UKRI; MRC [MR/K015583/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Universities Physics Alliance INSPIRE studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported in part by the Medical Research Council (http://www.mrc.ac.uk/, grant no. MR/K015583/1, WBA and GM), the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/, grant no. EP/I006826/1, GM), and the Biotechnology and Biological Sciences Research Council (BB/M018903/1). RA is supported by a Scottish Universities Physics Alliance INSPIRE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Medical Research Council (http://www.mrc.ac.uk/, grant no. MR/K015583/1, WBA and GM), the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/, grant no. EP/I006826/1, GM), and the Biotechnology and Biological Sciences Research Council (BB/M018903/1). R.A. is supported by a Scottish Universities Physics Alliance INSPIRE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Brakenhoff GJ, 1996, J MICROSC-OXFORD, V181, P253, DOI 10.1046/j.1365-2818.1996.97379.x; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; Chen XW, 2012, NAT PROTOC, V7, P1818, DOI 10.1038/nprot.2012.106; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Dempster J., 2014, WINFLUOR FLUORESCENC; Deniset-Besseau A, 2007, APPL OPTICS, V46, P8045, DOI 10.1364/AO.46.008045; Diaspro A., 2006, HDB BIOL CONFOCAL MI, P690, DOI 10.1007/978-0-387-45524-2_39; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Dunn GA, 2002, J MICROSC-OXFORD, V205, P109, DOI 10.1046/j.0022-2720.2001.001007.x; Fittinghoff DN, 2000, OPT EXPRESS, V7, P273, DOI 10.1364/OE.7.000273; Gan J, 2011, BRIT J PHARMACOL, V163, P984, DOI 10.1111/j.1476-5381.2011.01293.x; Hwang JY, 2011, BIOMED OPT EXPRESS, V2, P356, DOI 10.1364/BOE.2.000356; Knight MM, 2003, AM J PHYSIOL-CELL PH, V284, pC1083, DOI 10.1152/ajpcell.00276.2002; KOGELNIK H, 1966, APPL OPTICS, V5, P1550, DOI 10.1364/AO.5.001550; Ledgerwood CJ, 2011, BRIT J PHARMACOL, V162, P286, DOI 10.1111/j.1476-5381.2010.01015.x; Malkani N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018586; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; McDonald A, 2012, BIOMED OPT EXPRESS, V3, P1266, DOI 10.1364/BOE.3.001266; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Niesner R, 2007, BIOPHYS J, V93, P2519, DOI 10.1529/biophysj.106.102459; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Patterson GH, 2000, BIOPHYS J, V78, P2159, DOI 10.1016/S0006-3495(00)76762-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonle A, 1998, OPT LETT, V23, P325, DOI 10.1364/OL.23.000325; Smith NI, 2006, LASER PHYS LETT, V3, P154, DOI 10.1002/lapl.200510067; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Tsien R. Y., 2006, HDB BIOL CONFOCAL MI, V3rd, P338, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2_16]; VANDERKOOY D, 1979, SCIENCE, V204, P873, DOI 10.1126/science.441742; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Weiss M, 2004, TRAFFIC, V5, P662, DOI 10.1111/j.1600-0854.2004.00215.x; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899; [No title captured]	36	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147115	10.1371/journal.pone.0147115	http://dx.doi.org/10.1371/journal.pone.0147115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824845	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000369528600016
J	Cooper, JE; McCann, CJ; Natarajan, D; Choudhury, S; Boesmans, W; Delalande, JM; Vanden Berghe, P; Burns, AJ; Thapar, N				Cooper, Julie E.; McCann, Conor J.; Natarajan, Dipa; Choudhury, Shanas; Boesmans, Werend; Delalande, Jean-Marie; Vanden Berghe, Pieter; Burns, Alan J.; Thapar, Nikhil			In Vivo Transplantation of Enteric Neural Crest Cells into Mouse Gut; Engraftment, Functional Integration and Long-Term Safety	PLOS ONE			English	Article							SLOW-TRANSIT CONSTIPATION; NERVOUS-SYSTEM; HIRSCHSPRUNG DISEASE; STEM-CELLS; GASTROINTESTINAL-TRACT; INTERSTITIAL-CELLS; PRECURSOR CELLS; IMAGE-ANALYSIS; GLIAL-CELLS; NEURONS	Objectives Enteric neuropathies are severe gastrointestinal disorders with unsatisfactory outcomes. We aimed to investigate the potential of enteric neural stem cell therapy approaches for such disorders by transplanting mouse enteric neural crest cells (ENCCs) into ganglionic and aganglionic mouse gut in vivo and analysing functional integration and long-term safety. Design Neurospheres generated from yellow fluorescent protein (YFP) expressing ENCCs selected from postnatal Wnt1-cre; R26R-YFP/YFP murine gut were transplanted into ganglionic hindgut of wild-type littermates or aganglionic hindgut of Ednrb(tm1Ywa) mice (lacking functional endothelin receptor type-B). Intestines were then assessed for ENCC integration and differentiation using immunohistochemistry, cell function using calcium imaging, and long-term safety using PCR to detect off-target YFP expression. Results YFP+ ENCCs engrafted, proliferated and differentiated into enteric neurons and glia within recipient ganglionic gut. Transplanted cells and their projections spread along the endogenous myenteric plexus to form branching networks. Electrical point stimulation of endogenous nerve fibres resulted in calcium transients (F/F0 = 1.16 +/- 0.01; 43 cells, n = 6) in YFP+ transplanted ENCCs (abolished with TTX). Long-term follow-up (24 months) showed transplanted ENCCs did not give rise to tumours or spread to other organs (PCR negative in extraintestinal sites). In aganglionic gut ENCCs similarly spread and differentiated to form neuronal and glial networks with projections closely associated with endogenous neural networks of the transition zone. Conclusions Transplanted ENCCs successfully engrafted into recipient ganglionic and aganglionic gut showing appropriate spread, localisation and, importantly, functional integration without any long-term safety issues. This study provides key support for the development and use of enteric neural stem cell therapies.	[Cooper, Julie E.; McCann, Conor J.; Natarajan, Dipa; Choudhury, Shanas; Delalande, Jean-Marie; Burns, Alan J.; Thapar, Nikhil] UCL Inst Child Hlth, Stem Cells & Regenerat Med, 30 Guilford St, London, England; [Boesmans, Werend; Vanden Berghe, Pieter] Univ Leuven, Dept Clin & Expt Med, Translat Res Ctr GastroIntestinal Disorders, Lab Enter NeuroSci, Leuven, Belgium; [Delalande, Jean-Marie] Univ London, Barts & London Sch Med & Dent, Ctr Digest Dis, Blizard Bldg, London, England; [Burns, Alan J.] Erasmus MC Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Thapar, Nikhil] Great Ormond St Hosp NHS Fdn Trust, Dept Gastroenterol, Great Ormond St, London, England	University of London; University College London; KU Leuven; University of London; Queen Mary University London; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Burns, AJ; Thapar, N (corresponding author), UCL Inst Child Hlth, Stem Cells & Regenerat Med, 30 Guilford St, London, England.; Burns, AJ (corresponding author), Erasmus MC Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands.; Thapar, N (corresponding author), Great Ormond St Hosp NHS Fdn Trust, Dept Gastroenterol, Great Ormond St, London, England.	n.thapar@ucl.ac.uk; alan.burns@ucl.ac.uk	Burns, Alan/AAC-1266-2022; Burns, Alan J/C-4988-2008	Burns, Alan/0000-0002-1725-1071; Boesmans, Werend/0000-0002-2426-0451; Vanden Berghe, Pieter/0000-0002-0009-2094; McCann, Conor/0000-0002-9324-5984	Great Ormond Street Children's Charity (GOSHCC); GOSHCC grant; Medical Research Council [G0800973]; Fonds Wetenschappelijk Onderzoek [G.0501.10]; Bijzonder Onderzoeksfonds [OT 10/046]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London; MRC [G0800973] Funding Source: UKRI; Great Ormond Street Hospital Childrens Charity [V1258] Funding Source: researchfish	Great Ormond Street Children's Charity (GOSHCC); GOSHCC grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fonds Wetenschappelijk Onderzoek(FWO); Bijzonder Onderzoeksfonds; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Great Ormond Street Hospital Childrens Charity	NT is supported by Great Ormond Street Children's Charity (GOSHCC). JC, DN, CM and JMD are funded through a GOSHCC grant. JC was part-funded by the Medical Research Council (G0800973). PVB is supported by Fonds Wetenschappelijk Onderzoek (G.0501.10) and Bijzonder Onderzoeksfonds (OT 10/046). WB is a post-doctoral fellow of the Fonds Wetenschappelijk Onderzoek. The work was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Belkind-Gerson J, 2013, NEUROGASTROENT MOTIL, V25, P61, DOI 10.1111/nmo.12015; Binder E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119467; Boesmans W, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00183; Bondurand N, 2006, DEVELOPMENT, V133, P2075, DOI 10.1242/dev.02375; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; Burns AJ, 2006, NEUROGASTROENT MOTIL, V18, P876, DOI 10.1111/j.1365-2982.2006.00806.x; Burns AJ, 2005, INT J DEV BIOL, V49, P143, DOI 10.1387/ijdb.041935ab; Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226; Chuenkova MV, 2011, ADV PARASIT, V76, P195, DOI 10.1016/B978-0-12-385895-5.00009-8; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; De Giorgio R, 2004, NEUROGASTROENT MOTIL, V16, P515, DOI 10.1111/j.1365-2982.2004.00538.x; Dettmann HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097792; Dickson EJ, 2010, AM J PHYSIOL-GASTR L, V298, pG222, DOI 10.1152/ajpgi.00399.2009; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Facer P, 2001, BRIT J SURG, V88, P545, DOI 10.1046/j.1365-2168.2001.01731.x; Findlay Q, 2014, AM J PHYSIOL-GASTR L, V307, pG741, DOI 10.1152/ajpgi.00225.2014; FOX DA, 1983, J PHARMACOL EXP THER, V227, P538; Furness JB, 2006, AUTON NEUROSCI-BASIC, V125, P81, DOI 10.1016/j.autneu.2006.01.007; Geramizadeh B, 2009, HEPATO-GASTROENTEROL, V56, P1670; Ghoshal UC, 2012, WORLD J GASTROENTERO, V18, P3050, DOI 10.3748/wjg.v18.i24.3050; Giorgio V, 2013, NEUROGASTROENT MOTIL, V25, P70, DOI 10.1111/nmo.12016; Goto K, 2016, J PHYSIOL SCI, V66, P67, DOI 10.1007/s12576-015-0396-1; Hagl C, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12119; Hao MM, 2011, J NEUROSCI, V31, P15352, DOI 10.1523/JNEUROSCI.3053-11.2011; Hetz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093605; Hotta R, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01411.x; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Hotta Ryo, 2011, J Pediatr Gastroenterol Nutr, V53 Suppl 2, pS43; Hotta R, 2011, CURR OPIN PHARMACOL, V11, P617, DOI 10.1016/j.coph.2011.09.004; KAPUR RP, 1992, DEVELOPMENT, V116, P167; Kwok CKM, 2013, J PEDIATR SURG, V48, P619, DOI 10.1016/j.jpedsurg.2012.08.026; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Le Douarin NM, 1999, NEURAL CREST, V2; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; McKeown SJ, 2013, WIRES DEV BIOL, V2, P113, DOI 10.1002/wdev.57; Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Nishikawa R, 2015, CYTOTECHNOLOGY, V67, P661, DOI 10.1007/s10616-014-9754-8; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stamp LA, 2015, J NEUROGASTROENTEROL, V21, P552, DOI 10.5056/jnm15079; Takahashi T, 2003, J GASTROENTEROL, V38, P421, DOI 10.1007/s00535-003-1094-y; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wagner JP, 2014, J PEDIATR SURG, V49, P1809, DOI 10.1016/j.jpedsurg.2014.09.023; Wagner JP, 2014, J PEDIATR SURG, V49, P1319, DOI 10.1016/j.jpedsurg.2014.01.061; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600	52	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147989	10.1371/journal.pone.0147989	http://dx.doi.org/10.1371/journal.pone.0147989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824433	Green Published, gold			2022-12-27	WOS:000369528600084
J	Dominguez, A; Soldevila, N; Toledo, D; Godoy, P; Castilla, J; Force, L; Morales, M; Mayoral, JM; Egurrola, M; Tamames, S; Martin, V; Astray, J				Dominguez, Angela; Soldevila, Nuria; Toledo, Diana; Godoy, Pere; Castilla, Jesus; Force, Lluis; Morales, Maria; Maria Mayoral, Jose; Egurrola, Mikel; Tamames, Sonia; Martin, Vicente; Astray, Jenaro		Project Pl 12 02079	Factors Associated with Influenza Vaccination of Hospitalized Elderly Patients in Spain	PLOS ONE			English	Article							SEASONAL INFLUENZA; HIGH-RISK; OLDER-ADULTS; HEALTH; IMMUNIZATION; PEOPLE; RATES; CARE; COVERAGE; DEATHS	Vaccination of the elderly is an important factor in limiting the impact of influenza in the community. The aim of this study was to investigate the factors associated with influenza vaccination coverage in hospitalized patients aged >= 65 years hospitalized due to causes unrelated to influenza in Spain. We carried out a cross-sectional study. Bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking in to account sociodemographic variables and medical risk conditions. Multivariate analysis was performed using multilevel regression models. We included 1038 patients: 602 (58%) had received the influenza vaccine in the 2013-14 season. Three or more general practitioner visits (OR = 1.61; 95% CI 1.19-2.18); influenza vaccination in any of the 3 previous seasons (OR = 13.57; 95% CI 9.45-19.48); and 23-valent pneumococcal polysaccharide vaccination (OR = 1.97; 95% CI 1.38-2.80) were associated with receiving the influenza vaccine. Vaccination coverage of hospitalized elderly people is low in Spain and some predisposing characteristics influence vaccination coverage. Healthcare workers should take these characteristics into account and be encouraged to proactively propose influenza vaccination to all patients aged >= 65 years.	[Dominguez, Angela; Toledo, Diana] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Dominguez, Angela; Soldevila, Nuria; Godoy, Pere; Castilla, Jesus; Morales, Maria] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Godoy, Pere] Agencia Salut Publ Catalunya, Barcelona, Spain; [Godoy, Pere] Univ Lleida, Inst Recerca Biomed Lleida, Lleida, Spain; [Castilla, Jesus] Inst Invest Sanitaria Navarra, Inst Salud Publ, Pamplona, Spain; [Force, Lluis] Hosp Mataro, Mataro, Spain; [Morales, Maria] Univ Valencia, Valencia, Spain; [Maria Mayoral, Jose] Serv Vigilancia Andalucia, Seville, Spain; [Egurrola, Mikel] Hosp Galdakao, Usansolo, Spain; [Tamames, Sonia] Junta Castilla & Leon, Direcc Gen Salud Publ Invest Desarrollo & Innovac, Leon, Spain; [Martin, Vicente] Univ Leon, E-24071 Leon, Spain; [Astray, Jenaro] Consejeria Sanidad, Madrid, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University of Valencia; Galdakao Hospital; Universidad de Leon	Dominguez, A (corresponding author), Univ Barcelona, Dept Salut Publ, Barcelona, Spain.; Dominguez, A (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	angela.dominguez@ub.edu	Casado, Itziar/AAE-2973-2021; Fernández-Villa, Tania/R-6534-2017; Perez-Ruiz, Manuel/C-4419-2016; Martin, Vicente/A-1597-2008; Martin, Vicente/GRE-8306-2022; Casado, Itziar/B-1341-2017; Martin, Vicente/ABF-2276-2021; Castilla, Jesus/B-9048-2008; Antón, Andrés/B-3308-2011; Fernandez Natal, Isabel/C-9328-2015	Casado, Itziar/0000-0001-6879-4984; Martin, Vicente/0000-0003-0552-2804; Martin, Vicente/0000-0003-0552-2804; Casado, Itziar/0000-0001-6879-4984; Castilla, Jesus/0000-0002-6396-7265; Antón, Andrés/0000-0002-1476-0815; Fernandez Natal, Isabel/0000-0002-2701-9815; Espejo, Elena/0000-0001-9018-7515; Tamames, Sonia/0000-0001-5548-2594; Godoy, Pere/0000-0002-2896-7286; Dominguez-Berjon, Maria Felicitas/0000-0003-3551-0660; Torner, Nuria/0000-0003-0143-5295; Sanz, Francisco/0000-0003-4076-0816	National Plan; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion [PI12/02079]; Fondo Europeo de Desarrollo Regional (FEDER. Union Europea. Una manera de hacer Europa); Catalan Agency for the Management of Grants for University Research (AGAUR) [2014/ SGR 1403]	National Plan; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Fondo Europeo de Desarrollo Regional (FEDER. Union Europea. Una manera de hacer Europa); Catalan Agency for the Management of Grants for University Research (AGAUR)	This study was funded by the National Plan of I+D+I 2008-2011 and ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion (Project PI12/02079) and cofounded by Fondo Europeo de Desarrollo Regional (FEDER. Union Europea. Una manera de hacer Europa), and the Catalan Agency for the Management of Grants for University Research (AGAUR Grant number 2014/ SGR 1403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The other members of the Project PI12/02079 Working Group are: J. Diaz-Borrego (Servicio Andaluz de Salud), A. Morillo (Hospital Universitario Virgen del Rocio), M.J. Perez-Lozano (Hospital Universitario Virgen de Valme), J. Gutierrez (Hospital Universitario Puerta del Mar), M. Perez-Ruiz, M.A. Fernandez-Sierra (Hospital Universitario San Cecilio y Virgen de las Nieves), S. Rojo-Rello, R. Ortiz de Lejarazu (Hospital Clinico Universitario de Valladolid), M.I. Fernandez-Natal (Complejo Asistencial Universitario de Leon), T. Fernandez-Villa (GII-GAS-Grupo de Investigacion en Interaccion Gen-Ambiente y Salud, Universidad de Leon), A. Pueyo (Hospital Universitario de Burgos), A. Vilella (Hospital Clinic), A. Anton (Hospital Universitari Vall d'Hebron; Universitat Autonoma de Barcelona), G. Navarro (Corporacio Sanitaria i Universitaria Parc Tauli), M. Riera (Hospital Universitari Mutua Terrassa), E. Espejo (Hospital de Terrassa), M.D. Mas, R. Perez (ALTHAIA, Xarxa Hospitalaria de Manresa), J.A. Cayla, C. Rius (Agencia de Salut Publica de Barcelona; CIBERESP), N. Torner (Agencia de Salut Publica de Catalunya; Universitat de Barcelona; CIBERESP), I. Crespo (CIBERESP, Universitat de Barcelona), C. Izquierdo, R. Torra (Agencia de Salut Publica de Catalunya), M.F. Dominguez-Berjon, M.A. Gutierrez, S. Jimenez, E. Gil, F. Martin, R. Genova-Maleras (Consejeria de Sanidad), M.C. Prados, F. Ezzine de Blas (Hospital Universitario la Paz), J.C. Galan, E. Navas, L. Rodriguez (Hospital Ramon y Cajal), C.J. Alvarez, E. Banderas (Hospital Universitario 12 de Octubre), J. Chamorro (Complejo Hospitalario de Navarra), I. Casado, J. Diaz (Instituto de Salud Publica de Navarra), M.J. Lopez de Goicoechea (Hospital de Galdakao), F. Sanz (Consorci Hospital General Universitari de Valencia).	AGUILAR I, 2010, EUROSURVEILLANCE, V17, P20154; Al-Sukhni W, 2008, VACCINE, V26, P1432, DOI 10.1016/j.vaccine.2008.01.001; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Armstrong BG, 2004, BMJ-BRIT MED J, V329, P660, DOI 10.1136/bmj.38198.594109.AE; Baxter R, 2010, J INFECT DIS, V201, P186, DOI 10.1086/649568; Blank PR, 2009, INFECTION, V37, P390, DOI 10.1007/s15010-009-8467-y; Blank PR, 2008, WIEN MED WOCHENSCHR, V158, P583, DOI 10.1007/s10354-008-0582-3; Blaser, 2015, PRINCIPLES PRACTICE, P2000, DOI DOI 10.1016/B978-1-4557-4801-3.00167-3; Bohmer MM, 2011, VACCINE, V29, P4492, DOI 10.1016/j.vaccine.2011.04.039; Campos EC, 2012, CAD SAUDE PUBLICA, V28, P878, DOI 10.1590/S0102-311X2012000500007; Chiatti C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-207; Crawford VLS, 2011, AGE AGEING, V40, P35, DOI 10.1093/ageing/afq152; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; European Centre for Disease Prevention and Control, 2015, SEAS INFL VACC EUR O; Fiore AE, 2013, VACCINES, P257; Gil de Miguel A, 2008, MED PREVENTIVA SALUD, P992; Godoy P, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0259-0; Hottes TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022618; INE, POP HOUS CENS 2011 P; INE, 2013, REV MUN REG 2013; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jefferson T, 2010, COCHRANE DB SYST REV, V17, DOI DOI 10.1002/14651858.CD004876.PUB3; Katz MH., 2011, MULTIVARIABLE ANAL, P197, DOI [10.1017/CBO9780511974175, DOI 10.1017/CBO9780511974175]; Kroneman M, 2006, VACCINE, V24, P622, DOI 10.1016/j.vaccine.2005.08.040; Lau L, 2009, INT J NURS STUD, V46, P768, DOI 10.1016/j.ijnurstu.2008.12.006; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Ompad DC, 2006, EPIDEMIOL REV, V28, P54, DOI 10.1093/epirev/mxj004; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pena-Rey I, 2004, PUBLIC HEALTH, V118, P582, DOI 10.1016/j.puhe.2004.04.010; Privileggio L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-246; Reed C, 2014, MMWR-MORBID MORTAL W, V63, P1151; Regional Committee for Europe, 2012, STRATEGY ACTION PLAN; Ridenhour BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076318; Sarriá Antonio, 2002, Rev. Esp. Salud Publica, V76, P17, DOI 10.1590/S1135-57272002000100003; Schwartz AW, 2013, PREV MED, V56, P337, DOI 10.1016/j.ypmed.2013.01.019; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Cruzeta APS, 2013, INT J INFECT DIS, V17, pE1194, DOI 10.1016/j.ijid.2013.07.013; The Council of the European Union, COUNC REC SEAS INFL; Thomas RE, 2014, VACCINE, V32, P6884, DOI 10.1016/j.vaccine.2014.08.090; World Health Organization, 2003, PREV CONTR INFL PAND	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147931	10.1371/journal.pone.0147931	http://dx.doi.org/10.1371/journal.pone.0147931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824383	Green Published, gold			2022-12-27	WOS:000369528600075
J	Masias, VH; Valle, M; Morselli, C; Crespo, F; Vargas, A; Laengle, S				Hugo Masias, Victor; Valle, Mauricio; Morselli, Carlo; Crespo, Fernando; Vargas, Augusto; Laengle, Sigifredo			Modeling Verdict Outcomes Using Social Network Measures: The Watergate and Caviar Network Cases	PLOS ONE			English	Article							ILLEGAL NETWORKS; CENTRALITY; CLASSIFICATION; SIZE; CONSPIRACY; TERRORISM; CRIME; LINK	Modelling criminal trial verdict outcomes using social network measures is an emerging research area in quantitative criminology. Few studies have yet analyzed which of these measures are the most important for verdict modelling or which data classification techniques perform best for this application. To compare the performance of different techniques in classifying members of a criminal network, this article applies three different machine learning classifiers-Logistic Regression, Naive Bayes and Random Forest-with a range of social network measures and the necessary databases to model the verdicts in two real-world cases: the U.S. Watergate Conspiracy of the 1970' s and the now-defunct Canada-based international drug trafficking ring known as the Caviar Network. In both cases it was found that the Random Forest classifier did better than either Logistic Regression or Naive Bayes, and its superior performance was statistically significant. This being so, Random Forest was used not only for classification but also to assess the importance of the measures. For the Watergate case, the most important one proved to be betweenness centrality while for the Caviar Network, it was the effective size of the network. These results are significant because they show that an approach combining machine learning with social network analysis not only can generate accurate classification models but also helps quantify the importance social network variables in modelling verdict outcomes. We conclude our analysis with a discussion and some suggestions for future work in verdict modelling using social network measures.	[Hugo Masias, Victor; Laengle, Sigifredo] Univ Chile, Dept Management Control & Informat Syst, Santiago, Chile; [Morselli, Carlo] Univ Montreal, Ecole Criminol, CICC, Montreal, PQ, Canada; [Valle, Mauricio] Univ Finis Terrae, Fac Econ & Business, Santiago, Chile; [Crespo, Fernando] Univ Bernardo Ohiggins, Direcc Invest, CEDYTEC, Santiago, Chile; [Vargas, Augusto] Univ Tecn Federico Santa Maria, Dept Diseno & Manufactura DIMA, Vina Del Mar, Chile	Universidad de Chile; Universite de Montreal; Universidad Finis Terrae; Universidad  Bernardo O'Higgins; Universidad Tecnica Federico Santa Maria	Masias, VH (corresponding author), Univ Chile, Dept Management Control & Informat Syst, Santiago, Chile.	vmasias@fen.uchile.cl	Crespo, Fernando A/A-9122-2016; Schüler, Augusto Antonio Vargas/AAU-1133-2020; Masías, Victor Hugo/AAF-9609-2021; Valle, Mauricio A./AGJ-3275-2022	Crespo, Fernando A/0000-0001-9918-4492; Schüler, Augusto Antonio Vargas/0000-0001-6023-1706; Valle, Mauricio A./0000-0003-1362-2776; Laengle, Sigifredo/0000-0002-8396-4408				Airola A, 2009, P 3 INT WORKSH MACH, P15; Airola A, 2011, COMPUT STAT DATA AN, V55, P1828, DOI 10.1016/j.csda.2010.11.018; Airoldi EM, 2011, DECIS SUPPORT SYST, V51, P506, DOI 10.1016/j.dss.2011.02.014; Akyuz K, 2011, INT CRIM JUSTICE REV, V21, P134, DOI 10.1177/1057567711407332; Alfons A, 2012, USER 8 INT R US C JU; [Anonymous], 2002, CONNECTIONS; [Anonymous], 2013, SECUR INFORM, DOI [10.1186/2190-8532-2-4, DOI 10.1186/2190-8532-2-4]; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; BAKER WE, 1993, AM SOCIOL REV, V58, P837, DOI 10.2307/2095954; Ballester C, 2006, ECONOMETRICA, V74, P1403, DOI 10.1111/j.1468-0262.2006.00709.x; Berk R, 2011, J QUANT CRIMINOL, V27, P107, DOI 10.1007/s10940-010-9098-2; Berk Richard, 2010, ALB L REV, V74, P1071; Berk RichardA., 2012, CRIMINAL JUSTICE FOR; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Bostanci B., 2012, P 7 INT C BIOINSP CO, P15; Bouchard M, 2011, GLOB CRIME, V12, P70, DOI 10.1080/17440572.2011.548956; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brandes U., 2005, NETWORK ANAL METHODO, V3418; Brandes U, 2008, SOC NETWORKS, V30, P136, DOI 10.1016/j.socnet.2007.11.001; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Burt R. S, 1992, STRUCTURAL HOLES; Bushway SD, 2007, CRIME DELINQUENCY, V53, P156, DOI 10.1177/0011128706294444; Calderoni F, 2014, ENCY CRIMINOLOGY CRI, P4972; Calderoni F, 2012, CRIME LAW SOCIAL CH, V58, P321, DOI 10.1007/s10611-012-9387-9; Carley K, 2002, SUMMARY KEY NE UNPUB; Carley K., 2013, ORA USERS GUIDE 2013; Carley KM, 2003, INTERNATIONAL CONFERENCE ON INTEGRATION OF KNOWLEDGE INTENSIVE MULTI-AGENT SYSTEMS, P121, DOI 10.1109/KIMAS.2003.1245033; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Caruana R, 2008, P INT C MACH LEARN, P96, DOI DOI 10.1145/1390156.1390169; Cataltepe Z, 2014, LECT NOTES SOC NETW, P127, DOI 10.1007/978-3-7091-1797-2__7; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cortez P., 2011, Proceedings 2011 IEEE Symposium on Computational Intelligence and Data Mining (CIDM 2011), P341, DOI 10.1109/CIDM.2011.5949423; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dantzker ML, 2011, RES METHODS CRIMINOL; Nunez-Gonzalez JD, 2015, NEUROCOMPUTING, V166, P1, DOI 10.1016/j.neucom.2014.10.099; Davies T, 2014, J QUANTITATIVE CRIMI, V31, P1; De Meo P, 2012, KNOWL-BASED SYST, V30, P136, DOI 10.1016/j.knosys.2012.01.007; Dietterich T, 1996, 1 OR STAT U, V1, P1; Duijn P.A., 2014, NETWORKS NETWORK ANA, P121; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Faulkner R.R., 2013, CRIME NETWORKS CRIMI, P263; Faulkner RR, 2013, GLOB CRIME, V14, P197, DOI 10.1080/17440572.2013.790313; Faulkner RR, 2003, CRIMINOLOGY, V41, P511, DOI 10.1111/j.1745-9125.2003.tb00996.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fay MP, 2015, EXACT2X2 EXACT CONDI; Force USWSP, 1975, REP WAT SPEC PROS FO; Force USWSP, 1977, WAT SPEC PROS FORC F; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gibbons A, 1985, ALGORITHMIC GRAPH TH; Graham S, 2009, EVENT PARTICIPANT IN; Grana M, 2015, CYBERNET SYST, V46, P19, DOI 10.1080/01969722.2015.1007725; Haynie DL, 2002, J QUANT CRIMINOL, V18, P99, DOI 10.1023/A:1015227414929; Helms R, 2009, J CRIM JUST, V37, P10, DOI 10.1016/j.jcrimjus.2008.12.004; Herve M, 2014, RVAIDEMEMOIRE DIVERS; Hill J, 2010, J POLICING INTELLIGE, V5, P41, DOI [10.1080/18335300.2010.9686948, DOI 10.1080/18335300.2010.9686948]; Hill JB, 2013, J DEF MODEL SIMUL-AP, V10, P181, DOI 10.1177/1548512912455470; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hosseinkhani J., 2014, INT J ADV COMPUTER S, V3, P32; Kaikuo Xu, 2010, Proceedings of the Second International Conference on Communication Software and Networks (ICCSN 2010), P350, DOI 10.1109/ICCSN.2010.34; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Klerks P., 1999, CONNECTIONS, V24, P53; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; Kotsiantis S., 2006, GESTS INT T COMPUTER, V30, P25, DOI DOI 10.1007/978-0-387-09823-4_45; Krackhardt D, POWER INFLUENCE ORG, P21; Kutler Stanley I., 2010, WATERGATE BRIEF HIST; LANGLEY P, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P223; Ledolter J, 2013, DATA MINING AND BUSINESS ANALYTICS WITH R, P1, DOI 10.1002/9781118596289; Leisch F., 2006, BINDATA PACKAGE; Lewis D. D., 1998, LECT NOTES COMPUTER, P4, DOI DOI 10.1007/BFB0026666; Li XC, 2009, J COMPUT SCI TECH-CH, V24, P1010, DOI 10.1007/s11390-009-9290-8; Li XC, 2009, ISI: 2009 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS, P248, DOI 10.1109/ISI.2009.5137319; Liu YY, 2011, J QUANT CRIMINOL, V27, P547, DOI 10.1007/s10940-011-9137-7; Mabrey DJ, 2006, THESIS SAM HOUSTON S; Malm A, 2011, J RES CRIME DELINQ, V48, P271, DOI 10.1177/0022427810391535; Malm AE, 2008, SECUR J, V21, P77, DOI 10.1057/palgrave.sj.8350069; Masias VH, 2016, J INVESTIGA IN PRESS; Masias VH, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00379; Mastrobuoni G, 2012, REV NETW ECON, V11, DOI 10.1515/1446-9022.1324; Masys A, 2013, 2013 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P1479; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mitchell O, 2005, J QUANT CRIMINOL, V21, P439, DOI 10.1007/s10940-005-7362-7; Morselli C, 2004, CRIMINOLOGY, V42, P773, DOI 10.1111/j.1745-9125.2004.tb00536.x; Morselli C, 2006, CRIMINOLOGY, V44, P17, DOI 10.1111/j.1745-9125.2006.00041.x; Morselli C., 2010, J CONTEMP CRIM JUST, V26, P382, DOI [10.1177/1043986210377105, DOI 10.1177/1043986210377105]; Morselli C, 2013, CRIMINOLOGY JUSTICE; Morselli C, 2008, INSIDE CRIMINAL NETW; Myers Jr SL, 1985, J QUANTITATIVE CRIMI, V1, P191; Natarajan M, 2006, J QUANT CRIMINOL, V22, P171, DOI 10.1007/s10940-006-9007-x; Newman M, 2010, NETWORKS, P109, DOI [DOI 10.1093/ACPROF:OSO/9780199206650.003.0006, 10.1093/acprof:oso/9780199206650.003.0006, 10.1093/acprof:oso/9780199206650.001.0001/acprof-9780199206650-chapter-6]; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Ngo FT, 2014, AM J CRIM JUSTICE, P1; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Papachristos AV, 2011, ADV CRIM THEOR, V17, P101; Pfeffer J., 2012, PROC 21 INT C WORLD, P1043, DOI DOI 10.1145/2187980.2188239; Piquero AR, 2010, HANDBOOK OF QUANTITATIVE CRIMINOLOGY, P1, DOI 10.1007/978-0-387-77650-7_1; Plecas D, 2005, MARIHUANA GROWING OP, P1; Purushotham S, 2012, COMM COM INF SC, V270, P680; Qi YJ, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P307, DOI 10.1007/978-1-4419-9326-7_11; Radil SM, 2010, ANN ASSOC AM GEOGR, V100, P307, DOI 10.1080/00045600903550428; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Sammut C, 2010, ENCY MACHINE LEARNIN, P9, DOI DOI 10.1007/978-0-387-30164-8_3; Sammut C., 2011, ENCY MACHINE LEARNIN, DOI [10.1007/978-0-387-30164-8-469, DOI 10.1007/978-0-387-30164-8_469, DOI 10.1007/978-0-387-30164-8469]; Sammut C, 2010, ENCY MACHINE LEARNIN, P40; Shah M., 2011, EVALUATING LEARNING, DOI [10.1017/CBO9780511921803, DOI 10.1017/CBO9780511921803]; Sheskin D.J., 1997, HDB PARAMETRIC NONPA; SIMESTER DI, 1993, INT J FORECASTING, V9, P49, DOI 10.1016/0169-2070(93)90053-P; Skolnick P, 1997, J SOC ISSUES, V53, P503, DOI 10.1111/0022-4537.00031; SPARROW MK, 1991, SOC NETWORKS, V13, P251, DOI 10.1016/0378-8733(91)90008-H; Spohn C, 2000, CRIMINOLOGY, V38, P281, DOI 10.1111/j.1745-9125.2000.tb00891.x; SPOHN C, 1982, LAW SOC REV, V16, P71; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Strang S.J., 2014, NETWORK ANAL CRIMINA, P1, DOI [10.1007/978-3-319-04147-6_1, DOI 10.1007/978-3-319-04147-6_1]; Su P, 2013, INF SYST E-BUS MANAG, V11, P437, DOI 10.1007/s10257-012-0198-4; Su P, 2009, ISI: 2009 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS, P251, DOI 10.1109/ISI.2009.5137320; Sun YM, 2007, PATTERN RECOGN, V40, P3358, DOI 10.1016/j.patcog.2007.04.009; Szczepanski P. L., 2012, P 11 INT C AUT AG MU, P239; Tayebi MA, 2011, 2011 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2011), P171, DOI 10.1109/ASONAM.2011.120; THOMSON RJ, 1981, AM J SOCIOL, V86, P869, DOI 10.1086/227320; Ting K. M., 2010, ENCY MACHINE LEARNIN, P781, DOI DOI 10.1007/978-0-387-30164-8_652; Tita GE, 2011, J QUANT CRIMINOL, V27, P521, DOI 10.1007/s10940-011-9136-8; Torgo L, 2013, PACKAGE DMWR; WALKER J. T., 2012, STAT CRIMINOLOGY CRI; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei W, 2011, HANDLING WEIGHTED AS; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Yin Qiuju, 2012, Proceedings of the 2012 Second International Conference on Intelligent System Design and Engineering Application (ISDEA), P760, DOI 10.1109/ISdea.2012.546; Young JTN, 2011, J QUANT CRIMINOL, V27, P251, DOI 10.1007/s10940-010-9105-7; Young JTN., 2013, HDB LIFE COURSE CRIM, P159, DOI [DOI 10.1007/978-1-4614-5113-6_10, 10.1007/978-1-4614-5113-6_10]	137	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147248	10.1371/journal.pone.0147248	http://dx.doi.org/10.1371/journal.pone.0147248			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824351	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600019
J	Kataoka, H; Ariyama, Y; Deushi, M; Osaka, M; Nitta, K; Yoshida, M				Kataoka, Hiroshi; Ariyama, Yuno; Deushi, Michiyo; Osaka, Mizuko; Nitta, Kosaku; Yoshida, Masayuki			Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTERCELLULAR-ADHESION MOLECULE-1; 5-HYDROXYTRYPTAMINE 2A RECEPTOR; SMOOTH-MUSCLE-CELLS; 5-HT2A RECEPTOR; COUPLED RECEPTORS; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; VASCULAR ENDOTHELIUM; INSULIN-RESISTANCE	Background Although 5-HT2A serotonergic antagonists have been used to treat vascular disease in patients with diabetes mellitus or obesity, their effects on leukocyte-endothelial interactions have not been fully investigated. In this study, we assessed the effects of sarpogrelate hydrochloride (SRPO), a 5-HT2A receptor inverse agonist, on leukocyte-endothelial cell interactions in obesity both in vivo and in vitro. Methods and Findings In the in vivo experiment, C57BL/6 mice were fed a high-fat high-fructose diet (HFFD), comprising 20% fat and 30% fructose, with or without intraperitoneal injection of 5 mg/kg/day SRPO for 4 weeks. The body weight, visceral fat weight, and serum monocyte chemoattractant protein-1 levels in the mice increased significantly with the HFFD, but these effects were prevented by chronic injections of SRPO. Intravital microscopy of the femoral artery detected significant leukocyte-endothelial interactions after treatment with HFFD, but these leukocyte-endothelial interactions were reduced in the mice injected with SRPO. In the in vitro experiment, pre-incubation of activated human umbilical vein endothelial cells (HUVECs) with platelet-rich plasma (PRP) induced THP-1 cell adhesion under physiological flow conditions, but the adhesion was reduced by pretreatment of PRP with SRPO. A fluorescent immunobinding assay showed that PRP induced significant upregulation of E-selectin in HUVECs, but this upregulation was reduced by pretreatment of PRP with SRPO. In other in vitro conditions, pre-incubation of THP-1 cells with phorbol 12-myristate 13-acetate increased the adhesion of THP-1 cells to activated HUVECs under rotational conditions, but this adhesion was reduced by pretreatment with SRPO. Western blotting analysis showed that protein kinase C alpha activation in THP-1 cells was inhibited by SRPO. Conclusion Our findings indicated that SRPO inhibits vascular inflammation in obesity via inactivation of platelets and leukocytes, and improvement of obese.	[Kataoka, Hiroshi; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan; [Ariyama, Yuno; Deushi, Michiyo; Osaka, Mizuko; Yoshida, Masayuki] Tokyo Med & Dent Univ, Dept Life Sci & Bioeth, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Medical & Dental University (TMDU)	Yoshida, M (corresponding author), Tokyo Med & Dent Univ, Dept Life Sci & Bioeth, Grad Sch Med & Dent Sci, Tokyo, Japan.	masa.vasc@tmd.ac.jp	Kataoka, Hiroshi/AAD-1531-2019	Kataoka, Hiroshi/0000-0001-9543-7608				Abul Muntasir H, 2007, J PHARMACOL SCI, V104, P274, DOI 10.1254/jphs.SC0060241; Angelico F, 2006, DIABETOLOGIA, V49, P1169, DOI 10.1007/s00125-006-0222-7; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2938, DOI 10.1172/JCI118001; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Ferri C, 1999, HYPERTENSION, V34, P568, DOI 10.1161/01.HYP.34.4.568; Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Grewal JS, 1999, AM J PHYSIOL-RENAL, V276, pF922, DOI 10.1152/ajprenal.1999.276.6.F922; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Inoue M, 2011, INT IMMUNOPHARMACOL, V11, P67, DOI 10.1016/j.intimp.2010.10.007; Inoue Y, 2004, J IMMUNOL, V172, P2147, DOI 10.4049/jimmunol.172.4.2147; Ito T, 2000, CIRCULATION, V102, P2522, DOI 10.1161/01.CIR.102.20.2522; Kajiwara I, 2011, THROMB RES, V128, P547, DOI 10.1016/j.thromres.2011.06.001; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kojima C, 2007, J PHARMACOL EXP THER, V323, P855, DOI 10.1124/jpet.107.127944; Kuckleburg CJ, 2011, CARDIOVASC RES, V91, P134, DOI 10.1093/cvr/cvr040; Latek D, 2012, ACTA BIOCHIM POL, V59, P515; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; Machida T, 2011, EUR J PHARMACOL, V656, P19, DOI 10.1016/j.ejphar.2010.12.044; Missiou A, 2010, THROMB HAEMOSTASIS, V103, P788, DOI 10.1160/TH09-07-0463; Muntasir HA, 2006, J PHARMACOL SCI, V102, P189, DOI 10.1254/jphs.FP0060610; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Nishihira K, 2008, J THROMB HAEMOST, V6, P1207, DOI 10.1111/j.1538-7836.2008.02996.x; Nomura S, 2005, BLOOD COAGUL FIBRIN, V16, P423, DOI 10.1097/01.mbc.0000176197.48134.08; Nonogaki K, 2006, BIOCHEM BIOPH RES CO, V351, P1078, DOI 10.1016/j.bbrc.2006.10.173; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ogawa S, 2008, CLIN J AM SOC NEPHRO, V3, P362, DOI 10.2215/CJN.03450807; Osaka M, 2007, AM J PHYSIOL-HEART C, V292, pH1876, DOI 10.1152/ajpheart.00708.2006; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Proenca-Ferreira R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089012; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Santilli F, 2012, OBES REV, V13, P27, DOI 10.1111/j.1467-789X.2011.00930.x; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Shen KP, 2009, J PHARM PHARMACOL, V61, P517, DOI 10.1211/jpp/61.04.0015; Suguro T, 2006, ATHEROSCLEROSIS, V186, P275, DOI 10.1016/j.atherosclerosis.2005.08.007; Takishita E, 2004, J CARDIOVASC PHARM, V43, P266, DOI 10.1097/00005344-200402000-00015; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Uchida-Kitajima S, 2008, FEBS LETT, V582, P3037, DOI 10.1016/j.febslet.2008.07.044; Uchitomi Y, 2002, BIOL PSYCHIAT, V52, P1159, DOI 10.1016/S0006-3223(02)01420-8; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Xu YJ, 2012, J CELL MOL MED, V16, P2394, DOI 10.1111/j.1582-4934.2012.01554.x; Yan JC, 2003, ACTA PHARMACOL SIN, V24, P687; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143; Yu RN, 2006, OBESITY, V14, P1353, DOI 10.1038/oby.2006.153; Zhang HR, 2010, WORLD J CARDIOL, V2, P370, DOI 10.4330/wjc.v2.i11.370	52	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147929	10.1371/journal.pone.0147929	http://dx.doi.org/10.1371/journal.pone.0147929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824242	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600074
J	Li, J; Olshansky, M; Carbone, FR; Ma, JZ				Li, Jane; Olshansky, Moshe; Carbone, Francis R.; Ma, Joel Z.			Transcriptional Analysis of T Cells Resident in Human Skin	PLOS ONE			English	Article							TISSUE; EXPRESSION; INFECTION; SURVEILLANCE; IMMUNITY	Human skin contains various populations of memory T cells in permanent residence and in transit. Arguably, the best characterized of the skin subsets are the CD8(+) permanently resident memory T cells (T-RM) expressing the integrin subunit, CD103. In order to investigate the remaining skin T cells, we isolated skin-tropic (CLA(+)) helper T cells, regulatory T cells, and CD8(+) CD103-T cells from skin and blood for RNA microarray analysis to compare the transcriptional profiles of these groups. We found that despite their common tropism, the T cells isolated from skin were transcriptionally distinct from blood-derived CLA(+) T cells. A shared pool of genes contributed to the skin/blood discrepancy, with substantial overlap in differentially expressed genes between each T cell subset. Gene set enrichment analysis further showed that the differential gene profiles of each human skin T cell subset were significantly enriched for previously identified TRM core signature genes. Our results support the hypothesis that human skin may contain additional TRM or TRM-like populations.	[Li, Jane; Olshansky, Moshe; Carbone, Francis R.; Ma, Joel Z.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Li, Jane] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia	University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Li, J; Ma, JZ (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.; Li, J (corresponding author), Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia.	jane.melb@gmail.com; jzma@unimelb.edu.au	Carbone, Francis/ABF-2141-2020	Olshansky, Moshe/0000-0003-2085-9851; Ma, Joel/0000-0002-0448-6744	Australian National Health and Medical Research Council; Elizabeth and Vernon Puzey Scholarship; Victorian Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Elizabeth and Vernon Puzey Scholarship; Victorian Government	The work was supported by grants from the Australian National Health and Medical Research Council to FRC. JL is a recipient of the Elizabeth and Vernon Puzey Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all patients for participating in this study, and the team at the Royal Women's Hospital for assistance in obtaining tissue samples. We are grateful to Dr. D Fernandez-Ruiz for help in compiling the T<INF>RM</INF> gene set lists. Biospecimens and data used in this research were obtained from the Victorian Cancer Biobank, Victoria, Australia, with appropriate ethics approval. The Victorian Cancer Biobank is supported by the Victorian Government. We thank Dr. K Shaw for assistance with proofreading.	Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Dunning M, 2015, ILLUMINAHUMANV4 DB I; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Gagnon-Bartsch JA, 2014, RUV DETECT REMOVE UN; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Gebhardt T, 2013, TRENDS IMMUNOL, V34, P27, DOI 10.1016/j.it.2012.08.008; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kataoka T, 2009, J ANTIBIOT, V62, P655, DOI 10.1038/ja.2009.98; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; Nakatsuji T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2441; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; SPEED T. P, 2013, 820 U CAL DEP STAT; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang VA, 2010, J REPROD IMMUNOL, V87, P39, DOI 10.1016/j.jri.2010.06.155; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	38	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148351	10.1371/journal.pone.0148351	http://dx.doi.org/10.1371/journal.pone.0148351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824609	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600117
J	Lin, MY; Chang, DCK; Shen, YD; Lin, YK; Lin, CP; Wang, IJ				Lin, Meng-Yin; Chang, David C. K.; Shen, Yun-Dun; Lin, Yen-Kuang; Lin, Chang-Ping; Wang, I-Jong			Factors Influencing Intraocular Pressure Changes after Laser In Situ Keratomileusis with Flaps Created by Femtosecond Laser or Mechanical Microkeratome	PLOS ONE			English	Article							GOLDMANN APPLANATION TONOMETRY; CORVIS ST TONOMETER; PHOTOREFRACTIVE KERATECTOMY; REFRACTIVE SURGERY; CORNEAL THICKNESS; STROMAL BED; LASIK; MYOPIA; ASTIGMATISM; NONCONTACT	The aim of this study is to describe factors that influence the measured intraocular pressure (IOP) change and to develop a predictive model after myopic laser in situ keratomileusis (LASIK) with a femtosecond (FS) laser or a microkeratome (MK). We retrospectively reviewed preoperative, intraoperative, and 12-month postoperative medical records in 2485 eyes of 1309 patients who underwent LASIK with an FS laser or an MK for myopia and myopic astigmatism. Data were extracted, such as preoperative age, sex, IOP, manifest spherical equivalent (MSE), central corneal keratometry (CCK), central corneal thickness (CCT), and intended flap thickness and postoperative IOP (postIOP) at 1, 6 and 12 months. Linear mixed model (LMM) and multivariate linear regression (MLR) method were used for data analysis. In both models, the preoperative CCT and ablation depth had significant effects on predicting IOP changes in the FS and MK groups. The intended flap thickness was a significant predictor only in the FS laser group (P <.0001 in both models). In the FS group, LMM and MLR could respectively explain 47.00% and 18.91% of the variation of postoperative IOP underestimation (R-2 = 0.47 and R-2 = 0.1891). In the MK group, LMM and MLR could explain 37.79% and 19.13% of the variation of IOP underestimation (R-2 = 0.3779 and 0.1913 respectively). The best-fit model for prediction of IOP changes was the LMM in LASIK with an FS laser.	[Lin, Meng-Yin; Shen, Yun-Dun] Taipei Med Univ, Taipei Med Sch Med, Shuang Ho Hosp, Dept Ophthalmol, Taipei, Taipei County, Taiwan; [Lin, Meng-Yin] Natl Taiwan Univ, Sch Med, Inst Clin Med, Taipei 10764, Taiwan; [Chang, David C. K.] Nobel Eye Clin, Taipei, Taiwan; [Lin, Yen-Kuang] Taipei Med Univ, Biostat Ctr, Taipei, Taiwan; [Lin, Chang-Ping; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Wang, I-Jong] China Med Univ, Sch Med, Inst Clin Med, Taichung, Taiwan	Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan	Lin, CP; Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.; Wang, IJ (corresponding author), China Med Univ, Sch Med, Inst Clin Med, Taichung, Taiwan.	cpiling59@gmail.com; ijong@ms8.hinet.net		LIN, CHANG-PING/0000-0003-0302-7711; Wang, I-Jong/0000-0002-3045-0614				Agudelo LM, 2002, J REFRACT SURG, V18, P472; Alio JL, 2008, J REFRACT SURG, V24, P12, DOI 10.3928/1081597X-20080101-03; [Anonymous], 2006, COMPR REP GLOB REFR; [Anonymous], 2010, FTN EQUITY CAPITAL M; Aristeidou AP, 2011, GRAEF ARCH CLIN EXP, V249, P767, DOI 10.1007/s00417-010-1431-9; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Chan A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1484, DOI 10.1001/archopht.126.11.1484; Chang DH, 2005, OPHTHALMOLOGY, V112, P1009, DOI 10.1016/j.ophtha.2004.12.033; Chihara E, 2005, BRIT J OPHTHALMOL, V89, P160, DOI 10.1136/bjo.2004.048074; Cook JA, 2012, OPHTHALMOLOGY, V119, P1552, DOI 10.1016/j.ophtha.2012.02.030; Gimeno JAS, 2000, CORNEA, V19, P512, DOI 10.1097/00003226-200007000-00022; Hong JX, 2015, OPTOMETRY VISION SCI, V92, P589, DOI 10.1097/OPX.0000000000000575; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Iester M, 2009, J CATARACT REFR SURG, V35, P1623, DOI 10.1016/j.jcrs.2009.05.015; Jordao MLS, 2009, EYE, V23, P1364, DOI 10.1038/eye.2008.278; Kezirian GM, 2004, J CATARACT REFR SURG, V30, P804, DOI 10.1016/j.jcrs.2003.10.026; Ko YC, 2005, EYE, V19, P327, DOI 10.1038/sj.eye.6701458; Kohlhaas M, 2006, J REFRACT SURG, V22, P263, DOI 10.3928/1081-597X-20060301-11; Kymionis GD, 2014, BRIT J OPHTHALMOL, V98, P133, DOI 10.1136/bjophthalmol-2013-304023; Lam AKC, 2010, J CATARACT REFR SURG, V36, P631, DOI 10.1016/j.jcrs.2009.10.045; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Montes-Mico R, 2002, J REFRACT SURG, V18, P88; Moshirfar M, 2010, J CATARACT REFR SURG, V36, P1925, DOI 10.1016/j.jcrs.2010.05.027; Patel SV, 2007, OPHTHALMOLOGY, V114, P1482, DOI 10.1016/j.ophtha.2006.10.057; Pepose JS, 2007, AM J OPHTHALMOL, V143, P39, DOI 10.1016/j.ajo.2006.09.036; Qazi MA, 2009, J CATARACT REFR SURG, V35, P1774, DOI 10.1016/j.jcrs.2009.05.041; Sanchez-Naves J, 2008, J GLAUCOMA, V17, P611, DOI 10.1097/IJG.0b013e3181639ae2; Santhiago MR, 2015, J CATARACT REFRACTIV; Sarayba MA, 2007, J REFRACT SURG, V23, P331; Schallhorn JM, 2015, OPHTHALMOLOGY, V122, P471, DOI 10.1016/j.ophtha.2014.09.033; Shaikh NM, 2005, J REFRACT SURG, V21, P353; Shemesh G, 2007, J REFRACT SURG, V23, P405; SHIELDS MB, 1980, SURV OPHTHALMOL, V24, P211, DOI 10.1016/0039-6257(80)90042-9; Sugar A, 2002, OPHTHALMOLOGY, V109, P175, DOI 10.1016/S0161-6420(01)00966-6; Winkler M, 2013, INVEST OPHTH VIS SCI, V54, P7293, DOI 10.1167/iovs.13-13150; Yang CC, 2006, AM J OPHTHALMOL, V141, P530, DOI 10.1016/j.ajo.2005.10.022; Zadok D, 1999, J CATARACT REFR SURG, V25, P1344, DOI 10.1016/S0886-3350(99)00202-3	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147699	10.1371/journal.pone.0147699	http://dx.doi.org/10.1371/journal.pone.0147699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824754	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600047
J	Phu, VD; Wertheim, HFL; Larsson, M; Nadjm, B; Dinh, QD; Nilsson, LE; Rydell, U; Le, TTD; Trinh, SH; Pham, HM; Tran, CT; Doan, HTH; Tran, NT; Le, ND; Van Huynh, N; Tran, TP; Tran, BD; Nguyen, ST; Pham, TTN; Dang, TQ; Nguyen, CVV; Lam, YM; Thwaites, G; Van Nguyen, K; Hanberger, H				Vu Dinh Phu; Wertheim, Heiman F. L.; Larsson, Mattias; Nadjm, Behzad; Quynh-Dao Dinh; Nilsson, Lennart E.; Rydell, Ulf; Tuyet Thi Diem Le; Son Hong Trinh; Hung Minh Pham; Cang Thanh Tran; Hanh Thi Hong Doan; Nguyen Thua Tran; Nhan Duc Le; Nhuan Van Huynh; Thao Phuong Tran; Bao Duc Tran; Son Truong Nguyen; Thao Thi Ngoc Pham; Tam Quang Dang; Chau Van Vinh Nguyen; Yen Minh Lam; Guy Thwaites; Kinh Van Nguyen; Hanberger, Hakan			Burden of Hospital Acquired Infections and Antimicrobial Use in Vietnamese Adult Intensive Care Units	PLOS ONE			English	Article							NOSOCOMIAL INFECTIONS; POINT-PREVALENCE; INICC REPORT; SURVEILLANCE; RESISTANCE; COUNTRIES; TURKEY; NEED	Background Vietnam is a lower middle-income country with no national surveillance system for hospital-acquired infections (HAIs). We assessed the prevalence of hospital-acquired infections and antimicrobial use in adult intensive care units (ICUs) across Vietnam. Methods Monthly repeated point prevalence surveys were systematically conducted to assess HAI prevalence and antimicrobial use in 15 adult ICUs across Vietnam. Adults admitted to participating ICUs before 08: 00 a.m. on the survey day were included. Results Among 3287 patients enrolled, the HAI prevalence was 29.5% (965/3266 patients, 21 missing). Pneumonia accounted for 79.4% (804/1012) of HAIs Most HAIs (84.5% [855/1012]) were acquired in the survey hospital with 42.5% (363/855) acquired prior to ICU admission and 57.5% (492/855) developed during ICU admission. In multivariate analysis, the strongest risk factors for HAI acquired in ICU were: intubation (OR 2.76), urinary catheter (OR 2.12), no involvement of a family member in patient care (OR 1.94), and surgery after admission (OR 1.66). 726 bacterial isolates were cultured from 622/1012 HAIs, most frequently Acinetobacter baumannii (177/726 [24.4%]), Pseudomonas aeruginosa (100/726 [13.8%]), and Klebsiella pneumoniae (84/726 [11.6%]), with carbapenem resistance rates of 89.2%, 55.7%, and 14.9% respectively. Antimicrobials were prescribed for 84.8% (2787/ 3287) patients, with 73.7% of patients receiving two or more. The most common antimicrobial groups were third generation cephalosporins, fluoroquinolones, and carbapenems (20.1%, 19.4%, and 14.1% of total antimicrobials, respectively). Conclusion A high prevalence of HAIs was observed, mainly caused by Gram-negative bacteria with high carbapenem resistance rates. This in combination with a high rate of antimicrobial use illustrates the urgent need to improve rational antimicrobial use and infection control efforts.	[Vu Dinh Phu] Natl Hosp Trop Dis, Intens Care Unit, Hanoi, Vietnam; [Wertheim, Heiman F. L.; Nadjm, Behzad; Quynh-Dao Dinh] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hanoi, Vietnam; [Wertheim, Heiman F. L.; Nadjm, Behzad; Guy Thwaites] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX1 2JD, England; [Larsson, Mattias] Karolinska Inst, Global Hlth IHCAR, Stockholm, Sweden; [Nilsson, Lennart E.] Linkoping Univ, Dept Clin & Expt Med, Clin Microbiol, Linkoping, Sweden; [Rydell, Ulf; Hanberger, Hakan] Linkoping Univ, Dept Clin & Expt Med, Infect Dis, Linkoping, Sweden; [Tuyet Thi Diem Le] Bach Mai Hosp, Intens Care Unit, Hanoi, Vietnam; [Son Hong Trinh] Viet Duc Hosp, Board Directors, Hanoi, Vietnam; [Hung Minh Pham] St Paul Hosp, Pharm, Hanoi, Vietnam; [Cang Thanh Tran] Viet Tiep Hosp, Intens Care, Hai Phong, Vietnam; [Hanh Thi Hong Doan] Vietnam Sweden Uong Bi Hosp, Board Directors, Quang Ninh, Vietnam; [Nguyen Thua Tran] Hue Cent Gen Hosp, Dept Gen Internal Med & Geriatr, Hue, Vietnam; [Nhan Duc Le] Da Nang Hosp, Board Directors, Da Nang, Vietnam; [Nhuan Van Huynh] Binh Dinh Hosp, Infect Dept, Binh Dinh, Vietnam; [Thao Phuong Tran] Khanh Hoa Hosp, Intens Care Unit, Khanh Hoa, Vietnam; [Bao Duc Tran] Dak Lak Hosp, Planning Dept, Dak Lak, Vietnam; [Son Truong Nguyen; Thao Thi Ngoc Pham] Cho Ray Hosp, Board Directors, Ho Chi Minh City, Vietnam; [Tam Quang Dang] Can Tho Cent Gen Hosptial, Board Directors, Can Tho, Vietnam; [Chau Van Vinh Nguyen; Yen Minh Lam] Hosp Trop Dis, Board Directors, Ho Chi Minh City, Vietnam; [Guy Thwaites] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Kinh Van Nguyen] Natl Hosp Trop Dis, Board Directors, Hanoi, Vietnam	National Hospital of Tropical Diseases; University of Oxford; University of Oxford; Karolinska Institutet; Linkoping University; Linkoping University; University of Oxford; National Hospital of Tropical Diseases	Phu, VD (corresponding author), Natl Hosp Trop Dis, Intens Care Unit, Hanoi, Vietnam.; Wertheim, HFL (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hanoi, Vietnam.; Wertheim, HFL (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX1 2JD, England.	vudinhphu07@gmail.com; Heiman.wertheim@gmail.com	Thwaites, Guy E/R-4993-2019; Wertheim, Heiman FL/F-3338-2016; Larsson, Mattias/C-6434-2017	Thwaites, Guy E/0000-0002-2858-2087; Wertheim, Heiman FL/0000-0002-5003-5565; Larsson, Mattias/0000-0002-0514-7445; Nadjm, Behzad/0000-0002-7704-3629	The British Council [172698142] Funding Source: researchfish	The British Council		Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2004, INS MALPR FIN REP HO; Barrera L, 2011, AM J INFECT CONTROL, V39, P633, DOI 10.1016/j.ajic.2010.11.004; Behnke M, 2012, INFECT CONT HOSP EP, V33, P618, DOI 10.1086/665729; Bouadma L, 2012, CURR OPIN INFECT DIS, V25, P395, DOI 10.1097/QCO.0b013e328355a835; Dogru A, 2010, JPN J INFECT DIS, V63, P95; ECDC, 2012, HELICSWIN NET HWN; Erdem H, 2014, J INFECTION, V68, P131, DOI 10.1016/j.jinf.2013.11.001; European Center for Disease Control (ECDC), 2012, POINT PREV SURV HEAL; Hugonnet S, 2007, AM J EPIDEMIOL, V165, P1321, DOI 10.1093/aje/kwm041; Johansson M, 2011, TROP MED INT HEALTH, V16, P737, DOI 10.1111/j.1365-3156.2011.02753.x; Van Nguyen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1158; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V63, P243, DOI 10.1093/jac/dkn511; Magill SS, 2014, JAMA-J AM MED ASSOC, V312, P1438, DOI 10.1001/jama.2014.12923; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Nguyen HS, 2008, J CLIN MED, P63; Oostdijk EAN, 2012, J ANTIMICROB CHEMOTH, V67, P2250, DOI 10.1093/jac/dks187; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rosenthal VD, 2014, AM J INFECT CONTROL, V42, P942, DOI 10.1016/j.ajic.2014.05.029; Susan Hopkins KS, 2012, ENGLISH NATL POINT P; Van TD, 2014, J GLOB ANTIMICROB RE, V2, P318, DOI 10.1016/j.jgar.2014.05.003; Thu TA, 2011, INFECT CONT HOSP EP, V32, P1039, DOI 10.1086/661915; Truong AT, 2008, J CLIN MED, P51; Truong AT, 2008, J CLIN MED, P57; Vietnam Ministry of Health, 2012, PROJ DECR OV HOSP; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vu VG, 2008, J CLIN MED, P46; Vu VG, 2008, J CLIN MED, P39; Wertheim HFL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001429; WHO, 2014, VIET NAM HLTH PROF; WHO, 2011, WHO LIB CAT PUBL DAT	32	68	75	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147544	10.1371/journal.pone.0147544	http://dx.doi.org/10.1371/journal.pone.0147544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824228	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600034
J	Silva, JL; Peruchetti, DB; Moraes-Santos, F; Landgraf, SS; Silva, LS; Sirtoli, GM; Zamith-Miranda, D; Takiya, CM; Pinheiro, AAS; Diaz, BL; Caruso-Neves, C				Silva-Filho, Joao Luiz; Peruchetti, Diogo Barros; Moraes-Santos, Felipe; Landgraf, Sharon Schilling; Silva, Leandro Souza; Sirtoli, Gabriela Modenesi; Zamith-Miranda, Daniel; Takiya, Christina Maeda; Sa Pinheiro, Ana Acacia; Diaz, Bruno Lourenco; Caruso-Neves, Celso			Group V Secretory Phospholipase A(2) Is Involved in Tubular Integrity and Sodium Handling in the Kidney	PLOS ONE			English	Article							ARACHIDONIC-ACID RELEASE; REGULATORY T-CELLS; GROUP-II; EICOSANOID GENERATION; MAST-CELLS; GROUP-X; EXPRESSION; INDUCTION; CYCLOOXYGENASE-2; ENZYMES	Group V (GV) phospholipase A(2) (PLA(2)) is a member of the family of secreted PLA(2) (sPLA2) enzymes. This enzyme has been identified in several organs, including the kidney. However, the physiologic role of GV sPLA(2) in the maintenance of renal function remains unclear. We used mice lacking the gene encoding GV sPLA(2) (Pla2g5(-/-)) and wild- type breeding pairs in the experiments. Mice were individually housed in metabolic cages and 48-h urine was collected for biochemical assays. Kidney samples were evaluated for glomerular morphology, renal fibrosis, and expression/activity of the (Na+ + K+)-ATPase a1 subunit. We observed that plasma creatinine levels were increased in PLA2g5(-/-) mice following by a decrease in creatinine clearance. The levels of urinary protein were higher in PLA2g5(-/-) mice than in the control group. Markers of tubular integrity and function such as gamma-glutamyl transpeptidase, lactate dehydrogenase, and sodium excretion fraction (FENa+) were also increased in PLA(2)g5(-/-) mice. The increased FENa+ observed in PLA(2)g5(-/-) mice was correlated to alterations in cortical (Na+ + K+) ATPase activity/expression. In addition, the kidney from PLA2g5(-/-) mice showed accumulation of matrix in corticomedullary glomeruli and tubulointerstitial fibrosis. These data suggest GV sPLA(2) is involved in the maintenance of tubular cell function and integrity, promoting sodium retention through increased cortical (Na+ + K+)-ATPase expression and activity.	[Silva-Filho, Joao Luiz; Peruchetti, Diogo Barros; Moraes-Santos, Felipe; Landgraf, Sharon Schilling; Silva, Leandro Souza; Sirtoli, Gabriela Modenesi; Zamith-Miranda, Daniel; Sa Pinheiro, Ana Acacia; Diaz, Bruno Lourenco; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil; [Landgraf, Sharon Schilling] Inst Fed Educ Ciencia & Tecnol, Rio De Janeiro, RJ, Brazil; [Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, RJ, Brazil; [Sa Pinheiro, Ana Acacia] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Pesquisa Translac Saude & Ambiente Reg, Rio De Janeiro, RJ, Brazil; [Caruso-Neves, Celso] Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Instituto Federal do Rio de Janeiro (IFRJ); Instituto Federal do Sertao Pernambucano; Universidade Federal do Rio de Janeiro	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil.; Caruso-Neves, C (corresponding author), Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, RJ, Brazil.	caruso@biof.ufrj.br	Silva-Filho, João Luiz/I-5704-2016; Diaz, Bruno L./A-5673-2009; Takiya, Christina/AAU-5959-2021; Peruchetti, Diogo B/L-3706-2017; Sila, Leandro/B-1381-2018; Caruso-Neves, Celso/C-4014-2013; Zamith-Miranda, Daniel/E-8877-2013	Silva-Filho, João Luiz/0000-0003-4762-2205; Diaz, Bruno L./0000-0001-8393-3823; Takiya, Christina/0000-0002-8019-628X; Peruchetti, Diogo B/0000-0002-7572-9731; Sila, Leandro/0000-0001-8720-0088; Caruso-Neves, Celso/0000-0002-2415-7753; Zamith-Miranda, Daniel/0000-0001-7532-2432	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [57.3695/2008-3 AASP, 57.3767/2008-4 CCN, 471771/2013-9 CCN, 456997/2014-8 AASP]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/110.551/2010 CCN, 111681/2013 CCN, E-26/102.170/2013 AASP, E-26/201.197/2014 CCN]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br): 1. 57.3695/2008-3 AASP, 2. 57.3767/2008-4 CCN, 3. 471771/2013-9 CCN, 4. 456997/2014-8 AASP, and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br): 1. E-26/110.551/2010 CCN, 2. 111681/2013 CCN, 3. E-26/102.170/2013 AASP, 4. E-26/201.197/2014 CCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2006, BBA-MOL CELL BIOL L, V1761, P1280, DOI 10.1016/j.bbalip.2006.07.008; Balsinde J, 1999, J BIOL CHEM, V274, P25967, DOI 10.1074/jbc.274.37.25967; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Belizario JE, 2012, J APPL GENET, V53, P295, DOI 10.1007/s13353-012-0096-y; Berrut G, 1997, CLIN NEPHROL, V48, P92; Boyanovsky BB, 2005, J BIOL CHEM, V280, P32746, DOI 10.1074/jbc.M502067200; Boyanoysky BB, 2012, AM J PATHOL, V181, P1088, DOI 10.1016/j.ajpath.2012.05.037; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; CHEN J, 1994, BBA-LIPID LIPID MET, V1215, P115, DOI 10.1016/0005-2760(94)90099-X; Cho W, 2000, BBA-MOL CELL BIOL L, V1488, P48, DOI 10.1016/S1388-1981(00)00109-8; Choi K, 2013, ISPRS ANN PHOTO REM, VII-3/W2, P1; Chung ES, 2015, J IMMUNOL, V195, P4853, DOI 10.4049/jimmunol.1500386; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Diaz BL, 2006, BBA-MOL CELL BIOL L, V1761, P1489, DOI 10.1016/j.bbalip.2006.09.009; Enomoto A, 2000, BIOCHEM BIOPH RES CO, V276, P667, DOI 10.1006/bbrc.2000.3468; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gotfried J, 2012, CLEV CLIN J MED, V79, P121, DOI 10.3949/ccjm.79a.11030; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Harris Raymond C, 2013, Trans Am Clin Climatol Assoc, V124, P139; Herman MB, 2010, AM J PHYSIOL-RENAL, V298, pF1222, DOI 10.1152/ajprenal.00467.2009; Kalyvas A, 2009, BRAIN, V132, P1221, DOI 10.1093/brain/awp002; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kim H, 2015, KIDNEY INT, V88, P550, DOI 10.1038/ki.2015.147; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kim YJ, 2002, J BIOL CHEM, V277, P9358, DOI 10.1074/jbc.M110987200; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kvirkvelia N, 2013, AM J PHYSIOL-RENAL, V304, pF463, DOI 10.1152/ajprenal.00575.2012; Landgraf SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107549; Lee H, 2010, KIDNEY INT, V78, P1100, DOI 10.1038/ki.2010.139; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; MARTINO G, 1978, Bollettino Societa Italiana Biologia Sperimentale, V54, P2577; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Mukhopadhyay A, 1995, ARCH BIOCHEM BIOPHYS, V324, P78, DOI 10.1006/abbi.1995.9926; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Ohta S, 2013, J IMMUNOL, V190, P5927, DOI 10.4049/jimmunol.1203202; Ooi JD, 2011, KIDNEY INT, V79, P977, DOI 10.1038/ki.2010.541; Peruchetti DB, 2011, J BIOL CHEM, V286, P45041, DOI 10.1074/jbc.M111.260737; Pinhal CS, 2013, NEPHROL DIAL TRANSPL, V28, P2464, DOI 10.1093/ndt/gft304; Poschke A, 2012, AM J PHYSIOL-RENAL, V303, pF1435, DOI 10.1152/ajprenal.00512.2011; Portella VG, 2013, CRIT CARE MED, V41, P1056, DOI 10.1097/CCM.0b013e3182746696; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Santos C, 2010, TRANSPL P, V42, P3639, DOI 10.1016/j.transproceed.2010.06.024; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; van der Helm HA, 2001, BBA-MOL CELL BIOL L, V1530, P86, DOI 10.1016/S1388-1981(00)00171-2; VIEYRA A, 1986, J BIOL CHEM, V261, P4247	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147785	10.1371/journal.pone.0147785	http://dx.doi.org/10.1371/journal.pone.0147785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820468	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000369528400041
J	Yi, L; Lin, GG; Zhang, K; Wang, LN; Zhang, R; Xie, JH; Li, JM				Yi, Lang; Lin, Guigao; Zhang, Kuo; Wang, Lunan; Zhang, Rui; Xie, Jiehong; Li, Jinming			Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; PREANALYTICAL PHASE; RACIAL VARIABILITY; GILBERTS-SYNDROME; POLYMORPHISMS; UGT1A1-ASTERISK-28; CHEMOTHERAPY; PROMOTER; THERAPY; DNA	Irinotecan is widely used in the treatment of solid tumors, especially in colorectal cancer and lung cancer. Molecular testing for UGT1A1 genotyping is increasingly required in China for optimum irinotecan administration. In order to determine the performance of laboratories with regard to the whole testing process for UGT1A1 to ensure the consistency and accuracy of the test results, the National Center for Clinical Laboratories conducted an external quality assessment program for UGT1A1*28 genotyping in 2015. The panel, which comprised of four known mutational samples and six wild-type samples, was distributed to 45 laboratories that test for the presence of UGT1A1*28 polymorphisms. Participating laboratories were allowed to perform polymorphism analysis by using their routine methods. The accuracy of the genotyping and reporting of results was analyzed. Other information from the individual laboratories, including the number of samples tested each month, accreditation/ certification status, and test methodology, was reviewed. Forty-four of the 45 participants reported the correct results for all samples. There was only one genotyping error, with a corresponding analytical sensitivity of 99.44% (179/180 challenges; 95% confidence interval: 96.94-99.99%) and an analytical specificity of 100% (270/270 challenges; 95% confidence interval: 98.64-100%). Both commercial kits and laboratory development tests were commonly used by the laboratories, and pyrosequencing was the main methodology used (n = 26, 57.8%). The style of the written reports showed large variation, and many reports showed a shortage of information. In summary, the first UGT1A1 genotyping external quality assessment result demonstrated that UGT1A1 genotype analysis of good quality was performed in the majority of pharmacogenetic testing centers that were investigated. However, greater education on the reporting of UGT1A1 genetic testing results is needed.	[Yi, Lang; Lin, Guigao; Zhang, Kuo; Wang, Lunan; Zhang, Rui; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing 100730, Peoples R China; [Yi, Lang; Li, Jinming] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JM (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing 100730, Peoples R China.; Li, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China.	jmli@nccl.org.cn	Wang, Lunan/AAS-9785-2021	Wang, Lunan/0000-0003-3163-7891	Beijing Municipal Public Health Bureau [2011-4011-02]; National Population and Family Planning Commission of the P R China [201402018]	Beijing Municipal Public Health Bureau; National Population and Family Planning Commission of the P R China	This work was supported by the capital development fund from the Beijing Municipal Public Health Bureau (No. 2011-4011-02)(JL) and the Special Fund for Healthscientific Research in the Public Interest from National Population and Family Planning Commission of the P R China (No. 201402018)(JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PHARMACOGENOMICS, V6, P671; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Etienne-Grimaldi MC, 2015, FUND CLIN PHARMACOL, V29, P219, DOI 10.1111/fcp.12117; Farrar JS, 2011, CLIN CHEM, V57, P1303, DOI 10.1373/clinchem.2011.166306; Fesenko EE, 2013, CLIN CHEM LAB MED, V51, P1177, DOI 10.1515/cclm-2012-0656; Hu ZY, 2010, CLIN CANCER RES, V16, P3832, DOI 10.1158/1078-0432.CCR-10-1122; Inoue K, 2013, TOHOKU J EXP MED, V229, P107, DOI 10.1620/tjem.229.107; International Organization for Standardization (ISO), 2012, ISO15189 TC MED LAB; Kaniwa N, 2005, DRUG METAB DISPOS, V33, P458, DOI 10.1124/dmd.104.001800; Kaya AO, 2012, J CHEMOTHERAPY, V24, P217, DOI 10.1179/1973947812Y.0000000020; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Liu X, 2014, PHARMACOGENOMICS, V15, P1171, DOI [10.2217/pgs.14.78, 10.2217/PGS.14.78]; Malentacchi F, 2013, CLIN CHIM ACTA, V424, P274, DOI 10.1016/j.cca.2013.05.012; Marcuello E, 2004, BRIT J CANCER, V91, P678, DOI 10.1038/sj.bjc.6602042; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Minami H, 2007, PHARMACOGENET GENOM, V17, P497, DOI 10.1097/FPC.0b013e328014341f; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; Orlando C, 2007, CLIN CHEM, V53, P1349, DOI 10.1373/clinchem.2006.084004; Pazzagli M, 2013, METHODS, V59, P20, DOI 10.1016/j.ymeth.2012.10.007; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Saeki M, 2003, CLIN CHEM, V49, P1182, DOI 10.1373/49.7.1182; Shen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121485; Shulman K, 2011, CANCER-AM CANCER SOC, V117, P3156, DOI 10.1002/cncr.25735; Sunakawa Y, 2011, CANCER CHEMOTH PHARM, V68, P279, DOI 10.1007/s00280-010-1485-8; Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34; Takano M, 2009, ONCOLOGY-BASEL, V76, P315, DOI 10.1159/000209335; Wong FL, 2007, J CLIN LAB ANAL, V21, P167, DOI 10.1002/jcla.20177; Wu AHB, 2013, ARCH PATHOL LAB MED, V137, P1232, DOI 10.5858/arpa.2012-0261-CP; Xu JM, 2013, WORLD J GASTROENTERO, V19, P3899, DOI 10.3748/wjg.v19.i24.3899; Yong WP, 2006, BRIT J CLIN PHARMACO, V62, P35, DOI 10.1111/j.1365-2125.2006.02591.x; Zhang A, 2007, PHARMACOGENOMICS J, V7, P333, DOI 10.1038/sj.tpj.6500424	33	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148081	10.1371/journal.pone.0148081	http://dx.doi.org/10.1371/journal.pone.0148081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820647	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528400064
J	Chiva-Blanch, G; Suades, R; Crespo, J; Pena, E; Padro, T; Jimenez-Xarrie, E; Marti-Fabregas, J; Badimon, L				Chiva-Blanch, Gemma; Suades, Rosa; Crespo, Javier; Pena, Esther; Padro, Teresa; Jimenez-Xarrie, Elena; Marti-Fabregas, Joan; Badimon, Lina			Microparticle Shedding from Neural Progenitor Cells and Vascular Compartment Cells Is Increased in Ischemic Stroke	PLOS ONE			English	Article							CIRCULATING ENDOTHELIAL MICROPARTICLES; ACTIVE TISSUE FACTOR; SMOOTH-MUSCLE-CELLS; MARKER; BRAIN	Purpose Ischemic stroke has shown to induce platelet and endothelial microparticle shedding, but whether stroke induces microparticle shedding from additional blood and vascular compartment cells is unclear. Neural precursor cells have been shown to replace dying neurons at sites of brain injury; however, if neural precursor cell activation is associated to microparticle shedding, and whether this activation is maintained at long term and associates to stroke type and severity remains unknown. We analyzed neural precursor cells and blood and vascular compartment cells microparticle shedding after an acute ischemic stroke. Methods Forty-four patients were included in the study within the first 48h after the onset of stroke. The cerebral lesion size was evaluated at 3-7 days of the stroke. Circulating microparticles from neural precursor cells and blood and vascular compartment cells (platelets, endothelial cells, erythrocytes, leukocytes, lymphocytes, monocytes and smooth muscle cells) were analyzed by flow cytometry at the onset of stroke and at 7 and 90 days. Forty-four age-matched high cardiovascular risk subjects without documented vascular disease were used as controls. Results Compared to high cardiovascular risk controls, patients showed higher number of neural precursor cell-and all blood and vascular compartment cell-derived microparticles at the onset of stroke, and after 7 and 90 days. At 90 days, neural precursor cell-derived microparticles decreased and smooth muscle cell-derived microparticles increased compared to levels at the onset of stroke, but only in those patients with the highest stroke-induced cerebral lesions. Conclusions Stroke increases blood and vascular compartment cell and neural precursor cell microparticle shedding, an effect that is chronically maintained up to 90 days after the ischemic event. These results show that stroke induces a generalized blood and vascular cell activation and the initiation of neuronal cell repair process after stroke. Larger cerebral lesions associate with deeper vessel injury affecting vascular smooth muscle cells.	[Chiva-Blanch, Gemma; Suades, Rosa; Crespo, Javier; Pena, Esther; Padro, Teresa; Badimon, Lina] Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain; [Chiva-Blanch, Gemma; Suades, Rosa; Crespo, Javier; Pena, Esther; Padro, Teresa; Jimenez-Xarrie, Elena; Marti-Fabregas, Joan; Badimon, Lina] Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain; [Jimenez-Xarrie, Elena; Marti-Fabregas, Joan] Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Badimon, L (corresponding author), Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain.; Badimon, L (corresponding author), Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain.	lbadimon@csic-iccc.org	Soler, Rosa Suades/N-9330-2019; Chiva-Blanch, Gemma/O-8072-2018; Martí-Fàbregas, Joan/I-5933-2019; Peña, Esther/AAB-8217-2019; BADIMON, LINA/S-2950-2019; Badimon, Lina/O-4711-2014	Soler, Rosa Suades/0000-0002-0193-3115; Chiva-Blanch, Gemma/0000-0001-6093-0160; Martí-Fàbregas, Joan/0000-0001-9229-8649; Badimon, Lina/0000-0002-9162-2459; Padro, Teresa/0000-0003-1921-954X; Crespo, Javier/0000-0001-8248-0172; Pena, Esther/0000-0003-2750-0614	Instituto de Salud Carlos III [CD13/00023]; Spanish Ministry of Economy and Competitiveness [PNS-SAF2013-42962-R]; RETICS of Instituto Carlos III (RIC); RETICS of Instituto Carlos III (TERCEL); RETICS (FEDER) [INVICTUS-RD12/014/0002, FIS PI071062]; FEDER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); RETICS of Instituto Carlos III (RIC); RETICS of Instituto Carlos III (TERCEL); RETICS (FEDER); FEDER(European Commission)	GC-B is a Sara Borrell Postdoctoral Fellow (CD13/00023) from Instituto de Salud Carlos III and received the ImmunoTools special Award 2014. This work has been possible thanks to funding received from Spanish Ministry of Economy and Competitiveness (PNS-SAF2013-42962-R, to LB) and from RETICS of Instituto Carlos III (RIC and TERCEL to LB, and RETICS (INVICTUS-RD12/014/0002 and FEDER and FIS PI071062 to JM-F). None of the funders played any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso R, 2014, J AM COLL CARDIOL, V63, P1983, DOI 10.1016/j.jacc.2014.01.063; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brisset AC, 2003, THROMB HAEMOSTASIS, V90, P511, DOI 10.1160/TH02-12-0291; Cherian P, 2003, STROKE, V34, P2132, DOI 10.1161/01.STR.0000086466.32421.F4; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Hussein MNA, 2003, J THROMB HAEMOST, V1, P2434; Jung KH, 2009, ANN NEUROL, V66, P191, DOI 10.1002/ana.21681; Koga H, 2005, J AM COLL CARDIOL, V45, P1622, DOI 10.1016/j.jacc.2005.02.047; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lackner P, 2010, STROKE, V41, P2353, DOI 10.1161/STROKEAHA.110.584995; Latham SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16314; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Li PP, 2015, THROMB RES, V135, P375, DOI 10.1016/j.thromres.2014.12.006; Lindsberg PJ, 1996, CIRCULATION, V94, P939, DOI 10.1161/01.CIR.94.5.939; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Poittevin M, 2014, TRANSL STROKE RES, V5, P377, DOI 10.1007/s12975-013-0306-x; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Schecter AD, 2000, CIRC RES, V87, P126, DOI 10.1161/01.RES.87.2.126; Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Starke RM, 2014, TRANSL STROKE RES, V5, P338, DOI 10.1007/s12975-013-0290-1; Suades R, 2014, THROMB HAEMOSTASIS, V111, P111, DOI 10.1160/TH13-07-0612; Suades R, 2012, THROMB HAEMOSTASIS, V108, P1208, DOI 10.1160/TH12-07-0486; Switonska M, 2015, EUR J NEUROL, V22, P395, DOI 10.1111/ene.12591; Viera AJ, 2012, J AM SOC HYPERTENS, V6, P243, DOI 10.1016/j.jash.2012.06.003; WANG PY, 1993, STROKE, V24, P236, DOI 10.1161/01.STR.24.2.236	32	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148176	10.1371/journal.pone.0148176	http://dx.doi.org/10.1371/journal.pone.0148176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815842	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200074
J	Lindner, C; Mora, M; Farzam, P; Squarcia, M; Johansson, J; Weigel, UM; Halperin, I; Hanzu, FA; Durduran, T				Lindner, Claus; Mora, Mireia; Farzam, Parisa; Squarcia, Mattia; Johansson, Johannes; Weigel, Udo M.; Halperin, Irene; Hanzu, Felicia A.; Durduran, Turgut			Diffuse Optical Characterization of the Healthy Human Thyroid Tissue and Two Pathological Case Studies	PLOS ONE			English	Article							FLOW DOPPLER SONOGRAPHY; BLOOD-FLOW; CORRELATION SPECTROSCOPY; FEMALE BREAST; BENIGN; FLUORESCENCE; SCATTERING; DIFFERENTIATION; MANAGEMENT; DIAGNOSIS	The in vivo optical and hemodynamic properties of the healthy (n = 22) and pathological (n = 2) human thyroid tissue were measured non-invasively using a custom time-resolved spectroscopy (TRS) and diffuse correlation spectroscopy (DCS) system. Medical ultrasound was used to guide the placement of the hand-held hybrid optical probe. TRS measured the absorption and reduced scattering coefficients (mu(a), mu(s)') at three wavelengths (690, 785 and 830 nm) to derive total hemoglobin concentration (THC) and oxygen saturation (StO(2)). DCS measured the microvascular blood flow index (BFI). Their dependencies on physiological and clinical parameters and positions along the thyroid were investigated and compared to the surrounding sternocleidomastoid muscle. The THC in the thyroid ranged from 131.9 mu M to 144.8 mu M, showing a 25-44% increase compared to the surrounding sternocleidomastoid muscle tissue. The blood flow was significantly higher in the thyroid (BFIthyroid = 16.0 x 10(-9) cm(2)/s) compared to the muscle (BFImuscle = 7.8 x 10(-9) cm(2)/s), while StO(2) showed a small (StO(2), muscle = 63.8% to StO(2), thyroid = 68.4%), yet significant difference. Two case studies with thyroid nodules underwent the same measurement protocol prior to thyroidectomy. Their THC and BFI reached values around 226.5 mu M and 62.8 x 10(-9) cm(2)/s respectively showing a clear contrast to the nodule-free thyroid tissue as well as the general population. The initial characterization of the healthy and pathologic human thyroid tissue lays the ground work for the future investigation on the use of diffuse optics in thyroid cancer screening.	[Lindner, Claus; Farzam, Parisa; Johansson, Johannes; Weigel, Udo M.; Durduran, Turgut] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona, Spain; [Mora, Mireia; Halperin, Irene; Hanzu, Felicia A.] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Mora, Mireia; Halperin, Irene; Hanzu, Felicia A.] IDIBAPS, Barcelona, Spain; [Squarcia, Mattia] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain; [Weigel, Udo M.] Hemophoton SL, Mediterranean Technol Pk, Barcelona, Spain; [Durduran, Turgut] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; ICREA	Lindner, C (corresponding author), Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona, Spain.	claus.lindner@icfo.es	Mora, Mireia/R-6696-2018; Lindner, Claus/G-4601-2015; Durduran, Turgut/N-7768-2015	Mora, Mireia/0000-0002-5887-5016; Hanzu, Felicia Alexandra/0000-0002-2399-4023; Lindner, Claus/0000-0002-9878-037X; Johansson, Johannes/0000-0003-4910-0291; Halperin Rabinovich, Irene/0000-0003-3151-5990; Durduran, Turgut/0000-0001-5838-1027	Fundacio CELLEX Barcelona; Ministerio de Economia y Competitividad (PHOTOSTROKE); "Severo Ochoa" Programme for Centres of Excellence in RD [SEV-2015-0522]; Obra social "la Caixa" Foundation (LlumMedBcn); Marie Curie IEF (FP7 MOBODICT); LASERLAB-EUROPE III (BIOPTHICAL); ICREA Funding Source: Custom	Fundacio CELLEX Barcelona(Foundation CELLEXEuropean Commission); Ministerio de Economia y Competitividad (PHOTOSTROKE); "Severo Ochoa" Programme for Centres of Excellence in RD; Obra social "la Caixa" Foundation (LlumMedBcn); Marie Curie IEF (FP7 MOBODICT); LASERLAB-EUROPE III (BIOPTHICAL); ICREA(ICREA)	This study acknowledges support from Fundacio CELLEX Barcelona, Ministerio de Economia y Competitividad (PHOTOSTROKE), the "Severo Ochoa" Programme for Centres of Excellence in R&D (SEV-2015-0522), the Obra social "la Caixa" Foundation (LlumMedBcn), Marie Curie IEF (FP7 MOBODICT) and LASERLAB-EUROPE III (BIOPTHICAL). Hemophotonics S.L. provided support in the form of salaries for author UW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appetecchia M, 2006, HORM RES, V66, P249, DOI 10.1159/000096013; BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Brandao MP, 2015, J FLUORESC, V25, P465, DOI 10.1007/s10895-015-1542-0; Brandao M, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.6.067003; Chikunguwo S, 2007, SURG OBES RELAT DIS, V3, P631, DOI 10.1016/j.soard.2007.07.011; Choe R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099683; Choe R, 2012, IEEE J SEL TOP QUANT, V18, P1367, DOI 10.1109/JSTQE.2011.2177963; Chung SH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0578-z; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Das K, 2006, LASER MED SCI, V21, P192, DOI 10.1007/s10103-006-0397-7; Dogra VS, 2014, AM J ROENTGENOL, V202, pW552, DOI 10.2214/AJR.13.11433; Durduran T, 2005, OPT LETT, V30, P2915, DOI 10.1364/OL.30.002915; Durduran T, 2002, PHYS MED BIOL, V47, P2847, DOI 10.1088/0031-9155/47/16/302; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Erickson SJ, 2009, MED ENG PHYS, V31, P495, DOI 10.1016/j.medengphy.2008.10.004; Farzam P, 2014, PHYSIOL MEAS, V35, P1469, DOI 10.1088/0967-3334/35/7/1469; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Giubileo G, 2005, SPECTROSC-INT J, V19, P79, DOI 10.1155/2005/403826; Gross J., 2015, NORTEST TESTS NORMAL; Huang ZF, 2010, PHOTOMED LASER SURG, V28, pS129, DOI 10.1089/pho.2009.2563; Irwin D, 2011, BIOMED OPT EXPRESS, V2, P1969, DOI 10.1364/BOE.2.001969; Jonasz M, 1991, ABSORPTION COEFFICIE; McIver B, 2013, ORAL ONCOL, V49, P645, DOI 10.1016/j.oraloncology.2013.03.435; Mesquita RC, 2011, PHILOS T R SOC A, V369, P4390, DOI 10.1098/rsta.2011.0232; Milionis A., 2013, ISRN BIOMARKERS, V2013, P1, DOI [DOI 10.1155/2013/651494, 10.1155/2013/651494]; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Nam-Goong IS, 2004, CLIN ENDOCRINOL, V60, P21, DOI 10.1046/j.1365-2265.2003.01912.x; Ntziachristos V, 1999, REV SCI INSTRUM, V70, P193, DOI 10.1063/1.1149565; Pakalniskis MG, 2011, RADIOLOGY, V259, P365, DOI 10.1148/radiol.11100699; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Perry SW, 2012, ANN BIOMED ENG, V40, P277, DOI 10.1007/s10439-012-0512-9; Pinheiro J, 2015, NLME LINEAR NONLINEA; Pitman MJ, 2004, OTOLARYNG HEAD NECK, V131, P623, DOI 10.1016/j.otohns.2004.05.014; Prahl S, 1999, OPTICAL ABSORPTION H, P15; R Core Team, 2021, R LANGUAGE ENV STAT; Sancak S, 2010, HORM METAB RES, V42, P670, DOI 10.1055/s-0030-1255037; Schraml C, 2007, J MAGN RESON IMAGING, V26, P66, DOI 10.1002/jmri.20943; Sekar SKV, 2015, EUR C BIOM OPT INT S; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; Sipos JA, 2009, THYROID, V19, P1363, DOI 10.1089/thy.2009.1608; Spinelli L, 2004, J BIOMED OPT, V9, P1137, DOI 10.1117/1.1803546; Srinivasan S, 2003, P NATL ACAD SCI USA, V100, P12349, DOI 10.1073/pnas.2032822100; Suh H, 2011, ANN SURG ONCOL, V18, P1300, DOI 10.1245/s10434-010-1452-y; Sunar U, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2397548; Tanamai W, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3028012; Teixeira CSB, 2009, ANALYST, V134, P2361, DOI 10.1039/b822578h; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tromberg BJ, 2008, MED PHYS, V35, P2443, DOI 10.1118/1.2919078; WHITE DR, 1987, BRIT J RADIOL, V60, P907, DOI 10.1259/0007-1285-60-717-907; Yu GQ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.010901; Zhou C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798595; Zhu Q, 2005, RADIOLOGY, V237, P57, DOI 10.1148/radiol.2371041236	55	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147851	10.1371/journal.pone.0147851	http://dx.doi.org/10.1371/journal.pone.0147851			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815533	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528200058
J	Sinha, DK; Chandran, P; Timm, AE; Aguirre-Rojas, L; Smith, M				Sinha, Deepak K.; Chandran, Predeesh; Timm, Alicia E.; Aguirre-Rojas, Lina; Smith, Michael			RETRACTED: Virulent Diuraphis noxia Aphids Over-Express Calcium Signaling Proteins to Overcome Defenses of Aphid-Resistant Wheat Plants (Retracted article. See vol.13, artn.e0191678, 2018)	PLOS ONE			English	Article; Retracted Publication							HEMIPTERA APHIDIDAE; RUSSIAN WHEAT; ACYRTHOSIPHON-PISUM; FEEDING-BEHAVIOR; BIOTYPE 2; HOMOPTERA; SELECTION; GENES; PATHWAY; PLC	The Russian wheat aphid, Diuraphis noxia, an invasive phytotoxic pest of wheat, Triticum aestivum, and barley, Hordeum vulgare, causes huge economic losses in Africa, South America, and North America. Most acceptable and ecologically beneficial aphid management strategies include selection and breeding of D. noxia-resistant varieties, and numerous D. noxia resistance genes have been identified in T. aestivum and H. vulgare. North American D. noxia biotype 1 is avirulent to T. aestivum varieties possessing Dn4 or Dn7 genes, while biotype 2 is virulent to Dn4 and avirulent to Dn7. The current investigation utilized next-generation RNAseq technology to reveal that biotype 2 over expresses proteins involved in calcium signaling, which activates phosphoinositide (PI) metabolism. Calcium signaling proteins comprised 36% of all transcripts identified in the two D. noxia biotypes. Depending on plant resistance gene-aphid biotype interaction, additional transcript groups included those involved in tissue growth; defense and stress response; zinc ion and related cofactor binding; and apoptosis. Activation of enzymes involved in PI metabolism by D. noxia biotype 2 aphids allows depletion of plant calcium that normally blocks aphid feeding sites in phloem sieve elements and enables successful, continuous feeding on plants resistant to avirulent biotype 1. Inhibition of the key enzyme phospholipase C significantly reduced biotype 2 salivation into phloem and phloem sap ingestion.	[Sinha, Deepak K.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Sinha, Deepak K.; Chandran, Predeesh; Timm, Alicia E.; Aguirre-Rojas, Lina; Smith, Michael] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Kansas State University	Smith, M (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	cmsmith@ksu.edu	SINHA, DEEPAK K/AAM-9648-2020; Timm, Alicia E/A-1866-2008		Kansas Wheat Alliance [15-215-J]; Kansas State University Open Access Publishing Fund	Kansas Wheat Alliance; Kansas State University Open Access Publishing Fund	This work was supported by the Kansas Wheat Alliance (contribution #15-215-J; http://kswheatalliance.org/). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Drs. Subbaratnam Muthukrishnan, Yoonseong Park and Gregory Ragland for critical review of the manuscript, and Dr. John Reese for use of EPG equipment. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. This is contribution number 15-215-J from the Kansas Agricultural Experiment Station.	Anathakrishnan R, 2014, ARTHROPOD-PLANT INTE, V8, P79, DOI 10.1007/s11829-014-9293-4; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Baines AJ, 2009, MOL BIOL EVOL, V26, P2005, DOI 10.1093/molbev/msp115; Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Brubaker-Purkey BJ, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6801; Burd JD, 2006, J ECON ENTOMOL, V99, P1862, DOI 10.1603/0022-0493-99.5.1862; Chandran P, 2013, J ECON ENTOMOL, V106, P2234, DOI 10.1603/EC13126; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Cristofoletti PT, 2006, FEBS J, V273, P5574, DOI 10.1111/j.1742-4658.2006.05547.x; Cui F, 2012, INSECT SCI, V19, P429, DOI 10.1111/j.1744-7917.2011.01487.x; FAIN JN, 1979, BIOCHEM J, V178, P45, DOI 10.1042/bj1780045; FEBVAY G, 1988, CAN J ZOOL, V66, P2449, DOI 10.1139/z88-362; Ferreira C, 2015, INSECT MOL BIOL, V24, P222, DOI 10.1111/imb.12151; Gallun RL, 1980, BREEDING PLANTS RESI, P64; Getahun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058889; Giordanengo P, 2014, ARTHROPOD-PLANT INTE, V8, P163, DOI 10.1007/s11829-014-9298-z; Giordanengo P, 2010, CR BIOL, V333, P516, DOI 10.1016/j.crvi.2010.03.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greene WK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0972-5; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Haley SD, 2004, CROP SCI, V44, P1589, DOI 10.2135/cropsci2004.1589; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Jankielsohn A, 2011, J ECON ENTOMOL, V104, P1736, DOI 10.1603/EC11061; Khan SA, 2009, J ECON ENTOMOL, V102, P1654, DOI 10.1603/029.102.0433; Lazzari S, 2009, J ECON ENTOMOL, V102, P1291, DOI 10.1603/029.102.0356; Lehiy CJ, 2014, PEERJ, V2, DOI 10.7717/peerj.426; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Liu X, 2010, J ECON ENTOMOL, V103, P958, DOI 10.1603/EC09376; MARAIS GF, 1994, PLANT BREEDING, V113, P265, DOI 10.1111/j.1439-0523.1994.tb00735.x; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; Merrill SC, 2014, J ECON ENTOMOL, V107, P1471, DOI 10.1603/EC13557; Nicholson S. J., 2015, BMC Genomics, V16; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Nishida K., 2014, ZINC SIGNALS CELLULA, P89; Onstad D. W., 2008, INSECT RESISTANCE MA; Pannabecker TL, 2014, AM J PHYSIOL-REG I, V307, pR819, DOI 10.1152/ajpregu.00336.2014; Pinheiro P, 2014, J PROTEOME RES, V13, P2094, DOI 10.1021/pr4012415; Powell G, 2005, J GEN VIROL, V86, P469, DOI 10.1099/vir.0.80632-0; Quick JS, 2001, CROP SCI, V41, P1363, DOI 10.2135/cropsci2001.4141363x; Quisenberry SS, 1998, RESPONSE MODEL INTRO; Sadeghi A, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.6501; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; SHAPIRO SS, 1972, J AM STAT ASSOC, V67, P215, DOI 10.2307/2284728; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Smith C. Michael, 2005, P1; Smith CM, 2014, PEST MANAG SCI, V70, P528, DOI 10.1002/ps.3689; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swanevelder ZH, 2010, J ECON ENTOMOL, V103, P887, DOI 10.1603/EC09257; Teets NM, 2013, P NATL ACAD SCI USA, V110, P9154, DOI 10.1073/pnas.1306705110; Tjallingii W, 2008, PHYSIOL ENTOMOL, V18, P317; Tjallingii W.F., 1988, P95; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Tolmay VL, 2013, J APPL ENTOMOL, V137, P476, DOI 10.1111/jen.12008; van Bel AJE, 2014, J EXP BOT, V65, P1761, DOI 10.1093/jxb/ert425; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104	61	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146809	10.1371/journal.pone.0146809	http://dx.doi.org/10.1371/journal.pone.0146809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815857	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200021
J	Endres, HG; Kaufmann-Kolle, P; Steeb, V; Bauer, E; Bottner, C; Thurmann, P				Endres, Heinz G.; Kaufmann-Kolle, Petra; Steeb, Valerie; Bauer, Erik; Boettner, Caroline; Thuermann, Petra			Association between Potentially Inappropriate Medication (PIM) Use and Risk of Hospitalization in Older Adults: An Observational Study Based on Routine Data Comparing PIM Use with Use of PIM Alternatives	PLOS ONE			English	Article							BEERS CRITERIA; POLYPHARMACY; POPULATION; MANAGEMENT; PEOPLE; IMPACT; DRUGS	Objective The safety of potentially inappropriate medications (PIMs) in elderly patients is still debated. Using the PRISCUS list, we examined the incident all-cause hospitalization risk associated with PIMs compared to PIM alternatives during the 180 days post individual first pharmacy dispensing (index date). Methods Routine claims data from a German health insurer on 392,337 ambulatory patients aged >= 65 years, were used to estimate adjusted hazard ratios (HRs) for hospitalization associated with incident PIM use. Observation period was January 2009-December 2010. Users of PIM alternatives, as defined by the PRISCUS list, were the reference group. Patients with PIM dispensing or hospital stay in a six month "washout" period (second half of 2008) were excluded. All potential confounders were determined in the half year before the individual index date. Results In the total cohort 60.7% were female. Median age was 73 years. Of 79,041 incident PIM users, 58.4% had PIMs dispensed in one quarter of 2009 or 2010, 19.3% in two quarters, and 22.3% in three or more quarters. There were 126,535 hospitalizations during the observation period, and 47,470 of them occurred within 180 days post first dispensing. Multivariable Cox regression analysis revealed PIM use as a significant risk factor for hospitalization (HR 1.378; 95% CI 1.349-1.407) compared to use of PIM alternatives. Conclusions PIM use compared to use of PIM alternatives is associated with an increased risk of all-cause hospitalization in the 180 days following individual index date. Future analyses comparing a single PIM with its corresponding alternative may help identify those PIMs responsible for this.	[Endres, Heinz G.; Kaufmann-Kolle, Petra; Steeb, Valerie; Bauer, Erik; Boettner, Caroline] AQUA Inst Goettingen, Gottingen, Germany; [Thuermann, Petra] Univ Witten Herdecke, Chair Clin Pharmacol, Fac Hlth, Witten, Germany	Witten Herdecke University	Endres, HG (corresponding author), AQUA Inst Goettingen, Gottingen, Germany.	heinz.endres@aqua-institut.de		Thurmann, Petra/0000-0001-9724-1422				Albert SM, 2010, DRUG AGING, V27, P407, DOI 10.2165/11315990-000000000-00000; Amann U, 2012, DTSCH ARZTEBL INT, V109, P69, DOI 10.3238/arztebl.2012.0069; Bauer TK, 2012, PHARMACOEPIDEM DR S, V21, P1321, DOI 10.1002/pds.3357; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Benetos A, 2015, JAMA-J AM MED ASSOC, V314, P170, DOI 10.1001/jama.2015.7517; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Chang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094350; Eggli Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-25; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fromm MF, 2013, EUR J CLIN PHARMACOL, V69, P975, DOI 10.1007/s00228-012-1425-0; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Hamar GB, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0834-z; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Henschel Frank, 2015, Drugs Real World Outcomes, V2, P249; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; Laroche ML, 2007, BRIT J CLIN PHARMACO, V63, P177, DOI 10.1111/j.1365-2125.2006.02831.x; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; McLeod PJ, 1997, CAN MED ASSOC J, V156, P385; Narayan Sujita W, 2015, Drugs Real World Outcomes, V2, P137; Price SD, 2014, DRUG AGING, V31, P311, DOI 10.1007/s40266-014-0164-6; Prinja Shankar, 2010, Indian J Community Med, V35, P217, DOI 10.4103/0970-0218.66859; Reich O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105425; Renom-Guiteras A, 2015, EUR J CLIN PHARMACOL, V71, P861, DOI 10.1007/s00228-015-1860-9; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schubert I, 2013, PHARMACOEPIDEM DR S, V22, P719, DOI 10.1002/pds.3429; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Zimmermann T, 2013, BUNDESGESUNDHEITSBLA, V56, P941, DOI 10.1007/s00103-013-1767-5	28	53	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146811	10.1371/journal.pone.0146811	http://dx.doi.org/10.1371/journal.pone.0146811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840396	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200016
J	Wang, H; Sha, LL; Ma, TT; Zhang, LX; Chen, M; Zhao, MH				Wang, Huan; Sha, Li-Li; Ma, Tian-Tian; Zhang, Lu-Xia; Chen, Min; Zhao, Ming-Hui			Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SMALL-VESSEL VASCULITIS; DNA CF-DNA/NETS; CHINESE PATIENTS; MICROSCOPIC POLYANGIITIS; WEGENERS-GRANULOMATOSIS; DENDRITIC CELLS; RENAL HISTOLOGY; SERUM; MICE	Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of life-threatening disorders, and frequently affects the kidneys. This study investigated whether the circulating neutrophil extracellular traps (NETs) levels were associated with disease activity of AAV. We collected serum samples from 34 patients with AAV in active stage and 62 patients with AAV in remission. Cell free DNA in serum was quantified using the Quant-iT PicoGreen assay. NETs associated MPO-DNA complexes, citrullinated-histone H3-DNA (cit-H3-DNA) complexes and the concentration of deoxyribonuclease I (DNase I) were quantified using ELISA. The activity of DNase I was quantified using radial enzyme-diffusion method. Associations between circulating levels of NETs with clinico-pathological parameters were analyzed. Serum levels of NETs in active AAV patients were significantly higher than those in healthy controls, and the level of cell free DNA correlated with C-reactive protein (CRP). However, no correlation was found between MPO-DNA complexes or cit-H3DNA complexes level and CRP. Also there was no significant correlation between NETs level and initial serum creatinine, estimated glomerular filtration rate (eGFR), crescents formation or Birmingham Vasculitis Activity Score (BVAS). Furthermore, there was no significant difference of serum levels of cell free DNA or MPO-DNA complexes between active stage and remission of AAV. In conclusion, circulating levels of NETs cannot be used as a biomarker to assess disease activity in AAV patients.	[Wang, Huan; Sha, Li-Li; Ma, Tian-Tian; Zhang, Lu-Xia; Chen, Min; Zhao, Ming-Hui] Peking Univ, Hosp 1, Div Renal, Dept Med, Beijing 100034, Peoples R China; [Wang, Huan; Sha, Li-Li; Ma, Tian-Tian; Zhang, Lu-Xia; Chen, Min; Zhao, Ming-Hui] Peking Univ, Inst Nephrol, Beijing 100034, Peoples R China; [Wang, Huan; Sha, Li-Li; Ma, Tian-Tian; Zhang, Lu-Xia; Chen, Min; Zhao, Ming-Hui] Minist Hlth China, Key Lab Renal Dis, Beijing 100034, Peoples R China; [Wang, Huan; Sha, Li-Li; Ma, Tian-Tian; Zhang, Lu-Xia; Chen, Min; Zhao, Ming-Hui] Peking Univ, Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing 100034, Peoples R China; [Zhao, Ming-Hui] Peking Tsinghua Ctr Life Sci, Beijing 100034, Peoples R China; [Sha, Li-Li] Guizhou Med Univ, Guiyang 550004, Peoples R China	Peking University; Peking University; Peking University; Guizhou Medical University	Chen, M (corresponding author), Peking Univ, Hosp 1, Div Renal, Dept Med, Beijing 100034, Peoples R China.; Chen, M (corresponding author), Peking Univ, Inst Nephrol, Beijing 100034, Peoples R China.; Chen, M (corresponding author), Minist Hlth China, Key Lab Renal Dis, Beijing 100034, Peoples R China.	chenmin74@sina.com		Luxia, Zhang/0000-0003-2349-2936	Chinese 973 project [2012CB517700]; National Natural Science Fund [81425008, 81370829, 81321064]; Beijing Science and Technology Committee [D131100004713007]	Chinese 973 project(National Basic Research Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Committee	This study is supported by a grant of Chinese 973 project (No. 2012CB517700), three grants of the National Natural Science Fund (No. 81425008, No. 81370829 and No. 81321064), and a grant of Beijing Science and Technology Committee (D131100004713007).	Arai Y, 2013, BIOL BLOOD MARROW TR, V19, P1683, DOI 10.1016/j.bbmt.2013.09.005; Bajema IM, 1999, KIDNEY INT, V56, P1751, DOI 10.1046/j.1523-1755.1999.00758.x; Bajema IM, 1996, NEPHROL DIAL TRANSPL, V11, P1989, DOI 10.1093/oxfordjournals.ndt.a027086; Barrientos L, 2014, J IMMUNOL, V193, P5689, DOI 10.4049/jimmunol.1400586; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chen M, 2005, KIDNEY INT, V68, P2225, DOI 10.1111/j.1523-1755.2005.00679.x; Chen M, 2007, NEPHROL DIAL TRANSPL, V22, P139, DOI 10.1093/ndt/gfl509; Flossmann O, 2007, ANN RHEUM DIS, V66, P283, DOI 10.1136/ard.2005.051078; Fuchs TA, 2012, BLOOD, V120, P1157, DOI 10.1182/blood-2012-02-412197; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hauer HA, 2002, KIDNEY INT, V61, P80, DOI 10.1046/j.1523-1755.2002.00089.x; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kambas K, 2014, ANN RHEUM DIS, V73, P1854, DOI 10.1136/annrheumdis-2013-203430; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Leffler J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4264; Logters T, 2009, J ORTHOP RES, V27, P1401, DOI 10.1002/jor.20911; LUQMANI RA, 1994, Q J MED, V87, P671; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Macanovic M, 1997, CLIN EXP IMMUNOL, V108, P220, DOI 10.1046/j.1365-2249.1997.3571249.x; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Nakazawa D, 2014, J AM SOC NEPHROL, V25, P990, DOI 10.1681/ASN.2013060606; Nakazawa D, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00333; Odobasic D, 2013, BLOOD, V121, P4195, DOI 10.1182/blood-2012-09-456483; Rodriguez-Garcia M, 2009, CLIN IMMUNOL, V131, P374, DOI 10.1016/j.clim.2009.01.012; Sangaletti S, 2012, BLOOD, V120, P3007, DOI 10.1182/blood-2012-03-416156; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Soderberg D, 2015, RHEUMATOLOGY, V54, P2085, DOI 10.1093/rheumatology/kev217; Surmiak MP, 2015, CLIN EXP IMMUNOL, V181, P150, DOI 10.1111/cei.12628; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Tillack K, 2013, J NEUROIMMUNOL, V261, P108, DOI 10.1016/j.jneuroim.2013.05.004; Velez AMA, 2009, N AM J MED SCI, V1, P309; Xin G, 2004, CLIN DIAGN LAB IMMUN, V11, P559, DOI 10.1128/CDLI.11.3.559-562.2004; Zhang SG, 2014, INTERNAL MED, V53, P2763, DOI 10.2169/internalmedicine.53.2570	33	50	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148197	10.1371/journal.pone.0148197	http://dx.doi.org/10.1371/journal.pone.0148197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840412	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200096
J	Rocha, JN; Cohen, ND; Bordin, AI; Brake, CN; Giguere, S; Coleman, MC; Alaniz, RC; Lawhon, SD; Mwangi, W; Pillai, SD				Rocha, Joana N.; Cohen, Noah D.; Bordin, Angela I.; Brake, Courtney N.; Giguere, Steeve; Coleman, Michelle C.; Alaniz, Robert C.; Lawhon, Sara D.; Mwangi, Waithaka; Pillai, Suresh D.			Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi	PLOS ONE			English	Article							MEDIATED IMMUNE-RESPONSES; HYPERIMMUNE PLASMA; ADULT HORSES; CLINICAL-MANIFESTATIONS; ENDEMIC INFECTIONS; NEONATAL FOALS; IGG SUBCLASSES; PNEUMONIA; IMMUNIZATION; VACCINE	There is currently no licensed vaccine that protects foals against Rhodococcus equi-induced pneumonia. Oral administration of live, virulent R. equi to neonatal foals has been demonstrated to protect against subsequent intrabronchial challenge with virulent R. equi. Electron beam (eBeam)-inactivated R. equi are structurally intact and have been demonstrated to be immunogenic when administered orally to neonatal foals. Thus, we investigated whether eBeam inactivated R. equi could protect foals against developing pneumonia after experimental infection with live, virulent R. equi. Foals (n = 8) were vaccinated by gavaging with eBeam-inactivated R. equi at ages 2, 7, and 14 days, or gavaged with equal volume of saline solution (n = 4), and subsequently infected intrabronchially with live, virulent R. equi at age 21 days. The proportion of vaccinated foals that developed pneumonia following challenge was similar among the vaccinated (7/8; 88%) and unvaccinated foals (3/4; 75%). This vaccination regimen did not appear to be strongly immunogenic in foals. Alternative dosing regimens or routes of administration need further investigation and may prove to be immunogenic and protective.	[Rocha, Joana N.; Cohen, Noah D.; Bordin, Angela I.; Brake, Courtney N.; Coleman, Michelle C.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Giguere, Steeve] Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA; [Alaniz, Robert C.] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA; [Lawhon, Sara D.; Mwangi, Waithaka] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Pillai, Suresh D.] Texas A&M Univ, IAEA Collaborat Ctr Electron Beam Technol, Natl Ctr Electron Beam Res, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University System of Georgia; University of Georgia; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cohen, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA.; Pillai, SD (corresponding author), Texas A&M Univ, IAEA Collaborat Ctr Electron Beam Technol, Natl Ctr Electron Beam Res, College Stn, TX 77843 USA.	NCohen@cvm.tamu.edu; S-Pillai@tamu.edu	Lawhon, Sara D./G-5147-2011	Lawhon, Sara D./0000-0001-9154-8909	Grayson-Jockey Club Research Foundation; Link Equine Research Endowment; Texas AM University; University Libraries; Office of the Vice President for Research	Grayson-Jockey Club Research Foundation; Link Equine Research Endowment; Texas AM University; University Libraries; Office of the Vice President for Research	Funded by Grayson-Jockey Club Research Foundation (https://www.grayson-jockeyclub.org/) (Grant to NDC) and Link Equine Research Endowment (Support to NDC) The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research.	Ashour J, 2003, J BACTERIOL, V185, P2644, DOI 10.1128/JB.185.8.2644-2652.2003; Becu T, 1997, VET MICROBIOL, V56, P193, DOI 10.1016/S0378-1135(97)00088-6; Bordin AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105367; Bordin AI, 2012, VET IMMUNOL IMMUNOP, V145, P290, DOI 10.1016/j.vetimm.2011.11.012; Boyd NK, 2003, VET IMMUNOL IMMUNOP, V92, P75, DOI 10.1016/S0165-2427(03)00021-7; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Burton AJ, 2015, EQUINE VET J, V47, P467, DOI 10.1111/evj.12309; Caston SS, 2006, VET THER, V7, P361; Cauchard J, 2004, VET MICROBIOL, V104, P73, DOI 10.1016/j.vetmic.2004.09.006; Chaffin M. K., 2013, Proceedings of the 59th Annual Convention of the American Association of Equine Practitioners, Nashville, Tennessee, USA, 7-11 December 2013, P267; Chaffin MK, 2008, JAVMA-J AM VET MED A, V232, P1035, DOI 10.2460/javma.232.7.1035; Chauhan O. P., 2015, ELECT BEAM PASTEURIZ, P157, DOI DOI 10.1533/9781782421085.2.157; CHIRINOTREJO JM, 1987, CAN J VET RES, V51, P444; Cohen ND, 2003, AM J VET RES, V64, P153, DOI 10.2460/ajvr.2003.64.153; Donecker JM, 2006, EFFICACY IMMUNOMODUL; Giguere S, 1999, INFECT IMMUN, V67, P3548; Giguere S, 1997, VET MICROBIOL, V56, P313, DOI 10.1016/S0378-1135(97)00099-0; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Giguere S, 2003, J AM VET MED ASSOC, V222, P775, DOI 10.2460/javma.2003.222.775; Giguere S, 2002, J AM VET MED ASSOC, V220, P59, DOI 10.2460/javma.2002.220.59; Giles C, 2015, EQUINE VET J, V47, P510, DOI 10.1111/evj.12310; Hooper-McGrevy KE, 2005, VACCINE, V23, P5760, DOI 10.1016/j.vaccine.2005.07.050; Hooper-McGrevy KE, 2003, CLIN DIAGN LAB IMMUN, V10, P345, DOI 10.1128/CDLI.10.3.345-351.2003; HURLEY JR, 1995, AUST VET J, V72, P418, DOI 10.1111/j.1751-0813.1995.tb06192.x; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P669, DOI 10.1128/CVI.00042-07; Joller N, 2010, P NATL ACAD SCI USA, V107, P20441, DOI 10.1073/pnas.1013827107; Kohler AK, 2003, INFECT IMMUN, V71, P6329, DOI 10.1128/IAI.71.11.6329-6337.2003; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Lopez AM, 2002, CLIN DIAGN LAB IMMUN, V9, P1270, DOI 10.1128/CDLI.9.6.1270-1276.2002; MADIGAN JE, 1991, J REPROD FERTIL, P571; MARTENS RJ, 1989, EQUINE VET J, V21, P249, DOI 10.1111/j.2042-3306.1989.tb02161.x; Martens RJ, 1991, EQUINE VET J S, V12, P19; McQueen CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098710; Mealey RH, 2007, VACCINE, V25, P7582, DOI 10.1016/j.vaccine.2007.07.055; Muscatello G, 2012, VET J, V192, P20, DOI 10.1016/j.tvjl.2011.08.014; Pei Y, 2007, VET MICROBIOL, V125, P100, DOI 10.1016/j.vetmic.2007.05.007; Perkins GA, 2015, EQUINE VET J, V47, P267, DOI 10.1111/evj.12387; Phumoonna T, 2008, VACCINE, V26, P2457, DOI 10.1016/j.vaccine.2008.03.015; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Prescott JF, 1997, AM J VET RES, V58, P356; Ryan C, 2010, CLIN VACCINE IMMUNOL, V17, P1896, DOI 10.1128/CVI.00328-10; Sanz M, 2013, VET MICROBIOL, V167, P623, DOI 10.1016/j.vetmic.2013.09.018; Sanz MG, 2016, EQUINE VET J, V48, P103, DOI 10.1111/evj.12363; Sanz MG, 2015, VET IMMUNOL IMMUNOP, V164, P10, DOI 10.1016/j.vetimm.2015.01.004; Sedlinska M, 2006, ACTA VET BRNO, V75, P175, DOI 10.2754/avb200675020175; Sturgill TL, 2011, VET IMMUNOL IMMUNOP, V141, P124, DOI 10.1016/j.vetimm.2011.01.015; Sturgill TL, 2014, VACCINE, V32, P1362, DOI 10.1016/j.vaccine.2014.01.032; TAKAI S, 1991, INFECT IMMUN, V59, P4056, DOI 10.1128/IAI.59.11.4056-4060.1991; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; Takai S., 1995, J EQUINE SCI, V6, P105; TKACHUKSAAD O, 1991, J CLIN MICROBIOL, V29, P2696, DOI 10.1128/JCM.29.12.2696-2700.1991; Venner M, 2007, RES VET SCI, V83, P311, DOI 10.1016/j.rvsc.2007.01.009; Venner M, 2012, VET J, V192, P293, DOI 10.1016/j.tvjl.2011.07.004; Wilson EM, 2009, J VET INTERN MED, V23, P323, DOI 10.1111/j.1939-1676.2008.0254.x; Witonsky S, 2010, EQUINE VET EDUC, V22, P400, DOI 10.1111/j.2042-3292.2010.00106.x; WOOLCOCK JB, 1987, VET MICROBIOL, V14, P215, DOI 10.1016/0378-1135(87)90108-8	56	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148111	10.1371/journal.pone.0148111	http://dx.doi.org/10.1371/journal.pone.0148111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828865	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200063
J	Xia, LF; Xie, HX; Yu, YJ; Zhou, H; Wang, T; Yan, JC				Xia, Longfei; Xie, Hongxiang; Yu, Yinjing; Zhou, Hong; Wang, Ting; Yan, Jinchuan			The Effects of NF-kappa B and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-beta(2)GPI in Mouse	PLOS ONE			English	Article							ENDOTHELIAL-CELL ACTIVATION; TISSUE FACTOR EXPRESSION; ANTIPHOSPHOLIPID ANTIBODY SYNDROME; GLYCOPROTEIN-I ANTIBODIES; SMOOTH-MUSCLE-CELLS; BETA(2)-GLYCOPROTEIN I; PROTEIN-KINASE; FACTOR GENE; SIGNALING PATHWAYS; GROWTH-FACTOR	Our previous data demonstrated that nuclear factor-kappa B (NF-kappa B) and activator protein-1 (AP-1) are involved in the process of anti-beta(2)GPI/beta(2)GPI-induced tissue factor (TF) expression in monocytes. However, the role of NF-kappa B and AP-1 in pathogenic mechanisms of antiphospholipid syndrome (APS) in vivo has been rarely studied. This study aimed to investigate whether NF-kappa B and c-Jun/AP-1 are involved in anti-beta(2)-GPI-induced expression of prothrombotic and proinflammatory molecules in mouse. IgG-APS or anti-beta(2)GPI antibodies were injected into BALB/c mice in the presence or absence of PDTC (a specific inhibitor of NF kappa B) and Curcumin (a potent inhibitor of AP-1) treatment. Our data showed that both IgGAPS and anti-beta(2)GPI could induce the activation of NF-kappa B and c-Jun/AP-1 in mouse peritoneal macrophages. The anti-beta(2)GPI-induced TF activity in homogenates of carotid arteries and peritoneal macrophages from mice could significantly decrease after PDTC and/or Curcumin treatment, in which PDTC showed the strongest inhibitory effect, but combination of two inhibitors had no synergistic effect. Furthermore, anti-beta(2)-GPI-induced expression of TF, VCAM-1, ICAM-1 and E-selectin in the aorta and expression of TF, IL-1 beta, IL-6 and TNF-alpha in peritoneal macrophages of mice were also significantly attenuated by PDTC and/or Curcumin treatment. These results indicate that both NF-kappa B and c-Jun/AP-1 are involved in regulating anti-beta(2)-GPI-induced expression of prothrombotic and proinflammatory molecules in vivo. Inhibition of NF-kappa B and c-Jun/AP-1 pathways may be beneficial for the prevention and treatment of thrombosis and inflammation in patients with APS.	[Xia, Longfei; Xie, Hongxiang; Yu, Yinjing; Zhou, Hong; Wang, Ting] Jiangsu Univ, Sch Med, Jiangsu Key Lab Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Zhou, Hong; Yan, Jinchuan] Affiliated Hosp Jiangsu Univ, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Zhou, H (corresponding author), Jiangsu Univ, Sch Med, Jiangsu Key Lab Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China.; Zhou, H; Yan, JC (corresponding author), Affiliated Hosp Jiangsu Univ, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China.	hongzhou@ujs.edu.cn; yanjinchuan@hotmail.com			National Natural Science Foundation of China [81370614, 81170279]; Sci-Tech Innovation Team of Jiangsu Province [LJ201116]; Natural Science Foundation of Jiangsu Province, China [BK2011486]; Key Laboratory of Cardiovascular disease of Zhenjiang [SS2012002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Innovation Team of Jiangsu Province; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Key Laboratory of Cardiovascular disease of Zhenjiang	This project was supported by National Natural Science Foundation of China (no. 81370614) to Hong Zhou, Sci-Tech Innovation Team of Jiangsu Province (no. LJ201116), Natural Science Foundation of Jiangsu Province, China (BK2011486) and National Natural Science Foundation of China (81170279) and Key Laboratory of Cardiovascular disease of Zhenjiang (SS2012002) to Jinchuan Yan. The funders didn't play any role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Arad A, 2011, BLOOD, V117, P3453, DOI 10.1182/blood-2010-08-300715; Bierhaus A, 1997, THROMB HAEMOSTASIS, V77, P772; Bohgaki M, 2004, INT IMMUNOL, V16, P1633, DOI 10.1093/intimm/dxh166; Boles J, 2010, LUPUS, V19, P370, DOI 10.1177/0961203309360810; Borghi MO, 2014, LUPUS, V23, P1302, DOI 10.1177/0961203314536479; Cervera R, 2015, ANN RHEUM DIS, V74, P1011, DOI 10.1136/annrheumdis-2013-204838; Chabicovsky M, 2010, BASIC CLIN PHARMACOL, V107, P758, DOI 10.1111/j.1742-7843.2010.00573.x; Chaturvedi S, 2014, CURR OPIN HEMATOL, V21, P371, DOI 10.1097/MOH.0000000000000067; Clemens N, 2009, ANN NY ACAD SCI, V1173, P805, DOI 10.1111/j.1749-6632.2009.04632.x; Colasanti T, 2012, BLOOD, V120, P3360, DOI 10.1182/blood-2011-09-378851; de Larranaga GF, 2005, LUPUS, V14, P967, DOI 10.1191/0961203305lu2232cr; Dunoyer-Geindre S, 2002, THROMB HAEMOSTASIS, V88, P851, DOI 10.1055/s-0037-1613313; Efthymiou M, 2015, THROMB RES, V135, P1191, DOI 10.1016/j.thromres.2015.03.030; Erkan D, 2014, ANN RHEUM DIS, V73, P1176, DOI 10.1136/annrheumdis-2013-203622; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Guo DL, 2011, TUMOR BIOL, V32, P921, DOI 10.1007/s13277-011-0194-1; Jankowski M, 2003, BLOOD, V101, P157, DOI 10.1182/blood-2002-05-1310; Kappelmann M, 2014, EUR J CELL BIOL, V93, P76, DOI 10.1016/j.ejcb.2013.10.003; Ko WC, 2012, ACTA PHARMACOL SIN, V33, P49, DOI 10.1038/aps.2011.178; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM-US, V54, P301, DOI 10.1002/art.21549; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Mackman N, 2006, BLOOD CELL MOL DIS, V36, P104, DOI 10.1016/j.bcmd.2005.12.008; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; Mehdi AA, 2010, EUR J CLIN INVEST, V40, P451, DOI 10.1111/j.1365-2362.2010.02281.x; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Meroni PL, 2012, LUPUS, V21, P708, DOI 10.1177/0961203312438116; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Pierangeli SS, 1999, CIRCULATION, V99, P1997, DOI 10.1161/01.CIR.99.15.1997; PIERANGELI SS, 1995, THROMB HAEMOSTASIS, V74, P1361; Raschi E, 2008, LUPUS, V17, P937, DOI 10.1177/0961203308095140; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Seol DW, 2000, ONCOGENE, V19, P1132, DOI 10.1038/sj.onc.1203404; Seshan SV, 2009, BLOOD, V114, P1675, DOI 10.1182/blood-2009-01-199117; Sorice M, 2007, ARTHRITIS RHEUM-US, V56, P2687, DOI 10.1002/art.22802; Vaiopoulos AG, 2010, INT J BIOCHEM CELL B, V42, P1061, DOI 10.1016/j.biocel.2010.03.018; Vega-Ostertag M, 2005, ARTHRITIS RHEUM-US, V52, P1545, DOI 10.1002/art.21009; Vega-Ostertag ME, 2007, J THROMB HAEMOST, V5, P1828, DOI 10.1111/j.1538-7836.2007.02680.x; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Williams FMK, 2000, THROMB HAEMOSTASIS, V84, P742; Willis R, 2013, ANN NY ACAD SCI, V1285, P44, DOI 10.1111/nyas.12080; Xia LF, 2013, THROMB HAEMOSTASIS, V109, P643, DOI 10.1160/TH12-09-0655; Xie HX, 2014, BRIT J HAEMATOL, V164, P165, DOI 10.1111/bjh.12587; Xie HX, 2013, MOL IMMUNOL, V53, P246, DOI 10.1016/j.molimm.2012.08.012; Zhang JW, 2005, BLOOD, V105, P1964, DOI 10.1182/blood-2004-05-1708; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107634; Zhou H, 2013, THROMB RES, V132, P742, DOI 10.1016/j.thromres.2013.09.039; Zhou H, 2007, CELL RES, V17, P737, DOI 10.1038/cr.2007.33	49	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147958	10.1371/journal.pone.0147958	http://dx.doi.org/10.1371/journal.pone.0147958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829121	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200048
J	Bartels, K; Mayes, LM; Dingmann, C; Bullard, KJ; Hopfer, CJ; Binswanger, IA				Bartels, Karsten; Mayes, Lena M.; Dingmann, Colleen; Bullard, Kenneth J.; Hopfer, Christian J.; Binswanger, Ingrid A.			Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery	PLOS ONE			English	Article							ABUSE; RATES	Introduction Opioid-based analgesic therapy represents a cornerstone of pain management after surgery. The recent rise in opioid sales and opioid overdoses suggests it is important to maximize the safety of opioid prescribing after surgery. Given that patients may live with other family members in the home, safe storage and appropriate disposal of excess opioids after hospital discharge are necessary to prevent unintended secondary exposures. Identifying characteristics of patients who are likely to be prescribed excess opioids after surgery may enable more targeted prescription practices and safety interventions. Our study aimed to elucidate patient-reported opioid use patterns and modes of home storage of opioids among patients discharged home after Cesarean section (C-section) and thoracic surgery. Specifically, we sought to identify characteristics of patients who reported using about half or more versus less of the opioids prescribed to them for use after hospital discharge. Methods For this cohort study, we developed a survey on quality of analgesia following hospital discharge, amounts of opioids taken relative to the amount prescribed, reasons for not taking all prescribed medications, and storage and disposal methods for leftover opioids. Adult patients, who had C-section or thoracic surgery at a tertiary academic medical center, were given a web-based self-administered survey after discharge. Descriptive statistics (means and standard deviations, proportions) were used to describe the study sample and survey results. Comparisons between patients who reported taking about half or more versus less of the opioids prescribed to them for use after hospital discharge were made using unpaired t-tests, Mann-Whitney tests, and Chi-square tests as appropriate. Results The majority (53%) of respondents after C-section (N = 30) reported taking either no or very few (less than 5) prescribed opioid pills; 83% reported taking half or less; and 17% of women, reported taking all or nearly all (5 or fewer pills left over) of their opioid prescription. In a cohort of patients after thoracic surgery (n = 31) 45% reported taking either no or very few (5 or less) prescribed opioid pills; 71% reported taking half or less; and 29% of patients reported taking all or nearly all (5 or fewer pills left over) of their opioid prescription. In both cohorts, use of opioids while hospitalized was higher in the group reporting using about half or more of prescribed opioids after discharge. Leftover opioids were stored in an unlocked location in 77% and 73% of cases following C-section and thoracic surgery, respectively. Conclusion Our findings from surveys in two distinct patient populations at a single academic medical center suggest that current opioid prescribing practices for pain management at hospital discharge following Cesarean section and thoracic surgery may not account for individual patients' analgesic requirements. Excess opioid pills are commonly stored in unsecured locations and represent a potential source for non-medical opioid use and associated morbidity and mortality in patients and their families. Research to develop goal-directed and patient-centered post-discharge opioid prescription practices and encourage opioid safety practices after surgery is needed.	[Bartels, Karsten; Dingmann, Colleen; Bullard, Kenneth J.] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA; [Mayes, Lena M.] Childrens Hosp Colorado, Dept Anesthesiol, Aurora, CO USA; [Hopfer, Christian J.; Binswanger, Ingrid A.] Univ Colorado Denver, Dept Psychiat, Div Substance Dependence, Aurora, CO USA; [Binswanger, Ingrid A.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Binswanger, Ingrid A.] Univ Colorado Denver, Dept Med, Div Gen Internal Med, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bartels, K (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA.	karsten.bartels@ucdenver.edu	Binswanger, Ingrid/X-4496-2019; Bartels, Karsten/ABE-9152-2020	Binswanger, Ingrid/0000-0001-8862-8078; Bartels, Karsten/0000-0003-2028-4664	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards [UL1 TR001082]; National Institute On Drug Abuse of the National Institutes of Health [K24DA03255, R01DA035804, R34DA035952]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R34DA035952, R01DA035804] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards; National Institute On Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Grant Number UL1 TR001082. Dr. Hopfer was supported was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number K24DA03255 and Award Number R01DA035804. Dr. Binswanger was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number R34DA035952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Grant Number UL1 TR001082. Dr. Hopfer was supported by the National Institute On Drug Abuse of the National Institutes of Health Award Number K24DA03255 and Award Number R01DA035804. Dr. Binswanger was supported by the National Institute On Drug Abuse of the National Institutes of Health Award Number R34DA035952.	Bates C, 2011, J UROLOGY, V185, P551, DOI 10.1016/j.juro.2010.09.088; Binswanger IA, 2015, SUBST ABUS, V36, P141, DOI 10.1080/08897077.2014.991058; Centers for Disease Control and Prevention, 2010, NUMB ALL LIST PROC D; Clarke H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1251; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Dillman D., 2008, INTERNET MAIL MIXED; DILLMAN DA, 1974, AM SOCIOL REV, V39, P744, DOI 10.2307/2094318; Gammaitoni AR, 2003, CLIN J PAIN, V19, P286, DOI 10.1097/00002508-200309000-00002; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Groves R.M., 2004, SURVEY ERRORS SURVEY; GROVES RM, 1992, PUBLIC OPIN QUART, V56, P475, DOI 10.1086/269338; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Harris K, 2013, JAMA DERMATOL, V149, P317, DOI 10.1001/jamadermatol.2013.1871; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; KAVANAGH BP, 1994, ANESTHESIOLOGY, V81, P737, DOI 10.1097/00000542-199409000-00028; Kincaid J. P., 1988, Journal of Instructional Development, V11, P8, DOI 10.1007/BF02904998; Lavonas EJ, 2013, J PEDIATR-US, V163, P1377, DOI 10.1016/j.jpeds.2013.06.058; Longnecker DE, 2012, ANESTHESIOLOGY; Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P537; Maher DP, 2014, BRIT J ANAESTH, V113, P88, DOI 10.1093/bja/aeu192; Paulozzi LJ, 2012, J SAFETY RES, V43, P283, DOI 10.1016/j.jsr.2012.08.009; Rodgers J, 2012, J HAND SURG-AM, V37A, P645, DOI 10.1016/j.jhsa.2012.01.035; Savic RM, 2012, CLIN PHARMACOL THER, V92, P575, DOI 10.1038/clpt.2012.137; Tanabe P, 2012, J EMERG NURS, V38, P273, DOI 10.1016/j.jen.2011.09.023; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369	29	256	257	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147972	10.1371/journal.pone.0147972	http://dx.doi.org/10.1371/journal.pone.0147972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824844	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600080
J	Daryadel, A; Bourgeois, S; Figueiredo, MFL; Moreira, AG; Kampik, NB; Oberli, L; Mohebbi, N; Lu, XF; Meima, ME; Danser, AHJ; Wagner, CA				Daryadel, Arezoo; Bourgeois, Soline; Figueiredo, Marta F. L.; Moreira, Ana Gomes; Kampik, Nicole B.; Oberli, Lisa; Mohebbi, Nilufar; Lu, Xifeng; Meima, Marcel E.; Danser, A. H. Jan; Wagner, Carsten A.			Colocalization of the (Pro) renin Receptor/Atp6ap2 with H+-ATPases in Mouse Kidney but Prorenin Does Not Acutely Regulate Intercalated Cell H+-ATPase Activity	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; (PRO)RENIN RECEPTOR; V-ATPASE; METABOLIC-ACIDOSIS; PROTEIN-KINASE; MOLECULAR-CLONING; LUMINAL MEMBRANE; TURTLE-BLADDER; UP-REGULATION; RAT-KIDNEY	The (Pro) renin receptor (P)RR/Atp6ap2 is a cell surface protein capable of binding and non-proteolytically activate prorenin. Additionally, (P)RR is associated with H+-ATPases and alternative functions in H+-ATPase regulation as well as in Wnt signalling have been reported. Kidneys express very high levels of H+-ATPases which are involved in multiple functions such as endocytosis, membrane protein recycling as well as urinary acidification, bicarbonate reabsorption, and salt absorption. Here, we wanted to localize the (P)RR/Atp6ap2 along the murine nephron, exmaine whether the (P)RR/Atp6ap2 is coregulated with other H+-ATPase subunits, and whether acute stimulation of the (P)RR/Atp6ap2 with prorenin regulates H+-ATPase activity in intercalated cells in freshly isolated collecting ducts. We localized (P)PR/Atp6ap2 along the murine nephron by qPCR and immunohistochemistry. (P)RR/Atp6ap2 mRNA was detected in all nephron segments with highest levels in the collecting systemcoinciding with H+-ATPases. Further experiments demonstrated expression at the brush border membrane of proximal tubules and in all types of intercalated cells colocalizing with H+-ATPases. In mice treated with NH4Cl, NaHCO3, KHCO3, NaCl, or the mineralocorticoid DOCA for 7 days, (P)RR/Atp6ap2 and H+-ATPase subunits were regulated but not co-regulated at protein and mRNA levels. Immunolocalization in kidneys from control, NH4Cl or NaHCO3 treated mice demonstrated always colocalization of PRR/Atp6ap2 with H+-ATPase subunits at the brush border membrane of proximal tubules, the apical pole of type A intercalated cells, and at basolateral and/or apicalmembranes of non-type A intercalated cells. Microperfusion of isolated cortical collecting ducts and luminal application of prorenin did not acutely stimulate H+-ATPase activity. However, incubation of isolated collecting ducts with prorenin non-significantly increased ERK1/2 phosphorylation. Our results suggest that the PRR/Atp6ap2 may form a complex with H+-ATPases in proximal tubule and intercalated cells but that prorenin has no acute effect on H+-ATPase activity in intercalated cells.	[Daryadel, Arezoo; Bourgeois, Soline; Figueiredo, Marta F. L.; Moreira, Ana Gomes; Kampik, Nicole B.; Oberli, Lisa; Mohebbi, Nilufar; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Mohebbi, Nilufar] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Lu, Xifeng; Meima, Marcel E.; Danser, A. H. Jan] Erasmus MC, Dept Internal Med, Div Vasc Med & Pharmacol, Rotterdam, Netherlands	University of Zurich; University of Zurich; University Zurich Hospital; Erasmus University Rotterdam; Erasmus MC	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	Wagnerca@access.uzh.ch	Danser, Jan/GLR-1479-2022	Kampik Kijewski, Nicole Beate/0000-0002-2278-5940; Lu, Xifeng/0000-0002-4782-0300	Swiss National Science Foundation [31003A_138143]; Hartmann-Muller Stiftung (Zurich, Switzerland)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hartmann-Muller Stiftung (Zurich, Switzerland)	This work was supported by the Swiss National Science Foundation (grant No. 31003A_138143) to C. A. Wagner and Hartmann-Muller Stiftung (Zurich, Switzerland) to A. Daryadel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Alzamora R, 2010, J BIOL CHEM, V285, P24676, DOI 10.1074/jbc.M110.106278; Aruga S, 2000, KIDNEY INT, V58, P206, DOI 10.1046/j.1523-1755.2000.00155.x; BASTANI B, 1991, J CLIN INVEST, V88, P126, DOI 10.1172/JCI115268; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bonnici B, 2004, PFLUG ARCH EUR J PHY, V448, P16, DOI 10.1007/s00424-003-1227-4; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; BROWN D, 1991, KIDNEY INT, V40, pS79; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; CANNON C, 1985, NATURE, V314, P443, DOI 10.1038/314443a0; Christensen EI, 2012, COMPR PHYSIOL, V2, P805, DOI 10.1002/cphy.c100073; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Finberg KE, 2003, GENE, V318, P25, DOI 10.1016/S0378-1119(03)00790-X; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; GLUCK S, 1982, P NATL ACAD SCI-BIOL, V79, P4327, DOI 10.1073/pnas.79.14.4327; Gong F, 2010, AM J PHYSIOL-RENAL, V298, pF1162, DOI 10.1152/ajprenal.00645.2009; Gonzalez AA, 2014, AM J MED SCI, V348, P416, DOI 10.1097/MAJ.0000000000000335; Gonzalez AA, 2014, AM J PHYSIOL-RENAL, V307, pF962, DOI 10.1152/ajprenal.00267.2014; Gonzalez AA, 2013, HYPERTENSION, V61, P443, DOI 10.1161/HYPERTENSIONAHA.112.196303; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Hennings JC, 2012, EMBO MOL MED, V4, P1057, DOI 10.1002/emmm.201201527; Hermle T, 2013, EMBO J, V32, P245, DOI 10.1038/emboj.2012.323; Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057; Huang JQ, 2013, HYPERTENSION, V62, P317, DOI 10.1161/HYPERTENSIONAHA.113.01324; Huang JQ, 2012, HYPERTENSION, V59, P317, DOI 10.1161/HYPERTENSIONAHA.111.186056; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Krop M, 2013, HYPERTENSION, V61, P1075, DOI 10.1161/HYPERTENSIONAHA.111.00967; Krop M, 2013, PFLUG ARCH EUR J PHY, V465, P87, DOI 10.1007/s00424-012-1105-z; Krop M, 2011, J HYPERTENS, V29, P2138, DOI 10.1097/HJH.0b013e32834b1978; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lu XF, 2013, AM J PHYSIOL-RENAL, V305, pF417, DOI 10.1152/ajprenal.00037.2013; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Matavelli LC, 2012, AM J PHYSIOL-RENAL, V303, pF1652, DOI 10.1152/ajprenal.00204.2012; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Mohebbi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055286; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Norgett EE, 2012, P NATL ACAD SCI USA, V109, P13775, DOI 10.1073/pnas.1204257109; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Nowik M, 2010, CELL PHYSIOL BIOCHEM, V26, P1059, DOI 10.1159/000323984; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Pech V, 2006, AM J PHYSIOL RENAL P; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Rong R, 2015, PEPTIDES, V63, P156, DOI 10.1016/j.peptides.2014.12.007; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Schulz N, 2007, CELL PHYSIOL BIOCHEM, V20, P109, DOI 10.1159/000104159; SCHWARTZ GJ, 1985, J CLIN INVEST, V75, P1638, DOI 10.1172/JCI111871; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; Sihn G, 2010, KIDNEY INT, V78, P246, DOI 10.1038/ki.2010.151; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; Song RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063835; Stehberger PA, 2003, J AM SOC NEPHROL, V14, P3027, DOI 10.1097/01.ASN.0000099375.74789.AB; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wagner CA, 2003, PFLUG ARCH EUR J PHY, V446, P623, DOI 10.1007/s00424-003-1082-3; Wagner CA, 2002, KIDNEY INT, V62, P2109, DOI 10.1046/j.1523-1755.2002.00671.x; Wagner CA, 1998, P NATL ACAD SCI USA, V95, P9665, DOI 10.1073/pnas.95.16.9665; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wagner CA, 2011, CELL PHYSIOL BIOCHEM, V28, P513, DOI 10.1159/000335112; WATTS BA, 1994, J BIOL CHEM, V269, P20250; Welsh-Bacic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025240; Winter C, 2004, P NATL ACAD SCI USA, V101, P2636, DOI 10.1073/pnas.0307321101; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011	73	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147831	10.1371/journal.pone.0147831	http://dx.doi.org/10.1371/journal.pone.0147831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824839	Green Published, Green Accepted, gold			2022-12-27	WOS:000369528600064
J	Mangone, ER; Agarwal, S; L'Engle, K; Lasway, C; Zan, T; van Beijma, H; Orkis, J; Karam, R				Mangone, Emily R.; Agarwal, Smisha; L'Engle, Kelly; Lasway, Christine; Zan, Trinity; van Beijma, Hajo; Orkis, Jennifer; Karam, Robert			Sustainable Cost Models for mHealth at Scale: Modeling Program Data from m4RH Tanzania	PLOS ONE			English	Article							UNMET NEED; HEALTH; CONTRACEPTION; CHALLENGES; AFRICA	Background There is increasing evidence that mobile phone health interventions ("mHealth") can improve health behaviors and outcomes and are critically important in low-resource, low-access settings. However, the majority of mHealth programs in developing countries fail to reach scale. One reason may be the challenge of developing financially sustainable programs. The goal of this paper is to explore strategies for mHealth program sustainability and develop cost-recovery models for program implementers using 2014 operational program data from Mobile for Reproductive Health (m4RH), a national text-message (SMS) based health communication service in Tanzania. Methods We delineated 2014 m4RH program costs and considered three strategies for cost-recovery for the m4RH program: user pay-for-service, SMS cost reduction, and strategic partnerships. These inputs were used to develop four different cost-recovery scenarios. The four scenarios leveraged strategic partnerships to reduce per-SMS program costs and create per-SMS program revenue and varied the structure for user financial contribution. Finally, we conducted break-even and uncertainty analyses to evaluate the costs and revenues of these models at the 2014 user volume (125,320) and at any possible break-even volume. Results In three of four scenarios, costs exceeded revenue by $94,596, $34,443, and $84,571 at the 2014 user volume. However, these costs represented large reductions (54%, 83%, and 58%, respectively) from the 2014 program cost of $203,475. Scenario four, in which the lowest per-SMS rate ($0.01 per SMS) was negotiated and users paid for all m4RH SMS sent or received, achieved a $5,660 profit at the 2014 user volume. A Monte Carlo uncertainty analysis demonstrated that break-even points were driven by user volume rather than variations in program costs. Conclusions These results reveal that breaking even was only probable when all SMS costs were transferred to users and the lowest per-SMS cost was negotiated with telecom partners. While this strategy was sustainable for the implementer, a central concern is that health information may not reach those who are too poor to pay, limiting the program's reach and impact. Incorporating strategies presented here may make mHealth programs more appealing to funders and investors but need further consideration to balance sustainability, scale, and impact.	[Mangone, Emily R.; Agarwal, Smisha; L'Engle, Kelly; Lasway, Christine; Zan, Trinity] FHI 360, Durham, NC USA; [Mangone, Emily R.; Agarwal, Smisha] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [L'Engle, Kelly] Univ San Francisco, Sch Nursing & Hlth Profess, San Francisco, CA 94117 USA; [Lasway, Christine] Univ N Carolina, Kenan Flagler Sch Business, Chapel Hill, NC USA; [van Beijma, Hajo] Text Change, Amsterdam, Netherlands; [Orkis, Jennifer; Karam, Robert] Johns Hopkins Ctr Commun Programs, Baltimore, MD USA	FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mangone, ER (corresponding author), FHI 360, Durham, NC USA.; Mangone, ER (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.	Emilyrose.mangone@gmail.com		Agarwal, Smisha/0000-0002-7407-0066; Mangone, Emily Rose/0000-0001-7239-2208	Innovation Working Group Catalytic mHealth Grant Program [UNF-13-544]; Norwegian Agency for Development Cooperation (Norad); FHI 360-UNC Research Fellowship	Innovation Working Group Catalytic mHealth Grant Program; Norwegian Agency for Development Cooperation (Norad); FHI 360-UNC Research Fellowship	This work was supported with a grant to FHI 360 (Award #UNF-13-544) from the Innovation Working Group Catalytic mHealth Grant Program, funded by the Norwegian Agency for Development Cooperation (Norad) as part of the commitment to the UN Secretary General's Every Woman Every Child initiative. Effort by EM and SA was supported by the FHI 360-UNC Research Fellowship administered by the Gillings Global Gateway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, LESS LEARN WAY 50000; Aranda-Jan CB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-188; Berkley S., 2013, CELL PHONES ARE TRAN; CDC Foundation, 2014, MHEALTH TEXT MESS CA; Cleland J, 2014, STUD FAMILY PLANN, V45, P105, DOI 10.1111/j.1728-4465.2014.00380.x; Dupas P, 2014, SCIENCE, V345, P1279, DOI 10.1126/science.1256973; Dusabe J, 2013, J TELEMED TELECARE, V19, P295, DOI 10.1177/1357633X13492291; Farmer T, 2014, INT J STD AIDS, V25, P289, DOI 10.1177/0956462413502325; Gallup, 2014, AFR CONT GOING MOB M; GSM Association, 2015, M4D IMP SERV EV HUM; Guttmacher Institute, 2012, COSTS BEN INV CONTR; Jidenma N., 2014, AFRICANS MOBILE REVO; L'Engle KL, 2013, CONTRACEPTION, V87, P251, DOI 10.1016/j.contraception.2012.07.009; Lemaire J., 2011, SCALING MOBILE HLTH; Leon N, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-123; Lund S, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2941; Mechael P., 2010, BARRIERS GAPS AFFECT; Pew Research Center, 2015, CELL PHON AFR COMM L; Rodrigues R, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19036; Sedgh G, 2014, STUD FAMILY PLANN, V45, P151, DOI 10.1111/j.1728-4465.2014.00382.x; Sheoran B, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3583; The Kaiser Family Foundation, 2015, US GOV INT FAM PLANN; The World Bank, 2014, GDP PER CAP CURR USS; The World Bank, 2013, HLTH EXP PER CAP CUR; United States Agency for International Development, 2012, TECHN REC MAMA BANGL; Vahdat Heather L, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe2, DOI 10.1016/j.ijgo.2013.07.009; van Beijma H., 2010, PILOTITIS BIGGEST DI; Vodacom, 2015, CHCK BOMB; Zurovac D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052045	29	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148011	10.1371/journal.pone.0148011	http://dx.doi.org/10.1371/journal.pone.0148011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824747	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600087
J	Marzullo, TC				Marzullo, Timothy C.			Leg Regrowth in Blaberus discoidalis (Discoid Cockroach) following Limb Autotomy versus Limb Severance and Relevance to Neurophysiology Experiments	PLOS ONE			English	Article							REGENERATION; INSECTS	Background Many insects can regenerate limbs, but less is known about the regrowth process with regard to limb injury type. As part of our neurophysiology education experiments involving the removal of a cockroach leg, 1) the ability of Blaberus discoidalis cockroaches to regenerate a metathoracic leg was examined following autotomy at the femur/trochanter joint versus severance via a transverse coxa-cut, and 2) the neurophysiology of the detached legs with regard to leg removal type was studied by measuring spike firing rate and microstimulation movement thresholds. Leg Regrowth Results First appearance of leg regrowth was after 5 weeks in the autotomy group and 12 weeks in the coxa-cut group. Moreover, regenerated legs in the autotomy group were 72% of full size on first appearance, significantly larger (p<0.05) than coxa-cut legs (29% of full size at first appearance). Regenerated legs in both groups grew in size with each subsequent molt; the autotomy-removed legs grew to full size within 18 weeks, whereas coxa-cut legs took longer than 28 weeks to regrow. Removal of the metathoracic leg in both conditions did not have an effect on mortality compared to matched controls with unmolested legs. Neurophysiology Results Autotomy-removed legs had lower spontaneous firing rates, similar marked increased firing rates upon tactile manipulation of tibial barbs, and a 10% higher electrical microstimulation threshold for movement. Summary It is recommended that neurophysiology experiments on cockroach legs remove the limb at autotomy joints instead of coxa cuts, as the leg regenerates significantly faster when autotomized and does not detract from the neurophysiology educational content.	[Marzullo, Timothy C.] Backyard Brains Inc, Res & Dev, Ann Arbor, MI USA		Marzullo, TC (corresponding author), Backyard Brains Inc, Res & Dev, Ann Arbor, MI USA.	tim@backyardbrains.com			National Institutes of Mental Health Small Business Innovation Research [1-R43-MH-093334-01, 2-R44-MH-093334-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [R44MH093334, R43MH093334] Funding Source: NIH RePORTER	National Institutes of Mental Health Small Business Innovation Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This experiment was supported by the National Institutes of Mental Health Small Business Innovation Research grant 1-R43-MH-093334-01 and 2-R44-MH-093334-03: "Backyard Brains: Bringing Neurophysiology into Secondary Schools." The funder provided support in the form of salary for author TCM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Backyard Brains, the recipient of the research grant, is a small business specializing in physiology education services and equipment design, of which author TCM is a co-owner.	BADEN T, 2015, PLOS BIOL, V13, P7794; Bell W. J., 2007, COCKROACHES ECOLOGY; BODENSTEIN D, 1955, J EXP ZOOL, V129, P209, DOI 10.1002/jez.1401290110; Brindley H. H., 1897, Proceedings of the Zoological Society of London, P903; CHAPMAN KM, 1965, J EXP BIOL, V42, P191; COWDEN RR, 1961, EMBRYOLOGIA, V6, P36, DOI 10.1111/j.1440-169X.1961.tb00111.x; Cruse H, 2009, COGN SYST MONOGR, V1, P43; Dagda Ruben K, 2013, J Undergrad Neurosci Educ, V12, pA66; Harley CM, 2009, J EXP BIOL, V212, P1463, DOI 10.1242/jeb.028381; KUNKEL JG, 1977, BIOL BULL, V153, P145, DOI 10.2307/1540698; KUNKEL JG, 1966, J INSECT PHYSIOL, V12, P227, DOI 10.1016/0022-1910(66)90137-5; LINDER T M, 1992, American Journal of Physiology, V262, pS18; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MARKS EP, 1970, SCIENCE, V167, P61, DOI 10.1126/science.167.3914.61; Marzullo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030837; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Mongeau JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038003; Nijenhuis E. D., 1955, Proceedings Akademie van Wetenschappen Amsterdam (C), V58, P121; Nijenhuis ED, 1955, P KON NED AKAD WET C, VC58, P131; OFARRELL AF, 1953, AUST J BIOL SCI, V6, P485, DOI 10.1071/BI9530485; Penzlin H., 1963, Roux Archiv fuer Entwicklungsmechanik, V154, P434; Pringle JWS, 1939, J EXP BIOL, V16, P220; Ramos Raddy L, 2007, J Undergrad Neurosci Educ, V5, pA28; Reaumur Rene Antoine Ferchault de, 1734, MEMOIRES SERVIR HIST; Spence AJ, 2010, J EXP BIOL, V213, P1907, DOI 10.1242/jeb.042515; TRUBY PR, 1985, J EMBRYOL EXP MORPH, V85, P177; Truby RR, 1983, J EMBRYOL EXP MORPH, V75, P151; Watson JT, 2002, J COMP PHYSIOL A, V188, P55, DOI 10.1007/s00359-002-0278-x; WILLIS EDWIN R., 1958, ANN ENT SOC AMER, V51, P53; WOODRUFF LAURENCE C., 1939, ANN ENT SOC AMERICA, V32, P589; ZILL SN, 1980, BRAIN RES, V198, P253, DOI 10.1016/0006-8993(80)90743-X	31	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146778	10.1371/journal.pone.0146778	http://dx.doi.org/10.1371/journal.pone.0146778			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824931	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600009
J	Nebel, RA; Zhao, DJ; Pedrosa, E; Kirschen, J; Lachman, HM; Zheng, DY; Abrahams, BS				Nebel, Rebecca A.; Zhao, Dejian; Pedrosa, Erika; Kirschen, Jill; Lachman, Herbert M.; Zheng, Deyou; Abrahams, Brett S.			Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; COPY-NUMBER VARIANTS; AUTISM SPECTRUM DISORDERS; RECURRENT MICRODELETIONS; EXPRESSION ANALYSIS; BIPOLAR DISORDER; BREAKPOINTS 1; RISK-FACTORS; PROTEIN; 15Q11.2	Deletions encompassing the BP1-2 region at 15q11.2 increase schizophrenia and epilepsy risk, but only some carriers have either disorder. To investigate the role of CYFIP1, a gene within the region, we performed knockdown experiments in human neural progenitors derived from donors with 2 copies of each gene at the BP1-2 locus. RNA-seq and cellular assays determined that knockdown of CYFIP1 compromised cytoskeletal remodeling. FMRP targets and postsynaptic density genes, each implicated in schizophrenia, were significantly overrepresented among differentially expressed genes (DEGs). Schizophrenia and/or epilepsy genes, but not those associated with randomly selected disorders, were likewise significantly overrepresented. Mirroring the variable expressivity seen in deletion carriers, marked between-line differences were observed for dysregulation of disease genes. Finally, a subset of DEGs showed a striking similarity to known epilepsy genes and represents novel disease candidates. Results support a role for CYFIP1 in disease and demonstrate that disease-related biological signatures are apparent prior to neuronal differentiation.	[Nebel, Rebecca A.; Lachman, Herbert M.; Zheng, Deyou; Abrahams, Brett S.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zhao, Dejian; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Pedrosa, Erika; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Kirschen, Jill; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Lachman, Herbert M.; Zheng, Deyou; Abrahams, Brett S.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.; Abrahams, BS (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.	brett.abrahams@einstein.yu.edu	Zhao, Dejian/C-8321-2009	Zhao, Dejian/0000-0002-2105-3799; Zheng, Deyou/0000-0003-4354-5337	Albert Einstein New Investigator Development Award; IDDRC pilot award (NICHD) [P30HD071593]; Autism Center of Excellence Network Award (NIMH) [9R01 MH100027]; Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; CTSA Grants [UL1RR025750, KL2RR025749, TL1RR025748, 8UL1 TR000086]; NIMH [MH097893, MH087840, MH099452]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073, UL1TR000086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025749, TL1RR025748, UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099427, R21MH099452, R21MH097893, R01MH100027] Funding Source: NIH RePORTER	Albert Einstein New Investigator Development Award; IDDRC pilot award (NICHD); Autism Center of Excellence Network Award (NIMH); Training Program in Cellular and Molecular Biology and Genetics; CTSA Grants; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported through an Albert Einstein New Investigator Development Award, an IDDRC pilot award (P30HD071593; NICHD), and a subcontract from an Autism Center of Excellence Network Award (9R01 MH100027; NIMH) to BSA. Support for RAN was provided through the Training Program in Cellular and Molecular Biology and Genetics (T32 GM007491; NIGMS). Clinical recruitment efforts were supported by CTSA Grants (UL1RR025750, KL2RR025749, and TL1RR025748; NCRR and 8UL1 TR000086; NCATS). Support to HML was provided by the NIMH (MH097893 and MH087840). Support to D. Zheng was provided by the NIMH (MH099452).	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baum L, 2014, HUM GENET, V133, P651, DOI 10.1007/s00439-013-1405-1; Bavamian S, 2015, MOL PSYCHIATR, V20, P573, DOI 10.1038/mp.2014.176; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Bozdagi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042422; Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22; Buntup D, 2008, NEUROCHEM RES, V33, P248, DOI 10.1007/s11064-007-9527-2; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Chaste P, 2014, AUTISM RES, V7, P355, DOI 10.1002/aur.1378; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124597; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Das D K, 2015, Mol Neuropsychiatry, V1, P116; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Germain ND, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-44; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Gurses C, 2014, GENE, V538, P323, DOI 10.1016/j.gene.2014.01.030; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hashemi B, 2015, AM J MED GENET A, V167, P2098, DOI 10.1002/ajmg.a.37134; Hindorff LA, 2015, CATALOG PUBLISHED GE; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lin MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094968; Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mirza N, 2011, HUM MOL GENET, V20, P4381, DOI 10.1093/hmg/ddr365; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Oguro-Ando A, 2015, MOL PSYCHIATR, V20, P1069, DOI 10.1038/mp.2014.124; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Pedrosa E, 2011, J NEUROGENET, V25, P88, DOI 10.3109/01677063.2011.597908; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Puschmann A, 2009, PARKINSONISM RELAT D, V15, P390, DOI 10.1016/j.parkreldis.2008.08.002; Robicsek O, 2013, MOL PSYCHIATR, V18, P1067, DOI 10.1038/mp.2013.67; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Sima XT, 2014, MOL MED REP, V9, P1242, DOI 10.3892/mmr.2014.1977; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Topol A, 2015, BIOL PSYCHIAT, V78, pE29, DOI 10.1016/j.biopsych.2014.12.028; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Zeng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059685; Zhao DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132387; Zhao Q, 2013, SCHIZOPHRENIA BULL, V39, P712, DOI 10.1093/schbul/sbr197	74	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148039	10.1371/journal.pone.0148039	http://dx.doi.org/10.1371/journal.pone.0148039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824476	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600092
J	Wang, Z; Fu, CF; Chen, Y; Xu, F; Wang, ZY; Qu, ZG; Liu, Y				Wang, Zheng; Fu, Changfeng; Chen, Yong; Xu, Feng; Wang, Zhenyu; Qu, Zhigang; Liu, Yi			FoxC2 Enhances BMP7-Mediated Anabolism in Nucleus Pulposus Cells of the Intervertebral Disc	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; ADULT ARTICULAR CHONDROCYTES; OSTEOGENIC PROTEIN-1; TRANSCRIPTION FACTOR; TNF-ALPHA; TGF-BETA; KAPPA-B; MATRIX METALLOPROTEINASE-13; EXTRACELLULAR-MATRIX; WNT/BETA-CATENIN	Bone-morphogenetic protein-7 (BMP-7) is a growth factor that plays a major role in mediating anabolism and anti-catabolism of the intervertebral disc matrix and cell homeostasis. In osteoblasts, Forkhead box protein C2 (FoxC2) is a downstream target of BMPs and promotes cell proliferation and differentiation. However, the role FoxC2 may play in degenerative human intervertebral disc tissue and the relationship between FoxC2 and BMP-7 in nucleus pulposus (NP) cells remain to be elucidated. This study aims to investigate the presence and signaling mechanisms of FoxC2 in degenerative human intervertebral disc tissue and NP cells. Western blot and real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses were used to measure FoxC2 expression in the NP tissue and cells. Transfections were carried out to measure the effect of FoxC2 on BMP-7-mediated extracellular matrix upregulation. Adenoviral knock-down of Smad1 was performed to investigate the mechanism of BMP-7-induced FoxC2 expression. In degenerative NP tissue, FoxC2 was markedly upregulated and positively correlated with increased disc degeneration. Induction of NP cell proliferation was confirmed by using cell counting kit-8 assay, immunocytochemistry and real-time qRT-PCR for Ki67. FoxC2 led to decreased noggin expression and increased Smad1/5/8 phosphorylation. During combined treatment with BMP-7, FoxC2 greatly potentiated anabolism through synergistic mechanisms on ECM formation. Combination therapy using BMP-7 and FoxC2 may be beneficial to the treatment of intervertebral disc degeneration.	[Wang, Zheng; Fu, Changfeng; Xu, Feng; Wang, Zhenyu; Qu, Zhigang; Liu, Yi] Jilin Univ, Hosp 1, Dept Spinal Surg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China; [Chen, Yong] Jilin Univ, Hosp 1, Dept Neurosurg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China	Jilin University; Jilin University	Qu, ZG; Liu, Y (corresponding author), Jilin Univ, Hosp 1, Dept Spinal Surg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China.	spinal9493@foxmail.com; Liuyi89757@gmail.com						Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Applebaum M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0053-9; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Fujita H, 2006, CIRC RES, V98, P626, DOI 10.1161/01.RES.0000207407.51752.3c; Gozo MC, 2013, CELL DEATH DIFFER, V20, P1031, DOI 10.1038/cdd.2013.34; Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Hayashi H, 2008, J BIOL CHEM, V283, P23791, DOI 10.1074/jbc.M800190200; Hiyama A, 2008, BIOCHEM BIOPH RES CO, V369, P679, DOI 10.1016/j.bbrc.2008.02.087; Hiyama A, 2011, J CELL PHYSIOL, V226, P1139, DOI 10.1002/jcp.22438; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Hwang PY, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026360; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Imai Y, 2007, SPINE, V32, P1197, DOI 10.1097/BRS.0b013e3180574d26; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b; Masuda K, 2008, EUR SPINE J, V17, pS441, DOI 10.1007/s00586-008-0749-z; Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041; McCulloch JA, 1996, THE LUMBAR SPINE, P492; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Muddasani P, 2007, J BIOL CHEM, V282, P31409, DOI 10.1074/jbc.M706508200; Nasto LA, 2012, SPINE, V37, P1819, DOI 10.1097/BRS.0b013e31824ee8f7; Nifuji A, 2001, J BONE MINER RES, V16, P1765, DOI 10.1359/jbmr.2001.16.10.1765; Park SJ, 2011, BONE, V49, P428, DOI 10.1016/j.bone.2011.05.012; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Sartori R, 2014, TRENDS ENDOCRIN MET, V25, P464, DOI 10.1016/j.tem.2014.06.002; Seguin CA, 2008, SPINE, V33, P356, DOI 10.1097/BRS.0b013e3181642a5e; Takegami K, 2002, SPINE, V27, P1318, DOI 10.1097/00007632-200206150-00014; Than KD, 2012, NEUROSURGERY, V70, P996, DOI 10.1227/NEU.0b013e318235d65f; TOLONEN J, 1995, SPINE, V20, P271, DOI 10.1097/00007632-199502000-00003; Wang CF, 2011, J ORTHOP RES, V29, P838, DOI 10.1002/jor.21310; Wang S, 2014, CELL PROLIFERAT, V47, P381, DOI 10.1111/cpr.12121; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405; Yoon ST, 2006, EUR SPINE J, V15, pS379, DOI 10.1007/s00586-006-0155-3; You WL, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-199; Yu X. C., 2014, SCI CHINA EARTH SCI, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083080; Zhang Y, 2008, SPINE, V33, P831, DOI 10.1097/BRS.0b013e31816b1f38; Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09; Zhang YJ, 2004, AM J PHYS MED REHAB, V83, P515, DOI 10.1097/01.PHM.0000130031.64343.59	46	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147764	10.1371/journal.pone.0147764	http://dx.doi.org/10.1371/journal.pone.0147764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824865	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600056
J	Einarsson, EJ; Patel, M; Petersen, H; Wiebe, T; Magnusson, M; Moell, C; Fransson, PA				Einarsson, Einar-Jon; Patel, Mitesh; Petersen, Hannes; Wiebe, Thomas; Magnusson, Mans; Moell, Christian; Fransson, Per-Anders			Oculomotor Deficits after Chemotherapy in Childhood	PLOS ONE			English	Article							PURSUIT EYE-MOVEMENTS; TERM-FOLLOW-UP; SMOOTH-PURSUIT; PARKINSONS-DISEASE; BLOOD-ALCOHOL; VINCRISTINE; CHILDREN; SACCADES; CANCER; PERFORMANCE	Advances in the diagnosis and treatment of pediatric malignancies have substantially increased the number of childhood cancer survivors. However, reports suggest that some of the chemotherapy agents used for treatment can cross the blood brain barrier which may lead to a host of neurological symptoms including oculomotor dysfunction. Whether chemotherapy at young age causes oculomotor dysfunction later in life is unknown. Oculomotor performance was assessed with traditional and novel methods in 23 adults (mean age 25.3 years, treatment age 10.2 years) treated with chemotherapy for a solid malignant tumor not affecting the central nervous system. Their results were compared to those from 25 healthy, age-matched controls (mean age 25.1 years). Correlation analysis was performed between the subjective symptoms reported by the chemotherapy treated subjects (CTS) and oculomotor performance. In CTS, the temporal control of the smooth pursuit velocity (velocity accuracy) was markedly poorer (p<0.001) and the saccades had disproportionally shorter amplitude than normal for the associated saccade peak velocity (main sequence) (p = 0.004), whereas smooth pursuit and saccade onset times were shorter (p = 0.004) in CTS compared with controls. The CTS treated before 12 years of age manifested more severe oculomotor deficits. CTS frequently reported subjective symptoms of visual disturbances (70%), unsteadiness, light-headedness and that things around them were spinning or moving (87%). Several subjective symptoms were significantly related to deficits in oculomotor performance. To conclude, chemotherapy in childhood or adolescence can result in severe oculomotor dysfunctions in adulthood. The revealed oculomotor dysfunctions were significantly related to the subjects' self-perception of visual disturbances, dizziness, light-headedness and sensing unsteadiness. Assessments of oculomotor function may, thus, offer an objective method to track and rate the level of neurological complications following chemotherapy.	[Einarsson, Einar-Jon; Magnusson, Mans; Fransson, Per-Anders] Lund Univ, Dept Clin Sci, Lund, Sweden; [Einarsson, Einar-Jon; Petersen, Hannes] Univ Iceland, Fac Med, Reykjavik, Iceland; [Patel, Mitesh] Univ E London, Sch Biosci, London E15 4LZ, England; [Patel, Mitesh] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London, England; [Petersen, Hannes] Landspitali Univ Hosp, Dept Otorhinolaryngol, Reykjavik, Iceland; [Wiebe, Thomas; Moell, Christian] Skane Univ Hosp, Dept Paediat, Lund, Sweden; [Magnusson, Mans] Skane Univ Hosp, Dept Otorhinolaryngol, Lund, Sweden	Lund University; University of Iceland; University of East London; Imperial College London; Landspitali National University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Fransson, PA (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	Per-Anders.Fransson@med.lu.se		Patel, Mitesh/0000-0001-6926-941X; Magnusson, Mans/0000-0002-4266-1996; Fransson, Per-Anders/0000-0002-9789-1748; Patel, Mitesh/0000-0002-3594-5448; Wiebe, Thomas/0000-0002-7567-9076; Petersen, Hannes/0000-0002-2327-523X				Bahill T., 1975, MATH BIOSCI, V24, P191; Bertolini P, 2004, J PEDIAT HEMATOL ONC, V26, P649, DOI 10.1097/01.mph.0000141348.62532.73; BITTENCOURT P, 1980, LANCET, V2, P981; Blohm G, 2010, J NEUROPHYSIOL, V104, P2103, DOI 10.1152/jn.00728.2009; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Chambers JM, 2010, NEUROPSYCHOLOGIA, V48, P887, DOI 10.1016/j.neuropsychologia.2009.11.006; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Duman O, 2005, J PEDIAT HEMATOL ONC, V27, P241; Erkelens CJ, 2006, VISION RES, V46, P163, DOI 10.1016/j.visres.2005.06.027; Fransson PA, 2010, CLIN NEUROPHYSIOL, V121, P2134, DOI 10.1016/j.clinph.2010.05.003; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; Hartman A, 2006, CANCER, V106, P1395, DOI 10.1002/cncr.21706; Jacobson G P, 1991, J Am Acad Audiol, V2, P253; Kowler E., 2011, VISION RES, DOI [10.1016/j, DOI 10.1016/J]; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; Lacour M, 2009, ANN NY ACAD SCI, V1164, P268, DOI 10.1111/j.1749-6632.2008.03731.x; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Meyers Christina A, 2008, J Biol, V7, P11, DOI 10.1186/jbiol73; MOSKOWITZ H, 1973, PERCEPT MOTOR SKILL, V36, P801, DOI 10.2466/pms.1973.36.3.801; Muller L, 2004, PEDIATR BLOOD CANCER, V42, P287, DOI 10.1002/pbc.10301; Nicolao P, 2003, ONCOLOGY-BASEL, V65, P11, DOI 10.1159/000073352; Nilsson MH, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-33; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P216, DOI 10.1111/j.1749-6632.2002.tb02821.x; PierrotDeseilligny C, 1997, J NEUROL, V244, P65, DOI 10.1007/s004150050051; Taylor A, 2004, PEDIATR BLOOD CANCER, V42, P161, DOI 10.1002/pbc.10482; Taylor N, 2010, EUR J CANCER, V46, P1069, DOI 10.1016/j.ejca.2010.01.022; TUXEN MK, 1994, CANCER TREAT REV, V20, P191, DOI 10.1016/0305-7372(94)90027-2; Vainionpaa L, 1995, PEDIATR NEUROL, V13, P314, DOI 10.1016/0887-8994(95)00191-3; Verstappen CCP, 2005, NEUROLOGY, V64, P1076, DOI 10.1212/01.WNL.0000154642.45474.28; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; Zee D S, 1983, Neurol Clin, V1, P909	31	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147703	10.1371/journal.pone.0147703	http://dx.doi.org/10.1371/journal.pone.0147703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815789	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200046
J	Ndaimani, H; Tagwireyi, P; Sebele, L; Madzikanda, H				Ndaimani, Henry; Tagwireyi, Paradzayi; Sebele, Lovelater; Madzikanda, Hillary			An Ecological Paradox: The African Wild Dog (Lycaon Pictus) Is Not Attracted to Water Points When Water Is Scarce in Hwange National Park, Zimbabwe	PLOS ONE			English	Article							ELEPHANT LOXODONTA-AFRICANA; LARGE HERBIVORE RESPONSES; SPATIAL-DISTRIBUTION; SURFACE-WATER; DISTRIBUTION PATTERNS; PREY RELATIONSHIPS; FOOD-CONSUMPTION; SABLE ANTELOPE; LAND-USE; DESERT	In dry biomes, spatio-temporal variation in surface water resource stocks is pervasive, with unknown effects on the ranging behaviour of large predators. This study assessed the effect of spatial variation in surface water resources on the ranging behaviour of the African wild dog (Lycaon pictus). We analyzed data for 1992 (dry year with 20 water points) and 2000 (wet year with 30 water points) against presence-only data for five packs of L. pictus in a part of Hwange National Park and adjacent smallholder communal farming areas in western Zimbabwe. Modelling the potential habitat for L. pictus using Maxent with distance from water points (D-w) and Normalized Difference Vegetation Index (NDVI) as predictor variables was successful for 2000 (AUC = 0.793) but not successful for 1992 (AUC = 0.423), with L. pictus probability of occurrence near water points being more for year 2000 than for year 1992. The predicted L. pictus range was wider in 1992 (similar to 13888.1 km(2)) than in 2000 (similar to 958.4 km(2)) (Test of Proportions, chi(2) = 124.52, df = 1, P = 0.00). Using the 2nd order Multitype Nearest Neighbour Distance Function (Gcross), we also observed significant attraction between L. pictus and water points within only similar to 1km radius for 1992 but up to similar to 8km radius for 2000. Our study reinforced the notion that surface water resources attract wild dogs in the savannahs but paradoxically less so when water resources are scarce. In particular, our study furthers current understanding of the effects of changing water availability regimes on the endangered L. pictus, providing evidence that the endangered predator's home range encroaches into potential ecological traps (i.e., smallholder communal farming areas) when water resources are scarce.	[Ndaimani, Henry; Tagwireyi, Paradzayi] Univ Zimbabwe, Dept Geog & Environm Sci, Geoinformat & Earth Observat Ctr, Mt Pleasant, Harare, Zimbabwe; [Sebele, Lovelater] Zimbabwe Pk & Wildlife Management Author, Causeway, Harare, Zimbabwe; [Madzikanda, Hillary] Hwange Natl Pk, Painted Dog Conservat, Dete, Zimbabwe	University of Zimbabwe	Tagwireyi, P (corresponding author), Univ Zimbabwe, Dept Geog & Environm Sci, Geoinformat & Earth Observat Ctr, Mt Pleasant, Harare, Zimbabwe.	tagwireyi.1@buckeyemail.osu.edu	Ndaimani, Henry/AAE-4942-2021	Sebele, Lovelater/0000-0001-9355-048X				Abade L, 2014, BIOL CONSERV, V180, P241, DOI 10.1016/j.biocon.2014.10.005; Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Allen BL, 2012, AUST MAMMAL, V34, P251, DOI 10.1071/AM12012; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1988, ADV ECOL RES; Arjo WM, 2007, WEST N AM NATURALIST, V67, P389, DOI 10.3398/1527-0904(2007)67[389:CIKFRI]2.0.CO;2; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bean WT, 2014, J APPL ECOL, V51, P1116, DOI 10.1111/1365-2664.12281; Bennitt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101346; Bleich VC, 2009, CALIF FISH GAME, V95, P153; Cain JW, 2012, J ZOOL, V286, P58, DOI 10.1111/j.1469-7998.2011.00848.x; Cain JW, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2007-209; Chamaille-Jammes S, 2009, AFR J ECOL, V47, P804, DOI 10.1111/j.1365-2028.2009.01077.x; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S., 2002, AFRICAN WILD DOG BEH; Creel S, 2003, AFRICAN WILD DOG BEH; Crosmary WG, 2012, ANIM BEHAV, V83, P1367, DOI 10.1016/j.anbehav.2012.03.004; Darnell AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098846; de Boer WF, 2010, J MAMMAL, V91, P1280, DOI 10.1644/09-MAMM-A-392.1; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Duncan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051490; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Gaylard A., 2003, KRUGER EXPERIENCE EC, P171; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Green DM, 1966, SIGNAL DETECTION THE; Groom R, 2010, AFR J ECOL, V48, P159, DOI 10.1111/j.1365-2028.2009.01097.x; Hall LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067800; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2012, S AFR J WILDL RES, V42, P117, DOI 10.3957/056.042.0209; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Hensman MC, 2014, AFR J ECOL, V52, P237, DOI 10.1111/aje.12111; Herrmann SM, 2005, GLOBAL ENVIRON CHANG, V15, P394, DOI 10.1016/j.gloenvcha.2005.08.004; Jackson CR, 2012, WILDLIFE RES, V39, P31, DOI 10.1071/WR11070; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; Maloiy GMO, 2008, COMP BIOCHEM PHYS A, V151, P185, DOI 10.1016/j.cbpa.2008.06.019; Marnewick K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086265; Martin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118461; Matawa F, 2012, ECOL MODEL, V242, P189, DOI 10.1016/j.ecolmodel.2012.05.010; Mbizah MM, 2014, BIODIVERS CONSERV, V23, P1441, DOI 10.1007/s10531-014-0675-9; Mbizah MM, 2012, S AFR J WILDL RES, V42, P94, DOI 10.3957/056.042.0213; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; Morgart JR, 2005, WILDLIFE SOC B, V33, P51, DOI 10.2193/0091-7648(2005)33[51:SPUOAA]2.0.CO;2; Torres MEM, 2015, BEHAV PROCESS, V113, P163, DOI 10.1016/j.beproc.2015.02.006; Mponzi BP, 2014, HUM-WILDL INTERACT, V8, P218; MYNENI RB, 1994, REMOTE SENS ENVIRON, V49, P200, DOI 10.1016/0034-4257(94)90016-7; Newsome TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063931; O'Brien CS, 2006, WILDLIFE SOC B, V34, P582, DOI 10.2193/0091-7648(2006)34[582:WUOWCI]2.0.CO;2; Ogutu JO, 2014, BIODIVERS CONSERV, V23, P573, DOI 10.1007/s10531-013-0617-y; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; Ostrowski S, 2002, J MAMMAL, V83, P665, DOI 10.1644/1545-1542(2002)083<0665:WIAFCO>2.0.CO;2; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pole A, 2004, J ZOOL, V262, P207, DOI 10.1017/S0952836903004576; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Rasmussen GSA, 2012, J ZOOL, V286, P232, DOI 10.1111/j.1469-7998.2011.00874.x; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rogers CML, 1993, WOODY VEGETATION SUR; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Schmidt-Nielsen K., 1964, DESERT ANIMALS PHYSL; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Spackman KA, 1989, P 6 INT WORKSH MACH; Tilman D, 1984, Q REV BIOL, V59, P199, DOI [10.1086/413856, DOI 10.1086/413856]; Valeix M, 2007, J TROP ECOL, V23, P87, DOI 10.1017/S0266467406003609; Valeix M, 2011, BIOL CONSERV, V144, P902, DOI 10.1016/j.biocon.2010.10.029; van der Meer E, 2011, BEHAV ECOL, V22, P985, DOI 10.1093/beheco/arr079; van der Meer E, 2014, ORYX, V48, P285, DOI 10.1017/S0030605312001366; van der Meer E, 2014, AFR J ECOL, V52, P69, DOI 10.1111/aje.12092; Webster H, 2012, ETHOLOGY, V118, P147, DOI 10.1111/j.1439-0310.2011.01992.x; Western D., 1975, E AFR WILDL J, V13, P265, DOI DOI 10.1111/J.1365-2028.1975.TB00139.X; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; Whittington-Jones BM, 2014, S AFR J WILDL RES, V44, P135, DOI 10.3957/056.044.0201; Williams JB, 2001, J EXP BIOL, V204, P2301; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Winterbach HEK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100202; Woodroffe R, 1999, ORYX, V33, P132, DOI 10.1017/S0030605300030398; Woodroffe R, 2011, J MAMMAL, V92, P305, DOI 10.1644/10-MAMM-A-157.1; Yravedra J, 2014, ARCHAEOL ANTHROP SCI, V6, P113, DOI 10.1007/s12520-013-0164-1	84	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146263	10.1371/journal.pone.0146263	http://dx.doi.org/10.1371/journal.pone.0146263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816321	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200011
J	Donertas, HM; Cuesta, SM; Rahman, SA; Thornton, JM				Donertas, Handan Melike; Cuesta, Sergio Martinez; Rahman, Syed Asad; Thornton, Janet M.			Characterising Complex Enzyme Reaction Data	PLOS ONE			English	Article							GENOME-SCALE CLASSIFICATION; METABOLIC REACTIONS; CATALYTIC PROMISCUITY; EC NUMBERS; PREDICTION; EVOLUTION; TOOL; CHLOROPEROXIDASE; REPRESENTATION; PURIFICATION	The relationship between enzyme-catalysed reactions and the Enzyme Commission (EC) number, the widely accepted classification scheme used to characterise enzyme activity, is complex and with the rapid increase in our knowledge of the reactions catalysed by enzymes needs revisiting. We present a manual and computational analysis to investigate this complexity and found that almost one-third of all known EC numbers are linked to more than one reaction in the secondary reaction databases (e.g., KEGG). Although this complexity is often resolved by defining generic, alternative and partial reactions, we have also found individual EC numbers with more than one reaction catalysing different types of bond changes. This analysis adds a new dimension to our understanding of enzyme function and might be useful for the accurate annotation of the function of enzymes and to study the changes in enzyme function during evolution.	[Donertas, Handan Melike; Cuesta, Sergio Martinez; Rahman, Syed Asad; Thornton, Janet M.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England; [Donertas, Handan Melike] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey; [Cuesta, Sergio Martinez] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Middle East Technical University; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Thornton, JM (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	thornton@ebi.ac.uk	Cuesta, Sergio Martínez/H-4820-2019; Donertas, Handan Melike/J-5451-2019	Cuesta, Sergio Martínez/0000-0001-9806-2805; Donertas, Handan Melike/0000-0002-9788-6535; Rahman, Syed Asad/0000-0002-7602-6675; Thornton, Janet/0000-0003-0824-4096	European Molecular Biology Laboratory; Turkish National Agency [2012-1-TR1-ERA02-37071]	European Molecular Biology Laboratory; Turkish National Agency(Turkiye Cumhuriyeti Kalkinma Bakanligi)	This work was supported by the European Molecular Biology Laboratory (SMC, SAR, JMT) (http://www.embl.de/), the European Molecular Biology Laboratory International PhD programme (SMC) (http://www.embl.de/training/eipp/) and the Turkish National Agency (2012-1-TR1-ERA02-37071) for funding through an Erasmus Placement Activity (HMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara R, 2012, NUCLEIC ACIDS RES, V40, pD754, DOI 10.1093/nar/gkr1126; Anton BP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001638; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Apweiler R, 2010, NAT CHEM BIOL, V6, P785, DOI 10.1038/nchembio.460; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babbitt PC, 2003, CURR OPIN CHEM BIOL, V7, P230, DOI 10.1016/S1367-5931(03)00028-0; Bastard K, 2014, NAT CHEM BIOL, V10, P42, DOI 10.1038/NCHEMBIO.1387; Bernard T, 2014, BRIEF BIOINFORM, V15, P123, DOI 10.1093/bib/bbs058; Brecher J, 2008, PURE APPL CHEM, V80, P277, DOI 10.1351/pac200880020277; Chen WL, 2013, WIRES COMPUT MOL SCI, V3, P560, DOI 10.1002/wcms.1140; Cornish-Bowden A., 2014, PERSPECT SCI, V1, P74, DOI DOI 10.1016/J.PISC.2014.02.006; Cuesta SM, 2014, CURR OPIN STRUC BIOL, V26, P121, DOI 10.1016/j.sbi.2014.06.002; Daenzer JMI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002721; desJardins M, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P92; Egelhofer V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000661; Foster JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013576; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Gardossi L, 2010, TRENDS BIOTECHNOL, V28, P171, DOI 10.1016/j.tibtech.2010.01.001; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Geyer P, 2013, WORLD PAT INF, V35, P178, DOI 10.1016/j.wpi.2013.05.002; Green ML, 2005, NUCLEIC ACIDS RES, V33, P4035, DOI 10.1093/nar/gki711; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Holliday GL, 2011, FEBS J, V278, P3835, DOI 10.1111/j.1742-4658.2011.08190.x; Hu XY, 2010, J CHEM INF MODEL, V50, P1089, DOI 10.1021/ci9004833; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; Kaltenbach M, 2014, J EXP ZOOL PART B, V322, P468, DOI 10.1002/jez.b.22562; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawashima S, 2003, GENOME INFORMATICS, V14, P673; Kazlauskas RJ, 2005, CURR OPIN CHEM BIOL, V9, P195, DOI 10.1016/j.cbpa.2005.02.008; Kimura Y, 2001, PLANT CELL PHYSIOL, V42, P1169, DOI 10.1093/pcp/pce130; Kotera M, 2004, J AM CHEM SOC, V126, P16487, DOI 10.1021/ja0466457; Kotera M., 2014, PERSPECT SCI, V1, P24; Kotera M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001537; Kraut H, 2013, J CHEM INF MODEL, V53, P2884, DOI 10.1021/ci400442f; KUHM AE, 1990, BIOCHEM J, V266, P877; Kumar A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-6; Lang MR, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-42; Latino DARS, 2006, ANGEW CHEM INT EDIT, V45, P2066, DOI 10.1002/anie.200503833; Latino DARS, 2008, BIOINFORMATICS, V24, P2236, DOI 10.1093/bioinformatics/btn405; Latino DARS, 2009, J CHEM INF MODEL, V49, P1839, DOI 10.1021/ci900104b; LIM YH, 1993, J BACTERIOL, V175, P4213, DOI 10.1128/JB.175.13.4213-4217.1993; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McDonald AG, 2014, FEBS J, V281, P583, DOI 10.1111/febs.12530; McDonald AG, 2009, NUCLEIC ACIDS RES, V37, pD593, DOI 10.1093/nar/gkn582; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Mu FP, 2006, BIOINFORMATICS, V22, P3082, DOI 10.1093/bioinformatics/btl535; Mu FP, 2011, BIOINFORMATICS, V27, P1537, DOI 10.1093/bioinformatics/btr177; O'Boyle NM, 2007, J MOL BIOL, V368, P1484, DOI 10.1016/j.jmb.2007.02.065; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Ott MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-517; PIEPER DH, 1993, ARCH MICROBIOL, V160, P169; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rahman SA, 2014, NAT METHODS, V11, P171, DOI [10.1038/NMETH.2803, 10.1038/nmeth.2803]; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Renirie R, 2000, BIOCHEMISTRY-US, V39, P1133, DOI 10.1021/bi9921790; Sacher O, 2009, J CHEM INF MODEL, V49, P1525, DOI 10.1021/ci800277f; Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011; Schomburg I, 2014, PERSPECTIVESCI, V1, P15, DOI DOI 10.1016/J.PISC.2014.02.002; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schomburg KT, 2013, DRUG DISCOV TODAY, V18, P651, DOI 10.1016/j.drudis.2013.02.001; Shaw R, 2012, CURR SCI INDIA, V103, P1328; Shearer AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097250; SIMMONS ES, 1991, J CHEM INF COMP SCI, V31, P45, DOI 10.1021/ci00001a007; Sorokina M, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-10; Tipton K, 2000, BIOINFORMATICS, V16, P34, DOI 10.1093/bioinformatics/16.1.34; Tipton K. F., 2014, PERSPECT SCI, V1, P131, DOI [10.1016/j.pisc.2014.02.012, DOI 10.1016/J.PISC.2014.02.012]; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trivino JC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-46; Warr WA, 2014, MOL INFORM, V33, P469, DOI 10.1002/minf.201400052; Warr WA, 2011, WIRES COMPUT MOL SCI, V1, P557, DOI 10.1002/wcms.36; Woggon WD, 2001, J INORG BIOCHEM, V83, P289, DOI 10.1016/S0162-0134(00)00175-6; ZASS E, 1990, J CHEM INF COMP SCI, V30, P360, DOI 10.1021/ci00068a004	76	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147952	10.1371/journal.pone.0147952	http://dx.doi.org/10.1371/journal.pone.0147952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840640	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200073
J	Mansfeldt, CB; Richter, LV; Ahner, BA; Cochlan, WP; Richardson, RE				Mansfeldt, Cresten B.; Richter, Lubna V.; Ahner, Beth A.; Cochlan, William P.; Richardson, Ruth E.			Use of De Novo Transcriptome Libraries to Characterize a Novel Oleaginous Marine Chlorella Species during the Accumulation of Triacylglycerols	PLOS ONE			English	Article							ARTIFICIAL SEAWATER MEDIUM; RNA-SEQ ANALYSIS; LIPID-ACCUMULATION; NITROGEN DEPRIVATION; BIOFUEL PRODUCTION; CHLAMYDOMONAS; MICROALGAE; GENE; EXPRESSION; BIODIESEL	Marine chlorophytes of the genus Chlorella are unicellular algae capable of accumulating a high proportion of cellular lipids that can be used for biodiesel production. In this study, we examined the broad physiological capabilities of a subtropical strain (C596) of Chlorella sp. "SAG-211-18" including its heterotrophic growth and tolerance to low salt. We found that the alga replicates more slowly at diluted salt concentrations and can grow on a wide range of carbon substrates in the dark. We then sequenced the RNA of Chlorella strain C596 to elucidate key metabolic genes and investigate the transcriptomic response of the organism when transitioning from a nutrient-replete to a nutrient-deficient condition when neutral lipids accumulate. Specific transcripts encoding for enzymes involved in both starch and lipid biosynthesis, among others, were up-regulated as the cultures transitioned into a lipid-accumulating state whereas photosynthesis-related genes were down-regulated. Transcripts encoding for two of the up-regulated enzymes-a galactoglycerolipid lipase and a diacylglyceride acyl-transferase-were also monitored by reverse transcription quantitative polymerase chain reaction assays. The results of these assays confirmed the transcriptome-sequencing data. The present transcriptomic study will assist in the greater understanding, more effective application, and efficient design of Chlorella-based biofuel production systems.	[Mansfeldt, Cresten B.; Richter, Lubna V.; Ahner, Beth A.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Cochlan, William P.] San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Tiburon, CA USA; [Richardson, Ruth E.] Cornell Univ, Dept Civil & Environm Engn, Ithaca, NY 14853 USA	Cornell University; California State University System; San Francisco State University; Cornell University	Mansfeldt, CB (corresponding author), Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA.	cbm59@cornell.edu	Richardson, Ruth E/B-8265-2017		United States Department of Energy [DE-EE0003371]; Direct For Biological Sciences [1227231] Funding Source: National Science Foundation	United States Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The United States Department of Energy (www.energy.gov) provided funding under grant number DE-EE0003371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Peter Schweitzer, Dr. Qi Sun and Dr. Jennifer Mosher at Cornell University's Core Genomics Facility and Computational Biology Service Unit for sample preparation and sequencing and for advice on transcriptome analyses. Additionally, we thank Dr. Robert Bidigare (University of Hawaii) for performing lipid analyses, Dr. Zachary Johnson (Duke University) and Susan Brown (University of Hawaii) for providing the algal cultures, and Mr. Julian Herndon and Mr. Christopher Ikeda (SFSU) for assisting with culture experimentation. We also thank our funding source, the Department of Energy (DE-EE0003371).	Alexander H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00385; Andersen RA, 2005, RECIPES FRESHWATER S, P429; Berges JA, 2004, J PHYCOL, V40, P619, DOI 10.1111/j.1529-8817.2004.40301.x; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; Bittar TB, 2013, J PHYCOL, V49, P523, DOI 10.1111/jpy.12060; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Bogren K, 2002, 31115011H QUICKCHEM; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Bradley T, 2015, APPL ENERG, V154, P1052, DOI 10.1016/j.apenergy.2014.12.087; Cagliari A., 2011, International Journal of Plant Biology, V2, P40; Cakmak ZE, 2014, BIORESOURCE TECHNOL, V155, P379, DOI 10.1016/j.biortech.2013.12.093; Campenni' L, 2013, APPL MICROBIOL BIOT, V97, P1383, DOI 10.1007/s00253-012-4570-6; Cochlan WP, 2014, POSTER PRESENTED AT; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fan JH, 2015, PLANT PHYSIOL, V169, P2444, DOI 10.1104/pp.15.01174; Fan JH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-17; Gao CF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-582; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Goodenough U, 2014, EUKARYOT CELL, V13, P591, DOI 10.1128/EC.00013-14; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HARRISON PJ, 1980, J PHYCOL, V16, P28, DOI 10.1111/j.1529-8817.1980.tb02994.x; Hildebrand M, 2013, CURR OPIN CHEM BIOL, V17, P506, DOI 10.1016/j.cbpa.2013.02.027; Ho SH, 2014, BIOTECHNOL ADV, V32, P1448, DOI 10.1016/j.biotechadv.2014.09.002; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hung CH, 2013, FEBS LETT, V587, P2364, DOI 10.1016/j.febslet.2013.06.002; Huss VAR, 1999, J PHYCOL, V35, P587, DOI 10.1046/j.1529-8817.1999.3530587.x; Johnson ZI, PLOS ONE IN PRESS; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim S, 2013, BIORESOURCE TECHNOL, V144, P8, DOI 10.1016/j.biortech.2013.06.068; Klok AJ, 2014, TRENDS BIOTECHNOL, V32, P521, DOI 10.1016/j.tibtech.2014.07.004; Koid A, 2012, APPL ENVIRON MICROB, V78, P3958, DOI 10.1128/AEM.06941-11; Kong WB, 2013, FOOD TECHNOL BIOTECH, V51, P62; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2015, ALGAL RES, V11, P381, DOI 10.1016/j.algal.2015.02.028; Li TT, 2013, BIORESOURCE TECHNOL, V131, P60, DOI 10.1016/j.biortech.2012.11.121; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Li XB, 2012, EUKARYOT CELL, V11, P1451, DOI 10.1128/EC.00268-12; Li-Beisson Y, 2015, PLANT J, V82, P504, DOI 10.1111/tpj.12787; Liang YN, 2009, BIOTECHNOL LETT, V31, P1043, DOI 10.1007/s10529-009-9975-7; Lu WD, 2015, BIORESOURCE TECHNOL, V191, P433, DOI 10.1016/j.biortech.2015.02.069; Martin GJO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103389; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Muhlroth A, 2013, MAR DRUGS, V11, P4662, DOI 10.3390/md11114662; Nan Y, 2015, J SUPERCRIT FLUID, V97, P174, DOI 10.1016/j.supflu.2014.08.025; National Research Council, 2012, SUST DEV ALG BIOF US; PRICE N M, 1988, Biological Oceanography, V6, P443; Qiao HJ, 2009, CHIN J OCEANOL LIMN, V27, P762, DOI 10.1007/s00343-009-9216-x; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sheehan J., 1998, LOOK BACK US DEP ENE, V328; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; Simon DF, 2013, APPL ENVIRON MICROB, V79, P4774, DOI 10.1128/AEM.00998-13; SMITH P, 2001, 31107041E QUICKCHEM; Sun X, 2014, GENET MOL RES, V13, P8411, DOI 10.4238/2014.October.20.17; Sun X, 2014, BOT MAR, V57, P403, DOI 10.1515/bot-2014-0013; Sun ZL, 2016, PLANT BIOTECHNOL J, V14, P557, DOI 10.1111/pbi.12398; Tang HY, 2011, BIOTECHNOL BIOENG, V108, P2280, DOI 10.1002/bit.23160; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; Wan MX, 2014, APPL MICROBIOL BIOT, V98, P9473, DOI 10.1007/s00253-014-6088-6; Williams PJL, 2010, ENERG ENVIRON SCI, V3, P554, DOI 10.1039/b924978h; Yu MJ, 2016, MAR GENOM, V25, P69, DOI 10.1016/j.margen.2015.11.005; Zhu LD, 2015, RENEW SUST ENERG REV, V41, P1376, DOI 10.1016/j.rser.2014.09.040	71	9	10	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147527	10.1371/journal.pone.0147527	http://dx.doi.org/10.1371/journal.pone.0147527			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840425	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200043
J	Moll, J; Hoppe, B; Konig, S; Wubet, T; Buscot, F; Kruger, D				Moll, Julia; Hoppe, Bjoern; Koenig, Stephan; Wubet, Tesfaye; Buscot, Francois; Krueger, Dirk			Spatial Distribution of Fungal Communities in an Arable Soil	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; MICROBIAL COMMUNITIES; MULTIVARIATE-ANALYSIS; VERTICAL-DISTRIBUTION; SPECIES RICHNESS; LAND-USE; DIVERSITY; BACTERIAL; YEASTS; ROOTS	Fungi are prominent drivers of ecological processes in soils, so that fungal communities across different soil ecosystems have been well investigated. However, for arable soils taxonomically resolved fine-scale studies including vertical itemization of fungal communities are still missing. Here, we combined a cloning/Sanger sequencing approach of the ITS/LSU region as marker for general fungi and of the partial SSU region for arbuscular mycorrhizal fungi (AMF) to characterize the microbiome in different maize soil habitats. Four compartments were analyzed over two annual cycles 2009 and 2010: a) ploughed soil in 0-10 cm, b) rooted soil in 40-50 cm, c) root-free soil in 60-70 cm soil depth and d) maize roots. Ascomycota was the most dominant phylum across all compartments. Fungal communities including yeasts and AMF differed strongly between compartments. Inter alia, Tetracladium, the overall largest MOTU (molecular operational taxonomic unit), occurred in all compartments, whereas Trichosporon dominated all soil compartments. Sequences belonging to unclassified Helotiales were forming the most abundant MOTUs exclusively present in roots. This study gives new insights on spatial distribution of fungi and helps to link fungal communities to specific ecological properties such as varying resources, which characterize particular niches of the heterogeneous soil environment.	[Moll, Julia; Hoppe, Bjoern; Wubet, Tesfaye; Buscot, Francois; Krueger, Dirk] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Theodor Lieser Str 4, D-06120 Halle, Saale, Germany; [Moll, Julia; Buscot, Francois] Univ Leipzig, Inst Biol, Johannisallee 21-23, D-04103 Leipzig, Germany; [Koenig, Stephan] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants JKI Inst Natl & Int, Messeweg 11-12, D-38104 Braunschweig, Germany; [Wubet, Tesfaye; Buscot, Francois] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Julius Kuhn-Institut	Moll, J (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Theodor Lieser Str 4, D-06120 Halle, Saale, Germany.; Moll, J (corresponding author), Univ Leipzig, Inst Biol, Johannisallee 21-23, D-04103 Leipzig, Germany.	julia.moll@ufz.de	Koenig, Stephan/GRX-2480-2022; Buscot, Francois/A-4125-2016; Wubet, Tesfaye/C-6241-2012; Kruger, Dirk/C-3316-2012	Buscot, Francois/0000-0002-2364-0006; Wubet, Tesfaye/0000-0001-8572-4486; Kruger, Dirk/0000-0002-7305-5104; Hoppe, Bjorn/0000-0001-8689-4911	German Research Foundation (DFG) Research Unit FOR 918	German Research Foundation (DFG) Research Unit FOR 918(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG) (http://www.dfg.de/) Research Unit FOR 918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bahram M, 2015, NEW PHYTOL, V205, P1454, DOI 10.1111/nph.13206; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Becklin KM, 2012, MICROB ECOL, V63, P682, DOI 10.1007/s00248-011-9968-7; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Borriello R, 2012, BIOL FERT SOILS, V48, P911, DOI 10.1007/s00374-012-0683-4; Botha A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P221, DOI 10.1007/3-540-30985-3_11; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; Bridge PD, 2009, FUNGAL ECOL, V2, P66, DOI 10.1016/j.funeco.2008.10.008; Brito I, 2012, SOIL TILL RES, V121, P63, DOI 10.1016/j.still.2012.01.012; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buscot F, 2015, J PLANT PHYSIOL, V172, P55, DOI 10.1016/j.jplph.2014.08.013; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Ciccolini V, 2015, BIOL FERT SOILS, V51, P719, DOI 10.1007/s00374-015-1013-4; Cloete KJ, 2009, MICROB ECOL, V57, P624, DOI 10.1007/s00248-008-9457-9; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; Connell L, 2006, SOIL BIOL BIOCHEM, V38, P3083, DOI 10.1016/j.soilbio.2006.02.016; Cuenca G, 2010, BOTANY, V88, P54, DOI 10.1139/B09-100; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Castro AP, 2008, ARCH MICROBIOL, V190, P129, DOI 10.1007/s00203-008-0374-6; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; El-Mehalawy A. A., 2004, International Journal of Agriculture and Biology, V6, P599; Gai JP, 2015, J SOIL SEDIMENT, V15, P1200, DOI 10.1007/s11368-015-1060-3; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; Helgason BL, 2010, APPL SOIL ECOL, V46, P390, DOI 10.1016/j.apsoil.2010.10.002; Higo M, 2013, BIOL FERT SOILS, V49, P1085, DOI 10.1007/s00374-013-0807-5; Hoffland E, 2004, FRONT ECOL ENVIRON, V2, P258; IUSS WGW, 2007, WORLD SOIL RES REP, V103; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Klaubauf S, 2010, FUNGAL DIVERS, V44, P65, DOI 10.1007/s13225-010-0053-1; Konig S, 2010, APPL ENVIRON MICROB, V76, P3765, DOI 10.1128/AEM.02951-09; Kramer S, 2012, PEDOBIOLOGIA, V55, P111, DOI 10.1016/j.pedobi.2011.12.001; Kuhnert R, 2012, MICROB ECOL, V64, P79, DOI 10.1007/s00248-011-0001-y; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lynch MDJ, 2006, APPL ENVIRON MICROB, V72, P7050, DOI 10.1128/AEM.00826-06; Ma AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066146; Moll J, 2015, MICROB ECOL, V70, P390, DOI 10.1007/s00248-015-0569-8; Money N. P., 2007, BIOL FUNGAL CELL, P237; Morris EK, 2013, BIODIVERS CONSERV, V22, P2193, DOI 10.1007/s10531-013-0527-z; Muleta D, 2008, BIOL FERT SOILS, V44, P653, DOI 10.1007/s00374-007-0261-3; Oehl F, 2005, NEW PHYTOL, V165, P273, DOI 10.1111/j.1469-8137.2004.01235.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Pan JJ, 2008, NEW PHYTOL, V178, P147, DOI 10.1111/j.1469-8137.2007.02350.x; Pausch J, 2013, PLANT SOIL, V364, P273, DOI 10.1007/s11104-012-1363-8; Pausch J, 2012, SOIL BIOL BIOCHEM, V55, P40, DOI 10.1016/j.soilbio.2012.06.007; R Core Team, 2021, R LANGUAGE ENV STAT; Renker C, 2006, MYCORRHIZA, V16, P525, DOI 10.1007/s00572-006-0067-4; Renker C, 2004, FEMS YEAST RES, V4, P597, DOI 10.1016/j.femsyr.2004.01.001; Rime T, 2015, MOL ECOL, V24, P1091, DOI 10.1111/mec.13051; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Scharroba A, 2012, SOIL BIOL BIOCHEM, V50, P1, DOI 10.1016/j.soilbio.2012.03.002; Selosse MA, 2008, NEW PHYTOL, V178, P3, DOI 10.1111/j.1469-8137.2008.02390.x; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Singh BK, 2009, APPL SOIL ECOL, V41, P239, DOI 10.1016/j.apsoil.2008.10.003; Slavikova E, 2003, J BASIC MICROB, V43, P430, DOI 10.1002/jobm.200310277; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Tian H, 2011, APPL SOIL ECOL, V47, P141, DOI 10.1016/j.apsoil.2011.01.002; Torrecillas E, 2012, PLANT SOIL, V354, P97, DOI 10.1007/s11104-011-1047-9; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Verbruggen E, 2012, MOL ECOL, V21, P2341, DOI 10.1111/j.1365-294X.2012.05534.x; Vishniac HS, 2006, MICROB ECOL, V52, P90, DOI 10.1007/s00248-006-9066-4; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wubet T, 2006, MYCOL RES, V110, P1059, DOI 10.1016/j.mycres.2006.04.005; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Xu LH, 2012, FEMS MICROBIOL ECOL, V82, P736, DOI 10.1111/j.1574-6941.2012.01445.x; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004; Yurkov AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023671	77	46	48	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148130	10.1371/journal.pone.0148130	http://dx.doi.org/10.1371/journal.pone.0148130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840453	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200083
J	Rudolph, S; Klein, AN; Tusche, M; Schlosser, C; Elfgen, A; Brener, O; Teunissen, C; Gremer, L; Funke, SA; Kutzsche, J; Willbold, D				Rudolph, Stephan; Klein, Antonia Nicole; Tusche, Markus; Schlosser, Christine; Elfgen, Anne; Brener, Oleksandr; Teunissen, Charlotte; Gremer, Lothar; Funke, Susanne Aileen; Kutzsche, Janine; Willbold, Dieter			Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SECRETASE INHIBITORS; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; TRANSGENIC MICE; ION-CHANNEL; OLIGOMERS; LIGANDS; RELEVANCE; AD	Alzheimer's disease is the most prominent type of dementia and currently no causative treatment is available. According to recent studies, oligomeric species of the amyloid beta (A beta) peptide appear to be the most toxic A beta assemblies. A beta monomers, however, may be not toxic per se and may even have a neuroprotective role. Here we describe a competitive mirror image phage display procedure that allowed us to identify preferentially A beta(1-42) monomer binding and thereby stabilizing peptides, which destabilize and thereby eliminate toxic oligomer species. One of the peptides, called Mosd1 (monomer specific d-peptide 1), was characterized in more detail. Mosd1 abolished oligomers from a mixture of A beta(1-)42 species, reduced A beta(1-42) toxicity in cell culture, and restored the physiological phenotype in neuronal cells stably transfected with the gene coding for human amyloid precursor protein.	[Rudolph, Stephan; Klein, Antonia Nicole; Tusche, Markus; Schlosser, Christine; Elfgen, Anne; Brener, Oleksandr; Gremer, Lothar; Funke, Susanne Aileen; Kutzsche, Janine; Willbold, Dieter] Forschungszentrum Julich, Res Ctr, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Funke, Susanne Aileen] Hsch Angew Wissensch Coburg, Fak Angew Nat Wissensch, D-96450 Coburg, Germany; [Brener, Oleksandr; Gremer, Lothar; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Teunissen, Charlotte] VU Univ Med Ctr Amsterdam, Neurochem Lab & Biobank, Amsterdam, Netherlands	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Willbold, D (corresponding author), Forschungszentrum Julich, Res Ctr, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.; Willbold, D (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.	d.willbold@fz-juelich.de	Willbold, Dieter/A-6280-2013; Kutzsche, Janine/G-6287-2013; Gremer, Lothar/H-9128-2013	Willbold, Dieter/0000-0002-0065-7366; Kutzsche, Janine/0000-0003-0271-7390; Gremer, Lothar/0000-0001-7065-5027; Brener, Oleksandr/0000-0001-9771-7515; Elfgen, Anne/0000-0002-0548-2964	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft"; TT-Fonds of Technology Transfer Department of Forschungszentrum Julich	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft"; TT-Fonds of Technology Transfer Department of Forschungszentrum Julich	D.W. was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Re-search" and the Helmholtz-Validierungsfonds of the "Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft". This project was also supported by the TT-Fonds of the Technology Transfer Department of the Forschungszentrum Julich.	BAUER J, 1994, FORTSCHR NEUROL PSYC, V62, P417, DOI 10.1055/s-2007-1002299; Brener O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13222; Chang HN, 2015, ANGEW CHEM INT EDIT, V54, P11760, DOI 10.1002/anie.201506225; Chemerovski-Glikman M, 2014, TETRAHEDRON, V70, P7639, DOI 10.1016/j.tet.2014.07.097; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; Du DG, 2011, BIOCHEMISTRY-US, V50, P1607, DOI 10.1021/bi1013744; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Funke SA, 2009, MOL BIOSYST, V5, P783, DOI 10.1039/b904138a; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hoffmann S, 2010, MOL BIOSYST, V6, P126, DOI 10.1039/b910945e; James TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049728; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Lu CJ, 2012, BIOORG MED CHEM LETT, V22, P7683, DOI 10.1016/j.bmcl.2012.09.105; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Paranjape GS, 2013, J NEUROIMMUNE PHARM, V8, P312, DOI 10.1007/s11481-012-9424-6; Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.3.CO;2-5; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ritchie K, 2002, LANCET, V360, P1759, DOI 10.1016/S0140-6736(02)11667-9; Rzepecki P, 2004, J BIOL CHEM, V279, P47497, DOI 10.1074/jbc.M405914200; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Sela M, 1997, FASEB J, V11, P449; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharoar MG, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-104; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Sun N, 2012, J BIOTECHNOL, V161, P121, DOI 10.1016/j.jbiotec.2012.05.019; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; Van Regenmortel MHV, 1998, CURR OPIN BIOTECH, V9, P377, DOI 10.1016/S0958-1669(98)80011-6; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; Wiesehan K, 2003, CHEMBIOCHEM, V4, P811, DOI 10.1002/cbic.200300570; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Yin RH, 2014, CURR ALZHEIMER RES, V11, P755, DOI 10.2174/156720501108140910121425; Zahs KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00028; Zettl H, 2012, ACS CHEM BIOL, V7, P1488, DOI 10.1021/cb3001952	53	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147470	10.1371/journal.pone.0147470	http://dx.doi.org/10.1371/journal.pone.0147470			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840229	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200041
J	Bernard, J; Hutet, E; Paboeuf, F; Randriamparany, T; Holzmuller, P; Lancelot, R; Rodrigues, V; Vial, L; Le Potier, MF				Bernard, Jennifer; Hutet, Evelyne; Paboeuf, Frederic; Randriamparany, Tantely; Holzmuller, Philippe; Lancelot, Renaud; Rodrigues, Valerie; Vial, Laurence; Le Potier, Marie-Frederique			Effect of O. porcinus Tick Salivary Gland Extract on the African Swine Fever Virus Infection in Domestic Pig	PLOS ONE			English	Article							ORNITHODOROS-MOUBATA; DENDRITIC CELLS; LANGERHANS CELLS; INTRAMUSCULAR INOCULATION; ARGASID TICK; IMMUNE CELLS; SOFT TICKS; LYMPH-NODE; HOST; SKIN	African swine fever is a haemorrhagic disease in pig production that can have disastrous financial consequences for farming. No vaccines are currently available and animal slaughtering or area zoning to restrict risk-related movements are the only effective measures to prevent the spread of the disease. Ornithodoros soft ticks are known to transmit the African swine fever virus (ASFV) to pigs in farms, following the natural epidemiologic cycle of the virus. Tick saliva has been shown to modulate the host physiological and immunological responses during feeding on skin, thus affecting viral infection. To better understand the interaction between soft tick, ASFV and pig at the bite location and the possible influence of tick saliva on pig infection by ASFV, salivary gland extract (SGE) of Ornithodoros porcinus, co-inoculated or not with ASFV, was used for intradermal auricular inoculation. Our results showed that, after the virus triggered the disease, pigs inoculated with virus and SGE presented greater hyperthermia than pigs inoculated with virus alone. The density of Langerhans cells was modulated at the tick bite or inoculation site, either through recruitment by ASFV or inhibition by SGE. Additionally, SGE and virus induced macrophage recruitment each. This effect was enhanced when they were co-inoculated. Finally, the co-inoculation of SGE and virus delayed the early local spread of virus to the first lymph node on the inoculation side. This study has shown that the effect of SGE was powerful enough to be quantified in pig both on the systemic and local immune response. We believe this model should be developed with infected tick and could improve knowledge of both tick vector competence and tick saliva immunomodulation.	[Bernard, Jennifer; Hutet, Evelyne; Paboeuf, Frederic; Le Potier, Marie-Frederique] Univ Bretagne Loire, Agence Natl Securite Sanit Anses, Lab Ploufragan Plouzane, Unite Virol & Immunol Porcines, Ploufragan, France; [Randriamparany, Tantely] Lab Natl Diagnost Vet, Antananarivo, Madagascar; [Bernard, Jennifer; Holzmuller, Philippe; Lancelot, Renaud; Rodrigues, Valerie; Vial, Laurence] Ctr Cooperat Int Rech Agron Dve CIRAD, UMR CMAEE, Montpellier, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory; CIRAD	Le Potier, MF (corresponding author), Univ Bretagne Loire, Agence Natl Securite Sanit Anses, Lab Ploufragan Plouzane, Unite Virol & Immunol Porcines, Ploufragan, France.	marie-frederique.lepotier@anses.fr	Holzmuller, Philippe/F-7231-2019; Lancelot, Renaud/HGE-1086-2022	Holzmuller, Philippe/0000-0002-8919-9081; Lancelot, Renaud/0000-0002-5826-5242; RANDRIAMPARANY, Tantely/0000-0002-4829-4146	European Union [311931 - ASFORCE]; General Council of the Cotes d'Armor department; Regional Council of Languedoc Roussillon; CIRAD; ANSES	European Union(European Commission); General Council of the Cotes d'Armor department; Regional Council of Languedoc Roussillon(Region Occitanie); CIRAD; ANSES	This work was partly funded by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement no.311931 - ASFORCE, the General Council of the Cotes d'Armor department and the Regional Council of Languedoc Roussillon (Chercheur d'avenir project). JB received her Ph.D. grant from CIRAD and ANSES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JR, 1979, J IMMUNOL, V122, P563; Alonso C, 2013, VIRUS RES, V173, P42, DOI 10.1016/j.virusres.2012.12.006; Astigarraga A, 1997, PARASITE IMMUNOL, V19, P401, DOI 10.1046/j.1365-3024.1997.d01-236.x; Barclay AN, 2009, CURR OPIN IMMUNOL, V21, P47, DOI 10.1016/j.coi.2009.01.008; Barratt-Due A, 2013, J IMMUNOL, V191, P819, DOI 10.4049/jimmunol.1201909; Barratt-Due A, 2011, J IMMUNOL, V187, P4913, DOI 10.4049/jimmunol.1101000; Blome S, 2013, VIRUS RES, V173, P122, DOI 10.1016/j.virusres.2012.10.026; Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023; Brossard M, 1997, MED VET ENTOMOL, V11, P270, DOI 10.1111/j.1365-2915.1997.tb00406.x; Brossard M, 2004, PARASITOLOGY, V129, pS161, DOI 10.1017/S0031182004004834; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Costard S, 2013, VIRUS RES, V173, P191, DOI 10.1016/j.virusres.2012.10.030; Davison AC, 1997, BOOTSTRAP METHODS TH; del Moral MG, 1999, J VIROL, V73, P2173; Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020; Epaulard O, 2014, J IMMUNOL, V193, P2416, DOI 10.4049/jimmunol.1303339; Ezquerra A, 2009, DEV COMP IMMUNOL, V33, P284, DOI 10.1016/j.dci.2008.06.002; Ferreira HCD, 2013, VET MICROBIOL, V165, P296, DOI 10.1016/j.vetmic.2013.03.026; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Frischknecht F, 2007, CELL MICROBIOL, V9, P1630, DOI 10.1111/j.1462-5822.2007.00955.x; Galindo-Cardiel I, 2013, VIRUS RES, V173, P180, DOI 10.1016/j.virusres.2012.12.018; Goldstein H., 1999, MULTILEVEL STAT MODE; Gomez-Villamandos JC, 2013, VIRUS RES, V173, P140, DOI 10.1016/j.virusres.2013.01.017; GREGG DA, 1995, J VET DIAGN INVEST, V7, P44, DOI 10.1177/104063879500700106; GREGG DA, 1995, J VET DIAGN INVEST, V7, P23, DOI 10.1177/104063879500700104; Guinat C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0093-8; Howey EB, 2013, VIRUS RES, V178, P328, DOI 10.1016/j.virusres.2013.09.024; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Jamin A, 2006, VET IMMUNOL IMMUNOP, V114, P224, DOI 10.1016/j.vetimm.2006.08.009; JOHNSTON CM, 1985, INT J PARASITOL, V15, P621, DOI 10.1016/0020-7519(85)90007-4; King K, 2011, VACCINE, V29, P4593, DOI 10.1016/j.vaccine.2011.04.052; Kleiboeker SB, 1998, J VIROL, V72, P1711, DOI 10.1128/JVI.72.3.1711-1724.1998; Kleiboeker Steven B., 2001, Animal Health Research Reviews, V2, P121; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kramer CD, 2011, EXP PARASITOL, V127, P665, DOI 10.1016/j.exppara.2010.11.012; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016320; Mason LMK, 2014, TRENDS PARASITOL, V30, P95, DOI 10.1016/j.pt.2013.12.003; MCLAREN DJ, 1983, EXP PARASITOL, V56, P153, DOI 10.1016/0014-4894(83)90058-9; Michaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069662; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; NITHIUTHAI S, 1985, IMMUNOLOGY, V55, P157; NITHIUTHAI S, 1984, IMMUNOLOGY, V51, P133; Nuttall PA, 2004, PARASITOLOGY, V129, pS177, DOI 10.1017/S0031182004005633; OIE, 2012, MANUAL DIAGNOSTIC TE, V2, P1067; Oliveira CJF, 2008, INT J PARASITOL, V38, P705, DOI 10.1016/j.ijpara.2007.10.006; Owen J, 2013, IMMUNOLOGY; Penrith ML, 2009, J S AFR VET ASSOC, V80, P58; Pinheiro J., 2006, MIXED EFFECTS MODELS; Piriou-Guzylack L, 2008, VET RES, V39, DOI 10.1051/vetres:2008030; PLOWRIGHT W, 1970, ARCH GES VIRUSFORSCH, V31, P33, DOI 10.1007/BF01241664; Ravaomanana J, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-115; RIBEIRO JMC, 1991, COMP BIOCHEM PHYS A, V100, P109, DOI 10.1016/0300-9629(91)90190-N; RIEK RF, 1954, T ROY SOC TROP MED H, V48, P8; RUTHERFORD MS, 1993, J LEUKOCYTE BIOL, V53, P602, DOI 10.1002/jlb.53.5.602; Salguero FJ, 2005, J COMP PATHOL, V132, P289, DOI 10.1016/j.jcpa.2004.11.004; Salguero FJ, 2002, VET IMMUNOL IMMUNOP, V90, P11, DOI 10.1016/S0165-2427(02)00225-8; Sanchez EG, 2013, VIRUS RES, V173, P58, DOI 10.1016/j.virusres.2012.10.025; SCHWAN EV, 1991, EXP APPL ACAROL, V13, P107, DOI 10.1007/BF01193661; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Skallova A, 2008, J IMMUNOL, V180, P6186, DOI 10.4049/jimmunol.180.9.6186; Sonenshine DE, 2013, BIOL TICKS, V2nd; THEIS JH, 1974, EXP PARASITOL, V36, P77, DOI 10.1016/0014-4894(74)90115-5; Tignon M, 2011, J VIROL METHODS, V178, P161, DOI 10.1016/j.jviromet.2011.09.007; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Vial L, 2009, PARASITE, V16, P191, DOI 10.1051/parasite/2009163191; Wikel SK, 2001, VET PARASITOL, V101, P275, DOI 10.1016/S0304-4017(01)00556-8; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Xu QL, 2007, J IMMUNOL, V178, P5109, DOI 10.4049/jimmunol.178.8.5109	72	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147869	10.1371/journal.pone.0147869	http://dx.doi.org/10.1371/journal.pone.0147869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828597	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200040
J	Eom, HS; Park, HR; Jo, SK; Kim, YS; Moon, C; Kim, SH; Jung, U				Eom, Hyeon Soo; Park, Hae Ran; Jo, Sung Kee; Kim, Young Sang; Moon, Changjong; Kim, Sung-Ho; Jung, Uhee			Ionizing Radiation Induces Altered Neuronal Differentiation by mGluR1 through PI3K-STAT3 Signaling in C17.2 Mouse Neural Stem-Like Cells	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SUBVENTRICULAR ZONE; HIPPOCAMPAL NEUROGENESIS; ENDOGENOUS ACTIVATION; DENTATE GYRUS; PC12 CELLS; PROLIFERATION; IRRADIATION; GROWTH; P53	Most studies of IR effects on neural cells and tissues in the brain are still focused on loss of neural stem cells. On the other hand, the effects of IR on neuronal differentiation and its implication in IR-induced brain damage are not well defined. To investigate the effects of IR on C17.2 mouse neural stem-like cells and mouse primary neural stem cells, neurite outgrowth and expression of neuronal markers and neuronal function-related genes were examined. To understand this process, the signaling pathways including PI3K, STAT3, metabotrophic glutamate receptor 1 (mGluR1) and p53 were investigated. In C17.2 cells, irradiation significantly increased the neurite outgrowth, a morphological hallmark of neuronal differentiation, in a dose-dependent manner. Also, the expression levels of neuronal marker proteins, beta-III tubulin were increased by IR. To investigate whether IR-induced differentiation is normal, the expression of neuronal function-related genes including synaptophysin, a synaptic vesicle forming proteins, synaptotagmin1, a calcium ion sensor,gamma-aminobutyric acid (GABA) receptors, inhibitory neurotransmitter receptors and glutamate receptors, excitatory neurotransmitter receptors was examined and compared to that of neurotrophin-stimulated differentiation. IR increased the expression of synaptophysin, synaptotagmin1 and GABA receptors mRNA similarly to normal differentiation by stimulation of neurotrophin. Interestingly, the overall expression of glutamate receptors was significantly higher in irradiated group than normal differentiation group, suggesting that the IR-induced neuronal differentiation may cause altered neuronal function in C17.2 cells. Next, the molecular mechanism of the altered neuronal differentiation induced by IR was studied by investigating signaling pathways including p53, mGluR1, STAT3 and PI3K. Increases of neurite outgrowth, neuronal marker and neuronal function-related gene expressions by IR were abolished by inhibition of p53, mGluR-1, STAT3 or PI3K. The inhibition of PI3K blocked both p53 signaling and STAT3-mGluR1 signaling but inhibition of p53 did not affect STAT3-mGluR1 signaling in irradiated C17.2 cells. Finally, these results of the IR-induced altered differentiation in C17.2 cells were verified in ex vivo experiments using mouse primary neural stem cells. In conclusion, the results of this study demonstrated that IR is able to trigger the altered neuronal differentiation in undifferentiated neural stem-like cells through PI3K-STAT3-mGluR1 and PI3K-p53 signaling. It is suggested that the IR-induced altered neuronal differentiation may play a role in the brain dysfunction caused by IR.	[Eom, Hyeon Soo; Park, Hae Ran; Jo, Sung Kee; Jung, Uhee] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Biotechnol Res Div, Jeongeup, South Korea; [Eom, Hyeon Soo; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Daejeon, South Korea; [Moon, Changjong; Kim, Sung-Ho] Chonnam Natl Univ, Coll Vet Med, Dept Vet Anat, Gwangju, South Korea; [Park, Hae Ran; Jo, Sung Kee; Jung, Uhee] Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Daejeon, South Korea	Korea Atomic Energy Research Institute (KAERI); Chungnam National University; Chonnam National University; University of Science & Technology (UST)	Jung, U (corresponding author), Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Biotechnol Res Div, Jeongeup, South Korea.; Jung, U (corresponding author), Univ Sci & Technol, Dept Radiat Biotechnol & Appl Radioisotope, Daejeon, South Korea.	uhjung@kaeri.re.kr	Moon, Changjong/AAI-2005-2020	Moon, Changjong/0000-0003-2451-0374	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2012M2A2A7035656]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2012M2A2A7035656).	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; ABEYAMA K, 1995, FEBS LETT, V364, P298, DOI 10.1016/0014-5793(95)00412-3; Baudry M, 2011, NEUROBIOL LEARN MEM, V95, P125, DOI 10.1016/j.nlm.2010.11.015; Bendel O, 2005, NEUROSCI LETT, V377, P31, DOI 10.1016/j.neulet.2004.11.064; BERSTEIN M, 1981, NEUROSURGERY, V9, P741, DOI 10.1227/00006123-198112000-00022; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Castiglione M, 2008, NEUROPHARMACOLOGY, V55, P560, DOI 10.1016/j.neuropharm.2008.05.021; Chen H, 2012, NEUROLOGY, V78, P020; CHIANG CS, 1993, RADIOTHER ONCOL, V29, P60, DOI 10.1016/0167-8140(93)90174-7; Chuang JH, 2015, WORLD J STEM CELLS, V7, P437, DOI 10.4252/wjsc.v7.i2.437; COPANI A, 1995, J NEUROCHEM, V64, P101; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Eom HS, 2015, INT J RADIAT BIOL, V91, P585, DOI 10.3109/09553002.2015.1029595; Erichsen JL, 2015, BASIC CLIN PHARMACOL, V116, P329, DOI 10.1111/bcpt.12324; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiarsa JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00206; Gandhi R, 2008, J NEUROCHEM, V104, P155, DOI 10.1111/j.1471-4159.2007.04955.x; Girault JA, 2004, ARCH NEUROL-CHICAGO, V61, P641, DOI 10.1001/archneur.61.5.641; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; Henson MA, 2008, CEREB CORTEX, V18, P2560, DOI 10.1093/cercor/bhn017; Hughes AL, 2000, J BIOL CHEM, V275, P37829, DOI 10.1074/jbc.M003146200; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Hwang SY, 2006, INT J CANCER, V118, P2056, DOI 10.1002/ijc.21574; Hynds DL, 2003, J CELL SCI, V116, P1925, DOI 10.1242/jcs.00401; Inouye M, 2000, J RADIAT RES, V41, P303, DOI 10.1269/jrr.41.303; Isono M, 2012, NEUROSCI RES, V73, P263, DOI 10.1016/j.neures.2012.04.005; JENSH RP, 1995, INT J RADIAT BIOL, V67, P217, DOI 10.1080/09553009514550271; Jinguji S, 2013, J NEUROSURG-PEDIATR, V11, P454, DOI 10.3171/2012.12.PEDS12336; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kanzawa T, 2006, ONCOGENE, V25, P3638, DOI 10.1038/sj.onc.1209414; Kasid U, 1996, NATURE, V382, P813, DOI 10.1038/382813a0; Kiehna EN, 2006, J CLIN ONCOL, V24, P5283, DOI 10.1200/JCO.2005.03.8547; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Lang M, 2014, PHYSIOL REP, V2, DOI [10.1002/phy2.278, 10.14814/phy2.278]; Lawrence YR, 2010, INT J RADIAT ONCOL, V76, pS20, DOI 10.1016/j.ijrobp.2009.02.091; Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; Maric D, 2000, J NEUROSCI RES, V61, P652, DOI 10.1002/1097-4547(20000915)61:6<652::AID-JNR9>3.0.CO;2-J; Mateos JM, 2000, J NEUROCHEM, V74, P1301; Mirza B, 2000, NEUROSCIENCE, V95, P425; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Montano X, 1997, ONCOGENE, V15, P245, DOI 10.1038/sj.onc.1201215; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Moore DL, 2011, DEV NEUROBIOL, V71, P1186, DOI 10.1002/dneu.20934; Mrak RE, 2007, J NEUROPATH EXP NEUR, V66, P683, DOI 10.1097/nen.0b013e31812503e1; N'Gouemo P, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu123; Natarajan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100405; Oh SB, 2013, BRIT J PHARMACOL, V168, P421, DOI 10.1111/j.1476-5381.2012.02142.x; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Ozeki A, 2012, NEUROREPORT, V23, P290, DOI 10.1097/WNR.0b013e3283509a79; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Peissner W, 1999, MOL BRAIN RES, V71, P61, DOI 10.1016/S0169-328X(99)00170-9; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Poongodi GL, 2002, J BIOL CHEM, V277, P28200, DOI 10.1074/jbc.M202731200; Qian L, 2008, IMMUNOL RES, V41, P155, DOI 10.1007/s12026-008-8018-0; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Roy NS, 2000, NAT MED, V6, P271; Schacter DL, 2011, PSYCHOLOGY, P80; Schlett K, 2006, CURR TOP MED CHEM, V6, P949, DOI 10.2174/156802606777323665; Schneider L, 2013, STEM CELL REP, V1, P123, DOI 10.1016/j.stemcr.2013.06.004; Sen A, 2002, BIOTECHNOL PROGR, V18, P337, DOI 10.1021/bp010150t; Shigemoto R, 1997, J NEUROSCI, V1, P722; Surma-aho O, 2001, NEUROLOGY, V56, P1285, DOI 10.1212/WNL.56.10.1285; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wei ZZ, 2014, CELL MOL NEUROBIOL, V34, P881, DOI 10.1007/s10571-014-0067-4; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Wu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037677; Yang PB, 2012, NEUROSCI BULL, V28, P704, DOI 10.1007/s12264-012-1286-7; Yoshida T, 2012, FREE RADICAL RES, V46, P147, DOI 10.3109/10715762.2011.645207; Zhang R, 2011, BASIC CLIN PHARMACOL, V108, P63, DOI 10.1111/j.1742-7843.2010.00629.x; Zhao LY, 2012, J NEUROSCI RES, V90, P447, DOI 10.1002/jnr.22751	87	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147538	10.1371/journal.pone.0147538	http://dx.doi.org/10.1371/journal.pone.0147538			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828720	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200023
J	Francisco-Fernandez, M; Quintela-del-rio, A				Francisco-Fernandez, Mario; Quintela-del-Rio, Alejandro			Comparing Simultaneous and Pointwise Confidence Intervals for Hydrological Processes	PLOS ONE			English	Article							BANDWIDTH SELECTION; FREQUENCY-ANALYSIS; NONPARAMETRIC-ESTIMATION; CONSTRUCTION; UNCERTAINTY; BOOTSTRAP; QUANTILES	Distribution function estimation of the random variable of river flow is an important problem in hydrology. This issue is directly related to quantile estimation, and consequently to return level prediction. The estimation process can be complemented with the construction of confidence intervals (CIs) to perform a probabilistic assessment of the different variables and/or estimated functions. In this work, several methods for constructing CIs using bootstrap techniques, and parametric and nonparametric procedures in the estimation process are studied and compared. In the case that the target is the joint estimation of a vector of values, some new corrections to obtain joint coverage probabilities closer to the corresponding nominal values are also presented. A comprehensive simulation study compares the different approaches, and the application of the different procedures to real data sets from four rivers in the United States and one in Spain complete the paper.	[Francisco-Fernandez, Mario; Quintela-del-Rio, Alejandro] Univ A Coruna, Fac Comp Sci, Dept Math, Campus Elvina S-N, La Coruna 15071, Spain	Universidade da Coruna	Francisco-Fernandez, M (corresponding author), Univ A Coruna, Fac Comp Sci, Dept Math, Campus Elvina S-N, La Coruna 15071, Spain.	mariofr@udc.es	Francisco-Fernández, Mario/AAI-5349-2020; Francisco-Fernández, Mario/H-1672-2016	Francisco-Fernández, Mario/0000-0002-9201-5423; Francisco-Fernández, Mario/0000-0002-9201-5423	Ministerio de Ciencia e Innovacion [MTM2011-22392, MTM2014-52876-R]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Ministerio de Ciencia e Innovacion (ES) grant MTM2011-22392 and Ministerio de Ciencia e Innovacion (ES) grant MTM2014-52876-R.	ADAMOWSKI K, 1989, J HYDROL, V108, P295, DOI 10.1016/0022-1694(89)90290-4; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTMAN N, 1995, J STAT PLAN INFER, V46, P195, DOI 10.1016/0378-3758(94)00102-2; Auguie B, 2017, GRIDEXTRA MISCELLANE; Ba KM, 2001, NAT HAZARDS, V24, P1, DOI 10.1023/A:1011101700032; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Bowman A, 1998, BIOMETRIKA, V85, P799, DOI 10.1093/biomet/85.4.799; CHENG RCH, 1983, J ROY STAT SOC B MET, V45, P394; Chernick M.R., 2008, WILEY SERIES PROBABI, V2nd ed; Coles S., 2001, INTRO STAT MODELING; Davison AC, 1997, BOOTSTRAP METHODS TH; Davison AC, 2002, STAT COMPUTING STAT, V13, P6; DiCiccio TJ, 1996, STAT SCI, V11, P189; Ebtehaj M, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007981; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fisher RA, 1928, P CAMB PHILOS SOC, V24, P180, DOI 10.1017/S0305004100015681; Guo SL, 1996, J HYDROL, V185, P335, DOI 10.1016/0022-1694(95)02956-7; Hall MJ, 2004, HYDROL EARTH SYST SC, V8, P235, DOI 10.5194/hess-8-235-2004; Hosking J.R.M., 1997, REGIONAL FREQUENCY A, DOI DOI 10.1017/CBO9780511529443; Kim KD, 2002, J HYDROL, V260, P176, DOI 10.1016/S0022-1694(01)00613-8; Kottegoda NT., 2008, APPL STAT CIVIL ENV; Kysely J, 2010, THEOR APPL CLIMATOL, V101, P345, DOI 10.1007/s00704-009-0190-1; Kysely J, 2008, J APPL METEOROL CLIM, V47, P3236, DOI 10.1175/2008JAMC1763.1; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Montanari A, 2007, HYDROL PROCESS, V21, P841, DOI 10.1002/hyp.6623; Olejnik S, 1997, J EDUC BEHAV STAT, V22, P389, DOI 10.3102/10769986022004389; Parida BP, 2008, PHYS CHEM EARTH, V33, P614, DOI 10.1016/j.pce.2008.06.011; Polansky AM, 2000, J STAT COMPUT SIM, V65, P63, DOI 10.1080/00949650008811990; Quintela-del-Rio A, 2011, HYDROL PROCESS, V25, P671, DOI 10.1002/hyp.7852; Quintela-del-Rio A, 2012, J STAT SOFTW, V50, P1; Quintela-del-Rio A, 2011, CHEMOSPHERE, V82, P800, DOI 10.1016/j.chemosphere.2010.11.025; Ramos MH, 2010, METEOROL APPL, V17, P223, DOI 10.1002/met.202; Serinaldi F, 2009, J HYDROL, V376, P528, DOI 10.1016/j.jhydrol.2009.07.065; Sharma A, 1997, WATER RESOUR RES, V33, P291, DOI 10.1029/96WR02839; Silverman B.W., 1986, DENSITY ESTIMATION S; Simonoff J.S., 1996, SMOOTING METHODS STA, V2nd; van den Boogaard HFP, 2004, HYDROL EARTH SYST SC, V8, P1174, DOI 10.5194/hess-8-1174-2004; VECCHIA AV, 1987, WATER RESOUR RES, V23, P1237, DOI 10.1029/WR023i007p01237; Viglione A., 2013, NSRFA NONSUPERVISED; Villarini G, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007645; Wand MP., 1994, KERNEL SMOOTHING	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147505	10.1371/journal.pone.0147505	http://dx.doi.org/10.1371/journal.pone.0147505			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828651	Green Submitted, gold, Green Published			2022-12-27	WOS:000369548200022
J	Luo, HX; Du, H; Maurer, K; Belinson, JL; Wang, GX; Liu, ZH; Zhang, LJ; Zhou, YQ; Wang, C; Tang, JL; Qu, XF; Wu, RF				Luo, Hongxue; Du, Hui; Maurer, Kathryn; Belinson, Jerome L.; Wang, Guixiang; Liu, Zhihong; Zhang, Lijie; Zhou, Yanqiu; Wang, Chun; Tang, Jinlong; Qu, Xinfeng; Wu, Ruifang			An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; HYBRID CAPTURE 2; HUMAN-PAPILLOMAVIRUS; CLINICAL-EVALUATION; FTA CARTRIDGE; RISK; SAMPLES; WOMEN; ACCURACY; TRIAL	Objectives Determine the ability of the Cobas 4800 assay to detect high-risk human papillomavirus (HrHPV) and high-grade cervical lesions when using cervico-vaginal samples applied to liquid medium and solid media cards compared to a direct cervical sample. Methods Two cervico-vaginal specimens (pseudo self-collected) were obtained from 319 women. One was applied to an iFTA Card (FTA) then the brush placed in liquid-based medium (LSELF); the other was applied to a new solid media: POI card (POI). The clinical performance of Cobas4800 assay using the three aforementioned specimens was compared to direct collected endocervical specimens in liquid media (LDOC). Results The overall agreements of HrHPV detection were 84.2% (LSELF vs. LDOC), 81.0%(FTA vs. LDOC), and 82.3% (POI vs. LDOC). LSELF, FTA and POI identified 98.0%, 79.6%, and 97.5% positive cases of LDOC. Sensitivity to identify CIN2+ were 98.4% (LSELF), 73.8% (FTA), 95.1%(POI), and 93.4%(LDOC) respectively. FTA had 78.1% and 90.4% agreement with the LSELF samples for all HrHPV and HPV16/18 detection respectively, while POI had 91.6% for both. Conclusions Cobas4800 HPV test combined with cervico-vaginal specimens applied to both liquid media and POI solid card are accurate to detect HrHPV infection and high-grade cervical lesions as compared with direct endocervical samples in liquid media.	[Luo, Hongxue; Du, Hui; Wang, Guixiang; Liu, Zhihong; Zhang, Lijie; Zhou, Yanqiu; Wang, Chun; Tang, Jinlong; Wu, Ruifang] Peking Univ, Dept Obstet Gynecol, Shenzhen Hosp, Shenzhen, Peoples R China; [Luo, Hongxue; Du, Hui; Wang, Guixiang; Liu, Zhihong; Zhang, Lijie; Zhou, Yanqiu; Wang, Chun; Tang, Jinlong; Wu, Ruifang] Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China; [Maurer, Kathryn; Belinson, Jerome L.] Cleveland Clin, Div Gynecol Oncol, Womens Hlth Inst, Cleveland, OH 44106 USA; [Belinson, Jerome L.; Qu, Xinfeng] Prevent Oncol Int, Cleveland Hts, OH USA	Peking University; Cleveland Clinic Foundation	Wu, RF (corresponding author), Peking Univ, Dept Obstet Gynecol, Shenzhen Hosp, Shenzhen, Peoples R China.; Wu, RF (corresponding author), Shenzhen Key Lab Technol Early Diag Major Gynecol, Shenzhen, Peoples R China.	wurfpush@126.com		Maurer, Kathryn/0000-0002-5917-0173	Shenzhen Municipal Science and Technical Innovation Committee, Shenzhen, PR China [JCYJ20140415162338808, GJHZ20130417100103783]; Preventive Oncology International, Inc., Cleveland, Heights, Ohio, USA	Shenzhen Municipal Science and Technical Innovation Committee, Shenzhen, PR China; Preventive Oncology International, Inc., Cleveland, Heights, Ohio, USA	The study was supported by Shenzhen Municipal Science and Technical Innovation Committee, Shenzhen, PR China (No. JCYJ20140415162338808 & No. GJHZ20130417100103783); and by Preventive Oncology International, Inc., Cleveland, Heights, Ohio, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais AG, 2007, INT J CANCER, V120, P1505, DOI 10.1002/ijc.22484; Belinson J, 2001, GYNECOL ONCOL, V83, P439, DOI 10.1006/gyno.2001.6370; Belinson JL, 2014, GYNECOL ONCOL, V132, P636, DOI 10.1016/j.ygyno.2014.01.006; Belinson JL, 2012, INT J CANCER, V130, P1855, DOI 10.1002/ijc.26202; Belinson JL, 2011, AM J CLIN PATHOL, V135, P790, DOI 10.1309/AJCPKA6ATAPBZ6JQ; Bos AB, 2006, INT J CANCER, V119, P2372, DOI 10.1002/ijc.22114; Castle PE, 2009, J CLIN MICROBIOL, V47, P3344, DOI 10.1128/JCM.00725-09; de Bie RP, 2011, J MOL DIAGN, V13, P371, DOI 10.1016/j.jmoldx.2011.02.003; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Geraets DT, 2013, J CLIN VIROL, V57, P125, DOI 10.1016/j.jcv.2013.02.016; Gilbert L, 2013, J CLIN MICROBIOL, V51, P3412, DOI 10.1128/JCM.01391-13; Gonzalez P, 2012, J CLIN MICROBIOL, V50, P3870, DOI 10.1128/JCM.01698-12; Guan YY, 2013, J VIROL METHODS, V189, P167, DOI 10.1016/j.jviromet.2012.11.010; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Haguenoer K, 2014, GYNECOL ONCOL, V134, P302, DOI 10.1016/j.ygyno.2014.05.026; Isidean SD, 2014, EXPERT REV MOL DIAGN, V14, P5, DOI 10.1586/14737159.2014.865521; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Lenselink CH, 2009, J CLIN MICROBIOL, V47, P2564, DOI 10.1128/JCM.00285-09; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Lindemann MLM, 2012, J MOL DIAGN, V14, P65, DOI 10.1016/j.jmoldx.2011.09.005; Maurer KA, 2015, J CLIN VIROL ACCEPTE; Ogilvie GS, 2005, SEX TRANSM INFECT, V81, P207, DOI 10.1136/sti.2004.011858; Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023; Porras C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju400; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stanczuk GA, 2015, J CLIN PATHOL, V68, P567, DOI 10.1136/jclinpath-2014-202851; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Tirumala Radhika, 2013, 9 CLIN VIR S APR 26; Waller J, 2006, J MED SCREEN, V13, P208, DOI 10.1177/096914130601300409; Wang SM, 2014, ASIAN PAC J CANCER P, V15, P7085, DOI 10.7314/APJCP.2014.15.17.7085; Wolfgramm ED, 2009, FORENSIC SCI INT-GEN, V3, P125, DOI 10.1016/j.fsigen.2008.11.008; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	37	6	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148168	10.1371/journal.pone.0148168	http://dx.doi.org/10.1371/journal.pone.0148168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828360	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200076
J	Ouyang, M; White, EE; Ren, H; Guo, Q; Zhang, I; Gao, H; Yanyan, S; Chen, XB; Weng, YM; Da Fonseca, A; Shah, S; Manuel, ER; Zhang, LY; Vonderfecht, SL; Alizadeh, D; Berlin, JM; Badie, B				Ouyang, Mao; White, Ethan E.; Ren, Hui; Guo, Qin; Zhang, Ian; Gao, Hang; Yanyan, Song; Chen, Xuebo; Weng, Yiming; Da Fonseca, Anna; Shah, Sunny; Manuel, Edwin R.; Zhang, Leying; Vonderfecht, Steven L.; Alizadeh, Darya; Berlin, Jacob M.; Badie, Behnam			Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model	PLOS ONE			English	Article							RECURRENT GLIOBLASTOMA; MICE; MELANOMA; DELIVERY; GROWTH; CANCER; CELLS; TRIAL; OLIGODEOXYNUCLEOTIDE; MACROPHAGES	Even when treated with aggressive current therapies, most patients with glioblastoma survive less than two years. Rapid tumor growth, an invasive nature, and the blood-brain barrier, which limits the penetration of large molecules into the brain, all contribute to the poor tumor response associated with conventional therapies. Immunotherapy has emerged as a therapeutic approach that may overcome these challenges. We recently reported that single-walled carbon nanotubes (SWCNTs) can be used to dramatically increase the immunotherapeutic efficacy of CpG oligonucleotides in a mouse model of glioma. Following implantation in the mouse brain, the tumor cell line used in these previous studies (GL261) tends to form a spherical tumor with limited invasion into healthy brain. In order to evaluate SWCNT/CpG therapy under more clinically-relevant conditions, here we report the treatment of a more invasive mouse glioma model (K-Luc) that better recapitulates human disease. In addition, a CpG sequence previously tested in humans was used to formulate the SWCNT/CpG which was combined with temozolomide, the standard of care chemotherapy for glioblastoma patients. We found that, following two intracranial administrations, SWCNT/CpG is well-tolerated and improves the survival of mice bearing invasive gliomas. Interestingly, the efficacy of SWCNT/CpG was enhanced when combined with temozolomide. This enhanced anti-tumor efficacy was correlated to an increase of tumor-specific cytotoxic activity in splenocytes. These results reinforce the emerging understanding that immunotherapy can be enhanced by combining it with chemotherapy and support the continued development of SWCNT/CpG.	[Ouyang, Mao] Cent S Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Hunan, Peoples R China; [White, Ethan E.; Berlin, Jacob M.] Irell & Manella Grad Sch Biol Sci City Hope, Duarte, CA 91010 USA; [White, Ethan E.; Weng, Yiming; Berlin, Jacob M.] City Hope Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Ren, Hui] Jilin Univ, Hosp 2, Dept Gen Surg, Changchun 130023, Jilin Province, Peoples R China; [Guo, Qin] Cent S Univ, Xiangya Hosp 3, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Zhang, Ian; Shah, Sunny; Zhang, Leying; Alizadeh, Darya; Badie, Behnam] City Hope Beckman Res Inst, Div Neurosurg, Duarte, CA 91010 USA; [Gao, Hang] Jilin Univ, Hosp 1, Dept Bone & Joint Surg, Changchun 130023, Jilin Province, Peoples R China; [Yanyan, Song] Jilin Univ, Hosp 2, Dept Nephrol, Changchun 130023, Jilin Province, Peoples R China; [Chen, Xuebo] Jilin Univ, China Japan Union Hosp, Dept Gen Surg, Changchun 130023, Jilin Province, Peoples R China; [Da Fonseca, Anna] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Morfogenese Celular, Rio De Janeiro, Brazil; [Manuel, Edwin R.] City Hope Beckman Res Inst, Dept Virol, Div Translat Vaccine Res, Duarte, CA 91010 USA; [Vonderfecht, Steven L.] City Hope Beckman Res Inst, Div Comparat Med, Duarte, CA 91010 USA; [Badie, Behnam] City Hope Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA	Central South University; City of Hope; Beckman Research Institute of City of Hope; Jilin University; Central South University; City of Hope; Beckman Research Institute of City of Hope; Jilin University; Jilin University; Jilin University; Universidade Federal do Rio de Janeiro; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Berlin, JM (corresponding author), Irell & Manella Grad Sch Biol Sci City Hope, Duarte, CA 91010 USA.; Berlin, JM (corresponding author), City Hope Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA.; Badie, B (corresponding author), City Hope Beckman Res Inst, Div Neurosurg, Duarte, CA 91010 USA.; Badie, B (corresponding author), City Hope Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA.	jberlin@coh.org; bbadie@coh.org	da Fonseca, Anna Carolina Carvalho/AAQ-7440-2020; da Fonseca, Anna Carolina Carvalho/C-5825-2015	da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; da Fonseca, Anna Carolina Carvalho/0000-0002-8366-3146; Manuel, Edwin/0000-0002-4602-7060	Kenneth T. and Eileen L. Norris Foundation; STOP Cancer; National Cancer Institute of the National Institutes of Health [P30CA33572];  [R01CA155769];  [R21CA189223];  [R21 NS081594]; NATIONAL CANCER INSTITUTE [R21CA189223, R01CA155769, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081594] Funding Source: NIH RePORTER	Kenneth T. and Eileen L. Norris Foundation; STOP Cancer; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank R01CA155769, R21CA189223, R21 NS081594, The Kenneth T. and Eileen L. Norris Foundation and STOP Cancer for research funding. Research reported in this publication included work performed in the Light Microscopy Digital Imaging Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572.	Alizadeh D, 2014, CANCER RES, V74, P2663, DOI 10.1158/0008-5472.CAN-14-0301; Alizadeh D, 2010, CLIN CANCER RES, V16, P3399, DOI 10.1158/1078-0432.CCR-09-3087; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Badie B, 2013, IMMUNOTHERAPY-UK, V5, P1, DOI [10.2217/IMT.12.148, 10.2217/imt.12.148]; Banissi C, 2009, CANCER IMMUNOL IMMUN, V58, P1627, DOI 10.1007/s00262-009-0671-1; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.005; Carpentier A, 2006, NEURO-ONCOLOGY, V8, P60, DOI 10.1215/S1522851705000475; Carpentier A, 2010, NEURO-ONCOLOGY, V12, P401, DOI 10.1093/neuonc/nop047; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Drezek RA, 2010, NAT NANOTECHNOL, V5, P168, DOI 10.1038/nnano.2010.37; Fadul CE, 2011, NEURO-ONCOLOGY, V13, P393, DOI 10.1093/neuonc/noq204; Fan HT, 2012, CLIN CANCER RES, V18, P5628, DOI 10.1158/1078-0432.CCR-12-1911; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Gomez GG, 2006, GENE THER MOL BIOL, V10A, P133; Hurt RH, 2006, CARBON, V44, P1028, DOI 10.1016/j.carbon.2005.12.023; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; Kim HK, 2012, BIOMACROMOLECULES, V13, P636, DOI 10.1021/bm2014119; Kolosnjaj-Tabi J, 2010, ACS NANO, V4, P1481, DOI 10.1021/nn901573w; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee TH, 2009, SCAND J IMMUNOL, V70, P85, DOI 10.1111/j.1365-3083.2009.02273.x; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Manuel ER, 2011, CANCER RES, V71, P4183, DOI 10.1158/0008-5472.CAN-10-4676; Morimoto Y, 2012, NANOTOXICOLOGY, V6, P766, DOI 10.3109/17435390.2011.620719; Neyns B, 2010, CANCER-AM CANCER SOC, V116, P2868, DOI 10.1002/cncr.25035; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Ridolfi L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-135; Sanchez-Perez LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059082; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Sengupta S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831090; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Terada K, 2006, GENE THER, V13, P705, DOI 10.1038/sj.gt.3302717; Weber JS, 2009, CANCER, V115, P3944, DOI 10.1002/cncr.24473; Yamashita K, 2010, INFLAMMATION, V33, P276, DOI 10.1007/s10753-010-9182-7; ZALIPSKY S, 1993, BIOCONJUGATE CHEM, V4, P296, DOI 10.1021/bc00022a008; Zhang LY, 2009, GLIA, V57, P1458, DOI 10.1002/glia.20863; Zhao DC, 2011, CLIN CANCER RES, V17, P771, DOI 10.1158/1078-0432.CCR-10-2444	38	28	28	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148139	10.1371/journal.pone.0148139	http://dx.doi.org/10.1371/journal.pone.0148139			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829221	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200069
J	Tam, CC; O'Brien, SJ				Tam, Clarence C.; O'Brien, Sarah J.			Economic Cost of Campylobacter, Norovirus and Rotavirus Disease in the United Kingdom	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; GUILLAIN-BARRE-SYNDROME; GENERAL-PRACTICE; ENTERIC PATHOGENS; ENGLAND; COMMUNITY; GASTROENTERITIS; IMPACT; SALMONELLA; BURDEN	Objectives To estimate the annual cost to patients, the health service and society of infectious intestinal disease (IID) from Campylobacter, norovirus and rotavirus. Design Secondary data analysis. Setting The United Kingdom population, 2008-9. Main outcome measures Cases and frequency of health services usage due to these three pathogens; associated healthcare costs; direct, out-of-pocket expenses; indirect costs to patients and caregivers. Results The median estimated costs to patients and the health service at 2008-9 prices were: Campylobacter 50 pound million (95% CI: 33m- pound 75m) pound, norovirus 81 pound million (95% CI: 63m- pound 106m) pound, rotavirus 25m pound (95% CI: 18m- pound 35m) pound. The costs per case were approximately 30 pound for norovirus and rotavirus, and 85 pound for Campylobacter. This was mostly borne by patients and caregivers through lost income or out-of-pocket expenditure. The cost of Campylobacter- related Guillain-Barre syndrome hospitalisation was 1.26 pound million (95% CI: 0.4m- pound 4.2m) pound. Conclusions Norovirus causes greater economic burden than Campylobacter and rotavirus combined. Efforts to control IID must prioritise norovirus. For Campylobacter, estimated costs should be considered in the context of expenditure to control this pathogen in agriculture, food production and retail. Our estimates, prior to routine rotavirus immunisation in the UK, provide a baseline vaccine cost-effectiveness analyses.	[Tam, Clarence C.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tam, Clarence C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [O'Brien, Sarah J.] Univ Liverpool, NIHR, Hlth Protect Res Unit Gastrointestinal Infect, Liverpool L69 3BX, Merseyside, England; [O'Brien, Sarah J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; University of Liverpool	Tam, CC (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.; Tam, CC (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	clarence_tam@nuhs.edu.sg		O'Brien, Sarah Jane/0000-0003-2896-8999; Tam, Clarence/0000-0003-1697-286X	Medical Research Council [MC_U122785837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ajene AN, 2013, J HEALTH POPUL NUTR, V31, P299; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Bernsen RAJAM, 2002, J NEUROL SCI, V201, P13, DOI 10.1016/S0022-510X(02)00158-2; Curtis L., 2009, UNIT COSTS HLTH SOCI; Department of Health, 2009, NHS REF COSTS 2008 9; Food Standards Agency, 2000, REP STUD INF INT DIS; Food Standards Agency, 2011, FOODB DIS STRAT 2010; Harris JP, 2007, VACCINE, V25, P3962, DOI 10.1016/j.vaccine.2007.02.072; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; Health & Social Care Information Centre, 2009, HOSP EP STAT ADM PAT; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lorgelly PK, 2008, EPIDEMIOL INFECT, V136, P34, DOI 10.1017/S0950268807008163; Morgan C, 2010, CURR MED RES OPIN, V26, P2449, DOI 10.1185/03007995.2010.518135; Munro J, 2001, EVALUATION NHS DIREC; Neal KR, 1997, BRIT MED J, V314, P779, DOI 10.1136/bmj.314.7083.779; NOEL JS, 1994, J CLIN PATHOL, V47, P67, DOI 10.1136/jcp.47.1.67; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882; Roberts JA, 2003, EPIDEMIOL INFECT, V130, P1, DOI 10.1017/S0950268802007690; Santos AC, 2011, EPIDEMIOL INFECT, V139, P742, DOI 10.1017/S0950268810001615; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tsai CP, 2007, J CLIN NEUROSCI, V14, P625, DOI 10.1016/j.jocn.2006.03.020; Wall P G, 1996, Commun Dis Rep CDR Rev, V6, pR93; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	25	60	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0138526	10.1371/journal.pone.0138526	http://dx.doi.org/10.1371/journal.pone.0138526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828435	gold, Green Accepted, Green Published			2022-12-27	WOS:000369548200001
J	Choung, RS; Marietta, EV; Van Dyke, CT; Brantner, TL; Rajasekaran, J; Pasricha, PJ; Wang, T; Bei, K; Krishna, K; Krishnamurthy, HK; Snyder, MR; Jayaraman, V; Murray, JA				Choung, Rok Seon; Marietta, Eric V.; Van Dyke, Carol T.; Brantner, Tricia L.; Rajasekaran, John; Pasricha, Pankaj J.; Wang, Tianhao; Bei, Kang; Krishna, Karthik; Krishnamurthy, Hari K.; Snyder, Melissa R.; Jayaraman, Vasanth; Murray, Joseph A.			Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide Microarrays	PLOS ONE			English	Article							ARRAYS; AUTOIMMUNITY; RECOGNITION; DISCOVERY; DIAGNOSIS; SERUM	Background Most antibodies recognize conformational or discontinuous epitopes that have a specific 3-dimensional shape; however, determination of discontinuous B-cell epitopes is a major challenge in bioscience. Moreover, the current methods for identifying peptide epitopes often involve laborious, high-cost peptide screening programs. Here, we present a novel microarray method for identifying discontinuous B-cell epitopes in celiac disease (CD) by using a silicon-based peptide array and computational methods. Methods Using a novel silicon-based microarray platform with a multi-pillar chip, overlapping 12-mer peptide sequences of all native and deamidated gliadins, which are known to trigger CD, were synthesized in situ and used to identify peptide epitopes. Results Using a computational algorithm that considered disease specificity of peptide sequences, 2 distinct epitope sets were identified. Further, by combining the most discriminative 3-mer gliadin sequences with randomly interpolated3- or 6-mer peptide sequences, novel discontinuous epitopes were identified and further optimized to maximize disease discrimination. The final discontinuous epitope sets were tested in a confirmatory cohort of CD patients and controls, yielding 99% sensitivity and 100% specificity. Conclusions These novel sets of epitopes derived from gliadin have a high degree of accuracy in differentiating CD from controls, compared with standard serologic tests. The method of ultra-high-density peptide microarray described here would be broadly useful to develop high-fidelity diagnostic tests and explore pathogenesis.	[Choung, Rok Seon; Marietta, Eric V.; Van Dyke, Carol T.; Brantner, Tricia L.; Murray, Joseph A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Rajasekaran, John; Wang, Tianhao; Bei, Kang; Krishna, Karthik; Krishnamurthy, Hari K.; Jayaraman, Vasanth] Vibrant Sci LLC, San Carlos, CA USA; [Pasricha, Pankaj J.] Johns Hopkins Univ, Ctr Neurogastroenterol, Baltimore, MD USA; [Snyder, Melissa R.] Mayo Clin, Div Clin Biochem & Immunol, Rochester, MN USA	Mayo Clinic; Johns Hopkins University; Mayo Clinic	Murray, JA (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA.	Murray.Joseph@mayo.edu	Choung, Rok Seon/GLT-1518-2022; Krishnamurthy, Hari/AAA-7882-2021	Krishnamurthy, Hari/0000-0002-7832-8423	Mayo Foundation; Vibrant Sciences LLC	Mayo Foundation; Vibrant Sciences LLC	JAM and RSC were supported by the Mayo Foundation. Vibrant Sciences LLC provided support in the form of salaries for authors JR, VJ, KB, TW, HKK and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aleanzi M, 2001, CLIN CHEM, V47, P2023; Ballew JT, 2013, P NATL ACAD SCI USA, V110, P19330, DOI 10.1073/pnas.1314792110; Beyer M, 2007, SCIENCE, V318, P1888, DOI 10.1126/science.1149751; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Dam CE, 2014, SCAND J CLIN LAB INV, V74, P506, DOI 10.3109/00365513.2014.908474; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gao XL, 2003, PROTEOMICS, V3, P2135, DOI 10.1002/pmic.200300597; Katz KD, 2011, AM J GASTROENTEROL, V106, P1333, DOI 10.1038/ajg.2011.21; Kijanka G, 2009, J PROTEOMICS, V72, P936, DOI 10.1016/j.jprot.2009.02.006; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Medical Advisory Secretariat, 2010, Ont Health Technol Assess Ser, V10, P1; Molberg O, 1997, SCAND J IMMUNOL, V46, P103, DOI 10.1046/j.1365-3083.1997.d01-93.x; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Osman AA, 2000, CLIN EXP IMMUNOL, V121, P248, DOI 10.1046/j.1365-2249.2000.01312.x; Osorio C, 2012, FUNCT INTEGR GENOMIC, V12, P417, DOI 10.1007/s10142-012-0287-y; Pawloski AR, 2007, J VAC SCI TECHNOL B, V25, P2537, DOI 10.1116/1.2794325; Price JV, 2012, NAT MED, V18, P1434, DOI 10.1038/nm.2913; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Solier C, 2014, PROTEOMICS, V14, P774, DOI 10.1002/pmic.201300334; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Szekely GJ, 2005, J CLASSIF, V22, P151, DOI 10.1007/s00357-005-0012-9; ten Dam M, 1998, CLIN EXP IMMUNOL, V114, P189; Walker MM, 2010, GASTROENTEROLOGY, V139, P112, DOI 10.1053/j.gastro.2010.04.007	27	12	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147777	10.1371/journal.pone.0147777	http://dx.doi.org/10.1371/journal.pone.0147777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824466	Green Published, gold			2022-12-27	WOS:000369528600060
J	Galas, A; Miszczyk, J				Galas, Aleksander; Miszczyk, Justyna			Aberrations Involving Chromosome 1 as a Possible Predictor of Odds Ratio for Colon Cancer - Results from the Krakow Case-Control Study	PLOS ONE			English	Article							COLORECTAL-CANCER; RISK; DAMAGE; LYMPHOCYTES; FREQUENCY; COHORT	Background There is still an open question how to predict colorectal cancer risk before any morphological changes appear in the colon. Objective The purpose was to investigate aberrations in chromosomes 1, 2 and 4 in peripheral blood lymphocytes analyzed by fluorescence in situ hybridization technique as a tool to assess the likelihood of colorectal cancer. Methods A hospital-based case-control study included 20 colon cancer patients and 18 hospital-based controls. Information about potential covariates was collected by interview. The frequency of stable and unstable chromosome aberrations in chromosome 1, 2 and 4 was assessed by fluorescence in situ hybridization technique. Results Colorectal cancer patients, as compared to controls, had a relatively higher frequency of chromosome 1 translocations (median: 3.5 versus 1.0/1000 cells, p = 0.006), stable aberrations (3.8 versus 1.0/1000 cells, p = 0.007) and total aberrations (p = 0.009). There were no differences observed for chromosomes 2 and 4. Our results showed an increase in the odds of having colon cancer by about 50-80% associated with an increase by 1/1000 cells in the number of chromosome 1 aberrations. Conclusions The results revealed that the frequency of chromosomal aberrations, especially translocations in chromosome 1, seems to be a promising method to show a colon cancer risk. Additionally, our study suggests the reasonableness of use of biomarkers such as chromosome 1 aberrations in peripheral blood lymphocytes in screening prevention programs for individuals at higher colon cancer risk to identify those who are at increased risk and require more frequent investigations, e.g. by sigmoidoscopy.	[Galas, Aleksander] Jagiellonian Univ, Coll Med, Dept Epidemiol, Krakow, Poland; [Miszczyk, Justyna] Polish Acad Sci, Dept Expt Phys Complex Syst, Inst Nucl Phys, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences	Galas, A (corresponding author), Jagiellonian Univ, Coll Med, Dept Epidemiol, Krakow, Poland.	aleksander.galas@uj.edu.pl; mygalas@cyf-kr.edu.pl	Miszczyk, Justyna/V-8614-2018; Miszczyk, Justyna/AAL-1493-2020; Galas, Aleksander/G-9887-2013	Miszczyk, Justyna/0000-0001-7226-1750; Miszczyk, Justyna/0000-0001-7226-1750; Galas, Aleksander/0000-0002-9233-4301	National Science Centre, Poland [NN404034039, DEC-2013/09/D/NZ7/00324]; Ministry of Science and Education [2P05D05329]	National Science Centre, Poland(National Science Centre, Poland); Ministry of Science and Education	This research project was funded by the National Science Centre, Poland in 2010-2013 (No. NN404034039) - the principal investigator Aleksander Galas MD, PhD. Presented results were partially supported by the data from Ministry of Science and Education project (No. 2P05D05329) - the principal investigator Prof. Wieslaw Jedrychowski, MD, PhD. Some of these investigations were carried out as part of an extended examination of the 250 kV X-rays at IFJ PAN by cytogenetic and molecular methods and were partially supported by Grant DEC-2013/09/D/NZ7/00324 from the National Science Centre, Poland, principal investigator Justyna Miszczyk, PhD.	Arranz N, 2007, CHEM-BIOL INTERACT, V169, P63, DOI 10.1016/j.cbi.2007.05.006; Beaton LA, 2013, INT J RADIAT BIOL, V89, P1087, DOI 10.3109/09553002.2013.825060; Bishop R, 2010, BIOSCI HORIZONS, V3, P85, DOI DOI 10.1093/BIOHORIZONS/HZQ009; Boffetta P, 2007, AM J EPIDEMIOL, V165, P36, DOI 10.1093/aje/kwj367; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS59, DOI 10.1093/ije/26.suppl_1.S59; Bonassi S, 2000, CANCER RES, V60, P1619; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; Chen W, 2013, MOL BIOL REP, V40, P3457, DOI 10.1007/s11033-012-2338-9; Fucic A, 2007, TOXICOL LETT, V172, P4, DOI 10.1016/j.toxlet.2007.05.015; Galas A, 2015, EUR J NUTR, V54, P161, DOI 10.1007/s00394-014-0697-9; Galas A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-134; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Hagmar L, 2004, CANCER RES, V64, P2258, DOI 10.1158/0008-5472.CAN-03-3360; Hagmar Lars, 2004, IARC Sci Publ, P207; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; International Atomic Energy Agency, 2011, CYT DOS APPL PREP RE; Jedrychowski W, 2009, DIETARY PREVENTION C; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lipton L, 2006, FAM CANCER, V5, P221, DOI 10.1007/s10689-005-5673-3; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Munoz-Bellvis L, 2012, MODERN PATHOL, V25, P590, DOI 10.1038/modpathol.2011.195; Munro AF, 2012, BRIT J CANCER, V107, P71, DOI 10.1038/bjc.2012.232; Norat T, 2014, CANCER TREAT RES, V159, P35, DOI 10.1007/978-3-642-38007-5_3; Ogino S, 2015, CANCER CAUSE CONTROL, V26, P959, DOI 10.1007/s10552-015-0596-2; Rossner P, 2005, ENVIRON HEALTH PERSP, V113, P517, DOI 10.1289/ehp.6925; Terdiman JP, 1999, AM J GASTROENTEROL, V94, P2344; Turkez H, 2012, TOXICOL IND HEALTH, V28, P648, DOI 10.1177/0748233711420471; Xiao XY, 2007, DIAGN MOL PATHOL, V16, P96, DOI 10.1097/PDM.0b013e31803190f2; Zhou CZ, 2008, CHINESE MED J-PEKING, V121, P2479, DOI 10.1097/00029330-200812020-00003	34	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147658	10.1371/journal.pone.0147658	http://dx.doi.org/10.1371/journal.pone.0147658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824604	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528600045
J	Nayar, M; Vanderstay, R; Siegert, RJ; Turner-Stokes, L				Nayar, Meenakshi; Vanderstay, Roxana; Siegert, Richard J.; Turner-Stokes, Lynne			The UK Functional Assessment Measure (UK FIM plus FAM): Psychometric Evaluation in Patients Undergoing Specialist Rehabilitation following a Stroke from the National UK Clinical Dataset	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; INJURY REHABILITATION; INDEPENDENCE MEASURE; BRAIN INJURY; DISABILITY; NEGLECT; FIM+FAM; VERSION; SCALE	The UK Functional Assessment Measure (UKFIM+FAM) is the principal outcome measure for the UK Rehabilitation Outcomes Collaborative (UKROC) national database for specialist rehabilitation. Previously validated in a mixed neurorehabilitation cohort, this study is the first to explore its psychometric properties in a stroke population, and compare left and right hemispheric strokes (LHS vs RHS). We analysed in-patient episode data from 62 specialist rehabilitation units collated through the UKROC database 2010-2013. Complete data were analysed for 1,539 stroke patients (LHS: 588, RHS: 566 with clear localisation). For factor analysis, admission and discharge data were pooled and randomised into two equivalent samples; the first for exploratory factor analysis (EFA) using principal components analysis, and the second for confirmatory factor analysis (CFA). Responsiveness for each subject (change from admission to discharge) was examined using paired t-tests and differences between LHS and RHS for the entire group were examined using non-paired t-tests. EFA showed a strong general factor accounting for >48% of the total variance. A three-factor solution comprising motor, communication and psychosocial subscales, accounting for >69% total variance, provided acceptable fit statistics on CFA (Root Mean Square Error of Approximation was 0.08 and Comparative Fit Index/Tucker Lewis Index 0.922/0.907). All three subscales showed significant improvement between admission and discharge (p<0.001) with moderate effect sizes (>0.5). Total scores between LHS and RHS were not significantly different. However, LHS showed significantly higher motor scores (Mean 5.7, 95%CI 2.7, 8.6 p<0.001), while LHS had significantly lower cognitive scores, primarily in the communication domain (-6.8 95%CI -7.7, -5.8 p<0.001). To conclude, the UK FIM+FAM has a three-factor structure in stroke, similar to the general neurorehabilitation population. It is responsive to change during in-patient rehabilitation, and distinguishes between LHS and RHS. This tool extends stroke outcome measurement beyond physical disability to include cognitive, communication and psychosocial function.	[Nayar, Meenakshi; Vanderstay, Roxana; Turner-Stokes, Lynne] Kings Coll London, Fac Life Sci & Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Nayar, Meenakshi; Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Hyper Acute Rehabil Unit RHRU, London, England; [Siegert, Richard J.] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Siegert, Richard J.] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Auckland, New Zealand	University of London; King's College London; Imperial College London; Auckland University of Technology; Auckland University of Technology	Turner-Stokes, L (corresponding author), Kings Coll London, Fac Life Sci & Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England.; Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Hyper Acute Rehabil Unit RHRU, London, England.	lynne.turner-stokes@dial.pipex.com	Turner-Stokes, Lynne/F-4418-2012; Siegert, Richard J./K-2030-2019	Turner-Stokes, Lynne/0000-0002-3302-9462; Siegert, Richard/0000-0002-3074-0929	National Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical Trust; National Institute for Health Research [ACF-2013-17-021, RP-PG-0407-10185] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme (RP-PG-0407-10185). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3167; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; British Society of Rehabilitation Medicine, 2015, SPEC NEUR SERV PROV; Byrne Barbara M., 2013, STRUCTURAL EQUATION; COTE R, 1989, NEUROLOGY, V39, P638, DOI 10.1212/WNL.39.5.638; DEHAAN R, 1993, STROKE, V24, P1178, DOI 10.1161/01.STR.24.8.1178; Hadian MR, 2012, NEUROL NEUROCHIR POL, V46, P351, DOI 10.5114/ninp.2012.30268; Hall K.M., 1993, J HEAD TRAUMA REHAB, DOI [10.1097/00001199-199308020-00008, DOI 10.1097/00001199-199308020-00008]; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Hillis AE, 2003, STROKE, V34, P2392, DOI 10.1161/01.STR.0000089681.84041.69; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Intercollegiate Stroke Working Party, 2011, NAT SENT STROK CLIN; Jorge LL, 2011, INT J REHABIL RES, V34, P89, DOI 10.1097/MRR.0b013e32833ba55f; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Law J, 2009, DISABIL REHABIL, V31, P825, DOI 10.1080/09638280802355049; Linn R T, 1999, J Outcome Meas, V3, P339; Miki E, 2015, SCAND J OCCUP THER, V13, P1; Nilsson AL, 2011, J REHABIL MED, V43, P884, DOI 10.2340/16501977-0871; Ringman JM, 2004, NEUROLOGY, V63, P468, DOI 10.1212/01.WNL.0000133011.10689.CE; Spector P., 1994, SUMMATED RATING SCAL; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thompson B, 2004, EXPLORATORY CONFIRMA; Turner-Stokes L, 2002, DISABIL REHABIL, V24, P383, DOI 10.1080/096382801101550; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 2013, DISABIL REHABIL, V35, P1885, DOI 10.3109/09638288.2013.766271; Turner-Stokes L, 2012, DISABIL REHABIL, V34, P1871, DOI 10.3109/09638288.2012.670033; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Ween JE, 1996, NEUROLOGY, V47, P388, DOI 10.1212/WNL.47.2.388	31	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147288	10.1371/journal.pone.0147288	http://dx.doi.org/10.1371/journal.pone.0147288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824696	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600022
J	Roussel, M; Martinaud, O; Henon, H; Vercelletto, M; Bindschadler, C; Joseph, PA; Robert, P; Labauge, P; Godefroy, O				Roussel, Martine; Martinaud, Olivier; Henon, Hilde; Vercelletto, Martine; Bindschadler, Claire; Joseph, Pierre-Alain; Robert, Philippe; Labauge, Pierre; Godefroy, Olivier		GREFEX Study Grp	The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX Study	PLOS ONE			English	Article							IMPAIRMENT HARMONIZATION STANDARDS; MINI-MENTAL-STATE; POSTSTROKE DEPRESSION; FUNCTIONAL RECOVERY; APATHY; DYSFUNCTION; DEMENTIA; VALIDATION; FREQUENCY; INFARCTS	Background Many studies have highlighted the high prevalence of executive disorders in stroke. However, major uncertainties remain due to use of variable and non-validated methods. The objectives of this study were: 1) to characterize the executive disorder profile in stroke using a standardized battery, validated diagnosis criteria of executive disorders and validated framework for the interpretation of neuropsychological data and 2) examine the sensitivity of the harmonization standards protocol proposed by the National Institute of Neurological Disorders and Stroke and Canadian Stroke Network (NINDS-CSN) for the diagnosis of Vascular Cognitive Impairment. Methods 237 patients (infarct: 57; cerebral hemorrhage: 54; ruptured aneurysm of the anterior communicating artery (ACoA): 80; cerebral venous thrombosis (CVT): 46) were examined by using the GREFEX battery. The patients' test results were interpreted with a validated framework derived from normative data from 780 controls. Results Dysexecutive syndrome was observed in 88 (55.7%; 95%CI: 48-63.4) out of the 156 patients with full cognitive and behavioral data: 40 (45.5%) had combined behavioral and cognitive syndromes, 29 (33%) had a behavioral disorder alone and 19 (21.6%) had a cognitive syndrome alone. The dysexecutive profile was characterized by prominent impairments of initiation and generation in the cognitive domain and by hypoactivity with disinterest and anticipation loss in the behavioral domain. Cognitive impairment was more frequent (p = 0.014) in hemorrhage and behavioral disorders were more frequent (p = 0.004) in infarct and hemorrhage. The harmonization standards protocol underestimated (p = 0.007) executive disorders in CVT or ACoA. Conclusions This profile of executive disorders implies that the assessment should include both cognitive tests and a validated inventory for behavioral dysexecutive syndrome. Initial assessment may be performed with a short cognitive battery, such as the harmonization standards protocol. However, administration of a full cognitive battery is required in selected patients.	[Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Dept Neurol, Amiens, France; [Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Lab Funct Neurosci EA 4559, SFR CAP Sante FED 4231, Amiens, France; [Martinaud, Olivier] Univ Hosp Rouen, Dept Neurol, Rouen, France; [Henon, Hilde] Univ Hosp Lille, Dept Neurol, Lille, France; [Vercelletto, Martine] Univ Hosp Nantes, Res Memory Ctr, Nantes, France; [Bindschadler, Claire] Univ Lausanne Hosp, Dept Neuropsychol & Neurorehabilitat, Lausanne, Switzerland; [Joseph, Pierre-Alain] Univ Bordeaux, Res Grp EA Handicap & Nervous Syst Dis 4136, Bordeaux, France; [Robert, Philippe] Univ Nice Sophia Antipolis, CoBTeK Res Memory Ctr CHU, F-06189 Nice, France; [Labauge, Pierre] Univ Nimes Hosp, Dept Neurol, F-30006 Nimes, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Rouen; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); UDICE-French Research Universities; Universite de Bordeaux; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Nimes	Roussel, M (corresponding author), Univ Hosp Amiens, Dept Neurol, Amiens, France.; Roussel, M (corresponding author), Univ Hosp Amiens, Lab Funct Neurosci EA 4559, SFR CAP Sante FED 4231, Amiens, France.	roussel.martine@chu-amiens.fr	LEYS, Didier/G-2955-2016; Martinaud, Olivier/AAS-9307-2020	LEYS, Didier/0000-0003-4408-4392; Verny, Marc/0000-0001-7960-9705; Godefroy, Olivier/0000-0001-6789-6620				Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Benton AL, 1994, MULTILINGUAL APHASIA; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brodaty H, 2005, PSYCHOL MED, V35, P1707, DOI 10.1017/S0033291705006173; Bugnicourt JM, 2013, J NEUROL, V260, P1324, DOI 10.1007/s00415-012-6799-5; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Chabriat H, 2013, BEHAV COGNITIVE NEUR, P387; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia PY, 2013, J STROKE CEREBROVASC, V22, P80, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.013; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Godefroy O, 2002, NEUROPSYCHOLOGIA, V40, P2234, DOI 10.1016/S0028-3932(02)00109-4; GODEFROY O, 1992, ARCH NEUROL-CHICAGO, V49, P1285, DOI 10.1001/archneur.1992.00530360087023; Godefroy O, 2014, CORTEX, V54, P51, DOI 10.1016/j.cortex.2014.01.016; Godefroy O, 2012, INT J STROKE, V7, P362, DOI 10.1111/j.1747-4949.2012.00794.x; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Godefroy O, 2010, CEREBROVASC DIS, V29, P508, DOI 10.1159/000297968; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; Martinaud O, 2009, EUR J NEUROL, V16, P595, DOI 10.1111/j.1468-1331.2009.02546.x; Mayo NE, 2009, STROKE, V40, P3299, DOI 10.1161/STROKEAHA.109.554410; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nyenhuis D, 2013, BEHAV COGNITIVE NEUR, P410; Oveisgharan S, 2015, J NEUROL SCI, V349, P161, DOI 10.1016/j.jns.2015.01.010; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reyes S, 2009, NEUROLOGY, V72, P905, DOI 10.1212/01.wnl.0000344166.03470.f8; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Sala SD, 1995, ANN NY ACAD SCI, V769, P161, DOI 10.1111/j.1749-6632.1995.tb38137.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilson B.A., 1996, BEHAV ASSESSMENT DYS	42	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147602	10.1371/journal.pone.0147602	http://dx.doi.org/10.1371/journal.pone.0147602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824746	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600039
J	Szamado, S; Szalai, F; Scheuring, I				Szamado, Szabolcs; Szalai, Ferenc; Scheuring, Istvan			Deception Undermines the Stability of Cooperation in Games of Indirect Reciprocity	PLOS ONE			English	Article							GOSSIP; MIMICRY; REPUTATION; EVOLUTION; COMMUNICATION	Indirect reciprocity is often claimed as one of the key mechanisms of human cooperation. It works only if there is a reputational score keeping and each individual can inform with high probability which other individuals were good or bad in the previous round. Gossip is often proposed as a mechanism that can maintain such coherence of reputations in the face of errors of transmission. Random errors, however, are not the only source of uncertainty in such situations. The possibility of deceptive communication, where the signallers aim to misinform the receiver cannot be excluded. While there is plenty of evidence for deceptive communication in humans the possibility of deception is not yet incorporated into models of indirect reciprocity. Here we show that when deceptive strategies are allowed in the population it will cause the collapse of the coherence of reputations and thus in turn it results the collapse of cooperation. This collapse is independent of the norms and the cost and benefit values. It is due to the fact that there is no selection for honest communication in the framework of indirect reciprocity. It follows that indirect reciprocity can be only proposed plausibly as a mechanism of human cooperation if additional mechanisms are specified in the model that maintains honesty.	[Szamado, Szabolcs; Scheuring, Istvan] MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Szamado, Szabolcs] Hungarian Acad Sci, Ctr Social Sci, Orszaghaz U 30, H-1014 Budapest, Hungary; [Szalai, Ferenc] Engame Acad, Bajcsy Zsilinszky U 50, H-1054 Budapest, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Social Sciences	Szamado, S (corresponding author), MTA ELTE Theoret Biol & Evolutionary Ecol Res Grp, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.; Szamado, S (corresponding author), Hungarian Acad Sci, Ctr Social Sci, Orszaghaz U 30, H-1014 Budapest, Hungary.	szamszab@ludens.elte.hu	Számadó, Szabolcs/A-9804-2013; Scheuring, Istvan/A-5368-2011	Számadó, Szabolcs/0000-0003-2204-9705; Scheuring, Istvan/0000-0002-8108-8897	OTKA [112929, K100299]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	SzSz is supported by grant OTKA 112929. IS is supported by grant OTKA K100299; http://www.otka.hu/en.	ADAMS ES, 1990, ANIM BEHAV, V39, P706, DOI 10.1016/S0003-3472(05)80382-3; ADAMS ES, 1995, J THEOR BIOL, V175, P405, DOI 10.1006/jtbi.1995.0151; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; Backwell PRY, 2000, P ROY SOC B-BIOL SCI, V267, P719, DOI 10.1098/rspb.2000.1062; Beersma B, 2011, SOC PSYCHOL PERS SCI, V2, P642, DOI 10.1177/1948550611405073; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036260; Cong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035776; DOMINEY WJ, 1980, NATURE, V284, P546, DOI 10.1038/284546a0; Ellingsen T, 2008, EVOL HUM BEHAV, V29, P100, DOI 10.1016/j.evolhumbehav.2007.11.001; FISHER ME, 1988, IBM J RES DEV, V32, P76, DOI 10.1147/rd.321.0076; Hauber ME, 2007, BEHAV ECOL SOCIOBIOL, V61, P497, DOI 10.1007/s00265-006-0291-0; Hess NH, 2006, HUM NATURE-INT BIOS, V17, P337, DOI 10.1007/s12110-006-1013-z; JOHNSTONE RA, 1993, ANIM BEHAV, V46, P759, DOI 10.1006/anbe.1993.1253; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; LLOYD JE, 1965, SCIENCE, V149, P653, DOI 10.1126/science.149.3684.653; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nakamaru M, 2004, EVOL ECOL RES, V6, P261; Nakamura M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002113; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Piazza J, 2008, EVOL HUM BEHAV, V29, P172, DOI 10.1016/j.evolhumbehav.2007.12.002; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Redner S, 2001, GUIDE 1 PASSAGE PROC; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Sigmund K, 2012, J THEOR BIOL, V299, P25, DOI 10.1016/j.jtbi.2011.03.024; SMITH JM, 1991, ANIM BEHAV, V42, P1034, DOI 10.1016/S0003-3472(05)80161-7; Sommerfeld RD, 2008, P ROY SOC B-BIOL SCI, V275, P2529, DOI 10.1098/rspb.2008.0762; Sommerfeld RD, 2007, P NATL ACAD SCI USA, V104, P17435, DOI 10.1073/pnas.0704598104; STOWE MK, 1987, SCIENCE, V236, P964, DOI 10.1126/science.236.4804.964; Suzuki S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01435; Szalai F, 2009, ANIM BEHAV, V78, P949, DOI 10.1016/j.anbehav.2009.06.025; Szamado S, 2000, ANIM BEHAV, V59, P221, DOI 10.1006/anbe.1999.1293; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218	35	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147623	10.1371/journal.pone.0147623	http://dx.doi.org/10.1371/journal.pone.0147623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824895	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600041
J	Qu, SJ; Ji, Y				Qu, Shaojian; Ji, Ying			The Worst-Case Weighted Multi-Objective Game with an Application to Supply Chain Competitions	PLOS ONE			English	Article							PARETO EQUILIBRIA; WELL-POSEDNESS; ROBUST; OPTIMIZATION	In this paper, we propose a worst-case weighted approach to the multi-objective n-person non-zero sum game model where each player has more than one competing objective. Our "worst-case weighted multi-objective game" model supposes that each player has a set of weights to its objectives and wishes to minimize its maximum weighted sum objectives where the maximization is with respect to the set of weights. This new model gives rise to a new Pareto Nash equilibrium concept, which we call "robust-weighted Nash equilibrium". We prove that the robust-weighted Nash equilibria are guaranteed to exist even when the weight sets are unbounded. For the worst-case weighted multi-objective game with the weight sets of players all given as polytope, we show that a robust-weighted Nash equilibrium can be obtained by solving a mathematical program with equilibrium constraints (MPEC). For an application, we illustrate the usefulness of the worst-case weighted multiobjective game to a supply chain risk management problem under demand uncertainty. By the comparison with the existed weighted approach, we show that our method is more robust and can be more efficiently used for the real-world applications.	[Qu, Shaojian; Ji, Ying] Univ Shanghai Sci & Technol, Sch Business, Room 721,516 Jungong Rd, Shanghai 200093, Peoples R China; [Ji, Ying] Natl Univ Singapore, Logist Inst Asia Pacific, Singapore 117548, Singapore	University of Shanghai for Science & Technology; National University of Singapore	Qu, SJ (corresponding author), Univ Shanghai Sci & Technol, Sch Business, Room 721,516 Jungong Rd, Shanghai 200093, Peoples R China.	qushaojian@163.com						Adida E, 2011, OPER RES, V59, P156, DOI 10.1287/opre.1100.0863; Aghassi M, 2006, MATH PROGRAM, V107, P231, DOI 10.1007/s10107-005-0686-0; Ben-Tal A, 1998, MATH OPER RES, V23, P769, DOI 10.1287/moor.23.4.769; Blackwell David, 1956, PAC J MATH, V6, P1, DOI [10.2140/pjm.1956.6.1, DOI 10.2140/PJM.1956.6.1]; Borm P, 1999, MATH METHOD OPER RES, V49, P401, DOI 10.1007/s001860050057; Borm PEM., 1989, METH OPER RES, V60, P303; Corbett CJ, 2001, MANAGE SCI, V47, P966, DOI 10.1287/mnsc.47.7.966.9799; Deb K, 2006, EVOL COMPUT, V14, P463, DOI 10.1162/evco.2006.14.4.463; Ferris MC, 2000, J ECON DYN CONTROL, V24, P165, DOI 10.1016/S0165-1889(98)00092-X; Fletcher R, 2006, SIAM J OPTIMIZ, V17, P259, DOI 10.1137/S1052623402407382; Goh J, 2011, OPER RES, V59, P973, DOI 10.1287/opre.1110.0944; Hu J, 2012, OPER RES, V60, P936, DOI 10.1287/opre.1120.1071; Jian JB, 2006, APPL MATH OPT, V54, P17, DOI 10.1007/s00245-005-0848-8; Kakutani S., 1941, DUKE MATH J, P457, DOI DOI 10.1215/S0012-7094-41-00838-4; Kardes E, 2011, OPER RES, V59, P365, DOI 10.1287/opre.1110.0931; Lau AHL, 2005, EUR J OPER RES, V161, P203, DOI 10.1016/j.ejor.2003.08.040; Lindroth P, 2009, PREPRINT, P31; Meng XK, 2015, PHYS LETT A, V379, P767, DOI 10.1016/j.physleta.2014.12.051; Morgan J, 2005, ANN OPER RES, V137, P257, DOI 10.1007/s10479-005-2260-9; Peng JW, 2011, J OPTIMIZ THEORY APP, V150, P416, DOI 10.1007/s10957-011-9839-x; Qu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138970; Qu SJ, 2013, DISTRIBUTIONAL UNPUB; Radjef MS, 2008, APPL MATH LETT, V21, P1105, DOI 10.1016/j.aml.2007.12.009; Shapley L.S., 1959, NAV RES LOG Q, V6, P57, DOI [10.1002/nav.3800060107, DOI 10.1002/NAV.3800060107]; Soares GL, 2009, NONLINEAR ANAL-THEOR, V71, pE1818, DOI 10.1016/j.na.2009.02.077; Soares GL, 2009, IEEE T MAGN, V45, P1028, DOI 10.1109/TMAG.2009.2012563; WANG SY, 1993, J OPTIMIZ THEORY APP, V79, P373, DOI 10.1007/BF00940586; WEBER M, 1993, EUR J OPER RES, V67, P1, DOI 10.1016/0377-2217(93)90318-H; WHITE DJ, 1980, J OPER RES SOC, V31, P517, DOI 10.1057/jors.1980.95; White DJ, 1998, EUR J OPER RES, V105, P457, DOI 10.1016/S0377-2217(97)00056-8; WHITE DJ, 1990, J OPER RES SOC, V41, P669; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Yu J, 1998, COMPUT MATH APPL, V35, P17, DOI 10.1016/S0898-1221(98)00053-4; Yuan XZ, 1996, J MATH ANAL APPL, V204, P156, DOI 10.1006/jmaa.1996.0429; ZHAO J, 1991, INT J GAME THEORY, V20, P171, DOI 10.1007/BF01240277	37	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147341	10.1371/journal.pone.0147341	http://dx.doi.org/10.1371/journal.pone.0147341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820512	gold, Green Published			2022-12-27	WOS:000369528400020
J	Moseholm, E; Rydahl-Hansen, S; Lindhardt, BO				Moseholm, Ellen; Rydahl-Hansen, Susan; Lindhardt, Bjarne Orskov			Undergoing Diagnostic Evaluation for Possible Cancer Affects the Health-Related Quality of Life in Patients Presenting with Non-Specific Symptoms	PLOS ONE			English	Article							EORTC QLQ-C30; REFERENCE-VALUES; GENERAL-PRACTICE; LUNG-CANCER; GP SURVEY; POPULATION; QUESTIONNAIRE; INTERVALS; IMPLEMENTATION; MORBIDITY	Aim Undergoing diagnostic evaluation for possible cancer can affect health-related quality of life (HRQoL). The aims of this study were to examine the HRQoL in patients undergoing a diagnostic evaluation for possible cancer due to non-specific symptoms and further to investigate the impact of socio-demographic and medical factors associated with HRQoL at the time of diagnosis. Methods This was a prospective, multicenter survey study that included patients who were referred for a diagnostic evaluation due to non-specific cancer symptoms. Participants completed the EORTC-QLQ-C30 quality of life scale before and after completing the diagnostic evaluation. The baseline and follow-up EORTC-QLQ-C30 scores were compared with reference populations. The impact of socio-demographic and medical factors on HRQoL at follow-up was explored by bootstrapped multivariate linear regression. Results A total of 838 patients participated in the study; 680 (81%) also completed follow-up. Twenty-two percent of the patients received a cancer diagnosis at the end of follow-up. Patients presented initially with a high burden of symptoms, less role and emotional functioning and a lower global health/QoL. Most domains improved after diagnosis and no clinically important difference between baseline and follow-up scores was found. Patients reported effects on HRQoL both at baseline and at follow-up compared with the Danish reference population and had similar scores as a cancer reference population. Co-morbidity, being unemployed and receiving a cancer diagnosis had the greatest effect on HRQoL around the time of diagnosis. Conclusions Patients with non-specific symptoms reported an affected HRQoL while undergoing a diagnostic evaluation for possible cancer. Morbidity, being unemployed and receiving a cancer diagnosis had the greatest effect on HRQoL around the time of diagnosis.	[Moseholm, Ellen] Copenhagen Univ Hosp, Dept Pulm & Infect Dis, Hillerod, Denmark; [Rydahl-Hansen, Susan] Bispebjerg & Frederiksberg Univ Hosp, Res Unit Clin Nursing, Copenhagen, Denmark; [Rydahl-Hansen, Susan] Aarhus Univ, Dept Publ Hlth, Sect Nursing, Aarhus, Denmark; [Lindhardt, Bjarne Orskov] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Aarhus University; University of Copenhagen	Moseholm, E (corresponding author), Copenhagen Univ Hosp, Dept Pulm & Infect Dis, Hillerod, Denmark.	elar0073@regionh.dk		Rydahl-Hansen, Susan/0000-0001-6902-6485; Moseholm, Ellen/0000-0002-7195-8641	Novo Nordisk Foundation [NNF13OC0006093]; Copenhagen University Hospital, Nordsjaelland; Novo Nordisk Fonden [NNF13OC0006093] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Copenhagen University Hospital, Nordsjaelland; Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding was received from the Novo Nordisk Foundation (NNF13OC0006093) and Copenhagen University Hospital, Nordsjaelland (Research grant 2013): EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shakhli H, 2006, J PLAST RECONSTR AES, V59, P479, DOI 10.1016/j.bjps.2005.01.010; [Anonymous], 2012, DIAGN PAKK PAT MED U; Brocken P, 2015, PSYCHO-ONCOLOGY, V24, P433, DOI 10.1002/pon.3660; Brocken P, 2012, PSYCHO-ONCOLOGY, V21, P1, DOI 10.1002/pon.1929; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choung RS, 2013, J PUBLIC HEALTH-HEID, V21, P87, DOI 10.1007/s10389-012-0513-z; Derogar M, 2012, ACTA ONCOL, V51, P10, DOI 10.3109/0284186X.2011.614636; Fayers P, 2001, EORTC QLQ C30 SCORIN; Fayers PM, 2001, EUR J CANCER, V37, P1331, DOI 10.1016/S0959-8049(01)00127-7; Fossa SD, 2007, ACTA ONCOL, V46, P452, DOI 10.1080/02841860601182641; Harcourt D, 1998, BREAST, V7, P314, DOI 10.1016/S0960-9776(98)90073-X; Hjermstad M J, 1998, EUR J CANCER, V34; Hjermstad MJ, 1998, J CLIN ONCOL, V16, P1188, DOI 10.1200/JCO.1998.16.3.1188; Ingeman ML, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1424-5; Jensen H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1317-7; Jensen H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-636; Juul T, 2014, QUAL LIFE RES, V23, P2183, DOI 10.1007/s11136-014-0675-y; Klee M, 1997, QUAL LIFE RES, V6, P27; Lheureux M, 2004, LUNG CANCER, V43, P175, DOI 10.1016/j.lungcan.2003.08.018; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Meechan D, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654551; Michelson H, 2000, ACTA ONCOL, V39, P477; Montazeri A, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-21; Montazeri A, 2003, QUAL LIFE RES, V12, P157, DOI 10.1023/A:1022232624891; Montazeri A, 2008, BMC CANCER, V8; Mounter PJ, 1999, POSTGRAD MED J, V75, P2, DOI 10.1136/pgmj.75.879.2; Neal RD, 2014, BRIT J CANCER, V110, P584, DOI 10.1038/bjc.2013.791; Nielsen Tine Norgaard, 2010, Ugeskr Laeger, V172, P2827; Olesen F, 2009, BRIT J CANCER, V101, pS5, DOI 10.1038/sj.bjc.6605383; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Poole K, 1997, J ADV NURS, V25, P273, DOI 10.1046/j.1365-2648.1997.1997025273.x; Probst HB, 2012, HEALTH POLICY, V105, P65, DOI 10.1016/j.healthpol.2011.11.001; Schwarz R, 2001, EUR J CANCER, V37, P1345, DOI 10.1016/S0959-8049(00)00447-0; Scott NW, 2008, EORTC QLQ C30 REF VA; Stover AM, 2014, CANCER-AM CANCER SOC, V120, P1881, DOI 10.1002/cncr.28649; Torring ML, 2013, EUR J CANCER, V49, P2187, DOI 10.1016/j.ejca.2013.01.025; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P667, DOI 10.1016/j.ejca.2010.11.004	38	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148463	10.1371/journal.pone.0148463	http://dx.doi.org/10.1371/journal.pone.0148463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840866	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200139
J	Vinjamur, DS; Alhashem, YN; Mohamad, SF; Amin, P; Williams, DC; Lloyd, JA				Vinjamur, Divya S.; Alhashem, Yousef N.; Mohamad, Safa F.; Amin, Parth; Williams, David C., Jr.; Lloyd, Joyce A.			Kruppel-Like Transcription Factor KLF1 Is Required for Optimal gamma- and beta-Globin Expression in Human Fetal Erythroblasts	PLOS ONE			English	Article							HUMAN ERYTHROID-CELLS; FACTOR EKLF; HEMOGLOBIN EXPRESSION; GENE; ERYTHROPOIESIS; BCL11A; ROLES; MICE; DIFFERENTIATION; THALASSEMIA	In human adult erythroid cells, lower than normal levels of Kruppel-like transcription factor 1 (KLF1) are generally associated with decreased adult beta- and increased fetal.-globin gene expression. KLF1 also regulates BCL11A, a known repressor of adult gamma-globin expression. In seeming contrast to the findings in adult cells, lower amounts of KLF1 correlate with both reduced embryonic and reduced fetal beta-like globin mRNA in mouse embryonic erythroid cells. The role of KLF1 in primary human fetal erythroid cells, which express both gamma- and gamma-globin mRNA, is less well understood. Therefore, we studied the role of KLF1 in ex vivo differentiated CD34+ umbilical cord blood cells (UCB erythroblasts), representing the fetal milieu. In UCB erythroblasts, KLF1 binds to the beta-globin locus control region (LCR), and the beta-globin promoter. There is very little KLF1 binding detectable at the.-globin promoter. Correspondingly, when cultured fetal UCB erythroblasts are subjected to lentiviral KLF1 knockdown, the active histone mark H3K4me3 and RNA pol II recruitment are diminished at the beta-but not the.-globin gene. The amount of KLF1 expression strongly positively correlates with gamma-globin mRNA and weakly positively correlates with BCL11AmRNA. With modest KLF1 knockdown, mimicking haplo insufficiency, gamma-globin mRNA is increased in UCB erythroblasts, as is common in adult cells. However, a threshold level of KLF1 is evidently required, or there is no absolute increase in gamma-globinmRNA in UCB erythroblasts. Therefore, the role of KLF1 in.-globin regulation in fetal erythroblasts is complex, with both positive and negative facets. Furthermore, in UCB erythroblasts, diminished BCL11A is not sufficient to induce.-globin in the absence of KLF1. These findings have implications for the manipulation of BCL11A and/or KLF1 to induce gamma-globin for therapy of the beta-hemoglobinopathies.	[Vinjamur, Divya S.; Alhashem, Yousef N.; Mohamad, Safa F.; Amin, Parth; Lloyd, Joyce A.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Williams, David C., Jr.; Lloyd, Joyce A.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Williams, David C., Jr.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Williams, David C., Jr.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lloyd, JA (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA.; Lloyd, JA (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA.	jlloyd@vcu.edu		Vinjamur, Divya/0000-0002-9369-0412; Mohamad, Safa/0000-0002-6676-7912; Alhashem, Yousef N./0000-0003-4435-3003	National Institutes of Health [R01DK074694, R56DK097907]; NIH-NCI Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK097907, R01DK074694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health R01DK074694 and R56DK097907 to JAL. Services and products in support of the research project were generated by the VCU Massey Cancer Center Flow Cytometry Shared Resource, supported, in part, with funding from NIH-NCI Cancer Center Support Grant P30 CA016059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhashem YN, 2011, J BIOL CHEM, V286, P24819, DOI 10.1074/jbc.M111.247536; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Esteghamat F, 2013, BLOOD, V121, P2553, DOI 10.1182/blood-2012-06-434530; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Grieco AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129431; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Liu D, 2014, BLOOD, V124, P803, DOI 10.1182/blood-2014-03-561779; Magor GW, 2015, BLOOD; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Satta S, 2011, HAEMATOL-HEMATOL J, V96, P767, DOI 10.3324/haematol.2010.037333; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Tallack MR, 2012, GENOME RES, V22, P2385, DOI 10.1101/gr.135707.111; Trakarnsanga K, 2014, HAEMATOLOGICA, V99, P1677, DOI 10.3324/haematol.2014.110155; Vinjamur DS, 2014, HAEMATOLOGICA, V99, P1565, DOI 10.3324/haematol.2014.104943; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhou DW, 2006, J BIOL CHEM, V281, P16052, DOI 10.1074/jbc.M601182200; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	28	11	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146802	10.1371/journal.pone.0146802	http://dx.doi.org/10.1371/journal.pone.0146802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840243	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200015
J	Zhang, DL; Chen, DF; Cao, LR; Li, GH; Cheng, H				Zhang, Dinglin; Chen, Danfeng; Cao, Liaoran; Li, Guohui; Cheng, Hong			The Effect of Codon Mismatch on the Protein Translation System	PLOS ONE			English	Article							PEPTIDE-BOND FORMATION; TRANSFER-RNAS; RIBOSOMAL-SUBUNITS; ELONGATION; SEQUENCE; YEAST; DETERMINANTS; EFFICIENCY; INITIATION; GENES	Incorrect protein translation, caused by codon mismatch, is an important problem of living cells. In this work, a computational model was introduced to quantify the effects of codon mismatch and the model was used to study the protein translation of Saccharomyces cerevisiae. According to simulation results, the probability of codon mismatch will increase when the supply of amino acids is unbalanced, and the longer is the codon sequence, the larger is the probability for incorrect translation to occur, making the synthesis of long peptide chain difficult. By comparing to simulation results without codon mismatch effects taken into account, the fraction of mRNAs with bound ribosome decrease faster along the mRNAs, making the 5' ramp phenomenon more obvious. It was also found in our work that the premature mechanism resulted from codon mismatch can reduce the proportion of incorrect translation when the amino acid supply is extremely unbalanced, which is one possible source of high fidelity protein synthesis after peptidyl transfer.	[Zhang, Dinglin; Cao, Liaoran; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian 116023, Liaoning, Peoples R China; [Chen, Danfeng] Dalian City Fisherles Tech Extens Stn, Dalian 116025, Liaoning, Peoples R China; [Cheng, Hong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, Dalian 116023, Liaoning, Peoples R China.; Cheng, H (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China.	ghli@dicp.ac.cn; hcheng@sibs.ac.cn			National Science Foundation of China [31370714]; Ministry of Science and Technology of China 973 project [2012CB721002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China 973 project(Ministry of Science and Technology, ChinaNational Basic Research Program of China)	This study was supported by the National Science Foundation of China [no. 31370714], http://www.nsfc.gov.cn/, GHL, and the Ministry of Science and Technology of China 973 project [no. 2012CB721002], http://www.most.gov.cn/eng/, GHL.	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Cathopoulis TJT, 2008, BIOCHEMISTRY-US, V47, P7610, DOI 10.1021/bi800369q; Dana A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S6-S13; Effraim PR, 2009, NAT CHEM BIOL, V5, P947, DOI 10.1038/nchembio.255; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Green R, 2012, COLD SPRING HARBOR P, P4; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; HARLEY CB, 1981, J BIOL CHEM, V256, P786; Hausmann CD, 2007, NUCLEIC ACIDS RES, V35, P6094, DOI 10.1093/nar/gkm534; Hernandez G, 2008, TRENDS BIOCHEM SCI, V33, P58, DOI 10.1016/j.tibs.2007.11.002; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Karpinets TV, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-30; Kochetov AV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-318; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Piques M, 2009, MOL SYSTEMS BIOL, P5; Qian WF, 2012, PLOS GENET, P8; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Reuveni S, 2011, PLOS COMPUTATIONAL B, P7; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Robbins-Pianka A, 2010, BIOINFORMATICS, V26, P2651, DOI 10.1093/bioinformatics/btq509; Schrader JM, 2009, J MOL BIOL, V386, P1255, DOI 10.1016/j.jmb.2009.01.021; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Tuller T, 2013, PLOS COMPUTATIONAL B, P9; Tuller T, 2011, GENOME BIOL, P12; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Weygand-Durasevic I, 2010, SCIENCE, V329, P1473, DOI 10.1126/science.1195567; Williams CW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-586; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	48	2	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148302	10.1371/journal.pone.0148302	http://dx.doi.org/10.1371/journal.pone.0148302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840415	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200121
J	Harrison, JG; Gompert, Z; Fordyce, JA; Buerkle, CA; Grinstead, R; Jahner, JP; Mikel, S; Nice, CC; Santamaria, A; Forister, ML				Harrison, Joshua G.; Gompert, Zachariah; Fordyce, James A.; Buerkle, C. Alex; Grinstead, Rachel; Jahner, Joshua P.; Mikel, Scott; Nice, Christopher C.; Santamaria, Aldrin; Forister, Matthew L.			The Many Dimensions of Diet Breadth: Phytochemical, Genetic, Behavioral, and Physiological Perspectives on the Interaction between a Native Herbivore and an Exotic Host	PLOS ONE			English	Article							FORAGE QUALITY; PLANT; ALFALFA; COMMUNITY; PERFORMANCE; EVOLUTION; PREFERENCE; DIVERSITY; ASSOCIATION; CHEMISTRY	From the perspective of an herbivorous insect, conspecific host plants are not identical, and intraspecific variation in host nutritional quality or defensive capacity might mediate spatially variable outcomes in plant-insect interactions. Here we explore this possibility in the context of an ongoing host breadth expansion of a native butterfly (the Melissa blue, Lycaeides melissa) onto an exotic host plant (alfalfa, Medicago sativa). We examine variation among seven alfalfa populations that differed in terms of colonization by L. melissa; specifically, we examined variation in phytochemistry, foliar protein, and plant population genetic structure, as well as responses of caterpillars and adult butterflies to foliage from the same populations. Regional patterns of alfalfa colonization by L. melissa were well predicted by phytochemical variation, and colonized patches of alfalfa showed a similar level of inter-individual phytochemical diversity. However, phytochemical variation was a poor predictor of larval performance, despite the fact that survival and weight gain differed dramatically among caterpillars reared on plants from different alfalfa populations. Moreover, we observed a mismatch between alfalfa supporting the best larval performance and alfalfa favored by ovipositing females. Thus, the axes of plant variation that mediate interactions with L. melissa depend upon herbivore life history stage, which raises important issues for our understanding of adaptation to novel resources by an organism with a complex life history.	[Harrison, Joshua G.; Forister, Matthew L.] Univ Nevada, Dept Biol, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA; [Harrison, Joshua G.; Grinstead, Rachel; Jahner, Joshua P.; Mikel, Scott; Santamaria, Aldrin; Forister, Matthew L.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Gompert, Zachariah] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Fordyce, James A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Buerkle, C. Alex] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Nice, Christopher C.] SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Utah System of Higher Education; Utah State University; University of Tennessee System; University of Tennessee Knoxville; University of Wyoming; Texas State University System; Texas State University San Marcos	Harrison, JG (corresponding author), Univ Nevada, Dept Biol, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA.; Harrison, JG (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	joshuaharrison@unr.edu	Harrison, Joshua/J-8031-2019	Harrison, Joshua/0000-0003-2524-0273; Jahner, Joshua/0000-0001-8121-6783; Fordyce, James/0000-0002-2731-0418; Gompert, Zachariah/0000-0003-2248-2488	National Science Foundation (NSF) [DEB-1050726, DEB-1145609]; NSF [DEB-0614223, DEB-1050947]; University of Nevada, Reno; NSF REU program [DEB-1050726]; Direct For Biological Sciences [1050355, 1050947] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); University of Nevada, Reno; NSF REU program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Forister lab was supported by National Science Foundation (NSF) awards DEB-1050726 and DEB-1145609. The Fordyce lab was supported by NSF grants DEB-0614223 and DEB-1050947. J. G.H. was supported by the University of Nevada, Reno. R.G., S.M., and A.S. were supported by the NSF REU program (awards associated with DEB-1050726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Bangert RK, 2006, MOL ECOL, V15, P1379, DOI 10.1111/j.1365-294X.2005.02749.x; Barbour MA, 2015, FUNCT ECOL, V29, P995, DOI 10.1111/1365-2435.12409; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARROLL SP, 1992, EVOLUTION, V46, P1052, DOI 10.1111/j.1558-5646.1992.tb00619.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Denno RF, 2012, VARIABLE PLANTS HERB; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobler S, 1996, EVOLUTION, V50, P2373, DOI [10.2307/2410706, 10.1111/j.1558-5646.1996.tb03625.x]; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Dyer LA, 2004, ECOLOGY, V85, P2795, DOI 10.1890/03-0233; Elden TC, 1997, J ECON ENTOMOL, V90, P842, DOI 10.1093/jee/90.3.842; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Fordyce JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026785; Forister ML, 2013, OECOLOGIA, V172, P177, DOI 10.1007/s00442-012-2476-8; Forister ML, 2013, OIKOS, V122, P657, DOI 10.1111/j.1600-0706.2013.00251.x; Forister ML, 2011, P ROY SOC B-BIOL SCI, V278, P1539, DOI 10.1098/rspb.2010.1959; Forister ML, 2009, OECOLOGIA, V160, P551, DOI 10.1007/s00442-009-1310-4; Golawska S, 2007, J CHEM ECOL, V33, P1598, DOI 10.1007/s10886-007-9333-y; Gompert Z, 2015, MOL ECOL, V24, P2777, DOI 10.1111/mec.13199; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Gompert Z, 2012, EVOLUTION, V66, P2167, DOI 10.1111/j.1558-5646.2012.01587.x; Gotelli N, 2013, PRIMER ECOLOGICAL ST, P109; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; HEMMING JDC, 1995, OECOLOGIA, V103, P79, DOI 10.1007/BF00328428; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hunter MD, 1996, CHEMOECOLOGY, V7, P45, DOI 10.1007/BF01240637; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jahner JP, 2011, EVOLUTION, V65, P2719, DOI 10.1111/j.1558-5646.2011.01310.x; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Janzen D.H., 1985, Illinois Natural History Survey Bulletin, V33, P141; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Julier B, 2000, CROP SCI, V40, P365, DOI 10.2135/cropsci2000.402365x; Jung HG, 1997, CROP SCI, V37, P1361, DOI 10.2135/cropsci1997.0011183X003700040054x; Karban R., 1992, P195; Kruschke J. K, 2010, DOING BAYESIAN DATA; Lefevre T, 2011, P ROY SOC B-BIOL SCI, V278, P751, DOI 10.1098/rspb.2010.1479; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XH, 2009, CROP SCI, V49, P13, DOI 10.2135/cropsci2008.04.0205; Liu ZD, 2012, OECOLOGIA, V168, P459, DOI 10.1007/s00442-011-2103-0; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Marion Z.H., 2015, HIERDIVERSITY HIERAR; Marion ZH, 2015, AM NAT, V186, P348, DOI 10.1086/682369; MICHAUD R, 1988, AGRON MONOGR, V29, P25; NG D, 1988, NATURE, V334, P611, DOI 10.1038/334611a0; Nozzolillo C, 1997, J CHEM ECOL, V23, P995, DOI 10.1023/B:JOEC.0000006384.60488.94; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Preston MD, 2015, ECOL COMPLEX, V24, P1, DOI 10.1016/j.ecocom.2015.07.004; R Core Team, 2013, R LANG ENV STAT COMP; Ramirez RA, 2014, J CHEM ECOL, V40, P1099, DOI 10.1007/s10886-014-0504-3; Record S., 2012, VEGETARIAN JOST DIVE; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schakel A., 2015, OXFORD HDB TRANSFORM, P1; Scholl Cynthia F., 2012, International Journal of Ecology, P1; Seguin P, 2006, J SCI FOOD AGR, V86, P765, DOI 10.1002/jsfa.2412; Sen S, 1998, J AGR FOOD CHEM, V46, P131, DOI 10.1021/jf970389i; SINGER MC, 1992, AM NAT, V139, P9, DOI 10.1086/285310; SINGER MC, 1993, NATURE, V361, P251, DOI 10.1038/361251a0; Singer MC, 2000, ECOL LETT, V3, P101, DOI 10.1046/j.1461-0248.2000.00121.x; Singer MC, 2002, ECOL LETT, V5, P1, DOI 10.1046/j.1461-0248.2002.00282.x; Singer MC, 2012, ECOLOGY, V93, P2658, DOI 10.1890/11-2078.1; Singer MS, 2004, ECOLOGY, V85, P2747, DOI 10.1890/03-0827; Singer MS, 2001, OIKOS, V93, P194, DOI 10.1034/j.1600-0706.2001.930203.x; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Stochmal A, 2001, J AGR FOOD CHEM, V49, P753, DOI 10.1021/jf000876p; Strauss Sharon Y., 1998, P156; Szakiel A, 2011, PHYTOCHEM REV, V10, P471, DOI 10.1007/s11101-010-9177-x; Thompson J. N., 2005, INTERSPEC INTERACT; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Van Nouhuys S, 2003, ECOL ENTOMOL, V28, P193, DOI 10.1046/j.1365-2311.2003.00501.x; Venables WN., 2002, MODERN APPL STAT S 4; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wimp GM, 2007, MOL ECOL, V16, P5057, DOI 10.1111/j.1365-294X.2007.03544.x; ZANGERL AR, 1993, ECOLOGY, V74, P47, DOI 10.2307/1939500	79	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0147971	10.1371/journal.pone.0147971	http://dx.doi.org/10.1371/journal.pone.0147971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836490	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548500004
J	Almeida, AM; Palhinhas, RG; Kilminster, T; Scanlon, T; van Harten, S; Milton, J; Blache, D; Greeff, J; Oldham, C; Coelho, AV; Cardoso, LA				Almeida, Andre M.; Palhinhas, Rui G.; Kilminster, Tanya; Scanlon, Timothy; van Harten, Sofia; Milton, John; Blache, Dominique; Greeff, Johan; Oldham, Chris; Coelho, Ana Varela; Cardoso, Luis Alfaro			The Effect of Weight Loss on the Muscle Proteome in the Damara, Dorper and Australian Merino Ovine Breeds	PLOS ONE			English	Article							PLASMA LEPTIN CONCENTRATION; WINTER VELD HAY; PHOSPHOGLUCOMUTASE 1; LONGISSIMUS-DORSI; GENETIC-RESOURCES; ANIMAL PRODUCTION; FEED RESTRICTION; GUINEA-BISSAU; SHEEP BREEDS; MEAT QUALITY	Seasonal Weight Loss (SWL) is an important constraint, limiting animal production in the Tropics and the Mediterranean. As a result, the study of physiological and biochemical mechanisms by which domestic animal breeds respond to SWL is important to those interested in animal breeding and the improvement thereof. To that end, the study of the proteome has been instrumental in gathering important information on physiological mechanisms, including those underlying SWL. In spite of that, little information is available concerning physiological mechanisms of SWL in production animals. The objective of this study was to determine differential protein expression in the muscle of three different breeds of sheep, the Australian Merino, the Dorper and the Damara, each showing different levels of tolerance to weight loss (low, medium and high, respectively). Per breed, two experimental groups were established, one labeled "Growth" and the other labeled "Restricted." After forty-two days of dietary treatment, all animals were euthanized. Muscle samples were then taken. Total protein was extracted from the muscle, then quantified and two-dimensional gel electrophoresis were conducted using 24 cm pH 3-10 immobiline dry strips and colloidal coomassie staining. Gels were analyzed using Samespots (R) software and spots of interest were in-gel digested with trypsin. The isolated proteins were identified using MALDI-TOF/TOF. Results indicated relevant differences between breeds; several proteins are suggested as putative biomarkers of tolerance to weight loss: Desmin, Troponin T, Phosphoglucomutase and the Histidine Triad nucleotide-binding protein 1. This information is of relevance to and of possible use in selection programs aiming towards ruminant animal production in regions prone to droughts and weight loss.	[Almeida, Andre M.; van Harten, Sofia; Cardoso, Luis Alfaro] Fac Vet Med Lisbon, Ctr Interdisciplinar Invest Sanidade Anim, Lisbon, Portugal; [Almeida, Andre M.; Palhinhas, Rui G.; Coelho, Ana Varela] UNL, ITQB, Oeiras, Portugal; [Almeida, Andre M.] Ross Univ, Sch Vet Med, POB 334, Basseterre, St Kitts & Nevi; [Kilminster, Tanya; Scanlon, Timothy; Greeff, Johan; Oldham, Chris] Dept Agr & Food Western Australia, Perth, WA, Australia; [Milton, John; Blache, Dominique] Univ Western Australia, Inst Agr, Perth, WA 6009, Australia	Universidade de Lisboa; Universidade Nova de Lisboa; University of Western Australia	Almeida, AM (corresponding author), Fac Vet Med Lisbon, Ctr Interdisciplinar Invest Sanidade Anim, Lisbon, Portugal.; Almeida, AM (corresponding author), UNL, ITQB, Oeiras, Portugal.; Almeida, AM (corresponding author), Ross Univ, Sch Vet Med, POB 334, Basseterre, St Kitts & Nevi.	aalmeida@fmv.utl.pt	Blache, Dominique/H-4991-2014; Coelho, Ana V Varela/O-3977-2014; Coelho, Ana V/H-8885-2012; Almeida, Andre/I-4369-2013; van Harten, Sofia/K-8949-2016	Blache, Dominique/0000-0003-3476-3068; Coelho, Ana V Varela/0000-0002-6143-4203; Coelho, Ana V/0000-0002-6143-4203; Almeida, Andre/0000-0002-7810-3988; van Harten, Sofia/0000-0003-2091-4312; Scanlon, Timothy/0000-0001-5706-5487	FCT - Science and Technology Foundation of Portugal (Lisbon, Portugal) [POCI/CVT/57820/2004]; FCT [SFRH/BPD/90916/2012]; Department of Agriculture and Food of Government of Western Australia (Perth, WA, Australia)	FCT - Science and Technology Foundation of Portugal (Lisbon, Portugal); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Department of Agriculture and Food of Government of Western Australia (Perth, WA, Australia)	The Proteomics component of this work was supported by the FCT - Science and Technology Foundation of Portugal (Lisbon, Portugal), through the research project POCI/CVT/57820/2004 (Studies on genetic and physiological characterization of sheep adaptation to food restriction). Author AM Almeida acknowledges the FCT individual grant SFRH/BPD/90916/2012. Animal work was supported by the Department of Agriculture and Food of the Government of Western Australia (Perth, WA, Australia) to which author AM Almeida acknowledges a visiting scientist research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Animal work was supported by the Department of Agriculture and Food of the Government of Western Australia (Perth, WA, Australia) to which author AM Almeida acknowledges a visiting scientist research grant. The contribution of the technical staff of the Merredin Research Station: Alan Harrod, Leanne Young, Nicky Stanwyck, Elmer Kidson and Dr. Roy Butler, is appreciated. The Proteomics component of this work was supported by the FCT-Science and Technology Foundation of Portugal (Lisbon, Portugal), through the research project POCI/CVT/57820/2004 (Studies on genetic and physiological characterization of sheep adaptation to food restriction). Author AM Almeida acknowledges the FCT individual grant SFRH/BPD/90916/2012. Authors thank finally Mr. Blake Miller (RUSVM, St. Kitts and Nevis) for the English corrections made to this manuscript.	Almeida AM, 2007, SMALL RUMINANT RES, V73, P216, DOI 10.1016/j.smallrumres.2007.02.001; Almeida AM, 2006, TROP ANIM HEALTH PRO, V38, P443, DOI 10.1007/s11250-006-4368-6; Almeida AM, 2015, ANIMAL, V9, P1, DOI 10.1017/S1751731114002602; Almeida AM, 2010, ANIM GENET, V41, P260, DOI 10.1111/j.1365-2052.2009.01994.x; Almeida AM, 2008, SCAND J LAB ANIM SCI, V35, P259; Almeida AM, 2004, SMALL RUMINANT RES, V55, P141, DOI 10.1016/j.smallrumres.2004.01.009; Almeida AM, 2013, TROP ANIM HEALTH PRO, V45, P1305, DOI 10.1007/s11250-013-0361-z; Almeida AM, 2014, J PROTEOMICS, V103, P170, DOI 10.1016/j.jprot.2014.03.036; Almeida AM, 2011, TROP ANIM HEALTH PRO, V43, P1427, DOI 10.1007/s11250-011-9868-3; Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077313; Anderson MJ, 2014, MEAT SCI, V96, P379, DOI 10.1016/j.meatsci.2013.07.017; Arianmanesh M, 2011, J ENDOCRINOL, V210, P47, DOI 10.1530/JOE-10-0336; Atti N, 2004, SMALL RUMINANT RES, V53, P151, DOI 10.1016/j.smallrumres.2003.08.016; Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7; Bouley J, 2005, PROTEOMICS, V5, P490, DOI 10.1002/pmic.200400925; Brackley KI, 2009, CELL STRESS CHAPERON, V14, P23, DOI 10.1007/s12192-008-0057-x; Cardoso LA, 2013, FAO ANIMAL PRODUCTIO, V175, P37; Chelikani PK, 2004, DOMEST ANIM ENDOCRIN, V26, P33, DOI 10.1016/j.domaniend.2003.08.003; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P529, DOI 10.1007/s11250-008-9130-9; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P537, DOI 10.1007/s11250-008-9131-8; de Almeida AM, 2012, J PROTEOMICS, V75, P4296, DOI 10.1016/j.jprot.2012.04.010; Delavaud C, 2000, J ENDOCRINOL, V165, P519, DOI 10.1677/joe.0.1650519; Delavaud C, 2002, J ANIM SCI, V80, P1317; Eckersall PD, 2012, J PROTEOMICS, V75, P4187, DOI 10.1016/j.jprot.2012.05.014; Eryavuz A, 2007, REV MED VET-TOULOUSE, V158, P244; Ferlizza E, 2015, VET J, V204, P73, DOI 10.1016/j.tvjl.2015.01.023; Ferreira AM, 2013, J PROTEOMICS, V94, P110, DOI 10.1016/j.jprot.2013.09.012; Freer M., 2007, NUTR REQUIREMENTS DO; Ge L, 2015, PHARMACOL BIOCHEM BE, V131, P77, DOI 10.1016/j.pbb.2015.01.017; Hamelin M, 2006, J ANIM SCI, V84, P3266, DOI 10.2527/jas.2006-162; Hernandez-Castellano LE, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-85; Hnia K, 2014, CELL TISSUE IN PRESS; Holmstrom MH, 2013, METABOLISM, V62, P1258, DOI 10.1016/j.metabol.2013.04.001; Kim NK, 2008, MEAT SCI, V80, P1068, DOI 10.1016/j.meatsci.2008.04.027; Kim NK, 2009, BMB REP, V42, P433, DOI 10.5483/BMBRep.2009.42.7.433; Kunej T, 2007, OBESITY, V15, P2896, DOI 10.1038/oby.2007.344; Lamy E, 2012, ENV STRESS AMELIORAT, P19, DOI DOI 10.1007/978-3-642-29205-7_2; Lee Y, 2014, J BIOL CHEM, V289, P32010, DOI 10.1074/jbc.M114.597914; Martin J, 2011, BBA-BIOENERGETICS, V1807, P626, DOI 10.1016/j.bbabio.2011.02.001; Miller I, 2014, CURR PROTEIN PEPT SC, V15, P134, DOI 10.2174/1389203715666140221115135; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Paredi G, 2013, J PROTEOMICS, V88, P58, DOI 10.1016/j.jprot.2013.01.029; Paredi G, 2012, J PROTEOMICS, V75, P4275, DOI 10.1016/j.jprot.2012.04.011; Petriz BA, 2015, J PROTEOMICS, V113, P351, DOI 10.1016/j.jprot.2014.10.010; Ren MQ, 2002, DOMEST ANIM ENDOCRIN, V23, P371, DOI 10.1016/S0739-7240(02)00179-0; Scanlon TT, 2013, SMALL RUMINANT RES, V109, P101, DOI 10.1016/j.smallrumres.2012.08.004; Shibata M, 2009, J ANIM SCI, V87, P2700, DOI 10.2527/jas.2008-1486; Soares R, 2012, J PROTEOMICS, V75, P4190, DOI 10.1016/j.jprot.2012.04.009; Tshabalala PA, 2003, MEAT SCI, V65, P563, DOI 10.1016/S0309-1740(02)00249-8; van Harten S, 2013, ANIMAL, V7, P439, DOI 10.1017/S1751731112001589; van Harten S, 2003, NUTR RES, V23, P1447, DOI 10.1016/S0271-5317(03)00152-0; Vian Harten S, 2015, J SCI FOOD IN PRESS; Wilkes MJ, 2012, ANIM PROD SCI, V52, P30, DOI 10.1071/AN11033; Yu T.Y., 2015, EUPA OPEN PROTEOM, V6, P28, DOI [DOI 10.1016/J.EUPR0T.2015.01.001, 10.1016/j.euprot.2015.01.001, DOI 10.1016/J.EUPROT.2015.01.001]	54	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146367	10.1371/journal.pone.0146367	http://dx.doi.org/10.1371/journal.pone.0146367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828937	Green Published, gold			2022-12-27	WOS:000369548200008
J	Li, Z; Tang, JJ; Guo, F				Li, Zhao; Tang, Jijun; Guo, Fei			Identification of 14-3-3 Proteins Phosphopeptide-Binding Specificity Using an Affinity-Based Computational Approach	PLOS ONE			English	Article							STRUCTURAL BASIS; PREDICTION; SELECTION; CANCER	The 14-3-3 proteins are a highly conserved family of homodimeric and heterodimeric molecules, expressed in all eukaryotic cells. In human cells, this family consists of seven distinct but highly homologous 14-3-3 isoforms. 14-3-3s is the only isoform directly linked to cancer in epithelial cells, which is regulated by major tumor suppressor genes. For each 14-3-3 isoform, we have 1,000 peptide motifs with experimental binding affinity values. In this paper, we present a novel method for identifying peptide motifs binding to 14-3-3s isoform. First, we propose a sampling criteria to build a predictor for each new peptide sequence. Then, we select nine physicochemical properties of amino acids to describe each peptide motif. We also use auto-cross covariance to extract correlative properties of amino acids in any two positions. Finally, we consider elastic net to predict affinity values of peptide motifs, based on ridge regression and least absolute shrinkage and selection operator ( LASSO). Our method tests on the 1,000 known peptide motifs binding to seven 14-3-3 isoforms. On the 14-3-3s isoform, our method has overall pearson-product-moment correlation coefficient (PCC) and root mean squared error (RMSE) values of 0.84 and 252.31 for N-terminal sublibrary, and 0.77 and 269.13 for C-terminal sublibrary. We predict affinity values of 16,000 peptide sequences and relative binding ability across six permutated positions similar with experimental values. We identify phosphopeptides that preferentially bind to 14-33s over other isoforms. Several positions on peptide motifs are in the same amino acid category with experimental substrate specificity of phosphopeptides binding to 14-3-3s. Our method is fast and reliable and is a general computational method that can be used in peptide-protein binding identification in proteomics research.	[Li, Zhao; Tang, Jijun; Guo, Fei] Tianjin Univ, Sch Comp Sci & Technol, 92 Weijin Rd, Tianjin 300072, Peoples R China; [Tang, Jijun] Univ S Carolina, Sch Computat Sci & Engn, Columbia, SC 29208 USA	Tianjin University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Guo, F (corresponding author), Tianjin Univ, Sch Comp Sci & Technol, 92 Weijin Rd, Tianjin 300072, Peoples R China.	fguo@tju.edu.cn	Tang, Jijun/ABH-6528-2020		National Science Foundation of China [NSFC 61402326]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by a grant from National Science Foundation of China (NSFC 61402326).	AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Florencio P, 2002, CURR OPIN STRUC BIOL, V12, P368; Giguere S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-82; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Hastie R T Friedman, 2001, ELEMENTS STAT LEARNI; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Jang H, 2006, BIOINFORMATICS, V22, pE220, DOI 10.1093/bioinformatics/btl203; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Lu CHS, 2008, ANGEW CHEM INT EDIT, V47, P7438, DOI 10.1002/anie.200801395; Mathura VS, 2005, BIOINFORMATION, V1, P2, DOI 10.6026/97320630001002; Pan XY, 2010, J PROTEOME RES, V9, P4992, DOI 10.1021/pr100618t; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Qi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095386; Sluchanko NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072597; Stulp F, 2015, NEURAL NETWORKS, V69, P60, DOI 10.1016/j.neunet.2015.05.005; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; WAGNER I, 1983, ANGEW CHEM INT EDIT, V22, P816, DOI 10.1002/anie.198308161; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; You ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125811; You ZH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S10; Zaki N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-150; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang YD, 2014, TECHNOLOGIES, V2, DOI 10.3390/technologies2040164; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	31	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147467	10.1371/journal.pone.0147467	http://dx.doi.org/10.1371/journal.pone.0147467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828594	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200021
J	Liang, HW; Hwang, YH				Liang, Huey-Wen; Hwang, Yaw-Huei			Mobile Phone Use Behaviors and Postures on Public Transportation Systems	PLOS ONE			English	Article							GENDER-DIFFERENCES; SYMPTOMS; PAIN	Mobile phones are common in our daily life, but the users' preferences for postures or screen operating styles have not been studied. This was a cross-sectional and observational study. We randomly sampled passengers who used mobile phones on the Mass Rapid Transit (MRT) system in metropolitan Taipei. A checklist was used to observe their body postures and screen operating styles while sitting or standing. As a result, 1,230 subjects from 400 trips were observed. Overall, of all the passengers who were sitting, 41% of them were using mobile phones. The majority of the tasks involved browsing (84%) with their phones in a portrait orientation (93%). Different-hand holding/operating was the most commonly used operating style while sitting (46%) and same-hand holding/operating was the most common while standing (46%). The distribution of screen operating styles was significantly different for those sitting than for those standing and for different genders and age groups. The most frequently observed postures while sitting were having one's trunk against a backrest, feet on the floor and with or without an arm supported (58%). As for the users who were standing, the both-and different-hands groups had a high proportion of arms unsupported, feet on the floor and either their trunk supported or not. In contrast, the same-hand group tended to have their trunk unsupported, were holding a pole or handstrap and had both feet on floor. Further studies are warranted to characterize the ergonomic exposure of these commonly used postures and operating styles, and our results will help guide the selection of experimental conditions for laboratory settings.	[Liang, Huey-Wen] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Liang, Huey-Wen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hwang, Yaw-Huei] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, 17 Xu Zhou Rd, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Liang, HW (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Liang, HW (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan.	lianghw@ntu.edu.tw	LIANG, HUEY-WEN/AAN-8083-2020	LIANG, HUEY-WEN/0000-0003-0186-3126; HWANG, YAW-HUEI/0000-0003-1817-8969	Ministry of Science and Technology, Taiwan [104-2314-B-002-014-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, Taiwan, under Grant 104-2314-B-002-014-, https://www.most.gov.tw/, funding to HWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MOBILE MARKETING STA; Babadi-Akashe Zahra, 2014, Addict Health, V6, P93; Barr GC, 2015, J EMERG MED, V48, P366, DOI 10.1016/j.jemermed.2014.09.055; Berolo S, 2011, APPL ERGON, V42, P371, DOI 10.1016/j.apergo.2010.08.010; Bianchi A, 2005, CYBERPSYCHOL BEHAV, V8, P39, DOI 10.1089/cpb.2005.8.39; Boase J, 2013, J COMPUT-MEDIAT COMM, V18, P508, DOI 10.1111/jcc4.12021; Brezmes T, 2009, LECT NOTES COMPUT SC, V5518, P796, DOI 10.1007/978-3-642-02481-8_120; de Waard D, 2015, ACCIDENT ANAL PREV, V76, P42, DOI 10.1016/j.aap.2015.01.004; Duh HBL., 2006, P 8 C HUM COMP INT M, P181, DOI DOI 10.1145/1152215.1152254; Gold JE, 2012, APPL ERGON, V43, P408, DOI 10.1016/j.apergo.2011.06.015; Gustafsson E, 2010, J ELECTROMYOGR KINES, V20, P127, DOI 10.1016/j.jelekin.2008.11.010; Hakala PT, 2006, EUR J PUBLIC HEALTH, V16, P536, DOI 10.1093/eurpub/ckl025; Huth V, 2015, ACCIDENT ANAL PREV, V74, P42, DOI 10.1016/j.aap.2014.10.008; Ipsos MediaCT Mobile Marketing Association Interactive Advertising Bureau, 2013, OUR MOBILE PLANET RE; Kamp I, 2011, ERGONOMICS, V54, P1029, DOI 10.1080/00140139.2011.618230; Kietrys DM, 2015, APPL ERGON, V50, P98, DOI 10.1016/j.apergo.2015.03.003; Kim GY, 2012, J PHYS THER SCI, V24, P1255, DOI 10.1589/jpts.24.1255; Ko PH, 2016, ERGONOMICS, V59, P821, DOI 10.1080/00140139.2015.1088075; Korpinen L, 2013, ERGONOMICS, V56, P1134, DOI 10.1080/00140139.2013.802018; Lee S, 2015, ERGONOMICS, V58, P220, DOI 10.1080/00140139.2014.967311; Lopez-Rosenfeld M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125772; Repacholi MH, 2001, TOXICOL LETT, V120, P323, DOI 10.1016/S0378-4274(01)00285-5; Slijper H, 2000, EXP BRAIN RES, V135, P81, DOI 10.1007/s002210000492; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022	25	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148419	10.1371/journal.pone.0148419	http://dx.doi.org/10.1371/journal.pone.0148419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828797	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200100
J	Min, JH; Lee, CH; Ji, YW; Yeo, A; Noh, H; Song, I; Kim, EK; Lee, HK				Min, Ji Hwan; Lee, Chul Hee; Ji, Yong Woo; Yeo, Areum; Noh, Hyemi; Song, Insil; Kim, Eung Kweon; Lee, Hyung Keun			Activation of Dll4/Notch Signaling and Hypoxia-Inducible Factor-1 Alpha Facilitates Lymphangiogenesis in Lacrimal Glands in Dry Eye	PLOS ONE			English	Article							CHRONIC SKIN INFLAMMATION; NOTCH; ANGIOGENESIS; STIMULATION; EXPRESSION; DISEASE	Purpose By using hypoxia-inducible factor-1 alpha conditional knockout (HIF-1 alpha CKO) mice and a dry eye (DE) mouse model, we aimed to determine the role played by delta-like ligand 4 (Dll4)/Notch signaling and HIF-1 alpha in the lymphangiogenesis of lacrimal glands (LGs). Methods C57BL/6 mice were housed in a controlled-environment chamber for DE induction. During DE induction, the expression level of Dll4/Notch signaling and lymphangiogenesis in LGs was measured by quantitative RT-PCR, immunoblot, and immunofluorescence staining. Next, lymphangiogenesis was measured after Dll4/Notch signal inhibition by anti-Dll4 antibody or.-secretase inhibitor. Using HIF-1 alpha CKO mice, the expression of Dll4/Notch signaling and lymphangiogenesis in LGs of DE-induced HIF-1 alpha CKO mice were assessed. Additionally, the infiltration of CD45(+) cells in LGs was assessed by immunohistochemical (IHC) staining and flow cytometry for each condition. Results DE significantly upregulated Dll4/Notch and lymphangiogenesis in LGs. Inhibition of Dll4/Notch significantly suppressed lymphangiogenesis in LGs. Compared to wild-type (WT) mice, DE induced HIF-1 alpha CKO mice showed markedly low levels of Dll4/Notch and lymphangiogenesis. Inhibition of lymphangiogenesis by Dll4/Notch suppression resulted in increased CD45+ cell infiltration in LGs. Likewise, CD45+ cells infiltrated more in the LGs of HIF-1 alpha CKO DE mice than in non-DE HIF-1 alpha CKO mice. Conclusions Dll4/Notch signaling and HIF-1a are closely related to lymphangiogenesis in DE-induced LGs. Lymphangiogenesis stimulated by Dll4/Notch and HIF-1 alpha may play a role in protecting LGs from DE-induced inflammation by aiding the clearance of immune cells from LGs.	[Min, Ji Hwan; Lee, Chul Hee; Ji, Yong Woo; Yeo, Areum; Noh, Hyemi; Song, Insil; Kim, Eung Kweon; Lee, Hyung Keun] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul 120749, South Korea; [Ji, Yong Woo; Kim, Eung Kweon; Lee, Hyung Keun] Yonsei Univ, Coll Med, Dept Ophthalmol, Corneal Dystrophy Res Inst, Seoul 120749, South Korea; [Lee, Hyung Keun] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, HK (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul 120749, South Korea.; Lee, HK (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Corneal Dystrophy Res Inst, Seoul 120749, South Korea.; Lee, HK (corresponding author), Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea.	shadik@yuhs.ac		Ji, Yong Woo/0000-0002-7211-6278; Lee, Chul Hee/0000-0002-4107-4677; Kim, Eung Kweon/0000-0002-1453-8042	National Research Foundation of Korea (NRF) [NRF-2012R1A2A2A02009081]; Korean Health Technology R&D Project, Ministry of Health and welfare, Korea [HI13C0055]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry of Health and welfare, Korea	This work was supported by National Research Foundation of Korea (NRF), NRF-2012R1A2A2A02009081, HKL; Korean Health Technology R&D Project, Ministry of Health and welfare, Korea, HI13C0055, HKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer D, 2014, ANGIOGENESIS, V17, P383, DOI 10.1007/s10456-013-9404-3; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Bron AJ, 2009, OCUL SURF, V7, P78, DOI 10.1016/S1542-0124(12)70299-9; Calonge M, 2010, OCUL IMMUNOL INFLAMM, V18, P244, DOI 10.3109/09273941003721926; Chauhan Sunil K, 2014, J Clin Cell Immunol, V5; Coursey TG, 2014, CLIN OPHTHALMOL, V8, P1447, DOI 10.2147/OPTH.S35685; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; D'Alessio S, 2014, J CLIN INVEST, V124, P3863, DOI 10.1172/JCI72189; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070667; Fatima A, 2014, DEV DYNAM, V243, P957, DOI [10.1002/DVDY.24129, 10.1002/dvdy.24129]; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hagura A, 2014, J DERMATOL SCI, V73, P135, DOI 10.1016/j.jdermsci.2013.10.006; Hayashi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/407031; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Ji YW, 2013, INVEST OPHTH VIS SCI, V54, P7557, DOI 10.1167/iovs.12-11515; Kamoi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043688; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kim H, 2012, TRENDS IMMUNOL, V33, P350, DOI 10.1016/j.it.2012.03.006; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; NAKANO A, 1990, ACTA PATHOL JAPON, V40, P107; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Ran Sophia, 2012, Cancers (Basel), V4, P618, DOI 10.3390/cancers4030618; Seo Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.260; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; Xiao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115333; Zampell JC, 2012, FASEB J, V26, P1027, DOI 10.1096/fj.11-195321; Zhang YJ, 2013, DEVELOPMENT, V140, P594, DOI 10.1242/dev.082842	32	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147846	10.1371/journal.pone.0147846	http://dx.doi.org/10.1371/journal.pone.0147846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828208	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200037
J	Sulaberidze, L; Mirzazadeh, A; Chikovani, I; Shengelia, N; Tsereteli, N; Gotsadze, G				Sulaberidze, Lela; Mirzazadeh, Ali; Chikovani, Ivdity; Shengelia, Natia; Tsereteli, Nino; Gotsadze, George			Population Size Estimation of Men Who Have Sex with Men in Tbilisi, Georgia; Multiple Methods and Triangulation of Findings	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CENTRAL TENDENCY; KEY POPULATIONS; HIV; RISK	Introduction An accurate estimation of the population size of men who have sex with men (MSM) is critical to the success of HIV program planning and to monitoring of the response to epidemic as a whole, but is quite often missing. In this study, our aim was to estimate the population size of MSM in Tbilisi, Georgia and compare it with other estimates in the region. Methods In the absence of a gold standard for estimating the population size of MSM, this study reports a range of methods, including network scale-up, mobile/web apps multiplier, service and unique object multiplier, network-based capture-recapture, Handcock RDS-based and Wisdom of Crowds methods. To apply all these methods, two surveys were conducted: first, a household survey among 1,015 adults from the general population, and second, a respondent driven sample of 210 MSM. We also conducted a literature review of MSM size estimation in Eastern European and Central Asian countries. Results The median population size of MSM generated from all previously mentioned methods was estimated to be 5,100 (95% Confidence Interval (CI): 3,243 +/- 9,088). This corresponds to 1.42% (95% CI: 0.9% +/- 2.53%) of the adult male population in Tbilisi. Conclusion Our size estimates of the MSM population (1.42% (95% CI: 0.9% +/- 2.53%) of the adult male population in Tbilisi) fall within ranges reported in other Eastern European and Central Asian countries. These estimates can provide valuable information for country level HIV prevention program planning and evaluation. Furthermore, we believe, that our results will narrow the gap in data availability on the estimates of the population size of MSM in the region.	[Sulaberidze, Lela; Chikovani, Ivdity; Shengelia, Natia; Gotsadze, George] Curatio Int Fdn, Tbilisi, Georgia; [Mirzazadeh, Ali] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [Mirzazadeh, Ali] Kerman Univ Med Sci, Reg Knowledge Hub, Kerman, Iran; [Mirzazadeh, Ali] Kerman Univ Med Sci, WHO Collaborating Ctr HIV Surveillance, Inst Futures Studies Hlth, Kerman, Iran; [Tsereteli, Nino] Ctr Informat & Counseling Reprod Hlth Tanadgoma, Tbilisi, Georgia	University of California System; University of California San Francisco; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization	Sulaberidze, L (corresponding author), Curatio Int Fdn, Tbilisi, Georgia.	l.sulaberidze@curatio.com	Gotsadze, George/B-1129-2008; Sulaberidze, Lela/AAF-2133-2020; Mirzazadeh, Ali/AAJ-5907-2021; Chikovani, Ivdity/AAL-9870-2020	Gotsadze, George/0000-0002-8429-7125; Sulaberidze, Lela/0000-0003-3388-8731; Chikovani, Ivdity/0000-0001-6925-4904; Mirzazadeh, Ali/0000-0002-0478-3220	GFATM under the project "Establishment of the evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in the country" (GEO-H-GPIC)	GFATM under the project "Establishment of the evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in the country" (GEO-H-GPIC)	Funding for the Population Size Estimation study implementation was provided by GFATM under the project "Establishment of the evidence base for national HIV/AIDS program by strengthening of HIV/AIDS surveillance system in the country" (GEO-H-GPIC).	Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; AIDSinfo Online Database, 2014, AIDSINFO ONLINE DATA; [Anonymous], 2013, GLOB AIDS RESP PROGR; [Anonymous], 2014, RDS ANAL SOFTWARE AN; Berleva G., 2012, ESTIMATION SIZE POPU; Burrell ER, 2012, AIDS BEHAV, V16, P1816, DOI 10.1007/s10461-012-0277-z; Comiskey C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002203; Dombrowski Kirk, 2012, Adv Appl Sociol, V2, P245; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Guo W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071796; Handcock MS, 2015, BIOMETRICS, V71, P258, DOI 10.1111/biom.12255; Hosein SR, 2013, LANCET INFECT DIS, V13, P654, DOI 10.1016/S1473-3099(13)70185-3; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; Killworth PD, 1998, EVALUATION REV, V22, P289, DOI 10.1177/0193841X9802200205; Lee MD, 2011, MEM COGNITION, V39, P914, DOI 10.3758/s13421-010-0059-7; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Manikandan S, 2011, J PHARMACOL PHARMACO, V2, P140, DOI 10.4103/0976-500X.81920; Manikandan S, 2011, J PHARMACOL PHARMACO, V2, P214, DOI 10.4103/0976-500X.83300; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Okal J, 2013, SEX TRANSM INFECT, V89, P366, DOI 10.1136/sextrans-2013-051071; Paniotto V, 2009, ESTIMATING SIZE POPU; Politch JA, 2012, AIDS, V26, P1535, DOI 10.1097/QAD.0b013e328353b11b; Quaye S, 2015, AIDS BEHAV, V19, pS16, DOI 10.1007/s10461-014-0943-4; Rastegari Azam, 2013, Glob J Health Sci, V5, P217, DOI 10.5539/gjhs.v5n4p217; Republic of Mozambique National AIDS Control Council 2012, 2012, GLOB AIDS RESP PROGR; Rwanda Biomedical Center/Institute of HIV/AIDS Disease Prevention and Control Department (RBC/ IHDPC) School of Public Health (SPH) UNAIDS all, 2012, EST SIZ POP THOUGH H; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Tsereteli N, 2012, HIV RISK PREVENTION; UNAIDS, 2009, GLOB AIDS RESP PROGR; UNAIDS, 2014, GLOB AIDS RESP PROGR; UNAIDS, 2005, DEV SOFTW PACK EPP V; UNAIDS, 2011, GLOB AIDS RESP PROGR; UNAIDS the US Office of the Global AIDS Coordinator, 2012, CONS NETW SCAL UP OT; Vallejo A, 2013, RES VET SCI, V95, P405, DOI 10.1016/j.rvsc.2013.04.005; WHO, 2013, NETW SCAL UP METH WO; Wu E, 2013, ESTIMATION POPULATIO	37	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147413	10.1371/journal.pone.0147413	http://dx.doi.org/10.1371/journal.pone.0147413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828366	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200019
J	Williams, RC; Skelton, AJ; Todryk, SM; Rowan, AD; Preshaw, PM; Taylor, JJ				Williams, Rachel C.; Skelton, Andrew J.; Todryk, Stephen M.; Rowan, Andrew D.; Preshaw, Philip M.; Taylor, John J.			Leptin and Pro-Inflammatory Stimuli Synergistically Upregulate MMP-1 and MMP-3 Secretion in Human Gingival Fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; MATRIX METALLOPROTEINASES; PERIODONTAL-LIGAMENT; INTERLEUKIN (IL)-6; EXPRESSION; ACTIVATION; CARTILAGE; PATHWAYS; IL-8; LIPOPOLYSACCHARIDE	Introduction Gingival fibroblast-mediated extracellular matrix remodelling is implicated in the pathogenesis of periodontitis, yet the stimuli that regulate this response are not fully understood. The immunoregulatory adipokine leptin is detectable in the gingiva, human gingival fibroblasts express functional leptin receptor mRNA and leptin is known to regulate extracellular matrix remodelling responses in cardiac fibroblasts. We therefore hypothesised that leptin would enhance matrix metalloproteinase secretion in human gingival fibroblasts. Methods and Results We used in vitro cell culture to investigate leptin signalling and the effect of leptin on mRNA and protein expression in human gingival fibroblasts. We confirmed human gingival fibroblasts expressed cell surface leptin receptor, found leptin increased matrix metalloproteinase-1, -3, -8 and -14 expression in human gingival fibroblasts compared to unstimulated cells, and observed that leptin stimulation activated MAPK, STAT1/3 and Akt signalling in human gingival fibroblasts. Furthermore, leptin synergised with IL-1 or the TLR2 agonist pam2CSK4 to markedly enhance matrix metalloproteinase-1 and -3 production by human gingival fibroblasts. Signalling pathway inhibition demonstrated ERK was required for leptin-stimulated matrix metalloproteinase-1 expression in human gingival fibroblasts; whilst ERK, JNK, p38 and STAT3 were required for leptin+IL-1- and leptin+pam2CSK4-induced matrix metalloproteinase-1 expression. A genome-wide expression array and gene ontology analysis confirmed genes differentially expressed in leptin+ IL-1-stimulated human gingival fibroblasts (compared to unstimulated cells) were enriched for extracellular matrix organisation and disassembly, and revealed that matrix metalloproteinase-8 and -12 were also synergistically upregulated by leptin+ IL-1 in human gingival fibroblasts. Conclusions We conclude that leptin selectively enhances the expression and secretion of certain matrix metalloproteinases in human gingival fibroblasts, and suggest that gingival fibroblasts may have an ECM-degrading phenotype during conditions of hyperleptinaemia (e.g., obesity, type 2 diabetes mellitus, exogenous leptin therapy).	[Williams, Rachel C.; Preshaw, Philip M.; Taylor, John J.] Newcastle Univ, Ctr Oral Hlth Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Skelton, Andrew J.; Rowan, Andrew D.] Newcastle Univ, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Skelton, Andrew J.] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Williams, Rachel C.; Rowan, Andrew D.; Preshaw, Philip M.; Taylor, John J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Todryk, Stephen M.] Northumbria Univ, Fac Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Northumbria University	Taylor, JJ (corresponding author), Newcastle Univ, Ctr Oral Hlth Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Taylor, JJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	john.taylor@ncl.ac.uk	Todryk, Stephen/AAA-3950-2019; Taylor, John/R-5323-2018	Todryk, Stephen/0000-0003-4566-0793; Taylor, John/0000-0002-0766-186X	Medical Research Council; Faculty of Medical Sciences, Newcastle University; Oral and Dental Research trust [122602]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Medical Sciences, Newcastle University; Oral and Dental Research trust	This work was funded by a PhD studentship awarded to RW (funded jointly by the Medical Research Council and the Faculty of Medical Sciences, Newcastle University) and a grant from the Oral and Dental Research trust (No.122602) to RW and JT (see http://www.mrc.ac.uk/ & http://odrt.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay ZY, 2012, ODONTOLOGY, V100, P222, DOI 10.1007/s10266-011-0043-0; Barchowsky A, 2000, CYTOKINE, V12, P1469, DOI 10.1006/cyto.2000.0743; Bartold PM, 2006, PERIODONTOL 2000, V40, P29, DOI 10.1111/j.1600-0757.2005.00140.x; Bodet C, 2007, J CELL PHYSIOL, V212, P189, DOI 10.1002/jcp.21018; Chen YQE, 2004, AM J PATHOL, V165, P1069, DOI 10.1016/S0002-9440(10)63368-8; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cox SW, 2006, ORAL DIS, V12, P34, DOI 10.1111/j.1601-0825.2005.01153.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Domeij H, 2002, EUR J ORAL SCI, V110, P302, DOI 10.1034/j.1600-0722.2002.21247.x; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Herath TDK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-73; Hui W, 2012, ANN RHEUM DIS, V71, P455, DOI 10.1136/annrheumdis-2011-200372; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Iwayama T, 2012, J PERIODONTAL RES, V47, P563, DOI 10.1111/j.1600-0765.2012.01467.x; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kida Y, 2005, CYTOKINE, V29, P159, DOI 10.1016/j.cyto.2004.10.009; Kiili M, 2002, J CLIN PERIODONTOL, V29, P224, DOI 10.1034/j.1600-051x.2002.290308.x; Koskinen A, 2011, CLIN EXP RHEUMATOL, V29, P57; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Mahanonda R, 2007, J IMMUNOL, V178, P1151, DOI 10.4049/jimmunol.178.2.1151; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2034; Minami T, 2007, J DENT RES, V86, P1083, DOI 10.1177/154405910708601112; Morandini AC, 2013, J PERIODONTOL, V84, P1353, DOI 10.1902/jop.2012.120496; Morandini ACF, 2013, J PERIODONTOL, V84, P535, DOI 10.1902/jop.2012.120177; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park Hong-Gyu, 2013, International Journal of Oral Biology, V38, P73, DOI 10.11620/IJOB.2013.38.2.073; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Ruwanpura SMPM, 2004, J DENT RES, V83, P260, DOI 10.1177/154405910408300315; Saucillo DC, 2014, J IMMUNOL, V192, P136, DOI 10.4049/jimmunol.1301158; Schram K, 2011, ENDOCRINOLOGY, V152, P2037, DOI 10.1210/en.2010-1166; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Souza PPC, 2010, J DENT RES, V89, P802, DOI 10.1177/0022034510366898; Sukkar TZ, 2007, J PERIODONTAL RES, V42, P580, DOI 10.1111/j.1600-0765.2007.00986.x; Taylor John J, 2013, J Periodontol, V84, pS113, DOI [10.1111/jcpe.12059, 10.1902/jop.2013.134005]; Wisler BA, 2011, CURR SIGNAL TRANSD T, V6, P279; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	43	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148024	10.1371/journal.pone.0148024	http://dx.doi.org/10.1371/journal.pone.0148024			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829555	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000369548200053
J	Benesova, V; Kinterova, V; Kanka, J; Toralova, T				Benesova, Veronika; Kinterova, Veronika; Kanka, Jiri; Toralova, Tereza			Characterization of SCF-Complex during Bovine Preimplantation Development	PLOS ONE			English	Article							F-BOX PROTEIN; EARLY EMBRYONIC LETHALITY; MESSENGER-RNA; GENOME ACTIVATION; CULLIN PARTNERS; GENE-EXPRESSION; IN-VIVO; UBIQUITIN; LIGASE; MOUSE	The degradation of maternal proteins is one of the most important events during early development, and it is presumed to be essential for embryonic genome activation (EGA), but the precise mechanism is still not known. It is thought that a large proportion of the degradation of maternal proteins is mediated by the ubiquitin-proteolytic system. In this study we focused on the expression of the Skp1-Cullin1-F-box (SCF) complex, a modular RING-type E3 ubiquitin-ligase, during bovine preimplantation development. The complex consists of three invariable components-Cul1, Skp1, Rbx1 and F-box protein, which determines the substrate specificity. The protein level and mRNA expression of all three invariable members were determined. Cul1 and Skp1 mRNA synthesis was activated at early embryonic stages, at the 4c and early 8c stage, respectively, which suggests that these transcripts are necessary for preparing the embryo for EGA. CUL1 protein level increased from MII to the morula stage, with a significant difference between MII and L8c, and between MII and the morula. The CUL1 protein was localized primarily to nuclei and to a lesser extent to the cytoplasm, with a lower signal in the inner cell mass (ICM) compared to the trophectoderm (TE) at the blastocyst stage. The level of SKP1 protein significantly increased from MII oocytes to 4c embryos, but then significantly decreased again. The localization of the SKP1 protein was analysed throughout the cell and similarly to CUL1 at the blastocyst stage, the staining was less intensive in the ICM. There were no statistical differences in RBX1 protein level and localization. The active SCF-complex, which is determined by the interaction of Cul1 and Skp1, was found throughout the whole embryo during preimplantation development, but there was a difference at the blastocyst stage, which exhibits a much stronger signal in the TE than in the ICM. These results suggest that all these genes could play an important role during preimplantation development. This paper reveals comprehensive expression profile, the basic but important knowledge necessary for further studying.	[Benesova, Veronika; Kinterova, Veronika; Kanka, Jiri; Toralova, Tereza] Acad Sci Czech Republ Vvi, Inst Anim Physiol & Genet, Dev Biol Lab, Libechov, Czech Republic; [Benesova, Veronika] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Kinterova, Veronika] Czech Univ Life Sci Prague, Dept Vet Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague; Czech University of Life Sciences Prague	Benesova, V (corresponding author), Acad Sci Czech Republ Vvi, Inst Anim Physiol & Genet, Dev Biol Lab, Libechov, Czech Republic.	benesova@iapg.cas.cz	Petruskova, Veronika/N-1321-2017; Toralová, Tereza/AAL-9914-2020; Kinterova, Veronika/AAM-1888-2020	Petruskova, Veronika/0000-0002-5337-7042; Kinterova, Veronika/0000-0003-4255-3300	Czech Science Foundation [GACR 13-24730P]; Grant Agency of Charles University in Prague [GAUK 1280214]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University in Prague	This work was supported by the Czech Science Foundation (GACR 13-24730P) (TT) and Grant Agency of Charles University in Prague (GAUK 1280214) (VB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Davis W, 2000, DEV BIOL, V218, P275, DOI 10.1006/dbio.1999.9486; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Filippov V, 2000, J EXP BIOL, V203, P2747; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Hwang KC, 2004, MOL REPROD DEV, V69, P43, DOI 10.1002/mrd.20156; Jia LJ, 2011, J BIOL CHEM, V286, P3379, DOI 10.1074/jbc.M110.188425; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Kanka J, 2009, THERIOGENOLOGY, V72, P572, DOI 10.1016/j.theriogenology.2009.04.014; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Karabinova P, 2011, CELL TISSUE RES, V346, P1, DOI 10.1007/s00441-011-1235-1; Kepkova KV, 2011, THERIOGENOLOGY, V75, P1582, DOI 10.1016/j.theriogenology.2010.12.019; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lee YL, 2003, BIOL REPROD, V68, P375, DOI 10.1095/biolreprod.102.007336; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Mandel SA, 2012, NEURODEGENER DIS, V10, P220, DOI 10.1159/000333223; Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070; Moore R, 2004, GENESIS, V38, P1, DOI 10.1002/gene.10243; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Mtango NR, 2007, PHYSIOL GENOMICS, V31, P1, DOI 10.1152/physiolgenomics.00040.2007; Muzzopappa M, 2005, DEVELOPMENT, V132, P2561, DOI 10.1242/dev.01839; Ohlmeyer JT, 2003, DEVELOPMENT, V130, P6339, DOI 10.1242/dev.00855; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ohta T, 1999, ONCOGENE, V18, P6758, DOI 10.1038/sj.onc.1203115; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; PAVLOK A, 1992, MOL REPROD DEV, V31, P63, DOI 10.1002/mrd.1080310111; Pennetier S, 2005, BIOL REPROD, V73, P713, DOI 10.1095/biolreprod.105.041574; Piva R, 2002, MOL CELL BIOL, V22, P8375, DOI 10.1128/MCB.22.23.8375-8387.2002; Rhodes SL, 2013, ENVIRON RES, V126, P1, DOI 10.1016/j.envres.2013.08.001; Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062; Salilew-Wondim D, 2010, REPROD FERT DEVELOP, V22, P564, DOI 10.1071/RD09112; Sasagawa Y, 2003, GENES CELLS, V8, P857, DOI 10.1046/j.1365-2443.2003.00682.x; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sutovsky P, 2001, Cloning Stem Cells, V3, P157, DOI 10.1089/153623001753205115; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Svarcova O, 2007, MOL REPROD DEV, V74, P1428, DOI 10.1002/mrd.20727; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Toralova T, 2012, REPRODUCTION, V144, P349, DOI 10.1530/REP-12-0033; Toralova T, 2009, REPRODUCTION, V138, P783, DOI 10.1530/REP-09-0234; Verlhac MH, 2010, CURR OPIN CELL BIOL, V22, P758, DOI 10.1016/j.ceb.2010.09.003; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; YOKOI H, 1993, BIOCHEM BIOPH RES CO, V195, P769, DOI 10.1006/bbrc.1993.2112; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhang Q, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.1; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]	60	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147096	10.1371/journal.pone.0147096	http://dx.doi.org/10.1371/journal.pone.0147096			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824694	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600014
J	Cullen, B; Brennan, D; Manly, T; Evans, JJ				Cullen, Breda; Brennan, David; Manly, Tom; Evans, Jonathan J.			Towards Validation of a New Computerised Test of Goal Neglect: Preliminary Evidence from Clinical and Neuroimaging Pilot Studies	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; PROSPECTIVE MEMORY; BRAIN-INJURY; COGNITIVE REHABILITATION; HUMAN MULTITASKING; FRONTAL-LOBE; AREA 10; BEHAVIOR; QUESTIONNAIRE; ORGANIZATION	Objective Goal neglect is a significant problem following brain injury, and is a target for rehabilitation. It is not yet known how neural activation might change to reflect rehabilitation gains. We developed a computerised multiple elements test (CMET), suitable for use in neuroimaging paradigms. Design Pilot correlational study and event-related fMRI study. Methods In Study 1, 18 adults with acquired brain injury were assessed using the CMET, other tests of goal neglect (Hotel Test; Modified Six Elements Test) and tests of reasoning. In Study 2, 12 healthy adults underwent fMRI, during which the CMET was administered under two conditions: self-generated switching and experimenter-prompted switching. Results Among the clinical sample, CMET performance was positively correlated with both the Hotel Test (r = 0.675, p = 0.003) and the Modified Six Elements Test (r = 0.568, p = 0.014), but not with other clinical or demographic measures. In the healthy sample, fMRI demonstrated significant activation in rostro-lateral prefrontal cortex in the self-generated condition compared with the prompted condition (peak 40, 44, 4; Z(E) = 4.25, p((FWEcorr)) = 0.026). Conclusions These pilot studies provide preliminary evidence towards the validation of the CMET as a measure of goal neglect. Future studies will aim to further establish its psychometric properties, and determine optimum pre- and post-rehabilitation fMRI paradigms.	[Cullen, Breda; Evans, Jonathan J.] Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Brennan, David] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Dept Clin Phys, Glasgow, Lanark, Scotland; [Manly, Tom] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Glasgow; Queen Elizabeth University Hospital (QEUH); University of Glasgow	Cullen, B (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland.	Breda.Cullen@glasgow.ac.uk	Cullen, Breda/C-9154-2012; Cullen, Breda/N-3449-2019	Cullen, Breda/0000-0002-7259-9505; Cullen, Breda/0000-0002-7259-9505	Glasgow Neurosciences Foundation [2006/06]; West of Scotland RD Consortium [04CP17]; Dr Mortimer and Theresa Sackler Foundation; MRC [MC_U105559837] Funding Source: UKRI; Medical Research Council [MC_U105559837] Funding Source: researchfish	Glasgow Neurosciences Foundation; West of Scotland RD Consortium; Dr Mortimer and Theresa Sackler Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Glasgow Neurosciences Foundation (reference 2006/06) (BC, DB, JJE) and the West of Scotland R&D Consortium (reference 04CP17) (JJE). BC is supported by funding awarded to JJE by The Dr Mortimer and Theresa Sackler Foundation. The funders played no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Hynes SM., 2015, INT J DEV SCI, V9, P85, DOI [10.3233/DEV-140157, DOI 10.3233/DEV-140157]; Jansari A, 2004, BRAIN IMPAIR, V5, P110; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Roca M, 2011, NEUROPSYCHOLOGIA, V49, P3525, DOI 10.1016/j.neuropsychologia.2011.09.003; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Wechsler D, 1999, WECHSLER ADULT INTEL; Wechsler D., 2001, WECHSLER TEST ADULT; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148127	10.1371/journal.pone.0148127	http://dx.doi.org/10.1371/journal.pone.0148127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824704	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000369528600102
J	Wang, S; Zhao, SY; Xiao, SZ; Gu, FF; Liu, QZ; Tang, J; Guo, XK; Ni, YX; Han, LZ				Wang, Su; Zhao, Sheng-Yuan; Xiao, Shu-Zhen; Gu, Fei-Fei; Liu, Qing-Zhong; Tang, Jin; Guo, Xiao-Kui; Ni, Yu-Xing; Han, Li-Zhong			Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China	PLOS ONE			English	Article							EXTENDED-SPECTRUM; SUSCEPTIBILITY; EMERGENCE; AMERICA; BURDEN; EBURST; GENES; ST131; PCR	Escherichia coli (E. coli) is one of the most frequent and lethal causes of bloodstream infections (BSIs). We carried out a retrospective multicenter study on antimicrobial resistance and phylogenetic background of clinical E. coli isolates recovered from bloodstream in three hospitals in Shanghai. E. coli isolates causing BSIs were consecutively collected between Sept 2013 and Sept 2014. Ninety isolates randomly selected (30 from each hospital) were enrolled in the study. Antimicrobial susceptibility testing was performed by disk diffusion. PCR was used to detect antimicrobial resistance genes coding for beta-lactamases (TEM, CTX-M, OXA, etc.), carbapenemases (IMP, VIM, KPC, NDM-1 and OXA-48), and phylogenetic groups. eBURST was applied for analysis of multi-locus sequence typing (MLST). The resistance rates for penicillins, second-generation cephalosporins, fluoroquinolone and tetracyclines were high (>60%). Sixty-one of the 90 (67.8%) strains enrolled produced ESBLs and no carbapenemases were found. Molecular analysis showed that CTX-M-15 (25/61), CTX-M-14 (18/61) and CTX-M-55 (9/61) were the most common ESBLs. Phylogenetic group B2 predominated (43.3%) and exhibited the highest rates of ESBLs production. ST131 (20/90) was the most common sequence type and almost assigned to phylogenetic group B2 (19/20). The following sequence types were ST405 (8/90) and ST69 (5/90). Among 61 ESBL-producers isolates, B2 (26, 42.6%) and ST131 (18, 29.5%) were also the most common phylogenetic group and sequence type. Genetic diversity showed no evidence suggesting a spread of these antimicrobial resistant isolates in the three hospitals. In order to provide more comprehensive and reliable epidemiological information for preventing further dissemination, well-designed and continuous surveillance with more hospitals participating was important.	[Wang, Su; Xiao, Shu-Zhen; Gu, Fei-Fei; Ni, Yu-Xing; Han, Li-Zhong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China; [Zhao, Sheng-Yuan] Cent South Univ, Xiangya Hosp, Dept Clin Lab, Changsha, Hunan, Peoples R China; [Liu, Qing-Zhong] Shanghai Jiao Tong Univ, Sch Med, Dept Clin Lab, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Tang, Jin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Clin Lab, Shanghai 200030, Peoples R China; [Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Central South University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Han, LZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China.	hanlizhong1107@163.com	Wang, Su/M-9344-2014	Wang, Su/0000-0003-1103-2641; Guo, Xiao-Kui/0000-0002-1595-9965	Special Fund for Health-scientific Research in the Public Interest of China Program [201002021]; National Natural Science Foundation of China [81472010]	Special Fund for Health-scientific Research in the Public Interest of China Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Special Fund for Health-scientific Research in the Public Interest of China Program (grant no. 201002021) and the National Natural Science Foundation of China (grant no. 81472010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocati N, 2013, INT J ENV RES PUB HE, V10, P6235, DOI 10.3390/ijerph10126235; China NBoSo, 6 NATL POP CENS DAT; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT SUSC; [董海新 Dong Haixin], 2014, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V24, P2104; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gagliotti C, 2011, EUROSURVEILLANCE, V16, P20; Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Jean SS, 2015, FUTURE MICROBIOL, V10, P407, DOI [10.2217/FMB.14.135, 10.2217/fmb.14.135]; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P492, DOI 10.1111/1469-0691.12144; Laupland KB, 2013, EPIDEMIOL INFECT, V141, P174, DOI 10.1017/S0950268812000428; Lee JH, 2012, MED RES REV, V32, P216, DOI 10.1002/med.20210; [吕媛 Lv Yuan], 2014, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V30, P278; [马序竹 Ma Xuzhu], 2011, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V21, P5147; Matsumura Yasufumi, 2013, Rinsho Byori, V61, P1116; Matsumura Y, 2012, J ANTIMICROB CHEMOTH, V67, P2612, DOI 10.1093/jac/dks278; Mihaila L, 2010, J ANTIMICROB CHEMOTH, V65, P1537, DOI 10.1093/jac/dkq155; Mushtaq S, 2011, J ANTIMICROB CHEMOTH, V66, P2002, DOI 10.1093/jac/dkr226; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Novais A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-144; Peirano G, 2012, J CLIN MICROBIOL, V50, P294, DOI 10.1128/JCM.06025-11; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Schlackow I, 2012, J ANTIMICROB CHEMOTH, V67, P1514, DOI 10.1093/jac/dks082; Sheludchenko MS, 2010, APPL ENVIRON MICROB, V76, P4337, DOI 10.1128/AEM.00128-10; Sidjabat HE, 2015, EXPERT REV ANTI-INFE, V13, P575, DOI 10.1586/14787210.2015.1028365; Tsai YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079640; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Zhao SY, 2015, INFECT DIS-NOR, V47, P310, DOI 10.3109/00365548.2014.990509	34	36	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147740	10.1371/journal.pone.0147740	http://dx.doi.org/10.1371/journal.pone.0147740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824702	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600054
J	Li, Y; Burclaff, J; Anderson, JT				Li, Yan; Burclaff, Joseph; Anderson, James T.			Mutations in Mtr4 Structural Domains Reveal Their Important Role in Regulating tRNA(i)(Met) Turnover in Saccharomyces cerevisiae and Mtr4p Enzymatic Activities In Vitro	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; RIBOSOMAL-RNA; NUCLEAR-RNA; BOX PROTEIN; ARCH DOMAIN; EXOSOME; POLYADENYLATION; DEGRADATION; COMPLEX; BINDING	RNA processing and turnover play important roles in the maturation, metabolism and quality control of a large variety of RNAs thereby contributing to gene expression and cellular health. The TRAMP complex, composed of Air2p, Trf4p and Mtr4p, stimulates nuclear exosome-dependent RNA processing and degradation in Saccharomyces cerevisiae. The Mtr4 protein structure is composed of a helicase core and a novel so-called arch domain, which protrudes from the core. The helicase core contains highly conserved helicase domains RecA-1 and 2, and two structural domains of unclear functions, winged helix domain (WH) and ratchet domain. How the structural domains (arch, WH and ratchet domain) coordinate with the helicase domains and what roles they are playing in regulating Mtr4p helicase activity are unknown. We created a library of Mtr4p structural domain mutants for the first time and screened for those defective in the turnover of TRAMP and exosome substrate, hypo-modified tRNA(i)(Met). We found these domains regulate Mtr4p enzymatic activities differently through characterizing the arch domain mutants K700N and P731S, WH mutant K904N, and ratchet domain mutant R1030G. Arch domain mutants greatly reduced Mtr4p RNA binding, which surprisingly did not lead to significant defects on either in vivo tRNA(i)(Met) turnover, or in vitro unwinding activities. WH mutant K904N and Ratchet domain mutant R1030G showed decreased tRNA(i)(Met) turnover in vivo, as well as reduced RNA binding, ATPase and unwinding activities of Mtr4p in vitro. Particularly, K904 was found to be very important for steady protein levels in vivo. Overall, we conclude that arch domain plays a role in RNA binding but is largely dispensable for Mtr4p enzymatic activities, however the structural domains in the helicase core significantly contribute to Mtr4p ATPase and unwinding activities.	[Anderson, James T.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Li, Yan] Agr Univ Hebei, Coll Vet Med, Baoding 071001, Hebei, Peoples R China; [Burclaff, Joseph] Washington Univ, Div Biol & Biomed Sci, St Louis, MO 63110 USA	Marquette University; Hebei Agricultural University; Washington University (WUSTL)	Anderson, JT (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	james.anderson@marquette.edu		Burclaff, Joseph/0000-0002-0325-5039	National Institutes of Health National Institute of General Medical Sciences [1R15GM100445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100445] Funding Source: NIH RePORTER	National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health National Institute of General Medical Sciences, grant number 1R15GM100445 funding to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Domdey H, ANONYMOUS METHODS EN, P398; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Falk S, 2014, MOL CELL; Fasken MB, 2011, J BIOL CHEM, V286, P37429, DOI 10.1074/jbc.M111.271494; Halbach F, 2013, CELL, V154, P814, DOI 10.1016/j.cell.2013.07.017; Halbach F, 2012, RNA, V18, P124, DOI 10.1261/rna.029553.111; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Holub P, 2012, NUCLEIC ACIDS RES, V40, P5679, DOI 10.1093/nar/gks223; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jia HJ, 2012, P NATL ACAD SCI USA, V109, P7292, DOI 10.1073/pnas.1201085109; Jia HJ, 2011, CELL, V145, P890, DOI 10.1016/j.cell.2011.05.010; Johnson SJ, 2013, RNA BIOL, V10, P33, DOI 10.4161/rna.22101; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KADOWAKI T, 1994, J CELL BIOL, V126, P649, DOI 10.1083/jcb.126.3.649; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liang S, 1996, MOL CELL BIOL, V16, P5139; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taylor LL, 2014, NUCLEIC ACIDS RES, V42, P13861, DOI 10.1093/nar/gku1208; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Woodman IL, 2011, BIOCHEM SOC T, V39, P140, DOI 10.1042/BST0390140; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148090	10.1371/journal.pone.0148090	http://dx.doi.org/10.1371/journal.pone.0148090			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820724	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400065
J	Makowska, IJ; Weary, DM				Makowska, I. Joanna; Weary, Daniel M.			Differences in Anticipatory Behaviour between Rats (Rattus norvegicus) Housed in Standard versus Semi-Naturalistic Laboratory Environments	PLOS ONE			English	Article							BOVINE ALPHA(S1)-CASEIN; TRYPTIC HYDROLYSATE; WELFARE; AMPHETAMINE; ENRICHMENT; STRESS; VULNERABILITY; IMPULSIVITY; ACQUISITION; IMPAIRMENT	Laboratory rats are usually kept in relatively small cages, but research has shown that they prefer larger and more complex environments. The physiological, neurological and health effects of standard laboratory housing are well established, but fewer studies have addressed the sustained emotional impact of a standard cage environment. One method of assessing affective states in animals is to look at the animals' anticipatory behaviour between the presentation of a cue signalling the arrival of a reward and the arrival of that reward. The primary aim of this study was to use anticipatory behaviour to assess the affective state experienced by female rats a) reared and housed long-term in a standard laboratory cage versus a semi-naturalistic environment, and b) before and after treatment with an antidepressant or an anxiolytic. A secondary aim was to add to the literature on anticipatory behaviour by describing and comparing the frequency and duration of individual elements of anticipatory behaviour displayed by rats reared in these two systems. In all experiments, total behavioural frequency was higher in standard-housed rats compared to rats from the semi-naturalistic condition, suggesting that standard-housed rats were more sensitive to rewards and experiencing poorer welfare than rats reared in the semi-naturalistic environment. What rats did in anticipation of the reward also differed between housing treatments, with standard-housed rats mostly rearing and rats from the semi-naturalistic condition mostly sitting facing the direction of the upcoming treat. Drug interventions had no effect on the quantity or form of anticipatory behaviour, suggesting that the poorer welfare experienced by standard-housed rats was not analogous to depression or anxiety, or alternatively that the drug interventions were ineffective. This study adds to mounting evidence that standard laboratory housing for rats compromises rat welfare, and provides further scientific support for recommendations that current minimum standards be raised.	[Makowska, I. Joanna; Weary, Daniel M.] Univ British Columbia, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Makowska, IJ (corresponding author), Univ British Columbia, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	inez.joanna.makowska@gmail.com	Weary, Daniel M/A-8868-2010	Weary, Daniel M/0000-0002-0917-3982	National Sciences and Engineering Research Council (NSERC) of Canada Discovery grant [F10-05562]; NSERC Canada Graduate Scholarship; Charles River Scholarship in Animal Welfare; NSERC Discovery grant	National Sciences and Engineering Research Council (NSERC) of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Charles River Scholarship in Animal Welfare; NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by an National Sciences and Engineering Research Council (NSERC) of Canada Discovery grant to DMW (grant number: F10-05562) and by an NSERC Canada Graduate Scholarship and a Charles River Scholarship in Animal Welfare to IJM.; We extend our sincere thanks to animal care technician Anne Cheng for her enthusiasm and patience with our many unusual requests, and to Cathy El-Hinn who went above and beyond her role as laboratory assistant. IJM was supported by an NSERC Canada Graduate Scholarship and a Charles River Scholarship in Animal Welfare. This research was funded by an NSERC Discovery grant to DMW.	Aan Het Rot M, 2012, BIOL PSYCHIAT, V72, P537, DOI 10.1016/j.biopsych.2012.05.003; Abou-Ismail UA, 2011, LAB ANIM-UK, V45, P145, DOI 10.1258/la.2011.010149; Abou-Ismail UA, 2010, BEHAV PROCESS, V85, P172, DOI 10.1016/j.beproc.2010.07.002; AHMED SH, 1995, PSYCHOPHARMACOLOGY, V117, P116, DOI 10.1007/BF02245106; ALEXANDER BK, 1978, PSYCHOPHARMACOLOGY, V58, P175, DOI 10.1007/BF00426903; Barnett S.A., 1975, RAT STUDY BEHAV; BOICE R, 1981, PSYCHOL BULL, V89, P407, DOI 10.1037/0033-2909.89.3.407; BOICE R, 1977, J COMP PHYSIOL PSYCH, V91, P649, DOI 10.1037/h0077338; BRADSHAW AL, 1991, J EXP ANAL BEHAV, V55, P245, DOI 10.1901/jeab.1991.55-245; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Calhoun JB, 1963, PUBLIC HLTH SERVICE, V1008; Carrier N, 2013, NEUROPHARMACOLOGY, V70, P27, DOI 10.1016/j.neuropharm.2012.12.009; CHANG S, 1961, ACTA PSYCHOL TAIWAN, P44; COLLIER G, 1971, J COMP PHYSIOL PSYCH, V77, P155, DOI 10.1037/h0031588; Craig W, 1918, BIOL BULL-US, V34, P91, DOI 10.2307/1536346; Cryan JF, 2010, SCIENCE, V329, P913, DOI 10.1126/science.1194313; DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387; DENNY MS, 1975, ANIM LEARN BEHAV, V3, P245, DOI 10.3758/BF03213439; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; DRAPER WA, 1967, BEHAVIOUR, V28, P280, DOI 10.1163/156853967X00055; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Fraser D, 1997, ANIM WELFARE, V6, P187; GLUCK JP, 1977, DEV PSYCHOBIOL, V10, P143, DOI 10.1002/dev.420100207; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Iversen IH, 1998, J EXP ANAL BEHAV, V70, P103, DOI 10.1901/jeab.1998.70-103; JEROME EA, 1957, J COMP PHYSIOL PSYCH, V50, P588, DOI 10.1037/h0040264; Kamal A, 2010, EXP BRAIN RES, V201, P641, DOI 10.1007/s00221-009-2083-z; Katsnelson A, 2010, NAT NEWS, DOI [10.1038/news.2010.342, DOI 10.1038/NEWS.2010.342]; Kirkpatrick K, 2013, BEHAV NEUROSCI, V127, P712, DOI 10.1037/a0034124; Makowska IJ, 2013, APPL ANIM BEHAV SCI, V148, P1, DOI 10.1016/j.applanim.2013.07.017; McLennan IS, 2004, LAB ANIM-UK, V38, P384, DOI 10.1258/0023677041958927; Messaoudi M, 2009, FUND CLIN PHARMACOL, V23, P323, DOI 10.1111/j.1472-8206.2009.00672.x; Miclo L, 2001, FASEB J, V15, P1780, DOI 10.1096/fj.00-0685fje; Nissen HW, 1930, PEDAGOG SEMIN J GEN, V37, P361; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Patterson-Kane EC, 2001, LAB ANIM-UK, V35, P74, DOI 10.1258/0023677011911390; Patterson-Kane EG, 2002, ANIM WELFARE, V11, P327; Peplow M, 2004, NAT NEWS, DOI [10.1038/news040202-2, DOI 10.1038/NEWS040202-2]; Perry JL, 2008, BEHAV BRAIN RES, V193, P48, DOI 10.1016/j.bbr.2008.04.019; PIAZZA PV, 1990, BRAIN RES, V514, P22, DOI 10.1016/0006-8993(90)90431-A; PIJNENBURG AJJ, 1976, EUR J PHARMACOL, V35, P45, DOI 10.1016/0014-2999(76)90299-5; Small W. S., 1899, AM J PSYCHOL, V11, P80, DOI DOI 10.2307/1412730); Spangenberg E, 2011, SCAND J LAB ANIM SCI, V38, P47; Spruijt BM, 2001, APPL ANIM BEHAV SCI, V72, P145, DOI 10.1016/S0168-1591(00)00204-5; St-Pierre NR, 2007, J DAIRY SCI, V90, pE87, DOI 10.3168/jds.2006-612; Stryjek R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040642; Tizabi Y, 2012, NEUROSCIENCE, V213, P72, DOI 10.1016/j.neuroscience.2012.03.052; Van den Berg CL, 1999, BEHAV BRAIN RES, V106, P133, DOI 10.1016/S0166-4328(99)00099-6; van der Harst JE, 2005, BEHAV BRAIN RES, V161, P183, DOI 10.1016/j.bbr.2005.02.029; van der Harst JE, 2003, BEHAV BRAIN RES, V142, P151, DOI 10.1016/S0166-4328(02)00403-5; Van Der Harst JE, 2003, ANIM BEHAV, V66, P493, DOI 10.1006/anbe.2003.2201; Van der Horst JE, 2007, ANIM WELFARE, V16, P67; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Violle N, 2006, PHARMACOL BIOCHEM BE, V84, P517, DOI 10.1016/j.pbb.2006.06.017; Von Frijtag JC, 2002, PSYCHOPHARMACOLOGY, V162, P232, DOI 10.1007/s00213-002-1093-3; Von Frijtag JC, 2000, BEHAV BRAIN RES, V117, P137, DOI 10.1016/S0166-4328(00)00300-4; Watters JV, 2014, ZOO BIOL, V33, P251, DOI 10.1002/zoo.21144; Wood DA, 2006, PHYSIOL BEHAV, V88, P132, DOI 10.1016/j.physbeh.2006.03.024	60	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147595	10.1371/journal.pone.0147595	http://dx.doi.org/10.1371/journal.pone.0147595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820978	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400035
J	Bigdeli, M; Jacobs, B; Men, CR; Nilsen, K; Van Damme, W; Dujardin, B				Bigdeli, Maryam; Jacobs, Bart; Men, Chean Rithy; Nilsen, Kristine; Van Damme, Wim; Dujardin, Bruno			Access to Treatment for Diabetes and Hypertension in Rural Cambodia: Performance of Existing Social Health Protection Schemes	PLOS ONE			English	Article							CHRONIC DISEASES; LOW-INCOME; NONCOMMUNICABLE DISEASES; ESSENTIAL MEDICINES; HOUSEHOLD SURVEYS; DETERMINANTS; EXPENDITURE; POOR; CARE; EXPLORATION	Background Non-communicable diseases (NCD) pose challenges to Cambodia's health system. Medicines for NCD are on the National Essential Medicines List but no clinical guidelines support their utilization. Two social health protection schemes aimed at the informal sector population exist (Health Equity Funds and Insurance) together with two disease-specific interventions (a Peer Educator Network and Chronic Diseases Clinics) targeted at NCD patients. This study examines performance of these various schemes in relation to NCD. Methods Cross-sectional household survey among 709 individuals self-reporting diabetes and/or hypertension in three geographical locations in rural Cambodia using a structured questionnaire investigating diagnostic and treatment pathways, health seeking behaviour, health expenditures, and financial coping mechanisms. Results Two third of respondents with NCD were female and 55% did not belong to any scheme. The majority (59%) were diagnosed in the private sector and only 56% were on allopathic treatment that was mainly sought in the private sector (49%). Outpatient treatment cost was higher in the private sector and when using multiple providers of care. The majority were indebted, 11% due to health-related expenses. Contrary to social health protection schemes, disease-specific interventions offered better access to allopathic treatment and provided medicines in accordance with NEML. Conclusion The benefit packages of existing social health protection schemes and services in the public health sector should be adjusted to cater for the needs of people living with NCD in rural Cambodia. Initiatives that offer active disease management strategies and promote patients and community participation appear more successful in increasing treatment adherence and decreasing the risk of financial hardship.	[Bigdeli, Maryam] World Hlth Org, Alliance Hlth Policy & Syst Res, Geneva, Switzerland; [Jacobs, Bart] Deutsch Gesell Int Zusammenarbeit GIZ, Phnom Penh, Cambodia; [Men, Chean Rithy] Chean & Jaco Consulting Co, Phnom Penh, Cambodia; [Nilsen, Kristine] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Dujardin, Bruno] Univ Libre Bruxelles, Sch Publ Hlth, Sante Int, Ctr Rech Polit & Syst Sante, Brussels, Belgium	World Health Organization; University of Southampton; Institute of Tropical Medicine (ITM); Universite Libre de Bruxelles	Bigdeli, M (corresponding author), World Hlth Org, Alliance Hlth Policy & Syst Res, Geneva, Switzerland.	bigdelim@who.int	Albertin, Paloma C/X-1093-2018; Jacobs, Bart/AAF-2370-2019; Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007; Nilsen, Kristine/0000-0003-2009-4019	Alliance for Health Policy and Systems Research; Economic and Social Research Council [1226572] Funding Source: researchfish	Alliance for Health Policy and Systems Research; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Chean and Jaco Consulting Company is a not-for profit small research company founded by CM and BJ. None of them is salaried by the company. Chean and Jaco Consulting Company received funding from the Alliance for Health Policy and Systems Research to conduct this study, following a competitive bidding process. As principal and co-investigators of the concerned research, both CM and BJ were involved in the study design, data collection, analysis, decision to publish and preparation of the manuscript. However, this involvement was free of any conflict of interest. CM and BJ's respective contributions are stated in the "authors contributions" section.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Albanese E, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-153; [Anonymous], 2012, MOPOTSYO ANN REP 201; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bhojani U, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-306; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Brinda EM, 2012, INT PSYCHOGERIATR, V24, P1664, DOI 10.1017/S104161021200083X; Dalis P, 2014, CDRI WORKING PAPER S, V92; Eggermont N, 2011, EVALUATION PEER ED P; Gilson L, 2012, ED HLTH POLICY SYSTE; Minh HV, 2013, GLOBAL HEALTH ACTION, V6, P16, DOI 10.3402/gha.v5i0.18892; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Ir P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-383; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jiang CH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-988; Jing SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053062; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Mannava P, ASIA PACIFI IN PRESS; Meessen B, 2003, TROP MED INT HEALTH, V8, P581, DOI 10.1046/j.1365-3156.2003.01081.x; Meessen B, 2011, HEALTH POLICY PLANN, V26, pi30, DOI 10.1093/heapol/czr026; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Ministry of Health, 2009, ESS MED LIST; Ministry of Health, 2006, NAT GUID COMPL PACK; Ministry of Health, 2013, NAT STRAT PREV CONTR; Ministry of Health, 2012, STAND BEN PACK PROV; Ministry of Health, 2006, GUID IMPL COMM BAS H; Ministry of Health, 1996, NAT CHART HLTH FIN K; Ministry of Health, 2013, ANN HLTH FIN REP 201; Ministry of Health, 2006, GUID MIN PACK ACT HL; Ministry of Health, 2012, OUT OF POCK EXP HLTH; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; National Institute of Statistics, 2010, CAMB DEM HLTH SURV 2; Otgontuya D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-254; Ovesen J., 2010, CAMBODIANS THEIR DOC; Ozawa S, 2011, HEALTH POLICY PLANN, V26, pi20, DOI 10.1093/heapol/czr045; Peters D, 2012, NATURE, V487, P163, DOI 10.1038/487163a; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Porter T, 2009, J INT DEV, V21, P271, DOI 10.1002/jid.1552; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Raguenaud ME, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-33; Rahman Abdul Rashid Abdul, 2015, Asia Pac Fam Med, V14, P2, DOI 10.1186/s12930-015-0018-3; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Sarayani A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005859; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Smith-Spangler CM, 2012, DIABETES CARE, V35, P319, DOI 10.2337/dc11-1770; Trankell I-B, 2007, MED IDENTITIES HLTH; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; Van Pelt M., 2011, PEER ED NETWORKS PEO; Vialle-Valentin CE, 2015, HEALTH POLICY PLANN, V30, P1044, DOI 10.1093/heapol/czu107; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; Wang Q, 2015, HEALTH POLICY PLANN, V30, P242, DOI 10.1093/heapol/czu004; World Bank, 2013, CAMB RUR HLTH MARK; World Food Programme, 2015, CAMB FOOD PRIC WAG B; You X, 2011, APPL HEALTH ECON HEA, V9, P39, DOI 10.2165/11530730-000000000-00000	60	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146147	10.1371/journal.pone.0146147	http://dx.doi.org/10.1371/journal.pone.0146147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26815916	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000369528200008
J	Cavallo, LM; Di Somma, A; Solari, D; de Divitiis, O; Bracale, UM; Cappabianca, P				Cavallo, Luigi Maria; Di Somma, Alberto; Solari, Domenico; de Divitiis, Oreste; Bracale, Umberto Marcello; Cappabianca, Paolo			Preliminary Experience with a New Multidirectional Videoendoscope for Neuroendoscopic Surgical Procedures	PLOS ONE			English	Article							ENDOSCOPY; NEUROSURGERY; ENDONASAL	Purpose We assessed the applicability of a new multidirectional videoendoscope (digiCAMeleon, Karl Storz GmbH, Tuttlingen, Germany) in various neuroendoscopic procedures. Methods A 4-mm-diameter rigid videoendoscope (digiCAMeleon, Karl Storz GmbH, Tuttlingen, Germany) with 1 sensor and an internal LED light source was tested. The device offers a resolution of 1920 x 1080 pixels and weighs approximate to 215 g. The prototype was tested on three cadaveric heads using three different approaches: a) endoscopic endonasal transsphenoidal; b) frontal transcortical intraventricular; c) supraorbital. Results We identified several major benefits of the integrated system as applied to endoscopic endonasal, transcortical intraventricular, and endoscopic supraorbital keyhole approaches. These included improved maneuverability of the scope on account of reduced bulk and integration of the camera and fiberoptic light components, a variable angle of view from 0-70 degrees, and a novel feature that can be activated to maintain orientation of the surgical horizon. Our preliminary report highlights the potential for handling the videoendoscope in one hand, as one would a microsurgical instrument. The videoendoscope harbors all its electronic and lighting data into a unique and thin cable, thus resembling a modern "all-in-one" computer technology. Because of its reduced weight and ergonomic shape, controlling its movements is very easy and comfortable, even in the microsurgical environment. Furthermore, the videoendoscope offers the unique feature of orienting the horizon of vision, thanks to the possibility of offering angled views while working; this helps the surgeons to stay oriented with direct visualization and improved control of the instruments over a specific area of interest. Conclusions The videoendoscope prototype represents an HD-image quality versatile tool in a neurosurgical environment, thanks to its reduced weight and dimensions; in these preliminary simulations, we have identified optimized visibility and maneuverability as major benefits of this novel surgical adjunct.	[Cavallo, Luigi Maria; Di Somma, Alberto; Solari, Domenico; de Divitiis, Oreste; Cappabianca, Paolo] Univ Naples Federico II, Div Neurosurg, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Bracale, Umberto Marcello] Univ Naples Federico II, Unit Vasc & Endovasc Surg, Dept Publ Hlth, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Cavallo, LM (corresponding author), Univ Naples Federico II, Div Neurosurg, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy.	lcavallo@unina.it	Di Somma, Alberto/AAG-5690-2020; BRACALE, Umberto Marcello/AAH-8291-2021	Di Somma, Alberto/0000-0002-3253-3448; BRACALE, Umberto Marcello/0000-0001-9507-9791	Karl Storz GmbH and Co. KG, Tuttlingen	Karl Storz GmbH and Co. KG, Tuttlingen	The authors received unrestricted funding from Karl Storz GmbH and Co. KG, Tuttlingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryan HE, 2005, MINIM INVAS NEUROSUR, V48, P293, DOI 10.1055/s-2005-915602; Cappabianca P, 2008, NEUROSURGERY, V62, P575, DOI [10.1227/01.NEU.0000297107.42131.DF, 10.1227/01.neu.0000316262.74843.dd]; Cavallo LM, 2007, CHILD NERV SYST, V23, P665, DOI 10.1007/s00381-007-0332-7; Dandy WE, 1918, ANN SURG, V68, P569, DOI 10.1097/00000658-191812000-00001; Ebner FH, 2015, SURG INNOV, V22, P390, DOI 10.1177/1553350614543382; Ebner FH, 2012, CHILD NERV SYST, V28, P87, DOI 10.1007/s00381-011-1537-3; Fatemi N, 2009, NEUROSURGERY, V64, P269, DOI 10.1227/01.NEU.0000327857.22221.53; Herr HW, 2006, J UROLOGY, V176, P1313, DOI 10.1016/j.juro.2006.06.085; Levy ML, 2008, NEUROSURGERY, V62, P599, DOI [10.1227/01.neu.0000316263.51973.a7, 10.1227/01.NEU.0000220684.16997.31]; Shizuo O, 2005, J NEUROSURG, V102, P113, DOI 10.3171/ped.2005.102.1.0113; Wilson DA, 2014, WORLD NEUROSURG, V82, pS72, DOI 10.1016/j.wneu.2014.07.029; Zada G, 2013, WORLD NEUROSURG, V79, pS3, DOI 10.1016/j.wneu.2013.02.001	12	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147524	10.1371/journal.pone.0147524	http://dx.doi.org/10.1371/journal.pone.0147524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816293	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528200037
J	Peterson, JR; Blieden, LS; Chuang, AZ; Baker, LA; Rigi, M; Feldman, RM; Bell, NP				Peterson, Jeffrey R.; Blieden, Lauren S.; Chuang, Alice Z.; Baker, Laura A.; Rigi, Mohammed; Feldman, Robert M.; Bell, Nicholas P.			Establishing Age-Adjusted Reference Ranges for Iris-Related Parameters in Open Angle Eyes with Anterior Segment Optical Coherence Tomography	PLOS ONE			English	Article							VOLUME; PREVALENCE; MYDRIASIS; GLAUCOMA; ADULTS; WIDTH	Purpose Define criteria for iris-related parameters in an adult open angle population as measured with swept source Fourier domain anterior segment optical coherence tomography (ASOCT). Methods Ninety-eight eyes of 98 participants with open angles were included and stratified into 5 age groups (18-35, 36-45, 46-55, 56-65, and 66-79 years). ASOCT scans with 3D mode angle analysis were taken with the CASIA SS-1000 (Tomey Corporation, Nagoya, Japan) and analyzed using the Anterior Chamber Analysis and Interpretation software. Anterior iris surface length (AISL), length of scleral spur landmark (SSL) to pupillary margin (SSL-to-PM), iris contour ratio (ICR = AISL/SSL-to-PM), pupil radius, radius of iris centroid (RICe), and iris volume were measured. Outcome variables were summarized for all eyes and age groups, and mean values among age groups were compared using one-way analysis of variance. Stepwise regression analysis was used to investigate demographic and ocular characteristic factors that affected each iris-related parameter. Results Mean (+/- SD) values were 2.24 mm (+/- 0.46), 4.06 mm (+/- 0.27), 3.65 mm (+/- 0.48), 4.16 mm (+/- 0.47), 1.14 (+/- 0.04), 1.51 mm(2) (+/- 0.23), and 38.42 mu L (+/- 4.91) for pupillary radius, RICe, SSL-to-PM, AISL, ICR, iris cross-sectional area, and iris volume, respectively. Both pupillary radius (P = 0.002) and RICe (P = 0.027) decreased with age, while SSL-to-PM (P = 0.002) and AISL increased with age (P = 0.001). ICR (P = 0.54) and iris volume (P = 0.49) were not affected by age.	[Peterson, Jeffrey R.; Blieden, Lauren S.; Chuang, Alice Z.; Feldman, Robert M.; Bell, Nicholas P.] Univ Texas Hlth Sci Ctr Houston, UTHlth McGovern Med Sch, Ruiz Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Peterson, Jeffrey R.; Blieden, Lauren S.; Baker, Laura A.; Rigi, Mohammed; Feldman, Robert M.; Bell, Nicholas P.] Robert Cizik Eye Clin, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Bell, NP (corresponding author), Univ Texas Hlth Sci Ctr Houston, UTHlth McGovern Med Sch, Ruiz Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA.; Bell, NP (corresponding author), Robert Cizik Eye Clin, Houston, TX USA.	nbell@cizikeye.org		Feldman, Robert/0000-0001-8586-6345	National Eye Institute Vision Core Grant [P30EY010608]; Research to Prevent Blindness; Hermann Eye Fund; NATIONAL EYE INSTITUTE [P30EY010608] Funding Source: NIH RePORTER	National Eye Institute Vision Core Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hermann Eye Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Eye Institute Vision Core Grant P30EY010608, a Challenge Grant to The University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School from Research to Prevent Blindness, and the Hermann Eye Fund. The funders had no role in study design; collection, analysis, or interpretation of data; manuscript	Aptel F, 2010, OPHTHALMOLOGY, V117, pc, DOI 10.1016/j.ophtha.2009.10.030; Blieden LS, 2015, INVEST OPHTH VIS SCI, V56, P2842, DOI 10.1167/iovs.14-15883; Chan FM, 2015, LARYNGOSCOPE; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cumba RJ, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/487309; Dorairaj Syril, 2007, Trans Am Ophthalmol Soc, V105, P99; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Invernizzi A, 2015, INVEST OPHTH VIS SCI, V56, P4796, DOI 10.1167/iovs.15-16483; Lee RY, 2015, AM J OPHTHALMOL, V160, P506, DOI 10.1016/j.ajo.2015.06.002; Matsuki T, 2015, J GLAUCOMA, V24, P144, DOI 10.1097/IJG.0000000000000090; Mayama C, 2015, INVEST OPHTH VIS SCI, V56, P5681, DOI 10.1167/iovs.15-17208; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P708, DOI 10.1167/iovs.12-10844; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Rigi M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/590978; Seager FE, 2014, INVEST OPHTH VIS SCI, V55, P1672, DOI 10.1167/iovs.13-13641; Sharma R, 2015, J CLIN DIAGN RES, V9, DOI 10.7860/JCDR/2015/12764.6181; Spaeth G L, 1995, Trans Am Ophthalmol Soc, V93, P337; Spaeth G L, 1971, Trans Ophthalmol Soc U K, V91, P709; Tun TA, 2014, GRAEF ARCH CLIN EXP, V252, P1127, DOI 10.1007/s00417-014-2636-0; Wang YE, 2013, INVEST OPHTH VIS SCI, V54, P7717, DOI 10.1167/iovs.13-12850; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Yun SC, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/581719; Zhang Y, 2014, INVEST OPHTH VIS SCI, V55, P4405, DOI 10.1167/iovs.13-13782	23	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147760	10.1371/journal.pone.0147760	http://dx.doi.org/10.1371/journal.pone.0147760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815917	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200047
J	Pizzi, R; Wang, R; Rossetti, D				Pizzi, Rita; Wang, Rui; Rossetti, Danilo			Human Visual System as a Double-Slit Single Photon Interference Sensor: A Comparison between Modellistic and Biophysical Tests	PLOS ONE			English	Article							DELAYED-CHOICE; MODULATION SENSITIVITY; QUANTUM-THEORY; RETINAL RODS; REPRODUCIBILITY; INFORMATION; RHODOPSIN; RESPONSES; LIGHT; PHOSPHORYLATION	This paper describes a computational approach to the theoretical problems involved in the Young's single-photon double-slit experiment, focusing on a simulation of this experiment in the absence of measuring devices. Specifically, the human visual system is used in place of a photomultiplier or similar apparatus. Beginning with the assumption that the human eye perceives light in the presence of very few photons, we measure human eye performance as a sensor in a double-slit one-photon-at-a-time experimental setup. To interpret the results, we implement a simulation algorithm and compare its results with those of human subjects under identical experimental conditions. In order to evaluate the perceptive parameters exactly, which vary depending on the light conditions and on the subject's sensitivity, we first review the existing literature on the biophysics of the human eye in the presence of a dim light source, and then use the known values of the experimental variables to set the parameters of the computational simulation. The results of the simulation and their comparison with the experiment involving human subjects are reported and discussed. It is found that, while the computer simulation indicates that the human eye has the capacity to detect the corpuscular nature of photons under these conditions, this was not observed in practice. The possible reasons for the difference between theoretical prediction and experimental results are discussed.	[Pizzi, Rita; Wang, Rui; Rossetti, Danilo] Univ Milan, Dept Comp Sci, Milan, Italy	University of Milan	Pizzi, R (corresponding author), Univ Milan, Dept Comp Sci, Milan, Italy.	rita.pizzi@unimi.it	Pizzi, Rita/AAR-6563-2020	Pizzi, Rita/0000-0001-9447-7632				Adler SL, 2007, J PHYS A-MATH THEOR, V40, P2935, DOI 10.1088/1751-8113/40/12/S03; [Anonymous], 1956, AM J PHYS, V24, P272, DOI [DOI 10.1119/1.1934204, 10.1119/1.1934204]; [Anonymous], 1955, N BOHR DEV PHYS; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BARLOW HB, 1962, J PHYSIOL-LONDON, V160, P169, DOI 10.1113/jphysiol.1962.sp006839; BARTELL LS, 1980, PHYS REV D, V21, P1698, DOI 10.1103/PhysRevD.21.1698; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BELL J, 1990, PHYS WORLD, V3, P33, DOI 10.1088/2058-7058/3/8/26; Bell J. S., 2004, SPEAKABLE UNSPEAKABL, V2nd, DOI DOI 10.1017/CBO9780511815676; Bernroider G., 2016, PREPRINT; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; Bialek W., 2012, SEARCHING PRICIPLES; Bitbol M., 1996, BOSTON STUDIES PHILO, V188; Bloch AM, 1885, PARIS SOC BIOL MEM, P493; BOHM D, 1952, PHYS REV, V85, P166, DOI 10.1103/PhysRev.85.166; Bohm D., 1993, UNDIVIDED UNIVERSE O; Bohm D., 1951, QUANTUM THEORY; Bohr N., 1958, ATOMIC PHYSICS HUMAN, P67; Bohr N., 1934, ATOMIC THEORY FUNDAM; Bohr N., 1949, A EINSTEIN PHILOS SC, P201; Bohr N., 1987, PHILOS WRITINGS N BO, V2; Born M., 1953, BRIT J PHILOS SCI, V4, P95; BRINDLEY GS, 1954, J PHYSIOL-LONDON, V124, P400, DOI 10.1113/jphysiol.1954.sp005116; Brown J.L., 1965, VISION VISUAL PERCEP, P251; BROWN RH, 1957, PROC R SOC LON SER-A, V242, P300, DOI 10.1098/rspa.1957.0177; Brunner N, 2008, PHYS REV A, V78, P5; Bub J., 1997, INTERPRETING QUANTUM; Chen SS, 1996, P SOC PHOTO-OPT INS, V2824, P115, DOI 10.1117/12.258123; Chichilnisky EJ, 2005, J NEUROSCI, V25, P318, DOI 10.1523/JNEUROSCI.2339-04.2005; Clifton R, 2003, FOUND PHYS, V33, P1561, DOI 10.1023/A:1026056716397; CRAMER JG, 1986, REV MOD PHYS, V58, P647, DOI 10.1103/RevModPhys.58.647; CRAWFORD BH, 1947, PROC R SOC SER B-BIO, V134, P283, DOI 10.1098/rspb.1947.0015; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; DELANGEDZN H, 1958, J OPT SOC AM, V48, P784, DOI 10.1364/JOSA.48.000784; DeWitt CM, 1967, BATTELLE RENCONTRES, P318; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; DONATI O, 1973, AM J PHYS, V41, P639, DOI 10.1119/1.1987321; DOWKER F, 1995, PHYS REV LETT, V75, P3038, DOI 10.1103/PhysRevLett.75.3038; Eibenberger S, 2013, PHYS CHEM CHEM PHYS, V15, P14696, DOI 10.1039/c3cp51500a; Engel GS, 2011, PROCEDIA CHEM, V3, DOI 10.1016/j.proche.2011.08.029; Englert BG, 1996, PHYS REV LETT, V77, P2154, DOI 10.1103/PhysRevLett.77.2154; EVERETT H, 1957, REV MOD PHYS, V29, P454, DOI 10.1103/RevModPhys.29.454; Everett III H, 1956, THESIS PRINCETON U, P1; FAIN GL, 1975, SCIENCE, V187, P838, DOI 10.1126/science.1114328; Feynman R. P., 1988, QED STRANGE THEORY L; Feynman RP, 1965, LECT PHYS, VIII; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Fry TC, 1929, PROBABILITY ITS ENG; Fuchs CA, 2011, FOUND PHYS, V41, P345, DOI 10.1007/s10701-009-9404-8; Fulton JT, 2014, VISION CONCEPTS; FUORTES MGF, 1964, J GEN PHYSIOL, V47, P443, DOI 10.1085/jgp.47.3.443; Gell-Mann M, 1990, P 25 INT C HIGH EN P; Gell-Mann M, 1990, COMPLEXITY ENTROPY P, VVIII; Georgiev D, 2011, NEUROQUANTOLOGY, V9, P206; GHIRARDI GC, 1986, PHYS REV D, V34, P470, DOI 10.1103/PhysRevD.34.470; Ghirardi GC, 1985, MODEL UNIFIED QUANTU; Graham CH, 1965, VISION VISUAL PERCEP; GREEN M, 1981, VISION RES, V21, P861, DOI 10.1016/0042-6989(81)90186-3; Green M., 1984, PERCEPT PSYCHOPHYS, V34, P617; Griffiths R.B., 2003, CONSISTENT QUANTUM T; Hamer RD, 2003, J GEN PHYSIOL, V122, P419, DOI 10.1085/jgp.200308832; Hameroff S, 2006, FRONT COLLECT, P193, DOI 10.1007/3-540-36723-3_6; Harrigan N, 2010, FOUND PHYS, V40, P125, DOI 10.1007/s10701-009-9347-0; Hart W. M., 1987, ADLERS PHYSL EYE CLI, P429; Hayes FC, 1952, PHILOS PROBLEMS NUCL, P11; Hecht S, 1936, J GEN PHYSIOL, V19, P965, DOI 10.1085/jgp.19.6.965; Hecht S, 1922, J GEN PHYSIOL, V5, P1, DOI 10.1085/jgp.5.1.1; HECHT S, 1942, J OPT SOC AM, V38, P196; Heisenberg W., 1952, PHILOSOPHIC PROBLEMS, P41; Heisenberg Werner, 1958, PHYS PHILOS REVOLUTI, P44; Jacques V, 2007, SCIENCE, V315, P966, DOI 10.1126/science.1136303; Jammer M., 1974, PHILOS QUANTUM MECH; Jordan P., 1949, PHILOS SCI, V16, P269; JORDAN TF, 1993, PHYS REV A, V48, P2449, DOI 10.1103/PhysRevA.48.2449; Kandel E., 2000, PRINCIPLES NEURAL SC; Kim YH, 2000, PHYS REV LETT, V84, P1, DOI 10.1103/PhysRevLett.84.1; Koczyk P, 1996, AM J PHYS, V64, P240, DOI 10.1119/1.18211; KRAUSKOPF J, 1971, J PHYSIOL-LONDON, V219, P611, DOI 10.1113/jphysiol.1971.sp009680; Kwait PG, 2004, SCI ULTIMATE REALITY, P306; KWIAT PG, 1994, PHYS REV A, V49, P61, DOI 10.1103/PhysRevA.49.61; Langley S., 1889, PHILOS MAG, V27, P1; Manasseh G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00845; Ricci MLM, 2007, AM J PHYS, V75, P707, DOI 10.1119/1.2742400; Mehta DS, 2010, J LUMIN, V130, P96, DOI 10.1016/j.jlumin.2009.07.027; METHA AB, 1994, J OPT SOC AM A, V11, P1697, DOI 10.1364/JOSAA.11.001697; Namsrai K., 1985, NONLOCAL QUANTUM FIE; NICHIA Co, LIGHT EM DIOD LED; Omnes R., 1999, UNDERSTANDING QUANTU; OptoSigma Co, OPT COMP; Osterberg G, 1935, Acta Ophthalmol., V13, P11; PARKER S, 1972, AM J PHYS, V40, P1003, DOI 10.1119/1.1986731; Parker S, 1970, AM J PHYS, V39, P420; Penrose R, 1998, PHILOS T R SOC A, V356, P1927, DOI 10.1098/rsta.1998.0256; Peruzzo A, 2012, SCIENCE, V338, P634, DOI 10.1126/science.1226719; Potter MC, 2014, ATTEN PERCEPT PSYCHO, V76, P270, DOI 10.3758/s13414-013-0605-z; Purcell E., 1956, NATURE, V178, P1046; Rahnama M, 2009, NEUROQUANTOLOGY, V7, P491; Reingruber J, 2013, P NATL ACAD SCI USA, V110, P19378, DOI 10.1073/pnas.1314030110; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; Rosenfeld L, 1979, SELECTED PAPERS LEON, P536; Rosenfeld L., 1973, BOSTON STUDIES PHILO, V21, P688; Rovelli C, 1996, INT J THEOR PHYS, V35, P1637, DOI 10.1007/BF02302261; RUSHTON WAH, 1956, J PHYSIOL-LONDON, V134, P11, DOI 10.1113/jphysiol.1956.sp005622; RUSHTON WAH, 1956, J PHYSIOL-LONDON, V134, P30, DOI 10.1113/jphysiol.1956.sp005623; SAKITT B, 1972, J PHYSIOL-LONDON, V223, P131, DOI 10.1113/jphysiol.1972.sp009838; Sarovar M, 2010, NAT PHYS, V6, P462, DOI [10.1038/NPHYS1652, 10.1038/nphys1652]; Scharnowski F, 2007, VISION RES, V47, P2444, DOI 10.1016/j.visres.2007.05.004; Schlosshauer M, 2004, REV MOD PHYS, V76, P1267, DOI 10.1103/RevModPhys.76.1267; Schrodinger E., 1935, NATURWISSENSCHAFTEN, V23, P23; Schulten K, 2014, QUANTUM EFFECT BIOL; SCULLY MO, 1982, PHYS REV A, V25, P2208, DOI 10.1103/PhysRevA.25.2208; Sekatski P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.113601; Sia PI, 2014, CLIN EXP OPHTHALMOL, V42, P582, DOI 10.1111/ceo.12373; Stapp H.P., 1993, MIND MATTER QUANTUM; Strini G, 2009, EUR PHYS J D, V54, P723, DOI 10.1140/epjd/e2009-00207-5; Stryer L, 1996, P NATL ACAD SCI USA, V93, P557, DOI 10.1073/pnas.93.2.557; Taschenbuch H., 2001, SENSATION PERCEPTION; TeachSpin Inc., 2 SLIT INT ON PHOT T; Tegmark M, 2007, NATURE, V448, P23, DOI 10.1038/448023a; Thaheld FH, 2015, BIOSYSTEMS, V135, P50, DOI 10.1016/j.biosystems.2015.07.005; Timpson C., 2013, QUANTUM INFORM THEOR; TONOMURA A, 1989, AM J PHYS, V57, P117, DOI 10.1119/1.16104; Tscherbul TV, 2015, PHYS CHEM CHEM PHYS; Tsekov R., 2009, NEW ADV PHYS, V3, P35; TYLER CW, 1990, J OPT SOC AM A, V7, P743, DOI 10.1364/JOSAA.7.000743; TYLER CW, 1985, J OPT SOC AM A, V2, P393, DOI 10.1364/JOSAA.2.000393; van Fraassen BC, 2010, FOUND PHYS, V40, P390, DOI 10.1007/s10701-009-9326-5; VANDERVELDEN HA, 1946, OPHTHALMOLOGICA, V111, P321, DOI 10.1159/000300352; von Neumann J., 1932, MATH GRUNDLAGEN QUAN; Walborn SP, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033818; Weizsacker C. F. V., 1987, S FDN MOD PHYS COP I, P277; WEIZSACKER CF, 1971, QUANTUM THEORY, P25; Wheeler J. A., 1983, QUANTUM THEORY MEASU; Wheeler J.A., 1973, MANY WORLDS INTERPRE, VIII; Wheeler J.A., 1998, GEONS BLACK HOLES QU; Wigner E., 1995, COLLECTED WORKS E B, V6; WIGNER EP, 1963, AM J PHYS, V31, P6, DOI 10.1119/1.1969254; Woodward E., 2008, THESIS ROCHESTER I T; Woolf NJ, 2001, TRENDS COGN SCI, V5, P472, DOI 10.1016/S1364-6613(00)01774-5; ZAJONC AG, 1991, NATURE, V353, P507, DOI 10.1038/353507b0; Zeh HD, 2011, EUR PHYS J H, V36, P63, DOI 10.1140/epjh/e2011-10035-2; Zeh H. D., 1970, FOUND PHYS, V1, P69, DOI DOI 10.1007/BF00708656; Zeh HD, 2000, FOUND PHYS LETT, V13, P221, DOI 10.1023/A:1007895803485; Zeilinger A, 1999, REV MOD PHYS, V71, pS288, DOI 10.1103/RevModPhys.71.S288; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715; Zurek WH, 2000, ANN PHYS, V9, P822	149	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147464	10.1371/journal.pone.0147464	http://dx.doi.org/10.1371/journal.pone.0147464			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816029	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200035
J	Brown, BM; Stallings, JW; Clay, JS; Rhoads, ML				Brown, Britni M.; Stallings, Jon W.; Clay, John S.; Rhoads, Michelle L.			Periconceptional Heat Stress of Holstein Dams Is Associated with Differences in Daughter Milk Production during Their First Lactation	PLOS ONE			English	Article							SIRE; COWS	The fertility of lactating Holstein cows is severely reduced during periods of heat stress. Despite this reduction in fertility, however, some inseminations conducted during heat stress result in successful pregnancies from which heifer calves are born. Many of these heifer calves are retained and raised to enter the milking herd as replacement animals. Heat stress experienced by these females around the time they were conceived may confer long-lasting effects that alter subsequent milk production capacity. The objective of this study was to examine the relationship between periconceptional heat stress and subsequent milk production of primiparous cows. National Dairy Herd Improvement Association data was obtained from Dairy Records Management Systems. Records included Holstein cows that had completed at least one lactation in one of three states with large populations of dairy cattle and which are known for having hot, humid summers: Georgia, Florida or Texas. Dates of conception were calculated by subtracting 276 d from the recorded birth date of each individual cow. Records for cows conceived within the months of June, July, and August were retained as heat stress-conceived (HSC) cows (n = 94,440); cows conceived within the months of December, January, and February were retained as thermoneutral-conceived (TNC) contemporaries (n = 141,365). In order to account for the effects of environmental conditions on total milk production for a given lactation, cows were blocked by season of calving (winter, spring, summer or fall). Adjusted 305-day mature-equivalent milk production was evaluated with a mixed model ANOVA using SAS, in which random effects were used to account for variability between herds. Of the cows that calved in the summer, fall and winter, TNC cows had higher milk yield than the HSC cows in all states. Interestingly, the cows that calved in the spring presented a unique relationship, with HSC cows producing more milk. Overall however, heat stress at the time of conception is associated with lower milk production during the first lactation. While this association does not prove cause and effect, it does provide justification for additional investigation into whether heat stress around the time of conception results in long-term, detrimental consequences for the conceptus.	[Brown, Britni M.; Rhoads, Michelle L.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Stallings, Jon W.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Clay, John S.] N Carolina State Univ, Dept Anim Sci, Box 7621, Raleigh, NC 27695 USA	Virginia Polytechnic Institute & State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Rhoads, ML (corresponding author), Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	rhoadsm@vt.edu		Clay, John/0000-0001-7273-225X; Stallrich, Jonathan/0000-0002-0180-9309; Rhoads, Michelle/0000-0003-4652-6430	Virginia Agricultural Experiment Station; National Institute of Food and Agriculture, U.S. Department of Agriculture; Virginia Tech Open Access Subvention Fund	Virginia Agricultural Experiment Station; National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Virginia Tech Open Access Subvention Fund	Funding for this work was provided, in part, by the Virginia Agricultural Experiment Station and the Hatch Program of the National Institute of Food and Agriculture, U.S. Department of Agriculture and the Virginia Tech Open Access Subvention Fund.	Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Brown BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133574; COLLIER RJ, 1982, J DAIRY SCI, V65, P2213, DOI 10.3168/jds.S0022-0302(82)82484-3; Cruzen SM, 2014, J ANIM SCI UNPUB; Dhakal K, 2013, J DAIRY SCI, V96, P690, DOI 10.3168/jds.2012-5817; Dikmen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069202; Gaughan J. B., 2012, Environmental physiology of livestock, P243; Hernandez CE, 2010, PHYSIOL BEHAV, V101, P588, DOI 10.1016/j.physbeh.2010.08.020; Li QL, 2011, DNA CELL BIOL, V30, P247, DOI 10.1089/dna.2010.1133; Pegorer MF, 2007, THERIOGENOLOGY, V67, P692, DOI 10.1016/j.theriogenology.2006.09.042; Ravagnolo O, 2000, J DAIRY SCI, V83, P2120, DOI 10.3168/jds.S0022-0302(00)75094-6; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Satrapa RA, 2011, THERIOGENOLOGY, V76, P1162, DOI 10.1016/j.theriogenology.2011.05.026; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294; Zimbelman R. B., 2009, REEVALUATION IMACT T, P158	16	12	12	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148234	10.1371/journal.pone.0148234	http://dx.doi.org/10.1371/journal.pone.0148234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840076	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200105
J	Hare, JA; Morrison, WE; Nelson, MW; Stachura, MM; Teeters, EJ; Griffis, RB; Alexander, MA; Scott, JD; Alade, L; Bell, RJ; Chute, AS; Curti, KL; Curtis, TH; Kircheis, D; Kocik, JF; Lucey, SM; McCandless, CT; Milke, LM; Richardson, DE; Robillard, E; Walsh, HJ; McManus, MC; Marancik, KE; Griswold, CA				Hare, Jonathan A.; Morrison, Wendy E.; Nelson, Mark W.; Stachura, Megan M.; Teeters, Eric J.; Griffis, Roger B.; Alexander, Michael A.; Scott, James D.; Alade, Larry; Bell, Richard J.; Chute, Antonie S.; Curti, Kiersten L.; Curtis, Tobey H.; Kircheis, Daniel; Kocik, John F.; Lucey, Sean M.; McCandless, Camilla T.; Milke, Lisa M.; Richardson, David E.; Robillard, Eric; Walsh, Harvey J.; McManus, M. Conor; Marancik, Katrin E.; Griswold, Carolyn A.			A Vulnerability Assessment of Fish and Invertebrates to Climate Change on the Northeast US Continental Shelf	PLOS ONE			English	Article							OCEAN ACIDIFICATION; THERMAL TOLERANCE; SPECIES TRAITS; UNITED-STATES; RANGE SHIFTS; MARINE FISH; FISHERIES; IMPACTS; TEMPERATURE; RIVER	Climate change and decadal variability are impacting marine fish and invertebrate species worldwide and these impacts will continue for the foreseeable future. Quantitative approaches have been developed to examine climate impacts on productivity, abundance, and distribution of various marine fish and invertebrate species. However, it is difficult to apply these approaches to large numbers of species owing to the lack of mechanistic understanding sufficient for quantitative analyses, as well as the lack of scientific infrastructure to support these more detailed studies. Vulnerability assessments provide a framework for evaluating climate impacts over a broad range of species with existing information. These methods combine the exposure of a species to a stressor (climate change and decadal variability) and the sensitivity of species to the stressor. These two components are then combined to estimate an overall vulnerability. Quantitative data are used when available, but qualitative information and expert opinion are used when quantitative data is lacking. Here we conduct a climate vulnerability assessment on 82 fish and invertebrate species in the Northeast U.S. Shelf including exploited, forage, and protected species. We define climate vulnerability as the extent to which abundance or productivity of a species in the region could be impacted by climate change and decadal variability. We find that the overall climate vulnerability is high to very high for approximately half the species assessed; diadromous and benthic invertebrate species exhibit the greatest vulnerability. In addition, the majority of species included in the assessment have a high potential for a change in distribution in response to projected changes in climate. Negative effects of climate change are expected for approximately half of the species assessed, but some species are expected to be positively affected (e.g., increase in productivity or move into the region). These results will inform research and management activities related to understanding and adapting marine fisheries management and conservation to climate change and decadal variability.	[Hare, Jonathan A.; Bell, Richard J.; McCandless, Camilla T.; Richardson, David E.; Walsh, Harvey J.; Griswold, Carolyn A.] NOAA, NMFS, Northeast Fisheries Sci Ctr, Narragansett Lab, 28 Tarzwell Dr, Narragansett, RI 02818 USA; [Morrison, Wendy E.; Nelson, Mark W.; Teeters, Eric J.] NOAA, Earth Resources Technol Inc, NMFS, Off Sustainable Fisheries, 1315 East West Highway, Silver Spring, MD 20910 USA; [Stachura, Megan M.] NOAA, NMFS, Off Sustainable Fisheries, 1315 East West Highway, Silver Spring, MD 20910 USA; [Griffis, Roger B.] NOAA, NMFS, Off Sci & Technol, 1315 East West Highway, Silver Spring, MD 20910 USA; [Alexander, Michael A.; Scott, James D.] NOAA, OAR, Earth Syst Res Lab, 325 Broadway, Boulder, CO 80305 USA; [Alade, Larry; Chute, Antonie S.; Curti, Kiersten L.; Lucey, Sean M.; Robillard, Eric] NOAA, NMFS, Northeast Fisheries Sci Ctr, Woods Hole Lab, 166 Water St, Woods Hole, MA 02543 USA; [Curtis, Tobey H.] NOAA, NMFS, Greater Atlantic Reg Fisheries Off, 55 Great Republic Dr, Gloucester, MA 01930 USA; [Kircheis, Daniel; Kocik, John F.] NOAA, NMFS, Northeast Fisheries Sci Ctr, Maine Field Stn, 17 Godfrey Dr,Suite 1, Orono, ME 04473 USA; [Milke, Lisa M.] NOAA, NMFS, Northeast Fisheries Sci Ctr, Milford Lab, 212 Rogers Ave, Milford, CT 06460 USA; [McManus, M. Conor; Marancik, Katrin E.] NOAA, Integrated Stat, NMFS, Northeast Fisheries Sci Ctr,Narragansett Lab, 28 Tarzwell Dr, Narragansett, RI 02818 USA; [Stachura, Megan M.] NOAA, ECS Fed Inc, NMFS, NW Fisheries Sci Ctr, 2725 Montlake Blvd E, Seattle, WA 98112 USA; [Bell, Richard J.] Univ Rhode Isl, Nat Conservancy, Bay Campus, Narragansett, RI 02882 USA; [McManus, M. Conor] Univ Rhode Isl, Grad Sch Oceanog, 215 S Ferry Rd, Narragansett, RI 02882 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Nature Conservancy; University of Rhode Island; University of Rhode Island	Hare, JA (corresponding author), NOAA, NMFS, Northeast Fisheries Sci Ctr, Narragansett Lab, 28 Tarzwell Dr, Narragansett, RI 02818 USA.	jon.hare@noaa.gov	Alexander, Michael A/A-7097-2013; Kocik, John/AAV-7558-2021	Alexander, Michael A/0000-0001-9646-6427; Curtis, Tobey/0000-0003-0164-7335; McManus, Conor/0000-0003-3504-0371; Scott, James D/0000-0002-8709-8594; Griffis, Roger/0000-0001-9329-2230	National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Science and Technology; NOAA NMFS Office of Sustainable Fisheries; NOAA OAR Earth System Laboratory; NOAA NMFS Greater Atlantic Regional Fisheries Office; NOAA NMFS Northeast Fisheries Science Center; NOAA Ocean Acidification Program; NOAA NMFS Office of Science and Technology	National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Science and Technology; NOAA NMFS Office of Sustainable Fisheries; NOAA OAR Earth System Laboratory; NOAA NMFS Greater Atlantic Regional Fisheries Office; NOAA NMFS Northeast Fisheries Science Center; NOAA Ocean Acidification Program; NOAA NMFS Office of Science and Technology	Funding for this project was provided by the National Oceanic and Atmospheric Administration (NOAA) NMFS Office of Science and Technology, NOAA NMFS Office of Sustainable Fisheries, NOAA OAR Earth System Laboratory, NOAA NMFS Greater Atlantic Regional Fisheries Office, NOAA NMFS Northeast Fisheries Science Center, and the NOAA Ocean Acidification Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by the NOAA NMFS Office of Science and Technology, NOAA NMFS Office of Sustainable Fisheries, NOAA OAR Earth System Laboratory, NOAA NMFS Greater Atlantic Regional Fisheries Office, NOAA NMFS Northeast Fisheries Science Center, and the NOAA Ocean Acidification Program. We thank Antonietta Capotondi, Vince Saba, and Charles Stock for contributing to the description of projected changes in ocean currents in the Northwest Atlantic Ocean. We thank Mike Johnson for contributing to the description of projected sea level rise in the region. We thank Richard Balouskus, Diane Borggaard, Edith Carson, Sarah Laporte, Lynn Lankshear, Jessica Pruden, Rory Saunders, and Tara Trinko Lake for completing species profiles in preparation for the assessment. We thank Kim Hare for formatting references here and in the Supplemental Material and we thank Kris Gamble for help with the figures. Finally, we thank Diane Borggaard and Kimberly Damon-Randall for the encouragement and support throughout the project (before the beginning to the end). We also thank Ken Drinkwater, Jeff Hutchings, and Nick Caputi for their thoughtful and constructive advice during a Council of Independent Experts review of the Climate Vulnerability Assessment Methodology and this Northeast fisheries climate vulnerability assessment. Acknowledgment of the above individuals does not imply their endorsement of this work; the authors have sole responsibility for the content of this contribution. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its subagencies.	Able K. W., 2010, ECOLOGY ESTUARINE FI; [Anonymous], 2011, SCANNING CONSERVATIO; Atlantic States Marine Fisheries Commission (ASMFC), 2010, ATL CROAK 2010 BENCH; Barbier EB, 2012, REV ENV ECON POLICY, V6, P1, DOI 10.1093/reep/rer017; BAUMGARTNER TR, 1992, CAL COOP OCEAN FISH, V33, P24; Beever EA, 2016, CONSERV LETT, V9, P131, DOI 10.1111/conl.12190; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Bell RJ, 2014, ICES J MAR SCI, V71, P2416, DOI 10.1093/icesjms/fsu069; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Busch DS, 2013, ICES J MAR SCI, V70, P823, DOI 10.1093/icesjms/fst061; Chambers RC, 2014, BIOGEOSCIENCES, V11, P1613, DOI 10.5194/bg-11-1613-2014; Cheung WWL, 2015, PROG OCEANOGR, V130, P19, DOI 10.1016/j.pocean.2014.09.003; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Collette B. B, 2002, BIGELOW SCHROEDERS F, V3rd; Cooley SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124145; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; CRECCO VA, 1985, CAN J FISH AQUAT SCI, V42, P1640, DOI 10.1139/f85-205; Doubleday ZA, 2013, AQUACULT ENV INTERAC, V3, P163, DOI 10.3354/aei00058; Earth Systems Research Laboratory, 2014, NOAAS OC CLIM CHANG; Federal Register, FED REG, V78, P48944; Flato G., 2013, CONTRIBUTION WORKING, DOI DOI 10.1017/CB09781107415324.020; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Fogarty M, 2008, MITIG ADAPT STRAT GL, V13, P453, DOI 10.1007/s11027-007-9131-4; Friedland KD, 2007, CONT SHELF RES, V27, P2313, DOI 10.1016/j.csr.2007.06.001; Gaichas SK, 2014, ICES J MAR SCI, V71, P2323, DOI 10.1093/icesjms/fsu048; Gamito R, 2015, FISH RES, V161, P207, DOI 10.1016/j.fishres.2014.07.014; Garcia RA, 2014, J BIOGEOGR, V41, P724, DOI 10.1111/jbi.12257; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Griffis R., 2015, NMFSOSF3148 NOAA, P48; Hahn ME, 2011, AQUAT TOXICOL, V105, P67, DOI 10.1016/j.aquatox.2011.06.001; Hall CJ, 2011, LANDSCAPE ECOL, V26, P95, DOI 10.1007/s10980-010-9539-1; Hare JA, 2007, FISH OCEANOGR, V16, P31, DOI 10.1111/j.1365-2419.2006.00407.x; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; HETTLER WF, 1976, J FISH BIOL, V8, P55, DOI 10.1111/j.1095-8649.1976.tb03907.x; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Hollowed AB, 2009, ICES J MAR SCI, V66, P1584, DOI 10.1093/icesjms/fsp057; Jepson M., 2013, NOAA TECHNICAL MEMOR, P1; Ji RB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032010; Johnson JE, 2010, REV FISH SCI, V18, P106, DOI 10.1080/10641260903434557; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lehodey P, 2010, PROG OCEANOGR, V86, P302, DOI 10.1016/j.pocean.2010.04.021; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Link J. S., 2010, ECOSYSTEM BASED FISH; Link JS, 2011, FISH FISH, V12, P461, DOI 10.1111/j.1467-2979.2010.00398.x; Lovell S, 2011, 2013NMFSFSPO134 NOAA; Lynch PD, 2015, ICES J MAR SCI, V72, P374, DOI 10.1093/icesjms/fsu134; Mahrosh U, 2014, J HAZARD MATER, V280, P331, DOI 10.1016/j.jhazmat.2014.07.076; Mathis JT, 2015, PROG OCEANOGR, V136, P71, DOI 10.1016/j.pocean.2014.07.001; McKibben B, 2014, NEW YORK REV BOOKS, V61, P46; Methot RD, 2009, FISH FISHERIES SERIE, V31, P137, DOI 10.1007/978-1-4020-9210-7_9; Mid-Atlantic Fishery Management Council (MAFMC), PROT UNM FOR SPEC; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Murdy EO., 1997, FISHES CHESAPEAKE BA, P324; National Marine Fisheries Service, 2014, COMM FISH STAT; National Marine Fisheries Service, NMFS PROACT CONS PRO; National Marine Fisheries Service, 2010, NMFSFSPO108 NOAA US; National Marine Fisheries Service, END THREAT MAR SPEC; Northeast Fisheries Science Center, 2014, NE REG STOCK ASS WOR; Northeast Fisheries Science Center, 2012, 54 NE REG STOCK ASS, V12-18; Northeast Fisheries Science Center, 2014, EFH SOURC DOC LIF HI; Northeast Fisheries Science Center (NEFSC), 2008, 3 GROUNDF ASS REV M; Nye JA, 2013, ECOL MODEL, V264, P157, DOI 10.1016/j.ecolmodel.2012.08.019; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Patrick WS, 2010, FISH B-NOAA, V108, P305; Pecl GT, 2014, CLIMATIC CHANGE, V127, P505, DOI 10.1007/s10584-014-1284-z; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Petitgas P, 2012, MAR ECOL PROG SER, V444, P1, DOI 10.3354/meps09451; Pilgrim JM, 1998, J AM WATER RESOUR AS, V34, P1109, DOI 10.1111/j.1752-1688.1998.tb04158.x; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Saba V, REVIEW; Seney EE, 2013, CONSERV BIOL, V27, P1138, DOI 10.1111/cobi.12167; Shackell NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090662; Signorini SR, 2013, J GEOPHYS RES-OCEANS, V118, P5439, DOI 10.1002/jgrc.20369; Solomon A, 2011, B AM METEOROL SOC, V92, P141, DOI 10.1175/2010BAMS2962.1; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Stortini CH, 2015, ICES J MAR SCI, V72, P1731, DOI 10.1093/icesjms/fsv022; Strayer DL, 2014, BIOSCIENCE, V64, P496, DOI 10.1093/biosci/biu061; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Titus J. G., 2009, Coastal sensitivity to sea-level rise: a focus on the Mid-Atlantic Region; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Veilleux HD, 2015, NAT CLIM CHANGE, V5, P1074, DOI [10.1038/nclimate2724, 10.1038/NCLIMATE2724]; Walsh HJ, 2005, T AM FISH SOC, V134, P910, DOI 10.1577/T04-060.1; Walsh HJ, PLOS ONE IN PRESS; Walther BD, 2008, T AM FISH SOC, V137, P57, DOI 10.1577/T07-029.1; Weinberg JR, 2005, ICES J MAR SCI, V62, P1444, DOI 10.1016/j.icesjms.2005.04.020; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	106	284	292	4	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146756	10.1371/journal.pone.0146756	http://dx.doi.org/10.1371/journal.pone.0146756			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839967	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200013
J	Kim, K; Kim, N; Lee, GR				Kim, Kiwan; Kim, Najung; Lee, Gap Ryol			Transcription Factors Oct-1 and GATA-3 Cooperatively Regulate Th2 Cytokine Gene Expression via the RHS5 within the Th2 Locus Control Region	PLOS ONE			English	Article							RANGE INTRACHROMOSOMAL INTERACTIONS; HELPER TYPE-2 CYTOKINE; CD4 T-CELLS; OCTAMER FACTORS; ETS-DOMAIN; DIFFERENTIATION; BINDING; RESPONSES; PROMOTER; ELEMENTS	The T helper type 2 (Th2) locus control region (LCR) regulates Th2 cell differentiation. Several transcription factors bind to the LCR to modulate the expression of Th2 cytokine genes, but the molecular mechanisms behind Th2 cytokine gene regulation are incompletely understood. Here, we used database analysis and an oligonucleotide competition/electrophoretic mobility shift assays to search for transcription factors binding to RHS5, a DNase I hypersensitive site (DHS) within the Th2 LCR. Consequently, we demonstrated that GATA-binding protein-3 (GATA-3), E26 transformation-specific protein 1 (Ets-1), octamer transcription factor-1 (Oct-1), and Oct-2 selectively associate with RHS5. Furthermore, chromatin immunoprecipitation and luciferase reporter assays showed that Oct-1 and Oct-2 bound within the Il4 promoter region and the Th2 LCR, and that Oct-1 and GATA-3 or Oct-2 synergistically triggered the transactivational activity of the Il4 promoter through RHS5. These results suggest that Oct-1 and GATA-3/Oct-2 direct Th2 cytokine gene expression in a cooperative manner.	[Kim, Kiwan; Kim, Najung; Lee, Gap Ryol] Sogang Univ, Dept Life Sci, Seoul, South Korea	Sogang University	Lee, GR (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	grlee@sogang.ac.kr			National Research Foundation of Korea (NRF) - Korean government, Ministry of Science, ICT & Future Planning, Republic of Korea [2014-052545]	National Research Foundation of Korea (NRF) - Korean government, Ministry of Science, ICT & Future Planning, Republic of Korea	This work was supported by a National Research Foundation of Korea (NRF) grant funded by Korean government (2014-052545), Ministry of Science, ICT & Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Brunner C, 2007, EMBO J, V26, P3191, DOI 10.1038/sj.emboj.7601742; dela Paz NG, 2007, J BIOL CHEM, V282, P8424, DOI 10.1074/jbc.M606923200; Deyev IE, 2004, MOL BIOL+, V38, P40, DOI 10.1023/B:MBIL.0000015138.80503.81; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Grenningloh K, 2005, J EXP MED, V201, P615, DOI 10.1084/jem.20041330; Hwang SS, 2013, P NATL ACAD SCI USA, V110, P276, DOI 10.1073/pnas.1214682110; Hwang SS, 2011, BIOCHEM BIOPH RES CO, V410, P866, DOI 10.1016/j.bbrc.2011.06.080; Hwang SS, 2010, IMMUNOLOGY, V131, P50, DOI 10.1111/j.1365-2567.2010.03271.x; Kim LK, 2014, MOL CELL, V54, P56, DOI 10.1016/j.molcel.2014.02.004; Koh BH, 2010, P NATL ACAD SCI USA, V107, P10614, DOI 10.1073/pnas.1005383107; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Li-Weber M, 1998, J IMMUNOL, V161, P1380; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; PFEUFFER I, 1994, J IMMUNOL, V153, P5572; Salerno MS, 2001, CYTOKINE, V15, P4, DOI 10.1006/cyto.2001.0897; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Strempel JM, 2010, J IMMUNOL, V184, P1309, DOI 10.4049/jimmunol.0804162; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Williams A, 2013, P NATL ACAD SCI USA, V110, P6955, DOI 10.1073/pnas.1304720110; Wu GD, 1997, J BIOL CHEM, V272, P2396; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	37	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148576	10.1371/journal.pone.0148576	http://dx.doi.org/10.1371/journal.pone.0148576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840450	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200149
J	Torres, CW; Tsutsui, ND				Torres, Candice W.; Tsutsui, Neil D.			The Effect of Social Parasitism by Polyergus breviceps on the Nestmate Recognition System of Its Host, Formica altipetens	PLOS ONE			English	Article							DIRECT BEHAVIORAL EVIDENCE; CUTICULAR HYDROCARBONS; MICROSATELLITE LOCI; COLONY RECOGNITION; GENETIC DIVERSITY; RAIDING BEHAVIOR; CHEMICAL CUES; ANT; HYMENOPTERA; DISCRIMINATION	Highly social ants, bees and wasps employ sophisticated recognition systems to identify colony members and deny foreign individuals access to their nest. For ants, cuticular hydrocarbons serve as the labels used to ascertain nest membership. Social parasites, however, are capable of breaking the recognition code so that they can thrive unopposed within the colonies of their hosts. Here we examine the influence of the socially parasitic slave-making ant, Polyergus breviceps on the nestmate recognition system of its slaves, Formica altipetens. We compared the chemical, genetic, and behavioral characteristics of colonies of enslaved and free-living F. altipetens. We found that enslaved Formica colonies were more genetically and chemically diverse than their free-living counterparts. These differences are likely caused by the hallmark of slave-making ant ecology: seasonal raids in which pupa are stolen from several adjacent host colonies. The different social environments of enslaved and free-living Formica appear to affect their recognition behaviors: enslaved Formica workers were less aggressive towards non-nestmates than were free-living Formica. Our findings indicate that parasitism by P. breviceps dramatically alters both the chemical and genetic context in which their kidnapped hosts develop, leading to changes in how they recognize nestmates.	[Torres, Candice W.; Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Torres, CW (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	candicewt@gmail.com			United States Department of Agriculture National Institute of Food and Agriculture, Hatch project [CA-B-INS-0087-H]; Sigma Xi [G2007106132227470]	United States Department of Agriculture National Institute of Food and Agriculture, Hatch project; Sigma Xi	This work was supported by the United States Department of Agriculture National Institute of Food and Agriculture, Hatch project CA-B-INS-0087-H(http://nifa.usda.gov) and the Sigma Xi Grants-in-Aid of Research program (Grant ID:G2007106132227470; https://www.sigmaxi.org/programs/grants-in-aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Beye M, 1998, BEHAV ECOL SOCIOBIOL, V43, P67, DOI 10.1007/s002650050467; BONAVITACOUGOURDAN A, 1987, J ENTOMOL SCI, V22, P1; Bono JM, 2006, J INSECT BEHAV, V19, P429, DOI 10.1007/s10905-006-9035-2; Brandt M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-71; Breed M.D., 1987, P243; BUSCHINGER A, 1980, Z TIERPSYCHOL, V53, P245; Chapuisat M, 1996, MOL ECOL, V5, P599, DOI 10.1111/j.1365-294X.1996.tb00354.x; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; CUSHMAN JH, 1988, OECOLOGIA, V77, P522, DOI 10.1007/BF00377268; D'Ettorre Patrizia, 2001, Acta Ethologica, V3, P67, DOI 10.1007/s102110100038; Errard C, 2008, INSECT SOC, V55, P115, DOI 10.1007/s00040-008-0979-4; Errard C, 2006, BEHAV ECOL SOCIOBIOL, V59, P353, DOI 10.1007/s00265-005-0058-z; Errard C, 1997, INSECT SOC, V44, P189, DOI 10.1007/s000400050040; Errard C, 2006, CHEMOECOLOGY, V16, P235, DOI 10.1007/s00049-006-0358-4; Esponda F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2838; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Gyllenstrand N, 2002, MOL ECOL NOTES, V2, P67, DOI 10.1046/j.1471-8286.2002.00152.x; HABERSETZER C, 1993, PHYSIOL ENTOMOL, V18, P160, DOI 10.1111/j.1365-3032.1993.tb00463.x; Hasegawa E, 2004, MOL ECOL NOTES, V4, P200, DOI 10.1111/j.1471-8286.2004.00614.x; Hefetz A, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P477, DOI 10.1017/CBO9780511711909.021; Heinze J, 1996, ETHOLOGY, V102, P510; Helantera H, 2011, BEHAV ECOL, V22, P710, DOI 10.1093/beheco/arr037; Holldobler B., 1990, pi; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Johnson BR, 2011, BEHAV ECOL SOCIOBIOL, V65, P935, DOI 10.1007/s00265-010-1094-x; Johnson CA, 2001, J CHEM ECOL, V27, P1787, DOI 10.1023/A:1010456608626; Katzerke A, 2006, BEHAV ECOL SOCIOBIOL, V61, P143, DOI 10.1007/s00265-006-0245-6; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lalzar I, 2010, CHEMOECOLOGY, V20, P19, DOI 10.1007/s00049-009-0030-x; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; Liebert AE, 2004, ANN ZOOL FENN, V41, P747; LITT M, 1993, BIOTECHNIQUES, V15, P280; Liu Zhibin, 2003, Entomological Science, V6, P125, DOI 10.1046/j.1343-8786.2003.00014.x; Lorenzi MC, 2003, INSECT SOC, V50, P82, DOI 10.1007/s000400300013; Lucas C, 2005, J INSECT PHYSIOL, V51, P1148, DOI 10.1016/j.jinsphys.2005.06.003; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2008, BIOL J LINN SOC, V95, P131, DOI 10.1111/j.1095-8312.2008.01038.x; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Michener C.D., 1987, P209; MOREL L, 1990, ANN ENTOMOL SOC AM, V83, P642, DOI 10.1093/aesa/83.3.642; MORI A, 1991, ETHOLOGY, V88, P46; OBIN MS, 1989, ANN ENTOMOL SOC AM, V82, P649, DOI 10.1093/aesa/82.5.649; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Ozaki Mamiko, 2014, Insects, V5, P722, DOI 10.3390/insects5040722; Pamilo P, 1996, EVOLUTION SOCIAL INS, pviii; Pamminger T, 2012, BIOL LETTERS, V8, P748, DOI 10.1098/rsbl.2012.0499; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pirk CWW, 2001, BEHAV ECOL SOCIOBIOL, V49, P366, DOI 10.1007/s002650000315; RATNIEKS FLW, 1991, AM NAT, V137, P202, DOI 10.1086/285154; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; Sharma KR, 2015, CELL REP, V12, P1261, DOI 10.1016/j.celrep.2015.07.031; Sherman Paul W., 1997, P69; Singer TL, 1998, AM ZOOL, V38, P394; Smith BH, 1995, CHEM ECOLOGY INSECTS, V2, P433; SOROKER V, 1994, NATURWISSENSCHAFTEN, V81, P510; SOROKER V, 1995, J CHEM ECOL, V21, P365, DOI 10.1007/BF02036724; Starks PT, 1998, ANIM BEHAV, V56, P449, DOI 10.1006/anbe.1998.0778; Thomas ML, 1999, NATURWISSENSCHAFTEN, V86, P87, DOI 10.1007/s001140050578; TOPOFF H, 1985, SOUTHWEST NAT, V30, P259, DOI 10.2307/3670739; Topoff H, 1982, BIOL SOCIAL INSECTS, V9, P292; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; Trager JC, 2013, ZOOTAXA, V3722, P501; Tsutsui ND, 2004, ANN ZOOL FENN, V41, P713; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Wagner D, 2000, J CHEM ECOL, V26, P2245, DOI 10.1023/A:1005529224856; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543	72	2	2	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147498	10.1371/journal.pone.0147498	http://dx.doi.org/10.1371/journal.pone.0147498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840394	Green Published, gold			2022-12-27	WOS:000369550200042
J	Vaatainen, S; Cederberg, H; Roine, R; Keinanen-Kiukaanniemi, S; Saramies, J; Uusitalo, H; Tuomilehto, J; Martikainen, J				Vaatainen, Saku; Cederberg, Henna; Roine, Risto; Keinanen-Kiukaanniemi, Sirkka; Saramies, Jouko; Uusitalo, Hannu; Tuomilehto, Jaakko; Martikainen, Janne			Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC)	PLOS ONE			English	Article							STYLE; INSTRUMENTS; PREVENTION; OBESITY; MODEL; SF-36	Objectives Present study examines the relationship between the estimated risk of developing type 2 diabetes (T2D) and health-related quality of life (HRQoL). We quantify the association between Finnish Diabetes Risk Score (FINDRISC) and HRQoL, and examine the potential use of FINDRISC as tool to evaluate HRQoL indirectly. Methods We conducted a cross-sectional study comprising 707 Finnish people without a diagnosis of T2D between the ages of 51 and 75 years. The risk of developing T2D was assessed using the validated and widely used FINDRISC (range 0-26 points), and quality of life was measured using two preference-based HRQoL instruments (15D and SF-6D) and one health profile instrument (SF-36). Effects of the individual FINDRISC items and demographic and clinical characteristics, such as co-morbidities, on HRQoL were studied using multivariable Tobit regression models. Results Low HRQoL was significantly and directly associated with the estimated risk of developing T2D. An approximate 4-5 point change in FINDRISC score was observed to be associated with clinically noticeable changes in the preference-based instrument HRQoL index scores. The association between HRQoL and the risk of developing T2D was also observed for most dimensions of HRQoL in all applied HRQoL instruments. Overall, old age, lack of physical activity, obesity, and history of high blood glucose were the FINDRISC factors most prominently associated with lower HRQoL. Conclusions The findings may help the health care professionals to substantiate the possible improvement in glucose metabolism and HRQoL potentially achieved by lifestyle changes, and better convince people at high risk of T2D to take action towards healthier lifestyle habits. FINDRISC may also provide an accurate proxy for HRQoL, and thus by estimating the risk of T2D with the FINDRISC, information about patients' HRQoL may also be obtained indirectly, when it is not feasible to use HRQoL instruments.	[Vaatainen, Saku; Martikainen, Janne] Univ Eastern Finland, Sch Pharm, Pharmacoecon & Outcomes Res Unit PHORU, Kuopio, Finland; [Cederberg, Henna] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Roine, Risto] Univ Eastern Finland, Dept Hlth & Social Management, Res Ctr Comparat Effectiveness & Patient Safety R, Kuopio, Finland; [Roine, Risto] Univ Helsinki, Adm Grp, Helsinki, Finland; [Roine, Risto] Helsinki Univ Hosp, Helsinki, Finland; [Keinanen-Kiukaanniemi, Sirkka] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Unit Primary Hlth Care, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Saramies, Jouko] South Karelia Cent Hosp, Lappeenranta, Finland; [Uusitalo, Hannu] Univ Tampere, Sch Med, SILK, Dept Ophthalmol, FIN-33101 Tampere, Finland; [Uusitalo, Hannu] TAUH Eye Ctr, Tampere, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Tuomilehto, Jaakko] Dasman Diabet Inst, Kuwait, Kuwait	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Oulu; Tampere University; Danube University Krems; Finland National Institute for Health & Welfare; King Abdulaziz University	Vaatainen, S (corresponding author), Univ Eastern Finland, Sch Pharm, Pharmacoecon & Outcomes Res Unit PHORU, Kuopio, Finland.	saku.vaatainen@uef.fi		Cederberg, Henna/0000-0003-2901-9373	Finnish Cultural Foundation (skr.fi)	Finnish Cultural Foundation (skr.fi)	This study was supported by an individual grant to the corresponding author (SV) from the Finnish Cultural Foundation (skr.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanne S, 2014, QUAL LIFE RES, V22, P1; Andersson S, 2013, SCAND J PRIM HEALTH, V31, P111, DOI 10.3109/02813432.2013.784541; Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; Austin PC, 2000, QUAL LIFE RES, V9, P901, DOI 10.1023/A:1008938326604; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fayers PM, 2014, QUAL LIFE RES, V23, P1, DOI 10.1007/s11136-013-0443-4; Hawthorne G, 2001, ANN MED, V33, P358, DOI 10.3109/07853890109002090; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Heidemann C, 2009, EUR J EPIDEMIOL, V24, P281, DOI 10.1007/s10654-009-9338-7; Keating CL, 2013, OBESITY, V21, P652, DOI 10.1002/oby.20290; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Luo N, 2010, MED CARE, V48, P365, DOI 10.1097/MLR.0b013e3181c162a2; Neumann A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0150-z; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Saramies J., 2005, THESIS U KUOPIO FINL; Savolainen J, 2014, SCAND J PUBLIC HEALT, V42, P163, DOI 10.1177/1403494813504837; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Sliventoinen K, 2005, EUR J CARDIOV PREV R, V12, P451, DOI 10.1097/01.hjr.0000174793.31812.21; Tapp R, 2010, DIABETES CARE, V33, P757, DOI 10.2337/dc09-1107; Vaatainen S, 2014, QUAL LIFE RES, V23, P1935, DOI 10.1007/s11136-014-0638-3; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organization (WHO), 2009, GLOB HLTH RISK MORT; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	32	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147898	10.1371/journal.pone.0147898	http://dx.doi.org/10.1371/journal.pone.0147898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840374	Green Published, gold			2022-12-27	WOS:000369550200068
J	Yanagisawa, T; Takahashi, H; Suzuki, T; Masuda, A; Dohmae, N; Yokoyama, S				Yanagisawa, Tatsuo; Takahashi, Hideyuki; Suzuki, Takehiro; Masuda, Akiko; Dohmae, Naoshi; Yokoyama, Shigeyuki			Neisseria meningitidis Translation Elongation Factor P and Its Active-Site Arginine Residue Are Essential for Cell Viability	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; FACTOR EF-P; COMPLETE GENOME SEQUENCE; PEPTIDE-BOND FORMATION; ESCHERICHIA-COLI; AMINO-ACID; POSTTRANSLATIONAL MODIFICATION; PROMOTES TRANSLATION; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE	Translation elongation factor P (EF-P), a ubiquitous protein over the entire range of bacterial species, rescues ribosomal stalling at consecutive prolines in proteins. In Escherichia coli and Salmonella enterica, the post-translational beta-lysyl modification of Lys34 of EF-P is important for the EF-P activity. The beta-lysyl EF-P modification pathway is conserved among only 26-28% of bacteria. Recently, it was found that the Shewanella oneidensis and Pseudomonas aeruginosa EF-P proteins, containing an Arg residue at position 32, are modified with rhamnose, which is a novel post-translational modification. In these bacteria, EF-P and its Arg modification are both dispensable for cell viability, similar to the E. coli and S. enterica EF-P proteins and their Lys34 modification. However, in the present study, we found that EF-P and Arg32 are essential for the viability of the human pathogen, Neisseria meningitidis. We therefore analyzed the modification of Arg32 in the N. meningitidis EF-P protein, and identified the same rhamnosyl modification as in the S. oneidensis and P. aeruginosa EF-P proteins. N. meningitidis also has the orthologue of the rhamnosyl modification enzyme (EarP) from S. oneidensis and P. aeruginosa. Therefore, EarP should be a promising target for antibacterial drug development specifically against N. meningitidis. The pair of genes encoding N. meningitidis EF-P and EarP suppressed the slow-growth phenotype of the EF-P-deficient mutant of E. coli, indicating that the activity of N. meningitidis rhamnosyl-EF-P for rescuing the stalled ribosomes at proline stretches is similar to that of E. coli beta-lysyl-EF-P. The possible reasons for the unique requirement of rhamnosyl-EF-P for N. meningitidis cells are that more proline stretch-containing proteins are essential and/or the basal ribosomal activity to synthesize proline stretch-containing proteins in the absence of EF-P is lower in this bacterium than in others.	[Yanagisawa, Tatsuo; Yokoyama, Shigeyuki] RIKEN Struct Biol Lab, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Yanagisawa, Tatsuo; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Takahashi, Hideyuki] Natl Inst Infect Dis, Dept Bacteriol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan; [Suzuki, Takehiro; Masuda, Akiko; Dohmae, Naoshi] RIKEN Ctr Sustainable Resource Sci CSRS, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Masuda, Akiko] Natl Maritime Res Inst, 6-38-1 Shinkawa, Mitaka, Tokyo 1810004, Japan	RIKEN; RIKEN; National Institute of Infectious Diseases (NIID); RIKEN; National Maritime Research Institute	Yanagisawa, T; Yokoyama, S (corresponding author), RIKEN Struct Biol Lab, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Yanagisawa, T; Yokoyama, S (corresponding author), RIKEN Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	tatsuo.yanagisawa@riken.jp; yokoyama@riken.jp	Dohmae, Naoshi/C-2040-2011; Suzuki, Takehiro/B-3210-2013; Yokoyama, Shigeyuki/N-6911-2015	Dohmae, Naoshi/0000-0002-5242-9410; Yokoyama, Shigeyuki/0000-0003-3133-7338	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and development (AMED); Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24590545]; Kurata Memorial Hitachi Science and Technology Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurata Memorial Hitachi Science and Technology Foundation	This work was supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and development (AMED) (to S.Y.); the Targeted Proteins Research Program (TPRP) (to S.Y.); a Grants-in-Aid for Scientific Research (to H.T. grant number 24590545) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; and the Kurata Grant of the Kurata Memorial Hitachi Science and Technology Foundation (to T.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Balibar CJ, 2013, CURR MICROBIOL, V67, P293, DOI 10.1007/s00284-013-0363-0; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Choi S, 2011, PROTEINS, V79, P1688, DOI 10.1002/prot.22992; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Elgamal S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004553; Ganoza MC, 2002, MICROBIOL MOL BIOL R, V66, P460, DOI 10.1128/MMBR.66.3.460-485.2002; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Iannino F, 2012, MICROB PATHOGENESIS, V52, P31, DOI 10.1016/j.micpath.2011.09.008; Kang YS, 2004, J BACTERIOL, V186, P4921, DOI 10.1128/JB.186.15.4921-4930.2004; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Katz A, 2014, NUCLEIC ACIDS RES, V42, P3261, DOI 10.1093/nar/gkt1296; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kobayashi K, 2014, NUCLEIC ACIDS RES, V42, P12295, DOI 10.1093/nar/gku898; Lassak J, 2015, NAT CHEM BIOL, V11, P266, DOI [10.1038/nchembio.1751, 10.1038/NCHEMBIO.1751]; Marman HE, 2014, INFECT IMMUN, V82, P3612, DOI 10.1128/IAI.01532-13; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; Masuda A, 2013, ANAL BIOANAL CHEM, V405, P8073, DOI 10.1007/s00216-013-7056-1; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; PARK MH, 1982, J BIOL CHEM, V257, P7217; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Rajkovic A, 2015, MBIO, V6, DOI 10.1128/mBio.00823-15; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Starosta AL, 2014, CELL REP, V9, P476, DOI 10.1016/j.celrep.2014.09.008; Starosta AL, 2014, NUCLEIC ACIDS RES, V42, P10711, DOI 10.1093/nar/gku768; Sumida T, 2010, ACTA CRYSTALLOGR F, V66, P1115, DOI 10.1107/S1744309110032008; Takahashi H, 2002, MICROBIOL-SGM, V148, P229, DOI 10.1099/00221287-148-1-229; Takahashi H, 2008, INFECT IMMUN, V76, P5777, DOI 10.1128/IAI.00676-08; Takahashi H, 2008, FEMS IMMUNOL MED MIC, V52, P36, DOI 10.1111/j.1574-695X.2007.00342.x; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yanagisawa T, 2003, J BIOL CHEM, V278, P25887, DOI 10.1074/jbc.M302633200; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; Yasuno S, 1997, BIOSCI BIOTECH BIOCH, V61, P1944, DOI 10.1271/bbb.61.1944; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	57	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147907	10.1371/journal.pone.0147907	http://dx.doi.org/10.1371/journal.pone.0147907			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840407	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200069
J	Zoz, F; Iaconelli, C; Lang, E; Iddir, H; Guyot, S; Grandvalet, C; Gervais, P; Beney, L				Zoz, Fiona; Iaconelli, Cyril; Lang, Emilie; Iddir, Hayet; Guyot, Stephane; Grandvalet, Cosette; Gervais, Patrick; Beney, Laurent			Control of Relative Air Humidity as a Potential Means to Improve Hygiene on Surfaces: A Preliminary Approach with Listeria monocytogenes	PLOS ONE			English	Article							ESCHERICHIA-COLI; DESICCATION SURVIVAL; SODIUM-CHLORIDE; TEMPERATURE; CONTAMINATION; PREVALENCE; TOLERANCE; MEMBRANE; KINETICS; BACTERIA	Relative air humidity fluctuations could potentially affect the development and persistence of pathogenic microorganisms in their environments. This study aimed to characterize the impact of relative air humidity (RH) variations on the survival of Listeria monocytogenes, a bacterium persisting on food processing plant surfaces. To assess conditions leading to the lowest survival rate, four strains of L. monocytogenes (EGDe, CCL500, CCL128, and LO28) were exposed to different RH conditions (75%, 68%, 43% and 11%) with different drying kinetics and then rehydrated either progressively or instantaneously. The main factors that affected the survival of L. monocytogenes were RH level and rehydration kinetics. Lowest survival rates between 1% and 0.001% were obtained after 3 hours of treatment under optimal conditions (68% RH and instantaneous rehydration). The survival rate was decreased under 0.001% after prolonged exposure (16h) of cells under optimal conditions. Application of two successive dehydration and rehydration cycles led to an additional decrease in survival rate. This preliminary study, performed in model conditions with L. monocytogenes, showed that controlled ambient RH fluctuations could offer new possibilities to control foodborne pathogens in food processing environments and improve food safety.	[Zoz, Fiona; Iaconelli, Cyril; Lang, Emilie; Iddir, Hayet; Guyot, Stephane; Grandvalet, Cosette; Gervais, Patrick; Beney, Laurent] UMR PAM Univ Bourgogne Franche Comte AgroSup Dijo, Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne	Beney, L (corresponding author), UMR PAM Univ Bourgogne Franche Comte AgroSup Dijo, Dijon, France.	lbeney@u-bourgogne.fr	Lang, Emilie/U-8120-2019; Guyot, Stéphane/A-3482-2012	Guyot, Stéphane/0000-0002-2316-234X; Laurent, Beney/0000-0002-2757-2506	French Agence Nationale de la Recherche (ANR) under the project "EcoSec"; Agence Nationale de la Recherche (France)	French Agence Nationale de la Recherche (ANR) under the project "EcoSec"(French National Research Agency (ANR)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR))	This work was supported by French Agence Nationale de la Recherche (ANR) under the project "EcoSec". We thank all partners of EcoSec project: Labeyrie-Group, Dessica, MF conseil, IRSTEA, ANSES SBCL Unit: Staphylocoques, Bacillus, Clostridies et Lait, INRA-Theix UR454 Microbiologie.; This work received support from the Agence Nationale de la Recherche (France): Fiona Zoz grant (PhD student), materials, chemicals, equipment.	[Anonymous], 2014, SUNBURST FOODS RECAL; [Anonymous], 2011, ALPINE SLICING CHEES; Autio T, 1999, APPL ENVIRON MICROB, V65, P150; BATEMAN JB, 1962, J GEN MICROBIOL, V29, P207, DOI 10.1099/00221287-29-2-207; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Castro HP, 1995, APPL MICROBIOL BIOT, V44, P172, DOI [10.1007/BF00164498, 10.1007/s002530050537]; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; COX L J, 1989, Food Microbiology (London), V6, P49, DOI 10.1016/S0740-0020(89)80037-1; DUNKLIN EW, 1948, J EXP MED, V87, P87, DOI 10.1084/jem.87.2.87; Dupont S, 2014, APPL MICROBIOL BIOT, V98, P8821, DOI 10.1007/s00253-014-6028-5; Dupont S, 2010, BBA-BIOMEMBRANES, V1798, P975, DOI 10.1016/j.bbamem.2010.01.015; FENLON DR, 1985, J APPL BACTERIOL, V59, P537, DOI 10.1111/j.1365-2672.1985.tb03357.x; Gandhi M, 2007, INT J FOOD MICROBIOL, V113, P1, DOI 10.1016/j.ijfoodmicro.2006.07.008; Golowczyc MA, 2011, BIOTECHNOL LETT, V33, P681, DOI 10.1007/s10529-010-0491-6; Hingston PA, 2015, APPL ENV MI IN PRESS; Huang YN, 2015, FOOD MICROBIOL, V46, P443, DOI 10.1016/j.fm.2014.09.007; King And Prince Seafood Corp, 2011, ISS VOL REC NOT NOV; Kramarenko T, 2013, FOOD CONTROL, V30, P24, DOI 10.1016/j.foodcont.2012.06.047; Laksanalamai P, 2012, PLOS ONE, V7; Lambertz ST, 2012, INT J FOOD MICROBIOL, V160, P24, DOI 10.1016/j.ijfoodmicro.2012.09.010; Lemetais G, 2012, APPL MICROBIOL BIOT, V96, P471, DOI 10.1007/s00253-012-4014-3; Lin CM, 2006, J FOOD PROTECT, V69, P71, DOI 10.4315/0362-028X-69.1.71; MCCLURE PJ, 1989, LETT APPL MICROBIOL, V9, P95, DOI 10.1111/j.1472-765X.1989.tb00299.x; MCELDOWNEY S, 1988, LETT APPL MICROBIOL, V7, P83, DOI 10.1111/j.1472-765X.1988.tb01258.x; Miettinen MK, 1999, INT J FOOD MICROBIOL, V46, P187, DOI 10.1016/S0168-1605(98)00185-8; Mille Y, 2003, BIOTECHNOL BIOENG, V83, P578, DOI 10.1002/bit.10706; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; Parisi A, 2013, FOOD CONTROL, V29, P91, DOI 10.1016/j.foodcont.2012.05.036; Poirier I, 1998, APPL MICROBIOL BIOT, V50, P704, DOI 10.1007/s002530051354; Pompermayer DMC, 2000, FOOD MICROBIOL, V17, P361, DOI 10.1006/fmic.1999.0291; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Rome Packing Co. Inc., 2014, REC FRESH FROZ CRAB; Sleator RD, 2001, APPL ENVIRON MICROB, V67, P2692, DOI 10.1128/AEM.67.6.2692-2698.2001; STOKES RH, 1949, IND ENG CHEM, V41, P2013, DOI 10.1021/ie50477a041; Takahashi H, 2011, FOOD CONTROL, V22, P633, DOI 10.1016/j.foodcont.2010.09.003; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; VICENTE MF, 1985, FEMS MICROBIOL LETT, V30, P77; Vogel BF, 2010, INT J FOOD MICROBIOL, V140, P192, DOI 10.1016/j.ijfoodmicro.2010.03.035; WALKER SJ, 1990, J APPL BACTERIOL, V68, P157, DOI 10.1111/j.1365-2672.1990.tb02561.x; WATKINS J, 1981, J APPL BACTERIOL, V50, P1, DOI 10.1111/j.1365-2672.1981.tb00865.x; WEIS J, 1975, APPL MICROBIOL, V30, P29, DOI 10.1128/AEM.30.1.29-32.1975; WELSHIMER HJ, 1971, APPL MICROBIOL, V21, P516, DOI 10.1128/AEM.21.3.516-519.1971; Wilks SA, 2006, INT J FOOD MICROBIOL, V111, P93, DOI 10.1016/j.ijfoodmicro.2006.04.037; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465; Wolkers WF, 1998, BBA-GEN SUBJECTS, V1425, P127, DOI 10.1016/S0304-4165(98)00059-2	48	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148418	10.1371/journal.pone.0148418	http://dx.doi.org/10.1371/journal.pone.0148418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840373	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200133
J	Li, Z; Zhu, YZ; Huang, TL; Hisatome, I; Yamamoto, T; Cheng, JD				Li Zhi; Zhu Yuzhang; Huang Tianliang; Hisatome, Ichiro; Yamamoto, Tetsuya; Cheng Jidong			High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; GLUCOSE-UPTAKE; HEART-FAILURE; CAUSAL ROLE; RISK-FACTOR; DYSFUNCTION; PATHWAYS; SURVIVAL	Clinical studies have shown hyperuricemia strongly associated with insulin resistance as well as cardiovascular disease. Direct evidence of how high uric acid (HUA) affects insulin resistance in cardiomyocytes, but the pathological mechanism of HUA associated with cardiovascular disease remains to be clarified. We aimed to examine the effect of HUA on insulin sensitivity in cardiomyocytes and on insulin resistance in hyperuricemic mouse model. We exposed primary cardiomyocytes and a rat cardiomyocyte cell line, H9c2 cardiomyocytes, to HUA, then quantified glucose uptake with a fluorescent glucose analog, 2-NBDG, after insulin challenge and detected reactive oxygen species (ROS) production. Western blot analysis was used to examine the levels of insulin receptor (IR), phosphorylated insulin receptor substrate 1 (IRS1, Ser307) and phospho-Akt (Ser473). We monitored the impact of HUA on insulin resistance, insulin signaling and IR, phospho-IRS1 (Ser307) and phospho-Akt levels in myocardial tissue of an acute hyperuricemia mouse model established by potassium oxonate treatment. HUA inhibited insulin-induced glucose uptake in H9c2 and primary cardiomyocytes. It increased ROS production; pretreatment with N-acetyl-L-cysteine (NAC), a ROS scavenger, reversed HUA-inhibited glucose uptake induced by insulin. HUA exposure directly increased the phospho-IRS1 (Ser307) response to insulin and inhibited that of phospho-Akt in H9C2 cardiomyocytes, which was blocked by NAC. Furthermore, the acute hyperuricemic mice model showed impaired glucose tolerance and insulin tolerance accompanied by increased phospho-IRS1 (Ser307) and inhibited phospho-Akt response to insulin in myocardial tissues. HUA inhibited insulin signaling and induced insulin resistance in cardiomyocytes in vitro and in vivo, which is a novel potential mechanism of hyperuricemic-related cardiovascular disease.	[Li Zhi; Huang Tianliang; Cheng Jidong] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou, Guangdong, Peoples R China; [Li Zhi] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Internal Med, Shantou, Guangdong, Peoples R China; [Li Zhi] Chaozhou Peoples Hosp, Dept Internal Med, Chaozhou, Guangdong, Peoples R China; [Zhu Yuzhang] Second Hosp Jiaxing City, Dept Internal Med, Jiaxing, Zhejiang, Peoples R China; [Hisatome, Ichiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut, Yonago, Tottori, Japan; [Yamamoto, Tetsuya] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Shantou University; Shantou University; Tottori University; Hyogo College of Medicine	Cheng, JD (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou, Guangdong, Peoples R China.	jidongcheng36@126.com			National Natural Science Foundation of China [81070673]; Special Foundation of Guangdong Province College Talent Introduction [10027425]; Scientific Research Foundation for Returning Overseas Chinese Scholars, State Education Ministry [20111568]; Natural Science Foundation of Guangdong Province [S2011010005102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of Guangdong Province College Talent Introduction; Scientific Research Foundation for Returning Overseas Chinese Scholars, State Education Ministry; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Natural Science Foundation of China (81070673), the Special Foundation of Guangdong Province College Talent Introduction (10027425), the Project Sponsored by the Scientific Research Foundation for Returning Overseas Chinese Scholars, State Education Ministry (20111568), and the Natural Science Foundation of Guangdong Province (S2011010005102).	Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Barbu A, 2002, MOL CELL ENDOCRINOL, V190, P75, DOI 10.1016/S0303-7207(02)00009-6; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Doehner W, 2005, J AM COLL CARDIOL, V46, P1019, DOI 10.1016/j.jacc.2005.02.093; Dong F, 2006, DIABETOLOGIA, V49, P1421, DOI 10.1007/s00125-006-0230-7; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Hirofumi H, 2011, AM J PHYSIOL-CELL PH, V301, pC1415; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Leyva F, 1997, EUR HEART J, V18, P858; Li JM, 2011, EUR J PHARMACOL, V666, P196, DOI 10.1016/j.ejphar.2011.05.021; Liu Q, 2013, CHINESE MED J-PEKING, V126, P4037, DOI 10.3760/cma.j.issn.0366-6999.20130685; Matsui T, 2005, J MOL CELL CARDIOL, V38, P63, DOI 10.1016/j.yjmcc.2004.11.005; Mellor KM, 2010, CLIN EXP PHARMACOL P, V37, P222, DOI 10.1111/j.1440-1681.2009.05274.x; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Paolisso G, 1999, AM J CARDIOL, V83, P1338, DOI 10.1016/S0002-9149(99)00097-1; Ritchie RH, 2009, HEART LUNG CIRC, V18, P11, DOI 10.1016/j.hlc.2008.11.003; Santos FR, 2012, ARCH PHYSIOL BIOCHEM, V118, P231, DOI 10.3109/13813455.2012.713366; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Wang C, 2013, CARDIOVASC RES, V100, P114, DOI 10.1093/cvr/cvt160; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Yoneyama Y, 2013, MOL CELL BIOL, V33, P1991, DOI 10.1128/MCB.01394-12; Yu B, 1999, AM J PHYSIOL-ENDOC M, V277, pE259, DOI 10.1152/ajpendo.1999.277.2.E259; Yue RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050778; Zhang JX, 2015, ENDOCRINE, V48, P135, DOI 10.1007/s12020-014-0239-5; Zhang YN, 2013, MOL CELL ENDOCRINOL, V375, P89, DOI 10.1016/j.mce.2013.04.027; Zhu Y, 2013, MOL ENDOCRINOL, V27, P172, DOI 10.1210/me.2012-1210; Zhu YZ, 2014, BIOCHEM BIOPH RES CO, V447, P707, DOI 10.1016/j.bbrc.2014.04.080; Zhuang YB, 2014, AM J PHYSIOL-RENAL, V307, pF396, DOI 10.1152/ajprenal.00565.2013	31	28	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0147737	10.1371/journal.pone.0147737	http://dx.doi.org/10.1371/journal.pone.0147737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836389	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548500003
J	Sagili, KD; Satyanarayana, S; Chadha, SS				Sagili, Karuna D.; Satyanarayana, Srinath; Chadha, Sarabjit S.			Is Knowledge Regarding Tuberculosis Associated with Stigmatising and Discriminating Attitudes of General Population towards Tuberculosis Patients? Findings from a Community Based Survey in 30 Districts of India	PLOS ONE			English	Article							GENDER	Background Stigmatising and discriminating attitudes may discourage tuberculosis (TB) patients from actively seeking medical care, hide their disease status, and discontinue treatment. It is expected that appropriate knowledge regarding TB should remove stigmatising and discriminating attitudes. In this study we assessed the prevalence of stigmatising and discriminating attitudes towards TB patients among general population and their association with knowledge regarding TB. Method A cross-sectional knowledge, attitude and practice survey was conducted in 30 districts of India in January-March 2011. A total of 4562 respondents from general population were interviewed using semi-structured questionnaires which contained items to measure stigma, discrimination and knowledge on TB. Result Of the 4562 interviewed, 3823 were eligible for the current analysis. Of these, 73% (95% CI 71.4-74.2) had stigmatising and 98% (95% CI 97.4-98.3) had discriminating attitude towards TB patients. Only 17% (95% CI 15.6-18.0) of the respondents had appropriate knowledge regarding TB with even lower levels observed amongst females, rural areas and respondents from low income groups. Surprisingly stigmatising (adjusted OR 1.31 (0.782.18) and discriminating (adjusted OR 0.79 (0.43-1.44) attitudes were independent of knowledge regarding TB. Conclusion Stigmatising and discriminating attitudes towards TB patients remain high among the general population in India. Since these attitudes were independent of the knowledge regarding TB, it is possible that the current disseminated knowledge regarding TB which is mainly from a medical perspective may not be adequately addressing the factors that lead to stigma and discrimination towards TB patients. Therefore, there is an urgent need to review the messages and strategies currently used for disseminating knowledge regarding TB among general population and revise them appropriately. The disseminated knowledge should include medical, psycho-social and economic aspects of TB that not only informs people about medical aspects of TB disease, but also removes stigma and discrimination.	[Sagili, Karuna D.; Satyanarayana, Srinath; Chadha, Sarabjit S.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India		Sagili, KD (corresponding author), South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India.	drkarunas@gmail.com		Satyanarayana, Srinath/0000-0002-5420-2551	Global Fund [IDA-910-G17-T]; Program Management Unit at the Union South East Asia office	Global Fund; Program Management Unit at the Union South East Asia office	This study analyses the data from a community based KAP survey conducted as part of Project Axshya funded by Global Fund (IDA-910-G17-T). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the team at GfK MODE, New Delhi for their enthusiastic support in conducting this survey. We acknowledge the support of the Program Management Unit at the Union South East Asia office for their support in conducting the survey. We also thank the Deputy Director General (TB), Central TB Division, Ministry of Health and Family Welfare, Government of India for providing necessary consent to carry out this study, and the district TB officers and their staff of the various surveyed districts for supporting the data collection process. We are also thankful to Dr. Vivek Gupta, former OR Fellow at The Union South East Asia office for his support in statistical analysis.	Ali M, 2014, LANCET, V383, P2195, DOI 10.1016/S0140-6736(14)61063-1; [Anonymous], INF ED COMM MAT; Aryal S, 2012, Kathmandu Univ Med J (KUMJ), V10, P48; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Central Tuberculosis Division, 2005, HLTH COMM STRAT RNTC; Central Tuberculosis Division, 2003, BAS KAP STUD RNTCP P; Central Tuberculosis Division, 2014, OP HDB ADV COMM SOC; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Courtwright A, 2010, PUBLIC HLTH REPOR S4, V125; Dhingra V K, 2010, Indian J Tuberc, V57, P12; Ganapathy Sudha, 2008, Indian J Tuberc, V55, P9; Global health strategies, 2013, HDB TUB IND; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Jaggarajamma K, 2008, Indian J Tuberc, V55, P179; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Mathew AS, 2007, CLIN INFECT DIS, V45, P1247, DOI 10.1086/522312; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Sermrittirong S, 2015, LEPROSY REV, V86, P54; Sharma N, 2007, INT J TROPICAL MED, V4, P2; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; World Health Organization, 2014, GLOB TUB REP	23	24	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147274	10.1371/journal.pone.0147274	http://dx.doi.org/10.1371/journal.pone.0147274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829713	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200017
J	He, XH; Kong, QL; Patfield, S; Skinner, C; Rasooly, R				He, Xiaohua; Kong, Qiulian; Patfield, Stephanie; Skinner, Craig; Rasooly, Reuven			A New Immunoassay for Detecting All Subtypes of Shiga Toxins Produced by Shiga Toxin-Producing E. coli in Ground Beef	PLOS ONE			English	Article							ESCHERICHIA-COLI; UNITED-STATES; HEMORRHAGIC COLITIS; VARIANT; ENVIRONMENT; PATHOGENS; STRAINS; ILLNESS; FOOD	Background Shiga toxin (Stx) is a common virulence factor of all Shiga toxin producing E. coli (STEC) that cause a wide spectrum of disease, including hemorrhagic colitis and hemolytic uremic syndrome (HUS). Although several commercial kits are available for detection of Stx produced by STEC, none of them are capable of recognizing all subtypes of Stxs, which include three subtypes of Stx1 and seven subtypes of Stx2. Methods and Findings New monoclonal and polyclonal antibodies against Stx1 and Stx2 were developed. A universal sandwich ELISA capable of detecting all known subtypes of Stx1 and Stx2 was established using a pool of newly developed antibodies. To precisely monitor the sensitivity of the assay for each subtype of Stxs, recombinant toxoids were created and used as standards in ELISAs. Because of the high affinity of the antibodies incorporated, the ELISA assay is highly sensitive with a limit of detection for the different subtypes of Stx1a and Stx2a between 10 and 50 pg/mL in phosphate buffered saline (PBS). The assay was also able to identify STEC based on the production of Stxs using the supernatants of culture fluids or even single colonies on agar plates without lengthy enrichment in liquid medium. When applied to ground beef samples, this newly developed ELISA was capable of distinguishing beef samples spiked with a single bacterial cell. Conclusions A highly sensitive and universal assay for all subtypes of Stx1 and Stx2 was developed. It has significantly improved upon the current technologies by avoiding false negative results due to the narrow detection range of the assay. The assay developed in this study can be useful for prompt detection of new and emerging serotypes and screening ground beef samples for contamination of STEC at an early stage in the food supply chain, thus avoiding the need for possible recall.	[He, Xiaohua; Patfield, Stephanie; Skinner, Craig; Rasooly, Reuven] Agr Res Serv, Western Reg Res Ctr, US Dept Agr, Albany, CA USA; [Kong, Qiulian] Shanghai Shuneng Irradiat Technol Co Ltd, Shanghai Acad Agr Sci, Shanghai, Peoples R China	United States Department of Agriculture (USDA); Shanghai Academy of Agricultural Sciences	He, XH (corresponding author), Agr Res Serv, Western Reg Res Ctr, US Dept Agr, Albany, CA USA.	xiaohua.he@ars.usda.gov			USDA-ARS CRIS project [5325-42000-048-00D]; Shanghai Shuneng Irradiation Technology Co., Ltd.	USDA-ARS CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Shanghai Shuneng Irradiation Technology Co., Ltd.	This work was supported by USDA-ARS CRIS project 5325-42000-048-00D and Shanghai Shuneng Irradiation Technology Co., Ltd. Both funders provided support in the form of salaries for authors [XH, QK, SP, CS, RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to thank Andrew Gehring, Pina Fratamico, Robert Mandrell, Michael Cooley, and Anna Bates for providing STEC strains. This work was supported by USDA-ARS CRIS project 5325-42000-048-00D and Shanghai Shuneng Irradiation Technology Co., Ltd. The funders provided support in the form of salaries for authors [XH, QK, SP, CS, RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beutin L, 2008, APPL ENVIRON MICROB, V74, P4806, DOI 10.1128/AEM.00623-08; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fremaux B, 2008, VET MICROBIOL, V132, P1, DOI 10.1016/j.vetmic.2008.05.015; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076368; He XH, 2013, J IMMUNOL METHODS, V389, P18, DOI 10.1016/j.jim.2012.12.005; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Klein S, 2013, RISKY MEAT CSPI FIEL; Manning SD, 2007, EMERG INFECT DIS, V13, P318, DOI 10.3201/eid1302.060813; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; Mead PS, 1999, EMERG INFECT DIS, V5, P841, DOI 10.3201/eid0506.990625; OBRIEN AD, 1983, LANCET, V1, P702; OJEDA A, 1995, J CLIN MICROBIOL, V33, P2199, DOI 10.1128/JCM.33.8.2199-2201.1995; Park CH, 2003, J CLIN MICROBIOL, V41, P2650, DOI 10.1128/JCM.41.6.2650-2653.2003; Pierard D, 1998, J CLIN MICROBIOL, V36, P3317; Scheutz F., 2012, EXTERNAL QUALITY ASS; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Skinner C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132419; Skinner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099854; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076563; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059760; Vallieres E, 2013, J CLIN MICROBIOL, V51, P481, DOI 10.1128/JCM.02219-12; WEINSTEIN DL, 1988, J BACTERIOL, V170, P4223, DOI 10.1128/jb.170.9.4223-4230.1988; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741	25	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148092	10.1371/journal.pone.0148092	http://dx.doi.org/10.1371/journal.pone.0148092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824247	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600098
J	Lazzaro, SC; Rutledge, RB; Burghart, DR; Glimcher, PW				Lazzaro, Stephanie C.; Rutledge, Robb B.; Burghart, Daniel R.; Glimcher, Paul W.			The Impact of Menstrual Cycle Phase on Economic Choice and Rationality	PLOS ONE			English	Article							WOMENS PREFERENCES; GENDER-DIFFERENCES; ESTROGEN ACTIONS; DECISION-MAKING; OVULATORY CYCLE; PROSPECT-THEORY; LUTEAL PHASES; LOSS AVERSION; BEHAVIOR; RISK	It is well known that hormones affect both brain and behavior, but less is known about the extent to which hormones affect economic decision-making. Numerous studies demonstrate gender differences in attitudes to risk and loss in financial decision-making, often finding that women are more loss and risk averse than men. It is unclear what drives these effects and whether cyclically varying hormonal differences between men and women contribute to differences in economic preferences. We focus here on how economic rationality and preferences change as a function of menstrual cycle phase in women. We tested adherence to the Generalized Axiom of Revealed Preference (GARP), the standard test of economic rationality. If choices satisfy GARP then there exists a well-behaved utility function that the subject's decisions maximize. We also examined whether risk attitudes and loss aversion change as a function of cycle phase. We found that, despite large fluctuations in hormone levels, women are as technically rational in their choice behavior as their male counterparts at all phases of the menstrual cycle. However, women are more likely to choose risky options that can lead to potential losses while ovulating; during ovulation women are less loss averse than men and therefore more economically rational than men in this regard. These findings may have market-level implications: ovulating women more effectively maximize expected value than do other groups.	[Lazzaro, Stephanie C.] UCL, Inst Cognit Neurosci, London, England; [Rutledge, Robb B.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Rutledge, Robb B.] Max Planck UCL Ctr Computat Psychiat & Ageing Res, London, England; [Burghart, Daniel R.] Calif State Univ Sacramento, Inst Cognit Neurosci, Sacramento, CA 95819 USA; [Glimcher, Paul W.] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of London; University College London; University of London; University College London; California State University System; California State University Sacramento; New York University	Lazzaro, SC (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.lazzaro@ucl.ac.uk		Rutledge, Robb/0000-0001-7337-5039	National Institutes of Health [5R01NS054775]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grant number 5R01NS054775) to PWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriat S.N, 1967, INT ECON REV, V8, P67, DOI [DOI 10.2307/2525382, 10.2307/2525382]; Ball A, 2013, BIOL PSYCHOL, V93, P52, DOI 10.1016/j.biopsycho.2013.01.005; Burghart DR, 2013, J RISK UNCERTAINTY, V46, P215, DOI 10.1007/s11166-013-9167-7; Buser T, 2012, J ECON BEHAV ORGAN, V83, P1, DOI 10.1016/j.jebo.2011.06.006; Camille N, 2011, J NEUROSCI, V31, P7527, DOI 10.1523/JNEUROSCI.6527-10.2011; Chen Y, 2007, J ECON THEORY, V136, P513, DOI 10.1016/j.jet.2006.09.012; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Durante KM, 2014, J MARKETING RES, V51, P27, DOI 10.1509/jmr.11.0327; Durante KM, 2011, J CONSUM RES, V37, P921, DOI 10.1086/656575; Eckel CC., 2008, HDB EXPT EC RESULTS, DOI 10.1016/S1574-0722(07)00113-8; Evans SM, 2002, PSYCHOPHARMACOLOGY, V159, P397, DOI 10.1007/s00213-001-0944-7; FerreiraPoblete A, 1997, ADV CONTRACEPT, V13, P83, DOI 10.1023/A:1006527232605; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; HAMPSON E, 1992, P357; Harbaugh WT, 2001, AM ECON REV, V91, P1539, DOI 10.1257/aer.91.5.1539; Harris CR, 2013, SEX ROLES, V69, P507, DOI 10.1007/s11199-012-0229-0; Hill SE, 2009, PERS SOC PSYCHOL B, V35, P1592, DOI 10.1177/0146167209346303; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Houthakker HS, 1950, ECONOMICA-NEW SER, V17, P159, DOI 10.2307/2549382; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Justice AJH, 1999, PSYCHOPHARMACOLOGY, V145, P67, DOI 10.1007/s002130051033; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Mani S, 2008, ENDOCRINOLOGY, V149, P2750, DOI 10.1210/en.2008-0097; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Niederle M, 2011, ANNU REV ECON, V3, P601, DOI 10.1146/annurev-economics-111809-125122; Pearson M, 2013, GAME ECON BEHAV, V78, P1, DOI 10.1016/j.geb.2012.10.008; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Saad G, 2012, J CONSUM PSYCHOL, V22, P102, DOI 10.1016/j.jcps.2011.10.001; Samuelson PA, 1938, ECONOMICA-NEW SER, V5, P61, DOI 10.2307/2548836; SHERWIN BB, 1985, PSYCHONEUROENDOCRINO, V10, P325, DOI 10.1016/0306-4530(85)90009-5; Shughrue PJ, 1998, ENDOCRINOLOGY, V139, P5267, DOI 10.1210/en.139.12.5267; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Speroff L, 2005, SPEROFFS CLIN GYNECO, P573; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Tymula A, 2013, P NATL ACAD SCI USA, V110, P17143, DOI 10.1073/pnas.1309909110; Varian H. R., 1991, WORKING PAPER; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Wozniak D, 2014, J LABOR ECON, V32, P161, DOI 10.1086/673324	48	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0144080	10.1371/journal.pone.0144080	http://dx.doi.org/10.1371/journal.pone.0144080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824245	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600002
J	Wei, J; Lei, GH; Fu, L; Zeng, C; Yang, T; Peng, SF				Wei, Jie; Lei, Guang-hua; Fu, Lei; Zeng, Chao; Yang, Tuo; Peng, Shi-fang			Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults	PLOS ONE			English	Article							MORBIDLY OBESE-PATIENTS; METABOLIC SYNDROME; CHINESE ADULTS; ASCORBIC-ACID; INSULIN-RESISTANCE; ANTIOXIDANT STATUS; OXIDATIVE STRESS; STEATOHEPATITIS; CHILDREN; SERUM	Background Non-alcoholic fatty liver disease (NAFLD) has become one of the most prevalent chronic liver disease all over the world. The objective of this study was to evaluate the association between dietary vitamin C intake and NAFLD. Method Subjects were diagnosed with NAFLD by abdominal ultrasound examination and the consumption of alcohol was less than 40g/day for men or less than 20g/day for women. Vitamin C intake was classified into four categories according to the quartile distribution in the study population: <= 74.80 mg/day, 74.81-110.15 mg/day, 110.16-146.06 mg/day, and >= 146.07 mg/day. The energy and multi-variable adjusted odds ratio (OR), as well as their corresponding 95% confidence interval (CI), were used to determine the relationship between dietary vitamin C intake and NAFLD through logistic regression. Result The present cross-sectional study included 3471 subjects. A significant inverse association between dietary vitamin C intake and NAFLD was observed in the energy-adjusted and the multivariable model. The multivariable adjusted ORs (95% CI) for NAFLD were 0.69 (95% CI: 0.54-0.89), 0.93 (95% CI: 0.72-1.20), and 0.71 (95% CI: 0.53-0.95) in the second, third and fourth dietary vitamin C intake quartiles, respectively, compared with the lowest (first) quartile. The relative odds of NAFLD was decreased by 0.71 times in the fourth quartile of dietary vitamin C intake compared with the lowest quartile. After stratifying data by sex or the status of obesity, the inverse association remained valid in the male population or non-obesity population, but not in the female population or obesity population. Conclusion There might be a moderate inverse association between dietary vitamin C intake and NAFLD in middle-aged and older adults, especially for the male population and non-obesity population.	[Wei, Jie; Peng, Shi-fang] Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China; [Fu, Lei; Peng, Shi-fang] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Wei, Jie] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Lei, Guang-hua; Zeng, Chao; Yang, Tuo] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Peng, SF (corresponding author), Cent S Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Hunan, Peoples R China.; Peng, SF (corresponding author), Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China.	sfp1988@hotmail.com	Wei, Jie/ACR-8087-2022	Wei, Jie/0000-0003-3510-8241	Hunan Provincial Innovation Foundation for Postgraduate [CX2014B096]; Fundamental Research Funds for the Central Universities of Central South University [2014zzts070]	Hunan Provincial Innovation Foundation for Postgraduate; Fundamental Research Funds for the Central Universities of Central South University	JW accepted funding support from Hunan Provincial Innovation Foundation for Postgraduate (CX2014B096), the Fundamental Research Funds for the Central Universities of Central South University (2014zzts070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Bian SS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-106; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Canbakan B, 2007, ACTA GASTRO-ENT BELG, V70, P277; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chan R, 2015, PLOS ONE, V10; Da SH, 2014, J ACAD NUTR DIET, V114, P1181, DOI [10.1016/j.jand.2014.01.009, DOI 10.1016/J.JAND.2014.01.009]; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, 2006, ZHONGHUA GAN ZANG BI, V14, P161; Ford ES, 2003, DIABETES, V52, P2346, DOI 10.2337/diabetes.52.9.2346; Foster T, 2011, AM J GASTROENTEROL, V106, P71, DOI 10.1038/ajg.2010.299; Gambino R, 2011, ANTIOXID REDOX SIGN, V15, P1325, DOI 10.1089/ars.2009.3058; GINTER E, 1975, ANN NY ACAD SCI, V258, P410, DOI 10.1111/j.1749-6632.1975.tb29299.x; Han JM, 2014, J GASTROEN HEPATOL, V29, P1265, DOI 10.1111/jgh.12520; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Ipsen DH, 2014, NUTRIENTS, V6, P5473, DOI 10.3390/nu6125473; Jankovic A, 2014, METABOLISM, V63, P661, DOI 10.1016/j.metabol.2014.01.009; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li YR, 2013, ASIA PAC J CLIN NUTR, V22, P60, DOI 10.6133/apjcn.2013.22.1.06; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Lirussi F, 2007, COCHRANE DB SYST REV, pD4996; Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08; Mah E, 2011, J AM DIET ASSOC, V111, P737, DOI 10.1016/j.jada.2011.02.003; Motamed Soudabe, 2013, N Am J Med Sci, V5, P377, DOI 10.4103/1947-2714.114171; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; NAMBISAN B, 1975, ATHEROSCLEROSIS, V22, P447, DOI 10.1016/0021-9150(75)90024-6; Nobili V, 2006, ALIMENT PHARM THER, V24, P1553, DOI 10.1111/j.1365-2036.2006.03161.x; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Papandreou D, 2007, CLIN NUTR, V26, P409, DOI 10.1016/j.clnu.2007.02.002; Valdecantos MP, 2010, REDOX REP, V15, P207, DOI 10.1179/135100010X12826446921464; Polimeni L, 2015, WORLD J HEPATOL, V7, P1325, DOI 10.4254/wjh.v7.i10.1325; Rezazadeh A, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-26; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rose FJ, 2010, DIABETES OBES METAB, V12, P1084, DOI 10.1111/j.1463-1326.2010.01297.x; Sun C, 2013, NUTR FOOD HYGIENE; Sun W, 2015, QJM-INT J MED, V108, P617, DOI 10.1093/qjmed/hcv006; Uzun H, 2004, OBES SURG, V14, P659, DOI 10.1381/096089204323093453; Veena J, 2014, BRIT J NUTR, V112, P1858, DOI 10.1017/S0007114514002591; Wei J, 2015, PLOS ONE, V10; Wei J, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0007-2; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wu SJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000802; Yang CQ, 2015, NUTRIENTS, V7, P4778, DOI 10.3390/nu7064778; Yang YX, 2009, CHINA FOOD COMPOSITI; Zeng C., 2015, PLOS ONE, V10; Zeng C, 2015, J RHEUMATOL, V42, P1231, DOI 10.3899/jrheum.141414; Zhang ZC, 2015, J HEPATOL	48	37	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147985	10.1371/journal.pone.0147985	http://dx.doi.org/10.1371/journal.pone.0147985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824361	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600083
J	Mair, L; Ruete, A				Mair, Louise; Ruete, Alejandro			Explaining Spatial Variation in the Recording Effort of Citizen Science Data across Multiple Taxa	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; RANGE MAPS; BIAS; MODELS; UNCERTAINTY; RICHNESS; HOTSPOTS; ECOLOGY	The collation of citizen science data in open-access biodiversity databases makes temporally and spatially extensive species' observation data available to a wide range of users. Such data are an invaluable resource but contain inherent limitations, such as sampling bias in favour of recorder distribution, lack of survey effort assessment, and lack of coverage of the distribution of all organisms. Any technical assessment, monitoring program or scientific research applying citizen science data should therefore include an evaluation of the uncertainty of its results. We use 'ignorance' scores, i.e. spatially explicit indices of sampling bias across a study region, to further understand spatial patterns of observation behaviour for 13 reference taxonomic groups. The data is based on voluntary observations made in Sweden between 2000 and 2014. We compared the effect of six geographical variables (elevation, steepness, population density, log population density, road density and footpath density) on the ignorance scores of each group. We found substantial variation among taxonomic groups in the relative importance of different geographic variables for explaining ignorance scores. In general, road access and logged population density were consistently important variables explaining bias in sampling effort, indicating that access at a landscape-scale facilitates voluntary reporting by citizen scientists. Also, small increases in population density can produce a substantial reduction in ignorance score. However the between-taxa variation in the importance of geographic variables for explaining ignorance scores demonstrated that different taxa suffer from different spatial biases. We suggest that conservationists and researchers should use ignorance scores to acknowledge uncertainty in their analyses and conclusions, because they may simultaneously include many correlated variables that are difficult to disentangle.	[Mair, Louise; Ruete, Alejandro] Swedish Univ Agr Sci SLU, Species Informat Ctr, PO 7007, SE-75007 Uppsala, Sweden; [Ruete, Alejandro] Swedish Univ Agr Sci SLU, Dept Ecol, PO 7004, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Mair, L (corresponding author), Swedish Univ Agr Sci SLU, Species Informat Ctr, PO 7007, SE-75007 Uppsala, Sweden.	louise.mair@slu.se	Mair, Louise/AAL-4986-2020; Ruete, Alejandro/E-6024-2010	Mair, Louise/0000-0002-7419-7200; Ruete, Alejandro/0000-0001-7681-2812				Asher J, 2001, MILLENNIUM ATLAS BUT; Barbosa FG, 2015, ECOL MODEL, V313, P77, DOI 10.1016/j.ecolmodel.2015.06.014; Breed GA, 2013, NAT CLIM CHANGE, V3, P142, DOI [10.1038/nclimate1663, 10.1038/NCLIMATE1663]; Dennis RLH, 2000, J INSECT CONSERV, V4, P73, DOI 10.1023/A:1009690919835; Devictor V, 2007, BIOL CONSERV, V139, P29, DOI 10.1016/j.biocon.2007.05.021; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Fernandez D, 2015, ECOL MODEL, V299, P147, DOI 10.1016/j.ecolmodel.2014.12.017; FICETOLA GF, 2014, J BIOGEOGR, V41, P211, DOI DOI 10.1111/JBI.12206; Fithian W, 2015, METHODS ECOL EVOL, V6, P424, DOI 10.1111/2041-210X.12242; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Isaac NJB, 2011, J INSECT CONSERV, V15, P233, DOI 10.1007/s10841-010-9340-0; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Keil P, 2014, DIVERS DISTRIB, V20, P797, DOI 10.1111/ddi.12199; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Lemoine N, 2007, GLOBAL ECOL BIOGEOGR, V16, P55, DOI 10.1111/j.1466-8238.2006.00252.x; Mair L, 2012, GLOBAL CHANGE BIOL, V18, P2439, DOI 10.1111/j.1365-2486.2012.02730.x; McInerny GJ, 2014, TRENDS ECOL EVOL, V29, P148, DOI 10.1016/j.tree.2014.01.003; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Plummer, 2012, JAGS PROGRAM ANAL BA; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Romo H, 2006, ECOGRAPHY, V29, P873, DOI 10.1111/j.2006.0906-7590.04680.x; Ruete A, SIMPLE ALGO IN PRESS; Ruete A, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e5361; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Snall T, 2011, BIOL CONSERV, V144, P804, DOI 10.1016/j.biocon.2010.11.010; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stolar J, 2015, DIVERS DISTRIB, V21, P595, DOI 10.1111/ddi.12279; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tulloch AIT, 2013, DIVERS DISTRIB, V19, P465, DOI 10.1111/j.1472-4642.2012.00947.x; Tulloch AIT, 2012, EMU, V112, P313, DOI 10.1071/MU12009; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; Ward EJ, 2015, PEERJ, V3, DOI 10.7717/peerj.704; Warton DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079168	36	69	70	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147796	10.1371/journal.pone.0147796	http://dx.doi.org/10.1371/journal.pone.0147796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820846	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000369528400045
J	Amdur, RL; Mukherjee, M; Go, A; Barrows, IR; Ramezani, A; Shoji, J; Reilly, MP; Gnanaraj, J; Deo, R; Roas, S; Keane, M; Master, S; Teal, V; Soliman, EZ; Yang, P; Feldman, H; Kusek, JW; Tracy, CM; Raj, DS				Amdur, Richard L.; Mukherjee, Monica; Go, Alan; Barrows, Ian R.; Ramezani, Ali; Shoji, Jun; Reilly, Muredach P.; Gnanaraj, Joseph; Deo, Raj; Roas, Sylvia; Keane, Martin; Master, Steve; Teal, Valerie; Soliman, Elsayed Z.; Yang, Peter; Feldman, Harold; Kusek, John W.; Tracy, Cynthia M.; Raj, Dominic S.		CRIC Study Investigators	Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; ELEVATED INTERLEUKIN-6; PLASMA INTERLEUKIN-6; OXIDATIVE STRESS; INFLAMMATION; HEMODIALYSIS; MORTALITY; PREVALENCE; BIOMARKERS	Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with chronic kidney disease (CKD). In this study, we examined the association between inflammation and AF in 3,762 adults with CKD, enrolled in the Chronic Renal Insufficiency Cohort (CRIC) study. AF was determined at baseline by self-report and electrocardiogram (ECG). Plasma concentrations of interleukin(IL)-1, IL-1 Receptor antagonist, IL-6, tumor necrosis factor (TNF)-alpha, transforming growth factor-beta, high sensitivity C-Reactive protein, and fibrinogen, measured at baseline. At baseline, 642 subjects had history of AF, but only 44 had AF in ECG recording. During a mean follow-up of 3.7 years, 108 subjects developed new-onset AF. There was no significant association between inflammatory biomarkers and past history of AF. After adjustment for demographic characteristics, comorbid conditions, laboratory values, echocardiographic variables, and medication use, plasma IL-6 level was significantly associated with presence of AF at baseline (Odds ratio [OR], 1.61; 95% confidence interval [CI], 1.21 to 2.14; P = 0.001) and new-onset AF (OR, 1.25; 95% CI, 1.02 to 1.53; P = 0.03). To summarize, plasma IL-6 level is an independent and consistent predictor of AF in patients with CKD.	[Amdur, Richard L.] George Washington Univ, Med Fac Associates, Biostat Core, Washington, DC USA; [Mukherjee, Monica] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Go, Alan] Kaiser Permanente, Div Res, Oakland, CA USA; [Barrows, Ian R.] George Washington Univ, Sch Med, Washington, DC USA; [Ramezani, Ali; Shoji, Jun; Raj, Dominic S.] George Washington Univ, Sch Med, Div Renal Dis & Hypertens, Washington, DC USA; [Reilly, Muredach P.; Deo, Raj] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Gnanaraj, Joseph] Bridgeport Hosp, Bridgeport, CT USA; [Roas, Sylvia] Harvard Univ, Sch Med, Joslin Diabet Ctr, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Keane, Martin] Temple Heart & Vasc Ctr, Philadelphia, PA USA; [Master, Steve] Univ Penn, Perelman Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA; [Teal, Valerie; Yang, Peter; Feldman, Harold] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Soliman, Elsayed Z.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Kusek, John W.] NIDDK, Div Kidney Urol & Hematol Dis, Bethesda, MD 20892 USA; [Tracy, Cynthia M.] George Washington Univ, Sch Med, Div Cardiol, Washington, DC USA	George Washington University; Johns Hopkins University; Kaiser Permanente; George Washington University; George Washington University; University of Pennsylvania; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Wake Forest University; Wake Forest Baptist Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); George Washington University	Raj, DS (corresponding author), George Washington Univ, Sch Med, Div Renal Dis & Hypertens, Washington, DC USA.	draj@mfa.gwu.edu	Soliman, Elsayed Z/AAD-7135-2020; Amdur, Richard L/AAE-5345-2019; Go, Alan S./AAE-7745-2019	Soliman, Elsayed Z/0000-0001-5632-8150; Mukherjee, Monica/0000-0001-6088-0773; Master, Stephen/0000-0002-6808-631X; Amdur, Richard/0000-0002-4900-653X; Tracy, Cynthia/0000-0002-3647-6444; Reilly, Muredach/0000-0002-3035-9386	National Institutes of Health [R01 DK073665-01A1, 1U01DK099914-01, 1U01DK099924-01]; National Institute of Diabetes and Digestive and Kidney Diseases [U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, U01DK060902]; Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award NIH/NCATS [UL1TR000003]; Johns Hopkins University [UL1 TR-000424]; University of Maryland GCRC [M01 RR-16500]; Clinical and Translational Science Collaborative of Cleveland; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1TR000439]; NIH roadmap for Medical Research; Michigan Institute for Clinical and Health Research (MICHR) [UL1TR000433]; University of Illinois at Chicago CTSA [UL1RR029879]; Tulane University Translational Research in Hypertension and Renal Biology [P30GM103337]; Kaiser Permanente NIH/NCRR UCSF-CTSI [UL1 RR-024131]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award NIH/NCATS; Johns Hopkins University(Johns Hopkins University); University of Maryland GCRC; Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Institute for Clinical and Health Research (MICHR); University of Illinois at Chicago CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Tulane University Translational Research in Hypertension and Renal Biology; Kaiser Permanente NIH/NCRR UCSF-CTSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Dominic S. Raj is supported by R01 DK073665-01A1, 1U01DK099914-01 and 1U01DK099924-01 from the National Institutes of Health. Funding for the CRIC Study was obtained under a cooperative agreement from National Institute of Diabetes and Digestive and Kidney Diseases (U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK061028, U01DK060980, U01DK060963, and U01DK060902). In addition, this work was supported in part by: the Perelman School of Medicine at the University of Pennsylvania Clinical and Translational Science Award NIH/NCATS UL1TR000003, Johns Hopkins University UL1 TR-000424, University of Maryland GCRC M01 RR-16500, Clinical and Translational Science Collaborative of Cleveland, UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research, Michigan Institute for Clinical and Health Research (MICHR) UL1TR000433, University of Illinois at Chicago CTSA UL1RR029879, Tulane University Translational Research in Hypertension and Renal Biology P30GM103337, Kaiser Permanente NIH/NCRR UCSF-CTSI UL1 RR-024131.	Allison P. D., 1999, LOGISTIC REGRESSION; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Ananthapanyasut W, 2010, CLIN J AM SOC NEPHRO, V5, P173, DOI 10.2215/CJN.03170509; Anderson AH, 2012, AM J KIDNEY DIS, V60, P250, DOI 10.1053/j.ajkd.2012.04.012; [Anonymous], 2001, CIRCULATION, V104, P2118; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Baber U, 2011, CIRC-ARRHYTHMIA ELEC, V4, P26, DOI 10.1161/CIRCEP.110.957100; Bansal N, 2013, CIRCULATION, V127, P569, DOI 10.1161/CIRCULATIONAHA.112.123992; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Conen D, 2010, EUR HEART J, V31, P1730, DOI 10.1093/eurheartj/ehq146; Deo R, 2010, J CARD FAIL, V16, P55, DOI 10.1016/j.cardfail.2009.07.002; Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Genovesi S, 2005, AM J KIDNEY DIS, V46, P897, DOI 10.1053/j.ajkd.2005.07.044; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gupta J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124772; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Henningsen KMA, 2009, SCAND CARDIOVASC J, V43, P285, DOI 10.1080/14017430802653676; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kaireviciute D, 2010, THROMB HAEMOSTASIS, V104, P122, DOI 10.1160/TH09-12-0837; Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Lee SH, 2007, LIFE SCI, V80, P1806, DOI 10.1016/j.lfs.2007.02.029; Leftheriotis DI, 2009, INT J CARDIOL, V135, P361, DOI 10.1016/j.ijcard.2008.04.012; Li J, 2010, HEART RHYTHM, V7, P438, DOI 10.1016/j.hrthm.2009.12.009; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Marott SCW, 2010, J AM COLL CARDIOL, V56, P789, DOI 10.1016/j.jacc.2010.02.066; McManus DD, 2009, AM J CARDIOL, V104, P1551, DOI 10.1016/j.amjcard.2009.07.026; Miyasaka Y, 2008, AM J CARDIOL, V102, P568, DOI 10.1016/j.amjcard.2008.04.025; Navarro SL, 2012, CANCER EPIDEM BIOMAR, V21, P1167, DOI 10.1158/1055-9965.EPI-12-0110; Nelson SE, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002097; Prineas R., 1982, MINNESOTA CODE MANUA; Psychari SN, 2005, AM J CARDIOL, V95, P764, DOI 10.1016/j.amjcard.2004.11.032; Raj DSC, 2008, KIDNEY INT, V73, P1054, DOI 10.1038/ki.2008.21; Raj DSC, 2005, KIDNEY INT, V68, P2338, DOI 10.1111/j.1523-1755.2005.00695.x; Rao M, 2005, AM J KIDNEY DIS, V45, P324, DOI 10.1053/j.ajkd.2004.09.018; Raymond RJ, 2001, AM HEART J, V141, P435, DOI 10.1067/mhj.2001.113078; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Wing MR, 2014, OBESITY, V22, P1359, DOI 10.1002/oby.20692; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yan AT, 2010, EUR HEART J, V31, P875, DOI 10.1093/eurheartj/ehp454; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS169, DOI 10.1681/ASN.2006080910	52	45	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148189	10.1371/journal.pone.0148189	http://dx.doi.org/10.1371/journal.pone.0148189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840403	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200095
J	Ghith, N; Wagner, P; Frolich, A; Merlo, J				Ghith, Nermin; Wagner, Philippe; Frolich, Anne; Merlo, Juan			Short Term Survival after Admission for Heart Failure in Sweden: Applying Multilevel Analyses of Discriminatory Accuracy to Evaluate Institutional Performance	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; HOSPITAL VOLUME; COMORBIDITY MEASURES; LOGISTIC-REGRESSION; ANTIBIOTIC USE; RISK; MORTALITY; OUTCOMES; HEALTH	Background Hospital performance is frequently evaluated by analyzing differences between hospital averages in some quality indicators. The results are often expressed as quality charts of hospital variance (e.g., league tables, funnel plots). However, those analyses seldom consider patients heterogeneity around averages, which is of fundamental relevance for a correct evaluation. Therefore, we apply an innovative methodology based on measures of components of variance and discriminatory accuracy to analyze 30-day mortality after hospital discharge with a diagnosis of Heart Failure (HF) in Sweden. Methods We analyzed 36,943 patients aged 45-80 treated in 565 wards at 71 hospitals during 2007-2009. We applied single and multilevel logistic regression analyses to calculate the odds ratios and the area under the receiver-operating characteristic (AUC). We evaluated general hospital and ward effects by quantifying the intra-class correlation coefficient (ICC) and the increment in the AUC obtained by adding random effects in a multilevel regression analysis (MLRA). Finally, the Odds Ratios (ORs) for specific ward and hospital characteristics were interpreted jointly with the proportional change in variance (PCV) and the proportion of ORs in the opposite direction (POOR). Findings Overall, the average 30-day mortality was 9%. Using only patient information on age and previous hospitalizations for different diseases we obtained an AUC = 0.727. This value was almost unchanged when adding sex, country of birth as well as hospitals and wards levels. Average mortality was higher in small wards and municipal hospitals but the POOR values were 15% and 16% respectively. Conclusions Swedish wards and hospitals in general performed homogeneously well, resulting in a low 30-day mortality rate after HF. In our study, knowledge on a patient's previous hospitalizations was the best predictor of 30-day mortality, and this information did not improve by knowing the sex and country of birth of the patient or where the patient was treated.	[Ghith, Nermin; Wagner, Philippe; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden; [Ghith, Nermin; Frolich, Anne] Bispebjerg Hosp, Res Unit Chron Condit, Copenhagen, Denmark; [Wagner, Philippe] Uppsala Univ, Clin Res Ctr, Vasteras, Sweden	Lund University; University of Copenhagen; Bispebjerg Hospital; Uppsala University	Ghith, N (corresponding author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.; Ghith, N (corresponding author), Bispebjerg Hosp, Res Unit Chron Condit, Copenhagen, Denmark.	nermin_m.ghith@med.lu.se	Merlo, Juan/E-2136-2011; Ghith, Nermin/B-3163-2013	Merlo, Juan/0000-0001-8379-9708; Ghith, Nermin/0000-0002-5863-5442; Froelich, Anne/0000-0002-0500-9923	Swedish Research Council (VR) [2013-2484]; University of Copenhagen; Association of Hospitals in Copenhagen	Swedish Research Council (VR)(Swedish Research Council); University of Copenhagen; Association of Hospitals in Copenhagen	This work was supported by the Swedish Research Council (VR) [#2013-2484, Juan Merlo] and by grants from the University of Copenhagen and the Association of Hospitals in Copenhagen for Nermin Ghith as a PHD candidate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NW MEM HEALTHC DEATH; Ash A., 2011, STAT ISSUES ASSESSIN; Bernal-Delgado E, 2015, EUR J PUBLIC HEALTH, V25, P3, DOI 10.1093/eurpub/cku219; Bhatia RS, 2014, BMJ QUAL SAF, V23, P981, DOI 10.1136/bmjqs-2014-002816; Bottle A, 2013, HEALTH SERV RES, V48, P2081, DOI 10.1111/1475-6773.12074; Brinkman S, 2013, INTENS CARE MED, V39, P1925, DOI 10.1007/s00134-013-3042-5; Browne WJ., 2013, MCMC ESTIMATIN MLWIN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coiera E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-226; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Garcia-Armesto S, 2015, EUR J PUBLIC HEALTH, V25, P44, DOI 10.1093/eurpub/cku224; Gastmeier P, 2011, INFECTION, V39, P211, DOI 10.1007/s15010-011-0112-x; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Goldstein H, 2011, FISCAL STUDIES, DOI [10.1111/j.1475-5890.2011.00133, DOI 10.1111/J.1475-5890.2011.00133]; Harbarth S, 2001, CLIN INFECT DIS, V33, P1462, DOI 10.1086/322677; Harris S, 2011, CONGESTIVE HEART FAI, V17, P47, DOI [10.1111/j.1751-7133.2010.00194.x, DOI 10.1111/J.1751-7133.2010.00194.X]; Hosmer Jr DW, 2013, APPLIED LOGISTIC REG; HUGHES RG, 1988, MED CARE, V26, P1057, DOI 10.1097/00005650-198811000-00004; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Katzan IL, 2014, STROKE, V45, P918, DOI 10.1161/01.str.0000441948.35804.77; KHOURY MJ, 1985, AM J PUBLIC HEALTH, V75, P1204, DOI 10.2105/AJPH.75.10.1204; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; KRUMHOLZ HM, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F620; Lang CC, 2007, HEART, V93, P665, DOI 10.1136/hrt.2005.068296; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lee CS, 2014, BMC CARDIOVASC DISOR, V14, DOI [10.1186/1471-2334-14-47, 10.1186/1471-2261-14-73]; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lynch KF, 2010, J EPIDEMIOL COMMUN H, V64, P789, DOI 10.1136/jech.2008.083667; Merlo J, 2005, MED CARE, V43, P1092, DOI 10.1097/01.mlr.0000182484.14608.b9; Merlo J, 2005, EUR J EPIDEMIOL, V20, P737, DOI 10.1007/s10654-005-2065-9; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P323, DOI 10.1136/jech.55.5.323; Merlo J, 2001, LAKARTIDNINGEN, V98, P4838; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2015, PLOS ONE; Merlo J, 2013, MEASURES DISCR UNPUB; Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Mohammed MA, 2009, EVIDENCE METHODOLOGI, V15, P48; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; Ohlsson H, 2011, MED CARE, V49, P327, DOI 10.1097/MLR.0b013e31820325c5; Ohlsson H, 2010, MED CARE, V48, P757, DOI 10.1097/MLR.0b013e3181e80861; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Saunders L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095295; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tsai AC, 2006, HEALTH SERV RES, V41, P252, DOI 10.1111/j.1475-6773.2005.00461.x; Tu JV, 2008, CIRCULATION, V118, P2588, DOI 10.1161/CIRCULATIONAHA.107.729806; Umegaki T, 2010, CRIT CARE RESUSC, V12, P96; Varagunam M, 2015, BMJ QUAL SAF, V24, P195, DOI 10.1136/bmjqs-2014-003551; Vernaz N, 2008, J ANTIMICROB CHEMOTH, V62, P601, DOI 10.1093/jac/dkn199; Vernaz N, 2011, J ANTIMICROB CHEMOTH, V66, P928, DOI 10.1093/jac/dkq525; Wagner P, 2014, 20 IEA WORLD C EP WC	60	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148187	10.1371/journal.pone.0148187	http://dx.doi.org/10.1371/journal.pone.0148187			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840122	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200093
J	Horl, G; Froehlich, H; Ferstl, U; Ledinski, G; Binder, J; Cvirn, G; Stojakovic, T; Trauner, M; Koidl, C; Tafeit, E; Amrein, K; Scharnagl, H; Jurgens, G; Hallstrom, S				Hoerl, Gerd; Froehlich, Harald; Ferstl, Ulrika; Ledinski, Gerhard; Binder, Josepha; Cvirn, Gerhard; Stojakovic, Tatjana; Trauner, Michael; Koidl, Christoph; Tafeit, Erwin; Amrein, Karin; Scharnagl, Hubert; Juergens, Guenther; Hallstroem, Seth			Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ACUTE CORONARY SYNDROMES; INTIMA-MEDIA THICKNESS; OXIDIZED LDL; GRADIENT ULTRACENTRIFUGATION; SERUM-LIPOPROTEINS; APOLIPOPROTEIN-B; IMMUNOGLOBULIN-M; ARTERY-DISEASE; RISK-FACTORS	We investigated a polyethylene glycol non-precipitable low-density lipoprotein (LDL) subfraction targeted by IgG and the influence of statin therapy on plasma levels of these small LDL-IgG-immune complexes (LDL-IgG-IC). LDL-subfractions were isolated from 6 atherosclerotic subjects and 3 healthy individuals utilizing iodixanol density gradient ultracentrifugation. Cholesterol, apoB and malondialdehyde (MDA) levels were determined in each fraction by enzymatic testing, dissociation-enhanced lanthanide fluorescence immunoassay and high-performance liquid chromatography, respectively. The levels of LDL-IgG-IC were quantified densitometrically following lipid electrophoresis, particle size distribution was assessed with dynamic light scattering and size exclusion chromatography. The influence of simvastatin (40 mg/day for three months) on small LDL-IgG-IC levels and their distribution among LDL-subfractions (salt gradient separation) were investigated in 11 patients with confirmed coronary artery disease (CAD). We demonstrate that the investigated LDL-IgG-IC are small particles present in atherosclerotic patients and healthy subjects. In vitro assembly of LDL-IgG-IC resulted in particle density shifts indicating a composition of one single molecule of IgG per LDL particle. Normalization on cholesterol levels revealed MDA values twice as high for LDL-subfractions rich in small LDL-IgG-IC if compared to dominant LDL-subfractions. Reactivity of affinity purified small LDL-IgG-IC to monoclonal antibody OB/04 indicates a high degree of modified apoB and oxidative modification. Simvastatin therapy studied in the CAD patients significantly lowered LDL levels and to an even higher extent, small LDL-IgG-IC levels without affecting their distribution. In conclusion simvastatin lowers levels of small LDL-IgG-IC more effectively than LDL-cholesterol and LDL-apoB levels in atherosclerotic patients. This antiatherogenic effect may additionally contribute to the known beneficial effects of this drug in the treatment of atherosclerosis.	[Hoerl, Gerd; Ferstl, Ulrika; Ledinski, Gerhard; Cvirn, Gerhard; Tafeit, Erwin; Juergens, Guenther; Hallstroem, Seth] Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, Graz, Austria; [Froehlich, Harald] Med Univ Graz, Div Angiol, Dept Internal Med, Graz, Austria; [Binder, Josepha] Med Univ Graz, Div Cardiol, Dept Internal Med, Graz, Austria; [Stojakovic, Tatjana; Scharnagl, Hubert] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Trauner, Michael] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Med 3, Vienna, Austria; [Koidl, Christoph] Med Univ Graz, Inst Hyg, Graz, Austria; [Amrein, Karin] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Vienna; Medical University of Graz; Medical University of Graz	Horl, G (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, Graz, Austria.	gerd.hoerl@medunigraz.at		Froehlich, Harald/0000-0003-4415-9809; Hoerl, Gerd/0000-0002-0884-0851; Amrein, Karin/0000-0003-0915-085X; Trauner, Michael/0000-0002-1275-6425				Agar C, 2009, J THROMB HAEMOST, V7, P235, DOI 10.1111/j.1538-7836.2008.03223.x; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Asciutto G, 2015, ATHEROSCLEROSIS, V239, P289, DOI 10.1016/j.atherosclerosis.2015.01.023; Atchley DH, 2002, DIABETOLOGIA, V45, P1562, DOI 10.1007/s00125-002-0962-y; Bancells C, 2010, J LIPID RES, V51, P3508, DOI 10.1194/jlr.M009258; Bassi N, 2009, AUTOIMMUNITY, V42, P289, DOI 10.1080/08916930902828247; BAUMSTARK MW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P48, DOI 10.1016/0167-4838(90)90100-T; Carmena R, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000131511.50734.44; CARROLL RM, 1983, J LIPID RES, V24, P200; Chait A, 2000, CURR OPIN LIPIDOL, V11, P457, DOI 10.1097/00041433-200010000-00003; Chapman MJ, 1998, EUR HEART J, V19, pA24; CHAPMAN MJ, 1988, J LIPID RES, V29, P442; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Chyu Kuang-Yuh, 2014, Ther Adv Vaccines, V2, P56, DOI 10.1177/2051013613514327; Davies IG, 2003, CLIN CHEM, V49, P1865, DOI 10.1373/clinchem.2003.023366; Estruch M, 2015, BBA-MOL CELL BIOL L, V1851, P1442, DOI 10.1016/j.bbalip.2015.08.009; Fagerberg B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120744; Fraley AE, 2009, J AM COLL CARDIOL, V53, P2186, DOI 10.1016/j.jacc.2009.02.041; Frostegard J, 2010, CLIN IMMUNOL, V134, P47, DOI 10.1016/j.clim.2009.08.013; Goncalves I, 2009, AUTOIMMUNITY, V42, P203, DOI 10.1080/08916930802668602; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Gutierrez MM, 1999, BIOCHEMISTRY-US, V38, P1284, DOI 10.1021/bi981424x; HAMMER A, 1995, ARTERIOSCL THROM VAS, V15, P704, DOI 10.1161/01.ATV.15.5.704; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harmon EY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001232; Hermansson A, 2011, CIRCULATION, V123, P1083, DOI 10.1161/CIRCULATIONAHA.110.973222; Hunt KJ, 2013, ATHEROSCLEROSIS, V231, P315, DOI 10.1016/j.atherosclerosis.2013.09.027; Itabe H, 2003, BIOL PHARM BULL, V26, P1, DOI 10.1248/bpb.26.1; Itabe H, 2009, CLIN REV ALLERG IMMU, V37, P4, DOI 10.1007/s12016-008-8095-9; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Klein RL, 2011, J DIABETES COMPLICAT, V25, P73, DOI 10.1016/j.jdiacomp.2010.03.001; KLIMOV AN, 1988, ATHEROSCLEROSIS, V74, P41, DOI 10.1016/0021-9150(88)90189-X; Kobayashi K, 2007, LUPUS, V16, P929, DOI 10.1177/0961203307084170; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; Li SJ, 2013, MOL METAB, V2, P256, DOI 10.1016/j.molmet.2013.06.001; Lopes-Virella MF, 2007, ATHEROSCLEROSIS, V190, P359, DOI 10.1016/j.atherosclerosis.2006.02.007; Lopes-Virella MF, 2010, CLIN IMMUNOL, V134, P55, DOI 10.1016/j.clim.2009.04.001; Lopes-Virella MF, 1999, CLIN IMMUNOL, V90, P165, DOI 10.1006/clim.1998.4631; Lopes-Virella MF, 2004, DIABETES CARE, V27, P908, DOI 10.2337/diacare.27.4.908; Matsuura Eiji, 2002, Autoimmunity Reviews, V1, P348, DOI 10.1016/S1568-9972(02)00084-8; Matsuura Eiji, 2009, Curr Rheumatol Rep, V11, P61; Mironova MA, 2000, DIABETES, V49, P1033, DOI 10.2337/diabetes.49.6.1033; Nilsson J, 2012, CURR OPIN LIPIDOL, V23, P422, DOI 10.1097/MOL.0b013e328356ec7c; Nordestgaard BG, 1996, CURR OPIN LIPIDOL, V7, P269, DOI 10.1097/00041433-199610000-00002; Nowak B, 2012, ADV CLIN EXP MED, V21, P331; Orekhov AN, 2014, INT J MOL SCI, V15, P12807, DOI 10.3390/ijms150712807; Pilz J, 2000, J CHROMATOGR B, V742, P315, DOI 10.1016/S0378-4347(00)00174-2; POLZ E, 1979, FEBS LETT, V102, P183, DOI 10.1016/0014-5793(79)80955-2; Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Shoenfeld Y, 2005, CIRCULATION, V112, P3337, DOI 10.1161/CIRCULATIONAHA.104.507996; Shoenfeld Y, 2004, CIRCULATION, V110, P2552, DOI 10.1161/01.CIR.0000143225.07377.EA; Singh Y, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-47; Sobenin IA, 2013, INT J CARDIOL, V166, P747, DOI 10.1016/j.ijcard.2012.09.175; Soto Yosdel, 2009, Human Antibodies, V18, P109, DOI 10.3233/HAB-2009-0202; SPARROW CP, 1988, J LIPID RES, V29, P745; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stojakovic T, 2010, EUR J CLIN INVEST, V40, P187, DOI 10.1111/j.1365-2362.2009.02249.x; Su J, 2006, ATHEROSCLEROSIS, V188, P160, DOI 10.1016/j.atherosclerosis.2005.10.017; Tertov VV, 1996, ATHEROSCLEROSIS, V122, P191, DOI 10.1016/0021-9150(95)05737-4; Tertov VV, 1995, EXP MOL PATHOL, V62, P166, DOI 10.1006/exmp.1995.1018; Timar O, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4285; Toshima S, 2000, ARTERIOSCL THROM VAS, V20, P2243, DOI 10.1161/01.ATV.20.10.2243; TRIBBLE DL, 1995, J LIPID RES, V36, P662; Tsimikas S, 2004, CIRCULATION, V110, P1406, DOI 10.1161/01.CIR.0000141728.23033.B5; van Leeuwen M, 2009, AUTOIMMUN REV, V9, P53, DOI 10.1016/j.autrev.2009.03.001; Virella G, 2013, J IMMUNOASS IMMUNOCH, V34, P61, DOI 10.1080/15321819.2012.683500; Wu RH, 1998, ARTERIOSCL THROM VAS, V18, P626, DOI 10.1161/01.ATV.18.4.626; Yee MS, 2008, J LIPID RES, V49, P1364, DOI 10.1194/jlr.D700044-JLR200; Younis NN, 2012, CLIN SCI LOND; Zhang XL, 2014, J ATHEROSCLER THROMB, V21, P1140, DOI 10.5551/jat.24372; Zhu XM, 2014, J IMMUNOL, V193, P2483, DOI 10.4049/jimmunol.1303075	75	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148210	10.1371/journal.pone.0148210	http://dx.doi.org/10.1371/journal.pone.0148210			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840480	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200098
J	Samo, RN; Agha, A; Shah, SA; Altaf, A; Memon, A; Blevins, M; Qian, HZ; Vermund, SH				Samo, Rab Nawaz; Agha, Ajmal; Shah, Sharaf Ali; Altaf, Arshad; Memon, Ashraf; Blevins, Meridith; Qian, Han-Zhu; Vermund, Sten H.			Risk Factors for Loss to Follow-Up among People Who Inject Drugs in a Risk Reduction Program at Karachi, Pakistan. A Case-Cohort Study	PLOS ONE			English	Article							METHADONE-MAINTENANCE THERAPY; QUALITY-OF-LIFE; HIV RISK; ANTIRETROVIRAL THERAPY; SICHUAN PROVINCE; BUPRENORPHINE MAINTENANCE; SOUTHERN CHINA; UNITED-STATES; HEPATITIS-C; USERS	Introduction Retention of male people who inject drugs (PWIDs) is a major challenge for harm reduction programs that include sterile needle/syringe exchange in resource-limited settings like Pakistan. We assessed the risk factors for loss to follow-up among male PWIDs enrolled in a risk reduction program in Karachi, Pakistan. Methods We conducted a prospective cohort study among 636 HIV-uninfected male PWIDs enrolled during March-June 2009 in a harm reduction program for the estimation of incidence rate. At 24 months post-enrollment, clients who had dropped out of the program were defined as lost to follow-up and included as cases for case-cohort study. Results The median age of the participants was 29 years (interquartile range: 23-36). Active outreach accounted for 76% (483/636) of cohort recruits. Loss to follow-up at 24 months was 25.5% (162/636). In multivariable logistic regression, younger age (AOR: 0.97, 95% CI: 0.92-0.99, p = 0.028), clients from other provinces than Sindh (AOR: 1.49, 95% CI: 1.01-2.22, p = 0.046), having no formal education (AOR: 3.44, 95% CI: 2.35-4.90, p<0.001), a history of incarceration (AOR: 1.68, 95% CI: 1.14-2.46, p<0.008), and being homeless (AOR: 1.47, 95% CI: 1.00-2.19, p<0.049) were associated with loss to follow-up. Conclusions Our cohort retained 74.5% of male PWIDs in Karachi for 24 months. Its loss to follow up rate suggested substantial ongoing programmatic challenges. Programmatic enhancements are needed for the highest risk male PWIDs, i.e., younger men, men not from Sindh Province, men who are poorly educated, formerly incarcerated, and/or homeless.	[Samo, Rab Nawaz] World Hlth Org, Polio Eradicat Initiat, Larkana, Pakistan; [Agha, Ajmal] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Shah, Sharaf Ali; Altaf, Arshad] Bridge Consultants Fdn, Karachi, Pakistan; [Memon, Ashraf] Sindh AIDS Control Program, Karachi, Pakistan; [Blevins, Meridith; Qian, Han-Zhu; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Blevins, Meridith] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	World Health Organization; Aga Khan University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Samo, RN (corresponding author), World Hlth Org, Polio Eradicat Initiat, Larkana, Pakistan.	drsamo1974@yahoo.com	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698	National Institutes of Health Fogarty AIDS International Training and Research Program [D43TW001035]	National Institutes of Health Fogarty AIDS International Training and Research Program	The authors acknowledge support from the National Institutes of Health Fogarty AIDS International Training and Research Program (grant # D43TW001035).	Abdul Mujeeb S, 1988, J Pak Med Assoc, V38, P221; Ahmadi J, 2003, J SUBST ABUSE TREAT, V24, P217, DOI 10.1016/S0740-5472(03)00024-2; Ahmadi J, 2002, J SUBST ABUSE TREAT, V22, P157, DOI 10.1016/S0740-5472(02)00222-2; Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; Azim T, 2008, SUBST USE MISUSE, V43, P2124, DOI 10.1080/10826080802344583; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Canada Pakistan HIV/AIDS Surveillance Project (CIDA), 2008, HIV 2 GEN SURV SINDH; Celentano DD, 1998, J ACQ IMMUN DEF SYND, V17, P73, DOI 10.1097/00042560-199801010-00011; Chawarski MC, 2011, DRUG ALCOHOL DEPEN, V115, P237, DOI 10.1016/j.drugalcdep.2010.09.024; Chawarski MC, 2012, DRUG ALCOHOL DEPEN, V124, P177, DOI 10.1016/j.drugalcdep.2011.12.024; Che YH, 2011, AM J DRUG ALCOHOL AB, V37, P148, DOI 10.3109/00952990.2010.535578; Choi SYP, 2007, AIDS CARE, V19, P1, DOI 10.1080/09540120600900496; Choi SYP, 2006, SOC SCI MED, V62, P1672, DOI 10.1016/j.socscimed.2005.08.046; Choopanya K, 2003, JAIDS-J ACQ IMM DEF, V33, P88, DOI 10.1097/00126334-200305010-00013; Cohen JE, 2008, PLOS MED, V5, P1682, DOI 10.1371/journal.pmed.0050234; Cook C, 2008, 5 GLOBAL STATE HARM; Dev A, 2004, J GASTROEN HEPATOL, V19, P792, DOI 10.1111/j.1440-1746.2004.03381.x; Emmanuel Faran, 2006, J Pak Med Assoc, V56, P119; Hadland SE, 2012, AIDS PATIENT CARE ST, V26, P274, DOI 10.1089/apc.2011.0196; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Hammett TM, 2006, AIDS EDUC PREV, V18, P97, DOI 10.1521/aeap.2006.18.2.97; Hayashi K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-492; Hellard ME, 2006, AUST NZ J PUBL HEAL, V30, P519, DOI 10.1111/j.1467-842X.2006.tb00779.x; Husain S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-11; Hyder AA, 1999, PUBLIC HEALTH, V113, P39, DOI 10.1016/S0033-3506(99)00111-0; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; Jordan MR, 2009, INT J STD AIDS, V20, P418, DOI 10.1258/ijsa.2008.008389; Kazi AM, 2010, INT J INFECT DIS, V14, pE60, DOI 10.1016/j.ijid.2009.11.012; Kazi BM, 2000, J PUBLIC HEALTH MED, V22, P43, DOI 10.1093/pubmed/22.1.43; Kerr T, 2010, INT J DRUG POLICY, V21, P255, DOI 10.1016/j.drugpo.2009.08.002; KHANANI RM, 1988, AIDS RES HUM RETROV, V4, P149, DOI 10.1089/aid.1988.4.149; Kheirandish P, 2010, JAIDS-J ACQ IMM DEF, V53, P273, DOI 10.1097/QAI.0b013e3181be6dde; KHEIRANDISH P, 2009, URBAN HLTH, V86, P902, DOI DOI 10.1007/S11524-009-9393-0; Latkin C, 2009, HEALTH PSYCHOL, V28, P323, DOI 10.1037/a0014707; Latkin CA, 2009, SOC SCI MED, V68, P740, DOI 10.1016/j.socscimed.2008.11.019; Lawrinson P, 2008, ADDICTION, V103, P1484, DOI 10.1111/j.1360-0443.2008.02249.x; Li L, 2011, DRUG ALCOHOL DEPEN, V118, P335, DOI 10.1016/j.drugalcdep.2011.04.014; Lin C, 2011, PUBLIC HEALTH, V125, P269, DOI 10.1016/j.puhe.2011.01.009; Lin CQ, 2011, DRUG ALCOHOL DEPEN, V117, P45, DOI 10.1016/j.drugalcdep.2011.01.004; Lin CQ, 2010, J SUBST ABUSE TREAT, V38, P119, DOI 10.1016/j.jsat.2009.09.002; Luksamijarulkul Pipat, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P147; Malhotra S, 2002, Indian J Med Sci, V56, P602; Moore DM, 2010, HIV MED, V11, P299, DOI 10.1111/j.1468-1293.2009.00779.x; National AIDS Control Program, 2006, HIV 2 GEN SURV PAK N; National AIDS Control Program Ministry of Health Government of Pakistan, 2010, UNGASS PAK REP PROGR; National AIDS Control Program Ministry of Health Government of Pakistan; Islamabad, 2006, UNGASS IND COUNTR RE; NEWMAN RG, 1979, LANCET, V2, P485; Nishtar S, 2013, LANCET, V381, P2193, DOI 10.1016/S0140-6736(13)60019-7; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; Noordin NM, 2008, LANCET, V372, P1149, DOI 10.1016/S0140-6736(08)61479-8; PEAK A, 1995, AIDS, V9, P1067, DOI 10.1097/00002030-199509000-00013; Perngmark P, 2003, ADDICTION, V98, P1153, DOI 10.1046/j.1360-0443.2003.00446.x; Razani N, 2007, ADDICTION, V102, P1472, DOI 10.1111/j.1360-0443.2007.01914.x; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Rudolph AE, 2012, AIDS CARE, V24, P239, DOI 10.1080/09540121.2011.596517; Sabin LL, 2008, AIDS CARE, V20, P1242, DOI 10.1080/09540120801918651; Salter ML, 2010, AIDS EDUC PREV, V22, P558, DOI 10.1521/aeap.2010.22.6.558; Samo RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081715; Sarasvita R, 2012, J SUBST ABUSE TREAT, V42, P239, DOI 10.1016/j.jsat.2011.07.009; Sarin E, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-2; Sarkar S, 1995, Indian J Public Health, V39, P86; Shah SA, 2004, INT J STD AIDS, V15, P209, DOI 10.1258/095646204322916713; Shah SA, 1998, AIDS IN PAKISTAN; Shrestha I L, 2003, Kathmandu Univ Med J (KUMJ), V1, P101; Sullivan PS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000552; Ti LP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-189; UNODC, UNAIDS PAK COUNTR AD; Vanichseni S, 2004, JAIDS-J ACQ IMM DEF, V37, P1170, DOI 10.1097/01.qai.0000120821.38576.ec; VANICHSENI S, 1993, AIDS, V7, P887, DOI 10.1097/00002030-199306000-00020; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; Wang HH, 2010, J CLIN NURS, V19, P380, DOI 10.1111/j.1365-2702.2009.03048.x; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012; Wong KH, 2003, J SUBST ABUSE TREAT, V24, P233, DOI 10.1016/S0740-5472(03)00029-1; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang WD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-221; Zhang YZ, 2007, INT J INFECT DIS, V11, P318, DOI 10.1016/j.ijid.2006.09.001; Zhao L, 2012, AIDS CARE, V24, P195, DOI 10.1080/09540121.2011.596520	78	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147912	10.1371/journal.pone.0147912	http://dx.doi.org/10.1371/journal.pone.0147912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840414	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200070
J	Kicielinska, J; Szczygiel, A; Rossowska, J; Anger, N; Kempinska, K; Switalska, M; Kaszowska, M; Wietrzyk, J; Boratynski, J; Pajtasz-Piasecka, E				Kicielinska, Jagoda; Szczygiel, Agnieszka; Rossowska, Joanna; Anger, Natalia; Kempinska, Katarzyna; Switalska, Marta; Kaszowska, Marta; Wietrzyk, Joanna; Boratynski, Janusz; Pajtasz-Piasecka, Elzbieta			Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSE; IFN-GAMMA; ACTIVATION; ACID; MICE	Introduction Polymyxin B (PmB) belongs to the group of cyclic peptide antibiotics, which neutralize the activity of LPS by binding to lipid A. The aim of this study was to analyze the effect of PmB on the biological activity of lipooligosaccharide (LOS E. coli B, rough form of LPS) in vitro and in experimental metastasis models. Results Cultures of murine macrophage J774A. 1 cells and murine bone marrow-derived dendritic cells (BM-DC) stimulated in vitro with LOS and supplemented with PmB demonstrated a decrease in inflammatory cytokine production (IL-6, IL-10, TNF-alpha) and down-regulation of CD40, CD80, CD86 and MHC class II molecule expression. Additionally, PmB suspended in drinking water was given to the C57BL/6 mice seven or five days prior to the intravenous injection of B16 or LLC cells and intraperitoneal application of LOS. This strategy of PmB administration was continued throughout the duration of the experiments (29 or 21 days). In B16 model, statistically significant decrease in the number of metastases in mice treated with PmB and LOS (p<0.01) was found on the 14th day of the experiments, whereas themost intensive changes in surface-antigen expression and ex vivo production of IL-6, IL-1 beta and TNF-alpha by peritoneal cells were observed 7 days earlier. By contrast, antigen expression and ex vivo production of IL-6, IL-10, IFN-gamma by splenocytes remained relatively high and stable. Statistically significant decrease in LLC metastases number was observed after the application of LOS (p<0.01) and in the group of mice preconditioned by PmB and subsequently treated with LOS (LOS + PmB, p<0.01). Conclusions In conclusion, prolonged in vivo application of PmB was not able to neutralize the LOSinduced immune cell activity but its presence in the organism of treated mice was important in modulation of the LOS-mediated response against the development of metastases.	[Kicielinska, Jagoda; Szczygiel, Agnieszka; Rossowska, Joanna; Anger, Natalia; Kempinska, Katarzyna; Switalska, Marta; Kaszowska, Marta; Wietrzyk, Joanna; Boratynski, Janusz; Pajtasz-Piasecka, Elzbieta] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Pajtasz-Piasecka, E (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland.	pajtasz@iitd.pan.wroc.pl	Wietrzyk, Joanna/O-4392-2018; Rossowska, Joanna/E-9159-2015; Rossowska, Joanna/Y-6164-2019	Wietrzyk, Joanna/0000-0003-4980-6606; Rossowska, Joanna/0000-0002-3682-7160; Szczygiel, Agnieszka/0000-0003-1516-5636; Mierzejewska, Jagoda/0000-0001-7233-442X; Pajtasz-Piasecka, Elzbieta/0000-0002-0253-970X; Anger-Gora, Natalia/0000-0003-4942-9134; Kaszowska, Marta/0000-0003-4469-5660; Switalska, Marta/0000-0001-7920-2251; Boratynski, Janusz/0000-0001-5072-1162	Wroclaw Centre of Biotechnology, Programme The Leading National Research Centre (KNOW); Polish Ministry of Science-The National Centre for Research and Development [13-0089-06/2010]; Polish Ministry of Science and Higher Education-The National Centre for Research and Development [13-00-89-06/2010]	Wroclaw Centre of Biotechnology, Programme The Leading National Research Centre (KNOW); Polish Ministry of Science-The National Centre for Research and Development; Polish Ministry of Science and Higher Education-The National Centre for Research and Development	This work was supported by Wroclaw Centre of Biotechnology, Programme The Leading National Research Centre (KNOW) for years 2014-2018 and by the Polish Ministry of Science-The National Centre for Research and Development (http://www.ncbir.pl/en/): "Products of the Gram-negative bacteria lysis as potential anti-tumor agents. Determination of their chemical and biochemical properties as well as biological activities. Development of active substance production technology' (grants no. 13-0089-06/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Polish Ministry of Science and Higher Education-The National Centre for Research and Development grants no. 13-00-89-06/2010 and Wroclaw Centre of Biotechnology, Programme The Leading National Research Centre (KNOW) for years 2014-2018.	Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Bao Y, 2014, CELL RES, V24, P161, DOI 10.1038/cr.2013.155; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Ferrari D, 2004, J IMMUNOL, V173, P4652, DOI 10.4049/jimmunol.173.7.4652; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gaston JSH, 2002, CLIN EXP IMMUNOL, V127, P1, DOI 10.1046/j.1365-2249.2002.01759.x; HERSHBERGER C, 1968, J BIOL CHEM, V243, P1585; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; Kaszowska M, 2015, CARBOHYD RES, V413, P51, DOI 10.1016/j.carres.2015.04.023; Malleshappa P, 2011, Indian J Nephrol, V21, P41, DOI 10.4103/0971-4065.78077; Mares J, 2009, J BIOL CHEM, V284, P11498, DOI 10.1074/jbc.M806587200; McCarthy Edward F, 2006, Iowa Orthop J, V26, P154; Miernikiewicz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071036; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Rossowska J, 2007, FOLIA HISTOCHEM CYTO, V45, P349; Rossowska J, 2015, IMMUNOBIOLOGY, V220, P389, DOI 10.1016/j.imbio.2014.10.009; Rossowska J, 2009, ONCOL REP, V21, P1539, DOI 10.3892/or_00000386; RUGGIERO V, 1993, MEDIAT INFLAMM, V2, pS43, DOI 10.1155/S0962935193000754; Tzeng YL, 2002, J BACTERIOL, V184, P2379, DOI 10.1128/JB.184.9.2379-2388.2002; Valentinis B, 2005, J BIOL CHEM, V280, P14264, DOI 10.1074/jbc.M410791200; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Yoshino N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061643	28	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148156	10.1371/journal.pone.0148156	http://dx.doi.org/10.1371/journal.pone.0148156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829479	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200072
J	Viti, F; Landini, M; Mezzelani, A; Petecchia, L; Milanesi, L; Scaglione, S				Viti, Federica; Landini, Martina; Mezzelani, Alessandra; Petecchia, Loredana; Milanesi, Luciano; Scaglione, Silvia			Osteogenic Differentiation of MSC through Calcium Signaling Activation: Transcriptomics and Functional Analysis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BONE-FORMATION; POROUS HYDROXYAPATITE; PHOSPHATE CERAMICS; MODEL; GENE; BEHAVIOR; TISSUE; SCAFFOLDS	The culture of progenitor mesenchymal stem cells (MSC) onto osteoconductive materials to induce a proper osteogenic differentiation and mineralized matrix regeneration represents a promising and widely diffused experimental approach for tissue-engineering (TE) applications in orthopaedics. Among modern biomaterials, calcium phosphates represent the best bone substitutes, due to their chemical features emulating the mineral phase of bone tissue. Although many studies on stem cells differentiation mechanisms have been performed involving calcium-based scaffolds, results often focus on highlighting production of in vitro bone matrix markers and in vivo tissue ingrowth, while information related to the biomolecular mechanisms involved in the early cellular calcium-mediated differentiation is not well elucidated yet. Genetic programs for osteogenesis have been just partially deciphered, and the description of the different molecules and pathways operative in these differentiations is far from complete, as well as the activity of calcium in this process. The present work aims to shed light on the involvement of extracellular calcium in MSC differentiation: a better understanding of the early stage osteogenic differentiation program of MSC seeded on calcium-based biomaterials is required in order to develop optimal strategies to promote osteogenesis through the use of new generation osteoconductive scaffolds. A wide spectrum of analysis has been performed on time-dependent series: gene expression profiles are obtained from samples (MSC seeded on calcium-based scaffolds), together with related microRNAs expression and in vivo functional validation. On this basis, and relying on literature knowledge, hypotheses are made on the biomolecular players activated by the biomaterial calcium-phosphate component. Interestingly, a key role of miR-138 was highlighted, whose inhibition markedly increases osteogenic differentiation in vitro and enhance ectopic bone formation in vivo. Moreover, there is evidence that Ca-P substrate triggers osteogenic differentiation through genes (SMAD and RAS family) that are typically regulated during dexamethasone (DEX) induced differentiation.	[Viti, Federica; Petecchia, Loredana] CNR, Inst Biophys, Genoa, Italy; [Viti, Federica; Landini, Martina; Mezzelani, Alessandra; Milanesi, Luciano] CNR, Inst Biomed Technol, Segrate, MI, Italy; [Scaglione, Silvia] CNR, Inst Elect Comp & Telecommun Engn, Genoa, Italy; [Scaglione, Silvia] Adv Biotechnol Ctr CBA, Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Elettronica e di Ingegneria dell'Informazione e delle Telecomunicazioni (IEIIT-CNR)	Scaglione, S (corresponding author), CNR, Inst Elect Comp & Telecommun Engn, Genoa, Italy.; Scaglione, S (corresponding author), Adv Biotechnol Ctr CBA, Genoa, Italy.	silvia.scaglione@ieiit.cnr.it	scaglione, silvia/K-5378-2019; Viti, Federica/J-9305-2018; Scaglione, Silvia/B-7124-2014; Milanesi, Luciano/AAE-7230-2019; Mezzelani, Alessandra/B-3355-2014	scaglione, silvia/0000-0002-9464-3554; Scaglione, Silvia/0000-0002-9464-3554; Milanesi, Luciano/0000-0002-1201-3939; MEZZELANI, ALESSANDRA/0000-0001-7563-5869; Viti, Federica/0000-0002-9651-8896	Italian Ministry of Education and Research (MIUR) [PB05, RBFR13V4M2]	Italian Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the Italian Ministry of Education and Research (MIUR) through Flagship "InterOmics" (PB05) (received by SS) and through "Futuro in Ricerca 2013" (RBFR13V4M2) (received by FV).	Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Carlier A, 2011, ACTA BIOMATER, V7, P3573, DOI 10.1016/j.actbio.2011.06.021; Caterson E J, 2001, MedGenMed, pE1; Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.tea.2010.0160, 10.1089/ten.TEA.2010.0160]; Chan WC, 2012, GENOMICS, V100, P141, DOI 10.1016/j.ygeno.2012.06.007; Delaine-Smith RM, 2011, VITAM HORM, V87, P417, DOI 10.1016/B978-0-12-386015-6.00039-1; Deshpande S, 2013, J SURG RES, V185, P278, DOI 10.1016/j.jss.2013.06.063; Dua R, 2014, J BIOMED MATER RES B, V102, P922, DOI 10.1002/jbm.b.33073; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Eyckmans J, 2010, J CELL MOL MED, V14, P1845, DOI 10.1111/j.1582-4934.2009.00807.x; Farina NM, 2008, J MATER SCI-MATER M, V19, P1565, DOI 10.1007/s10856-008-3400-y; Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174; GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2; Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4; Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009; Gosain AK, 2005, PLAST RECONSTR SURG, V116, P1044, DOI 10.1097/01.prs.0000178402.77445.44; GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298; Graneli C, 2014, STEM CELL RES, V12, P153, DOI 10.1016/j.scr.2013.09.009; Guasch G, 2004, M S-MED SCI, V20, P265, DOI 10.1051/medsci/2004203265; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hronik-Tupaj M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-9; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Johnston N, 2004, DRUG DISCOV TODAY, V9, P994, DOI 10.1016/S1359-6446(04)03271-4; Jung GY, 2010, J MATER SCI-MATER M, V21, P1649, DOI 10.1007/s10856-010-4011-y; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kon E, 2000, J BIOMED MATER RES, V49, P328; Lee MW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/154919; Levi B, 2013, PLAST RECONSTR SURG, V132, P580, DOI 10.1097/PRS.0b013e31829ace13; Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264; MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Mizuno Hiroshi, 2003, Journal of Nippon Medical School, V70, P300; Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X; Nair MB, 2009, J BIOMED MATER RES A, V90A, P533, DOI 10.1002/jbm.a.32114; Noro T, 1999, BIO-MED MATER ENG, V9, P319; Olszewski Waldemar L, 2004, Ann Transplant, V9, P34; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Parrington J, 2014, ACTA PHYSIOL, V211, P285, DOI 10.1111/apha.12298; Pennesi G, 2011, CURR PHARM BIOTECHNO, V12, P151, DOI 10.2174/138920111794295684; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; R Core Team, 2018, R LANG ENV STAT COMP; Reh TA, 2001, BRAIN BEHAV EVOLUT, V58, P296, DOI 10.1159/000057571; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Ren JQ, 2011, CYTOTHERAPY, V13, P661, DOI 10.3109/14653249.2010.548379; Rezaee F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009690; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Scaglione S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00274; Schellenberg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094353; SHAH A, 2013, RAVAZI INT J MED, V1, P5, DOI DOI 10.17795/rijm14849; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Song W, 2011, J BIOACT COMPAT POL, V26, P242, DOI 10.1177/0883911511406327; Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com; Teixeira S, 2010, J BIOMED MATER RES A, V93A, P567, DOI 10.1002/jbm.a.32532; Tsuzuki N, 2012, RES VET SCI, V93, P1021, DOI 10.1016/j.rvsc.2011.12.002; von Heydebreck A, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P623; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	79	68	69	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148173	10.1371/journal.pone.0148173	http://dx.doi.org/10.1371/journal.pone.0148173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828589	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200078
J	Gong, W; Zhu, LY; Hao, Y				Gong, Wenjing; Zhu, Liyan; Hao, Ya			Lethal and Sublethal Toxicity Comparison of BFRs to Three Marine Planktonic Copepods: Effects on Survival, Metabolism and Ingestion	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; TETRABROMOBISPHENOL-A TBBPA; EURYTEMORA-AFFINIS; DIPHENYL ETHERS; HEXABROMOCYCLODODECANE; BIOACCUMULATION; ENVIRONMENT; ORGANISMS; BIOLOGY; TONSA	The estuarine planktonic copepods have a wide geographical distribution and commendable tolerance to various kinds of contaminants. The primary aim of the present study was to contrast the impacts of model POPs (TBBPA and HBCD) on three common estuarine planktonic copepods (Oithona similis, Acartia pacifica and Pseudodiaptomus inopinus) and establish a protocol for the assessment of acute toxicity of marine organic pollutants. We first quantified the 96h-LC50 (0.566, 0.04 and 0.257 mg/L of TBBPA to the three subjects above respectively and 0.314 mg/L of HBCD to P. inopinus; all reported concentrations are nominal values). In the sub-lethal toxicity tests, it was turned out that the effects of copepods exposed to TBBPA could product different influences on the energy ingestion and metabolism. Different type of pollutions, meanwhile, could also bring varying degree effect on the target copepods. In general, the indicators (the rate of oxygen consumption, ammonia excretion, food ingestion and filtration) in higher concentration groups showed marked significant difference compared with controls as well a dose-effect relationship. The study also extended the research on the joint toxicity of TBBPA and HBCD based on the survival rate of P. inopinus. Whether 1:1 concentration or 1:1 toxic level, the research showed synergy effect relative to single exposure conditions. The result indicated that current single ecological testing used for environmental protection activities may underestimate the risk for copepods. It was also demonstrated that short-term sub-lethal experiment could be a standard to evaluate the sensitivity of copepods to POPs.	[Gong, Wenjing; Zhu, Liyan; Hao, Ya] Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China	Ocean University of China	Zhu, LY (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China.	lyzhu@ouc.edu.cn			National Natural Science Foundation of China [31172412]; National key S&T Special Projects [2012ZX07501-003-06]; NSFC [31172412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key S&T Special Projects; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant No: 31172412, URLs: www.nsfc.gov.cn/, Grant recipient: LZ and the National key S&T Special Projects, Grant No: 2012ZX07501-003-06, URLs: www.nmp.gov.cn/, Grant recipient: LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the Grants of NSFC (Grant No. 31172412), and also supported by the Grants of the subitem of national key S&T Special Projects (Grant No. 2012ZX07501-003-06). The authors also thank professor Huang J. by the Laboratory of Ecology for hers help with the chemical analyses.	Alaee M, 2003, ENVIRON INT, V29, P683, DOI 10.1016/S0160-4120(03)00121-1; Alaee M, 2002, CHEMOSPHERE, V46, P579, DOI 10.1016/S0045-6535(01)00224-7; [Anonymous], 2004, E231704 ASTM INT; Barata C, 2005, ENVIRON TOXICOL CHEM, V24, P2992, DOI 10.1897/05-189R.1; Barata C, 2002, MAR ECOL PROG SER, V230, P183, DOI 10.3354/meps230183; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; CAHOON LB, 1981, DEEP-SEA RES, V28, P1215, DOI 10.1016/0198-0149(81)90057-1; Calbet A, 2007, MAR BIOL, V151, P195, DOI 10.1007/s00227-006-0468-0; Canesi L, 2005, AQUAT TOXICOL, V75, P277, DOI 10.1016/j.aquatox.2005.08.010; Covaci A, 2006, ENVIRON SCI TECHNOL, V40, P3679, DOI 10.1021/es0602492; Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; de Wit CA, 2006, CHEMOSPHERE, V64, P209, DOI 10.1016/j.chemosphere.2005.12.029; Devreker D, 2010, ESTUAR COAST SHELF S, V89, P245, DOI 10.1016/j.ecss.2010.07.010; Dur G, 2009, ECOL MODEL, V220, P1073, DOI 10.1016/j.ecolmodel.2008.12.013; Eriksson J, 2004, CHEMOSPHERE, V54, P117, DOI 10.1016/S0045-6535(03)00704-5; Esslinger S, 2003, ENVIRON SCI TECHNOL, V45, P3938; Feng AH, 2012, MAR POLLUT BULL, V64, P919, DOI 10.1016/j.marpolbul.2012.03.008; Fonseca VM, 2005, J THERM ANAL CALORIM, V79, P429, DOI 10.1007/s10973-005-0079-x; Fraser J. H., 1936, Journal of the Marine Biological Association Plymouth, V20, P523; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; FRYER G., 1957, PROC ZOOL SOC LONDON, V129, P1; Gaudy R, 2000, J EXP MAR BIOL ECOL, V247, P51, DOI 10.1016/S0022-0981(00)00139-8; Gourmelon A, 2007, ECOTOXICOLOGY, V16, P161, DOI 10.1007/s10646-006-0105-1; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Harris RP, 1973, J MAR BIOL ASSOC UK, V54, P141; Hornsby PR, 2007, SPRINGER SER MATER S, V97, P3; Huang Y, 2008, THESIS OCEAN U CHINA; HUNTLEY M, 1988, HYDROBIOLOGIA, V167, P83, DOI 10.1007/BF00026296; Hutchinson TH, 2006, AQUAT TOXICOL, V76, P69, DOI 10.1016/j.aquatox.2005.09.008; IPCS (International Program on Chemical Safety), 1995, ENV HLTH CRIT WHO; Kuiper RV, 2007, ECOTOX ENVIRON SAFE, V67, P349, DOI 10.1016/j.ecoenv.2006.12.001; Laurent Seuront, 2011, PLOS ONE, V6, P1; Lavorante BRBO, 2013, ECOTOX ENVIRON SAFE, V95, P52, DOI 10.1016/j.ecoenv.2013.05.010; Lee KW, 2008, CHEMOSPHERE, V72, P1359, DOI 10.1016/j.chemosphere.2008.04.023; Li Chao-Lun, 2002, Acta Ecologica Sinica, V22, P593; Li SJ, 1964, J AMOY U, V11, P93; Li Ya-ning, 2008, Shengtaixue Zazhi, V27, P263; Li YongDong, 2010, Journal of Environment and Health, V27, P933; Liu S.M., 2012, PERIOD OCEAN U CHINA, V42, P49, DOI [10.16441/j.cnki.hdxb.2012.12.007, DOI 10.16441/J.CNKI.HDXB.2012.12.007]; Lu DY, 2003, J HARBIN U COMMERCE, V19, P20; Marking L, 1977, AQUATIC TOXICOLOGY H, P99, DOI DOI 10.1520/STP32392S; Medina M, 2002, ARCH ENVIRON CON TOX, V42, P17, DOI 10.1007/s002440010286; Michalec FG, 2013, AQUAT TOXICOL, V138, P129, DOI 10.1016/j.aquatox.2013.05.007; Nakajima A., 2009, TOXICOL LETT, V05, P003; Niehoff B, 2007, PROG OCEANOGR, V74, P1, DOI 10.1016/j.pocean.2006.05.005; [彭浩 PENG Hao], 2006, [环境与健康杂志, Journal of Environment and Health], V23, P571; Powlik JJ, 1997, CRUSTACEANA, V70, P324, DOI 10.1163/156854097X00609; Remberger M, 2004, CHEMOSPHERE, V54, P9, DOI 10.1016/S0045-6535(03)00758-6; Research Group of Carcinology Institute of Zoology Academia Sinica, 1979, FAUN SIN; Saint-Louis R, 2004, ANALYST, V129, P724, DOI 10.1039/b400743n; Saito H, 1996, MAR BIOL, V125, P97, DOI 10.1007/BF00350764; Sellstrom U, 2003, ENVIRON SCI TECHNOL, V37, P5496, DOI 10.1021/es0300766; [史雅娟 Shi Yajuan], 2003, [世界科技研究与发展, World Sci-Tech R and D], V25, P73; Shi ZX, 2009, THESIS CHINESE CTR D; Sun YY, 2008, CHEMOSPHERE, V70, P1787, DOI 10.1016/j.chemosphere.2007.08.033; ten Dam G, 2012, J CHROMATOGR B, V898, P101, DOI 10.1016/j.jchromb.2012.04.025; The state oceanic administration of China, 2007, SPEC MAR MON; Tomy GT, 2008, ENVIRON SCI TECHNOL, V42, P3634, DOI 10.1021/es703083z; Troitzsch JH, 1998, CHIM OGGI, V16, P18; VOLKMANN-ROCCO B, 1973, Archivio di Oceanografia e Limnologia, V18, P71; Xu Dong-hui, 2010, Asian Journal of Ecotoxicology, V5, P543; Xu Fengfeng, 2013, Asian Journal of Ecotoxicology, V8, P737, DOI 10.7524/AJE.1673-5897.20130322001; Yi AX, 2014, ECOTOXICOLOGY, V23, P1314, DOI 10.1007/s10646-014-1274-y; Zegers BN, 2005, ENVIRON SCI TECHNOL, V39, P2095, DOI 10.1021/es049209t; ZHANG P., 2011, INNER MONGOLIA SCI T, V5, P51; Zheng Xiaoyan, 1989, Oceanologia et Limnologia Sinica, V20, P308; Zheng Z, 1984, MARINE ZOOPLANKTON B; Zhu JW, 2012, ENVIRON SCI TECHNOL, V25, P62; [No title captured]	70	8	8	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147790	10.1371/journal.pone.0147790	http://dx.doi.org/10.1371/journal.pone.0147790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824601	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600061
J	Kayser, EB; Sedensky, MM; Morgan, PG				Kayser, Ernst-Bernhard; Sedensky, Margaret M.; Morgan, Philip G.			Region-Specific Defects of Respiratory Capacities in the Ndufs4(KO) Mouse Brain	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; MITOCHONDRIAL PHOSPHOENOLPYRUVATE CARBOXYKINASE; LEIGH-LIKE-SYNDROME; AQDQ SUBUNIT; DISEASE; MUTATIONS; GENE; MICE; PROTEIN; MODEL	Background Lack of NDUFS4, a subunit of mitochondrial complex I (NADH: ubiquinone oxidoreductase), causes Leigh syndrome (LS), a progressive encephalomyopathy. Knocking out Ndufs4, either systemically or in brain only, elicits LS in mice. In patients as well as in KO mice distinct regions of the brain degenerate while surrounding tissue survives despite systemic complex I dysfunction. For the understanding of disease etiology and ultimately for the development of rationale treatments for LS, it appears important to uncover the mechanisms that govern focal neurodegeneration. Results Here we used the Ndufs4(KO) mouse to investigate whether regional and temporal differences in respiratory capacity of the brain could be correlated with neurodegeneration. In the KO the respiratory capacity of synaptosomes from the degeneration prone regions olfactory bulb, brainstem and cerebellum was significantly decreased. The difference was measurable even before the onset of neurological symptoms. Furthermore, neither compensating nor exacerbating changes in glycolytic capacity of the synaptosomes were found. By contrast, the KO retained near normal levels of synaptosomal respiration in the degeneration-resistant/resilient "rest" of the brain. We also investigated non-synaptic mitochondria. The KO expectedly had diminished capacity for oxidative phosphorylation (state 3 respiration) with complex I dependent substrate combinations pyruvate/malate and glutamate/malate but surprisingly had normal activity with alpha-ketoglutarate/malate. No correlation between oxidative phosphorylation (pyruvate/malate driven state 3 respiration) and neurodegeneration was found: Notably, state 3 remained constant in the KO while in controls it tended to increase with time leading to significant differences between the genotypes in older mice in both vulnerable and resilient brain regions. Neither regional ROS damage, measured as HNE-modified protein, nor regional complex I stability, assessed by blue native gels, could explain regional neurodegeneration. Conclusion Our data suggests that locally insufficient respiration capacity of the nerve terminals may drive focal neurodegeneration.	[Kayser, Ernst-Bernhard; Sedensky, Margaret M.; Morgan, Philip G.] Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA; [Sedensky, Margaret M.; Morgan, Philip G.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Kayser, EB (corresponding author), Seattle Childrens Res Inst, Ctr Dev Therapeut, Seattle, WA USA.	ernstbernhard.kayser@seattlechildrens.org			Seattle Children's Research Institute	Seattle Children's Research Institute	This work was supported by a seed fund from Seattle Children's Research Institute and by a gift from the Northwest Mitochondrial research Guild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assouline Z, 2012, BBA-MOL BASIS DIS, V1822, P1062, DOI 10.1016/j.bbadis.2012.01.013; Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; CHENG SC, 1972, ARCH BIOCHEM BIOPHYS, V151, P501, DOI 10.1016/0003-9861(72)90527-9; Choi SW, 2011, J NEUROSCI, V31, P4524, DOI 10.1523/JNEUROSCI.5817-10.2011; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188; Cobb CA, 2015, NEUROBIOL DIS, V84, P4, DOI 10.1016/j.nbd.2015.04.020; DRAHOTA Z, 1983, FEBS LETT, V157, P347, DOI 10.1016/0014-5793(83)80573-0; Falk MJ, 2010, CURR OPIN PEDIATR, V22, P711, DOI 10.1097/MOP.0b013e3283402e21; Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068831; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leshinsky-Silver E, 2009, MOL GENET METAB, V97, P185, DOI 10.1016/j.ymgme.2009.03.002; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Quintana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042904; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Ruhoy LS, 2014, APPL CLIN GENET, V7, P221, DOI 10.2147/TACG.S46176; Sakai Y, 2006, AM J NEURORADIOL, V27, P1924; Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; SCHMOLL D, 1995, EUR J BIOCHEM, V227, P308, DOI 10.1111/j.1432-1033.1995.tb20390.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134; SHANK RP, 1985, BRAIN RES, V329, P364, DOI 10.1016/0006-8993(85)90552-9; Spickett CM, 2013, REDOX BIOL, V1, P145, DOI 10.1016/j.redox.2013.01.007; Tsai L, 1998, P NATL ACAD SCI USA, V95, P7975, DOI 10.1073/pnas.95.14.7975; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Wang XY, 2011, J NEUROCHEM, V119, P1253, DOI 10.1111/j.1471-4159.2011.07525.x; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; WESTERGAARD N, 1994, NEUROSCI LETT, V176, P105, DOI 10.1016/0304-3940(94)90882-6; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200	41	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148219	10.1371/journal.pone.0148219	http://dx.doi.org/10.1371/journal.pone.0148219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824698	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600110
J	Moreno-Arriola, E; El Hafidi, M; Ortega-Cuellar, D; Carvajal, K				Moreno-Arriola, Elizabeth; El Hafidi, Mohammed; Ortega-Cuellar, Daniel; Carvajal, Karla			AMP-Activated Protein Kinase Regulates Oxidative Metabolism in Caenorhabditis elegans through the NHR-49 and MDT-15 Transcriptional Regulators	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; LIFE-SPAN; DIETARY RESTRICTION; C. ELEGANS; PPAR-ALPHA; GLUCOSE; INCREASES; PATHWAY; STRESS; AAK-2	Cellular energy regulation relies on complex signaling pathways that respond to fuel availability and metabolic demands. Dysregulation of these networks is implicated in the development of human metabolic diseases such as obesity and metabolic syndrome. In Caenorhabditis elegans the AMP-activated protein kinase, AAK, has been associated with longevity and stress resistance; nevertheless its precise role in energy metabolism remains elusive. In the present study, we find an evolutionary conserved role of AAK in oxidative metabolism. Similar to mammals, AAK is activated by AICAR and metformin and leads to increased glycolytic and oxidative metabolic fluxes evidenced by an increase in lactate levels and mitochondrial oxygen consumption and a decrease in total fatty acids and lipid storage, whereas augmented glucose availability has the opposite effects. We found that these changes were largely dependent on the catalytic subunit AAK-2, since the aak-2 null strain lost the observed metabolic actions. Further results demonstrate that the effects due to AAK activation are associated to SBP-1 and NHR-49 transcriptional factors and MDT-15 transcriptional co-activator, suggesting a regulatory pathway that controls oxidative metabolism. Our findings establish C. elegans as a tractable model system to dissect the relationship between distinct molecules that play a critical role in the regulation of energy metabolism in human metabolic diseases.	[Moreno-Arriola, Elizabeth; Ortega-Cuellar, Daniel; Carvajal, Karla] Inst Nacl Pediat, Lab Nutr Expt, Mexico City, DF, Mexico; [El Hafidi, Mohammed] Inst Nacl Cardiol, Dept Biomed Cardiovasc, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico	Carvajal, K (corresponding author), Inst Nacl Pediat, Lab Nutr Expt, Mexico City, DF, Mexico.	karla_ca@yahoo.com	El-Hafidi, Mohammed/AAN-4083-2021	Moreno-Arriola, Elizabeth/0000-0003-0160-6429; Ortega-Cuellar, Daniel/0000-0001-7950-4911; CARVAJAL, KARLA/0000-0002-5522-3266	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [239732]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors received no specific funding for this work. The authors thank Consejo Nacional de Ciencia y Tecnologia (CONACyT) for PhD scholarship (239732) given to EMA. EMA is a Ph.D. student at Programa de Doctorado en Ciencias Biomedicas, Facultad de Medicina, Universidad Nacional Autonoma de Mexico (UNAM, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Consejo Nacional de Ciencia y Tecnologia (CONACyT) for PhD scholarship (239732) given to Elizabeth Moreno-Arriola (EMA). EMA is a Ph.D. student at Programa de Doctorado en Ciencias Biomedicas, Facultad de Medicina, Universidad Nacional Autonoma de Mexico (UNAM, Mexico). We greatly thank Reyna Hernandez-Morales and Patricia Zarate-Grajales for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, DISSOLVED OXYGEN HDB; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2007, OBESITY REGULATION F; Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Bergmeyer H, 1974, METHOD ENZYMAT AN, P1463; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; CARLING D, 1994, J BIOL CHEM, V269, P11442; Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Da Silva D, 2012, IUBMB LIFE, V64, P766, DOI 10.1002/iub.1063; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111; El Hafidi M, 2001, J NUTR BIOCHEM, V12, P396, DOI 10.1016/S0955-2863(01)00154-1; Elle IC, 2008, LIPID INSIGHTS, V1, P13; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIUGLIANO D, 1993, DIABETES CARE, V16, P1387, DOI 10.2337/diacare.16.10.1387; Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102; Grad LI, 2004, HUM MOL GENET, V13, P303, DOI 10.1093/hmg/ddh027; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Haase TN, 2011, AM J PHYSIOL-REG I, V301, pR1501, DOI 10.1152/ajpregu.00775.2010; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hope IA., 1999, C ELEGANS PRACTICAL; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kemp BJ, 2012, CURR BIOL, V22, P2213, DOI 10.1016/j.cub.2012.09.047; Kniazeva M, 2003, GENETICS, V163, P159; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lee SK, 2012, CELL SIGNAL, V24, P2329, DOI 10.1016/j.cellsig.2012.07.022; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moreno-Arriola E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/705253; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Ortega-Cuellar D, 2010, J NUTRIGENET NUTRIGE, V3, P18, DOI 10.1159/000318054; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pino EC, 2013, JOVE-J VIS EXP, DOI 10.3791/50180; Qin Y, 2009, BBA-MOL CELL BIOL L, V1791, P140, DOI 10.1016/j.bbalip.2008.12.003; Ruiz-Ramirez A, 2011, AM J PHYSIOL-ENDOC M, V301, pE1198, DOI 10.1152/ajpendo.00631.2010; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tateya S, 2013, DIABETES, V62, P1913, DOI 10.2337/db12-0325; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Vazquez Garcia JC, 2000, REV I NAL ENF RESP M, V13, P6; Velazquez-Arellano A, 2011, MOL GENET METAB, V102, P69, DOI 10.1016/j.ymgme.2010.08.021; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; ZBOROWSK.DT, 1967, J APPL PHYSIOL, V22, P746, DOI 10.1152/jappl.1967.22.4.746; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	70	33	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148089	10.1371/journal.pone.0148089	http://dx.doi.org/10.1371/journal.pone.0148089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824904	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600097
J	Bardhan, KD; Cullis, J; Williams, NR; Arasaradnam, RP; Wilson, AJ				Bardhan, Karna D.; Cullis, James; Williams, Nigel R.; Arasaradnam, Ramesh P.; Wilson, Adrian J.			Quantification of (18)FDG in the Normal Colon-A First Step in Investigating Whether Its Presence Is a Marker of a Physiological Process	PLOS ONE			English	Article							WALL THICKNESS; CYSTIC-FIBROSIS; PET/CT; FDG; ACCUMULATION; F-18-FDG; CT	The visibility of the colon in positron emission tomography (PET) scans of patients without gastrointestinal disease indicating the presence of F-18 Fluorodeoxyglucose ((18)FDG) is well recognised, but unquantified and unexplained. In this paper a qualitative scoring system was applied to PET scans from 30 randomly selected patients without gastrointestinal disease to detect the presence of (18)FDG in 4 different sections of the colon and then both the total pixel value and the pixel value per unit length of each section of the colon were determined to quantify the amount of (18)FDG from a randomly selected subset of 10 of these patients. Analysis of the qualitative scores using a non-parametric ANOVA showed that all sections of the colon contained (18)FDG but there were differences in the amount of (18)FDG present between sections (p<0.05). Wilcoxon matched-pair signed-rank tests between pairs of segments showed statistically significant differences between all pairs (p<0.05) with the exception of the caecum and ascending colon and the descending colon. The same non-parametric statistical analysis of the quantitative measures showed no difference in the total amount of (18)FDG between sections (p>0.05), but a difference in the amount/unit length between sections (p<0.01) with only the caecum and ascending colon and the descending colon having a statistically significant difference (p<0.05). These results are consistent since the eye is drawn to focal localisation of the (18)FDG when qualitatively scoring the scans. The presence of (18)FDG in the colon is counterintuitive since it must be passing from the blood to the lumen through the colonic wall. There is no active mechanism to achieve this and therefore we hypothesise that the transport is a passive process driven by the concentration gradient of (18)FDG across the colonic wall. This hypothesis is consistent with the results obtained from the qualitative and quantitative measures analysed.	[Bardhan, Karna D.] Rotherham Gen Hosp, Dept Gastroenterol, Rotherham S60 2UD, S Yorkshire, England; [Bardhan, Karna D.] Univ Sheffield, Sch Med, Sheffield S10 2TN, S Yorkshire, England; [Cullis, James; Williams, Nigel R.] Univ Hosp, Dept Clin Phys & Bioengn, Nucl Med, Coventry CV2 2DX, W Midlands, England; [Arasaradnam, Ramesh P.] Univ Hosp, Dept Gastroenterol, Coventry CV2 2DX, W Midlands, England; [Arasaradnam, Ramesh P.] Univ Warwick, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Wilson, Adrian J.] Univ Hosp, Dept Res Dev & Innovat, Coventry CV2 2DX, W Midlands, England; [Wilson, Adrian J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Sheffield; University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Warwick	Bardhan, KD (corresponding author), Rotherham Gen Hosp, Dept Gastroenterol, Rotherham S60 2UD, S Yorkshire, England.; Bardhan, KD (corresponding author), Univ Sheffield, Sch Med, Sheffield S10 2TN, S Yorkshire, England.	Bardhan.Sec@rothgen.nhs.uk		Arasaradnam, Ramesh/0000-0002-2231-3062				Arasaradnam RP, 2012, NUCL MED COMMUN, V33, P1312, DOI 10.1097/MNM.0b013e328359d3a6; Corman ML, 2012, CORMANS COLON RECTAL; Dialer I, 2003, J CLIN GASTROENTEROL, V37, P55, DOI 10.1097/00004836-200307000-00014; FISHER JK, 1982, RADIOLOGY, V145, P415, DOI 10.1148/radiology.145.2.7134445; Franc B, 2003, CLIN NUCL MED, V28, P541, DOI 10.1097/00003072-200307000-00001; Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6; Haber HP, 1997, GUT, V40, P406, DOI 10.1136/gut.40.3.406; Kim Seok ki, 1999, Clin Positron Imaging, V2, P273, DOI 10.1016/S1095-0397(99)00030-8; LEVINE GM, 1982, AM J PHYSIOL, V242, pG455, DOI 10.1152/ajpgi.1982.242.5.G455; Miraldi F, 1998, CLIN NUCL MED, V23, P3, DOI 10.1097/00003072-199801000-00002; Murata Y, 2007, NUCL MED BIOL, V34, P961, DOI 10.1016/j.nucmedbio.2007.07.006; Nordin N, 2012, ADV ENV BIOTECHNOLOG; Otsuka H, 2005, ANN NUCL MED, V19, P101, DOI 10.1007/BF03027388; Ozguven MA, 2014, ANN NUCL MED, V28, P505, DOI 10.1007/s12149-014-0840-y; SIEGEL S., 1956, NONPARAMETRIC STAT B; Thomas JR, 1990, RES METHODS PHYS ACT; Wang K, 2012, NUCL MED COMMUN, V33, P641, DOI 10.1097/MNM.0b013e328350859b; Wiesner W, 2002, J COMPUT ASSIST TOMO, V26, P102, DOI 10.1097/00004728-200201000-00015	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147838	10.1371/journal.pone.0147838	http://dx.doi.org/10.1371/journal.pone.0147838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821281	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400048
J	Li, TH; Huang, CC; Yang, YY; Lee, KC; Hsieh, SL; Hsieh, YC; Alan, L; Lin, HC; Lee, SD; Tsai, CY				Li, Tzu-Hao; Huang, Chia-Chang; Yang, Ying-Ying; Lee, Kuei-Chuan; Hsieh, Shie-Liang; Hsieh, Yun-Cheng; Alan, Lin; Lin, Han-Chieh; Lee, Shou-Dong; Tsai, Chang-Youh			Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; FACTOR-ALPHA; NLRP3 INFLAMMASOME; ENDOTHELIAL-CELLS; ACTIVATION; SENSITIZATION; BIOSYNTHESIS; INHIBITION; CONTRIBUTE	Background and Aims By blocking TNF alpha-related effects, thalidomide not only inhibits hepatic fibrogenesis but improves peripheral vasodilatation and portal hypertension in cirrhotic rats. Nonetheless, the investigation of thalidomide's effects on splanchnic and collateral microcirculation has been limited. Our study explored the roles of intestinal and mesenteric TNF alpha along with inflammasome-related pathway in relation to cirrhosis and the splanchnic/collateral microcirculation. Methods Using in vivo and in vitro approaches, mechanisms of the effects of thalidomide on intestinal and mesenteric inflammatory, vasodilatory and angiogenic cascades-related abnormalities were explored in cirrhotic rats that had received 1-month thalidomide (C-T) treatment. Results In cirrhotic rats, high tumor necrosis factor (TNF)alpha, vascular endothelial growth factor (VEGF) and nitric oxide (NO)x levels were associated with the NOD-like receptors protein 3 (NLRP3), IL-1 beta and caspase-1 inflammasome over-expression in splenorenal shunt and mesenteric tissues. The thalidomide-related inhibition of mesenteric and splenorenal shunt inflammasome expression was accompanied by a significantly decreased intestinal mucosal injury and inflammasome immunohistochemical staining expression. Suppression of various angiogenic cascades, namely VEGF-NOS-NO, was paralleled by a decrease in mesenteric angiogenesis as detected by CD31 immunofluorescence staining and by reduced portosystemic shunting (PSS) in C-T rats. The down-regulation of the mesenteric and collateral vasodilatory VEGF-NOS-NO cascades resulted in a correction of vasoconstrictive hypo-responsiveness and in an attenuation of vasodilatory hyper-responsiveness when analyzed by in situ perfusion of the superior mesenteric arterial (SMA) and portosystemic collaterals. There was also a decrease in SMA blood flow and an increase in SMA resistance in the C-T rats. Additionally, acute incubation with thalidomide abolished TNF alpha-augmented VEGF-mediated migration of and tube formation of human umbilical vein endothelial cells, which was accompanied by corresponding changes in inflammatory and angiogenic substances release. Conclusions The suppression of inflammasome over-expression by chronic thalidomide treatment ameliorates inflammatory, angiogenic and vasodilatory cascades-related pathogenic changes in the splanchnic and collateral microcirculation of cirrhotic rats. Thalidomide seems to be a promising agent that might bring about beneficial changes to the disarrangements of peripheral, hepatic, splanchnic and collateral systems in cirrhosis.	[Li, Tzu-Hao; Tsai, Chang-Youh] Taipei Vet Gen Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Li, Tzu-Hao; Huang, Chia-Chang; Yang, Ying-Ying; Lee, Kuei-Chuan; Hsieh, Shie-Liang; Hsieh, Yun-Cheng; Alan, Lin; Lin, Han-Chieh; Tsai, Chang-Youh] Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan; [Huang, Chia-Chang; Yang, Ying-Ying] Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan; [Yang, Ying-Ying] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Lee, Kuei-Chuan; Hsieh, Yun-Cheng; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan; Cheng Hsin General Hospital	Yang, YY; Lin, HC (corresponding author), Natl Yang Ming Univ, Dept Med, Sch Med, Taipei 112, Taiwan.; Yang, YY (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gen Med, Taipei, Taiwan.; Yang, YY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan.; Lin, HC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	yangyy@vghtpe.gov.tw; hclin@vghtpe.gov.tw	Tsai, Chang-Youh/G-1747-2013; Hsieh, Shie-Liang Edmond/ABA-9184-2021; Lin, Han/GRF-1081-2022	Tsai, Chang-Youh/0000-0002-4154-4018; Huang, Chia-Chang/0000-0002-1313-4628; Yang, Ying-Ying/0000-0002-7719-0397	National Science Council [100-2314-B-010-059-MY3, NSC 101-2314-B-075-011]; Taipei Veterans General Hospital [V104C-023, V104C-022]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was partly supported by the grants 100-2314-B-010-059-MY3 and NSC 101-2314-B-075-011 from the National Science Council, and V104C-023 and V104C-022 by the Taipei Veterans General Hospital.	Abraldes JG, 2006, AM J PHYSIOL-GASTR L, V290, pG980, DOI 10.1152/ajpgi.00336.2005; Alvarez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071477; Anand RJ, 2008, AM J PHYSIOL-GASTR L, V294, pG109, DOI 10.1152/ajpgi.00331.2007; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; BAUDRY N, 1993, J APPL PHYSIOL, V75, P2392, DOI 10.1152/jappl.1993.75.6.2392; Buzzo CL, 2010, J BIOL CHEM, V285, P32087, DOI 10.1074/jbc.M110.124297; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Chang CC, 2009, J CHIN MED ASSOC, V72, P234, DOI 10.1016/S1726-4901(09)70063-2; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; DEVIERE J, 1990, HEPATOLOGY, V11, P628, DOI 10.1002/hep.1840110416; Dredge K, 2002, BRIT J CANCER, V87, P1166, DOI 10.1038/sj.bjc.6600607; Ehrenpreis ED, 1999, GASTROENTEROLOGY, V117, P1271, DOI 10.1016/S0016-5085(99)70276-3; Enomoto N, 2002, GASTROENTEROLOGY, V123, P291, DOI 10.1053/gast.2002.34161; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Geerts AM, 2006, LIVER INT, V26, P889, DOI 10.1111/j.1478-3231.2006.01308.x; Hartmann P, 2012, GASTROENTEROLOGY, V143, P1330, DOI 10.1053/j.gastro.2012.07.099; Keller M, 2009, J IMMUNOL, V183, P5593, DOI 10.4049/jimmunol.0900476; Komorowski J, 2006, LIFE SCI, V78, P2558, DOI 10.1016/j.lfs.2005.10.016; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; LopezTalavera JC, 1996, HEPATOLOGY, V23, P1616, DOI 10.1053/jhep.1996.v23.pm0008675185; LOPEZTALAVERA JC, 1995, GASTROENTEROLOGY, V108, P761, DOI 10.1016/0016-5085(95)90449-2; Lv P, 2006, PATHOL RES PRACT, V202, P777, DOI 10.1016/j.prp.2006.08.002; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Mashukova A, 2011, MOL CELL BIOL, V31, P756, DOI 10.1128/MCB.00811-10; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; POBER JS, 1986, J IMMUNOL, V136, P1680; ROSENKRANZWEISS P, 1994, J CLIN INVEST, V93, P2236, DOI 10.1172/JCI117221; Siegmund B, 2002, BIOCHEM PHARMACOL, V64, P1, DOI 10.1016/S0006-2952(02)01064-X; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tamilarasan KP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-17; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Weinheimer-Haus EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119106; WERNERFELMAYER G, 1993, J BIOL CHEM, V268, P1842; Wiest R, 1999, J CLIN INVEST, V104, P1223, DOI 10.1172/JCI7458; Yang M, 2012, JOVE-J VIS EXP, DOI 10.3791/3954; Yang YY, 2009, LIVER INT, V29, P678, DOI 10.1111/j.1478-3231.2009.01983.x; Yang YY, 2009, BIOCHEM BIOPH RES CO, V380, P666, DOI 10.1016/j.bbrc.2009.01.160	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147212	10.1371/journal.pone.0147212	http://dx.doi.org/10.1371/journal.pone.0147212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820153	Green Published, gold			2022-12-27	WOS:000369528400017
J	Ma, Y; Yin, F; Zhang, T; Zhou, XA; Li, XS				Ma, Yue; Yin, Fei; Zhang, Tao; Zhou, Xiaohua Andrew; Li, Xiaosong			Selection of the Maximum Spatial Cluster Size of the Spatial Scan Statistic by Using the Maximum Clustering Set-Proportion Statistic	PLOS ONE			English	Article							GEOGRAPHIC ANALYSIS; POWER COMPARISONS; DISEASE CLUSTERS; SURVIVAL-DATA	Spatial scan statistics are widely used in various fields. The performance of these statistics is influenced by parameters, such as maximum spatial cluster size, and can be improved by parameter selection using performance measures. Current performance measures are based on the presence of clusters and are thus inapplicable to data sets without known clusters. In this work, we propose a novel overall performance measure called maximum clustering set-proportion (MCS-P), which is based on the likelihood of the union of detected clusters and the applied dataset. MCS-P was compared with existing performance measures in a simulation study to select the maximum spatial cluster size. Results of other performance measures, such as sensitivity and misclassification, suggest that the spatial scan statistic achieves accurate results in most scenarios with the maximum spatial cluster sizes selected using MCS-P. Given that previously known clusters are not required in the proposed strategy, selection of the optimal maximum cluster size with MCS-P can improve the performance of the scan statistic in applications without identified clusters.	[Ma, Yue; Yin, Fei; Zhang, Tao; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Peoples R China; [Zhou, Xiaohua Andrew] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	Sichuan University; University of Washington; University of Washington Seattle	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Peoples R China.	publichealth.scu@gmail.com	Ma, Yue/U-7597-2019	Ma, Yue/0000-0002-1980-7520; Zhou, Xiaohua/0000-0001-7935-1222	National Natural Science Foundation of China [81402766]; National Science and Technology Mayor Project [2012ZX10004201-006]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Mayor Project; China Scholarship Council(China Scholarship Council)	This study was supported by National Natural Science Foundation of China (grant number 81402766), National Science and Technology Mayor Project (grant number 2012ZX10004201-006) and China Scholarship Council (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt V, 2014, STAT MED, V33, P1867, DOI 10.1002/sim.6075; Chaput EK, 2002, EMERG INFECT DIS, V8, P943, DOI 10.3201/eid0809.020103; Costa MA, 2012, COMPUT STAT DATA AN, V56, P1771, DOI 10.1016/j.csda.2011.11.001; Coulston JW, 2003, ENVIRON MANAGE, V31, P764, DOI 10.1007/s00267-002-0023-9; Donnan PT, 2005, MULT SCLER, V11, P403, DOI 10.1191/1352458505ms1191oa; Duczmal L, 2006, J COMPUTATIONAL GRAP, V15; Forand SP, 2002, HEALTH PLACE, V8, P191, DOI 10.1016/S1353-8292(01)00037-5; Glaz J., 2009, SCAN STAT METHODS AP, V2, P422, DOI [http://dx.doi.org/10.1007/978-0-8176-4749-0, DOI 10.1007/978-0-8176-4749-0]; Huang L, 2008, STAT MED, V27, P5111, DOI 10.1002/sim.3342; Huang L, 2007, BIOMETRICS, V63, P109, DOI 10.1111/j.1541-0420.2006.00661.x; Jacquez GM, 2009, SPAT SPATIO-TEMPORAL, V1, P19, DOI 10.1016/j.sste.2009.08.002; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Jung I, 2012, STAT MED, V31, P4040, DOI 10.1002/sim.5475; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2003, COMPUT STAT DATA AN, V42, P665, DOI 10.1016/S0167-9473(02)00160-3; Kulldorff M, SATSCAN TM USER GUID; Kulldorff M, SELECTED APPL FIELD; Kulldorff M, 2015, NE US BENCHMARK DATA; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Li XZ, 2011, MATH BIOSCI, V233, P135, DOI 10.1016/j.mbs.2011.07.004; Marek L, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/1476-072X-14-7; Neill DB, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-20; Ozonoff A, 2005, COMPUT STAT DATA AN, V48, P679, DOI 10.1016/j.csda.2004.03.012; Read S, 2013, J INF SCI, V39, P36, DOI 10.1177/0165551512469768; Read S, 2011, SPAT SPATIO-TEMPORAL, V2, P69, DOI 10.1016/j.sste.2011.01.002; Ribeiro SHR, 2012, SPAT SPATIO-TEMPORAL, V3, P107, DOI 10.1016/j.sste.2012.04.004; Savory DJ, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-1; Tango T, 2012, STAT MED, V31, P4207, DOI 10.1002/sim.5478; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; Torabi M, 2011, SPAT SPATIO-TEMPORAL, V2, P321, DOI 10.1016/j.sste.2011.10.003; Weisent J, 2011, GEOSPATIAL HEALTH, V6, P65, DOI 10.4081/gh.2011.158	35	15	15	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147918	10.1371/journal.pone.0147918	http://dx.doi.org/10.1371/journal.pone.0147918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820646	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400054
J	Rasche, L; Heiserich, L; Behrens, JR; Lenz, K; Pfuhl, C; Wakonig, K; Giess, RM; Freitag, E; Eberle, C; Wuerfel, J; Dorr, J; Bauer, P; Bellmann-Strobl, J; Paul, F; Roggenbuck, D; Ruprecht, K				Rasche, Ludwig; Heiserich, Lisa; Behrens, Janina Ruth; Lenz, Klaus; Pfuhl, Catherina; Wakonig, Katharina; Giess, Rene Markus; Freitag, Erik; Eberle, Caroline; Wuerfel, Jens; Doerr, Jan; Bauer, Peter; Bellmann-Strobl, Judith; Paul, Friedemann; Roggenbuck, Dirk; Ruprecht, Klemens			Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study	PLOS ONE			English	Article							H2AX PHOSPHORYLATION; OXIDATIVE STRESS; BIOMARKERS; BREAKS	Background In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as gamma-H2AX. Formation of gamma-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA double-strand breaks. gamma-H2AX expression in peripheral blood mononuclear cells (PBMCs) was recently proposed as a diagnostic and disease activity marker for multiple sclerosis (MS). Objective To evaluate the significance of gamma-H2AX and 53BP1 foci in PBMCs as diagnostic and disease activity markers in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS) using automated. gamma-H2AX and 53BP1 foci detection. Methods Immunocytochemistry was performed on freshly isolated PBMCs of patients with CIS/early RRMS (n = 25) and healthy controls (n = 27) with gamma-H2AX and 53BP1 specific antibodies. Nuclear gamma-H2AX and 53BP1 foci were determined using a fully automated reading system, assessing the numbers of gamma-H2AX and 53BP1 foci per total number of cells and the percentage of cells with foci. Patients underwent contrast enhanced 3 Tesla magnetic resonance imaging (MRI) and clinical examination including expanded disability status scale (EDSS) score. gamma-H2AX and 53BP1 were also compared in previously frozen PBMCs of each 10 CIS/early RRMS patients with and without contrast enhancing lesions (CEL) and 10 healthy controls. Results The median (range) number of gamma-H2AX (0.04 [0-0.5]) and 53BP1 (0.005 [0-0.2]) foci per cell in freshly isolated PBMCs across all study participants was low and similar to previously reported values of healthy individuals. For both, gamma-H2AX and 53BP1, the cellular focus number as well as the percentage of positive cells did not differ between patients with CIS/RRMS and healthy controls. gamma-H2AX and 53BP1 levels neither correlated with number nor volume of T2-weighted lesions on MRI, nor with the EDSS. Although gamma-H2AX, but not 53BP1, levels were higher in previously frozen PBMCs of patients with than without CEL, gamma-H2AX values of both groups overlapped and gamma-H2AX did not correlate with the number or volume of CEL. Conclusion gamma-H2AX and 53BP1 foci do not seem to be promising diagnostic or disease activity biomarkers in patients with early MS. Lymphocytic DNA double-strand breaks are unlikely to play a major role in the pathophysiology of MS.	[Rasche, Ludwig; Behrens, Janina Ruth; Pfuhl, Catherina; Wakonig, Katharina; Giess, Rene Markus; Freitag, Erik; Wuerfel, Jens; Doerr, Jan; Bellmann-Strobl, Judith; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Rasche, Ludwig; Behrens, Janina Ruth; Pfuhl, Catherina; Wakonig, Katharina; Giess, Rene Markus; Freitag, Erik; Doerr, Jan; Bellmann-Strobl, Judith; Paul, Friedemann; Ruprecht, Klemens] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Rasche, Ludwig; Pfuhl, Catherina; Giess, Rene Markus; Paul, Friedemann; Ruprecht, Klemens] Charite, Dept Neurol, D-13353 Berlin, Germany; [Heiserich, Lisa; Eberle, Caroline; Bauer, Peter; Roggenbuck, Dirk] Medipan GmbH, Dahlewitz, Germany; [Lenz, Klaus] Charite, Dept Med Biometr & Clin Epidemiol, D-13353 Berlin, Germany; [Wuerfel, Jens] MIAC AG, Basel, Switzerland; [Wuerfel, Jens; Bellmann-Strobl, Judith] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Wuerfel, Jens; Bellmann-Strobl, Judith] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wuerfel, Jens] Univ Med Gottingen, Inst Neuroradiol, Gottingen, Germany; [Roggenbuck, Dirk] Brandenburg Tech Univ Cottbus, Fac Sci, Senftenberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Gottingen; Brandenburg University of Technology Cottbus	Ruprecht, K (corresponding author), Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany.; Ruprecht, K (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	klemens.ruprecht@charite.de	Paul, Friedemann/ABF-9415-2020	Roggenbuck, Dirk/0000-0002-6861-6827; Bellmann-Strobl, Judith/0000-0003-2615-1643; Wuerfel, Jens/0000-0002-0034-8053; Wakonig, Katharina/0000-0003-1915-9583; paul, friedemann/0000-0002-6378-0070	German Ministry of Education and Research (BMBF/KKNMS) [01GI1312]; German Ministry of Education and Research (BMBF/KKNMS)	German Ministry of Education and Research (BMBF/KKNMS); German Ministry of Education and Research (BMBF/KKNMS)	Support was provided by the German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis, grant number 01GI1312) Charite Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medipan GmbH provided support in the form of salaries for authors (LH, CE, PB, and DR) and research materials. LH, CE, PB, and DR were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; The authors like to thank all participants of this study as well as Bibiane Seeger, Susan Pikol and Cynthia Kraut for excellent technical assistance. FP, JW and KR are supported by the German Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis).	Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dorr J, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0354-5; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Grecchi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044935; Heydenreich J, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/478324; Kuo LJ, 2008, IN VIVO, V22, P305; Marrie RA, 2015, MULT SCLER J, V21, P294, DOI 10.1177/1352458514564489; Meyer B, 2013, NUCLEIC ACIDS RES, V41, P6109, DOI 10.1093/nar/gkt304; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Mondal NK, 2010, MUTAT RES-GEN TOX EN, V697, P47, DOI 10.1016/j.mrgentox.2010.02.006; Oliveira SR, 2012, J NEUROL SCI, V321, P49, DOI 10.1016/j.jns.2012.07.045; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Raphael I, 2015, EXPERT REV CLIN IMMU, V11, P69, DOI 10.1586/1744666X.2015.991315; Reddig A, 2015, CYTOM PART A, V87A, P724, DOI 10.1002/cyto.a.22667; Reddig A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132702; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Scarpato R, 2011, FASEB J, V25, P685, DOI 10.1096/fj.10-168427; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sinnecker T, 2012, ARCH NEUROL-CHICAGO, V69, P739, DOI 10.1001/archneurol.2011.2450; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Traboulsee A, 2007, J NEUROL SCI, V256, pS19, DOI 10.1016/j.jns.2007.01.064; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Willitzki A, 2013, CYTOM PART A, V83, P1017, DOI 10.1002/cyto.a.22350; Willitzki A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/284740	29	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147968	10.1371/journal.pone.0147968	http://dx.doi.org/10.1371/journal.pone.0147968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820970	gold, Green Accepted, Green Published			2022-12-27	WOS:000369528400057
J	Chandra, S; Singh, D; Pathak, J; Kumari, S; Kumar, M; Poddar, R; Balyan, HS; Gupta, PK; Prabhu, KV; Mukhopadhyay, K				Chandra, Saket; Singh, Dharmendra; Pathak, Jyoti; Kumari, Supriya; Kumar, Manish; Poddar, Raju; Balyan, Harindra Singh; Gupta, Puspendra Kumar; Prabhu, Kumble Vinod; Mukhopadhyay, Kunal			De Novo Assembled Wheat Transcriptomes Delineate Differentially Expressed Host Genes in Response to Leaf Rust Infection	PLOS ONE			English	Article							RNA-SEQ; DEFENSE RESPONSES; SEQUENCING DATA; PLANT DEFENSE; PROTEIN; RESISTANCE; STRESS; ANNOTATION; METABOLISM; DISCOVERY	Pathogens like Puccinia triticina, the causal organism for leaf rust, extensively damages wheat production. The interaction at molecular level between wheat and the pathogen is complex and less explored. The pathogen induced response was characterized using mock-or pathogen inoculated near-isogenic wheat lines (with or without seedling leaf rust resistance gene Lr28). Four Serial Analysis of Gene Expression libraries were prepared from mock-and pathogen inoculated plants and were subjected to Sequencing by Oligonucleotide Ligation and Detection, which generated a total of 165,767,777 reads, each 35 bases long. The reads were processed and multiple k-mers were attempted for de novo transcript assembly; 22 k-mers showed the best results. Altogether 21,345 contigs were generated and functionally characterized by gene ontology annotation, mining for transcription factors and resistance genes. Expression analysis among the four libraries showed extensive alterations in the transcriptome in response to pathogen infection, reflecting reorganizations in major biological processes and metabolic pathways. Role of auxin in determining pathogenesis in susceptible and resistant lines were imperative. The qPCR expression study of four LRR-RLK (Leucine-rich repeat receptor-like protein kinases) genes showed higher expression at 24 hrs after inoculation with pathogen. In summary, the conceptual model of induced resistance in wheat contributes insights on defense responses and imparts knowledge of Puccinia triticina-induced defense transcripts in wheat plants.	[Chandra, Saket; Singh, Dharmendra; Pathak, Jyoti; Kumar, Manish; Poddar, Raju; Mukhopadhyay, Kunal] Birla Inst Technol, Dept Bioengn, Ranchi 835215, Jharkhand, India; [Kumari, Supriya; Balyan, Harindra Singh; Gupta, Puspendra Kumar] Ch Charan Singh Univ, Dept Genet & Plant Breeding, Meerut 200005, Uttar Pradesh, India; [Prabhu, Kumble Vinod] Indian Agr Res Inst, Div Genet, New Delhi 110012, India; [Singh, Dharmendra] Univ Queensland, Ctr Plant Sci, QAAF1, Brisbane, Qld 4072, Australia	Birla Institute of Technology Mesra; Chaudhary Charan Singh University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University of Queensland	Mukhopadhyay, K (corresponding author), Birla Inst Technol, Dept Bioengn, Ranchi 835215, Jharkhand, India.	kmukhopadhyay@bitmesra.ac.in	Mukhopadhyay, Kunal/L-9577-2017; Balyan, H./AAI-9077-2020; Chandra, Saket/O-6522-2018; Kumar, Manish/O-8149-2017; PODDAR, RAJU/R-1671-2018	Mukhopadhyay, Kunal/0000-0003-2213-8134; Chandra, Saket/0000-0001-5201-5106; Kumar, Manish/0000-0002-3023-9018; Singh, Dharmendra/0000-0002-8325-2726	Department of Biotechnology, Government of India [BT/PR6037/AGR/02/308/05, BT/PR3925/BID/7/384/2011]; Centre of Excellence, Technical Education Quality Improvement Program-II [NPIU/TEQIP II/FIN/31/158]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Centre of Excellence, Technical Education Quality Improvement Program-II	This work was supported by Department of Biotechnology, Government of India (Grant No. BT/PR6037/AGR/02/308/05 and BT/PR3925/BID/7/384/2011) and Centre of Excellence, Technical Education Quality Improvement Program-II, (Grant No. NPIU/TEQIP II/FIN/31/158). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bansal UK, 2008, J APPL GENET, V49, P141, DOI 10.1007/BF03195607; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cantu D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-492; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Catala C, 1997, PLANT J, V12, P417, DOI 10.1046/j.1365-313X.1997.12020417.x; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COSGROVE DJ, 1993, NEW PHYTOL, V124, P1, DOI 10.1111/j.1469-8137.1993.tb03795.x; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dhariwal R, 2015, FUNCT INTEGR GENOMIC, V15, P233, DOI 10.1007/s10142-014-0416-x; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fofana Bourlaye, 2007, Int J Plant Genomics, V2007, P17542, DOI 10.1155/2007/17542; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Goring DR, 2004, SCIENCE, V303, P1474, DOI 10.1126/science.1095764; Gou XP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan YF, 2008, PLANT PHYSIOL, V147, P852, DOI 10.1104/pp.108.118026; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; Higaki T, 2011, J PLANT RES, V124, P315, DOI 10.1007/s10265-011-0408-z; Hiltscher H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00475; Hu GG, 1998, MYCOL RES, V102, P391, DOI 10.1017/S0953756297005054; Igawa T, 2004, PLANT CELL PHYSIOL, V45, P1347, DOI 10.1093/pcp/pch195; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Kumar D, 2014, FUNCT PLANT BIOL, V41, P1295, DOI 10.1071/FP14077; Kumar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117559; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Less H, 2011, PLANT CELL, V23, P1264, DOI 10.1105/tpc.110.082867; Li AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028810; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Manickavelu A, 2012, DNA RES, V19, P165, DOI 10.1093/dnares/dss001; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Melicher D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-188; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Pellny TK, 2012, PLANT PHYSIOL, V158, P612, DOI 10.1104/pp.111.189191; Pont C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r119; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rudd S, 2003, TRENDS PLANT SCI, V8, P321, DOI 10.1016/S1360-1385(03)00131-6; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Satapathy L, 2014, MOL GENET GENOMICS, V289, P1289, DOI 10.1007/s00438-014-0890-9; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Schreiber AW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-492; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh D, 2012, MOL BIOL REP, V39, P9373, DOI 10.1007/s11033-012-1801-y; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Wan Jinrong, 2002, Funct Integr Genomics, V2, P259, DOI 10.1007/s10142-002-0080-4; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang XE, 2009, MOL PLANT MICROBE IN, V22, P1227, DOI 10.1094/MPMI-22-10-1227; Wanjugi H, 2009, GENOME, V52, P576, DOI [10.1139/G09-033, 10.1139/g09-033]; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wright CA, 2004, P NATL ACAD SCI USA, V101, P3269, DOI 10.1073/pnas.0400461101; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; Yang AH, 2005, PLANTA, V221, P493, DOI 10.1007/s00425-004-1462-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zabala MDT, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.74, 10.1038/nplants.2015.74]; Zhang D, 2004, GENETICS, V168, P595, DOI 10.1534/genetics.104.034785; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	97	28	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148453	10.1371/journal.pone.0148453	http://dx.doi.org/10.1371/journal.pone.0148453			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840746	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200138
J	Lane-Donovan, C; Herz, J				Lane-Donovan, Courtney; Herz, Joachim			High-Fat Diet Changes Hippocampal Apolipoprotein E (ApoE) in a Genotype- and Carbohydrate-Dependent Manner in Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; TARGETED REPLACEMENT; MEDITERRANEAN DIET; BETA AMYLOIDOSIS; MOUSE MODEL; CHOLESTEROL; RECEPTOR; BRAIN; GENE	Alzheimer's disease is a currently incurable neurodegenerative disease affecting millions of individuals worldwide. Risk factors for Alzheimer's disease include genetic risk factors, such as possession of e4 allele of apolipoprotein E (ApoE4) over the risk-neutral ApoE3 allele, and lifestyle risk factors, such as diet and exercise. The intersection of these two sources of disease risk is not well understood. We investigated the impact of diet on ApoE levels by feeding wildtype, ApoE3, and ApoE4 targeted replacement (TR) mice with chow, high-fat, or ketogenic (high-fat, very-low-carbohydrate) diets. We found that high-fat diet affected both plasma and hippocampal levels of ApoE in an isoform-dependent manner, with high-fat diet causing a surprising reduction of hippocampal ApoE levels in ApoE3 TR mice. Conversely, the ketogenic diet had no effect on hippocampal ApoE. Our findings suggest that the use of dietary interventions to slow the progression AD should take ApoE genotype into consideration.	[Lane-Donovan, Courtney; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Lane-Donovan, Courtney; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Lane-Donovan, Courtney; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Herz, Joachim] Univ Freiburg, Ctr Neurosci, Dept Neuroanat, Hugstetter Str 55, D-79106 Freiburg, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Freiburg	Lane-Donovan, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.; Lane-Donovan, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.; Lane-Donovan, C (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA.	Courtney.lane@utsouthwestern.edu			NIH [F30 AG047799, R37 HL63762]; American Health Assistance Foundation; Consortium for Frontotemporal Dementia Research; Bright Focus Foundation; Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG047799] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Consortium for Frontotemporal Dementia Research; Bright Focus Foundation(BrightFocus Foundation); Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant F30 AG047799 (to C.L.D.), NIH grant R37 HL63762 (to J. H.), the American Health Assistance Foundation (to J.H.), the Consortium for Frontotemporal Dementia Research (to J.H.), the Bright Focus Foundation (to J. H.), the Lupe Murchison Foundation (to J.H.), and The Ted Nash Long Life Foundation (to J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braak H, 1998, J NEURAL TRANSM-SUPP, P127; COLE TG, 1983, J CLIN ENDOCR METAB, V56, P1108, DOI 10.1210/jcem-56-6-1108; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Freeman LR, 2014, NUTR NEUROSCI, V17, P241, DOI 10.1179/1476830513Y.0000000092; Grant WB, 2014, J ALZHEIMERS DIS, V38, P611, DOI 10.3233/JAD-130719; GREENWOOD CE, 1990, BEHAV NEURAL BIOL, V53, P74, DOI 10.1016/0163-1047(90)90831-P; Head D, 2012, ARCH NEUROL-CHICAGO, V69, P636, DOI 10.1001/archneurol.2011.845; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; HERZ J, 1991, J BIOL CHEM, V266, P21232; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Liao F, 2014, J NEUROSCI, V34, P7281, DOI 10.1523/JNEUROSCI.0646-14.2014; Martinez-Lapiscina EH, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0393-7; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Petanceska SS, 2003, J MOL NEUROSCI, V20, P395, DOI 10.1385/JMN:20:3:395; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Singh B, 2014, J ALZHEIMERS DIS, V39, P271, DOI 10.3233/JAD-130830; Srivastava RAK, 1996, MOL CELL BIOCHEM, V155, P153, DOI 10.1007/BF00229312; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wang CS, 2005, NEUROBIOL DIS, V18, P390, DOI 10.1016/j.nbd.2004.10.013	24	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148099	10.1371/journal.pone.0148099	http://dx.doi.org/10.1371/journal.pone.0148099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828652	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200060
J	Mirvakili, A; Dadgarnia, MH; Baradaranfar, MH; Atighechi, S; Zand, V; Ansari, A				Mirvakili, Abbas; Dadgarnia, Mohammad Hossein; Baradaranfar, Mohammad Hossein; Atighechi, Saeid; Zand, Vahid; Ansari, Abdollah			Role of Platelet Parameters on Sudden Sensorineural Hearing Loss: A Case-Control Study in Iran	PLOS ONE			English	Article							HYPERBARIC-OXYGEN THERAPY; RISK-FACTORS; VOLUME; APHERESIS; SEVERITY	Sudden sensorineural hearing loss (SSNHL) is a common otological disorder characterized by a hearing loss greater than 30 dB over three consecutive frequencies, in less than 72 hours. It has been established that platelet parameters, such as mean platelet volume, are associated with ischemic heart events, whose clinical manifestations are similar to those of SSNHL. Hence, we aimed to determine if the platelet count, mean platelet volume and platelet distribution width are related to the occurrence and severity of sudden sensorineural hearing loss. A case-control prospective study was conducted in a teaching hospital in Iran. One hundred-eight patients with SSNHL and an equal number of healthy, age-and sex-matched controls were enrolled in the study. Peripheral venous blood samples were collected from the subjects, and the platelet count, mean platelet volume and platelet distribution width were measured with an automated blood cell counter. Analysis of the audiometry and hematological test results using SPSS22 software showed no statistical correlation between the platelet parameters and the occurrence of SSNHL, but correlation coefficients showed a significant correlation between PDW and hearing loss severity in patients group. However, further investigation is required to unequivocally establish the absence of correlation between the platelet parameters and occurrence of SSNHL.	[Mirvakili, Abbas; Dadgarnia, Mohammad Hossein; Baradaranfar, Mohammad Hossein; Atighechi, Saeid; Zand, Vahid; Ansari, Abdollah] Shahid Sadoughi Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Otorhinolaryngol Res Ctr, Yazd, Iran		Ansari, A (corresponding author), Shahid Sadoughi Univ Med Sci, Dept Otolaryngol Head & Neck Surg, Otorhinolaryngol Res Ctr, Yazd, Iran.	dr.ansaria6531@gmail.com	baradaranfar, Mohammad hossein/F-6328-2017; zand, vahid/F-6371-2017; atighechi, saeid/F-6352-2017; dadgarnia, mohammad hossein/F-6364-2017	baradaranfar, Mohammad hossein/0000-0002-3995-6822; zand, vahid/0000-0003-0658-7757; atighechi, saeid/0000-0002-9330-5342; dadgarnia, mohammad hossein/0000-0002-2802-9601; Zand, Vahid/0000-0001-6725-5196				Balta S, 2013, EUR ARCH OTO-RHINO-L, V270, P2373, DOI 10.1007/s00405-013-2522-0; Berrettini S, 1999, PEDIATR NEUROL, V20, P130, DOI 10.1016/S0887-8994(98)00123-4; Blaha M, 2014, EUROPEAN ARCH OTORHI, P3384; Bodur Serkan, 2013, Med Glas (Zenica), V10, P59; Capaccio P, 2005, AM J OTOLARYNG, V26, P383, DOI 10.1016/j.amjoto.2005.05.001; Chen YS, 2005, INT J PEDIATR OTORHI, V69, P817, DOI 10.1016/j.ijporl.2005.01.015; Cho SH, 2012, BMC EAR NOSE THROAT, V12, DOI 10.1186/1472-6815-12-5; De Felice C, 2000, LANCET, V356, P1237, DOI 10.1016/S0140-6736(00)02790-2; Finger RP, 2006, J CLIN APHERESIS, V21, P241, DOI 10.1002/jca.20081; Gerceker M, 2011, J INT ADV OTOL, V7, P67; Hato N, 2010, AURIS NASUS LARYNX, V37, P626, DOI 10.1016/j.anl.2010.01.008; Hausch RC, 1998, SEMIN ARTHRITIS RHEU, V28, P206, DOI 10.1016/S0049-0172(98)80038-3; Heigl F, 2009, ATHEROSCLEROSIS SUPP, V10, P95, DOI 10.1016/S1567-5688(09)71820-3; Hong SM, 2008, OTOLARYNG HEAD NECK, V139, P541, DOI 10.1016/j.otohns.2008.07.003; Inci E, 2011, J INT ADV OTOL, V7, P62; Itoh A, 2001, PUBLIC HEALTH, V115, P192; Karli R, 2013, INDIAN J OTOLARYNGOL, V65, P350, DOI 10.1007/s12070-013-0648-4; Klingel R, 2009, ATHEROSCLEROSIS SUPP, V10, P102, DOI 10.1016/S1567-5688(09)71821-5; Lazarini AR, 2006, OTORRINOLARINGOL, V72, P1; Leong AC, 2007, CLIN OTOLARYNGOL, V32, P391, DOI 10.1111/j.1749-4486.2007.01523.x; Massimo F, 2012, INT J AUDIOL, P1; Masuda M, 2013, WORLD J OTORHINOLARY, V28, P42; McRae S., 2008, IMVS NEWSLETTER SUMM, V68, P6; Mokhtari N, 2003, IRANIAN J EAR NOSE T, V35, P14; Nosrati-Zarenoe R., THESIS LINKOPING U; Nosrati-Zarenoe R, 2007, ACTA OTO-LARYNGOL, V127, P1168, DOI 10.1080/00016480701242477; Ohno Kazuchika, 2010, Journal of Medical and Dental Sciences, V57, P127; Ozcan M, BRAZILIAN J OTORHINO; Rudack C, 2004, HEARING RES, V191, P41, DOI 10.1016/j.heares.2004.01.002; Sagit M, 2013, J LARYNGOL OTOL, V127, P972, DOI 10.1017/S002221511300193X; Salahaldin Ahmed Harith, 2004, Int Tinnitus J, V10, P165; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Seo YJ, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/702807; Shah AR, 2013, NATL J MED RES, V3, P162; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; SUNDEL RP, 1990, J PEDIATR-US, V117, P371, DOI 10.1016/S0022-3476(05)81075-3; Suzuki H, 2008, AURIS NASUS LARYNX, V35, P192, DOI 10.1016/j.anl.2007.06.003; Ulu S, 2013, EUR ARCH OTO-RHINO-L, V270, P2875, DOI 10.1007/s00405-013-2348-9; Wang Yao-Ting, 2007, J Chin Med Assoc, V70, P294, DOI 10.1016/S1726-4901(07)70008-4	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148149	10.1371/journal.pone.0148149	http://dx.doi.org/10.1371/journal.pone.0148149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829393	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200071
J	Nguyen, TT; Parat, MO; Shaw, PN; Hewavitharana, AK; Hodson, MP				Nguyen, Thao T.; Parat, Marie-Odile; Shaw, Paul N.; Hewavitharana, Amitha K.; Hodson, Mark P.			Traditional Aboriginal Preparation Alters the Chemical Profile of Carica papaya Leaves and Impacts on Cytotoxicity towards Human Squamous Cell Carcinoma	PLOS ONE			English	Article							LEAF EXTRACT; TOXICITY; CANCER; L.	Carica papaya leaf decoction, an Australian Aboriginal remedy, has been used widely for its healing capabilities against cancer, with numerous anecdotal reports. In this study we investigated its in vitro cytotoxicity on human squamous cell carcinoma cells followed by metabolomic profiling of Carica papaya leaf decoction and leaf juice/brewed leaf juice to determine the effects imparted by the long heating process typical of the Aboriginal remedy preparation. MTT assay results showed that in comparison with the decoction, the leaf juice not only exhibited a stronger cytotoxic effect on SCC25 cancer cells, but also produced a significant cancer-selective effect as shown by tests on non-cancerous human keratinocyte HaCaT cells. Furthermore, evidence from testing brewed leaf juice on these two cell lines suggested that the brewing process markedly reduced the selective effect of Carica papaya leaf on SCC25 cancer cells. To tentatively identify the compounds that contribute to the distinct selective anticancer activity of leaf juice, an untargeted metabolomic approach employing Ultra High Performance Liquid Chromatography-Quadrupole Time of Flight-Mass Spectrometry followed by multivariate data analysis was applied. Some 90 and 104 peaks in positive and negative mode respectively were selected as discriminatory features from the chemical profile of leaf juice and >1500 putative compound IDs were obtained via database searching. Direct comparison of chromatographic and tandem mass spectral data to available reference compounds confirmed one feature as a match with its proposed authentic standard, namely pheophorbide A. However, despite pheophorbide A exhibiting cytotoxic activity on SCC25 cancer cells, it did not prove to be the compound contributing principally to the selective activity of leaf juice. With promising results suggesting stronger and more selective anticancer effects when compared to the Aboriginal remedy, Carica papaya leaf juice warrants further study to explore its activity on other cancer cell lines, as well as investigation to confirm the identity of compounds contributing to its selective effect, particularly those compounds altered by the long heating process applied during the traditional Aboriginal remedy preparation.	[Nguyen, Thao T.; Parat, Marie-Odile; Shaw, Paul N.; Hewavitharana, Amitha K.; Hodson, Mark P.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Hodson, Mark P.] Univ Queensland, Metabol Australia, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Hodson, MP (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.; Hodson, MP (corresponding author), Univ Queensland, Metabol Australia, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	m.hodson1@uq.edu.au	Hewavitharana, Amitha K/A-5533-2008; Shaw, Paul N/G-4418-2010; Hodson, Mark P/J-7609-2013; Parat, Marie-Odile/G-4410-2010; Shaw, Paul/Q-8454-2019	Hewavitharana, Amitha K/0000-0003-2935-9941; Shaw, Paul N/0000-0001-7154-592X; Hodson, Mark P/0000-0002-5436-1886; Parat, Marie-Odile/0000-0003-4895-7381; Shaw, Paul/0000-0001-7154-592X	Prime Minister's Australia Asia Endeavour Award from the Department of Education and Training [2997_2012]	Prime Minister's Australia Asia Endeavour Award from the Department of Education and Training	TTN was funded by a Prime Minister's Australia Asia Endeavour Award from the Department of Education and Training (2997_2012).	Afzan A, 2012, MOLECULES, V17, P4326, DOI 10.3390/molecules17044326; Ahmad Nisar, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P330, DOI 10.1016/S2221-1691(11)60055-5; Arkhipov A., 2014, Pharmacognosy Communications, V4, P10; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cheng XL, 2011, FOOD CHEM, V129, P1785, DOI 10.1016/j.foodchem.2011.06.026; Dai J, 2010, MOLECULES, V15, P7313, DOI 10.3390/molecules15107313; Emmanuelle Bournay UG-A, 2012, GLOB SOL UV IND; Food and Agriculture Organization, 2013, FAOSTAT PROD DAT; Gammulle A., 2012, ONLINE INT J MED PLA, V1, P21; Halim SZ, 2011, J MED PLANTS RES, V5, P1867; Hewitt H, 2000, W INDIAN MED J, V49, P32; Ismail Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/741470; JACKMAN RL, 1987, J FOOD BIOCHEM, V11, P201, DOI 10.1111/j.1745-4514.1987.tb00123.x; Krishna K. L., 2008, Natural Product Radiance, V7, P364; Leiter U, 2013, ADV EXP MED BIOL, V810, P120; Lucas TP, 1914, MOST WONDERFUL TREE; Mangal M, 2013, NUCLEIC ACIDS RES, V41, pD1124, DOI 10.1093/nar/gks1047; Mikhal'chik EV, 2004, B EXP BIOL MED+, V137, P560, DOI 10.1023/B:BEBM.0000042711.31775.f7; Morimoto C., 2008, US Patent, Patent No. 20080069907; Morton J. F., 1987, FRUITS WARM CLIMATES, P336; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nayak BS, 2007, INDIAN J EXP BIOL, V45, P739; Nguyen TTT, 2013, MOL NUTR FOOD RES, V57, P153, DOI 10.1002/mnfr.201200388; Otsuki N, 2010, J ETHNOPHARMACOL, V127, P760, DOI 10.1016/j.jep.2009.11.024; Qi LW, 2010, BIOCHEM PHARMACOL, V80, P947, DOI 10.1016/j.bcp.2010.06.023; Sirdaarta J., 2015, Pharmacognosy Communications, V5, P100, DOI 10.5530/pc.2015.2.2; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI 10.2174/18715206113139990308; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Subenthiran S., 2013, EVID-BASED COMPL ALT, V2013, P1, DOI [10.1155/2013/616737, DOI 10.1155/2013/616737]; Tietze HW, 2003, PAPAYA THE MED TREE; Vien D.T.H., 2013, ASEAN J CHEM ENG, V12, P43, DOI [10.22146/ajche.49742, DOI 10.22146/AJCHE.49742]; Wang CZ, 2006, J AGR FOOD CHEM, V54, P9936, DOI 10.1021/jf062467k; Xiang F, 2014, JAMA DERMATOL, V150, P1063, DOI 10.1001/jamadermatol.2014.762; Zunjar V, 2015, NAT PROD RES, V29, P2097, DOI 10.1080/14786419.2014.986658	35	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147956	10.1371/journal.pone.0147956	http://dx.doi.org/10.1371/journal.pone.0147956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829042	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200047
J	Hedegaard, CJ; Strube, ML; Hansen, MB; Lindved, BK; Lihme, A; Boye, M; Heegaard, PMH				Hedegaard, Chris J.; Strube, Mikael L.; Hansen, Marie B.; Lindved, Bodil K.; Lihme, Allan; Boye, Mette; Heegaard, Peter M. H.			Natural Pig Plasma Immunoglobulins Have Anti-Bacterial Effects: Potential for Use as Feed Supplement for Treatment of Intestinal Infections in Pigs	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; DRIED ANIMAL PLASMA; BLOOD BY-PRODUCTS; ESCHERICHIA-COLI; G AVIDITY; YOUNG CHICKENS; WEANED PIGS; DIAGNOSIS; ANTIBIOTICS; ANTIBODIES	There is an increasing demand for non-antibiotics solutions to control infectious disease in intensive pig production. Here, one such alternative, namely pig antibodies purified from slaughterhouse blood was investigated in order to elucidate its potential usability to control post-weaning diarrhoea (PWD), which is one of the top indications for antibiotics usage in the pig production. A very cost-efficient and rapid one-step expanded bed adsorption (EBA) chromatography procedure was used to purify pig immunoglobulin G from slaughterhouse pig plasma (more than 100 litres), resulting in >85% pure pig IgG (ppIgG). The ppIgG thus comprised natural pig immunoglobulins and was subsequently shown to contain activity towards four pig-relevant bacterial strains (three different types of Escherichia coli and one type of Salmonella enterica) but not towards a fish pathogen (Yersinia ruckeri), and was demonstrated to inhibit the binding of the four pig relevant bacteria to a pig intestinal cell line (IPEC-J2). Finally it was demonstrated in an in vivo weaning piglet model for intestinal colonization with an E. coli F4+ challenge strain that ppIgG given in the feed significantly reduced shedding of the challenge strain, reduced the proportion of the bacterial family Enterobacteriaceae, increased the proportion of families Enterococcoceae and Streptococcaceae and generally increased ileal microbiota diversity. Conclusively, our data support the idea that natural IgG directly purified from pig plasma and given as a feed supplement can be used in modern swine production as an efficient and cost-effective means for reducing both occurrence of PWD and antibiotics usage and with a potential for the prevention and treatment of other intestinal infectious diseases even if the causative agent might not be known.	[Hedegaard, Chris J.; Strube, Mikael L.; Boye, Mette; Heegaard, Peter M. H.] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark; [Hansen, Marie B.; Lindved, Bodil K.; Lihme, Allan] Upfront Chromatog AS, Copenhagen, Denmark	Technical University of Denmark	Heegaard, PMH (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark.	pmhh@vet.dtu.dk	Strube, Mikael/G-7949-2016; Heegaard, Peter/E-9794-2015	Strube, Mikael/0000-0003-0905-5705; Heegaard, Peter/0000-0003-4506-4932; Hedegaard, Chris Juul/0000-0003-1333-8687	Green Development and Demonstration Programme (Ministry of Food, Agriculture and Fisheries, The Danish AgriFish Agency) [34009-120471]	Green Development and Demonstration Programme (Ministry of Food, Agriculture and Fisheries, The Danish AgriFish Agency)	The project was supported by Green Development and Demonstration Programme (Ministry of Food, Agriculture and Fisheries, The Danish AgriFish Agency, Journal number: 34009-120471). The funder provided support in the form of salaries for the author CJH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation did provide purified plasma IgG for this study.	Bhandari SK, 2008, J ANIM SCI, V86, P836, DOI 10.2527/jas.2006-822; Boesen HT, 2005, VET MICROBIOL, V109, P105, DOI 10.1016/j.vetmic.2005.05.004; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Campbell JM, 2006, J ANIM SCI, V84, P2501, DOI 10.2527/jas.2005-722; CDC U, 2013, ANTIBIOTIC RESISTANC; Chan KH, 2007, CLIN VACCINE IMMUNOL, V14, P1433, DOI 10.1128/CVI.00056-07; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; DANMAP, 2014, US ANT AG OCC ANT RE; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; ECDC/EMEA, 2009, BACT CHALL TIM REACT, P54; EMEA, 2015, COL F4; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Hermann-Bank ML, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0419-4; HOORFAR J, 1994, CAN J VET RES, V58, P268; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; Jamroz D, 2012, J ANIM PHYSIOL AN N, V96, P319, DOI 10.1111/j.1439-0396.2011.01149.x; Jamroz D, 2011, BRIT POULTRY SCI, V52, P589, DOI 10.1080/00071668.2011.610298; Jenum PA, 1997, J CLIN MICROBIOL, V35, P1972, DOI 10.1128/JCM.35.8.1972-1977.1997; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Levast B, 2014, DEV COMP IMMUNOL, V44, P235, DOI 10.1016/j.dci.2013.12.012; Levett PN, 2005, J CLIN MICROBIOL, V43, P5873, DOI 10.1128/JCM.43.12.5873-5875.2005; Lihme A, 2010, ANAL BIOCHEM, V399, P102, DOI 10.1016/j.ab.2009.12.002; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Madi A, 2012, ADV EXP MED BIOL, V750, P198, DOI 10.1007/978-1-4614-3461-0_15; Melkebeek V, 2013, VET IMMUNOL IMMUNOP, V152, P37, DOI 10.1016/j.vetimm.2012.09.024; Niewold TA, 2007, VET MICROBIOL, V124, P362, DOI 10.1016/j.vetmic.2007.04.034; Nollet H, 1999, VET MICROBIOL, V65, P37, DOI 10.1016/S0378-1135(98)00282-X; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; Pierce JL, 2005, J ANIM SCI, V83, P2876; Rhee JH, 2012, CLIN EXP VACCINE RES, V1, P50, DOI 10.7774/cevr.2012.1.1.50; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Stahl M, 2011, VET MICROBIOL, V151, P307, DOI 10.1016/j.vetmic.2011.03.013; Strube ML, 2015, APPL ENVIRON MICROB, V81, P1668, DOI 10.1128/AEM.03582-14; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131; Viswanathan VK, 2009, NAT REV MICROBIOL, V7, P110, DOI 10.1038/nrmicro2053; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	36	34	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147373	10.1371/journal.pone.0147373	http://dx.doi.org/10.1371/journal.pone.0147373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824607	Green Published, gold			2022-12-27	WOS:000369528600029
J	Jiang, Y; Chen, JD; Wu, Y; Wang, Q; Li, HX				Jiang, Ying; Chen, Jiandong; Wu, Yue; Wang, Qiang; Li, Huixin			Sublethal Toxicity Endpoints of Heavy Metals to the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							BEHAVIORAL DEFECTS; OXIDATIVE DAMAGE; LIFE-SPAN; EXPOSURE; CADMIUM; STRESS; ACETYLCHOLINESTERASE; REPRODUCTION; SOIL; DICHLORVOS	Caenorhabditis elegans, a free-living nematode, is commonly used as a model organism in ecotoxicological studies. The current literatures have provided useful insight into the relative sensitivity of several endpoints, but few direct comparisons of multiple endpoints under a common set of experimental conditions. The objective of this study was to determine appropriate sublethal endpoints to develop an ecotoxicity screening and monitoring system. C. elegans was applied to explore the sublethal toxicity of four heavy metals (copper, zinc, cadmium and chromium). Two physiological endpoints (growth and reproduction), three behavioral endpoints (head thrash frequency, body bend frequency and feeding) and two enzymatic endpoints (acetylcholine esterase [AChE] and superoxide dismutase [SOD]) were selected for the assessment of heavy metal toxicity. The squared correlation coefficients (R-2) between the responses observed and fitted by Logit function were higher than 0.90 and the RMSE were lower than 0.10, indicating a good significance statistically. There was no significant difference among the half effect concentration (EC50) endpoints in physiological and behavioral effects of the four heavy metals, indicating similar sensitivity of physiological and behavioral effects. AChE enzyme was more sensitive to copper, zinc, and cadmium than to other physiological and behavioral effects, and SOD enzyme was most sensitive to chromium. The EC50 of copper, zinc, and cadmium, to the AChE enzyme in the nematodes were 0.68 mg/L, 2.76 mg/L, and 0.92 mg/L respectively and the EC50 of chromium to the SOD enzyme in the nematode was 1.58 mg/L. The results of this study showed that there was a good concentration-response relationship between all four heavy metals and the sublethal toxicity effects to C. elegans. Considering these sublethal endpoints in terms of simplicity, accuracy, repeatability and costs of the experiments, feeding is the relatively ideal sublethal toxicity endpoint of heavy metals to C. elegans.	[Jiang, Ying; Wang, Qiang] Henan Agr Univ, Coll Resources & Environm, Zhengzhou 450000, Peoples R China; [Jiang, Ying; Li, Huixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China; [Chen, Jiandong] Guangxi Univ Finance & Econ, Sch Management Sci & Engn, Nanning 530003, Peoples R China; [Wu, Yue] Soil & Fertilizer Bur Shandong Prov, Jinan 250100, Peoples R China	Henan Agricultural University; Nanjing Agricultural University; Guangxi University of Finance & Economics	Wang, Q (corresponding author), Henan Agr Univ, Coll Resources & Environm, Zhengzhou 450000, Peoples R China.; Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.	huixinli@njau.edu.cn; wstrong1970@163.com	Li, huixin/H-5573-2011		National Science Foundation of China [41401274]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (grant 41401274). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P1100, DOI 10.1897/1551-5028(2003)022&lt;1100:AOMTTN&gt;2.0.CO;2; BRENNER S, 1974, GENETICS, V77, P71; Cabreiro F, 2011, FREE RADICAL BIO MED, V51, P1575, DOI 10.1016/j.freeradbiomed.2011.07.020; Chen JD, 2013, ECOTOX ENVIRON SAFE, V94, P73, DOI 10.1016/j.ecoenv.2013.04.026; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; Dhawan R, 2000, ENVIRON TOXICOL CHEM, V19, P3061, DOI [10.1897/1551-5028(2000)019&lt;3061:ACOMIL&gt;2.0.CO;2, 10.1002/etc.5620191228]; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Gupta SC, 2005, BBA-GEN SUBJECTS, V1725, P81, DOI 10.1016/j.bbagen.2005.04.033; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; Jadhav KB, 2009, J BIOCHEM MOL TOXIC, V23, P9, DOI 10.1002/jbt.20258; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lehtonen KK, 2003, B ENVIRON CONTAM TOX, V71, P489, DOI 10.1007/s00128-003-8853-6; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Melstrom PC, 2007, BIOCHEM BIOPH RES CO, V357, P200, DOI 10.1016/j.bbrc.2007.03.122; MIDDENDORF PJ, 1993, J NEMATOL, V25, P573; Patrick R, 1988, GROUNDWATER CONTAMIN; RITTER WF, 1990, J ENVIRON SCI HEAL B, V25, P1, DOI 10.1080/03601239009372674; Roh JY, 2008, ECOTOX ENVIRON SAFE, V71, P483, DOI 10.1016/j.ecoenv.2007.11.007; Roh JY, 2007, TOXICOLOGY, V237, P126, DOI 10.1016/j.tox.2007.05.008; Shashikumar S, 2010, ECOTOX ENVIRON SAFE, V73, P1057, DOI 10.1016/j.ecoenv.2010.02.003; Silvestre F, 2006, AQUAT TOXICOL, V76, P46, DOI 10.1016/j.aquatox.2005.09.006; Swain SC, 2004, J MOL BIOL, V341, P951, DOI 10.1016/j.jmb.2004.06.050; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wang DY, 2008, ARCH ENVIRON CON TOX, V54, P447, DOI 10.1007/s00244-007-9050-0; Wang Da-Yong, 2007, Asian Journal of Ecotoxicology, V2, P297; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; Wang SC, 2008, TOXICOL SCI, V102, P345, DOI 10.1093/toxsci/kfm220; [汪洋 WANG Yang], 2007, [安全与环境学报, Journal of Safety and Environment], V7, P10; WILLIAMS PL, 1990, TOXICOL IND HEALTH, V6, P425, DOI 10.1177/074823379000600306; Wu QL, 2011, ENVIRON TOXICOL PHAR, V32, P175, DOI 10.1016/j.etap.2011.04.009; Yadav A, 2009, ECOTOXICOLOGY, V18, P325, DOI 10.1007/s10646-008-0286-x; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	40	22	23	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148014	10.1371/journal.pone.0148014	http://dx.doi.org/10.1371/journal.pone.0148014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824831	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528600088
J	McDonnell, MM; Burkhart, SE; Stoddard, JM; Wright, ZJ; Strader, LC; Bartel, B				McDonnell, Margaret M.; Burkhart, Sarah E.; Stoddard, Jerrad M.; Wright, Zachary J.; Strader, Lucia C.; Bartel, Bonnie			The Early-Acting Peroxin PEX19 Is Redundantly Encoded, Farnesylated, and Essential for Viability in Arabidopsis thaliana	PLOS ONE			English	Article							MATRIX PROTEIN-DEGRADATION; INDOLE-3-BUTYRIC ACID; MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; TARGETING SIGNAL; SACCHAROMYCES-CEREVISIAE; BETA-OXIDATION; ABSCISIC-ACID; BIOGENESIS; RECEPTOR	Peroxisomes are single-membrane bound organelles that are essential for normal development in plants and animals. In mammals and yeast, the peroxin (PEX) proteins PEX3 and PEX19 facilitate the early steps of peroxisome membrane protein (PMP) insertion and pre-peroxisome budding from the endoplasmic reticulum. The PEX3 membrane protein acts as a docking site for PEX19, a cytosolic chaperone for PMPs that delivers PMPs to the endoplasmic reticulum or peroxisomal membrane. PEX19 is farnesylated in yeast and mammals, and we used immunoblotting with prenylation mutants to show that PEX19 also is fully farnesylated in wild-type Arabidopsis thaliana plants. We examined insertional alleles disrupting either of the two Arabidopsis PEX19 isoforms, PEX19A or PEX19B, and detected similar levels of PEX19 protein in the pex19a-1 mutant and wild type; however, PEX19 protein was nearly undetectable in the pex19b-1 mutant. Despite the reduction in PEX19 levels in pex19b-1, both pex19a-1 and pex19b-1 single mutants lacked notable peroxisomal beta-oxidation defects and displayed normal levels and localization of peroxisomal matrix and membrane proteins. The pex19a-1 pex19b-1 double mutant was embryo lethal, indicating a redundantly encoded critical role for PEX19 during embryogenesis. Expressing YFP-tagged versions of either PEX19 isoform rescued this lethality, confirming that PEX19A and PEX19B act redundantly in Arabidopsis. We observed that pex19b-1 enhanced peroxisome-related defects of a subset of peroxin-defective mutants, supporting a role for PEX19 in peroxisome function. Together, our data indicate that Arabidopsis PEX19 promotes peroxisome function and is essential for viability.	[McDonnell, Margaret M.; Burkhart, Sarah E.; Stoddard, Jerrad M.; Wright, Zachary J.; Bartel, Bonnie] Rice Univ, Dept BioSci, Houston, TX USA; [Strader, Lucia C.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [McDonnell, Margaret M.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Burkhart, Sarah E.] Arizona Dept Publ Safety, Phoenix, AZ USA; [Stoddard, Jerrad M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	Rice University; Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center	Bartel, B (corresponding author), Rice Univ, Dept BioSci, Houston, TX USA.	bartel@rice.edu	Bartel, Bonnie/O-8119-2019; Bartel, Bonnie/D-3550-2011	Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X; Wright, Zachary J./0000-0002-8335-0203; Strader, Lucia/0000-0002-7600-7204	National Science Foundation [MCB-1244182, MCB-1516966, IOS-1453750]; Robert A. Welch Foundation [C-1309]; National Institutes of Health [S10RR026399-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026399] Funding Source: NIH RePORTER; Direct For Biological Sciences [1516966] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation (MCB-1244182 and MCB-1516966 to BB; IOS-1453750 to LCS) and the Robert A. Welch Foundation (C-1309 to BB). Confocal microscopy was performed on equipment obtained through a Shared Instrumentation Grant from the National Institutes of Health (S10RR026399-01 to BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baerends RJS, 1997, YEAST, V13, P1437; Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Bartel B., 2014, MOL MACHINES INVOLVE, P325, DOI [10.1007/978-3-7091-1788-0_14, 10.1007/978-3-7091-1788-0_14., DOI 10.1007/978-3-7091-1788-0_14]; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Burkhart SE, 2014, PLANT PHYSIOL, V166, P1329, DOI 10.1104/pp.114.247148; Burkhart SE, 2013, GENETICS, V193, P125, DOI 10.1534/genetics.112.146100; Chen YX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6790; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CORPAS FJ, 1994, EUR J CELL BIOL, V65, P280; Crowell DN, 2000, PROG LIPID RES, V39, P393, DOI 10.1016/S0163-7827(00)00010-2; Crowell DN, 2009, TRENDS PLANT SCI, V14, P163, DOI 10.1016/j.tplants.2008.12.001; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; De Rybel B, 2012, NAT CHEM BIOL, V8, P798, DOI [10.1038/NCHEMBIO.1044, 10.1038/nchembio.1044]; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Gotte K, 1998, MOL CELL BIOL, V18, P616; Hadden DA, 2006, MOL MEMBR BIOL, V23, P325, DOI 10.1080/09687860600738221; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Hua R, 2015, TRAFFIC, V16, P832, DOI 10.1111/tra.12292; Johnson CD, 2005, PLANT PHYSIOL, V139, P722, DOI 10.1104/pp.105.065045; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Khan BR, 2010, PLANT PHYSIOL, V154, P1602, DOI 10.1104/pp.110.162479; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kim PK, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00241; Koncz C., 1992, Methods in Arabidopsis research., P224; Lingard MJ, 2009, P NATL ACAD SCI USA, V106, P4561, DOI 10.1073/pnas.0811329106; Lisenbee CS, 2003, PLANT PHYSIOL, V132, P870, DOI 10.1104/pp.103.019976; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Mayerhofer PU, 2002, BIOCHEM BIOPH RES CO, V291, P1180, DOI 10.1006/bbrc.2002.6568; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Mohamed S, 2010, AM J MED GENET A, V152A, P2318, DOI 10.1002/ajmg.a.33560; Monroe-Augustus M, 2011, PLANT MOL BIOL, V77, P1, DOI 10.1007/s11103-011-9782-0; Mullen RT, 2001, TRENDS PLANT SCI, V6, P256, DOI 10.1016/S1360-1385(01)01951-3; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nito K, 2007, PLANT CELL PHYSIOL, V48, P763, DOI 10.1093/pcp/pcm053; Nyathi Y, 2012, FEBS LETT, V586, P2280, DOI 10.1016/j.febslet.2012.05.065; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Platta HW, 2014, BIOCHIMIE, V98, P16, DOI 10.1016/j.biochi.2013.12.009; Pracharoenwattana I, 2007, PLANT J, V50, P381, DOI 10.1111/j.1365-313X.2007.03055.x; Ramon NM, 2010, MOL BIOL CELL, V21, P1263, DOI 10.1091/mbc.E09-08-0672; Ratzel SE, 2011, TRAFFIC, V12, P121, DOI 10.1111/j.1600-0854.2010.01136.x; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rucktaschel R, 2009, J BIOL CHEM, V284, P20885, DOI 10.1074/jbc.M109.016584; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sato Y, 2010, EMBO J, V29, P4083, DOI 10.1038/emboj.2010.293; Schmidt F, 2010, J BIOL CHEM, V285, P25410, DOI 10.1074/jbc.M110.138503; Schueller N, 2010, EMBO J, V29, P2491, DOI 10.1038/emboj.2010.115; Snyder WB, 1999, MOL BIOL CELL, V10, P1745, DOI 10.1091/mbc.10.6.1745; STASINOPOULOS TC, 1990, PLANT PHYSIOL, V93, P1365, DOI 10.1104/pp.93.4.1365; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Strader LC, 2011, PLANT CELL, V23, P984, DOI 10.1105/tpc.111.083071; Strader LC, 2011, MOL PLANT, V4, P477, DOI 10.1093/mp/ssr006; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Theodoulou FL, 2013, BIOCHEM J, V451, P345, DOI 10.1042/BJ20130078; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Woodward AW, 2014, PLANT MOL BIOL, V86, P201, DOI 10.1007/s11103-014-0223-8; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Yagita Y, 2013, J CELL BIOL, V200, P651, DOI 10.1083/jcb.201211077; Zolman BK, 2007, PLANT MOL BIOL, V64, P59, DOI 10.1007/s11103-007-9134-2; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691; Zolman BK, 2004, P NATL ACAD SCI USA, V101, P1786, DOI 10.1073/pnas.0304368101; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550; Zolman BK, 2000, GENETICS, V156, P1323	71	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148335	10.1371/journal.pone.0148335	http://dx.doi.org/10.1371/journal.pone.0148335			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824478	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600116
J	Shah, D; Ali, M; Pasha, Z; Jaboori, AJ; Jassim, SH; Jain, S; Aakalu, VK				Shah, Dhara; Ali, Marwan; Pasha, Zeeshan; Jaboori, Assraa Jassim; Jassim, Sarmad H.; Jain, Sandeep; Aakalu, Vinay K.			Histatin-1 Expression in Human Lacrimal Epithelium	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; ANTIMICROBIAL PEPTIDES; GLAND EPITHELIUM; GENE-EXPRESSION; REGENERATION; PROTEOME; FGF10	Background Study of human lacrimal cell biology is limited by poor access to tissue samples, heterogeneous cell composition of tissue and a lack of established lacrimal epithelial markers. In order to further our understanding of lacrimal cell biology, we sought to find a better marker for human lacrimal epithelial cells, compared to what has been reported in the literature. Methods We utilized human Muller's muscle conjunctival resection (MMCR) specimens containing accessory lacrimal gland (ALG) and cadaveric main lacrimal gland (MLG) as sources of lacrimal tissue. Candidate markers were sought using human ALG tissue from MMCR specimens, isolated by laser capture microdissection (LCM). Affymetrix (R) analysis was performed on total RNA isolated from FFPE samples to profile transcription in ALG. MMCR tissue sections were assessed by immunofluorescence using antibodies for histatin-1, lactoferrin, E-cadherin (E-cad) and alpha-smooth muscle actin (ASMA). Reverse transcriptase polymerase chain reaction (RT-PCR) analysis was performed to analyze the expression of histatin-1, E-cad and lactoferrin from cadaveric MLG. Results Histatin-1 is expressed in ALG and MLG, localizes to lacrimal epithelium, and to a greater degree than do other putative lacrimal epithelial markers. Conclusions Histatin-1 is a good marker for human lacrimal epithelium in ALG and MLG and can be used to identify lacrimal cells in future studies.	[Shah, Dhara; Ali, Marwan; Pasha, Zeeshan; Jaboori, Assraa Jassim; Jassim, Sarmad H.; Jain, Sandeep; Aakalu, Vinay K.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Aakalu, VK (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA.	vaakalu@uic.edu			National Institute of Health-National Eye Institute [K08EY024339]; Illinois Society to Prevent Blindness; Midwest Eye Banks; National Institute of Health-National Eye Institute Core grant [2P30EY001792-36A1]; Research to Prevent Blindness (NY,NY); NATIONAL EYE INSTITUTE [P30EY001792, R01EY024966, K08EY024339, R01EY023656] Funding Source: NIH RePORTER	National Institute of Health-National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Illinois Society to Prevent Blindness; Midwest Eye Banks; National Institute of Health-National Eye Institute Core grant; Research to Prevent Blindness (NY,NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institute of Health-National Eye Institute Grant (K08EY024339), a seed grant from Illinois Society to Prevent Blindness, a Research Grant from Midwest Eye Banks, a Grant-in-Aid from Fight for Sight and Departmental Support through an National Institute of Health-National Eye Institute Core grant (2P30EY001792-36A1) and an Unrestricted Grant from Research to Prevent Blindness (NY,NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Brewitt H, 2001, SURV OPHTHALMOL, V45, pS199, DOI 10.1016/S0039-6257(00)00202-2; BUCKMAN G, 1989, OPHTHALMOLOGY, V96, P413; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; De Saint Jean M, 2004, EXP EYE RES, V78, P257, DOI 10.1016/j.exer.2003.10.006; Flanagan JL, 2009, BIOCHIMIE, V91, P35, DOI 10.1016/j.biochi.2008.07.007; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; Gusman H, 2004, ARCH ORAL BIOL, V49, P11, DOI 10.1016/S0003-9969(03)00182-1; Hirayama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3497; Hodges RR, 2003, INT REV CYTOL, V231, P129, DOI 10.1016/S0074-7696(03)31004-6; Huang LC, 2007, CURR EYE RES, V32, P595, DOI 10.1080/02713680701446653; Jumblatt MM, 2006, INFECT IMMUN, V74, P4058, DOI 10.1128/IAI.01951-05; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Kulchaiyawat V, 2010, ARVO 2010; Liu AJ, 2010, AM J SURG PATHOL, V34, P697, DOI 10.1097/PAS.0b013e3181db84aa; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; Manconi B, 2013, J PROTEOMICS, V91, P536, DOI 10.1016/j.jprot.2013.08.009; Melino S, 2014, FEBS J, V281, P657, DOI 10.1111/febs.12612; Oudhoff MJ, 2010, BIOL CHEM, V391, P541, DOI 10.1515/BC.2010.057; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Perumal N, 2015, PROTEOMICS, V15, P3370, DOI 10.1002/pmic.201400239; Santagati MG, 2005, OPHTHALMIC RES, V37, P270, DOI 10.1159/000087372; Shatos MA, 2012, INVEST OPHTH VIS SCI, V53, P2749, DOI 10.1167/iovs.11-9025; Si YF, 2013, J OCUL PHARMACOL TH, V29, P310, DOI 10.1089/jop.2012.0137; Spaniol K, 2015, TISSUE ENG PT A, V21, P2605, DOI [10.1089/ten.tea.2014.0694, 10.1089/ten.TEA.2014.0694]; Steele PS, 2004, ARVO 2004; Steele PS, 2002, ARVO 2002; Stoeckelhuber M, 2012, J HISTOCHEM CYTOCHEM, V60, P110, DOI 10.1369/0022155411432785; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tiwari S, 2014, SAUDI J OPHTHALMOL, V28, P12, DOI 10.1016/j.sjopt.2013.09.004; Tiwari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029458; Tsau C, 2011, DEVELOPMENT, V138, P3307, DOI 10.1242/dev.066241; Ubels JL, 2012, INVEST OPHTH VIS SCI, V53, P6738, DOI 10.1167/iovs.12-10750; Voronov D, 2013, INVEST OPHTH VIS SCI, V54, P3115, DOI 10.1167/iovs.13-11791; WILK CM, 1990, GRAEF ARCH CLIN EXP, V228, P65, DOI 10.1007/BF02764294	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148018	10.1371/journal.pone.0148018	http://dx.doi.org/10.1371/journal.pone.0148018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824896	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600089
J	Etzel, JA; Valchev, N; Gazzola, V; Keysers, C				Etzel, Joset A.; Valchev, Nikola; Gazzola, Valeria; Keysers, Christian			Is Brain Activity during Action Observation Modulated by the Perceived Fairness of the Actor?	PLOS ONE			English	Article							ACTION OBSERVATION NETWORK; MIRROR-NEURON SYSTEM; PRISONERS-DILEMMA; CYTOARCHITECTONIC MAPS; EMPATHIC BRAIN; RESPONSES; MOTOR; FMRI; METAANALYSIS; COOPERATION	Perceiving other people's actions triggers activity in premotor and parietal areas, brain areas also involved in executing and sensing our own actions. Paralleling this phenomenon, observing emotional states (including pain) in others is associated with activity in the same brain areas as activated when experiencing similar emotions directly. This emotion perception associated activity has been shown to be affected by the perceived fairness of the actor, and in-group membership more generally. Here, we examine whether action observation associated brain activity is also affected by the perceived social fairness of the actors. Perceived fairness was manipulated using an alternating iterated Prisoner's Dilemma game between the participant and two confederates, one of whom played fairly and the other unfairly. During fMRI scanning the participants watched movies of the confederates performing object-directed hand actions, and then performed hand actions themselves. Massunivariate analysis showed that observing the actions triggered robust activation in regions associated with action execution, but failed to identify a strong modulation of this activation based on perceived fairness. Multivariate pattern analysis, however, identified clusters potentially carrying information about the perceived fairness of the actor in the middle temporal gyrus, left postcentral gyrus, right inferior parietal lobule, right middle cingulate cortex, right angular gyrus, and right superioroccipital gyrus. Despite being identified by a wholebrain searchlight analysis (and so without anatomical restriction), these clusters fall into areas frequently associated with action observation. We conclude that brain activity during action observation may be modulated by perceived fairness, but such modulation is subtle; robust activity is associated with observing the actions of both fair and unfair individuals.	[Etzel, Joset A.; Valchev, Nikola; Gazzola, Valeria; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Etzel, Joset A.; Valchev, Nikola; Gazzola, Valeria; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Etzel, Joset A.] Washington Univ, Cognit Control & Psychopathol Lab, St Louis, MO USA; [Valchev, Nikola] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands; [Gazzola, Valeria; Keysers, Christian] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Social Brain Lab, Amsterdam, Netherlands; [Gazzola, Valeria; Keysers, Christian] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Groningen; University of Groningen; Washington University (WUSTL); University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam	Etzel, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands.; Etzel, JA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.; Etzel, JA (corresponding author), Washington Univ, Cognit Control & Psychopathol Lab, St Louis, MO USA.	jetzel@wustl.edu	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467; Gazzola, Valeria/0000-0003-0324-0619	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (N.W.O.) VIDI; Marie Curie Excellence grant; Calouste Gulbenkian Foundation (Lisbon, Portugal) [85430]; Portuguese Foundation for Science and Technology (FCT); Program for Human Potential; European Union [SFRH/BD/47576/2008]; VENI grant of the N.W.O.;  [NCRR 1S10RR022984-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022984] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (N.W.O.) VIDI(Netherlands Organization for Scientific Research (NWO)); Marie Curie Excellence grant(European Commission); Calouste Gulbenkian Foundation (Lisbon, Portugal); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Program for Human Potential; European Union(European Commission); VENI grant of the N.W.O.; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The research was supported by a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (N.W.O.) VIDI and a Marie Curie Excellence grant to Christian Keysers. Nikola Valchev was supported by a grant from the Calouste Gulbenkian Foundation (Lisbon, Portugal, process number: 85430) and a grant from the Portuguese Foundation for Science and Technology (FCT) co-funded by the Program for Human Potential and the European Union (SFRH/BD/47576/2008). Valeria Gazzola was financed by a VENI grant of the N.W.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by a Nederlandse Organisatie voor Wetenschappelijk Onderzoek (N.W.O.) VIDI and a Marie Curie Excellence grant to Christian Keysers. Nikola Valchev was supported by a grant from the Calouste Gulbenkian Foundation (Lisbon, Portugal, process number: 85430) and a grant from the Portuguese Foundation for Science and Technology (FCT) co-funded by the Program for Human Potential and the European Union (SFRH/BD/47576/2008). Valeria Gazzola was financed by a VENI grant of the N.W.O. Rudmer Menger assisted during data collection. Computations were performed using both the facilities of the Washington University (USA) Center for High Performance Computing (partially provided through grant NCRR 1S10RR022984-01A1) and the Centre for High-Performance Computing and Visualisation at the University of Groningen (The Netherlands).	Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bastiaansen JACJ, 2009, PHILOS T B IN PRESS; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cheng YW, 2007, CEREB CORTEX, V17, P1979, DOI 10.1093/cercor/bhl107; Chong TTJ, 2008, NEUROIMAGE, V40, P298, DOI 10.1016/j.neuroimage.2007.11.030; Cook R, 2014, BEHAV BRAIN SCI, V37, P177, DOI 10.1017/S0140525X13000903; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Del Giudice M, 2009, DEVELOPMENTAL SCI, V12, P350, DOI 10.1111/j.1467-7687.2008.00783.x; Dinstein I, 2007, J NEUROPHYSIOL, V98, P1415, DOI 10.1152/jn.00238.2007; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Etzel J.A., 2012, LECT NOTES ARTIF INT, P29, DOI DOI 10.1007/978-3-642-34713-9_4; Etzel JA, 2015, 5 INT WORKSH PATT RE; Etzel JA, 2013, NEUROIMAGE, V78, P261, DOI 10.1016/j.neuroimage.2013.03.041; Etzel JA, 2009, BRAIN RES, V1282, P114, DOI 10.1016/j.brainres.2009.05.090; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; FREAN MR, 1994, P ROY SOC B-BIOL SCI, V257, P75, DOI 10.1098/rspb.1994.0096; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hughett P., 2007, J STAT SOFTW CODE SN, V23, P1, DOI 10.18637/jss.v023.c01; Keysers C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0175; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Keysers C, 2009, CURR BIOL, V19, pR971, DOI 10.1016/j.cub.2009.08.026; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kim YT, 2011, BEHAV BRAIN RES, V223, P342, DOI 10.1016/j.bbr.2011.04.053; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Molenberghs P, 2013, NEUROSCI BIOBEHAV R, V37, P1530, DOI 10.1016/j.neubiorev.2013.06.002; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; NOWAK MA, 1994, J THEOR BIOL, V168, P219, DOI 10.1006/jtbi.1994.1101; Orgs G, 2008, EUR J NEUROSCI, V27, P3380, DOI 10.1111/j.1460-9568.2008.06271.x; PRUITT DG, 1967, J PERS SOC PSYCHOL, V7, P21, DOI 10.1037/h0024914; Rizzolatti G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0420; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Steele JD, 2004, NEUROIMAGE, V21, P868, DOI 10.1016/j.neuroimage.2003.09.066; Turella L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00637; Turella L, 2009, BRAIN LANG, V108, P10, DOI 10.1016/j.bandl.2007.11.002	59	7	7	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0145350	10.1371/journal.pone.0145350	http://dx.doi.org/10.1371/journal.pone.0145350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GF	26820995	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528400002
J	Wong, ZSY; Goldsman, D; Tsui, KL				Wong, Zoie Shui-Yee; Goldsman, David; Tsui, Kwok-Leung			Economic Evaluation of Individual School Closure Strategies: The Hong Kong 2009 H1N1 Pandemic	PLOS ONE			English	Article							COST-EFFECTIVENESS; INFLUENZA VACCINATION; INTERVENTIONS; TRANSMISSION; SPREAD; CHILDREN; IMPACT; VIRUS	Background School closures as a means of containing the spread of disease have received considerable attention from the public health community. Although they have been implemented during previous pandemics, the epidemiological and economic effects of the closure of individual schools remain unclear. Methodology This study used data from the 2009 H1N1 pandemic in Hong Kong to develop a simulation model of an influenza pandemic with a localised population structure to provide scientific justifications for and economic evaluations of individual-level school closure strategies. Findings The estimated cost of the study's baseline scenario was USD330 million. We found that the individual school closure strategies that involved all types of schools and those that used a lower threshold to trigger school closures had the best performance. The best scenario resulted in an 80% decrease in the number of cases (i. e., prevention of about 830,000 cases), and the cost per case prevented by this intervention was USD1,145; thus, the total cost was USD1.28 billion. Conclusion This study predicts the effects of individual school closure strategies on the 2009 H1N1 pandemic in Hong Kong. Further research could determine optimal strategies that combine various system-wide and district-wide school closures with individual school triggers across types of schools. The effects of different closure triggers at different phases of a pandemic should also be examined.	[Wong, Zoie Shui-Yee] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Goldsman, David] Georgia Inst Technol, Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Tsui, Kwok-Leung] City Univ Hong Kong, Dept Syst Engn & Engn Management, Hong Kong, Hong Kong, Peoples R China	University of New South Wales Sydney; University System of Georgia; Georgia Institute of Technology; City University of Hong Kong	Wong, ZSY (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	zoiesywong@gmail.com		TSUI, Kwok Leung/0000-0002-0558-2279	Research Grants Council Collaborative Research Fund [CityU8/CRF/12G]; Theme-Based Research Scheme [T32-102/14N]; National Natural Science Foundation of China (NSFC) [71420107023]	Research Grants Council Collaborative Research Fund(Hong Kong Research Grants Council); Theme-Based Research Scheme; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the Research Grants Council Collaborative Research Fund (Ref. CityU8/CRF/12G), Theme-Based Research Scheme (Ref.: T32-102/14N) and The National Natural Science Foundation of China (NSFC) (Grant No. 71420107023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07218; Andradottir S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S1; [Anonymous], 2015, HONG KONG GDP CAP; [Anonymous], 2009, CHP ADV SEC SCH SUSP; [Anonymous], 2015, PRINC GOV CLOS SCH O; [Anonymous], FEES AND CHARG; [Anonymous], 2009, EDB ANN 14 DAY CLASS; [Anonymous], 2009, SEC SCH IS ADV SUSP; [Anonymous], 2010, TOT HLTH EXP FIN SOU; [Anonymous], 2015, SUP PRIC WATCH; [Anonymous], 2011, HOSP AUTH STAT REP; [Anonymous], 2011, CAN PAND INFL PLAN H; [Anonymous], 2009, AV MED AG 2009 H1N1; [Anonymous], 2007, HONG KONGS PREP INFL; Baio G., 2011, STAT METHODS MED RES, DOI 0962280211419832; Bang HJ, 2012, J STAT THEORY PRACT, V6, P428, DOI 10.1080/15598608.2012.695571; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Cauchemez S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-207; Census and Statistics Department, 2010, HONG KONG ANN DIG ST; Chan Y, 2014, SCR SEMS 2014; Chan Y. H., 2012, P IEEE INT C IND ENG; Cooper NJ, 2004, HEALTH ECON, V13, P203, DOI 10.1002/hec.804; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Haber MJ, 2007, EMERG INFECT DIS, V13, P581, DOI 10.3201/eid1304.060828; Halder N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022087; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; HKSAR, 2012, HKSAR 2011 POP CENS; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Koonin LM, 2009, EMERG INFECT DIS, V15, P137, DOI 10.3201/eid1501.081289; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Ridenhour BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029640; Schooling C. M., 2009, Hong Kong Medical Journal, V15, P44; Tsui KL, 2013, IEEE INTELL SYST, V28, P60, DOI 10.1109/MIS.2013.149; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Wong ZSY, P 2015 WINT SIM C I; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Yeung RYT, 2006, 01030691 HHSRF	49	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147052	10.1371/journal.pone.0147052	http://dx.doi.org/10.1371/journal.pone.0147052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820982	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528400013
J	Wrange, AL; Charrier, G; Thonig, A; Rosenblad, MA; Blomberg, A; Havenhand, JN; Jonsson, PR; Andre, C				Wrange, Anna-Lisa; Charrier, Gregory; Thonig, Anne; Rosenblad, Magnus Alm; Blomberg, Anders; Havenhand, Jonathan N.; Jonsson, Per R.; Andre, Carl			The Story of a Hitchhiker: Population Genetic Patterns in the Invasive Barnacle Balanus (Amphibalanus) improvisus Darwin 1854	PLOS ONE			English	Article							INTERTIDAL BARNACLE; DNA-SEQUENCE; GEOGRAPHICAL VARIATION; MICROSATELLITE DATA; LARVAL DISPERSAL; COMPUTER-PROGRAM; MARINE INVADER; PELAGIC LARVAE; ACORN BARNACLE; OCEAN CURRENTS	Understanding the ecological and evolutionary forces that determine the genetic structure and spread of invasive species is a key component of invasion biology. The bay barnacle, Balanus improvisus (= Amphibalanus improvisus), is one of the most successful aquatic invaders worldwide, and is characterised by broad environmental tolerance. Although the species can spread through natural larval dispersal, human-mediated transport through (primarily) shipping has almost certainly contributed to the current global distribution of this species. Despite its worldwide distribution, little is known about the phylogeography of this species. Here, we characterize the population genetic structure and model dispersal dynamics of the barnacle B. improvisus, and describe how human-mediated spreading via shipping as well as natural larval dispersal may have contributed to observed genetic variation. We used both mitochondrial DNA (cytochrome c oxidase subunit I: COI) and nuclear microsatellites to characterize the genetic structure in 14 populations of B. improvisus on a global and regional scale (Baltic Sea). Genetic diversity was high in most populations, and many haplotypes were shared among populations on a global scale, indicating that longdistance dispersal (presumably through shipping and other anthropogenic activities) has played an important role in shaping the population genetic structure of this cosmopolitan species. We could not clearly confirm prior claims that B. improvisus originates from the western margins of the Atlantic coasts; although there were indications that Argentina could be part of a native region. In addition to dispersal via shipping, we show that natural larval dispersal may play an important role for further colonisation following initial introduction.	[Wrange, Anna-Lisa; Havenhand, Jonathan N.; Jonsson, Per R.; Andre, Carl] Univ Gothenburg, Dept Marine Sci, Tjarno, Sweden; [Charrier, Gregory] IUEM, Technopole Brest Iroise, Plouzane, France; [Thonig, Anne] Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark; [Rosenblad, Magnus Alm; Blomberg, Anders] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Roskilde University; University of Gothenburg	Wrange, AL (corresponding author), Univ Gothenburg, Dept Marine Sci, Tjarno, Sweden.	annalisa.wrange@gmail.com	Andre, Carl/B-4237-2010	Andre, Carl/0000-0003-4404-7292; Havenhand, Jonathan/0000-0001-6721-7763; Blomberg, Anders/0000-0002-1260-3920	Linnaeus grant from the Swedish Research Councils, VR; FORMAS; Wilhelm and Martina Lundgren Foundation; Helge Ax:son Johnson Foundation; BILS; Stiftelsen Wilhelm och Marina Lundgrens Vetenskapsfond	Linnaeus grant from the Swedish Research Councils, VR; FORMAS(Swedish Research Council Formas); Wilhelm and Martina Lundgren Foundation; Helge Ax:son Johnson Foundation; BILS; Stiftelsen Wilhelm och Marina Lundgrens Vetenskapsfond	This work was performed within Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu.se), which is supported by a Linnaeus grant from the Swedish Research Councils, VR (www.vr.se) and FORMAS (www.formas.se), as well as by Wilhelm and Martina Lundgren Foundation and Helge Ax:son Johnson Foundation. MAR was partly funded by BILS (www.bils.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Linnaeus-grant from the Swedish Research Councils, VR and Formas (http://www.cemeb.science.gu.se), as well as from Stiftelsen Wilhelm och Marina Lundgrens Vetenskapsfond. A special thanks to our collaborators worldwide for their help with collecting barnacles for this study: Toshi Yamaguchi, Richard Emlet, Daniel Rittschof, Eric Holm, Richard Osman, Eduardo Spivak, Alireza Sari, Ventzi Karamfilow, Tiia Moller, Christian Pansch and Daniel Johansson, as well as to Zuzanna Zadrodzka and Anna-Karin Ring for assistance in the lab.	ANIL AC, 1995, MAR ECOL PROG SER, V118, P159, DOI 10.3354/meps118159; Astanei I, 2005, MOL ECOL, V14, P1655, DOI 10.1111/j.1365-294X.2005.02530.x; Banks NC, 2015, ECOL LETT, V18, P188, DOI 10.1111/ele.12397; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; BARNES H., 1962, SOC SCI FENNICA COMMENTAT BIOL, V24, P3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berntsson KM, 2003, BIOFOULING, V19, P187, DOI 10.1080/0892701031000072091; Bilton DT, 2002, ESTUAR COAST SHELF S, V55, P937, DOI 10.1006/ecss.2002.1037; BLOM SVEN-ERIK, 1961, ZOOL BIDRAG UPPSALA, V33, P149; BLOM SVEN-ERIK, 1965, ZOOL BIDRAG UPPSALA, V37, P59; Bock DG, 2011, MOL ECOL, V20, P503, DOI 10.1111/j.1365-294X.2010.04971.x; Brownlow RJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-55; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Campo D, 2010, MAR BIOL, V157, P147, DOI 10.1007/s00227-009-1305-z; Carlton JT, 2011, INVADING NATURE SPRI, P716; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cheang CC, 2012, J BIOGEOGR, V39, P1819, DOI 10.1111/j.1365-2699.2012.02742.x; Cheang CC, 2010, J PHYCOL, V46, P1063, DOI 10.1111/j.1529-8817.2010.00901.x; Chen HN, 2014, BIOFOULING, V30, P1067, DOI 10.1080/08927014.2014.967232; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corell H, 2012, MAR ECOL PROG SER, V467, P29, DOI 10.3354/meps09963; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crooks JA, 2011, BIOL INVASIONS, V13, P165, DOI 10.1007/s10530-010-9799-3; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C., 1854, MONOGRAPH SUBCLASS C; de Rivera CE, 2011, DIVERS DISTRIB, V17, P1198, DOI 10.1111/j.1472-4642.2011.00790.x; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; DOOS K, 1995, J GEOPHYS RES-OCEANS, V100, P13499, DOI 10.1029/95JC00337; Drummond AJ, 2010, GENEIOUS; DUNGAN ML, 1985, PALEOBIOLOGY, V11, P165, DOI 10.1017/S0094837300011489; Dupont L, 2003, MAR ECOL PROG SER, V253, P183, DOI 10.3354/meps253183; Duvernell DD, 2008, MOL ECOL, V17, P1344, DOI 10.1111/j.1365-294X.2007.03648.x; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flight PA, 2012, J HERED, V103, P153, DOI 10.1093/jhered/esr083; FOSTER BA, 1979, NEW ZEAL J MAR FRESH, V13, P143, DOI 10.1080/00288330.1979.9515788; Fu YX, 1997, GENETICS, V147, P915; FURMAN E, 1989, OPHELIA, V30, P35, DOI 10.1080/00785326.1989.10430834; FURMAN ER, 1989, J MAR BIOL ASSOC UK, V69, P511, DOI 10.1017/S0025315400030927; FURMAN ER, 1990, J MAR BIOL ASSOC UK, V70, P721, DOI 10.1017/S0025315400059002; FURMAN ER, 1990, J EXP MAR BIOL ECOL, V144, P235, DOI 10.1016/0022-0981(90)90030-G; FYHN HJ, 1976, COMP BIOCHEM PHYS A, V53, P19, DOI 10.1016/S0300-9629(76)80004-7; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Garroway CJ, 2013, EVOLUTION, V67, P3488, DOI 10.1111/evo.12121; Geller J, 2008, MAR ECOL PROG SER, V358, P211, DOI 10.3354/meps07466; Gislen T, 1950, FAUNA FLORA, V45, P32; Godhe A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1599; Gollasch S, 2002, BIOFOULING, V18, P105, DOI 10.1080/08927010290011361; Gomoiu MT, 1996, CHANGEMENTS RECENTS, V1, P34; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goulletquer P, 2002, OPEN ATLANTIC COAST, P276; Grigorovich IA, 2003, BIOL INVASIONS, V5, P103, DOI 10.1023/A:1024050824073; GRUET Y, 1976, CAH BIOL MAR, V17, P173; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hoffman J, 2012, PLOS ONE, V7; Hordoir R, 2013, CONT SHELF RES, V64, P1, DOI 10.1016/j.csr.2013.05.006; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; JOHANNESSON K, 1995, P NATL ACAD SCI USA, V92, P2602, DOI 10.1073/pnas.92.7.2602; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, AMBIO, V40, P179, DOI 10.1007/s13280-010-0129-x; Karlsson U, 1979, KROKSTRAND 1870 1940; Katsanevakis S, 2013, OCEAN COAST MANAGE, V76, P64, DOI 10.1016/j.ocecoaman.2013.02.024; KAWAHARA T, 1963, NATURE, V198, P301, DOI 10.1038/198301a0; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; KENNEDY VS, 1983, ESTUARIES, V6, P95, DOI 10.2307/1351700; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lenz M, 2011, ENVIRON RES, V111, P943, DOI 10.1016/j.envres.2011.05.001; Leppakoski E, 2002, CAN J FISH AQUAT SCI, V59, P1175, DOI 10.1139/F02-089; Leppakoski Erkki, 2000, Biological Invasions, V2, P151, DOI 10.1023/A:1010052809567; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Limborg MT, 2009, MAR ECOL PROG SER, V379, P213, DOI 10.3354/meps07889; Madec G, 2010, TECHNICAL REPORT; MANTEL N, 1967, CANCER RES, V27, P209; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nei M., 1987, pi; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pansch C, 2013, MAR BIOL, V160, P2023, DOI 10.1007/s00227-012-2069-4; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Qiu JW, 1999, MAR ECOL PROG SER, V188, P123, DOI 10.3354/meps188123; Rainbow PS, 2004, MAR BIOL, V144, P271, DOI 10.1007/s00227-003-1197-2; Real KM, 2009, CONSERV GENET RESOUR, V1, P411, DOI 10.1007/s12686-009-9095-7; Remerie T, 2009, J BIOGEOGR, V36, P39, DOI 10.1111/j.1365-2699.2008.01970.x; Reusch TBH, 2010, MOL ECOL, V19, P2690, DOI 10.1111/j.1365-294X.2010.04701.x; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schmidt PS, 2001, EVOLUTION, V55, P1336; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; SLATKIN M, 1995, GENETICS, V139, P1463; Smit AFA, 2010, REPEATMASKER OPEN 3; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; STANLEY SM, 1980, PALEOBIOLOGY, V6, P173, DOI 10.1017/S0094837300006734; TAJIMA F, 1989, GENETICS, V123, P585; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; TEMPLETON AR, 1992, GENETICS, V132, P619; Tepolt CK, 2015, BIOL INVASIONS, V17, P887, DOI 10.1007/s10530-014-0825-8; Todd CD, 1998, J EXP MAR BIOL ECOL, V228, P1, DOI 10.1016/S0022-0981(98)00005-7; Turpayeva YP, 1961, T I OCEANOL, V49, P205; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veliz D, 2006, MOL ECOL, V15, P4193, DOI 10.1111/j.1365-294X.2006.03078.x; Wares JP, 2005, MECHANISMS THAT DRIV, P229; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wrange AL, 2014, BMC EVOL BIOL, V14; Yamaguchi T, 2009, BIOFOULING, V25, P325, DOI 10.1080/08927010902738048; York KL, 2008, MOL ECOL, V17, P1948, DOI 10.1111/j.1365-294X.2008.03735.x; Zakas C, 2009, MAR ECOL PROG SER, V394, P165, DOI 10.3354/meps08265; Zardoya R, 2007, BMC EVOL BIOL, V7; Zhan AB, 2012, DIVERS DISTRIB, V18, P1042, DOI 10.1111/j.1472-4642.2012.00894.x; Zullo VA, 1979, MARINE FLORA FAUNA N; Zullo VA, 1969, EARLY RECORDS BARNAC, V75, P1	137	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147082	10.1371/journal.pone.0147082	http://dx.doi.org/10.1371/journal.pone.0147082			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821161	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400014
J	Cabrita, MA; Vanzyl, EJ; Hamill, JD; Pan, E; Marcellus, KA; Tolls, VJ; Alonzi, RC; Pastic, A; Rambo, TME; Sayed, H; McKay, BC				Cabrita, Miguel A.; Vanzyl, Erin J.; Hamill, Jeff D.; Pan, Elysia; Marcellus, Kristen A.; Tolls, Victoria J.; Alonzi, Rhea C.; Pastic, Alyssa; Rambo, Teeghan M. E.; Sayed, Hadil; McKay, Bruce C.			A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing	PLOS ONE			English	Article							CELL-CYCLE ARREST; TARGETING C-MYC; TUMOR-SUPPRESSOR; DNA-DAMAGE; COLORECTAL-CANCER; TRANSCRIPTIONAL REPRESSION; MIR-34A CONTRIBUTES; APOPTOSIS; PROTEIN; NETWORK	The p53 tumour suppressor is a transcription factor that can regulate the expression of numerous genes including many encoding proteins and microRNAs (miRNAs). The predominant outcomes of a typical p53 response are the initiation of apoptotic cascades and the activation of cell cycle checkpoints. HT29-tsp53 cells express a temperature sensitive variant of p53 and in the absence of exogenous DNA damage, these cells preferentially undergo G(1) phase cell cycle arrest at the permissive temperature that correlates with increased expression of the cyclin-dependent kinase inhibitor p21(WAF1). Recent evidence also suggests that a variety of miRNAs can induce G(1) arrest by inhibiting the expression of proteins like CDK4 and CDK6. Here we used oligonucleotide microarrays to identify p53-regulated miRNAs that are induced in these cells undergoing G(1) arrest. At the permissive temperature, the expression of several miRNAs was increased through a combination of either transcriptional or post-transcriptional regulation. In particular, miR-34a-5p, miR-143-3p and miR-145-5p were strongly induced and they reached levels comparable to that of reference miRNAs (miR-191 and miR-103). Importantly, miR-34a-5p and miR-145-5p are known to silence the Cdk4 and/or Cdk6 G(1) cyclin-dependent kinases (cdks). Surprisingly, there was no p53-dependent decrease in the expression of either of these G(1) cdks. To search for other potential targets of p53-regulated miRNAs, p53-downregulated mRNAs were identified through parallel microarray analysis of mRNA expression. Once again, there was no clear effect of p53 on the repression of mRNAs under these conditions despite a remarkable increase in p53-induced mRNA expression. Therefore, despite a strong p53 transcriptional response, there was no clear evidence that p53-responsive miRNA contributed to gene silencing. Taken together, the changes in cell cycle distribution in this cell line at the permissive temperature is likely attributable to transcriptional upregulation of the CDKN1A mRNA and p21(WAF1) protein and not to the down regulation of CDK4 or CDK6 by p53-regulated miRNAs.	[Cabrita, Miguel A.; Hamill, Jeff D.; Pan, Elysia; Marcellus, Kristen A.; McKay, Bruce C.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Vanzyl, Erin J.; Tolls, Victoria J.; Pastic, Alyssa; Rambo, Teeghan M. E.; Sayed, Hadil; McKay, Bruce C.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Alonzi, Rhea C.; McKay, Bruce C.] Carleton Univ, Inst Biochem, Ottawa, ON K1S 5B6, Canada	University of Ottawa; Ottawa Hospital Research Institute; Carleton University; Carleton University	McKay, BC (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	bruce_mckay@carleton.ca	McKay, Bruce C/I-4081-2013	McKay, Bruce C/0000-0002-7921-1331	Carleton University Dean's Summer Research Internship Awards; Carleton University I-CUREUS award; Carleton University; Canadian Institutes of Health Research [69031]; National Sciences and Engineering Council of Canada [RGPIN 2014-03645]	Carleton University Dean's Summer Research Internship Awards; Carleton University I-CUREUS award; Carleton University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We would also like to acknowledge the assistance of Microarray Core Facility of StemCore Laboratories at the Ottawa Hospital Research Institute. E.V., T.R. and H.S. were recipients of Carleton University Dean's Summer Research Internship Awards and E.V. was a recipient of a Carleton University I-CUREUS award.; This work was supported with funds from Carleton University to BCM., Canadian Institutes of Health Research to BCM. (Grant# 69031, http://www.cihr-irsc.gc.ca/e/193.html), National Sciences and Engineering Council of Canada (RGPIN 2014-03645, http://www.nserc-crsng.gc.ca/index_eng.asp) to BCM. EJV, TMER and HS were recipients of Carleton University Dean's Summer Research Internship Awards. EJV was a recipient of a Carleton University I-CUREUS award.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; EWEN ME, 1995, GENE DEV, V9, P204, DOI 10.1101/gad.9.2.204; GANNON JV, 1991, NATURE, V349, P802; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hattori H, 2014, CELL CYCLE, V13, P2572, DOI 10.4161/15384101.2015.942209; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; KASTAN MB, 1993, ENVIRON HEALTH PERSP, V101, P55, DOI 10.2307/3431842; KASTAN MB, 1991, CANCER RES, V51, P6304; Kozomara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104286; Krol J, NATURE REV, V11, P597; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Mayya VK, 2015, NUCLEIC ACIDS RES, V43, P7556, DOI 10.1093/nar/gkv720; McKay BC, 2000, MOL BIOL CELL, V11, P2543, DOI 10.1091/mbc.11.8.2543; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Melanson BD, 2011, RNA, V17, P2222, DOI 10.1261/rna.030122.111; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Merchant AK, 1996, ONCOGENE, V13, P2631; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinn JL, 2011, TRENDS CELL BIOL, V21, P344, DOI 10.1016/j.tcb.2011.04.002; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Sanchez-Martinez C, 2015, BIOORG MED CHEM LETT, V25, P3420, DOI 10.1016/j.bmcl.2015.05.100; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen K, 2014, FEBS J, V281, P3609, DOI 10.1111/febs.12880; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Stubbert LJ, 2007, CELL CYCLE, V6, P1730, DOI 10.4161/cc.6.14.4427; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Villadsen SB, 2012, BRIT J CANCER, V106, P366, DOI 10.1038/bjc.2011.520; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yamamura S, 2012, CARCINOGENESIS, V33, P294, DOI 10.1093/carcin/bgr286; Younger ST, 2015, NUCLEIC ACIDS RES, V43, P4447, DOI 10.1093/nar/gkv284; Zhang H, ONCOLOGY REPORTS, V24, P1363; Zhang XF, 2015, ONCOTARGET, V6, P4144, DOI 10.18632/oncotarget.2864; Zhao RB, 2000, GENE DEV, V14, P981	62	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148529	10.1371/journal.pone.0148529	http://dx.doi.org/10.1371/journal.pone.0148529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840126	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200145
J	Gossner, MM; Struwe, JF; Sturm, S; Max, S; McCutcheon, M; Weisser, WW; Zytynska, SE				Gossner, Martin M.; Struwe, Jan-Frederic; Sturm, Sarah; Max, Simeon; McCutcheon, Michelle; Weisser, Wolfgang W.; Zytynska, Sharon E.			Searching for the Optimal Sampling Solution: Variation in Invertebrate Communities, Sample Condition and DNA Quality	PLOS ONE			English	Article							FLIGHT-INTERCEPTION TRAPS; DEAD WOOD; VERTICAL STRATIFICATION; ARTHROPOD COMMUNITIES; BEETLES COLEOPTERA; SPECIES RICHNESS; EUROPEAN BEECH; PITFALL TRAPS; NORWAY SPRUCE; FOREST FLOOR	There is a great demand for standardising biodiversity assessments in order to allow optimal comparison across research groups. For invertebrates, pitfall or flight-interception traps are commonly used, but sampling solution differs widely between studies, which could influence the communities collected and affect sample processing (morphological or genetic). We assessed arthropod communities with flight-interception traps using three commonly used sampling solutions across two forest types and two vertical strata. We first considered the effect of sampling solution and its interaction with forest type, vertical stratum, and position of sampling jar at the trap on sample condition and community composition. We found that samples collected in copper sulphate were more mouldy and fragmented relative to other solutions which might impair morphological identification, but condition depended on forest type, trap type and the position of the jar. Community composition, based on order-level identification, did not differ across sampling solutions and only varied with forest type and vertical stratum. Species richness and species-level community composition, however, differed greatly among sampling solutions. Renner solution was highly attractant for beetles and repellent for true bugs. Secondly, we tested whether sampling solution affects subsequent molecular analyses and found that DNA barcoding success was species-specific. Samples from copper sulphate produced the fewest successful DNA sequences for genetic identification, and since DNA yield or quality was not particularly reduced in these samples additional interactions between the solution and DNA must also be occurring. Our results show that the choice of sampling solution should be an important consideration in biodiversity studies. Due to the potential bias towards or against certain species by Ethanol-containing sampling solution we suggest ethylene glycol as a suitable sampling solution when genetic analysis tools are to be used and copper sulphate when focusing on morphological species identification and facing financial restrictions in biodiversity studies.	[Gossner, Martin M.; Sturm, Sarah; Max, Simeon; McCutcheon, Michelle; Weisser, Wolfgang W.; Zytynska, Sharon E.] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Sch Life Sci Weihenstephan, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany; [Struwe, Jan-Frederic] Zool Res Museum Alexander Koenig, Adenauerallee 160-162, D-53113 Bonn, Germany	Technical University of Munich; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Gossner, MM (corresponding author), Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Sch Life Sci Weihenstephan, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.	martin.gossner@tum.de	Zytynska, Sharon/C-9089-2011; Gossner, Martin M./J-2730-2015; Weisser, Wolfgang W/B-9718-2014	Zytynska, Sharon/0000-0002-0174-3303; Gossner, Martin M./0000-0003-1516-6364; Weisser, Wolfgang W/0000-0002-2757-8959	DFG [1374, WE 3081/19-1, WE 3081/21-1]; German Research Foundation (DFG); Technische Universitat Munchen	DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	The work has been partly funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (WE 3081/19-1, WE 3081/21-1) (www.exploratories.de). In addition, it was supported by the German Research Foundation (DFG; www.dfg.de) and the Technische Universitat Munchen within the funding programme Open Access Publishing (http://www.ub.tum.de/open-access-publikationsfonds-der-tum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Hara S, 1998, J ARACHNOL, V26, P397; AATI, 2012, GDNA AN FRAGM AN AUT, P2; Ammer U, 2003, FAUNISTISCH OKOLOGIS, V8, P297; Ammer Ulrich, 2008, P531; Basset Y., 1997, P27; Bisanti M, 2009, ENTOMOL EXP APPL, V130, P290, DOI 10.1111/j.1570-7458.2008.00821.x; Bouget C, 2009, AGR FOREST ENTOMOL, V11, P143, DOI 10.1111/j.1461-9563.2008.00400.x; Bouget C, 2011, FOREST ECOL MANAG, V261, P211, DOI 10.1016/j.foreco.2010.10.007; Byers JA, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P89; BYERS JA, 1992, J CHEM ECOL, V18, P2385, DOI 10.1007/BF00984957; Cardoso P, 2009, BIODIVERS CONSERV, V18, P3949, DOI 10.1007/s10531-009-9690-7; Cervantes-Cervantes MP, 2005, BIOL TRACE ELEM RES, V103, P229, DOI 10.1385/BTER:103:3:229; Darriet P, 2001, VITIS, V40, P93; Dillon N, 1996, INSECT MOL BIOL, V5, P21, DOI 10.1111/j.1365-2583.1996.tb00036.x; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Dorow W, 2010, FORSTARCHIV, V8, P61; Dray S, 2014, ECOLOGY, V95, P14, DOI 10.1890/13-0196.1; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fountain-Jones NM, 2015, ECOL ENTOMOL, V40, P1, DOI 10.1111/een.12158; Gossner M, 2006, EUR J FOREST RES, V125, P345, DOI 10.1007/s10342-006-0126-6; Gossner M, 2006, EUR J FOREST RES, V125, P221, DOI 10.1007/s10342-006-0113-y; Gossner Martin, 2008, P119; Gossner MM, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00177.1; Gossner MM, 2014, BIODIVERS CONSERV, V23, P945, DOI 10.1007/s10531-014-0644-3; Gossner MM, 2013, FOREST ECOL MANAG, V302, P404, DOI 10.1016/j.foreco.2013.03.039; Gossner MM, 2009, EUR J ENTOMOL, V106, P241, DOI 10.14411/eje.2009.032; Gossner MM, 2009, AM NAT, V173, P599, DOI 10.1086/597603; GRAHAM K, 1968, CAN J ZOOLOG, V46, P905, DOI 10.1139/z68-127; Grimbacher PS, 2007, AUSTRAL ECOL, V32, P77, DOI 10.1111/j.1442-9993.2007.01735.x; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hardy S, 2007, PRIMEFACT, V757, P1; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Hessenmoller D., 2011, Forstarchiv, V82, P171; Hill D., 2005, HDB BIODIVERSITY MET, DOI DOI 10.1017/CBO9780511542084; Hoefer Hubert, 2015, Arachnologische Mitteilungen, P30, DOI 10.5431/aramit5005; Holopainen J.K., 1990, P339; HOLOPAINEN JK, 1992, PEDOBIOLOGIA, V36, P257; Hribik M, 2012, J HYDROL HYDROMECH, V60, P319, DOI 10.2478/v10098-012-0028-x; Jose GP, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-9; Jud P, 2008, ENTOMOL EXP APPL, V129, P356, DOI 10.1111/j.1570-7458.2008.00773.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kohler F, 2000, RECKLINGHAUSEN LANDE; Koivula M, 2003, ENTOMOL FENNICA, V14, P1; Kowalski E, 2011, ENTOMOL EXP APPL, V140, P35, DOI 10.1111/j.1570-7458.2011.01134.x; Lamarre GPA, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.216.3332; Lange M, 2011, METHODS ECOL EVOL, V2, P185, DOI 10.1111/j.2041-210X.2010.00062.x; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lloyd DR, 1999, MUTAT RES-FUND MOL M, V424, P23, DOI 10.1016/S0027-5107(99)00005-6; Maguire DY, 2014, ENVIRON ENTOMOL, V43, P9, DOI 10.1603/EN13056; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; McCravy Kenneth W., 2007, Great Lakes Entomologist, V40, P154; Muller J, 2015, ECOGRAPHY, V38, P499, DOI 10.1111/ecog.00908; Muller J, 2010, BIOL CONSERV, V143, P625, DOI 10.1016/j.biocon.2009.11.027; Obrist MK, 2010, BIODIVERS CONSERV, V19, P2201, DOI 10.1007/s10531-010-9832-y; Oertli B, 2005, AQUAT CONSERV, V15, P665, DOI 10.1002/aqc.744; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Parker Geoffrey G., 1995, P73; Pinheiro J, 2020, R PACKAGE VERSION 31; Plachter H, 2003, ENTWICKLUNG FESTLEGU; Pokluda P, 2014, EUR J ENTOMOL, V111, P175, DOI 10.14411/eje.2014.024; R Core Team, 2021, R LANGUAGE ENV STAT; Ranius T, 2011, BIODIVERS CONSERV, V20, P2903, DOI 10.1007/s10531-011-0124-y; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Renner, 1982, FAUNISTISCH OKOLOGIS, V5, P137; Roder J, 2010, FOREST ECOL MANAG, V259, P1513, DOI 10.1016/j.foreco.2010.01.027; Scherber C, 2014, OECOLOGIA, V174, P1387, DOI 10.1007/s00442-013-2865-7; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Schmidt MH, 2006, J ARACHNOL, V34, P159, DOI 10.1636/T04-95.1; Sereda E, 2014, J ARACHNOL, V42, P44, DOI 10.1636/P13-16.1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sobek S, 2009, ECOL ENTOMOL, V34, P772, DOI 10.1111/j.1365-2311.2009.01132.x; Sobek S, 2009, DIVERS DISTRIB, V15, P660, DOI 10.1111/j.1472-4642.2009.00570.x; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Stoeckle BC, 2010, ENTOMOL EXP APPL, V135, P217, DOI 10.1111/j.1570-7458.2010.00977.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; TEVIOTDALE B L, 1989, California Agriculture, V43, P30; TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401; Vialatte A, 2010, P ROY SOC B-BIOL SCI, V277, P2227, DOI 10.1098/rspb.2010.0365; Vink CJ, 2005, INVERTEBR SYST, V19, P99, DOI 10.1071/IS04039; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Weeks RD, 1997, ENTOMOL EXP APPL, V82, P267, DOI 10.1046/j.1570-7458.1997.00140.x; Zehetmair T, 2015, INSECT CONSERV DIVER, V8, P193, DOI 10.1111/icad.12101; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	92	6	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148247	10.1371/journal.pone.0148247	http://dx.doi.org/10.1371/journal.pone.0148247			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840598	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200110
J	Stilson, KT; Hopkins, SSB; Davis, EB				Stilson, Kelsey T.; Hopkins, Samantha S. B.; Davis, Edward Byrd			Osteopathology in Rhinocerotidae from 50 Million Years to the Present	PLOS ONE			English	Article							BODY-MASS; PERISSODACTYLA; PHYLOGENIES; EVOLUTION; ORIGINS; TIME	Individual elements of many extinct and extant North American rhinocerotids display osteopathologies, particularly exostoses, abnormal textures, and joint margin porosity, that are commonly associated with localized bone trauma. When we evaluated six extinct rhinocerotid species spanning 50 million years (Ma), we found the incidence of osteopathology increases from 28% of all elements of Eocene Hyrachyus eximius to 65-80% of all elements in more derived species. The only extant species in this study, Diceros bicornis, displayed less osteopathologies (50%) than the more derived extinct taxa. To get a finer-grained picture, we scored each fossil for seven pathological indicators on a scale of 1-4. We estimated the average mass of each taxon using M1-3 length and compared mass to average pathological score for each category. We found that with increasing mass, osteopathology also significantly increases. We then ran a phylogenetically-controlled regression analysis using a time-calibrated phylogeny of our study taxa. Mass estimates were found to significantly covary with abnormal foramen shape and abnormal bone textures. This pattern in osteopathological expression may reflect a part of the complex system of adaptations in the Rhinocerotidae over millions of years, where increased mass, cursoriality, and/or increased life span are selected for, to the detriment of long-term bone health. This work has important implications for the future health of hoofed animals and humans alike.	[Stilson, Kelsey T.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Hopkins, Samantha S. B.; Davis, Edward Byrd] Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; [Hopkins, Samantha S. B.] Univ Oregon, Clark Honors Coll, Eugene, OR 97403 USA; [Davis, Edward Byrd] Univ Oregon, Museum Nat & Cultural Hist, Eugene, OR 97403 USA	University of Texas System; University of Texas Austin; University of Oregon; University of Oregon; University of Oregon	Stilson, KT (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	stilson@utexas.edu	Stilson, Kelsey Tull/AAY-4116-2021		University of Oregon Museum of Natural and Cultural History; University of Oregon Clark Honors College	University of Oregon Museum of Natural and Cultural History; University of Oregon Clark Honors College	This work was partially funded by the University of Oregon Museum of Natural and Cultural History and the University of Oregon Clark Honors College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, JMP VERS 10; Aufderheide AC, 1998, CAMBRIDGE ENCY HUMAN, DOI [10.1525/aa.2000.102.1.171, DOI 10.1525/AA.2000.102.1.171]; Bapst DW, 2013, METHODS ECOL EVOL, V4, P724, DOI 10.1111/2041-210X.12081; Bartosiewicz L, 1997, KONINKLIJK MUSEUM MI, V281, P147; Brandt KD, 2001, ATLAS OSTEOARTHRITIS; Burt N.M., 2013, IDENTIFICATION INTER; Cerdeno E, 1998, PALAEOGEOGR PALAEOCL, V141, P13, DOI 10.1016/S0031-0182(98)00003-0; Cerdeno Esperanza, 1995, American Museum Novitates, V3143, P1; Clauss M, 2009, COMP BIOCHEM PHYS A, V154, P376, DOI 10.1016/j.cbpa.2009.07.016; Damuth J., 1990, P229; DeSantis LRG, 2008, PALAEOGEOGR PALAEOCL, V266, P59, DOI 10.1016/j.palaeo.2008.03.032; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fortelius M., 2008, ZOOLOGICAL J LINNEAN, V108, P85, DOI [DOI 10.1111/J.1096-3642.1993.TB02560.X, 10.1111/j.1096-3642.1993.tb02560.x.]; FOX HERBERT, 1939, TRANS AMER PHIL SOC, V31, P73, DOI 10.2307/1005560; Galateanu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068493; Gems D, 2011, PHILOS T R SOC B, V366, P108, DOI 10.1098/rstb.2010.0288; Healy K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0298; Hooker Jeremy J., 2005, P199; Janis CM, 2002, PALAEOGEOGR PALAEOCL, V177, P183, DOI 10.1016/S0031-0182(01)00359-5; Janis CM, 1998, EVOLUTION TERTIARY M, V1, DOI [10.1017/CBO9780511529924, DOI 10.1017/CB09780511529924]; Lyman R.L., 2001, VERTEBRATE TAPHONOMY; Martin LD, 1993, PALEOPATHOLOGY DIS F, DOI [10.1002/ajhb.1310060322, DOI 10.1002/AJHB.1310060322]; Mendoza M, 2006, J ZOOL, V270, P90, DOI 10.1111/j.1469-7998.2006.00094.x; Mihlbachler Matthew C., 2007, Journal of Mammalian Evolution, V14, P217, DOI 10.1007/s10914-007-9048-4; OLeary M. A., 2012, MORPHOBANK 3 0 WEB A; Owen-Smith R. N., 1998, EMEGAHERBIVORES INFL, DOI [10.1017/CBO9780511565441, DOI 10.1017/CB09780511565441]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Prothero DR, 2005, EVOLUTION N AM RHINO, DOI [10.1017/S0016756806302051, DOI 10.1017/S0016756806302051]; Radinsky LB., 1967, AM MUS NOVIT, V2316, P1; Regnault S, 2013, J ZOO WILDLIFE MED, V44, P918, DOI 10.1638/2012-0277R1.1; Rogers J., 1995, FIELD GUIDE JOINT DI; Rothschild BM, 2001, CLIN EXP RHEUMATOL, V19, P628; RStudio, 2012, RSTUDIO INT DEV ENV; Schoch RM, 1989, EVOLUTION PERISSODAC, DOI [10.1016/0169-5347(90)90187-I, DOI 10.1016/0169-5347(90)90187-I]; Scott K.M., 1990, P301; SILBERMAN MS, 1979, J ZOO ANIM MED, V10, P6, DOI 10.2307/20094402; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Steuer P, 2011, COMP BIOCHEM PHYS A, V160, P355, DOI 10.1016/j.cbpa.2011.07.005; Tougard C, 2001, MOL PHYLOGENET EVOL, V19, P34, DOI 10.1006/mpev.2000.0903; VOORHIES MR, 1979, SCIENCE, V206, P331, DOI 10.1126/science.206.4416.331; Waldron T, 2009, PALEOPATHOLOGY, DOI [10.1002/ajhb.1310080303, DOI 10.1002/AJHB.1310080303]; WALLACH JD, 1967, J AM VET MED ASSOC, V151, P887	42	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146221	10.1371/journal.pone.0146221	http://dx.doi.org/10.1371/journal.pone.0146221			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840633	gold, Green Published			2022-12-27	WOS:000369550200007
J	Zhao, X; Vazquez-Gutierrez, JL; Johansson, DP; Landberg, R; Langton, M				Zhao, Xue; Vazquez-Gutierrez, Jose Luis; Johansson, Daniel P.; Landberg, Rikard; Langton, Maud			Yellow Mealworm Protein for Food Purposes - Extraction and Functional Properties	PLOS ONE			English	Article							NUTRIENT COMPOSITION; GELATION PROPERTIES; OIL; INSECTS; FEED	A protocol for extraction of yellow mealworm larvae proteins was established, conditions were evaluated and the resulting protein extract was characterised. The freeze-dried yellow mealworm larvae contained around 33% fat, 51% crude protein and 43% true protein on a dry matter basis. The true protein content of the protein extract was about 75%, with an extraction rate of 70% under optimised extraction conditions using 0.25 M NaOH, a NaOH solution: ethanol defatted worm ratio of 15: 1 mL/g, 40 degrees C for 1 h and extraction twice. The protein extract was a good source of essential amino acids. The lowest protein solubility in distilled water solution was found between pH 4 and 5, and increased with either increasing or decreasing pH. Lower solubility was observed in 0.5 M NaCl solution compared with distilled water. The rheological tests indicated that temperature, sample concentration, addition of salt and enzyme, incubation time and pH alterations influenced the elastic modulus of yellow mealworm protein extract (YMPE). These results demonstrate that the functional properties of YMPE can be modified for different food applications.	[Zhao, Xue; Vazquez-Gutierrez, Jose Luis; Johansson, Daniel P.; Landberg, Rikard; Langton, Maud] Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences	Zhao, X (corresponding author), Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden.	xue.zhao@slu.se	Vázquez-Gutiérrez, José L./M-6510-2015; Zhao, Xue/E-7033-2017	Vázquez-Gutiérrez, José L./0000-0003-1493-5539; Zhao, Xue/0000-0002-0211-3549; Langton, Maud/0000-0003-1565-6996; Johansson, Daniel/0000-0002-9677-8233	Swedish University of Agricultural Sciences; Swedish research council Formas; Swedish research council VR	Swedish University of Agricultural Sciences; Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish research council VR(Swedish Research Council)	The project was financially supported by Strategic research funding for young research leaders from Swedish University of Agricultural Sciences and salary of RL was funded by grants from the Swedish research council Formas and VR.	Aguilera JM, 2005, J FOOD ENG, V67, P3, DOI 10.1016/j.jfoodeng.2004.05.050; ALKAHTANI HA, 1993, CEREAL CHEM, V70, P619; AOAC, 1990, OFF METH AN ASS AN C; Azadmard-Damirchi S, 2008, J AM OIL CHEM SOC, V85, P13, DOI 10.1007/s11746-007-1170-1; Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Damodaran S., 1997, FOOD PROTEINS THEIR; FAO, 2013, REP FAO EXP CONS, P27; Ferreira-Dias S, 2003, GRASAS ACEITES, V54, P378; Finke MD, 2007, ZOO BIOL, V26, P105, DOI 10.1002/zoo.20123; Finke MD, 2015, ZOO BIOL, V34, P554, DOI 10.1002/zoo.21246; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; FINKEL AJ, 1948, PHYSIOL ZOOL, V21, P111, DOI 10.1086/physzool.21.2.30151989; Gauche C, 2010, LWT-FOOD SCI TECHNOL, V43, P214, DOI 10.1016/j.lwt.2009.08.009; GOULET G, 1978, NUTR REP INT, V18, P11; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Jones LD, 1972, J ZOO ANIM MED, V3, P34, DOI DOI 10.2307/20094161; Kwiatkowski JR, 2002, J AM OIL CHEM SOC, V79, P825, DOI 10.1007/s11746-002-0565-8; L'Hocine L, 2006, J FOOD SCI, V71, pC137, DOI 10.1111/j.1365-2621.2006.tb15609.x; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; LIN MJY, 1974, J FOOD SCI, V39, P368, DOI 10.1111/j.1365-2621.1974.tb02896.x; LIU HJ, 1995, J AOAC INT, V78, P736; Liu LH, 1998, J FOOD SCI, V63, P331; Lopez-Sanchez P, 2011, J SCI FOOD AGR, V91, P207, DOI 10.1002/jsfa.4168; Naik A, 2012, APPL BIOCHEM BIOTECH, V167, P1290, DOI 10.1007/s12010-012-9632-9; OZIMEK L, 1985, J FOOD SCI, V50, P1327, DOI 10.1111/j.1365-2621.1985.tb10469.x; Ramirez-Suarez JC, 2003, MEAT SCI, V65, P899, DOI 10.1016/S0309-1740(02)00297-8; SCHUT J, 1976, FOOD EMULSIONS, P385; Suliman Mashair A., 2006, PAK J NUTR, V5, P589; Sun XD, 2012, FOOD HYDROCOLLOID, V27, P394, DOI 10.1016/j.foodhyd.2011.11.001; Sun XD, 2011, J FOOD ENG, V107, P226, DOI 10.1016/j.jfoodeng.2011.06.019; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Wu LM, 2009, J FOOD COMPOS ANAL, V22, P242, DOI 10.1016/j.jfca.2008.10.022; Yi LY, 2013, FOOD CHEM, V141, P3341, DOI 10.1016/j.foodchem.2013.05.115; Zhang BuNing, 2009, Modern Applied Science, V3, P77	35	105	106	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147791	10.1371/journal.pone.0147791	http://dx.doi.org/10.1371/journal.pone.0147791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840533	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000369550200059
J	Halada, P; Brugger, D; Volc, J; Peterbauer, CK; Leitner, C; Haltrich, D				Halada, Petr; Brugger, Dagmar; Volc, Jindrich; Peterbauer, Clemens K.; Leitner, Christian; Haltrich, Dietmar			Oxidation of Phe454 in the Gating Segment Inactivates Trametes multicolor Pyranose Oxidase during Substrate Turnover	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; PROTEIN PHARMACEUTICALS; ENZYMATIC OXIDATION; CATALYZED REACTIONS; GLUCOSE-OXIDASE; 2-OXIDASE; OXYGEN; SUGARS; PURIFICATION; MECHANISMS	The flavin-dependent enzyme pyranose oxidase catalyses the oxidation of several pyranose sugars at position C-2. In a second reaction step, oxygen is reduced to hydrogen peroxide. POx is of interest for biocatalytic carbohydrate oxidations, yet it was found that the enzyme is rapidly inactivated under turnover conditions. We studied pyranose oxidase from Trametes multicolor (TmPOx) inactivated either during glucose oxidation or by exogenous hydrogen peroxide using mass spectrometry. MALDI-MS experiments of proteolytic fragments of inactivated TmPOx showed several peptides with a mass increase of 16 or 32 Da indicating oxidation of certain amino acids. Most of these fragments contain at least one methionine residue, which most likely is oxidised by hydrogen peroxide. One peptide fragment that did not contain any amino acid residue that is likely to be oxidised by hydrogen peroxide (DAFSYGAVQQSIDSR) was studied in detail by LC-ESI-MS/MS, which showed a +16 Da mass increase for Phe454. We propose that oxidation of Phe454, which is located at the flexible active-site loop of TmPOx, is the first and main step in the inactivation of TmPOx by hydrogen peroxide. Oxidation of methionine residues might then further contribute to the complete inactivation of the enzyme.	[Halada, Petr; Volc, Jindrich] Acad Sci Czech Republic, Inst Microbiol, Vvi, Videnska 1083, Prague, Czech Republic; [Brugger, Dagmar; Peterbauer, Clemens K.; Leitner, Christian; Haltrich, Dietmar] BOKU Univ Nat Resources & Life Sci Vienna, Food Biotechnol Lab, Vienna, Austria; [Brugger, Dagmar; Peterbauer, Clemens K.; Haltrich, Dietmar] BOKU Univ Nat Resources & Life Sci Vienna, Doctoral Programme BioToP Mol Biotechnol Prot, Vienna, Austria	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Haltrich, D (corresponding author), BOKU Univ Nat Resources & Life Sci Vienna, Food Biotechnol Lab, Vienna, Austria.; Haltrich, D (corresponding author), BOKU Univ Nat Resources & Life Sci Vienna, Doctoral Programme BioToP Mol Biotechnol Prot, Vienna, Austria.	dietmar.haltrich@boku.ac.at	Haltrich, Dietmar/N-2624-2019; Halada, Petr/H-3330-2014	Haltrich, Dietmar/0000-0002-8722-8176; Halada, Petr/0000-0002-7229-3450; Peterbauer, Clemens/0000-0002-8033-198X	BOKU University of Natural Resources and Life Sciences; Austrian Science Fund (FWF), Doctoral Programme BioToP-Biomolecular Technology of Proteins [FWF W1224]; programme for Scientific Technical Cooperation KONTAKT Austria-Czech Republic [MEB060910]; Institutional Research Project [RVO61388971]; Ministry of Education, Youth and Sports of the Czech Republic [LO1509]; Operational Program Prague - Competitiveness project [CZ.2.16/3.1.00/24023]; EU;  [FWF P22094]	BOKU University of Natural Resources and Life Sciences; Austrian Science Fund (FWF), Doctoral Programme BioToP-Biomolecular Technology of Proteins(Austrian Science Fund (FWF)); programme for Scientific Technical Cooperation KONTAKT Austria-Czech Republic; Institutional Research Project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Operational Program Prague - Competitiveness project; EU(European Commission); 	This work was funded by BOKU University of Natural Resources and Life Sciences (BOKU Doc Program), by the Austrian Science Fund (FWF), Doctoral Programme BioToP-Biomolecular Technology of Proteins (FWF W1224), the programme for Scientific Technical Cooperation KONTAKT Austria-Czech Republic (MEB060910), individual project FWF P22094 (to CKP), and by Institutional Research Project RVO61388971 (IMIC). The authors also gratefully acknowledge the support by the project LO1509 of the Ministry of Education, Youth and Sports of the Czech Republic and by Operational Program Prague - Competitiveness project (CZ.2.16/3.1.00/24023) supported by the EU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger D, 2014, BIOTECHNOL J, V9, P474, DOI 10.1002/biot.201300336; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Decamps K, 2012, FOOD CHEM, V131, P1485, DOI 10.1016/j.foodchem.2011.10.041; Freinbichler W, 2011, CELL MOL LIFE SCI, V68, P2067, DOI 10.1007/s00018-011-0682-x; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Giffhorn F, 2000, ENZYME MICROB TECH, V27, P734, DOI 10.1016/S0141-0229(00)00293-3; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Halada P, 2003, ANAL BIOCHEM, V314, P235, DOI 10.1016/S0003-2697(02)00661-9; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Kwon KY, 2014, ELECTROANAL, V26, P2075, DOI 10.1002/elan.201400170; Leitner C, 2002, APPL BIOCHEM BIOTECH, V98, P497, DOI 10.1385/ABAB:98-100:1-9:497; Leitner C, 2001, APPL ENVIRON MICROB, V67, P3636, DOI 10.1128/AEM.67.8.3636-3644.2001; Leitner C, 1998, BIOCATAL BIOTRANSFOR, V16, P365, DOI 10.3109/10242429809003629; Leitner C, 1998, APPL BIOCHEM BIOTECH, V70-2, P237, DOI 10.1007/BF02920140; LI SH, 1995, BIOTECHNOL BIOENG, V48, P490, DOI 10.1002/bit.260480511; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Maria G, 2012, J MOL CATAL B-ENZYM, V74, P209, DOI 10.1016/j.molcatb.2011.10.007; Pisanelli I, 2009, J BIOTECHNOL, V142, P97, DOI 10.1016/j.jbiotec.2009.03.019; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Savige W E, 1977, Methods Enzymol, V47, P453; Schneider K, 2012, BIOTECHNOL BIOENG, V109, P2941, DOI 10.1002/bit.24572; Spadiut O, 2009, FEBS J, V276, P776, DOI 10.1111/j.1742-4658.2008.06823.x; Spadiut O, 2010, FEBS J, V277, P2892, DOI 10.1111/j.1742-4658.2010.07705.x; Spadiut O, 2010, ELECTROANAL, V22, P813, DOI 10.1002/elan.200980015; Spadiut Oliver, 2009, Biotechnology Journal, V4, P525, DOI 10.1002/biot.200800260; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Swoboda M, 2012, ACS NANO, V6, P6364, DOI 10.1021/nn301895c; Tasca F, 2007, ELECTROANAL, V19, P294, DOI 10.1002/elan.200603740; Treitz G, 2001, J BIOTECHNOL, V85, P271, DOI 10.1016/S0168-1656(00)00371-0; Wongnate T, 2013, FEBS J, V280, P3009, DOI 10.1111/febs.12280	33	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148108	10.1371/journal.pone.0148108	http://dx.doi.org/10.1371/journal.pone.0148108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828796	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200062
J	Kiertiburanakul, S; Pinsai, S; Chantratita, W; Pasomsub, E; Leechawengwongs, M; Thipmontree, W; Siriyakorn, N; Sungkanuparph, S				Kiertiburanakul, Sasisopin; Pinsai, Subencha; Chantratita, Wasun; Pasomsub, Ekawat; Leechawengwongs, Manoon; Thipmontree, Wilawan; Siriyakorn, Nirada; Sungkanuparph, Somnuek			Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance Assay	PLOS ONE			English	Article							ANTIRETROVIRAL-NAIVE INDIVIDUALS; HIV-1-INFECTED PATIENTS; THRESHOLD SURVEY; SCALING-UP; MUTATIONS; THERAPY; IMPACT; EPIDEMIOLOGY; TRANSMISSION; INFECTION	Background HIV drug resistance (HIVDR) is the major cause of treatment failure after scaling up of anti-retroviral therapy (ART). HIVDR testing prior to ART initiation is not routinely performed in resource-limited settings. We aimed to assess the prevalence of primary HIVDR by short reverse transcriptase (RT) genotypic resistance assay and evaluate of the impact of the mutations on the treatment outcomes. Methods A prospective cohort study was conducted in treatment-naive HIV-infected patients. Fourteen major mutations of codon 99-191 on the RT gene were selected (K103N, V106A/M, V108I, Q151M, Y181C/I, M184V/I, Y188C/L/H, and G190S/A) at a cost of testing of 35 USD. The association between the presence of primary HIVDR and undetectable HIV RNA (< 50 copies/mL) after 6 months of ART was determined. Results A total of 265 HIV-infected patients were included, with a median age of 35.2 (range, 16.8-75.2) years; 62.6% were males. The median (interquartile range) CD4 cell count at ART initiation was 216 (77-381) cells/mm(3). The overall prevalence of primary HIVDR was 7.9%. The prevalence of each HIVDR mutation were K103N 6.0%, V106I 1.1%, V108I 0.4%, Y181C 2.3%, Y181I 0.7%, Y181V 0.4%, M184V 3.0%, M184I 1.5%, and G190A 2.3%. No associated factor of having primary HIVDR was determined. By multiple stepwise logistic regression, factors associated with undetectable HIV RNA after 6 months of ART were: having M184V/I (odds ratio [OR] 0.11; 95% confidence interval [CI] 0.02-0.62, p = 0.013), condom use (OR 2.38; 95% CI 1.12-5.06, p = 0.024), and adherence per 5% increase (OR 1.16; 95% CI 1.00-1.35, p = 0.044). Conclusions The prevalence of primary HIVDR is approximately 8%; it is associated with detectable HIV RNA at 6 months after ART initiation. Routine "short RT" genotypic resistance assay should be considered in resource-limited settings to maximize treatment outcome.	[Kiertiburanakul, Sasisopin; Pinsai, Subencha; Sungkanuparph, Somnuek] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Chantratita, Wasun; Pasomsub, Ekawat] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand; [Leechawengwongs, Manoon] Vichaiyut Hosp, Bangkok, Thailand; [Thipmontree, Wilawan; Siriyakorn, Nirada] Maharat Nakhon Ratchasima Hosp, Dept Med, Nakhon Ratchasima, Thailand	Mahidol University; Mahidol University	Kiertiburanakul, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand.	sasisopin.kie@mahidol.ac.th			Thai AIDS Society	Thai AIDS Society	Source of support: Thai AIDS Society (http://www.thaiaidssociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Division Bureau of AIDS TB and STIs, 2014, THAIL NAT GUID HIV A; Apisarnthanarak A, 2008, HIV MED, V9, P322, DOI 10.1111/j.1468-1293.2008.00562.x; Apisarnthanarak A, 2008, CLIN INFECT DIS, V46, P1630, DOI 10.1086/587753; Bansi L, 2010, JAIDS-J ACQ IMM DEF, V53, P633, DOI 10.1097/QAI.0b013e3181c070d2; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Booth C, 2006, ANTIRETROVIRAL RESIS; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; Chasombat Sanchai, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P704; Dai L, 2014, J ANTIVIR ANTIRETROV, V6; Frentz D, 2012, AIDS REV, V14, P17; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hong Steven Y., 2011, Infectious Disorders - Drug Targets, V11, P124; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Jongwutiwes U, 2007, CURR HIV RES, V5, P355, DOI 10.2174/157016207780636551; Kiertiburanakul S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062057; Kiertiburanakul S, 2009, CURR HIV RES, V7, P273, DOI 10.2174/157016209788347976; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Manosuthi W, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0053-z; Manosuthi W, 2013, J MED VIROL, V85, P194, DOI 10.1002/jmv.23452; Margot NA, 2009, JAIDS-J ACQ IMM DEF, V52, P209, DOI 10.1097/QAI.0b013e3181b05f7c; Nguyen HT, 2008, ANTIVIR THER, V13, P115; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Phanuphak P, 2014, JAIDS-J ACQ IMM DEF, V66, P74, DOI 10.1097/QAI.0000000000000108; Public Health Agency of Canada, PRIM HIV ANT DRUG RE; Shafer RW, 2008, ANTIVIR THER, V13, P59; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sirivichoyaku S, 2008, ANTIVIR THER, V13, P109; Sukasem C, 2007, JPN J INFECT DIS, V60, P284; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Sungkanuparph S, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-12; Sungkanuparph S, 2011, CLIN INFECT DIS, V52, P1053, DOI 10.1093/cid/cir107; Van Vaerenbergh K, 2001, Verh K Acad Geneeskd Belg, V63, P447; Vergne L, 2006, ANTIVIR THER, V11, P575; Wensing Annemarie M. J., 2003, AIDS Reviews, V5, P140; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organization, 2014, CONS GUID HIV PREV D; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147945	10.1371/journal.pone.0147945	http://dx.doi.org/10.1371/journal.pone.0147945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828876	gold, Green Published			2022-12-27	WOS:000369548200044
J	Marques-Neto, SR; Castiglione, RC; Pontes, A; Oliveira, DF; Ferraz, EB; Nascimento, JHM; Bouskela, E				Marques-Neto, Silvio Rodrigues; Castiglione, Raquel Carvalho; Pontes, Aiza; Oliveira, Dahienne Ferreira; Ferraz, Emanuelle Baptista; Matheus Nascimento, Jose Hamilton; Bouskela, Eliete			Effects of Incretin-Based Therapies on Neuro-Cardiovascular Dynamic Changes Induced by High Fat Diet in Rats	PLOS ONE			English	Article							MICROVASCULAR DYSFUNCTION; GLUCOSE; MITOCHONDRIA; INSULIN; OBESITY; LIRAGLUTIDE; SITAGLIPTIN	Background and Aims Obesity promotes cardiac and cerebral microcirculatory dysfunction that could be improved by incretin-based therapies. However, the effects of this class of compounds on neuro-cardiovascular system damage induced by high fat diet remain unclear. The aim of this study was to investigate the effects of incretin-based therapies on neuro-cardiovascular dysfunction induced by high fat diet in Wistar rats. Methods and Results We have evaluated fasting glucose levels and insulin resistance, heart rate variability quantified on time and frequency domains, cerebral microcirculation by intravital microscopy, mean arterial blood pressure, ventricular function and mitochondrial swelling. High fat diet worsened biometric and metabolic parameters and promoted deleterious effects on autonomic, myocardial and haemodynamic parameters, decreased capillary diameters and increased functional capillary density in the brain. Biometric and metabolic parameters were better improved by glucagon like peptide-1 (GLP-1) compared with dipeptdyl peptidase-4 (DPP-4) inhibitor. On the other hand, both GLP-1 agonist and DPP-4 inhibitor reversed the deleterious effects of high fat diet on autonomic, myocardial, haemodynamic and cerebralmicrovascular parameters. GLP-1 agonist and DPP-4 inhibitor therapy also increased mitochondrial permeability transition pore resistance in brain and heart tissues of rats subjected to high fat diet. Conclusion Incretin-based therapies improve deleterious cardiovascular effects induced by high fat diet and may have important contributions on the interplay between neuro-cardiovascular dynamic controls through mitochondrial dysfunction associated to metabolic disorders.	[Marques-Neto, Silvio Rodrigues; Castiglione, Raquel Carvalho; Pontes, Aiza; Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil; [Oliveira, Dahienne Ferreira; Ferraz, Emanuelle Baptista; Matheus Nascimento, Jose Hamilton] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Cardiac Electrophysiol Lab, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Marques-Neto, SR (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil.	marquesilvio@gmail.com	Nascimento, Jose Hamilton/L-3722-2018	Nascimento, Jose Hamilton/0000-0001-7052-254X; Marques-Neto, Silvio/0000-0001-5742-4646; Ferreira de Oliveira, Dahienne/0000-0002-8104-9476	National Research Council (CNPq) [474116/2008-5]; Research Supporting Agency of Rio de Janeiro State (FAPERJ) [E-26/111.732/2011]; Coordination for the Improvement of Higher Education Personnel (CAPES)	National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Supporting Agency of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from the National Research Council (CNPq - 474116/2008-5), the Research Supporting Agency of Rio de Janeiro State (FAPERJ - E-26/111.732/2011) and Coordination for the Improvement of Higher Education Personnel (CAPES). Further information concerning those agencies can be found at the following URLs: CNPq: http //www.cnpq.br http://www.cnpq.br/web/guest/, FAPERJ: http://www.faperj.br/, CAPES: http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Burcelin R, 2010, DIABETES METAB, V36, pS54, DOI 10.1016/S1262-3636(10)70468-7; Burcelin R, 2014, PHYSIOLOGY, V29, P108, DOI 10.1152/physiol.00009.2013; De Boer MP, 2012, MICROCIRCULATION, V19, P5, DOI 10.1111/j.1549-8719.2011.00130.x; DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI 10.1185/03007990802418851 ; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Li WG, 2013, AM J PHYSIOL-REG I, V304, pR1001, DOI 10.1152/ajpregu.00523.2012; Maranhao PA, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-32; Neto SRM, 2013, ACTA PHYSIOL, V208, P166, DOI 10.1111/apha.12056; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Nakabayashi H, 1996, AM J PHYSIOL-ENDOC M, V271, pE808, DOI 10.1152/ajpendo.1996.271.5.E808; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Pannacciulli P, 2007, NEUROIMAGE, V86, P573; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Rowell LB, 1993, HUMAN CARDIOVASCULAR, P268; Serne EH, 2007, HYPERTENSION, V50, P204, DOI 10.1161/HYPERTENSIONAHA.107.089680; Shah GN, 2013, BIOCHEM BIOPH RES CO, V440, P354, DOI 10.1016/j.bbrc.2013.09.086; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Sivitz WI, 2010, US ENDOCRINOL, V6, P20, DOI [10.17925/USE.2010.06.1.20, DOI 10.17925/USE.2010.06.1.20]; Torekov SS, 2011, OBES REV, V12, P593, DOI 10.1111/j.1467-789X.2011.00860.x; Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958; van Raalte DH, 2013, DIABETOLOGIA, V56, P2383, DOI 10.1007/s00125-013-3016-8	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148402	10.1371/journal.pone.0148402	http://dx.doi.org/10.1371/journal.pone.0148402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828649	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200098
J	Minick, SG; Stafford, CL; Kertz, BL; Cully, JA; Stanley, MA; Davila, JA; Dang, BN; Rodriguez-Barradas, MC; Giordano, TP				Minick, Sophie G.; Stafford, Crystal L.; Kertz, Barbara L.; Cully, Jeffery A.; Stanley, Melinda A.; Davila, Jessica A.; Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.			Veterans' Perspectives on Interventions to Improve Retention in HIV Care	PLOS ONE			English	Article							CASE-MANAGEMENT; ENGAGEMENT; ADHERENCE; CONTINUUM; HIV/AIDS; SERVICES; OUTCOMES; PROGRAM	Poor retention in HIV medical care is associated with increased mortality among patients with HIV/AIDS. Developing new interventions to improve retention in HIV primary care is needed. The Department of Veteran Affairs (VA) is the largest single provider of HIV care in the US. We sought to understand what veterans would want in an intervention to improve retention in VA HIV care. We conducted 18 one-on-one interviews and 15 outpatient focus groups with 46 patients living with HIV infection from the Michael E. DeBakey VAMC (MEDVAMC). Analysis identified three focus areas for improving retention in care: developing an HIV friendly clinic environment, providing mental health and substance use treatment concurrent with HIV care and encouraging peer support from other Veterans with HIV.	[Minick, Sophie G.; Stafford, Crystal L.; Cully, Jeffery A.; Stanley, Melinda A.; Davila, Jessica A.; Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Baylor Coll Med, Houston Ctr Innovat Qual Safety & Effectiveness, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Kertz, Barbara L.] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Giordano, TP (corresponding author), Baylor Coll Med, Houston Ctr Innovat Qual Safety & Effectiveness, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.	tpg@bcm.tcm.edu		Giordano, Thomas/0000-0002-9346-5530	Department of Veterans Affiars Health Services and Development (VA HSRD) [IBB 09-033]; National Institutes of Health [R01 MH085527-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085527] Funding Source: NIH RePORTER	Department of Veterans Affiars Health Services and Development (VA HSRD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Department of Veterans Affiars Health Services and Development (VA HSR&D) grant IBB 09-033 and National Institutes of Health (R01 MH085527-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TP Giordano is a researcher at the Center for Innovations in Quality, Safety and Effectiveness at the Michael E. DeBakey VA Medical Center, Houston, TX.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Braverman J, 2008, COMMUN RES, V35, P666, DOI 10.1177/0093650208321785; Byrd KK, 2015, AIDS CARE, V27, P1387, DOI 10.1080/09540121.2015.1114991; Chinman C, 2012, PEER SPECIALIST TOOL; Chinman M, 2015, J BEHAV HEALTH SER R, V42, P109, DOI 10.1007/s11414-013-9343-1; Clarke G N, 2000, Ment Health Serv Res, V2, P155, DOI 10.1023/A:1010141826867; Cully JA, 2012, AIDS PATIENT CARE ST, V26, P165, DOI 10.1089/apc.2011.0248; Dang BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054729; Dang BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042980; Davila JA, 2013, AIDS CARE, V25, P202, DOI 10.1080/09540121.2012.689811; Department of Veteran Affairs, 2011, DEPARTMENT OF VETERA; Dodds S, 2004, PUBLIC HEALTH REP, V119, P48, DOI 10.1177/003335490411900111; Doshi RK, 2015, CLIN INFECT DIS, V60, P117, DOI 10.1093/cid/ciu722; Gardner LI, 2014, CLIN INFECT DIS, V59, P725, DOI 10.1093/cid/ciu357; Gardner LI, 2012, CLIN INFECT DIS, V55, P1124, DOI 10.1093/cid/cis623; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Kaaya S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001447; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Krippendorff K., 1989, INT ENCY COMMUNICATI, V1; Morgan DL, 1997, FOCUS GROUPS QUALITA, P7; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; O'Donnell M, 1999, AUST NZ J PSYCHIAT, V33, P684, DOI 10.1046/j.1440-1614.1999.00629.x; Rajabiun S, 2007, AIDS PATIENT CARE ST, V21, pS20, DOI 10.1089/apc.2007.9990; Rivera JJ, 2007, PSYCHIAT SERV, V58, P802, DOI 10.1176/appi.ps.58.6.802; Sells D, 2006, PSYCHIAT SERV, V57, P1179, DOI 10.1176/appi.ps.57.8.1179; Sherer R, 2002, AIDS CARE, V14, pS31, DOI 10.1080/09540120220149975; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; SOLOMON P, 1995, J MENT HEALTH ADMIN, V22, P135, DOI 10.1007/BF02518754; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tobias C, 2007, AIDS PATIENT CARE ST, V21, pS3, DOI 10.1089/apc.2007.9992; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148163	10.1371/journal.pone.0148163	http://dx.doi.org/10.1371/journal.pone.0148163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26829641	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200074
J	Wyshak, G				Wyshak, Grace			Income and Subjective Well-Being: New Insights from Relatively Healthy American Women, Ages 49-79	PLOS ONE			English	Article							RELIGION	The interests of economists, psychologists, social scientists and others on the relations of income, demographics, religion and subjective well-being, have generated a vast global literature. It is apparent that biomedical research has focused on white with men. The Women's Health Initiative and Observational Study (WHI OS) was initiated in 1992. The OS represents the scientific need for social priorities to improve the health and welfare of women; it includes 93.676 relatively healthy postmenopausal women, 49 to 79, from diverse backgrounds. The objective of this study is to examine how lifestyle and other factors influence women's health. Data from the WHI OS questionnaire were analyzed. Statistical methods included descriptive statistics square, correlations, linear regression and analyses of covariance (GLM). New findings and insights relate primarily to general health, religion, club attendance, and likelihood of depression. The most important predictor of excellent or very good health is quality of life and general health is a major predictor of quality of life. A great deal of strength and comfort from religion was reported by 62.98% of the women, with little variation by denomination. More from religion related to poorer health, and less likelihood of depression. Religion and lower income are in accord with of across country studies. Attendance at clubs was associated with religion and with all factors associated with religion, except income. Though general health and likelihood of depression are highly correlated, better health is associated with higher income; however, likelihood of depression is not associated with income-contrary to conventional wisdom about socioeconomic disparities and mental health. Subjective well-being variables, with the exception of quality of life, were not associated with income. Social networks-religion and clubs-among a diverse population, warrant further attention from economists, psychologists, sociologists, and others.	[Wyshak, Grace] Harvard Univ, Sch Med, Cambridge Hosp, Boston, MA USA; [Wyshak, Grace] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Wyshak, G (corresponding author), Harvard Univ, Sch Med, Cambridge Hosp, Boston, MA USA.; Wyshak, G (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	Wyshak@hsph.harvard.edu						[Anonymous], 2000, WOM HLTH NIH HAS INC; [Anonymous], 2014, SAS 9 3 AN SYST; Barro RJ, 2003, AM SOCIOL REV, V68, P760, DOI 10.2307/1519761; Cantril H., 1965, PATTERN HUMAN CONCER; Diener E, 2011, J PERS SOC PSYCHOL, V101, P1278, DOI 10.1037/a0024402; Easterlin R. A., 1974, NATIONS HOUSEHOLDS E, P89, DOI [DOI 10.1016/B978-0-12-205050-3.50008-7, 10.1016/b978-0-12-205050-3.50008-7]; Easterlin RA, 2010, P NATL ACAD SCI USA, V107, P22463, DOI 10.1073/pnas.1015962107; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Maselko J, 2011, SOC SCI MED, V73, P759, DOI 10.1016/j.socscimed.2011.06.019; McDowell I., 1996, MEASURING HLTH GUIDE; Rossouw J E, 1995, J Am Med Womens Assoc (1972), V50, P50; Vijayamohanan PN, 2013, OBJECTIVIZING SUBJEC, V1; Ware JE, 1979, RAND CORP MENT HLTH; Wilson WR, 1960, THESIS NW U; Wyshak G, 2013, SCAND J PUBLIC HEALT, V41, P230, DOI 10.1177/1403494812470508	16	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146303	10.1371/journal.pone.0146303	http://dx.doi.org/10.1371/journal.pone.0146303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828901	gold, Green Published			2022-12-27	WOS:000369548200006
J	Bach, M; Schafer, K				Bach, Michael; Schaefer, Kerstin			Visual Acuity Testing: Feedback Affects Neither Outcome nor Reproducibility, but Leaves Participants Happier	PLOS ONE			English	Article							TASK	Assessment of visual acuity is a well standardized procedure at least for expert opinions and clinical trials. It is often recommended not giving patients feedback on the correctness of their responses. As this viewpoint has not been quantitatively examined so far, we quantitatively assessed possible effects of feedback on visual acuity testing. In 40 normal participants we presented Landolt Cs in 8 orientations using the automated Freiburg Acuity Test (FrACT, <michaelbach.de/fract. Over a run comprising 24 trials, the acuity threshold was measured with an adaptive staircase procedure. In an ABCDDCBA scheme, trial-by-trial feedback was provided in 2 x 4 conditions: (A) no feedback, (B) acoustic signals indicating correctness, (C) visual indication of correct orientation, and (D) a combination of (B) and (C). After each run the participants judged comfort. Main outcome measures were absolute visual acuity (logMAR), its test-retest agreement (limits of agreement) and participants' comfort estimates on a 5-step symmetric Likert scale. Feedback influenced acuity outcome significantly (p = 0.02), but with a tiny effect size: 0.02 logMAR poorer acuity for (D) compared to (A), even weaker effects for (B) and (C). Test-retest agreement was high (limits of agreement: +/- 1.0 lines) and did not depend on feedback (p>0.5). The comfort ranking clearly differed, by 2 steps on the Likert scale: the condition (A)-no feedback-was on average "slightly uncomfortable", the other three conditions were "slightly comfortable" (p<0.0001). Feedback affected neither reproducibility nor the acuity outcome to any relevant extent. The participants, however, reported markedly greater comfort with any kind of feedback. We conclude that systematic feedback (as implemented in FrACT) offers nothing but advantages for routine use.	[Bach, Michael; Schaefer, Kerstin] Univ Freiburg, Med Ctr, Electrophysiol Eye Ctr, Sect Visual Funct, Killianstr 5, D-79106 Freiburg, Germany	University of Freiburg	Bach, M (corresponding author), Univ Freiburg, Med Ctr, Electrophysiol Eye Ctr, Sect Visual Funct, Killianstr 5, D-79106 Freiburg, Germany.	michael.bach@uni-freiburg.de	Bach, Michael/A-6637-2010	Bach, Michael/0000-0003-2028-535X				American National Standards Institute and Optical Laboratories Association, 2004, AM NAT STAND OPHTH I; ARDITI A, 1993, INVEST OPHTH VIS SCI, V34, P120; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bach M, 2009, HOMEPAGE FREIBURG VI; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; Fahle M, 2002, PERCEPTUAL LEARNING; Goldhacker M, 2014, VISION RES, V99, P99, DOI 10.1016/j.visres.2013.11.010; Heinrich SP, 2011, GRAEF ARCH CLIN EXP, V249, P1319, DOI 10.1007/s00417-011-1675-z; Herzog MH, 1997, VISION RES, V37, P2133, DOI 10.1016/S0042-6989(97)00043-6; International Council of Ophthalmology, 1984, VIS AC MEAS STAND; International Organization for Standardization, 2009, 85962009 ISO; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kingdom FAA, 2009, PSYCHOPHYSICS PRACTI; Li JR, 2015, VISION RES, V114, P161, DOI 10.1016/j.visres.2015.01.017; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; R Development Core Team, 2014, R LANG ENV STAT COMP; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; World Medical Association, 2008, DECL HELS ETH PRINC	23	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147803	10.1371/journal.pone.0147803	http://dx.doi.org/10.1371/journal.pone.0147803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824693	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600062
J	Hampson, L; Maranga, IO; Masinde, MS; Oliver, AW; Batman, G; He, XT; Desai, M; Okemwa, PM; Stringfellow, H; Martin-Hirsch, P; Mwaniki, AM; Gichangi, P; Hampson, IN				Hampson, Lynne; Maranga, Innocent O.; Masinde, Millicent S.; Oliver, Anthony W.; Batman, Gavin; He, Xiaotong; Desai, Minaxi; Okemwa, Parmenas M.; Stringfellow, Helen; Martin-Hirsch, Pierre; Mwaniki, Alex M.; Gichangi, Peter; Hampson, Ian N.			A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HIV PROTEASE INHIBITORS; INTRAEPITHELIAL NEOPLASIA; CANCER; EFFICACY; PERFORMANCE; EXPRESSION; MANAGEMENT; THERAPY; SAFETY	Background Cervical cancer is the most common female malignancy in the developing nations and the third most common cancer in women globally. An effective, inexpensive and self-applied topical treatment would be an ideal solution for treatment of screen-detected, pre-invasive cervical disease in low resource settings. Methods Between 01/03/2013 and 01/08/2013, women attending Kenyatta National Hospital's Family Planning and Gynaecology Outpatients clinics were tested for HIV, HPV (Cervista1) and liquid based cervical cytology (LBC - ThinPrep (R)). HIV negative women diagnosed as high-risk HPV positive with high grade squamous intraepithelial lesions (HSIL) were examined by colposcopy and given a 2 week course of 1 capsule of Lopimune (CIPLA) twice daily, to be self-applied as a vaginal pessary. Colposcopy, HPV testing and LBC were repeated at 4 and 12 weeks post-start of treatment with a final punch biopsy at 3 months for histology. Primary outcome measures were acceptability of treatment with efficacy as a secondary consideration. Results A total of 23 women with HSIL were treated with Lopimune during which time no adverse reactions were reported. A maximum concentration of 10 ng/ml of lopinavir was detected in patient plasma 1 week after starting treatment. HPV was no longer detected in 12/23 (52.2%, 95% CI: 30.6-73.2%). Post-treatment cytology at 12 weeks on women with HSIL, showed 14/22 ( 63.6%, 95% CI: 40.6-82.8%) had no dysplasia and 4/22 (18.2%, 95% CI: 9.9-65.1%) were now low grade demonstrating a combined positive response in 81.8% of women of which 77.8% was confirmed by histology. These data are supported by colpo-scopic images, which show regression of cervical lesions. Conclusions These results demonstrate the potential of Lopimune as a self-applied therapy for HPV infection and related cervical lesions. Since there were no serious adverse events or detectable post-treatment morbidity, this study indicates that further trials are clearly justified to define optimal regimes and the overall benefit of this therapy.	[Hampson, Lynne; Oliver, Anthony W.; Batman, Gavin; He, Xiaotong; Hampson, Ian N.] Univ Manchester, Viral Oncol Labs, Inst Canc Sci, St Marys Hosp, Res Floor 5,Oxford Rd, Manchester M13 9WL, Lancs, England; [Maranga, Innocent O.] Kenyatta Natl Hosp, Dept Reprod Hlth, POB 20723-00202, Nairobi, Kenya; [Maranga, Innocent O.; Masinde, Millicent S.; Okemwa, Parmenas M.; Mwaniki, Alex M.; Gichangi, Peter] Univ Nairobi, Coll Hlth Sci, Dept Gynaecol, POB 19676-00202, Nairobi, Kenya; [Maranga, Innocent O.; Masinde, Millicent S.; Okemwa, Parmenas M.; Mwaniki, Alex M.; Gichangi, Peter] Univ Nairobi, Coll Hlth Sci, Dept Pathol, POB 19676-00202, Nairobi, Kenya; [Desai, Minaxi] Cent Manchester Univ Hosp NHS Trust, Cytol Labs, POB 208,Clinical Sci Bldg 2,Oxford Rd, Manchester M13 9WW, Lancs, England; [Stringfellow, Helen] Royal Preston Hosp, Dept Pathol, Sharoe Green Lane, Preston PR2 9HT, Lancs, England; [Martin-Hirsch, Pierre] Royal Preston Hosp, Dept Obstet & Gynaecol, Sharoe Green Lane, Preston PR2 9HT, Lancs, England	University of Manchester; Kenyatta National Hospital; University of Nairobi; University of Nairobi; Royal Preston Hospital; Royal Preston Hospital	Hampson, IN (corresponding author), Univ Manchester, Viral Oncol Labs, Inst Canc Sci, St Marys Hosp, Res Floor 5,Oxford Rd, Manchester M13 9WL, Lancs, England.	ian.hampson@manchester.ac.uk		Hampson, Lynne/0000-0002-0656-0127	Janice Cholerton Research Fund/East Africa Medical Trust (EAMT); Caring Cancer Trust	Janice Cholerton Research Fund/East Africa Medical Trust (EAMT); Caring Cancer Trust	This study was primarily funded by Mr. Ken Cholerton from the Janice Cholerton Research Fund/East Africa Medical Trust (EAMT) and the Caring Cancer Trust, http://www.caringcancertrust.com/. Other contributors were: The Cancer Prevention Research Trust (http://www.cancerpreventionresearch.co.uk/), Quest Cancer Research, The Humane Research Trust (http://www.humaneresearch.org.uk/), and United-in-Cancer Charitable Trust. The authors would also like to thank the following: Hologic Inc for the loan of diagnostic equipment plus set-up maintenance and running costs; Central Manchester Foundation NHS Trust for the donation of two electro-diathermy units; Lancashire Teaching Hospitals NHS Trust for the donation of two colposcopes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RD, 2003, CANCER EPIDEM BIOMAR, V12, P114; Barillari G, 2012, AIDS, V26, P909, DOI 10.1097/QAD.0b013e328351f7a5; Batman G, 2011, FUTURE VIROL, V6, P1021, DOI 10.2217/FVL.11.75; Batman G, 2011, ANTIVIR THER, V16, P515, DOI 10.3851/IMP1786; Bernard HU, 2004, J ANTIMICROB CHEMOTH, V53, P137, DOI 10.1093/jac/dkh023; Bernstein WB, 2008, CURR OPIN HIV AIDS, V3, P666, DOI 10.1097/COH.0b013e328313915d; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chen FP, 2013, TAIWAN J OBSTET GYNE, V52, P475, DOI 10.1016/j.tjog.2013.10.004; Chow WA, 2009, LANCET ONCOL, V10, P61, DOI 10.1016/S1470-2045(08)70334-6; Day SP, 2009, J CLIN VIROL, V45, pS63, DOI 10.1016/S1386-6532(09)70010-1; Djerada Z, 2013, J PHARMACEUT BIOMED, V86, P100, DOI 10.1016/j.jpba.2013.08.002; Hampson L, 2006, ANTIVIR THER, V11, P813; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kwara A, 2008, CLIN INFECT DIS, V46, P719, DOI 10.1086/527387; Lahiri CD, 2015, J ACQUIR IMMUNE DEFI; Lin CT, 2012, TAIWAN J OBSTET GYNE, V51, P533, DOI 10.1016/j.tjog.2012.09.006; Lindeque BG, 2005, BEST PRACT RES CL OB, V19, P545, DOI 10.1016/j.bpobgyn.2005.02.008; Maranga Innocent O, 2013, Open Virol J, V7, P19, DOI 10.2174/1874357901307010019; Martin-Hirsch PL, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001318; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Pasley MV, 2013, AIDS REV, V15, P38; Passmore Jo-Ann S, 2007, J Inflamm (Lond), V4, P8, DOI 10.1186/1476-9255-4-8; PRENDIVILLE W, 1989, BRIT J OBSTET GYNAEC, V96, P1054, DOI 10.1111/j.1471-0528.1989.tb03380.x; Rahangdale L, 2013, AM J OBSTET GYNECOL, V210, P314, DOI DOI 10.1016/J.AJ0G.2013.12.042; Sankaranarayanan R, 2003, INT J CANCER, V106, P404, DOI 10.1002/ijc.11245; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Schlecht NF, 2003, JNCI-J NATL CANCER I, V95, P1336, DOI 10.1093/jnci/djg037; Stern PL, 2012, VACCINE, V30, pF71, DOI 10.1016/j.vaccine.2012.05.091; Tao XH, 2014, PHOTODIAGN PHOTODYN, V11, P104, DOI 10.1016/j.pdpdt.2014.02.012; Temmerman M, 1999, INT J GYNECOL OBSTET, V65, P171, DOI 10.1016/S0020-7292(99)00043-0; Van Pachterbeke C, 2009, GYNECOL ONCOL, V115, P69, DOI 10.1016/j.ygyno.2009.06.042; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wright TC, 2014, INT J CANCER, V134, P1835, DOI 10.1002/ijc.28514; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	35	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147917	10.1371/journal.pone.0147917	http://dx.doi.org/10.1371/journal.pone.0147917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824902	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000369528600073
J	Chen, SC; Lee, WH; Hsu, PC; Lee, CS; Lee, MK; Yen, HW; Lin, TH; Voon, WC; Lai, WT; Sheu, SH; Su, HM				Chen, Szu-Chia; Lee, Wen-Hsien; Hsu, Po-Chao; Lee, Chee-Siong; Lee, Meng-Kuang; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung; Su, Ho-Ming			Association of the Ratio of Early Mitral Inflow Velocity to the Global Diastolic Strain Rate with a Rapid Renal Function Decline in Atrial Fibrillation	PLOS ONE			English	Article							INDEX-BEAT; ECHOCARDIOGRAPHIC PARAMETERS; CARDIAC OUTCOMES; FILLING PRESSURE; ANNULUS VELOCITY; WAVE VELOCITY; VALIDATION; CREATININE; GUIDELINES; MANAGEMENT	The ratio of early mitral inflow velocity (E) to the global diastolic strain rate (E'sr) has been correlated with left ventricular filling pressure and predicts adverse cardiac outcomes in atrial fibrillation (AF). The relationship between the E/E'sr ratio and renal outcomes in AF has not been evaluated. This study examined the ability of the E/E'sr ratio in predicting progression to the renal endpoint, which is defined as a >= 25% decline in the estimated glomerular filtration rate in patients with AF. Comprehensive echocardiography was performed on 149 patients with persistent AF, and E'sr was assessed from three standard apical views using the index beat method. During a median follow-up period of 2.3 years, 63 patients (42.3%) were reaching the renal endpoint. Multivariate analysis showed that an increased E/E'sr ratio (per 10 cm) (hazard ratio, 1.230; 95% confidence interval, 1.088 to 1.391; p = 0.001) was associated with an increased renal endpoint. In a direct comparison, the E/E'sr ratio outperformed the ratio of E to early diastolic mitral annular velocity (E') in predicting progression to the renal endpoint in both univariate and multivariate models (p <= 0.039). Moreover, adding the E/E'sr ratio to a clinical model and echocardiographic parameters provided an additional benefit in the prediction of progression to the renal endpoint (p = 0.006). The E/E'sr ratio is a useful parameter and is stronger than the E/E' ratio in predicting the progression to the renal endpoint, and it may offer an additional prognostic benefit over conventional clinical and echocardiographic parameters in patients with AF.	[Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Lee, Wen-Hsien; Hsu, Po-Chao; Lee, Chee-Siong; Lee, Meng-Kuang; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung; Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Chen, Szu-Chia; Lee, Wen-Hsien; Lee, Meng-Kuang; Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Lee, Wen-Hsien; Hsu, Po-Chao; Lee, Chee-Siong; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung; Su, Ho-Ming] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.; Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Su, HM (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan.	cobeshm@seed.net.tw	蘇, 河名/AAE-9843-2019	Su, Ho-Ming/0000-0003-0247-3250; Lin, Tsung-Hsien/0000-0002-7226-8730				Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; Chen SC, 2013, NEPHRON CLIN PRACT, V123, P52, DOI 10.1159/000351513; Chen SC, 2012, NEPHROL DIAL TRANSPL, V27, P1064, DOI 10.1093/ndt/gfr407; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Chen SC, 2011, HYPERTENS RES, V34, P1052, DOI 10.1038/hr.2011.95; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dokainish H, 2008, AM J CARDIOL, V101, P1504, DOI 10.1016/j.amjcard.2008.01.037; Feinberg WM, 1997, STROKE, V28, P1101, DOI 10.1161/01.STR.28.6.1101; Ford ML, 2010, HYPERTENSION, V55, P1110, DOI 10.1161/HYPERTENSIONAHA.109.143024; Furukawa M, 2011, NEPHRON CLIN PRACT, V117, pC341, DOI 10.1159/000321512; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Govindan M, 2011, J AM SOC ECHOCARDIOG, V24, P1141, DOI 10.1016/j.echo.2011.07.002; Guo YT, 2013, INT J CARDIOL, V168, P4678, DOI 10.1016/j.ijcard.2013.07.179; Hsiao SH, 2011, CIRC J, V75, P1942, DOI 10.1253/circj.CJ-11-0033; Hsu PC, 2014, J AM SOC ECHOCARDIOG, V27, P717, DOI 10.1016/j.echo.2014.03.011; Kimura K, 2012, ECHOCARDIOGR-J CARD, V29, P404, DOI 10.1111/j.1540-8175.2011.01587.x; Kusunose K, 2012, J AM SOC ECHOCARDIOG, V25, P953, DOI 10.1016/j.echo.2012.06.009; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee CS, 2012, J AM SOC ECHOCARDIOG, V25, P945, DOI 10.1016/j.echo.2012.06.006; Lee WH, 2015, INT J MED SCI, V12, P618, DOI 10.7150/ijms.11924; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Sohn DW, 1999, J AM SOC ECHOCARDIOG, V12, P927, DOI 10.1016/S0894-7317(99)70145-8; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882	25	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147446	10.1371/journal.pone.0147446	http://dx.doi.org/10.1371/journal.pone.0147446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820304	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528400029
J	Clements, J; Schoville, S; Peterson, N; Lan, Q; Groves, RL				Clements, Justin; Schoville, Sean; Peterson, Nathan; Lan, Que; Groves, Russell L.			Characterizing Molecular Mechanisms of Imidacloprid Resistance in Select Populations of Leptinotarsa decemlineata in the Central Sands Region of Wisconsin	PLOS ONE			English	Article							COLORADO POTATO BEETLE; RNA-SEQ; NEONICOTINOID INSECTICIDES; CROSS-RESISTANCE; OVER-EXPRESSION; COLEOPTERA	The Colorado potato beetle, Leptinotarsa decemlineata (Say), is a major agricultural pest in the Central Sands region of Wisconsin. Imidacloprid, a neonicotinoid insecticide, has commonly been used for control of L. decemlineata since its registration in 1995. In the last 10 years, many field populations of L. decemlineata have begun to show increasing imidacloprid resistance. We studied resistance phenotype as a phenomenon that reduces neonicotinoid efficacy and has practical consequences for potato pest management. Although we have not observed complete field failure following the use of these products, multiple studies have demonstrated that the lethal concentration to kill 50% of the test organisms (LC50) in different field populations of L. decemlineata varies greatly which may suggest that resistance of L. decemlineata is heritable and involves genetic changes. An important challenge in understanding resistance is assessing the genetic mechanisms associated with resistance and classifying up-regulated genes that may be involved in combating an insecticide insult. In this study we uncovered trends in imidacloprid phenotypic response that have developed in the region by estimating the LC50 values among different field populations against a range of imidacloprid doses. The LC50 values collected in 2008-2011, and more recently in 2013 and 2014, show that some field locations remain susceptible to imidacloprid, while nearby fields (<100km) have developed high levels of resistance. We also sought to uncover potential mechanisms of resistance at each field location. We compiled a transcriptome for populations, characterized as phenotypically 'susceptible' and 'resistant', by isolating mRNA from adult beetles and analyzing gene expression level differences. Strong differences were observed in constituently up and down-regulated genes among different field populations. Most significantly, the up-regulation of 3 cytochrome p450s and a glutathione synthetase related protein in multiple resistant populations provide a mechanistic explanation of resistance evolution in L. decemlineata.	[Clements, Justin; Schoville, Sean; Peterson, Nathan; Lan, Que; Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Groves, RL (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	groves@entomology.wisc.edu	Schoville, Sean D./J-8061-2012; Clements, Justin/Q-6248-2018; Schoville, Sean D./AAY-5324-2020	Schoville, Sean D./0000-0001-7364-434X; Clements, Justin/0000-0001-5482-7984; Schoville, Sean D./0000-0001-7364-434X	Wisconsin Potato Industry Board; National Potato Council's State Cooperative Research Program; University of Wisconsin	Wisconsin Potato Industry Board; National Potato Council's State Cooperative Research Program; University of Wisconsin	This research was partially supported by a combination of funding from the: (1) Wisconsin Potato Industry Board, (2) National Potato Council's State Cooperative Research Program FY11-13, and (3) University of Wisconsin, Hatch Formula 142 Funds.	Alyokhin A, 2006, AM J POTATO RES, V83, P485, DOI 10.1007/BF02883509; Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; Casida JE, 2011, NEONICOTINOID METABO, P2923; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Fox J, 2004, GETTING STARTED R CO, P1; Geer LY, 2009, NUCL ACIDS RES S1, V38, P492; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huseth AS, 2013, J ECON ENTOMOL, V106, P2491, DOI 10.1603/EC13277; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Kennedy C.J., 2013, ENVIRON TOXICOL, P689, DOI DOI 10.1007/978-1-4614-5764-0_23; KUMAR A, 2014, PLOS ONE, V9; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Mota-Sanchez D, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P32, DOI 10.1079/9781845933531.0032; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAS Institute, 2011, SAS STAT 9 3 US GUID; Sexson DL, 2005, J ECON ENTOMOL, V98, P716, DOI 10.1603/0022-0493-98.3.716; Szendrei Z, 2012, PEST MANAG SCI, V68, P941, DOI 10.1002/ps.3258; Tao T, 2008, STANDALONE BLAST SET, P1; Tomizawa M, 2009, ACCOUNTS CHEM RES, V42, P260, DOI 10.1021/ar800131p; Weber D., 2003, Pesticide Outlook, V14, P256, DOI 10.1039/b314847p; Zhao JZ, 2000, J ECON ENTOMOL, V93, P1508, DOI 10.1603/0022-0493-93.5.1508; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	29	41	45	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147844	10.1371/journal.pone.0147844	http://dx.doi.org/10.1371/journal.pone.0147844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821361	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400049
J	Giri, AK; Midha, S; Banerjee, P; Agrawal, A; Mehdi, SJ; Dhingra, R; Kaur, I; Kumar, GR; Lakhotia, R; Ghosh, S; Das, K; Mohindra, S; Rana, S; Bhasin, DK; Garg, PK; Bharadwaj, D				Giri, Anil K.; Midha, Shallu; Banerjee, Priyanka; Agrawal, Ankita; Mehdi, Syed Jafar; Dhingra, Rajan; Kaur, Ismeet; Kumar, Ramesh G.; Lakhotia, Ritika; Ghosh, Saurabh; Das, Kshaunish; Mohindra, Samir; Rana, Surinder; Bhasin, Deepak K.; Garg, Pramod K.; Bharadwaj, Dwaipayan		INDIPAN & INDICO Consortium	Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis	PLOS ONE			English	Article							TROPICAL CALCIFIC PANCREATITIS; CATIONIC TRYPSINOGEN GENE; INHIBITOR MUTATIONS; RECURRENT ACUTE; ASSOCIATION; SPINK1; POLYMORPHISMS; EXPRESSION; REGION; PRSS1	A recent genome-wide association study (GWAS) identified association with variants in X-linked CLDN2 and MORC4, and PRSS1-PRSS2 loci with chronic pancreatitis (CP) in North American patients of European ancestry. We selected 9 variants from the reported GWAS and replicated the association with CP in Indian patients by genotyping 1807 unrelated Indians of Indo-European ethnicity, including 519 patients with CP and 1288 controls. The etiology of CP was idiopathic in 83.62% and alcoholic in 16.38% of 519 patients. Our study confirmed a significant association of 2 variants in CLDN2 gene (rs4409525-OR 1.71, P = 1.38 x 10(-09); rs12008279-OR 1.56, P = 1.53 x 10(-04)) and 2 variants in MORC4 gene (rs12688220-OR 1.72, P = 9.20 x 10(-09); rs6622126-OR 1.75, P = 4.04x10(-05)) in Indian patients with CP. We also found significant association at PRSS1-PRSS2 locus (OR 0.60; P = 9.92 x 10(-06)) and SAMD12-TNFRSF11B (OR 0.49, 95% CI [0.31-0.78], P = 0.0027). A variant in the gene MORC4 (rs12688220) showed significant interaction with alcohol (OR for homozygous and heterozygous risk allele -14.62 and 1.51 respectively, P = 0.0068) suggesting gene-environment interaction. A combined analysis of the genes CLDN2 and MORC4 based on an effective risk allele score revealed a higher percentage of individuals homozygous for the risk allele in CP cases with 5.09 fold enhanced risk in individuals with 7 or more effective risk alleles compared with individuals with 3 or less risk alleles (P = 1.88 x 10(-14)). Genetic variants in CLDN2 and MORC4 genes were associated with CP in Indian patients.	[Giri, Anil K.; Banerjee, Priyanka; Agrawal, Ankita; Mehdi, Syed Jafar; Kaur, Ismeet; Kumar, Ramesh G.; Lakhotia, Ritika; Bharadwaj, Dwaipayan] CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, New Delhi, India; [Giri, Anil K.; Bharadwaj, Dwaipayan] CSIR, Acad Sci & Innovat Res, Inst Genom & Integrat Biol Campus, New Delhi 110001, India; [Midha, Shallu; Dhingra, Rajan; Garg, Pramod K.] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Das, Kshaunish] Inst Post Grad Med Educ & Res, Dept Gastroenterol, Kolkata, India; [Mohindra, Samir] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow, Uttar Pradesh, India; [Rana, Surinder; Bhasin, Deepak K.] Postgrad Inst Med Educ & Res, Dept Gastroenterol, Chandigarh, India; [Bharadwaj, Dwaipayan] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Statistical Institute; Indian Statistical Institute Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Jawaharlal Nehru University, New Delhi	Bharadwaj, D (corresponding author), CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, New Delhi, India.; Bharadwaj, D (corresponding author), CSIR, Acad Sci & Innovat Res, Inst Genom & Integrat Biol Campus, New Delhi 110001, India.; Garg, PK (corresponding author), All India Inst Med Sci, Dept Gastroenterol, New Delhi, India.; Bharadwaj, D (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India.	pkgarg@aiims.ac.in; db@igib.res.in	Prabhakaran, Dorairaj/B-4147-2011; Agrawal, Ankita/R-2437-2016; Banerjee, Priyanka/N-6890-2019; Mehdi, Syed/P-3498-2019; Banerjee, Priyanka/C-3927-2019; Madhu, S/AAH-7431-2019	Prabhakaran, Dorairaj/0000-0002-3172-834X; Agrawal, Ankita/0000-0003-1055-9142; Banerjee, Priyanka/0000-0001-5054-3095; Mehdi, Syed/0000-0002-2388-0480; Banerjee, Priyanka/0000-0001-5054-3095; Madhu, S/0000-0003-0018-5984; Bharadwaj, Dwaipayan/0000-0001-5268-8482; Banerjee, Monisha/0000-0002-5371-8791; Bandesh, Khushdeep/0000-0002-5057-7313; Tabassum, Rubina/0000-0002-3120-3041; Garg, Pramod Kumar/0000-0001-7015-4396; Reddy, K Srinath/0000-0003-3416-3548; /0000-0003-0941-1458; Agrawal, Anurag/0000-0002-0340-5252	"Genome Wide Association Study of Chronic Pancreatitis" - Department of Biotechnology (DBT) [GAP-83]; "Center for Cardiovascular and Metabolic Disease Research" (CARDIOMED) - Council of Scientific and Industrial Research (CSIR), Government of India [BSC-0122-3]	"Genome Wide Association Study of Chronic Pancreatitis" - Department of Biotechnology (DBT); "Center for Cardiovascular and Metabolic Disease Research" (CARDIOMED) - Council of Scientific and Industrial Research (CSIR), Government of India	This work was supported by "Genome Wide Association Study of Chronic Pancreatitis" (GAP-83) funded by Department of Biotechnology (DBT) and "Center for Cardiovascular and Metabolic Disease Research" (CARDIOMED) (BSC-0122-3), funded by the Council of Scientific and Industrial Research (CSIR), Government of India.	Avanthi SU, 2015, J GASTROEN HEPATOL, V30, P1796, DOI 10.1111/jgh.13029; Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Boulling A, 2015, GUT, V64, P1837, DOI 10.1136/gutjnl-2015-310254; Chandak GR, 2004, GUT, V53, P723, DOI 10.1136/gut.2003.026526; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Derikx MH, 2015, GUT, V64, P1426, DOI 10.1136/gutjnl-2014-307453; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Garg PK, 2004, J GASTROEN HEPATOL, V19, P998, DOI 10.1111/j.1440-1746.2004.03426.x; Garg Pramod Kumar, 2012, Curr Gastroenterol Rep, V14, P118, DOI 10.1007/s11894-012-0241-0; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; INdian DIabetes COnsortium, 2011, Hugo J, V5, P65, DOI 10.1007/s11568-011-9157-2; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kume K, 2009, GUT, V58, P820, DOI 10.1136/gut.2008.151688; Lee JH, 2011, ONCOL REP, V25, P971, DOI 10.3892/or.2011.1132; Liggins AP, 2007, BRIT J HAEMATOL, V138, P479, DOI 10.1111/j.1365-2141.2007.06680.x; Mahurkar S, 2006, GUT, V55, P1270, DOI 10.1136/gut.2005.087403; Masamune A, 2015, GUT, V64, P1345, DOI 10.1136/gutjnl-2015-309802; Midha S, 2010, GUT, V59, P800, DOI 10.1136/gut.2009.191239; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Santhosh S, 2008, PANCREAS, V36, P317, DOI 10.1097/MPA.0b013e31815db4b3; Satoh K, 2001, PANCREAS, V23, P251, DOI 10.1097/00006676-200110000-00005; Schrader J, 2007, DIABETOLOGIA, V50, P1243, DOI 10.1007/s00125-007-0672-6; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Soderman J, 2013, WORLD J GASTROENTERO, V19, P4935, DOI 10.3748/wjg.v19.i30.4935; Sundaresan S, 2009, PANCREATOLOGY, V9, P145, DOI 10.1159/000178885; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Toffoli B, 2011, MOL CELL ENDOCRINOL, V331, P136, DOI 10.1016/j.mce.2010.08.019; Wang W, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-269; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125	40	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147345	10.1371/journal.pone.0147345	http://dx.doi.org/10.1371/journal.pone.0147345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820620	gold, Green Published			2022-12-27	WOS:000369528400021
J	Lee, JY; Bae, KH; Park, KA; Lyu, JI; Oh, SY				Lee, Ju-Yeun; Bae, Kunho; Park, Kyung-Ah; Lyu, In Jeong; Oh, Sei Yeul			Correlation between Extraocular Muscle Size Measured by Computed Tomography and the Vertical Angle of Deviation in Thyroid Eye Disease	PLOS ONE			English	Article							GRAVES OPHTHALMOPATHY; OPTIC NEUROPATHY; ORBITAL FAT; VOLUME; CT; STRABISMUS; DIAGNOSIS; MRI	The aim of this study was to investigate extraocular muscle (EOM) volume and cross-sectional area using computed tomography (CT), and to determine the relationship between EOM size and the vertical angle of deviation in thyroid eye disease (TED). Twenty-nine TED patients (58 orbits) with vertical strabismus were enrolled in the study. All patients underwent complete ophthalmic examination including prism, alternate cover, and Krimsky tests. Orbital CT scans were also performed on each patient. Digital image analysis was used to quantify superior rectus (SR) and inferior rectus (IR) muscle cross-sectional areas and volumes. Measurements were compared with those of controls. The correlation between muscle size and degree of vertical angle deviation was evaluated. The mean vertical angle of deviation was 26.2 +/- 4.1 prism diopters. The TED group had a greater maximum cross-sectional area and EOM volume in the SR and IR than the control group (all p<0.001). Area and volume of the IR were correlated with the angle of deviation, but the SR alone did not show a significant correlation. The maximum cross-sectional area and volume of [Right IR + Left SR -Right SR-Left IR] was strongly correlated with the vertical angle of deviation (P<0.001). Quantitative CT of the orbit with evaluation of the area and volume of EOMs may be helpful in anticipating and monitoring vertical strabismus in TED patients.	[Lee, Ju-Yeun; Bae, Kunho; Park, Kyung-Ah; Lyu, In Jeong; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu						Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Bijlsma WR, 2006, ORBIT, V25, P83, DOI 10.1080/01676830600675319; Carlow TJ, 1998, AM J NEURORADIOL, V19, P95; CHEN YL, 1994, ACTA OPHTHALMOL, V72, P472; Dagi LR, 2011, OPHTHAL PLAST RECONS, V27, P102, DOI 10.1097/IOP.0b013e3181e9a063; Demer JL, 2002, J AAPOS, V6, P337, DOI 10.1067/mpa.2002.129040; Detorakis ET, 2003, INVEST OPHTH VIS SCI, V44, P4307, DOI 10.1167/iovs.03-0171; ENZMANN DR, 1979, J COMPUT ASSIST TOMO, V3, P815; FELDON SE, 1985, ARCH OPHTHALMOL-CHIC, V103, P213, DOI 10.1001/archopht.1985.01050020065021; FELDON SE, 1990, BRIT J OPHTHALMOL, V74, P484, DOI 10.1136/bjo.74.8.484; FELDON SE, 1984, ARCH OPHTHALMOL-CHIC, V102, P1469, DOI 10.1001/archopht.1984.01040031189015; FELDON SE, 1982, ARCH OPHTHALMOL-CHIC, V100, P1266, DOI 10.1001/archopht.1982.01030040244006; Firbank MJ, 2001, MAGN RESON IMAGING, V19, P257, DOI 10.1016/S0730-725X(01)00234-X; Firbank MJ, 2000, BRIT J RADIOL, V73, P1282, DOI 10.1259/bjr.73.876.11205672; FORBES G, 1986, AM J NEURORADIOL, V7, P651; HALLIN ES, 1988, BRIT J OPHTHALMOL, V72, P674, DOI 10.1136/bjo.72.9.674; HALLIN ES, 1988, BRIT J OPHTHALMOL, V72, P678, DOI 10.1136/bjo.72.9.678; KRAHE T, 1989, ROFO FORTSCHR RONTG, V151, P597, DOI 10.1055/s-2008-1047248; NUGENT RA, 1990, RADIOLOGY, V177, P675, DOI 10.1148/radiology.177.3.2243967; Ozgen A, 1999, BRIT J RADIOL, V72, P757, DOI 10.1259/bjr.72.860.10624341; Schotthoefer EO, 2007, CURR OPIN OPHTHALMOL, V18, P361, DOI 10.1097/ICU.0b013e32827038f2; Shin SY, 2015, AM J OPHTHALMOL, V159, P1169, DOI 10.1016/j.ajo.2015.02.019; Szucs-Farkas Z, 2005, THYROID, V15, P146, DOI 10.1089/thy.2005.15.146; Szucs-Farkas Z, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1791005; Tian S, 2000, GRAEF ARCH CLIN EXP, V238, P393, DOI 10.1007/s004170050370; TROKEL SL, 1979, AM J OPHTHALMOL, V87, P503, DOI 10.1016/0002-9394(79)90239-3	26	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148167	10.1371/journal.pone.0148167	http://dx.doi.org/10.1371/journal.pone.0148167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820406	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400074
J	Choi, HJ; Chung, TW; Park, MJ; Lee, KS; Yoon, Y; Kim, HS; Lee, JH; Kwon, SM; Lee, SO; Kim, KJ; Baek, JH; Ha, KT				Choi, Hee-Jung; Chung, Tae-Wook; Park, Mi-Ju; Lee, Kyu Sup; Yoon, Youngjin; Kim, Hyung Sik; Lee, Jun Hee; Kwon, Sang-Mo; Lee, Syng-Ook; Kim, Keuk-Jun; Baek, Jin-Ho; Ha, Ki-Tae			Paeonia lactiflora Enhances the Adhesion of Trophoblast to the Endometrium via Induction of Leukemia Inhibitory Factor Expression	PLOS ONE			English	Article							EMBRYONIC IMPLANTATION DYSFUNCTION; CHINESE HERBAL MEDICINE; UNEXPLAINED INFERTILITY; PREVENTS IMPLANTATION; UTERINE RECEPTIVITY; MENSTRUAL-CYCLE; CELL-ADHESION; FACTOR LIF; KAPPA-B; PAEONIFLORIN	In the present study, we investigated the role of Paeonia lactiflora Pall. extract on embryo implantation in vitro and in vivo. A polysaccharides depleted-water extract of P. lactiflora (PL-PP) increased LIF expression in human endometrial Ishikawa cells at non-cytotoxic doses. PL-PP significantly increased the adhesion of the human trophectoderm-derived JAr spheroids to endometrial Ishikawa cells. PL-PP-induced LIF expression was decreased in the presence of a p38 kinase inhibitor SB203580 and an MEK/ERK inhibitor U0126. Furthermore, endometrial LIF knockdown by shRNA reduced the expression of integrins beta 3 and beta 5 and adhesion of JAr spheroids to Ishikawa cells. In vivo administration of PL-PP restored the implantation of mouse blastocysts in a mifepristone-induced implantation failure mice model. Our results demonstrate that PL-PP increases LIF expression via the p38 and MEK/ERK pathways and favors trophoblast adhesion to endometrial cells.	[Choi, Hee-Jung; Chung, Tae-Wook; Park, Mi-Ju; Ha, Ki-Tae] Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan, Gyeongsangnam D, South Korea; [Choi, Hee-Jung; Chung, Tae-Wook; Park, Mi-Ju; Ha, Ki-Tae] Pusan Natl Univ, Korean Med Res Ctr Hlth Aging, Yangsan, Gyeongsangnam D, South Korea; [Lee, Kyu Sup] Pusan Natl Univ Hosp, Dept Obstet & Gynecol, Pusan, South Korea; [Yoon, Youngjin] Pusan Natl Univ, Sch Korean Med, Dept Korean Obstet & Gynecol, Pusan 609735, South Korea; [Kim, Hyung Sik] Sungkyunkwan Univ, Sch Pharm, Mol Toxicol Lab, Suwon, Gyeonggi Do, South Korea; [Lee, Jun Hee; Kwon, Sang-Mo] Pusan Natl Univ, Sch Med, Med Res Inst, Lab Vasc Med & Stem Cell Biol,Dept Physiol, Yangsan, Gyeongsangnam D, South Korea; [Lee, Syng-Ook] Keimyung Univ, Dept Food Sci & Technol, Daegu, South Korea; [Kim, Keuk-Jun] TaeKyeung Univ, Dept Clin Pathol, Gyongsan, South Korea; [Baek, Jin-Ho] Daechubatbaek Korean Med Clin, Gyeongju, Gyeongsangbuk D, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Sungkyunkwan University (SKKU); Pusan National University; Pusan National University Hospital; Keimyung University	Ha, KT (corresponding author), Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan, Gyeongsangnam D, South Korea.; Ha, KT (corresponding author), Pusan Natl Univ, Korean Med Res Ctr Hlth Aging, Yangsan, Gyeongsangnam D, South Korea.	hagis@pusan.ac.kr		Chung, Tae-Wook/0000-0001-5243-5020; Lee, Syng-Ook/0000-0002-8958-8634	Traditional Korean Medicine R&D Project, Ministry of Health Welfare [HI13C0502]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MISP), Korea Government [2014R1A5A20009936]	Traditional Korean Medicine R&D Project, Ministry of Health Welfare; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MISP), Korea Government	This study was supported by a grant of the Traditional Korean Medicine R&D Project, Ministry of Health & Welfare (Grant no. HI13C0502), and by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning (MISP), Korea Government (Grant no. 2014R1A5A20009936).	Agca C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.323; Aghajanova L, 2010, CURR OPIN OBSTET GYN, V22, P213, DOI 10.1097/GCO.0b013e32833848e5; ARICI A, 1995, J CLIN ENDOCR METAB, V80, P1908, DOI 10.1210/jc.80.6.1908; Aschenbach LC, 2013, CONTRACEPTION, V87, P813, DOI 10.1016/j.contraception.2012.09.032; Brown JK, 2012, MOL HUM REPROD, V18, P111, DOI 10.1093/molehr/gar068; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Castelbaum AJ, 1997, J CLIN ENDOCR METAB, V82, P136, DOI 10.1210/jc.82.1.136; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; da Costa SV, 2010, LEUKEMIA RES, V34, P507, DOI 10.1016/j.leukres.2009.10.012; Danielsson KG, 1997, HUM REPROD, V12, P1293; Diedrich K, 2007, HUM REPROD UPDATE, V13, P365, DOI 10.1093/humupd/dmm011; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; Gao D., 1997, ENCY CHINESE MED; Gao WN, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/678390; Giudice LC, 1999, HUM REPROD, V14, P3, DOI 10.1093/humrep/14.suppl_2.3; Gui J, 2012, AM J REPROD IMMUNOL, V67, P383, DOI 10.1111/j.1600-0897.2011.01097.x; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; He DY, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00010; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; Jia W, 2006, PHYTOTHER RES, V20, P819, DOI 10.1002/ptr.1905; Koot YEM, 2013, CURR OPIN OBSTET GYN, V25, P274, DOI 10.1097/GCO.0b013e3283630d94; Laird SM, 2000, MOL HUM REPROD, V6, P34, DOI 10.1093/molehr/6.1.34; Lalitkumar PGL, 2007, HUM REPROD, V22, P3031, DOI 10.1093/humrep/dem297; Lee B, 2008, ARCH PHARM RES, V31, P445, DOI 10.1007/s12272-001-1177-6; Lessey BA, 1998, HUM REPROD, V13, P247, DOI 10.1093/humrep/13.suppl_3.247; LESSEY BA, 1992, J CLIN INVEST, V90, P188, DOI 10.1172/JCI115835; Li QX, 2002, J BIOL CHEM, V277, P46447, DOI 10.1074/jbc.M203555200; Lian F, 2013, J ALTERN COMPLEM MED, V19, P353, DOI 10.1089/acm.2011.0410; Liu DF, 2006, CLIN EXP PHARMACOL P, V33, P332, DOI 10.1111/j.1440-1681.2006.04371.x; Macklon NS, 2006, ENDOCR REV, V27, P170, DOI 10.1210/er.2005-0015; Mao QQ, 2012, PHARM BIOL, V50, P72, DOI 10.3109/13880209.2011.602696; Menkhorst E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019665; Poncelet C, 2002, ACTA OBSTET GYN SCAN, V81, P195, DOI 10.1034/j.1600-0412.2002.810302.x; Ried K, 2011, COMPLEMENT THER MED, V19, P319, DOI 10.1016/j.ctim.2011.09.003; Robertson SA, 2010, J REPROD IMMUNOL, V85, P51, DOI 10.1016/j.jri.2010.01.008; ROBLERO LS, 1987, CONTRACEPTION, V36, P549, DOI 10.1016/0010-7824(87)90007-2; Steck T, 2004, EUR J OBSTET GYN R B, V112, P69, DOI 10.1016/S0301-2115(03)00315-4; Tabibzadeh SRGJDALCGS, 2004, ENDOMETRIUM; Terakawa J, 2011, J REPROD DEVELOP, V57, P700, DOI 10.1262/jrd.11-048H; THIE M, 1995, EUR J CELL BIOL, V66, P180; TOMODA M, 1993, BIOL PHARM BULL, V16, P1207, DOI 10.1248/bpb.16.1207; Tong HB, 2014, CARBOHYD POLYM, V105, P20, DOI 10.1016/j.carbpol.2014.01.039; Vogiagis D, 1996, J ENDOCRINOL, V148, P95, DOI 10.1677/joe.0.1480095; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; Wu M, 2013, CYTOKINE, V62, P334, DOI 10.1016/j.cyto.2013.03.002; Yu N, 2011, J ETHNOPHARMACOL, V137, P389, DOI 10.1016/j.jep.2011.05.037; Zhang MM, 2008, J HUAZHONG U SCI-MED, V28, P65, DOI 10.1007/s11596-008-0116-7; Zheng YQ, 2007, INFLAMM RES, V56, P182, DOI 10.1007/s00011-006-6002-5	50	17	17	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148232	10.1371/journal.pone.0148232	http://dx.doi.org/10.1371/journal.pone.0148232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839969	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200104
J	Jin, WB; Wu, FL				Jin, Weibo; Wu, Fangli			Proteome-Wide Identification of Lysine Succinylation in the Proteins of Tomato (Solanum lycopersicum)	PLOS ONE			English	Article							NUCLEOSOME; TARGETS	Post-translational modification of proteins through lysine succinylation plays important regulatory roles in living cells. Lysine succinylation was recently identified as a novel post-translational modification in Escherichia coli, yeast, Toxoplasma gondii, HeLa cells, and mouse liver. Interestingly, only a few sites of lysine succinylation have been detected in plants to date. In this study, we identified 347 sites of lysine succinylation in 202 proteins in tomato by using high-resolution mass spectrometry. Succinylated proteins are implicated in the regulation of diverse metabolic processes, including chloroplast and mitochondrial metabolism. Bioinformatic analysis showed that succinylated proteins are evolutionarily conserved and involved in various cellular functions such as metabolism and epigenetic regulation. Moreover, succinylated proteins exhibit diverse subcellular localizations. We also defined six types of definitively conserved succinylation motifs. These results provide the first in-depth analysis of the lysine succinylome and novel insights into the role of succinylation in tomato, thereby elucidating lysine succinylation in the context of cellular physiology and metabolite biosynthesis in plants.	[Jin, Weibo; Wu, Fangli] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Wu, FL (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China.	wfl@zstu.edu.cn			Natural Science Foundation of China [31372075]; Natural Science Foundation of Zhejiang Province [LQ15C140021]; 521 Talent Foundation of Zhejiang Sci-Tech University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); 521 Talent Foundation of Zhejiang Sci-Tech University	This work was supported by the grants of the Natural Science Foundation of China (grant No. 31372075), and the website is (http://isisn.nsfc.gov.en/). This work was supported by the Natural Science Foundation of Zhejiang Province (grant No. LQ15C140021), and the website is (http:/www.zjnsf.gov.cn/). This work was supported by the 521 Talent Foundation of Zhejiang Sci-Tech University, and the website is (http://www.zstu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fransz P, 2011, PLANT J, V66, P4, DOI 10.1111/j.1365-313X.2011.04526.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li XL, 2014, J PROTEOME RES, V13, P6087, DOI 10.1021/pr500992r; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Pfluger J, 2007, CURR OPIN PLANT BIOL, V10, P645, DOI 10.1016/j.pbi.2007.07.013; Sadeh R, 2011, CELL, V147, P263, DOI 10.1016/j.cell.2011.09.042; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	16	54	56	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147586	10.1371/journal.pone.0147586	http://dx.doi.org/10.1371/journal.pone.0147586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828863	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200025
J	Bonde, Y; Eggertsen, G; Rudling, M				Bonde, Ylva; Eggertsen, Gosta; Rudling, Mats			Mice Abundant in Muricholic Bile Acids Show Resistance to Dietary Induced Steatosis, Weight Gain, and to Impaired Glucose Metabolism	PLOS ONE			English	Article							INTESTINAL-ABSORPTION; INSULIN-RESISTANCE; INDUCED OBESITY; CHOLIC-ACID; MODULATION; FXR	High endogenous production of, or treatment with muricholic bile acids, strongly reduces the absorption of cholesterol. Mice abundant in muricholic bile acids may therefore display an increased resistance against dietary induced weight gain, steatosis, and glucose intolerance due to an anticipated general reduction in lipid absorption. To test this hypothesis, mice deficient in steroid 12-alpha hydroxylase (Cyp8b1(-/-)) and therefore abundant inmuricholic acids were monitored for 11 weeks while fed a high fat diet. Food intake and body and liver weights were determined, and lipids in liver, serum and feces were measured. Further, responses during oral glucose and intraperitoneal insulin tolerance tests were evaluated. On the high fat diet, Cyp8b1(-/-) mice displayed less weight gain compared to wildtype littermates (Cyp8b1(+/+)). In addition, liver enlargement with steatosis and increases in serum LDL-cholesterol were strongly attenuated in Cyp8b1(-/-) mice on high fat diet. Fecal excretion of cholesterol was increased and there was a strong trend for doubled fecal excretion of free fatty acids, while excretion of triglycerides was unaltered, indicating dampened lipid absorption. On high fat diet, Cyp8b1(-/-) mice also presented lower serum glucose levels in response to oral glucose gavage or to intraperitoneal insulin injection compared to Cyp8b1(+/+). In conclusion, following exposure to a high fat diet, Cyp8b1(-/-) mice are more resistant against weight gain, steatosis, and to glucose intolerance than Cyp8b1(+/+) mice. Reduced lipid absorption may in part explain these findings. Overall, the results suggest that muricholic bile acids may be beneficial against the metabolic syndrome.	[Bonde, Ylva; Rudling, Mats] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med, Stockholm, Sweden; [Bonde, Ylva; Rudling, Mats] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Eggertsen, Gosta] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Bonde, Y; Rudling, M (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med, Stockholm, Sweden.; Bonde, Y; Rudling, M (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	ylva.bonde@ki.se; mats.rudling@ki.se			 [K2013-55X-15075-10-3];  [20130518];  [DIA 2014-064];  [20130327]	; ; ; 	This work was supported by http://www.vr.se, Grant no. K2013-55X-15075-10-3, http://www.hjart-lungfonden. se, Grant no. 20130518, http://www.diabetes.se/diabetesfonden, Grant no. DIA 2014-064, http://www.cardiovascular.se, Grant no. Not applicable, and http://www.sll.se/, Grant no. 20130327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BOTHAM KM, 1983, EUR J BIOCHEM, V134, P191, DOI 10.1111/j.1432-1033.1983.tb07550.x; Chen WD, 2011, BBA-MOL BASIS DIS, V1812, P888, DOI 10.1016/j.bbadis.2010.12.006; Galman C, 2008, GASTROENTEROLOGY, V134, P1127, DOI 10.1053/j.gastro.2008.01.032; Ge HF, 2014, J BIOL CHEM, V289, P30470, DOI 10.1074/jbc.M114.592022; Hu X, 2014, J INTERN MED, V275, P27, DOI 10.1111/joim.12140; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; Naugler WE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097426; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rudling M, 2015, DIGEST DIS, V33, P376, DOI 10.1159/000371690; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641	22	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147772	10.1371/journal.pone.0147772	http://dx.doi.org/10.1371/journal.pone.0147772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824238	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600058
J	Rankinen, T; Fuku, N; Wolfarth, B; Wang, G; Sarzynski, MA; Alexeev, DG; Ahmetov, II; Boulay, MR; Cieszczyk, P; Eynon, N; Filipenko, ML; Garton, FC; Generozov, EV; Govorun, VM; Houweling, PJ; Kawahara, T; Kostryukova, ES; Kulemin, NA; Larin, AK; Maciejewska-Karlowska, A; Miyachi, M; Muniesa, CA; Murakami, H; Ospanova, EA; Padmanabhan, S; Pavlenko, AV; Pyankova, ON; Santiago, C; Sawczuk, M; Scott, RA; Uyba, VV; Yvert, T; Perusse, L; Ghosh, S; Rauramaa, R; North, KN; Lucia, A; Pitsiladis, Y; Bouchard, C				Rankinen, Tuomo; Fuku, Noriyuki; Wolfarth, Bernd; Wang, Guan; Sarzynski, Mark A.; Alexeev, Dmitry G.; Ahmetov, Ildus I.; Boulay, Marcel R.; Cieszczyk, Pawel; Eynon, Nir; Filipenko, Maxim L.; Garton, Fleur C.; Generozov, Edward V.; Govorun, Vadim M.; Houweling, Peter J.; Kawahara, Takashi; Kostryukova, Elena S.; Kulemin, Nickolay A.; Larin, Andrey K.; Maciejewska-Karlowska, Agnieszka; Miyachi, Motohiko; Muniesa, Carlos A.; Murakami, Haruka; Ospanova, Elena A.; Padmanabhan, Sandosh; Pavlenko, Alexander V.; Pyankova, Olga N.; Santiago, Catalina; Sawczuk, Marek; Scott, Robert A.; Uyba, Vladimir V.; Yvert, Thomas; Perusse, Louis; Ghosh, Sujoy; Rauramaa, Rainer; North, Kathryn N.; Lucia, Alejandro; Pitsiladis, Yannis; Bouchard, Claude			No Evidence of a Common DNA Variant Profile Specific to World Class Endurance Athletes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL GENETIC-VARIATION; EXERCISE HEART-RATE; HERITAGE FAMILY; AEROBIC POWER; LINKAGE SCAN; POLYMORPHISM; PERFORMANCE; IDENTIFICATION; GENOTYPE	There are strong genetic components to cardiorespiratory fitness and its response to exercise training. It would be useful to understand the differences in the genomic profile of highly trained endurance athletes of world class caliber and sedentary controls. An international consortium (GAMES) was established in order to compare elite endurance athletes and ethnicity-matched controls in a case-control study design. Genome-wide association studies were undertaken on two cohorts of elite endurance athletes and controls (GENATHLETE and Japanese endurance runners), from which a panel of 45 promising markers was identified. These markers were tested for replication in seven additional cohorts of endurance athletes and controls: from Australia, Ethiopia, Japan, Kenya, Poland, Russia and Spain. The study is based on a total of 1520 endurance athletes (835 who took part in endurance events in World Championships and/or Olympic Games) and 2760 controls. We hypothesized that world-class athletes are likely to be characterized by an even higher concentration of endurance performance alleles and we performed separate analyses on this subsample. The meta-analysis of all available studies revealed one statistically significant marker (rs558129 at GALNTL6 locus, p = 0.0002), even after correcting for multiple testing. As shown by the low heterogeneity index (I-2 = 0), all eight cohorts showed the same direction of association with rs558129, even though p-values varied across the individual studies. In summary, this study did not identify a panel of genomic variants common to these elite endurance athlete groups. Since GAMES was underpowered to identify alleles with small effect sizes, some of the suggestive leads identified should be explored in expanded comparisons of world-class endurance athletes and sedentary controls and in tightly controlled exercise training studies. Such studies have the potential to illuminate the biology not only of world class endurance performance but also of compromised cardiac functions and cardiometabolic diseases.	[Rankinen, Tuomo; Sarzynski, Mark A.; Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA; [Fuku, Noriyuki] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Wolfarth, Bernd] Humboldt Univ, Dept Sport Med, D-10099 Berlin, Germany; [Wolfarth, Bernd] Charite, Sch Med, D-13353 Berlin, Germany; [Wang, Guan; Pitsiladis, Yannis] Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Eastbourne, England; [Alexeev, Dmitry G.; Ahmetov, Ildus I.; Generozov, Edward V.; Govorun, Vadim M.; Kostryukova, Elena S.; Kulemin, Nickolay A.; Larin, Andrey K.; Ospanova, Elena A.; Pavlenko, Alexander V.] Res Inst Physical Chem Med, Moscow, Russia; [Ahmetov, Ildus I.] Volga Reg State Acad Phys Culture Sport & Tourism, Sport Technol Res Ctr, Kazan, Russia; [Boulay, Marcel R.; Perusse, Louis] Univ Laval, Dept Kinesiol, Ste Foy, PQ, Canada; [Cieszczyk, Pawel; Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Univ Szczecin, Dept Phys Educ & Hlth Promot, PL-70453 Szczecin, Poland; [Cieszczyk, Pawel] Acad Phys Educ & Sport, Dept Tourism & Recreat, Gdansk, Poland; [Eynon, Nir] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia; [Filipenko, Maxim L.; Houweling, Peter J.; Pyankova, Olga N.] RAS, Inst Chem Biol & Fundamental Med, Pharmacogen Lab, SB, Novosibirsk, Russia; [Filipenko, Maxim L.; Houweling, Peter J.; Pyankova, Olga N.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Garton, Fleur C.; North, Kathryn N.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic 3010, Australia; [Garton, Fleur C.; North, Kathryn N.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Garton, Fleur C.; North, Kathryn N.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Westmead, NSW, Australia; [Kawahara, Takashi] Japan Inst Sports Sci, Dept Sports Med, Tokyo, Japan; [Miyachi, Motohiko; Murakami, Haruka] Natl Inst Hlth & Nutr, Dept Hlth Promot & Exercise, Tokyo 162, Japan; [Muniesa, Carlos A.; Santiago, Catalina; Yvert, Thomas; Lucia, Alejandro] Univ Europea & Res Inst I 12, Madrid, Spain; [Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Scott, Robert A.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England; [Uyba, Vladimir V.] Fed Med Biol Agcy, Moscow, Russia; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Ctr Computat Biol, Singapore, Singapore; [Rauramaa, Rainer] Univ Eastern Finland, Kuopio Res Inst Exercise Med, Kuopio, Finland; [Sarzynski, Mark A.] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29208 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Juntendo University; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Brighton; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Volga Region State Academy of Physical Culture, Sport & Tourism; Laval University; University of Szczecin; Gdansk University of Physical Education & Sport; Victoria University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Sydney; National Institute of Health & Nutrition - Japan; University of Glasgow; University of Cambridge; National University of Singapore; National University of Singapore; University of Eastern Finland; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bouchard, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA USA.	claude.bouchard@pbrc.edu	Generozov, Edward V/U-3431-2017; Perusse, Louis/A-3444-2012; Houweling, Peter/B-4157-2016; Cieszczyk, Pawel/AAG-3328-2022; Padmanabhan, Sandosh/S-3963-2016; Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019; Ghosh, Sujoy/I-3729-2017; North, Kathryn N/K-6476-2012; Wang, Guan/AAN-9249-2020; Govorun, Vadim M/A-9043-2018; Filipenko, Maksim/AAU-9552-2020; Ahmetov, Ildus I/C-6163-2009; Kostryukova, Elena/D-8064-2014; Garton, Fleur/H-7713-2016; Sawczuk, Marek/S-3609-2017; Sarzynski, Mark/A-9798-2014; Garton, Fleur C./D-2744-2017; Kulemin, Nikolay A./F-3571-2017; Alexeev, Dmitry/A-6167-2013; Cieszczyk, Pawel/AFK-4645-2022; Rankinen, Tuomo/N-1984-2017; Santiago, Catalina/P-8177-2019; Miyachi, Motohiko/AAW-3403-2020	Generozov, Edward V/0000-0002-6314-4883; Perusse, Louis/0000-0001-6440-9698; Houweling, Peter/0000-0001-6132-2554; Cieszczyk, Pawel/0000-0002-7735-7580; Bouchard, Claude/0000-0002-0048-491X; Ghosh, Sujoy/0000-0002-7601-165X; North, Kathryn N/0000-0003-0841-8009; Wang, Guan/0000-0002-7432-7933; Filipenko, Maksim/0000-0002-8950-5368; Ahmetov, Ildus I/0000-0002-6335-4020; Kostryukova, Elena/0000-0002-0457-6803; Garton, Fleur/0000-0002-1490-5930; Garton, Fleur C./0000-0002-1490-5930; Kulemin, Nikolay A./0000-0002-8588-3206; Alexeev, Dmitry/0000-0003-0783-1176; Cieszczyk, Pawel/0000-0002-7735-7580; Santiago, Catalina/0000-0003-3852-8217; Miyachi, Motohiko/0000-0002-1146-0905; Eynon, Nir/0000-0003-4046-8276; Yvert, Thomas/0000-0002-9451-9799; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; Lucia, Alejandro/0000-0002-5565-0997; Sawczuk, Marek/0000-0002-5730-5249; Fuku, Noriyuki/0000-0001-7792-5835; Murakami, Haruka/0000-0001-9160-0033; Padmanabhan, Sandosh/0000-0003-3869-5808; Wolfarth, Bernd/0000-0001-6501-3003; Pitsiladis, Yannis/0000-0001-6210-2449	Prince Faisal Prize awarded; John W. Barton Jr Chair in Genetics and Nutrition; Federal Medical-Biological Agency; Fondo de Investigaciones Sanitarias [PI12/00914]; Consejo Superior de Deportes (CSD); Ministry of Education, Culture, Sports, Science and Technology [24650414]	Prince Faisal Prize awarded; John W. Barton Jr Chair in Genetics and Nutrition; Federal Medical-Biological Agency; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Consejo Superior de Deportes (CSD); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Partial funding for the study has been received from the Prince Faisal Prize awarded to Drs. C. Bouchard, T. Rankinen, M. Sarzynski and B. Wolfahrt. CB is partially funded by the John W. Barton Jr Chair in Genetics and Nutrition. The study in Russia was supported by a grant from the Federal Medical-Biological Agency ("Sportgen project"), http://fmbaros.ru/en/fmba/infor/. The Spanish group (AL, CAM, CS, TY) was funded by Fondo de Investigaciones Sanitarias (grant # PI12/00914). Research in sports genetics to A. Lucia in Spain was funded by grants from the Consejo Superior de Deportes (CSD). This work in Japan was supported in part by grants from the programs Grants-in-Aid for Challenging Exploratory Research (24650414 to NF) from the Ministry of Education, Culture, Sports, Science and Technology; and by a grant-in-aid for scientific research from the Ministry of Health, Labor, and Welfare of Japan (to MM). No specific funding for this work was received for the studies performed in Australia, Poland, Kenya and Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetov II, 2010, BRIT J SPORT MED, V44, P649, DOI 10.1136/bjsm.2008.051540; Argyropoulos G, 2009, PHYSIOL GENOMICS, V36, P79, DOI 10.1152/physiolgenomics.00003.2008; Ash GI, 2011, MED SCI SPORT EXER, V43, P590, DOI 10.1249/MSS.0b013e3181f70bd6; Bouchard C, 1994, Obes Res, V2, P400; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Buxens A, 2011, SCAND J MED SCI SPOR, V21, P570, DOI 10.1111/j.1600-0838.2009.01079.x; Chagnon YC, 1984, J SPORT SCI, V2, P121, DOI 10.1080/02640418408729707; COUTURE L, 1986, CAN J APPL SPORT SCI, V11, P16; de Garay A. L., 1974, GENETIC ANTHR STUDIE; De Moor MHM, 2007, TWIN RES HUM GENET, V10, P812, DOI 10.1375/twin.10.6.812; Eynon N, 2009, EXP PHYSIOL, V94, P1147, DOI 10.1113/expphysiol.2009.049668; GEDDA L, 1960, Acta Genet Med Gemellol (Roma), V9, P387; Ghosh S, 2013, J APPL PHYSIOL, V115, P1343, DOI 10.1152/japplphysiol.01487.2012; HAMEL P, 1986, MED SCI SPORT EXER, V18, P690; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; LORTIE G, 1982, HUM BIOL, V54, P801; Mikami E, 2013, SCAND J MED SCI SPOR, V23, P593, DOI 10.1111/j.1600-0838.2011.01424.x; Mikami E, 2011, BRIT J SPORT MED, V45, P1179, DOI 10.1136/bjsm.2010.072371; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Pitsiladis Y, 2013, BRIT J SPORT MED, V47, P550, DOI 10.1136/bjsports-2013-092400; PRUDHOMME D, 1984, MED SCI SPORT EXER, V16, P489, DOI 10.1249/00005768-198410000-00012; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rankinen T, 2000, J APPL PHYSIOL, V88, P1571, DOI 10.1152/jappl.2000.88.5.1571; Rankinen T, 2011, ENCY SPORTS MED, P177; Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011; Rice TK, 2012, EUR J APPL PHYSIOL, V112, P2969, DOI 10.1007/s00421-011-2274-8; Rivera MA, 1997, MED SCI SPORT EXER, V29, P1311, DOI 10.1097/00005768-199710000-00006; Rivera MA, 1999, INT J OBESITY, V23, P666, DOI 10.1038/sj.ijo.0800900; Scott RA, 2003, MED SCI SPORT EXER, V35, P1727, DOI 10.1249/01.MSS.0000089335.85254.89; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Spielmann N, 2007, AM J PHYSIOL-HEART C, V293, pH3366, DOI 10.1152/ajpheart.00042.2007; Stutz AM, 2009, EUR J HUM GENET, V17, P1481, DOI 10.1038/ejhg.2009.64; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wolfarth B, 2008, SCAND J MED SCI SPOR, V18, P485, DOI 10.1111/j.1600-0838.2007.00717.x; Wolfarth B, 2000, MED SCI SPORT EXER, V32, P1709, DOI 10.1097/00005768-200010000-00008; Wolfarth B, 2011, ENCY SPORTS MED, VXVIII, P151; Wolfarth B, 2007, METABOLISM, V56, P1649, DOI 10.1016/j.metabol.2007.07.006; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Zarebska A, 2013, J STRENGTH COND RES, V27, P2898, DOI 10.1519/JSC.0b013e31828155b5	46	70	70	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147330	10.1371/journal.pone.0147330	http://dx.doi.org/10.1371/journal.pone.0147330			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824906	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600025
J	Yang, L; Yu, D; Mo, R; Zhang, JR; Hua, H; Hu, L; Feng, Y; Wang, S; Zhang, WY; Yin, N; Mo, XM				Yang, Lei; Yu, Di; Mo, Ran; Zhang, Jiru; Hua, Hu; Hu, Liang; Feng, Yu; Wang, Song; Zhang, Wei-yan; Yin, Ning; Mo, Xu-Ming			The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; PROTEIN-COUPLED RECEPTORS; CHRONIC HYPOXIA; HEART-FAILURE; RATS; MONOCROTALINE; INHIBITION; EXPRESSION; KINASE; CANCER	Background Pulmonary arterial hypertension is characterized by increased pressure overload that leads to right ventricular hypertrophy (RVH). GPR91 is a formerly orphan G-protein-coupled receptor (GPCR) that has been characterized as a receptor for succinate; however, its role in RVH remains unknown. Methods and Results We investigated the role of succinate-GPR91 signaling in a pulmonary arterial banding (PAB) model of RVH induced by pressure overload in SD rats. GPR91 was shown to be located in cardiomyocytes. In the sham and PAB rats, succinate treatment further aggravated RVH, up-regulated RVH-associated genes and increased p-Akt/t-Akt levels in vivo. In vitro, succinate treatment up-regulated the levels of the hypertrophic gene marker anp and p-Akt/t-Akt in cardiomyocytes. All these effects were inhibited by the PI3K antagonist wortmannin both in vivo and in vitro. Finally, we noted that the GPR91-PI3K/Akt axis was also up-regulated compared to that in human RVH. Conclusions Our findings indicate that succinate-GPR91 signaling may be involved in RVH via PI3K/Akt signaling in vivo and in vitro. Therefore, GPR91 may be a novel therapeutic target for treating pressure overload-induced RVH.	[Yang, Lei] Nanjing Med Univ, Dept Gastroenterol, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Yu, Di; Hua, Hu; Hu, Liang; Feng, Yu; Wang, Song; Zhang, Wei-yan; Mo, Xu-Ming] Nanjing Med Univ, Dept Cardiothorac Surg, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Mo, Ran] Nanjing Univ, Sch Med, Dept Cardiothorac Surg, Nanjing Drum Tower Hosp,Affiliated Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Jiru] Jiangnan Univ, Dept Anesthesiol, Affiliated Hosp, Wuxi Peoples Hosp 4, Nanjing, Jiangsu, Peoples R China; [Yin, Ning] Southeast Univ, Dept Anesthesiol, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University; Jiangnan University; Southeast University - China	Mo, XM (corresponding author), Nanjing Med Univ, Dept Cardiothorac Surg, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China.; Yin, N (corresponding author), Southeast Univ, Dept Anesthesiol, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China.	yinning882000@126.com; mohsuming15@sina.com	Yang, Mi/GQA-8758-2022	Hu, Liang/0000-0002-0013-7440	National Natural Science Foundation of China [81370277, 81500243]; National 12th Five-Year technology based plan topic [2011BAI11B22]; Research and Innovation Project for College Graduates of Jiangsu Province [CXLX-0560]; Young talent of Nanjing Children's Hospital Affiliated to Nanjing Medical University; Medical Science and technology development Foundation; Nanjing Department of Health [YKK14116]; Hospital Management Center Project of Wuxi [YGZXY1307]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 12th Five-Year technology based plan topic; Research and Innovation Project for College Graduates of Jiangsu Province; Young talent of Nanjing Children's Hospital Affiliated to Nanjing Medical University; Medical Science and technology development Foundation; Nanjing Department of Health; Hospital Management Center Project of Wuxi	This work was supported by the National Natural Science Foundation of China (81370277, 81500243), the National 12th Five-Year technology based plan topic (2011BAI11B22), was sponsored by the Research and Innovation Project for College Graduates of Jiangsu Province (CXLX-0560), and by Young talent of Nanjing Children's Hospital Affiliated to Nanjing Medical University and Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (YKK14116) and Hospital Management Center Project of Wuxi (YGZXY1307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli E, 2012, CARDIOTHORAC SURG, V2012, DOI [10.1093/mmcts/mms010, DOI 10.1093/MMCTS/MMS010]; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Billard MJ, 2014, AM J CLIN EXP IMMUNO, V3, P97; Blyth Kevin G, 2011, Pulm Circ, V1, P470, DOI 10.4103/2045-8932.93546; Chiarini A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/471790; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cooke CL, 2014, J DEV ORIG HLTH DIS, V5, P36, DOI 10.1017/S2040174413000524; Camberos MD, 2014, J BIOENERG BIOMEMBR, V46, P357, DOI 10.1007/s10863-014-9563-y; Dempsie Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-159; Dunlop K, 2014, FREE RADICAL BIO MED, V69, P35, DOI 10.1016/j.freeradbiomed.2014.01.008; Engi SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105172; Farmer DGS, 2014, PULM PHARMACOL THER, V29, P7, DOI 10.1016/j.pupt.2014.01.002; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hu JY, 2013, EXP EYE RES, V109, P31, DOI 10.1016/j.exer.2013.01.011; Huffman KM, 2014, DIABETOLOGIA, V57, P2282, DOI 10.1007/s00125-014-3343-4; Iftikar FI, 2014, J EXP BIOL, V217, P2348, DOI 10.1242/jeb.098798; Janssen W, 2013, EXP PHYSIOL, V98, P1274, DOI 10.1113/expphysiol.2012.069138; Kim KC, 2012, J KOREAN MED SCI, V27, P605, DOI 10.3346/jkms.2012.27.6.605; Komers R, 2013, CLIN SCI, V124, P553, DOI 10.1042/CS20120468; Kumar S, 2012, AM J PHYSIOL-HEART C, V302, pH1655, DOI 10.1152/ajpheart.00756.2011; Lang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043433; Lee KK, 2015, HEPATOLOGY, V61, P326, DOI 10.1002/hep.27385; Liu CP, 2014, KAOHSIUNG J MED SCI, V30, P267, DOI 10.1016/j.kjms.2014.02.014; Liu XX, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-356; Lyu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101438; Mivelaz Y, 2011, J DEV ORIG HLTH DIS, V2, P184, DOI 10.1017/S2040174411000171; Oudit GY, 2008, CARDIOVASC RES, V78, P505, DOI 10.1093/cvr/cvn041; Palomer X, 2013, INT J CARDIOL, V168, P3160, DOI 10.1016/j.ijcard.2013.07.150; Pecsi I, 2014, MBIO, V5, DOI 10.1128/mBio.01093-14; Peters THF, 2013, CELL BIOCHEM BIOPHYS, V67, P305, DOI 10.1007/s12013-013-9710-9; Piao L, 2013, J MOL MED, V91, P1185, DOI 10.1007/s00109-013-1064-7; Piao L, 2012, CIRCULATION, V126, P2859, DOI 10.1161/CIRCULATIONAHA.112.109868; Piao L, 2010, J MOL MED, V88, P1011, DOI 10.1007/s00109-010-0679-1; Pluznick JL, 2013, AM J PHYSIOL-RENAL, V305, pF439, DOI 10.1152/ajprenal.00252.2013; Prigent A, 2014, SEMIN NUCL MED, V44, P110, DOI 10.1053/j.semnuclmed.2013.10.006; Qazi AK, 2015, CANCER LETT, V359, P47, DOI 10.1016/j.canlet.2014.12.034; Qi D, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0159-1; Rogers NM, 2013, PULM CIRC, V3, P936, DOI 10.1086/674754; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Ruiz-Cano MJ, 2015, INT J CARDIOL, V181, P232, DOI 10.1016/j.ijcard.2014.11.118; Ryan JJ, 2013, HANDB EXP PHARMACOL, V218, P105, DOI 10.1007/978-3-642-38664-0_5; Stuckey DJ, 2014, CIRC-CARDIOVASC IMAG, V7, P240, DOI 10.1161/CIRCIMAGING.113.000993; Sundstrom L, 2013, FEBS LETT, V587, P2399, DOI 10.1016/j.febslet.2013.05.067; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Tautermann CS, 2014, BIOORG MED CHEM LETT, V24, P4073, DOI 10.1016/j.bmcl.2014.07.009; Tigchelaar W, 2015, AM J PHYSIOL-CELL PH, V308, pC155, DOI 10.1152/ajpcell.00227.2014; Wagenaar GTM, 2014, AM J PHYSIOL-LUNG C, V307, pL261, DOI 10.1152/ajplung.00345.2013; Wang YL, 2014, EXP CELL RES, V328, P143, DOI 10.1016/j.yexcr.2014.07.029; Wang YL, 2011, J PHARMACOL EXP THER, V336, P56, DOI 10.1124/jpet.110.172668; Wang ZG, 2015, MED SCI MONITOR, V21, P9, DOI 10.12659/MSM.891063; Waskova-Arnostova P, 2014, CELL PHYSIOL BIOCHEM, V33, P310, DOI 10.1159/000356671; Yavuz T, 2013, PATHOL RES PRACT, V209, P302, DOI 10.1016/j.prp.2013.03.002; Yoshikawa N, 2014, BIOCHEM BIOPH RES CO, V453, P600, DOI 10.1016/j.bbrc.2014.09.135; Yousefi B, 2014, DNA REPAIR, V22, P24, DOI 10.1016/j.dnarep.2014.07.001; Zhang DX, 2014, LIFE SCI, V98, P39, DOI 10.1016/j.lfs.2013.12.208; Zhang LY, 2013, CIRC-HEART FAIL, V6, P1039, DOI 10.1161/CIRCHEARTFAILURE.112.000228; Zheng Y, 2013, EUR J CLIN INVEST, V43, P397, DOI 10.1111/eci.12050	58	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147597	10.1371/journal.pone.0147597	http://dx.doi.org/10.1371/journal.pone.0147597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824665	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600038
J	Chen, HL; Koprowski, JL				Chen, Hsiang Ling; Koprowski, John L.			Differential Effects of Roads and Traffic on Space Use and Movements of Native Forest-Dependent and Introduced Edge-Tolerant Species	PLOS ONE			English	Article							SQUIRRELS TAMIASCIURUS-HUDSONICUS; GRAHAM RED SQUIRREL; SMALL MAMMALS; ABERTS SQUIRRELS; MIXED-CONIFER; HOME RANGES; HABITAT USE; CANE TOADS; FRAGMENTATION; POPULATION	Anthropogenic infrastructure such as roads and non-native species are major causes of species endangerment. Understanding animal behavioral responses to roads and traffic provides insight into causes and mechanisms of effects of linear development on wildlife and aids effective mitigation and conservation. We investigated effects of roads and traffic on space use and movements of two forest-dwelling species: endemic, forest-dependent Mount Graham red squirrels (Tamiasciurus hudsonicus grahamensis) and introduced, edge-tolerant Abert's squirrels (Sciurus aberti). To assess the effects of roads on space use and movement patterns, we compared the probability that a squirrel home range included roads and random lines in forests, and assessed effects of traffic intensity on rate of road crossing and movement patterns. Red squirrels avoided areas adjacent to roads and rarely crossed roads. In contrast, Abert's squirrels were more likely to include roads in their home ranges compared to random lines in forests. Both red squirrels and Abert's squirrels increased speed when crossing roads, compared to before and after road crossings. Increased hourly traffic volume reduced the rate of road crossings by both species. Behavioral responses of red squirrels to roads and traffic resemble responses to elevated predation risk, including reduced speed near roads and increased tortuosity of movement paths with increased traffic volume. In contrast, Abert's squirrels appeared little affected by roads and traffic with tortuosity of movement paths reduced as distance to roads decreased. We found that species with similar body size category (< 1 kg) but different habitat preference and foraging strategy responded to roads differently and demonstrated that behavior and ecology are important when considering effects of roads on wildlife. Our results indicate that roads restricted movements and space use of a native forest-dependent species while creating habitat preferred by an introduced, edge-tolerant species.	[Chen, Hsiang Ling; Koprowski, John L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA	University of Arizona	Chen, HL (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA.	hchen@mail.sdsu.edu		Koprowski, John/0000-0003-1406-9853	University of Arizona; Arizona Agriculture Experiment Station; TE Inc; American Society of Mammalogists	University of Arizona; Arizona Agriculture Experiment Station; TE Inc; American Society of Mammalogists	This study was funded by University of Arizona http://www.arizona.edu/, Arizona Agriculture Experiment Station https://ag.arizona.edu/aes/, T&E Inc. Incorporated's Grants for Conservation Research, and the American Society of Mammalogists' Grants-in-Aid Program http://www.mammalsociety.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SM, 2005, CAN GEOGR-GEOGR CAN, V49, P321, DOI 10.1111/j.0008-3658.2005.00099.x; Andrews KM, 2005, COPEIA, P772, DOI 10.1643/0045-8511(2005)005[0772:HDHISM]2.0.CO;2; Angold PG, 1997, J APPL ECOL, V34, P409, DOI 10.2307/2404886; [Anonymous], 1998, QUANTITATIVE ANAL MO; Bakker VJ, 2006, J MAMMAL, V87, P124, DOI 10.1644/04-MAMM-A-050R2.1; Bakker VJ, 2004, CONSERV BIOL, V18, P689, DOI 10.1111/j.1523-1739.2004.00149.x; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bates D. M., 2013, LME4 LINEAR MIXED EF; Beyer H. L, 2012, GEOSPATIAL MODELLING; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bhattacharya M, 2003, BIOL CONSERV, V109, P37, DOI 10.1016/S0006-3207(02)00130-1; Bissonette JA, 2009, ECOL SOC, V14; Bowker JM, 2012, SRS160 US FISH WILDL; Bowman J, 2010, CAN J ZOOL, V88, P454, DOI 10.1139/Z10-019; Brehme CS, 2013, CONSERV BIOL, V27, P710, DOI 10.1111/cobi.12081; BROWN DE, 1984, ARIZONAS TREE SQUIRR; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; BROWN JS, 1994, ECOLOGY, V75, P2286, DOI 10.2307/1940884; Buenau KE, 2004, ANIM CONSERV, V7, P17, DOI 10.1017/S1367943003001124; BURNETT SE, 1992, WILDLIFE RES, V19, P95, DOI 10.1071/WR9920095; Central Intelligence Agency, 2014, WORLD FACTBOOK; Chen HL, 2015, BARRIER EFFECTS ROAD; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; COLEMAN JS, 1989, J WILDLIFE MANAGE, V53, P782, DOI 10.2307/3809213; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; DAVIS R, 1988, SOUTHWEST NAT, V33, P490, DOI 10.2307/3672222; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dodd NL, 2006, RESTOR ECOL, V14, P537, DOI 10.1111/j.1526-100X.2006.00165.x; Dussault C, 2007, J WILDLIFE MANAGE, V71, P2338, DOI 10.2193/2006-499; Dyer SJ, 2002, CAN J ZOOL, V80, P839, DOI [10.1139/z02-060, 10.1139/Z02-060]; Edelman AJ, 2006, CAN J ZOOL, V84, P404, DOI 10.1139/z06-009; Edelman AJ, 2005, SOUTHWEST NAT, V50, P461, DOI 10.1894/0038-4909(2005)050[0461:DATUOA]2.0.CO;2; Edelman Andrew J., 2009, P358; Edelman AJ, 2009, J MAMMAL, V90, P167, DOI 10.1644/07-MAMM-A-282.1; EMMONS LH, 1980, ECOL MONOGR, V50, P31, DOI 10.2307/2937245; FAHRIG L, 1988, THEOR POPUL BIOL, V34, P194, DOI 10.1016/0040-5809(88)90042-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2009, ECOL SOC, V14; FERNER J W, 1974, Southwestern Naturalist, V18, P470, DOI 10.2307/3670306; Flaherty EA, 2008, CAN J ZOOL, V86, P1050, DOI 10.1139/Z08-084; Food and Agriculture Organization of the United Nations, 2010, 163 FAO UN; Ford AT, 2008, J MAMMAL, V89, P895, DOI 10.1644/07-MAMM-A-320.1; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2000, CONSERV BIOL, V14, P36, DOI 10.1046/j.1523-1739.2000.99088.x; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frid A, 2002, CONSERV ECOL, V6; Fuentes-Montemayor E, 2009, J ANIM ECOL, V78, P857, DOI 10.1111/j.1365-2656.2009.01551.x; Goosem M, 1997, WILDLIFE RES, V24, P613, DOI 10.1071/WR96063; Goosem M, 2000, WILDLIFE RES, V27, P151, DOI 10.1071/WR98091; Goosem M, 2002, WILDLIFE RES, V29, P277, DOI 10.1071/WR01058; Goosem M, 2001, WILDLIFE RES, V28, P351, DOI 10.1071/WR99093; Goosem M, 2007, CURR SCI INDIA, V93, P1587; Gurnell J, 2004, J ANIM ECOL, V73, P26, DOI 10.1111/j.1365-2656.2004.00791.x; Haddad NM, 1999, AM NAT, V153, P215, DOI 10.1086/303163; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Hurly TA, 1997, J MAMMAL, V78, P529, DOI 10.2307/1382904; Hutton KA, 2003, SOUTHWEST NAT, V48, P257, DOI 10.1894/0038-4909(2003)048&lt;0257:UOMASF&gt;2.0.CO;2; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; KEITH JO, 1965, ECOLOGY, V46, P150, DOI 10.2307/1935266; Kerth G., 2009, BIOL CONSERV, V142, P270, DOI DOI 10.1016/j.biocon.2008.10.022; Koprowski JL, 2005, ANIM CONSERV, V8, P369, DOI 10.1017/S1367943005002416; Koprowski John L., 2008, Endangered Species Research, V4, P227, DOI 10.3354/esr00026; LARSEN KW, 1994, ECOLOGY, V75, P214, DOI 10.2307/1939395; Laurance SGW, 2004, CONSERV BIOL, V18, P1099, DOI 10.1111/j.1523-1739.2004.00268.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Leonard KM, 2009, AM MIDL NAT, V162, P125, DOI 10.1674/0003-0031-162.1.125; Lurz PWW, 2001, LANDSCAPE ECOL, V16, P407, DOI 10.1023/A:1017508711713; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; Marsh DM, 2005, CONSERV BIOL, V19, P2004, DOI 10.1111/j.1523-1739.2005.00238.x; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Merrick MJ, 2007, J WILDLIFE MANAGE, V71, P1958, DOI 10.2193/2006-260; Millennium Ecosystem Assessment, 2005, ECOSYSTEM HUMAN WELL; Minckley WL., 1968, J ARIZONA ACAD SCI, V5, P110; Minor RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143927; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; NASH D J, 1977, Mammalian Species, V80, P1; Pepper H, 1994, 191 UK FOR COMM; Reed RA, 1996, CONSERV BIOL, V10, P1098, DOI 10.1046/j.1523-1739.1996.10041098.x; Rico A, 2007, ACTA THERIOL, V52, P85, DOI 10.1007/BF03194203; RIEGE DA, 1991, J MAMMAL, V72, P152, DOI 10.2307/1381990; Roedenbeck IA, 2007, ECOL SOC, V12; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; Rushton SP, 2006, BIOL CONSERV, V131, P121, DOI 10.1016/j.biocon.2006.02.010; Rytwinski T, 2007, LANDSCAPE ECOL, V22, P1501, DOI 10.1007/s10980-007-9134-2; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Sanderson H.R., 2009, LAST REFUGE MT GRAHA; Saunders SC, 2002, BIOL CONSERV, V103, P209, DOI 10.1016/S0006-3207(01)00130-6; Schauffert CA, 2002, SOUTHWEST NAT, V47, P498, DOI 10.2307/3672515; Schubert GH, 1970, RM58 USDA FOR SERV; Seabrook WA, 1996, J WILDLIFE MANAGE, V60, P363, DOI 10.2307/3802236; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; SMITH AA, 1994, J WILDLIFE MANAGE, V58, P437, DOI 10.2307/3809314; Steele M. A., 2001, N AM TREE SQUIRRELS; Steele Michael A., 1998, Mammalian Species, V586, P1; Stiles JH, 1998, LANDSCAPE ECOL, V13, P335, DOI 10.1023/A:1008073813734; Strasburg JL, 2006, NATURE, V440, P875, DOI 10.1038/440875a; SWIHART RK, 1984, J MAMMAL, V65, P357, DOI 10.2307/1381184; TEMPLE SA, 1987, ECOLOGY, V68, P669, DOI 10.2307/1938472; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; U. S. Fish and Wildlife Service, 1993, MOUNT GRAH RED SQUIR; U.S. Fish and Wildlife Service, 1987, FED REGISTER, V52, P20994; U.S. Fish and Wildlife Service, 2011, DRAFT REC PLAN MOUNT; Urban Land Institute, 2013, INFR 2013 GLOB PRIOR; van der Ree R, 2010, ECOL SOC, V15; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Whittington J, 2004, ECOL SOC, V9; World Population Clock, 2015, WORLD POP CLOCK WORL; Zugmeyer CA, 2009, FOREST ECOL MANAG, V257, P464, DOI 10.1016/j.foreco.2008.09.020	115	18	18	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148121	10.1371/journal.pone.0148121	http://dx.doi.org/10.1371/journal.pone.0148121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821366	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528400070
J	Thomas, BE; Velayutham, B; Thiruvengadam, K; Nair, D; Barman, SB; Jayabal, L; Ovung, S; Swaminathan, S				Thomas, Beena Elizabeth; Velayutham, Banurekha; Thiruvengadam, Kannan; Nair, Dina; Barman, Sukendu Bikas; Jayabal, Lavanya; Ovung, Senthanro; Swaminathan, Soumya			Perceptions of Private Medical Practitioners on Tuberculosis Notification: A Study from Chennai, South India	PLOS ONE			English	Article							SEEKING BEHAVIOR; TAMIL-NADU; SECTOR; IMPACT; CARE; PROGRAM; MIX	Background The Government of India declared TB as a notifiable disease in 2012. There is a paucity of information on the government's mandatory TB notification order from the perspective of private medical practitioners (PPs). Objective To understand the awareness, perception and barriers on TB notification among PPs in Chennai, India. Methods Total of 190 PPs were approached in their clinics by trained field staff who collected data using a semi-structured and pre-coded questionnaire after getting informed consent. The data collected included PPs' specialization, TB management practices, awareness about the TB notification order, barriers in its implementation and their suggestions to improve notification. Results Of 190 PPs from varied specializations, 138 (73%) had diagnosed TB cases in the prior three months, of whom 78% referred these patients to government facilities. Of 138 PPs, 73% were aware of the order on mandatory TB notification, of whom 46 (33%) had ever notified a TB case. Of 120 PPs, 63% reported reasons for not notifying TB cases. The main reasons reported for not notifying were lack of time (50%), concerns regarding patients' confidentiality (24%) and fear of offending patients (11%). Of 145 PPs, 76% provided feedback about information they felt uncomfortable reporting during notification. PPs felt most uncomfortable reporting patient's government-issued Aadhar number (77%), followed by patient's phone number (37%) and residential address (26%). The preferred means of notification was through mobile phone communication (24%), SMS (18%) and e-mail (17%). Conclusion This study highlights that one-fourth of PPs were not aware of the TB notification order and not all those who were aware were notifying. While it is important to sensitize PPs on the importance of TB notification it is also important to understand the barriers faced by PPs and to make the process user-friendly in order to increase TB notification.	[Thomas, Beena Elizabeth; Velayutham, Banurekha; Thiruvengadam, Kannan; Nair, Dina; Ovung, Senthanro] ICMR, Natl Inst Res TB, Madras, Tamil Nadu, India; [Barman, Sukendu Bikas] ICMR, Natl Inst Res Tribal Hlth, Jabalpur, India; [Jayabal, Lavanya] Corp Chennai, Madras, Tamil Nadu, India; [Swaminathan, Soumya] Dept Hlth Res, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR)	Thomas, BE (corresponding author), ICMR, Natl Inst Res TB, Madras, Tamil Nadu, India.	beenaelli09@gmail.com	Thiruvengadam, Kannan/AAQ-8532-2021	Thiruvengadam, Kannan/0000-0002-3758-1094				Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2014, TB IND 2014 REV NAT; Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379; Datta Kisalay, 2010, Indian J Tuberc, V57, P199; Government of India, 2012, Z2801522012TB GOV IN; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Lal SS, 2011, INT J TUBERC LUNG D, V15, P97; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Mahendradhata Y, 2007, TROP MED INT HEALTH, V12, P315, DOI 10.1111/j.1365-3156.2007.01816.x; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Nagaraja SB, 2014, INT J TUBERC LUNG D, V18, P1353, DOI 10.5588/ijtld.13.0836; Philip S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123286; Quy HT, 2003, INT J TUBERC LUNG D, V7, P464; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Selvam JM, 2007, INT J TUBERC LUNG D, V11, P161; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; Ullah AZ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001534; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Vyas RM, 2003, INT J TUBERC LUNG D, V7, P543; World Health Organization (WHO), 2014, GLOB TB REP 2014	19	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147579	10.1371/journal.pone.0147579	http://dx.doi.org/10.1371/journal.pone.0147579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820750	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000369528400033
J	Zhang, B; Liang, L; Dong, YH; Lian, ZY; Chen, WB; Liang, CH; Zhang, SX				Zhang, Bin; Liang, Long; Dong, Yuhao; Lian, Zhouyang; Chen, Wenbo; Liang, Changhong; Zhang, Shuixing			Intravoxel Incoherent Motion MR Imaging for Staging of Hepatic Fibrosis	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; ASSESSING LIVER FIBROSIS; ULTRASOUND ELASTOGRAPHY; B-VALUES; IN-VIVO; DIAGNOSIS; CIRRHOSIS; PERFUSION; MODEL; LESIONS	Objectives To determine the potential of intravoxel incoherent motion (IVIM) MR imaging for staging of hepatic fibrosis (HF). Methods We searched PubMed and EMBASE from their inception to 31 July 2015 to select studies reporting IVIM MR imaging and HF staging. We defined F1-2 as non-advanced HF, F3-4 as advanced HF, F0 as normal liver, F1 as very early HF, and F2-4 as significant HF. Then we compared stage F0 with F1, F0-1 with F2-3, and F1-2 with F3-4 using IVIM-derived parameters (pseudo-diffusion coefficient D*, perfusion fraction f, and pure molecular diffusion parameter D). The effect estimate was expressed as a pooled weighted mean difference (WMD) with 95% confidence interval (CI), using the fixed-effects model. Results Overall, we included six papers (406 patients) in this study. Significant differences in D* were observed between F0 and F1, F0-1 and F2-3, and F1-2 and F3-4 (WMD 2.46, 95% CI 0.83-4.09, P = 0.006; WMD 13.10, 95% CI 9.53-16.67, P < 0.001; WMD 14.34, 95% CI 10.26-18.42, P < 0.001, respectively). Significant differences in f were also found between F0 and F1, F0-1 and F2-3, and F1-2 and F3-4 (WMD 1.62, 95% CI 0.06-3.18, P = 0.027; WMD 5.63, 95% CI 2.74-8.52, P < 0.001; WMD 3.30, 95% CI 2.10-4.50, P < 0.001, respectively). However, D showed no differences between F0 and F1, F0-1 and F2-3, and F1-2 and F3-4 (WMD 0.05, 95% CI -0.01-0.11, P = 0.105; WMD 0.04, 95% CI -0.01-0.10, P = 0.230; WMD 0.02, 95% CI -0.02-0.06, P = 0.378, respectively). Conclusions IVIM MR imaging provides an effective method of staging HF and can distinguish early HF from normal liver, significant HF from normal liver or very early HF, and advanced HF from non-advanced HF.	[Zhang, Bin; Liang, Long; Dong, Yuhao; Lian, Zhouyang; Chen, Wenbo; Liang, Changhong; Zhang, Shuixing] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Bin; Liang, Long; Lian, Zhouyang] Southern Med Univ, Grad Coll, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Zhang, SX (corresponding author), Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	shui7515@126.com	Zhang, Bin/AAH-4560-2019; Liang, Chang Hong/L-1885-2016; Zhang, Bin/M-3689-2014	Zhang, Bin/0000-0002-6286-6227; Zhang, Bin/0000-0001-7313-9300	National Scientific Foundation of China [81171329]; Guangdong Science Foundation [S2011010000790]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science Foundation	This study was supported by grants from the National Scientific Foundation of China (81171329) and the Guangdong Science Foundation (S2011010000790). The study sponsor had no involvement in the conduct of the study or the writing of the manuscript.	Afdhal NH, 2003, HEPATOLOGY, V37, P972, DOI 10.1053/jhep.2003.50223; Annet L, 2007, J MAGN RESON IMAGING, V25, P122, DOI 10.1002/jmri.20771; Chen CY, 2014, CHINESE MED J-PEKING, V127, P3082, DOI 10.3760/cma.j.issn.0366-6999.20140346; Chow AM, 2012, J MAGN RESON IMAGING, V36, P159, DOI 10.1002/jmri.23607; Chung SR, 2015, ACTA RADIOL, V56, P1428, DOI 10.1177/0284185114559763; Cohen-Ezra O, 2015, HAREFUAH, V154, P209; Cohen-Ezra O, 2015, HAREFUAH, V154, P210; Cohen-Ezra Oranit, 2015, Harefuah, V154, P204; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Feier D, 2015, EUR RADIOL; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Girometti R, 2008, J MAGN RESON IMAGING, V28, P411, DOI 10.1002/jmri.21461; Guiu B, 2012, RADIOLOGY, V265, P96, DOI 10.1148/radiol.12112478; Hayashi T, 2013, J MAGN RESON IMAGING, V38, P148, DOI 10.1002/jmri.23966; Hu GW, 2015, J MAGN RESON IMAGING, V42, P331, DOI 10.1002/jmri.24796; Ichikawa S, 2015, J MAGN RESON IMAGING, V42, P204, DOI 10.1002/jmri.24760; Kang KM, 2014, RADIOLOGY, V270, P444, DOI 10.1148/radiol.13122712; Kim AI, 2005, AM J MED, V118, P808, DOI 10.1016/j.amjmed.2005.01.073; Koinuma M, 2005, J MAGN RESON IMAGING, V22, P80, DOI 10.1002/jmri.20344; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee EYP, 2014, EUR RADIOL, V24, P1506, DOI 10.1007/s00330-014-3160-7; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; Leporq B, 2015, J MAGN RESON IMAGING, V41, P1209, DOI 10.1002/jmri.24693; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Lu PX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113846; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Lutz HH, 2015, DIGEST DIS SCI, V60, P2825, DOI 10.1007/s10620-015-3682-0; Moteki T, 2006, J MAGN RESON IMAGING, V24, P637, DOI 10.1002/jmri.20682; Muller MF, 1998, EUR J RADIOL, V26, P297, DOI 10.1016/S0720-048X(97)01161-3; Palmucci S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/874201; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Sakamoto J, 2014, MAGN RESON IMAGING, V32, P860, DOI 10.1016/j.mri.2014.05.002; Sandrasegaran K, 2009, AM J ROENTGENOL, V193, P1556, DOI 10.2214/AJR.09.2436; Sigmund EE, 2011, MAGN RESON MED, V65, P1437, DOI 10.1002/mrm.22740; Soresi M, 2014, WORLD J GASTROENTERO, V20, P18131, DOI 10.3748/wjg.v20.i48.18131; Suk KT, 2015, WORLD J HEPATOL, V7, P607, DOI 10.4254/wjh.v7.i3.607; Tang A, 2015, AM J ROENTGENOL, V205, P33, DOI 10.2214/AJR.15.14553; Tang A, 2015, AM J ROENTGENOL, V205, P22, DOI 10.2214/AJR.15.14552; Wang LL, 2014, EUR RADIOL, V24, P1914, DOI 10.1007/s00330-014-3176-z; Wu CH, 2015, EUR RADIOL, V25, P3552, DOI 10.1007/s00330-015-3774-4; Yoon JH, 2014, J COMPUT ASSIST TOMO, V38, P110, DOI 10.1097/RCT.0b013e3182a589be; Yoon JH, 2014, J MAGN RESON IMAGING, V39, P276, DOI 10.1002/jmri.24158; Zhang SX, 2014, EUR RADIOL, V24, P1998, DOI 10.1007/s00330-014-3203-0; Zhang Y, 2013, MAGN RESON IMAGING, V31, P1017, DOI 10.1016/j.mri.2013.03.007	45	24	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147789	10.1371/journal.pone.0147789	http://dx.doi.org/10.1371/journal.pone.0147789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820668	Green Published, gold			2022-12-27	WOS:000369528400043
J	Krupka, J; May, F; Weimer, T; Pragst, I; Kleinschnitz, C; Stoll, G; Panousis, C; Dickneite, G; Nolte, MW				Krupka, Jennifer; May, Frauke; Weimer, Thomas; Pragst, Ingo; Kleinschnitz, Christoph; Stoll, Guido; Panousis, Con; Dickneite, Gerhard; Nolte, Marc W.			The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; THROMBUS FORMATION; PROVIDES PROTECTION; CONTACT PATHWAY; STROKE; ACTIVATION; SYSTEM; MICE; INFESTIN-4; DEFICITS	Background and Purpose Ischemic stroke provokes severe brain damage and remains a predominant disease in industrialized countries. The coagulation factor XII (FXII)-driven contact activation system plays a central, but not yet fully defined pathogenic role in stroke development. Here, we investigated the efficacy of the FXIIa inhibitor rHA-Infestin-4 in a rat model of ischemic stroke using both a prophylactic and a therapeutic approach. Methods For prophylactic treatment, animals were treated intravenously with 100 mg/kg rHA-Infestin-4 or an equal volume of saline 15 min prior to transient middle cerebral artery occlusion (tMCAO) of 90 min. For therapeutic treatment, 100 mg/kg rHA-Infestin-4, or an equal volume of saline, was administered directly after the start of reperfusion. At 24 h after tMCAO, rats were tested for neurological deficits and blood was drawn for coagulation assays. Finally, brains were removed and analyzed for infarct area and edema formation. Results Within prophylactic rHA-Infestin-4 treatment, infarct areas and brain edema formation were reduced accompanied by better neurological scores and survival compared to controls. Following therapeutic treatment, neurological outcome and survival were still improved although overall effects were less pronounced compared to prophylaxis. Conclusions With regard to the central role of the FXII-driven contact activation system in ischemic stroke, inhibition of FXIIa may represent a new and promising treatment approach to prevent cerebral ischemia/reperfusion injury.	[Krupka, Jennifer; May, Frauke; Weimer, Thomas; Pragst, Ingo; Dickneite, Gerhard; Nolte, Marc W.] CSL Behring GmbH, Marburg, Germany; [Kleinschnitz, Christoph; Stoll, Guido] Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, Wurzburg, Germany; [Panousis, Con] CSL Ltd, Inst Bio21, Parkville, Vic, Australia	CSL; University of Wurzburg; CSL	Nolte, MW (corresponding author), CSL Behring GmbH, Marburg, Germany.	marc.nolte@cslbehring.com		Kleinschnitz, Christoph/0000-0002-1650-8875	CSL Behring GmbH; CSL Limited	CSL Behring GmbH; CSL Limited	JK, FM, TW, IP and MWN are employees of CSL Behring GmbH, GD has been an employee of CSL Behring GmbH and CP is an employee of CSL Limited. Thereby, CSL Behring GmbH and CSL Limited provided support in the form of salaries and/or research materials for authors JK, FM, TW, IP, MWN, GD and CP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, GS has been a consultant of CSL Behring GmbH. CK receives financial support from CSL Behring GmbH to conduct research on FXII in experimental stroke. Thereby, GS and CK received no funding for this work.	Adams RJ, 2008, STROKE, V39, P1647, DOI 10.1161/STROKEAHA.107.189063; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Arboix A, 2015, WORLD J CLIN CASES, V3, P418, DOI 10.12998/wjcc.v3.i5.418; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Baker AH, 2007, P NATL ACAD SCI USA, V104, P3597, DOI 10.1073/pnas.0611112104; Bendszus M, 2006, LANCET NEUROL, V5, P364, DOI 10.1016/S1474-4422(06)70412-4; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bjorkqvist J, 2015, J CLIN INVEST, V125, P3132, DOI 10.1172/JCI77139; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Cai TQ, 2015, BLOOD COAGULATION FI; Campos ITN, 2004, ACTA CRYSTALLOGR D, V60, P2051, DOI 10.1107/S0907444904021596; Candelario-Jalil E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-3; Cao ZH, 2015, J ALLERGY CLIN IMMUN, V135, pAB194, DOI 10.1016/j.jaci.2014.12.1570; Chen JW, 2012, JACC-CARDIOVASC IMAG, V5, P1127, DOI 10.1016/j.jcmg.2012.01.025; Davis AE, 2008, MOL IMMUNOL, V45, P4057, DOI 10.1016/j.molimm.2008.06.028; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Dunnett SB, 1998, NEUROSCI LETT, V246, P1, DOI 10.1016/S0304-3940(98)00194-3; Edmunds LH, 2002, PERFUSION-UK, V17, P243, DOI 10.1191/0267659102pf585oa; Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Gob E, 2015, ANN NEUROL, V77, P784, DOI 10.1002/ana.24380; Grotta JC, 2015, STROKE, V46, P1447, DOI 10.1161/STROKEAHA.115.008384; Gruber A, 2014, THROMB RES, V133, pS45, DOI 10.1016/j.thromres.2014.03.019; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Hopp S, 2014, 87 K DTSCH GES NEUR; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kenna E, 2014, DRUG DISCOV TODAY, V19, P1459, DOI 10.1016/j.drudis.2014.06.024; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Larsson M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006804; Leung PY, 2012, TRANSL STROKE RES, V3, P381, DOI 10.1007/s12975-012-0186-5; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Maas C, 2011, SEMIN THROMB HEMOST, V37, P375, DOI 10.1055/s-0031-1276586; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Pham M, 2012, J MOL MED, V90, P119, DOI 10.1007/s00109-011-0812-9; Muller F, 2008, CURR OPIN HEMATOL, V15, P516, DOI 10.1097/MOH.0b013e328309ec85; Muller F, 2011, CURR OPIN HEMATOL, V18, P349, DOI 10.1097/MOH.0b013e3283497e61; Muller T, 2013, DTSCH ARZTEBL INT, V110, P159, DOI 10.3238/arztebl.2013.0159; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; O'Carroll CB, 2015, NEUROHOSPITALIST, V5, P122, DOI 10.1177/1941874415587681; Paciaroni M, 2007, STROKE, V38, P423, DOI 10.1161/01.STR.0000254600.92975.1f; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Renne Thomas, 2007, Expert Rev Cardiovasc Ther, V5, P733, DOI 10.1586/14779072.5.4.733; Renne T, 2012, BLOOD, V120, P4296, DOI 10.1182/blood-2012-07-292094; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; Sandercock PAG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub3; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; Schmaier AH, 2010, THROMB RES, V125, P105, DOI 10.1016/j.thromres.2009.09.023; Schousboe I, 2008, BIOCHEM PHARMACOL, V75, P1007, DOI 10.1016/j.bcp.2007.10.003; Siegerink B, 2010, CIRCULATION, V122, P1854, DOI 10.1161/CIRCULATIONAHA.110.943738; Sniecinski RM, 2011, ANESTH ANALG, V113, P1319, DOI 10.1213/ANE.0b013e3182354b7e; Stavrou E, 2010, THROMB RES, V125, P210, DOI 10.1016/j.thromres.2009.11.028; Undas A, 2014, POL ARCH MED WEWN, V124, P124, DOI 10.20452/pamw.2138; Wagner S, 2002, J NEUROL SCI, V202, P75, DOI 10.1016/S0022-510X(02)00208-3; Winter B, 2004, STROKE, V35, P191, DOI 10.1161/01.STR.0000107188.29688.2C; Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5	62	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146783	10.1371/journal.pone.0146783	http://dx.doi.org/10.1371/journal.pone.0146783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815580	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200019
J	Barbui, C; Bighelli, I; Carra, G; Castellazzi, M; Lucii, C; Martinotti, G; Nose, M; Ostuzzi, G				Barbui, Corrado; Bighelli, Irene; Carra, Giuseppe; Castellazzi, Mariasole; Lucii, Claudio; Martinotti, Giovanni; Nose, Michela; Ostuzzi, Giovanni		STAR NETWORK INVESTIGATORS	Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval	PLOS ONE			English	Article							TORSADE-DE-POINTES; PROLONGATION; SCHIZOPHRENIA; DRUG; TOLERABILITY; MEDICATIONS; EFFICACY; DOSAGES; RISK	Antipsychotic (AP) drugs have the potential to cause prolongation of the QT interval corrected for heart rate (QTc). As this risk is dose-dependent, it may be associated with the number of AP drugs concurrently prescribed, which is known to be associated with increased cumulative equivalent AP dosage. This study analysed whether AP dose mediates the relationship between polypharmacy and QTc interval. We used data from a cross-sectional survey that investigated the prevalence of QTc lengthening among people with psychiatric illnesses in Italy. AP polypharmacy was tested for evidence of association with AP dose and QTc interval using the Baron and Kenny mediational model. A total of 725 patients were included in this analysis. Of these, 186 (26%) were treated with two or more AP drugs (AP polypharmacy). The mean cumulative AP dose was significantly higher in those receiving AP polypharmacy (prescribed daily dose/defined daily dose = 2.93, standard deviation 1.31) than monotherapy (prescribed daily dose/defined daily dose = 0.82, standard deviation 0.77) (z = -12.62, p < 0.001). Similarly, the mean QTc interval was significantly longer in those receiving AP polypharmacy (mean = 420.86 milliseconds, standard deviation 27.16) than monotherapy (mean = 413.42 milliseconds, standard deviation 31.54) (z = -2.70, p = 0.006). The Baron and Kenny mediational analysis showed that, after adjustment for confounding variables, AP dose mediates the association between polypharmacy and QTc interval. The present study found that AP polypharmacy is associated with QTc interval, and this effect is mediated by AP dose. Given the high prevalence of AP polypharmacy in real-world clinical practice, clinicians should consider not only the myriad risk factors for QTc prolongation in their patients, but also that adding a second AP drug may further increase risk as compared with monotherapy.	[Barbui, Corrado; Bighelli, Irene; Castellazzi, Mariasole; Nose, Michela; Ostuzzi, Giovanni] Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Sect Psychiat, I-37100 Verona, Italy; [Carra, Giuseppe] UCL, Div Psychiat, London WC1E 6BT, England; [Carra, Giuseppe] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy; [Lucii, Claudio] Dept Mental Hlth, Siena, Italy; [Martinotti, Giovanni] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy	University of Verona; University of London; University College London; University of Milano-Bicocca; G d'Annunzio University of Chieti-Pescara	Barbui, C (corresponding author), Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Sect Psychiat, I-37100 Verona, Italy.	corrado.barbui@univr.it	Bighelli, Irene/I-1118-2019; Ostuzzi, Giovanni/O-3824-2017; Gastaldon, Chiara/AAN-5630-2020; Martinotti, Giovanni/AAC-7592-2022; Signorelli, Maria/E-6155-2010; Bartoli, Francesco/K-5755-2016; Quattrone, Diego/I-2362-2019; Carrà, Giuseppe/C-6091-2012; Clerici, Massimo/U-3074-2019; Magni, Laura Rosa/J-7776-2016; Rossi, Giuseppe/G-6158-2017; Luca, Antonina/AAA-6605-2022; Signorelli, Maria Salvina/E-6155-2010	Bighelli, Irene/0000-0002-5661-5149; Ostuzzi, Giovanni/0000-0003-2248-9524; Gastaldon, Chiara/0000-0001-7257-2962; Martinotti, Giovanni/0000-0002-7292-2341; Signorelli, Maria/0000-0002-6941-9454; Bartoli, Francesco/0000-0003-2612-4119; Quattrone, Diego/0000-0002-6051-8309; Carrà, Giuseppe/0000-0002-6877-6169; Clerici, Massimo/0000-0001-8769-6474; Magni, Laura Rosa/0000-0002-1479-8733; Rossi, Giuseppe/0000-0002-5902-2568; Luca, Antonina/0000-0002-8397-3478; Prestia, Davide/0000-0003-0469-7688; Luca, Maria/0000-0001-5935-8283; Papola, Davide/0000-0001-6482-8593; Caroleo, Mariarita/0000-0001-5856-5344; ribolsi, michele/0000-0002-0466-6913; magnani, nadia/0000-0001-7486-8169; Signorelli, Maria Salvina/0000-0001-5835-4176; Aguglia, Andrea/0000-0002-2003-2101; Pinna, Federica/0000-0002-3108-9509				Barbui C, 2006, INT CLIN PSYCHOPHARM, V21, P355, DOI 10.1097/01.yic.0000224785.68040.43; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beach SR, 2013, PSYCHOSOMATICS, V54, P1, DOI 10.1016/j.psym.2012.11.001; Biancosino B, 2005, INT CLIN PSYCHOPHARM, V20, P305, DOI 10.1097/00004850-200511000-00004; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Haddad PM, 2002, DRUGS, V62, P1649, DOI 10.2165/00003495-200262110-00006; Hasnain M, 2014, CNS DRUGS, V28, P887, DOI 10.1007/s40263-014-0196-9; Howland RH, 2014, PSYCHOSOMATICS, V55, P741, DOI 10.1016/j.psym.2014.07.004; John AP, 2015, J CLIN PSYCHOPHARM, V35, P193, DOI 10.1097/JCP.0000000000000280; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kuipers E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1173; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; McNamara RK, 2011, SCHIZOPHR RES, V129, P66, DOI 10.1016/j.schres.2011.03.016; Meyer-Massetti Carla, 2010, J Hosp Med, V5, pE8, DOI 10.1002/jhm.691; Nose M, 2016, EPIDEMIOL P IN PRESS; Nose M, 2008, EPIDEMIOL PSICHIAT S, V17, P186, DOI 10.1017/S1121189X00001263; Nose M, 2008, INT CLIN PSYCHOPHARM, V23, P287, DOI 10.1097/YIC.0b013e328303ac75; Polcwiartek C, 2015, PSYCHOPHARMACOLOGY, V232, P3297, DOI 10.1007/s00213-015-4024-9; Rabkin SW, 2015, CAN J PSYCHIAT, V60, P206, DOI 10.1177/070674371506000502; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Sernyak MJ, 2004, J CLIN PSYCHIAT, V65, P1597, DOI 10.4088/JCP.v65n1203; Stahl SM, 2013, REV PSIQUIATR SALUD, V6, P97, DOI 10.1016/j.rpsm.2013.01.001; Takeuchi H, 2015, CAN J PSYCHIAT, V60, P215, DOI 10.1177/070674371506000503; Tani H, 2013, SCHIZOPHR RES, V143, P215, DOI 10.1016/j.schres.2012.10.015; Targher G, 2014, NUTR METAB CARDIOVAS, V24, P663, DOI 10.1016/j.numecd.2014.01.005; van Bennekom MWHL, 2013, J PSYCHOPHARMACOL, V27, P327, DOI 10.1177/0269881113477709; Wenzel-Seifert K, 2011, DTSCH ARZTEBL INT, V108, P687, DOI 10.3238/arztebl.2011.0687	28	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148212	10.1371/journal.pone.0148212	http://dx.doi.org/10.1371/journal.pone.0148212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840602	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200099
J	Gilbert, AL; Lattanzio, MS				Gilbert, Anthony L.; Lattanzio, Matthew S.			Ontogenetic Variation in the Thermal Biology of Yarrow's Spiny Lizard, Sceloporus jarrovii	PLOS ONE			English	Article							WEST-INDIAN LIZARD; CLIMATE-CHANGE; LOCOMOTOR PERFORMANCE; INTRASPECIFIC COMPETITION; THERMOREGULATORY BEHAVIOR; GROWTH-RATES; WATER-LOSS; FOOD; SIZE; TEMPERATURE	Climate change is rapidly altering the way current species interact with their environment to satisfy life-history demands. In areas anticipated to experience extreme warming, rising temperatures are expected to diminish population growth, due either to environmental degradation, or the inability to tolerate novel temperature regimes. Determining how at risk ectotherms, and lizards in particular, are to changes in climate traditionally emphasizes the thermal ecology and thermal sensitivity of physiology of adult members of a population. In this study, we reveal ontogenetic differences in thermal physiological and ecological traits that have been used to anticipate how ectotherms will respond to climate change. We show that the thermal biological traits of juvenile Yarrow's Spiny Lizards (Sceloporus jarrovii) differ from the published estimates of the same traits for adult lizards. Juvenile S. jarrovii differ in their optimal performance temperature, field field-active body temperature, and critical thermal temperatures compared to adult S. jarrovii. Within juvenile S. jarrovii, males and females exhibit differences in field-active body temperature and desiccation tolerance. Given the observed age-and sex-related variation in thermal physiology, we argue that not including physiological differences in thermal biology throughout ontogeny may lead to misinterpretation of patterns of ecological or evolutionary change due to climate warming. Further characterizing the potential for ontogenetic changes in thermal biology would be useful for a more precise and accurate estimation of the role of thermal physiology in mediating population persistence in warmer environments.	[Gilbert, Anthony L.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Lattanzio, Matthew S.] Christopher Newport Univ, Dept Organismal & Environm Biol, Newport News, VA 23606 USA	University System of Ohio; Ohio University	Gilbert, AL (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	ag499412@ohio.edu			Ohio University Graduate Student Senate Original Work Grant	Ohio University Graduate Student Senate Original Work Grant	Funding for this work was received from the Ohio University Graduate Student Senate Original Work Grant (to ALG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2014, AM NAT, V184, pE50, DOI 10.1086/677386; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; BALLINGER RE, 1973, ECOLOGY, V54, P269, DOI 10.2307/1934336; Beal MS, 2014, ECOL EVOL, V4, P4220, DOI 10.1002/ece3.1297; Bennett A.F., 1990, Oxford Surveys in Evolutionary Biology, V7, P251; Boggs CL, 2012, ECOL LETT, V15, P502, DOI 10.1111/j.1461-0248.2012.01766.x; Bowen KD, 2003, J HERPETOL, V37, P729, DOI 10.1670/46-03N; Brown RP, 2005, J THERM BIOL, V30, P79, DOI 10.1016/j.jtherbio.2004.07.005; Buckley LB, 2015, FUNCT ECOL, V29, P1038, DOI 10.1111/1365-2435.12406; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Carrier DR, 1996, PHYSIOL ZOOL, V69, P467, DOI 10.1086/physzool.69.3.30164211; Clobert J, 2000, FUNCT ECOL, V14, P675, DOI 10.1046/j.1365-2435.2000.00477.x; Clusella-Trullas S, 2011, SCIENCE, V332, DOI 10.1126/science.1195193; Cox RM, 2007, HERPETOLOGICA, V63, P245, DOI 10.1655/0018-0831(2007)63[245:GATTDO]2.0.CO;2; DAWSON WR, 1966, ECOLOGY, V47, P589, DOI 10.2307/1933936; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Durtsche RD, 1997, ECOGRAPHY, V20, P336, DOI 10.1111/j.1600-0587.1997.tb00378.x; Galan P, 2008, ANIM BIOL, V58, P173, DOI 10.1163/157075608X328026; GARLAND T, 1985, J ZOOL, V207, P425; Garland T, 1991, EVOLUTION; Gienapp P, 2014, QUANTITATIVE GENETICS IN THE WILD, P254; Gunderson AR, 2015, AM NAT, V185, P653, DOI 10.1086/680849; Gunderson AR, 2011, J COMP PHYSIOL B, V181, P965, DOI 10.1007/s00360-011-0576-0; Haenel GJ, 2003, COPEIA, P113, DOI 10.1643/0045-8511(2003)003[0113:HRAISU]2.0.CO;2; Haenel GJ, 2003, COPEIA, DOI DOI 10.1643/0045-8511(2003)003%5B0099:HRAISU%5D2.0.CO%3B2; Herczeg G, 2008, OECOLOGIA, V155, P1, DOI 10.1007/s00442-007-0886-9; Herrel A, 2006, BIOL J LINN SOC, V89, P443, DOI 10.1111/j.1095-8312.2006.00685.x; HERTZ PE, 1983, EVOLUTION, V37, P1075, DOI 10.1111/j.1558-5646.1983.tb05634.x; HERTZ PE, 1981, ECOLOGY, V62, P515, DOI 10.2307/1937714; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; Hertz PE, 1982, ANIM BEHAV, V1982; Huey R.B., 1991, American Naturalist, V137, P91; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; HUEY RB, 1979, AM ZOOL, V19, P357; Huey RB, 1998, AM ZOOL; Husak JF, 2006, EVOLUTION, V60, P2122, DOI 10.1111/j.0014-3820.2006.tb01849.x; Irschick DJ, 2000, FUNCT ECOL, V14, P438, DOI 10.1046/j.1365-2435.2000.00447.x; Jeglinski JWE, 2013, J ANIM ECOL, V82, P694, DOI 10.1111/1365-2656.12019; Kearney MR, 2013, ECOL LETT, V16, P1470, DOI 10.1111/ele.12192; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Leal M, 2012, AM NAT, V180, P815, DOI 10.1086/668077; Logan ML, 2015, FUNCT ECOL, V29, P694, DOI 10.1111/1365-2435.12379; Logan ML, 2014, P NATL ACAD SCI USA, V111, P14165, DOI 10.1073/pnas.1404885111; Lovern MB, 2001, HORM BEHAV, V39, P131, DOI 10.1006/hbeh.2000.1637; MOORE MC, 1987, GEN COMP ENDOCR, V65, P225, DOI 10.1016/0016-6480(87)90170-5; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; POUGH FH, 1983, ECOLOGY, V64, P244, DOI 10.2307/1937072; POUNDS JA, 1988, ECOL MONOGR, V58, P299, DOI 10.2307/1942542; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Robson MA, 2000, FUNCT ECOL, V14, P338, DOI 10.1046/j.1365-2435.2000.00427.x; Rosenblum EB, 2005, COPEIA, P586, DOI 10.1643/CP-04-154R1; RUBY DE, 1978, COPEIA, P430; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SMITH GR, 1994, FUNCT ECOL, V8, P215, DOI 10.2307/2389904; STAMPS J, 1981, ECOLOGY, V62, P33, DOI 10.2307/1936665; STAMPS JA, 1983, BEHAV ECOL SOCIOBIOL, V12, P19, DOI 10.1007/BF00296929; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; TEMPLETON JAMES R., 1960, PHYSIOL ZOOL, V33, P136; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; VANBERKUM FH, 1989, FUNCT ECOL, V3, P97; Wake DB, 2007, P NATL ACAD SCI USA, V104, P8201, DOI 10.1073/pnas.0702506104; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; West-Eberhard MJ, 2005, J EXP ZOOL PART B, V304B, P610, DOI 10.1002/jez.b.21071; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Williams JB, 1996, AUK, V113, P457, DOI 10.2307/4088912; Wilson D, 2007, BIOL LETT-UK, V3, P40, DOI 10.1098/rsbl.2006.0574; Withers PC, 2000, AUST J ZOOL, V48, P111, DOI 10.1071/ZO99007; Wood SN, 2006, WILEY INTERDISCIPLIN, DOI DOI 10.1002/WICS.10/FULL\; Xu XF, 2006, COMP BIOCHEM PHYS A, V143, P118, DOI 10.1016/j.cbpa.2005.11.004; Zajitschek SRK, 2012, BIOL J LINN SOC, V107, P573, DOI 10.1111/j.1095-8312.2012.01963.x	74	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146904	10.1371/journal.pone.0146904	http://dx.doi.org/10.1371/journal.pone.0146904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840620	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200020
J	Pandya, A; Eggman, AA; Kamel, H; Gupta, A; Schackman, BR; Sanelli, PC				Pandya, Ankur; Eggman, Ashley A.; Kamel, Hooman; Gupta, Ajay; Schackman, Bruce R.; Sanelli, Pina C.			Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRAVENOUS THROMBOLYSIS; EARLY MANAGEMENT; SYMPTOM ONSET; UNKNOWN TIME; HEALTH; CARE; ASSOCIATION; VALIDATION	Background Thrombolytic treatment (tissue-type plasminogen activator [tPA]) is only recommended for acute ischemic stroke patients with stroke onset time <4.5 hours. tPA is not recommended when stroke onset time is unknown. Diffusion-weighted MRI (DWI) and fluid attenuated inversion recovery (FLAIR) MRI mismatch information has been found to approximate stroke onset time with some accuracy. Therefore, we developed a micro-simulation model to project health outcomes and costs of MRI-based treatment decisions versus no treatment for acute wake-up stroke patients. Methods and Findings The model assigned simulated patients a true stroke onset time from a specified probability distribution. DWI-FLAIR mismatch estimated stroke onset <4.5 hours with sensitivity and specificity of 0.62 and 0.78, respectively. Modified Rankin Scale (mRS) scores reflected tPA treatment effectiveness accounting for patients' true stroke onset time. Discounted lifetime costs and benefits (quality-adjusted life years [QALYs]) were projected for each strategy. Incremental cost-effectiveness ratios (ICERs) were calculated for the MRI-based strategy in base-case and sensitivity analyses. With no treatment, 45.1% of simulated patients experienced a good stroke outcome (mRS score 0-1). Under the MRI-based strategy, in which 17.0% of all patients received tPA despite stroke onset times >4.5 hours, 46.3% experienced a good stroke outcome. Lifetime discounted QALYs and costs were 5.312 and $88,247 for the no treatment strategy and 5.342 and $90,869 for the MRI-based strategy, resulting in an ICER of $88,000/QALY. Results were sensitive to variations in patient-and provider-specific factors such as sleep duration, hospital travel and door-to-needle times, as well as onset probability distribution, MRI specificity, and mRS utility values. Conclusions Our model-based findings suggest that an MRI-based treatment strategy for this population could be cost-effective and quantifies the impact that patient-and provider-specific factors, such as sleep duration, hospital travel and door-to-needle times, could have on the optimal decision for wake-up stroke patients.	[Pandya, Ankur] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Eggman, Ashley A.; Schackman, Bruce R.; Sanelli, Pina C.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Kamel, Hooman] New York Presbyterian Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Gupta, Ajay; Sanelli, Pina C.] New York Presbyterian Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Sanelli, Pina C.] North Shore LIJ Hlth Syst, Dept Radiol, Manhasset, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Cornell University; Cornell University; Cornell University; Northwell Health	Pandya, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	anpandya@hsph.harvard.edu	Kamel, Hooman/AGG-9071-2022; Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932	American Heart Association [14CRP18730014]; NIH/NINDS; Michael Goldberg Stroke Research Fund	American Heart Association(American Heart Association); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael Goldberg Stroke Research Fund	Dr. Pandya's effort for this paper was supported by a grant from the American Heart Association (http://www.heart.org/HEARTORG/) (14CRP18730014). Dr. Kamel reports grants from NIH/NINDS and grants from Michael Goldberg Stroke Research Fund during the conduct of the study; and personal fees from Genentech, outside the submitted work. Dr. Gupta reports grants from Foundation of the American Society of Neuroradiology and grants from Association of University Radiologists-GERRAF Award, outside the submitted work. The other authors had no potential conflict of interests to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Albers GW, 2008, CHEST, V133, p630S, DOI 10.1378/chest.08-0720; Breuer L, 2010, INT J STROKE, V5, P68, DOI 10.1111/j.1747-4949.2010.00410.x; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Buck D, 2014, STROKE, V45, P1869, DOI 10.1161/STROKEAHA.114.005126; Caro JJ, 1999, STROKE, V30, P2574, DOI 10.1161/01.STR.30.12.2574; Centers for Medicare and Medicaid Services, 2013, PHYS FEE SCHED; Chambers MG, 2002, VALUE HEALTH, V5, P82, DOI 10.1046/j.1524-4733.2002.52011.x; Earnshaw SR, 2009, VALUE HEALTH, V12, P507, DOI 10.1111/j.1524-4733.2008.00467.x; Ebinger M, 2012, EUR J NEUROL, V19, P348, DOI 10.1111/j.1468-1331.2011.03504.x; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Ehlers L, 2007, STROKE, V38, P85, DOI 10.1161/01.STR.0000251790.19419.a8; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Fink JN, 2002, STROKE, V33, P988, DOI 10.1161/01.STR.0000014585.17714.67; Fink JN, 2002, STROKE, V33, P954, DOI 10.1161/01.STR.0000013069.24300.1D; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HCUP National Inpatient Sample (NIS), 2012, HEALTHC COST UT PROJ; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Huisa BN, 2013, J STROKE CEREBROVASC, V22, P972, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.004; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kang DW, 2012, INT J STROKE, V7, P311, DOI 10.1111/j.1747-4949.2012.00779.x; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Samsa GP, 1999, J CLIN EPIDEMIOL, V52, P259, DOI 10.1016/S0895-4356(98)00151-6; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Serena J, 2003, CEREBROVASC DIS, V16, P128, DOI 10.1159/000070592; Sheppard JP, 2015, AM J HYPERTENS, V28, P30, DOI 10.1093/ajh/hpu104; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; Stahl JE, 2003, RADIOLOGY, V228, P659, DOI 10.1148/radiol.2283021557; Tatlisumak T, 2002, STROKE, V33, P2144, DOI 10.1161/01.STR.0000026862.42440.AA; Thomalla G, 2014, INT J STROKE, V9, P829, DOI 10.1111/ijs.12011; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651; Tung CE, 2011, STROKE, V42, P2257, DOI 10.1161/STROKEAHA.111.615682; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Young KC, 2010, NEUROLOGY, V75, P1678, DOI 10.1212/WNL.0b013e3181fc2838	42	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148106	10.1371/journal.pone.0148106	http://dx.doi.org/10.1371/journal.pone.0148106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840397	Green Published, gold			2022-12-27	WOS:000369550200081
J	Prudkovsky, AA; Ivanenko, VN; Nikitin, MA; Lukyanov, KA; Belousova, A; Reimer, JD; Berumen, ML				Prudkovsky, Andrey A.; Ivanenko, Viatcheslav N.; Nikitin, Mikhail A.; Lukyanov, Konstantin A.; Belousova, Anna; Reimer, James D.; Berumen, Michael L.			Green Fluorescence of Cytaeis Hydroids Living in Association with Nassarius Gastropods in the Red Sea	PLOS ONE			English	Article							GFP-LIKE PROTEINS; EVOLUTION; BIOLUMINESCENCE; HYDROZOA; FAMILY; DIVERSITY; CNIDARIA; RNA	Green Fluorescent Proteins (GFPs) have been reported from a wide diversity of medusae, but only a few observations of green fluorescence have been reported for hydroid colonies. In this study, we report on fluorescence displayed by hydroid polyps of the genus Cytaeis Eschscholtz, 1829 (Hydrozoa: Anthoathecata: Filifera) found at night time in the southern Red Sea (Saudi Arabia) living on shells of the gastropod Nassarius margaritifer (Dunker, 1847) (Neogastropoda: Buccinoidea: Nassariidae). We examined the fluorescence of these polyps and compare with previously reported data. Intensive green fluorescence with a spectral peak at 518 nm was detected in the hypostome of the Cytaeis polyps, unlike in previous reports that reported fluorescence either in the basal parts of polyps or in other locations on hydroid colonies. These results suggest that fluorescence may be widespread not only in medusae, but also in polyps, and also suggests that the patterns of fluorescence localization can vary in closely related species. The fluorescence of polyps may be potentially useful for field identification of cryptic species and study of geographical distributions of such hydroids and their hosts.	[Prudkovsky, Andrey A.; Ivanenko, Viatcheslav N.; Belousova, Anna] Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow, Russia; [Nikitin, Mikhail A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Lukyanov, Konstantin A.] Inst Bioorgan Chem, Moscow, Russia; [Reimer, James D.] Univ Ryukyus, Dept Biol Chem & Marine Sci, Fac Sci, Mol Invertebrate Systemat & Ecol Lab, Nishihara, Okinawa 90301, Japan; [Reimer, James D.] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan; [Berumen, Michael L.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal, Saudi Arabia	Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of the Ryukyus; University of the Ryukyus; King Abdullah University of Science & Technology	Ivanenko, VN (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Invertebrate Zool, Moscow, Russia.	ivanenko.slava@gmail.com	Lukyanov, Konstantin A/D-4030-2013; Prudkovsky, Andrey/R-8248-2016; Reimer, James Davis/AAP-1331-2020; Ivanenko, Viatcheslav N/B-8198-2008; Berumen, Michael/F-7745-2011; Nikitin, Mikhail/K-3417-2013	Lukyanov, Konstantin A/0000-0001-9845-2088; Ivanenko, Viatcheslav N/0000-0003-1255-0491; Berumen, Michael/0000-0003-2463-2742; Nikitin, Mikhail/0000-0003-4855-8057	King Abdullah University of Science and Technology Office of Competitive Research Funds [CRG-1-2012-BER-002]; Russian Foundation for Basic Research [15-29-02601]; Russian Scientific Foundation [14-50-00029]	King Abdullah University of Science and Technology Office of Competitive Research Funds; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Foundation(Russian Science Foundation (RSF))	Fieldwork was supported by the King Abdullah University of Science and Technology Office of Competitive Research Funds under grant number CRG-1-2012-BER-002; molecular laboratory work and data analysis were conducted with support from the Russian Foundation for Basic Research (#15-29-02601); microscopic study and processing of the paper were supported by the Russian Scientific Foundation (#14-50-00029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglyamova GV, 2011, PHOTOCH PHOTOBIO SCI, V10, P1303, DOI 10.1039/c1pp05068k; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; ANDERSON JM, 1973, J BIOL CHEM, V248, P2937; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Dougherty JR, 2005, J SHELLFISH RES, V24, P35; Fourrage C, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130206; FREEMAN G, 1987, ROUX ARCH DEV BIOL, V196, P30, DOI 10.1007/BF00376020; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gravili C, 2013, MAR ECOL-EVOL PERSP, V34, P41, DOI 10.1111/maec.12023; Haddock SHD, 2015, BIOL OPEN, V4, P1094, DOI 10.1242/bio.012138; Hastings JW, 2006, METHOD BIOCHEM ANAL, V47, P15; Hunt ME, 2012, PHOTOCH PHOTOBIO SCI, V11, P637, DOI 10.1039/c1pp05238a; KRAMP P. L., 1965, DANA REP CARLSBERG FOUND, V63, P1; Kubota S, 2011, KUROSHIO BIOSPHERE, V7, P41; Kubota S, 2010, KUROSHIO BIOSPHERE, V6, P11; Kubota Shin, 2011, Biogeography, V13, P9; Kubota S, 2008, J MAR BIOL ASSOC UK, V88, P1743, DOI 10.1017/S0025315408002580; LEVINE LD, 1982, COMP BIOCHEM PHYS B, V72, P77, DOI 10.1016/0305-0491(82)90013-X; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miglietta MP, 2012, EVOLUTION, V66, P3876, DOI 10.1111/j.1558-5646.2012.01717.x; Millard NAH, 1975, ANN S AFR MUS, V68, P1; MORIN JG, 1974, BIOL BULL-US, V147, P397, DOI 10.2307/1540457; Morse VJ, 2013, THESIS CARDIFF U; NAVAS-PEREIRA D, 1991, Boletim do Instituto Oceanografico, V39, P25; Petrov NB, 2005, MOL BIOL+, V39, P503, DOI 10.1007/s11008-005-0067-z; Puce S, 2004, HYDROBIOLOGIA, V530, P503; Rees W.J., 1962, BR MUS NAT HIST, V8, P381; Rees WJ, 1967, J MOLLUS STUD, V37, P213, DOI DOI 10.1093/OXFORDJOURNALS.MOLLUS.A064991; Ryusaku D, 2012, BULLETIN OF MIYAGI U, V47, P95; Schuchert P, 2007, REV SUISSE ZOOL, V114, P195, DOI 10.5962/bhl.part.80395; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsuji FI, 2010, MICROSC RES TECHNIQ, V73, P785, DOI 10.1002/jemt.20821; VANDERAUWERA G, 1994, FEBS LETT, V338, P133, DOI 10.1016/0014-5793(94)80350-1; Xia NS, 2002, MAR BIOTECHNOL, V4, P155, DOI 10.1007/s10126-001-0081-7; Yanushevich YG, 2005, RUSS J BIOORG CHEM+, V31, P43, DOI 10.1007/s11171-005-0005-9	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146861	10.1371/journal.pone.0146861	http://dx.doi.org/10.1371/journal.pone.0146861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840497	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200019
J	Snitz, K; Arzi, A; Jacobson, M; Secundo, L; Weissler, K; Yablonka, A				Snitz, Kobi; Arzi, Anat; Jacobson, Merav; Secundo, Lavi; Weissler, Kineret; Yablonka, Adi			A Cross Modal Performance-Based Measure of Sensory Stimuli Intricacy	PLOS ONE			English	Article							ODOR	We define a new measure of sensory stimuli which has the following properties: It is cross modal, performance based, robust, and well defined. We interpret this measure as the intricacy or complexity of the stimuli, yet its validity is independent of its interpretation. We tested the validity and cross modality of our measure using three olfactory and one visual experiment. In order to test the link between our measure and cognitive performance we also conducted an additional visual experiment. We found that our measure is correlated with the results of the well-established Rapid Serial Visual Presentation masking experiment. Specifically, ranking stimuli according to our measure was correlated at r = 0.75 (p < 0.002) with masking effectiveness. Thus, our novel measure of sensory stimuli provides a new quantitative tool for the study of sensory processing.	[Snitz, Kobi; Arzi, Anat; Jacobson, Merav; Secundo, Lavi; Weissler, Kineret; Yablonka, Adi] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Snitz, K (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	kobi.snitz@weizmann.ac.il		Arzi, Anat/0000-0003-1005-1752	ISF - Israel Science Foundation - India-Israel Joint Academic Research Program in neurobiology [1599/14]	ISF - Israel Science Foundation - India-Israel Joint Academic Research Program in neurobiology	This work was supported by ISF - Israel Science Foundation - India-Israel Joint Academic Research Program in neurobiology, grant number 1599/14.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brodatz P, 1966, TEXTURES PHOTOGRAPHI; Dravnieks A, 1982, ATLAS ODOR CHARACTER; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Golan T, 2014, ATTEN PERCEPT PSYCHO, V76, P391, DOI 10.3758/s13414-013-0562-6; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Kermen F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00206; Kleiner M, 2007, PERCEPTION, V36, P14; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Marr D., 1982, VISION COMPUTATIONAL; Morrison D. F., 1990, MULTIVARIATE STAT ME; Stevenson R, 2010, LEARNING TO SMELL OL; Weissler K, 2016, THESIS TEL AVIV U; Wise PM, 2000, CHEM SENSES, V25, P429, DOI 10.1093/chemse/25.4.429; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639	15	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147449	10.1371/journal.pone.0147449	http://dx.doi.org/10.1371/journal.pone.0147449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840072	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200040
J	Wilk, M; Hessler, R; Mugridge, K; Jolly, C; Fehr, M; Lenarz, T; Scheper, V				Wilk, Maciej; Hessler, Roland; Mugridge, Kenneth; Jolly, Claude; Fehr, Michael; Lenarz, Thomas; Scheper, Verena			Impedance Changes and Fibrous Tissue Growth after Cochlear Implantation Are Correlated and Can Be Reduced Using a Dexamethasone Eluting Electrode	PLOS ONE			English	Article							CHRONIC ELECTRICAL-STIMULATION; GUINEA-PIG MODEL; NECROSIS-FACTOR-ALPHA; AUDITORY-NERVE; POSTOPERATIVE IMPEDANCES; RESIDUAL HEARING; SHORT-TERM; PROTECTION; HYDROGEL; SURFACES	Background The efficiency of cochlear implants (CIs) is affected by postoperative connective tissue growth around the electrode array. This tissue formation is thought to be the cause behind post-operative increases in impedance. Dexamethasone (DEX) eluting CIs may reduce fibrous tissue growth around the electrode array subsequently moderating elevations in impedance of the electrode contacts. Methods For this study, DEX was incorporated into the silicone of the CI electrode arrays at 1% and 10% (w/w) concentration. Electrodes prepared by the same process but without dexamethasone served as controls. All electrodes were implanted into guinea pig cochleae though the round window membrane approach. Potential additive or synergistic effects of electrical stimulation (60 minutes) were investigated by measuring impedances before and after stimulation (days 0, 7, 28, 56 and 91). Acoustically evoked auditory brainstem responses were recorded before and after CI insertion as well as on experimental days 7, 28, 56, and 91. Additionally, histology performed on epoxy embedded samples enabled measurement of the area of scala tympani occupied with fibrous tissue. Results In all experimental groups, the highest levels of fibrous tissue were detected in the basal region of the cochlea in vicinity to the round window niche. Both DEX concentrations, 10% and 1% (w/w), significantly reduced fibrosis around the electrode array of the CI. Following 3 months of implantation impedance levels in both DEX-eluting groups were significantly lower compared to the control group, the 10% group producing a greater effect. The same effects were observed before and after electrical stimulation. Conclusion To our knowledge, this is the first study to demonstrate a correlation between the extent of new tissue growth around the electrode and impedance changes after cochlear implantation. We conclude that DEX-eluting CIs are a means to reduce this tissue reaction and improve the functional benefits of the implant by attenuating electrode impedance.	[Wilk, Maciej; Lenarz, Thomas; Scheper, Verena] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Wilk, Maciej; Fehr, Michael] Univ Vet Med, Clin Exot Pets Reptiles Pet & Feral Birds, Hannover, Germany; [Hessler, Roland; Mugridge, Kenneth; Jolly, Claude] MEDEl GmbH, Innsbruck, Austria; [Lenarz, Thomas; Scheper, Verena] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School	Scheper, V (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.; Scheper, V (corresponding author), Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany.	scheper.verena@mh-hannover.de	Scheper, Verena/J-4298-2019	Scheper, Verena/0000-0001-8618-8793	MED-EL Hearing Implants GmbH, Innsbruck, Austria	MED-EL Hearing Implants GmbH, Innsbruck, Austria	MW received funding from MED-EL Hearing Implants GmbH, Innsbruck, Austria. RH, KM, and CJ are affiliated with MED-EL and were involved in study design, data analysis, and manuscript preparation.	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Bas E, 2012, ANAT REC, V295, P1944, DOI 10.1002/ar.22585; Bas E, 2012, ANAT REC, V295, P1909, DOI 10.1002/ar.22574; Braun S, 2011, ORL-J OTO-RHIN-LARYN, V73, P219, DOI 10.1159/000329791; Burghard A, 2014, HEARING RES, V312, P21, DOI 10.1016/j.heares.2014.02.002; Connolly TM, 2011, AUDIOL NEURO-OTOL, V16, P137, DOI 10.1159/000314757; De Ceulaer G, 2003, OTOL NEUROTOL, V24, P769, DOI 10.1097/00129492-200309000-00014; deSauvage RC, 1997, HEARING RES, V110, P119, DOI 10.1016/S0378-5955(97)00066-X; Dinh CT, 2009, AUDIOL NEURO-OTOL, V14, P383, DOI 10.1159/000241895; DORMAN MF, 1992, J SPEECH HEAR RES, V35, P1126, DOI 10.1044/jshr.3505.1126; DYMOND AM, 1976, IEEE T BIO-MED ENG, V23, P274, DOI 10.1109/TBME.1976.324585; Eshraghi A A, 2011, Cochlear Implants Int, V12 Suppl 1, pS51, DOI 10.1179/146701011X13001035753254; Eshraghi AA, 2007, OTOL NEUROTOL, V28, P842, DOI 10.1097/MAO.0b013e31805778fc; Eshraghi AA, 2013, LARYNGOSCOPE, V123, pS1, DOI 10.1002/lary.23902; Farhadi Mohammad, 2013, Cochlear Implants Int, V14, P45; Huang Christie Qi, 2007, Cochlear Implants Int, V8, P123, DOI 10.1002/cii.336; Hutten M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104564; Ibrahim H N, 2010, Cochlear Implants Int, V11 Suppl 1, P431, DOI 10.1179/146701010X12671177204345; Ichimiya I, 2000, INT J PEDIATR OTORHI, V56, P45, DOI 10.1016/S0165-5876(00)00408-0; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Joseph J, 2010, J MATER SCI-MATER M, V21, P1665, DOI 10.1007/s10856-010-4015-7; Kamel M, 2001, J BIOMED MATER RES, V58, P88, DOI 10.1002/1097-4636(2001)58:1<88::AID-JBM130>3.0.CO;2-7; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Lee J, 2013, AUDIOL NEURO-OTOL, V18, P392, DOI 10.1159/000353582; Lenarz T, 2015, FREE RADICALS IN ENT; Liu Y., 2015, EUR ARCH OTORHINOL; Maeda K, 2005, HEARING RES, V202, P154, DOI 10.1016/j.heares.2004.08.022; Maini S, 2009, AUDIOL NEURO-OTOL, V14, P402, DOI 10.1159/000241897; Newbold Carrie, 2014, Cochlear Implants Int, V15, P191, DOI 10.1179/1754762813Y.0000000050; NI DF, 1992, HEARING RES, V62, P63, DOI 10.1016/0378-5955(92)90203-Y; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61; Paasche G, 2009, OTOL NEUROTOL, V30, P592, DOI 10.1097/MAO.0b013e3181ab8fba; Piu F, 2011, OTOL NEUROTOL, V32, P171, DOI 10.1097/MAO.0b013e3182009d29; Satoh H, 2002, LARYNGOSCOPE, V112, P1627, DOI 10.1097/00005537-200209000-00019; Seyyedi M, 2014, OTOL NEUROTOL, V35, P1545, DOI 10.1097/MAO.0000000000000540; SHEPHERD RK, 1994, HEARING RES, V81, P150, DOI 10.1016/0378-5955(94)90162-7; Silverman BG, 1996, ANN INTERN MED, V124, P744, DOI 10.7326/0003-4819-124-8-199604150-00008; Stathopoulos Dimitra, 2014, Cochlear Implants Int, V15, P254, DOI 10.1179/1754762813Y.0000000054; Wrzeszcz A, 2015, J BIOMED MATER RES B, V103, P169, DOI 10.1002/jbm.b.33187; Wrzeszcz A, 2014, J BIOMED MATER RES A, V102, P442, DOI 10.1002/jbm.a.34719; Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1; Yoshida K, 1999, HEARING RES, V137, P155, DOI 10.1016/S0378-5955(99)00134-3	43	99	101	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147552	10.1371/journal.pone.0147552	http://dx.doi.org/10.1371/journal.pone.0147552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840740	Green Published, gold			2022-12-27	WOS:000369550200046
J	Bergstrom, I; Kilteni, K; Slater, M				Bergstroem, Ilias; Kilteni, Konstantina; Slater, Mel			First-Person Perspective Virtual Body Posture Influences Stress: A Virtual Reality Body Ownership Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RUBBER-HAND ILLUSION; ILLUSORY OWNERSHIP; SELF-ATTRIBUTION; TOUCH; PART; OBJECTS; THATS; SKIN	In immersive virtual reality (IVR) it is possible to replace a person's real body by a life-sized virtual body that is seen from first person perspective to visually substitute their own. Multisensory feedback from the virtual to the real body (such as the correspondence of touch and also movement) can also be present. Under these conditions participants typically experience a subjective body ownership illusion (BOI) over the virtual body, even though they know that it is not their real one. In most studies and applications the posture of the real and virtual bodies are as similar as possible. Here we were interested in whether the BOI is diminished when there are gross discrepancies between the real and virtual body postures. We also explored whether a comfortable or uncomfortable virtual body posture would induce feelings and physiological responses commensurate with the posture. We carried out an experiment with 31 participants in IVR realized with a wide field-of-view head-mounted display. All participants were comfortably seated. Sixteen of them were embodied in a virtual body designed to be in a comfortable posture, and the remainder in an uncomfortable posture. The results suggest that the uncomfortable body posture led to lesser subjective BOI than the comfortable one, but that participants in the uncomfortable posture experienced greater awareness of their autonomic physiological responses. Moreover their heart rate, heart rate variability, and the number of mistakes in a cognitive task were associated with the strength of their BOI in the uncomfortable posture: greater heart rate, lower heart rate variability and more mistakes were associated with higher levels of the BOI. These findings point in a consistent direction-that the BOI over a body that is in an uncomfortable posture can lead to subjective, physiological and cognitive effects consistent with discomfort that do not occur with the BOI over a body in a comfortable posture.	[Bergstroem, Ilias; Kilteni, Konstantina; Slater, Mel] Univ Barcelona, Fac Psicol, Event Lab, Barcelona, Spain; [Slater, Mel] UCL, Dept Comp Sci, London, England; [Slater, Mel] ICREA, Barcelona, Spain; [Bergstroem, Ilias] Royal Inst Technol, KTH, Mobile Life, Stockholm, Sweden; [Kilteni, Konstantina] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden	University of Barcelona; University of London; University College London; ICREA; Royal Institute of Technology; Karolinska Institutet	Slater, M (corresponding author), Univ Barcelona, Fac Psicol, Event Lab, Barcelona, Spain.; Slater, M (corresponding author), UCL, Dept Comp Sci, London, England.; Slater, M (corresponding author), ICREA, Barcelona, Spain.	melslater@ub.edu	Slater, Mel/M-5210-2014; Kilteni, Konstantina/J-7754-2015	Slater, Mel/0000-0002-6223-0050; Kilteni, Konstantina/0000-0002-6887-6434	European Union; Aeronautics and Transport; VR-HYPERSPACE project; Framework 7; ICREA Funding Source: Custom	European Union(European Commission); Aeronautics and Transport; VR-HYPERSPACE project; Framework 7; ICREA(ICREA)	This work was supported by the European Union, Framework 7, Aeronautics and Transport, VR-HYPERSPACE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2005, J BODYW MOV THER, V9, P134, DOI 10.1016/j.jbmt.2004.04.001; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Banakou D, 2014, P NATL ACAD SCI USA, V111, P17678, DOI 10.1073/pnas.1414936111; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blom KJ, 2014, PERCEPTION, V43, P275, DOI 10.1068/p7618; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Cameron JA, 1996, INT J IND ERGONOM, V18, P389, DOI 10.1016/0169-8141(95)00101-8; Camm AJ, 1996, EUR HEART J, V17, P354; de la Pena N, 2010, PRESENCE-TELEOP VIRT, V19, P291, DOI 10.1162/PRES_a_00005; Dishman RK, 2000, INT J PSYCHOPHYSIOL, V37, P121, DOI 10.1016/S0167-8760(00)00085-4; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Giannopoulos Elias, 2012, International Journal of Virtual Reality, V11, P19; Giummarra MJ, 2010, PERCEPTION, V39, P103, DOI 10.1068/p6519; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Hohwy J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009416; Ide M, 2013, PERCEPTION, V42, P103, DOI 10.1068/p7322; Ionta S, 2013, COGN AFFECT BEHAV NE, V13, P197, DOI 10.3758/s13415-012-0120-z; Jones JA, 2008, APGV 2008: PROCEEDINGS OF THE SYMPOSIUM ON APPLIED PERCEPTION IN GRAPHICS AND VISUALIZATION, P9; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Kilteni K, 2013, IEEE T VIS COMPUT GR, V19, P597, DOI 10.1109/TVCG.2013.29; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Liu WW, 2008, EUR J APPL PHYSIOL, V103, P361, DOI 10.1007/s00421-008-0718-6; Llobera J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0300; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; MANDLER G, 1958, J ABNORM SOC PSYCH, V56, P367, DOI 10.1037/h0048083; Maselli A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00693; Maselli A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00083; Mehler B., 2011, P 6 INT DRIV S HUM F, P590, DOI [10.17077/drivingassessment.1451, DOI 10.17077/DRIVINGASSESSMENT]; MESHKATI N, 1988, P101; Miyatsuji Aya, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P67, DOI 10.2114/jpa.21.67; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Pellecchia GL, 2001, J MOTOR BEHAV, V33, P9, DOI 10.1080/00222890109601898; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Slater M, 2006, PRESENCE-VIRTUAL AUG, V15, P553, DOI 10.1162/pres.15.5.553; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Thomas ML, 2011, ASSESSMENT, V18, P291, DOI 10.1177/1073191110374797	54	45	46	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148060	10.1371/journal.pone.0148060	http://dx.doi.org/10.1371/journal.pone.0148060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828365	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000369548200057
J	Wilczynska, A; Git, A; Argasinska, J; Belloc, E; Standart, N				Wilczynska, Ania; Git, Anna; Argasinska, Joanna; Belloc, Eulalia; Standart, Nancy			CPEB and miR-15/16 Co-Regulate Translation of Cyclin E1 mRNA during Xenopus Oocyte Maturation	PLOS ONE			English	Article							CYTOPLASMIC POLYADENYLATION ELEMENTS; MEIOTIC METAPHASE ARREST; BINDING PROTEINS; MICRORNA REPRESSION; TARGET SITES; CANCER; DEADENYLATION; ROLES; FAMILY; GW182	Cell cycle transitions spanning meioticmaturation of the Xenopus oocyte and early embryogenesis are tightly regulated at the level of stored inactive maternal mRNA. We investigated here the translational control of cyclin E1, required for metaphase II arrest of the unfertilised egg and the initiation of S phase in the early embryo. We show that the cyclin E1 mRNA is regulated by both cytoplasmic polyadenylation elements (CPEs) and two miR-15/16 target sites within its 3'UTR. Moreover, we provide evidence that maternal miR-15/16 microRNAs co-immunoprecipitate with CPE-binding protein (CPEB), and that CPEB interacts with the RISC component Ago2. Experiments using competitor RNA and mutated cyclin E1 3'UTRs suggest cooperation of the regulatory elements to sustain repression of the cyclin E1 mRNA during early stages of maturation when CPEB becomes limiting and cytoplasmic polyadenylation of repressed mRNAs begins. Importantly, injection of anti-miR-15/16 LNA results in the early polyadenylation of endogenous cyclin E1 mRNA during meiotic maturation, and an acceleration of GVBD, altogether strongly suggesting that the proximal CPEB and miRNP complexes act to mutually stabilise each other. We conclude that miR-15/16 and CPEB co-regulate cyclin E1 mRNA. This is the first demonstration of the co-operation of these two pathways.	[Wilczynska, Ania; Argasinska, Joanna; Standart, Nancy] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [Git, Anna] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Belloc, Eulalia] Inst Res Biomed, Barcelona, Spain; [Wilczynska, Ania] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England; [Argasinska, Joanna] EMBL European Bioinformat Inst, Cambridge, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Leicester; European Molecular Biology Laboratory (EMBL)	Standart, N (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	nms23@cam.ac.uk		Wilczynska, Ania/0000-0003-4548-9367; Argasinska, Joanna/0000-0003-2678-2824	Biotechnology and Biological Sciences Research Council [BB/E016316/1]; Cancer Research UK; RATHER consortium; Cambridge Overseas Trust; Parke Davis Bursary (Downing College); BBSRC [BB/E016316/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); RATHER consortium; Cambridge Overseas Trust; Parke Davis Bursary (Downing College); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Biotechnology and Biological Sciences Research Council (BB/E016316/1). AG was funded by Cancer Research UK and the RATHER consortium, and JA was funded by the Cambridge Overseas Trust and the Parke Davis Bursary (Downing College). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Armisen J, 2009, GENOME RES, V19, P1766, DOI 10.1101/gr.093054.109; Balagopal V, 2012, BBA-GENE REGUL MECH, V1819, P593, DOI 10.1016/j.bbagrm.2012.01.001; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Chevalier S, 1996, J CELL SCI, V109, P1173; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Gillian-Daniel DL, 1998, MOL CELL BIOL, V18, P6152, DOI 10.1128/MCB.18.10.6152; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Kamenska A, 2014, BIOCHEM SOC T, V42, P1238, DOI 10.1042/BST20140063; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Lau NC, 2009, EMBO J, V28, P2945, DOI 10.1038/emboj.2009.237; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Marnef A, 2010, RNA, V16, P2094, DOI 10.1261/rna.2295410; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Minshall N, 1999, RNA, V5, P27, DOI 10.1017/S1355838299981220; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Minshall N, 2010, METHODS, V51, P165, DOI 10.1016/j.ymeth.2010.02.018; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Mortensen RD, 2011, PNAS, V108, P8261; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; SIMON R, 1992, GENE DEV, V6, P2580, DOI 10.1101/gad.6.12b.2580; Slevin MK, 2007, NUCLEIC ACIDS RES, V35, P2167, DOI 10.1093/nar/gkm084; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sun GH, 2010, NUCLEIC ACIDS RES, V38, P239, DOI 10.1093/nar/gkp870; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tunquist BJ, 2002, CURR BIOL, V12, P1027, DOI 10.1016/S0960-9822(02)00894-1; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Villalba A, 2011, CURR OPIN GENET DEV, V21, P452, DOI 10.1016/j.gde.2011.04.006; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wormington M, 1996, EMBO J, V15, P900, DOI 10.1002/j.1460-2075.1996.tb00424.x; Zhang S, 1999, METHODS, V17, P46, DOI 10.1006/meth.1998.0706; Zhang Y, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-7; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	77	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146792	10.1371/journal.pone.0146792	http://dx.doi.org/10.1371/journal.pone.0146792			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829217	Green Published, gold			2022-12-27	WOS:000369548200011
J	Fumoto, S; Nishimura, K; Nishida, K; Kawakami, S				Fumoto, Shintaro; Nishimura, Koyo; Nishida, Koyo; Kawakami, Shigeru			Three-Dimensional Imaging of the Intracellular Fate of Plasmid DNA and Transgene Expression: ZsGreen1 and Tissue Clearing Method CUBIC Are an Optimal Combination for Multicolor Deep Imaging in Murine Tissues	PLOS ONE			English	Article							SINGLE-CELL RESOLUTION; NUCLEAR IMPORT; IN-VIVO; FLUORESCENT PROTEINS; GENE TRANSFECTION; EFFICIENT; DELIVERY; LIVER; MICE; SYSTEMS	Evaluation methods for determining the distribution of transgene expression in the body and the in vivo fate of viral and non-viral vectors are necessary for successful development of in vivo gene delivery systems. Here, we evaluated the spatial distribution of transgene expression using tissue clearing methods. After hydrodynamic injection of plasmid DNA into mice, whole tissues were subjected to tissue clearing. Tissue clearing followed by con-focal laser scanning microscopy enabled evaluation of the three-dimensional distribution of transgene expression without preparation of tissue sections. Among the tested clearing methods (Clear(T2), SeeDB, and CUBIC), CUBIC was the most suitable method for determining the spatial distribution of transgene expression in not only the liver but also other tissues such as the kidney and lung. In terms of the type of fluorescent protein, the observable depth for green fluorescent protein ZsGreen1 was slightly greater than that for red fluorescent protein tdTomato. We observed a depth of similar to 1.5 mm for the liver and 500 mu m for other tissues without preparation of tissue sections. Furthermore, we succeeded in multicolor deep imaging of the intracellular fate of plasmid DNA in the murine liver. Thus, tissue clearing would be a powerful approach for determining the spatial distribution of plasmid DNA and transgene expression in various murine tissues.	[Fumoto, Shintaro; Nishimura, Koyo; Nishida, Koyo; Kawakami, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University	Fumoto, S; Kawakami, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan.	sfumoto@nagasaki-u.ac.jp; skawakam@nagasaki-u.ac.jp	Kawakami, Shigeru/R-1460-2019; Wilson, Matthew H/K-3193-2013		Japan Society for the Promotion of Science [25350553]; Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant Number 25350553), and by the Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dean DA, 1999, EXP CELL RES, V253, P713, DOI 10.1006/excr.1999.4716; Denk W., 1990, NATURE, V248, P73, DOI DOI 10.1126/SCIENCE.2321027; Fumoto S, 2003, PHARM RES-DORDR, V20, P1452, DOI 10.1023/A:1025766429175; Fumoto S, 2012, MOL PHARMACEUT, V9, P1962, DOI 10.1021/mp2006592; Gomme EA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002971; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hama S, 2006, MOL THER, V13, P786, DOI 10.1016/j.ymthe.2005.10.007; Hu YX, 2013, ACS NANO, V7, P5376, DOI 10.1021/nn4012384; Kawakami S, 2000, PHARMACEUT RES, V17, P306, DOI 10.1023/A:1007501122611; Kawakami S, 2002, BIOCHEM BIOPH RES CO, V294, P46, DOI 10.1016/S0006-291X(02)00432-1; Kawakami S, 2014, J CONTROL RELEASE, V190, P542, DOI 10.1016/j.jconrel.2014.06.001; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Koksharov MI, 2012, BIOTECHNOL J, V2, DOI [10.5936/csbj.201209004, DOI 10.5936/CSBJ.201209004]; Kurosaki T, 2014, J CONTROL RELEASE, V176, P24, DOI 10.1016/j.jconrel.2013.12.023; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Morris LM, 2010, BIOTECH HISTOCHEM, V85, P379, DOI 10.3109/10520290903504753; Mutze J, 2012, BIOPHYS J, V102, P934, DOI 10.1016/j.bpj.2011.12.056; Nomoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4545; Picconi JL, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.14; Richard JC, 2003, GENE THER, V10, P2074, DOI 10.1038/sj.gt.3302117; Richards B, 2002, CYTOMETRY, V48, P106, DOI 10.1002/cyto.10117; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shimizu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041319; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tamaru M, 2014, INT J NANOMED, V9, P4267, DOI 10.2147/IJN.S65402; Un K, 2010, BIOMATERIALS, V31, P7813, DOI 10.1016/j.biomaterials.2010.06.058; Vacik J, 1999, GENE THER, V6, P1006, DOI 10.1038/sj.gt.3300924; Wilson GL, 1999, J BIOL CHEM, V274, P22025, DOI 10.1074/jbc.274.31.22025; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhu D, 2013, LASER PHOTONICS REV, V7, P732, DOI 10.1002/lpor.201200056	33	25	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148233	10.1371/journal.pone.0148233	http://dx.doi.org/10.1371/journal.pone.0148233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824850	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600112
J	Geng, XX; Jiang, CH; Yang, J; Wang, LJ; Wu, XM; Wei, WH				Geng, Xinxin; Jiang, Chenghong; Yang, Jie; Wang, Lijun; Wu, Xiaoming; Wei, Wenhui			Rapid Identification of Candidate Genes for Seed Weight Using the SLAF-Seq Method in Brassica napus	PLOS ONE			English	Article							QUANTITATIVE TRAIT ANALYSIS; COMPLEX TRAITS; SILIQUE LENGTH; LARGE GRAIN; YIELD; L.; ARABIDOPSIS; HYBRID; QTL; MAP	Seed weight is a critical and direct trait for oilseed crop seed yield. Understanding its genetic mechanism is of great importance for yield improvement in Brassica napus breeding. Two hundred and fifty doubled haploid lines derived bymicrospore culture were developed from a cross between a large-seed lineG-42 and a small-seed line 7-9. According to the 1000-seed weight (TSW) data, the individual DNA of the heaviest 46 lines and the lightest 47 lines were respectively selected to establish two bulked DNA pools. A new high-throughput sequencing technology, Specific Locus Amplified Fragment Sequencing (SLAF-seq), was used to identify candidate genes of TSWin association analysis combined with bulked segregant analysis (BSA). A total of 1,933 high quality polymorphic SLAF markers were developed and 4 associated markers of TSW were procured. A hot region of similar to 0.58 Mb at nucleotides 25,401,885-25,985,931 on ChrA09 containing 91 candidate genes was identified as tightly associated with the TSW trait. From annotation information, four genes (GSBRNA2T00037136001, GSBRNA2T00037157001, GSBRNA2T00037129001 and GSBRNA2T00069389001) might be interesting candidate genes that are highly related to seed weight.	[Geng, Xinxin; Jiang, Chenghong; Yang, Jie; Wang, Lijun; Wu, Xiaoming; Wei, Wenhui] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wei, WH (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan 430062, Peoples R China.	wuxm@oilcrops.cn; whwei@oilcrops.cn			National Natural Science Foundation of China [31371664, 31470088]; Scientific and Technological Project of Wuhan City [2013020501010174]; National Nonprofit Institute Research Grant [1610172012001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Wuhan City; National Nonprofit Institute Research Grant	This work was supported by the National Natural Science Foundation of China (grant no. 31371664 and 31470088), the Scientific and Technological Project of Wuhan City (grant no. 2013020501010174) and the National Nonprofit Institute Research Grant (grant no. 1610172012001). WHW received all of the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; Cai GQ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-105; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Deza E, 2009, ENCY DISTANCES, P94, DOI [10.1007/978-3-642-30958-8, DOI 10.1007/978-3-642-30958-8]; Fan CC, 2010, THEOR APPL GENET, V121, P1289, DOI 10.1007/s00122-010-1388-4; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hu ZJ, 2012, J INTEGR PLANT BIOL, V54, P979, DOI 10.1111/jipb.12008; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li F, 2014, PHYS REV APPL, V1, DOI 10.1103/PhysRevApplied.1.051001; Li N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-114; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu J, 2015, P NATL ACAD SCI USA, V112, pE5123, DOI 10.1073/pnas.1502160112; Liu TM, 2009, THEOR APPL GENET, V118, P1509, DOI 10.1007/s00122-009-0999-0; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Nelson MN, 2009, THEOR APPL GENET, V119, P497, DOI 10.1007/s00122-009-1056-8; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Quijada PA, 2006, THEOR APPL GENET, V113, P549, DOI 10.1007/s00122-006-0323-1; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Song GL, 1998, ACTA GOSSYPII SIN, V10, P273; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Udall JA, 2006, THEOR APPL GENET, V113, P597, DOI 10.1007/s00122-006-0324-0; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122206; Yang P, 2012, THEOR APPL GENET, V125, P285, DOI 10.1007/s00122-012-1833-7; Zhang LW, 2011, THEOR APPL GENET, V122, P21, DOI 10.1007/s00122-010-1419-1; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; [朱恒星 Zhu Hengxing], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P843	47	48	55	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147580	10.1371/journal.pone.0147580	http://dx.doi.org/10.1371/journal.pone.0147580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824525	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600037
J	Jan, HU; Abbadi, A; Lucke, S; Nichols, RA; Snowdon, RJ				Jan, Habib U.; Abbadi, Amine; Luecke, Sophie; Nichols, Richard A.; Snowdon, Rod J.			Genomic Prediction of Testcross Performance in Canola (Brassica napus)	PLOS ONE			English	Article							HYBRID PERFORMANCE; GENETIC DIVERSITY; RIDGE-REGRESSION; QUANTITATIVE TRAITS; COMBINING ABILITY; BREEDING VALUES; LINKAGE DISEQUILIBRIUM; GENOMEWIDE SELECTION; INBRED LINES; SSR MARKERS	Genomic selection (GS) is a modern breeding approach where genome-wide single-nucleotide polymorphism (SNP) marker profiles are simultaneously used to estimate performance of untested genotypes. In this study, the potential of genomic selection methods to predict testcross performance for hybrid canola breeding was applied for various agronomic traits based on genome-wide marker profiles. A total of 475 genetically diverse spring-type canola pollinator lines were genotyped at 24,403 single-copy, genome-wide SNP loci. In parallel, the 950 F1 testcross combinations between the pollinators and two representative testers were evaluated for a number of important agronomic traits including seedling emergence, days to flowering, lodging, oil yield and seed yield along with essential seed quality characters including seed oil content and seed glucosinolate content. A ridge-regression best linear unbiased prediction (RR-BLUP) model was applied in combination with 500 cross-validations for each trait to predict testcross performance, both across the whole population as well as within individual subpopulations or clusters, based solely on SNP profiles. Subpopulations were determined using multidimensional scaling and K-means clustering. Genomic prediction accuracy across the whole population was highest for seed oil content (0.81) followed by oil yield (0.75) and lowest for seedling emergence (0.29). For seed yield, seed glucosinolate, lodging resistance and days to onset of flowering (DTF), prediction accuracies were 0.45, 0.61, 0.39 and 0.56, respectively. Prediction accuracies could be increased for some traits by treating subpopulations separately; a strategy which only led to moderate improvements for some traits with low heritability, like seedling emergence. No useful or consistent increase in accuracy was obtained by inclusion of a population substructure covariate in the model. Testcross performance prediction using genome-wide SNP markers shows considerable potential for pre-selection of promising hybrid combinations prior to resource-intensive field testing over multiple locations and years.	[Jan, Habib U.; Snowdon, Rod J.] Univ Giessen, IFZ Res Ctr Biosyst Land Use & Nutr, Dept Plant Breeding, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany; [Abbadi, Amine] NPZ Innovat GmbH, D-24363 Hohenlieth, Holtsee, Germany; [Luecke, Sophie] Norddeutsch Pflanzenzucht Hans Georg Lembke KG, D-24363 Hohenlieth, Holtsee, Germany; [Nichols, Richard A.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England	Justus Liebig University Giessen; University of London; Queen Mary University London	Snowdon, RJ (corresponding author), Univ Giessen, IFZ Res Ctr Biosyst Land Use & Nutr, Dept Plant Breeding, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	rod.snowdon@agrar.uni-giessen.de	Nichols, Richard Alan/T-4773-2019; Jan, Habib/ABE-2476-2021	Jan, Habib/0000-0001-9085-7398; Nichols, Richard Alan/0000-0002-4801-9312	Deutsche Forschungsgemeinschaft (DFG) [SN14/16-1]; European Union FP7 Marie Curie Initial Training Network INTERCROSSING; Norddeutsche Pflanzenzucht Hans-Georg Lembke KG; NPZ Innovation GmbH	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union FP7 Marie Curie Initial Training Network INTERCROSSING; Norddeutsche Pflanzenzucht Hans-Georg Lembke KG; NPZ Innovation GmbH	The work was funded by Deutsche Forschungsgemeinschaft (DFG) grant SN14/16-1 to RS and funding to RN, RS, and HJ from the European Union FP7 Marie Curie Initial Training Network INTERCROSSING. AA is an employee of NPZ Innovation GmbH and SL is an employee of Norddeutsche Pflanzenzucht Hans-Georg Lembke KG. These companies provided support in the form of salaries for AA and SL, but neither they nor the other funding bodies had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Badani AG, 2006, GENOME, V49, P1499, DOI 10.1139/G06-091; Basunanda P, 2007, PLANT BREEDING, V126, P581, DOI 10.1111/j.1439-0523.2007.01404.x; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; BECK DL, 1990, MAYDICA, V35, P279; BECKER HC, 1995, THEOR APPL GENET, V91, P62, DOI 10.1007/BF00220859; Bekele WA, 2014, PLANT CELL ENVIRON, V37, P707, DOI 10.1111/pce.12189; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; BRANDLE JE, 1989, CROP SCI, V29, P1191, DOI 10.2135/cropsci1989.0011183X002900050020x; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Cho YI, 2004, BREEDING SCI, V54, P389, DOI 10.1270/jsbbs.54.389; Cowling WA, 2007, FIELD CROP RES, V104, P103, DOI 10.1016/j.fcr.2006.12.014; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de Roos APW, 2009, GENETICS, V183, P1545, DOI 10.1534/genetics.109.104935; Delourme R, 2006, THEOR APPL GENET, V113, P1331, DOI 10.1007/s00122-006-0386-z; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Duvick J, 2001, ENVIRON HEALTH PERSP, V109, P337, DOI 10.2307/3435028; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Girke A, 2012, THEOR APPL GENET, V124, P1017, DOI 10.1007/s00122-011-1765-7; GRANT I, 1985, CAN J GENET CYTOL, V27, P472, DOI 10.1139/g85-069; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hasan M, 2006, GENET RESOUR CROP EV, V53, P793, DOI 10.1007/s10722-004-5541-2; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hofheinz N, 2014, G3-GENES GENOM GENET, V4, P539, DOI 10.1534/g3.113.010025; Hofheinz N, 2012, THEOR APPL GENET, V125, P1639, DOI 10.1007/s00122-012-1940-5; Iniguez-Luy FL, 2001, GENETICS GENOMICS BR, P291; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Jonas E, 2013, TRENDS BIOTECHNOL, V31, P497, DOI 10.1016/j.tibtech.2013.06.003; LEFORTBUSON M, 1987, GENOME, V29, P413, DOI 10.1139/g87-072; Li YY, 2006, EUPHYTICA, V152, P25, DOI 10.1007/s10681-006-9173-9; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Mei JQ, 2011, PLANT BREEDING, V130, P333, DOI 10.1111/j.1439-0523.2011.01850.x; Melchinger AE, 1998, CSSA SPEC PUBL, P29; Meuwissen THE, 2001, GENETICS, V157, P1819; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Qian W, 2007, THEOR APPL GENET, V115, P27, DOI 10.1007/s00122-007-0537-x; Qian W, 2005, THEOR APPL GENET, V110, P1187, DOI 10.1007/s00122-005-1932-9; R 3.1.0 Development Core Team R, 2014, LANG ENV STAT COMP; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Reif JC, 2013, PLANT BREEDING, V132, P107, DOI 10.1111/pbr.12007; Renard M, 1997, GCIRC B, P114; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Riedelsheimer C, 2013, GENETICS, V194, P493, DOI 10.1534/genetics.113.150227; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Saatchi M, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-40; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Schrag TA, 2006, THEOR APPL GENET, V113, P1037, DOI 10.1007/s00122-006-0363-6; SHAHIDI F, 1990, CANOLA RAPESEED PROD, P3; Snowdon R, 2012, NATURE, V490, P37, DOI 10.1038/490037d; Snowdon RJ, 2015, TRENDS PLANT SCI, V20, P410, DOI 10.1016/j.tplants.2015.04.013; Snowdon RJ, 2012, PLANT BREEDING, V131, P351, DOI 10.1111/j.1439-0523.2012.01976.x; Solberg TR, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-29; Technow F, 2012, THEOR APPL GENET, V125, P1181, DOI 10.1007/s00122-012-1905-8; Teklewold A, 2006, THEOR APPL GENET, V112, P752, DOI 10.1007/s00122-005-0180-3; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080569; Wang Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-556; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Windhausen VS, 2012, G3-GENES GENOM GENET, V2, P1427, DOI 10.1534/g3.112.003699; Wu JG, 2006, GENET MOL BIOL, V29, P533, DOI 10.1590/S1415-47572006000300023; Wurschum T, 2014, PLANT BREEDING, V133, P45, DOI 10.1111/pbr.12137; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Zhao YS, 2013, CROP SCI, V53, P802, DOI 10.2135/cropsci2012.08.0463; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Zou J, 2010, THEOR APPL GENET, V120, P283, DOI 10.1007/s00122-009-1201-4; [No title captured]	77	46	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147769	10.1371/journal.pone.0147769	http://dx.doi.org/10.1371/journal.pone.0147769			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824924	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600057
J	Liao, JF; Ma, L; Du, XJ; Lan, M; Guo, Y; Zheng, L; Xia, YF; Luo, W				Liao, Jun-Fang; Ma, Li; Du, Xiao-Jing; Lan, Mei; Guo, Ying; Zheng, Lie; Xia, Yun-Fei; Luo, Wei			Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							CONVENTIONAL 2-DIMENSIONAL RADIOTHERAPY; BARR-VIRUS DNA; CLINICAL-OUTCOMES; FAILURE; CHEMOTHERAPY; METAANALYSIS; PATTERNS; TRIAL; MRI	Purpose To investigate the prognostic value of cavernoussinus invasion (CSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). Patients and Methods Retrospective review of data from 1,087 patients with biopsy-proven, non-metastatic NPC. All patients were diagnosed using magnetic resonance imaging (MRI) scans and received IMRT as the primary treatment. Results The incidence of cavernoussinus invasion in this cohort was 12.1%. In univariate analysis, 5-year overall survival (OS) (70.6% vs. 88.5%, P < 0.001) and distant metastasis-free survival (DMFS) (71.4% vs. 87.7%, P < 0.001), but not locoregional relapse-free survival (LRFS) (93.9% vs. 93.7%, P = 0.341), were significantly different between patients with and without cavernoussinus invasion. In the T4 subgroup, the 5-year OS, DMFS, and LRFS of patients with and without cavernoussinus extension were 70.6% vs. 81.9%(P = 0.011), 71.4% vs. 84.1% (P = 0.011), and 91.2% vs. 89.7% (P = 0.501), respectively. In multivariate analysis, cavernoussinus invasion was an independent prognostic factor for poorer OS (HR = 1.782; P = 0.013) and DMFS (HR = 1.771; P = 0.016), but not LRFS (HR = 0.632; P = 0.294). In patients with lymph node metastasis, the DMFS rates of patients with and without cavernoussinus invasion were significantly different (P < 0.001). Preliminaryanalysis indicated that neoadjuvant chemotherapy led to better DMFS and OS in patients with cavernoussinus invasion than concurrent chemotherapy or radiotherapy alone; however, the differences were not significant. Conclusions In the IMRT era, cavernoussinus invasion remains a prognostic factor for poor DMFS and OS in NPC, even in patients with T4 disease.	[Liao, Jun-Fang; Ma, Li; Du, Xiao-Jing; Lan, Mei; Xia, Yun-Fei; Luo, Wei] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Guo, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Med Stat & Epidemiol, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Zheng, Lie] Sun Yat Sen Univ, Ctr Canc, Dept Imaging Dept, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Luo, W (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China.	luowei@sysucc.org.cn	luo, wei/GPW-6269-2022	Lan, Mei/0000-0002-5591-2678	Crossing Research Projects Situations [B2013-002-01]	Crossing Research Projects Situations	This work was supported by a Crossing Research Projects Situations (No. B2013-002-01).	Bakan AA, 2015, CLIN NEURORADIOL, V25, P109, DOI 10.1007/s00062-014-0360-0; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Brigette BY, 2008, ORAL ONCOL, V44, P1067, DOI [10.1016/j.oraloncology.2008.02.001, DOI 10.1016/J.ORALONCOLOGY.2008.02.001]; Cao CN, 2013, ORAL ONCOL, V49, P175, DOI 10.1016/j.oraloncology.2012.08.013; Chen L, 2012, INT J RADIAT ONCOL, V84, P196, DOI 10.1016/j.ijrobp.2011.11.021; Chen L, 2011, HEAD NECK-J SCI SPEC, V33, P1309, DOI 10.1002/hed.21606; Cheng SH, 2005, INT J RADIAT ONCOL, V61, P456, DOI 10.1016/j.ijrobp.2004.05.047; COX DR, 1972, J R STAT SOC B, V34, P187; Ding Jian-hui, 2006, Zhonghua Zhongliu Zazhi, V28, P530; Edge SB, 2010, AJCC CANC STAGING MA, P41, DOI [10.1007/978-0-387-88441-7_4, DOI 10.1007/978-0-387-88441-7_4]; Feng M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-208; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Hung TM, 2014, ORAL ONCOL, V50, P228, DOI 10.1016/j.oraloncology.2013.12.005; Jinkins JR, 2000, ATLAS OF NEURORADIOL; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; King AD, 2011, RADIOLOGY, V258, P531, DOI 10.1148/radiol.10101241; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Leung SF, 2003, CANCER, V98, P288, DOI 10.1002/cncr.11496; Liu X, 2014, BRIT J CANCER, V110, P1465, DOI 10.1038/bjc.2014.27; Lo YMD, 2000, ANN NY ACAD SCI, V906, P99; MILLER RG, 1981, SURVIVAL ANAL, P114; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Tan T, 2015, INT J RADIAT ONCOL, V91, P952, DOI 10.1016/j.ijrobp.2015.01.002; Yu MC, 1990, PROG CLIN BIOL RES, V346, P93; Zhao Chong, 2004, Ai Zheng, V23, P1532	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146787	10.1371/journal.pone.0146787	http://dx.doi.org/10.1371/journal.pone.0146787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824230	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600010
J	Rechner, S; Berger, A				Rechner, Steffen; Berger, Annabell			Marathon: An Open Source Software Library for the Analysis of Markov-Chain Monte Carlo Algorithms	PLOS ONE			English	Article							GRAPHS	We present the software library marathon, which is designed to support the analysis of sampling algorithms that are based on the Markov-Chain Monte Carlo principle. The main application of this library is the computation of properties of so-called state graphs, which represent the structure of Markov chains. We demonstrate applications and the usefulness of marathon by investigating the quality of several bounding methods on four well-known Markov chains for sampling perfect matchings and bipartite graphs. In a set of experiments, we compute the total mixing time and several of its bounds for a large number of input instances. We find that the upper bound gained by the famous canonical path method is often several magnitudes larger than the total mixing time and deteriorates with growing input size. In contrast, the spectral bound is found to be a precise approximation of the total mixing time.	[Rechner, Steffen; Berger, Annabell] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Saale, Germany; [Berger, Annabell] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg	Rechner, S (corresponding author), Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Saale, Germany.	steffen.rechner@informatik.uni-halle.de						Berger A, 2010, LECT NOTES COMPUT SC, V6410, P220; Bezakova I, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P900, DOI 10.1145/1109557.1109656; Broder A, 1986, P 18 ANN ACM S THEOR, P50, DOI DOI 10.1145/12130.12136; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Diaconis P, 1999, IMS LECT NOTES MONOG, P195; Diaconis P, 2009, B AM MATH SOC, V46, P179; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Greenhill C., 2015, 26 ANN ACM SIAM S DI, P1564, DOI DOI 10.1137/1.9781611973730.103; Jerrum M, 2004, J ACM, V51, P671, DOI 10.1145/1008731.1008738; JERRUM M, 1989, SIAM J COMPUT, V18, P1149, DOI 10.1137/0218077; JERRUM MR, 1986, THEOR COMPUT SCI, V43, P169, DOI 10.1016/0304-3975(86)90174-X; Kannan R, 1999, RANDOM STRUCT ALGOR, V14, P293, DOI 10.1002/(SICI)1098-2418(199907)14:4<293::AID-RSA1>3.0.CO;2-G; Kashtan N, 2005, MFINDER NETWORK MOTI; Lehoucq RB, ARPACK USERS GUIDE S; Levin D. A., 2006, MARKOV CHAINS MIXING; Lovasz L, 1996, BOLYAI MATH STUD, V2, P353; Miklos I., 2013, ELECRON J COMBIN, V20, P1; Nvidia, 2015, CUBLAS; Nvidia, 2015, CUDA TOOLK; Nvidia, 2015, CUBLAS XT; Petersen J., 1891, ACTA MATH, P193, DOI DOI 10.1007/BF02392606; SINCLAIR A, 1992, LECT NOTES COMPUT SC, V583, P474; Sinclair A, 2009, CS294 MARKOV CHAIN M; TUTTE WT, 1952, CAN J MATH, V4, P314, DOI 10.4153/CJM-1952-028-2; Xianyi Z, 2015, OPENBLAS	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147935	10.1371/journal.pone.0147935	http://dx.doi.org/10.1371/journal.pone.0147935			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824442	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600076
J	Shaffer, JF; Dang, JV; Lee, AK; Dacanay, SJ; Alam, U; Wong, HY; Richards, GJ; Kadandale, P; Sato, BK				Shaffer, Justin F.; Dang, Jennifer V.; Lee, Amanda K.; Dacanay, Samantha J.; Alam, Usman; Wong, Hollie Y.; Richards, George J.; Kadandale, Pavan; Sato, Brian K.			A Familiar(ity) Problem: Assessing the Impact of Prerequisites and Content Familiarity on Student Learning	PLOS ONE			English	Article							BLOOMS TAXONOMY; PERFORMANCE; EDUCATION; COLLEGE; COURSES; STEM; FRAMEWORK; EXPERT; NOVICE	Prerequisites are embedded in most STEM curricula. However, the assumption that the content presented in these courses will improve learning in later courses has not been verified. Because a direct comparison of performance between students with and without required prerequisites is logistically difficult to arrange in a randomized fashion, we developed a novel familiarity scale, and used this to determine whether concepts introduced in a prerequisite course improved student learning in a later course (in two biology disciplines). Exam questions in the latter courses were classified into three categories, based on the degree to which the tested concept had been taught in the prerequisite course. If content familiarity mattered, it would be expected that exam scores on topics covered in the prerequisite would be higher than scores on novel topics. We found this to be partially true for "Very Familiar" questions (concepts covered in depth in the prerequisite). However, scores for concepts only briefly discussed in the prerequisite ("Familiar") were indistinguishable from performance on topics that were "Not Familiar" (concepts only taught in the later course). These results imply that merely "covering" topics in a prerequisite course does not result in improved future performance, and that some topics may be able to removed from a course thereby freeing up class time. Our results may therefore support the implementation of student-centered teaching methods such as active learning, as the time-intensive nature of active learning has been cited as a barrier to its adoption. In addition, we propose that our familiarity system could be broadly utilized to aid in the assessment of the effectiveness of prerequisites.	[Shaffer, Justin F.; Wong, Hollie Y.; Richards, George J.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Dang, Jennifer V.; Lee, Amanda K.; Dacanay, Samantha J.; Alam, Usman; Kadandale, Pavan; Sato, Brian K.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Shaffer, JF (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.; Sato, BK (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	j.shaffer@uci.edu; bsato@uci.edu						Andrews TC, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-05-0084; Bussey TJ, 2013, CHEM EDUC RES PRACT, V14, P9, DOI 10.1039/c2rp20145c; CANADAY SD, 1985, J MED EDUC, V60, P757; Caplan RM, 1996, ACAD MED, V71, P920, DOI 10.1097/00001888-199608000-00023; CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; Christensen DG, 2012, J EDUC BUS, V87, P42, DOI 10.1080/08832323.2011.555790; Crismond D, 2001, J RES SCI TEACH, V38, P791, DOI 10.1002/tea.1032; Crisp G, 2009, AM EDUC RES J, V46, P924, DOI 10.3102/0002831209349460; Crowe A, 2008, CBE-LIFE SCI EDUC, V7, P368, DOI 10.1187/cbe.08-05-0024; Daley BJ, 1999, ADULT EDUC QUART, V49, P133, DOI 10.1177/074171369904900401; Dancy M, 2010, AM J PHYS, V78, P1056, DOI 10.1119/1.3446763; Dochy F, 2002, ACTIVE LEARNING HIGH, V3, P265, DOI [10.1177/1469787402003003006, DOI 10.1177/1469787402003003006]; Duffy Thomas M., 1996, HDB RES ED COMMUNICA, P170; Duschl RA, 2007, TAKING SCIENCE TO SC; Eddy SL, 2014, CBE-LIFE SCI EDUC, V13, P453, DOI 10.1187/cbe.14-03-0050; EYLON BS, 1988, REV EDUC RES, V58, P251, DOI 10.2307/1170256; Forester JP, 2002, CLIN ANAT, V15, P160, DOI 10.1002/ca.1114; Freeman S, 2011, CBE-LIFE SCI EDUC, V10, P175, DOI 10.1187/cbe.10-08-0105; Hammer D.M., 2005, TRANSFER LEARNING MO, P89, DOI DOI 10.1002/CAR.1158; James KE, 2006, BUS PROF COMMUN Q, V69, P374, DOI 10.1177/1080569906294634; Jonassen D, 1999, INSTRUCTIONAL-DESIGN THEORIES AND MODELS, VOL II, P215; Kalina C., 2009, EDUCATION, V130, P241, DOI DOI 10.1037/0022-0663.93.3.571; KATZ LG, 1992, J TEACH EDUC, V43, P376, DOI 10.1177/0022487192043005007; Kazerounian K, 2007, J MECH DESIGN, V129, P761, DOI 10.1115/1.2739569; Kirst MW, 1997, ELEM SCHOOL J, V97, P315, DOI 10.1086/461868; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Louca L, 2004, EDUC PSYCHOL-US, V39, P57, DOI 10.1207/s15326985ep3901_6; Maltese AV, 2011, SCI EDUC, V95, P877, DOI 10.1002/sce.20441; Mcrae MP, 2010, J CHIPROPR EDUC, V24, P30, DOI 10.7899/1042-5055-24.1.30; Rask K, 2010, ECON EDUC REV, V29, P892, DOI 10.1016/j.econedurev.2010.06.013; Scherr RE, 2009, COGNITION INSTRUCT, V27, P147, DOI 10.1080/07370000902797379; Schwartz MS, 2009, SCI EDUC, V93, P798, DOI 10.1002/sce.20328; STEELE MW, 1982, AM J HUM GENET, V34, P501; Tanner JR., 2009, J INFORM SYSTEMS ED, V20, P29; van de Sande CC, 2012, J LEARN SCI, V21, P1, DOI 10.1080/10508406.2011.639000; Vygotsky L, READINGS ON THE DEVE, V23, P34; Wright R, 2009, CBE-LIFE SCI EDUC, V8, P44, DOI 10.1187/cbe.07-10-0093	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148051	10.1371/journal.pone.0148051	http://dx.doi.org/10.1371/journal.pone.0148051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824700	Green Published, gold			2022-12-27	WOS:000369528600094
J	Ansseau, E; Eidahl, JO; Lancelot, C; Tassin, A; Matteotti, C; Yip, C; Liu, J; Leroy, B; Hubeau, C; Gerbaux, C; Cloet, S; Wauters, A; Zorbo, S; Meyer, P; Pirson, I; Laoudj-Chenivesse, D; Wattiez, R; Harper, SQ; Belayew, A; Coppee, F				Ansseau, Eugenie; Eidahl, Jocelyn O.; Lancelot, Celine; Tassin, Alexandra; Matteotti, Christel; Yip, Cassandre; Liu, Jian; Leroy, Baptiste; Hubeau, Celine; Gerbaux, Cecile; Cloet, Samuel; Wauters, Armelle; Zorbo, Sabrina; Meyer, Pierre; Pirson, Isabelle; Laoudj-Chenivesse, Dalila; Wattiez, Ruddy; Harper, Scott Q.; Belayew, Alexandra; Coppee, Frederique			Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; DOUBLE HOMEOBOX GENE; RNA HELICASE DDX5; MYOTUBE FORMATION; OXIDATIVE STRESS; CANDIDATE GENE; EXPRESSION; BINDING; MICROTUBULE; D4Z4	Hundreds of double homeobox (DUX) genes map within 3.3-kb repeated elements dispersed in the human genome and encode DNA-binding proteins. Among these, we identified DUX4, a potent transcription factor that causes facioscapulohumeral muscular dystrophy (FSHD). In the present study, we performed yeast two-hybrid screens and protein co-purifications with HaloTag-DUX fusions or GST-DUX4 pull-down to identify protein partners of DUX4, DUX4c (which is identical to DUX4 except for the end of the carboxyl terminal domain) and DUX1 (which is limited to the double homeodomain). Unexpectedly, we identified and validated (by co-immunoprecipitation, GST pull-down, co-immunofluorescence and in situ Proximal Ligation Assay) the interaction of DUX4, DUX4c and DUX1 with type III intermediate filament protein desmin in the cytoplasm and at the nuclear periphery. Desmin filaments link adjacent sarcomere at the Z-discs, connect them to sarcolemma proteins and interact with mitochondria. These intermediate filament also contact the nuclear lamina and contribute to positioning of the nuclei. Another Z-disc protein, LMCD1 that contains a LIM domain was also validated as a DUX4 partner. The functionality of DUX4 or DUX4c interactions with cytoplasmic proteins is underscored by the cytoplasmic detection of DUX4/DUX4c upon myoblast fusion. In addition, we identified and validated (by co-immunoprecipitation, co-immunofluorescence and in situ Proximal Ligation Assay) as DUX4/4c partners several RNA-binding proteins such as C1QBP, SRSF9, RBM3, FUS/TLS and SFPQ that are involved in mRNA splicing and translation. FUS and SFPQ are nuclear proteins, however their cytoplasmic translocation was reported in neuronal cells where they associated with ribonucleoparticles (RNPs). Several other validated or identified DUX4/DUX4c partners are also contained in mRNP granules, and the co-localizations with cytoplasmic DAPI-positive spots is in keeping with such an association. Large muscle RNPs were recently shown to exit the nucleus via a novel mechanism of nuclear envelope budding. Following DUX4 or DUX4c overexpression in muscle cell cultures, we observed their association with similar nuclear buds. In conclusion, our study demonstrated unexpected interactions of DUX4/4c with cytoplasmic proteins playing major roles during muscle differentiation. Further investigations are on-going to evaluate whether these interactions play roles during muscle regeneration as previously suggested for DUX4c.	[Ansseau, Eugenie; Lancelot, Celine; Tassin, Alexandra; Matteotti, Christel; Yip, Cassandre; Hubeau, Celine; Gerbaux, Cecile; Cloet, Samuel; Wauters, Armelle; Zorbo, Sabrina; Belayew, Alexandra; Coppee, Frederique] Univ Mons, Res Inst Hlth Sci & Technol, Mol Biol Lab, B-7000 Mons, Belgium; [Eidahl, Jocelyn O.; Liu, Jian; Harper, Scott Q.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Leroy, Baptiste; Wattiez, Ruddy] Univ Mons, Res Inst Biosci, Lab Prote & Microbiol, B-7000 Mons, Belgium; [Meyer, Pierre] CHRU Montpellier, Dept Pediat, Montpellier, France; [Pirson, Isabelle] Free Univ Brussels, IRIBHM, 808 Route Lennik, Brussels, Belgium; [Laoudj-Chenivesse, Dalila] INSERM, U1046, Lab Physiol & Expt Med, Montpellier, France; [Harper, Scott Q.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University of Mons; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Mons; Universite de Montpellier; CHU de Montpellier; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University System of Ohio; Ohio State University	Coppee, F (corresponding author), Univ Mons, Res Inst Hlth Sci & Technol, Mol Biol Lab, B-7000 Mons, Belgium.	Frederique.coppee@umons.ac.be	BELAYEW, Alexandra/D-5205-2013; Laoudj-Chenivesse, dalila/N-7097-2018	BELAYEW, Alexandra/0000-0001-5115-2424; Laoudj-Chenivesse, dalila/0000-0003-4356-9187; Meyer, Pierre/0000-0001-5710-7376; Leroy, Baptiste/0000-0001-7166-4478; wattiez, ruddy/0000-0003-2071-4310	ABMM; AFM; FSH Society; FSH Stichting; NIH [NS046242, 5T32NS077984-02, 5 R01 AR 062123 -03, 758814]; FNRS/FRIA; FSH Society [FSHS-MGBF-020 82013-03, 82096215]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD060848] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077984] Funding Source: NIH RePORTER	ABMM; AFM(Association Francaise contre les Myopathies); FSH Society; FSH Stichting; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FNRS/FRIA(Fonds de la Recherche Scientifique - FNRS); FSH Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by ABMM [http://www.telethon.be/]; AFM [http://www.afm-telethon.fr/association]; FSH Society [https://www.fshsociety.org/]; FSH Stichting [http://www.fshd.nl/index.php/en/]; NIH NS046242 [http://www.nih.gov/]; and FNRS/FRIA [http://www.fnrs.be/]. Scott Q. Harper at the Center for Gene Therapy, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA:-NIH T32 Postdoctoral Fellowship 5T32NS077984-02 (T32 Fellowship)-Sponsor Reference # KL2RR025754 - Children's # 627011 (KL2)-NIH Sponsor Reference # 5 R01 AR 062123 -03 - Children's # 758814 (RO1) (web site already refer in point 1)-FSH Society Fellowship FSHS-MGBF-020 82013-03 (FSH Society Fellowship) (web site already refer in point 1)-Sponsor Reference # none-Children's # 82096215 (Chris Carrino Foundation) http://www.chriscarrinofoundation.org/. The T32, FSH Society and Carrino have funded salary of JOE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J CELL SCI, V117, P6523, DOI 10.1242/jcs.01574; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Ayala FJ, 2009, FASEB J, V23, P2022, DOI [DOI 10.1096/FJ.09-0703, 10.1096/fj.09-0703]; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Bian ZY, 2010, HYPERTENSION, V55, P257, DOI 10.1161/HYPERTENSIONAHA.109.135665; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Cadot B, 2012, EMBO REP, V13, P741, DOI 10.1038/embor.2012.89; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Coppee F, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P117; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Cozzolino M, 2013, MOL CELL NEUROSCI, V55, P44, DOI 10.1016/j.mcn.2012.06.001; Dandapat A, 2013, STEM CELLS DEV, V22, P2440, DOI 10.1089/scd.2012.0643; Corona ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075614; Dardenne E, 2014, CELL REP, V7, P1900, DOI 10.1016/j.celrep.2014.05.010; Davidovic L, 2008, J MED GENET, V45, P679, DOI 10.1136/jmg.2008.060541; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; Ding H, 1996, DNA CELL BIOL, V15, P429, DOI 10.1089/dna.1996.15.429; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Feng Q, 2015, ELIFE, V4, DOI 10.7554/eLife.04996; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Frank D, 2010, J MOL CELL CARDIOL, V49, P673, DOI 10.1016/j.yjmcc.2010.06.009; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086808; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Grunwald M, 2013, EMBO J, V32, P899, DOI 10.1038/emboj.2013.29; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Hendricks AG, 2012, CURR BIOL, V22, P632, DOI 10.1016/j.cub.2012.02.023; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Hnia K, 2015, CELL TISSUE RES, V360, P591, DOI 10.1007/s00441-014-2016-4; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Homma S, 2015, ANN CLIN TRANSL NEUR, V2, P151, DOI 10.1002/acn3.158; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Huang LJ, 2008, INVEST OPHTH VIS SCI, V49, P5243, DOI 10.1167/iovs.07-1625; Huang LQ, 2002, ACTA BIOCH BIOPH SIN, V34, P219; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jayasena CS, 2012, J CELL BIOL, V199, P453, DOI 10.1083/jcb.201204138; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kapranov Philipp, 2012, Frontiers in Genetics, V3, P60, DOI 10.3389/fgene.2012.00060; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Kato Y, 2012, DEV GROWTH DIFFER, V54, P19, DOI 10.1111/j.1440-169X.2011.01314.x; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kawazu M, 2007, J IMMUNOL, V179, P5335, DOI 10.4049/jimmunol.179.8.5335; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krom YD, 2012, AM J PATHOL, V181, P1387, DOI 10.1016/j.ajpath.2012.07.007; Landeras-Bueno S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002397; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lassche S, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-144; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Leinhart K, 2011, GENES-BASEL, V2, P210, DOI 10.3390/genes2010210; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lete C, 2012, J VIROL, V86, P11567, DOI 10.1128/JVI.00456-12; Li HQ, 2009, FASEB J, V23, P1988, DOI 10.1096/fj.08-125542; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Lin Jung-Chun, 2012, Front Biosci (Schol Ed), V4, P181; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Lopez MP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5778; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Mancini A, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-36; Maragh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105460; McLendon PM, 2011, AM J PHYSIOL-HEART C, V301, pH1220, DOI 10.1152/ajpheart.00601.2011; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Myhre JL, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/712315; Olive M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f; Ostlund C, 2005, BIOCHEMISTRY-US, V44, P2378, DOI 10.1021/bi047992w; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Pistoni M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003186; Pizon V, 2005, EMBO J, V24, P3781, DOI 10.1038/sj.emboj.7600842; Ploski JE, 2004, MOL CELL BIOL, V24, P4824, DOI 10.1128/MCB.24.11.4824-4834.2004; Poon KL, 2012, CARDIOVASC RES, V94, P418, DOI 10.1093/cvr/cvs095; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Reed P, 2006, ANN NEUROL, V59, P289, DOI 10.1002/ana.20750; Richards M, 2012, HUM GENET, V131, P325, DOI 10.1007/s00439-011-1100-z; Richardson BE, 2008, TRAFFIC, V9, P1050, DOI 10.1111/j.1600-0854.2008.00756.x; Rickard AM, 2015, HUM MOL GENET, V24, P5901, DOI 10.1093/hmg/ddv315; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Rogers MT, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P277; ROSS KFA, 1964, Q J MICROSC SCI, V105, P423; Sancisi V, 2014, AM J PHYSIOL-REG I, V306, pR124, DOI 10.1152/ajpregu.00379.2013; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; Saporita AJ, 2011, CANCER RES, V71, P6708, DOI 10.1158/0008-5472.CAN-11-1472; Satoh M, 1999, J BIOL CHEM, V274, P34598, DOI 10.1074/jbc.274.49.34598; Serebriiskii I, 2000, BIOTECHNIQUES, V28, P328, DOI 10.2144/00282rr03; Sharma V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064691; Sharon N, 2012, STEM CELL RES, V9, P261, DOI 10.1016/j.scr.2012.08.003; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Strong MJ, 2011, FEBS J, V278, P3569, DOI 10.1111/j.1742-4658.2011.08277.x; Sury MD, 2015, MOL CELL PROTEOMICS, V14, P50, DOI 10.1074/mcp.M114.039370; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Tassin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051865; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Turki A, 2012, FREE RADICAL BIO MED, V53, P1068, DOI 10.1016/j.freeradbiomed.2012.06.041; Vandenbroere I, 2003, BIOCHEM BIOPH RES CO, V300, P494, DOI 10.1016/S0006-291X(02)02894-2; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326; Winokur ST, 1996, HUM MOL GENET, V5, P1567, DOI 10.1093/hmg/5.10.1567; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Winter DL, 2014, HISTOCHEM CELL BIOL, V141, P1, DOI 10.1007/s00418-013-1148-z; Wu SL, 2014, CELL TISSUE RES, V358, P551, DOI 10.1007/s00441-014-1974-x; Wu SL, 2010, DEV DYNAM, V239, P927, DOI 10.1002/dvdy.22210; Yamamoto DL, 2008, J HISTOCHEM CYTOCHEM, V56, P881, DOI 10.1369/jhc.2008.951228; Yang JW, 2014, DEV CELL, V31, P87, DOI 10.1016/j.devcel.2014.08.025; Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251; Ye WD, 2011, BBA-MOL CELL RES, V1813, P1654, DOI 10.1016/j.bbamcr.2011.01.013; Yoshikawa H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006148; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255; Zhong YF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-169; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	133	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146893	10.1371/journal.pone.0146893	http://dx.doi.org/10.1371/journal.pone.0146893			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816005	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528200022
J	Huang, H; Veien, ES; Zhang, H; Ayers, DC; Song, J				Huang, Henry; Veien, Eric S.; Zhang, Hong; Ayers, David C.; Song, Jie			Skeletal Characterization of Smurf2-Deficient Mice and In Vitro Analysis of Smurf2-Deficient Chondrocytes	PLOS ONE			English	Article							TGF-BETA; UBIQUITIN LIGASE; BONE; SMURF2; OSTEOARTHRITIS; DIFFERENTIATION; DEGRADATION; CARTILAGE; AGE; HISTOPATHOLOGY	Overexpression of Smad ubiquitin regulatory factor 2 (Smurf2) in chondrocytes was reported to cause spontaneous osteoarthritis (OA) in mice. However, it is unclear whether Smurf2 is involved in bone and cartilage homeostasis and if it is required for OA pathogenesis. Here we characterized age-related changes in the bone and articular cartilage of Smurf2-deficient (MT) mice by microCT and histology, and examined whether reduced Smurf2 expression affected the severity of OA upon surgical destabilization of the medial meniscus (DMM). Using immature articular chondrocytes (iMAC) from MT and wild-type (WT) mice, we also examined how Smurf2 deficiency affects chondrogenic and catabolic gene expressions and Smurf2 and Smurf1 proteins upon TGF-beta 3 or IL-1 beta treatment in culture. We found no differences in cortical, subchondral and trabecular bone between WT and MT in young (4 months) and old mice (16-24 months). The articular cartilage and age-related alterations between WT and MT were also similar. However, 2 months following DMM, young MT showed milder OA compared toWT (similar to 70% vs similar to 30% normal or exhibiting only mild OA cartilage phenotype). The majority of the older WT and MT mice developed moderate/severe OA 2 months after DMM, but a higher subset of aged MT cartilage (27% vs. 9% WT) remained largely normal. Chondrogenic gene expression (Sox9, Col2, Acan) trended higher in MT iMACs than WT with/without TGF-beta 3 treatment. IL-1 beta treatment suppressed chondrgenic gene expression, but Sox9 expression in MT remained significantly higher than WT. Smurf2 protein inWT iMACs increased upon TGF-beta 3 treatment and decreased upon IL-1 beta treatment in a dose-dependent manner. Smurf1 protein elevated more in MT than WT upon TGF-beta 3 treatment, suggesting a potential, but very mild compensatory effect. Overall, our data support a role of Smurf2 in regulating OA development but suggest that inhibiting Smurf2 alone may not be sufficient to prevent or consistently mitigate post-traumatic OA across a broad age range.	[Huang, Henry; Veien, Eric S.; Ayers, David C.; Song, Jie] Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01605 USA; [Huang, Henry; Zhang, Hong; Song, Jie] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Song, J (corresponding author), Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01605 USA.; Song, J (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA.	Jie.Song@umassmed.edu		Song, Jie/0000-0001-7554-5564	University of Massachusetts Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM107000] Funding Source: NIH RePORTER	University of Massachusetts Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by the University of Massachusetts Medical School. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauge C, 2014, AGING DIS, V5, P394, DOI 10.14336/AD.2014.0500394; Bizet AA, 2012, J CELL BIOCHEM, V113, P238, DOI 10.1002/jcb.23349; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Li TF, 2010, ARTHRITIS RHEUM-US, V62, P2359, DOI 10.1002/art.27537; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; McNulty MA, 2012, OSTEOARTHR CARTILAGE, V20, P949, DOI 10.1016/j.joca.2012.05.001; Rahman MS, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.5; Ramkumar C, 2012, CANCER RES, V72, P2714, DOI 10.1158/0008-5472.CAN-11-3773; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; Rowan AD, 2007, FRONT BIOSCI-LANDMRK, V12, P536, DOI 10.2741/2080; Seeman E, 2013, J GERONTOL A-BIOL, V68, P1218, DOI 10.1093/gerona/glt071; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Stok KS, 2009, BONE, V45, P414, DOI 10.1016/j.bone.2009.05.017; Suire C, 2012, BLOOD, V119, pE86, DOI 10.1182/blood-2011-08-372334; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Verdier MP, 2005, RHEUMATOL INT, V25, P118, DOI 10.1007/s00296-003-0409-x; Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946; Wu QQ, 2008, J ORTHOP RES, V26, P704, DOI 10.1002/jor.20563; Xing LP, 2010, J CELL BIOCHEM, V110, P554, DOI 10.1002/jcb.22586; Yamamoto K, 2005, J Orthop Surg (Hong Kong), V13, P8; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	38	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148088	10.1371/journal.pone.0148088	http://dx.doi.org/10.1371/journal.pone.0148088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815610	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528200072
J	Calderon-Sanchez, E; Diaz, I; Ordonez, A; Smani, T				Calderon-Sanchez, Eva; Diaz, Ignacio; Ordonez, Antonio; Smani, Tarik			Urocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2	PLOS ONE			English	Article							REPERFUSION INJURY; HEART-FAILURE; SIGNAL-TRANSDUCTION; APOPTOSIS; ACTIVATION; PROTECTS; MECHANISMS; POLYMORPHISM; PKA	Aims Urocortin-1 (Ucn-1) is an endogenous peptide that protects heart from ischemia and reperfusion (I/R) injuries. Ucn-1 is known to prevent cardiac cell death, but its role in the transcription of specific genes related to survival signaling pathway has not been fully defined. The aim of this study was to investigate the molecular signaling implicated in the improvement of cardiac myocytes survival induced by Ucn-1. Methods and Results Ucn-1 administration before ischemia and at the onset of reperfusion, in rat hearts perfused in Langendorff system, fully recovered heart contractility and other hemodynamic parameters. Ucn-1 enhanced cell viability and decreased lactate dehydrogenase (LDH) release in adult cardiac myocytes subjected to simulated I/R. Annexin V-FITC/PI staining indicated that Ucn-1 promoted cell survival and decreased cell necrosis through Epac2 (exchange protein directly activated by cAMP) and ERK1/2 (extracellular signal-regulated kinases 1/2) activation. We determined that Ucn-1 shifted cell death from necrosis to apoptosis and activated caspases 9 and 3/7. Furthermore, mini-array, RT-qPCR and protein analyses of apoptotic genes showed that Ucn-1 upregulated the expression of CD40lg, Xiap and BAD in cells undergoing I/R, involving Epac2 and ERK1/2 activation. Conclusions Our data indicate that Ucn- 1 efficiently protected hearts from I/R damage by increasing the cell survival and stimulated apoptotic genes, CD40lg, Xiap and BAD, overexpression through the activation of Epac2 and ERK1/2.	[Calderon-Sanchez, Eva; Diaz, Ignacio; Ordonez, Antonio; Smani, Tarik] Univ Seville, CSIC, IBiS, Grp Fisiopatol Cardiovasc,HUVR, Seville, Spain; [Smani, Tarik] Univ Seville, Dept Fisiol Med & Biofis, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Sevilla	Ordonez, A; Smani, T (corresponding author), Univ Seville, CSIC, IBiS, Grp Fisiopatol Cardiovasc,HUVR, Seville, Spain.; Smani, T (corresponding author), Univ Seville, Dept Fisiol Med & Biofis, Seville, Spain.	antorfernan@us.es; tasmani@us.es	IBIS, CARDIOVASCULAR/P-3910-2015; Calderón-Sánchez, Eva María/B-5906-2016; Ordoñez, Antonio/G-9195-2018; Hajami, Tarik Smani/D-5372-2016	Calderón-Sánchez, Eva María/0000-0002-9599-3513; Ordoñez, Antonio/0000-0002-4344-8660; Hajami, Tarik Smani/0000-0002-1877-7438	Spanish Ministry of Economy and Competitiveness [BFU-2013-45564-C2-2-P]; Institute of Carlos III and Cardiovascular Network "RIC" [RD12/0042/0041, PI12/00941]; Andalusia Government [PI-0108-2012, P10-CVI-6095]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute of Carlos III and Cardiovascular Network "RIC"; Andalusia Government	This study was supported by Spanish Ministry of Economy and Competitiveness [BFU-2013-45564-C2-2-P]; Institute of Carlos III and Cardiovascular Network "RIC" [RD12/0042/0041; PI12/00941]; and from the Andalusia Government [PI-0108-2012; P10-CVI-6095].	Adao R, 2015, DRUG DISCOV TODAY, V20, P906, DOI 10.1016/j.drudis.2015.02.012; Boonprasert P, 2008, INT J CARDIOL, V127, P307, DOI 10.1016/j.ijcard.2007.11.026; Brar BK, 2000, J BIOL CHEM, V275, P8508, DOI 10.1074/jbc.275.12.8508; Brar BK, 2004, ENDOCRINOLOGY, V145, P24, DOI 10.1210/en.2003-0689; Brar BK, 1999, MOL CELL ENDOCRINOL, V158, P55, DOI 10.1016/S0303-7207(99)00183-5; Calderon-Sanchez E, 2009, CARDIOVASC RES, V83, P717, DOI 10.1093/cvr/cvp161; Chambers DJ, 2010, PHARMACOL THERAPEUT, V127, P41, DOI 10.1016/j.pharmthera.2010.04.001; Chen-Scarabelli C, 2004, AM HEART J, V148, P196, DOI 10.1016/j.ahj.2004.03.030; Chen-Scarabelli Carol, 2013, JAKSTAT, V2, pe24812, DOI 10.4161/jkst.24812; Dautzenberg FM, 2002, TRENDS PHARMACOL SCI, V23, P71, DOI 10.1016/S0165-6147(02)01946-6; Diaz I, 2013, CURR VASC PHARMACOL, V11, P457; Gao XF, 2015, MOL CELL BIOCHEM, V398, P135, DOI 10.1007/s11010-014-2213-1; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang X, 2015, APOPTOSIS, V20, P1033, DOI 10.1007/s10495-015-1130-4; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Lawrence KM, 2005, FASEB J, V19, P831, DOI 10.1096/fj.04-2506fje; Malarstig A, 2006, ARTERIOSCL THROM VAS, V26, P1667, DOI 10.1161/01.ATV.0000222908.78873.36; Calderon-Sanchez EM, 2011, CELL CALCIUM, V50, P84, DOI 10.1016/j.ceca.2011.05.010; Markovic D, 2011, BBA-MOL CELL RES, V1813, P896, DOI 10.1016/j.bbamcr.2011.02.005; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Ovize M, 2010, CARDIOVASC RES, V87, P406, DOI 10.1093/cvr/cvq129; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Rademaker MT, 2015, INT J CARDIOL, V197, P56, DOI 10.1016/j.ijcard.2015.06.011; Rademaker MT, 2011, HYPERTENSION, V57, P1136, DOI 10.1161/HYPERTENSIONAHA.111.173203; Rehmann H, 2013, SCI REP, P3; Reutenauer-Patte J, 2012, AM J PATHOL, V180, P749, DOI 10.1016/j.ajpath.2011.10.038; Rigaud S, 2011, BLOOD, V118, P252, DOI 10.1182/blood-2011-01-328849; Ruiz-Hurtado G, 2013, J MOL CELL CARDIOL, V58, P162, DOI 10.1016/j.yjmcc.2012.11.021; Ruiz-Hurtado G, 2012, J MOL CELL CARDIOL, V53, P617, DOI 10.1016/j.yjmcc.2012.08.004; Scarabelli TM, 2006, CURR PROB CARDIOLOGY, V31, P181, DOI 10.1016/j.cpcardiol.2005.11.002; Scarabelli TM, 2002, J AM COLL CARDIOL, V40, P155, DOI 10.1016/S0735-1097(02)01930-7; Schulman D, 2002, AM J PHYSIOL-HEART C, V283, pH1481, DOI 10.1152/ajpheart.01089.2001; Smani T, 2011, CLIN EXP PHARMACOL P, V38, P71, DOI 10.1111/j.1440-1681.2010.05466.x; Smani T, 2010, CARDIOVASC RES, V87, P459, DOI 10.1093/cvr/cvq063; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tsatsanis C, 2005, FEBS LETT, V579, P4259, DOI 10.1016/j.febslet.2005.06.057; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Zhang XY, 2013, CIRC RES, V112, P498, DOI 10.1161/CIRCRESAHA.112.273896	43	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147375	10.1371/journal.pone.0147375	http://dx.doi.org/10.1371/journal.pone.0147375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840743	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200034
J	Jacob, F; Yonis, AY; Cuello, F; Luther, P; Schulze, T; Eder, A; Streichert, T; Mannhardt, I; Hirt, MN; Schaaf, S; Stenzig, J; Force, T; Eschenhagen, T; Hansen, A				Jacob, Fabian; Yonis, Amina Y.; Cuello, Friederike; Luther, Pradeep; Schulze, Thomas; Eder, Alexandra; Streichert, Thomas; Mannhardt, Ingra; Hirt, Marc N.; Schaaf, Sebastian; Stenzig, Justus; Force, Thomas; Eschenhagen, Thomas; Hansen, Arne			Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue	PLOS ONE			English	Article							INDUCED CARDIOTOXICITY; CELL-DEATH; IN-VITRO; IMATINIB; MITOCHONDRIA; MECHANISMS; SUNITINIB; AUTOPHAGY; CARDIOMYOCYTES; SORAFENIB	Introduction Left ventricular dysfunction is a frequent and potentially severe side effect of many tyrosine kinase inhibitors (TKI). The mode of toxicity is not identified, but may include impairment of mitochondrial or sarcomeric function, autophagy or angiogenesis, either as an on-target or off-target mechanism. Methods and Results We studied concentration-response curves and time courses for nine TKIs in three-dimensional, force generating engineered heart tissue (EHT) from neonatal rat heart cells. We detected a concentration-and time-dependent decline in contractile force for gefitinib, lapatinib, sunitinib, imatinib, sorafenib, vandetanib and lestaurtinib and no decline in contractile force for erlotinib and dasatinib after 96 hours of incubation. The decline in contractile force was associated with an impairment of autophagy (LC3 Western blot) and appearance of autophagolysosomes (transmission electron microscopy). Conclusion This study demonstrates the feasibility to study TKI-mediated force effects in EHTs and identifies an association between a decline in contractility and inhibition of autophagic flux.	[Jacob, Fabian; Cuello, Friederike; Schulze, Thomas; Eder, Alexandra; Mannhardt, Ingra; Hirt, Marc N.; Schaaf, Sebastian; Stenzig, Justus; Eschenhagen, Thomas; Hansen, Arne] Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Jacob, Fabian; Cuello, Friederike; Schulze, Thomas; Eder, Alexandra; Mannhardt, Ingra; Hirt, Marc N.; Schaaf, Sebastian; Stenzig, Justus; Eschenhagen, Thomas; Hansen, Arne] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany; [Yonis, Amina Y.; Luther, Pradeep] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Mol Med Sect, London, England; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Cent Labs, Hamburg, Germany; [Force, Thomas] Temple Univ, Sch Med, Div Cardiol, Ctr Translat Med, Philadelphia, PA 19140 USA; [Streichert, Thomas] Univ Hosp Cologne, Dept Clin Chem, Cologne, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Imperial College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Cologne	Hansen, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Dept Expt Pharmacol & Toxicol, Hamburg, Germany.; Hansen, A (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany.	ar.hansen@uke.de		Force, Thomas/0000-0002-0450-8659; Luther, Pradeep/0000-0002-8841-4368	Deutsche Herzstiftung [F/13/10]; German Research Foundation [DFG Es 88/12-1]; German Ministry of Research and Education (DZHK, German Centre for Cardiovascular Research); European Commission; British Heart Foundation [RG/11/21/29335] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119234] Funding Source: NIH RePORTER	Deutsche Herzstiftung; German Research Foundation(German Research Foundation (DFG)); German Ministry of Research and Education (DZHK, German Centre for Cardiovascular Research); European Commission(European CommissionEuropean Commission Joint Research Centre); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funds from Deutsche Herzstiftung (F/13/10), the German Research Foundation (DFG Es 88/12-1), the German Ministry of Research and Education (DZHK, German Centre for Cardiovascular Research), the European Commission with FP7 Projects Angioscaff and Biodesign.	Abi-Gerges N, 2013, J MOL CELL CARDIOL, V64, P108, DOI 10.1016/j.yjmcc.2013.09.004; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Cheng H, 2011, CIRC RES, V109, P1401, DOI 10.1161/CIRCRESAHA.111.255695; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; Cross MJ, 2015, BRIT J PHARMACOL, V172, P957, DOI 10.1111/bph.12979; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Eder A, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0436-7; French KJ, 2010, TOXICOL PATHOL, V38, P691, DOI 10.1177/0192623310373775; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Herman EH, 2011, TOXICOL PATHOL, V39, P1091, DOI 10.1177/0192623311419524; Hill JA, 2011, PEDIATR CARDIOL, V32, P282, DOI 10.1007/s00246-010-9883-6; Hirt MN, 2014, J MOL CELL CARDIOL, V74, P151, DOI 10.1016/j.yjmcc.2014.05.009; Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z; HOLEN I, 1995, J BIOL CHEM, V270, P12823, DOI 10.1074/jbc.270.21.12823; Hu WY, 2012, TOXICOL SCI, V129, P188, DOI 10.1093/toxsci/kfs192; Ikeda T, 2013, J PHARMACOL SCI, V121, P67, DOI 10.1254/jphs.12158FP; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Laverty HG, 2011, BRIT J PHARMACOL, V163, P675, DOI 10.1111/j.1476-5381.2011.01255.x; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Pegram M, 2006, ADV DRUG DELIVER REV, V58, P723, DOI 10.1016/j.addr.2006.05.003; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157; Zhao YQ, 2010, TOXICOL APPL PHARM, V248, P20, DOI 10.1016/j.taap.2010.07.007	29	29	29	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0145937	10.1371/journal.pone.0145937	http://dx.doi.org/10.1371/journal.pone.0145937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840448	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200005
J	Pandey, RV; Pabinger, S; Kriegner, A; Weinhausel, A				Pandey, Ram Vinay; Pabinger, Stephan; Kriegner, Albert; Weinhaeusel, Andreas			MutAid: Sanger and NGS Based Integrated Pipeline for Mutation Identification, Validation and Annotation in Human Molecular Genetics	PLOS ONE			English	Article							READ ALIGNMENT; BREAST-CANCER; HUMAN GENOME; GENERATION; VARIANTS; SEQUENCE; DISEASE; DISCOVERY; TOOL	Traditional Sanger sequencing as well as Next-Generation Sequencing have been used for the identification of disease causing mutations in human molecular research. The majority of currently available tools are developed for research and explorative purposes and often do not provide a complete, efficient, one-stop solution. As the focus of currently developed tools is mainly on NGS data analysis, no integrative solution for the analysis of Sanger data is provided and consequently a one-stop solution to analyze reads from both sequencing platforms is not available. We have therefore developed a new pipeline called MutAid to analyze and interpret raw sequencing data produced by Sanger or several NGS sequencing platforms. It performs format conversion, base calling, quality trimming, filtering, read mapping, variant calling, variant annotation and analysis of Sanger and NGS data under a single platform. It is capable of analyzing reads from multiple patients in a single run to create a list of potential disease causing base substitutions as well as insertions and deletions. MutAid has been developed for expert and non-expert users and supports four sequencing platforms including Sanger, Illumina, 454 and Ion Torrent. Furthermore, for NGS data analysis, five read mappers including BWA, TMAP, Bowtie, Bowtie2 and GSNAP and four variant callers including GATK-HaplotypeCaller, SAMTOOLS, Freebayes and VarScan2 pipelines are supported. MutAid is freely available at https://sourceforge.net/projects/mutaid.	[Pandey, Ram Vinay; Pabinger, Stephan; Kriegner, Albert; Weinhaeusel, Andreas] Austrian Inst Technol, Hlth & Environm Dept, Mol Diagnost, Vienna, Austria; [Pandey, Ram Vinay] Vetmeduni Vienna, Inst Populat Genet, Vet Pl 1, A-1210 Vienna, Austria	Austrian Institute of Technology (AIT); University of Veterinary Medicine Vienna	Pandey, RV (corresponding author), Austrian Inst Technol, Hlth & Environm Dept, Mol Diagnost, Vienna, Austria.; Pandey, RV (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vet Pl 1, A-1210 Vienna, Austria.	ramvinay.pandey@gmail.com	Pandey, Ram Vinay/AAA-3544-2022; Weinhaeusel, Andreas/A-7644-2018; Pandey, Ram Vinay/AAL-1701-2021	Pandey, Ram Vinay/0000-0002-2533-8687; Pabinger, Stephan/0000-0001-9876-5965				Ardeshirdavani A, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0071-9; Babraham Bioinformatics, FASTQC QUAL CONTR TO; Baird RD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-151; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Beck T, 2014, EUR J HUM GENET, V22, P949, DOI 10.1038/ejhg.2013.274; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Blue Cross and Blue Shield Association, 2013, Technol Eval Cent Assess Program Exec Summ, V28, P1; Criscuolo A, 2013, GENOMICS, V102, P500, DOI 10.1016/j.ygeno.2013.07.011; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fischer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041948; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Hosen MJ, 2015, J INVEST DERMATOL, V135, P992, DOI 10.1038/jid.2014.421; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Quesada V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-124; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Renkema KY, 2014, NAT REV NEPHROL, V10, P433, DOI 10.1038/nrneph.2014.95; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ulahannan D, 2013, BRIT J CANCER, V109, P827, DOI 10.1038/bjc.2013.416; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Vandrovcova J, 2013, GENET MED, V15, P948, DOI 10.1038/gim.2013.55; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	33	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147697	10.1371/journal.pone.0147697	http://dx.doi.org/10.1371/journal.pone.0147697			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840129	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200054
J	Tagliaferri, D; De Angelis, MT; Russo, NA; Marotta, M; Ceccarelli, M; Del Vecchio, L; De Felice, M; Falco, G				Tagliaferri, Daniela; De Angelis, Maria Teresa; Russo, Nicola Antonino; Marotta, Maria; Ceccarelli, Michele; Del Vecchio, Luigi; De Felice, Mario; Falco, Geppino			Retinoic Acid Specifically Enhances Embryonic Stem Cell Metastate Marked by Zscan4	PLOS ONE			English	Article							MOUSE ES CELLS; TELOMERE ELONGATION; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; IDENTIFICATION; POTENCY; STATE	Pluripotency confers Embryonic Stem Cells (ESCs) the ability to differentiate in ectoderm, endoderm, and mesoderm derivatives, producing the majority of cell types. Although the majority of ESCs divide without losing pluripotency, it has become evident that ESCs culture consists of multiple cell populations with different degrees of potency that are spontaneously induced in regular ESC culture conditions. Zscan4, a key pluripotency factor, marks ESC subpopulation that is referred to as high-level of pluripotency metastate. Here, we report that in ESC cultures treated with retinoic acid (RA), Zscan4 ESCs metastate is strongly enhanced. In particular, we found that induction of Zscan4 metastate is mediated via RA receptors (RAR-alpha, RAR-beta, and RAR-gamma), and it is dependent on phosphoinositide-3-kinase (PI3K) signaling. Remarkably, Zscan4 metastate induced by RA lacks canonical pluripotency genes Oct3/4 and Nanog but retained both self-renewal and pluripotency capabilities. Finally we demonstrated that the conditional ablation of Zscan4 subpopulation is dispensable for both endoderm and mesoderm but is required for ectoderm lineage. In conclusion, our research provides new insights about the role of RA signaling during ESCs high pluripotency metastate fluctuation.	[Tagliaferri, Daniela; De Angelis, Maria Teresa; Russo, Nicola Antonino; Marotta, Maria; De Felice, Mario; Falco, Geppino] Ist Ric Genet Gaetano Salvatore Biogem Scarl, Biogem, Ariano Irpino, Italy; [Ceccarelli, Michele] HBKU, Qatar Comp Res Inst, Doha, Qatar; [Del Vecchio, Luigi; De Felice, Mario] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Falco, Geppino] Univ Sannio, Dept Sci, Benevento, Italy; [Falco, Geppino] Univ Naples Federico II, Dept Biol, Naples, Italy	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; University of Naples Federico II; Italfarmaco; University of Sannio; University of Naples Federico II	Falco, G (corresponding author), Univ Sannio, Dept Sci, Benevento, Italy.; Falco, G (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	geppino.falco@unina.it	Ceccarelli, Michele/AGP-1739-2022; Russo, Nicola Antonino/AAC-6602-2020	falco, geppino/0000-0001-6193-7233; Ceccarelli, Michele/0000-0002-4702-6617; Russo, Nicola Antonino/0000-0001-5773-0803; De Angelis, Maria Teresa/0000-0003-3926-0611	European International Reintegration Grant Marie Curie FP7th; FIRB MIUR; Biogem Research Institute "Gaetano Salvatore"; InterOmics; IEOS; CNR	European International Reintegration Grant Marie Curie FP7th; FIRB MIUR(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Biogem Research Institute "Gaetano Salvatore"; InterOmics; IEOS; CNR(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by European International Reintegration Grant Marie Curie FP7th; FIRB MIUR and Biogem Research Institute "Gaetano Salvatore", InterOmics, IEOS, CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Casanova EA, 2011, STEM CELLS, V29, P474, DOI 10.1002/stem.588; Cerulo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083235; Chen W, 2012, BIOCHEM BIOPH RES CO, V418, P571, DOI 10.1016/j.bbrc.2012.01.078; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; DAiuto L, 2015, ORGANOGENESIS, V28, P0; Dan JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03492; De Angelis MT, 2014, STEM CELL REV REP, V10, P269, DOI 10.1007/s12015-013-9489-5; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Idres N, 2005, BIOCHEM PHARMACOL, V69, P1595, DOI 10.1016/j.bcp.2005.02.024; Laing AF, 2015, DEV BIOL, V397, P56, DOI 10.1016/j.ydbio.2014.10.007; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Redner RL, 2013, CLIN CANCER RES, V19, P2277, DOI 10.1158/1078-0432.CCR-13-0386; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Takahashi M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-87; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882	27	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147683	10.1371/journal.pone.0147683	http://dx.doi.org/10.1371/journal.pone.0147683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840068	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200053
J	Tapia, V; Betran, AP; Gonzales, GF				Tapia, Vilma; Betran, Ana Pilar; Gonzales, Gustavo F.			Caesarean Section in Peru: Analysis of Trends Using the Robson Classification System	PLOS ONE			English	Article							DELIVERY; RATES; WOMEN	Introduction Cesarean section rates continue to increase worldwide while the reasons appear to be multiple, complex and, in many cases, country specific. Over the last decades, several classification systems for caesarean section have been created and proposed to monitor and compare caesarean section rates in a standardized, reliable, consistent and action-oriented manner with the aim to understand the drivers and contributors of this trend. The aims of the present study were to conduct an analysis in the three Peruvian geographical regions to assess levels and trends of delivery by caesarean section using the Robson classification for caesarean section, identify the groups of women with highest caesarean section rates and assess variation of maternal and perinatal outcomes according to caesarean section levels in each group over time. Material and Methods Data from 549,681 pregnant women included in the Peruvian Perinatal Information System database from 43 maternal facilities in three Peruvian geographical regions from 2000 and 2010 were studied. The data were analyzed using the Robson classification and women were studied in the ten groups in the classification. Cochran-Armitage test was used to evaluate time trends in the rates of caesarean section rates and; logistic regression was used to evaluate risk for each classification. Results The caesarean section rate was 27% and a yearly increase in the overall caesarean section rates from 2000 to 2010 from 23.5% to 30% (time trend p<0.001) was observed. Robson groups 1, 3 (nulliparous and multiparas, respectively, with a single cephalic term pregnancy in spontaneous labour), 5 (multiparas with a previous uterine scar with a single, cephalic, term pregnancy) and 7 (multiparas with a single breech pregnancy with or without previous scars) showed an increase in the caesarean section rates over time. Robson groups 1 and 3 were significantly associated with stillbirths (OR 1.43, CI95% 1.17-1.72; OR 3.53, CI95% 2.95-4.2) and maternal mortality (OR 3.39, CI95% 1.59-7.22; OR 8.05, CI95% 3.34-19.41). Discussion The caesarean section rates increased in the last years as result of increased CS in groups with spontaneous labor and in-group of multiparas with a scarred uterus. Women included in groups 1 y 3 were associated to maternal perinatal complications. Women with previous cesarean section constitute the most important determinant of overall cesarean section rates. The use of Robson classification becomes an useful tool for monitoring cesarean section in low human development index countries.	[Tapia, Vilma; Gonzales, Gustavo F.] Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru; [Betran, Ana Pilar] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Gonzales, Gustavo F.] Univ Peruana Cayetano Heredia, Fac Sci & Philosophy, Dept Biol & Physiol Sci, Lima, Peru	Universidad Peruana Cayetano Heredia; The World Bank; United Nations Population Fund; World Health Organization; Universidad Peruana Cayetano Heredia	Gonzales, GF (corresponding author), Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru.; Gonzales, GF (corresponding author), Univ Peruana Cayetano Heredia, Fac Sci & Philosophy, Dept Biol & Physiol Sci, Lima, Peru.	gustavo.gonzales@upch.pe	Gonzales, Gustavo F/I-9153-2016	Gonzales, Gustavo F/0000-0003-1611-2894	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction at the Department of Reproductive Health and Research of the World Health Organization	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction at the Department of Reproductive Health and Research of the World Health Organization	The UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction at the Department of Reproductive Health and Research of the World Health Organization have supported this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aleem H, 2013, INT J GYNECOL OBSTET, V123, P119, DOI 10.1016/j.ijgo.2013.05.011; Ajuzieogu OV, 2011, SAUDI J ANAESTH, V5, P15, DOI 10.4103/1658-354X.76480; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Betran Ana P, 2009, Reprod Health, V6, P18, DOI 10.1186/1742-4755-6-18; Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769; Betran AP, 2015, BJOG; Betran AP, 1990, INCREASING TRE UNPUB; Boutsikou T, 2011, ACTA PAEDIATR, V100, P1518, DOI 10.1111/j.1651-2227.2011.02477.x; Brennan DJ, 2009, AM J OBSTET GYNECOL, V13, pe1; Brennan DJ, 2011, OBSTET GYNECOL, V117, P273, DOI 10.1097/AOG.0b013e318204521a; Chong C, 2012, ACTA OBSTET GYN SCAN, V91, P1422, DOI 10.1111/j.1600-0412.2012.01529.x; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Gonzales GF, 2013, INT J WOMENS HEALTH, V5, P637, DOI 10.2147/IJWH.S46392; Grytten J, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-267; INEI Peru, 2013, ENCUESTA DEMOGRAFICA, P1; Josipovic Ljiljana Bilobrk, 2015, Coll Antropol, V39, P145; Kelly S, 2013, J OBSTET GYNAECOL CA, V35, P206, DOI 10.1016/S1701-2163(15)30992-0; Linhares JJ, 2014, REV BRAS GINECOL OBS, V36, P259, DOI 10.1590/S0100-720320140004812; Litorp H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-107; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Robson M, 2013, BEST PRACT RES CL OB, V27, P297, DOI 10.1016/j.bpobgyn.2012.09.004; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Sorbye IK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-55; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; Volpe FM, 2011, REV PANAM SALUD PUBL, V29, P303, DOI 10.1590/S1020-49892011000500001	26	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148138	10.1371/journal.pone.0148138	http://dx.doi.org/10.1371/journal.pone.0148138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840693	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200085
J	Contreras, F; Albacete, A; Castellvi, P; Cano, A; Benejam, B; Menchon, JM				Contreras, Fernando; Albacete, Auria; Castellvi, Pere; Cano, Agnes; Benejam, Bessy; Manuel Menchon, Jose			Counterfactual Reasoning Deficits in Schizophrenia Patients	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; SOCIAL COGNITION; DECISION-MAKING; REPRESENTATIONS; DELUSIONS; CRITERIA; THINKING; PEOPLE	Background Counterfactual thinking is a specific type of conditional reasoning that enables the generation of mental simulations of alternatives to past factual events. Although it has been broadly studied in the general population, research on schizophrenia is still scarce. The aim of the current study was to further examine counterfactual reasoning in this illness. Methods Forty schizophrenia patients and 40 controls completed a series of tests that assessed the influence of the "causal order effect" on counterfactual thinking, and the ability to generate counterfactual thoughts and counterfactually derive inferences from a hypothetical situation. Socio-demographic and clinical characteristics, as well as neurocognitive variables, were also examined. Results Compared to controls, the schizophrenia patients generated fewer counterfactual thoughts when faced with a simulated scenario. The pattern of response when assessing the causality effect of the order was also different between the groups, with the patients being more frequently unable to attribute any ordering of events than the control subjects. Additionally, the schizophrenia patients showed more difficulties when deriving normative counterfactual inferences from hypothetical social situations. None of the counterfactual reasoning measures was associated to any of the cognitive functions or clinical and socio-demographic variables assessed. Conclusions A global impairment in counterfactual thinking characterizes schizophrenia patients. Because of the potential impact of such deficits on psychosocial functioning, targeting counterfactual reasoning for improvement might be considered in future treatment approaches.	[Contreras, Fernando; Albacete, Auria; Castellvi, Pere; Benejam, Bessy; Manuel Menchon, Jose] Bellvitge Univ Hosp, IDIBELL, Dept Psychiat, Barcelona, Spain; [Contreras, Fernando; Albacete, Auria; Manuel Menchon, Jose] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Contreras, Fernando; Manuel Menchon, Jose] Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos III Hlth Inst, Barcelona, Spain; [Cano, Agnes] Univ Girona, Dept Psychol, Girona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universitat de Girona	Contreras, F (corresponding author), Bellvitge Univ Hosp, IDIBELL, Dept Psychiat, Barcelona, Spain.; Contreras, F (corresponding author), Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain.; Contreras, F (corresponding author), Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos III Hlth Inst, Barcelona, Spain.	fcontreras@bellvitgehospital.cat	Castellvi Obiols, Pere/A-7533-2015; Menchon, Jose/A-5242-2009	Castellvi Obiols, Pere/0000-0002-3920-8576; Albacete Belzunces, Auria/0000-0003-4156-4972; Menchon, Jose/0000-0002-6231-6524	University of Barcelona; Agency of University and Research Funding Management of the Catalan Government (AGAUR) [2009SGR1554]	University of Barcelona; Agency of University and Research Funding Management of the Catalan Government (AGAUR)	A.A. was supported by a trainee research staff grant awarded by the University of Barcelona (APIF-UB grants). [http://www.ub.edu/web/ub/ca/] P.C. was supported by a contract awarded by the Agency of University and Research Funding Management of the Catalan Government (AGAUR; 2009SGR1554). [http://www10.gencat.net/agaur_web/AppJava/english/index.jsp] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; APA, 1987, GLOB ASS FUNCT GAF D; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; Beldarrain MG, 2005, COGNITIVE BRAIN RES, V24, P723, DOI 10.1016/j.cogbrainres.2005.03.013; Bellack AS, 2007, SCHIZOPHRENIA BULL, V33, P805, DOI 10.1093/schbul/sbl035; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentall RP, 2001, CLIN PSYCHOL REV, V21, P1143, DOI 10.1016/S0272-7358(01)00106-4; Byrne RMJ, 2000, J EXP PSYCHOL LEARN, V26, P1318, DOI 10.1037//0278-7393.26.5.1318; Byrne RMJ, 2016, ANNU REV PSYCHOL, V67, P135, DOI 10.1146/annurev-psych-122414-033249; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; Crider A, 1997, SCHIZOPHRENIA BULL, V23, P63, DOI 10.1093/schbul/23.1.63; Dickinson D, 2004, BIOL PSYCHIAT, V55, P826, DOI 10.1016/j.biopsych.2003.12.010; Epstude K, 2008, PERS SOC PSYCHOL REV, V12, P168, DOI 10.1177/1088868308316091; First M. B., 1997, STRUCTURED CLIN INTE; Freeman D, 2007, CLIN PSYCHOL REV, V27, P425, DOI 10.1016/j.cpr.2006.10.004; Garety PA, 1999, BRIT J CLIN PSYCHOL, V38, P113, DOI 10.1348/014466599162700; Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Goldman-Rakic P S, 1996, FUNCTIONAL PARCELLAT, V7-34; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Hooker C, 2000, PSYCHIATRY, V63, P326, DOI 10.1080/00332747.2000.11024925; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jackowski AP, 2012, REV BRAS PSIQUIATR, V34, P207, DOI 10.1590/S1516-44462012000200014; JOHNSONLAIRD PN, 1992, PSYCHOL REV, V99, P418, DOI 10.1037/0033-295X.99.3.418; KAHNEMAN D, 1990, J PERS SOC PSYCHOL, V59, P1101, DOI 10.1037/0022-3514.59.6.1101; Kahneman D, 1982, SIMULATION HEURISTIC; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe R, 2006, TXB SCHIZOPHRENIA, P245; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kern RS, 2009, PSYCHOL MED, V39, P645, DOI 10.1017/S0033291708003966; Knight Robert T., 1995, P1357; Larquet M, 2010, SCHIZOPHR RES, V116, P266, DOI 10.1016/j.schres.2009.11.010; Markman K. D., 2009, HDB IMAGINATION MENT; McNamara P, 2003, J NEUROL NEUROSUR PS, V74, P1065, DOI 10.1136/jnnp.74.8.1065; Moritz S, 2010, COGN NEUROPSYCHIATRY, V15, P406, DOI 10.1080/13546800903399993; Owen GS, 2007, BRIT J PSYCHIAT, V191, P453, DOI 10.1192/bjp.bp.107.037309; Peralta V, 1994, ACTAS LUSO-ESP NEUR, V4, P44; Preda A, 2011, HANDBOOK OF SCHIZOPHRENIA SPECTRUM DISORDERS, VOL II: PHENOTYPIC AND ENDOPHENOTYPIC PRESENTATIONS, P33, DOI 10.1007/978-94-007-0831-0_2; Roese Neal J., 1995, WHAT MIGHT HAVE BEEN; Roese NJ, 1996, J EXP SOC PSYCHOL, V32, P197, DOI 10.1006/jesp.1996.0010; Roese NJ, 1997, PSYCHOL BULL, V121, P133, DOI 10.1037/0033-2909.121.1.133; Segarra N, 2011, EUR PSYCHIAT, V26, P69, DOI 10.1016/j.eurpsy.2009.11.001; Sergi MJ, 2007, SCHIZOPHR RES, V90, P316, DOI 10.1016/j.schres.2006.09.028; Solca F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126773; SPITZER R. L., 1994, STRUCTURED CLIN INTE; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004; Van Hoeck N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00420; Van Hoeck N, 2013, SOC COGN AFFECT NEUR, V8, P556, DOI 10.1093/scan/nss031; Vauth R, 2004, PSYCHIAT RES, V128, P155, DOI 10.1016/j.psychres.2004.05.018; Ventura J, 2013, SCHIZOPHRENIA BULL, V39, P102, DOI 10.1093/schbul/sbr067; WECHSLER D, 1999, WECHSLER ADULTS INTE; WELLS GL, 1987, J PERS SOC PSYCHOL, V53, P421, DOI 10.1037/0022-3514.53.3.421; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	56	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148440	10.1371/journal.pone.0148440	http://dx.doi.org/10.1371/journal.pone.0148440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828931	Green Published, gold			2022-12-27	WOS:000369548200103
J	Jasprova, J; Dal Ben, M; Vianello, E; Goncharova, I; Urbanova, M; Vyroubalova, K; Gazzin, S; Tiribelli, C; Sticha, M; Cerna, M; Vitek, L				Jasprova, Jana; Dal Ben, Matteo; Vianello, Eleonora; Goncharova, Iryna; Urbanova, Marie; Vyroubalova, Karolina; Gazzin, Silvia; Tiribelli, Claudio; Sticha, Martin; Cerna, Marcela; Vitek, Libor			The Biological Effects of Bilirubin Photoisomers	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; INDUCED CELL-DEATH; NEONATAL JAUNDICE; IX-ALPHA; CIRCULAR-DICHROISM; PHOTOBILIRUBIN-II; PHOTOTHERAPY; BINDING; LIGHT; HYPERBILIRUBINEMIA	Although phototherapy was introduced as early as 1950's, the potential biological effects of bilirubin photoisomers (PI) generated during phototherapy remain unclear. The aim of our study was to isolate bilirubin PI in their pure forms and to assess their biological effects in vitro. The three major bilirubin PI (ZE- and EZ-bilirubin and Z-lumirubin) were prepared by photo-irradiation of unconjugated bilirubin. The individual photoproducts were chromatographically separated (TLC, HPLC), and their identities verified by mass spectrometry. The role of Z-lumirubin (the principle bilirubin PI) on the dissociation of bilirubin from albumin was tested by several methods: peroxidase, fluorescence quenching, and circular dichroism. The biological effects of major bilirubin PI (cell viability, expression of selected genes, cell cycle progression) were tested on the SH-SY5Y human neuroblastoma cell line. Lumirubin was found to have a binding site on human serum albumin, in the subdomain IB (or at a close distance to it); and thus, different from that of bilirubin. Its binding constant to albumin was much lower when compared with bilirubin, and lumirubin did not affect the level of unbound bilirubin (Bf). Compared to unconjugated bilirubin, bilirubin PI did not have any effect on either SH-SY5Y cell viability, the expression of genes involved in bilirubin metabolism or cell cycle progression, nor in modulation of the cell cycle phase. The principle bilirubin PI do not interfere with bilirubin albumin binding, and do not exert any toxic effect on human neuroblastoma cells.	[Jasprova, Jana; Vyroubalova, Karolina; Vitek, Libor] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Dal Ben, Matteo; Vianello, Eleonora; Gazzin, Silvia; Tiribelli, Claudio] Italian Liver Fdn, CSF, Trieste, Italy; [Goncharova, Iryna; Urbanova, Marie] Prague Inst Chem Technol, CR-16628 Prague, Czech Republic; [Sticha, Martin] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Cerna, Marcela] Inst Mother & Child Hlth, Prague, Czech Republic; [Vitek, Libor] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic	Charles University Prague; University of Chemistry & Technology, Prague; Charles University Prague; Charles University Prague	Vitek, L (corresponding author), Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic.; Vitek, L (corresponding author), Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic.	vitek@cesnet.cz	Dal Ben, Matteo/N-6658-2015; Vitek, Libor/A-2645-2008; Sticha, Martin/E-6158-2017; Urbanová, Marie/E-4286-2014; Jasprova, Jana/H-7839-2017; Tiribelli, Claudio/A-4716-2014; Vianello, Eleonora/Y-2458-2018	Dal Ben, Matteo/0000-0001-9294-2107; Vitek, Libor/0000-0002-5318-0151; Sticha, Martin/0000-0001-8008-7668; Jasprova, Jana/0000-0002-0579-0895; Tiribelli, Claudio/0000-0001-6596-7595; Urbanova, Marie/0000-0003-3402-9998; Vianello, Eleonora/0000-0003-0342-4055	Czech Ministry of Health [RVO-VFN64165/2015]; Charles University in Prague [SW2665161/2015, 556912, PRVOUK-P25/LF1/2]; Czech Science Foundation [P206/11/0836]; Czech Ministry of Education [KONTAKT LH15097]	Czech Ministry of Health(Ministry of Health, Czech Republic); Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded by the Czech Ministry of Health, grant RVO-VFN64165/2015 (http://www.mzcr.cz/), the Charles University in Prague, grants SW2665161/2015, GAUK No. 556912, and PRVOUK-P25/LF1/2 (http://www.cuni.cz/), and the Czech Science Foundation, grant P206/11/0836 (http://www.gacr.cz/). This work was also supported in part by the Czech Ministry of Education, grant KONTAKT LH15097 (http://www.msmt.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Ahlfors CE, 2004, SEMIN PERINATOL, V28, P334, DOI 10.1053/j.semperi.2004.09.002; Ahlfors CE, 2000, ANAL BIOCHEM, V279, P130, DOI 10.1006/abio.2000.4485; Arnold C, 2014, SEMIN PERINATOL, V38, P452, DOI 10.1053/j.semperi.2014.08.008; Beken S, 2014, FETAL PEDIATR PATHOL, V33, P151, DOI 10.3109/15513815.2014.883456; BONNETT R, 1984, BIOCHEM J, V219, P1053, DOI 10.1042/bj2191053; BRODERSEN R, 1979, CRC CR REV CL LAB SC, V11, P305; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calligaris SD, 2007, PEDIATR RES, V62, P576, DOI 10.1203/PDR.0b013e3181568c94; CHRISTENSEN T, 1994, ACTA PAEDIATR, V83, P7, DOI 10.1111/j.1651-2227.1994.tb12943.x; CHRISTENSEN T, 1990, J PHOTOCH PHOTOBIO B, V7, P337, DOI 10.1016/1011-1344(90)85166-T; Christensen T, 2000, J PHOTOCH PHOTOBIO B, V58, P170, DOI 10.1016/S1011-1344(00)00126-3; CREMER RJ, 1958, LANCET, V1, P1094; Gazzin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016165; Goncharova I, 2013, BIOPHYS CHEM, V180, P55, DOI 10.1016/j.bpc.2013.06.004; Goncharova I, 2008, ANAL BIOANAL CHEM, V392, P1355, DOI 10.1007/s00216-008-2427-8; KNOBLOCH E, 1991, J CHROMATOGR-BIOMED, V566, P89, DOI 10.1016/0378-4347(91)80113-Q; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V26; LIGHTNER DA, 1984, ACCOUNTS CHEM RES, V17, P417, DOI 10.1021/ar00108a002; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; MCDONAGH AF, 1982, J AM CHEM SOC, V104, P6867, DOI 10.1021/ja00388a104; MCDONAGH AF, 1982, J AM CHEM SOC, V104, P6865, DOI 10.1021/ja00388a103; MCDONAGH AF, 1989, PHOTOCHEM PHOTOBIOL, V50, P305, DOI 10.1111/j.1751-1097.1989.tb04164.x; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Mreihil K, 2010, PEDIATR RES, V67, P656, DOI 10.1203/PDR.0b013e3181dcedc0; ONISHI S, 1980, BIOCHEM J, V190, P533, DOI 10.1042/bj1900533; ONISHI S, 1984, BIOCHEM J, V218, P667, DOI 10.1042/bj2180667; Ostrow JD, 2003, EUR J CLIN INVEST, V33, P988, DOI 10.1046/j.1365-2362.2003.01261.x; Pestell RG, 2013, AM J PATHOL, V183, P3, DOI 10.1016/j.ajpath.2013.03.001; Raghavan K, 2005, J MATERN-FETAL NEO M, V18, P129, DOI 10.1080/14767050500233076; Rigato L, 2004, BIOCHEM J, V383, P335, DOI 10.1042/BJ20040599; Roll EB, 2005, ACTA PAEDIATR, V94, P1437, DOI 10.1080/08035250510032646; Roll EB, 2005, ACTA PAEDIATR, V94, P1443, DOI 10.1080/08035250510032637; Roll EB, 2005, ACTA PAEDIATR, V94, P1448, DOI 10.1080/08035250510032655; ROYER RE, 1983, FEBS LETT, V157, P28, DOI 10.1016/0014-5793(83)81109-0; SILBERBERG D, 1970, Birth Defects Original Article Series, V6, P119; SILBERBERG DH, 1970, J PEDIATR-US, V77, P613, DOI 10.1016/S0022-3476(70)80202-5; STOLL MS, 1979, BIOCHEM J, V183, P139, DOI 10.1042/bj1830139; STOLL MS, 1982, BIOCHEM J, V201, P179, DOI 10.1042/bj2010179; Tatli MM, 2008, MUTAT RES-GEN TOX EN, V654, P93, DOI 10.1016/j.mrgentox.2007.06.013; Tyson JE, 2012, J PERINATOL, V32, P677, DOI 10.1038/jp.2012.64; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Vreman HJ, 2005, ANAL BIOCHEM, V341, P280, DOI 10.1016/j.ab.2005.03.019; Xiong T, 2011, EUR J PEDIATR, V170, P1247, DOI 10.1007/s00431-011-1454-1; Zsila F, 2013, MOL PHARMACEUT, V10, P1668, DOI 10.1021/mp400027q	46	22	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148126	10.1371/journal.pone.0148126	http://dx.doi.org/10.1371/journal.pone.0148126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829016	Green Published, gold			2022-12-27	WOS:000369548200067
J	Mauvais, FX; Gonzales, E; Davit-Spraul, A; Jacquemin, E; Brauner, R				Mauvais, Francois-Xavier; Gonzales, Emmanuel; Davit-Spraul, Anne; Jacquemin, Emmanuel; Brauner, Raja			Cholestasis Reveals Severe Cortisol Deficiency in Neonatal Pituitary Stalk Interruption Syndrome	PLOS ONE			English	Article							GROWTH-HORMONE DEFICIENCY; CONGENITAL HYPOPITUITARISM; IDIOPATHIC HYPOPITUITARISM; LIVER DYSFUNCTION; GH THERAPY; LONG-TERM; INFANTS; HYPOGLYCEMIA; HEPATITIS; MORTALITY	Objectives Cholestasis has been reported during the course of congenital hypothalamic-pituitary deficiency, but crucial information is lacking regarding both its origin and prognosis. We aimed to characterize the course of cholestasis and factors contributing to it in patients with deficiency due to pituitary stalk interruption syndrome (PSIS). Methods We conducted a retrospective single-center, case-cohort study including 16 patients with PSIS diagnosed before one year of age. We collected clinical and biological parameters from medical records and compared the characteristics of the endocrine syndrome in PSIS patients with and without cholestasis. Results 5/16 patients had cholestasis, all with a neonatal onset and multiple hypothalamic-pituitary deficiency. Patients with cholestasis presented with lower Apgar score and higher rate of ophthalmic malformations: 3/5 vs 1/11, p = 0.03 and 5/5 vs 4/11, p = 0.02, respectively. The plasma cortisol level was strongly decreased in patients with cholestasis: 12.4 ng/mL (8-15 ng/mL) vs 79.4 ng/mL (10-210 ng/mL), p = 0.04. Cholestasis resolved within 9 months following hormone supplementation. No development of chronic liver disease was observed during a median follow-up of 9.4 years (range, 1.3-13.3 years). Conclusions Cholestasis is a frequent symptom at presentation of PSIS during the neonatal period that may help earlier diagnosis and that indicates a profound cortisol deficiency.	[Mauvais, Francois-Xavier; Gonzales, Emmanuel; Jacquemin, Emmanuel] Hop Bicetre, AP HP, Reference Ctr Pediat Liver Dis DHU Hepatinov, Pediat Hepatol & Liver Transplantat Unit, Le Kremlin Bicetre, France; [Mauvais, Francois-Xavier] INSERM, Unite 1151, Paris, France; [Mauvais, Francois-Xavier] CNRS, UMR8253, Paris, France; [Mauvais, Francois-Xavier; Brauner, Raja] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Gonzales, Emmanuel; Jacquemin, Emmanuel] Univ Paris 11, INSERM, UMR S 1174, F-91405 Orsay, France; [Gonzales, Emmanuel] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Davit-Spraul, Anne] Hop Bicetre, AP HP, Biochem Lab, Le Kremlin Bicetre, France; [Brauner, Raja] Fdn Ophtalmol Adolphe De Rothschild, Pediat Endocrinol Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Mauvais, FX (corresponding author), Hop Bicetre, AP HP, Reference Ctr Pediat Liver Dis DHU Hepatinov, Pediat Hepatol & Liver Transplantat Unit, Le Kremlin Bicetre, France.; Mauvais, FX (corresponding author), INSERM, Unite 1151, Paris, France.; Mauvais, FX (corresponding author), CNRS, UMR8253, Paris, France.; Mauvais, FX (corresponding author), Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France.	francois-xavier.mauvais@inserm.fr	jacquemin, emmanuel/J-8673-2013; Mauvais, François-Xavier/AAA-4989-2019	Mauvais, François-Xavier/0000-0002-5240-4280; GONZALES, Emmanuel/0000-0002-1546-3193				Al-Hussaini A, 2012, SAUDI J GASTROENTERO, V18, P339, DOI 10.4103/1319-3767.101137; ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Arrigo T, 1998, EUR J ENDOCRINOL, V139, P84, DOI 10.1530/eje.0.1390084; BAUMAN JW, 1966, ACTA ENDOCRINOL-COP, V52, P404, DOI 10.1530/acta.0.0520404; Binder G, 2007, J PEDIATR ENDOCR MET, V20, P695; Braslavsky D, 2011, ARQ BRAS ENDOCRINOL, V55, P622, DOI 10.1590/S0004-27302011000800017; DeSalvo D, 2008, J NATL MED ASSOC, V100, P342, DOI 10.1016/S0027-9684(15)31249-9; DROP SLS, 1979, ACTA PAEDIATR SCAND, V68, P277, DOI 10.1111/j.1651-2227.1979.tb05003.x; Dupuis-Girod S, 2001, J PEDIATR-US, V138, P129, DOI 10.1067/mpd.2001.109200; ELLAWAY CJ, 1995, J PAEDIATR CHILD H, V31, P51, DOI 10.1111/j.1440-1754.1995.tb02914.x; GARTNER LM, 1972, AM J PHYSIOL, V222, P1091, DOI 10.1152/ajplegacy.1972.222.5.1091; Gonc EN, 2006, TURKISH J PEDIATR, V48, P376; Grammatikopoulos A, 2006, J PEDIAT GASTROENTER, V42; HERMAN SP, 1975, J PEDIATR-US, V87, P892, DOI 10.1016/S0022-3476(75)80900-0; HODGES S, 1984, ARCH DIS CHILD, V59, P1200, DOI 10.1136/adc.59.12.1200; Huet F, 1999, EUR J ENDOCRINOL, V140, P29, DOI 10.1530/eje.0.1400029; Jacquemin E, 1998, J PEDIATR-US, V133, P563, DOI 10.1016/S0022-3476(98)70070-8; Karnsakul W, 2007, ANN HEPATOL, V6, P97; KAUFMAN FR, 1984, ARCH DIS CHILD, V59, P787, DOI 10.1136/adc.59.8.787; LACY DE, 1993, J PEDIATR GASTR NUTR, V17, P438, DOI 10.1097/00005176-199311000-00018; LANES R, 1978, AM J DIS CHILD, V132, P926, DOI 10.1001/archpedi.1978.02120340102022; LEBLANC A, 1981, J PEDIATR-US, V99, P577, DOI 10.1016/S0022-3476(81)80260-0; Leblanc T, 2003, J PEDIATR-US, V142, P358, DOI 10.1067/mpd.2003.57; LOVINGER RD, 1975, J PEDIATR-US, V87, P1171, DOI 10.1016/S0022-3476(75)80132-6; Lu Y, 2012, GASTROENTEROLOGY, V143, P1630, DOI 10.1053/j.gastro.2012.08.029; Machado MK, 2011, ARCH ARGENT PEDIATR, V109, pE59, DOI 10.1590/S0325-00752011000300014; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Pena-Almazan S, 2001, J CLIN ENDOCR METAB, V86, P5691, DOI 10.1210/jc.86.12.5691; Pham LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053189; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Reynaud R, 2006, J CLIN ENDOCR METAB, V91, P3329, DOI 10.1210/jc.2005-2173; Simon FR, 2006, AM J PHYSIOL-GASTR L, V290, pG595, DOI 10.1152/ajpgi.00240.2005; Spray CH, 2000, ACTA PAEDIATR, V89, P951, DOI 10.1080/080352500750043413; Taback SP, 1996, J CLIN ENDOCR METAB, V81, P1693, DOI 10.1210/jc.81.5.1693; Vallette-Kasic S, 2005, J CLIN ENDOCR METAB, V90, P1323, DOI 10.1210/jc.2004-1300	35	9	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147750	10.1371/journal.pone.0147750	http://dx.doi.org/10.1371/journal.pone.0147750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829045	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200030
J	Ogawa, K; Fukuda, T; Han, J; Kitamura, Y; Shiba, K; Odani, A				Ogawa, Kazuma; Fukuda, Tadahisa; Han, Jaegab; Kitamura, Yoji; Shiba, Kazuhiro; Odani, Akira			Evaluation of Chlorella as a Decorporation Agent to Enhance the Elimination of Radioactive Strontium from Body	PLOS ONE			English	Article							CESIUM; CHERNOBYL; EXCRETION; ALGINATE; SR-90; CONTAMINATION; ABSORPTION; BINDING	Background Release of radionuclides, such as Cs-137 and Sr-90, into the atmosphere and the ocean presents an important problem because internal exposure to Cs-137 and Sr-90 could be very harmful to humans. Chlorella has been reported to be effective in enhancing the excretion of heavy metals; thus, we hypothesized that Chlorella could also enhance the elimination of Cs-137 or Sr-90 from the body. We evaluated the potential of Chlorella as a decorporation agent in vitro and in vivo, using Sr-85 instead of Sr-90. Methods In vitro experiments of adsorption of Cs-137 and Sr-85 to Chlorella were performed under wide pH conditions. The maximum sorption capacity of Chlorella to strontium was estimated using the Langmuir model. A Sr-85 solution was orally administrated to mice pretreated with Chlorella. At 48 h after Sr-85 administration, the biodistribution of radioactivity was determined. Results In the in vitro experiments, although Sr-85 barely adsorbed to Chlorella at low pH, the Sr-85 adsorption ratio to Chlorella increased with increasing pH. The maximum sorption capacity of Chlorella to strontium was 9.06 mg / g. Cs-137 barely adsorbed to Chlorella under any pH conditions. In the biodistribution experiments, bone accumulation of radioactivity after Sr-85 administration was significantly decreased in the Chlorella pretreatment group compared with the non-treatment control group. Conclusions In conclusion, these results indicated that Chlorella could inhibit the absorption of Sr-90 into the blood and enhance the elimination of Sr-90 from the body through adsorption in intestine. Further studies are required to elucidate the mechanism and the components of Chlorella needed for adsorption to strontium and could promote the development of more effective decorporation agents.	[Ogawa, Kazuma; Fukuda, Tadahisa; Odani, Akira] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ogawa, Kazuma] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan; [Han, Jaegab] DAESANG Corp, Seoul, South Korea; [Kitamura, Yoji; Shiba, Kazuhiro] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Ogawa, K (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.; Ogawa, K (corresponding author), Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan.	kogawa@p.kanazawa-u.ac.jp	ODANI, Akira/B-3043-2011; Ogawa, Kazuma/D-8406-2015	ODANI, Akira/0000-0003-3786-6740; Ogawa, Kazuma/0000-0002-1691-7302	DAESANG Corporation	DAESANG Corporation	This study was funded by DAESANG Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BARNES DWH, 1970, INT J RADIAT BIOL RE, V18, P531, DOI 10.1080/09553007014551461; Brumfiel G, 2011, NATURE, V474, P135, DOI 10.1038/474135a; Chaalal O, 2001, J ENVIRON MANAGE, V61, P51, DOI 10.1006/jema.2000.0399; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; Davis J, 2000, J NUCL MED, V41, P183; DUNGWORTH DL, 1969, BLOOD-J HEMATOL, V34, P610, DOI 10.1182/blood.V34.5.610.610; Evangeliou N, 2014, ENVIRON INT, V64, P17, DOI 10.1016/j.envint.2013.11.020; Faustino PJ, 2008, J PHARMACEUT BIOMED, V47, P114, DOI 10.1016/j.jpba.2007.11.049; Froidevaux P, 2010, CHEMOSPHERE, V80, P519, DOI 10.1016/j.chemosphere.2010.04.049; FRY FA, 1987, LANCET, V2, P160; Haratake M, 2012, CHEM PHARM BULL, V60, P1258, DOI 10.1248/cpb.c12-00430; HESP R, 1965, NATURE, V208, P1341, DOI 10.1038/2081341a0; Idota Y, 2013, BIOL PHARM BULL, V36, P485, DOI 10.1248/bpb.b12-00899; Kanai Y, 2012, J ENVIRON RADIOACTIV, V111, P33, DOI 10.1016/j.jenvrad.2011.10.011; Leggett RW, 2003, SCI TOTAL ENVIRON, V317, P235, DOI 10.1016/S0048-9697(03)00333-4; Leggett RW, 1998, RADIAT PROT DOSIM, V79, P335, DOI 10.1093/oxfordjournals.rpd.a032422; MCKINLEY MK, 1993, FUND APPL TOXICOL, V21, P425, DOI 10.1006/faat.1993.1118; Mercola Joseph, 2001, Journal of Nutritional and Environmental Medicine (Abingdon), V11, P53, DOI 10.1080/13590840020030267; Morita K, 1999, J NUTR, V129, P1731, DOI 10.1093/jn/129.9.1731; NISHIMURA Y, 1991, Radioisotopes, V40, P244; Ogawa K, 2012, CURR MED CHEM, V19, P3290, DOI 10.2174/092986712801215865; Queiroz MLS, 2003, INT IMMUNOPHARMACOL, V3, P889, DOI 10.1016/S1567-5769(03)00082-1; Shim JA, 2009, NUTR RES PRACT, V3, P15, DOI 10.4162/nrp.2009.3.1.15; SUTTON A, 1967, NATURE, V216, P1005, DOI 10.1038/2161005a0; Timchalk C, 2010, HEALTH PHYS, V99, P420, DOI 10.1097/HP.0b013e3181bca9b0; VERZIJL JM, 1992, J TOXICOL-CLIN TOXIC, V30, P215, DOI 10.3109/15563659209038633; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P5, DOI [10.1111/j.1749-6632.2009.04821.x, 10.1111/j.1749-6632.2009.04820.x]	28	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148080	10.1371/journal.pone.0148080	http://dx.doi.org/10.1371/journal.pone.0148080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828430	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200058
J	Banskota, S; Gautam, J; Regmi, SC; Gurung, P; Park, MH; Kim, SJ; Nam, TG; Jeong, BS; Kim, JA				Banskota, Suhrid; Gautam, Jaya; Regmi, Sushil C.; Gurung, Pallavi; Park, Myo-Hyeon; Kim, Seung Joo; Nam, Tae-gyu; Jeong, Byeong-Seon; Kim, Jung-Ae			BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; ANTIANGIOGENIC ACTIVITY; VENOUS THROMBOEMBOLISM; OXIDATIVE STRESS; CARCINOID-TUMORS; ROS GENERATION; CANCER; PHOSPHORYLATION; KINASE; ANTIOXIDANTS	5-Hydroxytryptamine (5-HT) induces proliferation of cancer cells and vascular cells. In addition to 5-HT production by several cancer cells including gastrointestinal and breast cancer, a significant level of 5-HT is released from activated platelets in the thrombotic environment of tumors, suggesting that inhibition of 5-HT signaling may constitute a new target for antiangiogenic anticancer drug discovery. In the current study we clearly demonstrate that 5-HT-induced angiogenesis was mediated through the 5-HT1 receptor-linked G beta gamma/Src/PI3K pathway, but not through the MAPK/ERK/p38 pathway. In addition, 5-HT induced production of NADPH oxidase (NOX)-derived reactive oxygen species (ROS). In an effort to develop new molecularly targeted anticancer agents against 5-HT action in tumor growth, we demonstrate that BJ-1108, a derivative of 6-amino-2,4,5-trimethylpyridin-3-ol, significantly inhibited 5-HT-induced angiogenesis. In addition, BJ-1108 induced a significant reduction in the size and weight of excised tumors in breast cancer cell-inoculated CAM assay, showing proportionate suppression of tumor growth along with inhibition of angiogenesis. In human umbilical vein endothelial cells (HUVECs), BJ-1108 significantly suppressed 5-HT-induced ROS generation and phosphorylation of PI3K/Akt but not of Src. Unlike NOX inhibitors, BJ-1108, which showed better antioxidant activity than vitamin C, barely suppressed superoxide anion induced by mevalonate or geranylgeranyl pyrophosphate which directly activates NOX without help from other signaling molecules in HUVECs, implying that the anti-angiogenic action of BJ-1108 was not mediated through direct action on NOX activation, or free radical scavenging activity. In conclusion, BJ-1108 inhibited 5-HT-induced angiogenesis through PI3K/NOX signaling but not through Src, ERK, or p38.	[Banskota, Suhrid; Gautam, Jaya; Regmi, Sushil C.; Gurung, Pallavi; Park, Myo-Hyeon; Kim, Seung Joo; Jeong, Byeong-Seon; Kim, Jung-Ae] Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea; [Nam, Tae-gyu] Hanyang Univ, Dept Pharm, Ansan 15588, South Korea	Yeungnam University; Hanyang University	Jeong, BS; Kim, JA (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea.	jeongb@ynu.ac.kr; jakim@yu.ac.kr	Banskota, Suhrid/AAF-2315-2020; Banskota, Suhrid/Q-8485-2016	Banskota, Suhrid/0000-0003-3183-6268; Banskota, Suhrid/0000-0003-3183-6268	Yeungnam University research grant	Yeungnam University research grant	This work was supported by a Yeungnam University research grant.	Ahn MR, 2009, MOL NUTR FOOD RES, V53, P643, DOI 10.1002/mnfr.200800021; Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-88; Asada M, 2009, NEOPLASIA, V11, P408, DOI 10.1593/neo.81630; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Banskota S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0379-0; Bianchi P, 2005, FASEB J, V19, P641, DOI 10.1096/fj.04-2518fje; CATTANEO MG, 1995, EUR J PHARM-MOLEC PH, V291, P209, DOI 10.1016/0014-2999(95)90106-X; Corydon TJ, 2015, HUM GENE THER, V26, P777, DOI 10.1089/hum.2015.064.cxn; Elshabrawy HA, 2015, ANGIOGENESIS, V18, P433, DOI 10.1007/s10456-015-9477-2; EMSON PC, 1984, CANCER, V54, P715, DOI 10.1002/1097-0142(1984)54:4<715::AID-CNCR2820540420>3.0.CO;2-6; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Iwabayashi M, 2012, ATHEROSCLEROSIS, V220, P337, DOI 10.1016/j.atherosclerosis.2011.10.042; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kang Y, 2015, ARCH PHARM RES, V38, P249, DOI 10.1007/s12272-014-0535-x; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kim DG, 2014, EUR J MED CHEM, V78, P126, DOI 10.1016/j.ejmech.2014.03.045; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Lee H, 2014, BIOORG MED CHEM LETT, V24, P3131, DOI 10.1016/j.bmcl.2014.05.005; Lee YM, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0800-7; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; LUSCHER TF, 1990, CLIN PHYSIOL BIOCH, V8, P108; Mao CY, 1998, INT J PANCREATOL, V23, P153, DOI 10.1385/IJGC:23:2:153; Mukhin YV, 2000, BIOCHEM J, V347, P61, DOI 10.1042/0264-6021:3470061; Nakagawa K, 2007, J NUTR, V137, P1938, DOI 10.1093/jn/137.8.1938; NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; Nocito A, 2008, CANCER RES, V68, P5152, DOI 10.1158/0008-5472.CAN-08-0202; Omata Y, 2010, FREE RADICAL BIO MED, V48, P1358, DOI 10.1016/j.freeradbiomed.2010.02.018; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; PAKALA R, 1994, CIRCULATION, V90, P1919, DOI 10.1161/01.CIR.90.4.1919; Park BC, 2007, EUR J PHARMACOL, V567, P193, DOI 10.1016/j.ejphar.2007.04.014; Park BC, 2009, J PHARMACOL SCI, V111, P1, DOI 10.1254/jphs.08305FP; Park SY, 2008, ARCH PHARM RES, V31, P195, DOI 10.1007/s12272-001-1141-2; Qin LL, 2013, BLOOD, V121, P2154, DOI 10.1182/blood-2012-07-443903; Regmi SC, 2014, FREE RADICAL BIO MED, V69, P377, DOI 10.1016/j.freeradbiomed.2014.02.003; Serwa R, 2010, CHEM-EUR J, V16, P14106, DOI 10.1002/chem.201001382; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Soll C, 2010, HEPATOLOGY, V51, P1244, DOI 10.1002/hep.23441; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Tesselaar MET, 2007, CURR OPIN PULM MED, V13, P362, DOI 10.1097/MCP.0b013e328209413c; Thapa D, 2008, J PHARMACOL EXP THER, V327, P353, DOI 10.1124/jpet.108.141887; TUTTON PJM, 1982, BRIT J CANCER, V46, P260, DOI 10.1038/bjc.1982.191; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Zamani A, 2012, FEBS LETT, V586, P2360, DOI 10.1016/j.febslet.2012.05.047	49	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148133	10.1371/journal.pone.0148133	http://dx.doi.org/10.1371/journal.pone.0148133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824764	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600103
J	Zazo, R; Lozano-Diez, A; Gonzalez-Dominguez, J; Toledano, DT; Gonzalez-Rodriguez, J				Zazo, Ruben; Lozano-Diez, Alicia; Gonzalez-Dominguez, Javier; Toledano, Doroteo T.; Gonzalez-Rodriguez, Joaquin			Language Identification in Short Utterances Using Long Short-Term Memory (LSTM) Recurrent Neural Networks	PLOS ONE			English	Article							SPEAKER	Long Short Term Memory (LSTM) Recurrent Neural Networks (RNNs) have recently outperformed other state-of-the-art approaches, such as i-vector and Deep Neural Networks (DNNs), in automatic Language Identification (LID), particularly when dealing with very short utterances (similar to 3s). In this contribution we present an open-source, end-to-end, LSTM RNN system running on limited computational resources (a single GPU) that outperforms a reference i-vector system on a subset of the NIST Language Recognition Evaluation (8 target languages, 3s task) by up to a 26%. This result is in line with previously published research using proprietary LSTM implementations and huge computational resources, which made these former results hardly reproducible. Further, we extend those previous experiments modeling unseen languages (out of set, OOS, modeling), which is crucial in real applications. Results show that a LSTM RNN with OOS modeling is able to detect these languages and generalizes robustly to unseen OOS languages. Finally, we also analyze the effect of even more limited test data (from 2.25s to 0.1s) proving that with as little as 0.5s an accuracy of over 50% can be achieved.	[Zazo, Ruben; Lozano-Diez, Alicia; Gonzalez-Dominguez, Javier; Toledano, Doroteo T.; Gonzalez-Rodriguez, Joaquin] Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain	Autonomous University of Madrid	Zazo, R (corresponding author), Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain.	ruben.zazo@uam.es	Lozano-Diez, Alicia/U-4476-2019; Toledano, Doroteo T/C-7750-2014	Toledano, Doroteo T/0000-0003-1159-6455	project CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Sennal de Voz - Ministerio de Economia y Competitividad, Spain [TEC2012-37585-C02-01]	project CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Sennal de Voz - Ministerio de Economia y Competitividad, Spain	This work has been supported by project CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Sennal de Voz (TEC2012-37585-C02-01), funded by Ministerio de Economia y Competitividad, Spain.	[Anonymous], P OD 2012 SPEAK LANG; Bengio Y, 2013, INT CONF ACOUST SPEE, P8624, DOI 10.1109/ICASSP.2013.6639349; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Dehak N., 2011, P INTERSPEECH, V2011, P857; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Frinken V, 2012, INT C PATT RECOG, P701; Ganapathy S, 2014, INTERSPEECH 2014; Gers F., 2001, LONG SHORT TERM MEMO; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Gonzalez-Dominguez J, 2014, FRAME FRAME LANGUAGE; Gonzalez-Dominguez J., 2014, INTERSPEECH, P2155, DOI DOI 10.21437/INTERSPEECH.2014-483; Gonzalez-Dominguez J, 2010, IEEE J-STSP, V4, P1084, DOI 10.1109/JSTSP.2010.2076071; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A, 2013, 2013 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P273, DOI 10.1109/ASRU.2013.6707742; Greff K., 2016, ARXIV150304069, P2222, DOI [10.1109/TNNLS.2016.2582924, DOI 10.1109/TNNLS.2016.2582924]; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Kenny P, 2008, IEEE T AUDIO SPEECH, V16, P980, DOI 10.1109/TASL.2008.925147; Lei Y, 2014, P OD 2014 SPEAK LANG; Li HZ, 2013, P IEEE, V101, P1136, DOI 10.1109/JPROC.2012.2237151; Lopez-Moreno I, 2014, AC SPEECH S IN PRESS; Lozano-Diez A, 2014, LECT NOTES ARTIF INT, V8854, P79, DOI 10.1007/978-3-319-13623-3_9; Martinez D, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P868; Mikolov T, 2011, INT CONF ACOUST SPEE, P5528; Mohamed AR, 2012, INT CONF ACOUST SPEE, P4273, DOI 10.1109/ICASSP.2012.6288863; Muthusamy YK, 1994, IEEE SIGNAL PROC MAG, V11, P33, DOI 10.1109/79.317925; Pascanu R, 2012, ARXIV12115063; Povey Daniel, 2011, P ASRU BIG ISL HI US; REYNOLDS DA, 1995, SPEECH COMMUN, V17, P91, DOI 10.1016/0167-6393(95)00009-D; Richardson F, 2015, IEEE SIGNAL PROC LET, V22, P1671, DOI 10.1109/LSP.2015.2420092; SCHMIDHUBER J, 1992, NEURAL COMPUT, V4, P234, DOI 10.1162/neco.1992.4.2.234; Singer E, 2012, OD 2012 THE SPEAK LA; Song Y, 2013, ELECTRON LETT, V49, P1569, DOI 10.1049/el.2013.1721; Torres-Carrasquillo P. A., 2002, P INT C SPOK LANG PR, P89; Van Segbroeck M, 2015, IEEE-ACM T AUDIO SPE, V23, P1118, DOI 10.1109/TASLP.2015.2419978; Weninger F, 2014, J MACHINE LEARNING R, P15; Weninger Felix, 2013, CUDA ENABLED MACHINE; Yu D, 2011, IEEE SIGNAL PROC MAG, V28, P145, DOI 10.1109/MSP.2010.939038	40	75	78	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146917	10.1371/journal.pone.0146917	http://dx.doi.org/10.1371/journal.pone.0146917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824467	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600012
J	Yee, A; Danaee, M; Loh, HS; Sulaiman, AH; Ng, CG				Yee, Anne; Danaee, Mahmoud; Loh, Huai Seng; Sulaiman, Ahmad Hatim; Ng, Chong Guan			Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment	PLOS ONE			English	Article							MEN RECEIVING METHADONE; NEUROPSYCHIATRIC INTERVIEW MINI; ERECTILE DYSFUNCTION; INTERNATIONAL INDEX; OPIOID DEPENDENCE; TESTOSTERONE; BEHAVIOR; USERS; METAANALYSIS; EJACULATION	Introduction Methadone has long been regarded as an effective treatment for opioid dependence. However, many patients discontinue maintenance therapy because of its side effects, with one of the most common being sexual dysfunction. Buprenorphine is a proven alternative to methadone. This study aimed to investigate sexual dysfunction in opioid-dependent men on buprenorphine maintenance treatment (BMT) and methadone maintenance treatment (MMT). The secondary aim was to investigate the correlation between sexual dysfunction and the quality of life in these patients. Methods Two hundred thirty-eight men participated in this cross-sectional study. Four questionnaires were used, the Mini International Neuropsychiatric Interview, Opiate Treatment Index, Malay version of the International Index of Erectile Function 15 (Mal-IIEF-15), and World Health Organization Quality of Life-BREF Scale. Multivariate analysis of covariance was used to examine the relationship between MMT and BMT and the Mal-IIEF 15 scores while controlling for all the possible confounders. Results The study population consisted of 171 patients (71.8%) on MMT and 67 (28.2%) on BMT. Patients in the MMT group who had a sexual partner scored significantly lower in the sexual desire domain (p < 0.012) and overall satisfaction (p = 0.043) domain compared with their counterparts in the BMT group. Similarly, patients in the MMT group without a sexual partner scored significantly lower in the orgasmic function domain (p = 0.008) compared with those in the BMT group without a partner. Intercourse satisfaction (p = 0.026) and overall satisfaction (p = 0.039) were significantly associated with the social relationships domain after adjusting for significantly correlated sociodemographic variables. Conclusions Sexual functioning is critical for improving the quality of life in patients in an opioid rehabilitation program. Our study showed that buprenorphine causes less sexual dysfunction than methadone. Thus, clinicians may consider the former when treating heroin dependents who have concerns about sexual function.	[Yee, Anne; Danaee, Mahmoud; Sulaiman, Ahmad Hatim; Ng, Chong Guan] Univ Malaya, Fac Med, Dept Psychol Med, Ctr Addict Sci, Kuala Lumpur, Malaysia; [Loh, Huai Seng] Newcastle Univ Med Malaysia, Clin Acad Unit Family Med, Nusajaya, Johor, Malaysia	Universiti Malaya	Yee, A (corresponding author), Univ Malaya, Fac Med, Dept Psychol Med, Ctr Addict Sci, Kuala Lumpur, Malaysia.	annyee17@um.edu.my	Danaee, Mahmoud/F-4147-2012; Hway Ann, Yee/D-7968-2012; Ng, Chong Guan/G-6170-2010; Loh, Huai Seng/G-9604-2013; Danaee, Mahmomoud/AAW-3097-2021; SULAIMAN, AHMAD HATIM/B-8156-2010	Danaee, Mahmoud/0000-0002-5014-5684; Hway Ann, Yee/0000-0002-9835-6798; Danaee, Mahmomoud/0000-0002-5014-5684; SULAIMAN, AHMAD HATIM/0000-0002-8364-4594				Argiolas A, 2013, PROG NEUROBIOL, V108, P80, DOI 10.1016/j.pneurobio.2013.06.006; Babakhanian M, 2012, ARCH IRAN MED, V15, P751, DOI 0121512/AIM.006; Balon R., 2005, HDB SEXUAL DYSFUNCTI; Bawor M, 2015, DRUG ALCOHOL DEPEN, V149, P1, DOI 10.1016/j.drugalcdep.2015.01.038; Bliesener N, 2005, J CLIN ENDOCR METAB, V90, P203, DOI 10.1210/jc.2004-0929; Bodie J, 2003, J UROLOGY, V169, P2262, DOI 10.1097/01.ju.0000063940.19080.58; Brown R, 2005, J ADDICT DIS, V24, P91, DOI 10.1300/J069v24n02_08; Chekuri V, 2012, ADDICT BEHAV, V37, P124, DOI 10.1016/j.addbeh.2011.08.005; Chen W, 2012, J ADDICT MED, V6, P212, DOI 10.1097/ADM.0b013e318259b2c4; CICERO TJ, 1975, NEW ENGL J MED, V292, P882, DOI 10.1056/NEJM197504242921703; Cioe PA, 2010, J ADDICT DIS, V29, P455, DOI 10.1080/10550887.2010.509279; Curcio F, 2011, EUR REV MED PHARMACO, V15, P871; DARKE S, 1991, 11 NDARC; Gill JS, 2007, ASEAN J PSYCHIATR, V8, P64; GLADUE BA, 1980, ENDOCRINOLOGY, V106, P1917, DOI 10.1210/endo-106-6-1917; Hallinan R, 2009, INT J ANDROL, V32, P131, DOI 10.1111/j.1365-2605.2007.00824.x; Hallinan R, 2008, J SEX MED, V5, P684, DOI 10.1111/j.1743-6109.2007.00702.x; HANBURY R, 1977, AM J DRUG ALCOHOL AB, V4, P13, DOI 10.3109/00952997709002743; Hariri AG, 2009, COMPR PSYCHIAT, V50, P353, DOI 10.1016/j.comppsych.2008.09.009; Hasanah C I, 2003, Med J Malaysia, V58, P79; Heidari Z, 2012, INT J HIGH RISK BEHA, V1, P12; Hospital Kuala Lumpur, 2009, METH MAINT THER PHAR; Huong AGW, 2009, ASEAN J PSYCHIATR, V10, P8; HYYPPA M, 1970, ACTA NEUROL SCAND, V46, P223; JOHNSON AR, 1992, J UROLOGY, V147, P1542, DOI 10.1016/S0022-5347(17)37620-6; Levine SB, 2003, ARCH SEX BEHAV, V32, P279, DOI 10.1023/A:1023421819465; Maremmani I., 2010, PRINCIPLE PRACTICE M; Matuszewich L, 1995, PSYCHOPHARMACOLOGY, V122, P330, DOI 10.1007/BF02246262; Meuleman EJ, 2015, CLIN UROANDROLOGY, P133; Nimroozi R, 2014, J DEV DRUGS, V3, P2, DOI DOI 10.4172/2329-6631.1000117; NOVICK DM, 1993, DRUG ALCOHOL DEPEN, V33, P235, DOI 10.1016/0376-8716(93)90110-C; Pfaus JG, 2009, J SEX MED, V6, P1506, DOI 10.1111/j.1743-6109.2009.01309.x; Quaglio G, 2008, DRUG ALCOHOL DEPEN, V94, P12, DOI 10.1016/j.drugalcdep.2007.09.025; Quek KF, 2002, INT J IMPOT RES, V14, P310, DOI 10.1038/sj.ijir.3900902; Ramdurg S, 2012, J SEX MED, V9, P3198, DOI 10.1111/j.1743-6109.2011.02219.x; Ramli M, 2009, Malays Fam Physician, V4, P77; Rosen RC, 2002, INT J IMPOT RES, V14, P226, DOI 10.1038/sj.ijir.3900857; Rowland D, 2010, J SEX MED, V7, P1668, DOI 10.1111/j.1743-6109.2010.01782.x; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Tatari Faezeh, 2010, Iran J Psychiatry, V5, P164; Xia YH, 2013, PSYCHOL HEALTH MED, V18, P321, DOI 10.1080/13548506.2012.729845; Yee A, 2014, INT J IMPOT RES, V26, P161, DOI 10.1038/ijir.2014.18; Yee A, 2014, J SEX MED, V11, P22, DOI 10.1111/jsm.12352; Zhang Yao, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P739, DOI 10.3969/j.issn.1672-7347.2011.08.007	45	28	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147852	10.1371/journal.pone.0147852	http://dx.doi.org/10.1371/journal.pone.0147852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820154	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400050
J	Lee, SG; Poole, K; Linn, CE; Vickers, NJ				Lee, Seong-Gyu; Poole, Kathy; Linn, Charles E., Jr.; Vickers, Neil J.			Transplant Antennae and Host Brain Interact to Shape Odor Perceptual Space in Male Moths	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; TOBACCO BUDWORM MOTH; PHEROMONE-BLEND DISCRIMINATION; ASSULTA GUENEE LEPIDOPTERA; LOBE PROJECTION PATTERNS; FEMALE SEX-PHEROMONE; HELIOTHIS-VIRESCENS; MACROGLOMERULAR COMPLEX; CHEMICAL COMMUNICATION; HELICOVERPA-ZEA	6 Behavioral responses to odors rely first upon their accurate detection by peripheral sensory organs followed by subsequent processing within the brain's olfactory system and higher centers. These processes allow the animal to form a unified impression of the odor environment and recognize combinations of odorants as single entities. To investigate how interactions between peripheral and central olfactory pathways shape odor perception, we transplanted antennal imaginal discs between larval males of two species of moth Heliothis virescens and Heliothis subflexa that utilize distinct pheromone blends. During metamorphic development olfactory receptor neurons originating from transplanted discs formed connections with host brain neurons within olfactory glomeruli of the adult antennal lobe. The normal antennal receptor repertoire exhibited by males of each species reflects the differences in the pheromone blends that these species employ. Behavioral assays of adult transplant males revealed high response levels to two odor blends that were dissimilar from those that attract normal males of either species. Neurophysiological analyses of peripheral receptor neurons and central olfactory neurons revealed that these behavioral responses were a result of: 1. the specificity of H. virescens donor olfactory receptor neurons for odorants unique to the donor pheromone blend and, 2. central odor recognition by the H. subflexa host brain, which typically requires peripheral receptor input across 3 distinct odor channels in order to elicit behavioral responses.	[Lee, Seong-Gyu; Vickers, Neil J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Poole, Kathy; Linn, Charles E., Jr.] Cornell Univ, Dept Entomol, Geneva, NY 14456 USA; [Lee, Seong-Gyu] Shin Hwa Tech Co Ltd, Ulsan Technopk Rm A-409, Ulsan, South Korea	Utah System of Higher Education; University of Utah; Cornell University	Vickers, NJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	vickers@biology.utah.edu		Vickers, Neil/0000-0002-0378-8724	National Science Foundation [0640655, 0641014, 1147233]; NSF-IOS [0640655, 0641014, 1147233]; Direct For Biological Sciences [1147233] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSF-IOS(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation 0640655 (CEL), National Science Foundation 0641014 (NJV), and National Science Foundation 1147233 (NJV) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Callie Musto (Cornell University) for helping to rear the heliothine moths and for conducting some of the flight tunnel tests. We thank Lindsey Enright and Katy Schramm (University of Utah) for technical assistance. Supported by NSF-IOS 0641014 and NSF-IOS 1147233 to NJV and NSF-IOS 0640655 to CEL.	ALMAAS TJ, 1990, J CHEM ECOL, V16, P1331, DOI 10.1007/BF01021030; ALMAAS TJ, 1991, J CHEM ECOL, V17, P953, DOI 10.1007/BF01395602; Anton S, 1999, P ROY SOC B-BIOL SCI, V266, P1813, DOI 10.1098/rspb.1999.0851; Anton S, 2003, ARTHROPOD STRUCT DEV, V32, P319, DOI 10.1016/j.asd.2003.09.002; BACON JP, 1977, BRAIN RES, V138, P359, DOI 10.1016/0006-8993(77)90753-3; Baker TC, 2006, BRAIN BEHAV EVOLUT, V68, P75, DOI 10.1159/000093375; Baker TC, 2004, J COMP PHYSIOL A, V190, P155, DOI 10.1007/s00359-003-0483-2; BENNETT HS, 1976, STAIN TECHNOL, V51, P71, DOI 10.3109/10520297609116677; Berg Bente G., 2014, Insects, V5, P742, DOI 10.3390/insects5040742; Berg BG, 1998, J COMP PHYSIOL A, V183, P669, DOI 10.1007/s003590050290; CHRISTENSEN TA, 1995, J COMP PHYSIOL A, V177, P545, DOI 10.1007/BF00207184; Cork A, 2003, ENTOMOL EXP APPL, V107, P201, DOI 10.1046/j.1570-7458.2003.00052.x; CORK A, 1992, J CHEM ECOL, V18, P403, DOI 10.1007/BF00994240; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Galizia CG, 2008, ENTOMOL EXP APPL, V128, P81, DOI 10.1111/j.1570-7458.2007.00661.x; GODDE J, 1989, J NEUROSCI METH, V29, P77, DOI 10.1016/0165-0270(89)90111-8; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; HANSSON BS, 1995, J COMP PHYSIOL A, V177, P535, DOI 10.1007/BF00207183; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Hansson BS, 1997, INSECT PHEROMONE RESEARCH, P164; Hillier NK, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0401; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; JURENKA RA, 1991, ARCH INSECT BIOCHEM, V17, P81, DOI 10.1002/arch.940170203; Kaissling KE, 1974, BIOCH SENSORY FUNCTI, P243; Kalberer NM, 2010, J EXP BIOL, V213, P1272, DOI 10.1242/jeb.033167; Karpati Z, 2008, J EXP BIOL, V211, P2841, DOI 10.1242/jeb.017319; Karpati Z, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-286; LAVENSEAU L, 1982, INT J INSECT MORPHOL, V11, P359, DOI 10.1016/0020-7322(82)90025-3; Lee SG, 2006, CHEM SENSES, V31, P821, DOI 10.1093/chemse/bjl025; Lee SG, 2006, J COMP PHYSIOL A, V192, P351, DOI 10.1007/s00359-005-0071-8; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; Linn C, 1999, J COMP PHYSIOL A, V184, P273, DOI 10.1007/s003590050325; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; Ochieng SA, 2003, J COMP PHYSIOL A, V189, P19, DOI 10.1007/s00359-002-0371-1; OCHIENG SA, 1995, TISSUE CELL, V27, P221, DOI 10.1016/S0040-8166(95)80024-7; Rossler W, 1999, J NEUROBIOL, V38, P521, DOI 10.1002/(SICI)1097-4695(199903)38:4<521::AID-NEU8>3.0.CO;2-9; Sakuma C, 2014, GENES GENET SYST, V89, P17, DOI 10.1266/ggs.89.17; SCHNEIDERMAN AM, 1982, NATURE, V298, P844, DOI 10.1038/298844a0; SCHNEIDERMAN AM, 1986, NATURE, V323, P801, DOI 10.1038/323801a0; SUGIE H, 1991, APPL ENTOMOL ZOOL, V26, P151, DOI 10.1303/aez.26.151; Todd JL, 1995, PHYSIOL ENTOMOL, V20, P349, DOI 10.1111/j.1365-3032.1995.tb00826.x; VANDERPERS JNC, 1978, J INSECT PHYSIOL, V24, P337, DOI 10.1016/0022-1910(78)90033-1; Vickers NJ, 2006, BRAIN BEHAV EVOLUT, V68, P90, DOI 10.1159/000093376; Vickers NJ, 2006, BRAIN BEHAV EVOLUT, V68, P63, DOI 10.1159/000093374; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Vickers NJ, 2003, CHEM SENSES, V28, P325, DOI 10.1093/chemse/28.4.325; Vickers NJ, 2005, J COMP NEUROL, V491, P141, DOI 10.1002/cne.20725; Vickers NJ, 2003, J COMP NEUROL, V466, P377, DOI 10.1002/cne.10890; Vickers NJ, 2002, J CHEM ECOL, V28, P1255, DOI 10.1023/A:1016242019571; WILLIS MA, 1995, J COMP PHYSIOL A, V176, P205, DOI 10.1007/BF00239923; Wu H, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00206; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	53	2	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147906	10.1371/journal.pone.0147906	http://dx.doi.org/10.1371/journal.pone.0147906			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816291	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528200063
J	Tchernov, BG; Katz, T; Shaked, Y; Qupty, N; Kanari, M; Niemi, T; Agnon, A				Tchernov, Beverly Goodman; Katz, Timor; Shaked, Yonathan; Qupty, Nairooz; Kanari, Mor; Niemi, Tina; Agnon, Amotz			Offshore Evidence for an Undocumented Tsunami Event in the 'Low Risk' Gulf of Aqaba-Eilat, Northern Red Sea	PLOS ONE			English	Article							STORM DEPOSITS; CORAL-REEFS; EARTHQUAKES; SEDIMENTARY	Although the Gulf of Aqaba-Eilat is located in the tectonically active northern Red Sea, it has been described as low-risk with regard to tsunami activity because there are no modern records of damaging tsunami events and only one tsunami (1068 AD) referred to in historical records. However, this assessment may be poorly informed given that the area was formed by and is located along the seismically active Dead Sea Fault, its population is known to fluctuate in size and literacy in part due to its harsh hyper-arid climate, and there is a dearth of field studies addressing the presence or absence of tsunamigenic deposits. Here we show evidence from two offshore cores for a major paleotsunami that occurred similar to 2300 years ago with a sedimentological footprint that far exceeds the scarce markers of the historically mentioned 1068 AD event. The interpretation is based on the presence of a laterally continuous and synchronous, anomalous sedimentological deposit that includes allochtonous inclusions and unique structural characteristics. Based on sedimentological parameters, these deposits could not be accounted for by other transport events, or other known background sedimentological processes.	[Tchernov, Beverly Goodman; Qupty, Nairooz] Univ Haifa, Har Hakarmel, Israel; [Katz, Timor; Kanari, Mor] Israel Oceanog & Limnol Res, Shikmona, Israel; [Shaked, Yonathan] Interuniv Inst Marine Sci Eilat, Coral Beach, Israel; [Kanari, Mor] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Niemi, Tina] Univ Kansas Missouri, Kansas City, MO USA; [Agnon, Amotz] Hebrew Univ Jerusalem, Jerusalem, Israel	University of Haifa; Israel Oceanographic & Limnological Research Institute; Tel Aviv University; Hebrew University of Jerusalem	Tchernov, BG (corresponding author), Univ Haifa, Har Hakarmel, Israel.	bgoodman@univ.haifa.ac.il	Agnon, Amotz/AAC-8753-2019	Kanari, Mor/0000-0002-4293-1714	Hebrew University	Hebrew University	Funding was provided through fellowship coverage during postdoctoral research through the Hebrew University (Lady Davis Fellowship to BG). National Geographic provided funding during filming of a television special which covered the costs of core collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes F, 2005, QUATERNARY SCI REV, V24, P2477, DOI 10.1016/j.quascirev.2004.04.009; Al-Arifi NS, 2012, EARTH SCI RES J, V16, P35; Al-Tarazi E, 2000, NAT HAZARDS, V22, P17, DOI 10.1023/A:1008109810031; Ambraseys N., 2009, EARTHQUAKES MEDITERR; Ambraseys N, 2010, J EARTHQ ENG, V14, P309, DOI 10.1080/13632460903277593; [Anonymous], 2006, EOS T AM GEOPHYS UN, DOI DOI 10.1029/2006EO210002; Anschutz P, 2002, J MAR RES, V60, P835, DOI 10.1357/002224002321505156; Baird AH, 2005, CURR BIOL, V15, P1926, DOI 10.1016/j.cub.2005.09.036; BENAVRAHAM Z, 1985, J GEOPHYS RES-SOLID, V90, P703, DOI 10.1029/JB090iB01p00703; Beyth M., 2011, GELOGY ELAT SHEET EX; Bourgeois J., 2009, SEA, V15, P53; Campbell SJ, 2007, IMPACT SUMATRA ADAMA; Dey H., 2014, J OFROMAN ARCHAEOLOG, V27, P357, DOI [10.1017/S1047759414001287, DOI 10.1017/S1047759414001287]; Didenkulova I, 2011, PURE APPL GEOPHYS, V168, P1239, DOI 10.1007/s00024-010-0232-8; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; FREUND R, 1970, PHILOS T R SOC S-A, V267, P107, DOI 10.1098/rsta.1970.0027; GARFUNKEL Z, 1981, TECTONOPHYSICS, V80, P1, DOI 10.1016/0040-1951(81)90139-6; Goff J, 2012, SEDIMENT GEOL, V243, P70, DOI 10.1016/j.sedgeo.2011.11.002; Goodman-Tchernov BN, 2009, GEOLOGY, V37, P943, DOI 10.1130/G25704A.1; GVIRTZMAN G, 1992, MAR GEOL, V108, P29, DOI 10.1016/0025-3227(92)90211-Y; Hartman G, 2015, SEDIMENTOLOGY, V62, P516, DOI 10.1111/sed.12179; Hawkes AD, 2007, MAR GEOL, V242, P169, DOI 10.1016/j.margeo.2007.02.017; Hofstetter A, 2003, J SEISMOL, V7, P99, DOI 10.1023/A:1021206930730; Jourdan B., 2008, SCI TSUNAMI HAZARD, V27, P31; Katz O, 2015, MAR GEOL, V369, P100, DOI 10.1016/j.margeo.2015.08.006; Katz T, 2015, EARTH PLANET SC LETT, V417, P87, DOI 10.1016/j.epsl.2015.02.025; Katz T, EARTH PLANET SCI LET; Kortekaas S, 2007, SEDIMENT GEOL, V200, P208, DOI 10.1016/j.sedgeo.2007.01.004; Kunkel CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027892; Migowski C, 2004, EARTH PLANET SC LETT, V222, P301, DOI 10.1016/j.epsl.2004.02.015; Morton RA, 2007, SEDIMENT GEOL, V200, P184, DOI 10.1016/j.sedgeo.2007.01.003; Parker ST, 2013, ASRO ARCHAEOL REPORT, V19; Pilarczyk JE, 2012, SEDIMENT GEOL, V282, P78, DOI 10.1016/j.sedgeo.2012.08.011; Pilarczyk JE, 2012, MAR GEOL, V295, P128, DOI 10.1016/j.margeo.2011.12.002; Pratico Gary., 1993, NELSON GLUECKS 1938; Ramirez-Herrera MT, 2012, GEOMORPHOLOGY, V139, P360, DOI 10.1016/j.geomorph.2011.11.002; Reicherter K, 2010, Z GEOMORPHOL, V54, P147, DOI 10.1127/0372-8854/2010/0054S3-0023; Reinhardt EG, 2006, GEOLOGY, V34, P1061, DOI 10.1130/G22780A.1; Rositasari R, 2008, J COAST DEV, V12, P30; SADE A, 2008, ISR J EARTH SCI, V57, P139, DOI DOI 10.1560/IJES.57.2.139; Salem ESM, 2009, ARAB J GEOSCI, V2, P185, DOI 10.1007/s12517-008-0027-8; Shaked Y, 2004, TERRA NOVA, V16, P133, DOI 10.1111/j.1365-3121.2004.00541.x; Shaked Y., 2002, EGU STEPHAN MUELLER, V2, P105, DOI [10.5194/smsps-2- 105-2002, DOI 10.5194/SMSPS-2-105-2002]; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Sidebotham S. E., 1995, EXPEDITION, V37, P39; Sidebotham S.E., 1998, SAHARA, V10, P85; Smedile A, 2012, NAT HAZARD EARTH SYS, V12, P2557, DOI 10.5194/nhess-12-2557-2012; Szczucinski W, 2012, EARTH PLANETS SPACE, V64, P843, DOI 10.5047/eps.2012.07.007; Szczucinski W, 2012, NAT HAZARDS, V60, P115, DOI 10.1007/s11069-011-9956-8; Tappin DR, 2007, SEDIMENT GEOL, V200, P151, DOI 10.1016/j.sedgeo.2007.01.001; Tibor G, 2010, GEO-MAR LETT, V30, P561, DOI 10.1007/s00367-010-0194-y; van den Bergh GD, 2003, SHALLOW MARINE TSUNA, V197, DOI [10.1016/S0025-3227(03)00088-4, DOI 10.1016/S0025-3227(03)00088-4]; Varela Augusto N, 2011, Lat. Am. j. sedimentol. basin anal., V18, P63; Vott A, 2009, GLOBAL PLANET CHANGE, V66, P112, DOI 10.1016/j.gloplacha.2008.03.015; Weiss R, 2006, J SEDIMENT RES, V76, P1267, DOI 10.2110/jsr.2006.110	55	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0145802	10.1371/journal.pone.0145802	http://dx.doi.org/10.1371/journal.pone.0145802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815553	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200005
J	Wu, SQ; Zhu, XL; Liu, ZX; Shao, ES; Rebeca, CL; Guo, YJ; Xiong, YT; Mou, YN; Xu, RX; Hu, X; Liang, GH; Zou, SQ; Guan, X; Zhang, FP				Wu, Songqing; Zhu, Xiaoli; Liu, Zhaoxia; Shao, Ensi; Rebeca, Carballar-Lejarazu; Guo, Yajie; Xiong, Yueting; Mou, Yani; Xu, Runxue; Hu, Xia; Liang, Guanghong; Zou, Shuangquan; Guan, Xiong; Zhang, Feiping			Identification of Genes Relevant to Pesticides and Biology from Global Transcriptome Data of Monochamus alternatus Hope (Coleoptera: Cerambycidae) Larvae	PLOS ONE			English	Article							RED FLOUR BEETLE; MANDUCA-SEXTA AMINOPEPTIDASE; PATTERN-RECOGNITION RECEPTOR; GLUTATHIONE S-TRANSFERASES; MOSQUITO INNATE IMMUNITY; COMPLEMENT-LIKE PROTEIN; BRUSH-BORDER MEMBRANE; BACILLUS-THURINGIENSIS; ANOPHELES-GAMBIAE; SCAVENGER RECEPTORS	Monochamus alternatus Hope is the main vector in China of the Pine Wilt Disease caused by the pine wood nematode Bursaphelenchus xylophilus. Although chemical control is traditionally used to prevent pine wilt disease, new strategies based in biological control are promising ways for the management of the disease. However, there is no deep sequence analysis of Monochamus alternatus Hope that describes the transcriptome and no information is available about gene function of this insect vector. We used next generation sequencing technology to sequence the whole fourth instar larva transcriptome of Monochamus alternatus Hope and successfully built a Monochamus alternatus Hope transcriptome database. In total, 105,612 unigenes were assigned for Gene Ontology (GO) terms, information for 16,730 classified unigenes was obtained in the Clusters of Orthologous Groups (COGs) database, and 13,024 unigenes matched with 224 predicted pathways in the Kyoto Encyclopedia of Genes and Genome (KEGG). In addition, genes related to putative insecticide resistance-related genes, RNAi, the Bt receptor, intestinal digestive enzymes, possible future insect control targets and immune-related molecules are described. This study provides valuable basic information that can be used as a gateway to develop new molecular tools for Monochamus alternatus Hope control strategies.	[Wu, Songqing; Guo, Yajie; Xiong, Yueting; Mou, Yani; Hu, Xia; Liang, Guanghong; Zou, Shuangquan; Zhang, Feiping] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou 350002, Peoples R China; [Wu, Songqing; Zhu, Xiaoli; Liu, Zhaoxia; Shao, Ensi; Xiong, Yueting; Mou, Yani; Xu, Runxue; Guan, Xiong] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou 350002, Peoples R China; [Wu, Songqing; Zhu, Xiaoli; Liu, Zhaoxia; Shao, Ensi; Guan, Xiong] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China; [Rebeca, Carballar-Lejarazu] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; University of California System; University of California Irvine	Zhang, FP (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou 350002, Peoples R China.; Guan, X (corresponding author), Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou 350002, Peoples R China.; Guan, X (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China.	guanxfafu@126.com; fpzhang1@163.com	hu, xia hong/GQP-8544-2022		Special Fund for Forestry Research in the Public Interest of China [201304401]; Project of Fujian-Taiwan Joint Center for Ecological Control of Crop Pests [51]; United Fujian Provincial Health and Education Project for Tackling Key Research [WKJ-FJ-25]; National Natural Science Foundation of China [31301724, 31201574, 31401802]; Education Department Foundation of Fujian Province Distinguished Young Scholars in Universities of Fujian Province [JA12092]; Science Fund for Distinguished Young Scholars of Fujian Agriculture and Forestry University [xjq201203]; Key Projects of Fujian Provincial Department of Science and Technology [2013N0003, 2011\ N5003]; Natural Science Foundation of Fujian Province [2013J01079]; Programme for New Century Excellent Talents in Fujian Province [JA13089]; Special Fund for Grain Research in the Public Interest of China [201313002-3]; Special Fund for Key Construction Project of Fujian Agriculture and Forestry University [6112C035003]; National Undergraduate Training Programme for Innovation and Entrepreneurship [201510389013, 201510389018, 201510389023, 201510389025, 201510389028, 201510389101, 201510389173]; Science and Technology Project in Fujian Province Department of Education [JA15161]; Central Finance Forestry Science and Technology Demonstration Project [Min] [TG017]	Special Fund for Forestry Research in the Public Interest of China; Project of Fujian-Taiwan Joint Center for Ecological Control of Crop Pests; United Fujian Provincial Health and Education Project for Tackling Key Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department Foundation of Fujian Province Distinguished Young Scholars in Universities of Fujian Province; Science Fund for Distinguished Young Scholars of Fujian Agriculture and Forestry University; Key Projects of Fujian Provincial Department of Science and Technology; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Programme for New Century Excellent Talents in Fujian Province; Special Fund for Grain Research in the Public Interest of China; Special Fund for Key Construction Project of Fujian Agriculture and Forestry University; National Undergraduate Training Programme for Innovation and Entrepreneurship; Science and Technology Project in Fujian Province Department of Education; Central Finance Forestry Science and Technology Demonstration Project [Min]	This study was supported by the Special Fund for Forestry Research in the Public Interest of China [Grant No. 201304401], Project of Fujian-Taiwan Joint Center for Ecological Control of Crop Pests [Minjiaoke (2013) 51], the United Fujian Provincial Health and Education Project for Tackling Key Research [Grant No. WKJ-FJ-25], National Natural Science Foundation of China [Grant No. 31301724, No. 31201574 and No. 31401802], Education Department Foundation of Fujian Province Distinguished Young Scholars in Universities of Fujian Province [Grant No. JA12092], Science Fund for Distinguished Young Scholars of Fujian Agriculture and Forestry University [Grant No. xjq201203], Key Projects of Fujian Provincial Department of Science and Technology [No. 2011 vertical bar N5003 and No. 2013N0003], Natural Science Foundation of Fujian Province [Grant No. 2013J01079] and Programme for New Century Excellent Talents in Fujian Province [JA13089], the Special Fund for Grain Research in the Public Interest of China [Grant No. 201313002-3], the Special Fund for Key Construction Project of Fujian Agriculture and Forestry University [Grant No. 6112C035003], National Undergraduate Training Programme for Innovation and Entrepreneurship [Grant No. 201510389013, No. 201510389018, No. 201510389023, No. 201510389025, No. 201510389028, No. 201510389101 and No. 201510389173]. Science and Technology Project in Fujian Province Department of Education [JA15161], Central Finance Forestry Science and Technology Demonstration Project [Min (2015) TG017].	Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Agaisse H, 2004, IMMUNOL REV, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Ai JW, 2011, GENE, V480, P42, DOI 10.1016/j.gene.2011.03.002; Akov S., 1982, Current Themes in Tropical Science, V1, P197; Altincicek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Barrett AJ, 1980, PROTEIN DEGRADATION, P37; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayyareddy K, 2009, INSECT BIOCHEM MOLEC, V39, P279, DOI 10.1016/j.ibmb.2009.01.002; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721; Bown DP, 2004, INSECT BIOCHEM MOLEC, V34, P305, DOI 10.1016/j.ibmb.2003.11.005; Bravo A, 2013, MICROB BIOTECHNOL, V6, P17, DOI 10.1111/j.1751-7915.2012.00342.x; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Cancino-Rodezno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037034; CARLSSON A, 1991, INFECT IMMUN, V59, P3040, DOI 10.1128/IAI.59.9.3040-3045.1991; Carrillo L, 2011, TRANSGENIC RES, V20, P305, DOI 10.1007/s11248-010-9417-2; CHEN CL, 1995, BIOCHEM J, V310, P23, DOI 10.1042/bj3100023; Contreras E, 2013, J BIOL CHEM, V288, P18013, DOI 10.1074/jbc.M113.474445; Crava CM, 2010, INSECT BIOCHEM MOLEC, V40, P506, DOI 10.1016/j.ibmb.2010.04.010; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; De Cadiz AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074840; Deist BR, 2014, TOXINS, V6, P3005, DOI 10.3390/toxins6103005; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Dobson AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076521; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ENGLISH LH, 1989, INSECT BIOCHEM, V19, P145, DOI 10.1016/0020-1790(89)90085-1; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; Franc NC, 2000, MICROBES INFECT, V2, P243, DOI 10.1016/S1286-4579(00)00304-X; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; GARCZYNSKI SF, 1995, INSECT BIOCHEM MOLEC, V25, P409, DOI 10.1016/0965-1748(94)00072-7; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRISWOLD CM, 1993, GENETICS, V134, P781; Gullipalli D, 2010, COMP BIOCHEM PHYS B, V156, P33, DOI 10.1016/j.cbpb.2010.01.016; Hajek AE, 2008, USE OF MICROBES FOR; Hamilton KA, 2003, INT J PARASITOL, V33, P773, DOI 10.1016/S0020-7519(03)00089-4; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Hetru C, 2003, J INFECT DIS, V187, pS327, DOI 10.1086/374758; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hossain M, 2008, INSECT BIOCHEM MOLEC, V38, P1001, DOI 10.1016/j.ibmb.2008.08.006; Hughes AL, 2014, MOL PHYLOGENET EVOL, V76, P127, DOI 10.1016/j.ympev.2014.03.014; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; IIJIMA R, 1993, J BIOL CHEM, V268, P12055; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNIGHT PJK, 1995, J BIOL CHEM, V270, P17765, DOI 10.1074/jbc.270.30.17765; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; Kuwar S, 2015, INSECT BIOCH MOL BIO; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li X, 2013, PLOS ONE, V8, P374; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; LOWENBERGER C, 1995, INSECT BIOCHEM MOLEC, V25, P867, DOI 10.1016/0965-1748(95)00043-U; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; MATSUYAMA K, 1988, J BIOL CHEM, V263, P17117; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9; Niu GD, 2011, INSECT BIOCHEM MOLEC, V41, P244, DOI 10.1016/j.ibmb.2010.12.009; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Pace KE, 2002, GLYCOCONJUGATE J, V19, P607, DOI 10.1023/B:GLYC.0000014092.86763.2f; Parthasarathy R, 2009, ARCH INSECT BIOCHEM, V70, P57, DOI 10.1002/arch.20288; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Peiser L, 2002, INFECT IMMUN, V70, P5346, DOI 10.1128/IAI.70.10.5346-5354.2002; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Rausell C, 2007, BBA-BIOMEMBRANES, V1768, P2293, DOI 10.1016/j.bbamem.2007.06.014; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schuler MA, 2013, J CHEM ECOL, V39, P1232, DOI 10.1007/s10886-013-0335-7; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smith C, 2015, TRENDS IMMUNOL, V36, P59, DOI 10.1016/j.it.2014.12.007; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; State Forestry Bureau of China, 2014, THE ANNOUNCEMENT OF; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P126, DOI 10.1016/j.cbpb.2006.05.005; Walters FS, 2008, APPL ENVIRON MICROB, V74, P367, DOI 10.1128/AEM.02165-07; Wang LH, 2006, EMBO J, V25, P5005, DOI 10.1038/sj.emboj.7601363; Wang XG, 2005, MOL BIOCHEM PARASIT, V139, P65, DOI 10.1016/j.molbiopara.2004.09.009; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Y-H, 2011, J NANJING AGR U EDIT, P4; Welchman David P, 2009, Cell Host Microbe, V6, P107, DOI 10.1016/j.chom.2009.07.008; Wu XQ, 2013, INT J BIOL SCI, V9, P34, DOI 10.7150/ijbs.5071; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia X, 2015, SCIENTIFIC REPORTS, P5; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yang YuanLiang, 2013, Scientia Silvae Sinicae, V49, P103; Yang ZQ, 2014, BIOL CONTROL, V68, P117, DOI 10.1016/j.biocontrol.2013.06.010; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang Yan-Long, 2012, Acta Entomologica Sinica, V55, P426; Zhao B.G., 2008, PINE WILT DIS, DOI DOI 10.1007/978-4-431-75655-2; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	149	16	20	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147855	10.1371/journal.pone.0147855	http://dx.doi.org/10.1371/journal.pone.0147855			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815657	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200059
J	Novoa, A; Talley, TS; Talley, DM; Crooks, JA; Reyns, NB				Novoa, Anai; Talley, Theresa S.; Talley, Drew M.; Crooks, Jeffrey A.; Reyns, Nathalie B.			Spatial and Temporal Examination of Bivalve Communities in Several Estuaries of Southern California and Northern Baja California, MX	PLOS ONE			English	Article							LAND-USE; PATTERNS; COASTAL; BAY; ASSEMBLAGES; PREDATION; ABUNDANCE; DECLINES; IMPACTS; MUSSEL	A combination of historical bivalve surveys spanning 30-50 years and contemporary sampling were used to document the changes in bivalve community structure over time at four southern California and one northern Baja California estuaries. While there are limitations to the interpretation of historic data, we observed generally similar trends of reduced total bivalve species richness, losses of relatively large and/or deeper-dwelling natives, and gains of relatively small, surface dwelling introduced species across the southern California estuaries, despite fairly distinct bivalve communities. A nearly 50-year absence of bivalves from two wetlands surveyed in a Baja California estuary continued. A combination of site history and current characteristics (e.g., location, depth) likely contributes to maintenance of distinct communities, and both episodic and gradual environmental changes likely contribute to within-estuary temporal shifts (or absences). We highlight future research needed to determine mechanisms underlying patterns so that we can better predict responses of bivalve communities to future scenarios, including climate change and restoration.	[Novoa, Anai; Talley, Drew M.; Reyns, Nathalie B.] Univ San Diego, Dept Environm & Ocean Sci, San Diego, CA 92110 USA; [Talley, Theresa S.] Univ Calif San Diego, Scripps Inst Oceanog, Dept Calif Sea Grant Extens Program, La Jolla, CA 92093 USA; [Crooks, Jeffrey A.] Dept Tijuana River Natl Estuarine Res Reserve, Imperial Beach, CA USA	University of San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Novoa, A (corresponding author), Univ San Diego, Dept Environm & Ocean Sci, San Diego, CA 92110 USA.	anovoa@sandiego.edu	Reyns, Nathalie/P-1242-2016; Talley, Drew/M-7872-2019	Reyns, Nathalie/0000-0002-9967-0199; 	California Sea Grant [A/EA-AR-37]	California Sea Grant	No external funding was received for this study. Some resources (supplies and research assistance) were donated by T.S. Talley through California Sea Grant Project A/EA-AR-37, and D.M. Talley and N. Reyns through Environmental and Ocean Sciences at University of San Diego. The statements, findings, conclusions and recommendations are those of the researchers and do not necessarily reflect the views of the aforementioned organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beller E.E., 2014, SFEI PUBLICATION, V#722; Bendell LI, 2014, ESTUAR COAST, V37, P369, DOI 10.1007/s12237-013-9677-1; Boesch DF, 2000, BIOLOGICAL RESOURCE MANAGEMENT: CONNECTING SCIENCE AND POLICY, P93; BOURNE N, 1982, Journal of Shellfish Research, V2, P47; Bradshaw J, 1968, REPORT ECOLOGICAL RE; Byers JE, 2005, ECOLOGY, V86, P487, DOI 10.1890/03-0580; Calabretta CJ, 2008, MAR POLLUT BULL, V56, P1680, DOI 10.1016/j.marpolbul.2008.07.012; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coan EV, 2000, SANTA BARBARA MUSEUM; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Corbin JD, 2012, INVAS PLANT SCI MANA, V5, P117, DOI 10.1614/IPSM-D-11-00005.1; Crooks JA, 1999, J EXP MAR BIOL ECOL, V240, P53, DOI 10.1016/S0022-0981(99)00041-6; Crooks Jeffrey A., 2001, Biological Invasions, V3, P23, DOI 10.1023/A:1011404914338; Dauer DM, 2000, ESTUARIES, V23, P80, DOI 10.2307/1353227; Desmond JS, 2002, ESTUARIES, V25, P552, DOI 10.1007/BF02804890; Dexter Deborah M., 2000, Bulletin Southern California Academy of Sciences, V99, P128; Dudas SE, 2005, J EXP MAR BIOL ECOL, V325, P8, DOI 10.1016/j.jembe.2005.04.015; Duggan RM, 1989, THESIS SAN DIEGO STA; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Hechinger R. F., 2011, Ecology, V92, P791, DOI 10.1890/10-1383.1; Herring ML, 1991, KENDALL FROST MISSIO; HOFFMAN EJ, 1984, ENVIRON SCI TECHNOL, V18, P580, DOI 10.1021/es00126a003; Hosmer SC, 1977, THESIS SAN DIEGO STA; Houlahan JE, 2006, WETLANDS, V26, P79, DOI 10.1672/0277-5212(2006)26[79:TEOALU]2.0.CO;2; Kittinger J.N., 2014, MARINE HIST ECOLOGY; Kramer GW, 1976, THESIS HUMBOLDT STAT; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Leet WS, 2001, UC D ANR PUB, P435; LEVIN LA, 1984, ECOLOGY, V65, P1185, DOI 10.2307/1938326; Lewis TL, 2007, MAR ECOL PROG SER, V329, P131, DOI 10.3354/meps329131; Ma AP, 1987, 821178 US FISH WILDL, V82; MACDONALD KB, 1969, ECOL MONOGR, V39, P33, DOI 10.2307/1948564; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; MARCUS L, 1989, COASTAL WETLANDS SAN; Melillo JM, 2014, CLIMATE CHANGE IMPAC, V841, DOI DOI 10.7930/J0Z31WJ2; Miller J.N., 1966, THESIS U CALIFORNIA; MORRISON R, 1930, THESIS U SO CALIFORN; Morrison RL, 1952, ANN REPORT, P32; NORDBY CS, 1991, ESTUARIES, V14, P80, DOI 10.2307/1351985; Nordby CS, 1986, 8575 US FISH WILDL S, V85; Novoa A, 2014, THESIS U SAN DIEGO; Onuf CP, 1987, 85715 US FISH WILDL, V85; PETERSON CH, 1985, PALEOBIOLOGY, V11, P139; PETERSON CH, 1975, ECOLOGY, V56, P958, DOI 10.2307/1936306; Phleger FB, 1969, LAGUNAS COSTERAS S, P319; Pranovi F, 2006, BIOL INVASIONS, V8, P595, DOI 10.1007/s10530-005-1602-5; R Core Team, 2021, R LANGUAGE ENV STAT; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; SAS Institute Inc, 1989, JMP VERS 12 0 1; Schiff K, 2004, ENVIRON TOXICOL CHEM, V23, P1815, DOI 10.1897/03-401; Seitz RD, 2011, INTEGR COMP BIOL, V51, P598, DOI 10.1093/icb/icr098; Smith JR, 2006, ECOLOGY, V87, P1153, DOI 10.1890/0012-9658(2006)87[1153:DDIMBC]2.0.CO;2; Stein ED, 2014, 826 SO CAL COAST WAT; Strayer DL, 1999, BIOSCIENCE, V49, P19, DOI 10.2307/1313490; Talley DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118891; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Tuskes Paul M., 2012, Festivus, V44, P13; van der Zee EM, 2012, ECOSYSTEMS, V15, P664, DOI 10.1007/s10021-012-9538-y; Vellend M, 2013, AM J BOT, V100, P1294, DOI 10.3732/ajb.1200503; Vinagre C, 2008, J APPL ICHTHYOL, V24, P238, DOI 10.1111/j.1439-0426.2008.01055.x; Walling DE, 2006, GEOMORPHOLOGY, V79, P192, DOI 10.1016/j.geomorph.2006.06.019; Ward DH, 2003, ESTUARIES, V26, P1529, DOI 10.1007/BF02803661; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wing SR, 2011, MAR ECOL PROG SER, V422, P201, DOI 10.3354/meps08911; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Zar J. H, 2009, BIOSTAT ANAL, P960; Zedler JB, 2001, HDB RESTORING TIDAL, P1; Zhou Y, 2006, MAR ECOL PROG SER, V317, P127, DOI 10.3354/meps317127	70	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148220	10.1371/journal.pone.0148220	http://dx.doi.org/10.1371/journal.pone.0148220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840744	Green Published, gold			2022-12-27	WOS:000369550200100
J	Syme, RA; Tan, KC; Hane, JK; Dodhia, K; Stoll, T; Hastie, M; Furuki, E; Ellwood, SR; Williams, AH; Tan, YF; Testa, AC; Gorman, JJ; Oliver, RP				Syme, Robert A.; Tan, Kar-Chun; Hane, James K.; Dodhia, Kejal; Stoll, Thomas; Hastie, Marcus; Furuki, Eiko; Ellwood, Simon R.; Williams, Angela H.; Tan, Yew-Foon; Testa, Alison C.; Gorman, Jeffrey J.; Oliver, Richard P.			Comprehensive Annotation of the Parastagonospora nodorum Reference Genome Using Next-Generation Genomics, Transcriptomics and Proteogenomics	PLOS ONE			English	Article							STAGONOSPORA-NODORUM; NECROTROPHIC EFFECTORS; PEPTIDE IDENTIFICATION; G-ALPHA; WHEAT; PATHOGENICITY; SPORULATION; METABOLISM; DISEASE; SENSITIVITY	Parastagonospora nodorum, the causal agent of Septoria nodorum blotch (SNB), is an economically important pathogen of wheat (Triticum spp.), and a model for the study of necrotrophic pathology and genome evolution. The reference P. nodorum strain SN15 was the first Dothideomycete with a published genome sequence, and has been used as the basis for comparison within and between species. Here we present an updated reference genome assembly with corrections of SNP and indel errors in the underlying genome assembly from deep resequencing data as well as extensive manual annotation of gene models using transcriptomic and proteomic sources of evidence (https://github.com/robsyme/Parastagonospora_nodorum_SN15). The updated assembly and annotation includes 8,366 genes with modified protein sequence and 866 new genes. This study shows the benefits of using a wide variety of experimental methods allied to expert curation to generate a reliable set of gene models.	[Syme, Robert A.; Tan, Kar-Chun; Hane, James K.; Dodhia, Kejal; Furuki, Eiko; Ellwood, Simon R.; Williams, Angela H.; Testa, Alison C.; Oliver, Richard P.] Curtin Univ, Dept Environm & Agr, Ctr Crop & Dis Management, Bentley, WA, Australia; [Hane, James K.] Curtin Univ, Curtin Inst Computat, Bentley, WA, Australia; [Stoll, Thomas; Hastie, Marcus; Gorman, Jeffrey J.] QIMR Berghofer Med Res Inst, Prot Discovery Ctr, Herston, Qld, Australia; [Tan, Yew-Foon] Telethon Kids Inst, Subiaco, WA, Australia	Curtin University; Curtin University; QIMR Berghofer Medical Research Institute; Telethon Kids Institute	Oliver, RP (corresponding author), Curtin Univ, Dept Environm & Agr, Ctr Crop & Dis Management, Bentley, WA, Australia.	Richard.Oliver@curtin.edu.au	Tan, Kar-Chun/AAQ-4674-2021; Ellwood, Simon/K-2023-2013; Hane, James/A-7062-2011; Hastie, Marcus L/L-4366-2016; Williams, Angela/M-5256-2015	Tan, Kar-Chun/0000-0001-6094-823X; Ellwood, Simon/0000-0002-2673-0816; Hane, James/0000-0002-7651-0977; Hastie, Marcus L/0000-0002-8386-5549; Syme, Robert/0000-0002-8721-2350; Williams, Angela/0000-0003-0196-0022; Dodhia, Kejal/0000-0002-7891-1088; Stoll, Thomas/0000-0002-6275-3433	Australian Government National Collaborative Research Infrastructure Strategy; Education Investment Fund Super Science Initiative; Grains Research and Development Corporation [CUR00012]; Australian Government; GRDC [GRS10061]; Curtin University	Australian Government National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Education Investment Fund Super Science Initiative; Grains Research and Development Corporation(Grains R&D Corp); Australian Government(Australian GovernmentCGIAR); GRDC; Curtin University	This work was supported through access to facilities managed by BioPlatforms Australia (http://www.bioplatforms.com) and funded by the Australian Government National Collaborative Research Infrastructure Strategy and Education Investment Fund Super Science Initiative and Grains Research and Development Corporation (http://www.grdc.com.au) research grant CUR00012. This research was undertaken with the assistance of resources provided at the NCI Specialised Facility in Bioinformatics at The University of Queensland through the National Computational Merit Allocation Scheme supported by the Australian Government and by iVEC through the use of advanced computing resources located at the Pawsey Supercomputing Centre. RAS received funding through scholarships from GRDC (GRS10061) and Curtin University (http://www.curtin.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bonnal RJ, 2012, BIOINFORMATICS; Bringans S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-301; Casey T, 2010, PROTEOMICS, V10, P38, DOI 10.1002/pmic.200900474; Chain P, 2009, SCIENCE, V326; Chevreux B, 1999, GERM C BIOINF; Chooi Yit-Heng, 2014, Mycology, V5, P192, DOI 10.1080/21501203.2014.928386; Clarke JD., 2009, COLD SPRING HARBOR P, V2009, ppdbprot5177, DOI [10.1101/pdb.prot5177, DOI 10.1101/PDB.PROT5177]; COOLEY RN, 1991, MOL GEN GENET, V228, P17; Crook AD, 2012, PHYTOPATHOLOGY, V102, P498, DOI 10.1094/PHYTO-08-11-0238; Diament BJ, 2011, J PROTEOME RES, V10, P3871, DOI 10.1021/pr101196n; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Goto N., 2010, BIOINFORMATICS; Grandaubert J, 2015, G3 GENESGENOMESGENET; Gummer JPA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-131; Haibao Tang BP, 2015, GOA TOOLS 2015; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hane JK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004281; Hane JK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r45; Hane JK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-655; Hastie ML, 2012, MOL CELL PROTEOMICS, V11, P108, DOI 10.1074/mcp.M111.015909; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Ipcho SVS, 2012, MOL PLANT PATHOL, V13, P531, DOI 10.1111/j.1364-3703.2011.00770.x; Ipcho SVS, 2010, EUKARYOT CELL, V9, P1100, DOI 10.1128/EC.00064-10; Jin YJ, 1997, J BIOL CHEM, V272, P7352, DOI 10.1074/jbc.272.11.7352; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Lees JG, 2014, NUCLEIC ACIDS RES, V42, pD240, DOI 10.1093/nar/gkt1205; Liu ZH, 2004, PHYTOPATHOLOGY, V94, P1056, DOI 10.1094/PHYTO.2004.94.10.1056; Liu ZH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000581; Lowe RGT, 2009, FUNGAL GENET BIOL, V46, P381, DOI 10.1016/j.fgb.2009.02.002; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Park CY, 2008, J PROTEOME RES, V7, P3022, DOI 10.1021/pr800127y; Quaedvlieg W, 2013, STUD MYCOL, P307, DOI 10.3114/sim0017; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Solomon PS, 2006, BIOCHEM J, V399, P231, DOI 10.1042/BJ20060891; Solomon PS, 2006, MOL MICROBIOL, V62, P367, DOI 10.1111/j.1365-2958.2006.05380.x; Solomon PS, 2005, CURR GENET, V48, P60, DOI 10.1007/s00294-005-0588-y; Solomon PS, 2004, MOL PLANT MICROBE IN, V17, P456, DOI 10.1094/MPMI.2004.17.5.456; Solomon PS, 2004, MOL MICROBIOL, V53, P1065, DOI 10.1111/j.1365-2958.2004.04178.x; Solomon PS, 2006, MICROBIOL-SGM, V152, P1533, DOI 10.1099/mic.0.28556-0; Solomon PS, 2005, MOL PLANT MICROBE IN, V18, P110, DOI 10.1094/MPMI-18-0110; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Syme RA, 2013, G3-GENES GENOM GENET, V3, P959, DOI 10.1534/g3.112.004994; Tan KC, 2008, EUKARYOT CELL, V7, P1916, DOI 10.1128/EC.00237-08; Tan KC, 2014, CROP PASTURE SCI, V65, P150, DOI 10.1071/CP13443; Tan KC, 2010, FUNCT PLANT BIOL, V37, P907, DOI 10.1071/FP10067; Tan KC, 2009, METABOLOMICS, P1; Tange O., 2018, USENIX MAGAZINE, V36, P42; Testa AC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1344-4; Urban M, 2014, NUCL ACIDS RES; Vincent D, 2012, METHODS MOL BIOL, V835, P75, DOI 10.1007/978-1-61779-501-5_5; Vleeshouwers VGAA, 2014, MOL PLANT MICROBE IN, V27, P196, DOI 10.1094/MPMI-10-13-0313-IA; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	69	24	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147221	10.1371/journal.pone.0147221	http://dx.doi.org/10.1371/journal.pone.0147221			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840125	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200028
J	Yong, HS; Song, SL; Lim, PE; Eamsobhana, P; Suana, IW				Yong, Hoi-Sen; Song, Sze-Looi; Lim, Phaik-Eem; Eamsobhana, Praphathip; Suana, I. Wayan			Complete Mitochondrial Genome of Three Bactrocera Fruit Flies of Subgenus Bactrocera (Diptera: Tephritidae) and Their Phylogenetic Implications	PLOS ONE			English	Article							SPECIES DIPTERA; TRANSFER-RNA; MOLECULAR PHYLOGENY; COI; SEQUENCES; MODEL; LOOP	Bactrocera latifrons is a serious pest of solanaceous fruits and Bactrocera umbrosa is a pest of Artocarpus fruits, while Bactrocera melastomatos infests the fruit of Melastomataceae. They are members of the subgenus Bactrocera. We report here the complete mitochondrial genome of these fruit flies determined by next-generation sequencing and their phylogeny with other taxa of the subgenus Bactrocera. The whole mitogenomes of these three species possessed 37 genes namely, 13 protein-coding genes (PCGs), 2 rRNA and 22 tRNA genes. The mitogenome of B. latifrons (15,977 bp) was longer than those of B. melastomatos (15,954 bp) and B. umbrosa (15,898 bp). This difference can be attributed to the size of the intergenic spacers (283 bp in B. latifrons, 261 bp in B. melastomatos, and 211 bp in B. umbrosa). Most of the PCGs in the three species have an identical start codon, except for atp8 (adenosine triphosphate synthase protein 8), which had an ATG instead of GTG in B. umbrosa, whilst the nad3 (NADH dehydrogenase subunit 3) and nad6 (NADH dehydrogenase subunit 6) genes were characterized by an ATC instead of ATT in B. melastomatos. The three species had identical stop codon for the respective PCGs. In B. latifrons and B. melastomatos, the T.C (thymidine-pseudouridine-cytidine)-loop was absent in trnF (phenylalanine) and DHU (dihydrouracil)-loop was absent in trnS1 (serine S1). In B. umbrosa, trnN (asparagine), trnC (cysteine) and trnF lacked the T.C-loop, while trnS1 lacked the DHU-stem. Molecular phylogeny based on 13 PCGs was in general concordant with 15 mitochondrial genes (13 PCGs and 2 rRNA genes), with B. latifrons and B. umbrosa forming a sister group basal to the other species of the subgenus Bactrocera which was monophyletic. The whole mitogenomes will serve as a useful dataset for studying the genetics, systematics and phylogenetic relationships of the many species of Bactrocera genus in particular, and tephritid fruit flies in general.	[Yong, Hoi-Sen] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Yong, Hoi-Sen; Song, Sze-Looi] Univ Malaya, Chancellory High Impact Res, Kuala Lumpur, Malaysia; [Lim, Phaik-Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Eamsobhana, Praphathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand; [Suana, I. Wayan] Mataram Univ, Fac Sci & Math, Mataram, Indonesia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Mahidol University; Universitas Mataram	Yong, HS (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.; Yong, HS; Song, SL (corresponding author), Univ Malaya, Chancellory High Impact Res, Kuala Lumpur, Malaysia.; Lim, PE (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia.	yong@um.edu.my; looi511@hotmail.com; phaikeem@um.edu.my	LIM, Phaik Eem/B-5331-2010; Yong, Hoi Sen/C-1548-2010; Suana, I Wayan/J-2665-2012; Eamsobhana, Praphathip/H-3343-2012; Song, Sze-Looi/E-7939-2015; song, sl/GRS-1884-2022	LIM, Phaik Eem/0000-0001-9186-1487; Yong, Hoi Sen/0000-0002-9832-8826; Suana, I Wayan/0000-0003-1443-9017; Song, Sze Looi/0000-0002-1188-9728	Ministry of Higher Education High Impact Research Grant [H-50001-00-A000025]; University of Malaya [H-5620009]	Ministry of Higher Education High Impact Research Grant; University of Malaya(Universiti Malaya)	This study was funded in part by Ministry of Higher Education High Impact Research Grant (H-50001-00-A000025) and the University of Malaya (H-5620009).	Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Asokan R, 2011, FLA ENTOMOL, V94, P1026, DOI 10.1653/024.094.0441; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boykin LM, 2014, J APPL ENTOMOL, V138, P235, DOI 10.1111/jen.12047; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Chan CW, 2013, WIRES RNA, V4, P507, DOI 10.1002/wrna.1175; Choudhary JS, 2015, GENE, V569, P191, DOI 10.1016/j.gene.2015.05.066; De Meyer M, 2011, INVASIVE FRUIT FLY P; Drew R.A.I., 2013, TROPICAL FRUIT FLIES; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hendrickson TL, 2001, P NATL ACAD SCI USA, V98, P13473, DOI 10.1073/pnas.251549298; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishida Tatsuaki, 2005, Research Bulletin of the Plant Protection Service Japan, V41, P39; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Krosch MN, 2012, MOL PHYLOGENET EVOL, V64, P513, DOI 10.1016/j.ympev.2012.05.006; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08527; Liu Shen-Si, 2014, Acta Entomologica Sinica, V57, P343; McQuate Grant T., 2013, Insecta Mundi, V289, P1; Mwatawala Maulid, 2010, Journal of Afrotropical Zoology, V6, P83; Nakahara Shigehito, 2008, Research Bulletin of the Plant Protection Service Japan, P1; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Rambaut A., 2012, FIGTREE VERSION 1 4; Schutze MK, 2015, SYST ENTOMOL, V40, P456, DOI 10.1111/syen.12113; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith PT, 2003, MOL PHYLOGENET EVOL, V26, P8, DOI 10.1016/S1055-7903(02)00293-2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vargas RI, 2015, INSECTS, V6, P297, DOI 10.3390/insects6020297; Virgilio M, 2015, MOL PHYLOGENET EVOL, V85, P171, DOI 10.1016/j.ympev.2015.01.007; White P. Scott, 1992, P29; Yong HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15155; Yong HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129455; YONG HS, 1995, B ENTOMOL RES, V85, P431, DOI 10.1017/S0007485300036166; Yong HS, 2013, J SCI TECHNOL TROP, V9, P127; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308	43	23	23	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148201	10.1371/journal.pone.0148201	http://dx.doi.org/10.1371/journal.pone.0148201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840430	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200097
J	Bobak, AK; Dowsett, AJ; Bate, S				Bobak, Anna Katarzyna; Dowsett, Andrew James; Bate, Sarah			Solving the Border Control Problem: Evidence of Enhanced Face Matching in Individuals with Extraordinary Face Recognition Skills	PLOS ONE			English	Article							DEVELOPMENTAL PROSOPAGNOSIA; MEMORY TEST; IDENTIFICATION; PERCEPTION; PEOPLE; IMAGES; SEX	Photographic identity documents (IDs) are commonly used despite clear evidence that unfamiliar face matching is a difficult and error-prone task. The current study set out to examine the performance of seven individuals with extraordinary face recognition memory, so called "super recognisers" (SRs), on two face matching tasks resembling border control identity checks. In Experiment 1, the SRs as a group outperformed control participants on the "Glasgow Face Matching Test", and some case-by-case comparisons also reached significance. In Experiment 2, a perceptually difficult face matching task was used: the "Models Face Matching Test". Once again, SRs outperformed controls both on group and mostly in case-by-case analyses. These findings suggest that SRs are considerably better at face matching than typical perceivers, and would make proficient personnel for border control agencies.	[Bobak, Anna Katarzyna; Bate, Sarah] Bournemouth Univ, Fac Sci & Technol, Psychol Res Ctr, Poole BH12 5BB, Dorset, England; [Dowsett, Andrew James] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland	Bournemouth University; University of Aberdeen	Bobak, AK (corresponding author), Bournemouth Univ, Fac Sci & Technol, Psychol Res Ctr, Poole BH12 5BB, Dorset, England.	abobak@bournemouth.ac.uk		Bobak, Anna Katarzyna/0000-0002-4100-5807	Economic and Social Research Council [1215797] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Alenezi HM, 2013, APPL COGNITIVE PSYCH, V27, P735, DOI 10.1002/acp.2968; Bate S., 2014, SOC COGN AFFECT NEUR; Bate S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00491; Bate S, 2012, NEUROPSYCHOLOGY, V26, P670, DOI 10.1037/a0029443; Bennetts RJ, 2015, MOVEMENT CUES AID FA; Bindemann M, 2012, J EXP PSYCHOL-APPL, V18, P277, DOI 10.1037/a0029635; Bobak AK, 2016, APPL COGNITIVE PSYCH, V30, P81, DOI 10.1002/acp.3170; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; Braje WL, 1998, PSYCHOBIOLOGY, V26, P371; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; BURTON AM, 1990, BRIT J PSYCHOL, V81, P361, DOI 10.1111/j.2044-8295.1990.tb02367.x; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Dalrymple KA, 2014, DEV COGN NEUROS-NETH, V10, P10, DOI 10.1016/j.dcn.2014.07.003; Dowsett AJ, 2016, Q J EXP PSYCHOL, V69, P1, DOI 10.1080/17470218.2015.1017513; Dowsett AJ, 2015, BRIT J PSYCHOL, V106, P433, DOI 10.1111/bjop.12103; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Jenkins R, 2011, PHILOS T R SOC B, V366, P1671, DOI 10.1098/rstb.2010.0379; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Macmillan N. A., 2004, DETECTION THEORY USE; McIntyre AH, 2013, APPL COGNITIVE PSYCH, V27, P725, DOI 10.1002/acp.2966; Megreya AM, 2013, APPL COGNITIVE PSYCH, V27, P700, DOI 10.1002/acp.2965; Megreya AM, 2011, Q J EXP PSYCHOL, V64, P1473, DOI 10.1080/17470218.2011.575228; Megreya AM, 2011, ACTA PSYCHOL, V137, P83, DOI 10.1016/j.actpsy.2011.03.003; Norell K, 2015, J FORENSIC SCI, V60, P331, DOI 10.1111/1556-4029.12660; Russell R, 2012, NEUROPSYCHOLOGIA, V50; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; Sekiguchi T, 2011, ACTA PSYCHOL, V137, P1, DOI 10.1016/j.actpsy.2011.01.014; Shakeshaft NG, 2015, P NATL ACAD SCI USA, V112, P12887, DOI 10.1073/pnas.1421881112; Towler A, 2014, PERCEPTION, V43, P214, DOI 10.1068/p7676; White D, 2015, P ROY SOC B-BIOL SCI, V282, P73, DOI 10.1098/rspb.2015.1292; White D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139827; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; Wilhelm O, 2010, J PERS SOC PSYCHOL, V99, P530, DOI 10.1037/a0019972; WOODHEAD MM, 1979, ERGONOMICS, V22, P333, DOI 10.1080/00140137908924617	39	68	68	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148148	10.1371/journal.pone.0148148	http://dx.doi.org/10.1371/journal.pone.0148148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26829321	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000369548200070
J	D'Souza, CA; Zhao, FLD; Li, XJ; Xu, Y; Dunn, SE; Zhang, L				D'Souza, Cheryl A.; Zhao, Fei Linda; Li, Xujian; Xu, Yan; Dunn, Shannon E.; Zhang, Li			OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages	PLOS ONE			English	Article							EXTRACELLULAR ACIDIFICATION; IFN-GAMMA; OGR1; EAE; INFLAMMATION; RECEPTORS; PH; PROLIFERATION; SUPEROXIDE; INHIBITION	Ovarian cancer G protein-coupled receptor 1 (OGR1) is a proton-sensing molecule that can detect decreases in extracellular pH that occur during inflammation. Although OGR1 has been shown to have pro-inflammatory functions in various diseases, its role in autoimmunity has not been examined. We therefore sought to determine whether OGR1 has a role in the development of T cell autoimmunity by contrasting the development of experimental autoimmune encephalomyelitis between wild type and OGR1-knockout mice. OGR1-knockout mice showed a drastically attenuated clinical course of disease that was associated with a profound reduction in the expansion of myelin oligodendrocyte glycoprotein 35-55-reactive T helper 1 (Th1) and Th17 cells in the periphery and a reduced accumulation of Th1 and Th17 effectors in the central nervous system. We determined that these impaired T cell responses in OGR1-knockout mice associated with a reduced frequency and number of dendritic cells in draining lymph nodes during EAE and a higher production of nitric oxide by macrophages. Our studies suggest that OGR1 plays a key role in regulating T cell responses during autoimmunity.	[D'Souza, Cheryl A.; Li, Xujian; Dunn, Shannon E.; Zhang, Li] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Zhao, Fei Linda; Dunn, Shannon E.; Zhang, Li] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Xu, Yan] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Dunn, Shannon E.] Womens Coll Res Inst, Toronto, ON, Canada; [Zhang, Li] Univ Toronto, Dept Lab Med & Pathobiol & Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Indiana University System; Indiana University Bloomington; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto	Dunn, SE; Zhang, L (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.; Dunn, SE; Zhang, L (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Dunn, SE (corresponding author), Womens Coll Res Inst, Toronto, ON, Canada.; Zhang, L (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol & Immunol, Toronto, ON, Canada.	sdunn@uhnresearch.ca; lzhang@uhnresearch.ca			Canadian Institutes of Health Research [MOP341319]; NIH [5R01CA155145]; Ralph C. Wilson, Sr. and Ralph C. Wilson, Jr. Medical Research Foundation; NATIONAL CANCER INSTITUTE [R01CA155145] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph C. Wilson, Sr. and Ralph C. Wilson, Jr. Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Canadian Institutes of Health Research grant (Grant number MOP341319) to LZ, NIH 5R01CA155145 (to YX and LZ) and Ralph C. Wilson, Sr. and Ralph C. Wilson, Jr. Medical Research Foundation grant (to YX). LZ is the Maria H. Bacardi Chair in Transplantation at the University Health Network. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aoki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079985; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Bogdan C, 1998, J EXP MED, V187, P1361, DOI 10.1084/jem.187.9.1361; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Boullerne AI, 1999, J NEUROCHEM, V72, P1050, DOI 10.1046/j.1471-4159.1999.0721050.x; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Dalton DK, 2005, J NEUROIMMUNOL, V160, P110, DOI 10.1016/j.jneuroim.2004.11.004; de Valliere C, 2015, INFLAMM BOWEL DIS, V21, P1269, DOI 10.1097/MIB.0000000000000375; FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99; Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940; Figueiredo CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101947; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Fujii W, 2015, ARTHRITIS RHEUMATOLO; Garthwaite G, 2002, NEUROSCIENCE, V109, P145, DOI 10.1016/S0306-4522(01)00447-X; Gold DP, 1997, EUR J IMMUNOL, V27, P2863, DOI 10.1002/eji.1830271118; Hoey S, 1997, J IMMUNOL, V159, P5132; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Jiang ZL, 2014, IMMUNOL LETT, V160, P17, DOI 10.1016/j.imlet.2014.03.006; Juedes AE, 2001, J IMMUNOL, V166, P5168, DOI 10.4049/jimmunol.166.8.5168; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005705; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Mayhan WG, 2000, BRAIN RES, V866, P101, DOI 10.1016/S0006-8993(00)02254-X; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Murata N, 2009, CELL IMMUNOL, V259, P21, DOI 10.1016/j.cellimm.2009.05.008; Niedbala W, 2002, P NATL ACAD SCI USA, V99, P16186, DOI 10.1073/pnas.252464599; Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Pahan K, 2012, J CLIN CELLULAR IMMU, V3; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Prat E, 2002, J REHABIL RES DEV, V39, P187; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Rao Praveen, 2012, Methods Mol Biol, V900, P363, DOI 10.1007/978-1-60761-720-4_18; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Seuwen K, 2006, J RECEPT SIG TRANSD, V26, P599, DOI 10.1080/10799890600932220; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; van der Veen RC, 1999, CELL IMMUNOL, V193, P194, DOI 10.1006/cimm.1999.1471; van der Veen RC, 2000, CELL IMMUNOL, V199, P43, DOI 10.1006/cimm.1999.1597; Wei WC, 2015, P NATL ACAD SCI USA, V112, P10738, DOI 10.1073/pnas.1506085112; Willenborg DO, 1999, J IMMUNOL, V163, P5278; Wu GF, 2011, J AUTOIMMUN, V36, P56, DOI 10.1016/j.jaut.2010.10.006; Yamazaki H, 2005, J IMMUNOL, V175, P1586, DOI 10.4049/jimmunol.175.3.1586; Yan L, 2014, ONCOGENE, V33, P157, DOI 10.1038/onc.2012.566; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	52	12	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148439	10.1371/journal.pone.0148439	http://dx.doi.org/10.1371/journal.pone.0148439			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828924	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200102
J	de Vos, P; Smink, AM; Paredes, G; Lakey, JRT; Kuipers, J; Giepmans, BNG; de Haan, BJ; Faas, MM				de Vos, Paul; Smink, Alexandra M.; Paredes, Genaro; Lakey, Jonathan R. T.; Kuipers, Jeroen; Giepmans, Ben N. G.; de Haan, Bart J.; Faas, Marijke M.			Enzymes for Pancreatic Islet Isolation Impact Chemokine-Production and Polarization of Insulin-Producing beta-Cells with Reduced Functional Survival of Immunoisolated Rat Islet-Allografts as a Consequence	PLOS ONE			English	Article							ALGINATE-PLL CAPSULES; INFLAMMATORY RESPONSES; INDUCIBLE PROTEIN-10; BIOCOMPATIBILITY; TRANSPLANTATION; GRAFTS; MICROENCAPSULATION; ENCAPSULATION; PURIFICATION; COLLAGENASE	The primary aim of this study was to determine whether normal variations in enzyme-activities of collagenases applied for rat-islet isolation impact longevity of encapsulated islet grafts. Also we studied the functional and immunological properties of rat islets isolated with different enzyme preparations to determine whether this impacts these parameters. Rat-islets were isolated from the pancreas with two different collagenases with commonly accepted collagenase, neutral protease, and clostripain activities. Islets had a similar and acceptable glucose-induced insulin-release profile but a profound statistical significant difference in production of the chemokines IP-10 and Gro-alpha. The islets were studied with nanotomy which is an EM-based technology for unbiased study of ultrastructural features of islets such as cell-cell contacts, endocrine-cell condition, ER stress, mitochondrial conditions, and cell polarization. The islet-batch with higher chemokine-production had a lower amount of polarized insulin-producing beta-cells. All islets had more intercellular spaces and less interconnected areas with tight cell-cell junctions when compared to islets in the pancreas. Islet-graft function was studied by implanting encapsulated and free islet grafts in rat recipients. Alginate-based encapsulated grafts isolated with the enzymelot inducing higher chemokine production and lower polarization survived for a two-fold shorter period of time. The lower survival-time of the encapsulated grafts was correlated with a higher influx of inflammatory cells at 7 days after implantation. Islets from the same two batches transplanted as free unencapsulated-graft, did not show any difference in survival or function in vivo. Lack of insight in factors contributing to the current lab-to-lab variation in longevity of encapsulated islet-grafts is considered to be a threat for clinical application. Our data suggest that seemingly minor variations in activity of enzymes applied for islet-isolation might contribute to longevity-variations of immunoisolated isletgrafts.	[de Vos, Paul; Smink, Alexandra M.; Paredes, Genaro; de Haan, Bart J.; Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Immunoendocrinol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Lakey, Jonathan R. T.] Univ Calif Irvine, Dept Surg & Biomed Engn, Orange, CA 92868 USA; [Kuipers, Jeroen; Giepmans, Ben N. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, POB 196, NL-9700 AD Groningen, Netherlands	University of Groningen; University of California System; University of California Irvine; University of Groningen	de Vos, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Immunoendocrinol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	p.de.vos@umcg.nl	Smink, Alexandra/AAP-5285-2021; de Vos, Paul/A-3170-2013; Giepmans, Ben N.G./R-4564-2016; Paredes, Genaro A/R-6633-2016	Smink, Alexandra/0000-0002-9714-1779; Giepmans, Ben N.G./0000-0001-5105-5915; Paredes, Genaro A/0000-0002-6621-7830; de vos, paul/0000-0001-9618-2408	Juvenile Diabetes Research Foundation [17-2013288]; ZonM grant [91111.006]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); ZonM grant	This research was supported by the Juvenile Diabetes Research Foundation (17-2013288) and ZonM grant 91111.006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Barkai U, 2013, CELL TRANSPLANT, V22, P1463, DOI 10.3727/096368912X657341; Basta G, 2004, TRANSPL IMMUNOL, V13, P289, DOI 10.1016/j.trim.2004.10.003; Basta G, 2011, CURR DIABETES REP, V11, P384, DOI 10.1007/s11892-011-0219-6; Bunger CM, 2003, J BIOMED MATER RES A, V67A, P1219, DOI 10.1002/jbm.a.10094; Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151; Cowley MJ, 2012, CELL TRANSPLANT, V21, P2063, DOI 10.3727/096368911X627372; de Haan BJ, 2004, PANCREAS, V29, pE15, DOI 10.1097/00006676-200407000-00063; de Haan BJ, 2003, CELL TRANSPLANT, V12, P617, DOI 10.3727/000000003108747226; De Haan BJ, 2002, BIOTECHNIQUES, V32, P612, DOI 10.2144/02323rr03; De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381; de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345; de Vos P, 2003, DIABETOLOGIA, V46, P666, DOI 10.1007/s00125-003-1087-7; de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8; de Vos P, 2007, J BIOMED MATER RES A, V80A, P813, DOI 10.1002/jbm.a.30979; de Vos P, 2004, CELL TRANSPLANT, V13, P515, DOI 10.3727/000000004783983738; de Vos P, 2014, ADV DRUG DELIVER REV, V67-68, P15, DOI 10.1016/j.addr.2013.11.005; de Vos P, 2012, BIOMATERIALS, V33, P5552, DOI 10.1016/j.biomaterials.2012.04.039; de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014; de Vos Paul, 2006, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V6, P139; DeVos P, 1997, BIOMATERIALS, V18, P1085, DOI 10.1016/S0142-9612(97)00040-9; DeVos P, 1996, TRANSPLANTATION, V62, P888, DOI 10.1097/00007890-199610150-00003; DeVos P, 1996, TRANSPLANTATION, V62, P893, DOI 10.1097/00007890-199610150-00004; DeVos P, 1997, DIABETOLOGIA, V40, P262; deVos P, 1997, TRANSPL P, V29, P756, DOI 10.1016/S0041-1345(96)00456-3; DeVos P, 1997, TRANSPLANTATION, V63, P824, DOI 10.1097/00007890-199703270-00006; Dominguez-Bendala J, 2012, EXPERT OPIN BIOL TH, V12, P731, DOI 10.1517/14712598.2012.679654; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20; Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541; Eldor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056924; FRITSCHY WM, 1991, TRANSPLANTATION, V52, P777, DOI 10.1097/00007890-199111000-00004; FRITSCHY WM, 1994, TRANSPLANT INT, V7, P264, DOI 10.1111/j.1432-2277.1994.tb01572.x; Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0; Houwing H, 1996, CELL TRANSPLANT, V5, P21, DOI 10.1016/0963-6897(95)02019-5; IIDA N, 1990, MOL CELL BIOL, V10, P5596, DOI 10.1128/MCB.10.10.5596; Juhl K, 2010, CURR OPIN ORGAN TRAN, V15, P79, DOI 10.1097/MOT.0b013e3283344932; Jun HS, 2010, ADV EXP MED BIOL, V654, P627, DOI 10.1007/978-90-481-3271-3_27; Kin T, 2007, AM J TRANSPLANT, V7, P1233, DOI 10.1111/j.1600-6143.2007.01760.x; Kin T, 2007, TRANSPLANTATION, V83, P7, DOI 10.1097/01.tp.0000243169.09644.e6; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Lacik I, 2006, AUST J CHEM, V59, P508, DOI 10.1071/CH06197; Lakey JRT, 2003, TRANSPL INT, V16, P613, DOI 10.1007/s00147-003-0651-x; Ludwig B, 2012, P NATL ACAD SCI USA, V109, P5022, DOI 10.1073/pnas.1201868109; McCarthy RC, 2011, TRANSPLANTATION, V91, P137, DOI 10.1097/TP.0b013e3181ffff7d; Melzi R, 2010, CELL TRANSPLANT, V19, P1031, DOI 10.3727/096368910X514639; Nano R, 2005, DIABETOLOGIA, V48, P906, DOI 10.1007/s00125-005-1725-3; Omer A, 2003, XENOTRANSPLANTATION, V10, P240, DOI 10.1034/j.1399-3089.2003.01150.x; Orive G, 2015, TRENDS PHARMACOL SCI, V36, P537, DOI 10.1016/j.tips.2015.05.003; Orive G, 2014, NAT MED, V20, P233, DOI 10.1038/nm.3486; Paredes Juarez Genaro Alberto, 2014, Front Bioeng Biotechnol, V2, P26, DOI 10.3389/fbioe.2014.00026; Paredes-Juarez GA, 2014, MATERIALS, V7, P2087, DOI 10.3390/ma7032087; Paredes-Juarez GA, 2013, J CONTROL RELEASE, V172, P983, DOI 10.1016/j.jconrel.2013.09.009; Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014; Ravelli RBG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01804; Rheinheimer J, 2014, ISLETS, V6, DOI 10.4161/19382014.2014.977118; Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010; Santos E, 2010, ADV EXP MED BIOL, V670, P5; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Shimoda M, 2012, CELL TRANSPLANT, V21, P501, DOI 10.3727/096368911X605411; Shimoda M, 2012, CELL TRANSPLANT, V21, P465, DOI 10.3727/096368911X605376; Spasojevic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109837; Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929; Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006; Tam SK, 2009, J BIOMED MATER RES A, V89A, P609, DOI 10.1002/jbm.a.32002; Tatarkiewicz K, 2001, DIABETOLOGIA, V44, P646, DOI 10.1007/s001250051672; Vaithilingam V, 2011, J MICROENCAPSUL, V28, P499, DOI 10.3109/02652048.2011.586067; VANSUYLICHEM PTR, 1992, J SURG RES, V53, P502, DOI 10.1016/0022-4804(92)90097-J; VANSUYLICHEM PTR, 1994, TRANSPLANTATION, V57, P1010, DOI 10.1097/00007890-199404150-00005; VANSUYLICHEM PTR, 1992, DIABETOLOGIA, V35, P917, DOI 10.1007/BF00401419; VOSSCHEPERKEUTER GH, 1994, TRANSPLANT P, V26, P641	72	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147992	10.1371/journal.pone.0147992	http://dx.doi.org/10.1371/journal.pone.0147992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824526	Green Published, gold			2022-12-27	WOS:000369528600085
J	Komac, B; Esteban, P; Trapero, L; Caritg, R				Komac, Benjamin; Esteban, Pere; Trapero, Laura; Caritg, Roger			Modelization of the Current and Future Habitat Suitability of Rhododendron ferrugineum Using Potential Snow Accumulation	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ADAPTIVE REGRESSION SPLINES; ALPINE PLANT-DISTRIBUTION; CLIMATE-CHANGE; SPATIAL AUTOCORRELATION; CENTRAL PYRENEES; ACCURACY ASSESSMENT; ECOLOGICAL MODELS; PRESENCE-ABSENCE; DISTRIBUTIONS	Mountain areas are particularly sensitive to climate change. Species distribution models predict important extinctions in these areas whose magnitude will depend on a number of different factors. Here we examine the possible impact of climate change on the Rhododendron ferrugineum (alpenrose) niche in Andorra (Pyrenees). This species currently occupies 14.6 km(2) of this country and relies on the protection afforded by snow cover in winter. We used high-resolution climatic data, potential snow accumulation and a combined forecasting method to obtain the realized niche model of this species. Subsequently, we used data from the high-resolution Scampei project climate change projection for the A2, A1B and B1 scenarios to model its future realized niche model. The modelization performed well when predicting the species's distribution, which improved when we considered the potential snow accumulation, the most important variable influencing its distribution. We thus obtained a potential extent of about 70.7 km(2) or 15.1% of the country. We observed an elevation lag distribution between the current and potential distribution of the species, probably due to its slow colonization rate and the small-scale survey of seedlings. Under the three climatic scenarios, the realized niche model of the species will be reduced by 37.9-70.1 km(2) by the end of the century and it will become confined to what are today screes and rocky hillside habitats. The particular effects of climate change on seedling establishment, as well as on the species' plasticity and sensitivity in the event of a reduction of the snow cover, could worsen these predictions.	[Komac, Benjamin; Trapero, Laura; Caritg, Roger] IEA, CENMA, AD-600 St Julia De Loria, Andorra; [Esteban, Pere] Univ Barcelona, Fac Geog & Hist, Dept Geog Fis & Anal Geog Reg, Barcelona 08001, Spain	University of Barcelona	Komac, B (corresponding author), IEA, CENMA, Avinguda Rocafort 21-23, AD-600 St Julia De Loria, Andorra.	bkomac.cenma@iea.ad		Esteban, Pere/0000-0001-5095-1187				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2012, PIRINEOS, DOI DOI 10.3989/Pirineos.2012.167005; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Batalla M., 2011, ATLES CLIMATIC DIGIT; Binaghi E, 1999, PATTERN RECOGN LETT, V20, P935, DOI 10.1016/S0167-8655(99)00061-6; Black J.T, 1992, MULTIVARIATE DATA AN; Brieman L, 1984, CLASSIFICATION REGRE; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buisson L, 2010, AM FISH S S, V73, P327; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; Carreras J, 2013, MAPA DIGITAL DELS HA; Castroviejo S, 1993, FLORA IBERICA PLANTA; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Cliff A. D., 1981, SPATIAL PROCESSES MO; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Comes Hans Peter, 2004, New Phytol, V164, P11, DOI 10.1111/j.1469-8137.2004.01194.x; CONGALTON RG, 1993, PHOTOGRAMM ENG REM S, V59, P641; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Deque M, 2011, RES ATMOSPHERIC OCEA, V41, P11; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dullinger S, 2003, ARCT ANTARCT ALP RES, V35, P434, DOI 10.1657/1523-0430(2003)035[0434:POSIIH]2.0.CO;2; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Escaravage N, 2001, AM J BOT, V88, P68, DOI 10.2307/2657128; Escaravage N, 1998, MOL ECOL, V7, P975, DOI 10.1046/j.1365-294x.1998.00415.x; Esteban P, 2005, INT J CLIMATOL, V25, P319, DOI 10.1002/joc.1103; Falk W, 2013, J CLIMATOL, DOI 10.1155/2013/787250; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; FORTIN MJ, 1989, VEGETATIO, V83, P209, DOI 10.1007/BF00031693; Friedel H., 1961, MITTEILUNGEN FORSTLI, V59, P317; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Gracia M, 2007, FOREST ECOL MANAG, V242, P391, DOI 10.1016/j.foreco.2007.01.056; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Gray LK, 2013, CLIMATIC CHANGE, V117, P289, DOI 10.1007/s10584-012-0548-8; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2000, PHYTOCOENOLOGIA, V30, P353; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Habel JC, 2011, GLOBAL CHANGE BIOL, V17, P194, DOI 10.1111/j.1365-2486.2010.02233.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jay F, 2012, MOL ECOL, V21, P2354, DOI 10.1111/j.1365-294X.2012.05541.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jump AS, 2006, GLOBAL CHANGE BIOL, V12, P2163, DOI 10.1111/j.1365-2486.2006.01250.x; Kirtman B., 2013, IPCC 2013 CLIMATE CH, P953; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Komac B, 2014, J NAT CONSERV, V22, P247, DOI 10.1016/j.jnc.2014.01.005; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Korner C., 2005, ADV GLOB CHANGE RES, P367; Kreyling J, 2011, RESTOR ECOL, V19, P433, DOI 10.1111/j.1526-100X.2011.00777.x; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P L, 2000, NUMERICAL ECOLOGY; Lischke H, 1998, POLIT SCI ENVIRONM, P309; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lopez-Moreno JI, 2008, INT J CLIMATOL, V28, P1535, DOI 10.1002/joc.1645; Lopez-Moreno JI, 2014, THEOR APPL CLIMATOL, V117, P207, DOI 10.1007/s00704-013-0991-0; Lopez-Moreno JI, 2007, CLIM RES, V33, P257, DOI 10.3354/cr033257; Louis A, 2010, PLANTA MED, V76, P1550, DOI 10.1055/s-0029-1241016; Lutz C, 2005, PHYTON-ANN REI BOT A, V45, P139; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martinez I, 2012, GLOBAL CHANGE BIOL, V18, P1714, DOI 10.1111/j.1365-2486.2012.02660.x; Mayr S, 2010, OECOLOGIA, V164, P321, DOI 10.1007/s00442-010-1648-7; Montgomery D. C., 2021, INTRO LINEAR REGRESS, P12; Neuner G, 1999, TREE PHYSIOL, V19, P725; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; OPCC PCCO, 2013, MAIN CLIM REG PYR; Pasche F, 2004, BIOL CONSERV, V118, P101, DOI 10.1016/j.biocon.2003.07.012; Pauli H, 2001, ADV GLOB CHANGE RES, V9, P45; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Pornon A, 2000, MOL ECOL, V9, P1099, DOI 10.1046/j.1365-294x.2000.00976.x; Pornon A, 1997, PLANT ECOL, V130, P1, DOI 10.1023/A:1009724216796; Randin CF, 2014, ECOHYDROLOGY, pn/a; Randin CF, 2009, ARCT ANTARCT ALP RES, V41, P347, DOI 10.1657/1938-4246-41.3.347; Reichert P, 1997, ECOL MODEL, V95, P289, DOI 10.1016/S0304-3800(96)00043-9; Ridgeway G., 1999, COMPUT SCI STAT, P172; Ripley B. D., 1996, PATTERN RECOGNITION; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Ruiz-Labourdette D, 2012, J BIOGEOGR, V39, P162, DOI 10.1111/j.1365-2699.2011.02592.x; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Szczypta C, 2015, J HYDROL, V521, P84, DOI 10.1016/j.jhydrol.2014.11.060; Tardif J, 2003, ECOL MONOGR, V73, P241, DOI 10.1890/0012-9615(2003)073[0241:SVITGI]2.0.CO;2; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W., 2013, BIOMOD2 ENSEMBLE PLA; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Vittoz P, 2009, GLOBAL CHANGE BIOL, V15, P209, DOI 10.1111/j.1365-2486.2008.01707.x; Williams-Tripp M, 2012, SCI WORLD J, DOI 10.1100/2012/612965; Wintle BA, 2003, CONSERV BIOL, V17, P1579, DOI 10.1111/j.1523-1739.2003.00614.x; Wintle BA, 2005, AUSTRAL ECOL, V30, P719, DOI 10.1111/j.1442-9993.2005.01514.x; Zaghi D, 2008, MANAGEMENT NATURA 20; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	111	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147324	10.1371/journal.pone.0147324	http://dx.doi.org/10.1371/journal.pone.0147324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824847	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600024
J	Miller, AS; Shepherd, GR; Fratantoni, PS				Miller, Alicia S.; Shepherd, Gary R.; Fratantoni, Paula S.			Offshore Habitat Preference of Overwintering Juvenile and Adult Black Sea Bass, Centropristis striata, and the Relationship to Year-Class Success	PLOS ONE			English	Article							MIDDLE ATLANTIC BIGHT; ENGLAND SHELFBREAK FRONT; OF-THE-YEAR; NORTH-CAROLINA; INTERANNUAL VARIABILITY; WINTER MORTALITY; MORONE-SAXATILIS; CAPE-HATTERAS; GEORGES BANK; RED DRUM	Black sea bass (Centropristis striata) migrations are believed to play a role in overwinter survival and connectivity between juvenile and adult populations. This study investigated oceanographic drivers of winter habitat choice and regional differences between populations of juvenile and adult black sea bass. Trends in cohort strength, as a result of juvenile survival, were also identified. Oceanographic and fisheries survey data were analyzed using generalized additive models. Among the oceanographic variables investigated, salinity was the main driver in habitat selection with an optimal range of 33-35 practical salinity units (PSU) for both juveniles and adults. Preferred temperature ranges varied between juveniles and adults, but held a similar minimum preference of >8 degrees C. Salinity and temperature ranges also differed by regions north and south of Hudson Canyon. Shelf water volume had less of an effect than temperature or salinity, but showed an overall negative relationship with survey catch. The effect of winter conditions on juvenile abundance was also observed across state and federal survey index trends. A lack of correlation observed among surveys in the fall paired with a strong correlation in the spring identifies the winter period as a factor determining year-class strength of new recruits to the population. A rank order analysis of spring indices identified three of the largest year classes occurring during years with reduced shelf water volumes, warmer winter shelf waters, and a 34 PSU isohaline aligned farther inshore. While greater catches of black sea bass in the northwest Atlantic Ocean remain south of Hudson Canyon, the species' range has expanded north in recent years.	[Miller, Alicia S.; Shepherd, Gary R.; Fratantoni, Paula S.] Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, 166 Water St, Woods Hole, MA 02543 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Miller, AS (corresponding author), Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, 166 Water St, Woods Hole, MA 02543 USA.	Alicia.Miller@noaa.gov						Anderson DA, 2014, ICES J MAR SCI, V71, P1010, DOI 10.1093/icesjms/fst041; [Anonymous], 2014, R LANG ENV STAT COMP; Atwood HL, 2001, N AM J AQUACULT, V63, P285, DOI 10.1577/1548-8454(2001)063&lt;0285:SATTOB&gt;2.0.CO;2; Beardsley R. C., 1976, Memoires de la Societe Royal des Sciences de Liege. Collection in-8, V10, P209; Bell R.J., 2014, ICES J MARINE SCI; Berlinsky DL, 2004, J WORLD AQUACULT SOC, V35, P335, DOI 10.1111/j.1749-7345.2004.tb00097.x; Bisagni JJ, 2009, J MARINE SYST, V78, P337, DOI 10.1016/j.jmarsys.2008.11.020; CHAPMAN DC, 1989, J PHYS OCEANOGR, V19, P384, DOI 10.1175/1520-0485(1989)019<0384:OTOOSW>2.0.CO;2; CHAPMAN DC, 1986, J PHYS OCEANOGR, V16, P758, DOI 10.1175/1520-0485(1986)016<0758:OTCOMF>2.0.CO;2; Fabrizio MC, 2014, FISH B-NOAA, V112, P82, DOI 10.7755/FB.112.1.6; Fratantoni PS, 2007, J PHYS OCEANOGR, V37, P2509, DOI 10.1175/JPO3123.1; Gartner JV, 2008, MAR BIOL, V153, P825, DOI 10.1007/s00227-007-0855-1; Gawarkiewicz G, 2001, J PHYS OCEANOGR, V31, P2783, DOI 10.1175/1520-0485(2001)031<2783:IOASEW>2.0.CO;2; Gawarkiewicz GG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00553; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Gong D, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005520; Hales LS, 2001, MAR BIOL, V139, P45; Hare JA, 2007, FISH OCEANOGR, V16, P31, DOI 10.1111/j.1365-2419.2006.00407.x; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; Houghton RW, 2006, PROG OCEANOGR, V70, P289, DOI 10.1016/j.pocean.2006.05.001; HUNT RL, 1969, J FISH RES BOARD CAN, V26, P1473, DOI 10.1139/f69-138; Hurst TP, 1998, CAN J FISH AQUAT SCI, V55, P1122, DOI 10.1139/cjfas-55-5-1122; Hurst TP, 2007, JOURNAL OF FISH BIOL, V55, P1122; Jorgensen C, 2008, ECOLOGY, V89, P3436, DOI 10.1890/07-1469.1; Kendall AW, 1977, 7 NEFC SAND HOOK LAB; Kerr LA, 2009, REV FISH SCI, V17, P267, DOI 10.1080/10641260802667067; Lankford TE, 2001, T AM FISH SOC, V130, P236, DOI 10.1577/1548-8659(2001)130&lt;0236:LTTOAA&gt;2.0.CO;2; Lentz SJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001859; LEVITUS S, 1987, J PHYS OCEANOGR, V17, P197, DOI 10.1175/1520-0485(1987)017<0197:ACOTAC>2.0.CO;2; Linder CA, 1998, J GEOPHYS RES-OCEANS, V103, P18405, DOI 10.1029/98JC01438; Lozier MS, 2002, J PHYS OCEANOGR, V32, P924, DOI 10.1175/1520-0485(2002)032<0924:IOASF>2.0.CO;2; MANNING J, 1991, CONT SHELF RES, V11, P123, DOI 10.1016/0278-4343(91)90058-E; Martino EJ, 2012, CAN J FISH AQUAT SCI, V69, P430, DOI 10.1139/F2011-149; McCartney MA, 2013, J BIOGEOGR, V40, P1386, DOI 10.1111/jbi.12103; Miller TJ, 2010, NEFSC CENTER REFEREN; Moser J, 2009, J NW ATLANTIC FISHER, V139, P241; MOUNTAIN DG, 1991, CONT SHELF RES, V11, P251, DOI 10.1016/0278-4343(91)90068-H; Mountain DG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001044; Murase H, 2009, ICES J MAR SCI, V66, P1417, DOI 10.1093/icesjms/fsp105; MUSICK JA, 1977, T AM FISH SOC, V106, P12, DOI 10.1577/1548-8659(1977)106<12:SDOBSB>2.0.CO;2; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; Northeast Fisheries Science Center (NEFSC), 2012, 53 NE REG STOCK ASS; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pickart RS, 2000, J PHYS OCEANOGR, V30, P2668, DOI 10.1175/1520-0485(2001)031<2668:BBLSAD>2.0.CO;2; Post DM, 1998, CAN J FISH AQUAT SCI, V55, P2588, DOI 10.1139/cjfas-55-12-2588; Roy EM, 2012, MAR COAST FISH, V4, P391, DOI 10.1080/19425120.2012.675983; Ryan JP, 1999, LIMNOL OCEANOGR, V44, P1, DOI 10.4319/lo.1999.44.1.0001; Sagarese SR, 2014, CAN J FISH AQUAT SCI, V71, P847, DOI 10.1139/cjfas-2013-0342; Shepherd GR, 1994, 122 NOAA; STEIMLE FW, 1999, NMFSNE149 NOAA; Stewart CB, 2008, T AM FISH SOC, V137, P1089, DOI 10.1577/T07-176.1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zhang WFG, 2013, J GEOPHYS RES-OCEANS, V118, P517, DOI 10.1002/jgrc.20068	54	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147627	10.1371/journal.pone.0147627	http://dx.doi.org/10.1371/journal.pone.0147627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824350	Green Published, gold			2022-12-27	WOS:000369528600043
J	Lin, H; Travisano, M; Kazlauskas, RJ				Lin, Hui; Travisano, Michael; Kazlauskas, Romas J.			Experimental Evolution of Trichoderma citrinoviride for Faster Deconstruction of Cellulose	PLOS ONE			English	Article							ESCHERICHIA-COLI; REESEI; BIOMASS; GENE; IMPROVEMENT; ADAPTATION; EXPRESSION; STRATEGIES; DYNAMICS	Engineering faster cellulose deconstruction is difficult because it is a complex, cooperative, multi-enzyme process. Here we use experimental evolution to select for populations of Trichoderma citrinoviride that deconstruct up to five-fold more cellulose. Ten replicate populations of T. citrinoviride were selected for growth on filter paper by serial culture. After 125 periods of growth and transfer to fresh media, the filter paper deconstruction increased an average of 2.5 fold. Two populations were examined in more detail. The activity of the secreted cellulase mixtures increased more than two-fold relative to the ancestor and the largest increase was in the extracellular beta-glucosidase activity. qPCR showed at least 16-fold more transcribed RNA for egl4 (endoglucanase IV gene), cbh1 (cellobiohydrolase I gene) and bgl1 (extracellular beta-glucosidase I gene) in selected populations as compared to the ancestor, and earlier peak expressions of these genes. Deep sequencing shows that the regulatory strategies used to alter cellulase secretion differ in the two strains. The improvements in cellulose deconstruction come from earlier expression of all cellulases and increased relative amount of beta-glucosidase, but with small increases in the total secreted protein and therefore little increase in metabolic cost.	[Lin, Hui; Travisano, Michael; Kazlauskas, Romas J.] Univ Minnesota, Inst Biotechnol, St Paul, MN USA; [Travisano, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN USA; [Kazlauskas, Romas J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Travisano, M; Kazlauskas, RJ (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN USA.; Travisano, M (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN USA.; Kazlauskas, RJ (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN USA.	travisan@umn.edu; rjk@umn.edu	Travisano, Michael/AAI-4809-2020; Lin, Hui/C-9747-2013	Kazlauskas, Romas/0000-0002-3570-2411; Travisano, Michael/0000-0001-8168-0842	University of Minnesota Biotechnology Institute	University of Minnesota Biotechnology Institute(University of Minnesota System)	This work was supported by the University of Minnesota Biotechnology Institute (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghcheh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112799; Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Andric P, 2010, BIOTECHNOL ADV, V28, P308, DOI 10.1016/j.biotechadv.2010.01.003; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Chandra M, 2010, BIOMASS BIOENERG, V34, P805, DOI 10.1016/j.biombioe.2010.01.024; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Freimoser FM, 1999, APPL ENVIRON MICROB, V65, P3727; GESSNER MO, 1991, MICROBIAL ECOL, V22, P285, DOI 10.1007/BF02540230; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; Hakkinen M, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-14; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Yu-Kyoung, 2012, ISRN Microbiol, V2012, P650563, DOI 10.5402/2012/650563; Kindermann J, 1998, FUNGAL GENET BIOL, V24, P298, DOI 10.1006/fgbi.1998.1049; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Mandels M., 1971, J POLYM SCI, V36, P445, DOI DOI 10.1002/POLC.5070360133; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nitta M, 2012, FUNGAL GENET BIOL, V49, P388, DOI 10.1016/j.fgb.2012.02.009; Parekh S, 2000, APPL MICROBIOL BIOT, V54, P287, DOI 10.1007/s002530000403; Peterson R, 2012, MICROBIOL-SGM, V158, P58, DOI 10.1099/mic.0.054031-0; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuster A, 2011, APPL ENVIRON MICROB, V77, P4553, DOI 10.1128/AEM.00513-11; Seiboth B, 2011, BIOFUEL PRODUCTION R, DOI [10.5772/16848, DOI 10.5772/16848]; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steiger MG, 2010, J BIOTECHNOL, V145, P30, DOI 10.1016/j.jbiotec.2009.10.012; STERNBERG D, 1976, APPL ENVIRON MICROB, V31, P648, DOI 10.1128/AEM.31.5.648-654.1976; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zingaro KA, 2012, MBIO, V3, DOI 10.1128/mBio.00308-12	40	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147024	10.1371/journal.pone.0147024	http://dx.doi.org/10.1371/journal.pone.0147024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820897	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528400012
J	Tata, M; Wolfinger, MT; Amman, F; Roschanski, N; Dotsch, A; Sonnleitner, E; Haussler, S; Blasi, U				Tata, Muralidhar; Wolfinger, Michael T.; Amman, Fabian; Roschanski, Nicole; Doetsch, Andreas; Sonnleitner, Elisabeth; Haeussler, Susanne; Blaesi, Udo			RNA(Seq) Based Transcriptional Profiling of Pseudomonas aeruginosa PA14 after Short- and Long-Term Anoxic Cultivation in Synthetic Cystic Fibrosis Sputum Medium	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; MOLYBDENUM COFACTOR BIOSYNTHESIS; MULTIDRUG EFFLUX PUMPS; BIOFILM FORMATION; ESCHERICHIA-COLI; GENE-EXPRESSION; ANAEROBIC GROWTH; STENOTROPHOMONAS-MALTOPHILIA; ANTIBIOTIC-RESISTANCE; PLANKTONIC CULTURES	The opportunistic human pathogen Pseudomonas aeruginosa can thrive under microaerophilic to anaerobic conditions in the lungs of cystic fibrosis patients. RNASeq based comparative RNA profiling of the clinical isolate PA14 cultured in synthetic cystic fibrosis medium was performed after planktonic growth (OD600 = 2.0; P), 30 min after shift to anaerobiosis (A-30) and after anaerobic biofilm growth for 96h (B-96) with the aim to reveal differentially regulated functions impacting on sustained anoxic biofilm formation as well as on tolerance towards different antibiotics. Most notably, functions involved in sulfur metabolism were found to be up-regulated in B-96 cells when compared to A-30 cells. Based on the transcriptome studies a set of transposon mutants were screened, which revealed novel functions involved in anoxic biofilm growth. In addition, these studies revealed a decreased and an increased abundance of the oprD and the mexCD-oprJ operon transcripts, respectively, in B-96 cells, which may explain their increased tolerance towards meropenem and to antibiotics that are expelled by the MexCD-OprD efflux pump. The OprI protein has been implicated as a target for cationic antimicrobial peptides, such as SMAP-29. The transcriptome and subsequent Northern-blot analyses showed that the abundance of the oprI transcript encoding the OprI protein is strongly decreased in B-96 cells. However, follow up studies revealed that the susceptibility of a constructed PA14.oprI mutant towards SMAP-29 was indistinguishable from the parental wild-type strain, which questions OprI as a target for this antimicrobial peptide in strain PA14.	[Tata, Muralidhar; Roschanski, Nicole; Sonnleitner, Elisabeth; Blaesi, Udo] Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Dept Microbiol Immunobiol & Genet, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Wolfinger, Michael T.] Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Ctr Integrat Bioinformat Vienna, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Amman, Fabian] Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Dept Chromosome Biol, Dr Bohr Gasse 9, A-1030 Vienna, Austria; [Roschanski, Nicole] Free Univ Berlin, Inst Anim Hyg & Environm Hlth, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany; [Doetsch, Andreas; Haeussler, Susanne] Helmholtz Ctr Infect Res, Dept Mol Bacteriol, Inhoffenstr 7, D-38124 Braunschweig, Germany; [Haeussler, Susanne] Ctr Expt & Clin Infect Res, Twincore, Inst Mol Bacteriol, Feodor Lynen Str 7, D-30625 Hannover, Germany; [Wolfinger, Michael T.; Amman, Fabian] Univ Vienna, Inst Theoret Chem, Wahringer Str 17, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Free University of Berlin; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Vienna	Blasi, U (corresponding author), Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Dept Microbiol Immunobiol & Genet, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	udo.blaesi@univie.ac.at	Häussler, Susanne/I-2605-2014; Pohl, Sarah/B-3102-2016; Muralidhar, Tata/ABG-2075-2021; Dötsch, Andreas/AAL-6015-2020; Dötsch, Andreas/H-1383-2013; Wolfinger, Michael Thomas/N-9538-2014	Häussler, Susanne/0000-0001-6141-9102; Pohl, Sarah/0000-0003-2655-7037; Muralidhar, Tata/0000-0001-6026-6167; Dötsch, Andreas/0000-0001-9086-2584; Dötsch, Andreas/0000-0001-9086-2584; Wolfinger, Michael Thomas/0000-0003-0925-5205; Amman, Fabian/0000-0002-8646-859X; Sonnleitner, Elisabeth/0000-0002-6961-9536	Austrian Science Fund through the Special Research Program [RNA-REG F43, AF4311]; doctoral program RNA-Biology [W-1207]	Austrian Science Fund through the Special Research Program; doctoral program RNA-Biology	The work was supported by the Austrian Science Fund (www.fwf.ac.at/en) through the Special Research Program RNA-REG F43, subproject AF4311(UB), and the doctoral program RNA-Biology W-1207 (MT).	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Aendekerk S, 2002, MICROBIOL-SGM, V148, P2371, DOI 10.1099/00221287-148-8-2371; ALLISON DG, 1994, J BASIC MICROB, V34, P217, DOI 10.1002/jobm.3620340403; An BC, 2010, INT J RADIAT BIOL, V86, P400, DOI 10.3109/09553000903567953; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Broderick JB, 2001, COENZYMES COFACTORS; Campanini B, 2015, CURR MED CHEM, V22, P187; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; DUCHENE M, 1989, J BACTERIOL, V171, P4130; Eichner A, 2014, INT J MED MICROBIOL, V304, P1050, DOI 10.1016/j.ijmm.2014.07.014; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; He FQ, 2014, INTEGR BIOL-UK, V6, P215, DOI 10.1039/c3ib40180d; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hogan D, 2002, CURR OPIN MICROBIOL, V5, P472, DOI 10.1016/S1369-5274(02)00357-0; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; KATZ E, 1977, BACTERIOL REV, V41, P449, DOI 10.1128/MMBR.41.2.449-474.1977; Kertesz MA, 1999, J BACTERIOL, V181, P1464, DOI 10.1128/JB.181.5.1464-1473.1999; Kolpen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084353; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Lenz AP, 2008, APPL ENVIRON MICROB, V74, P4463, DOI 10.1128/AEM.00710-08; Li XZ, 2003, J ANTIMICROB CHEMOTH, V51, P803, DOI 10.1093/jac/dkg148; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; Linares JF, 2010, ENVIRON MICROBIOL, V12, P3196, DOI 10.1111/j.1462-2920.2010.02292.x; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Mac Aogain M, 2012, MICROBIOL-SGM, V158, P2598, DOI 10.1099/mic.0.058636-0; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; MIZUNO T, 1979, J BIOCHEM-TOKYO, V85, P115, DOI 10.1093/oxfordjournals.jbchem.a132300; Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x; Moreno R, 2009, PROTEOMICS, V9, P2910, DOI 10.1002/pmic.200800918; Morita Y, 2001, FEMS MICROBIOL LETT, V202, P139, DOI 10.1111/j.1574-6968.2001.tb10794.x; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RIVERS SL, 1993, MOL MICROBIOL, V8, P1071, DOI 10.1111/j.1365-2958.1993.tb01652.x; Sanchez MB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-148; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Sekiya H, 2003, ANTIMICROB AGENTS CH, V47, P2990, DOI 10.1128/AAC.47.9.2990-2992.2003; Sheldon Albert T Jr, 2005, Clin Lab Sci, V18, P170; Shih PC, 2002, J ANTIMICROB CHEMOTH, V49, P309, DOI 10.1093/jac/49.2.309; Southey-Pillig CJ, 2005, J BACTERIOL, V187, P8114, DOI 10.1128/JB.187.23.8114-8126.2005; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Srikumar R, 1997, J BACTERIOL, V179, P7875, DOI 10.1128/jb.179.24.7875-7881.1997; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; Su HC, 2010, ANTIMICROB AGENTS CH, V54, P4626, DOI 10.1128/AAC.00762-10; Tielen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071845; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; Vilain S, 2004, ANAL BIOCHEM, V329, P120, DOI 10.1016/j.ab.2004.02.014; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Wessel AK, 2013, J BACTERIOL, V195, P213, DOI 10.1128/JB.01253-12; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wolfinger Michael T, 2015, F1000Res, V4, P50, DOI 10.12688/f1000research.6157.2; Wu MH, 2005, J BACTERIOL, V187, P8185, DOI 10.1128/JB.187.23.8185-8190.2005; YE RW, 1995, J BACTERIOL, V177, P3606, DOI 10.1128/jb.177.12.3606-3609.1995; Yin YS, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01031-13; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	77	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147811	10.1371/journal.pone.0147811	http://dx.doi.org/10.1371/journal.pone.0147811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821182	Green Published, gold			2022-12-27	WOS:000369528400047
J	Valletta, E; Kucera, L; Prokes, L; Amato, F; Pivetta, T; Hampl, A; Havel, J; Vanhara, P				Valletta, Elisa; Kucera, Lukas; Prokes, Lubomir; Amato, Filippo; Pivetta, Tiziana; Hampl, Ales; Havel, Josef; Vanhara, Petr			Multivariate Calibration Approach for Quantitative Determination of Cell-Line Cross Contamination by Intact Cell Mass Spectrometry and Artificial Neural Networks	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LASER-DESORPTION/IONIZATION-TIME; LEAST-SQUARES REGRESSION; MALDI-TOF; EXPERIMENTAL-DESIGN; CANCER-DIAGNOSIS; MAMMALIAN-CELLS; CLASSIFICATION; SPECTRA; CULTURE	Cross-contamination of eukaryotic cell lines used in biomedical research represents a highly relevant problem. Analysis of repetitive DNA sequences, such as Short Tandem Repeats (STR), or Simple Sequence Repeats (SSR), is a widely accepted, simple, and commercially available technique to authenticate cell lines. However, it provides only qualitative information that depends on the extent of reference databases for interpretation. In this work, we developed and validated a rapid and routinely applicable method for evaluation of cell culture cross-contamination levels based on mass spectrometric fingerprints of intact mammalian cells coupled with artificial neural networks (ANNs). We used human embryonic stem cells (hESCs) contaminated by either mouse embryonic stem cells (mESCs) or mouse embryonic fibroblasts (MEFs) as a model. We determined the contamination level using a mass spectra database of known calibration mixtures that served as training input for an ANN. The ANN was then capable of correct quantification of the level of contamination of hESCs by mESCs or MEFs. We demonstrate that MS analysis, when linked to proper mathematical instruments, is a tangible tool for unraveling and quantifying heterogeneity in cell cultures. The analysis is applicable in routine scenarios for cell authentication and/or cell phenotyping in general.	[Valletta, Elisa; Prokes, Lubomir; Amato, Filippo; Havel, Josef] Masaryk Univ, Fac Sci, Dept Chem, Brno, Czech Republic; [Valletta, Elisa; Pivetta, Tiziana] Univ Cagliari, Dept Chem & Geol Sci, Monserrato, CA, Italy; [Kucera, Lukas; Hampl, Ales; Vanhara, Petr] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic; [Hampl, Ales] St Annes Univ Hosp Brno, Int Clin Res Ctr, Pekarska 53, Brno 65691, Czech Republic	Masaryk University Brno; University of Cagliari; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Vanhara, P (corresponding author), Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic.	pvanhara@med.muni.cz	Pivetta, Tiziana/AAB-2372-2021; Vanhara, Petr/G-5363-2011; Mendez, Eladia María Peña/AAB-2431-2019; Prokes, Lubomir/AAK-3363-2021; Prokeš, Lubomír/V-1045-2019; Pivetta, Tiziana/AAA-4922-2020; Hampl, Ales/N-1632-2016; Prokeš, Lubomír/AAF-2109-2020	Pivetta, Tiziana/0000-0001-9881-3584; Vanhara, Petr/0000-0002-7470-177X; Mendez, Eladia María Peña/0000-0002-1474-3134; Prokes, Lubomir/0000-0001-6044-3602; Hampl, Ales/0000-0002-8963-9235; 	Grant Agency of Masaryk University [MUNI/M/0041/2013, MUNI/A/1558/2014]; European Regional Development Fund [CZ.1.05/1.1.00/02.0123, CZ.1.07/2.3.00/20.0185]; Faculty of Medicine MU; Masaryk University, Department of Chemistry	Grant Agency of Masaryk University; European Regional Development Fund(European Commission); Faculty of Medicine MU; Masaryk University, Department of Chemistry	This study was supported by Grant Agency of Masaryk University (MUNI/M/0041/2013 and MUNI/A/1558/2014), from the European Regional Development Fund (CZ.1.05/1.1.00/02.0123 and CZ.1.07/2.3.00/20.0185) and by funds from the Faculty of Medicine MU to junior researcher (Petr Vanhara). Elisa Valletta gratefully acknowledges the Masaryk University and its Department of Chemistry, for the kind hospitality and for funding her stay in Brno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Alfassi ZB, 2004, J AM SOC MASS SPECTR, V15, P385, DOI 10.1016/j.jasms.2003.11.008; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Amato F, 2012, TALANTA, V93, P72, DOI 10.1016/j.talanta.2012.01.044; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Asakawa Daiki, 2012, Mass Spectrom (Tokyo), V1, pA0002, DOI 10.5702/massspectrometry.A0002; Baradez MO, 2015, CYTOM PART A, V87A, P624, DOI 10.1002/cyto.a.22637; Barta T, 2010, STEM CELLS, V28, P1143, DOI 10.1002/stem.451; Bas D, 2007, J FOOD ENG, V78, P836, DOI 10.1016/j.jfoodeng.2005.11.024; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Brougham DF, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/158094; Buchanan CM, 2007, RAPID COMMUN MASS SP, V21, P3452, DOI 10.1002/rcm.3253; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Chiu NHL, 2015, ENVIRON TOXICOL CHEM, V34, P161, DOI 10.1002/etc.2774; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Didion JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-847; Dong HJ, 2011, ANALYST, V136, P5181, DOI 10.1039/c1an15750g; Filzmoser P, 2012, J CHEMOMETR, V26, P42, DOI 10.1002/cem.1418; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hanrieder J, 2011, ANAL BIOANAL CHEM, V401, P135, DOI 10.1007/s00216-011-5043-y; Hilario M, 2006, MASS SPECTROM REV, V25, P409, DOI 10.1002/mas.20072; Holubcova Z, 2011, STEM CELLS, V29, P46, DOI 10.1002/stem.549; Houska J, 2014, J APPL BIOMED, V12, P119, DOI 10.1016/j.jab.2013.12.001; Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290; Ibanez AJ, 2015, ELECTROPHORESIS; Kober SL, 2015, ANAL BIOANAL CHEM; Kotasova H, 2012, J CELL BIOCHEM, V113, P563, DOI 10.1002/jcb.23380; Li H, 2002, ACTA CHIM SINICA, V60, P1264; Lokhov P, 2009, RAPID COMMUN MASS SP, V23, P680, DOI 10.1002/rcm.3928; Lui H, 2012, CANCER RES, V72, P2491, DOI 10.1158/0008-5472.CAN-11-4061; Marx V, 2014, NAT METHODS, V11, P483, DOI 10.1038/nmeth.2932; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Maurer K, 2013, ORAL ONCOL, V49, P152, DOI 10.1016/j.oraloncology.2012.08.012; Mehling M, 2014, CURR OPIN BIOTECH, V25, P95, DOI 10.1016/j.copbio.2013.10.005; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Munteanu B, 2014, ANAL CHEM, V86, P4642, DOI 10.1021/ac500038j; Munteanu B, 2013, BIOANALYSIS, V5, P885, DOI [10.4155/BIO.13.47, 10.4155/bio.13.47]; Munteanu B, 2012, ANAL BIOANAL CHEM, V404, P2277, DOI 10.1007/s00216-012-6357-0; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; Nienow AW, 2006, CYTOTECHNOLOGY, V50, P9, DOI 10.1007/s10616-006-9005-8; Pivetta T, 2013, TALANTA, V115, P84, DOI 10.1016/j.talanta.2013.04.031; Povey JF, 2014, J BIOTECHNOL, V184, P84, DOI 10.1016/j.jbiotec.2014.04.028; Rasmussen MA, 2012, CHEMOMETR INTELL LAB, V119, P21, DOI 10.1016/j.chemolab.2012.10.003; Volta P, 2012, J LIMNOL, V71, P164, DOI 10.4081/jlimnol.2012.e17; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xie WY, 2015, ANAL CHEM, V87, P7052, DOI 10.1021/acs.analchem.5b00010; Zhang X, 2006, J AM SOC MASS SPECTR, V17, P490, DOI 10.1016/j.jasms.2005.12.007	48	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147414	10.1371/journal.pone.0147414	http://dx.doi.org/10.1371/journal.pone.0147414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821236	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400026
J	Kark, S; Sutherland, WJ; Shanas, U; Klass, K; Achisar, H; Dayan, T; Gavrieli, Y; Justo-Hanani, R; Mandelik, Y; Orion, N; Pargament, D; Portman, M; Reisman-Berman, O; Safriel, UN; Schaffer, G; Steiner, N; Tauber, I; Levin, N				Kark, Salit; Sutherland, William J.; Shanas, Uri; Klass, Keren; Achisar, Hila; Dayan, Tamar; Gavrieli, Yael; Justo-Hanani, Ronit; Mandelik, Yael; Orion, Nir; Pargament, David; Portman, Michelle; Reisman-Berman, Orna; Safriel, Uriel N.; Schaffer, Gad; Steiner, Noa; Tauber, Israel; Levin, Noam			Priority Questions and Horizon Scanning for Conservation: A Comparative Study	PLOS ONE			English	Article							ECOSYSTEM SERVICES; MANAGEMENT; BIODIVERSITY; FUTURE; POLICY; IDENTIFICATION; DESALINATION; LESSONS; THREATS	Several projects aimed at identifying priority issues for conservation with high relevance to policy have recently been completed in several countries. Two major types of projects have been undertaken, aimed at identifying (i) policy-relevant questions most imperative to conservation and (ii) horizon scanning topics, defined as emerging issues that are expected to have substantial implications for biodiversity conservation and policy in the future. Here, we provide the first overview of the outcomes of biodiversity and conservation-oriented projects recently completed around the world using this framework. We also include the results of the first questions and horizon scanning project completed for a Mediterranean country. Overall, the outcomes of the different projects undertaken (at the global scale, in the UK, US, Canada, Switzerland and in Israel) were strongly correlated in terms of the proportion of questions and/or horizon scanning topics selected when comparing different topic areas. However, some major differences were found across regions. There was large variation among regions in the percentage of proactive (i.e. action and response oriented) versus descriptive (non-response oriented) priority questions and in the emphasis given to sociopolitical issues. Substantial differences were also found when comparing outcomes of priority questions versus horizon scanning projects undertaken for the same region. For example, issues related to climate change, human demography and marine ecosystems received higher priority as horizon scanning topics, while ecosystem services were more emphasized as current priority questions. We suggest that future initiatives aimed at identifying priority conservation questions and horizon scanning topics should allow simultaneous identification of both current and future priority issues, as presented here for the first time. We propose that further emphasis on social-political issues should be explicitly integrated into future related projects.	[Kark, Salit] Univ Queensland, ARC Ctr Excellence Environm Decis, Sch Biol Sci, Biodivers Res Grp, Brisbane, Qld 4072, Australia; [Kark, Salit; Klass, Keren; Achisar, Hila] Hebrew Univ Jerusalem, Biodivers Res Grp, IL-91904 Jerusalem, Israel; [Sutherland, William J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England; [Shanas, Uri] Univ Haifa, Dept Biol & Environm, IL-36006 Tivon, Israel; [Klass, Keren] Israel Acad Sci & Humanities, HaMaarag Israel Natl Program Ecosyst Assessment, Albert Einstein Sq, IL-91040 Jerusalem, Israel; [Dayan, Tamar; Justo-Hanani, Ronit] Tel Aviv Univ, Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Gavrieli, Yael] Tel Aviv Univ, Dept Zool, Nat Campus, IL-69978 Tel Aviv, Israel; [Mandelik, Yael] Hebrew Univ Jerusalem, Dept Entomol, POB 012, IL-76100 Rehovot, Israel; [Orion, Nir] Weizmann Inst Sci, Dept Sci Teaching, Earth & Environm Sci Grp, POB 26, IL-76100 Rehovot, Israel; [Pargament, David] Yarqon River Author, POB 6297, IL-61067 Tel Aviv, Israel; [Portman, Michelle] Technion Israel Inst Technol, Fac Architecture & Town Planning, IL-32000 Haifa, Israel; [Reisman-Berman, Orna] Ben Gurion Univ Negev, Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Sede Boqer Campus, IL-84990 Sede Boqer, Israel; [Safriel, Uriel N.] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, IL-91904 Jerusalem, Israel; [Schaffer, Gad; Levin, Noam] Hebrew Univ Jerusalem, Fac Social Sci, Dept Geog, IL-91905 Jerusalem, Israel; [Steiner, Noa] Israel Minist Environm Protect, Open Landscapes & Biodivers Div, Jerusalem, Israel; [Tauber, Israel] Jewish Natl Fund, Land Dev Author, Forest Dept, Forest Management Monitoring & GIS,KKL, Eshtaol, Israel; [Tauber, Israel] Thema, 1 Palmer Gate St POB 33189, IL-31331 Haifa, Israel	University of Queensland; Hebrew University of Jerusalem; University of Cambridge; University of Haifa; Tel Aviv University; Tel Aviv University; Hebrew University of Jerusalem; Weizmann Institute of Science; Technion Israel Institute of Technology; Ben Gurion University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Kark, S (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, Sch Biol Sci, Biodivers Res Grp, Brisbane, Qld 4072, Australia.; Kark, S (corresponding author), Hebrew Univ Jerusalem, Biodivers Res Grp, IL-91904 Jerusalem, Israel.	s.kark@uq.edu.au	Gavrieli, Yael/A-5389-2017; Kark, Salit/I-7123-2013; Schaffer, Gad/I-9414-2019; Sutherland, William/B-1291-2013; Kark, Salit/C-6795-2016; Levin, Noam/D-2180-2013	Kark, Salit/0000-0002-7183-3988; Kark, Salit/0000-0002-7183-3988; Levin, Noam/0000-0002-9434-7501; Justo-Hanani, Ronit/0000-0002-4553-5012	phylantropic Rothschild Foundation; Arcadia; Australian Research Council	phylantropic Rothschild Foundation; Arcadia; Australian Research Council(Australian Research Council)	The project was funded by The phylantropic Rothschild Foundation (Yad Hanadiv). http://www.yadhanadiv.org.il/. WJS is funded by Arcadia. SK is supported by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2011, UNSAID, V6th; Achiron-Frumkin T, 2011, REPORT STATE NATURE; Axelrod MY, 2010, ISRAELS 2 NATL UNPUB; Clarke Stewart J., 2009, Freshwater Reviews, V2, P51, DOI 10.1608/FRJ-2.1.3; Cooke SJ, 2010, J FISH BIOL, V76, P2261, DOI 10.1111/j.1095-8649.2010.02666.x; Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007; Feitelson E, 2012, GEOFORUM, V43, P272, DOI 10.1016/j.geoforum.2011.08.011; Fissel D, 2012, 40 PRIORITY RES QUES; Fleishman E, 2011, BIOSCIENCE, V61, P290, DOI 10.1525/bio.2011.61.4.9; Ingram JSI, 2013, FOOD SECUR, V5, P617, DOI 10.1007/s12571-013-0294-4; Kark S, 2012, ECOLOGY ENV, V3, P132; Kark S, 2015, CONSERV BIOL, V29, P1573, DOI 10.1111/cobi.12562; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Levin N, 2007, LANDSCAPE URBAN PLAN, V79, P53, DOI 10.1016/j.landurbplan.2006.04.001; Mazor T, 2013, DIVERS DISTRIB, V19, P1380, DOI 10.1111/ddi.12095; Morin E, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009798; Naveh Z, 1973, MEDITERRANEAN TYPE E, p[7, 373]; Orenstein DE, 2009, LAND USE POLICY, V26, P984, DOI 10.1016/j.landusepol.2008.12.003; Orenstein DE, 2004, POPUL ENVIRON, V26, P41, DOI 10.1023/B:POEN.0000039952.74913.53; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Potchter O., 1998, STUD GEOGR ISRAEL, V15, P179; Potschin MB, 2011, PROG PHYS GEOG, V35, P575, DOI 10.1177/0309133311423172; Pretty J, 2010, INT J AGR SUSTAIN, V8, P219, DOI 10.3763/ijas.2010.0534; Rita H, 2008, ANN ZOOL FENN, V45, P66, DOI 10.5735/086.045.0106; Rudd MA, 2011, CONSERV BIOL, V25, P860, DOI 10.1111/j.1523-1739.2011.01712.x; Rudd MA, 2011, CONSERV BIOL, V25, P476, DOI 10.1111/j.1523-1739.2010.01625.x; Safriel UN, 2006, NATO SCI PEACE SECUR, V3, P227; Safriel UN, 2010, ISRAELS NATL BIODIVE; Samuels R, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016322; Shaffer B, 2011, ENERG POLICY, V39, P5379, DOI 10.1016/j.enpol.2011.05.026; Shanas U, 2006, BIOL CONSERV, V132, P292, DOI 10.1016/j.biocon.2006.04.021; Shohami D, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016004; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Sutherland WJ, 2008, J APPL ECOL, V45, P821, DOI 10.1111/j.1365-2664.2008.01474.x; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Sutherland WJ, 2012, IBIS, V154, P663, DOI 10.1111/j.1474-919X.2012.01261.x; Sutherland WJ, 2012, ORYX, V46, P368, DOI 10.1017/S0030605311001724; Sutherland WJ, 2012, PHILOS T R SOC B, V367, P322, DOI 10.1098/rstb.2011.0181; Sutherland WJ, 2011, TRENDS ECOL EVOL, V26, P10, DOI 10.1016/j.tree.2010.11.002; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Tal A, 2011, ENVIRONMENT, V53, P34, DOI 10.1080/00139157.2011.604009; Walzer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053139; Zohary D., 2000, DOMESTICATION PLANTS, DOI 10.1006/anbo.2001.1505	44	14	14	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0145978	10.1371/journal.pone.0145978	http://dx.doi.org/10.1371/journal.pone.0145978			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26815653	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528200006
J	Kawiak, A; Lojkowska, E				Kawiak, Anna; Lojkowska, Ewa			RETRACTED: Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells (Publication with Expression of Concern. See vol. 14, 2019) (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							PLUMBAGIN; INHIBITOR; GROWTH; TRASTUZUMAB; INDUCTION; PATHWAY; 7-METHYLJUGLONE; INVASION; BCL-2; MICE	The phosphoinositide 3-kinase (PI3K) signaling pathway plays an important role in processes critical for breast cancer progression and its upregulation confers increased resistance of cancer cells to chemotherapy and radiation. The present study aimed at determining the activity of ramentaceone, a constituent of species in the plant genera Drosera, toward breast cancer cells and defining the involvement of PI3K/Akt inhibition in ramentaceone-mediated cell death induction. The results showed that ramentaceone exhibited high antiproliferative activity toward breast cancer cells, in particular HER2-overexpressing breast cancer cells. The mode of cell death induced by ramentaceone was through apoptosis as determined by cytometric analysis of caspase activity and Annexin V staining. Apoptosis induction was found to be mediated by inhibition of PI3K/Akt signaling and through targeting its downstream anti-apoptotic effectors. Ramentaceone inhibited PI3-kinase activity, reduced the expression of the PI3K protein and inhibited the phosphorylation of the Akt protein in breast cancer cells. The expression of the anti-apoptotic Bcl-2 protein was decreased and the levels of the pro-apoptotic proteins, Bax and Bak, were elevated. Moreover, inhibition of PI3K and silencing of Akt expression increased the sensitivity of cells to ramentaceone-induced apoptosis. In conclusion, our results indicate that ramentaceone induces apoptosis in breast cancer cells through PI3K/Akt signaling inhibition. These findings suggest further investigation of ramentaceone as a potential therapeutic agent in breast cancer therapy, in particular HER2-positive breast cancer.	[Kawiak, Anna; Lojkowska, Ewa] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Kladki 24, PL-80822 Gdansk, Poland; [Kawiak, Anna; Lojkowska, Ewa] Med Univ Gdansk, Kladki 24, PL-80822 Gdansk, Poland; [Kawiak, Anna] Med Univ Gdansk, Fac Hlth Sci, Subfac Nursing, Lab Human Physiol, Tuwima 15, PL-80210 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Kawiak, A (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Kladki 24, PL-80822 Gdansk, Poland.; Kawiak, A (corresponding author), Med Univ Gdansk, Kladki 24, PL-80822 Gdansk, Poland.; Kawiak, A (corresponding author), Med Univ Gdansk, Fac Hlth Sci, Subfac Nursing, Lab Human Physiol, Tuwima 15, PL-80210 Gdansk, Poland.	anna.kawiak@biotech.ug.edu.pl	Lojkowska, Ewa/S-3402-2019; Kawiak, Anna/L-6060-2014	Lojkowska, Ewa/0000-0001-8640-2307; Kawiak, Anna/0000-0001-8105-2555	National Science Centre [2011/03/B/NZ7/06144]; European Commission [GA 316094]; European Commission from the FP7 project MOBI4Health [GA 316094]	National Science Centre(National Science Centre, Poland); European Commission(European CommissionEuropean Commission Joint Research Centre); European Commission from the FP7 project MOBI4Health	This work was supported by the grant of the National Science Centre No. 2011/03/B/NZ7/06144 (https://www.ncn.gov.pl/), funding received by AK. Publication supported by the European Commission from the FP7 project MOBI4Health, GA 316094; funding received by the Intercollegiate Faculty of Biotechnology of the University of Gdansk.; This work was supported by the grant of the National Science Centre No. 2011/03/B/NZ7/06144. Open access publication supported by the European Commission from the FP7 project MOBI4Health, GA 316094.	Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Aziz MH, 2008, CANCER RES, V68, P9024, DOI 10.1158/0008-5472.CAN-08-2494; Bapela NB, 2006, PHYTOMEDICINE, V13, P630, DOI 10.1016/j.phymed.2006.08.001; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; Crawford Anatasha, 2011, Current Pharmacogenomics & Personalized Medicine, V9, P184; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gu JQ, 2004, J NAT PROD, V67, P1156, DOI 10.1021/np040027m; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; JONES SE, 1985, J CLIN ONCOL, V3, P92, DOI 10.1200/JCO.1985.3.1.92; Juniper B.E., 1989, CARNIVOROUS PLANTS P, P229; Kawiak A, 2007, TOXICOL APPL PHARM, V223, P267, DOI 10.1016/j.taap.2007.05.018; Kawiak A, 2012, J NAT PROD, V75, P747, DOI 10.1021/np3000409; Kawiak A, 2012, J NAT PROD, V75, P9, DOI 10.1021/np200247g; Kawiak A, 2011, BIOTECHNOL LETT, V33, P2309, DOI 10.1007/s10529-011-0700-y; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Li YZ, 2003, P NATL ACAD SCI USA, V100, P2674, DOI 10.1073/pnas.0538044100; Lu CH, 2007, CLIN CANCER RES, V13, P5883, DOI 10.1158/1078-0432.CCR-06-2837; Mahapatra A, 2007, BIOORGAN MED CHEM, V15, P7638, DOI 10.1016/j.bmc.2007.08.064; Manu KA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-107; MARSTON A, 1984, PLANTA MED, V50, P279, DOI 10.1055/s-2007-969704; Mebe PP, 1998, PHYTOCHEMISTRY, V47, P311, DOI 10.1016/S0031-9422(97)00398-1; OBrien PJ, 1991, CHEM-BIOL INTERACT, V8, P1; Ozbay T, 2010, CANCER CHEMOTH PHARM, V65, P697, DOI 10.1007/s00280-009-1075-9; Park JW, 2008, CLIN BREAST CANCER, V8, P392, DOI 10.3816/CBC.2008.n.047; Raghu D, 2014, J NAT PROD, V77, P1130, DOI 10.1021/np4010085; Singh F, 2003, CANCER LETT, V200, P115, DOI 10.1016/S0304-3835(03)00239-8; Sung B, 2012, MOL CANCER THER, V11, P350, DOI 10.1158/1535-7163.MCT-11-0731; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Witters LM, 2007, ONCOL REP, V17, P465; Yao E, 2009, CLIN CANCER RES, V15, P4147, DOI 10.1158/1078-0432.CCR-08-2814; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972	34	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147718	10.1371/journal.pone.0147718	http://dx.doi.org/10.1371/journal.pone.0147718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840401	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200056
J	Lu, J; Zhang, XQ; Li, JZ; Yu, L; Chen, EM; Zhu, DH; Zhang, YM; Li, LJ				Lu, Juan; Zhang, Xiaoqian; Li, Jianzhou; Yu, Liang; Chen, Ermei; Zhu, Danhua; Zhang, Yimin; Li, LanJuan			A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; HEPATOCYTE CULTURE; GENE-EXPRESSION; SHEAR FORCE; C3A CELLS; STABILITY; ENCAPSULATION; COCULTURE; TRANSPORT; PERFUSION	A fluidized bed bioreactor containing encapsulated hepatocytes may be a valuable alternative to a hollow fiber bioreactor for achieving the improved mass transfer and scale-up potential necessary for clinical use. However, a conventional fluidized bed bioreactor (FBB) operating under high perfusion velocity is incapable of providing the desired performance due to the resulting damage to cell-containing microcapsules and large void volume. In this study, we developed a novel diversion-type microcapsule-suspension fluidized bed bioreactor (DMFBB). The void volume in the bioreactor and stability of alginate/chitosan microcapsules were investigated under different flow rates. Cell viability, synthesis and metabolism functions, and expression of metabolizing enzymes at transcriptional levels in an encapsulated hepatocyte line (C3A cells) were determined. The void volume was significantly less in the novel bioreactor than in the conventional FBB. In addition, the microcapsules were less damaged in the DMFBB during the fluidization process as reflected by the results for microcapsule retention rates, swelling, and breakage. Encapsulated C3A cells exhibited greater viability and CYP1A2 and CYP3A4 activity in the DMFBB than in the FBB, although the increases in albumin and urea synthesis were less prominent. The transcription levels of several CYP450-related genes and an albumin-related gene were dramatically greater in cells in the DMFBB than in those in the FBB. Taken together, our results suggest that the DMFBB is a promising alternative for the design of a bioartificial liver system based on a fluidized bed bioreactor with encapsulated hepatocytes for treating patients with acute hepatic failure or other severe liver diseases.	[Lu, Juan; Zhang, Xiaoqian; Li, Jianzhou; Yu, Liang; Chen, Ermei; Zhu, Danhua; Zhang, Yimin; Li, LanJuan] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Coll Me, Hangzhou 310003, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Coll Me, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			Chinese High Tech Research and Development (863) Program [2012AA020204]; National AT Major Project [2012ZX10002004-001]; Fundamental Research Funds for the Central Universities [2014XZZX008]	Chinese High Tech Research and Development (863) Program; National AT Major Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Chinese High Tech Research and Development (863) Program (2012AA020204), National A&T Major Project (2012ZX10002004-001), Fundamental Research Funds for the Central Universities (2014XZZX008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753; Chamuleau RAFM, 2006, THER APHER DIAL, V10, P168, DOI 10.1111/j.1744-9987.2006.00359.x; Chia SM, 2000, TISSUE ENG, V6, P481, DOI 10.1089/107632700750022134; Coward SM, 2009, ARTIF ORGANS, V33, P1117, DOI 10.1111/j.1525-1594.2009.00821.x; David B, 2004, BIOTECHNOL PROGR, V20, P1204, DOI 10.1021/bp034301z; Desille M, 2002, CRIT CARE MED, V30, P658, DOI 10.1097/00003246-200203000-00027; Dixit V, 1998, EUR J SURG, V164, P71; Dore E, 1999, Ther Apher, V3, P264, DOI 10.1046/j.1526-0968.1999.00152.x; Esterl S, 2003, BIOTECHNOL BIOENG, V83, P780, DOI 10.1002/bit.10723; Feng SJ, 2015, ENVIRON SCI POLLUT R, V22, P9067, DOI 10.1007/s11356-014-4045-7; Flendrig LM, 1997, J HEPATOL, V26, P1379, DOI 10.1016/S0168-8278(97)80475-8; Gaserod O, 1999, BIOMATERIALS, V20, P773, DOI 10.1016/S0142-9612(98)00230-0; Gautier A, 2011, EUR CELLS MATER, V21, P94, DOI 10.22203/eCM.v021a08; GERLACH JC, 1994, INT J ARTIF ORGANS, V17, P301; Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Henderson JM, 2004, ANN SURG, V239, P667; INLOES DS, 1983, BIOTECHNOL BIOENG, V25, P2653, DOI 10.1002/bit.260251113; Kaiser P, 2014, BIOTECHNOL BIOENG, V111, P2571, DOI 10.1002/bit.25304; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kinasiewicz A, 2007, TRANSPL P, V39, P2911, DOI 10.1016/j.transproceed.2007.08.062; Legallais C, 2000, ARTIF ORGANS, V24, P519, DOI 10.1046/j.1525-1594.2000.06510.x; Legallais C, 2001, J MEMBRANE SCI, V181, P81, DOI 10.1016/S0376-7388(00)00539-1; Li SW, 2014, LAB CHIP, V14, P4475, DOI 10.1039/c4lc00956h; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; Lv GL, 2011, BIOTECHNOL BIOENG, V108, P2229, DOI 10.1002/bit.23150; Mazariegos GV, 2002, AM J TRANSPLANT, V2, P260, DOI 10.1034/j.1600-6143.2002.20311.x; Neubauer MP, 2014, ADV COLLOID INTERFAC, V207, P65, DOI 10.1016/j.cis.2013.11.016; Nibourg GAA, 2013, LIVER INT, V33, P516, DOI 10.1111/liv.12090; Pless G, 2005, TRANSPLANT P, V37, P3893, DOI 10.1016/j.transproceed.2005.09.113; Portner R, 2005, J BIOSCI BIOENG, V100, P235, DOI 10.1263/jbb.100.235; Richert L, 2006, DRUG METAB DISPOS, V34, P870, DOI 10.1124/dmd.105.007708; Sadamori H, 2002, EUR J GASTROEN HEPAT, V14, P435, DOI 10.1097/00042737-200204000-00018; Selden C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082312; Tay JH, 2001, APPL MICROBIOL BIOT, V57, P227; THOMAS CA, 1994, J ANDROL, V15, P489; Tilles A W, 2002, Technol Health Care, V10, P177; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Wolfe RP, 2013, BIOTECHNOL BIOENG, V110, P1231, DOI 10.1002/bit.24782; Wollenberg LA, 2014, APPL BIOCHEM BIOTECH, V172, P1293, DOI 10.1007/s12010-013-0537-z; Wu FJ, 1996, BIOTECHNOL BIOENG, V52, P34, DOI 10.1002/(SICI)1097-0290(19961005)52:1<34::AID-BIT4>3.0.CO;2-#; Yang Y, 2013, BIOTECHNOL BIOENG, V110, P958, DOI 10.1002/bit.24752; Zhao F, 2005, BIOTECHNOL PROGR, V21, P1269, DOI 10.1021/bp0500664	44	17	20	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147376	10.1371/journal.pone.0147376	http://dx.doi.org/10.1371/journal.pone.0147376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840840	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200035
J	Nair, ADS; Cheng, C; Ganta, CK; Sanderson, MW; Alleman, AR; Munderloh, UG; Ganta, RR				Nair, Arathy D. S.; Cheng, Chuanmin; Ganta, Chanran K.; Sanderson, Michael W.; Alleman, Arthur R.; Munderloh, Ulrike G.; Ganta, Roman R.			Comparative Experimental Infection Study in Dogs with Ehrlichia canis, E. chaffeensis, Anaplasma platys and A. phagocytophilum	PLOS ONE			English	Article							SERUM ANTIPLATELET ANTIBODIES; MONOCYTIC EHRLICHIOSIS; CYCLIC THROMBOCYTOPENIA; HUMORAL IMMUNITY; NESTED PCR; DISEASES; ASSAY; LYMPHOCYTOSIS; COINFECTION; DIAGNOSIS	Dogs acquire infections with the Anaplasmataceae family pathogens, E. canis, E. chaffeensis, E. ewingii, A. platys and A. phagocytophilum mostly during summer months when ticks are actively feeding on animals. These pathogens are also identified as causing diseases in people. Despite the long history of tick-borne diseases in dogs, much remains to be defined pertaining to the clinical and pathological outcomes of infections with these pathogens. In the current study, we performed experimental infections in dogs with E. canis, E. chaffeensis, A. platys and A. phagocytophilum. Animals were monitored for 42 days to evaluate infection-specific clinical, hematological and pathological differences. All four pathogens caused systemic persistent infections detectible throughout the 6 weeks of infection assessment. Fever was frequently detected in animals infected with E. canis, E. chaffeensis, and A. platys, but not in dogs infected with A. phagocytophilum. Hematological differences were evident in all four infected groups, although significant overlap existed between the groups. A marked reduction in packed cell volume that correlated with reduced erythrocytes and hemoglobin was observed only in E. canis infected animals. A decline in platelet numbers was common with E. canis, A. platys and A. phagocytophilum infections. Histopathological lesions in lung, liver and spleen were observed in all four groups of infected dogs; infection with E. canis had the highest pathological scores, followed by E. chaffeensis, then A. platys and A. phagocytophilum. All four pathogens induced IgG responses starting on day 7 post infection, which was predominantly comprised of IgG2 subclass antibodies. This is the first detailed investigation comparing the infection progression and host responses in dogs after inoculation with four pathogens belonging to the Anaplasmataceae family. The study revealed a significant overlap in clinical, hematological and pathological changes resulting from the infections.	[Nair, Arathy D. S.; Cheng, Chuanmin; Sanderson, Michael W.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA; [Ganta, Chanran K.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA; [Alleman, Arthur R.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN USA	Kansas State University; Kansas State University; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities	Ganta, RR (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			PHS from the National Institute of Allergy and Infectious Diseases [AI070908]; Abaxis Inc., Union City, CA; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	PHS from the National Institute of Allergy and Infectious Diseases; Abaxis Inc., Union City, CA; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PHS grant # AI070908 from the National Institute of Allergy and Infectious Diseases, https://projectreporter.nih.gov/project_info_details.cfm?aid=8900898&icde=27122417&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC. The project also received funding from the Abaxis Inc., Union City, CA; http://www.abaxis.com/. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The authors declare that the funder had no role in guiding or evaluating their research or preparing this manuscript.	Beall MJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-29; Chang WL, 1996, J CLIN MICROBIOL, V34, P3142, DOI 10.1128/JCM.34.12.3142-3146.1996; Chang WL, 1997, J VET MED SCI, V59, P849, DOI 10.1292/jvms.59.849; Dawson JE, 1996, J PARASITOL, V82, P52, DOI 10.2307/3284115; de Castro MB, 2004, VET PARASITOL, V119, P73, DOI 10.1016/j.vetpar.2003.10.012; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; DUMLER JS, 1991, NEW ENGL J MED, V325, P1109, DOI 10.1056/NEJM199110103251517; Eberts MD, 2011, J AM ANIM HOSP ASSOC, V47, pE86, DOI 10.5326/JAAHA-MS-5578; FRENCH TW, 1983, AM J VET RES, V44, P2407; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Gaunt SD, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-33; Greene C.E., 2006, INFECT DIS DOG CAT; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Harrus S, 1996, VET IMMUNOL IMMUNOP, V51, P13, DOI 10.1016/0165-2427(95)05516-9; HARVEY JW, 1978, J INFECT DIS, V137, P182, DOI 10.1093/infdis/137.2.182; Heeb HL, 2003, J AM ANIM HOSP ASSOC, V39, P379, DOI 10.5326/0390379; Hess PR, 2006, VET IMMUNOL IMMUNOP, V109, P117, DOI 10.1016/j.vetimm.2005.07.027; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jouret-Gourjault S, 2006, ANN NY ACAD SCI, V89, P470; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Little SE, 2014, PARASITE VECTOR, V7, P1756; Little SE, 2010, VET CLIN N AM-SMALL, V40, P1121, DOI 10.1016/j.cvsm.2010.07.004; Maggi RG, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-103; Massung RF, 1998, J CLIN MICROBIOL, V36, P1090, DOI 10.1128/JCM.36.4.1090-1095.1998; Nair AD, 2015, INFECT IMMUN, V27, P00487; Nair ADS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109056; Nicholson WL, 2010, TRENDS PARASITOL, V26, P205, DOI 10.1016/j.pt.2010.01.007; O'Connor TP, 2006, AM J VET RES, V67, P206, DOI 10.2460/ajvr.67.2.206; Paddock CD, 1997, J CLIN MICROBIOL, V35, P2496, DOI 10.1128/JCM.35.10.2496-2502.1997; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Perez M, 2006, ANN NY ACAD SCI, V1078, P110, DOI 10.1196/annals.1374.016; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; RIKIHISA Y, 1994, J CLIN MICROBIOL, V32, P2107, DOI 10.1128/JCM.32.9.2107-2112.1994; Rotondano TE, 2012, SCI WORLD J, P22; Saito TB, 2015, J INFECT DIS, V211, P452, DOI 10.1093/infdis/jiu372; SAMBROOK J, 2000, MOL CLONING LAB MANU; Scorpio DG, 2011, VECTOR-BORNE ZOONOT, V11, P223, DOI 10.1089/vbz.2009.0262; Sehdev AES, 2003, AM J CLIN PATHOL, V119, P859, DOI 10.1309/F7EAB5P7321716LJ; Shaw SE, 2001, TRENDS PARASITOL, V17, P74, DOI 10.1016/S1471-4922(00)01856-0; Starkey LA, 2015, J VET INTERN MED, V29, P552, DOI 10.1111/jvim.12567; Unver A, 2009, CLIN MICROBIOL INFEC, V15, P59, DOI 10.1111/j.1469-0691.2008.02634.x; WANER T, 1995, VET IMMUNOL IMMUNOP, V48, P177, DOI 10.1016/0165-2427(95)05420-B; Waner T, 2001, VET PARASITOL, V95, P1, DOI 10.1016/S0304-4017(00)00407-6; WEISER MG, 1991, J AM ANIM HOSP ASSOC, V27, P84; Wen BH, 1997, J CLIN MICROBIOL, V35, P1852, DOI 10.1128/JCM.35.7.1852-1855.1997; Winslow GM, 2003, ANN NY ACAD SCI, V990, P435, DOI 10.1111/j.1749-6632.2003.tb07408.x; Winslow GM, 2000, INFECT IMMUN, V68, P2187, DOI 10.1128/IAI.68.4.2187-2195.2000; WOODY BJ, 1991, VET CLIN N AM-SMALL, V21, P75, DOI 10.1016/S0195-5616(91)50009-7; Yabsley MJ, 2010, VET PARASITOL, V167, P136, DOI 10.1016/j.vetpar.2009.09.015; Yager E, 2005, INFECT IMMUN, V73, P8009, DOI 10.1128/IAI.73.12.8009-8016.2005; Zhang XF, 2003, J MED MICROBIOL, V52, P1021, DOI 10.1099/jmm.0.05234-0	51	33	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148239	10.1371/journal.pone.0148239	http://dx.doi.org/10.1371/journal.pone.0148239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840398	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200107
J	Sahraoui, A; Dewachter, C; de Medina, G; Naeije, R; Bouguerra, SA; Dewachter, L				Sahraoui, Abdelhamid; Dewachter, Celine; de Medina, Geoffrey; Naeije, Robert; Bouguerra, Souhila Aouichat; Dewachter, Laurence			Myocardial Structural and Biological Anomalies Induced by High Fat Diet in Psammomys obesus Gerbils	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEART-FAILURE; DIABETIC CARDIOMYOPATHY; MOUSE MODEL; RAT-HEART; OBESITY; CHOLESTEROL; EXPRESSION; INFARCTION; DISEASE	Background Psammomys obesus gerbils are particularly prone to develop diabetes and obesity after brief period of abundant food intake. A hypercaloric high fat diet has been shown to affect cardiac function. Here, we sought to determine whether a short period of high fat feeding might alter myocardial structure and expression of calcium handling proteins in this particular strain of gerbils. Methods Twenty Psammomys obesus gerbils were randomly assigned to receive a normal plant diet (controls) or a high fat diet. At baseline and 16-week later, body weight, plasma biochemical parameters (including lipid and carbohydrate levels) were evaluated. Myocardial samples were collected for pathobiological evaluation. Results Sixteen-week high fat dieting resulted in body weight gain and hyperlipidemia, while levels of carbohydrates remained unchanged. At myocardial level, high fat diet induced structural disorganization, including cardiomyocyte hypertrophy, lipid accumulation, interstitial and perivascular fibrosis and increased number of infiltrating neutrophils. Myocardial expressions of pro-apoptotic Bax-to-Bcl-2 ratio, pro-inflammatory cytokines [interleukin (IL)-1 beta and tumor necrosis factor (TNF)-alpha], intercellular (ICAM1) and vascular adhesion molecules (VCAM1) increased, while gene encoding cardiac muscle protein, the alpha myosin heavy polypeptide (MYH6), was downregulated. Myocardial expressions of sarco(endo)plasmic calcium-ATPase (SERCA2) and voltage-dependent calcium channel (Cacna1c) decreased, while protein kinase A (PKA) and calcium-calmodulin-dependent protein kinase (CaMK2D) expressions increased. Myocardial expressions of ryanodine receptor, phospholamban and sodium/calcium exchanger (Slc8a1) did not change. Conclusions We conclude that a relative short period of high fat diet in Psammomys obesus results in severe alterations of cardiac structure, activation of inflammatory and apoptotic processes, and altered expression of calcium-cycling determinants.	[Sahraoui, Abdelhamid; Dewachter, Celine; de Medina, Geoffrey; Naeije, Robert; Dewachter, Laurence] Univ Libre Bruxelles, Fac Med, Lab Physiol & Pharmacol, Brussels, Belgium; [Sahraoui, Abdelhamid; Bouguerra, Souhila Aouichat] Houari Boumediene Univ Sci & Technol, Fac Biol Sci, Team Cellular & Mol Physiopathol, Algiers, Algeria	Universite Libre de Bruxelles; University Science & Technology Houari Boumediene	Dewachter, L (corresponding author), Univ Libre Bruxelles, Fac Med, Lab Physiol & Pharmacol, Brussels, Belgium.	ldewacht@ulb.ac.be		Aouichat, Souhila/0000-0002-1079-6722	Fonds de la Recherche Scientifique Medicale [3.4637.09]; Belgian Foundation for Cardiac Surgery; "Fonds National de la Recherche Scientifique" (FNRS); FNRS	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian Foundation for Cardiac Surgery; "Fonds National de la Recherche Scientifique" (FNRS)(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS)	The present work was supported by grants from the "Fonds de la Recherche Scientifique Medicale" (grant number 3.4637.09), the Belgian Foundation for Cardiac Surgery. CD was supported by the "Fonds National de la Recherche Scientifique" (FNRS) as a doctoral fellow ("Aspirant FNRS"; Belgium). LD was supported by a FNRS postdoctoral fellow ("Chargee de Recherches"; Belgium).	Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Begieneman MPV, 2008, HEART, V94, P450, DOI 10.1136/hrt.2007.118638; Bouguerra S A, 2001, Int J Exp Diabetes Res, V2, P37, DOI 10.1155/EDR.2001.37; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Clark C, 2011, PHYSIOL RES, V60, P291, DOI 10.33549/physiolres.931999; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; CLEUTJENS JPM, 1995, AM J PATHOL, V147, P325; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Dewachter L, 2009, EUR RESPIR J, V34, P1100, DOI 10.1183/09031936.00183008; DILLMANN WH, 1984, MOL CELL ENDOCRINOL, V34, P169, DOI 10.1016/0303-7207(84)90173-4; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Flagg TP, 2009, CIRC RES, V104, P95, DOI 10.1161/CIRCRESAHA.108.186809; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; Herron TJ, 2001, CIRC RES, V89, P1184, DOI 10.1161/hh2401.101908; Howell WH, 1997, AM J CLIN NUTR, V65, P1747, DOI 10.1093/ajcn/65.6.1747; KALDERON B, 1986, DIABETES, V35, P717, DOI 10.2337/diabetes.35.6.717; KAWAKAMI K, 1989, CLIN CHIM ACTA, V185, P147, DOI 10.1016/0009-8981(89)90037-5; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kiang JG, 2006, CHINESE J PHYSIOL, V49, P223; KINOSIAN B, 1995, J INVEST MED, V43, P443; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lebeche D, 2008, NAT CLIN PRACT CARD, V5, P715, DOI 10.1038/ncpcardio1347; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; Lin JHC, 1996, ATHEROSCLEROSIS, V127, P185, DOI 10.1016/S0021-9150(96)05951-5; Liu HR, 2009, CARDIOVASC RES, V81, P344, DOI 10.1093/cvr/cvn308; Lopaschuk GD, 2007, CIRC RES, V101, P335, DOI 10.1161/CIRCRESAHA.107.150417; MacLennan DH, 1998, ANN NY ACAD SCI, V853, P31, DOI 10.1111/j.1749-6632.1998.tb08254.x; Maier LS, 2005, BRAZ J MED BIOL RES, V38, P1293, DOI 10.1590/S0100-879X2005000900002; Mandavia CH, 2012, METABOLISM, V61, P1205, DOI 10.1016/j.metabol.2012.02.013; MARQUIE G, 1984, DIABETES, V33, P438, DOI 10.2337/diabetes.33.5.438; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; NEELY J R, 1972, Progress in Cardiovascular Diseases, V15, P289, DOI 10.1016/0033-0620(72)90029-1; Osborn S, 1860, CELLULAR PATHOLOGY B; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; PRITCHARD KA, 1991, ARTERIOSCLER THROMB, V11, P1175, DOI 10.1161/01.ATV.11.5.1175; Rider OJ, 2013, INT J OBESITY, V37, P972, DOI 10.1038/ijo.2012.170; Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111; Shafrir E, 2006, ILAR J, V47, P212, DOI 10.1093/ilar.47.3.212; Slater-Jefferies JL, 2010, PROSTAG LEUKOTR ESS, V83, P219, DOI 10.1016/j.plefa.2010.07.006; Slim RM, 1996, J AM COLL NUTR, V15, P289; Staiano RL, 2009, EUR J IMMUNOL, V39, P1405, DOI 10.1002/eji.200838792; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Sun YO, 1998, J MOL CELL CARDIOL, V30, P1559, DOI 10.1006/jmcc.1998.0721; Tsuji T, 2001, J CARDIOVASC PHARM, V38, P868, DOI 10.1097/00005344-200112000-00008; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Walder K, 2002, INT J OBESITY, V26, P605, DOI 10.1038/sj.ijo.0801965; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Wu CK, 2011, CRIT CARE MED, V39, P984, DOI 10.1097/CCM.0b013e31820a91b9; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	56	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148117	10.1371/journal.pone.0148117	http://dx.doi.org/10.1371/journal.pone.0148117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840416	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200082
J	Yang, QY; Wang, R; Xiao, WF; Sun, FY; Yuan, H; Pan, QH				Yang, Qingyuan; Wang, Rui; Xiao, Weifan; Sun, Fenyong; Yuan, Hong; Pan, Qiuhui			Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor	PLOS ONE			English	Article							EXPRESSION; CRABP2; CANCER; PROLIFERATION; METASTASIS; GROWTH	Esophageal squamous cell carcinoma (ESCC) is the predominant pathotype of esophageal carcinoma (EC) in China, especially in Henan province, with poor prognosis and limited 5-year survival rate. Cellular retinoic acid binding protein 2 (CRABP2) is a member of the retinoic acid (RA) and lipocalin/cytosolic fatty-acid binding protein family and plays a completely contrary role in tumorigenesis through the retinoid signaling pathway, depending on the nuclear RA receptors (RAR) and PPARbeta/delta receptors. Presently, the biological role of CRABP2 in the development of ESCC has never been reported. Here, we firstly evaluated the expression of CRABP2 at both mRNA and protein levels and showed that it was remarkably downregulated in clinical ESCC tissues and closely correlated with the occurrence position, pathology, TNM stage, size, infiltration depth and cell differentiation of the tumor. Additionally, the biological function assays demonstrated that CRABP2 acted as a tumor suppressor in esophageal squamous carcinogenesis by significantly inhibiting cell growth, inducing cell apoptosis and blocking cell metastasis both in vitro and in vivo. All in all, our finding simplicate that CRABP2 is possibly an efficient molecular marker for diagnosing and predicting the development of ESCC.	[Yang, Qingyuan; Wang, Rui; Sun, Fenyong] Tongji Univ, Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China; [Xiao, Weifan; Pan, Qiuhui] Tongji Univ, Peoples Hosp 10, Cent Lab, Shanghai 200072, Peoples R China; [Yuan, Hong] Dalian Med Univ, Affiliated Hosp 1, Dept Clin Lab Med, Tianjin 300070, Peoples R China	Tongji University; Tongji University; Dalian Medical University	Pan, QH (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Clin Lab Med, Tianjin 300070, Peoples R China.	yuanhonglab@163.com; sloganmore@163.com			National natural science foundation of China [81272292, 81371913, 81472624, 81472124, 81502425]; Shanghai Young Science and Technology Talents Sailing Program [15YF1409300]	National natural science foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Young Science and Technology Talents Sailing Program	Funding for this work came from National natural science foundation of China http://www.nsfc.gov.cn/ to Fenyong Sun and Qiuhui Pan, 81272292, 81371913, 81472624, 81472124, 81502425; and Shanghai Young Science and Technology Talents Sailing Program, to Qingyuan Yang, http://www.stcsm.gov.cn/, 15YF1409300.	Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Campos B, 2012, INT J CANCER, V131, P1963, DOI 10.1002/ijc.27446; Delva L, 1999, MOL CELL BIOL, V19, P7158; Favorskaya I, 2014, TUMOR BIOL, V35, P10295, DOI 10.1007/s13277-014-2348-4; Geiger T, 2012, CANCER RES, V72, P2428, DOI 10.1158/0008-5472.CAN-11-3711; Gupta S, 2012, CLIN CANCER RES, V18, P280, DOI 10.1158/1078-0432.CCR-11-2165; Mallikarjuna K, 2010, PROTEOM CLIN APPL, V4, P449, DOI 10.1002/prca.200900069; McEwan J, 2011, DEV DYNAM, V240, P1259, DOI 10.1002/dvdy.22555; Nakajima M, 2013, EXPERT OPIN PHARMACO, V14, P1345, DOI 10.1517/14656566.2013.801454; Okuducu AF, 2005, INT J ONCOL, V27, P1273; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Stachurska E, 2011, ACTA BIOCHIM POL, V58, P19; Takahashi M, 2002, CANCER RES, V62, P6598; Tang YL, 2015, INT J CLIN EXP PATHO, V8, P11224; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uchikado Y, 2006, INT J ONCOL, V29, P1337; Vreeland AC, 2014, J BIOL CHEM, V289, P34065, DOI 10.1074/jbc.M114.604041; Vreeland AC, 2014, MOL CELL BIOL, V34, P2135, DOI 10.1128/MCB.00281-14; Wang JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042281; Xiao WB, 2014, HUM PATHOL, V45, P1177, DOI 10.1016/j.humpath.2014.01.014; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang QY, 2014, CARCINOGENESIS, V35, P1643, DOI 10.1093/carcin/bgu084; Yang QY, 2014, J CHEMOTHERAPY, V26, P235, DOI 10.1179/1973947813Y.0000000138; Yuan J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055479, 10.4161/psb.25026]; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598	27	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148381	10.1371/journal.pone.0148381	http://dx.doi.org/10.1371/journal.pone.0148381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839961	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200130
J	Ceolin, L; Romitti, M; Siqueira, DR; Ferreira, CV; Scapineli, JO; Assis-Brazil, B; Maximiano, RV; Amarante, TD; Nunes, MCD; Weber, G; Maia, AL				Ceolin, Lucieli; Romitti, Mirian; Siqueira, Debora Rodrigues; Ferreira, Carla Vaz; Scapineli, Jessica Oliboni; Assis-Brazil, Beatriz; Maximiano, Rodolfo Vieira; Amarante, Tauanne Dias; de Souza Nunes, Miriam Celi; Weber, Gerald; Maia, Ana Luiza			Effect of 3 ' UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma	PLOS ONE			English	Article							HIRSCHSPRUNG-DISEASE; SOMATIC MUTATIONS; SEQUENCE VARIANT; FOLLOW-UP; PROTOONCOGENE; POLYMORPHISMS; CANCER; GENE; HAPLOTYPES; S836S	Background The RET S836S variant has been associated with early onset and increased risk for metastatic disease in medullary thyroid carcinoma (MTC). However, the mechanism by which this variant modulates MTC pathogenesis is still open to discuss. Of interest, strong linkage disequilibrium (LD) between RET S836S and 3'UTR variants has been reported in Hirschsprung's disease patients. Objective To evaluate the frequency of the RET 3' UTR variants (rs76759170 and rs3026785) in MTC patients and to determine whether these variants are in LD with S836S polymorphism. Methods Our sample comprised 152 patients with sporadic MTC. The RET S836S and 3' UTR (rs76759170 and rs3026785) variants were genotyped using Custom TaqMan Genotyping Assays. Haplotypes were inferred using the phase 2.1 program. RET mRNA structure was assessed by Vienna Package. Results The mean age of MTC diagnosis was 48.5+/-15.5 years and 57.9% were women. The minor allele frequencies of RET polymorphisms were as follows: S836S, 5.6%; rs76759170, 5.6%; rs3026785, 6.2%. We observed a strong LD among S836S and 3' UTR variants (|D'| = -1, r(2) = 1 and |D'| = -1, r2 = 0,967). Patients harboring the S836S/3' UTR variants presented a higher percentage of lymph node and distant metastasis (P = 0.013 and P<0.001, respectively). Accordingly, RNA folding analyses demonstrated different RNA secondary structure predictions for WT(TCCGT), S836S(TTCGT) or 3' UTR(GTCAC) haplotypes. The S836S/3' UTR haplotype presented a greater number of double helices sections and lower levels of minimal free energy when compared to the wild-type haplotype, suggesting that these variants provides the most thermodynamically stable mRNA structure, which may have functional consequences on the rate of mRNA degradation. Conclusion The RET S836S polymorphism is in LD with 3' UTR variants. In silico analysis indicate that the 3' UTR variants may affect the secondary structure of RET mRNA, suggesting that these variants might play a role in posttranscriptional control of the RET transcripts.	[Ceolin, Lucieli; Romitti, Mirian; Siqueira, Debora Rodrigues; Ferreira, Carla Vaz; Scapineli, Jessica Oliboni; Maia, Ana Luiza] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Thyroid Sect, Porto Alegre, RS, Brazil; [Assis-Brazil, Beatriz] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Dept Pathol, Porto Alegre, RS, Brazil; [Maximiano, Rodolfo Vieira; Amarante, Tauanne Dias; de Souza Nunes, Miriam Celi; Weber, Gerald] Univ Fed Minas Gerais, Computat Biophys Grp, Dept Phys, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Minas Gerais	Maia, AL (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Thyroid Sect, Porto Alegre, RS, Brazil.	almaia@ufrgs.br	Weber, Gerald/A-8669-2010; Maia, Ana Luiza/F-9201-2012; CEOLIN, LUCIELI/U-5261-2019	Weber, Gerald/0000-0002-2935-1571; Maia, Ana Luiza/0000-0002-4186-5532; Ceolin, Lucieli/0000-0001-6794-6042; Dias Amarante, Tauanne/0000-0002-1999-9753	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio a Pesquisa do Rio Grande do Sul (FAPERGS); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE), Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE), Brazil	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Apoio a Pesquisa do Rio Grande do Sul (FAPERGS), and Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE), Brazil.	Asai N, 2006, PATHOL INT, V56, P164, DOI 10.1111/j.1440-1827.2006.01942.x; Attie Tania, 1994, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V188, P499; Berard I, 2004, CLIN GENET, V65, P150, DOI 10.1111/j.0009-9163.2004.00172.x; Borrego S, 2003, AM J HUM GENET, V72, P88, DOI 10.1086/345466; Borrego S, 1999, J MED GENET, V36, P771, DOI 10.1136/jmg.36.10.771; Brondani LA, 2012, INVEST OPHTH VIS SCI, V53, P7449, DOI 10.1167/iovs.12-10660; Ceolin L, 2012, EUR J ENDOCRINOL, V166, P847, DOI 10.1530/EJE-11-1060; Ceolin L, 2012, INT J MOL SCI, V13, P221, DOI 10.3390/ijms13010221; Clark JR, 2005, LARYNGOSCOPE, V115, P1445, DOI 10.1097/01.mlg.0000168114.90852.a6; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; de Silanes IL, 2007, CELL ONCOL, V29, P1; Ding Y, 2006, RNA, V12, P323, DOI 10.1261/rna.2274106; Elisei R, 2004, J CLIN ENDOCR METAB, V89, P3579, DOI 10.1210/jc.2003-031898; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P682, DOI 10.1210/jc.2007-1714; Eng C, 1998, J CLIN ENDOCR METAB, V83, P4310, DOI 10.1210/jc.83.12.4310; ENG C, 1995, GENE CHROMOSOME CANC, V12, P209, DOI 10.1002/gcc.2870120308; Fernandez RM, 2006, THYROID, V16, P411, DOI 10.1089/thy.2006.16.411; Figlioli G, 2013, MUTAT RES-REV MUTAT, V752, P36, DOI 10.1016/j.mrrev.2012.09.002; Fitze G, 2003, HUM MOL GENET, V12, P3207, DOI 10.1093/hmg/ddg354; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; Gimm O, 1999, ONCOGENE, V18, P1369, DOI 10.1038/sj.onc.1202418; Griseri P, 2005, HUM MUTAT, V25, P189, DOI 10.1002/humu.20135; Griseri P, 2000, EUR J HUM GENET, V8, P721, DOI 10.1038/sj.ejhg.5200521; Griseri P, 2002, AM J HUM GENET, V71, P969, DOI 10.1086/342774; Griseri P, 2007, HUM MUTAT, V28, P168, DOI 10.1002/humu.20397; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HEDRICK PW, 1987, J HERED, V78, P204, DOI 10.1093/oxfordjournals.jhered.a110358; Lantieri F, 2006, ANN HUM GENET, V70, P12, DOI 10.1111/j.1529-8817.2005.00196.x; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lou F, 2010, BIOINFORMATICS, V26, pi278, DOI 10.1093/bioinformatics/btq218; LYONNET S, 1994, CR ACAD SCI III-VIE, V317, P358; Maia AL, 2014, ARQ BRAS ENDOCRINOL, V58, P667, DOI 10.1590/0004-2730000003427; Marsh DJ, 1996, CLIN ENDOCRINOL, V44, P249, DOI 10.1046/j.1365-2265.1996.681503.x; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; MYERS SM, 1995, ONCOGENE, V11, P2039; O'Sullivan Brian, 2003, Semin Surg Oncol, V21, P30, DOI 10.1002/ssu.10019; Pelizzo MR, 2007, EJSO-EUR J SURG ONC, V33, P493, DOI 10.1016/j.ejso.2006.10.021; Richardson DS, 2012, MOL BIOL CELL, V23, P3838, DOI 10.1091/mbc.E12-02-0114; Romei C, 1996, J CLIN ENDOCR METAB, V81, P1619, DOI 10.1210/jc.81.4.1619; Ruiz A, 2001, CLIN ENDOCRINOL, V55, P399, DOI 10.1046/j.1365-2265.2001.01328.x; SANTORO M, 1990, ONCOGENE, V5, P1595; Sharma BP, 2011, J BIOSCIENCES, V36, P603, DOI 10.1007/s12038-011-9095-0; Siqueira DR, 2010, ENDOCR-RELAT CANCER, V17, P953, DOI 10.1677/ERC-09-0312; Siqueira DR, 2014, EUR J ENDOCRINOL, V170, P821, DOI 10.1530/EJE-14-0084; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamanaha R, 2009, CLIN ENDOCRINOL, V71, P56, DOI 10.1111/j.1365-2265.2008.03491.x; Wells Jr SA, 2015, THYROID; Wohllk N, 2005, REV MED CHILE, V133	48	6	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147840	10.1371/journal.pone.0147840	http://dx.doi.org/10.1371/journal.pone.0147840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829565	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200036
J	Juhl, K; Christensen, A; Persson, M; Ploug, M; Kjaer, A				Juhl, Karina; Christensen, Anders; Persson, Morten; Ploug, Michael; Kjaer, Andreas			Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; UROKINASE RECEPTOR; SURGICAL MARGINS; CANCER; PET; LOCALIZATION; EXPRESSION; ANTIBODIES	Near infrared intra-operative optical imaging is an emerging technique with clear implications for improved cancer surgery by enabling a more distinct delineation of the tumor margins during resection. This modality has the potential to increase the number of patients having a curative radical tumor resection. In the present study, a new uPAR-targeted fluorescent probe was developed and the in vivo applicability was evaluated in a human xenograft mouse model. Most human carcinomas express high level of uPAR in the tumor-stromal interface of invasive lesions and uPAR is therefore considered an ideal target for intra-operative imaging. Conjugation of the flourophor indocyanine green (ICG) to the uPAR agonist (AE105) provides an optical imaging ligand with sufficiently high receptor affinity to allow for a specific receptor targeting in vivo. For in vivo testing, human glioblastoma xenograft mice were subjected to optical imaging after i.v. injection of ICG-AE105, which provided an optimal contrast in the time window 6-24 h post injection. Specificity of the uPAR-targeting probe ICG-AE105 was demonstrated in vivo by 1) no uptake of unconjugated ICG after 15 hours, 2) inhibition of ICG-AE105 tumor uptake by a bolus injection of the natural uPAR ligand pro-uPA, and finally 3) the histological colocalization of ICG-AE105 fluorescence and immunohistochemical detected human uPAR on resected tumor slides. Taken together, our data supports the potential use of this probe for intra-operative optical guidance in cancer surgery to ensure complete removal of tumors while preserving adjacent, healthy tissue.	[Juhl, Karina; Christensen, Anders; Persson, Morten; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Juhl, Karina; Christensen, Anders; Persson, Morten; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Juhl, Karina; Christensen, Anders; Persson, Morten; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Christensen, Anders] Rigshosp, Dept Otolaryngol Head & Neck Surg & Audiol, DK-2100 Copenhagen, Denmark; [Ploug, Michael] Rigshosp, Finsen Lab, Strandboulevarden 49, DK-2100 Copenhagen, Denmark; [Ploug, Michael] Univ Copenhagen, BRIC, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kjaer, A (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark.; Kjaer, A (corresponding author), Rigshosp, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark.; Kjaer, A (corresponding author), Univ Copenhagen, Copenhagen, Denmark.	akjaer@sund.ku.dk	; Kjaer, Andreas/E-8932-2015	Ploug, Michael/0000-0003-2215-4265; Kjaer, Andreas/0000-0002-2706-5547	Lundbeck Foundation [R198-2015-1107] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0007149] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)		Alander JT, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/940585; Atallah I, 2015, HEAD NECK; Atkins J, 2012, J SURG RES, V177, P109, DOI 10.1016/j.jss.2012.03.045; Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707; Boonstra MC, 2015, ONCOTARGET; Cozzi PJ, 2006, HUM PATHOL, V37, P1442, DOI 10.1016/j.humpath.2006.05.002; Crane LMA, 2011, GYNECOL ONCOL, V120, P291, DOI 10.1016/j.ygyno.2010.10.009; Day KE, 2013, MOL IMAGING BIOL; Dullin C, 2009, MOL IMAGING, V8, P2, DOI 10.2310/7290.2009.00001; Eldeeb Hany, 2012, Cancer Biology Medicine, V9, P29, DOI 10.3969/j.issn.2095-3941.2012.01.005; Foekens JA, 2000, CANCER RES, V60, P636; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Hansen L, 2013, NANOSCALE, V5, P8192, DOI 10.1039/c3nr32922d; Hutteman M, 2011, EJSO-EUR J SURG ONC, V37, P252, DOI 10.1016/j.ejso.2010.12.014; Keereweer S, 2013, CLIN CANCER RES, V19, P3745, DOI 10.1158/1078-0432.CCR-12-3598; Keereweer S, 2011, MOL IMAGING BIOL, V13, P199, DOI 10.1007/s11307-010-0373-2; LeBeau AM, 2014, THERANOSTICS, V4, P267, DOI 10.7150/thno.7323; LeBeau AM, 2015, IMAGING ACTIVE UROKI; Li ZB, 2008, CLIN CANCER RES, V14, P4758, DOI 10.1158/1078-0432.CCR-07-4434; Liu DJ, 2009, BIOCONJUGATE CHEM, V20, P888, DOI 10.1021/bc800433y; Marshall Milton V, 2010, Open Surg Oncol J, V2, P12; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Nguyen QT, 2013, FLUORESCENCE GUIDED, P1; Noh H, 2013, THERANOSTICS, V3, P487, DOI 10.7150/thno.4218; Ogawa M, 2009, BIOCONJUGATE CHEM, V20, P2177, DOI 10.1021/bc900362k; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Persson M, 2015, THERANOSTICS; Persson M, 2013, CLIN PHYSIOL FUNCT I, V33, P329, DOI 10.1111/cpf.12037; Persson M, 2013, NUCL MED BIOL, V40, P618, DOI 10.1016/j.nucmedbio.2013.03.001; Persson M, 2012, NUCL MED BIOL, V39, P560, DOI 10.1016/j.nucmedbio.2011.10.011; Persson M, 2012, J NUCL MED, V53, P138, DOI 10.2967/jnumed.110.083386; Ploug M, 2001, BIOCHEMISTRY-US, V40, P12157, DOI 10.1021/bi010662g; Ploug M, 2013, THERANOSTICS, V3, P467, DOI 10.7150/thno.3791; Pogue BW, 2010, IEEE J SEL TOP QUANT, V16, P493, DOI 10.1109/JSTQE.2009.2034541; RONNE E, 1995, BREAST CANCER RES TR, V33, P199, DOI 10.1007/BF00665944; Rosenthal EL, 2015, ANN SURG, V261, P46, DOI 10.1097/SLA.0000000000000622; Rosenthal EL, 2015, CLIN CANC RES; Sano K, 2013, BIOCONJUGATE CHEM, V24, P811, DOI 10.1021/bc400050k; Sun CL, 2014, BIOTECHNOL LETT, V36, P1203, DOI 10.1007/s10529-014-1478-5; Swindle P, 2005, J UROLOGY, V174, P903, DOI 10.1097/01.ju.0000169475.00949.78; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van Driel PBAA, 2014, INT J CANCER, V134, P2663, DOI 10.1002/ijc.28601; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Yang LL, 2014, THERANOSTICS, V4, P106, DOI 10.7150/thno.7409	47	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147428	10.1371/journal.pone.0147428	http://dx.doi.org/10.1371/journal.pone.0147428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828431	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200020
J	Kamma-Lorger, CS; Pinali, C; Martinez, JC; Harris, J; Young, RD; Bredrup, C; Crosas, E; Malfois, M; Rodahl, E; Meek, KM; Knupp, C				Kamma-Lorger, Christina S.; Pinali, Christian; Carlos Martinez, Juan; Harris, Jon; Young, Robert D.; Bredrup, Cecilie; Crosas, Eva; Malfois, Marc; Rodahl, Eyvind; Meek, Keith M.; Knupp, Carlo			Role of Decorin Core Protein in Collagen Organisation in Congenital Stromal Corneal Dystrophy (CSCD)	PLOS ONE			English	Article							BINDING FORCE; FAMILY; MUTATION; TOMOGRAPHY; PROTEOGLYCANS	The role of Decorin in organising the extracellular matrix was examined in normal human corneas and in corneas from patients with Congenital Stromal Corneal Dystrophy (CSCD). In CSCD, corneal clouding occurs due to a truncating mutation (c.967delT) in the decorin (DCN) gene. Normal human Decorin protein and the truncated one were reconstructed in silico using homology modelling techniques to explore structural changes in the diseased protein. Corneal CSCD specimens were also examined using 3-D electron tomography and Small Angle X-ray diffraction (SAXS), to image the collagen-proteoglycan arrangement and to quantify fibrillar diameters, respectively. Homology modelling showed that truncated Decorin had a different spatial geometry to the normal one, with the truncation removing a major part of the site that interacts with collagen, compromising its ability to bind effectively. Electron tomography showed regions of abnormal stroma, where collagen fibrils came together to form thicker fibrillar structures, showing that Decorin plays a key role in the maintenance of the order in the normal corneal extracellular matrix. Average diameter of individual fibrils throughout the thickness of the cornea however remained normal.	[Kamma-Lorger, Christina S.; Carlos Martinez, Juan; Crosas, Eva; Malfois, Marc] ALBA Synchrotron Light Source, NCD BL11, Barcelona 08290, Spain; [Kamma-Lorger, Christina S.; Pinali, Christian; Harris, Jon; Young, Robert D.; Meek, Keith M.; Knupp, Carlo] Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF24 4HQ, S Glam, Wales; [Bredrup, Cecilie; Rodahl, Eyvind] Haukeland Hosp, Dept Ophthalmol, N-5021 Bergen, Norway; [Rodahl, Eyvind] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway	Cardiff University; University of Bergen; Haukeland University Hospital; University of Bergen	Kamma-Lorger, CS (corresponding author), ALBA Synchrotron Light Source, NCD BL11, Barcelona 08290, Spain.; Kamma-Lorger, CS (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Struct Biophys Res Grp, Cardiff CF24 4HQ, S Glam, Wales.	ckamma@cells.es	Bredrup, Cecilie/GPK-4303-2022; Malfois, Marc/L-2974-2014; Martinez Guil, Juan Carlos/R-6601-2018	Malfois, Marc/0000-0001-5231-1896; Martinez Guil, Juan Carlos/0000-0003-2411-5446; Pinali, Christian/0000-0001-9815-6940; Young, Robert D./0000-0002-1452-6682	Medical Research Council [G0600755, MR/K000837/1]; Biotechnology and Biological Sciences Research Council [BB/F022077]; MRC [MR/K000837/1, G0600755] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The project was supported by Medical Research Council 5-year programme grants G0600755 and MR/K000837/1 (www.mrc.ac.uk) and a Biotechnology and Biological Sciences Research Council research grant BB/F022077 (www.bbsrc.ac.uk) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; Banerjee-Basu S, 2001, Methods Biochem Anal, V43, P253; Boote C, 2011, BIOPHYS J, V101, P33, DOI 10.1016/j.bpj.2011.05.029; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Bredrup C, 2010, INVEST OPHTH VIS SCI, V51, P5578, DOI 10.1167/iovs.09-4933; Chaudhari MI, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3521484; Chen S, 2014, MATRIX BIOL, V35, P103, DOI 10.1016/j.matbio.2014.01.004; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cousins KR, 2011, J AM CHEM SOC, V133, P8388, DOI 10.1021/ja204075s; D'Alfonso G, 2001, J STRUCT BIOL, V134, P246, DOI 10.1006/jsbi.2001.4351; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hocking AM, 1998, MATRIX BIOL, V17, P1; Islam M, 2014, J BIOL CHEM, V288, P35526; Jing Y, 2014, CORNEA, V33, P288, DOI 10.1097/ICO.0000000000000055; Jolles P., 1994, PROTEOGLYCANS; Kamma-Lorger CS, 2009, EXP EYE RES, V88, P953, DOI 10.1016/j.exer.2008.12.005; Kim JH, 2011, CORNEA, V30, P1473, DOI 10.1097/ICO.0b013e3182137788; KRANTZ DD, 1991, J BIOL CHEM, V266, P16801; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lewis PN, 2010, STRUCTURE, V18, P239, DOI 10.1016/j.str.2009.11.013; Maurice DM., 1957, J PHYSL, V136, P263; McEvoy FJ, 2007, VET RADIOL ULTRASOUN, V48, P528, DOI 10.1111/j.1740-8261.2007.00290.x; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; MEEK KM, 1986, COLLAGEN REL RES, V6, P203; Meek KM, 2001, PROG RETIN EYE RES, V20, P95, DOI 10.1016/S1350-9462(00)00016-1; Molecular Operating Environment (MOE), 2005, MOE US MAN; Nareyeck G, 2004, EUR J BIOCHEM, V271, P3389, DOI 10.1111/j.1432-1033.2004.04273.x; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Parfitt GJ, 2010, J STRUCT BIOL, V170, P392, DOI 10.1016/j.jsb.2010.01.019; Ress DB, 2004, STRUCTURE, V12, P1763, DOI 10.1016/j.str.2004.07.022; Rodahl E, 2006, AM J OPHTHALMOL, V142, P520, DOI 10.1016/j.ajo.2006.03.064; SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; Scott PG, 2006, J BIOMECH, V39, P1159, DOI 10.1016/j.jbiomech.2006.01.011; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Van Ginderdeuren R, 2002, CORNEA, V21, P118, DOI 10.1097/00003226-200201000-00025; Vesentini S, 2006, J BIOMECH, V39, P1160, DOI 10.1016/j.jbiomech.2006.01.013; Vesentini S, 2005, J BIOMECH, V38, P433, DOI 10.1016/j.jbiomech.2004.04.032; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Zubay G, 1998, BIOCHEMISTRY	44	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147948	10.1371/journal.pone.0147948	http://dx.doi.org/10.1371/journal.pone.0147948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828927	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200045
J	Lu, L; Pandey, AK; Houseal, MT; Mulligan, MK				Lu, Lu; Pandey, Ashutosh K.; Houseal, M. Trevor; Mulligan, Megan K.			The Genetic Architecture of Murine Glutathione Transferases	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; OPEN-ANGLE GLAUCOMA; HIPPOCAMPAL THETA RHYTHM; GENOME-WIDE ASSOCIATION; AGE-AT-ONSET; S-TRANSFERASE; OXIDATIVE STRESS; ELEVATED EXPRESSION; CELL-PROLIFERATION; SIGNALING PATHWAY	Glutathione S-transferase (GST) genes play a protective role against oxidative stress and may influence disease risk and drug pharmacokinetics. In this study, massive multiscalar trait profiling across a large population of mice derived from a cross between C57BL/6J (B6) and DBA2/J (D2)-the BXD family-was combined with linkage and bioinformatic analyses to characterize mechanisms controlling GST expression and to identify downstream consequences of this variation. Similar to humans, mice show a wide range in expression of GST family members. Variation in the expression of Gsta4, Gstt2, Gstz1, Gsto1, and Mgst3 is modulated by local expression QTLs (eQTLs) in several tissues. Higher expression of Gsto1 in brain and liver of BXD strains is strongly associated (P < 0.01) with inheritance of the B6 parental allele whereas higher expression of Gsta4 and Mgst3 in brain and liver, and Gstt2 and Gstz1 in brain is strongly associated with inheritance of the D2 parental allele. Allele-specific assays confirmed that expression of Gsto1, Gsta4, and Mgst3 are modulated by sequence variants within or near each gene locus. We exploited this endogenous variation to identify coexpression networks and downstream targets in mouse and human. Through a combined systems genetics approach, we provide new insight into the biological role of naturally occurring variants in GST genes.	[Lu, Lu; Pandey, Ashutosh K.; Houseal, M. Trevor; Mulligan, Megan K.] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38106 USA; [Lu, Lu] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Nantong University	Mulligan, MK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38106 USA.	mulliganmk@gmail.com		Mulligan, Megan/0000-0003-4909-635X	NIH [R01AA023774, R01ES022614]; Natural Science Foundation of China [30971591]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants R01AA023774 and R01ES022614, and a grant from the Natural Science Foundation of China (30971591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Nimer F, 2013, ANTIOXID REDOX SIGN, V18, P784, DOI 10.1089/ars.2011.4440; Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Alcivar A, 2003, ONCOGENE, V22, P291, DOI 10.1038/sj.onc.1206099; Aleksunes LM, 2012, DRUG METAB DISPOS, V40, P1366, DOI 10.1124/dmd.112.045112; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Amarillo IE, 2014, AM J MED GENET A, V164, P958, DOI 10.1002/ajmg.a.36393; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Ashbrook DG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-850; Ashton KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072278; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BAMMLER TK, 1994, BIOCHEM J, V298, P385, DOI 10.1042/bj2980385; Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Bernardini S, 2005, CLIN CHEM, V51, P944, DOI 10.1373/clinchem.2004.045955; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; BOARD PG, 1981, FEBS LETT, V124, P163, DOI 10.1016/0014-5793(81)80127-5; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Cai QL, 2014, TUMOR BIOL, V35, P247, DOI 10.1007/s13277-013-1030-6; Capurso C, 2010, REJUV RES, V13, P645, DOI 10.1089/rej.2010.1052; CHENEVIXTRENCH G, 1995, CARCINOGENESIS, V16, P1655, DOI 10.1093/carcin/16.7.1655; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Ching GY, 1999, J NEUROSCI, V19, P2974; Chowdhury UK, 2006, TOXICOL APPL PHARM, V216, P446, DOI 10.1016/j.taap.2006.06.014; Ciobanu DC, 2010, GENETICS, V184, P119, DOI 10.1534/genetics.109.107474; Coggan M, 1998, BIOCHEM J, V334, P617, DOI 10.1042/bj3340617; Coggan M, 2002, BIOCHEM J, V366, P323, DOI 10.1042/bj20011878; Coles BF, 2001, PHARMACOGENETICS, V11, P663, DOI 10.1097/00008571-200111000-00004; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Dasgupta S, 2013, CLIN CANCER RES, V19, P4621, DOI 10.1158/1078-0432.CCR-13-0585; Davalieva K, 2015, PROSTATE, V75, P1586, DOI 10.1002/pros.23034; Pinhel MAD, 2013, ARQ NEURO-PSIQUIAT, V71, P527, DOI 10.1590/0004-282X20130076; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Di Curzio DL, 2011, MAMM GENOME, V22, P209, DOI 10.1007/s00335-011-9315-9; Dickson TC, 2005, NEUROBIOL DIS, V18, P286, DOI 10.1016/j.nbd.2004.10.001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Dreyer J, 2004, J NEUROSCI, V24, P10454, DOI 10.1523/JNEUROSCI.2265-04.2004; Dumont M, 2009, FREE RADICAL BIO MED, V47, P1019, DOI 10.1016/j.freeradbiomed.2009.07.008; Dwivedi S, 2006, TOXICOLOGY, V218, P58, DOI 10.1016/j.tox.2005.10.012; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fernandez-Canon JM, 2002, MOL CELL BIOL, V22, P4943, DOI 10.1128/MCB.22.13.4943-4951.2002; Fernandez-Canon JM, 1999, GENOMICS, V58, P263, DOI 10.1006/geno.1999.5832; Fu ZD, 2014, TOXICOL APPL PHARM, V274, P137, DOI 10.1016/j.taap.2013.11.003; Gaier ED, 2014, ANN NY ACAD SCI, V1314, P15, DOI 10.1111/nyas.12378; Ghosh T, 2012, ASIAN J PSYCHIATR, V5, P160, DOI 10.1016/j.ajp.2012.02.023; Giffen PS, 2002, TOXICOL PATHOL, V30, P365, DOI 10.1080/01926230252929945; Goldman SM, 2012, MOVEMENT DISORD, V27, P1652, DOI 10.1002/mds.25216; GRAY JA, 1970, SCIENCE, V168, P1246, DOI 10.1126/science.168.3936.1246; Guan M, 2015, TUMOR BIOL, V36, P2973, DOI 10.1007/s13277-014-2930-9; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Hirose K, 2013, ANIM SCI J, V84, P213, DOI 10.1111/j.1740-0929.2012.01066.x; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Isaacs AM, 2011, CURR ALZHEIMER RES, V8, P246; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Jang SG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-16; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kegelman TP, 2015, EXPERT OPIN THER TAR, V19, P97, DOI 10.1517/14728222.2014.959495; Kegelman TP, 2014, NEURO-ONCOLOGY, V16, P50, DOI 10.1093/neuonc/not157; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kim WY, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.1; Kolsch H, 2004, NEUROLOGY, V63, P2255, DOI 10.1212/01.WNL.0000147294.29309.47; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Ladner JE, 2004, BIOCHEMISTRY-US, V43, P352, DOI 10.1021/bi035832z; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Lee YM, 2013, MOL GENET METAB, V110, P275, DOI 10.1016/j.ymgme.2013.06.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li K, 2014, INT J CLIN EXP PATHO, V7, P6486; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lim CEL, 2004, AM J PATHOL, V165, P679, DOI 10.1016/S0002-9440(10)63332-9; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu XM, 2014, ONCOL REP, V32, P2810, DOI 10.3892/or.2014.3498; Liu Y, 2015, AM J MED GENET A, V167, P1381, DOI 10.1002/ajmg.a.37050; Loh YN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-174; Longo GS, 2013, ARQ NEURO-PSIQUIAT, V71, P446, DOI 10.1590/0004-282X20130060; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Matejcic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029366; Mazzetti AP, 2015, NEUROCHEM INT, V82, P10, DOI 10.1016/j.neuint.2015.01.008; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meng XH, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-122; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nishimura M, 2004, NEUROSCI LETT, V368, P140, DOI 10.1016/j.neulet.2004.06.076; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Ozturk A, 2005, NEUROBIOL AGING, V26, P1161, DOI 10.1016/j.neurobiolaging.2004.11.001; Pandey AK, 2014, INT REV NEUROBIOL, V116, P195, DOI 10.1016/B978-0-12-801105-8.00008-4; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Piacentini S, 2012, J NEUROL SCI, V317, P137, DOI 10.1016/j.jns.2012.01.026; Piacentini S, 2012, NEUROSCI LETT, V506, P203, DOI 10.1016/j.neulet.2011.11.005; Pinhel MAS, 2008, CLIN CHEM LAB MED, V46, P439, DOI 10.1515/CCLM.2008.102; Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Rakhshandehroo M, 2012, AM J PHYSIOL-ENDOC M, V302, pE595, DOI 10.1152/ajpendo.00299.2011; Regard JB, 2004, J NEUROSCI, V24, P4092, DOI 10.1523/JNEUROSCI.4252-03.2004; Reitz C, 2009, ANN NY ACAD SCI, V1180, P75, DOI 10.1111/j.1749-6632.2009.04945.x; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Robinson A, 2004, BIOCHEM J, V379, P541, DOI 10.1042/BJ20031656; Ronis MJJ, 2015, AM J PHYSIOL-GASTR L, V308, pG403, DOI 10.1152/ajpgi.00154.2014; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Sarasqueta AF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-277; Schmuck E, 2008, INT J BIOCHEM CELL B, V40, P2553, DOI 10.1016/j.biocel.2008.04.017; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Shroads AL, 2015, J CLIN PHARMACOL, V55, P50, DOI 10.1002/jcph.371; Singh M, 2008, MOL CELL BIOCHEM, V312, P131, DOI 10.1007/s11010-008-9728-2; Singh SP, 2010, J GERONTOL A-BIOL, V65, P14, DOI 10.1093/gerona/glp165; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Smith KT, 2012, MOL CELL PROTEOMICS, V11, P1815, DOI 10.1074/mcp.M112.020255; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Spalletta G, 2007, AM J GERIAT PSYCHIAT, V15, P879, DOI 10.1097/JGP.0b013e3180547076; Speed D, 2014, HUM MOL GENET, V23, P247, DOI 10.1093/hmg/ddt403; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Suga K, 2015, NEUROSCI LETT, V604, P30, DOI 10.1016/j.neulet.2015.07.017; Sun MK, 2001, J NEUROPHYSIOL, V85, P269, DOI 10.1152/jn.2001.85.1.269; Tamura H, 2006, J NEUROL SCI, V246, P79, DOI 10.1016/j.jns.2006.02.009; TAYLOR BA, 1973, P SOC EXP BIOL MED, V143, P629, DOI 10.3181/00379727-143-37380; Tew KD, 2012, ANTIOXID REDOX SIGN, V17, P1728, DOI 10.1089/ars.2012.4640; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Tzeng HF, 2000, CHEM RES TOXICOL, V13, P231, DOI 10.1021/tx990175q; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Xiao Q, 2014, ANN HEMATOL, V93, P1381, DOI 10.1007/s00277-014-2050-z; Xu PT, 2006, NEUROBIOL DIS, V21, P256, DOI 10.1016/j.nbd.2005.07.004; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; Yang Y, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3442; Ye R, 2014, GENES BRAIN BEHAV, V13, P247, DOI 10.1111/gbb.12092; Yochim BP, 2012, J GLAUCOMA, V21, P250, DOI 10.1097/IJG.0b013e3182071b7e; Zarrindast MR, 2012, BEHAV BRAIN RES, V229, P68, DOI 10.1016/j.bbr.2011.12.033; Zhao YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000472; Zhou TB, 2014, AM J EPIDEMIOL, V180, P1, DOI 10.1093/aje/kwu112	149	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148230	10.1371/journal.pone.0148230	http://dx.doi.org/10.1371/journal.pone.0148230			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829228	gold, Green Published			2022-12-27	WOS:000369548200088
J	Maksimchuk, KR; Alser, KA; Mou, R; Valdivia, RH; McCafferty, DG				Maksimchuk, Kenneth R.; Alser, Katherine A.; Mou, Rui; Valdivia, Raphael H.; McCafferty, Dewey G.			The Chlamydia trachomatis Protease CPAF Contains a Cryptic PDZ-Like Domain with Similarity to Human Cell Polarity and Tight Junction PDZ-Containing Proteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FUNCTIONAL-ANALYSIS; LIGAND RECOGNITION; HOST; SPECIFICITY; HOMEOSTASIS; ACTIVATION; GENERATION; PLASTICITY	The need for more effective anti-chlamydial therapeutics has sparked research efforts geared toward further understanding chlamydial pathogenesis mechanisms. Recent studies have implicated the secreted chlamydial serine protease, chlamydial protease-like activity factor (CPAF) as potentially important for chlamydial pathogenesis. By mechanisms that remain to be elucidated, CPAF is directed to a discrete group of substrates, which are subsequently cleaved or degraded. While inspecting the previously solved CPAF crystal structure, we discovered that CPAF contains a cryptic N-terminal PSD95 Dlg ZO-1 (PDZ) domain spanning residues 106-212 (CPAF106-212). This PDZ domain is unique in that it bears minimal sequence similarity to canonical PDZ-forming sequences and displays little sequence and structural similarity to known chlamydial PDZ domains. We show that the CPAF106-212 sequence is homologous to PDZ domains of human tight junction proteins.	[Maksimchuk, Kenneth R.; McCafferty, Dewey G.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Alser, Katherine A.; Mou, Rui; McCafferty, Dewey G.] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Valdivia, Raphael H.] Duke Univ, Mol Genet & Microbiol, Durham, NC USA; [Maksimchuk, Kenneth R.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	Duke University; Duke University; Duke University; University of North Carolina; North Carolina State University	McCafferty, DG (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; McCafferty, DG (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.	dewey.mccafferty@duke.edu	Valdivia, Raphael/R-5377-2019	Valdivia, Raphael/0000-0003-0961-073X	National Institutes of Health Allergy and Infectious Diseases Institute [R01 AI107951]; Duke University; National Science Foundation Predoctoral Graduate Research Fellowship (NSF) [GRFP 2011121201]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107951] Funding Source: NIH RePORTER	National Institutes of Health Allergy and Infectious Diseases Institute; Duke University; National Science Foundation Predoctoral Graduate Research Fellowship (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was generously supported by research grant R01 AI107951 from the National Institutes of Health Allergy and Infectious Diseases Institute (to DGM and RV) and by support from Duke University. KRM was kindly supported by a National Science Foundation Predoctoral Graduate Research Fellowship (NSF GRFP 2011121201).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bednar MM, 2011, BIOCHEMISTRY-US, V50, P7441, DOI 10.1021/bi201098r; Beebe KD, 2000, BIOCHEMISTRY-US, V39, P3149, DOI 10.1021/bi992709s; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Bohl J, 2007, J BIOL CHEM, V282, P9392, DOI 10.1074/jbc.M610002200; Brown HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100763; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Centers for Disease Control and Prevention, 2014, SEX TRANSM DIS SURV; Chen D, 2010, MICROBIOL-SGM, V156, P3031, DOI 10.1099/mic.0.040527-0; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Endo H, SOLUTION STRUCTURE P; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fujiwara Y, 2015, PROTEIN SCI, V24, P376, DOI 10.1002/pro.2628; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Harris BZ, 2003, BIOCHEMISTRY-US, V42, P2797, DOI 10.1021/bi027061p; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmes K, 2007, CHLAMYDIA TRACHOMATI, P575; Hozjan V, CRYSTAL STRUCTURE 1; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Hultqvist G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050055; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huston WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024547; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Joshi M, 2006, ANGEW CHEM INT EDIT, V45, P3790, DOI 10.1002/anie.200503965; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kessler M, 2012, AM J PATHOL, V180, P186, DOI 10.1016/j.ajpath.2011.09.015; Kohlmann F, 2015, J BACTERIOL, V197, P211, DOI 10.1128/JB.02140-14; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Kusunoki H, 2006, PROTEINS, V64, P804, DOI 10.1002/prot.21028; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Monteiro AC, 2013, MOL BIOL CELL, V24, P2849, DOI 10.1091/mbc.E13-06-0298; Nedyalkova L, CRYSTAL STRUCTURE PD; Papagrigoriou E, CRYSTAL STRUCTURE 1; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodriguez-Tirado C, 2012, MICROBES INFECT, V14, P290, DOI 10.1016/j.micinf.2011.11.002; Rowley J, 2012, GLOBAL INCIDENCE PRE; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Saro D, HIGHER RESOLUTION CR; Savijoki K, 2008, FEMS IMMUNOL MED MIC, V54, P375, DOI 10.1111/j.1574-695X.2008.00488.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slep KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050097; Snavely EA, 2014, PATHOG DIS, V71, P336, DOI 10.1111/2049-632X.12179; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Sun JR, 2009, MICROBES INFECT, V11, P12, DOI 10.1016/j.micinf.2008.10.001; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Ugochukwu E, CRYSTAL STRUCTURE C1; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207	75	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147233	10.1371/journal.pone.0147233	http://dx.doi.org/10.1371/journal.pone.0147233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829550	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200015
J	Vinit, S; Keomani, E; Deramaudt, TB; Bonay, M; Petitjean, M				Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Bonay, Marcel; Petitjean, Michel			Reorganization of Respiratory Descending Pathways following Cervical Spinal Partial Section Investigated by Transcranial Magnetic Stimulation in the Rat	PLOS ONE			English	Article							CROSSED-PHRENIC PHENOMENON; MOTOR CORTICAL REPRESENTATION; CORD-INJURY; HUMAN DIAPHRAGM; TIDAL VOLUME; RECOVERY; HEMISECTION; MOTONEURONS; PLASTICITY; FACILITATION	High cervical spinal cord injuries lead to permanent respiratory deficits. One preclinical model of respiratory insufficiency in adult rats is the C2 partial injury which causes unilateral diaphragm paralysis. This model allows the investigation of a particular population of respiratory bulbospinal axons which cross the midline at C3-C6 spinal segment, namely the crossed phrenic pathway. Transcranial magnetic stimulation (TMS) is a non-invasive technique that can be used to study supraspinal descending respiratory pathways in the rat. Interestingly, a lateral C2 injury does not affect the amplitude and latency of the largest motor-evoked potential recorded from the diaphragm (MEPdia) ipsilateral to the injury in response to a single TMS pulse, compared to a sham animal. Although the rhythmic respiratory activity on the contralateral diaphragm is preserved at 7 days post-injury, no diaphragm activity can be recorded on the injured side. However, a profound reorganization of the MEPdia evoked by TMS can be observed. The MEPdia is reduced on the non-injured rather than the injured side. This suggests an increase in ipsilateral phrenic motoneurons excitability. Moreover, correlations between MEPdia amplitude and spontaneous contralateral diaphragmatic activity were observed. The larger diaphragm activity correlated with a larger MEPdia on the injured side, and a smaller MEPdia on the non-injured side. This suggests, for the first time, the occurrence of a functional neuroplasticity process involving changes in motoneuron excitability balance between the injured and non-injured sides at a short post-lesional delay.	[Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Bonay, Marcel; Petitjean, Michel] Univ Versailles St Quentin En Yvelines, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France; [Vinit, Stephane; Keomani, Emilie; Deramaudt, Therese B.; Bonay, Marcel; Petitjean, Michel] Inserm U1179, Lab Physiol TITAN, End Icap, Montigny Le Bretonneux, France; [Deramaudt, Therese B.; Bonay, Marcel] CSM, LIA BAHN, 8 Quai Antoine Ier, MC-98000 Monaco, Monaco; [Bonay, Marcel; Petitjean, Michel] Grp Hosp Paris Ile de France Ouest, Hop Ambroise Pare, AP HP, Serv Physiol Explorat Fonctionnelles, Boulogne Billancourt, France	UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Petitjean, M (corresponding author), Univ Versailles St Quentin En Yvelines, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France.; Petitjean, M (corresponding author), Inserm U1179, Lab Physiol TITAN, End Icap, Montigny Le Bretonneux, France.; Petitjean, M (corresponding author), Grp Hosp Paris Ile de France Ouest, Hop Ambroise Pare, AP HP, Serv Physiol Explorat Fonctionnelles, Boulogne Billancourt, France.	michel.petitjean134@gmail.com	Bonay, Marcel/ABG-2039-2020	Bonay, Marcel/0000-0003-1446-7456; vinit, stephane/0000-0001-7013-1741	European Union [246556]	European Union(European Commission)	This work was supported by funding from the European Union Seventh framework Programme (FP7/2007-2013) under grant agreement No. 246556 (European project RBUCE-UP), HandiMedEx allocated by the French Public Investment Board, the Chancellerie des Universites de Paris (Legs Poix), the "Centre d'Assistance Respiratoire a Domicile d'Ile de France (CARDIF)", the "Fonds de Dotation de Recherche en Sante Respiratoire", LVL Medical, and Universite de Versailles Saint-Quentin-en-Yvelines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov VG, 2007, J PHYSIOL PHARMACOL, V58, P17; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Bonay M, 2014, NEURAL REGEN RES, V9, P1949, DOI 10.4103/1673-5374.145367; Boulenguez P, 2007, BRAIN RES, V1148, P96, DOI 10.1016/j.brainres.2007.02.060; Buttry JL, 2015, J NEUROSCI METH, V241, P137, DOI 10.1016/j.jneumeth.2014.12.013; Corfield DR, 1998, RESP PHYSIOL, V114, P109, DOI 10.1016/S0034-5687(98)00083-8; Darlot F, 2012, EXP NEUROL, V236, P88, DOI 10.1016/j.expneurol.2012.04.004; Davey NJ, 1996, RESP PHYSIOL, V106, P127, DOI 10.1016/S0034-5687(96)00069-2; Dougherty BJ, 2012, J APPL PHYSIOL, V112, P96, DOI 10.1152/japplphysiol.00690.2011; Ferrini F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/429815; Fuller DD, 2009, RESP PHYSIOL NEUROBI, V165, P245, DOI 10.1016/j.resp.2008.12.010; Fuller DD, 2006, J APPL PHYSIOL, V100, P800, DOI 10.1152/japplphysiol.00960.2005; GANDEVIA SC, 1987, J PHYSIOL-LONDON, V384, P109, DOI 10.1113/jphysiol.1987.sp016445; Golder FJ, 2005, J NEUROSCI, V25, P2925, DOI 10.1523/JNEUROSCI.0148-05.2005; Golder FJ, 2003, J NEUROSCI, V23, P2494; Goshgarian HG, 2009, RESP PHYSIOL NEUROBI, V169, P85, DOI 10.1016/j.resp.2009.06.005; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; Keomani E, 2014, JOVE-J VIS EXP, DOI 10.3791/51235; Khedr EM, 2001, EUR J APPL PHYSIOL, V85, P560, DOI 10.1007/s004210100504; Lane MA, 2011, RESP PHYSIOL NEUROBI, V179, P3, DOI 10.1016/j.resp.2011.07.004; Lane MA, 2009, RESP PHYSIOL NEUROBI, V169, P123, DOI 10.1016/j.resp.2009.08.007; LIPSKI J, 1986, EXP BRAIN RES, V61, P280; LISSENS MA, 1994, J NEUROL SCI, V124, P204, DOI 10.1016/0022-510X(94)90327-1; Lovett-Barr MR, 2012, J NEUROSCI, V32, P3591, DOI 10.1523/JNEUROSCI.2908-11.2012; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Mantilla CB, 2014, EXP NEUROL, V261, P190, DOI 10.1016/j.expneurol.2014.05.027; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; Minor KH, 2006, EXP NEUROL, V200, P486, DOI 10.1016/j.expneurol.2006.02.125; Navarrete-Opazo A, 2015, EXP NEUROL, V266, P1, DOI 10.1016/j.expneurol.2015.02.007; Polentes J, 2004, NEUROBIOL DIS, V16, P638, DOI 10.1016/j.nbd.2004.04.009; Sharshar T, 2003, J APPL PHYSIOL, V95, P26, DOI 10.1152/japplphysiol.00918.2002; Shionoya K, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00128; SPERRY MA, 1993, EXP NEUROL, V120, P233, DOI 10.1006/exnr.1993.1058; Vinit S, 2006, J NEUROTRAUM, V23, P1137, DOI 10.1089/neu.2006.23.1137; Vinit S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113251; Vinit S, 2011, RESP PHYSIOL NEUROBI, V176, P130, DOI 10.1016/j.resp.2011.02.008; Vinit S, 2009, RESP PHYSIOL NEUROBI, V169, P115, DOI 10.1016/j.resp.2009.08.004; Vinit S, 2009, RESP PHYSIOL NEUROBI, V169, P210, DOI 10.1016/j.resp.2009.07.023; Windelborn JA, 2012, RESP PHYSIOL NEUROBI, V180, P61, DOI 10.1016/j.resp.2011.10.011; Winslow C, 2003, AM J PHYS MED REHAB, V82, P803, DOI 10.1097/01.PHM.0000078184.08835.01; Zimmer MB, 2015, J SPINAL CORD MED, V38, P224, DOI 10.1179/2045772314Y.0000000220	41	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148180	10.1371/journal.pone.0148180	http://dx.doi.org/10.1371/journal.pone.0148180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828648	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200079
J	Bagci, C; Allmer, J				Bagci, Caner; Allmer, Jens			One Step Forward, Two Steps Back; Xeno-MicroRNAs Reported in Breast Milk Are Artifacts	PLOS ONE			English	Article							SMALL RNAS; GENE; ALIGNMENT	Background MicroRNAs (miRNAs) are short RNA sequences that guide post-transcriptional regulation of gene expression via complementarity to their target mRNAs. Discovered only recently, miRNAs have drawn a lot of attention. Multiple protein complexes interact to first cleave a hairpin from nascent RNA, export it into the cytosol, trim its loop, and incorporate it into the RISC complex which is important for binding its target mRNA. This process works within one cell, but circulating miRNAs have been described suggesting a role in cell-cell communication. Motivation Viruses and intracellular parasites like Toxoplasma gondii use miRNAs to manipulate host gene expression from within the cellular environment. However, recent research has claimed that a rice miRNA may regulate human gene expression. Despite ongoing debates about these findings and general reluctance to accept them, a recent report claimed that foodborne plant miRNAs pass through the digestive tract, travel through blood to be incorporated by alveolar cells excreting milk. The miRNAs are then said to have some immune-related function in the newborn. Principal Findings We acquired the data that supports their claim and performed further analyses. In addition to the reported miRNAs, we were able to detect almost complete mRNAs and found that the foreign RNA expression profiles among samples are exceedingly similar. Inspecting the source of the data helped understand how RNAs could contaminate the samples. Conclusion Viewing these findings in context with the difficulties foreign RNAs face on their route into breast milk and the fact that many identified foodborne miRNAs are not from actual food sources, we can conclude beyond reasonable doubt that the original claims and evidence presented may be due to artifacts. We report that the study claiming their existence is more likely to have detected RNA contamination than miRNAs.	[Bagci, Caner] Izmir Inst Technol, Dept Biotechnol, Izmir, Turkey; [Allmer, Jens] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey; [Allmer, Jens] Bionia Inc, IZTEKGEB A8, Izmir, Turkey	Izmir Institute of Technology; Izmir Institute of Technology; Izmir Metropolitan Municipality	Allmer, J (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey.; Allmer, J (corresponding author), Bionia Inc, IZTEKGEB A8, Izmir, Turkey.	jens@allmer.de	Allmer, Jens/E-2335-2016; Bağcı, Caner/ABB-6795-2020	Allmer, Jens/0000-0002-2164-7335; Bağcı, Caner/0000-0003-4428-9515	Scientific and Technological Research Council of Turkey (TUBITAK) [113E326]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was supported by a grant to JA from the The Scientific and Technological Research Council of Turkey (TUBITAK; http://www.tubitak.gov.tr/en) with the grant number 113E326. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bionia Incorporated provided support in the form of computational resources for author JA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, BIOINFORMATICS; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Erson-Bensan AE, 2014, METHODS MOL BIOL, V1107, P1, DOI 10.1007/978-1-62703-748-8_1; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hamid SM, 2014, METHODS MOL BIOL, V1107, P303, DOI 10.1007/978-1-62703-748-8_18; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li CF, 2014, PROTEIN CELL, V5, P348, DOI 10.1007/s13238-014-0039-y; Lukasik A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099963; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Sacar Muserref Duygu, 2014, Genomics Proteomics & Bioinformatics, V12, P228, DOI 10.1016/j.gpb.2014.09.002; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Tufekci KU, 2014, METHODS MOL BIOL, V1107, P33, DOI 10.1007/978-1-62703-748-8_3; Zhang Lixiao, 2011, AGR ENG, V1, P1, DOI DOI 10.1038/CR.2011.158; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	24	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0145065	10.1371/journal.pone.0145065	http://dx.doi.org/10.1371/journal.pone.0145065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824347	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600003
J	Follin, C; Gabery, S; Petersen, A; Sundgren, PC; Bjorkman-Burtcher, I; Latt, J; Mannfolk, P; Erfurth, EM				Follin, Cecilia; Gabery, Sanaz; Petersen, Asa; Sundgren, Pia C.; Bjorkman-Burtcher, Isabella; Latt, Jimmy; Mannfolk, Peter; Erfurth, Eva Marie			Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CARDIOVASCULAR RISK; CIRCULATING GHRELIN; ADULT SURVIVORS; HORMONE; OBESITY; BRAIN; PREVALENCE; RESISTANCE; NUCLEUS	Metabolic complications are prevalent in individuals treated with cranial radiotherapy (CRT) for childhood acute lymphoblastic leukemia (ALL). The hypothalamus is a master regulator of endocrine and metabolic control. The aim of this study was to investigate whether the hypothalamic volume would be associated to metabolic parameters in ALL survivors. Thirty-eight (21 women) survivors participated in this study 34 years after diagnosis and with a median age of 38 (27-46) years. All were treated with a median CRT dose of 24 Gy and 11 years (3-13) of complete hormone supplementation. Comparisons were made to 31 matched controls. We performed analyses of fat mass, fat free mass, plasma (p)-glucose, p-insulin, Homa-Index (a measure of insulin resistance), serum (s)-leptin, s-ghrelin and of the hypothalamic volume in scans obtained by magnetic resonance imaging (MRI) at 3 Tesla. Serum leptin/kg fat mass (r = -0.4, P = 0.04) and fat mass (r = -0.4, P = 0.01) were negatively correlated with the HT volume among ALL survivors, but not among controls. We also detected significantly higher BMI, waist, fat mass, p-insulin, Homa-Index, leptin/kg fat mass and s-ghrelin and significantly lower fat free mass specifically among female ALL survivors (all P<0.01). Interestingly, s-ghrelin levels increased with time since diagnosis and with low age at diagnosis for childhood ALL. Our results showed that leptin/kg fat mass and fat mass were associated with a reduced HT volume 34 years after ALL diagnosis and that women treated with CRT after ALL are at high risk of metabolic abnormalities. Taken together our data suggest that the hypothalamus is involved in the metabolic consequences after CRT in ALL survivors.	[Follin, Cecilia; Erfurth, Eva Marie] Lund Univ, Dept Endocrinol, Skane Univ Hosp, Lund, Sweden; [Follin, Cecilia; Sundgren, Pia C.; Bjorkman-Burtcher, Isabella; Latt, Jimmy; Mannfolk, Peter; Erfurth, Eva Marie] Lund Univ, IKVL, Lund, Sweden; [Gabery, Sanaz; Petersen, Asa] Lund Univ, Translat Neuroendocrine Res Unit, Dept Expt Med Sci, Lund, Sweden; [Sundgren, Pia C.; Bjorkman-Burtcher, Isabella; Latt, Jimmy; Mannfolk, Peter] Lund Univ, Dept Diagnost Radiol, Skane Univ Hosp, Lund, Sweden; [Bjorkman-Burtcher, Isabella] Lund Univ, Lund Univ Bioimaging Ctr LBIC, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Skane University Hospital; Lund University	Follin, C (corresponding author), Lund Univ, Dept Endocrinol, Skane Univ Hosp, Lund, Sweden.; Follin, C (corresponding author), Lund Univ, IKVL, Lund, Sweden.	Cecilia.follin@med.lu.se		Sundgren, Pia/0000-0001-9237-1236	Swedish Childhood Cancer Foundation	Swedish Childhood Cancer Foundation(European Commission)	This study was supported by the Swedish Childhood Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao AM, 2005, BRAIN, V128, P1301, DOI 10.1093/brain/awh448; Brennan B, 1999, CLIN ENDOCRINOL, V61, P683; Briggs DI, 2014, ENDOCRINOLOGY, V155, P2411, DOI 10.1210/en.2013-1861; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Eden Engstrom B, 2003, J CLIN ENDOCR METAB, V88, P5093; Egido EM, 2002, EUR J ENDOCRINOL, V146, P241, DOI 10.1530/eje.0.1460241; Filippi BM, 2013, REV ENDOCR METAB DIS, V14, P365, DOI 10.1007/s11154-013-9258-4; Flanagan DE, 2003, AM J PHYSIOL-ENDOC M, V284, pE313, DOI 10.1152/ajpendo.00569.2001; Follin C, 2006, J CLIN ENDOCR METAB, V91, P1872, DOI 10.1210/jc.2005-2298; Follin C, 2010, J CLIN ENDOCR METAB, V95, P3726, DOI 10.1210/jc.2010-0117; Gabery S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117593; Gordon-Dseagu V, 2015, PLOS ONE, V18, P1; GUSTAFSSON G, 1981, ACTA PAEDIATR SCAND, V70, P609, DOI 10.1111/j.1651-2227.1981.tb05754.x; Ha J, 2013, DIS MARKERS, V2013, P249, DOI 10.1155/2013/531736; Hempel R, 2012, DIABETES-METAB RES, V28, P76, DOI 10.1002/dmrr.1230; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holmer H, 2010, J CLIN ENDOCR METAB, V95, P5395, DOI 10.1210/jc.2010-0993; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Howlader N, 2011, SEER CANC STAT REV 1; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kohno D, 2007, ENDOCRINOLOGY, V148, P2251, DOI 10.1210/en.2006-1240; Link K, 2004, J CLIN ENDOCR METAB, V89, P5003, DOI 10.1210/jc.2004-0126; Lustig RH, 2003, J CLIN ENDOCR METAB, V88, P611, DOI 10.1210/jc.2002-021180; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Maison P, J CLIN ENDOCRINOL ME, V89, P2192; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; O'Brien LM, 2006, HARVARD REV PSYCHIAT, V14, P141, DOI 10.1080/10673220600784119; Peper JS, 2010, PSYCHONEUROENDOCRINO, V35, P133, DOI 10.1016/j.psyneuen.2009.05.025; Saad MF, 2002, J CLIN ENDOCR METAB, V87, P3997, DOI 10.1210/jc.87.8.3997; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Schneeberger M, 2014, J ENDOCRINOL, V220, pT25, DOI 10.1530/JOE-13-0398; Sklar CA, 2000, MED PEDIATR ONCOL, V35, P91, DOI 10.1002/1096-911X(200008)35:2<91::AID-MPO1>3.0.CO;2-G; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stahl R, 2007, RADIOLOGY, V243, P483, DOI 10.1148/radiol.2432051714; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Vestergaard ET, 2007, J CLIN ENDOCR METAB, V92, P297, DOI 10.1210/jc.2006-1435	37	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147575	10.1371/journal.pone.0147575	http://dx.doi.org/10.1371/journal.pone.0147575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824435	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600036
J	He, GL; Luo, Z; Yang, J; Shen, TT; Chen, Y; Yang, XS				He, Gen-Lin; Luo, Zhen; Yang, Ju; Shen, Ting-ting; Chen, Yi; Yang, Xue-Sen			Curcumin Ameliorates the Reduction Effect of PGE(2) on Fibrillar beta-Amyloid Peptide (1-42)-Induced Microglial Phagocytosis through the Inhibition of EP2-PKA Signaling in N9 Microglial Cells	PLOS ONE			English	Article							REDUCES OXIDATIVE DAMAGE; ALZHEIMERS-DISEASE; MOUSE MODEL; PROSTAGLANDIN E-2; A-BETA; IN-VITRO; CYTOKINES; NEUROPATHOLOGY; NEUROTOXICITY; ACCUMULATION	Inflammatory activation of microglia and beta amyloid (A beta) deposition are considered to work both independently and synergistically to contribute to the increased risk of Alzheimer's disease (AD). Recent studies indicate that long-term use of phenolic compounds provides protection against AD, primarily due to their anti-inflammatory actions. We previously suggested that phenolic compound curcumin ameliorated phagocytosis possibly through its anti-inflammatory effects rather than direct regulation of phagocytic function in electromagnetic field-exposed N9 microglial cells (N9 cells). Here, we explored the prostaglandin-E-2 (PGE(2))-related signaling pathway that involved in curcumin-mediated phagocytosis in fibrillar beta-amyloid peptide (1-42) (fA beta(42))-stimulated N9 cells. Treatment with fA beta(42) increased phagocytosis of fluorescent-labeled latex beads in N9 cells. This increase was attenuated in a dose-dependent manner by endogenous and exogenous PGE(2), as well as a selective EP2 or protein kinase A (PKA) agonist, but not by an EP4 agonist. We also found that an antagonist of EP2, but not EP4, abolished the reduction effect of PGE(2) on fA beta(42)-induced microglial phagocytosis. Additionally, the increased expression of endogenous PGE(2), EP2, and cyclic adenosine monophosphate (AMP), and activation of vasodilator-stimulated phosphoprotein, cyclic AMP responsive element-binding protein, and PKA were depressed by curcumin administration. This reduction led to the amelioration of the phagocytic abilities of PGE(2)-stimulated N9 cells. Taken together, these data suggested that curcumin restored the attenuating effect of PGE(2) on fA beta(42)-induced microglial phagocytosis via a signaling mechanism involving EP2 and PKA. Moreover, due to its immune modulatory effects, curcumin may be a promising pharmacological candidate for neurodegenerative diseases.	[He, Gen-Lin; Luo, Zhen; Yang, Ju; Shen, Ting-ting; Chen, Yi; Yang, Xue-Sen] Third Mil Med Univ, Inst Trop Med, Dept Trop Hyg, Chongqing, Peoples R China	Army Medical University	Yang, XS (corresponding author), Third Mil Med Univ, Inst Trop Med, Dept Trop Hyg, Chongqing, Peoples R China.	xuesenyyy@aliyun.com	He, Gen-Lin/B-5715-2016	He, Gen-Lin/0000-0002-5625-4347	National Natural Science Foundation of China [81172647]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (81172647). The funder's website is http://www.nsfc.gov.cn/. The corresponding author XY received the funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Babcock AA, 2015, BRAIN BEHAV IMMUN, V48, P86, DOI 10.1016/j.bbi.2015.03.006; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Benz PM, 2008, INT IMMUNOPHARMACOL, V8, P319, DOI 10.1016/j.intimp.2007.10.004; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Cimino PJ, 2013, EXP MOL PATHOL, V94, P366, DOI 10.1016/j.yexmp.2013.01.002; Cole GM, 2004, ANN NY ACAD SCI, V1035, P68, DOI 10.1196/annals.1332.005; Combrinck M, 2006, J NEUROL NEUROSUR PS, V77, P85, DOI 10.1136/jnnp.2005.063131; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; CORRADIN SB, 1993, GLIA, V7, P255, DOI 10.1002/glia.440070309; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; He GL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-49; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Johansson JU, 2015, J CLIN INVEST, V125, P350, DOI 10.1172/JCI77487; Kang G, 2004, J PHARMACOL SCI, V94, P325, DOI 10.1254/jphs.94.325; Karlstetter M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-125; Keene CD, 2010, AM J PATHOL, V177, P346, DOI 10.2353/ajpath.2010.090840; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kojima F, 2009, PROSTAG OTH LIPID M, V89, P26, DOI 10.1016/j.prostaglandins.2009.03.001; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Nagano T, 2010, BRAIN RES, V1323, P11, DOI 10.1016/j.brainres.2010.01.086; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; Shi J, 2012, ANN NEUROL, V72, P788, DOI 10.1002/ana.23677; Shie FS, 2005, AM J PATHOL, V166, P1163, DOI 10.1016/S0002-9440(10)62336-X; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Wang P, 2014, AGING CELL, V13, P605, DOI 10.1111/acel.12209; Woodling NS, 2014, J NEUROSCI, V34, P5882, DOI 10.1523/JNEUROSCI.0410-14.2014; Xiang ZM, 2002, GENE EXPRESSION, V10, P271, DOI 10.3727/000000002783992352; Yamada M, 2015, ADV EXP MED BIOL, V863, P79, DOI 10.1007/978-3-319-18365-7_4; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; YANKNER BA, 1991, NEW ENGL J MED, V325, P1849; Zhang L, 2006, J ALZHEIMERS DIS, V10, P1; Zhang T, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0275-y; Zhen GH, 2012, NEUROBIOL AGING, V33, P2215, DOI 10.1016/j.neurobiolaging.2011.09.017	45	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147721	10.1371/journal.pone.0147721	http://dx.doi.org/10.1371/journal.pone.0147721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824354	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600051
J	Padroni, M; Bernardoni, A; Tamborino, C; Roversi, G; Borrelli, M; Saletti, A; De Vito, A; Azzini, C; Borgatti, L; Marcello, O; d'Esterre, C; Ceruti, S; Casetta, I; Lee, TY; Fainardi, E				Padroni, Marina; Bernardoni, Andrea; Tamborino, Carmine; Roversi, Gloria; Borrelli, Massimo; Saletti, Andrea; De Vito, Alessandro; Azzini, Cristiano; Borgatti, Luca; Marcello, Onofrio; d'Esterre, Christopher; Ceruti, Stefano; Casetta, Ilaria; Lee, Ting-Yim; Fainardi, Enrico			Cerebral Blood Volume ASPECTS Is the Best Predictor of Clinical Outcome in Acute Ischemic Stroke: A Retrospective, Combined Semi-Quantitative and Quantitative Assessment	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY PERFUSION; CT PERFUSION; INFARCT CORE; HEMORRHAGIC TRANSFORMATION; THROMBOLYTIC THERAPY; IMAGING SELECTION; PENUMBRA; RECANALIZATION; TRIAL; SCORE	Introduction The capability of CT perfusion (CTP) Alberta Stroke Program Early CT Score (ASPECTS) to predict outcome and identify ischemia severity in acute ischemic stroke (AIS) patients is still questioned. Methods 62 patients with AIS were imaged within 8 hours of symptom onset by non-contrast CT, CT angiography and CTP scans at admission and 24 hours. CTP ASPECTS was calculated on the affected hemisphere using cerebral blood flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT) maps by subtracting 1 point for any abnormalities visually detected or measured within multiple cortical circular regions of interest according to previously established thresholds. MTT-CBV ASPECTS was considered as CTP ASPECTS mismatch. Hemorrhagic transformation (HT), recanalization status and reperfusion grade at 24 hours, final infarct volume at 7 days andmodified Rankin scale (mRS) at 3 months after onset were recorded. Results Semi-quantitative and quantitative CTP ASPECTS were highly correlated (p<0.00001). CBF, CBV and MTT ASPECTS were higher in patients with no HT and mRS <= 2 and inversely associated with final infarct volume and mRS (p values: from p<0.05 to p<0.00001). CTP ASPECTS mismatch was slightly associated with radiological and clinical outcomes (p values: from p<0.05 to p<0.02) only if evaluated quantitatively. A CBV ASPECTS of 9 was the optimal semi-quantitative value for predicting outcome. Conclusions Our findings suggest that visual inspection of CTP ASPECTS recognizes infarct and ischemic absolute values. Semi-quantitative CBV ASPECTS, but not CTP ASPECTS mismatch, represents a strong prognostic indicator, implying that core extent is the main determinant of outcome, irrespective of penumbra size.	[Padroni, Marina; Tamborino, Carmine; Roversi, Gloria; Casetta, Ilaria] Univ Ferrara, Dept Biol Psychiat & Psychol Sci, Neurol Sect, I-44100 Ferrara, Italy; [Bernardoni, Andrea] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Diagnost Imaging, I-44100 Ferrara, Italy; [Borrelli, Massimo; Saletti, Andrea; Borgatti, Luca; Marcello, Onofrio; Ceruti, Stefano; Fainardi, Enrico] Azienda Osped Univ, Dept Neurosci & Rehabil, Neuroradiol Unit, Ferrara, Italy; [De Vito, Alessandro; Azzini, Cristiano] Azienda Osped Univ, Dept Neurosci & Rehabil, Neurol Unit, Ferrara, Italy; [d'Esterre, Christopher] Univ Calgary, Dept Clin Neurosci, Calgary Stroke Program, Calgary, AB, Canada; [d'Esterre, Christopher; Lee, Ting-Yim] Univ Western Ontario, Robarts Res Inst, Imaging Res Lab, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Lawson Hlth Res Inst, Imaging program, London, ON, Canada	University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Arcispedale Sant'Anna; University of Calgary; Western University (University of Western Ontario); Western University (University of Western Ontario)	Fainardi, E (corresponding author), Azienda Osped Univ, Dept Neurosci & Rehabil, Neuroradiol Unit, Ferrara, Italy.	henryfai@tin.it	Lee, Ting-Yim/M-1721-2013; Casetta, Ilaria/K-5289-2016	Casetta, Ilaria/0000-0003-4099-8875; Padroni, Marina/0000-0001-8410-3039; SALETTI, ANDREA/0000-0001-6984-113X; De Vito, Alessandro/0000-0002-7572-819X	Italian National Health System-Research Program entitled "Nuove conoscenze e problematiche assistenziali nell'ictus cerebrale: un Programma Strategico di Ricerca e Sviluppo" [502/92, PG/2007/0293184]; Canadian Stroke Network and European Stroke Network; Canadian Institutes of Health Research; Ontario Research Fund and GE Healthcare	Italian National Health System-Research Program entitled "Nuove conoscenze e problematiche assistenziali nell'ictus cerebrale: un Programma Strategico di Ricerca e Sviluppo"; Canadian Stroke Network and European Stroke Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund and GE Healthcare(General Electric)	This work has been supported by Italian National Health System-Research Program entitled "Nuove conoscenze e problematiche assistenziali nell'ictus cerebrale: un Programma Strategico di Ricerca e Sviluppo" ex art. 12-12bis/D.Lgs n. 502/92, PG/2007/0293184. The authors would also like to thank the Canadian Stroke Network and European Stroke Network, Canadian Institutes of Health Research, Ontario Research Fund and GE Healthcare for partial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermaier A, 2015, J STROKE CEREBROVASC, V24, P2306, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.025; Aviv RI, 2007, AM J NEURORADIOL, V28, P1975, DOI 10.3174/ajnr.A0689; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; d'Esterre CD, 2015, NEUROL SCI, V36, P1777, DOI 10.1007/s10072-015-2244-8; Eilaghi A, 2013, RADIOLOGY, V269, P240, DOI 10.1148/radiol.13122327; Finlayson O, 2013, STROKE, V44, P234, DOI 10.1161/STROKEAHA.112.665208; Goyal M, 2010, NEURORADIOLOGY, V52, P341, DOI 10.1007/s00234-009-0636-2; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Jain AR, 2013, AM J NEURORADIOL, V34, P1895, DOI 10.3174/ajnr.A3502; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Kamalian S, 2012, AM J NEURORADIOL, V33, P545, DOI 10.3174/ajnr.A2809; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Lin K, 2009, NEURORADIOLOGY, V51, P17, DOI 10.1007/s00234-008-0454-y; Lum C, 2014, STROKE, V45, P2683, DOI 10.1161/STROKEAHA.114.006163; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; Nagar VA, 2009, AM J ROENTGENOL, V193, P1629, DOI 10.2214/AJR.09.2664; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; Psychogios MN, 2013, STROKE, V44, P2188, DOI 10.1161/STROKEAHA.113.001068; Puetz V, 2009, INT J STROKE, V4, P354, DOI 10.1111/j.1747-4949.2009.00337.x; Sanelli PC, 2014, AM J NEURORADIOL, V35, P1045, DOI 10.3174/ajnr.A3518; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Sillanpaa N, 2011, CEREBROVASC DIS EXTR, V1, P6, DOI 10.1159/000324324; Soares BP, 2010, STROKE, V41, pE34, DOI 10.1161/STROKEAHA.109.568766; Souza LCS, 2012, CEREBROVASC DIS, V33, P8, DOI 10.1159/000331914; The Thrombolysis In Myocardial Infarction (TIMI) trial, 1985, N ENGL J MED, V312, P932; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Yoo AJ, 2012, STROKE, V43, P1323, DOI 10.1161/STROKEAHA.111.639401	33	34	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147910	10.1371/journal.pone.0147910	http://dx.doi.org/10.1371/journal.pone.0147910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824672	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600070
J	Wardil, L; Hauert, C				Wardil, Lucas; Hauert, Christoph			Targeted Cooperative Actions Shape Social Networks	PLOS ONE			English	Article							PROMOTE COOPERATION; EVOLUTIONARY GAMES; FAIRNESS; STRATEGY	Individual acts of cooperation give rise to dynamic social networks. Traditionally, models for cooperation in structured populations are based on a separation of individual strategies and of population structure. Individuals adopt a strategy-typically cooperation or defection, which determines their behaviour toward their neighbours as defined by an interaction network. Here, we report a behavioural experiment that amalgamates strategies and structure to empirically investigate the dynamics of social networks. The action of paying a cost c to provide a benefit b is represented as a directed link point from the donor to the recipient. Participants can add and/or remove links to up to two recipients in each round. First, we show that dense networks emerge, where individuals are characterized by fairness: they receive to the same extent they provide. More specifically, we investigate how participants use information about the generosity and payoff of others to update their links. It turns out that aversion to payoff inequity was the most consistent update rule: adding links to individuals that are worse off and removing links to individuals that are better off. We then investigate the effect of direct reciprocation, showing that the possibility of direct reciprocation does not increase cooperation as compared to the treatment where participants are totally unaware of who is providing benefits to them.	[Wardil, Lucas; Hauert, Christoph] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Wardil, Lucas] Univ Fed Ouro Preto, Dept Fis, Ouro Preto, MG, Brazil	University of British Columbia; Universidade Federal de Ouro Preto	Wardil, L (corresponding author), Univ Fed Ouro Preto, Dept Fis, Ouro Preto, MG, Brazil.	wardil@math.ubc.ca	Hauert, Christoph/E-5369-2011; Wardil, Lucas/B-3526-2015	Hauert, Christoph/0000-0002-1239-281X; Wardil, Lucas/0000-0003-2964-948X	Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-05795]; Foundational Questions in Evolutionary Biology Fund [RFP-12-10]; Brazilian agency CNPq	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Foundational Questions in Evolutionary Biology Fund; Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support is acknowledged from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/index_eng.asp), grant RGPIN-2015-05795, the Foundational Questions in Evolutionary Biology Fund (www.templeton.org), grant RFP-12-10, and the Brazilian agency CNPq (www.cnpq.br).	Alexander R., 2008, ESSAYS PEDAGOGY; Bala V, 2000, ECONOMETRICA, V68, P1181, DOI 10.1111/1468-0262.00155; Barclay P, 2013, EVOL HUM BEHAV, V34, P164, DOI 10.1016/j.evolhumbehav.2013.02.002; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; BOYD R, 1989, SOC NETWORKS, V11, P213, DOI 10.1016/0378-8733(89)90003-8; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Grujic J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04615; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hauert C, 2001, P ROY SOC B-BIOL SCI, V268, P761, DOI 10.1098/rspb.2000.1424; Nishi A, 2015, NATURE, V526, P426, DOI 10.1038/nature15392; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rand DG, 2014, P NATL ACAD SCI USA, V111, P17093, DOI 10.1073/pnas.1400406111; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Shirado H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3814; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szathmary E, 1995, MAJOR TRANSITIONS EV; Taylor C, 2006, THEOR POPUL BIOL, V69, P243, DOI 10.1016/j.tpb.2005.06.009; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang J, 2012, P NATL ACAD SCI USA, V109, P14363, DOI 10.1073/pnas.1120867109; Wardil L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05725	31	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147850	10.1371/journal.pone.0147850	http://dx.doi.org/10.1371/journal.pone.0147850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824240	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600066
J	Zhao, H; Hu, CZ; Zhang, D; Liu, HJ; Qu, JH				Zhao, He; Hu, Chengzhi; Zhang, Di; Liu, Huijuan; Qu, Jiuhui			Probing Coagulation Behavior of Individual Aluminum Species for Removing Corresponding Disinfection Byproduct Precursors: The Role of Specific Ultraviolet Absorbance	PLOS ONE			English	Article							NATURAL ORGANIC-MATTER; SIZE-EXCLUSION CHROMATOGRAPHY; WATER-TREATMENT; DRINKING-WATER; POLYALUMINUM CHLORIDE; ENHANCED COAGULATION; HUMIC ACIDS; CHLORINATION; SPECIATION; AL-13	Coagulation behavior of aluminum chloride and polyaluminum chloride (PACl) for removing corresponding disinfection byproduct (DBP) precursors was discussed in this paper. CHCl3, bromine trihalomethanes (THM-Br), dichloroacetic acid (DCAA) and trichloroacetic acid (TCAA) formation potential yields were correlated with specific ultraviolet absorbance (SUVA) values in different molecular weight (MW) fractions of humic substances (HS), respectively. Correlation analyses and principal component analysis were performed to examine the relationships between SUVA and different DBP precursors. To acquire more structural characters of DBP precursors and aluminum speciation, freeze-dried precipitates were analyzed by fourier transform infrared (FTIR) and C 1s, Al 2p X-ray photoelectron spectroscopy (XPS). The results indicated that TCAA precursors (no MW limits), DCAA and CHCl3 precursors in low MWfractions (MW<30 kDa) had a relatively good relations with SUVA values. These DBP precursors were coagulated more easily by in situ Al-13 of AlCl3 at pH 5.0. Due to relatively low aromatic content and more aliphatic structures, THM-Br precursors (no MW limits) and CHCl3 precursors in high MW fractions (MW>30 kDa) were preferentially removed by PACl coagulation with preformed Al-13 species at pH 5.0. Additionally, for DCAA precursors in high MWfractions (MW>30 kDa) with relatively low aromatic content and more carboxylic structures, the greatest removal occurred at pH 6.0 through PACl coagulation with aggregated Al-13 species.	[Zhao, He; Hu, Chengzhi; Liu, Huijuan] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State key Lab Environm Aquat Chem, Beijing 100085, Peoples R China; [Zhao, He; Zhang, Di] Chinese Acad Sci, Inst Proc Engn, Key Lab Green Proc & Engn, Beijing Engn Res Ctr Proc Pollut Control, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Process Engineering, CAS	Liu, HJ (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State key Lab Environm Aquat Chem, Beijing 100085, Peoples R China.	hjliu@rcees.ac.cn	Zhao, He/D-6011-2014	Zhao, He/0000-0002-0162-7388	National Natural Science Foundation of China [51108441, 50921064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, grant number 51108441 (HZ) and grant number 50921064 (JHQ).	Abouelwafa R, 2008, BIORESOURCE TECHNOL, V99, P6112, DOI 10.1016/j.biortech.2007.12.033; Allpike BP, 2005, ENVIRON SCI TECHNOL, V39, P2334, DOI 10.1021/es0496468; CHADIK PA, 1987, J ENVIRON ENG-ASCE, V113, P1234, DOI 10.1061/(ASCE)0733-9372(1987)113:6(1234); Chang EE, 2001, CHEMOSPHERE, V44, P1231, DOI 10.1016/S0045-6535(00)00499-9; Chen C, 2008, SCI TOTAL ENVIRON, V397, P140, DOI 10.1016/j.scitotenv.2008.02.032; Chow CWK, 2008, ENVIRON SCI TECHNOL, V42, P6683, DOI 10.1021/es800794r; Chow CWK, 2009, DESALINATION, V245, P120, DOI 10.1016/j.desal.2008.06.014; COLLINS MR, 1986, ENVIRON SCI TECHNOL, V20, P1028, DOI 10.1021/es00152a011; Duong LV, 2005, MATER LETT, V59, P1932, DOI 10.1016/j.matlet.2005.02.029; Edzwald JK, 1999, WATER SCI TECHNOL, V40, P63, DOI 10.2166/wst.1999.0444; Her N, 2003, WATER RES, V37, P4295, DOI 10.1016/S0043-1354(03)00317-8; Hu CZ, 2006, ENVIRON SCI TECHNOL, V40, P325, DOI 10.1021/es051423+; Hua GH, 2006, ENVIRON SCI TECHNOL, V40, P3050, DOI 10.1021/es0519278; Hua GH, 2007, ENVIRON SCI TECHNOL, V41, P3309, DOI 10.1021/es062178c; HUNDT TR, 1988, J AM WATER WORKS ASS, V80, P176; Hyun-Chul K, 2007, J HAZARD MATER, V143, P486, DOI 10.1016/j.jhazmat.2006.09.063; Kazpard V, 2006, WATER RES, V40, P1965, DOI 10.1016/j.watres.2006.03.014; Kitis M, 2002, WATER RES, V36, P3834, DOI 10.1016/S0043-1354(02)00094-5; Korshin G, 2009, WATER RES, V43, P1541, DOI 10.1016/j.watres.2008.12.041; Leenheer JA, 2003, ENVIRON SCI TECHNOL, V37, p18A, DOI 10.1021/es032333c; Liang L, 2003, ENVIRON SCI TECHNOL, V37, P2920, DOI 10.1021/es026230q; Lin JL, 2008, WATER RES, V42, P4281, DOI 10.1016/j.watres.2008.07.028; Lin JL, 2009, WATER RES, V43, P4285, DOI 10.1016/j.watres.2009.06.023; Lu JF, 2009, J HAZARD MATER, V162, P140, DOI 10.1016/j.jhazmat.2008.05.058; Matilainen A, 2011, CHEMOSPHERE, V83, P1431, DOI 10.1016/j.chemosphere.2011.01.018; Matilainen A, 2010, ADV COLLOID INTERFAC, V159, P189, DOI 10.1016/j.cis.2010.06.007; Monteil-Rivera F, 2000, ANAL CHIM ACTA, V424, P243, DOI 10.1016/S0003-2670(00)01139-9; RECKHOW DA, 1990, ENVIRON SCI TECHNOL, V24, P1655, DOI 10.1021/es00081a005; RECKHOW DA, 1984, J AM WATER WORKS ASS, V76, P151; Shi BY, 2007, SEP PURIF TECHNOL, V54, P88, DOI 10.1016/j.seppur.2006.08.011; STEVENS AA, 1976, J AM WATER WORKS ASS, V68, P615; STEVENSON FJ, 1971, GEOCHIM COSMOCHIM AC, V35, P471, DOI 10.1016/0016-7037(71)90044-5; USEPA, 1990, EPA CINCINNATI; VANBENSCHOTEN JE, 1990, WATER RES, V24, P1527, DOI 10.1016/0043-1354(90)90087-M; Wang DS, 2004, COLLOID SURFACE A, V243, P1, DOI 10.1016/j.colsurfa.2004.04.073; Wassink JK, 2011, WATER SCI TECH-W SUP, V11, P621, DOI 10.2166/ws.2011.101; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Xing LA, 2012, J ENVIRON SCI-CHINA, V24, P1174, DOI 10.1016/S1001-0742(11)60923-6; Yang X, 2008, WATER RES, V42, P2329, DOI 10.1016/j.watres.2007.12.021; Zhao H, 2008, ENVIRON SCI TECHNOL, V42, P5752, DOI 10.1021/es8006035; Zhao H, 2009, J COLLOID INTERF SCI, V330, P105, DOI 10.1016/j.jcis.2008.10.020; Zhao H, 2009, ENVIRON SCI TECHNOL, V43, P5067, DOI 10.1021/es8034347	42	2	2	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148020	10.1371/journal.pone.0148020	http://dx.doi.org/10.1371/journal.pone.0148020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824243	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600090
J	Wostmann, B; Simon, T; Neuhauser-Berthold, M; Rehmann, P				Woestmann, Bernd; Simon, Teresa; Neuhaeuser-Berthold, Monika; Rehmann, Peter			Pilot Study on the Influence of Nutritional Counselling and Implant Therapy on the Nutritional Status in Dentally Compromised Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; ORAL-HEALTH; CHEWING ABILITY; NUTRIENT INTAKE; MASTICATORY PERFORMANCE; EDENTULOUS PATIENTS; DIETARY-INTAKE; TOOTH LOSS; OVERDENTURES; SATISFACTION	Objectives To investigate the impact of implant-prosthetic rehabilitation combined with nutritional counseling on the nutritional status of patients with severely reduced dentitions. Design An explorative intervention study including an intra-individual comparison of 20 patients with severely reduced dentitions in terms of nutrition-and quality of life-related parameters recorded at baseline and at six and twelve months after implant-prosthetic rehabilitation. Participants Twenty patients from the Department of Prosthetic Dentistry of Justus-Liebig University of Giessen, with an mean age of 63 years, who had fewer than ten pairs of antagonists. Measurements The baseline data collection included dental status, a chewing ability test, laboratory parameters, anthropometric data (body mass index), energy supply, a 3-day dietary record, an analysis of the oral health-related quality of life (OHRQoL) with the OHIP-G14, the Mini-Mental Status (MMS) and Mini Nutritional Assessment (MNA). Six months after implantation and prosthetic rehabilitation, individual nutritional counseling was performed by a dietician. Data were again collected and analyzed. A final follow-up was conducted 12 months after prosthetic rehabilitation. Results Despite the highly significant improvement in masticatory ability and OHRQoL after implant-prosthetic rehabilitation, no significant changes were observed regarding MNA, anthropometric data or energy supply. Except for cholinesterase (p = 0.012), ferritin (p = 0.003), folic acid (p = 0.019) and vitamin A (p = 0.004), no laboratory parameter changed significantly during the investigation period. In addition, no general significant differences were observed for nutrient intake or food choice. Conclusion The present study does not confirm the assumption that the implant-prosthetic rehabilitation of patients with severely reduced residual dentitions with or without an individual nutritional counseling influences nutritional status.	[Woestmann, Bernd; Simon, Teresa; Rehmann, Peter] Univ Giessen, Dept Prosthodont, D-35390 Giessen, Germany; [Neuhaeuser-Berthold, Monika] Univ Giessen, Dept Agr Sci Nutr Sci & Environm Management, Inst Nutr Sci, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Wostmann, B (corresponding author), Univ Giessen, Dept Prosthodont, D-35390 Giessen, Germany.	bernd.woestmann@dentist.med.uni-giessen.de						Allen F, 2002, CLIN ORAL IMPLAN RES, V13, P320, DOI 10.1034/j.1600-0501.2002.130313.x; Allen PF, 2006, J DENT RES, V85, P547, DOI 10.1177/154405910608500613; Allen PF, 2001, J PROSTHET DENT, V85, P141, DOI 10.1067/mpr.2001.113214; Awad MA, 2012, J DENT RES, V91, P39, DOI 10.1177/0022034511423396; Awad MA, 2003, INT J PROSTHODONT, V16, P117; Borges TD, 2011, BRIT J NUTR, V105, P990, DOI 10.1017/S000711451000471X; Bradbury J, 2006, J DENT RES, V85, P463, DOI 10.1177/154405910608500513; Brennan DS, 2008, QUAL LIFE RES, V17, P227, DOI 10.1007/s11136-007-9293-2; Brennan M, 2010, INT J ORAL MAX IMPL, V25, P791; BRODEUR JM, 1993, J PROSTHET DENT, V70, P468, DOI 10.1016/0022-3913(93)90087-5; Cousson PY, 2012, GERODONTOLOGY, V29, pE685, DOI 10.1111/j.1741-2358.2011.00545.x; de Oliveira Terezinha R C, 2004, Gerodontology, V21, P205, DOI 10.1111/j.1741-2358.2004.00032.x; Ellis JS, 2010, CLIN ORAL IMPLAN RES, V21, P386, DOI 10.1111/j.1600-0501.2009.01859.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guigoz Y, 1996, NUTR REV, V54, pS59; Heydecke G, 2003, COMMUNITY DENT ORAL, V31, P161, DOI 10.1034/j.1600-0528.2003.00029.x; Heydecke G, 2003, CLIN ORAL IMPLAN RES, V14, P125, DOI 10.1034/j.1600-0501.2003.140117.x; Inoue M, 2011, J ORAL REHABIL, V38, P818, DOI 10.1111/j.1365-2842.2011.02222.x; Inukai M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-118; John MT, 2006, COMMUNITY DENT ORAL, V34, P277, DOI 10.1111/j.1600-0528.2006.00279.x; Kossioni AE, 2007, CLIN INTERV AGING, V2, P591; Luhrmann PM, 1999, EUR J NUTR, V38, P235, DOI 10.1007/s003940050066; Marcenes Wagner, 2003, Cad. Saúde Pública, V19, P809, DOI 10.1590/S0102-311X2003000300013; McKenna G, 2012, GERODONTOLOGY, V29, pE883, DOI 10.1111/j.1741-2358.2011.00579.x; Millwood J, 2000, Gerodontology, V17, P25, DOI 10.1111/j.1741-2358.2000.00025.x; Mojon P, 1999, AGE AGEING, V28, P463, DOI 10.1093/ageing/28.5.463; Morais JA, 2003, J DENT RES, V82, P53, DOI 10.1177/154405910308200112; Moynihan PJ, 2012, J DENT, V40, P843, DOI 10.1016/j.jdent.2012.07.001; Moynihan PJ, 2000, J DENT, V28, P557, DOI 10.1016/S0300-5712(00)00044-0; Muller F, 2012, CLIN ORAL IMPLAN RES, V23, P144, DOI 10.1111/j.1600-0501.2011.02213.x; Muller F, 2005, Z GERONTOL GERIATR, V38, P334, DOI 10.1007/s00391-005-0329-3; Muller Katia, 2008, Braz. Dent. J., V19, P145, DOI 10.1590/S0103-64402008000200011; Nakata M, 1998, Int Dent J, V48, P540; Nguyen C, 1999, EURO J GER, V1, P84; Llamas FP, 2011, NUTR HOSP, V26, P1134, DOI [10.3305/nh.2011.26.5.5248, 10.1590/S0212-16112011000500033]; Saletti A, 2005, GERONTOLOGY, V51, P192, DOI 10.1159/000083993; Sheiham A, 2001, PUBLIC HEALTH NUTR, V4, P797, DOI 10.1079/PHN2000116; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; Singh KA, 2012, GERODONTOLOGY, V29, P106, DOI 10.1111/j.1741-2358.2010.00412.x; Slade G D, 1994, Community Dent Health, V11, P3; Soini Helena, 2003, Spec Care Dentist, V23, P209, DOI 10.1111/j.1754-4505.2003.tb00314.x; Thomason J Mark, 2012, J Evid Based Dent Pract, V12, P182, DOI 10.1016/S1532-3382(12)70032-5; Volkert D., 2000, KLIN GERIATRIE; Volkert D, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/247315; Walls AWG, 2004, MECH AGEING DEV, V125, P853, DOI 10.1016/j.mad.2004.07.011; WAYLER AH, 1984, J GERONTOL, V39, P284, DOI 10.1093/geronj/39.3.284; Wostmann B, 2008, J DENT, V36, P816, DOI 10.1016/j.jdent.2008.05.017	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147193	10.1371/journal.pone.0147193	http://dx.doi.org/10.1371/journal.pone.0147193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821352	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400016
J	Battiston, F; Iacovacci, J; Nicosia, V; Bianconi, G; Latora, V				Battiston, Federico; Iacovacci, Jacopo; Nicosia, Vincenzo; Bianconi, Ginestra; Latora, Vito			Emergence of Multiplex Communities in Collaboration Networks	PLOS ONE			English	Article							SCALE-FREE NETWORKS	Community structures in collaboration networks reflect the natural tendency of individuals to organize their work in groups in order to better achieve common goals. Inmost of the cases, individuals exploit their connections to introduce themselves to new areas of interests, giving rise to multifaceted collaborations which span different fields. In this paper, we analyse collaborations in science and among movie actors as multiplex networks, where the layers represent respectively research topics and movie genres, and we show that communities indeed coexist and overlap at the different layers of such systems. We then propose a model to grow multiplex networks based on two mechanisms of intra and inter-layer triadic closure which mimic the real processes by which collaborations evolve. We show that our model is able to explain the multiplex community structure observed empirically, and we infer the strength of the two underlying social mechanisms from real-world systems. Being also able to correctly reproduce the values of intra-layer and inter-layer assortativity correlations, the model contributes to a better understanding of the principles driving the evolution of social networks.	[Battiston, Federico; Iacovacci, Jacopo; Nicosia, Vincenzo; Bianconi, Ginestra; Latora, Vito] Queen Mary Univ London, Sch Math Sci, London E1 4NS, England; [Latora, Vito] Univ Catania, Dipartimento Fis & Astron, I-95123 Catania, Italy; [Latora, Vito] INFN, I-95123 Catania, Italy	University of London; Queen Mary University London; University of Catania; Istituto Nazionale di Fisica Nucleare (INFN)	Battiston, F; Iacovacci, J (corresponding author), Queen Mary Univ London, Sch Math Sci, London E1 4NS, England.	f.battiston@qmul.ac.uk; j.iacovacci@qmul.ac.uk	Nicosia, Vincenzo/C-7890-2013; Bianconi, Ginestra/I-5742-2018; Bianconi, Ginestra/AAE-4114-2020	Nicosia, Vincenzo/0000-0003-0636-3278; Bianconi, Ginestra/0000-0002-3380-887X; Bianconi, Ginestra/0000-0002-3380-887X; Latora, Vito/0000-0002-0984-8038	Project LASAGNE - European Commission [318132]	Project LASAGNE - European Commission(European Commission)	F.B., V.N. and V.L. acknowledge support by the Project LASAGNE, Contract No. 318132 (STREP), funded by the European Commission.; F.B., V.N. and V.L. acknowledge support by the Project LASAGNE, Contract No. 318132 (STREP), funded by the European Commission.	Battiston F, 2015, ARXIV150501378; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Bianconi G, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042806; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Cozzo E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050801; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; De Domenico M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7868; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026107; Iacovacci J, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042806; John S., 2000, SOCIAL NETWORK ANAL; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Lee D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026112; Murase Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052810; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025102; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Nicosia V, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042807; Nicosia V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058701; Nicosia V, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032805; Peixoto TP, 2015, ARXIV150402381; RAPOPORT ANATOL, 1953, BULL MATH BIOPHYS, V15, P523, DOI 10.1007/BF02476440; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Valles-Catala T, 2014, ARXIV14111098; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	34	27	27	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147451	10.1371/journal.pone.0147451	http://dx.doi.org/10.1371/journal.pone.0147451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815700	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200033
J	Liu, JB; Shen, B; Shi, MX; Cai, J				Liu, Jibin; Shen, Biao; Shi, Minxin; Cai, Jing			Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; NORWEGIAN MEN; CONSUMPTION; INHIBITION; CANCER; TEA; ACID; DNA; METASTASIS; ACTIVATION	Background Several epidemiological studies have determined the associations between coffee intake level and skin cancer risk; however, the results were not yet conclusive. Herein, we conducted a systematic review and meta-analysis of the cohort and case-control studies for the association between coffee intake level and malignant melanoma (MM) risk. Methods Studies were identified through searching the PubMed and MEDLINE databases (to November, 2015). Study-specific risk estimates were pooled under the random-effects model. Results Two case-control studies (846 MM patients and 843 controls) and five cohort studies (including 844,246 participants and 5,737 MM cases) were identified. For caffeinated coffee, the pooled relative risk (RR) of MM was 0.81 [95% confidential interval (95% CI) = 0.68-0.97; P-value for Q-test = 0.003; I-2 = 63.5%] for those with highest versus lowest quantity of intake. In the dose-response analysis, the RR of MM was 0.955 (95% CI = 0.912-0.999) for per 1 cup/day increment of caffeinated coffee consumption and linearity dose-response association was found (P-value for nonlinearity = 0.326). Strikingly, no significant association was found between the decaffeinated coffee intake level and MM risk (pooled RR = 0.92, 95% CI = 0.81-1.05; P-value for Q-test = 0.967; I-2 = 0%; highest versus lowest quantity of intake). Conclusions This meta-analysis suggested that caffeinated coffee might have chemo-preventive effects against MM but not decaffeinated coffee. However, larger prospective studies and the intervention studies are warranted to confirm these findings.	[Liu, Jibin; Shen, Biao; Shi, Minxin; Cai, Jing] Nantong Tumor Hosp, Tong Yang Rd 30, Nantong Pingchao Town 226361, Jiangsu, Peoples R China		Cai, J (corresponding author), Nantong Tumor Hosp, Tong Yang Rd 30, Nantong Pingchao Town 226361, Jiangsu, Peoples R China.	caijingnantong@sina.com			China Post-doctoral Science Foundation [2013M541563]	China Post-doctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the China Post-doctoral Science Foundation (NO: 2013M541563) and the peak of six personnel Foundation in Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakos L, 2013, AN BRAS DERMATOL, V88, P226, DOI 10.1590/S0365-05962013000200007; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BOWDEN GT, 1980, CHEM-BIOL INTERACT, V33, P101, DOI 10.1016/0009-2797(80)90047-2; Conney AH, 2007, TOXICOL APPL PHARM, V224, P209, DOI 10.1016/j.taap.2006.11.001; Conney AH, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00144; Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194; de Waure C, 2015, PUBLIC HEALTH, V129, P1099, DOI 10.1016/j.puhe.2015.06.015; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferrucci LM, 2014, EUR J CANCER PREV, V23, P296, DOI 10.1097/CEJ.0000000000000037; Fortes C, 2013, CANCER CAUSE CONTROL, V24, P1779, DOI 10.1007/s10552-013-0255-4; Gude RP, 2001, J EXP CLIN CANC RES, V20, P287; Higuchi K, 2000, CANCER LETT, V152, P157, DOI 10.1016/S0304-3835(99)00449-8; Jiang AJ, 2015, BRIT J DERMATOL, V172, P885, DOI 10.1111/bjd.13500; Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Lang R, 2008, J AGR FOOD CHEM, V56, P11114, DOI 10.1021/jf802838s; Larsson SC, 2014, STROKE, V45, P309, DOI 10.1161/STROKEAHA.113.003131; Lee KJ, 2007, TOXICOL LETT, V173, P80, DOI 10.1016/j.toxlet.2007.06.008; Lee KA, 2012, J BIOMED SCI, V19, DOI [10.1186/1423-0127-19-60, 10.6117/kmeps.2012.19.3.001]; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; Lentini A, 1998, MELANOMA RES, V8, P131, DOI 10.1097/00008390-199804000-00005; Liu H, 2015, NUTR CANCER, V67, P392, DOI 10.1080/01635581.2015.1004727; Loftfield E, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju421; Lu YP, 2008, CANCER RES, V68, P2523, DOI 10.1158/0008-5472.CAN-07-5955; Lu YP, 2011, CANCER PREV RES, V4, P1118, DOI 10.1158/1940-6207.CAPR-11-0116; Lu YP, 2000, CANCER RES, V60, P4785; Naldi L, 2004, EUR J CANCER PREV, V13, P503, DOI 10.1097/00008469-200412000-00007; Nilsson LM, 2010, CANCER CAUSE CONTROL, V21, P1533, DOI 10.1007/s10552-010-9582-x; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Ravi D, 2008, MOL CELL BIOCHEM, V308, P193, DOI 10.1007/s11010-007-9628-x; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shen ZY, 2015, CLIN RES HEPATOL GAS, V39, P245, DOI 10.1016/j.clinre.2014.09.005; Song FJ, 2012, CANCER RES, V72, P3282, DOI 10.1158/0008-5472.CAN-11-3511; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; STENSVOLD I, 1994, CANCER CAUSE CONTROL, V5, P401, DOI 10.1007/BF01694753; Thompson BC, 2014, EXP DERMATOL, V23, P509, DOI 10.1111/exd.12430; Thompson BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117491; Veierod MB, 1997, INT J CANCER, V71, P600, DOI 10.1002/(SICI)1097-0215(19970516)71:4&lt;600::AID-IJC15&gt;3.0.CO;2-F; Wei WC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-94; Wu HT, 2015, EUR J CANCER PREV, V24, P347, DOI 10.1097/CEJ.0000000000000093; Wu SW, 2015, EPIDEMIOLOGY, V26, P898, DOI 10.1097/EDE.0000000000000360; Wu WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09051; Xie Y, 2015, EUR J CLIN NUTR; Yang G, 2014, CANCER PREV RES, V7, P1056, DOI 10.1158/1940-6207.CAPR-14-0141; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140; Zajdela F, 1978, Natl Cancer Inst Monogr, P133; Zhou Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep13410	48	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147056	10.1371/journal.pone.0147056	http://dx.doi.org/10.1371/journal.pone.0147056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816289	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200023
J	Cassmann, E; White, R; Atherly, T; Wang, C; Sun, YX; Khoda, S; Mosher, C; Ackermann, M; Jergens, A				Cassmann, Eric; White, Robin; Atherly, Todd; Wang, Chong; Sun, Yaxuan; Khoda, Samir; Mosher, Curtis; Ackermann, Mark; Jergens, Albert			Alterations of the Ileal and Colonic Mucosal Microbiota in Canine Chronic Enteropathies	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INVASIVE ESCHERICHIA-COLI; IN-SITU HYBRIDIZATION; MOLECULAR-PHYLOGENETIC CHARACTERIZATION; TARGETED OLIGONUCLEOTIDE PROBES; CROHNS-DISEASE; GRANULOMATOUS COLITIS; E. COLI; DOGS; BACTERIA	Background The intestinal microbiota is increasingly linked to the pathogenesis of chronic enteropathies (CE) in dogs. While imbalances in duodenal and fecal microbial communities have been associated with mucosal inflammation, relatively little is known about alterations in mucosal bacteria seen with CE involving the ileum and colon. Aim To investigate the composition and spatial organization of mucosal microbiota in dogs with CE and controls. Methods Tissue sections from endoscopic biopsies of the ileum and colon from 19 dogs with inflammatory bowel disease (IBD), 6 dogs with granulomatous colitis (GC), 12 dogs with intestinal neoplasia, and 15 controls were studied by fluorescence in situ hybridization (FISH) on a quantifiable basis. Results The ileal and colonic mucosa of healthy dogs and dogs with CE is predominantly colonized by bacteria localized to free and adherent mucus compartments. CE dogs harbored more (P < 0.05) mucosal bacteria belonging to the Clostridium-coccoides/Eubacterium rectale group, Bacteroides, Enterobacteriaceae, and Escherichia coli versus controls. Within the CE group, IBD dogs had increased (P < 0.05) Enterobacteriaceae and E. coli bacteria attached onto surface epithelia or invading within the intestinal mucosa. Bacterial invasion with E. coli was observed in the ileal and colonic mucosa of dogs with GC (P < 0.05). Dogs with intestinal neoplasia had increased (P < 0.05) adherent (total bacteria, Enterobacteriaceae, E. coli) and invasive (Enterobacteriaceae, E. coli, and Bacteroides) bacteria in biopsy specimens. Increased numbers of total bacteria adherent to the colonic mucosa were associated with clinical disease severity in IBD dogs (P < 0.05). Conclusion Pathogenic events in canine CE are associated with different populations of the ileal and colonic mucosal microbiota.	[Cassmann, Eric; White, Robin; Khoda, Samir; Jergens, Albert] Iowa State Univ, Dept Vet Clin Sci, Coll Vet Med, Ames, IA USA; [Atherly, Todd] ARS, USDA, Ames, IA USA; [Wang, Chong; Sun, Yaxuan] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA USA; [Mosher, Curtis] Iowa State Univ, Coll Liberal Arts & Sci, Dept Genet Dev & Cell Biol, Ames, IA USA; [Ackermann, Mark] Iowa State Univ, Dept Vet Pathol, Coll Vet Med, Ames, IA USA	Iowa State University; United States Department of Agriculture (USDA); Iowa State University; Iowa State University; Iowa State University	Jergens, A (corresponding author), Iowa State Univ, Dept Vet Clin Sci, Coll Vet Med, Ames, IA USA.	ajergens@iastate.edu	Wang, Chong/AAI-3796-2020; Cassmann, Eric D/B-2749-2016	Wang, Chong/0000-0003-4489-4344; Cassmann, Eric D/0000-0002-7130-2650; White, Robin/0000-0003-4811-2573				Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Allenspach K, 2011, VET CLIN N AM-SMALL, V41, P345, DOI 10.1016/j.cvsm.2011.01.004; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Casamian-Sorrosal D, 2010, J VET INTERN MED, V24, P80, DOI 10.1111/j.1939-1676.2009.0427.x; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Glanemann B, 2008, J VET INTERN MED, V22, P1090, DOI 10.1111/j.1939-1676.2008.0147.x; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Jergens AE, 2014, VET PATHOL, V51, P946, DOI 10.1177/0300985813511123; Jergens AE, 2009, J VET INTERN MED, V23, P16, DOI 10.1111/j.1939-1676.2008.0211.x; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; JERGENS AE, 1992, J AM VET MED ASSOC, V201, P1603; Jergens Albert E, 2012, Front Biosci (Elite Ed), V4, P1404; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Kopp ZA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00017; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kuhbacher T, 2006, GUT, V55, P833, DOI 10.1136/gut.2005.078303; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Manchester AC, 2013, J VET INTERN MED, V27, P56, DOI 10.1111/jvim.12020; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martinez-Medina M, 2011, APPL ENVIRON MICROB, V77, P5813, DOI 10.1128/AEM.02614-10; McGregor DP, 1996, BIOTECHNIQUES, V21, P463; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Mira- Pascual L, 2014, J GASTROENTEROL; Packey CD, 2008, J INTERN MED, V263, P597, DOI 10.1111/j.1365-2796.2008.01962.x; POULSEN LK, 1994, INFECT IMMUN, V62, P5191, DOI 10.1128/IAI.62.11.5191-5194.1994; Priestnall SL, 2004, J CLIN MICROBIOL, V42, P2144, DOI 10.1128/JCM.42.5.2144-2151.2004; Procoli F, 2013, J VET INTERN MED, V27, P268, DOI 10.1111/jvim.12041; Sartor R Balfour, 2007, Curr Gastroenterol Rep, V9, P497; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Simpson KW, 2011, VET CLIN N AM-SMALL, V41, P381, DOI 10.1016/j.cvsm.2011.02.003; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Vasquez N, 2007, INFLAMM BOWEL DIS, V13, P684, DOI 10.1002/ibd.20084; Willard MD, 2002, J AM VET MED ASSOC, V220, P1177, DOI 10.2460/javma.2002.220.1177; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Zhu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090849	49	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147321	10.1371/journal.pone.0147321	http://dx.doi.org/10.1371/journal.pone.0147321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840462	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200032
J	Winchester, JM				Winchester, Julia M.			MorphoTester: An Open Source Application for Morphological Topographic Analysis	PLOS ONE			English	Article							DENTAL TOPOGRAPHY; GEOMETRIC MORPHOMETRICS; MOLAR WEAR; COMPLEXITY; EVOLUTION; SHAPE; DIET	The increased prevalence and affordability of 3D scanning technology is beginning to have significant effects on the research questions and approaches available for studies of morphology. As the current trend of larger and more precise 3D datasets is unlikely to slow in the future, there is a need for efficient and capable tools for high-throughput quantitative analysis of biological shape. The promise and the challenge of implementing relatively automated methods for characterizing surface shape can be seen in the example of dental topographic analysis. Dental topographic analysis comprises a suite of techniques for quantifying tooth surfaces and component features. Topographic techniques have provided insight on mammalian molar form-function relationships and these methods could be applied to address other topics and questions. At the same time implementing multiple complementary topographic methods can have high time and labor costs, and comparability of data formats and approaches is difficult to predict. To address these challenges I present MorphoTester, an open source application for visualizing and quantifying topography from 3D triangulated polygon meshes. This application is Python-based and is free to use. MorphoTester implements three commonly used dental topographic metrics- Dirichlet normal energy, relief index, and orientation patch count rotated (OPCR). Previous OPCR algorithms have used raster-based grid data, which is not directly interchangeable with vector-based triangulated polygon meshes. A 3D-OPCR algorithm is provided here for quantifying complexity from polygon meshes. The efficacy of this metric is tested in a sample of mandibular second molars belonging to four species of cercopithecoid primates. Results suggest that 3D-OPCR is at least as effective for quantifying complexity as previous approaches, and may be more effective due to finer resolution of surface data considered here. MorphoTester represents an advancement in the automated quantification of morphology, and can be modified to adapt to future needs and priorities.	[Winchester, Julia M.] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Winchester, JM (corresponding author), SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA.	julia.winchester@stonybrook.edu			National Science Foundation [BCS 1341120]; Division Of Behavioral and Cognitive Sci [1341120] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by the National Science Foundation (www.nsf.gov) Doctoral Dissertation Improvement Grant BCS 1341120 to JW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Akkari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135243; Boyer DM, 2014, AM J PHYS ANTHROPOL, V153, P85; Boyer DM, 2015, ANAT REC, V298, P1816, DOI 10.1002/ar.23202; Boyer DM, 2010, AM J PHYS ANTHROPOL, V142, P194, DOI 10.1002/ajpa.21211; Boyer DM, 2008, J HUM EVOL, V55, P1118, DOI 10.1016/j.jhevol.2008.08.002; Bunn JM, 2011, AM J PHYS ANTHROPOL, V145, P247, DOI 10.1002/ajpa.21489; Bunn JM, 2009, AM J PRIMATOL, V71, P466, DOI 10.1002/ajp.20676; Dennis JC, 2004, AM J PHYS ANTHROPOL, V125, P152, DOI 10.1002/ajpa.10379; Desbrun M, 1999, COMP GRAPH, P317, DOI 10.1145/311535.311576; Evans A, 2009, J VERTEBR PALEONTOL, V29, p92A; Evans AR, 2014, ANN ZOOL FENN, V51, P73, DOI 10.5735/086.051.0209; Evans AR, 2013, HYSTRIX, V24, P133, DOI 10.4404/hystrix-24.1-6363; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Godfrey LR, 2012, AM J PHYS ANTHROPOL, V148, P215, DOI 10.1002/ajpa.21615; Guy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138802; Guy F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066142; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jernvall Jukka, 1999, Palaeontologia Electronica, V2, P1; Kallonen A, 2014, B INT ASS PALEODONTO, V8, P103; Klukkert Zachary S, 2012, Methods Mol Biol, V915, P145, DOI 10.1007/978-1-61779-977-8_9; Klukkert ZS, 2012, AM J PHYS ANTHROPOL, V148, P276, DOI 10.1002/ajpa.21592; Lawing AM, 2010, J ZOOL, V280, P1, DOI 10.1111/j.1469-7998.2009.00620.x; Ledogar JA, 2013, AM J PHYS ANTHROPOL, V150, P107, DOI 10.1002/ajpa.22181; M'Kirera F, 2003, AM J PRIMATOL, V60, P31, DOI 10.1002/ajp.10077; Min P., 2015, MESHCONV; Muller R, 2009, NAT REV RHEUMATOL, V5, P373, DOI 10.1038/nrrheum.2009.107; Plyusnin I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001742; Ramachandran P, 2011, COMPUT SCI ENG, V13, P40, DOI 10.1109/MCSE.2011.35; Salazar-Ciudad I, 2013, NATURE, V497, P361, DOI 10.1038/nature12142; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Skinner MM, 2010, AM J PHYS ANTHROPOL, V142, P157, DOI 10.1002/ajpa.21248; Ungar P.S., 2008, TECHNIQUE APPL DENT, V53, P253; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; van Rossum G., 1994, PYTHON REFERENCE MAN; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Winchester JM, 2014, AM J PHYS ANTHROPOL, V153, P29, DOI 10.1002/ajpa.22398; Zaslansky P, 2010, DENT MATER, V26, pE1, DOI 10.1016/j.dental.2009.09.007; Zohdy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109528	41	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147649	10.1371/journal.pone.0147649	http://dx.doi.org/10.1371/journal.pone.0147649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839960	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200052
J	Muntion, S; Ramos, TL; Diez-Campelo, M; Roson, B; Sanchez-Abarca, LI; Misiewicz-Krzeminska, I; Preciado, S; Sarasquete, ME; de las Rivas, J; Gonzalez, M; Sanchez-Guijo, F; del Canizo, MC				Muntion, Sandra; Ramos, Teresa L.; Diez-Campelo, Maria; Roson, Beatriz; Ignacio Sanchez-Abarca, Luis; Misiewicz-Krzeminska, Irena; Preciado, Silvia; Sarasquete, Maria-Eugenia; de las Rivas, Javier; Gonzalez, Marcos; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo			Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients	PLOS ONE			English	Article							BONE-MARROW; STEM-CELLS; EXTRACELLULAR VESICLES; MICRORNAS; EXPRESSION; MECHANISM; MDM2; HEMATOPOIESIS; COMMUNICATION; PATHOGENESIS	Exosomes/microvesicles (MVs) provide a mechanism of intercellular communication. Our hypothesis was that mesenchymal stromal cells (MSC) from myelodysplastic syndrome (MDS) patients could modify CD34(+) cells properties by MVs. They were isolated from MSC from MDS patients and healthy donors (HD). MVs from 30 low-risk MDS patients and 27 HD were purified by ExoQuick-TC (TM) or ultracentrifugation and identified by transmission electron microscopy, flow cytometry (FC) and western blot for CD63. Incorporation of MVs into CD34(+) cells was analyzed by FC, and confocal and fluorescence microscopy. Changes in hematopoietic progenitor cell (HPC) properties were assessed from modifications in microRNAs and gene expression in CD34(+) cells as well as viability and clonogenic assays of CD34(+) cells after MVs incorporation. Some microRNAs were overexpressed in MVs from patients MSC and two of them, miR-10a and miR-15a, were confirmed by RT-PCR. These microRNAs were transferred to CD34(+) cells, modifying the expression of MDM2 and P53 genes, which was evaluated by RT-PCR and western blot. Finally, examining CD34(+) cells properties after incorporation, higher cell viability (p = 0.025) and clonogenic capacity (p = 0.037) were observed when MVs from MDS patients were incorporated. In summary, we show that BM-MSC release MVs with a different cargo in MDS patients compared with HD. These structures are incorporated into HPC and modify their properties.	[Muntion, Sandra; Ramos, Teresa L.; Diez-Campelo, Maria; Ignacio Sanchez-Abarca, Luis; Misiewicz-Krzeminska, Irena; Preciado, Silvia; Sarasquete, Maria-Eugenia; Gonzalez, Marcos; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain; [Muntion, Sandra; Diez-Campelo, Maria; Ignacio Sanchez-Abarca, Luis; Preciado, Silvia; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Ctr Red Med Regenerat & Terapia Celular Castilla, Salamanca, Spain; [Muntion, Sandra; Diez-Campelo, Maria; Roson, Beatriz; Ignacio Sanchez-Abarca, Luis; Preciado, Silvia; de las Rivas, Javier; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Inst Nacl Salud Carlos III, Red Nacl Terapia Celular TerCel, Madrid, Spain; [Ignacio Sanchez-Abarca, Luis; Misiewicz-Krzeminska, Irena; Preciado, Silvia; Gonzalez, Marcos; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Univ Salamanca, CSIC, IBMCC, Ctr Invest Canc, E-37008 Salamanca, Spain; [Muntion, Sandra; Ramos, Teresa L.; Diez-Campelo, Maria; Ignacio Sanchez-Abarca, Luis; Preciado, Silvia; Sarasquete, Maria-Eugenia; Gonzalez, Marcos; Sanchez-Guijo, Fermin; del Canizo, Maria-Consuelo] Hosp Univ Salamanca, IBSAL, Salamanca, Spain; [Misiewicz-Krzeminska, Irena] Natl Med Inst, Warsaw, Poland	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; National Medicines Institute Lekow (NIL)	del Canizo, MC (corresponding author), Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain.	concarol@usal.es	De Las Rivas, Javier/G-5936-2014; Garcia-Sanz, Ramon/B-7986-2017; Roson Burgo, Beatriz/ABA-6235-2021; Sanchez-Guijo, Fermin/D-8542-2018; Preciado, silvia/AAV-7364-2021; Ramos, Teresa/GXG-4223-2022; Misiewicz-Krzeminska, Irena/M-4629-2015; sarasquete, Maria E/U-8063-2018	De Las Rivas, Javier/0000-0002-0984-9946; Garcia-Sanz, Ramon/0000-0003-4120-2787; Roson Burgo, Beatriz/0000-0002-9851-2025; Sanchez-Guijo, Fermin/0000-0002-7076-7739; Ramos, Teresa/0000-0002-0696-7197; Misiewicz-Krzeminska, Irena/0000-0002-4206-8586; sarasquete, Maria E/0000-0001-7335-3657; Diez Campelo, Maria/0000-0002-1467-6779; Muntion Olave, Sandra/0000-0001-7164-0767; Diez Campelo, Maria/0000-0003-0386-4835; PRECIADO, SILVIA/0000-0002-7811-4679; Gonzalez Diaz, Marcos/0000-0001-6637-1072	Gerencia Regional de Salud de Castilla y Leon [GRS 873/A/13]; Fondo de Investigaciones Sanitarias [PS09/01530]; Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [CEI10-1-0010)]; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/86451/2012]	Gerencia Regional de Salud de Castilla y Leon; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica(Ministry of Science and Innovation, Spain (MICINN)); Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Gerencia Regional de Salud de Castilla y Leon (GRS 873/A/13) MCC, Fondo de Investigaciones Sanitarias (PS09/01530) MCC, Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, 2008-2011 (CEI10-1-0010) MCC. A fellowship from the Portuguese Fundacao para a Ciencia e Tecnologia (SFRH/BD/86451/2012) TLR.	Abbas HA, 2011, CELL CYCLE, V10, P3257, DOI 10.4161/cc.10.19.17721; Abbas HA, 2010, CELL STEM CELL, V7, P606, DOI 10.1016/j.stem.2010.09.013; Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Blau O, 2011, BLOOD, V118, P5583, DOI 10.1182/blood-2011-03-343467; Bruno S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0304; Chen LH, 1997, J BIOL CHEM, V272, P22966, DOI 10.1074/jbc.272.36.22966; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Corrado C, 2014, CANCER LETT, V348, P71, DOI 10.1016/j.canlet.2014.03.009; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Fang J, 2012, CURR PHARM DESIGN, V18, P3170, DOI 10.2174/1381612811209023170; Flores-Figueroa E, 2008, LEUKEMIA RES, V32, P1407, DOI 10.1016/j.leukres.2008.02.013; Gajos-Michniewicz A, 2014, CANCER LETT, V347, P29, DOI 10.1016/j.canlet.2014.02.004; Gelderman MP, 2008, METHODS MOL BIOL, V484, P79, DOI 10.1007/978-1-59745-398-1_6; Gentalen ET, 2015, METHODS MOL BIOL, V1219, P139, DOI 10.1007/978-1-4939-1661-0_11; Geyh S, 2013, LEUKEMIA, V27, P1841, DOI 10.1038/leu.2013.193; Grange C, 2014, INT J MOL MED, V33, P1055, DOI 10.3892/ijmm.2014.1663; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Issa JPJ, 2013, BLOOD, V121, P3811, DOI 10.1182/blood-2013-02-451757; Li X, 2013, HAEMATOLOGICA, V98, P414, DOI 10.3324/haematol.2012.071753; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Pereira JKN, 2012, LEUKEMIA RES, V36, P1300, DOI 10.1016/j.leukres.2012.06.010; Pons A, 2009, LEUKEMIA LYMPHOMA, V50, P1854, DOI 10.3109/10428190903147645; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Ramos TL, 2015, CELL COMMUNICATIONS; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Rustandi Richard R, 2013, Methods Mol Biol, V988, P181, DOI 10.1007/978-1-62703-327-5_11; Sanchez MBH, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt514; Santamaria C, 2012, HAEMATOL-HEMATOL J, V97, P1218, DOI 10.3324/haematol.2011.054437; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Tauro S, 2001, HAEMATOLOGICA, V86, P1038; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilatou D, 2013, EPIGENETICS-US, V8, P561, DOI 10.4161/epi.24897; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Villaron EM, 2007, TRANSFUS APHER SCI, V37, P145, DOI 10.1016/j.transci.2007.05.001; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002; Zhao ZG, 2012, CANCER LETT, V317, P136, DOI 10.1016/j.canlet.2011.08.030	46	60	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0146722	10.1371/journal.pone.0146722	http://dx.doi.org/10.1371/journal.pone.0146722			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836120	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548500001
J	Li, HY; Ruberu, K; Karl, T; Garner, B				Li, Hongyun; Ruberu, Kalani; Karl, Tim; Garner, Brett			Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LIFE-SPAN; STRESS RESISTANCE; BINDING-PROPERTIES; PREFRONTAL CORTEX; ARACHIDONIC-ACID; HUMAN APOD; PROTEIN; HIPPOCAMPUS; DROSOPHILA	Recent studies have shown that cerebral apoD levels increase with age and in Alzheimer's disease (AD). In addition, loss of cerebral apoD in the mouse increases sensitivity to lipid peroxidation and accelerates AD pathology. Very little data are available, however, regarding the expression of apoD protein levels in different brain regions. This is important as both brain lipid peroxidation and neurodegeneration occur in a region-specific manner. Here we addressed this using western blotting of seven different regions (olfactory bulb, hippocampus, frontal cortex, striatum, cerebellum, thalamus and brain stem) of the mouse brain. Our data indicate that compared to most brain regions, the hippocampus is deficient in apoD. In comparison to other major organs and tissues (liver, spleen, kidney, adrenal gland, heart and skeletal muscle), brain apoD was approximately 10-fold higher (corrected for total protein levels). Our analysis also revealed that brain apoD was present at a lower apparent molecular weight than tissue and plasma apoD. Utilising peptide N-glycosidase-F and neuraminidase to remove N-glycans and sialic acids, respectively, we found that N-glycan composition (but not sialylation alone) were responsible for this reduction in molecular weight. We extended the studies to an analysis of human brain regions (hippocampus, frontal cortex, temporal cortex and cerebellum) where we found that the hippocampus had the lowest levels of apoD. We also confirmed that human brain apoD was present at a lower molecular weight than in plasma. In conclusion, we demonstrate apoD protein levels are variable across different brain regions, that apoD levels are much higher in the brain compared to other tissues and organs, and that cerebral apoD has a lower molecular weight than peripheral apoD; a phenomenon that is due to the N-glycan content of the protein.	[Li, Hongyun; Ruberu, Kalani; Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Li, Hongyun; Ruberu, Kalani; Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Karl, Tim] Neurosci Res Australia, Randwick, NSW 2031, Australia; [Karl, Tim] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Karl, Tim] Schizophrenia Res Inst, Randwick, NSW 2031, Australia	University of Wollongong; University of Wollongong; Neuroscience Research Australia; University of New South Wales Sydney	Garner, B (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.; Garner, B (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	brettg@uow.edu.au	Karl, Tim/E-2088-2011; Li, Hongyun/G-2301-2011	Karl, Tim/0000-0001-9904-8482; Li, Hongyun/0000-0003-3332-3132; Ruberu, Kalani/0000-0003-2575-5242	National Health and Medical Research Council (NHMRC) of Australia [1065982]; NHMRC [1045643, 1109831]; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) [R28AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded by a National Health and Medical Research Council (NHMRC) of Australia (http://www.nhmrc.gov.au/) Project Grant (Grant No. 1065982) awarded to TK and BG. TK and BG are supported by NHMRC Research Fellowships (Grant No. 1045643 and No. 1109831, respectively). The human brain tissue used in this work was supplied by the New South Wales Tissue Resource Centre at the University of Sydney and the Sydney Brain Bank, which are supported by the University of New South Wales, Neuroscience Research Australia, Schizophrenia Research Institute and the National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R28AA012725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajo-Graneras R, 2011, J NEUROCHEM, V117, P949, DOI 10.1111/j.1471-4159.2011.07266.x; Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; Bhatia S, 2013, J ALZHEIMERS DIS, V35, P475, DOI 10.3233/JAD-122278; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; CABRAL JHM, 1995, FEBS LETT, V366, P53, DOI 10.1016/0014-5793(95)00484-Q; Cofer S, 1996, GENE, V171, P261, DOI 10.1016/0378-1119(96)00099-6; CURRY MD, 1977, BIOCHIM BIOPHYS ACTA, V491, P232, DOI 10.1016/0005-2795(77)90059-9; Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148; DILLEY WG, 1990, BREAST CANCER RES TR, V16, P253, DOI 10.1007/BF01806333; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Garcia-Mateo N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00374; Glockner F, 2003, NEUROSCIENCE, V122, P103, DOI 10.1016/S0306-4522(03)00529-3; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Lea O A, 1988, Steroids, V52, P337, DOI 10.1016/0039-128X(88)90135-3; Li HY, 2015, NEUROBIOL AGING, V36, P1820, DOI 10.1016/j.neurobiolaging.2015.02.010; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MCCONATH.WJ, 1973, FEBS LETT, V37, P178, DOI 10.1016/0014-5793(73)80453-3; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Navarro A, 1998, NEUROSCI LETT, V254, P17, DOI 10.1016/S0304-3940(98)00639-9; Navarro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077852; Navarro A, 2010, AGE, V32, P85, DOI 10.1007/s11357-009-9117-0; Oakley AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034057; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; PEARLMAN WH, 1973, J BIOL CHEM, V248, P5736; PROVOST PR, 1991, J LIPID RES, V32, P1959; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Ruiz M, 2013, FEBS J, V280, P3928, DOI 10.1111/febs.12394; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sanchez D, 2015, EXP GERONTOL, V67, P19, DOI 10.1016/j.exger.2015.04.003; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Terrisse L, 1999, MOL BRAIN RES, V70, P26, DOI 10.1016/S0169-328X(99)00123-0; Thomas EA, 2003, BIOL PSYCHIAT, V54, P136, DOI 10.1016/S0006-3223(02)01976-5; Thomas EA, 2001, J NEUROCHEM, V79, P1059, DOI 10.1046/j.1471-4159.2001.00654.x; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Vogt M, 2001, J MOL RECOGNIT, V14, P79, DOI 10.1002/1099-1352(200101/02)14:1<79::AID-JMR521>3.0.CO;2-4; Walker DW, 2006, CURR BIOL, V16, P674, DOI 10.1016/j.cub.2006.01.057; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	45	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148238	10.1371/journal.pone.0148238	http://dx.doi.org/10.1371/journal.pone.0148238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829325	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200089
J	Royal, W; Cherner, M; Burdo, TH; Umlauf, A; Letendre, SL; Jumare, J; Abimiku, A; Alabi, P; Alkali, N; Bwala, S; Okwuasaba, K; Eyzaguirre, LM; Akolo, C; Guo, M; Williams, KC; Blattner, WA				Royal, Walter, III; Cherner, Mariana; Burdo, Tricia H.; Umlauf, Anya; Letendre, Scott L.; Jumare, Jibreel; Abimiku, Alash'le; Alabi, Peter; Alkali, Nura; Bwala, Sunday; Okwuasaba, Kanayo; Eyzaguirre, Lindsay M.; Akolo, Christopher; Guo, Ming; Williams, Kenneth C.; Blattner, William A.			Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria	PLOS ONE			English	Article							HEMOGLOBIN SCAVENGER RECEPTOR; IMMUNODEFICIENCY-VIRUS-INFECTION; NEUROCOGNITIVE IMPAIRMENT; ANTIRETROVIRAL THERAPY; SOLUBLE CD163; NEUROPSYCHOLOGICAL PERFORMANCE; MICROBIAL TRANSLOCATION; MONONUCLEAR PHAGOCYTES; DISEASE PROGRESSION; IMMUNE ACTIVATION	The potential role of gender in the occurrence of HIV-related neurocognitive impairment (NCI) and associations with markers of HIV-related immune activity has not been previously examined. In this study 149 antiretroviral-naive seropositive subjects in Nigeria (SP, 92 women and 57 men) and 58 seronegative (SN, 38 women and 20 men) were administered neuropsychological testing that assessed 7 ability domains. From the neuropsychological test scores was calculated a global deficit score (GDS), a measure of overall NCI. Percentages of circulating monocytes and plasma HIV RNA, soluble CD163 and soluble CD14 levels were also assessed. HIV SP women were found to be younger, more educated and had higher CD4+ T cell counts and borderline higher viral load measures than SP men. On the neuropsychological testing, SP women were more impaired in speed of information processing and verbal fluency and had a higher mean GDS than SN women. Compared to SP men, SP women were also more impaired in speed of information processing and verbal fluency as well as on tests of learning and memory. Numbers of circulating monocytes and plasma sCD14 and sCD163 levels were significantly higher for all SP versus all SN individuals and were also higher for SP women and for SP men versus their SN counterparts. Among SP women, soluble CD14 levels were slightly higher than for SP men, and SP women had higher viral load measurements and were more likely to have detectable virus than SP men. Higher sCD14 levels among SP women correlated with more severe global impairment, and higher viral load measurements correlated with higher monocyte numbers and sCD14 and sCD14 levels, associations that were not observed for SP men. These studies suggest that the risk of developing NCI differ for HIV infected women and men in Nigeria and, for women, may be linked to effects from higher plasma levels of HIV driving activation of circulating monocytes.	[Royal, Walter, III; Guo, Ming] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Cherner, Mariana; Umlauf, Anya] Univ Calif San Diego, Sch Med, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Burdo, Tricia H.; Letendre, Scott L.; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Jumare, Jibreel; Abimiku, Alash'le; Okwuasaba, Kanayo; Akolo, Christopher; Blattner, William A.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Jumare, Jibreel; Abimiku, Alash'le; Okwuasaba, Kanayo; Eyzaguirre, Lindsay M.; Akolo, Christopher] Inst Human Virol Nigeria, Abuja, Nigeria; [Alabi, Peter] Univ Abuja, Teaching Hosp, Gwagwalada, Abuja, Nigeria; [Alkali, Nura] Abubakar Tafawa Balewa Univ, Teaching Hosp, Bauchi, Nigeria; [Bwala, Sunday] Natl Hosp, Abuja, Nigeria	University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego; Boston College; University System of Maryland; University of Maryland Baltimore	Royal, W (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.	wroyal@som.umaryland.edu	Alkali, Nura/AAH-6357-2020; Letendre, Scott L./GLU-6874-2022; cherner, mariana/N-4810-2015	cherner, mariana/0000-0002-5479-7401; Okwuasaba, Kanayo/0000-0001-8625-528X	National Institute of Mental Health, NIH [R01 MH086356]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH086356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA040550] Funding Source: NIH RePORTER	National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work received grant support from the National Institute of Mental Health, NIH Grant #R01 MH086356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2014, J NEUROVIROL, V20, P380, DOI 10.1007/s13365-014-0254-6; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; BACKE E, 1991, J CLIN PATHOL, V44, P936, DOI 10.1136/jcp.44.11.936; Beck AT, 1996, PSYCHOL ASSESS; Bergmann S, 1998, RESP PHYSIOL, V114, P269, DOI 10.1016/S0034-5687(98)00098-X; Brauer KB, 2000, HANDBOOD CROSS CULTU, P73; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cherner M, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200401001-00005; Denton ML, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.110501; Durvasula RS, 2001, J CLIN EXP NEUROPSYC, V23, P149, DOI 10.1076/jcen.23.2.149.1211; Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508; Goodwin GM, 1996, AIDS, V10, P431, DOI 10.1097/00002030-199604000-00012; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hestad KA, 2012, J NERV MENT DIS, V200, P336, DOI 10.1097/NMD.0b013e31824cc225; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Huang ZS, 1996, ARTERIOSCL THROM VAS, V16, P256, DOI 10.1161/01.ATV.16.2.256; Jarrin I, 2008, AM J EPIDEMIOL, V168, P532, DOI 10.1093/aje/kwn179; Jaworowski A, 2007, J INFECT DIS, V196, P38, DOI 10.1086/518443; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Lopez OL, 1999, EUR J NEUROL, V6, P205, DOI 10.1111/j.1468-1331.1999.tb00014.x; Lyons JL, 2011, JAIDS-J ACQ IMM DEF, V57, P371, DOI 10.1097/QAI.0b013e3182237e54; MARDER K, 1995, ARCH NEUROL-CHICAGO, V52, P1174, DOI 10.1001/archneur.1995.00540360052016; MELTZER MS, 1990, ANNU REV IMMUNOL, V8, P169, DOI 10.1146/annurev.iy.08.040190.001125; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Naranbhai V, 2014, J INFECT DIS, V209, P500, DOI 10.1093/infdis/jit494; Odiase F, 2006, J NATL MED ASSOC, V98, P1260; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Robertson KR, 2004, JAIDS-J ACQ IMM DEF, V36, P817, DOI 10.1097/00126334-200407010-00008; Royal W, 2012, J NEUROVIROL, V18, P191, DOI 10.1007/s13365-012-0097-y; Ryan LA, 2001, J INFECT DIS, V184, P699, DOI 10.1086/323036; Sacktor NC, 1996, J NEUROVIROL, V2, P404, DOI 10.3109/13550289609146906; Salawu FK, 2008, J NEUROL SCI, V267, P142, DOI 10.1016/j.jns.2007.10.013; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Stern RA, 1998, J INT NEUROPSYCH SOC, V4, P172, DOI 10.1017/S1355617798001726; Timmerman KL, 2008, J LEUKOCYTE BIOL, V84, P1271, DOI 10.1189/jlb.0408244; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; World Health Organisation, 2007, WHO CAS DEF HIV SURV	51	59	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147182	10.1371/journal.pone.0147182	http://dx.doi.org/10.1371/journal.pone.0147182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829391	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200013
J	Kaucsar, T; Godo, M; Revesz, C; Kovacs, M; Mocsai, A; Kiss, N; Albert, M; Krenacs, T; Szenasi, G; Hamar, P				Kaucsar, Tamas; Godo, Maria; Revesz, Csaba; Kovacs, Miklos; Mocsai, Attila; Kiss, Norbert; Albert, Mihaly; Krenacs, Tibor; Szenasi, Gabor; Hamar, Peter			Urine/Plasma Neutrophil Gelatinase Associated Lipocalin Ratio Is a Sensitive and Specific Marker of Subclinical Acute Kidney Injury in Mice	PLOS ONE			English	Article							EPITHELIAL-CELLS; PROTECTS MICE; NGAL; CREATININE; BIOMARKER; ACTIVATION; IDENTIFICATION; SURGERY; URINE; RNA	Background Detection of acute kidney injury (AKI) is still a challenge if conventional markers of kidney function are within reference range. We studied the sensitivity and specificity of NGAL as an AKI marker at different degrees of renal ischemia. Methods Male C57BL/6J mice were subjected to 10-, 20- or 30-min unilateral renal ischemia, to control operation or no operation, and AKI was evaluated 1 day later by histology, immunohistochemistry, BUN, creatinine, NGAL (plasma and urine) and renal NGAL mRNA expression. Results A short (10-min) ischemia did not alter BUN or kidney histology, but elevated plasma and urinary NGAL level and renal NGAL mRNA expression although to a much smaller extent than longer ischemia. Surprisingly, control operation elevated plasma NGAL and renal NGAL mRNA expression to a similar extent as 10-min ischemia. Further, the ratio of urine to plasma NGAL was the best parameter to differentiate a 10-min ischemic injury from control operation, while it was similar in the non and control-operated groups. Conclusions These results suggest that urinary NGAL excretion and especially ratio of urine to plasma NGAL are sensitive and specific markers of subclinical acute kidney injury in mice.	[Kaucsar, Tamas; Godo, Maria; Revesz, Csaba; Kiss, Norbert; Szenasi, Gabor; Hamar, Peter] Semmelweis Univ, Inst Pathophysiol, H-1085 Budapest, Hungary; [Kovacs, Miklos; Mocsai, Attila] Semmelweis Univ, Dept Physiol, MTA SE Lendlet Inflammat Physiol Res Grp, H-1085 Budapest, Hungary; [Albert, Mihaly] CEVA Phylaxia Ltd, Budapest, Hungary; [Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, MTA SE Tumor Progress Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Ceva Sante Animale; Semmelweis University	Hamar, P (corresponding author), Semmelweis Univ, Inst Pathophysiol, H-1085 Budapest, Hungary.	hamar.peter@med.semmelweis-univ.hu	Szénási, Gábor/K-3136-2017; Kiss, Norbert/O-5821-2016; Szenasi, Gabor/ABH-2591-2021; Hamar, Peter/A-8996-2010; Revesz, Csaba/AAA-5722-2022; Kaucsár, Tamás/H-4904-2016	Szénási, Gábor/0000-0002-7350-6091; Kiss, Norbert/0000-0002-9947-1755; Hamar, Peter/0000-0002-1095-3564; Kaucsár, Tamás/0000-0003-4460-1265	Hungarian Research Fund [OTKA ANN-110810, SNN-114619, ETT 07-011/2009]; Bolyai Research Scholarship of the Hungarian Academy of Sciences and Merit Award of Semmelweis University; Lendulet program of the Hungarian Academy of Sciences [LP2013-66]	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Research Scholarship of the Hungarian Academy of Sciences and Merit Award of Semmelweis University; Lendulet program of the Hungarian Academy of Sciences	Support was provided to PH from the Hungarian Research Fund: OTKA ANN-110810, SNN-114619, ETT 07-011/2009 and Bolyai Research Scholarship of the Hungarian Academy of Sciences and Merit Award of Semmelweis University (to PH), as well as by the Lendulet program of the Hungarian Academy of Sciences (LP2013-66 to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON L, 1995, SCAND J CLIN LAB INV, V55, P577, DOI 10.3109/00365519509110257; Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2; Cai LJ, 2010, CLIN J AM SOC NEPHRO, V5, P2229, DOI 10.2215/CJN.00980110; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clerico A, 2012, CLIN CHEM LAB MED, V50, P1505, DOI 10.1515/cclm-2011-0814; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Efrati S, 2012, NEPHROLOGY, V17, P591, DOI 10.1111/j.1440-1797.2012.01638.x; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase-Fielitz A, 2014, ANN CLIN BIOCHEM, V51, P335, DOI 10.1177/0004563214521795; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Helmersson-Karlqvist J, 2013, CLIN BIOCHEM, V46, P70, DOI 10.1016/j.clinbiochem.2012.09.022; Hjortrup PB, 2013, CRIT CARE, V17, DOI 10.1186/cc11855; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Jakus Z, 2010, ARTHRITIS RHEUM-US, V62, P1899, DOI 10.1002/art.27438; Kaucsar T, 2013, NUCLEIC ACID THER, V23, P344, DOI 10.1089/nat.2013.0438; Krenacs T, 2010, METHODS MOL BIOL, V664, P163, DOI 10.1007/978-1-60761-806-5_16; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Lacquaniti A, 2013, RADIOLOGY, V267, P86, DOI 10.1148/radiol.12120578; Leelahavanichkul A, 2014, AM J PHYSIOL-RENAL, V307, pF939, DOI 10.1152/ajprenal.00025.2013; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCullough PA, 2013, CONTRIB NEPHROL, V182, P13, DOI 10.1159/000349963; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nielsen SE, 2010, DIABETIC MED, V27, P1144, DOI 10.1111/j.1464-5491.2010.03083.x; Paragas N, 2012, BBA-MOL CELL RES, V1823, P1451, DOI 10.1016/j.bbamcr.2012.06.014; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Pera M, 2003, J GASTROINTEST SURG, V7, P783, DOI 10.1016/S1091-255X(03)00111-2; ROSEN SM, 1972, BRIT J ANAESTH, V44, P252, DOI 10.1093/bja/44.3.252; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Schock-Kusch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071519; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Singer E, 2013, ACTA PHYSIOL, V207, P663, DOI 10.1111/apha.12054; Steinhauser ML, 1999, J IMMUNOL, V162, P5437; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Tsai WH, 2013, J CHIN MED ASSOC, V76, P486, DOI 10.1016/j.jcma.2013.05.004; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062; Yang C, 2008, CELL DEATH DIFFER, V15, P530, DOI 10.1038/sj.cdd.4402287	48	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148043	10.1371/journal.pone.0148043	http://dx.doi.org/10.1371/journal.pone.0148043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824608	Green Published, gold, Green Accepted			2022-12-27	WOS:000369528600093
J	Stacchiotti, A; Favero, G; Lavazza, A; Golic, I; Aleksic, M; Korac, A; Rodella, LF; Rezzani, R				Stacchiotti, Alessandra; Favero, Gaia; Lavazza, Antonio; Golic, Igor; Aleksic, Marija; Korac, Aleksandra; Rodella, Luigi Fabrizio; Rezzani, Rita			Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL DYSFUNCTION; PROTECTIVE ROLE; ADIPOSE-TISSUE; DIABETIC MICE; MOUSE-LIVER; OBESITY; METABOLISM; ZONATION	Background Obesity is a common risk factor for non-alcoholic fatty liver disease (NAFLD). Currently, there are no specific treatments against NAFLD. Thus, examining any molecule with potential benefits against this condition emerged melatonin as a molecule that influences metabolic dysfunctions. The aim of this study was to determine whether melatonin would function against NAFDL, studying morphological, ultrastuctural and metabolic markers that characterize the liver of ob/ob mice. Methods Lean and ob/ob mice were supplemented with melatonin in the drinking water for 8 weeks. Histology and stereology were performed to assess hepatic steatosis and glycogen deposition. Ultrastructural features of mitochondria, endoplasmic reticulum (ER) and their juxtapositions were evaluated in livers of all experimental groups. Furthermore, hepatic distribution and expression of markers of ER and mitochondria (calnexin, ATP sintase beta, GRP78 and CHOP) and metabolic dysfunction (RPB4, beta-catenin) and cellular longevity (SIRT1) were analyzed. Results Melatonin significantly reduced glycemia, identified also by a decrease of hepatic RBP4 expression, reversed macrosteatosis in microsteatosis at the hepatic pericentral zone, enlarged ER-mitochondrial distance and ameliorated the morphology and organization of these organelles in ob/ob mouse liver. Furthermore, in ob/ob mice, calnexin and ATP synthase beta were partially restored, GRP78 and CHOP decreased in periportal and midzonal hepatocytes and beta-catenin expression was, in part, restored in peripheral membranes of hepatocytes. Melatonin supplementation to ob/ob mice improves hepatic morphological, ultrastructural and metabolic damage that occurs as a result of NAFLD. Conclusions Melatonin may be a potential adjuvant treatment to limit NAFLD and its progression into irreversible complications.	[Stacchiotti, Alessandra; Favero, Gaia; Rodella, Luigi Fabrizio; Rezzani, Rita] Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Viale Europa 11, I-25123 Brescia, Italy; [Stacchiotti, Alessandra; Rodella, Luigi Fabrizio; Rezzani, Rita] Univ Brescia, Interdipartimental Univ Ctr Res Adapt & Regenerat, I-25121 Brescia, Italy; [Lavazza, Antonio] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Via Bianchi 7-9, I-25124 Brescia, Italy; [Golic, Igor; Aleksic, Marija; Korac, Aleksandra] Univ Belgrade, Fac Biol, Ctr Electron Microscopy, Belgrade, Serbia	University of Brescia; University of Brescia; IZS Lombardia e Emilia; University of Belgrade	Rezzani, R (corresponding author), Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Viale Europa 11, I-25123 Brescia, Italy.; Rezzani, R (corresponding author), Univ Brescia, Interdipartimental Univ Ctr Res Adapt & Regenerat, I-25121 Brescia, Italy.	rita.rezzani@unibs.it	Golic, Igor/B-4492-2009; Stacchiotti, Alessandra/AAA-2193-2019; Stacchiotti, Alessandra/AAL-7239-2021; lavazza, antonio/G-8182-2011	Golic, Igor/0000-0001-5944-5053; lavazza, antonio/0000-0002-7646-3592	New Petfood Italia S.r.l.; Fondazione Cariplo e Regione Lombardia [2014-2256]	New Petfood Italia S.r.l.; Fondazione Cariplo e Regione Lombardia	Sincere thanks to New Petfood Italia S.r.l. and Fondazione Cariplo e Regione Lombardia, "New opportunities and ways towards ERC" (Project 2014-2256) for grants donation.	Acuna Castroviejo Dario, 2002, Curr Top Med Chem, V2, P133; Agabiti-Rosei C, 2014, J HYPERTENS, V32, P1264, DOI 10.1097/HJH.0000000000000178; Agil A, 2015, J PINEAL RES, V59, P70, DOI 10.1111/jpi.12241; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Berasain C, 2014, HEPATOLOGY, V59, P2080, DOI 10.1002/hep.27000; Bousette N, 2014, J CELL PHYSIOL, V229, P374, DOI 10.1002/jcp.24459; Carloni S, 2014, J PINEAL RES, V57, P192, DOI 10.1111/jpi.12156; Chalasani N, 2008, J HEPATOL, V48, P829, DOI 10.1016/j.jhep.2008.01.016; Christou GA, 2012, HORM METAB RES, V44, P6, DOI 10.1055/s-0031-1295491; Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Codenotti S, 2015, ONCOL REP, V34, P279, DOI 10.3892/or.2015.3987; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; de Luxan-Delgado B, 2014, J PINEAL RES, V56, P126, DOI 10.1111/jpi.12104; den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e; El-Badry AM, 2007, HEPATOLOGY, V45, P855, DOI 10.1002/hep.21625; Favero G, 2015, NUTR RES, V35, P891, DOI 10.1016/j.nutres.2015.07.001; Favero G, 2015, AGE, V37, DOI 10.1007/s11357-015-9804-y; Favero G, 2014, ACTA HISTOCHEM, V116, P272, DOI 10.1016/j.acthis.2013.08.006; Favero G, 2013, ACTA HISTOCHEM, V115, P783, DOI 10.1016/j.acthis.2013.02.014; Garcia JJ, 2014, J PINEAL RES, V56, P225, DOI 10.1111/jpi.12128; Garcia-Ruiz I, 2007, HEPATOLOGY, V46, P414, DOI 10.1002/hep.21687; Ge YX, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/945076; Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491; Giorgi C, 2015, ANTIOXID REDOX SIGN, V22, P995, DOI 10.1089/ars.2014.6223; Govender J, 2014, J PINEAL RES, V57, P367, DOI 10.1111/jpi.12176; Hempel M, 2015, CELL MOL LIFE SCI, V72, P2599, DOI 10.1007/s00018-015-1861-y; Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007; Ikura Y, 2014, WORLD J HEPATOL, V6, P894, DOI 10.4254/wjh.v6.i12.894; Lee D, 2015, J BIOL CHEM, V290, P5725, DOI 10.1074/jbc.M114.635474; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07973; Macias M, 2003, EUR J BIOCHEM, V270, P832, DOI 10.1046/j.1432-1033.2003.03430.x; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Mansouri M, 2014, J DIABETES INVEST, V5, P484, DOI 10.1111/jdi.12186; Marseglia L, 2013, J PEDIATR-US, V162, P357, DOI 10.1016/j.jpeds.2012.07.019; Martin M, 2002, INT J BIOCHEM CELL B, V34, P348, DOI 10.1016/S1357-2725(01)00138-8; Martin M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x; Masarone M, 2014, REV RECENT CLIN TRIA, V9, P126, DOI 10.2174/1574887109666141216111143; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Mozdzan M, 2014, ARCH MED SCI, V10, P669, DOI 10.5114/aoms.2014.44858; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Purushotham A, 2009, AGING-US, V1, P669, DOI 10.18632/aging.100076; Radogna F, 2008, J PINEAL RES, V44, P316, DOI 10.1111/j.1600-079X.2007.00532.x; Reiter RJ, 2012, ANN MED, V44, P564, DOI 10.3109/07853890.2011.586365; Rios-Lugo MJ, 2010, J PINEAL RES, V49, P342, DOI 10.1111/j.1600-079X.2010.00798.x; Rodella LF, 2013, AGE, V35, P103, DOI 10.1007/s11357-011-9336-z; Rodella LF, 2012, CELLS TISSUES ORGANS, V195, P252, DOI 10.1159/000324919; Sartori C, 2009, ENDOCRINOLOGY, V150, P5311, DOI 10.1210/en.2009-0425; Sodhi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128648; Solis-Munoz P, 2011, J PINEAL RES, V51, P113, DOI 10.1111/j.1600-079X.2011.00868.x; Stacchiotti A, 2009, FOOD CHEM TOXICOL, V47, P2834, DOI 10.1016/j.fct.2009.09.003; Tan DX, 2011, OBES REV, V12, P167, DOI 10.1111/j.1467-789X.2010.00756.x; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Tsutsumi A, 2015, INT J OCCUP MED ENV, V28, P4, DOI 10.2478/s13382-014-0319-z; Venegas C, 2013, J PINEAL RES, V54, P313, DOI 10.1111/jpi.12019; Wang CJ, 2014, DIABETES, V63, P947, DOI 10.2337/db13-1096; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x	65	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148115	10.1371/journal.pone.0148115	http://dx.doi.org/10.1371/journal.pone.0148115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824477	Green Published, gold			2022-12-27	WOS:000369528600100
J	Tewfik, A; Bell, SS; McCann, KS; Morrow, K				Tewfik, Alexander; Bell, Susan S.; McCann, Kevin S.; Morrow, Kristina			Predator Diet and Trophic Position Modified with Altered Habitat Morphology	PLOS ONE			English	Article							EXPOSED SANDY BEACHES; CRABS OCYPODE-QUADRATA; FOOD-WEB COMPLEXITY; GHOST CRABS; COMMUNITY STRUCTURE; MARINE SUBSIDIES; STABLE-ISOTOPES; CHAIN LENGTH; OCEAN BEACH; MACROFAUNA	Empirical patterns that emerge from an examination of food webs over gradients of environmental variation can help to predict the implications of anthropogenic disturbance on ecosystems. This "dynamic food web approach" is rarely applied at the coastal margin where aquatic and terrestrial systems are coupled and human development activities are often concentrated. We propose a simple model of ghost crab (Ocypode quadrata) feeding that predicts changing dominant prey (Emerita talpoida, Talorchestia sp., Donax variablis) along a gradient of beach morphology and test this model using a suite of 16 beaches along the Florida, USA coast. Assessment of beaches included quantification of morphological features (width, sediments, slope), macrophyte wrack, macro-invertebrate prey and active ghost crab burrows. Stable isotope analysis of carbon (C-13/C-12) and nitrogen (N-15/N-14) and the SIAR mixing model were used to determine dietary composition of ghost crabs at each beach. The variation in habitat conditions displayed with increasing beach width was accompanied by quantifiable shifts in ghost crab diet and trophic position. Patterns of ghost crab diet were consistent with differences recorded across the beach width gradient with respect to the availability of preferred micro-habitats of principal macro-invertebrate prey. Values obtained for trophic position also suggests that the generalist ghost crab assembles and augments its diet in fundamentally different ways as habitat morphology varies across a highly dynamic ecosystem. Our results offer support for a functional response in the trophic architecture of a common food web compartment (ghost crabs, macro-invertebrate prey) across well-known beach morphologies. More importantly, our "dynamic food web approach" serves as a basis for evaluating how globally wide-spread sandy beach ecosystems should respond to a variety of anthropogenic impacts including beach grooming, beach re-nourishment, introduction of non-native or feral predators and human traffic on beaches.	[Tewfik, Alexander; Bell, Susan S.; Morrow, Kristina] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA; [McCann, Kevin S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	State University System of Florida; University of South Florida; University of Guelph	Tewfik, A (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	atewfik@wcs.org			National Science Foundation [043180]; Biological Oceanography Program; Natural Sciences and Engineering Research Council of Canada Discovery	National Science Foundation(National Science Foundation (NSF)); Biological Oceanography Program; Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science Foundation grant 043180, Biological Oceanography Program to SSB, and Natural Sciences and Engineering Research Council of Canada Discovery Grant to KSM.	Adams TS, 2000, LIMNOL OCEANOGR, V45, P601, DOI 10.4319/lo.2000.45.3.0601; Adin R, 2003, ESTUAR COAST SHELF S, V56, P91, DOI 10.1016/S0272-7714(02)00124-5; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Barros F, 2001, BIOL CONSERV, V97, P399, DOI 10.1016/S0006-3207(00)00116-6; Barton BT, 2008, BIOL CONSERV, V141, P2139, DOI 10.1016/j.biocon.2008.06.013; Bergamino L, 2011, ESTUAR COAST SHELF S, V91, P536, DOI 10.1016/j.ecss.2010.12.007; Britton J. C., 1989, SHORE ECOLOGY GULF M; BRITTON JC, 1994, OCEANOGR MAR BIOL, V32, P369; Chan BKK, 2006, HYDROBIOLOGIA, V560, P43, DOI 10.1007/s10750-005-1088-2; Christoffers EWI, 1986, ECOLOGY GHOST CRAB O; COHEN JE, 1985, PROC R SOC SER B-BIO, V224, P449, DOI 10.1098/rspb.1985.0043; Colombini I, 2000, MAR BIOL, V136, P531, DOI 10.1007/s002270050713; Coupland GT, 2007, ECOSYSTEMS, V10, P1341, DOI 10.1007/s10021-007-9102-3; de la Huz R, 2005, ESTUAR COAST SHELF S, V65, P19, DOI 10.1016/j.ecss.2005.03.024; de la Huz R, 2002, J SEA RES, V47, P85, DOI 10.1016/S1385-1101(02)00108-9; Defeo O, 2005, MAR ECOL PROG SER, V295, P1, DOI 10.3354/meps295001; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Degraer S, 1999, ESTUARIES, V22, P742, DOI 10.2307/1353107; DELANCEY LB, 1989, J COASTAL RES, V5, P477; Doi H, 2009, OIKOS, V118, P138, DOI 10.1111/j.1600-0706.2008.17171.x; Dolson R, 2009, OIKOS, V118, P1230, DOI 10.1111/j.1600-0706.2009.17351.x; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; Dugan JE, 2013, GEOMORPHOLOGY, V199, P95, DOI 10.1016/j.geomorph.2013.04.043; FALES R R, 1976, Chesapeake Science, V17, P65, DOI 10.2307/1350581; Foster CR, 2009, ESTUAR COAST, V32, P1079, DOI 10.1007/s12237-009-9224-2; France RL, 1997, CAN J FISH AQUAT SCI, V54, P1255, DOI 10.1139/f97-044; Fry B., 2006, STABLE ISOTOPE ECOLO; GRIFFITHS CL, 1981, ESTUAR COAST SHELF S, V12, P645, DOI 10.1016/S0302-3524(81)80062-X; HALEY S R, 1972, Crustaceana (Leiden), V23, P1, DOI 10.1163/156854072X00011; Hobbs CH, 2008, J COASTAL RES, V24, P1450, DOI 10.2112/07-0856.1; Holmes C.W., 2011, GULF MEXICO ORIGIN W, V3, P89; Horwith MJ, 2005, INTEGR COMP BIOL, V45, P1147; Huijbers CM, 2013, LANDSCAPE URBAN PLAN, V119, P1, DOI 10.1016/j.landurbplan.2013.06.004; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Huxel GR, 1998, AM NAT, V152, P460, DOI 10.1086/286182; Ince R, 2007, ESTUAR COAST SHELF S, V74, P77, DOI 10.1016/j.ecss.2007.03.029; Jackson DA, 1997, ECOLOGY, V78, P929; James RJ, 1996, ESTUAR COAST SHELF S, V43, P81, DOI 10.1006/ecss.1996.0058; Jaramillo E, 2001, MAR ECOL-P S Z N I, V22, P323, DOI 10.1046/j.1439-0485.2001.01752.x; JARAMILLO E, 1993, ESTUAR COAST SHELF S, V37, P615, DOI 10.1006/ecss.1993.1077; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; LEBER KM, 1982, B MAR SCI, V32, P86; Little C, 2000, BIOL SOFT SHORES EST, P35; Lucrezi S, 2014, OCEANOGR MAR BIOL, V52, P201; Manning LM, 2014, MAR ECOL PROG SER, V508, P1, DOI 10.3354/meps10870; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; MASSELINK G, 1993, J COASTAL RES, V9, P785; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McLachlan A, 1995, OCEANOGR MAR BIOL, V33, P305; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; McLachlan A, 2006, ECOLOGY SANDY SHORES; Mellbrand K, 2011, ECOSYSTEMS, V14, P732, DOI 10.1007/s10021-011-9442-x; Morrow K, 2014, MAR ECOL PROG SER, V502, P197, DOI 10.3354/meps10728; NELSON WG, 1986, OPHELIA, V26, P305, DOI 10.1080/00785326.1986.10421996; Olabarria C, 2007, MAR ENVIRON RES, V63, P19, DOI 10.1016/j.marenvres.2006.06.001; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pavesi L, 2013, J COAST CONSERV, V17, P841, DOI 10.1007/s11852-013-0285-9; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson CH, 2000, J COASTAL RES, V16, P368; Peterson CH, 2006, J EXP MAR BIOL ECOL, V338, P205, DOI 10.1016/j.jembe.2006.06.021; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; Pinotti RM, 2014, BIOTA NEOTROP, V14, DOI 10.1590/1676-06032014006914; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Pombo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083792; Poore AGB, 2013, HYDROBIOLOGIA, V701, P117, DOI 10.1007/s10750-012-1263-1; Porri F, 2011, MAR ECOL PROG SER, V426, P253, DOI 10.3354/meps08951; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Quijon P, 2001, CRUSTACEANA, V74, P91, DOI 10.1163/156854001505460; Rakocinski CF, 1996, J COASTAL RES, V12, P326; Fernandes RSR, 2006, MAR ECOL-EVOL PERSP, V27, P160, DOI 10.1111/j.1439-0485.2006.00093.x; ROBERTSON JR, 1982, J EXP MAR BIOL ECOL, V59, P1, DOI 10.1016/0022-0981(82)90102-2; Schlacher TA, 2015, ESTUAR COAST SHELF S, V157, P1, DOI 10.1016/j.ecss.2015.02.002; Schlacher TA, 2013, ACTA OECOL, V48, P7, DOI 10.1016/j.actao.2013.01.007; Schlacher TA, 2011, ECOL INDIC, V11, P284, DOI 10.1016/j.ecolind.2010.05.006; Schlacher TA, 2009, ECOSYSTEMS, V12, P311, DOI 10.1007/s10021-008-9224-2; SHORT AD, 1979, J GEOL, V87, P553, DOI 10.1086/628445; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Stapp P, 2003, OECOLOGIA, V134, P496, DOI 10.1007/s00442-002-1146-7; STEINER AJ, 1981, BIOL CONSERV, V20, P111, DOI 10.1016/0006-3207(81)90022-7; Stenroth P, 2008, OECOLOGIA, V156, P681, DOI 10.1007/s00442-008-1019-9; Strachan PH, 1999, SCI MAR, V63, P51, DOI 10.3989/scimar.1999.63n151; Tewfik A, 2005, ECOLOGY, V86, P2726, DOI 10.1890/04-1537; Tewfik A, 2007, CAN J FISH AQUAT SCI, V64, P956, DOI 10.1139/F07-071; Tunney TD, 2014, P NATL ACAD SCI USA, V111, P8077, DOI 10.1073/pnas.1319618111; Tunney TD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2098; Turra A, 2005, J NAT HIST, V39, P2163, DOI 10.1080/00222930500060165; Valero-Pacheco E, 2007, CRUSTACEANA, V80, P313, DOI 10.1163/156854007780162479; van der Zee EM, 2012, ECOSYSTEMS, V15, P664, DOI 10.1007/s10021-012-9538-y; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; WADE BA, 1967, B MAR SCI, V17, P149; WILLIAMS JA, 1982, MAR BIOL, V69, P65, DOI 10.1007/BF00396962; WOLCOTT TG, 1978, J EXP MAR BIOL ECOL, V31, P67, DOI 10.1016/0022-0981(78)90137-5; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; WRIGHT LD, 1984, MAR GEOL, V56, P93, DOI 10.1016/0025-3227(84)90008-2; Zar J.H., 2010, BIOSTAT ANAL	100	33	33	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147759	10.1371/journal.pone.0147759	http://dx.doi.org/10.1371/journal.pone.0147759			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824766	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600055
J	Chowdhury, B; Seetharam, A; Wang, ZP; Liu, YL; Lossie, AC; Thimmapuram, J; Irudayaraj, J				Chowdhury, Basudev; Seetharam, Arun; Wang, Zhiping; Liu, Yunlong; Lossie, Amy C.; Thimmapuram, Jyothi; Irudayaraj, Joseph			A Study of Alterations in DNA Epigenetic Modifications (5mC and 5hmC) and Gene Expression Influenced by Simulated Microgravity in Human Lymphoblastoid Cells	PLOS ONE			English	Article							STRESS-RESPONSE; SPACE-FLIGHT; METHYLATION; GENOME; 5-HYDROXYMETHYLCYTOSINE; INSTABILITY; ACTIVATION; METHYLOME; APOPTOSIS; EPIGENOME	Cells alter their gene expression in response to exposure to various environmental changes. Epigenetic mechanisms such as DNA methylation are believed to regulate the alterations in gene expression patterns. In vitro and in vivo studies have documented changes in cellular proliferation, cytoskeletal remodeling, signal transduction, bone mineralization and immune deficiency under the influence of microgravity conditions experienced in space. However microgravity induced changes in the epigenome have not been well characterized. In this study we have used Next-generation Sequencing (NGS) to profile ground-based "simulated" microgravity induced changes on DNA methylation (5-methylcytosine or 5mC), hydroxymethylation (5-hydroxymethylcytosine or 5hmC), and simultaneous gene expression in cultured human lymphoblastoid cells. Our results indicate that simulated microgravity induced alterations in the methylome (similar to 60% of the differentially methylated regions or DMRs are hypomethylated and similar to 92% of the differentially hydroxymethylated regions or DHMRs are hyperhydroxymethylated). Simulated microgravity also induced differential expression in 370 transcripts that were associated with crucial biological processes such as oxidative stress response, carbohydrate metabolism and regulation of transcription. While we were not able to obtain any global trend correlating the changes of methylation/hydroxylation with gene expression, we have been able to profile the simulated microgravity induced changes of 5mC over some of the differentially expressed genes that includes five genes undergoing differential methylation over their promoters and twenty five genes undergoing differential methylation over their gene-bodies. To the best of our knowledge, this is the first NGS-based study to profile epigenomic patterns induced by short time exposure of simulated microgravity and we believe that our findings can be a valuable resource for future explorations.	[Chowdhury, Basudev] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Chowdhury, Basudev; Lossie, Amy C.; Irudayaraj, Joseph] Purdue Univ, Bindley Biosci Ctr, Discovery Pk, W Lafayette, IN 47907 USA; [Wang, Zhiping; Liu, Yunlong] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Wang, Zhiping; Liu, Yunlong] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Thimmapuram, Jyothi] Purdue Univ, Bioinformat Core, W Lafayette, IN 47907 USA; [Lossie, Amy C.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Irudayaraj, Joseph] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Lossie, Amy C.] NIH, Off Behav & Social Sci Res, Bldg 10, Bethesda, MD 20892 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA	Irudayaraj, J (corresponding author), Purdue Univ, Bindley Biosci Ctr, Discovery Pk, W Lafayette, IN 47907 USA.; Thimmapuram, J (corresponding author), Purdue Univ, Bioinformat Core, W Lafayette, IN 47907 USA.; Irudayaraj, J (corresponding author), Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA.	jyothit@purdue.edu; josephi@purdue.edu		Seetharam, Arun/0000-0002-6789-9298; Irudayaraj, Joseph/0000-0002-0630-1520	NASA [NNX12AN09G]; NIH, NCI, Cancer Prevention Internship Program [R25CA128770]; Indiana CTSI [TR000006]; W.M. Keck Foundation; Purdue Center for Cancer Research [P30CA023168]; National Aeronautics and Space Administration (NASA) [NNX12AN09G]; National Institute of Health (NIH), National Cancer Institute (NCI), Cancer Prevention Internship Program [R25CA128770]; Indiana Clinical and Translational Sciences Institute (CTSI) [TR000006]; NATIONAL CANCER INSTITUTE [R25CA128770, P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR000006] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH, NCI, Cancer Prevention Internship Program; Indiana CTSI; W.M. Keck Foundation(W.M. Keck Foundation); Purdue Center for Cancer Research; National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Institute of Health (NIH), National Cancer Institute (NCI), Cancer Prevention Internship Program; Indiana Clinical and Translational Sciences Institute (CTSI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors would like to acknowledge the following agencies for their support in funding this study: a) NASA (NNX12AN09G); b) NIH, NCI R25CA128770 Cancer Prevention Internship Program; c) Indiana CTSI (TR000006); d) W.M. Keck Foundation; e) Purdue Center for Cancer Research (P30CA023168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the National Aeronautics and Space Administration (NASA) task "Defining Epigenetic Programming During Flight Expeditions in Differentiating Embryonic Stem Cells" (NNX12AN09G) for the funding. Partial support provided by the W. M. Keck Foundation; National Institute of Health (NIH), National Cancer Institute (NCI) R25CA128770 Cancer Prevention Internship Program; Indiana Clinical and Translational Sciences Institute (CTSI) (TR000006) and Purdue Center for Cancer Research (P30CA023168) is appreciated. We thank Dr. Phillip Miguel for generating the NGS data and Dr. Hongyu Gao for submitting the Sequencing data in NCBI GEO.	Andrews S., 2009, FASTQC QUALITY CONTR; Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baudouin-Cornu P, 2006, BIOCHIMIE, V88, P1673, DOI 10.1016/j.biochi.2006.03.001; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Butcher LM, 2010, METHODS, V52, P223, DOI 10.1016/j.ymeth.2010.04.003; Carmeliet G, 2001, CRIT REV EUKAR GENE, V11, P131; Chowdhury B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09281; Dang BR, 2014, LIFE SCI, V97, P123, DOI 10.1016/j.lfs.2013.12.008; Degan P, 2001, J Gravit Physiol, V8, pP21; Degan P, 2005, J CELL BIOCHEM, V94, P460, DOI 10.1002/jcb.20302; Dietrich LCaJ, 2010, MEDIPS MEDIP SEQ DAT; Haffner MC, 2011, ONCOTARGET, V2, P627; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Hussain T, 2012, INT J MOL CELL MED, V1, P75; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; LEVY JA, 1968, CANCER-AM CANCER SOC, V22, P517, DOI 10.1002/1097-0142(196809)22:3<517::AID-CNCR2820220305>3.0.CO;2-A; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li WW, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870726; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Londin ER, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-464; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; Marinov GK, 2014, G3-GENES GENOM GENET, V4, P209, DOI 10.1534/g3.113.008680; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morey-Holton E R, 1991, Adv Space Biol Med, V1, P37; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ou XF, 2010, GENOME, V53, P524, DOI [10.1139/G10-030, 10.1139/g10-030]; Ou XF, 2009, MUTAT RES-FUND MOL M, V662, P44, DOI 10.1016/j.mrfmmm.2008.12.004; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Roman TN, 2015, BIOTECHNOLOGY; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schwartz JL, 2004, MUTAGENESIS, V19, P477, DOI 10.1093/mutage/geh060; Shimada N, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-10; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Sonnenfeld Gerald, 2003, Rev Environ Health, V18, P1; Strollo F, 1998, AVIAT SPACE ENVIR MD, V69, P777; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wan J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1271-4; WATANABE T, 1995, LEUKEMIA, V9, P1926; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilson GA, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-3; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002; Yen JL, 2012, MOL CELL, V48, P288, DOI 10.1016/j.molcel.2012.08.015; Yu YJ, 1998, CANCER RES, V58, P4277	72	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147514	10.1371/journal.pone.0147514	http://dx.doi.org/10.1371/journal.pone.0147514			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820575	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400031
J	Heo, H; Kim, S; Lee, HH; Cho, HR; Xu, WJ; Lee, SH; Park, CK; Park, S; Choi, SH; Kim, H				Heo, Hwon; Kim, Sungjin; Lee, Hyeong Hun; Cho, Hye Rim; Xu, Wen Jun; Lee, Se-Hoon; Park, Chul-Kee; Park, Sunghyouk; Choi, Seung Hong; Kim, Hyeonjin			On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; IN-VIVO; HUMAN BRAIN; RAT-BRAIN; H-1 MRS; NEUROCHEMICAL PROFILE; H-1-NMR SPECTROSCOPY; SPECTRA; QUANTIFICATION; SIGNAL	Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) are frequently found in brain tumors, and the resulting onco-metabolite, 2-hydroxyglutarate (2HG), has been suggested to be a potential diagnostic and prognostic biomarker of the diseases. Indeed, recent studies have demonstrated the feasibility of non-invasively detecting 2HG by using proton magnetic resonance spectroscopy (1H-MRS). Due to severe spectral overlaps of 2HG with its background metabolites and spectral baselines, however, the majority of those previous studies employed spectral editing methods with long echo times (TEs) instead of the most commonly used short TE approach with spectral fitting. Consequently, the results obtained with spectral editing methods may potentially be prone to errors resulting from substantial signal loss due to relaxation. Given that the spectral region where the main signal of 2HG resides is particularly sensitive to spectral baseline in metabolite quantification, we have investigated the impact of incorporating voxel-specifically measured baselines into the spectral basis set on the performance of the conventional short TE approach in 2HG detection in rodent models (Fisher 344 rats; n = 19) of IDH1/2 mutant-overexpressing F98 glioma at 9.4T. Metabolite spectra were acquired (SPECIAL sequence) for a tumor region and the contralateral normal region of the brain for each animal. For the estimation of spectral baselines metabolite-nulled spectra were obtained (double-inversion-recovery SPECIAL sequence) for each individual voxels. Data were post-processed with and without the measured baselines using MRUI and LCModel-the two most widely used data post-processing packages. Our results demonstrate that in-vivo detection of 2HG using the conventional short TE approach is challenging even at 9.4T. However, incorporation of voxel-specifically measured spectral baselines may potentially improve its performance. Upon more thorough validation in a larger number of animals and more importantly in human patients, the potential utility of the proposed short TE acquisition with voxel-specific baseline measurement approach in 2HG detection may need to be considered in the study design.	[Heo, Hwon; Kim, Sungjin; Lee, Hyeong Hun; Kim, Hyeonjin] Seoul Natl Univ, Dept Biomed Sci, Seoul, South Korea; [Cho, Hye Rim; Choi, Seung Hong; Kim, Hyeonjin] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Xu, Wen Jun; Park, Sunghyouk] Seoul Natl Univ, Nat Product Res Inst, Coll Pharm, Seoul, South Korea; [Lee, Se-Hoon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Park, Chul-Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Choi, Seung Hong; Kim, Hyeonjin] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, H (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Seoul, South Korea.; Choi, SH; Kim, H (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.; Choi, SH; Kim, H (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	verocay1@snu.ac.kr; hyeonjinkim@snu.ac.kr	Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019; Kim, Hyeonjin/M-3761-2019	Park, Chul-Kee/0000-0002-2350-9876; Seo, Munjun/0000-0002-6805-2267	Ministry for Health, Welfare & Family Affairs in Korea [HI13C0015]	Ministry for Health, Welfare & Family Affairs in Korea	This study was supported by a grant from the Ministry for Health, Welfare & Family Affairs (HI13C0015) in Korea.	Allen PS, 1997, NMR BIOMED, V10, P435, DOI 10.1002/(SICI)1099-1492(199712)10:8<435::AID-NBM480>3.0.CO;2-D; Andronesi OC, 2013, J CLIN INVEST, V123, P3659, DOI 10.1172/JCI67229; Andronesi OC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002693; Auer DP, 2001, MAGN RESON MED, V46, P615, DOI 10.1002/mrm.1235; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; Cabanes E, 2001, J MAGN RESON, V150, P116, DOI 10.1006/jmre.2001.2318; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Chaumeil MM, 2014, CANCER RES, V74, P4247, DOI 10.1158/0008-5472.CAN-14-0680; Choi CH, 2013, NMR BIOMED, V26, P1242, DOI 10.1002/nbm.2943; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chronaiou I, 2014, ACTA ONCOL, V53, P580, DOI 10.3109/0284186X.2014.891046; Cudalbu C, 2008, NMR BIOMED, V21, P627, DOI 10.1002/nbm.1234; Cudalbu C, 2012, J ALZHEIMERS DIS, V31, pS101, DOI 10.3233/JAD-2012-120100; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Graaf RA, 2006, MAGN RESON MED, V56, P386, DOI 10.1002/mrm.20946; DIXON WT, 1991, MAGN RESON MED, V18, P257, DOI 10.1002/mrm.1910180202; Gottschalk M, 2008, NMR BIOMED, V21, P507, DOI 10.1002/nbm.1219; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Hofmann L, 2002, MAGNET RESON MED, V48, P440, DOI 10.1002/mrm.10246; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Kim H, 2005, MAGNET RESON MED, V53, P760, DOI 10.1002/mrm.20434; Kim H, 2004, MAGNET RESON MED, V51, P263, DOI 10.1002/mrm.10697; Lee Y, 2013, MAGN RESON MED, V70, P620, DOI 10.1002/mrm.24510; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; McLean MA, 2002, PROC INTL SOC MAG RE, V10, P529; Mlynarik V, 2006, MAGN RESON MED, V56, P965, DOI 10.1002/mrm.21043; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Opstad KS, 2008, MAGN RESON MED, V60, P1237, DOI 10.1002/mrm.21496; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pels P, 2006, NMR BIOMED, V19, P188, DOI 10.1002/nbm.1008; Penner J, 2015, MAGN RESON MED, V74, P4, DOI 10.1002/mrm.25380; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Pope WB, 2012, J NEURO-ONCOL, V107, P197, DOI 10.1007/s11060-011-0737-8; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Provencher SW., 2014, LCMODEL LCMGUI USERS; Ratiney H, 2004, MAGN RESON MATER PHY, V16, P284, DOI 10.1007/s10334-004-0037-9; Schaller B, 2014, MAGN RESON MED, V72, P934, DOI 10.1002/mrm.24995; Seeger U, 2003, MAGNET RESON MED, V49, P19, DOI 10.1002/mrm.10332; Shi JL, 2015, TUMOR BIOL, V36, P655, DOI 10.1007/s13277-014-2644-z; SLOTBOOM J, 1994, J MAGN RESON SER A, V108, P38, DOI 10.1006/jmra.1994.1086; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Stanley JA, 2001, MAGNET RESON MED, V45, P390, DOI 10.1002/1522-2594(200103)45:3<390::AID-MRM1051>3.0.CO;2-D; Tkac I, 2005, APPL MAGN RESON, V29, P139, DOI 10.1007/BF03166960; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; VANDENBOOGAART A, 1994, MAGNET RESON MED, V31, P347, DOI 10.1002/mrm.1910310402; Wen H, 2015, J NEUROCHEM, V132, P183, DOI 10.1111/jnc.12950; Wylezinska M, 2011, NMR BIOMED, V24, P231, DOI 10.1002/nbm.1578; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	54	10	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147794	10.1371/journal.pone.0147794	http://dx.doi.org/10.1371/journal.pone.0147794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820720	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400044
J	Norisada, J; Hirata, Y; Amaya, F; Kiuchi, K; Oh-Hashi, K				Norisada, Junpei; Hirata, Yoko; Amaya, Fumimasa; Kiuchi, Kazutoshi; Oh-Hashi, Kentaro			A Comparative Analysis of the Molecular Features of MANF and CDNF	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROTROPHIC FACTOR; ER STRESS; SENSITIVE ASSAY; CYSTEINE-RICH; SECRETION; PROTEIN; KDEL; PROLIFERATION; BIOSYNTHESIS	Cerebral dopamine neurotrophic factor (CDNF) is a paralogous protein of mesencephalic astrocyte-derived neurotrophic factor (MANF). Both proteins have been reported to show a common cytoprotective effect on dopaminergic neurons as a secretory protein containing the KDEL-likemotif of the ER retrieval signal at the C-terminus, RTDL in MANF and [Q/K] TEL in CDNF among many species, although functions of paralogous proteins tend to differ from each other. In this study, we focused on post-translational regulations of their retention in the endoplasmic reticulum (ER) and secretion and performed comparative experiments on characterization of mouse MANF and mouse CDNF according to our previous report about biosynthesis and secretion of mouse MANF using a NanoLuc system. In this study, co-expression of glucose-regulated protein 78 kDa (GRP78), KDEL receptor 1 or mutant Sar1 into HEK293 cells similarly decreased MANF and CDNF secretion with some degree of variation. Next, we investigated whether CDNF affects the secretion of mouse cysteine-rich with EGF-like domains 2 (CRELD2) because mouse wild-type (wt) MANF but not its KDEL-likemotif deleted mutant (Delta C-MANF) was found to promote the CRELD2 release from the transfected cells. Co-expressing CRELD2 with wt or Delta C CDNF, we found that CDNF and Delta C-MANF hardly elevated the CRELD2 secretion. We then investigated effects of the four or six C-terminal amino acids of MANF and CDNF on the CRELD2 secretion. As a result, co-transfection of mouse CDNF having the mouse MANF-type C-terminal amino acids (CDNFRTDL and CDNFSARTDL) increased the CRELD2 secretion to a small extent, but mouse CDNF having human CDNF-type ones (CDNFKTEL and CDNFHPKTEL) well increased the CRELD2 secretion. On the other hand, the replacement of C-terminal motifs of mouse MANF with those of mouse CDNF (MANF(QTEL) and MANF(YPQTEL)) enhanced the CRELD2 secretion, and the mouse MANF having human CDNF-type ones (MANF(KTEL) and MANF(HPKTEL)) dramatically potentiated the CRELD2 secretion. These results indicate that the secretion of mouse MANF and mouse CDNF is fundamentally regulated in the same manner and that the variation of four C-terminal amino acids in the MANF and CDNF among species might influence their intracellular functions. This finding could be a hint to identify physiological functions of MANF and CDNF.	[Norisada, Junpei; Hirata, Yoko; Kiuchi, Kazutoshi; Oh-Hashi, Kentaro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011193, Japan; [Hirata, Yoko; Kiuchi, Kazutoshi; Oh-Hashi, Kentaro] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, 1-1 Yanagido, Gifu 5011193, Japan; [Amaya, Fumimasa] Kyoto Prefectural Univ Med, Dept Anesthesiol, Kamikyo Ku, Kawaramachi Hirokoji, Kyoto 6020841, Japan	Gifu University; Gifu University; Kyoto Prefectural University of Medicine	Oh-Hashi, K (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011193, Japan.; Oh-Hashi, K (corresponding author), Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, 1-1 Yanagido, Gifu 5011193, Japan.	oohashi@gifu-u.ac.jp	amaya, fumimasa/AAD-7176-2020; Hirata, Yoko/AAG-6798-2020; Hirata, Yoko/L-3142-2019	Hirata, Yoko/0000-0002-7081-4937; amaya, fumimasa/0000-0003-2934-0845	 [26670692]; Grants-in-Aid for Scientific Research [15H04969] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Challenging Exploratory Research (no. 26670692, to F.A.).	Alanen HI, 2011, J MOL BIOL, V409, P291, DOI 10.1016/j.jmb.2011.03.070; Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Evron E, 1997, CANCER RES, V57, P2888; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; Hikiji T, 2015, BIOCHEM BIOPH RES CO, V463, P881, DOI 10.1016/j.bbrc.2015.05.132; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Norisada J, 2014, BIOCHEM BIOPH RES CO, V449, P483, DOI 10.1016/j.bbrc.2014.05.031; Oh-hashi K, 2015, BIOL PHARM BULL, V38, P722, DOI 10.1248/bpb.b14-00825; Oh-hashi K, 2014, CELL BIOL TOXICOL, V30, P127, DOI 10.1007/s10565-014-9274-5; Oh-Hashi K, 2013, CELL MOL BIOL LETT, V18, P398, DOI 10.2478/s11658-013-0096-x; Oh-hashi K, 2012, MOL CELL BIOCHEM, V363, P35, DOI 10.1007/s11010-011-1155-0; Oh-hashi K, 2011, FEBS LETT, V585, P2481, DOI 10.1016/j.febslet.2011.06.029; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shridhar R, 1996, CANCER RES, V56, P5576; Sun ZP, 2011, J NEUROCHEM, V117, P121, DOI 10.1111/j.1471-4159.2011.07179.x; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu YQ, 2010, J CEREBR BLOOD F MET, V30, P79, DOI 10.1038/jcbfm.2009.181; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	42	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146923	10.1371/journal.pone.0146923	http://dx.doi.org/10.1371/journal.pone.0146923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820513	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528400009
J	Sur, S; Swier, VJ; Radwan, MM; Agrawal, DK				Sur, Swastika; Swier, Vicki J.; Radwan, Mohamed M.; Agrawal, Devendra K.			Increased Expression of Phosphorylated Polo-Like Kinase 1 and Histone in Bypass Vein Graft and Coronary Arteries following Angioplasty	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; INTERFERON-GAMMA; INTIMAL HYPERPLASIA; DOWN-REGULATION; SAPHENOUS-VEIN; DNA-DAMAGE; PLK1; CANCER; CYTOKINESIS; ACTIVATION	Interventional procedures, including percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass surgery (CABG) to re-vascularize occluded coronary arteries, injure the vascular wall and cause endothelial denudation and medial vascular smooth muscle cell (VSMCs) metaplasia. Proliferation of the phenotypically altered SMCs is the key event in the pathogenesis of intimal hyperplasia (IH). Several kinases and phosphatases regulate cell cycle in SMC proliferation. It is our hypothesis that increased expression and activity of polo-like kinase-1 (PLK1) in SMCs, following PTCA and CABG, contributes to greater SMC proliferation in the injured than uninjured blood vessels. Using immunofluorescence (IF), we assessed the expression of PLK1 and phosphorylated-PLK1 (pPLK1) in post-PTCA coronary arteries, and superficial epigastric vein grafts (SEV) and compared it with those in the corresponding uninjured vessels. We also compared the expressions of mitotic marker phospho-histone, synthetic-SMC marker, contractile SMC marker, IFN-gamma and phosphorylated STAT-3 in the post-PTCA arteries, SEV-grafts, and the uninjured vessels. Immunostaining demonstrated an increase in the number of cells expressing PLK1 and pPLK1 in the neointima of post PTCA-coronary arteries and SEV grafts compared to their uninjured counterparts. VSMCs in the neointima showed an increased expression of phospho-histone, synthetic and contractile SMC markers, IFN-gamma and phosphorylated STAT-3. However, VSMCs of uninjured coronaries and SEV had no significant expression of the aforementioned proteins. These data suggest that PLK1 might play a critical role in VSMC mitosis in hyperplastic intima of the injured vessels. Thus, novel therapies to inhibit PLK1 could be developed to inhibit the mitogenesis of VSMCs and control neointimal hyperplasia.	[Sur, Swastika; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Swier, Vicki J.; Radwan, Mohamed M.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68178 USA	Creighton University; Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.; Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68178 USA.	dkagr@creighton.edu	Agrawal, Devendra/GLR-3925-2022; Sur, Swastika/AAI-9802-2020	Agrawal, Devendra/0000-0001-5445-0013; Swier, Vicki/0000-0001-7509-9920; Radwan Ahmed, Mohamed/0000-0002-8074-2535	National Institutes of Health, USA [R01HL104516, R01HL112597, R01HL116042, R01HL128063]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128063, R01HL104516, R01HL116042, R01HL112597] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research work was supported by research grants R01HL104516, R01HL112597, R01HL116042, and R01HL128063 from the National Institutes of Health, USA, to DK Agrawal. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Donaldson MM, 2001, J CELL SCI, V114, P2357; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Foijer F, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-8; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Gupta GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042789; Hinohara T, 2001, Keio J Med, V50, P152; HOLTRICH U, 1994, P NATL ACAD SCI USA, V91, P1736, DOI 10.1073/pnas.91.5.1736; Jia GH, 2009, J CELL MOL MED, V13, P547, DOI 10.1111/j.1582-4934.2008.00384.x; Kneisel L, 2002, J CUTAN PATHOL, V29, P354, DOI 10.1034/j.1600-0560.2002.290605.x; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lin DC, 2011, CLIN CANCER RES, V17, P4285, DOI 10.1158/1078-0432.CCR-10-3236; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Luo JJ, 2012, PROTEIN CELL, V3, P182, DOI 10.1007/s13238-012-2020-y; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Macmillan JC, 2001, ANN SURG ONCOL, V8, P729, DOI 10.1245/aso.2001.8.9.729; Paschal CR, 2012, CHROMOSOMA, V121, P565, DOI 10.1007/s00412-012-0375-8; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rose ML, 2007, CIRC RES, V101, P542, DOI 10.1161/CIRCRESAHA.107.160911; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Shan WW, 2012, CLIN CANCER RES, V18, P3352, DOI 10.1158/1078-0432.CCR-11-3058; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sur S, 2014, CAN J PHYSIOL PHARM, V92, P531, DOI 10.1139/cjpp-2013-0445; Swier V. J., 2015, HISTOL HISTOPATHOL, P11652, DOI DOI 10.14670/HH-11-652; Takai N, 2001, CANCER LETT, V169, P41, DOI 10.1016/S0304-3835(01)00522-5; Takai N, 2001, CANCER LETT, V164, P41, DOI 10.1016/S0304-3835(00)00703-5; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; VEITH FJ, 1986, J VASC SURG, V3, P104; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050; Wolf G, 2000, PATHOL RES PRACT, V196, P753, DOI 10.1016/S0344-0338(00)80107-7; Yuan JP, 1997, AM J PATHOL, V150, P1165; Zhou Z, 2013, EXP CELL RES, V319, P3104, DOI 10.1016/j.yexcr.2013.09.012; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147937	10.1371/journal.pone.0147937	http://dx.doi.org/10.1371/journal.pone.0147937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820885	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400056
J	Vidal, F; Guerby, P; Luyckx, M; Haddad, P; Stoeckle, E; Morice, P; Leblanc, E; Lecuru, F; Darai, E; Classe, JM; Pomel, C; Filleron, T; Ferron, G; Querleu, D; Rafii, A				Vidal, Fabien; Guerby, Paul; Luyckx, Mathieu; Haddad, Pascale; Stoeckle, Eberhard; Morice, Philippe; Leblanc, Eric; Lecuru, Fabrice; Darai, Emile; Classe, Jean Marc; Pomel, Christophe; Filleron, Thomas; Ferron, Gwenael; Querleu, Denis; Rafii, Arash			Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?	PLOS ONE			English	Article							EPITHELIAL OVARIAN; 1ST-LINE TREATMENT; IV OVARIAN; CYTOREDUCTIVE SURGERY; INTERGROUP TRIAL; DES CANCERS; PACLITAXEL; CARCINOMA; CHEMOTHERAPY; CARBOPLATIN	Objective Early recurrence (ER) after completion of therapeutic regimen in advanced-stage ovarian cancer is a challenging clinical situation. Patients are perceived as invariably having a poor prognosis. We investigated the possibility of defining different prognostic subgroups and the parameters implicated in prognosis of ER patients. Study Design We analyzed a multi-centric database of 527 FIGO stage IIIC and IV ovarian cancer patients. We defined patients relapsing within 12 months as ER and investigated using Cox logistic regression the prognostic factors in ER group. We subsequently divided ER patients into good and poor prognosis groups according to a lower or higher overall survival (OS) at 12 months after relapse and determined parameters associated to poor prognosis. Results The median follow up was 49 months. One hundred and thirty eight patients recurred within 12 months. OS and Disease Free Survival (DFS) were 24.6 and 8.6 months, respectively, in this group of patients. Among the ER patients, 73 had a poor prognosis with an OS after relapse below 12 months (mean OS = 5.2 months) and 65 survived after one year (mean OS = 26.9 months). Residual disease (RD) after debulking surgery and mucinous histological subtype negatively impacted prognosis (HR = 1.758, p = 0.017 and HR = 8.641, p = 0.001 respectively). The relative risk of death within 12 months following relapse in ER patients was 1.61 according to RD status. However, RD did not affect DFS (HR = 0.889, p = 0.5). Conclusion ER in advanced-stage ovarian cancer does not inevitably portend a short-term poor prognosis. RD status after initial cytoreduction strongly modulates OS, that gives additional support to the concept of maximum surgical effort even in patients who will experience early recurrence. The heterogeneity in outcomes within the ER group suggests a role for tumor biology in addition to classical clinical parameters.	[Vidal, Fabien; Rafii, Arash] Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar; [Vidal, Fabien; Rafii, Arash] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Vidal, Fabien; Guerby, Paul] Toulouse Acad Hosp, Dept Gynecol Surg, F-31059 Toulouse, France; [Luyckx, Mathieu] Catholic Univ Louvain, St Luc Acad Hosp, Dept Gynecol Surg, Brussels, Belgium; [Haddad, Pascale] Qatar Fdn, Weill Cornell Med Coll Qatar, Biostat Core, Doha, Qatar; [Stoeckle, Eberhard] Ctr Comprehens Canc, Inst Bergonie, Dept Surg, Bordeaux, France; [Morice, Philippe] Inst Gustave Roussy, Dept Gynecol, Canc Campus, Villejuif, France; [Leblanc, Eric] Ctr Oscar Lambret, Dept Gynecol Oncol, F-59037 Lille, France; [Lecuru, Fabrice] Georges Pompidou European Hosp, Dept Gynecol Oncol, Paris, France; [Darai, Emile] Tenon Hosp, Dept Gynecol Surg, Paris, France; [Classe, Jean Marc] Ctr Comprehens Canc, Ctr Gauducheau, Dept Surg Oncol, St Herblain, France; [Pomel, Christophe] Jean Perrin Canc Ctr, Dept Surg Oncol, Clermont Ferrand, France; [Filleron, Thomas; Ferron, Gwenael] Ctr Comprehens Canc, Inst Claudius Regaud, Dept Surg Oncol, F-31052 Toulouse, France	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Qatar Foundation (QF); Weill Cornell Medical College Qatar; UNICANCER; Centre Eugene Marquis; Institut Bergonie; UNICANCER; Gustave Roussy; UNICANCER; Centre Oscar Lambret; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Centre Eugene Marquis; UNICANCER; Centre Jean Perrin; UNICANCER; Centre Eugene Marquis; Institut Claudius Regaud	Vidal, F (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Stem Cell & Microenvironm Lab, Doha, Qatar.; Vidal, F (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.; Vidal, F (corresponding author), Toulouse Acad Hosp, Dept Gynecol Surg, F-31059 Toulouse, France.	dox_94@yahoo.fr	Ferron, Gwenael/P-6193-2014; filleron, thomas/C-3554-2014; Morice, Philippe/ABC-3179-2021	Ferron, Gwenael/0000-0002-8545-4700; filleron, thomas/0000-0003-0724-0659; leblanc, eric/0000-0001-7299-0339; Morice, Philippe/0000-0003-0579-9993	Qatar Foundation; NPRP [09-1099-3-279]; Qatar Foundation [06-116-1-023]	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); NPRP; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was funded by Qatar Foundation and NPRP Grant 09-1099-3-279; Qatar Foundation 44 UREP Grant 06-116-1-023; and a Qatar Foundation Qatar Technology Transfer Grant. Its Manuscript2 45 contents are solely the responsibility of the authors and do not necessarily represent the official 46 views of the Qatar National Research Fund.	Alberts DS, 2008, GYNECOL ONCOL, V108, P90, DOI 10.1016/j.ygyno.2007.08.075; Alexandre J, 2010, ANN ONCOL, V21, P2377, DOI 10.1093/annonc/mdq257; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; BURKE TW, 1994, OBSTET GYN CLIN N AM, V21, P167; du Bois A, 2006, J CLIN ONCOL, V24, P1127, DOI 10.1200/JCO.2005.03.2938; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Esquivel J, 1999, G Chir, V20, P81; Harter P, 2006, ANN SURG ONCOL, V13, P1702, DOI 10.1245/s10434-006-9058-0; Impellizzeri P, 2014, EUR J PEDIATR SURG, V24, P174, DOI 10.1055/s-0033-1333634; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038340; Luyckx M, 2012, INT J GYNECOL CANCER, V22, P1337, DOI 10.1097/IGC.0b013e31826a3559; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Naumann RW, 2011, DRUGS, V71, P1397, DOI 10.2165/11591720-000000000-00000; Pfisterer J, 2006, JNCI-J NATL CANCER I, V98, P1036, DOI 10.1093/jnci/djj296; Pujade-Lauraine E, 2010, J CLIN ONCOL, V28, P3323, DOI 10.1200/JCO.2009.25.7519; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singer CF, 2009, ENDOCR-RELAT CANCER, V16, P73, DOI 10.1677/ERC-08-0065; Tagliabue E, 2003, LANCET, V362, P527, DOI 10.1016/S0140-6736(03)14112-8; Touboul C, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-28; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019	25	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147787	10.1371/journal.pone.0147787	http://dx.doi.org/10.1371/journal.pone.0147787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820579	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400042
J	Wang, Q; Taylor, JE				Wang, Qi; Taylor, John E.			Patterns and Limitations of Urban Human Mobility Resilience under the Influence of Multiple Types of Natural Disaster	PLOS ONE			English	Article							HURRICANE SANDY; VULNERABILITY; IMPACT; LEVEL	Natural disasters pose serious threats to large urban areas, therefore understanding and predicting human movements is critical for evaluating a population's vulnerability and resilience and developing plans for disaster evacuation, response and relief. However, only limited research has been conducted into the effect of natural disasters on human mobility. This study examines how natural disasters influence human mobility patterns in urban populations using individuals' movement data collected from Twitter. We selected fifteen destructive cases across five types of natural disaster and analyzed the human movement data before, during, and after each event, comparing the perturbed and steady state movement data. The results suggest that the power-law can describe human mobility in most cases and that human mobility patterns observed in steady states are often correlated with those in perturbed states, highlighting their inherent resilience. However, the quantitative analysis shows that this resilience has its limits and can fail in more powerful natural disasters. The findings from this study will deepen our understanding of the interaction between urban dwellers and civil infrastructure, improve our ability to predict human movement patterns during natural disasters, and facilitate contingency planning by policymakers.	[Wang, Qi] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA; [Taylor, John E.] Virginia Tech, Civil Engn Network, Dynam Lab, Jr Dept Civil & Environm Engn, Charles E Via, Blacksburg, VA 24061 USA	Harvard University; Virginia Polytechnic Institute & State University	Taylor, JE (corresponding author), Virginia Tech, Civil Engn Network, Dynam Lab, Jr Dept Civil & Environm Engn, Charles E Via, Blacksburg, VA 24061 USA.	jet@vt.edu			National Science Foundation [1142379]; Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant; Virginia Tech's Open Access Subvention Fund; Directorate For Engineering [1142379] Funding Source: National Science Foundation; Div Of Civil, Mechanical, & Manufact Inn [1733695] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant; Virginia Tech's Open Access Subvention Fund; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study is supported by the National Science Foundation under Grant No. 1142379 [http://www.nsf.gov/] and by the Virginia Tech BioBuild Interdisciplinary Graduate Education Program (IGEP) grant [http://biobuild.mlsoc.vt.edu/]. Open access publication of this article was supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; AMUNDSEN PA, 1988, J FISH BIOL, V33, P697, DOI 10.1111/j.1095-8649.1988.tb05515.x; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Beasley D, 2014, REUTERS; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Bodeen C, 2013, ASSCIATED PRESS; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Centers for Disease Control and Prevention, 2013, DEATHS ASS HURR SAND; Chaintreau A, 2007, IEEE T MOBILE COMPUT, V6, P606, DOI 10.1109/TMC.2007.1060; Chakraborty J., 2005, NAT HAZARDS REV, V6, P23, DOI [10.1061/(ASCE)1527-6988(2005)6:1(23), DOI 10.1061/(ASCE)1527-6988(2005)6:1(23)]; Cheng Z, 2011, INT C WEBL SOC MED; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Dow K, 1998, COAST MANAGE, V26, P237, DOI 10.1080/08920759809362356; Drabek T. E., 2000, Cornell Hotel and Restaurant Administration Quarterly, V41, P48, DOI 10.1177/001088040004100414; Feeley M, 2004, LECT NOTES COMPUT SC, V3158, P324; Ferris E., 2013, YEAR RECURRING DISAS; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hawelka B, 2013, ARXIV13110680; Horanont T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081153; Kimura M, 2006, LECT NOTES ARTIF INT, V4213, P259; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Kleinberg J, 2007, NATURE, V449, P287, DOI 10.1038/449287a; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Marguta R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1317; MORROWJONES HA, 1991, DISASTERS, V15, P126, DOI 10.1111/j.1467-7717.1991.tb00441.x; Natural Disasters Trends, 2012, INT DIS DAT; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Pan XS, 2007, AI SOC, V22, P113, DOI 10.1007/s00146-007-0126-1; Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Robusto C., 1957, AM MATH MON, V64, P38, DOI [DOI 10.1111/2041-210X.12107, 10.2307/2309088]; Rosenzweig C, 2014, GLOBAL ENVIRON CHANG, V28, P395, DOI 10.1016/j.gloenvcha.2014.05.003; Saltelli A., 2008, GLOBAL SENSITIVITY A; Sampson R, 2013, NEW SCI, V218, P28, DOI 10.1016/S0262-4079(13)61183-5; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Schuerman M, 2013, CITY EVACUATION RATE; Schwarz AM, 2011, GLOBAL ENVIRON CHANG, V21, P1128, DOI 10.1016/j.gloenvcha.2011.04.011; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Statistic Brain, 2014, TWITT STAT 2014; Sun LJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1089; Toole JL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1128; United Nations International Strategy for Disaster Reduction, 2013, DIS IMP 2000 2012; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a; Wang P, 2012, SCI REPORTS, P2; Wang Q, 2016, J COMPUT CIVIL ENG, V30, DOI 10.1061/(ASCE)CP.1943-5487.0000469; Wang Q, 2014, PROC ECON FINANC, V18, P33, DOI 10.1016/S2212-5671(14)00910-1; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Weber EU, 2010, WIRES CLIM CHANGE, V1, P332, DOI 10.1002/wcc.41; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Wolshon B, 2007, J URBAN PLAN DEV, V133, P73, DOI 10.1061/(ASCE)0733-9488(2007)133:1(73); Yan XY, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0834	56	50	51	10	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147299	10.1371/journal.pone.0147299	http://dx.doi.org/10.1371/journal.pone.0147299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GF	26820404	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400019
J	Phyu, WK; Ong, KC; Wong, KT				Phyu, Win Kyaw; Ong, Kien Chai; Wong, Kum Thong			A Consistent Orally-Infected Hamster Model for Enterovirus A71 Encephalomyelitis Demonstrates Squamous Lesions in the Paws, Skin and Oral Cavity Reminiscent of Hand-Foot-and-Mouth Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOUSE MODEL; RHABDOMYOSARCOMA CELLS; 71 NEUROPATHOGENESIS; CYNOMOLGUS MONKEYS; TAIWAN; FEATURES; HUMAN-ENTEROVIRUS-71; MANIFESTATIONS; INFLAMMATION	Enterovirus A71 (EV-A71) causes self-limiting, hand-foot-and-mouth disease (HFMD) that may rarely be complicated by encephalomyelitis. Person-to-person transmission is usually by fecal-oral or oral-oral routes. To study viral replication sites in the oral cavity and other tissues, and to gain further insights into virus shedding and neuropathogenesis, we developed a consistent, orally-infected, 2-week-old hamster model of HFMD and EV-A71 encephalomyelitis. Tissues from orally-infected, 2-week-old hamsters were studied by light microscopy, immunohistochemistry and in situ hybridization to detect viral antigens and RNA, respectively, and by virus titration. Hamsters developed the disease and died after 4-8 days post infection; LD50 was 25 CCID50. Macroscopic cutaneous lesions around the oral cavity and paws were observed. Squamous epithelium in the lip, oral cavity, paw, skin, and esophagus, showed multiple small inflammatory foci around squamous cells that demonstrated viral antigens/RNA. Neurons (brainstem, spinal cord, sensory ganglia), acinar cells (salivary gland, lacrimal gland), lymphoid cells (lymph node, spleen), and muscle fibres (skeletal, cardiac and smooth muscles), liver and gastric epithelium also showed varying amounts of viral antigens/RNA. Intestinal epithelium, Peyer's patches, thymus, pancreas, lung and kidney were negative. Virus was isolated from oral washes, feces, brain, spinal cord, skeletal muscle, serum, and other tissues. Our animal model should be useful to study squamous epitheliotropism, neuropathogenesis, oral/fecal shedding in EV-A71 infection, person-to-person transmission, and to test anti-viral drugs and vaccines.	[Phyu, Win Kyaw; Wong, Kum Thong] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Ong, Kien Chai] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Wong, KT (corresponding author), Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia.	wongkt@ummc.edu.my	Ibrahim, Essam Hassan/G-1960-2018; ONG, KIEN CHAI/B-9452-2010; ONG, KIEN CHAI/D-6582-2015; Wong, Kum Thong/B-2788-2010	Ibrahim, Essam Hassan/0000-0003-0130-2257; ONG, KIEN CHAI/0000-0003-3845-9303; 	UM/MoHE High Impact Research Grant [H-20001-E00004]; Ministry of Higher Education, Malaysia; University of Malaya, Kuala Lumpur, Malaysia [RG141/09HTM]	UM/MoHE High Impact Research Grant; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); University of Malaya, Kuala Lumpur, Malaysia(Universiti Malaya)	This work was supported by the UM/MoHE High Impact Research Grant H-20001-E00004, Ministry of Higher Education, Malaysia, and the research grant RG141/09HTM, University of Malaya, Kuala Lumpur, Malaysia.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Ch'ng WC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-155; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Fujii K, 2013, P NATL ACAD SCI USA, V110, P14753, DOI 10.1073/pnas.1217563110; He Y, 2013, AM J PATHOL, V184, P715; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsiung G. D., 2000, Journal of Microbiology Immunology and Infection, V33, P1; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Knipe DM, 2001, ENTEROVIRUSES POLIOV; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; Lin YW, 2013, POPULAR TRIBUNE, P8; Liu LD, 2011, VIROLOGY, V412, P91, DOI 10.1016/j.virol.2010.12.058; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Ong KC, 2015, BRAIN PATHOL, V25, P614, DOI 10.1111/bpa.12279; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shi WF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-327; Shieh SJ, 2001, EMERG INFECT DIS, V7, P146; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Tan SH, 2014, J NEUROPATH EXP NEUR, V73, P999, DOI 10.1097/NEN.0000000000000122; Taylor SL, 2005, J VIROL, V79, P11501, DOI 10.1128/JVI.79.17.11501-11506.2005; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wong KT, 2012, NEUROPATH APPL NEURO, V38, P443, DOI 10.1111/j.1365-2990.2011.01247.x; Wong KT, 2008, J NEUROPATH EXP NEUR, V67, P162, DOI 10.1097/nen.0b013e318163a990; World Health Organization, 2004, POL LAB MAN, V4th; Yang XD, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.35; Yu P, 2014, VIRUS RES, V189, P121, DOI 10.1016/j.virusres.2014.05.006; Zhang W, 2014, BIOCHEM BIOPH RES CO, V447, P550, DOI 10.1016/j.bbrc.2014.04.021	40	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147463	10.1371/journal.pone.0147463	http://dx.doi.org/10.1371/journal.pone.0147463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815859	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200034
J	Reiser, K; Mathys, L; Curbo, S; Pannecouque, C; Noppen, S; Liekens, S; Engman, L; Lundberg, M; Balzarini, J; Karlsson, A				Reiser, Kathrin; Mathys, Leen; Curbo, Sophie; Pannecouque, Christophe; Noppen, Sam; Liekens, Sandra; Engman, Lars; Lundberg, Mathias; Balzarini, Jan; Karlsson, Anna			The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN DISULFIDE-ISOMERASE; NECROSIS-FACTOR-ALPHA; THIOREDOXIN REDUCTASE; REVERSE-TRANSCRIPTASE; DIORGANYL TELLURIDES; HUMAN CANCER; IN-VITRO; TYPE-1; CELLS	Background The entry of HIV into its host cell is an interesting target for chemotherapeutic intervention in the life-cycle of the virus. During entry, reduction of disulfide bridges in the viral envelope glycoprotein gp120 by cellular oxidoreductases is crucial. The cellular thioredoxin reductase-1 plays an important role in this oxidoreduction process by recycling electrons to thioredoxin-1. Therefore, thioredoxin reductase-1 inhibitors may inhibit gp120 reduction during HIV-1 entry. In this present study, tellurium-based thioredoxin reductase-1 inhibitors were investigated as potential inhibitors of HIV entry. Results The organotellurium compounds inhibited HIV-1 and HIV-2 replication in cell culture at low micromolar concentrations by targeting an early event in the viral infection cycle. Time-of-drug-addition studies pointed to virus entry as the drug target, more specifically: the organotellurium compound TE-2 showed a profile similar or close to that of the fusion inhibitor enfuvirtide (T-20). Surface plasmon resonance-based interaction studies revealed that the compounds do not directly interact with the HIV envelope glycoproteins gp120 and gp41, nor with soluble CD4, but instead, dose-dependently bind to thioredoxin reductase-1. By inhibiting the thioredoxin-1/thioredoxin reductase-1-directed oxidoreduction of gp120, the organotellurium compounds prevent conformational changes in the viral glycoprotein which are necessary during viral entry. Conclusion Our findings revealed that thioredoxin-1/thioredoxin reductase-1 acts as a cellular target for the inhibition of HIV entry.	[Reiser, Kathrin; Curbo, Sophie; Lundberg, Mathias; Karlsson, Anna] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, F68, Huddinge, Sweden; [Mathys, Leen; Pannecouque, Christophe; Noppen, Sam; Liekens, Sandra; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Minderbroederstr 10, Leuven, Belgium; [Engman, Lars] Uppsala Univ, Dept Chem BMC, BOX 576, Uppsala, Sweden	Karolinska Institutet; KU Leuven; Uppsala University	Reiser, K (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Lab Med, F68, Huddinge, Sweden.	Kathrin.Reiser@ki.se	Pannecouque, Christophe/C-2793-2018; curbo, sophie/AAA-8614-2020; Karlsson, Anna/E-7945-2018; Noppen, Sam/F-8681-2018	Pannecouque, Christophe/0000-0002-1254-4473; curbo, sophie/0000-0002-0964-0712; Noppen, Sam/0000-0002-2831-5042; Karlsson, Anna/0000-0001-6843-6685	KU Leuven [GOA 10/014, PF 10/018, FWO G.0528.12N]; Swedish Research Council [AK 521-2010-2828, LE 621-2011-4006]; Karolinska Institute; Stiftelsen Sigurd och Elsa Goljes Minne; L'Oreal-UNESCO, in collaboration with the Belgian FWO: fellowship	KU Leuven(KU Leuven); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute(Karolinska Institutet); Stiftelsen Sigurd och Elsa Goljes Minne; L'Oreal-UNESCO, in collaboration with the Belgian FWO: fellowship(L'Oreal Group)	This work was supported by the following grants: KU Leuven: GOA 10/014 (JB, LM, SL, SN, CP), PF 10/018 (JB, LM, SL, SN) and FWO G.0528.12N (JB), URL: http://www.kuleuven.be; the Swedish Research Council: AK 521-2010-2828 (AK, SC, KR) and LE 621-2011-4006 (LE), URL: http://www.vr.se/; the Karolinska Institute (AK, SC, KR), URL: www.ki.se; Stiftelsen Sigurd och Elsa Goljes Minne (KR), URL: http://www.lindhes.se/stiftelseforvaltning/stiftelseforvaltning-2; and L'Oreal-UNESCO, in collaboration with the Belgian FWO: fellowship (LM), URL: http://www.loreal.com/csrcommitments/foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLASHI DV, 1995, CLIN DIAGN VIROL, V4, P1, DOI 10.1016/0928-0197(95)00005-S; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; Baker A, 1997, CANCER RES, V57, P5162; BALZARINI J, 1992, J BIOL CHEM, V267, P11831; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Borkow G, 2002, AIDS RES HUM RETROV, V18, P711, DOI 10.1089/088922202760072339; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330; Davis DA, 1997, J BIOL CHEM, V272, P25935, DOI 10.1074/jbc.272.41.25935; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Engman L, 2003, ANTI-CANCER DRUG, V14, P153, DOI 10.1097/00001813-200302000-00009; Engman L, 2000, ANTI-CANCER DRUG DES, V15, P323; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Frentz D, 2012, AIDS REV, V14, P17; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hoorelbeke B, 2010, ANTIMICROB AGENTS CH, V54, P3287, DOI 10.1128/AAC.00254-10; HORWITZ JP, 1964, J ORG CHEM, V29, P2076, DOI 10.1021/jo01030a546; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Kanda T, 1999, J ORG CHEM, V64, P8161, DOI 10.1021/jo990842k; Kean W. F., 2008, Inflammopharmacology, V16, P112, DOI 10.1007/s10787-007-0021-x; LaBonte J, 2003, NAT REV DRUG DISCOV, V2, P345, DOI 10.1038/nrd1091; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; McNaughton M, 2004, J MED CHEM, V47, P233, DOI 10.1021/jm030916r; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; Pennings PS, 2013, INFECT DIS REP, V5, P21, DOI 10.4081/idr.2013.s1.e5; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Reiser K, 2012, INT J BIOCHEM CELL B, V44, P556, DOI 10.1016/j.biocel.2011.12.015; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Ryser HJP, 2005, DRUG DISCOV TODAY, V10, P1085, DOI 10.1016/S1359-6446(05)03550-6; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Sahaf B, 1997, EXP CELL RES, V236, P181, DOI 10.1006/excr.1997.3699; Shapiro DL, 1996, J RHEUMATOL, V23, P1818; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Spielberger JC, 2008, J CELL BIOCHEM, V104, P1879, DOI 10.1002/jcb.21762; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; Vandamme AM, 2000, METH MOLEC MED, V24, P223, DOI 10.1385/1-59259-245-7:223; VANDAMME EJM, 1988, PHYSIOL PLANTARUM, V73, P52, DOI 10.1111/j.1399-3054.1988.tb09192.x; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; World C, 2011, ARTERIOSCL THROM VAS, V31, P1890, DOI 10.1161/ATVBAHA.111.226340; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	48	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147773	10.1371/journal.pone.0147773	http://dx.doi.org/10.1371/journal.pone.0147773			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816344	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200050
J	Cai, BL; Li, Y; Shen, LL; Zhao, JL; Liu, Y; Wu, JZ; Liu, YP; Yu, B				Cai, Bo-Lei; Li, Yan; Shen, Liang-Liang; Zhao, Jin-Long; Liu, Yuan; Wu, Jun-Zheng; Liu, Yan-Pu; Yu, Bo			Nuclear Multidrug Resistance-Related Protein 1 Is Highly Associated with Better Prognosis of Human Mucoepidermoid Carcinoma through the Suppression of Cell Proliferation, Migration and Invasion	PLOS ONE			English	Article							SALIVARY-GLAND TUMORS; LUNG-CANCER; PAROTID-GLAND; EXPRESSION; GENE; GLUTATHIONE; MRP1/ABCC1; TRANSPORT; SURVIVAL; MRP1	Objectives Multidrug resistance-related protein 1 (MRP1) overexpression is a well acknowledged predictor of poor response to chemotherapy, but MRP1 also correlated to better prognosis in some reports, especially for patients not pretreated with chemotherapy. In our previous study, we found nuclear translocation of MRP1 in mucoepidermoid carcinoma (MEC) for the first time. The purpose of this study was to further investigate the function of nuclear MRP1 in MEC. Materials and Methods Human MEC tissue samples of 125 patients were selected and stained using immunohistochemistry. The expression level of total MRP1/nuclear MRP1 of each sample was evaluated by expression index (EI) which was scored using both qualitative and quantitative analysis. The correlations between the clinicopathologic parameters and the EI of nuclear MRP1 were analyzed using Spearman's rank correlation analysis, respectively. The effects of RNAi-mediated downregulation of nuclear MRP1 on MEC cells were assessed using flow cytometric analysis, MTT assay, plate colony formation assay, transwell invasion assay and monolayer wound healing assay. Results In this study, we found the EI of nuclear MRP1 was negatively correlated to the pathologic grading (r = -0.498, P<0.01) /clinical staging (r = -0.41, P<0.01) /tumor stage (r = -0.28, P = 0.02) /nodal stage (r = -0.29, P<0.01) of MEC patients. The RNAi-mediated downregulation of nuclear MRP1 further proved that the downregulation of nuclear MRP1 could increase the cell replication, growth speed, colony formation efficiency, migration and invasion ability of MEC cells. Conclusion Our results suggested that nuclear MRP1 is highly associated with better prognosis of human mucoepidermoid carcinoma and further study of its function mechanism would provide clues in developing new treatment modalities of MEC.	[Cai, Bo-Lei; Zhao, Jin-Long; Liu, Yan-Pu; Yu, Bo] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China; [Li, Yan] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Prosthodont, Xian 710032, Peoples R China; [Shen, Liang-Liang] Fourth Mil Med Univ, State Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Liu, Yuan] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral Histol & Pathol, Xian 710032, Peoples R China; [Wu, Jun-Zheng] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral Biol, 145 Chang Le Xi Rd, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, YP; Yu, B (corresponding author), Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China.	liuyanpu@fmmu.edu.cn; yubofmmu@163.com			National Natural Science Research Program of China [81502338, 31501036]; China Scholarship Council; Shaanxi Provincial Science & Technology Foundation [S2011SF1279]	National Natural Science Research Program of China; China Scholarship Council(China Scholarship Council); Shaanxi Provincial Science & Technology Foundation	This work was supported by National Natural Science Research Program of China (81502338) to Dr. Bo-Lei Cai; and National Natural Science Research Program of China (31501036) to Dr. Yan Li. The authors also gratefully acknowledge the financial support from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Research Program of China (81502338) to Dr. Bo-Lei Cai; National Natural Science Research Program of China (31501036) to Dr. Yan Li; Shaanxi Provincial Science & Technology Foundation (S2011SF1279) to Prof. Bo Yu. The authors also gratefully acknowledge the financial support from China Scholarship Council.	Bell RB, 2005, J ORAL MAXIL SURG, V63, P917, DOI 10.1016/j.joms.2005.03.006; Berger W, 2005, J CANCER RES CLIN, V131, P355, DOI 10.1007/s00432-004-0653-9; Cai BL, 2011, ORAL ONCOL, V47, P1134, DOI 10.1016/j.oraloncology.2011.08.005; Cai BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069611; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Goode RK, 1998, CANCER, V82, P1217, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C; Guzzo M, 2002, ANN SURG ONCOL, V9, P688, DOI 10.1007/BF02574486; He SM, 2011, CURR MED CHEM, V18, P439, DOI 10.2174/092986711794839197; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; HICKS MJ, 1995, HEAD NECK-J SCI SPEC, V17, P89, DOI 10.1002/hed.2880170203; Hong BX, 2015, INT J CANCER, V136, P34, DOI 10.1002/ijc.28958; Hosokawa Y, 1999, ORAL ONCOL, V35, P105, DOI 10.1016/S1368-8375(98)00053-0; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Leverstein H, 1998, BRIT J SURG, V85, P1267; Liu ZG, 2015, MOL MED REP, V12, P248, DOI 10.3892/mmr.2015.3366; Lopes MA, 1999, J ORAL PATHOL MED, V28, P264; Garcia-Gimenez JL, 2013, BBA-GEN SUBJECTS, V1830, P3304, DOI 10.1016/j.bbagen.2012.10.005; Monoo Katsumi, 2003, Nihon Jibiinkoka Gakkai Kaiho, V106, P192; Nance MA, 2008, CANCER, V113, P2082, DOI 10.1002/cncr.23825; Nooter K, 1996, ANN ONCOL, V7, P75; Rapidis AD, 2007, ORAL ONCOL, V43, P130, DOI 10.1016/j.oraloncology.2006.03.001; SKALOVA A, 1994, HUM PATHOL, V25, P929, DOI 10.1016/0046-8177(94)90014-0; SPIRO RH, 1991, AM J SURG, V162, P330, DOI 10.1016/0002-9610(91)90142-Z; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Tew KD, 2011, FREE RADICAL BIO MED, V51, P299, DOI 10.1016/j.freeradbiomed.2011.04.013; Vattemi E, 2008, EXPERT REV ANTICANC, V8, P393, DOI 10.1586/14737140.8.3.393; Wen Y, 2001, Hua Xi Kou Qiang Yi Xue Za Zhi, V19, P296; Zhang YF, 2010, CANCER LETT, V292, P1, DOI 10.1016/j.canlet.2009.11.003; Zhu QR, 1999, ANAL QUANT CYTOL, V21, P336	32	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148223	10.1371/journal.pone.0148223	http://dx.doi.org/10.1371/journal.pone.0148223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829120	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200087
J	Chen, YA; Wang, TT; Fang, LC; Li, XP; Yin, TM				Chen, Yingnan; Wang, Tiantian; Fang, Lecheng; Li, Xiaoping; Yin, Tongming			Confirmation of Single-Locus Sex Determination and Female Heterogamety in Willow Based on Linkage Analysis	PLOS ONE			English	Article							PRIMITIVE Y-CHROMOSOME; MALE-SPECIFIC REGION; POPULUS-TREMULA; GENETIC-MAP; SALIX; MARKERS; GENOME; AFLP; EVOLUTION; DIOECY	In this study, we constructed high-density genetic maps of Salix suchowensis and mapped the gender locus with an F1 pedigree. Genetic maps were separately constructed for the maternal and paternal parents by using amplified fragment length polymorphism (AFLP) markers and the pseudo-testcross strategy. The maternal map consisted of 20 linkage groups that spanned a genetic distance of 2333.3 cM; whereas the paternal map contained 21 linkage groups that covered 2260 cM. Based on the established genetic maps, it was found that the gender of willow was determined by a single locus on linkage group LG_03, and the female was the heterogametic gender. Aligned with mapped SSR markers, linkage group LG_03 was found to be associated with chromosome XV in willow. It is noteworthy that marker density in the vicinity of the gender locus was significantly higher than that expected by chance alone, which indicates severe recombination suppression around the gender locus. In conclusion, this study confirmed the findings on the single-locus sex determination and female heterogamety in willow. It also provided additional evidence that validated the previous studies, which found that different autosomes evolved into sex chromosomes between the sister genera of Salix (willow) and Populus (poplar).	[Chen, Yingnan; Fang, Lecheng; Li, Xiaoping; Yin, Tongming] Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Wang, Tiantian] Forestry Res Inst Jingdezhen, Jingdezhen, Jiangxi, Peoples R China	Nanjing Forestry University	Yin, TM (corresponding author), Nanjing Forestry Univ, Coll Forestry, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.	tmyin@njfu.com.cn			National Basic Research Project [2012CB114505]; Natural Science Foundation of China [31125008, 31400564]; Jiangsu Province [BK20130968]	National Basic Research Project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province	This work was supported by the National Basic Research Project (2012CB114505, http://www.forestry.gov.cn/), the Natural Science Foundation of China (31125008, 31400564, http://isisn.nsfc.gov.cn/egrantweb/) and Jiangsu Province (BK20130968, http://www.jstd.gov.cn/). It was also enabled by the Innovative Research Team of the Educational Department of China (http://www.moe.gov.cn/), the Innovative Research Team of the Universities of Jiangsu Province (http://www.jsrcgz.gov.cn), and the PAPD (Priority Academic Program Development) program at Nanjing Forestry University (http://www.njfu.edu.en/index.php).	Akagi T, 2014, SCIENCE, V346, P646, DOI 10.1126/science.1257225; AlstromRapaport C, 1997, THEOR APPL GENET, V94, P493, DOI 10.1007/s001220050442; Barcaccia G, 2003, HEREDITY, V90, P169, DOI 10.1038/sj.hdy.6800213; Berlin S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-129; Blackburn KB, 1924, BR J EXP BIOL, V1, P413; BRADSHAW HD, 1993, THEOR APPL GENET, V86, P301, DOI 10.1007/BF00222092; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Dai XG, 2014, CELL RES, V24, P1274, DOI 10.1038/cr.2014.83; Dorken ME, 2004, P ROY SOC B-BIOL SCI, V271, P213, DOI 10.1098/rspb.2003.2580; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; EINSPAHR D. W., 1963, SILVAE GENET, V12, P51; Erlanson EW, 1927, MICH ACAD SCI ARTS, V8, P97; Filatov DA, 2005, GENETICS, V170, P975, DOI 10.1534/genetics.104.037069; Fraser LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-102; Fu HH, 2002, P NATL ACAD SCI USA, V99, P1082, DOI 10.1073/pnas.022635499; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; Geraldes A, 2015, MOL ECOL, V24, P3243, DOI 10.1111/mec.13126; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Gunter LE, 2003, J HERED, V94, P185, DOI 10.1093/jhered/esg023; Hanley S, 2002, THEOR APPL GENET, V105, P1087, DOI 10.1007/s00122-002-0979-0; Hanley SJ, 2007, TREE GENET GENOMES, V3, P35, DOI 10.1007/s11295-006-0049-x; Hou J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09076; Islam-Faridi MN, 2009, CYTOGENET GENOME RES, V125, P74, DOI 10.1159/000218749; Johnsson H, 1940, HEREDITAS, V26, P321; Lan T, 2006, CYTOGENET GENOME RES, V114, P175, DOI 10.1159/000093335; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060181; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Ma H, 2004, GENETICS, V166, P419, DOI 10.1534/genetics.166.1.419; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Markussen T, 2007, SILVAE GENET, V56, P180, DOI 10.1515/sg-2007-0027; Ming R, 2007, AM J BOT, V94, P141, DOI 10.3732/ajb.94.2.141; Muller HJ, 1914, J EXP ZOOL, V17, P325, DOI 10.1002/jez.1400170303; Muntzing A, 1935, HEREDITAS, V21, P383; NAKAJIMA G., 1937, Cytologia, VFujii Jubilee VoL, P282, DOI 10.1508/cytologia.FujiiJubilaei.282; NEI M, 1969, GENETICS, V63, P681; Ohno S., 1967, SEX CHROMOSOMES SEX; Pakull B, 2011, CAN J FOREST RES, V41, P245, DOI 10.1139/X10-206; Pakull B, 2009, TREE GENET GENOMES, V5, P505, DOI 10.1007/s11295-009-0204-2; Paolucci I, 2010, TREE GENET GENOMES, V6, P863, DOI 10.1007/s11295-010-0297-7; Parker JS., 1990, CHROMOSOMES TODAY, V10, P187; Peichel CL, 2004, DEV CELL, V7, P327; PETO F. H., 1938, CANADIAN JOUR RES SECT C BOT SCI, V16, P445; Pucholt P, 2015, HEREDITY, V114, P575, DOI 10.1038/hdy.2014.125; RECHINGER KH, 1992, P ROY SOC EDINB B, V98, P1, DOI 10.1017/S0269727000007417; Remington DL, 1999, THEOR APPL GENET, V98, P1279, DOI 10.1007/s001220051194; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Ronnberg-Wastljung A. C., 2003, Forest Genetics, V10, P185; Rottenberg A, 2000, CAN J FOREST RES, V30, P482, DOI 10.1139/cjfr-30-3-482; Semerikov V, 2003, HEREDITY, V91, P293, DOI 10.1038/sj.hdy.6800327; SiljakYakovlev S, 1996, SEX PLANT REPROD, V9, P127, DOI 10.1007/BF02221391; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Spigler RB, 2008, HEREDITY, V101, P507, DOI 10.1038/hdy.2008.100; TANKSLEY SD, 1992, GENETICS, V132, P1141; Telgmann-Rauber A, 2007, MOL GENET GENOMICS, V278, P221, DOI 10.1007/s00438-007-0235-z; Tsarouhas V, 2002, THEOR APPL GENET, V105, P277, DOI 10.1007/s00122-002-0918-0; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2012, TREE GENET GENOMES, V8, P559, DOI 10.1007/s11295-012-0495-6; VAN BUUTENEN J. P., 1959, BOT GAZETTE, V121, P60, DOI 10.1086/336044; van DILLEWIJN C., 1940, GENETICA, V22, P131, DOI 10.1007/BF01984285; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; WESTERGAARD M, 1958, ADV GENET, V9, P217, DOI 10.1016/S0065-2660(08)60163-7; Wolf DE, 2001, GENETICS, V159, P1243; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; Yu QY, 2007, MOL GENET GENOMICS, V278, P177, DOI 10.1007/s00438-007-0243-z; Zhang WL, 2008, GENOME RES, V18, P1938, DOI 10.1101/gr.078808.108; Zhou WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126077	72	17	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147671	10.1371/journal.pone.0147671	http://dx.doi.org/10.1371/journal.pone.0147671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828940	Green Published, gold			2022-12-27	WOS:000369548200028
J	Kuwae, A; Momose, F; Nagamatsu, K; Suyama, Y; Abe, A				Kuwae, Asaomi; Momose, Fumitaka; Nagamatsu, Kanna; Suyama, Yasuharu; Abe, Akio			BteA Secreted from the Bordetella bronchiseptica Type III Secetion System Induces Necrosis through an Actin Cytoskeleton Signaling Pathway and Inhibits Phagocytosis by Macrophages	PLOS ONE			English	Article							HOST PLASMA-MEMBRANE; PERTUSSIS; EFFECTOR; PROTEIN; INFECTIONS; REQUIRES; CELLS; BOPB; IPAC	BteA is one of the effectors secreted from the Bordetella bronchiseptica type III secretion system. It has been reported that BteA induces necrosis in mammalian cells; however, the roles of BteA during the infection process are largely unknown. In order to investigate the BteA functions, morphological changes of the cells infected with the wild-type B. bronchiseptica were examined by time-lapse microscopy. L2 cells, a rat lung epithelial cell line, spread at 1.6 hours after B. bronchiseptica infection. Membrane ruffles were observed at peripheral parts of infected cells during the cell spreading. BteA-dependent cytotoxicity and cell detachment were inhibited by addition of cytochalasin D, an actin polymerization inhibitor. Domain analyses of BteA suggested that two separate amino acid regions, 200312 and 400-658, were required for the necrosis induction. In order to examine the intra/intermolecular interactions of BteA, the amino-and the carboxyl-terminal moieties were purified as recombinant proteins from Escherichia coli. The amino-terminal moiety of BteA appeared to interact with the carboxyl-terminal moiety in the pull-down assay in vitro. When we measured the amounts of bacteria phagocytosed by J774A. 1, a macrophage-like cell line, the phagocytosed amounts of B. bronchiseptica strains that deliver BteA into the host cell cytoplasm were significantly lower than those of strains that lost the ability to translocate BteA into the host cell cytoplasm. These results suggest that B. bronchiseptica induce necrosis by exploiting the actin polymerization signaling pathway and inhibit macrophage phagocytosis.	[Kuwae, Asaomi; Nagamatsu, Kanna; Suyama, Yasuharu; Abe, Akio] Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Tokyo 1088641, Japan; [Momose, Fumitaka] Kitasato Univ, Grad Sch Infect Control Sci, Lab Viral Infect 2, Tokyo 1088641, Japan; [Nagamatsu, Kanna] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA	Kitasato University; Kitasato University; Washington University (WUSTL)	Kuwae, A (corresponding author), Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Tokyo 1088641, Japan.	kuwae@lisci.kitasato-u.ac.jp	Abe, Akio/AAQ-2464-2020		MEXT/JSPS KAKENHI [24390108, 25670215, 23790484, 26460535]; Kitasato University; Oyama Health Foundation; Naito Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University; Oyama Health Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by MEXT/JSPS KAKENHI (www.jsps.go.jp) grant number 24390108 (AA), 25670215 (AA), 23790484 (AK), and 26460535 (AK), by a Grant-in-Aid from the Kitasato University Research Grant (www.kitasato-u.ac.jp) for Young Researchers in 2005 (AK) and 2006 (AK), by a research grant from the Oyama Health Foundation (http://www.disclo-koeki.org/10a/01044/index.html) in 2011 (AK), and by a research grant from The Naito Foundation (www.naito-f.or.jp/en/) in 2012 (AK). The funders had no role in the study design, data collection or analysis, the decision to publish, or the preparation of the manuscript.	Bibova I, 2015, RNA BIOL, V12, P175, DOI 10.1080/15476286.2015.1017237; Chaigne-Delalande B, 2008, J IMMUNOL, V181, P7630, DOI 10.4049/jimmunol.181.11.7630; Francois M, 2000, INFECT IMMUN, V68, P1289, DOI 10.1128/IAI.68.3.1289-1296.2000; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Kurushima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038925; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Kuwae A, 2001, J BIOL CHEM, V276, P32230, DOI 10.1074/jbc.M103831200; Kuwae A, 2003, CELL MICROBIOL, V5, P973, DOI 10.1046/j.1462-5822.2003.00341.x; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nogawa H, 2004, J BACTERIOL, V186, P3806, DOI 10.1128/JB.186.12.3806-3813.2004; Nonaka T, 2003, MICROBIOL-SGM, V149, P2513, DOI 10.1099/mic.0.26341-0; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Tang YW, 1998, CLIN INFECT DIS, V26, P389, DOI 10.1086/516323; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984; WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243, DOI 10.1128/CMR.4.3.243-255.1991; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x	23	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148387	10.1371/journal.pone.0148387	http://dx.doi.org/10.1371/journal.pone.0148387			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828590	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200097
J	Pinnell, RC; Almajidy, RK; Kirch, RD; Cassel, JC; Hofmann, UG				Pinnell, Richard C.; Almajidy, Rand K.; Kirch, Robert D.; Cassel, Jean C.; Hofmann, Ulrich G.			A Wireless EEG Recording Method for Rat Use inside the Water Maze	PLOS ONE			English	Article							THETA-RHYTHMS; SMALL ANIMALS; PLACE FIELDS; MEMORY TASK; OSCILLATIONS; HIPPOCAMPUS; ACQUISITION; MULTICHANNEL; COORDINATION; SYSTEM	With the continued miniaturisation of portable embedded systems, wireless EEG recording techniques are becoming increasingly prevalent in animal behavioural research. However, in spite of their versatility and portability, they have seldom been used inside water-maze tasks designed for rats. As such, a novel 3D printed implant and waterproof connector is presented, which can facilitate wireless water-maze EEG recordings in freely-moving rats, using a commercial wireless recording system (W32; Multichannel Systems). As well as waterproofing the wireless system, battery, and electrode connector, the implant serves to reduce movement-related artefacts by redistributing movement-related forces away from the electrode connector. This implant/connector was able to successfully record high-quality LFP in the hippocampo-striatal brain regions of rats as they undertook a procedurallearning variant of the double-H water-maze task. Notably, there were no significant performance deficits through its use when compared with a control group across a number of metrics including number of errors and speed of task completion. Taken together, this method can expand the range of measurements that are currently possible in this diverse area of behavioural neuroscience, whilst paving the way for integration with more complex behaviours.	[Pinnell, Richard C.; Almajidy, Rand K.; Kirch, Robert D.; Hofmann, Ulrich G.] Univ Med Ctr Freiburg, Dept Neurosurg, Neuroelect Syst, Freiburg, Germany; [Almajidy, Rand K.] Univ Lubeck, Inst Signal Proc, Lubeck, Germany; [Almajidy, Rand K.] Univ Diyala, Coll Med, Diyala, Iraq; [Cassel, Jean C.] Univ Strasbourg, LNCA, F-67000 Strasbourg, France; [Cassel, Jean C.] CNRS, LNCA UMR 7364, F-67000 Strasbourg, France	University of Freiburg; University of Lubeck; University of Diyala; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pinnell, RC (corresponding author), Univ Med Ctr Freiburg, Dept Neurosurg, Neuroelect Syst, Freiburg, Germany.	rpinne@gmail.com	Hofmann, Ulrich/D-7107-2013	Hofmann, Ulrich/0000-0002-6264-3701; Pinnell, Richard/0000-0002-2102-2028	University of Strasbourg; Neurex-Neuroscience Upper Rhine Network; BrainLinks-BrainTools Cluster of Excellence - German Research Foundation (DFG) [EXC 1086]	University of Strasbourg; Neurex-Neuroscience Upper Rhine Network; BrainLinks-BrainTools Cluster of Excellence - German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by University of Strasbourg and Neurex-Neuroscience Upper Rhine Network (post-doc fellowship awarded to RCP), and BrainLinks-BrainTools Cluster of Excellence funded by the German Research Foundation (DFG, grant number EXC 1086).	Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; BRAGIN A, 1995, J NEUROSCI, V15, P47; Cassel R, 2012, BEHAV BRAIN RES, V230, P333, DOI 10.1016/j.bbr.2012.02.021; Chang PS, 2011, J NEUROSCI METH, V201, P106, DOI 10.1016/j.jneumeth.2011.07.018; DeCoteau WE, 2007, P NATL ACAD SCI USA, V104, P5644, DOI 10.1073/pnas.0700818104; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kirch RD, 2015, JOVE-J VIS EXP, DOI 10.3791/52667; Korshunov VA, 2007, J NEUROSCI METH, V165, P244, DOI 10.1016/j.jneumeth.2007.06.014; Korshunov VA, 2012, J NEUROSCI METH, V206, P15, DOI 10.1016/j.jneumeth.2012.02.007; Lapray D, 2008, J NEUROSCI METH, V168, P119, DOI 10.1016/j.jneumeth.2007.09.029; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Liu CC, 2006, IEEE SENS J, V6, P187, DOI 10.1109/JSEN.2005.860358; Pinnell R C, 2015, J NEUROSCI METHODS I; Pol-Bodetto S, 2011, BEHAV BRAIN RES, V218, P138, DOI 10.1016/j.bbr.2010.11.043; Richter Anja, 2013, Front Neuroeng, V6, P6, DOI 10.3389/fneng.2013.00006; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3	24	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147730	10.1371/journal.pone.0147730	http://dx.doi.org/10.1371/journal.pone.0147730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828947	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200029
J	Wilkinson, LL; Ferriday, D; Bosworth, ML; Godinot, N; Martin, N; Rogers, PJ; Brunstrom, JM				Wilkinson, Laura L.; Ferriday, Danielle; Bosworth, Matthew L.; Godinot, Nicolas; Martin, Nathalie; Rogers, Peter J.; Brunstrom, Jeffrey M.			Keeping Pace with Your Eating: Visual Feedback Affects Eating Rate in Humans	PLOS ONE			English	Article							ENERGY-INTAKE; PORTION SIZE; FOOD-INTAKE; BITE SIZE; OBESITY; PALATABILITY; OVERWEIGHT; APPETITE	Deliberately eating at a slower pace promotes satiation and eating quickly has been associated with a higher body mass index. Therefore, understanding factors that affect eating rate should be given high priority. Eating rate is affected by the physical/textural properties of a food, by motivational state, and by portion size and palatability. This study explored the prospect that eating rate is also influenced by a hitherto unexplored cognitive process that uses ongoing perceptual estimates of the volume of food remaining in a container to adjust intake during a meal. A 2 (amount seen; 300ml or 500ml) x 2 (amount eaten; 300ml or 500ml) between-subjects design was employed (10 participants in each condition). In two 'congruent' conditions, the same amount was seen at the outset and then subsequently consumed (300ml or 500ml). To dissociate visual feedback of portion size and actual amount consumed, food was covertly added or removed from a bowl using a peristaltic pump. This created two additional 'incongruent' conditions, in which 300ml was seen but 500ml was eaten or vice versa. We repeated these conditions using a savoury soup and a sweet dessert. Eating rate (ml per second) was assessed during lunch. After lunch we assessed fullness over a 60-minute period. In the congruent conditions, eating rate was unaffected by the actual volume of food that was consumed (300ml or 500ml). By contrast, we observed a marked difference across the incongruent conditions. Specifically, participants who saw 300ml but actually consumed 500ml ate at a faster rate than participants who saw 500ml but actually consumed 300ml. Participants were unaware that their portion size had been manipulated. Nevertheless, when it disappeared faster or slower than anticipated they adjusted their rate of eating accordingly. This suggests that the control of eating rate involves visual feedback and is not a simple reflexive response to orosensory stimulation.	[Wilkinson, Laura L.; Ferriday, Danielle; Bosworth, Matthew L.; Rogers, Peter J.; Brunstrom, Jeffrey M.] Univ Bristol, Sch Expt Psychol, Nutr & Behav Unit, Bristol, Avon, England; [Godinot, Nicolas; Martin, Nathalie] Nestle Res Ctr, Behav & Percept Grp, CH-1000 Lausanne, Switzerland; [Wilkinson, Laura L.] Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales	University of Bristol; Nestle SA; Swansea University	Ferriday, D (corresponding author), Univ Bristol, Sch Expt Psychol, Nutr & Behav Unit, Bristol, Avon, England.	danielle.ferriday@bristol.ac.uk	Bosworth, Matthew/O-8544-2016; Brunstrom, Jeff/AAS-3433-2021; Brunstrom, Jeffrey M/C-7892-2009	Bosworth, Matthew/0000-0003-1391-7515; Brunstrom, Jeff/0000-0003-4657-7799; Brunstrom, Jeffrey M/0000-0003-4657-7799; Wilkinson, Laura/0000-0002-8093-0843; Ferriday, Dani/0000-0003-2665-0055; Godinot, Nicolas/0000-0003-3285-9234; martin, nathalie/0000-0002-2086-3773	Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/J005622/1]; Nestle Research Centre (Switzerland); European Union [607310]; Biotechnology and Biological Sciences Research Council [BB/J005622/1, BB/I012370/1] Funding Source: researchfish; BBSRC [BB/I012370/1, BB/J005622/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nestle Research Centre (Switzerland)(Nestle SA); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a grant (Grant number: BB/J005622/1) awarded to JMB (PI) and PJR (Co-I) from the Biotechnology and Biological Sciences Research Council (United Kingdom - http://www.bbsrc.ac.uk/home/home.aspx) and by Nestle Research Centre (Switzerland - http://www.research.nestle.com/). The Nutrition and Behaviour Unit (University of Bristol) also receives support from the European Union Seventh Framework Programme (FP7/2007-2013 - http://cordis.europa.eu/fp7/home_en.html) under Grant Agreement 607310 (Nudge-it -http://www.nudge-it.eu/). The researchers from Nestle Research Centre [NG and NM] contributed to the design, implementation, analysis, and interpretation of the data. The specific roles of these authors are articulated in the 'author contribution' section.	Almiron-Roig E, 2015, PHYSIOL BEHAV, V139, P297, DOI 10.1016/j.physbeh.2014.11.041; Attwood AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043007; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; BOBROFF EM, 1986, APPETITE, V7, P85, DOI 10.1016/S0195-6663(86)80044-7; Bolhuis Dieuwerke P, 2014, PLoS One, V9, pe93370, DOI 10.1371/journal.pone.0093370; Bolhuis DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053288; Brunstrom JM, 2006, BRIT J NUTR, V96, P761, DOI 10.1079//BJN20061880; Brunstrom JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050707; Brunstrom JM, 2011, APPETITE, V56, P310, DOI 10.1016/j.appet.2011.01.002; Burger KS, 2011, OBESITY, V19, P546, DOI 10.1038/oby.2010.233; Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437; Cecil JE, 1998, APPETITE, V31, P377, DOI 10.1006/appe.1998.0177; DAVIS JD, 1973, J COMP PHYSIOL PSYCH, V83, P379, DOI 10.1037/h0034667; Davis JD, 2009, PHYSIOL BEHAV, V97, P293, DOI 10.1016/j.physbeh.2009.03.028; de Graaf C, 2012, PHYSIOL BEHAV, V107, P496, DOI 10.1016/j.physbeh.2012.05.008; de Graaf C, 2011, P NUTR SOC, V70, P162, DOI 10.1017/S0029665111000012; de Graaf C, 2010, NAT REV ENDOCRINOL, V6, P290, DOI 10.1038/nrendo.2010.41; Fay SH, 2011, APPETITE, V56, P284, DOI 10.1016/j.appet.2011.01.006; Field A, 2013, DISCOVERING STAT USI; Ford AL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5388; Forde CG, 2013, APPETITE, V60, P208, DOI 10.1016/j.appet.2012.09.015; HABER GB, 1977, LANCET, V2, P679; HILL SW, 1984, APPETITE, V5, P73, DOI 10.1016/S0195-6663(84)80026-4; Hinton EC, 2013, APPETITE, V63, P31, DOI 10.1016/j.appet.2012.12.008; Hogenkamp PS, 2013, TRENDS FOOD SCI TECH, V34, P67, DOI 10.1016/j.tifs.2013.08.010; Maruyama K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2002; Oldham-Cooper RE, 2011, AM J CLIN NUTR, V93, P308, DOI 10.3945/ajcn.110.004580; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Robinson E, 2014, AM J CLIN NUTR, V100, P123, DOI 10.3945/ajcn.113.081745; Sasaki S, 2003, INT J OBESITY, V27, P1405, DOI 10.1038/sj.ijo.0802425; SPIEGEL TA, 1989, APPETITE, V13, P45, DOI 10.1016/0195-6663(89)90026-3; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Viskaal-van Dongen M, 2011, APPETITE, V56, P25, DOI 10.1016/j.appet.2010.11.141; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; WOOLEY SC, 1972, PSYCHOSOM MED, V34, P62, DOI 10.1097/00006842-197201000-00007; Yeomans MR, 1996, APPETITE, V27, P119, DOI 10.1006/appe.1996.0040	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147603	10.1371/journal.pone.0147603	http://dx.doi.org/10.1371/journal.pone.0147603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828922	Green Published, gold, Green Accepted			2022-12-27	WOS:000369548200026
J	Gloux, K; Anba-Mondoloni, J				Gloux, Karine; Anba-Mondoloni, Jamila			Unique beta-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INVASIVE ESCHERICHIA-COLI; GENOME-WIDE ASSOCIATION; FAECALIBACTERIUM-PRAUSNITZII; INTESTINAL MICROFLORA; MUTAGENIC ACTIVATION; BILIARY METABOLITES; ULCERATIVE-COLITIS; ILEAL MUCOSA; BACTERIA	Crohn's disease, an incurable chronic inflammatory bowel disease, has been attributed to both genetic predisposition and environmental factors. A dysbiosis of the gut microbiota, observed in numerous patients but also in at least one hundred unaffected first-degree relatives, was proposed to have a causal role. Gut microbiota beta-D-glucuronidases (EC 3.2.1.33) hydrolyse beta-D-glucuronate from glucuronidated compounds. They include a GUS group, that is homologous to the Escherichia coli GusA, and a BG group, that is homologous to metagenomically identified H11G11 BG and has unidentified natural substrates. H11G11 BG is part of the functional core of the human gut microbiota whereas GusA, known to regenerate various toxic products, is variably found in human subjects. We investigated potential risk markers for Crohn's disease using DNA-sequence-based exploration of the beta-D-glucuronidase loci (GUS or Firmicute H11G11-BG and the respective co-encoded glucuronide transporters). Crohn's disease-related microbiomes revealed a higher frequency of a C7D2 glucuronide transporter (12/13) compared to unrelated healthy subjects (8/32). This transporter was in synteny with the potential harmful GUS beta-D-glucuronidase as only observed in a Eubacterium eligens plasmid. A conserved NH2-terminal sequence in the transporter (FGDFGND motif) was found in 83% of the disease-related subjects and only in 12% of controls. We propose a microbiota-pathology hypothesis in which the presence of this unique beta-glucuronidase locus may contribute to an increase risk for Crohn's disease.	[Gloux, Karine; Anba-Mondoloni, Jamila] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gloux, K (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France.	karine.gloux@jouy.inra.fr	Gloux, karine/AAC-4451-2019	gloux, karine/0000-0002-8880-6628				Ahmad Syed, 2011, Curr Chem Genomics, V5, P13, DOI 10.2174/1875397301105010013; Ardizzone S, 2007, INFLAMM BOWEL DIS, V13, P516, DOI 10.1002/ibd.20108; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baker Phillip I, 2009, Expert Rev Gastroenterol Hepatol, V3, P535, DOI 10.1586/egh.09.47; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Blokzijl H, 2008, J BIOL CHEM, V283, P35630, DOI 10.1074/jbc.M804374200; Chan SSM, 2013, AM J GASTROENTEROL, V108, P575, DOI 10.1038/ajg.2012.453; Chen G, 2010, CANCER RES, V70, P7543, DOI 10.1158/0008-5472.CAN-09-4582; Cohen O, 2010, MOL BIOL EVOL, V27, P703, DOI 10.1093/molbev/msp240; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Duong CN, 2011, WATER SCI TECHNOL, V64, P1750, DOI 10.2166/wst.2011.739; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Hedin C, 2016, GUT, V65, P944, DOI 10.1136/gutjnl-2014-308896; Hemminki K, 2009, ANN ONCOL, V20, P574, DOI 10.1093/annonc/mdn595; Humblot C, 2007, CARCINOGENESIS, V28, P2419, DOI 10.1093/carcin/bgm170; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jia WJ, 2010, FEMS MICROBIOL LETT, V310, P138, DOI 10.1111/j.1574-6968.2010.02057.x; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Khalili H, 2015, INFLAMM BOWEL DIS, V21, P361, DOI 10.1097/MIB.0000000000000283; Kim DH, 2001, ARCH PHARM RES, V24, P564, DOI 10.1007/BF02975166; Klimesova K, 2013, INFLAMM BOWEL DIS, V19, P1266, DOI 10.1097/MIB.0b013e318281330a; Knasmuller S, 2001, MUTAT RES-FUND MOL M, V480, P129, DOI 10.1016/S0027-5107(01)00176-2; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li Y, 2015, INT J CLIN EXP MED, V8, P5310; Liu JZ, 2014, BEST PRACT RES CL GA, V28, P373, DOI 10.1016/j.bpg.2014.04.009; LoGuidice A, 2012, J PHARMACOL EXP THER, V341, P447, DOI 10.1124/jpet.111.191122; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; McIntosh FM, 2012, ENVIRON MICROBIOL, V14, P1876, DOI 10.1111/j.1462-2920.2012.02711.x; Michielan A, 2013, DIGEST LIVER DIS, V45, P894, DOI 10.1016/j.dld.2013.01.017; MOROTOMI M, 1985, MUTAT RES, V149, P171, DOI 10.1016/0027-5107(85)90023-5; Muller J, 2009, J ANTIMICROB CHEMOTH, V64, P1187, DOI 10.1093/jac/dkp363; NANNO M, 1986, J MED MICROBIOL, V22, P351, DOI 10.1099/00222615-22-4-351; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Patel AG, 2010, SCIENCE, V330, P766, DOI 10.1126/science.1198310; Pfeiffer E, 2006, MOL NUTR FOOD RES, V50, P385, DOI 10.1002/mnfr.200500198; Pituch-Zdanowska A, 2016, ADV MED SCI-POLAND, V61, P28, DOI 10.1016/j.advms.2015.07.004; Prindiville T, 2004, INFLAMM BOWEL DIS, V10, P824, DOI 10.1097/00054725-200411000-00017; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Tachibana M, 2005, DRUG METAB DISPOS, V33, P803, DOI 10.1124/dmd.104.003178; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; WAKABAYASHI M, 1961, J BIOL CHEM, V236, P996; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Yang J, 2013, J BIOL CHEM, V288, P31115, DOI 10.1074/jbc.M113.503912; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001; Yang QF, 2015, J DIGEST DIS, V16, P22, DOI 10.1111/1751-2980.12205	63	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148291	10.1371/journal.pone.0148291	http://dx.doi.org/10.1371/journal.pone.0148291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824357	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600115
J	Herve, V; Ketter, E; Pierrat, JC; Gelhaye, E; Frey-Klett, P				Herve, Vincent; Ketter, Elodie; Pierrat, Jean-Claude; Gelhaye, Eric; Frey-Klett, Pascale			Impact of Phanerochaete chrysosporium on the Functional Diversity of Bacterial Communities Associated with Decaying Wood	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; FUNGI; SOIL; LIGNIN; BIODEGRADATION; DECOMPOSITION; DYNAMICS; QUALITY; GROWTH; LOGS	Bacteria and fungi naturally coexist in various environments including forest ecosystems. While the role of saprotrophic basidiomycetes in wood decomposition is well established, the influence of these fungi on the functional diversity of the wood-associated bacterial communities has received much less attention. Based on a microcosm experiment, we tested the hypothesis that both the presence of the white-rot fungus Phanerochaete chrysosporium and the wood, as a growth substrate, impacted the functional diversity of these bacterial communities. Microcosms containing sterile sawdust were inoculated with a microbial inoculum extracted from a forest soil, in presence or in absence of P. chrysosporium and subsequently, three enrichment steps were performed. First, bacterial strains were isolated from different microcosms previously analyzed by 16S rRNA gene-based pyrosequencing. Strains isolated from P. chrysosporium mycosphere showed less antagonism against this fungus compared to the strains isolated from the initial forest soil inoculum, suggesting a selection by the fungus of less inhibitory bacterial communities. Moreover, the presence of the fungus in wood resulted in a selection of cellulolytic and xylanolytic bacterial strains, highlighting the role of mycospheric bacteria in wood decomposition. Additionally, the proportion of siderophore-producing bacteria increased along the enrichment steps, suggesting an important role of bacteria in iron mobilization in decaying-wood. Finally, taxonomic identification of 311 bacterial isolates revealed, at the family level, strong similarities with the high-throughput sequencing data as well as with other studies in terms of taxonomic composition of the wood-associated bacterial community, highlighting that the isolated strains are representative of the wood-associated bacterial communities.	[Herve, Vincent; Ketter, Elodie; Gelhaye, Eric; Frey-Klett, Pascale] INRA, Interact Arbres Microorganismes, UMR1136, F-54280 Champenoux, France; [Herve, Vincent; Ketter, Elodie; Gelhaye, Eric; Frey-Klett, Pascale] Univ Lorraine, Interact Arbres Microorganismes, UMR1136, F-54500 Vandoeuvre Les Nancy, France; [Pierrat, Jean-Claude] INRA, UMR LERFOB 1092, F-54280 Champenoux, France; [Pierrat, Jean-Claude] AgroParisTech, UMR LERFOB 1092, F-54000 Nancy, France	INRAE; Universite de Lorraine; Universite de Lorraine; INRAE; AgroParisTech	Herve, V (corresponding author), INRA, Interact Arbres Microorganismes, UMR1136, F-54280 Champenoux, France.; Herve, V (corresponding author), Univ Lorraine, Interact Arbres Microorganismes, UMR1136, F-54500 Vandoeuvre Les Nancy, France.	vincent.herve8@gmail.com		Herve, Vincent/0000-0002-3495-561X	French National Research Agency (ANR), "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01]; Agence Nationale de la Recherche [ANR-09-BLAN-0012]	French National Research Agency (ANR), "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR))	The UMR IaM is supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). Agence Nationale de la Recherche ANR-09-BLAN-0012 http://www.agence-nationalerecherche.fr/. Funding was received by VH EK EG PFK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Antony-Babu S, 2014, ENVIRON MICROBIOL, V16, P2831, DOI 10.1111/1462-2920.12294; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baldrian P, 2008, BR MYCOL SY, V28, P19; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; BLANCHETTE RA, 1991, ANNU REV PHYTOPATHOL, V29, P381, DOI 10.1146/annurev.py.29.090191.002121; Blomqvist J, 2014, BIOTECHNOL APPL BIOC, V61, P58, DOI 10.1002/bab.1153; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Clausen CA, 1996, INT BIODETER BIODEGR, V37, P101, DOI 10.1016/0964-8305(95)00109-3; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; FEKETE FA, 1989, APPL ENVIRON MICROB, V55, P2720, DOI 10.1128/AEM.55.10.2720-2722.1989; Folman LB, 2008, FEMS MICROBIOL ECOL, V63, P181, DOI 10.1111/j.1574-6941.2007.00425.x; Frey P, 1997, APPL ENVIRON MICROB, V63, P1852, DOI 10.1128/AEM.63.5.1852-1860.1997; Frey-Klett P, 2005, NEW PHYTOL, V165, P317, DOI 10.1111/j.1469-8137.2004.01212.x; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Fukasawa Y, 2015, FOREST ECOL MANAG, V349, P29, DOI 10.1016/j.foreco.2015.04.010; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Herve V, 2014, ENVIRON MICROBIOL, V16, P2238, DOI 10.1111/1462-2920.12347; Hoppe B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09456; Hoppe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088141; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CS, 2010, INT J SYST EVOL MICR, V60, P281, DOI 10.1099/ijs.0.013367-0; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Lequy E, 2014, SCI TOTAL ENVIRON, V487, P206, DOI 10.1016/j.scitotenv.2014.04.028; Leveau JHJ, 2010, ENVIRON MICROBIOL, V12, P281, DOI 10.1111/j.1462-2920.2009.02010.x; LINDAHL V, 1995, FEMS MICROBIOL ECOL, V16, P135, DOI 10.1111/j.1574-6941.1995.tb00277.x; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Murray AC, 2007, FOREST PATHOL, V37, P217, DOI 10.1111/j.1439-0329.2007.00490.x; Pion M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2242; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RADTKE C, 1994, APPL MICROBIOL BIOT, V41, P274, DOI 10.1007/BF00186972; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Schilling JS, 2015, SOIL BIOL BIOCHEM, V88, P58, DOI 10.1016/j.soilbio.2015.05.002; Schilling JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120679; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stopnisek N, 2014, ENVIRON MICROBIOL, V16, P1503, DOI 10.1111/1462-2920.12211; Sun H, 2014, GEOMICROBIOL J, V31, P315, DOI 10.1080/01490451.2013.827763; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Tornberg K, 2003, BIOL FERT SOILS, V37, P190, DOI 10.1007/s00374-002-0574-1; Ulrich A, 2008, MICROB ECOL, V55, P512, DOI 10.1007/s00248-007-9296-0; Uroz S, 2011, CENT EUR J BIOL, V6, P817, DOI 10.2478/s11535-011-0053-5; Valaskova V, 2009, ISME J, V3, P1218, DOI 10.1038/ismej.2009.64; VanInsberghe D, 2013, APPL ENVIRON MICROB, V79, P2096, DOI 10.1128/AEM.03112-12; Vetrovsky T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089108; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warmink JA, 2009, ENVIRON MICROBIOL, V11, P300, DOI 10.1111/j.1462-2920.2008.01767.x; Watts Joy E.M., 2013, Diversity-Basel, V5, P641, DOI 10.3390/d5030641; Weisshaupt P, 2013, MYCOL PROG, V12, P283, DOI 10.1007/s11557-012-0834-x; Woo HL, 2014, SYST APPL MICROBIOL, V37, P60, DOI 10.1016/j.syapm.2013.10.001; ZAK JC, 1994, SOIL BIOL BIOCHEM, V26, P1101, DOI 10.1016/0038-0717(94)90131-7; Zhang HB, 2008, INT BIODETER BIODEGR, V62, P471, DOI 10.1016/j.ibiod.2008.06.001	60	27	27	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147100	10.1371/journal.pone.0147100	http://dx.doi.org/10.1371/journal.pone.0147100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824755	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600015
J	Tong, JF; Li, LJ; Ballermann, B; Wang, ZX				Tong, Junfeng; Li, Laiji; Ballermann, Barbara; Wang, Zhixiang			Phosphorylation and Activation of RhoA by ERK in Response to Epidermal Growth Factor Stimulation	PLOS ONE			English	Article							KINASE SIGNALING PATHWAY; VASCULAR SMOOTH-MUSCLE; STRESS FIBER FORMATION; NUCLEAR-LOCALIZATION; CANCER CELLS; REGULATED KINASE; POLYBASIC REGION; DOCKING DOMAINS; RAC1 FUNCTION; MAP KINASES	The small GTPase RhoA has been implicated in various cellular activities, including the formation of stress fibers, cell motility, and cytokinesis. In addition to the canonical GTPase cycle, recent findings have suggested that phosphorylation further contributes to the tight regulation of Rho GTPases. Indeed, RhoA is phosphorylated on serine 188 (S-188) by a number of protein kinases. We have recently reported that Rac1 is phosphorylated on threonine 108 (T-108) by extracellular signal-regulated kinases (ERK) in response to epidermal growth factor (EGF) stimulation. Here, we provide evidence that RhoA is phosphorylated by ERK on S-88 and T-100 in response to EGF stimulation. We show that ERK interacts with RhoA and that this interaction is dependent on the ERK docking site (D-site) at the C-terminus of RhoA. EGF stimulation enhanced the activation of the endogenous RhoA. The phosphomimetic mutant, GFP-RhoA S88E/T100E, when transiently expressed in COS-7 cells, displayed higher GTP-binding than wild type RhoA. Moreover, the expression of GFP-RhoA S88E/T100E increased actin stress fiber formation in COS-7 cells, which is consistent with its higher activity. In contrast to Rac1, phosphorylation of RhoA by ERK does not target RhoA to the nucleus. Finally, we show that regardless of the phosphorylation status of RhoA and Rac1, substitution of the RhoA PBR with the Rac1 PBR targets RhoA to the nucleus and substitution of Rac1 PBR with RhoA PBR significantly reduces the nuclear localization of Rac1. In conclusion, ERK phosphorylates RhoA on S-88 and T-100 in response to EGF, which upregulates RhoA activity.	[Tong, Junfeng; Wang, Zhixiang] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; [Li, Laiji; Ballermann, Barbara] Univ Alberta, Dept Med, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada; [Tong, Junfeng; Li, Laiji; Ballermann, Barbara; Wang, Zhixiang] Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta; University of Alberta	Wang, ZX (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada.; Wang, ZX (corresponding author), Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB T6G 2H7, Canada.	zhixiang.wang@ualberta.ca	Ballermann, Barbara J/G-5349-2016	Ballermann, Barbara J/0000-0002-8220-6381	Alberta Cancer Foundation; Canadian Institutes of Health Research (CIHR) [RES0006924]	Alberta Cancer Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Alberta Cancer Foundation and the Canadian Institutes of Health Research (CIHR: RES0006924).	Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Baldassare JJ, 1997, J BIOL CHEM, V272, P4911, DOI 10.1074/jbc.272.8.4911; Bellizzi A, 2008, INT J MOL MED, V22, P25; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Bolshakova A, 2015, HISTOCHEM CELL BIOL; Burbelo P, 2004, BREAST CANCER RES TR, V84, P43, DOI 10.1023/B:BREA.0000018422.02237.f9; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Dubash AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017380; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Gayard M, 2011, ARTERIOSCL THROM VAS, V31, P2634, DOI 10.1161/ATVBAHA.111.228304; Gest C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-63; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Julian Linda, 2014, Small GTPases, V5, pe29846, DOI 10.4161/sgtp.29846; Kakiashvili E, 2011, J BIOL CHEM, V286, P9268, DOI 10.1074/jbc.M110.179903; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Kusama T, 2001, CANCER RES, V61, P4885; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Li XR, 2006, EJSO-EUR J SURG ONC, V32, P1130, DOI 10.1016/j.ejso.2006.05.012; Li YY, 2011, MOL MED REP, V4, P1115, DOI 10.3892/mmr.2011.556; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Liu M, 2012, TRENDS CELL BIOL, V22, P365, DOI 10.1016/j.tcb.2012.04.004; Loirand G, 2006, TRENDS CARDIOVAS MED, V16, P199, DOI 10.1016/j.tcm.2006.03.010; Mettouchi Amel, 2012, Small GTPases, V3, P102, DOI 10.4161/sgtp.19221; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Ngok SP, 2014, J CELL SCI, V127, P3205, DOI 10.1242/jcs.153197; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Nusser N, 2006, CELL SIGNAL, V18, P704, DOI 10.1016/j.cellsig.2005.06.010; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Ojaniemi M, 1997, J BIOL CHEM, V272, P25993, DOI 10.1074/jbc.272.41.25993; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tang J, 2014, J NEUROSCI, V34, P7425, DOI 10.1523/JNEUROSCI.5449-13.2014; Tao Y, 2008, WORLD J GASTROENTERO, V14, P1175, DOI 10.3748/wjg.14.1175; Tao Y, 2012, ONCOL LETT, V3, P1283, DOI 10.3892/ol.2012.667; Tong JF, 2013, MOL CELL BIOL, V33, P4538, DOI 10.1128/MCB.00822-13; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; von Thun A, 2013, MOL CELL BIOL, V33, P4526, DOI 10.1128/MCB.00585-13; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041354; Xu D, 2012, CELL SIGNAL, V24, P282, DOI 10.1016/j.cellsig.2011.09.013; Xu J, 2013, ONCOL REP, V30, P1878, DOI 10.3892/or.2013.2638; Zhao XS, 2009, CANCER RES, V69, P483, DOI 10.1158/0008-5472.CAN-08-2907; Zuckerbraun BS, 2003, CIRCULATION, V108, P876, DOI 10.1161/01.CIR.0000081947.00070.07	69	28	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147103	10.1371/journal.pone.0147103	http://dx.doi.org/10.1371/journal.pone.0147103			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816343	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200024
J	AbuDagga, A; Wolfe, SM; Carome, M; Oshel, RE				AbuDagga, Azza; Wolfe, Sidney M.; Carome, Michael; Oshel, Robert E.			Cross-Sectional Analysis of the 1039 US Physicians Reported to the National Practitioner Data Bank for Sexual Misconduct, 2003-2013	PLOS ONE			English	Article							MEDICAL EXAMINERS; OREGON BOARD; PROFESSIONALS; COMPLAINTS; ABUSE	Background Little information exists on U.S. physicians who have been disciplined with licensure or restriction-of-clinical-privileges actions or have had malpractice payments because of sexual misconduct. Our objectives were to: (1) determine the number of these physicians and compare their age groups' distribution with that of the general U.S. physician population; (2) compare the type of disciplinary actions taken against these physicians with actions taken against physicians disciplined for other offenses; (3) compare the characteristics and type of injury among victims of these physicians with those of victims in reports for physicians with other offenses in malpractice-payment reports; and (4) determine the percentages of physicians with clinical-privileges or malpractice-payment reports due to sexual misconduct who were not disciplined by medical boards. Methods and Results We conducted a cross-sectional analysis of physician reports submitted to the National Practitioner Data Bank (NPDB) from January 1, 2003, through September 30, 2013. A total of 1039 physicians had >= 1 sexual-misconduct-related reports. The majority (75.6%) had only licensure reports, and 90.1% were 40 or older. For victims in malpractice-payment reports, 87.4% were female, and "emotional injury only" was the predominant type of injury. We found a higher percentage of serious licensure actions and clinical-privileges revocations in sexual-misconduct-related reports than in reports for other offenses (89.0% vs 68.1%, P = < .001, and 29.3% vs 18.8%, P = .002, respectively). Seventy percent of the physicians with a clinical-privileges or malpractice-payment report due to sexual misconduct were not disciplined by medical boards for this problem. Conclusions A small number of physicians were reported to the NPDB because of sexual misconduct. It is concerning that a majority of the physicians with a clinical-privileges action or malpractice- payment report due to sexual misconduct were not disciplined by medical boards for this unethical behavior.	[AbuDagga, Azza; Wolfe, Sidney M.; Carome, Michael] Publ Citizen, Hlth Res Grp, Washington, DC USA; [Oshel, Robert E.] Natl Practitioner Data Bank, Dept Hlth & Human Serv, Silver Spring, MD USA		AbuDagga, A (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC USA.	aabudagga@citizen.org	AbuDagga, Azza/H-3246-2019		Public Citizen	Public Citizen	AA, SMW, and MC are employees of Public Citizen. This study was funded by Public Citizen: www.citizen.org. REO received no specific funding for this work and contributed his time and efforts on this study in-kind to Pubic Citizen. The funder had no role in study design, data selection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, BMJ OPEN, V5, pe166; Alam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050558; BOUHOUTSOS J, 1983, PROF PSYCHOL-RES PR, V14, P185, DOI 10.1037/0735-7028.14.2.185; Chandra Amitabh, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Dehlendorf CE, 1998, JAMA-J AM MED ASSOC, V279, P1883, DOI 10.1001/jama.279.23.1883; Disch E, 2001, AM J ORTHOPSYCHIAT, V71, P204, DOI 10.1037/0002-9432.71.2.204; Disch E, 2006, WOMEN THER, V29, P41, DOI 10.1300/J015v29n01_03; Eichenberg C., 2010, HEALTH-LONDON, V2, P1018, DOI [10.4236/HEALTH.2010.29150, DOI 10.4236/HEALTH.2010.29150]; Enbom JA, 2004, AM J OBSTET GYNECOL, V190, P1642, DOI 10.1016/j.ajog.2004.02.058; Enbom JA, 1997, AM J OBSTET GYNECOL, V176, P1340, DOI 10.1016/S0002-9378(97)70355-7; FAHY T, 1992, BRIT MED J, V304, P1519, DOI 10.1136/bmj.304.6841.1519; Federation of State Medical Boards, 2014, US MED REG TRENDS AC; Federation of State Medical Boards of the United States Inc, 2006, ADDR SEX BOUND GUID; GARTRELL N, 1987, AM J ORTHOPSYCHIAT, V57, P287, DOI 10.1111/j.1939-0025.1987.tb03539.x; Health Professions Regulatory Advisory Council, 2011, LIT REV SEX REL PAT; Jousset N, 2008, MED SCI LAW, V48, P203, DOI 10.1258/rsmmsl.48.3.203; Levine Alan S., 2011, STATE MED BOARDS FAI; Luepker ET, 1999, J AM ACAD PSYCHIATRY, V27, P51; MCMURRAY RJ, 1991, JAMA-J AM MED ASSOC, V266, P2741, DOI 10.1001/jama.1991.03470190089035; OSHEL RE, 1995, PUBLIC HEALTH REP, V110, P383; POPE KS, 1988, J COUNS DEV, V67, P222, DOI 10.1002/j.1556-6676.1988.tb02587.x; Public Citizen, 2014, PET HHS CLOS CORP SH; Shepherd J, 2014, VANDERBILT LAW REV, V67, P151; [U.S. Department of Health and Human Services Health Resources and Services Administration], 2015, NAT PRACT DAT BANK G; [U.S. Department of Health and Human Services Health Resources and Services Administration], 2014, NAT PRACT DAT BANK P; Veatch R, 1989, CROSS CULTURAL PERSP, P6; Wolfe S. M., 2012, PUBLIC CITIZENS HLTH; Young A, 2011, J MED REGULATION, V96, P10	28	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147800	10.1371/journal.pone.0147800	http://dx.doi.org/10.1371/journal.pone.0147800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840639	gold, Green Published			2022-12-27	WOS:000369550200060
J	Asadzadeh, J; Neligan, N; Kramer, SG; Labrador, JP				Asadzadeh, Jamshid; Neligan, Niamh; Kramer, Sunita G.; Labrador, Juan-Pablo			Tinman Regulates NetrinB in the Cardioblasts of the Drosophila Dorsal Vessel	PLOS ONE			English	Article							COMMISSURAL AXONS; TUBE FORMATION; HEART; SLIT; GUIDANCE; GENES; DIVERSIFICATION; MORPHOGENESIS; REPULSION; ADHESION	Morphogenesis of the Drosophila dorsal vessel (DV) shares similarities with that of the vertebrate heart. Precursors line up at both sides of the embryo, migrate towards the midline and fuse to form a tubular structure. Guidance receptors and their ligands have been implicated in this process in vertebrates and invertebrates, as have been a series of evolutionarily conserved cardiogenic transcriptional regulators including Tinman, the Drosophila homolog of the transcription factor Nkx-2.5. NetrinB (NetB), a repulsive ligand for the Unc-5 receptor is required to preserve the dorsal vessel hollow. It localizes to the luminal space of the dorsal vessel but its source and its regulation is unknown. Here, using genetics together with in situ hybridization with single cell resolution, we show how tin is required for NetrinB expression in cardioblasts during DV tubulogenesis and sufficient to promote NetB transcription ectopically. We further identify a dorsal vessel-specific NetB enhancer and show that it is also regulated by tin in a similar fashion to NetB.	[Asadzadeh, Jamshid; Neligan, Niamh; Labrador, Juan-Pablo] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Asadzadeh, Jamshid; Labrador, Juan-Pablo] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Kramer, Sunita G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Trinity College Dublin; Trinity College Dublin; Rutgers State University New Brunswick; Rutgers State University Medical Center	Labrador, JP (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.; Labrador, JP (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.	labradoj@tcd.ie	Labrador, Juan Pablo/C-3018-2014	Labrador, Juan Pablo/0000-0003-3671-848X; Kramer, Sunita/0000-0001-8372-5928	SFI [07/IN.1/B913, 08/ RFP/NSC1617]; IRC; Trinity research award; Science Foundation Ireland (SFI) [07/IN.1/B913, 08/ RFP/NSC1617]; Irish Research Council (IRC) New Foundations Award; Trinity College Dublin	SFI(Science Foundation Ireland); IRC; Trinity research award; Science Foundation Ireland (SFI)(Science Foundation Ireland); Irish Research Council (IRC) New Foundations Award(Irish Research Council for Science, Engineering and Technology); Trinity College Dublin	Brian McCabe, Jim Skeath, Hanh Nguyen, Manfred Frasch and Matthew Wolf kindly provided us with stocks, antibodies and other various reagents. Funding sources of this work were as follows: SFI grants 07/IN.1/B913 and 08/ RFP/NSC1617 and a New Foundations Award from the IRC to JPL and a Trinity research award to JA.; This work was supported by the Science Foundation Ireland (SFI) awards 07/IN.1/B913 and 08/ RFP/NSC1617 (http://www.sfi.ie), the Irish Research Council (IRC) New Foundations Award 2012 to JPL (http://research.ie), and the Trinity Research Award 2009 from Trinity College Dublin (http://www.tcd.ie) to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Asadzadeh J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137688; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BODMER R, 1993, DEVELOPMENT, V118, P719; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Lee HK, 2009, JOVE-J VIS EXP, DOI [10.3791/1647, DOI 10.3791/1647]; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Macabenta FD, 2013, DEV BIOL, V380, P233, DOI 10.1016/j.ydbio.2013.05.007; Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100; Medioni C, 2010, DEV DYNAM, V239, P3303, DOI 10.1002/dvdy.22449; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Mommersteeg MTM, 2013, CIRC RES, V112, P465, DOI 10.1161/CIRCRESAHA.112.277426; Qian L, 2005, CURR BIOL, V15, P2271, DOI 10.1016/j.cub.2005.10.037; Santiago C, 2014, CELL REP, V7, P153, DOI 10.1016/j.celrep.2014.02.037; Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Zaffran S, 2006, DEVELOPMENT, V133, P4073, DOI 10.1242/dev.02586; Zarin AA, 2014, NEURON, V81, P1297, DOI 10.1016/j.neuron.2014.01.038; Zarin AA, 2014, CELL MOL LIFE SCI, V71, P419, DOI 10.1007/s00018-013-1434-x; Zarin AA, 2012, DEVELOPMENT, V139, P1798, DOI 10.1242/dev.070656	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148526	10.1371/journal.pone.0148526	http://dx.doi.org/10.1371/journal.pone.0148526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840059	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200144
J	Choi, JW; Jang, KM; Jung, KY; Kim, MS; Kim, KH				Choi, Jeong Woo; Jang, Kyoung-Mi; Jung, Ki-Young; Kim, Myung-Sun; Kim, Kyung Hwan			Reduced Theta-Band Power and Phase Synchrony during Explicit Verbal Memory Tasks in Female, Non-Clinical Individuals with Schizotypal Traits	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; RECOGNITION MEMORY; EPISODIC MEMORY; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; COGNITIVE PERFORMANCE; GAMMA OSCILLATIONS; HEALTHY-ADULTS; TEMPORAL-LOBE; ODDBALL TASK	The study of non-clinical individuals with schizotypal traits has been considered to provide a promising endophenotypic approach to understanding schizophrenia, because schizophrenia is highly heterogeneous, and a number of confounding factors may affect neuropsychological performance. Here, we investigated whether deficits in explicit verbal memory in individuals with schizotypal traits are associated with abnormalities in the local and inter-regional synchrony of brain activity. Memory deficits have been recognized as a core problem in schizophrenia, and previous studies have consistently shown explicit verbal memory impairment in schizophrenic patients. However, the mechanism of this impairment has not been fully revealed. Seventeen individuals with schizotypal traits and 17 age-matched, normal controls participated. Multichannel event-related electroencephalograms (EEGs) were recorded while the subjects performed a continuous recognition task. Event-related spectral perturbations (ERSPs) and inter-regional theta-band phase locking values (TPLVs) were investigated to determine the differences in local and global neural synchrony between the two subject groups. Additionally, the connection patterns of the TPLVs were quantitatively analyzed using graph theory measures. An old/new effect was found in the induced thetaband ERSP in both groups. However, the difference between the old and new was larger in normal controls than in schizotypal trait group. The tendency of elevated old/new effect in normal controls was observed in anterior-posterior theta-band phase synchrony as well. Our results suggest that explicit memory deficits observed in schizophrenia patients can also be found in non-clinical individuals with psychometrically defined schizotypal traits.	[Choi, Jeong Woo; Kim, Kyung Hwan] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, Gangwon Do, South Korea; [Jang, Kyoung-Mi; Kim, Myung-Sun] Sungshin Womans Univ, Dept Psychol, Seoul, South Korea; [Jung, Ki-Young] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea	Yonsei University; Sungshin Women's University; Seoul National University (SNU)	Kim, KH (corresponding author), Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, Gangwon Do, South Korea.	khkim0604@yonsei.ac.kr		Kim, Kyung Hwan/0000-0001-9044-0437; Choi, Jeong Woo/0000-0001-5824-8859	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014R1A2A2A04003858]; Ministry of Science, ICT & Future Planning [20100018840]; Defense Acquisition Program Administration [UD140069ID]; Center for Integrated Smart Sensors - Ministry of Science, ICT & Future Planning [CISS-2011-0031867]	National Research Foundation of Korea (NRF) - Korean government (MSIP)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Defense Acquisition Program Administration; Center for Integrated Smart Sensors - Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2014R1A2A2A04003858) and (No. 20100018840) funded by the Ministry of Science, ICT & Future Planning, a grant to CABMC (Control of Animal Brain using MEMS Chip) funded by the Defense Acquisition Program Administration (UD140069ID), and by the Center for Integrated Smart Sensors funded by the Ministry of Science, ICT & Future Planning as Global Frontier Project (CISS-2011-0031867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou C, 2015, SCHIZOPHR RES, V161, P299, DOI 10.1016/j.schres.2014.12.018; Baving L, 2000, J PSYCHOPHYSIOL, V14, P87, DOI 10.1027//0269-8803.14.2.87; Burke JF, 2013, J NEUROSCI, V33, P292, DOI 10.1523/JNEUROSCI.2057-12.2013; Caspi A, 2003, SCHIZOPHR RES, V65, P87, DOI 10.1016/S0920-9964(03)00056-2; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Chang TG, 2011, PSYCHIAT CLIN NEUROS, V65, P596, DOI 10.1111/j.1440-1819.2011.02255.x; Choi JW, 2010, NEUROSCI LETT, V468, P156, DOI 10.1016/j.neulet.2009.10.088; Choi JW, 2012, PLOS ONE, V7; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Dastjerdi M, 2011, P NATL ACAD SCI USA, V108, P3023, DOI 10.1073/pnas.1017098108; DELISI LE, 1991, BIOL PSYCHIAT, V29, P159, DOI 10.1016/0006-3223(91)90044-M; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dickinson D, 2008, BIOL PSYCHIAT, V64, P823, DOI 10.1016/j.biopsych.2008.04.005; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; Doege K, 2009, PSYCHOPHYSIOLOGY, V46, P566, DOI 10.1111/j.1469-8986.2009.00785.x; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Ford JM, 2002, BIOL PSYCHIAT, V51, P485, DOI 10.1016/S0006-3223(01)01335-X; Friedman D, 2000, BIOL PSYCHOL, V54, P175, DOI 10.1016/S0301-0511(00)00056-9; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Jalili M, 2011, COMPUT BIOL MED, V41, P1178, DOI 10.1016/j.compbiomed.2011.05.004; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kayser J, 2010, INT J PSYCHOPHYSIOL, V75, P194, DOI 10.1016/j.ijpsycho.2009.12.001; Kayser J, 2009, INT J PSYCHOPHYSIOL, V73, P186, DOI 10.1016/j.ijpsycho.2009.02.003; Kim H, 2009, BRAIN RES, V1282, P103, DOI 10.1016/j.brainres.2009.05.080; Kim KH, 2008, BRAIN RES, V1236, P105, DOI 10.1016/j.brainres.2008.07.118; Kim MS, 2004, PSYCHIAT CLIN NEUROS, V58, P465, DOI 10.1111/j.1440-1819.2004.01287.x; Kim MS, 2011, COMPR PSYCHIAT, V52, P511, DOI 10.1016/j.comppsych.2010.10.010; Klimesch W, 2000, CLIN NEUROPHYSIOL, V111, P781, DOI 10.1016/S1388-2457(00)00254-6; Klimesch W., 1994, CLIN NEUROPHYSIOL, V91, P428, DOI [10.1016/0013-4694(94)90164-3, DOI 10.1016/0013-4694(94)90164-3]; Kotter R, 2002, NEUROSCIENCE DATABAS, P171; Krishna N, 2014, SCHIZOPHR RES, V157, P198, DOI 10.1016/j.schres.2014.05.035; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Mecklinger A, 2000, PSYCHOPHYSIOLOGY, V37, P565, DOI 10.1111/1469-8986.3750565; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Moon H. O., 1997, J KOREAN NEUROPSYCHI, V36, P329; Nelson MT, 2013, NEUROSCI BIOBEHAV R, V37, P317, DOI 10.1016/j.neubiorev.2013.01.004; Nestor PG, 2007, PSYCHIAT RES-NEUROIM, V155, P21, DOI 10.1016/j.pscychresns.2006.12.020; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Preston Alison R, 2005, Curr Neurol Neurosci Rep, V5, P249, DOI 10.1007/s11910-005-0067-3; Ragland JD, 2009, AM J PSYCHIAT, V166, P863, DOI 10.1176/appi.ajp.2009.08091307; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sanfilipo M, 2002, PSYCHIAT RES-NEUROIM, V116, P1, DOI 10.1016/S0925-4927(02)00046-X; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Schmiedt C, 2005, COGNITIVE BRAIN RES, V25, P936, DOI 10.1016/j.cogbrainres.2005.09.015; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Seidman LJ, 1998, J INT NEUROPSYCH SOC, V4, P342, DOI 10.1017/S1355617798003427; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shim M, 2014, SCHIZOPHR RES, V156, P197, DOI 10.1016/j.schres.2014.04.012; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siever LJ, 2004, AM J PSYCHIAT, V161, P398, DOI 10.1176/appi.ajp.161.3.398; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; Song BY, 2011, BIOL PSYCHOL, V87, P49, DOI 10.1016/j.biopsycho.2011.02.001; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stark CEL, 2000, HIPPOCAMPUS, V10, P329, DOI 10.1002/1098-1063(2000)10:3<329::AID-HIPO13>3.0.CO;2-Z; Stefaniak N, 2015, COGN NEUROPSYCHIATRY, V20, P243, DOI 10.1080/13546805.2015.1020147; Summerfield C, 2005, NEUROIMAGE, V24, P692, DOI 10.1016/j.neuroimage.2004.09.012; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tendolkar I, 2002, PSYCHOL MED, V32, P1261, DOI 10.1017/S0033291702006335; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tracy JI, 2001, SCHIZOPHR RES, V50, P199, DOI 10.1016/S0920-9964(01)00241-9; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van Erp TGM, 2008, PSYCHIAT RES, V159, P271, DOI 10.1016/j.psychres.2007.03.003; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vilberg KL, 2007, NEUROPSYCHOLOGIA, V45, P2216, DOI 10.1016/j.neuropsychologia.2007.02.027; Wagner AD, 2001, NAT NEUROSCI, V4, P1159, DOI 10.1038/nn1201-1159; Wang Y, 2015, SCHIZOPHRENIA BULL, V41, pS444, DOI 10.1093/schbul/sbu178; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiss AP, 2003, BIOL PSYCHIAT, V53, P48, DOI 10.1016/S0006-3223(02)01541-X; Weiss S, 2000, NEUROREPORT, V11, P2357, DOI 10.1097/00001756-200008030-00005; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	86	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148272	10.1371/journal.pone.0148272	http://dx.doi.org/10.1371/journal.pone.0148272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840071	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200118
J	Connolly, NMC; D'Orsi, B; Monsefi, N; Huber, HJ; Prehn, JHM				Connolly, Niamh M. C.; D'Orsi, Beatrice; Monsefi, Naser; Huber, Heinrich J.; Prehn, Jochen H. M.			Computational Analysis of AMPK-Mediated Neuroprotection Suggests Acute Excitotoxic Bioenergetics and Glucose Dynamics Are Regulated by a Minimal Set of Critical Reactions	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENERGY-METABOLISM; NEURONAL SURVIVAL; MITOCHONDRIAL BIOENERGETICS; GLUTAMATE EXCITOTOXICITY; CALCIUM-CONCENTRATION; ATP CONCENTRATION; INDUCED APOPTOSIS; CULTURED NEURONS; MEMBRANE	Loss of ionic homeostasis during excitotoxic stress depletes ATP levels and activates the AMP-activated protein kinase (AMPK), re-establishing energy production by increased expression of glucose transporters on the plasma membrane. Here, we develop a computational model to test whether this AMPK-mediated glucose import can rapidly restore ATP levels following a transient excitotoxic insult. We demonstrate that a highly compact model, comprising a minimal set of critical reactions, can closely resemble the rapid dynamics and cell-to-cell heterogeneity of ATP levels and AMPK activity, as confirmed by single-cell fluorescence microscopy in rat primary cerebellar neurons exposed to glutamate excitotoxicity. The model further correctly predicted an excitotoxicity-induced elevation of intracellular glucose, and well resembled the delayed recovery and cell-to-cell heterogeneity of experimentally measured glucose dynamics. The model also predicted necrotic bioenergetic collapse and altered calcium dynamics following more severe excitotoxic insults. In conclusion, our data suggest that a minimal set of critical reactions may determine the acute bioenergetic response to transient excitotoxicity and that an AMPK-mediated increase in intracellular glucose may be sufficient to rapidly recover ATP levels following an excitotoxic insult.	[Connolly, Niamh M. C.; Monsefi, Naser; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, Dublin 2, Ireland; [Connolly, Niamh M. C.; D'Orsi, Beatrice; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Study Neurol Disorders, Dublin 2, Ireland; [Huber, Heinrich J.] Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Leuven, Belgium	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; KU Leuven	Prehn, JHM (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Leuven, Belgium.	Heinrich.Huber@med.kuleuven.be; prehn@rcsi.ie	Connolly, Niamh M. C./U-6083-2019; Prehn, Jochen HM/A-3928-2010; D'Orsi, Beatrice/AAC-8990-2021	Connolly, Niamh M. C./0000-0002-6005-1307; Prehn, Jochen HM/0000-0003-3479-7794; D'Orsi, Beatrice/0000-0002-4335-3995	Science Foundation Ireland [08/IN.1/B1949, 14/JPND/B3077]; Health Research Board in Ireland [PhD/2007/11]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board in Ireland	The authors acknowledge funding from Science Foundation Ireland (08/IN.1/B1949 and 14/JPND/B3077; www.sfi.ie) and the Health Research Board in Ireland (PhD/2007/11; www.hrb.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2010, BBA-GEN SUBJECTS, V1800, P297, DOI 10.1016/j.bbagen.2009.08.002; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Berndt N, 2013, FEBS J, V280, P5080, DOI 10.1111/febs.12480; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; Brennan-Minnella AM, 2015, ANTIOXID REDOX SIGN, V22, P161, DOI 10.1089/ars.2013.5767; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; Concannon CG, 2008, J NEUROCHEM, V105, P891, DOI 10.1111/j.1471-4159.2007.05187.x; Concannon CG, 2010, J CELL BIOL, V189, P83, DOI 10.1083/jcb.200909166; Connolly NMC, 2015, J BIOENERG BIOMEMBR, V47, P75, DOI 10.1007/s10863-014-9578-4; Connolly NMC, 2014, J NEUROSCI, V34, P10192, DOI 10.1523/JNEUROSCI.3127-13.2014; CREMER JE, 1981, BRAIN RES, V221, P331, DOI 10.1016/0006-8993(81)90782-4; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; D'Orsi B, 2015, J NEUROSCI, V35, P1706, DOI 10.1523/JNEUROSCI.2453-14.2015; D'Orsi B, 2012, J NEUROSCI, V32, P1847, DOI 10.1523/JNEUROSCI.2345-11.2012; Davila D, 2012, CELL DEATH DIFFER, V19, P1677, DOI 10.1038/cdd.2012.49; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; GARTHWAITE G, 1986, NEUROSCI LETT, V66, P193, DOI 10.1016/0304-3940(86)90189-8; GEAR CW, 1971, COMMUN ACM, V14, P176, DOI 10.1145/362566.362571; Gerencser AA, 2005, BIOPHYS J, V88, P698, DOI 10.1529/biophysj.104.050062; Gleichmann M, 2009, J NEUROCHEM, V109, P644, DOI 10.1111/j.1471-4159.2009.05997.x; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; Khayat ZA, 1998, BIOCHEM J, V333, P713, DOI 10.1042/bj3330713; Kushnareva YE, 2005, J BIOL CHEM, V280, P28894, DOI 10.1074/jbc.M503090200; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Liu HB, 2006, J MECH DESIGN, V128, P326, DOI 10.1115/1.2159025; Liu XL, 2008, J BIOSCI BIOENG, V105, P106, DOI 10.1263/jbb.105.106; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; MAHER F, 1994, BIOCHEM J, V301, P379, DOI 10.1042/bj3010379; MARCAIDA G, 1995, BRAIN RES, V695, P146, DOI 10.1016/0006-8993(95)00703-S; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nicholls DG, 2015, J BIOENERG BIOMEMBR, V47, P63, DOI 10.1007/s10863-014-9573-9; Nicholls DG, 1999, ANN NY ACAD SCI, V893, P1, DOI 10.1111/j.1749-6632.1999.tb07813.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; RAICHLE ME, 1983, ANN NEUROL, V13, P2, DOI 10.1002/ana.410130103; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sonntag AG, 2012, FEBS J, V279, P3314, DOI 10.1111/j.1742-4658.2012.08582.x; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tabernero A, 1996, NEUROSCI RES, V26, P369, DOI 10.1016/S0168-0102(96)01121-2; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Ward MW, 2005, J NEUROCHEM, V92, P1081, DOI 10.1111/j.1471-4159.2004.02928.x; Ward MW, 2000, J NEUROSCI, V20, P7208; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241	71	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148326	10.1371/journal.pone.0148326	http://dx.doi.org/10.1371/journal.pone.0148326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840769	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200125
J	Elorinne, AL; Alfthan, G; Erlund, I; Kivimaki, H; Paju, A; Salminen, I; Turpeinen, U; Voutilainen, S; Laakso, J				Elorinne, Anna-Liisa; Alfthan, Georg; Erlund, Iris; Kivimaki, Hanna; Paju, Annukka; Salminen, Irma; Turpeinen, Ursula; Voutilainen, Sari; Laakso, Juha			Food and Nutrient Intake and Nutritional Status of Finnish Vegans and Non-Vegetarians	PLOS ONE			English	Article							VITAMIN-D; SERUM 25-HYDROXYVITAMIN-D; DIETARY-INTAKE; IODINE STATUS; VEGETARIANS; SELENIUM; PLASMA; OMNIVORES	Background Vegetarian and vegan diets have become more popular among adolescents and young adults. However, few studies have investigated the nutritional status of vegans, who may be at risk of nutritional deficiencies. Objective To compare dietary intake and nutritional status of Finnish long-term vegans and non-vegetarians. Methods Dietary intake and supplement use were estimated using three-day dietary records. Nutritional status was assessed by measuring biomarkers in plasma, serum, and urine samples. Vegans' (n = 22) data was compared with those of sex-and age-matched non-vegetarians (n = 19). Results All vegans adhered strictly to their diet; however, individual variability was marked in food consumption and supplementation habits. Dietary intakes of key nutrients, vitamins B12 and D, were lower (P < 0.001) in vegans than in non-vegetarians. Nutritional biomarker measurements showed lower concentrations of serum 25-hydroxyvitamin D3 (25(OH) D3), iodine and selenium (corrected for multiple comparisons, P < 0.001), Vegans showed more favorable fatty acid profiles (P < 0.001) as well as much higher concentrations of polyphenols such as genistein and daidzein (P < 0.001). Eicosapentaenoic acid proportions in vegans were higher than expected. The median concentration of iodine in urine was below the recommended levels in both groups. Conclusions Long-term consumption of a vegan diet was associated with some favorable laboratory measures but also with lowered concentrations of key nutrients compared to reference values. This study highlights the need for nutritional guidance to vegans.	[Elorinne, Anna-Liisa] Univ Eastern Finland, Sch Appl Educ Sci & Teacher Educ, Savonlinna, Finland; [Alfthan, Georg; Erlund, Iris; Salminen, Irma] Natl Inst Hlth & Welf, Genom & Biomarkers Unit, Helsinki, Finland; [Kivimaki, Hanna; Voutilainen, Sari] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Paju, Annukka] Univ Helsinki, Cent Hosp, Dept Clin Chem & Hematol, Cent Hosp Lab, Helsinki, Finland; [Turpeinen, Ursula] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Laakso, Juha] Finnish Safety & Chem Agcy, Helsinki, Finland	University of Eastern Finland; Finland National Institute for Health & Welfare; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Elorinne, AL (corresponding author), Univ Eastern Finland, Sch Appl Educ Sci & Teacher Educ, Savonlinna, Finland.	Anna-Liisa.Elorinne@uef.fi	Erlund, Iris/AAA-4108-2019		Juho Vainio Foundation	Juho Vainio Foundation	This work was supported by The Juho Vainio Foundation (A-LE and JL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfthan G, 2011, COMBATING MICRONUTRIENT DEFICIENCIES: FOOD-BASED APPROACHES, P312, DOI 10.1079/9781845937140.0312; Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692; Chan J, 2009, AM J CLIN NUTR, V89, pS1686, DOI 10.3945/ajcn.2009.26736X; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; Elmadfa I, 2009, AM J CLIN NUTR, V89, pS1693, DOI 10.3945/ajcn.2009.26736Y; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; GARDINER PHE, 1995, J TRACE ELEM MED BIO, V9, P74, DOI 10.1016/S0946-672X(11)80014-3; Haddad EH, 1999, AM J CLIN NUTR, V70, p586S, DOI 10.1093/ajcn/70.3.586s; Hakala P, 1996, FOOD CHEM, V57, P71, DOI 10.1016/0308-8146(96)00077-5; HERBERT V, 1988, AM J CLIN NUTR, V48, P852, DOI 10.1093/ajcn/48.3.852; Ho-Pham LT, 2012, EUR J CLIN NUTR, V66, P75, DOI 10.1038/ejcn.2011.131; JACOBSON BE, 1988, CLIN CHEM, V34, P709; KADRABOVA J, 1995, BIOL TRACE ELEM RES, V50, P13, DOI 10.1007/BF02789145; Kilkkinen A, 2006, AM J EPIDEMIOL, V163, P687, DOI 10.1093/aje/kwj080; Knoll N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-141; Kornsteiner M, 2008, ANN NUTR METAB, V52, P37, DOI 10.1159/000118629; Kosonen H, 2005, SOZ PRAVENTIV MED, V50, P142, DOI 10.1007/s00038-005-3167-6; Krajcovicova-Kudlackova M, 2003, ANN NUTR METAB, V47, P183, DOI 10.1159/000070483; KTL-National Public Health Institute, 2008, PUBL NAT PUBL HLTH I; LAMBERG-ALLARDT C, 1993, AM J CLIN NUTR, V58, P684, DOI 10.1093/ajcn/58.5.684; Larsson CL, 2001, PUBLIC HEALTH NUTR, V4, P1005, DOI 10.1079/PHN2001167; Larsson CL, 2002, AM J CLIN NUTR, V76, P100; Leung AM, 2011, J CLIN ENDOCR METAB, V96, pE1303, DOI 10.1210/jc.2011-0256; Miettinen ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100235; National Nutrition Council, FINN NUTR REC 2014; Obersby D, 2013, BRIT J NUTR, V109, P785, DOI 10.1017/S000711451200520X; Ohashi T, 2000, CLIN CHEM, V46, P529; Outila TA, 2000, J AM DIET ASSOC, V100, P434, DOI 10.1016/S0002-8223(00)00134-6; Paturi M, FINRAVINTO 2007 TUTK; RAUMA AL, 1994, NUTR RES, V14, P1789, DOI 10.1016/S0271-5317(05)80715-8; Rauma AL, 2000, NUTRITION, V16, P111, DOI 10.1016/S0899-9007(99)00267-1; RAUMA AL, 1995, J NUTR, V125, P2511; Sanders TAB, 2009, PROSTAG LEUKOTR ESS, V81, P137, DOI 10.1016/j.plefa.2009.05.013; Soderholm PP, 2012, NUTR METAB CARDIOVAS, V22, P575, DOI 10.1016/j.numecd.2010.09.011; STOFFEL W, 1958, P SOC EXP BIOL MED, V99, P238; Vinnari M, 2009, PUBLIC HEALTH NUTR, V12, P481, DOI 10.1017/S1368980008002486; Virtanen JK, 2011, EUR J NUTR, V50, P305, DOI 10.1007/s00394-010-0138-3	39	117	126	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148235	10.1371/journal.pone.0148235	http://dx.doi.org/10.1371/journal.pone.0148235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840251	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200106
J	Ferrua, M; Sicotte, C; Lalloue, B; Minvielle, E				Ferrua, Marie; Sicotte, Claude; Lalloue, Benoit; Minvielle, Etienne			Comparative Quality Indicators for Hospital Choice: Do General Practitioners Care?	PLOS ONE			English	Article							HEALTH-CARE; PUBLIC MANAGEMENT; PERFORMANCE DATA; OF-CARE; INFORMATION; IMPACT	Context The strategy of publicly reporting quality indicators is being widely promoted through public policies as a way to make health care delivery more efficient. Objective To assess general practitioners' (GPs) use of the comparative hospital quality indicators made available by public services and the media, as well as GPs' perceptions of their qualities and usefulness. Method A telephone survey of a random sample representing all self-employed GPs in private practice in France. Results A large majority (84.1%-88.5%) of respondents (n = 503; response rate of 56%) reported that they never used public comparative indicators, available in the mass media or on government and non-government Internet sites, to influence their patients' hospital choices. The vast majority of GPs rely mostly on traditional sources of information when choosing a hospital. At the same time, this study highlights favourable opinions shared by a large proportion of GPs regarding several aspects of hospital quality indicators, such as their good qualities and usefulness for other purposes. In sum, the results show that GPs make very limited use of hospital quality indicators based on a consumer choice paradigm but, at the same time, see them as useful in ways corresponding more to the usual professional paradigms, including as a means to improve quality of care.	[Ferrua, Marie; Sicotte, Claude; Lalloue, Benoit; Minvielle, Etienne] Inst Gustave Roussy, EHESP MOS, 114 Rue Edouard Vaillant, F-94805 Villejuif, France; [Sicotte, Claude] Univ Montreal, Dept Adm Sante, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada	UNICANCER; Gustave Roussy; Universite de Montreal	Sicotte, C (corresponding author), Inst Gustave Roussy, EHESP MOS, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	claude.sicotte@umontreal.ca		Lalloue, Benoit/0000-0002-7433-9678	Agence Nationale de la Recherche, France [ANR-10-BLAN-1820]	Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, France (Grant number: ANR-10-BLAN-1820), www.agence-nationale-recherche.fr (MF CS BL EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asworth R, 2013, BRIT J MANAGE, V24, pS1; Birk HO, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-126; Couralet M, 2013, BMJ QUAL SAF, V22, P155, DOI 10.1136/bmjqs-2012-001170; Damman OC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-423; Dourgnon P, 2010, HEALTH POLICY, V94, P129, DOI 10.1016/j.healthpol.2009.09.001; Faber M, 2009, MED CARE, V47, P1, DOI 10.1097/MLR.0b013e3181808bb5; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Hermeling P, 2013, GESUNDHEITSWESEN, V75, P155, DOI 10.1055/s-0032-1321744; Hibbard JH, 2008, ANN INTERN MED, V148, P160, DOI 10.7326/0003-4819-148-2-200801150-00011; Ikkersheim D, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-95; Lega F, 2005, HEALTH POLICY, V74, P261, DOI 10.1016/j.healthpol.2005.01.010; Mannion R, 2003, J EVAL CLIN PRACT, V9, P277, DOI 10.1046/j.1365-2753.2003.00388.x; Minvielle E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-93; Mukamel DB, 2014, ANNU REV PUBL HEALTH, V35, P477, DOI 10.1146/annurev-publhealth-082313-115826; Pollit Ch., 2011, PUBLIC MANAGEMENT RE, V3rd; Reay T, 2009, ORGAN STUD, V30, P629, DOI 10.1177/0170840609104803; Reibling N, 2012, CURR SOCIOL, V60, P489, DOI 10.1177/0011392112438333; Robinowitz DL, 2006, ANNU REV PUBL HEALTH, V27, P517, DOI 10.1146/annurev.publhealth.27.021405.102210; Simonet D, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-57; Simonet D, 2008, CAN PUBLIC ADMIN, V51, P617, DOI 10.1111/j.1754-7121.2008.00044.x; Victoor A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-272; Vrangbaek K, 2007, HEALTH ECON POLICY L, V2, P125, DOI 10.1017/S174413310700401X; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Zwijnenberg NC, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-101	24	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147296	10.1371/journal.pone.0147296	http://dx.doi.org/10.1371/journal.pone.0147296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840429	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200031
J	Kim, JH; Choi, SC; Park, CY; Park, JH; Choi, JH; Joo, HJ; Hong, SJ; Lim, DS				Kim, Jong-Ho; Choi, Seung-Cheol; Park, Chi-Yeon; Park, Jae-Hyoung; Choi, Ji-Hyun; Joo, Hyung-Joon; Hong, Soon-Jun; Lim, Do-Sun			Transplantation of Immortalized CD34+and CD34-Adipose-Derived Stem Cells Improve Cardiac Function and Mitigate Systemic Pro-Inflammatory Responses	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ADIPOSE STROMAL CELLS; MYOCARDIAL-INFARCTION; POSTNATAL NEOVASCULARIZATION; CARDIOVASCULAR-DISEASE; TELOMERASE EXPRESSION; HINDLIMB ISCHEMIA; BONE-MARROW; LIFE-SPAN; TISSUE	Adipose-derived stem cells (ADSCs) have the potential to differentiate into various cell lineages and they are easily obtainable from patients, which makes them a promising candidate for cell therapy. However, a drawback is their limited life span during in vitro culture. Therefore, hTERT-immortalized CD34+ and CD34-mouse ADSC lines (mADSCs(hTERT)) tagged with GFP were established. We evaluated the proliferation capacity, multi-differentiation potential, and secretory profiles of CD34+ and CD34-mADSCs(hTERT) in vitro, as well as their effects on cardiac function and systemic inflammation following transplantation into a rat model of acute myocardial infarction (AMI) to assess whether these cells could be used as a novel cell source for regeneration therapy in the cardiovascular field. CD34+ and CD34- mADSCs(hTERT) demonstrated phenotypic characteristics andmulti-differentiation potentials similar to those of primary mADSCs. CD34+ mADSCs(hTERT) exhibited a higher proliferation ability compared to CD34-mADSCs(hTERT), whereas CD34-mADSCs(hTERT) showed a higher osteogenic differentiation potential compared to CD34+ mADSCs(hTERT). Primary mADSCs, CD34+, and CD34-mADSCs(hTERT) primarily secreted EGF, TGF-beta 1, IGF-1, IGF-2, MCP-1, and HGFR. CD34+ mADSCs(hTERT) had higher secretion of VEGF and SDF-1 compared to CD34-mADSCs(hTERT). IL-6 secretion was severely reduced in both CD34+ and CD34-mADSCs(hTERT) compared to primary mADSCs. Transplantation of CD34+ and CD34-mADSCs(hTERT) significantly improved the left ventricular ejection fraction and reduced infarct size compared to AMI-induced rats after 28 days. At 28 days after transplantation, engraftment of CD34+ and CD34-mADSCs(hTERT) was confirmed by positive Y chromosome staining, and differentiation of CD34+ and CD34-mADSCs(hTERT) into endothelial cells was found in the infarcted myocardium. Significant decreases were observed in circulating IL-6 levels in CD34+ and CD34-mADSCs(hTERT) groups compared to the AMI-induced control group. Transplantation of CD34-mADSCs(hTERT) significantly reduced circulating MCP-1 levels compared to the AMI control and CD34+ mADSCs(hTERT) groups. GFP-tagged CD34+ and CD34-mADSCs(hTERT) are valuable resources for cell differentiation studies in vitro as well as for regeneration therapy in vivo.	[Kim, Jong-Ho; Choi, Seung-Cheol; Park, Chi-Yeon; Park, Jae-Hyoung; Choi, Ji-Hyun; Joo, Hyung-Joon; Hong, Soon-Jun; Lim, Do-Sun] Korea Univ, Anam Hosp, Dept Cardiol, Cardiovasc Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lim, DS (corresponding author), Korea Univ, Anam Hosp, Dept Cardiol, Cardiovasc Ctr, Seoul, South Korea.	dslmd@kumc.or.kr	Park, Chi-Yeon/ABH-9980-2020; Joo, Hyung Joon/Q-4875-2016	Joo, Hyung Joon/0000-0003-1846-8464; Kim, Jong-Ho/0000-0002-1309-0821; Park, Chi-Yeon/0000-0002-9400-9078	Ministry of Health & Welfare, Republic of Korea [A120275]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120275).	Anastassiadis K, 2010, GENESIS, V48, P220, DOI 10.1002/dvg.20605; Balducci L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt452; Banas A, 2008, STEM CELLS, V26, P2705, DOI 10.1634/stemcells.2008-0034; Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Carceller MC, 2015, CYTOTHERAPY, V17, P1230, DOI 10.1016/j.jcyt.2015.06.001; Cho HH, 2009, CELL PHYSIOL BIOCHEM, V24, P511, DOI 10.1159/000257495; Choi SC, 2015, J CELL PHYSIOL, V230, P1807, DOI 10.1002/jcp.24892; Choi YS, 2010, J CELL MOL MED, V14, P878, DOI 10.1111/j.1582-4934.2010.01009.x; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Dong ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080364; Dredge K, 2002, J IMMUNOL, V168, P4914, DOI 10.4049/jimmunol.168.10.4914; Frangogiannis NG, 1998, CIRCULATION, V98, P699, DOI 10.1161/01.CIR.98.7.699; Frangogiannis NG, 1998, J MOL CELL CARDIOL, V30, P2567, DOI 10.1006/jmcc.1998.0829; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gu YP, 2006, EXP CELL RES, V312, P831, DOI 10.1016/j.yexcr.2005.11.029; He J, 2013, MOL MED REP, V7, P1111, DOI 10.3892/mmr.2013.1307; Kang SK, 2004, STEM CELLS, V22, P1356, DOI 10.1634/stemcells.2004-0023; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Lee SC, 2015, SURGERY, V157, P934, DOI 10.1016/j.surg.2014.12.016; Li N, 2014, REGEN MED RES, V2, DOI 10.1186/2050-490X-2-6; Mazo M, 2012, CELL TRANSPLANT, V21, P1023, DOI 10.3727/096368911X623862; Mert T, 2015, INFLAMMATION, V38, P1302, DOI 10.1007/s10753-014-0101-1; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pizzolato MC, 2003, TRANSPLANTATION, V75, P542, DOI 10.1097/01.TP.0000048492.91165.FC; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Scherberich Arnaud, 2013, World J Stem Cells, V5, P1, DOI 10.4252/wjsc.v5.i1.1; Shin S, 2013, INT J MED SCI, V10, P8, DOI 10.7150/ijms.5385; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Suga H, 2009, STEM CELLS DEV, V18, P1201, DOI 10.1089/scd.2009.0003; Sun CK, 2012, CRIT CARE MED, V40, P1279, DOI 10.1097/CCM.0b013e31823dae23; Suzuki E, 2015, WORLD J CARDIOL, V7, P454, DOI 10.4330/wjc.v7.i8.454; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Vandervelde S, 2007, CARDIOVASC RES, V73, P783, DOI 10.1016/j.cardiores.2006.11.030; Varma MJO, 2007, STEM CELLS DEV, V16, P91, DOI 10.1089/scd.2006.0026; Weng NP, 2000, J CLIN IMMUNOL, V20, P257; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Zhang SJ, 2014, STEM CELLS, V32, P1616, DOI 10.1002/stem.1632; Zhang XH, 2006, BIOCHEM BIOPH RES CO, V351, P853, DOI 10.1016/j.bbrc.2006.10.125	49	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147853	10.1371/journal.pone.0147853	http://dx.doi.org/10.1371/journal.pone.0147853			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840069	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200066
J	Wu, SS; Ma, CN; Yang, ZY; Yang, P; Chu, YH; Zhang, HY; Li, HJ; Hua, WY; Tang, YQ; Li, C; Wang, QY				Wu, Shuangsheng; Ma, Chunna; Yang, Zuyao; Yang, Peng; Chu, Yanhui; Zhang, Haiyan; Li, Hongjun; Hua, Weiyu; Tang, Yaqing; Li, Chao; Wang, Quanyi			Hygiene Behaviors Associated with Influenza-Like Illness among Adults in Beijing, China: A Large, Population-Based Survey	PLOS ONE			English	Article							HAND HYGIENE; TRANSMISSION; PREVENTION; STRATEGIES; VACCINE; REDUCE	The objective of this study was to identify possible hygiene behaviors associated with the incidence of ILI among adults in Beijing. In January 2011, we conducted a multi-stage sampling, cross-sectional survey of adults living in Beijing using self-administered anonymous questionnaires. The main outcome variable was self-reported ILI within the past year. Multivariate logistic regression was used to identify factors associated with self-reported ILI. A total of 13003 participants completed the questionnaires. 6068 (46.7%) of all participants reported ILI during the past year. After adjusting for demographic characteristics, the variables significantly associated with a lower likelihood of reporting ILI were regular physical exercise (OR 0.80; 95% CI 0.74-0.87), optimal hand hygiene (OR 0.87; 95% CI 0.80-0.94), face mask use when going to hospitals (OR 0.87; 95% CI 0.80-0.95), and not sharing of towels and handkerchiefs (OR 0.68; 95% CI 0.63-0.73). These results highlight that personal hygiene behaviors were potential preventive factors against the incidence of ILI among adults in Beijing, and future interventions to improve personal hygiene behaviors are needed in Beijing.	[Wu, Shuangsheng; Ma, Chunna; Yang, Peng; Wang, Quanyi] Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China; [Yang, Zuyao] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Chu, Yanhui] Xicheng Dist Ctr Dis Prevent & Control, Dept Epidemiol, Beijing, Peoples R China; [Zhang, Haiyan] Dongcheng Dist Ctr Dis Prevent & Control, Dept Epidemiol, Beijing, Peoples R China; [Li, Hongjun] Tongzhou Dist Ctr Dis Prevent & Control, Dept Epidemiol, Beijing, Peoples R China; [Hua, Weiyu] Haidian Dist Ctr Dis Prevent & Control, Dept Epidemiol, Beijing, Peoples R China; [Tang, Yaqing] Changping Dist Ctr Dis Prevent & Control, Dept Epidemiol, Beijing, Peoples R China; [Li, Chao] Huairou Dist Ctr Dis Prevent & Control, Dept Epidemiol, Beijing, Peoples R China	Chinese University of Hong Kong	Wang, QY (corresponding author), Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China.	bjcdcxm@126.com			Beijing Municipal Science and Technology Commission [D141100003114002]; capital health research and development of special [2014-1-1011]; Beijing Health System High Level Health Technology Talent Cultivation Plan [2013-3-098]; Beijing Young Top-notch Talent Project [2014000021223ZK36]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); capital health research and development of special; Beijing Health System High Level Health Technology Talent Cultivation Plan; Beijing Young Top-notch Talent Project	This work was supported by the research funds for Beijing Municipal Science and Technology Commission (D141100003114002), the capital health research and development of special (2014-1-1011), Beijing Health System High Level Health Technology Talent Cultivation Plan (2013-3-098) and Beijing Young Top-notch Talent Project (2014000021223ZK36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2002, LANCET INFECT DIS, V2, P103, DOI 10.1016/S1473-3099(02)00184-6; Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Bachi Andre L L, 2013, Results Immunol, V3, P10, DOI 10.1016/j.rinim.2013.01.001; Christian LM, 2014, VACCINE, V32, P2958, DOI 10.1016/j.vaccine.2014.03.075; Debing Y, 2013, CURR OPIN VIROL, V3, P217, DOI 10.1016/j.coviro.2013.03.001; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Garcia-Sastre A, 2013, CURR OPIN VIROL, V3, P210, DOI 10.1016/j.coviro.2013.02.001; Huang F, 2011, INT J VIROL, V11, P97; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub3; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Jiang RJ, 2005, CHN J PUBLIC HLTH, V21, P925; Kohut ML, 2009, J INFECT DIS, V200, P1434, DOI 10.1086/606014; Lee HK, 2014, KOREAN J FAM MED, V35, P119, DOI 10.4082/kjfm.2014.35.3.119; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Millot JL, 2002, OCCUP MED-OXFORD, V52, P281, DOI 10.1093/occmed/52.5.281; Pantelic J, 2009, J R SOC INTERFACE, V6, pS715, DOI 10.1098/rsif.2009.0311.focus; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Tang JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059970; Warren-Gash C, 2013, INFLUENZA OTHER RESP, V7, P738, DOI 10.1111/irv.12015; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040	22	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148448	10.1371/journal.pone.0148448	http://dx.doi.org/10.1371/journal.pone.0148448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840614	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200137
J	Xu, YS; Gao, ZH; Tao, JM; Jiang, WH; Zhang, SJ; Wang, QN; Qu, SC				Xu, Yanshuai; Gao, Zhihong; Tao, Jianmin; Jiang, Weihua; Zhang, Shijie; Wang, Qiunan; Qu, Shenchun			Genome-Wide Detection of SNP and SV Variations to Reveal Early Ripening-Related Genes in Grape	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHETIC-PATHWAY; VINIFERA CV SHIRAZ; ABSCISIC-ACID; BERRY DEVELOPMENT; FRUIT MATURATION; ETHYLENE; EXPRESSION; POLYMORPHISM; GROWTH; COLOR	Early ripening in grape (Vitis vinifera L.) is a crucial agronomic trait. The fruits of the grape line 'Summer Black' (SBBM), which contains a bud mutation, can be harvested approximately one week earlier than the 'Summer Black' (SBC) control. To investigate the molecular mechanism of the bud mutation related to early ripening, we detected genome-wide genetic variations based on re-sequencing. In total, 3,692,777 single nucleotide polymorphisms (SNPs) and 81,223 structure variations (SVs) in the SBC genome and 3,823,464 SNPs and 85,801 SVs in the SBBM genome were detected compared with the reference grape sequence. Of these, 635 SBC-specific genes and 665 SBBM-specific genes were screened. Ripening and colour-associated unigenes with non-synonymous mutations (NS), SVs or frame-shift mutations (F) were analysed. The results showed that 90 unigenes in SBC, 76 unigenes in SBBM and 13 genes that mapped to large fragment indels were filtered. The expression patterns of eight genes were confirmed using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The re-sequencing data showed that 635 SBC-specific genes and 665 SBBM-specific genes associated with early ripening were screened. Among these, NCED6 expression appears to be related to NCED1 and is involved in ABA biosynthesis in grape, which might play a role in the onset of anthocyanin accumulation. The SEP and ERF genes probably play roles in ethylene response.	[Xu, Yanshuai; Gao, Zhihong; Tao, Jianmin; Zhang, Shijie; Qu, Shenchun] Nanjing Agr Univ, Coll Hort, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China; [Jiang, Weihua; Wang, Qiunan] Agr Bur & Forestry Workstn, Wujin Dist 213000, Changzhou, Peoples R China; [Xu, Yanshuai] Jiangsu Key Lab Hort Crop Genet Improvement, 50 Zhongling St, Nanjing 210014, Jiangsu, Peoples R China	Nanjing Agricultural University	Qu, SC (corresponding author), Nanjing Agr Univ, Coll Hort, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	qscnj@njau.edu.cn	zhang, shijie/HGF-0836-2022		Key Projects in the Science & Technology Pillar Program of the Agricultural Bureau of Forestry Workstation Changzhou Wujin District [CE20132009]; Qinglan Project of Jiangsu Province	Key Projects in the Science & Technology Pillar Program of the Agricultural Bureau of Forestry Workstation Changzhou Wujin District; Qinglan Project of Jiangsu Province	This study was funded by Key Projects in the Science & Technology Pillar Program of the Agricultural Bureau of Forestry Workstation Changzhou Wujin District (CE20132009) and the Qinglan Project of Jiangsu Province.	Ageorges A, 2006, PLANT SCI, V170, P372, DOI 10.1016/j.plantsci.2005.09.007; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Ban T, 2003, J HORTIC SCI BIOTECH, V78, P586, DOI 10.1080/14620316.2003.11511668; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Bottcher C, 2013, AM J ENOL VITICULT, V64, P527, DOI 10.5344/ajev.2013.13053; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Castellarin SD, 2011, J EXP BOT, V62, P4345, DOI 10.1093/jxb/err150; CAWTHON DL, 1982, HORTSCIENCE, V17, P490; Cazzonelli CI, 1998, AUST J PLANT PHYSIOL, V25, P513, DOI 10.1071/PP98013; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; COOMBE BG, 1973, PLANT PHYSIOL, V51, P629, DOI 10.1104/pp.51.4.629; Cota-Sanchez JH, 2006, PLANT MOL BIOL REP, V24, P161, DOI 10.1007/BF02914055; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; Dong TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095559; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Galeano CH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-629; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Hu H, 2001, CHEM PHYS LETT, V345, P25, DOI 10.1016/S0009-2614(01)00851-X; Iannetta PPM, 2006, PHYSIOL PLANTARUM, V127, P247, DOI 10.1111/j.1399-3054.2006.00656.x; INABA A, 1976, J JPN SOC HORTIC SCI, V45, P245, DOI 10.2503/jjshs.45.245; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Ji K, 2014, J EXP BOT, V65, P5243, DOI 10.1093/jxb/eru288; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; Liu MC, 2014, NEW PHYTOL, V203, P206, DOI 10.1111/nph.12771; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mazza G, 1999, J AGR FOOD CHEM, V47, P4009, DOI 10.1021/jf990449f; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moschou PN, 2010, METHODOLOGIES AND RESULTS IN GRAPEVINE RESEARCH, P193, DOI 10.1007/978-90-481-9283-0_13; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Bicudo MOP, 2014, PLANT FOOD HUM NUTR, V69, P142, DOI 10.1007/s11130-014-0406-0; Schaffer RJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls047; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI DOI 10.1016/S1360-1385(01)02187-2; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; Shan HY, 2007, AGR TECHNICAL SERVIC, V24, P95; Soar CJ, 2004, FUNCT PLANT BIOL, V31, P659, DOI 10.1071/FP03238; Sun JH, 2013, J PLANT GROWTH REGUL, V32, P461, DOI 10.1007/s00344-012-9312-6; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Symons GM, 2006, PLANT PHYSIOL, V140, P150, DOI 10.1104/pp.105.070706; Tucker GA, 2013, BIOCH PLANTS, V12, P265; Wang B., 2013, THESIS SHANGHAI JIAO; Wang HC, 2007, PLANT GROWTH REGUL, V52, P189, DOI 10.1007/s10725-007-9189-8; Wang ZW, 2014, GENE, V538, P1, DOI 10.1016/j.gene.2014.01.035; WEAVER RJ, 1978, AM J ENOL VITICULT, V29, P282; Wheeler S, 2009, AUST J GRAPE WINE R, V15, P195, DOI 10.1111/j.1755-0238.2008.00045.x; Yan LL, 2014, DECIDUOUS FRUITS, V46, P42; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zarei A, 2011, PLANT MOL BIOL, V75, P321, DOI 10.1007/s11103-010-9728-y; Zhang M, 2009, J PLANT PHYSIOL, V166, P1241, DOI 10.1016/j.jplph.2009.01.013; Zhang SJ, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.45; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zhang XR, 2003, J AM SOC HORTIC SCI, V128, P316, DOI 10.21273/JASHS.128.3.0316; Zhao J, 2006, ANAL CHIM ACTA, V571, P79, DOI 10.1016/j.aca.2006.04.060; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114; Zhu CF, 2007, J PLANT PHYSIOL, V164, P195, DOI 10.1016/j.jplph.2006.02.010; Zou XL, 2014, MOL BREEDING, V33, P769, DOI 10.1007/s11032-013-9997-7	63	16	21	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147749	10.1371/journal.pone.0147749	http://dx.doi.org/10.1371/journal.pone.0147749			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840449	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200058
J	Doyard, M; Chappard, D; Leroyer, P; Roth, MP; Loreal, O; Guggenbuhl, P				Doyard, Mathilde; Chappard, Daniel; Leroyer, Patricia; Roth, Marie-Paule; Loreal, Olivier; Guggenbuhl, Pascal			Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss	PLOS ONE			English	Article							BETA-THALASSEMIA MAJOR; MESENCHYMAL STEM-CELLS; MINERAL DENSITY; IRON OVERLOAD; HEREDITARY HEMOCHROMATOSIS; RECEPTOR ACTIVATOR; TEXTURE ANALYSIS; ADOLESCENTS; DISEASE; OSTEOPROTEGERIN	Osteoporosis may complicate iron overload diseases such as genetic hemochromatosis. However, molecular mechanisms involved in the iron-related osteoporosis remains poorly understood. Recent in vitro studies support a role of osteoblast impairment in iron-related osteoporosis. Our aim was to analyse the impact of excess iron in Hfe(-/-) mice on osteoblast activity and on bone microarchitecture. We studied the bone formation rate, a dynamic parameter reflecting osteoblast activity, and the bone phenotype of Hfe(-/-) male mice, a mouse model of human hemochromatosis, by using histomorphometry. Hfe(-/-) animals were sacrificed at 6 months and compared to controls. We found that bone contains excess iron associated with increased hepatic iron concentration in Hfe(-/-) mice. We have shown that animals with iron overload have decreased bone formation rate, suggesting a direct impact of iron excess on active osteoblasts number. For bone mass parameters, we showed that iron deposition was associated with bone loss by producing microarchitectural impairment with a decreased tendency in bone trabecular volume and trabecular number. A disorganization of trabecular network was found with marrow spaces increased, which was confirmed by enhanced trabecular separation and star volume of marrow spaces. These microarchitectural changes led to a loss of connectivity and complexity in the trabecular network, which was confirmed by decreased interconnectivity index and increased Minkowski's fractal dimension. Our results suggest for the first time in a genetic hemochromatosis mouse model, that iron overload decreases bone formation and leads to alterations in bone mass and microarchitecture. These observations support a negative effect of iron on osteoblast recruitment and/or function, which may contribute to iron-related osteoporosis.	[Doyard, Mathilde; Leroyer, Patricia; Loreal, Olivier; Guggenbuhl, Pascal] INSERM, UMR U991, F-35033 Rennes, France; [Doyard, Mathilde; Leroyer, Patricia; Loreal, Olivier; Guggenbuhl, Pascal] Univ Rennes 1, IFR 140, F-35043 Rennes, France; [Chappard, Daniel] CHU Angers, IRIS IBM, Inst Biol Sante, GEROM LHEA, F-49933 Angers, France; [Roth, Marie-Paule] INSERM, U1043, F-31300 Toulouse, France; [Loreal, Olivier] Hop Pontchaillou, CHU, Serv Malad Foie, F-35033 Rennes, France; [Guggenbuhl, Pascal] CHU, Hop Sud, Serv Rhumatol, F-35033 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; CHU Rennes	Guggenbuhl, P (corresponding author), INSERM, UMR U991, F-35033 Rennes, France.; Guggenbuhl, P (corresponding author), Univ Rennes 1, IFR 140, F-35043 Rennes, France.; Guggenbuhl, P (corresponding author), CHU, Hop Sud, Serv Rhumatol, F-35033 Rennes, France.	pascal.guggenbuhl@chu-rennes.fr	Loreal, Olivier/G-3366-2013; Roth, Marie-Paule/Q-2866-2018	Loreal, Olivier/0000-0002-7428-3766; Roth, Marie-Paule/0000-0001-9691-4234; Guggenbuhl, Pascal/0000-0002-8260-1824	Region Bretagne; "Societe Francaise de Rhumatologie" Paris, France	Region Bretagne(Region Bretagne); "Societe Francaise de Rhumatologie" Paris, France	This work was supported by grants from Region Bretagne (MD) and the "Societe Francaise de Rhumatologie" Paris, France.; We thank Mrs. Guenaelle Brossard and Nadine Gaborit for their skilful technical assistance with histomorphometry study. This work was supported by grants from Region Bretagne (MD) and the "Societe Francaise de Rhumatologie" Paris, France.	Angelopoulos NG, 2007, J BONE MINER METAB, V25, P60, DOI 10.1007/s00774-006-0728-6; BARRY M, 1971, LANCET, V1, P100; Brissot P, 2005, TRANSFUS CLIN BIOL, V12, P77, DOI 10.1016/j.tracli.2005.04.040; Brissot P, 2010, PATHOL BIOL, V58, P316, DOI 10.1016/j.patbio.2009.10.011; Chappard D, 1999, MICROSC RES TECHNIQ, V45, P303, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<303::AID-JEMT14>3.3.CO;2-#; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; CONTE D, 1989, AM J GASTROENTEROL, V84, P1231; DEVERNEJOUL MC, 1984, AM J PATHOL, V116, P377; Doyard M, 2012, OSTEOPOROSIS INT, V23, P2435, DOI 10.1007/s00198-011-1871-z; Guggenbuhl P, 2011, OSTEOPOROSIS INT, V22, P2313, DOI 10.1007/s00198-010-1456-2; Guggenbuhl P, 2008, METABOLISM, V57, P903, DOI 10.1016/j.metabol.2008.02.004; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Guggenbuhl P, 2009, JOINT BONE SPINE, V76, P595, DOI 10.1016/j.jbspin.2009.10.001; Jensen CE, 1998, J PEDIATR ENDOCR MET, V11, P975; Jensen CE, 1998, BRIT J HAEMATOL, V103, P911; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Karimi M, 2007, INDIAN PEDIATR, V44, P29; Kudo H, 2008, TOXICOLOGY, V246, P143, DOI 10.1016/j.tox.2008.01.004; Lespessailles E, 2007, CALCIFIED TISSUE INT, V80, P97, DOI 10.1007/s00223-006-0216-y; Mahachoklertwattana P, 2003, J CLIN ENDOCR METAB, V88, P3966, DOI 10.1210/jc.2002-021548; Mahachoklertwattana P, 2003, CLIN ENDOCRINOL, V58, P273, DOI 10.1046/j.1365-2265.2003.01707.x; Matsushima S, 2001, TOXICOL PATHOL, V29, P623, DOI 10.1080/019262301753385951; McDermott JH, 2005, J CLIN ENDOCR METAB, V90, P2451, DOI 10.1210/jc.2004-0980; Messer JG, 2009, BONE, V45, P972, DOI 10.1016/j.bone.2009.07.073; Morabito N, 2004, J BONE MINER RES, V19, P722, DOI 10.1359/JBMR.040113; Oliveira FS, 2012, J CELL BIOCHEM, V113, P204, DOI 10.1002/jcb.23345; Pawlotsky Y, 1989, REV RHUM MAL OSTEO, V46, P91; PECK WA, 1993, AM J MED, V94, P646; Pictrangelo A, 2004, NAT CLIN PRACT GASTR, V1, P39, DOI 10.1038/ncpgasthep0019; Plaisant M, 2009, STEM CELLS, V27, P703, DOI 10.1634/stemcells.2008-0888; Rachidi M, 2008, SKELETAL RADIOL, V37, P541, DOI 10.1007/s00256-008-0463-2; Shamshirseliz AA, 2007, PEDIATR HEMAT ONCOL, V24, P469, DOI 10.1080/08880010701533702; Sinigaglia L, 1997, J RHEUMATOL, V24, P1809; Skordis Nicos, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P107; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Valenti L, 2009, OSTEOPOROSIS INT, V20, P549, DOI 10.1007/s00198-008-0701-4; Vichinsky EP, 1998, ANN NY ACAD SCI, V850, P344, DOI 10.1111/j.1749-6632.1998.tb10491.x; Vogiatzi MG, 2009, J BONE MINER RES, V24, P543, DOI [10.1359/jbmr.080505, 10.1359/JBMR.080505]; Vogiatzi MG, 2005, ANN NY ACAD SCI, V1054, P462, DOI 10.1196/annals.1345.063; Vogiatzi MG, 2006, BONE, V38, P571, DOI 10.1016/j.bone.2005.10.001; Voskaridou E, 2005, EUR J HAEMATOL, V74, P359, DOI 10.1111/j.1600-0609.2004.00395.x; Yamasaki K, 2009, TOXICOL LETT, V191, P211, DOI 10.1016/j.toxlet.2009.08.023; Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337	43	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148292	10.1371/journal.pone.0148292	http://dx.doi.org/10.1371/journal.pone.0148292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829642	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200093
J	Volckmar, AL; Han, CT; Putter, C; Haas, S; Vogel, CIG; Knoll, N; Struve, C; Gobel, M; Haas, K; Herrfurth, N; Jarick, I; Grallert, H; Schurmann, A; Al-Hasani, H; Hebebrand, J; Sauer, S; Hinney, A				Volckmar, Anna-Lena; Han, Chung Ting; Puetter, Carolin; Haas, Stefan; Vogel, Carla I. G.; Knoll, Nadja; Struve, Christoph; Goebel, Maria; Haas, Katharina; Herrfurth, Nikolas; Jarick, Ivonne; Grallert, Harald; Schuermann, Annette; Al-Hasani, Hadi; Hebebrand, Johannes; Sauer, Sascha; Hinney, Anke			Analysis of Genes Involved in Body Weight Regulation by Targeted Re-Sequencing	PLOS ONE			English	Article							MELANOCORTIN-4 RECEPTOR GENE; STIMULATED GLUCOSE-UPTAKE; LIFE-STYLE INTERVENTION; ONSET EXTREME OBESITY; GENOME-WIDE ANALYSIS; MASS INDEX; FTO GENE; FAT MASS; OVERWEIGHT CHILDREN; DIABETES-MELLITUS	Introduction Genes involved in body weight regulation that were previously investigated in genome-wide association studies (GWAS) and in animal models were target-enriched followed by massive parallel next generation sequencing. Methods We enriched and re-sequenced continuous genomic regions comprising FTO, MC4R, TMEM18, SDCCAG8, TKNS, MSRA and TBC1D1 in a screening sample of 196 extremely obese children and adolescents with age and sex specific body mass index (BMI) >= 99th percentile and 176 lean adults (BMI <= 15th percentile). 22 variants were confirmed by Sanger sequencing. Genotyping was performed in up to 705 independent obesity trios (extremely obese child and both parents), 243 extremely obese cases and 261 lean adults. Results and Conclusion We detected 20 different non-synonymous variants, one frame shift and one nonsense mutation in the 7 continuous genomic regions in study groups of different weight extremes. For SNP Arg695Cys (rs58983546) in TBC1D1 we detected nominal association with obesity (p(TDT) = 0.03 in 705 trios). Eleven of the variants were rare, thus were only detected heterozygously in up to ten individual(s) of the complete screening sample of 372 individuals. Two of them (in FTO and MSRA) were found in lean individuals, nine in extremely obese. In silico analyses of the 11 variants did not reveal functional implications for the mutations. Concordant with our hypothesis we detected a rare variant that potentially leads to loss of FTO function in a lean individual. For TBC1D1, in contrary to our hypothesis, the loss of function variant (Arg443Stop) was found in an obese individual. Functional in vitro studies are warranted.	[Volckmar, Anna-Lena; Knoll, Nadja; Struve, Christoph; Goebel, Maria; Haas, Katharina; Herrfurth, Nikolas; Hebebrand, Johannes; Hinney, Anke] Univ Hosp Essen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Essen, Germany; [Han, Chung Ting; Haas, Stefan; Sauer, Sascha] Max Planck Inst Mol Genet, Nutrigen & Gene Regulat, Ihnestr 73, D-14195 Berlin, Germany; [Han, Chung Ting] Inst Mol Biol IMB, Core Facil & Technol, Genom, Mainz, Germany; [Puetter, Carolin] Univ Hosp Essen, IMIBE, Essen, Germany; [Vogel, Carla I. G.] Santa Catarina State Univ, Dept Anim & Food Prod, Lages, Brazil; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Grallert, Harald] Helmholtz Zentrum Munich, Inst Epidemiol, Munich, Germany; [Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Inst Expt Diabetol, Nuthetal, Germany; [Schuermann, Annette; Al-Hasani, Hadi] German Ctr Diabet Res DZD, Munich, Germany; [Al-Hasani, Hadi] German Diabet Ctr, Inst Pathobiochem, Dusseldorf, Germany; [Al-Hasani, Hadi] German Ctr Diabet Res, Dusseldorf, Germany; [Sauer, Sascha] Univ Wurzburg, CU Syst Med, Wurzburg, Germany	University of Duisburg Essen; Max Planck Society; Institute of Molecular Biology (IMB); University of Duisburg Essen; Universidade do Estado de Santa Catarina; Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Diabetes-Zentrum (DDZ); University of Wurzburg	Hinney, A (corresponding author), Univ Hosp Essen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Essen, Germany.	anke.hinney@uni-due.de	Hinney, Anke/D-6953-2011; Vogel, Carla Ivane/X-3419-2019; Grallert, Harald/B-3424-2013; Volckmar, Anna-Lena/ABE-3676-2021	Hinney, Anke/0000-0001-5659-0706; Schurmann, Annette/0000-0002-4113-4377; Haas, Stefan/0000-0003-3418-3688; Han, Chung-Ting/0000-0003-1916-0314; Vogel, Carla/0000-0003-1715-2556	Deutsche Forschungsgemeinschaft (DFG); Deutsche Forschungsgesellschaft [HI865/2-1]; Bundesministerium fur Bildung and Forschung [01KU0903, 0315082/01EA1303, NGFNplus: 01GS0820]; IFORES program of the University of Duisburg-Essen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF)); IFORES program of the University of Duisburg-Essen	The ascertainment of study groups belonging to different weight extremes was supported by the Deutsche Forschungsgemeinschaft (DFG). All other analyses were supported by the Deutsche Forschungsgesellschaft (HI865/2-1, AH) and the Bundesministerium fur Bildung and Forschung (01KU0903, AH; 0315082/01EA1303, SS; NGFNplus: 01GS0820, JH) and the IFORES program of the University of Duisburg-Essen (AH, JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Billingsley G, 2012, OPHTHALMIC GENET, V33, P150, DOI 10.3109/13816810.2012.689411; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Busch AM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-211; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chadt A, 2015, DIABETES, V64, P746, DOI 10.2337/db14-0368; Chang S, 2010, AGING-US, V2, P639, DOI 10.18632/aging.100221; Cheng KKY, 2014, DIABETES, V63, P3748, DOI 10.2337/db14-0337; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Dokas J, 2013, ENDOCRINOLOGY, V154, P3502, DOI 10.1210/en.2012-2147; Dusatkova L, 2013, FOLIA BIOL-PRAGUE, V59, P123; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao JB, 2011, PATHOL ONCOL RES, V17, P685, DOI 10.1007/s12253-011-9369-8; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Hebebrand J, 2013, DTSCH ARZTEBL INT, V110, P338, DOI 10.3238/arztebl.2013.0338; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hinney A, 2013, J PEDIATR ENDOCR MET, V26, P1209, DOI 10.1515/jpem-2013-0179; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Ikels K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105349; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jurvansuu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025317; Kim MK, 2012, EMBO REP, V13, P724, DOI 10.1038/embor.2012.86; Knuppel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068941; Livingstone KM, 2015, OBES REV, V16, P666, DOI 10.1111/obr.12290; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Monda KL, 2013, NAT GENET, V45, P690, DOI 10.1038/ng.2608; Mullhaus J, 2012, HORM RES PAEDIAT, V77, P358, DOI 10.1159/000338999; Mumby HS, 2011, J OBES, V2011, DOI 10.1155/2011/180729; Pellatt AJ, 2013, GENE CHROMOSOME CANC, V52, P595, DOI 10.1002/gcc.22056; Pellatt AJ, 2012, INT J MOL EPIDEMIOL, V3, P184; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Putter C, 2011, HUM HERED, V72, P173, DOI 10.1159/000332824; Quail M. A., 2009, CURRENT PROTOCOLS HU, V18, P18, DOI DOI 10.1002/0471142905.HG1802S62; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rask-Andersen M, 2012, EUR J HUM GENET, V20, P192, DOI 10.1038/ejhg.2011.176; Rohde K, 2014, J MOL MED, V92, P881, DOI 10.1007/s00109-014-1154-1; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Scherag A, 2012, OBESITY, V20, P466, DOI 10.1038/oby.2011.339; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Styskal J, 2013, FREE RADICAL BIO MED, V56, P123, DOI 10.1016/j.freeradbiomed.2012.10.544; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; WHO, 2011, OB AND OV; Zee RYL, 2011, ATHEROSCLEROSIS, V218, P144, DOI 10.1016/j.atherosclerosis.2011.05.013; Zheng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067039	63	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147904	10.1371/journal.pone.0147904	http://dx.doi.org/10.1371/journal.pone.0147904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828654	Green Published, gold, Green Accepted			2022-12-27	WOS:000369548200041
J	Bar, RJ; DeSouza, JFX				Bar, Rachel J.; DeSouza, Joseph F. X.			Tracking Plasticity: Effects of Long-Term Rehearsal in Expert Dancers Encoding Music to Movement	PLOS ONE			English	Article							BRAIN STRUCTURE CHANGES; CORTICAL MOTOR AREAS; BASAL GANGLIA; LEARNING-TASK; CHUNKING; CORTEX; PERCEPTION; IMAGERY; PERFORMANCE; MECHANISMS	Our knowledge of neural plasticity suggests that neural networks show adaptation to environmental and intrinsic change. In particular, studies investigating the neuroplastic changes associated with learning and practicing motor tasks have shown that practicing such tasks results in an increase in neural activation in several specific brain regions. However, studies comparing experts and non-experts suggest that experts employ less neuronal activation than non-experts when performing a familiar motor task. Here, we aimed to determine the long-term changes in neural networks associated with learning a new dance in professional ballet dancers over 34 weeks. Subjects visualized dance movements to music while undergoing fMRI scanning at four time points over 34-weeks. Results demonstrated that initial learning and performance at seven weeks led to increases in activation in cortical regions during visualization compared to the first week. However, at 34 weeks, the cortical networks showed reduced activation compared to week seven. Specifically, motor learning and performance over the 34 weeks showed the typical inverted-U-shaped function of learning. Further, our result demonstrate that learning of a motor sequence of dance movements to music in the real world can be visualized by expert dancers using fMRI and capture highly significant modeled fits of the brain network variance of BOLD signals from early learning to expert level performance.	[Bar, Rachel J.] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada; [DeSouza, Joseph F. X.] York Univ, Canadian Act & Percept Network CAPnet, Grad Program Interdisciplinary Studies, Ctr Vis Res,Dept Psychol,Dept Biol,Neurosci Grad, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	DeSouza, JFX (corresponding author), York Univ, Canadian Act & Percept Network CAPnet, Grad Program Interdisciplinary Studies, Ctr Vis Res,Dept Psychol,Dept Biol,Neurosci Grad, Toronto, ON M3J 2R7, Canada.	desouza@yorku.ca	DeSouza, Joseph FX/B-5615-2009	DeSouza, Joseph FX/0000-0001-6931-0849	National Science and Engineering Research Council (NSERC) Discovery [RGPIN/346135-2012]; Faculty of Health Minor Research Grant at York University; Irpinia Club of Toronto; NSERC USRA; RAY programs	National Science and Engineering Research Council (NSERC) Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Faculty of Health Minor Research Grant at York University; Irpinia Club of Toronto; NSERC USRA(Natural Sciences and Engineering Research Council of Canada (NSERC)); RAY programs	A National Science and Engineering Research Council (NSERC) Discovery grant to JFXD (RGPIN/346135-2012), Faculty of Health Minor Research Grant at York University, and a generous donation from the Irpinia Club of Toronto helped fund this project. RJB was supported by the NSERC USRA and the RAY programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna DE, 2014, J NEUROPHYSIOL, V112, P1849, DOI 10.1152/jn.00028.2014; Andrieux M, 2013, EXP BRAIN RES, V229, P125, DOI 10.1007/s00221-013-3598-x; ANNETT J, 1995, NEUROPSYCHOLOGIA, V33, P1395, DOI 10.1016/0028-3932(95)00072-B; Bach J, CONCERTO IN C MAJOR; Bar RJ, 2012, SEEING PERCEIVING, V25, P45; BATTIG K, 1960, J COMP PHYSIOL PSYCH, V53, P400, DOI 10.1037/h0047392; Bidhan L, 2015, BRAIN CONNECTIVITY; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; BRINKMAN C, 1979, J NEUROPHYSIOL, V42, P681, DOI 10.1152/jn.1979.42.3.681; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Cameron IGM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00022; CHOROVER SL, 1963, SCIENCE, V141, P826, DOI 10.1126/science.141.3583.826; Churchland MM, 2014, COLD SH Q B, V79, P67, DOI 10.1101/sqb.2014.79.024703; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cruz-Garza JG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00188; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Dhami P, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01478; Di Noto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059244; Diedrichsen J, 2015, TRENDS COGN SCI, V19, P227, DOI 10.1016/j.tics.2015.02.003; DIVAC I, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P461; Dorris MC, 2000, J NEUROSCI, V20; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Fink A, 2009, NEUROIMAGE, V46, P854, DOI 10.1016/j.neuroimage.2009.02.036; Foster PP, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00004; Gobet F, 2001, TRENDS COGN SCI, V5, P236, DOI 10.1016/S1364-6613(00)01662-4; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Houston S, 2013, ARTS HEALTH, V5, P103, DOI 10.1080/17533015.2012.745580; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Kao JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8759; KARNI A, 1995, NATURE, V377, P155; Karpati FJ, 2015, ANN NY ACAD SCI, V1337, P140, DOI 10.1111/nyas.12632; Kirsch LP, 2015, ANN NY ACAD SCI, V1337, P130, DOI 10.1111/nyas.12634; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Kropff E, 2015, NATURE, V523, P419, DOI 10.1038/nature14622; Leonardo M, 1995, HUM BRAIN MAPP, V3, P83, DOI 10.1002/hbm.460030205; Medee B, 2010, NEUROPSYCHOL REHABIL, V20, P854, DOI 10.1080/09602011.2010.499309; Merchant H, 2015, PHILOS T R SOC B, V370, P91, DOI 10.1098/rstb.2014.0093; Moody TD, 2004, BEHAV NEUROSCI, V118, P438, DOI 10.1037/0735-7044.118.2.438; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Olshansky MP, 2015, NEUROCASE, V21, P607, DOI 10.1080/13554794.2014.960428; Olsson C-J, 2008, Open Neuroimag J, V2, P5, DOI 10.2174/1874440000802010005; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Picard N, 1997, J NEUROPHYSIOL, V77, P2197, DOI 10.1152/jn.1997.77.4.2197; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Sack AT, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00214; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Sevdalis V, 2011, BRAIN COGNITION, V77, P231, DOI 10.1016/j.bandc.2011.08.005; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shenoy K, 2015, 2015 NEUR M PLANN WA; TANJI J, 1982, J NEUROPHYSIOL, V48, P633, DOI 10.1152/jn.1982.48.3.633; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; TERRACE HS, 1987, NATURE, V325, P149, DOI 10.1038/325149a0; Tremblay PL, 2010, EXP BRAIN RES, V205, P375, DOI 10.1007/s00221-010-2372-6; TYSZKA JM, 1994, ANN NEUROL, V35, P746, DOI 10.1002/ana.410350617; Van Nostrand Kirby K., 1993, ADV DATA ANAL SYSTAT; Weis T, 2013, J NEUROPHYSIOL, V110, P1860, DOI 10.1152/jn.00128.2013; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	71	29	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147731	10.1371/journal.pone.0147731	http://dx.doi.org/10.1371/journal.pone.0147731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824475	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600052
J	Castells-Roca, L; Pijuan, J; Ferrezuelo, F; Belli, G; Herrero, E				Castells-Roca, Laia; Pijuan, Jordi; Ferrezuelo, Francisco; Belli, Gemma; Herrero, Enrique			Cth2 Protein Mediates Early Adaptation of Yeast Cells to Oxidative Stress Conditions	PLOS ONE			English	Article							VACUOLAR IRON STORAGE; RNA-BINDING-PROTEINS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; DEFICIENCY; STABILITY; DIOXYGEN; OXYGEN	Cth2 is an mRNA-binding protein that participates in remodeling yeast cell metabolism in iron starvation conditions by promoting decay of the targeted molecules, in order to avoid excess iron consumption. This study shows that in the absence of Cth2 immediate upregulation of expression of several of the iron regulon genes (involved in high affinity iron uptake and intracellular iron redistribution) upon oxidative stress by hydroperoxide is more intense than in wild type conditions where Cth2 is present. The oxidative stress provokes a temporary increase in the levels of Cth2 (itself a member of the iron regulon). In such conditions Cth2 molecules accumulate at P bodies-like structures when the constitutive mRNA decay machinery is compromised. In addition, a null.cth2 mutant shows defects, in comparison to CTH2 wild type cells, in exit from a factor-induced arrest at the G1 stage of the cell cycle when hydroperoxide treatment is applied. The cell cycle defects are rescued in conditions that compromise uptake of external iron into the cytosol. The observations support a role of Cth2 in modulating expression of diverse iron regulon genes, excluding those specifically involved in the reductive branch of the high-affinity transport. This would result in immediate adaptation of the yeast cells to an oxidative stress, by controlling uptake of oxidant-promoting iron cations.	[Castells-Roca, Laia; Pijuan, Jordi; Ferrezuelo, Francisco; Belli, Gemma; Herrero, Enrique] Univ Lleida, IRBLleida, Dept Ciencies Med Basiques, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Herrero, E (corresponding author), Univ Lleida, IRBLleida, Dept Ciencies Med Basiques, Lleida, Spain.	enric.herrero@cmb.udl.cat	Pijuan, Jordi/P-9651-2015; Bellí, Gemma/AAD-5325-2019; Castells-Roca, Laia/I-1227-2015; Ferrezuelo, Francisco/E-7511-2010; belli, gemma/A-7424-2011; Herrero, Enrique/B-5592-2009	Pijuan, Jordi/0000-0003-0350-6376; Bellí, Gemma/0000-0002-4161-3204; Castells-Roca, Laia/0000-0002-4604-9999; Ferrezuelo, Francisco/0000-0001-9403-0355; belli, gemma/0000-0002-4161-3204; Herrero, Enrique/0000-0002-6763-111X	Spanish Ministerio de Economia y Competitividad [BFU2010-17656]; Ministerio de Economia y Competitividad	Spanish Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government)	This study was supported by grant BFU2010-17656 from Spanish Ministerio de Economia y Competitividad (www.mineco.gob.es). JP was the recipient of a predoctoral grant from Ministerio de Economia y Competitividad. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2001, MOL BIOL CELL, V12, P1801, DOI 10.1091/mbc.12.6.1801; Batista-Nascimento L, 2013, BBA-MOL CELL RES, V1833, P997, DOI 10.1016/j.bbamcr.2012.12.018; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Castells-Roca L, 2011, MOL MICROBIOL, V81, P232, DOI 10.1111/j.1365-2958.2011.07689.x; Castells-Roca L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017272; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dix D, 1997, J BIOL CHEM, V272, P11770, DOI 10.1074/jbc.272.18.11770; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Ferrezuelo F, 2009, CELL CYCLE, V8, P239, DOI 10.4161/cc.8.2.7543; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Halliwell B., 2007, FREE RADICALS BIOL M; Hassett RF, 1998, J BIOL CHEM, V273, P7628, DOI 10.1074/jbc.273.13.7628; Holmes-Hampton GP, 2013, BIOCHEMISTRY-US, V52, P105, DOI 10.1021/bi3015339; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Lee JW, 1996, J BIOL CHEM, V271, P24885, DOI 10.1074/jbc.271.40.24885; Lesuisse E, 2001, MICROBIOL-UK, V147, P289, DOI 10.1099/00221287-147-2-289; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; Martinez-Pastor M, 2013, MOL CELL BIOL, V33, P2178, DOI 10.1128/MCB.01458-12; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Moreno-Cermeno A, 2013, BBA-MOL CELL RES, V1833, P3326, DOI 10.1016/j.bbamcr.2013.09.019; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Perez-Ortin JE, 2013, J MOL BIOL, V425, P3750, DOI 10.1016/j.jmb.2013.02.029; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Protchenko O, 2001, J BIOL CHEM, V276, P49244, DOI 10.1074/jbc.M109220200; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Sanvisens N, 2011, MOL CELL, V44, P759, DOI 10.1016/j.molcel.2011.09.021; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Wanke V, 1999, MOL MICROBIOL, V32, P753, DOI 10.1046/j.1365-2958.1999.01391.x; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200	45	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148204	10.1371/journal.pone.0148204	http://dx.doi.org/10.1371/journal.pone.0148204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824473	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600108
J	Kalokhe, AS; Stephenson, R; Kelley, ME; Dunkle, KL; Paranjape, A; Solas, V; Karve, L; del Rio, C; Sahay, S				Kalokhe, Ameeta S.; Stephenson, Rob; Kelley, Mary E.; Dunkle, Kristin L.; Paranjape, Anuradha; Solas, Vikram; Karve, Latika; del Rio, Carlos; Sahay, Seema			The Development and Validation of the Indian Family Violence and Control Scale	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; MARRIED YOUNG-WOMEN; DOMESTIC VIOLENCE; RISK-FACTORS; PHYSICAL VIOLENCE; CHILD-MORTALITY; SEXUAL VIOLENCE; SOUTH-INDIA; RURAL INDIA; SYMPTOMS	The high prevalence of domestic violence (DV) among married women in India and associated negative health repercussions highlight the need for effective prevention strategies and tools to measure the efficacy of such interventions. Literature supporting differing manifestations of DV by culture underscores the need for a culturally-tailored scale to more effectively measure DV in the Indian context. We therefore aimed to develop and validate such a tool, the Indian Family Violence and Control Scale (IFVCS), through a mixed-methods study. The psychometric development of IFVCS is herein discussed. After field pre-testing and expert review, a 63-item questionnaire was administered to a random sample of 630 married women from May-July 2013 in Pune, India. The item response theory approach for binary data to explore the IFVCS structure suggested that IFVCS is reliable, with the majority of items having high (>0.5) and significant factor loadings. Concurrent validity, assessed by comparing responses to IFVCS with the validated, abridged Conflict Tactics Scale-2, was high (r = 0.899, p<0.001) as was the construct validity, demonstrated by its significant association with several established DV correlates. Therefore, initial assessment of the IFVCS psychometric properties suggests that it is an effective tool for measuring DV among married women in India and speaks to its capacity for enhancing understanding of DV epidemiology and for evaluating the effectiveness of future DV interventions.	[Kalokhe, Ameeta S.; del Rio, Carlos] Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30322 USA; [Kalokhe, Ameeta S.; del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Stephenson, Rob] Univ Michigan, Sch Nursing, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA; [Kelley, Mary E.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Dunkle, Kristin L.] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Paranjape, Anuradha] Temple Univ, Dept Med, Sch Med, Gen Internal Med Sect, Philadelphia, PA 19122 USA; [Solas, Vikram; Karve, Latika; Sahay, Seema] Natl AIDS Res Inst, Dept Social & Behav Res, Pune, Maharashtra, India	Emory University; Emory University; Rollins School Public Health; University of Michigan System; University of Michigan; Emory University; Rollins School Public Health; South African Medical Research Council; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Kalokhe, AS (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30322 USA.; Kalokhe, AS (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA.; Sahay, S (corresponding author), Natl AIDS Res Inst, Dept Social & Behav Res, Pune, Maharashtra, India.	akalokh@emory.edu; ssahay@nariindia.org	del Rio, Carlos/B-3763-2012; Dunkle, Kristin/AAU-5488-2020	del Rio, Carlos/0000-0002-0153-3517; Dunkle, Kristin/0000-0003-3071-5544	Fogarty International Center of the National Institutes of Health Global Health Fellowship [R25 TW009337]; Indian Council of Medical Research;  [K01 TW009664]; FOGARTY INTERNATIONAL CENTER [R25TW009337, K01TW009664] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes of Health Global Health Fellowship; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Research supported in this publication was supported by the Fogarty International Center of the National Institutes of Health Global Health Fellowship (R25 TW009337) and Award number K01 TW009664 to ASK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Indian Council of Medical Research for supporting this work, members of the NARI behavioral sciences quantitative study team, Meena Chivate, Vidula Hulyalkar, and Yogini Borhade, for their skillful conduct of participant interviews, Nayana Yenbhar and Basit Momin for their vigilant data entry and management, and the NARI Director, Dr. Ramesh Paranjape for his continued support and guidance. We would also like to sincerely thank each of the individuals who participated in the study and shared their personal experiences with us.	A. International, 2000, DRAFT GUID COND TEST, P1; Ackerson LK, 2008, AM J EPIDEMIOL, V167, P1188, DOI 10.1093/aje/kwn049; Ackerson LK, 2009, PEDIATRICS, V124, pE878, DOI 10.1542/peds.2009-0524; Chandra PS, 2009, ARCH WOMEN MENT HLTH, V12, P203, DOI 10.1007/s00737-009-0065-6; Chowdhury Arabinda N, 2009, Indian J Psychiatry, V51, P96, DOI 10.4103/0019-5545.49448; Daga AS, 1999, J FAM WELFARE, V45, P1; Fernandez M, 1997, J INTERPERS VIOLENCE, V12, P433, DOI 10.1177/088626097012003008; Fontes L.A., 2011, SOURCEBOOK VIOLENCE, P151, DOI DOI 10.4135/9781452224916.N8; Indu P V, 2011, Indian J Psychiatry, V53, P218, DOI 10.4103/0019-5545.86811; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF, P493; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jejeebhoy SJ, 2013, GLOB PUBLIC HEALTH, V8, P1151, DOI 10.1080/17441692.2013.860466; Jeyaseelan L, 2007, J BIOSOC SCI, V39, P657, DOI 10.1017/S0021932007001836; Jutla RK, 2004, J BURN CARE REHABIL, V25, P165, DOI 10.1097/01.BCR.0000111929.70876.1F; Kalokhe AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120909; Kalokhe AS, 2015, GLOB PUBLIC IN PRESS; Kelley ME, 2008, STAT MED, V27, P3674, DOI 10.1002/sim.3267; Kermode M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-225; Leela Visaria, 2008, Economic and Political Weekly, V43, P60; Mahapatro M, 2011, J INTERPERS VIOLENCE, V26, P2973, DOI 10.1177/0886260510390948; Maselko J, 2008, J EPIDEMIOL COMMUN H, V62, P817, DOI 10.1136/jech.2007.069351; Nongrum Rida, 2014, Indian J Psychol Med, V36, P179, DOI 10.4103/0253-7176.130989; Panchanadeswaran S, 2005, VIOLENCE AGAINST WOM, V11, P736, DOI 10.1177/1077801205276088; Pandey S, 2013, MATERN CHILD HLTH J, V17, P1499, DOI 10.1007/s10995-012-1163-z; Peedicayil A, 2004, BJOG-INT J OBSTET GY, V111, P682, DOI 10.1111/j.1471-0528.2004.00151.x; Petrisor BA, 2013, LANCET, V382, P866, DOI 10.1016/S0140-6736(13)61205-2; Pett MA, 2003, MAKING SENSE FACTOR, DOI DOI 10.4135/9781412984898; Rao V, 1997, SOC SCI MED, V44, P1169, DOI 10.1016/S0277-9536(96)00252-3; Rathod SD, 2011, J INTERPERS VIOLENCE, V26, P2437, DOI 10.1177/0886260510385125; Rocca CH, 2009, INT J EPIDEMIOL, V38, P577, DOI 10.1093/ije/dyn226; Sabarwal S, 2014, J INTERPERS VIOLENCE, V29, P332, DOI 10.1177/0886260513505144; Sabarwal S, 2012, J TROP PEDIATRICS, V58, P107, DOI 10.1093/tropej/fmr052; Sabri B, 2014, WOMEN HEALTH, V54, P281, DOI 10.1080/03630242.2014.896445; Santhya KG, 2007, INT FAM PLAN PERSPEC, V33, P124, DOI 10.1363/3312407; Sarkar Madhutandra, 2010, Indian J Community Med, V35, P311, DOI 10.4103/0970-0218.66881; Shroff MR, 2011, SOC SCI MED, V73, P447, DOI 10.1016/j.socscimed.2011.05.040; Silverman JG, 2008, JAMA-J AM MED ASSOC, V300, P703, DOI 10.1001/jama.300.6.703; Singh P, 2008, J OBSTET GYNAECOL, V28, P272, DOI 10.1080/01443610802042589; Sohani Z, 2013, J INTERPERS VIOLENCE, V28, P1455, DOI 10.1177/0886260512468244; Subramanian SV, 2007, INT J EPIDEMIOL, V36, P569, DOI 10.1093/ije/dym007; Sudha G, REDDY KSN INFERTILIT; Varghese S, 2013, NATL MED J INDIA, V26, P142; Weiss HA, 2008, SEX TRANSM INFECT, V84, P133, DOI 10.1136/sti.2007.026039; Winter A, 2013, INT J GYNECOL OBSTET, V121, P218, DOI 10.1016/j.ijgo.2012.12.018; World Health Organization, 2001, WHOFCHGWH011; Yoshikawa K, 2012, BIOSCI TRENDS, V6, P115, DOI 10.5582/bst.2012.v6.3.115; Zheng XH, 2007, STATA J, V7, P313, DOI 10.1177/1536867X0700700302	47	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148120	10.1371/journal.pone.0148120	http://dx.doi.org/10.1371/journal.pone.0148120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824611	Green Published, gold			2022-12-27	WOS:000369528600101
J	Kumar, R; Kumar, A; Sharma, NK; Kaur, N; Chunduri, V; Chawla, M; Sharma, S; Singh, K; Garg, M				Kumar, Rohit; Kumar, Aman; Sharma, Nand Kishor; Kaur, Navneet; Chunduri, Venkatesh; Chawla, Meenakshi; Sharma, Saloni; Singh, Kashmir; Garg, Monika			Soft and Hard Textured Wheat Differ in Starch Properties as Indicated by Trimodal Distribution, Morphology, Thermal and Crystalline Properties	PLOS ONE			English	Article							GRANULE SIZE DISTRIBUTION; IN-VITRO DIGESTIBILITY; FINE-STRUCTURE; PHYSICOCHEMICAL CHARACTERISTICS; DEVELOPING ENDOSPERM; A-TYPE; AMYLOSE; WAXY; RETROGRADATION; GELATINIZATION	Starch and proteins are major components in the wheat endosperm that affect its end product quality. Between the two textural classes of wheat i.e. hard and soft, starch granules are loosely bound with the lipids and proteins in soft wheat due to higher expression of interfering grain softness proteins. It might have impact on starch granules properties. In this work for the first time the physiochemical and structural properties of different sized starch granules (A-, B-and C-granules) were studied to understand the differences in starches with respect to soft and hard wheat. A-, B- and C-type granules were separated with >95% purity. Average number and proportion of A-, B-, and C-type granules was 18%, 56%, 26% and 76%, 19%, 5% respectively. All had symmetrical birefringence pattern with varied intensity. All displayed typical A-type crystallites. A-type granules also showed V-type crystallinity that is indicative of starch complexes with lipids and proteins. Granules differing in gelatinization temperature (Delta H) and transition temperature (Delta T), showed different enthalpy changes during heating. Substitution analysis indicated differences in relative substitution pattern of different starch granules. Birefringence, percentage crystallinity, transmittance, gelatinization enthalpy and substitution decreased in order of A>B>C being higher in hard wheat than soft wheat. Amylose content decreased in order of A>B>C being higher in soft wheat than hard wheat. Reconstitution experiment showed that starch properties could be manipulated by changing the composition of starch granules. Addition of A-granules to total starch significantly affected its thermal properties. Effect of A-granule addition was higher than B-and C-granules. Transmittance of the starch granules paste showed that starch granules of hard wheat formed clear paste. These results suggested that in addition to differences in protein concentration, hard and soft wheat lines have differences in starch composition also.	[Kumar, Rohit; Kumar, Aman; Sharma, Nand Kishor; Kaur, Navneet; Chunduri, Venkatesh; Chawla, Meenakshi; Sharma, Saloni; Garg, Monika] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India; [Singh, Kashmir] Panjab Univ, Chandigarh 160014, Punjab, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University	Garg, M (corresponding author), Natl Agri Food Biotechnol Inst, Mohali, Punjab, India.	mgarg100@yahoo.com	Singh, Kashmir/ABA-3329-2020; Kumar, Aman/AAY-3202-2020	Singh, Kashmir/0000-0002-9646-9043; Venkatesh, Chunduri/0000-0002-1909-8867; Kumar, Aman/0000-0002-0904-0792; Garg, Monika/0000-0002-2297-1137; Sharma, Saloni/0000-0003-4221-3277	NABI's core grant for agricultural biotechnology for the research project "Improvement of processing and nutritional quality in wheat"; Department of Biotechnology, Govt. of India	NABI's core grant for agricultural biotechnology for the research project "Improvement of processing and nutritional quality in wheat"; Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	The project was funded by NABI's core grant for agricultural biotechnology for the research project "Improvement of processing and nutritional quality in wheat". The authors thank Department of Biotechnology, Govt. of India for fellowship provided to RK.	Ao ZH, 2007, CARBOHYD POLYM, V67, P46, DOI 10.1016/j.carbpol.2006.04.013; Bechtel DB, 2003, CEREAL CHEM, V80, P175, DOI 10.1094/CCHEM.2003.80.2.175; Benmoussa M, 2007, J AGR FOOD CHEM, V55, P1475, DOI 10.1021/jf062349x; Bertolini AC, 2003, CEREAL CHEM, V80, P544, DOI 10.1094/CCHEM.2003.80.5.544; Blazek J, 2008, CARBOHYD POLYM, V71, P380, DOI 10.1016/j.carbpol.2007.06.010; BRIARTY LG, 1979, ANN BOT-LONDON, V44, P641, DOI 10.1093/oxfordjournals.aob.a085779; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Chung HJ, 2006, J CEREAL SCI, V43, P353, DOI 10.1016/j.jcs.2005.12.001; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Copeland L, 2009, FOOD HYDROCOLLOID, V23, P1527, DOI 10.1016/j.foodhyd.2008.09.016; Davis JP, 2003, STARCH-STARKE, V55, P107, DOI 10.1002/star.200390036; Dey P.M., 1990, METHODS PLANT BIOCH, V2, P323; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; GERNAT C, 1990, STARCH-STARKE, V42, P175, DOI 10.1002/star.19900420504; Hermansson AM, 1996, TRENDS FOOD SCI TECH, V7, P345, DOI 10.1016/S0924-2244(96)10036-4; HUGHES CE, 1976, STARKE, V28, P336, DOI 10.1002/star.19760281003; JANE JL, 1994, STARCH-STARKE, V46, P121, DOI 10.1002/star.19940460402; Kim HS, 2010, J CEREAL SCI, V51, P256, DOI 10.1016/j.jcs.2009.11.015; KLUCINEC JD, 2005, FOOD BIOTECHNOL, P675; Langeveld SMJ, 2000, J EXP BOT, V51, P1357, DOI 10.1093/jexbot/51.349.1357; Li JZ, 2014, MICROENCAPSULATION IN THE FOOD INDUSTRY: A PRACTICAL IMPLEMENTATION GUIDE, P195, DOI 10.1016/B978-0-12-404568-2.00018-2; Li WH, 2013, J AGR FOOD CHEM, V61, P6477, DOI 10.1021/jf400943h; Li WenYang, 2008, Agricultural Sciences in China, V7, P907, DOI 10.1016/S1671-2927(08)60129-7; Mischnick P, 1996, CARBOHYD RES, V290, P199, DOI 10.1016/0008-6215(96)00141-3; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Myllarinen P, 2002, CARBOHYD POLYM, V48, P41, DOI 10.1016/S0144-8617(01)00208-9; NARA S, 1983, STARKE, V35, P407, DOI 10.1002/star.19830351202; Oates CG, 1997, TRENDS FOOD SCI TECH, V8, P375, DOI 10.1016/S0924-2244(97)01090-X; PARKER ML, 1985, J CEREAL SCI, V3, P271, DOI 10.1016/S0733-5210(85)80001-1; Paul C, 1997, NATURE, V389, P338; Peng M, 1999, CEREAL CHEM, V76, P375, DOI 10.1094/CCHEM.1999.76.3.375; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; Sahlstrom S, 1998, J CEREAL SCI, V28, P157, DOI 10.1006/jcrs.1998.0192; SARKO A, 1978, STARKE, V30, P73, DOI 10.1002/star.19780300302; Sasaki T, 2000, CEREAL CHEM, V77, P58, DOI 10.1094/CCHEM.2000.77.1.58; Sasaki T, 2009, FOOD CHEM, V116, P137, DOI 10.1016/j.foodchem.2009.02.024; Singh N, 2007, STARCH-STARKE, V59, P10, DOI 10.1002/star.200600527; Syahariza ZA, 2013, FOOD CHEM, V136, P742, DOI 10.1016/j.foodchem.2012.08.053; Takeda Y, 1999, CARBOHYD POLYM, V38, P109, DOI 10.1016/S0144-8617(98)00105-2; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wickramasinghe HAM, 2008, FOOD SCI TECHNOL RES, V14, P49, DOI 10.3136/fstr.14.49; Wilson JD, 2006, CEREAL CHEM, V83, P259, DOI 10.1094/CC-83-0259; Xie XJ, 2008, FOOD RES INT, V41, P882, DOI 10.1016/j.foodres.2008.07.016; Yonemoto PG, 2007, CIENCIA TECNOL ALIME, V27, P761, DOI 10.1590/S0101-20612007000400015; You SY, 2014, CARBOHYD POLYM, V112, P729, DOI 10.1016/j.carbpol.2014.06.065; Zhao YS, 2011, J AGR FOOD CHEM, V59, P9700, DOI 10.1021/jf202002c	48	20	22	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147622	10.1371/journal.pone.0147622	http://dx.doi.org/10.1371/journal.pone.0147622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824830	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600040
J	Schenk, JJ				Schenk, John J.			Consequences of Secondary Calibrations on Divergence Time Estimates	PLOS ONE			English	Article							MOLECULAR EVOLUTION; ABSOLUTE RATES; DIVERSIFICATION; LIKELIHOOD; SPECIATION; MODEL; PHYLOGEOGRAPHY; UNCERTAINTY; HISTORY; FOSSILS	Secondary calibrations (calibrations based on the results of previous molecular dating studies) are commonly applied in divergence time analyses in groups that lack fossil data; however, the consequences of applying secondary calibrations in a relaxed-clock approach are not fully understood. I tested whether applying the posterior estimate from a primary study as a prior distribution in a secondary study results in consistent age and uncertainty estimates. I compared age estimates from simulations with 100 randomly replicated secondary trees. On average, the 95% credible intervals of node ages for secondary estimates were significantly younger and narrower than primary estimates. The primary and secondary age estimates were significantly different in 97% of the replicates after Bonferroni corrections. Greater error in magnitude was associated with deeper than shallower nodes, but the opposite was found when standardized by median node age, and a significant positive relationship was determined between the number of tips/age of secondary trees and the total amount of error. When two secondary calibrated nodes were analyzed, estimates remained significantly different, and although the minimum and median estimates were associated with less error, maximum age estimates and credible interval widths had greater error. The shape of the prior also influenced error, in which applying a normal, rather than uniform, prior distribution resulted in greater error. Secondary calibrations, in summary, lead to a false impression of precision and the distribution of age estimates shift away from those that would be inferred by the primary analysis. These results suggest that secondary calibrations should not be applied as the only source of calibration in divergence time analyses that test time-dependent hypotheses until the additional error associated with secondary calibrations is more properly modeled to take into account increased uncertainty in age estimates.	[Schenk, John J.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	University System of Georgia; Georgia Southern University	Schenk, JJ (corresponding author), Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA.	jschenk@georgiasouthern.edu						Andujar C, 2014, METHODS ECOL EVOL, V5, P226, DOI 10.1111/2041-210X.12151; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Dos Reis M, 2013, J SYST EVOL, V51, P30, DOI 10.1111/j.1759-6831.2012.00236.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duchene D, 2015, NELSI; Duchene S, 2014, MOL PHYLOGENET EVOL, V78, P277, DOI 10.1016/j.ympev.2014.05.032; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASEGAWA M, 1989, J HUM EVOL, V18, P461, DOI 10.1016/0047-2484(89)90075-4; Hedges SB, 2004, TRENDS GENET, V20, P242, DOI 10.1016/j.tig.2004.03.004; Hipsley CA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00138; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kornilios P, 2013, MOL PHYLOGENET EVOL, V68, P35, DOI 10.1016/j.ympev.2013.03.009; Kuriyama T, 2011, J BIOGEOGR, V38, P259, DOI 10.1111/j.1365-2699.2010.02403.x; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Maddison WP, 2019, MESQUITE MODULAR SYS; Magallon SA, 2004, INT J PLANT SCI, V165, pS7, DOI 10.1086/383336; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; Miller M.A., 2010, P GAT COMP ENV WORKS; Morrison DA, 2010, 10013586 ARXIV; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; R Development Core Team, 2005, R LANG ENV STAT COMP; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ruiz-Sanchez E, 2013, J BIOGEOGR, V40, P1336, DOI 10.1111/jbi.12073; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Ryberg M, 2011, EVOLUTION, V65, P1862, DOI 10.1111/j.1558-5646.2011.01251.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schenk JJ, 2010, SYSTEMATIC BOT, V35, P1; Schenk JJ, 2013, SYST BIOL, V62, P837, DOI 10.1093/sysbio/syt050; Schenk JJ, 2013, J BIOGEOGR, V40, P455, DOI 10.1111/jbi.12018; Shaul S, 2002, GENE, V300, P59, DOI 10.1016/S0378-1119(02)00851-X; Siler CD, 2012, J BIOGEOGR, V39, P1217, DOI 10.1111/j.1365-2699.2011.02680.x; Swofford DL, 2012, PAUP PHYLOGENETIC AN; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhao YP, 2013, MOL PHYLOGENET EVOL, V68, P300, DOI 10.1016/j.ympev.2013.03.025; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	56	40	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148228	10.1371/journal.pone.0148228	http://dx.doi.org/10.1371/journal.pone.0148228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824760	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600111
J	Kiessling, MK; Curioni-Fontecedro, A; Samaras, P; Lang, S; Scharl, M; Aguzzi, A; Oldrige, DA; Maris, JM; Rogler, G				Kiessling, Michael K.; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis; Lang, Silvia; Scharl, Michael; Aguzzi, Adriano; Oldrige, Derek A.; Maris, John M.; Rogler, Gerhard			Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma	PLOS ONE			English	Article							HARBORING NRAS; IN-VITRO; MUTATIONS; MELANOMA; PATHWAY; BRAF; ARRY-142886; COMBINATION; INHIBITOR; LANDSCAPE	High-risk neuroblastoma remains lethal in about 50% of patients despite multimodal treatment. Recent attempts to identify molecular targets for specific therapies have shown that Neuroblastoma RAS (NRAS) is significantly mutated in a small number of patients. However, few inhibitors for the potential treatment for NRAS mutant neuroblastoma have been investigated so far. In this in-vitro study, we show that MEK inhibitors AZD6244, MEK162 and PD0325901 block cell growth in NRAS mutant neuroblastoma cell lines but not in NRAS wild-type cell lines. Several studies show that mutant NRAS leads to PI3K pathway activation and combined inhibitors of PI3K/mTOR effectively block cell growth. However, we observed the combination of MEK inhibitors with PI3K or AKT inhibitors did not show synergestic effects on cell growth. Thus, we tested single mTOR inhibitors Everolimus and AZD8055. Interestingly, Everolimus and AZD8055 alone were sufficient to block cell growth in NRAS mutant cell lines but not in wild-type cell lines. We found that Everolimus alone induced apoptosis in NRAS mutant neuroblastoma. Furthermore, the combination of mTOR and MEK inhibitors resulted in synergistic growth inhibition. Taken together, our results show that NRAS mutant neuroblastoma can be targeted by clinically available Everolimus alone or in combination with MEK inhibitors which could impact future clinical studies.	[Kiessling, Michael K.; Lang, Silvia; Scharl, Michael; Rogler, Gerhard] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Kiessling, Michael K.; Curioni-Fontecedro, Alessandra; Samaras, Panagiotis] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland; [Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Oldrige, Derek A.; Maris, John M.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Kiessling, MK (corresponding author), Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.; Kiessling, MK (corresponding author), Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland.	Michael.kiessling@usz.ch	Rogler, Gerhard/O-5308-2015; Curioni-Fontecedro, Alessandra/R-4950-2018	Rogler, Gerhard/0000-0002-1733-9188; Aguzzi, Adriano/0000-0002-0344-6708; Curioni-Fontecedro, Alessandra/0000-0002-5778-5270; Scharl, Michael/0000-0002-6729-1469	Forschungskredit Zurich University; Stiftung zur Krebsbekaempfung; US National Institutes of Health [RC1MD004418, CA98543, CA98413]; NATIONAL CANCER INSTITUTE [U10CA098543, U10CA098413] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004418] Funding Source: NIH RePORTER	Forschungskredit Zurich University; Stiftung zur Krebsbekaempfung; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	M.K.K. was supported by Forschungskredit Zurich University and Stiftung zur Krebsbekaempfung. D.O. and J.M.M. were supported in part by US National Institutes of Health grants RC1MD004418 to the TARGET consortium, and CA98543 and CA98413 to the Children's Oncology Group for patient sample acquisition and annotation.	Adjei A, 2015, ASCO ANN M; Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Catalanotti F, 2013, CLIN CANCER RES, V19, P2257, DOI 10.1158/1078-0432.CCR-12-3476; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; COSMIC G, 2015, CATALOGUE OF SOMATIC; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DA Eleveld Thomas F. O., 2015, NATURE GENE IN PRESS; Davies Barry R A L, 2007, MOL CANC THER, V6; Finn R. S., 2012, PHASE 1 STUDY MEK IN; Fouladi M, 2007, J CLIN ONCOL, V25, P4806, DOI 10.1200/JCO.2007.11.4017; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hauschild Axel JJG, 2012, 2012 ASCO ANN M; Heist RS, 2013, J CLIN ONCOL, V31; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huynh H, 2007, MOL CANCER THER, V6, P138, DOI 10.1158/1535-7163.MCT-06-0436; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Louis CU, 2015, ANNU REV MED, V66, P49, DOI 10.1146/annurev-med-011514-023121; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Moore NF, 2014, ONCOTARGET, V5, P8737, DOI 10.18632/oncotarget.2372; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Tolcher AW, 2015, CLIN CANCER RES, V21, P739, DOI 10.1158/1078-0432.CCR-14-1901; Vujic I, 2014, ONCOTARGET, V5, P7936, DOI 10.18632/oncotarget.2326	32	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147682	10.1371/journal.pone.0147682	http://dx.doi.org/10.1371/journal.pone.0147682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821351	Green Published, gold			2022-12-27	WOS:000369528400038
J	Uezu, A; Metzger, JP				Uezu, Alexandre; Metzger, Jean Paul			Time-Lag in Responses of Birds to Atlantic Forest Fragmentation: Restoration Opportunity and Urgency	PLOS ONE			English	Article							LANDSCAPE ECOLOGY PERSPECTIVE; EXTINCTION DEBT; BIODIVERSITY CONSERVATION; HABITAT FRAGMENTATION; SPECIES RICHNESS; UNDERSTORY BIRDS; CONNECTIVITY; COVER; THRESHOLDS; HISTORY	There are few opportunities to evaluate the relative importance of landscape structure and dynamics upon biodiversity, especially in highly fragmented tropical landscapes. Conservation strategies and species risk evaluations often rely exclusively on current aspects of landscape structure, although such limited assumptions are known to be misleading when time-lag responses occur. By relating bird functional-group richness to forest patch size and isolation in ten-year intervals (1956, 1965, 1978, 1984, 1993 and 2003), we revealed that birds with different sensitivity to fragmentation display contrasting responses to landscape dynamics in the Brazilian Atlantic Forest. For non-sensitive groups, there was no time-lag in response: the recent degree of isolation best explains their variation in richness, which likely relates to these species' flexibility to adapt to changes in landscape structure. However, for sensitive bird groups, the 1978 patch area was the best explanatory variable, providing evidence for a 25-year time-lag in response to habitat reduction. Time-lag was more likely in landscapes that encompass large patches, which can support temporarily the presence of some sensitive species, even when habitat cover is relatively low. These landscapes potentially support the most threatened populations and should be priorities for restoration efforts to avoid further species loss. Although time-lags provide an opportunity to counteract the negative consequences of fragmentation, it also reinforces the urgency of restoration actions. Fragmented landscapes will be depleted of biodiversity if landscape structure is only maintained, and not improved. The urgency of restoration action may be even higher in landscapes where habitat loss and fragmentation history is older and where no large fragment remained to act temporarily as a refuge.	[Uezu, Alexandre] Inst Pesquisas Ecol, Nazare Paulista, SP, Brazil; [Metzger, Jean Paul] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, SP, Brazil	Instituto de Pesquisas Ecologicas; Universidade de Sao Paulo	Uezu, A (corresponding author), Inst Pesquisas Ecol, Nazare Paulista, SP, Brazil.	aleuezu@ipe.org.br	Uezu, Alexandre/G-5435-2014; Metzger, Jean Paul/C-2514-2012	Metzger, Jean Paul/0000-0002-0087-5240	FAPESP (The Sao Paulo State Research Foundation) [02/01746-1]; Idea Wild and the Association of Field Ornithologists; Brazilian Science Council (Conselho Nacional de Desenvolvimento Cientifico) [307934/2011-0]	FAPESP (The Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Idea Wild and the Association of Field Ornithologists; Brazilian Science Council (Conselho Nacional de Desenvolvimento Cientifico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by FAPESP (The Sao Paulo State Research Foundation, process no. 02/01746-1), Idea Wild and the Association of Field Ornithologists. J.P. Metzger thanks the Brazilian Science Council (Conselho Nacional de Desenvolvimento Cientifico) for his research fellowship (process no. 307934/2011-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleixo Alexandre, 1995, Revista Brasileira de Zoologia, V12, P493, DOI 10.1590/S0101-81751995000300004; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Antunes Alexsander Zamorano, 2005, ARARAJUBA, V13, P47; Awade M, 2008, AUSTRAL ECOL, V33, P863, DOI 10.1111/j.1442-9993.2008.01857.x; Banks-leite AC, 2016, SOURCE, V93, P2560; Blondel J, ALAUDA, V38, P55; Bommarco R, 2014, DIVERS DISTRIB, V20, P591, DOI 10.1111/ddi.12187; Brooks T, 1999, ANIM CONSERV, V2, P211, DOI 10.1111/j.1469-1795.1999.tb00067.x; Brown JH, 2008, ADV SCI, V292, P101; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Christiansen MB, 1997, SPECIES LOSS FOREST, P80; Cousins SAO, 2009, J VEG SCI, V20, P3, DOI 10.1111/j.1654-1103.2009.05647.x; Cowlishaw G, 1999, CONSERV BIOL, V13, P1183, DOI 10.1046/j.1523-1739.1999.98433.x; DAFONSECA GAB, 1985, BIOL CONSERV, V34, P17, DOI 10.1016/0006-3207(85)90055-2; Dean Warren, 1996, FERRO FOGO HIST DEVA, V6; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Elkie P, 1999, PATCH ANAL USERS MAN; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Ferreira Develey Pedro, 2006, P269; Rigueira DMG, 2013, BIODIVERS CONSERV, V22, P3141, DOI 10.1007/s10531-013-0575-4; Greenberg R, 1989, CAN J ZOOL; Guardiola M, 2013, DIVERS DISTRIB, V19, P825, DOI 10.1111/ddi.12045; Hansbauer MM, 2010, LANDSCAPE ECOL, V25, P407, DOI 10.1007/s10980-009-9418-9; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; Huxel GR, 1999, RESTOR ECOL, V7, P309, DOI 10.1046/j.1526-100X.1999.72024.x; Hylander K, 2013, TRENDS ECOL EVOL, V28, P341, DOI 10.1016/j.tree.2013.01.010; Joly CA, 2014, NEW PHYTOL, V204, P459, DOI 10.1111/nph.12989; Knick ST, 2000, ECOLOGY, V81, P220, DOI 10.1890/0012-9658(2000)081[0220:GOHPCO]2.0.CO;2; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Leite MD, 2013, NAT CONSERVACAO, V11, P108; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lira PK, 2012, J APPL ECOL, V49, P1325, DOI 10.1111/j.1365-2664.2012.02214.x; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Metzger JP, 2013, NAT CONSERVACAO, V11, P103, DOI 10.4322/natcon.2013.018; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagelkerke K, 2002, APPLYING LANDSCAPE ECOLOGY IN BIOLOGICAL CONSERVATION, P330; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Parker Theodore A. Iii, 1996, P113; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Rappaport DI, 2015, J APPL ECOL, V52, P590, DOI 10.1111/1365-2664.12405; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ribon R, 2003, CONSERV BIOL, V17, P1827, DOI 10.1111/j.1523-1739.2003.00377.x; Ridgely RS, 2003, DIGITAL DISTRIBUTION, P0; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Stouffer PC, 2009, 20 YEARS UNDERSTOREY, P88; Tabanez AAJ, 2000, BIOTROPICA, V32, P925; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Tambosi LR, 2014, RESTOR ECOL, V22, P169, DOI 10.1111/rec.12049; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Uezu A, 2005, BIOL CONSERV; Uezu A, 2011, BIODIVERS CONSERV, V20, P3627, DOI 10.1007/s10531-011-0154-5; WILLIS E O, 1979, Papeis Avulsos de Zoologia (Sao Paulo), V33, P1	59	26	28	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147909	10.1371/journal.pone.0147909	http://dx.doi.org/10.1371/journal.pone.0147909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820548	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528400053
J	Sun, XD; Xu, YY; Wang, L; Zhang, FH; Zhang, JH; Fu, XM; Jing, T; Han, J				Sun, Xudong; Xu, Yuanyuan; Wang, Li; Zhang, Fuhua; Zhang, Jinhua; Fu, Ximei; Jing, Tao; Han, Jian			Association between TNFA Gene Polymorphisms and Helicobacter pylori Infection: A Meta-Analysis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PEPTIC-ULCER PATIENTS; DUODENAL-ULCER; GASTRIC-CANCER; POPULATION; INTERLEUKIN-1-BETA; REGION; RISK; IL-1; HAPLOTYPE	Background Several host genetic factors are thought to affect susceptibility to Helicobacter pylori infection-related diseases, including tumor necrosis factor (TNF)-alpha. Previous studies have evaluated the association between TNFA gene polymorphisms and H. pylori infection, but the results were inconclusive. We conducted this meta-analysis to clarify the association between TNFA polymorphisms and H. pylori infection. Methods Published literature within PubMed, Embase, and the Cochrane Library were used in our meta-analysis. Data were analyzed with the Stata13.1 software package using pooled odds ratios (ORs) with 95% confidence intervals (CI). Results A total of 24 studies were included in our study. The TNFA-308G> A polymorphism was associated with decreasing H. pylori infection (AA vs. AG+GG, OR = 0.64, 95% CI = 0.43-0.97; AA vs. GG,OR = 0.64, 95% CI = 0.43-0.97). A significantly decreased risk was also found for -1031T>C polymorphism (CC vs. CT+TT, OR = 0.61, 95% CI = 0.44-0.84). -863C>A polymorphism was associated with increasing risk of H. pylori infection (AA+AC vs. CC, OR = 1.47, 95% CI = 1.16-1.86; A allele vs. C allele, OR = 1.40, 95% CI = 1.14-1.72). There was no significant association between -857C>T polymorphism and H. pylori infection. When stratified analysis was conducted on H. pylori infection detection methods, -857C>T and -863C>A polymorphisms were associated with H. pylori infection for the non-ELISA subgroup. When stratified for ethnicity or study design, -863C>A significantly increased the risk and -1031T>C decreased the risk for the Asian subgroup and hospital-based subgroup. Conclusion Results of our meta-analysis demonstrate that TNFA -308G>A and -1031T>C polymor-phisms may be protective factors against H. pylori infection, and -863C>A may be a risk factor, especially in Asian populations. Further studies with larger sample sizes are required to validate these results.	[Sun, Xudong; Xu, Yuanyuan; Wang, Li; Fu, Ximei; Jing, Tao; Han, Jian] Lanzhou Univ, Sch Basic Med Sci, Dept Pathogen Biol, Lanzhou 730000, Peoples R China; [Zhang, Fuhua; Zhang, Jinhua] Second Hosp Gansu Prov, Dept Gastroenterol, Lanzhou, Peoples R China	Lanzhou University	Han, J (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Dept Pathogen Biol, Lanzhou 730000, Peoples R China.	hanj@lzu.edu.cn			open fund of Key Laboratory for Gastrointestinal Diseases of Gansu Province [gswcky-2013-002]	open fund of Key Laboratory for Gastrointestinal Diseases of Gansu Province	This research was supported by the open fund of Key Laboratory for Gastrointestinal Diseases of Gansu Province (gswcky-2013-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiev S, 2010, NAGOYA J MED SCI, V72, P167; Ando T, 2006, GUT, V55, P158, DOI 10.1136/gut.2005.072942; Atsuta Yoshiko, 2006, Int J Clin Oncol, V11, P140, DOI 10.1007/s10147-005-0549-y; Axon A, 2014, HELICOBACTER, V19, P68, DOI 10.1111/hel.12155; Basso D, 2004, CRIT REV CL LAB SCI, V41, P313, DOI 10.1080/10408360490472804; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Bjorkholm B, 2003, J INTERN MED, V253, P102, DOI 10.1046/j.1365-2796.2003.01119.x; Chakravorty M, 2008, J GENET, V87, P299, DOI 10.1007/s12041-008-0048-9; Cheng HH, 2010, J GASTROEN HEPATOL, V25, P1443, DOI 10.1111/j.1440-1746.2010.06310.x; D'Elios MM, 2014, HELICOBACTER, V19, P19, DOI 10.1111/hel.12156; Gao L, 2009, EUR J CANCER, V45, P2860, DOI 10.1016/j.ejca.2009.04.015; Garcia-Gonzalez MA, 2005, INT J IMMUNOGENET, V32, P299, DOI 10.1111/j.1744-313X.2005.00528.x; Garcia-Gonzalez MA, 2009, HUM IMMUNOL, V70, P935, DOI 10.1016/j.humimm.2009.07.024; Goto Hidemi, 2003, Nagoya J Med Sci, V66, P77; Guo XF, 2013, WORLD J GASTROENTERO, V19, P9461, DOI 10.3748/wjg.v19.i48.9461; Hamajima Nobuyuki, 2003, Nagoya J Med Sci, V66, P103; Hamajima Nobuyuki, 2003, Gastric Cancer, V6, P230, DOI 10.1007/s10120-003-0258-z; Hamajima N, 2010, PERS MED, V7, P249, DOI 10.2217/PME.10.14; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x; Kang JM, 2012, HELICOBACTER, V17, P86, DOI 10.1111/j.1523-5378.2011.00918.x; Kim N, 2006, HELICOBACTER, V11, P105, DOI 10.1111/j.1523-5378.2006.00384.x; Kimang'a AN, 2012, ETHIOP J HEALTH SCI, V22, P163; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kulmambetova GN, 2014, ASIAN PAC J CANCER P, V15, P7763, DOI 10.7314/APJCP.2014.15.18.7763; Kunstmann E, 1999, ELECTROPHORESIS, V20, P1756, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1756::AID-ELPS1756>3.3.CO;2-2; Li C, 2005, AM J GASTROENTEROL, V100, P290, DOI 10.1111/j.1572-0241.2005.40806.x; Lu CC, 2005, AM J GASTROENTEROL, V100, P1274, DOI 10.1111/j.1572-0241.2005.40852.x; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; McNulty CAM, 2011, HELICOBACTER, V16, P10, DOI 10.1111/j.1523-5378.2011.00875.x; Patel SK, 2014, WORLD J GASTROENTERO, V20, P12847, DOI 10.3748/wjg.v20.i36.12847; Queiroz D. M. M., 2013, PLoS ONE, V8, pe57420, DOI 10.1371/journal.pone.0057420; Queiroz DMM, 2009, MICROBES INFECT, V11, P980, DOI 10.1016/j.micinf.2009.07.008; Roberts-Thomson IC, 2005, J GASTROEN HEPATOL, V20, P793, DOI 10.1111/j.1440-1746.2005.03938.x; Ryan BM, 2001, IRISH J MED SCI, V170, P90, DOI 10.1007/BF03168814; Saijo Y, 2007, WORLD J GASTROENTERO, V13, P4445; Salagacka A, 2014, GUT LIVER, V8, P632, DOI 10.5009/gnl13224; Salagacka A, 2014, INT J HUM GENET, V14, P9, DOI 10.1080/09723757.2014.11886221; Santos JC, 2012, BRAZ J MED BIOL RES, V45, P811, DOI 10.1590/S0100-879X2012007500099; Soga Y, 2003, J CLIN PERIODONTOL, V30, P524, DOI 10.1034/j.1600-051X.2003.00287.x; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P51, DOI 10.1111/j.1440-1746.2006.04442.x; Sun XD, 2015, MICROB PATHOGENESIS, V86, P45, DOI 10.1016/j.micpath.2015.07.010; Szoke D, 2008, EUR J GASTROEN HEPAT, V20, P191, DOI 10.1097/MEG.0b013e3282f1d29f; Tseng FC, 2006, HELICOBACTER, V11, P425, DOI 10.1111/j.1523-5378.2006.00433.x; Wells BSGA, 2011, NEWCASTLE OTTAWA SCA; Xiang Yu, 2009, Chinese Journal of Biologicals, V22, P1010; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhang BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057167; Zhao Y, 2013, WORLD J GASTROENTERO, V19, P8758, DOI 10.3748/wjg.v19.i46.8758	49	7	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147410	10.1371/journal.pone.0147410	http://dx.doi.org/10.1371/journal.pone.0147410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815578	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200032
J	Morgenstern, M; Erichsen, C; Hackl, S; Mily, J; Militz, M; Friederichs, J; Hungerer, S; Buhren, V; Moriarty, TF; Post, V; Richards, RG; Kates, SL				Morgenstern, Mario; Erichsen, Christoph; Hackl, Simon; Mily, Julia; Militz, Matthias; Friederichs, Jan; Hungerer, Sven; Buehren, Volker; Moriarty, T. Fintan; Post, Virginia; Richards, R. Geoff; Kates, Stephen L.			Antibiotic Resistance of Commensal Staphylococcus aureus and Coagulase-Negative Staphylococci in an International Cohort of Surgeons: A Prospective Point-Prevalence Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; CASSETTE CHROMOSOME MEC; NASAL CARRIAGE; UNITED-STATES; ANTIMICROBIAL SUSCEPTIBILITY; COLONIZATION; MRSA; EPIDEMIOLOGY; INFECTION; MICROBIOLOGY	Nasal colonization with antibiotic resistant bacteria represents both a risk factor for the colonized individual and their immediate contacts. Despite the fact that healthcare workers such as orthopedic surgeons are at a critical interface between the healthcare environment and an at-risk patient population, the prevalence of antibiotic resistant bacteria within the surgical profession remains unclear. This study offers a snapshot of the rate of nasal colonization of orthopedic surgeons with multi-resistant staphylococci including methicillin-resistant S. aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCoNS). We performed a prospective, observational study obtained at a single time point in late 2013. The participants were active orthopedic, spine and head & neck surgeons from 75 countries. The prevalence of nasal carriage of the different bacteria and the corresponding 95% confidence interval were calculated. From a cohort of 1,166 surgeons, we found an average S. aureus nasal colonization rate of 28.0% (CI 25.4; 30.6) and MRSA rate of 2.0% (CI 1.3; 2.9), although significant regional variations were observed. The highest rates of MRSA colonization were found in Asia (6.1%), Africa (5.1%) and Central America (4.8%). There was no MRSA carriage detected within our population of 79 surgeons working in North America, and a low (0.6%) MRSA rate in 657 surgeons working in Europe. High rates of MRCoNS nasal carriage were also observed (21.4% overall), with a similar geographic distribution. Recent use of systemic antibiotics was associated with higher rates of carriage of resistant staphylococci. In conclusion, orthopedic surgeons are colonized by S. aureus and MRSA at broadly equivalent rates to the general population. Crucially, geographic differences were observed, which may be partially accounted for by varying antimicrobial stewardship practices between the regions. The elevated rates of resistance within the coagulase-negative staphylococci are of concern, due to the increasing awareness of their importance in hospital acquired and device-associated infection.	[Morgenstern, Mario; Erichsen, Christoph; Hackl, Simon; Mily, Julia; Militz, Matthias; Friederichs, Jan; Hungerer, Sven; Buehren, Volker] Trauma Ctr Murnau, Dept Trauma Surg, Murnau, Germany; [Morgenstern, Mario; Erichsen, Christoph; Hackl, Simon; Moriarty, T. Fintan; Post, Virginia; Richards, R. Geoff] AO Res Inst, Davos, Switzerland; [Kates, Stephen L.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Hungerer, Sven] Paracelsus Med Univ, Salzburg, Austria	Virginia Commonwealth University; Paracelsus Private Medical University	Morgenstern, M (corresponding author), Trauma Ctr Murnau, Dept Trauma Surg, Murnau, Germany.	morgenstern.mario@gmail.com	Hungerer, med Sven/T-7329-2019; Morgenstern, Mario/L-8153-2019; Morgenstern, Mario/AAL-8268-2020; Richards, Robert G/I-8235-2015	Morgenstern, Mario/0000-0001-5108-0731; Richards, Robert G/0000-0002-7778-2480; Moriarty, Fintan/0000-0003-2307-0397	AO Trauma, AO Foundation, Davos Switzerland	AO Trauma, AO Foundation, Davos Switzerland	This project was funded by AO Trauma, AO Foundation, Davos Switzerland, https://aotrauma.aofoundation.org (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; ALY R, 1970, APPL MICROBIOL, V20, P240, DOI 10.1128/AEM.20.2.240-244.1970; ARMSTRONGESTHER CA, 1976, ANN HUM BIOL, V3, P221, DOI 10.1080/03014467600001381; Askarian M, 2009, INT J INFECT DIS, V13, pE241, DOI 10.1016/j.ijid.2008.11.026; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Blok HEM, 2003, INFECT CONT HOSP EP, V24, P679, DOI 10.1086/502275; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Brady RRW, 2009, EUR J CLIN MICROBIOL, V28, P991, DOI 10.1007/s10096-009-0718-4; Brown DFJ, 2016, J ANTIMICROB CHEMOTH, V71, P3, DOI 10.1093/jac/dkv287; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CDC, 2013, ANTIBIOTIC RESISTANC; Cespedes C, 2002, J CLIN MICROBIOL, V40, P2594, DOI 10.1128/JCM.40.7.2594-2597.2002; Cole AM, 2001, CLIN DIAGN LAB IMMUN, V8, P1064, DOI 10.1128/CDLI.8.6.1064-1069.2001; Conceicao T, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.010; Conceicao T, 2014, MICROB DRUG RESIST, V20, P57, DOI 10.1089/mdr.2013.0136; Cox RA, 1997, J HOSP INFECT, V35, P117, DOI 10.1016/S0195-6701(97)90100-6; Dalstrom DJ, 2008, J BONE JOINT SURG AM, V90A, P1022, DOI 10.2106/JBJS.G.00689; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Danzmann L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-98; Dawson SJ, 1997, J HOSP INFECT, V37, P75, DOI 10.1016/S0195-6701(97)90078-5; De Sousa MA, 2000, MICROB DRUG RESIST, V6, P133, DOI 10.1089/107662900419447; Diekema D, 2001, CLIN INFECT DIS   S2, V32, P114; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; European Centre for Disease Prevention and Control, 2013, ANN REP EUR ANT RES; Gamblin J, 2013, J MED MICROBIOL, V62, P437, DOI 10.1099/jmm.0.051854-0; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Haddadin AS, 2002, POSTGRAD MED J, V78, P385, DOI 10.1136/pmj.78.921.385; Hanssen AM, 2004, ANTIMICROB AGENTS CH, V48, P285, DOI 10.1128/AAC.48.1.285-296.2004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hawkins G, 2011, J HOSP INFECT, V77, P285, DOI 10.1016/j.jhin.2010.09.038; Iyer A, 2014, J INFECT DEV COUNTR, V8, P372, DOI 10.3855/jidc.3589; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Johnston CP, 2007, INFECT CONT HOSP EP, V28, P1404, DOI 10.1086/523865; Kalenic S, 2010, INT J INFECT CONTROL, V6, P1, DOI [10.3396/ijic.v6i2.5138, DOI 10.3396/IJIC.V6I2.5138]; Kateete David P, 2011, BMC Res Notes, V4, P326, DOI 10.1186/1756-0500-4-326; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; NOBLE WC, 1967, J HYG-CAMB, V65, P567, DOI 10.1017/S002217240004609X; NOBLE WC, 1964, J CLIN PATHOL, V17, P79, DOI 10.1136/jcp.17.1.79; NOBLE WC, 1974, ACTA DERM-VENEREOL, V54, P403; Nulens E, 2005, EUR J CLIN MICROBIOL, V24, P145, DOI 10.1007/s10096-004-1258-6; Olsen K, 2013, EPIDEMIOL INFECT, V141, P143, DOI 10.1017/S0950268812000465; Parnaby RM, 1996, J HOSP INFECT, V33, P201, DOI 10.1016/S0195-6701(96)90003-1; Schwarzkopf R, 2010, J BONE JOINT SURG AM, V92A, P1815, DOI 10.2106/JBJS.I.00991; Solberg CO, 2000, SCAND J INFECT DIS, V32, P587, DOI 10.1080/003655400459478; Tacconelli E, 2008, J ANTIMICROB CHEMOTH, V61, P26, DOI 10.1093/jac/dkm416; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; Treesirichod A, 2013, J INFECT PUBLIC HEAL, V6, P196, DOI 10.1016/j.jiph.2012.12.004; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P1123, DOI 10.1086/507922; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111627; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wertheim HFL, 2004, ANN INTERN MED, V140, P419, DOI 10.7326/0003-4819-140-6-200403160-00007; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Zinn CS, 2004, MICROB DRUG RESIST, V10, P160, DOI 10.1089/1076629041310055	67	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148437	10.1371/journal.pone.0148437	http://dx.doi.org/10.1371/journal.pone.0148437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840492	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200136
J	Wan, JH; Yan, DH; Fu, GB; Hao, L; Yue, YJ; Li, RX; Li, YP; Liu, JG; Deng, J				Wan, Jinhong; Yan, Denghua; Fu, Guobin; Hao, Lu; Yue, Yaojie; Li, Ruoxi; Li, Yunpeng; Liu, Jiangang; Deng, Jun			Temporal and Spatial Variations of Drought in China: Reconstructed from Historical Memorials Archives during 1689-1911	PLOS ONE			English	Article							EASTERN CHINA; CLIMATE; AGRICULTURE; VARIABILITY; IMPACTS; EVENTS	In China, Zou Zhe (Memorials to the Throne, or Palace Memorials), an official communication to the emperors of China by local officials, offers an opportunity to reconstruct the spatial-temporal distributions of droughts at a high-resolution. A 223-year, 1689-1911, time series of drought events was reconstructed in this study based on 2494 pieces of Zou Zhe. The results show that: 1) on the temporal scale, the drought affected areas, i.e., number of affected counties, showed three peak periods during the last 223 years and nine extreme drought years with more than 300 counties affected have been identified; 2) on the spatial scale, there existed three drought-prone areas in China, i.e., Gansu province and Ningxia Hui Autonomous Region in Northwest China, Shandong, Hebei, and Henan provinces and Tianjin in the North China, and Anhui and Jiangsu provinces in Jianghuai area, respectively; 3) the drought-prone areas have been expanding from North China to South China since the second half of 19th century; 4) on the seasonal scale, summer witnessed the largest number of drought events. Meanwhile, the uncertainties of the results were also discussed, i.e. what caused the spatial-temporal distribution of drought. The results of this study can be used to mitigate the adverse effects of extreme weather events on food increasing and stable production.	[Wan, Jinhong; Yan, Denghua; Li, Ruoxi; Li, Yunpeng; Liu, Jiangang; Deng, Jun] China Inst Water Resources & Hydropower Res, Beijing, Peoples R China; [Wan, Jinhong; Yan, Denghua] State Key Lab Simulat & Regulat Water Cycle River, Beijing, Peoples R China; [Wan, Jinhong; Yue, Yaojie] Beijing Normal Univ, Sch Geog, Beijing 100875, Peoples R China; [Fu, Guobin] CSIRO, Land & Water Flagship, Private Bag 5, Wembley, WA, Australia; [Hao, Lu] Nanjing Univ Informat Sci & Technol, Int Ctr Ecol Meteorol & Environm IceMe, Jiangsu Key Lab Agr Meteorol, Nanjing, Jiangsu, Peoples R China	China Institute of Water Resources & Hydropower Research; Beijing Normal University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Nanjing University of Information Science & Technology	Wan, JH (corresponding author), China Inst Water Resources & Hydropower Res, Beijing, Peoples R China.; Wan, JH (corresponding author), State Key Lab Simulat & Regulat Water Cycle River, Beijing, Peoples R China.; Wan, JH (corresponding author), Beijing Normal Univ, Sch Geog, Beijing 100875, Peoples R China.	roaringwan@sina.com	Fu, Guobin/A-3243-2008; Yue, Yaojie/AAF-2489-2019	Fu, Guobin/0000-0002-3968-4871; Yue, Yaojie/0000-0001-5198-1281	Special Fund of National Science and Technology China [2009FY220200, 2014FY130500]	Special Fund of National Science and Technology China	This study is supported by the Special Fund of National Science and Technology China (No. 2009FY220200, No. 2014FY130500).	[Anonymous], 2006, B FLOOD DROUGHT DIS; BRADLEY RS, 1999, PALEOCLIMATOLOGY; [方修琦 Fang Xiuqi], 2005, [地理科学, Scientia Geographica Sinica], V25, P129; Fu GB, 2009, J CLIMATE, V22, P2111, DOI 10.1175/2008JCLI2605.1; Fye FK, 2003, B AM METEOROL SOC, V84, P901, DOI 10.1175/BAMS-84-7-901; Ge Q., 2011, CLIMATE CHANGE CHINA; Ge QS, 2005, B AM METEOROL SOC, V86, P671, DOI 10.1175/BAMS-86-5-671; Hao ZX, 2010, CHINESE SCI BULL, V55, P3001, DOI 10.1007/s11434-010-3243-z; Issar AS, 1998, ENV SOC TIMES CLIMAT; Zheng JY, 2006, TERR ATMOS OCEAN SCI, V17, P579, DOI 10.3319/TAO.2006.17.3.579(A); [刘毅 Liu Yi], 2012, [地理学报, Acta Geographica Sinica], V67, P291; National Research Group of Major Natural Disaster of China, 1993, CHIN MAJ NAT DIS DIS; PARRY ML, 1989, CLIMATIC CHANGE, V15, P95, DOI 10.1007/BF00138848; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Shen C, 2007, CLIMATIC CHANGE, V85, P453, DOI 10.1007/s10584-007-9283-y; Shi P, 2007, NATURAL DISASTER; The Ministry of Water Resources of the People's Republic of China, 2013, B FLOOD DROUGHT DIS; [王静爱 Wang Jingai], 2002, [自然灾害学报, Journal of Natural Disasters], V11, P1; WANG PK, 1992, J METEOROL SOC JPN, V70, P423, DOI 10.2151/jmsj1965.70.1B_423; WANG PK, 1988, B AM METEOROL SOC, V69, P753, DOI 10.1175/1520-0477(1988)069<0753:AITSHG>2.0.CO;2; Yao ZY, 2004, J NANJING AGR U SOCI, V4, P75; Zhang D, 2005, PAGES NEWS, V13, P22; Zhang DE, 2010, ADV CLIM CHANG RES, V1, P91, DOI 10.3724/SP.J.1248.2010.00091; Zhang J, 1982, HIST ARCHAEOL, V2, P100; Zheng G., 2009, QIUSHI, V23, P47	25	12	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0148072	10.1371/journal.pone.0148072	http://dx.doi.org/10.1371/journal.pone.0148072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836807	Green Published, gold			2022-12-27	WOS:000369548500006
J	Anderwald, P; Haller, RM; Filli, F				Anderwald, Pia; Haller, Rudolf M.; Filli, Flurin			Heterogeneity in Primary Productivity Influences Competitive Interactions between Red Deer and Alpine Chamois	PLOS ONE			English	Article							CAPREOLUS-CAPREOLUS DEER; HORN GROWTH; CERVUS-ELAPHUS; HABITAT; POPULATION; VEGETATION; MIGRATION; COEXISTENCE; DENSITIES; RESPONSES	Habitat heterogeneity can promote coexistence between herbivores of different body size limited to different extents by resource quantity and quality. Red deer (Cervus elaphus) are known as superior competitors to smaller species with similar diets. We compared competitive interactions and habitat use between red deer and Alpine chamois (Rupicapra rupicapra) in two adjacent valleys in a strictly protected area in the Central Alps. Red deer density was higher in the valley with higher primary productivity. Only here was horn growth in kid and yearling chamois (as a measure for body condition) negatively correlated with red deer population size, suggesting interspecific competition, and chamois selected meadows with steeper slopes and lower productivity than available on average. Conversely, red deer selected meadows of high productivity, particularly in the poorer area. As these were located mainly at lower elevations, this led to strong altitudinal segregation between the two species here. Local differences in interspecific competition thus coincided with differences in habitat preference and-segregation between areas. This suggests that spatial habitat and resource heterogeneity at the scale of adjacent valleys can provide competition refuges for competitively inferior mountain ungulates which differ from their superior competitor in their metabolic requirements.	[Anderwald, Pia; Haller, Rudolf M.; Filli, Flurin] Chaste Planta Wildenberg, Swiss Natl Pk, CH-7530 Zernez, Switzerland		Anderwald, P (corresponding author), Chaste Planta Wildenberg, Swiss Natl Pk, CH-7530 Zernez, Switzerland.	pia.anderwald@nationalpark.ch						Anderwald P, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00365.1; Begon M., 1996, ECOLOGY; BELOVSKY GE, 1986, AM ZOOL, V26, P51; Bertolino S, 2009, J ZOOL, V277, P63, DOI 10.1111/j.1469-7998.2008.00512.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Chirichella R, 2013, EVOL ECOL, V27, P145, DOI 10.1007/s10682-012-9583-1; Cook RC, 2013, WILDLIFE MONOGR, V184, DOI 10.1002/wmon.1008; Cote SD, 2001, OECOLOGIA, V127, P230, DOI 10.1007/s004420000584; Cote SD, 1998, J MAMMAL, V79, P406, DOI 10.2307/1382971; Danilkin A, 1995, BEHAV ECOLOGY SIBERI; Darmon G, 2012, ECOGRAPHY, V35, P44, DOI 10.1111/j.1600-0587.2011.06664.x; DEBOER WF, 1990, OECOLOGIA, V82, P264, DOI 10.1007/BF00323544; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Ferretti F, 2015, BEHAV ECOL, V26, P550, DOI 10.1093/beheco/aru226; Festa-Bianchet M, 2004, BEHAV ECOL, V15, P305, DOI 10.1093/beheco/arh014; Frank Douglas A., 2006, Conservation Biology Series (Cambridge), V11, P326; Giacometti M, 2002, J MAMMAL, V83, P245, DOI 10.1644/1545-1542(2002)083<0245:ATISAH>2.0.CO;2; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GORDON IJ, 1989, OECOLOGIA, V79, P383, DOI 10.1007/BF00384318; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Haller Ruedi, 2006, Nationalpark-Forschung in der Schweiz, V93, P45; Herfindal I, 2006, J ANIM ECOL, V75, P1110, DOI 10.1111/j.1365-2656.2006.01138.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hobbs N. T., 2010, DYNAMICS LARGE HERBI, P141; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Jenny H., 2014, NATIONALPARK FORSCHU, P235; Jorgenson JT, 1998, J WILDLIFE MANAGE, V62, P1011, DOI 10.2307/3802554; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Latham J, 1997, J ZOOL, V242, P681, DOI 10.1111/j.1469-7998.1997.tb05820.x; Latham J, 1996, J ZOOL, V240, P285, DOI 10.1111/j.1469-7998.1996.tb05285.x; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Lone K, 2015, ANIM BEHAV, V102, P127, DOI 10.1016/j.anbehav.2015.01.012; Lovari S, 2014, ANIM CONSERV, V17, P359, DOI 10.1111/acv.12103; Macandza VA, 2012, OIKOS, V121, P891, DOI 10.1111/j.1600-0706.2012.20250.x; Mazerolle M. J., 2014, AICCMODAVG MODEL SEL; Mbora DNM, 2009, AM J PHYS ANTHROPOL, V140, P562, DOI 10.1002/ajpa.21113; MeteoSwiss, 2015, IDAWEB DAT PORT TEAC; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Nagy L, 2009, BIOL ALPINE HABITATS; Nahlik Andras, 2009, Acta Silvatica & Lignaria Hungarica, V5, P109; OOSENBRUG SM, 1980, ARCTIC, V33, P59; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; Perez-Barberia FJ, 2001, EVOL ECOL RES, V3, P221; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; R Core Team, 2021, R LANGUAGE ENV STAT; Rammig A, 2010, BIOGEOSCIENCES, V7, P2013, DOI 10.5194/bg-7-2013-2010; Richard E, 2010, OECOLOGIA, V163, P91, DOI 10.1007/s00442-009-1538-z; Rughetti M, 2011, J ANIM ECOL, V80, P438, DOI 10.1111/j.1365-2656.2010.01773.x; Rughetti M, 2010, J WILDLIFE MANAGE, V74, P1024, DOI 10.2193/2009-335; Saether BE, 2002, ECOLOGY, V83, P3457, DOI 10.2307/3072094; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHIMEL D, 1985, ECOLOGY, V66, P276, DOI 10.2307/1941328; Schroder J., 1984, ACTA ZOOL FENN, V172, P85; Schweiger AK, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0033-x; Schweiger AK, 2015, J VEG SCI, V26, P175, DOI 10.1111/jvs.12214; Toigo C, 1999, J MAMMAL, V80, P1021, DOI 10.2307/1383272; Vladyshevsky D. V., 1968, Zoologicheskii Zhurnal, V47, P438; White PJ, 2010, J MAMMAL, V91, P827, DOI 10.1644/08-MAMM-A-252.1; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; ZOLLER H, 1995, NATIONALPARK FORSCHU, V85, P1	65	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146458	10.1371/journal.pone.0146458	http://dx.doi.org/10.1371/journal.pone.0146458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824867	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600008
J	Fosu-Nyarko, J; Nicol, P; Naz, F; Gill, R; Jones, MGK				Fosu-Nyarko, John; Nicol, Paul; Naz, Fareeha; Gill, Reetinder; Jones, Michael G. K.			Analysis of the Transcriptome of the Infective Stage of the Beet Cyst Nematode, H-schachtii	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; ESOPHAGEAL GLAND-CELLS; CELLULOSE-BINDING PROTEIN; CHORISMATE MUTASE; GLOBODERA-PALLIDA; EFFECTOR PROTEIN; FUNCTIONAL-CHARACTERIZATION; DEVELOPMENTAL EXPRESSION; DISEASE RESISTANCE; PRATYLENCHUS SPP.	The beet cyst nematode, Heterodera schachtii, is a major root pest that significantly impacts the yield of sugar beet, brassicas and related species. There has been limited molecular characterisation of this important plant pathogen: to identify target genes for its control the transcriptome of the pre-parasitic J2 stage of H. schachtii was sequenced using Roche GS FLX. Ninety seven percent of reads (i.e., 387,668) with an average PHRED score > 22 were assembled with CAP3 and CLC Genomics Workbench into 37,345 and 47,263 contigs, respectively. The transcripts were annotated by comparing with gene and genomic sequences of other nematodes and annotated proteins on public databases. The annotated transcripts were much more similar to sequences of Heterodera glycines than to those of Globodera pallida and root knot nematodes (Meloidogyne spp.). Analysis of these transcripts showed that a subset of 2,918 transcripts was common to free-living and plant parasitic nematodes suggesting that this subset is involved in general nematode metabolism and development. A set of 148 contigs and 183 singletons encoding putative homologues of effectors previously characterised for plant parasitic nematodes were also identified: these are known to be important for parasitism of host plants during migration through tissues or feeding from cells or are thought to be involved in evasion or modulation of host defences. In addition, the presence of sequences from a nematode virus is suggested. The sequencing and annotation of this transcriptome significantly adds to the genetic data available for H. schachtii, and identifies genes primed to undertake required roles in the critical pre-parasitic and early post-parasitic J2 stages. These data provide new information for identifying potential gene targets for future protection of susceptible crops against H. schachtii.	[Fosu-Nyarko, John; Nicol, Paul; Naz, Fareeha; Gill, Reetinder; Jones, Michael G. K.] Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Biotechnol Res Grp, Perth, WA, Australia; [Fosu-Nyarko, John] Murdoch Univ, Western Australian State Agr Biotechnol Ctr, NemGenix Pty Ltd, Perth, WA, Australia	Murdoch University; Murdoch University	Jones, MGK (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Biotechnol Res Grp, Perth, WA, Australia.	J.Fosu-Nyarko@murdoch.edu.au; M.Jones@murdoch.edu.au	Jones, Michael G.K./M-5932-2013; Fosu-Nyarko, John/E-5533-2018	Jones, Michael G.K./0000-0001-5002-0227; Fosu-Nyarko, John/0000-0002-2997-7881	Murdoch University; Australian India Strategic Research Fund Grant [BF030027]; Nemgenix Pty. Ltd.	Murdoch University; Australian India Strategic Research Fund Grant; Nemgenix Pty. Ltd.	Murdoch University provided PhD studentship for PN; RG was supported by an Australian India Strategic Research Fund Grant (BF030027); Nemgenix Pty. Ltd. contributed funds for consumables and support in the form of salaries for JFN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ABAWI GS, 1980, PHYTOPATHOLOGY, V70, P481, DOI 10.1094/Phyto-70-481; Adam MAM, 2008, PHYSIOL MOL PLANT P, V72, P21, DOI 10.1016/j.pmpp.2008.05.002; Ali S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115042; Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Bekal S, 2003, MOL PLANT MICROBE IN, V16, P439, DOI 10.1094/MPMI.2003.16.5.439; Bekal S, 2011, J GEN VIROL, V92, P1870, DOI 10.1099/vir.0.030585-0; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Burke M, 2015, NEMATOLOGY, V17, P621, DOI 10.1163/15685411-00002901; Burt OR, 1996, J NEMATOL, V28, P457; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpentier J, 2012, MOL PLANT PATHOL, V13, P546, DOI 10.1111/j.1364-3703.2011.00769.x; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; De Boer JM, 2002, MOL PLANT PATHOL, V3, P261, DOI 10.1046/j.1364-3703.2002.00122.x; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Eves-van den Akker S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004391; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Fosu-Nyarko J, 2016, MOL PLANT PATHOL, V17, P532, DOI 10.1111/mpp.12301; Fosu-Nyarko J, 2015, ADV BOT RES, V73, P339, DOI 10.1016/bs.abr.2014.12.012; Fuller VL, 2008, NEW PHYTOL, V180, P27, DOI 10.1111/j.1469-8137.2008.02508.x; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Gao BL, 2002, INT J PARASITOL, V32, P1293, DOI 10.1016/S0020-7519(02)00110-8; Gao BL, 2001, MOL PLANT MICROBE IN, V14, P1247, DOI 10.1094/MPMI.2001.14.10.1247; Guiliano DB, 2006, PLOS GENET, V2, P1871, DOI 10.1371/journal.pgen.0020198; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamamouch N, 2012, J EXP BOT, V63, P3683, DOI 10.1093/jxb/ers058; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Hewezi T, 2008, PLANT CELL, V20, P3080, DOI 10.1105/tpc.108.063065; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Jaouannet M, 2012, NEW PHYTOL, V194, P924, DOI 10.1111/j.1469-8137.2012.04164.x; Jaubert S, 2004, INT J PARASITOL, V34, P873, DOI 10.1016/j.ijpara.2004.02.008; Jaubert S, 2002, FEBS LETT, V522, P109, DOI 10.1016/S0014-5793(02)02906-X; Jones JT, 2009, MOL PLANT PATHOL, V10, P815, DOI 10.1111/j.1364-3703.2009.00585.x; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Jones JT, 2003, MOL PLANT PATHOL, V4, P43, DOI 10.1046/j.1364-3703.2003.00140.x; Jones JT, 2000, NEMATOLOGY, V2, P887, DOI 10.1163/156854100750112833; Jones MGK, 2014, ANN APPL BIOL, V164, P163, DOI 10.1111/aab.12105; JONES MGK, 1972, J CELL SCI, V10, P789; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; JONES MGK, 1975, PHYSIOL PLANT PATHOL, V5, P119, DOI 10.1016/0048-4059(75)90015-6; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096311; Lee C, 2011, PLANT PHYSIOL, V155, P866, DOI 10.1104/pp.110.167197; Lee KZ, 2003, MOL BIOL EVOL, V20, P2097, DOI 10.1093/molbev/msg225; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; Lu SW, 2008, MOL BIOCHEM PARASIT, V162, P1, DOI 10.1016/j.molbiopara.2008.06.002; Mitreva-Dautova M, 2006, MOL PLANT MICROBE IN, V19, P521, DOI 10.1094/MPMI-19-0521; Muller J, 1999, HELMINTHOLOGIA, V36, P205; Neveu C, 2003, PHYSIOL MOL PLANT P, V63, P159, DOI 10.1016/j.pmpp.2003.10.005; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Noon JB, 2015, PHYTOPATHOLOGY, V105, P1362, DOI 10.1094/PHYTO-02-15-0049-R; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Postma WJ, 2012, PLANT PHYSIOL, V160, P944, DOI 10.1104/pp.112.200188; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Qin L, 2004, NATURE, V427, P30, DOI 10.1038/427030a; Robertson L, 2000, MOL BIOCHEM PARASIT, V111, P41, DOI 10.1016/S0166-6851(00)00295-4; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; SIJMONS PC, 1991, PLANT J, V1, P245, DOI 10.1111/j.1365-313X.1991.00245.x; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Thorpe P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-923; Torto-Alalibo T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S1; Vanholme B, 2006, PARASITOL RES, V98, P414, DOI 10.1007/s00436-005-0029-3; Vanholme B, 2007, MOL PLANT PATHOL, V8, P267, DOI 10.1111/J.1364-3703.2007.00392.X; Vanholme B, 2009, NEMATOLOGY, V11, P739, DOI 10.1163/156854109X404599; Wang JY, 2011, MOL PLANT PATHOL, V12, P177, DOI 10.1111/j.1364-3703.2010.00660.x; Wang XH, 2001, MOL PLANT MICROBE IN, V14, P536, DOI 10.1094/MPMI.2001.14.4.536; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x	81	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147511	10.1371/journal.pone.0147511	http://dx.doi.org/10.1371/journal.pone.0147511			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824923	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600033
J	Singla, DK; Singla, R; Wang, J				Singla, Dinender K.; Singla, Reetu; Wang, Jing			BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; MONOCYTE ADHESION; CELLS; ATHEROSCLEROSIS; POLARIZATION; ACTIVATION; MOUSE; MODEL; PROLIFERATION; EXPRESSION	Inflammation plays a fundamental role in the inception and development of atherosclerosis (ATH). Mechanisms of inflammation include the infiltration of monocytes into the injured area and subsequent differentiation into either pro-inflammatory M1 macrophages or anti-inflammatory M2 macrophages. We have previously published data suggesting bone morphogenetic protein-7 (BMP-7) enhances M2 macrophage differentiation and anti-inflammatory cytokine secretion in vitro. In this regard, we hypothesized BMP-7 would inhibit plaque formation in an animal model of ATH through monocytic plasticity mediation. ATH was generated in male and female Apo E-/- mice via partial left carotid artery (PLCA) ligation and mice were divided into 3 groups: Sham, PLCA, and PLCA+BMP-7 (200ug/kg; i.v.). Our data suggest that BMP-7 inhibits plaque formation and increases arterial systolic velocity. Furthermore, we report inhibition of monocyte infiltration and a decrease in associated pro-inflammatory cytokines (MCP-1, TNF-alpha, and IL-6) in the PLCA+BMP-7 mice. In contrast, our data suggest a significant (p<0.05) increase in M2 macrophage populations with consequential enhanced anti-inflammatory cytokine (IL-1RA, IL-10, and Arginase 1) expression following BMP-7 treatment. We have also observed that mechanisms promoting monocyte into M2 macrophage differentiation by BMP-7 involve the upregulation and activation of the BMP-7 receptor (BMP-7RII). In conclusion, we report that BMP-7 has the potential to mediate cellular plasticity and mitigate the inflammatory immune response, which results in decreased plaque formation and improved blood velocity.	[Singla, Dinender K.; Singla, Reetu; Wang, Jing] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Div Metab & Cardiovasc Sci,Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Div Metab & Cardiovasc Sci,Biomol Sci Ctr, Orlando, FL 32816 USA.	dsingla@ucf.edu			National Institutes of Health [R01HL117241]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health [R01HL117241 to DKS].	Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; den Hartigh LJ, 2014, AM J PHYSIOL-HEART C, V306, pH109, DOI 10.1152/ajpheart.00137.2013; Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M; Fadini GP, 2013, ACTA DIABETOL, V50, P977, DOI 10.1007/s00592-013-0517-3; Grenon SM, 2012, J SURG RES, V177, pE35, DOI 10.1016/j.jss.2012.04.010; Guedj K, 2014, CARDIOVASC RES, V101, P434, DOI 10.1093/cvr/cvt263; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lee MJ, 2003, J IMMUNOL, V170, P2557, DOI 10.4049/jimmunol.170.5.2557; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Mahmood DFD, 2013, J CELL PHYSIOL, V228, P1577, DOI 10.1002/jcp.24319; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Maric I, 2003, J CELL PHYSIOL, V196, P258, DOI 10.1002/jcp.10275; Merino H, 2013, MOL CELL BIOCHEM, V372, P267, DOI 10.1007/s11010-012-1468-7; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Papadopoulou C, 2008, CYTOKINE, V43, P181, DOI 10.1016/j.cyto.2008.05.009; Pendse AA, 2009, J LIPID RES, V50, pS178, DOI 10.1194/jlr.R800070-JLR200; Perron JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008198; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rocher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084009; Rocher C, 2012, CAN J PHYSIOL PHARM, V90, P947, DOI [10.1139/Y2012-102, 10.1139/y2012-102]; Saika S, 2005, LAB INVEST, V85, P474, DOI 10.1038/labinvest.3700247; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; Takahashi T, 2011, CELL TISSUE RES, V344, P321, DOI 10.1007/s00441-011-1154-1; Torroella-Kouri M, 2013, IMMUNOL RES, V57, P86, DOI 10.1007/s12026-013-8438-3; Urbina P, 2014, AM J PHYSIOL-HEART C, V307, pH762, DOI 10.1152/ajpheart.00367.2014; Zhang XL, 2005, J AM SOC NEPHROL, V16, P79, DOI 10.1681/ASN.2004050395	35	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147897	10.1371/journal.pone.0147897	http://dx.doi.org/10.1371/journal.pone.0147897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824441	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600068
J	O'Brien, LM; Stewart, LD; Strain, SAJ; Grant, IR				O'Brien, Lorna M.; Stewart, Linda D.; Strain, Sam A. J.; Grant, Irene R.			Novel Monoclonal Antibody and Peptide Binders for Mycobacterium avium subsp paratuberculosis and Their Application for Magnetic Separation	PLOS ONE			English	Article							MEDIATED CAPTURE PCR; IMMUNOMAGNETIC SEPARATION; SALMONELLA-TYPHIMURIUM; ACCURATE ENUMERATION; JOHNES-DISEASE; PHAGE ASSAY; MILK; TUBERCULOSIS; SPECIFICITY; CULTURE	The generation of novel Mycobacterium avium subsp. paratuberculosis (MAP)-specific monoclonal antibodies and phage-display derived peptide binders, along with their application for the magnetic separation (MS) of MAP cells, is described. Our aim was to achieve even greater MAP capture capability than is possible with peptide-mediated magnetic separation (PMS) using a 50: 50 mix of biotinylated-aMp3 and biotinylated-aMptD peptide-coated beads. Gamma-irradiated whole MAP cells and ethanol extracted antigens (EEA) from these cells were used to elicit an immune response and as phage-display biopanning targets. A range of novel binders was obtained and coated onto paramagnetic beads, both individually and in various combinations, for MS evaluation. IS900 PCR was employed after MS to provide quick results. Capture sensitivity was assessed using a range of MAP concentrations after which the most promising beads were tested for their specificity for MAP, by performing MS followed by culture using 10 other Mycobacterium species. Magnetic beads coated with the biotinylated EEA402 peptide demonstrated a greater level of MAP capture than the current PMS method, even when low numbers of MAP (< 10 cfu/ml) were present; however these beads also captured a range of other mycobacteria and so lacked capture specificity. Magnetic beads coated with monoclonal antibodies 6G11 and 15D10 (used as a 50: 50 mix or as dually coated beads) also demonstrated improved MAP capture relative to the current PMS method, but with little cross-reactivity to other Mycobacterium spp. Therefore, two new MS protocols are suggested, the application of which would be dependent upon the required endpoint. Biotinylated EEA402-coated beads could potentially be used with a MAP-specific PCR to ensure detection specificity, while beads coated with 6G11 and 15D10 monoclonal antibodies could be used with culture or the phage amplification assay.	[O'Brien, Lorna M.; Stewart, Linda D.; Grant, Irene R.] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Inst Global Food Secur, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Strain, Sam A. J.] Anim Hlth & Welf Northern Ireland, 97 Moy Rd, Dungannon BT71 7DX, Tyrone, North Ireland	Queens University Belfast	Grant, IR (corresponding author), Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Inst Global Food Secur, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	i.grant@qub.ac.uk	Stewart, Linda/AFS-8631-2022; Strain, Sam/AAI-7289-2020	Grant, Irene/0000-0001-5860-3769; Stewart, Linda/0000-0002-2400-6162	PhD studentship to Lorna M. O'Brien as part of a larger project (ICONMAP) [11S141]; Department of Agriculture, Food and Marine, Republic of Ireland under the Food Institutional Research Measure (FIRM); Department of Agriculture, Food and the Marine, Republic of Ireland [RSF11/S/141 ICONMAP]	PhD studentship to Lorna M. O'Brien as part of a larger project (ICONMAP); Department of Agriculture, Food and Marine, Republic of Ireland under the Food Institutional Research Measure (FIRM); Department of Agriculture, Food and the Marine, Republic of Ireland	Research was funded by a PhD studentship to Lorna M. O'Brien as part of a larger project (ICONMAP, Project no. 11S141) funded by the Department of Agriculture, Food and Marine, Republic of Ireland under the Food Institutional Research Measure (FIRM). This work was supported by a research grant from the Department of Agriculture, Food and the Marine, Republic of Ireland (RSF11/S/141 ICONMAP). The authors sincerely thank Dr Antonio Foddai for his advice in relation to magnetic separation, and Dr Douwe Bakker, Central Veterinary Institute of Wageningen University, Lelystad, for providing several additional monoclonal antibodies for evaluation during this study. Funder website: http://www.agriculture.gov.ie/research/foodinstitutionalresearchmeasurefirm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2007, J APPL MICROBIOL, V103, P892, DOI 10.1111/j.1365-2672.2007.03339.x; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; de Juan L, 2006, APPL ENVIRON MICROB, V72, P5927, DOI 10.1128/AEM.00451-06; Dennis MM, 2008, VET MICROBIOL, V131, P154, DOI 10.1016/j.vetmic.2008.02.017; Eda S, 2006, CLIN VACCINE IMMUNOL, V13, P837, DOI 10.1128/CVI.00148-06; Foddai A, 2011, J CLIN MICROBIOL, V49, P2017, DOI 10.1128/JCM.00429-11; Foddai A, 2010, APPL ENVIRON MICROB, V76, P7550, DOI 10.1128/AEM.01432-10; Foddai A, 2009, APPL ENVIRON MICROB, V75, P3896, DOI 10.1128/AEM.00294-09; Foddai ACG, 2015, INT DAIRY J, V51, P16, DOI 10.1016/j.idairyj.2015.07.004; GlatmanFreedman A, 1996, J CLIN MICROBIOL, V34, P2795, DOI 10.1128/JCM.34.11.2795-2802.1996; Grant IR, 1998, APPL ENVIRON MICROB, V64, P3153; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOLK AHJ, 1984, CLIN EXP IMMUNOL, V58, P511; Lavers CJ, 2014, J DAIRY SCI, V97, P299, DOI 10.3168/jds.2013-7101; Marce C, 2011, PREV VET MED, V100, P116, DOI 10.1016/j.prevetmed.2011.02.004; More SJ, 2013, J DAIRY SCI, V96, P1581, DOI 10.3168/jds.2012-5918; Morton J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074312; Mutharia LM, 1997, INFECT IMMUN, V65, P387, DOI 10.1128/IAI.65.2.387-394.1997; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-14; Paoli GC, 2004, J IMMUNOL METHODS, V289, P147, DOI 10.1016/j.jim.2004.04.001; Plain KM, 2014, J CLIN MICROBIOL, V52, P745, DOI 10.1128/JCM.03233-13; Sevilla IA, 2014, APPL ENVIRON MICROB, V80, P3757, DOI 10.1128/AEM.01026-14; Slana I, 2008, VET MED-CZECH, V53, P283, DOI 10.17221/1859-VETMED; Steingroewer J, 2005, ENG LIFE SCI, V5, P267, DOI 10.1002/elsc.200420072; Steingroewer J, 2007, J MAGN MAGN MATER, V311, P295, DOI 10.1016/j.jmmm.2006.10.1192; Stewart LD, 2012, J CLIN MICROBIOL, V50, P1598, DOI 10.1128/JCM.05747-11; Stratmann J, 2002, J CLIN MICROBIOL, V40, P4244, DOI 10.1128/JCM.40.11.4244-4250.2002; Stratmann J, 2006, APPL ENVIRON MICROB, V72, P5150, DOI 10.1128/AEM.00590-06; SWEENEY RW, 1992, J CLIN MICROBIOL, V30, P166, DOI 10.1128/JCM.30.1.166-171.1992; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2	33	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147870	10.1371/journal.pone.0147870	http://dx.doi.org/10.1371/journal.pone.0147870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815790	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528200060
J	De Jesus, AM; Aghvami, M; Sander, EA				De Jesus, Aribet M.; Aghvami, Maziar; Sander, Edward A.			A Combined In Vitro Imaging and Multi-Scale Modeling System for Studying the Role of Cell Matrix Interactions in Cutaneous Wound Healing	PLOS ONE			English	Article							MECHANICAL BOUNDARY-CONDITIONS; HYPERTROPHIC SCAR FORMATION; CONTACT GUIDANCE; AVERAGING THEORY; COLLAGEN; FIBRIN; MANAGEMENT; ALIGNMENT; MECHANOTRANSDUCTION; MECHANOBIOLOGY	Many cell types remodel the extracellular matrix of the tissues they inhabit in response to a wide range of environmental stimuli, including mechanical cues. Such is the case in dermal wound healing, where fibroblast migrate into and remodel the provisional fibrin matrix in a complex manner that depends in part on the local mechanical environment and the evolving multi-scale mechanical interactions of the system. In this study, we report on the development of an image-based multi-scale mechanical model that predicts the short-term (24 hours), structural reorganization of a fibrin gel by fibroblasts. These predictive models are based on an in vitro experimental system where clusters of fibroblasts (i.e., explants) were spatially arranged into a triangular geometry onto the surface of fibrin gels that were subjected to either Fixed or Free in-plane mechanical constraints. Experimentally, regional differences in short-term structural remodeling and cell migration were observed for the two gel boundary conditions. A pilot experiment indicated that these small differences in the short-term remodeling of the fibrin gel translate into substantial differences in long-term (4 weeks) remodeling, particularly in terms of collagen production. The multi-scale models were able to predict some regional differences in remodeling and qualitatively similar reorganization patterns for the two boundary conditions. However, other aspects of the model, such as the magnitudes and rates of deformation of gel, did not match the experiments. These discrepancies between model and experiment provide fertile ground for challenging model assumptions and devising new experiments to enhance our understanding of how this multi-scale system functions. These efforts will ultimately improve the predictions of the remodeling process, particularly as it relates to dermal wound healing and the reduction of patient scarring. Such models could be used to recommend patient-specific mechanical-based treatment dependent on parameters such as wound geometry, location, age, and health.	[De Jesus, Aribet M.; Aghvami, Maziar; Sander, Edward A.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA	University of Iowa	Sander, EA (corresponding author), Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.	edward-sander@uiowa.edu			National Institutes of Health [R03-AR063967]; National Science Foundation (CAREER) [1452728]; Carver Charitable Trust [14-4384]; U.S. Department of Education Graduate Assistance in Areas of National Need Fellowship (GAANN) [P200A120071]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (CAREER)(National Science Foundation (NSF)); Carver Charitable Trust; U.S. Department of Education Graduate Assistance in Areas of National Need Fellowship (GAANN); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support for the work was provided by the National Institutes of Health (R03-AR063967), the National Science Foundation (CAREER 1452728), and the Carver Charitable Trust (#14-4384) to ES. A U.S. Department of Education Graduate Assistance in Areas of National Need Fellowship (GAANN P200A120071) supported AD.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Abhilash AS, 2014, BIOPHYS J, V107, P1829, DOI 10.1016/j.bpj.2014.08.029; Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90; Aghvami M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024460; Akaishi S, 2010, PLAST RECONSTR SURG, V126, p109E, DOI 10.1097/PRS.0b013e3181df7073; Atkinson JAM, 2005, PLAST RECONSTR SURG, V116, P1648, DOI 10.1097/01.prs.0000187147.73963.a5; Baum BJ, 2006, BBA-BIOMEMBRANES, V1758, P1071, DOI 10.1016/j.bbamem.2005.11.006; Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158; Blackstone BN, 2012, ADV WOUND CARE, V1, P69, DOI 10.1089/wound.2011.0345; Bonet J., 1997, NONLINEAR CONTINUUM; CARR ME, 1988, THROMB HAEMOSTASIS, V59, P535; Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369; Chaubaroux C, 2015, TISSUE ENG C; Chen Margaret A, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P242, DOI 10.1097/01.moo.0000170525.74264.f8; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; De Jesus AM, 2014, JOVE-J VIS EXP, DOI 10.3791/50918; Derderian CA, 2005, ANN PLAS SURG, V55, P69, DOI 10.1097/01.sap.0000168160.86221.e9; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241; Duscher D, 2014, J BIOMECH, V47, P1997, DOI 10.1016/j.jbiomech.2014.03.031; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Eming SA., 2012, DERMATOLOGY; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Evans ND, 2013, J MECH BEHAV BIOMED, V28, P397, DOI 10.1016/j.jmbbm.2013.04.023; Fernandez P, 2009, INTEGR BIOL-UK, V1, P252, DOI 10.1039/b822897c; Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3; Gauglitz GG, 2013, CLIN COSMET INV DERM, V6, P103, DOI 10.2147/CCID.S35252; Gold MH, 2014, DERMATOL SURG, V40, P817, DOI 10.1111/dsu.0000000000000049; Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107; Gurtner GC, 2011, ANN SURG, V254, P217, DOI 10.1097/SLA.0b013e318220b159; Hadi MF, 2012, MECH MATER, V44, P72, DOI 10.1016/j.mechmat.2011.07.003; Hadi MF, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007097; Hartmann A, 2006, BLOOD CELL MOL DIS, V36, P191, DOI 10.1016/j.bcmd.2005.12.033; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587; John J, 2010, ANN BIOMED ENG, V38, P658, DOI 10.1007/s10439-009-9856-1; Kamath S, 2003, QJM-INT J MED, V96, P711, DOI 10.1093/qjmed/hcg129; Kessler-Becker D, 2004, BIOCHEM J, V379, P351, DOI 10.1042/BJ20031371; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Krishnan L, 2008, CARDIOVASC RES, V78, P324, DOI 10.1093/cvr/cvn055; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Levinson H, 2013, ADV WOUND CARE, V2, P149, DOI 10.1089/wound.2012.0389; Lu F, 2011, ANN PLAS SURG, V66, P296, DOI 10.1097/SAP.0b013e3181ea1e9b; Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Ogawa R, 2011, WOUND REPAIR REGEN, V19, pS2, DOI 10.1111/j.1524-475X.2011.00707.x; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Raghupathy R, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005170; Reinhardt JW, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024463; Robinson PS, 2009, TISSUE ENG PT A, V15, P2763, DOI 10.1089/ten.tea.2008.0426; Rouillard AD, 2014, BIOPHYS J, V106, P932, DOI 10.1016/j.bpj.2013.12.002; Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2; Sander EA, 2009, J BIOMED MATER RES A, V88A, P322, DOI 10.1002/jbm.a.31847; Sander EA, 2014, BIOMATERIALS AND REGENERATIVE MEDICINE, P295; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; Sander EA, 2009, IEEE ENG MED BIOL, V28, P10, DOI 10.1109/MEMB.2009.932486; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387; Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019; Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105; Thomopoulos S, 2005, J BIOMECH ENG-T ASME, V127, P742, DOI 10.1115/1.1992525; Tranquillo Robert T., 1999, P27; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Wang HL, 2013, P NATL ACAD SCI USA, V110, P20923, DOI 10.1073/pnas.1313662110; Weinbaum JS, 2013, CELL MOL BIOENG, V6, P279, DOI 10.1007/s12195-013-0289-4; Wong VW, 2013, ADV WOUND CARE, V2, P185, DOI 10.1089/wound.2012.0396; Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212; Yagmur C, 2010, PLAST RECONSTR SURG, V126, P426, DOI 10.1097/PRS.0b013e3181df715d; Yuan Ye K, 2011, J VIS EXP; Zarkoob H, 2015, CELL MOL BIOENG, V8, P32, DOI 10.1007/s12195-015-0377-8	72	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148254	10.1371/journal.pone.0148254	http://dx.doi.org/10.1371/journal.pone.0148254			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840835	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200112
J	Hummler, HD; Banke, K; Wolfson, MR; Buonocore, G; Ebsen, M; Bernhard, W; Tsikas, D; Fuchs, H				Hummler, Helmut D.; Banke, Katharina; Wolfson, Marla R.; Buonocore, Giuseppe; Ebsen, Michael; Bernhard, Wolfgang; Tsikas, Dimitrios; Fuchs, Hans			The Effects of Lung Protective Ventilation or Hypercapnic Acidosis on Gas Exchange and Lung Injury in Surfactant Deficient Rabbits	PLOS ONE			English	Article							OXIDATION PROTEIN PRODUCTS; PARTIAL LIQUID VENTILATION; PERMISSIVE HYPERCAPNIA; THERAPEUTIC HYPERCAPNIA; MECHANICAL VENTILATION; PULMONARY; BIRTH; INFLAMMATION; MORTALITY; VOLUME	Background Permissive hypercapnia has been shown to reduce lung injury in subjects with surfactant deficiency. Experimental studies suggest that hypercapnic acidosis by itself rather than decreased tidal volume may be a key protective factor. Objectives To study the differential effects of a lung protective ventilatory strategy or hypercapnic acidosis on gas exchange, hemodynamics and lung injury in an animal model of surfactant deficiency. Methods 30 anesthetized, surfactant-depleted rabbits were mechanically ventilated (FiO(2) = 0.8, PEEP = 7cmH(2)O) and randomized into three groups: Normoventilation-Normocapnia (NN)-group: tidal volume (Vt) = 7.5 ml/kg, target PaCO2 = 40 mmHg; Normoventilation-Hypercapnia (NH)-group: Vt = 7.5 ml/kg, target PaCO2 = 80 mmHg by increasing FiCO(2); and a Hypoventilation-Hypercapnia (HH)-group: Vt = 4.5 ml/kg, target PaCO2 = 80 mmHg. Plasma lactate and interleukin (IL)-8 were measured every 2 h. Animals were sacrificed after 6 h to perform bronchoalveolar lavage (BAL), to measure lung wet-to-dry weight, lung tissue IL-8, and to obtain lung histology. Results PaO2 was significantly higher in the HH-group compared to the NN-group (p<0.05), with values of the NH-group between the HH- and NN-groups. Other markers of lung injury (wet-dry-weight, BAL-Protein, histology-score, plasma-IL-8 and lung tissue IL-8) resulted in significantly lower values for the HH-group compared to the NN-group and trends for the NH-group towards lower values compared to the NN-group. Lactate was significantly lower in both hypercapnia groups compared to the NN-group. Conclusion Whereas hypercapnic acidosis may have some beneficial effects, a significant effect on lung injury and systemic inflammatory response is dependent upon a lower tidal volume rather than resultant arterial CO2 tensions and pH alone.	[Hummler, Helmut D.; Banke, Katharina; Fuchs, Hans] Univ Ulm, Dept Pediat, Childrens Hosp, Div Neonatol & Pediat Crit Care, D-89070 Ulm, Germany; [Wolfson, Marla R.] CENTRe Collaborat Environm & Neonatal Therapeut R, Dept Physiol, Philadelphia, PA USA; [Wolfson, Marla R.] CENTRe Collaborat Environm & Neonatal Therapeut R, Dept Med, Philadelphia, PA USA; [Wolfson, Marla R.] CENTRe Collaborat Environm & Neonatal Therapeut R, Dept Pediat, Philadelphia, PA USA; [Wolfson, Marla R.] Temple Lung Ctr, Philadelphia, PA USA; [Wolfson, Marla R.] Temple Univ, Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA; [Buonocore, Giuseppe] Univ Hosp Siena, Dept Mol & Dev Med, Pediat Neonatol Unit, Siena, Italy; [Ebsen, Michael] Staedt Krankenhaus Kiel, Med Versorgungszentrum, Inst Pathol, Kiel, Germany; [Bernhard, Wolfgang] Univ Tubingen, Childrens Hosp, Dept Neonatol, Tubingen, Germany; [Tsikas, Dimitrios] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Ulm University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena; University Hospital of Siena; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Hannover Medical School	Hummler, HD (corresponding author), Univ Ulm, Dept Pediat, Childrens Hosp, Div Neonatol & Pediat Crit Care, D-89070 Ulm, Germany.	helmut.hummler@uni-ulm.de	Hummler, Helmut/AAN-7297-2021; Bernhard, Wolfgang/AAT-1393-2021; Buonocore, Giuseppe/U-3873-2019	Buonocore, Giuseppe/0000-0002-7921-7485; Bernhard, Wolfgang/0000-0003-0307-223X	Department of Defense/Office of Naval Research [N000141210597, N000141210810]	Department of Defense/Office of Naval Research(Office of Naval ResearchUnited States Department of Defense)	Work performed in this study was supported in part by the Department of Defense/Office of Naval Research N000141210597 and N000141210810 (MRW).	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Bernhard W, 2007, PEDIATR PULM, V42, P794, DOI 10.1002/ppul.20657; Broccard AF, 2001, AM J RESP CRIT CARE, V164, P802, DOI 10.1164/ajrccm.164.5.2007060; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Buonocore G, 2000, PEDIATR RES, V47, P221, DOI 10.1203/00006450-200002000-00012; Carlo WA, 2002, J PEDIATR-US, V141, P370, DOI 10.1067/mpd.2002.127507; Clark RH, 2001, J PEDIATR-US, V139, P478, DOI 10.1067/mpd.2001.118201; COATES AL, 1991, PEDIATR PULM, V11, P350, DOI 10.1002/ppul.1950110413; Contreras M, 2012, CRIT CARE MED, V40, P2622, DOI 10.1097/CCM.0b013e318258f8b4; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Feihl F, 2000, AM J RESP CRIT CARE, V162, P209, DOI 10.1164/ajrccm.162.1.9907119; Fritz KI, 2005, PEDIATR RES, V57, P299, DOI 10.1203/01.PDR.0000148718.47137.9B; Fuchs H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023816; Haitsma JJ, 2000, INTENS CARE MED, V26, P1515, DOI 10.1007/s001340000648; HICKLING KG, 1994, CRIT CARE MED, V22, P1568, DOI 10.1097/00003246-199422100-00011; HILLERED L, 1984, J CEREBR BLOOD F MET, V4, P430, DOI 10.1038/jcbfm.1984.62; HOOD VL, 1988, AM J PHYSIOL, V255, pF479, DOI 10.1152/ajprenal.1988.255.3.F479; Hood VL, 1998, NEW ENGL J MED, V339, P819, DOI 10.1056/NEJM199809173391207; Hummler HD, 2001, PEDIATR RES, V49, P572, DOI 10.1203/00006450-200104000-00021; Kantores C, 2006, AM J PHYSIOL-LUNG C, V291, pL912, DOI 10.1152/ajplung.00480.2005; LACHMANN B, 1980, ACTA ANAESTH SCAND, V24, P231, DOI 10.1111/j.1399-6576.1980.tb01541.x; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Lee WL, 2001, SEMIN RESP CRIT CARE, V22, P269, DOI 10.1055/s-2001-15784; Mariani G, 1999, PEDIATRICS, V104, P1082, DOI 10.1542/peds.104.5.1082; Masood A, 2009, AM J PHYSIOL-LUNG C, V297, pL920, DOI 10.1152/ajplung.00139.2009; NETO GS, 1992, PEDIATR PULM, V12, P146, DOI 10.1002/ppul.1950120304; Paffetti P, 2006, BIOL TRACE ELEM RES, V112, P221, DOI 10.1385/BTER:112:3:221; Rai S, 2004, PEDIATR RES, V55, P42, DOI 10.1203/01.PDR.0000098502.72182.55; Raith M, 2012, J APPL PHYSIOL, V112, P1317, DOI 10.1152/japplphysiol.00887.2011; Sinclair SE, 2002, AM J RESP CRIT CARE, V166, P403, DOI 10.1164/rccm.200112-117OC; STEINHART CR, 1983, AM J PHYSIOL, V244, pH46, DOI 10.1152/ajpheart.1983.244.1.H46; Strand M, 2003, PEDIATR RES, V53, P468, DOI 10.1203/01.PDR.0000049463.76133.8F; Subramanian Siva, 2011, Matern Child Health J, V15 Suppl 1, pS17, DOI 10.1007/s10995-011-0863-0; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Thome UH, 2001, CRIT CARE MED, V29, P1175, DOI 10.1097/00003246-200106000-00018; Thome UH, 2006, BIOL NEONATE, V90, P218, DOI 10.1159/000092723; Thome UH, 2015, LANCET RESP MED, V3, P534, DOI 10.1016/S2213-2600(15)00204-0; Tomimatsu T, 2006, PEDIATR RES, V60, P711, DOI 10.1203/01.pdr.0000246308.37154.ce; Tsikas D, 2003, J CHROMATOGR B, V794, P237, DOI 10.1016/S1570-0232(03)00457-4; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Wolthuis EK, 2008, ANESTHESIOLOGY, V108, P46, DOI 10.1097/01.anes.0000296068.80921.10; Yamamoto Y, 2001, J APPL PHYSIOL, V91, P1121, DOI 10.1152/jappl.2001.91.3.1121	44	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147807	10.1371/journal.pone.0147807	http://dx.doi.org/10.1371/journal.pone.0147807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840779	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200061
J	Jelen, V; de Jonge, R; Van de Peer, Y; Javornik, B; Jakse, J				Jelen, Vid; de Jonge, Ronnie; Van de Peer, Yves; Javornik, Branka; Jakse, Jernej			Complete mitochondrial genome of the Verticillium-wilt causing plant pathogen Verticillium nonalfalfae	PLOS ONE			English	Article							OPEN SOFTWARE; REVEALS; ORGANIZATION; EXPRESSION; EVOLUTION; VIRULENCE; ALIGNMENT; TOOL	Verticillium nonalfalfae is a fungal plant pathogen that causes wilt disease by colonizing the vascular tissues of host plants. The disease induced by hop isolates of V. nonalfalfae manifests in two different forms, ranging from mild symptoms to complete plant dieback, caused by mild and lethal pathotypes, respectively. Pathogenicity variations between the causal strains have been attributed to differences in genomic sequences and perhaps also to differences in their mitochondrial genomes. We used data from our recent Illumina NGS-based project of genome sequencing V. nonalfalfae to study the mitochondrial genomes of its different strains. The aim of the research was to prepare a V. nonalfalfae reference mitochondrial genome and to determine its phylogenetic placement in the fungal kingdom. The resulting 26,139 bp circular DNA molecule contains a full complement of the 14 "standard" fungal mitochondrial protein-coding genes of the electron transport chain and ATP synthase subunits, together with a small rRNA subunit, a large rRNA subunit, which contains ribosomal protein S3 encoded within a type IA-intron and 26 tRNAs. Phylogenetic analysis of this mitochondrial genome placed it in the Verticillium spp. lineage in the Glomerellales group, which is also supported by previous phylogenetic studies based on nuclear markers. The clustering with the closely related Verticillium dahliae mitochondrial genome showed a very conserved synteny and a high sequence similarity. Two distinguishing mitochondrial genome features were also found-a potential long non-coding RNA (orf414) contained only in the Verticillium spp. of the fungal kingdom, and a specific fragment length polymorphism observed only in V. dahliae and V. nubilum of all the Verticillium spp., thus showing potential as a species specific biomarker.	[Jelen, Vid; Javornik, Branka; Jakse, Jernej] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [de Jonge, Ronnie; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, Ghent, Belgium; [de Jonge, Ronnie; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Van de Peer, Yves] Bioinformat Inst Ghent, Technol Pk 927, B-9052 Ghent, Belgium; [Van de Peer, Yves] Univ Pretoria, Dept Genet, Genom Res Inst, ZA-0002 Pretoria, South Africa	University of Ljubljana; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Pretoria	Jelen, V (corresponding author), Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.	vid.jelen1@gmail.com	de Jonge, Ronnie/I-3260-2016; Van de Peer, Yves/D-4388-2009; Van de Peer, Yves/AAE-7666-2019	de Jonge, Ronnie/0000-0001-5065-8538; Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Jakse, Jernej/0000-0002-8907-1627	grant - Javni sklad Republike Slovenije za razvoj kadrov in stipendije [163]; grant - Javna agencija za raziskovalno dejavnost Republike Slovenije [P4-0077]	grant - Javni sklad Republike Slovenije za razvoj kadrov in stipendije; grant - Javna agencija za raziskovalno dejavnost Republike Slovenije	VJ received the grant - Javni sklad Republike Slovenije za razvoj kadrov in stipendije - 163. JR (http://www.sklad-kadri.si) BJ received the grant - Javna agencija za raziskovalno dejavnost Republike Slovenije - P4-0077 (www.arrs.gov.si). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Al-Reedy RM, 2012, FUNGAL GENET BIOL, V49, P2, DOI 10.1016/j.fgb.2011.11.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Broad Institute, 2014, VERT GROUP DAT; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; Duressa D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-607; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Haas, 2015, TRANSDECODER; Hausner G, 2003, APPLIED MYCOLOGY AND BIOTECHNOLOGY, VOL 3, P101; Hegedusova E, 2014, CURR GENET, V60, P49, DOI 10.1007/s00294-013-0410-1; Himmelstrand K, 2014, CURR GENET, V60, P303, DOI 10.1007/s00294-014-0436-z; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Inderbitzin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065990; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Jung PP, 2012, G3-GENES GENOM GENET, V2, P1103, DOI 10.1534/g3.112.003152; Keyworth WG, 1942, ANN APPL BIOL, V29, P346, DOI 10.1111/j.1744-7348.1942.tb06138.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Li J, 2013, MICRO NANO LETT, V8, P8, DOI 10.1049/mnl.2012.0578; LI KN, 1994, APPL ENVIRON MICROB, V60, P4324, DOI 10.1128/AEM.60.12.4324-4331.1994; Litter J, 2005, ANTON LEEUW INT J G, V88, P249, DOI 10.1007/s10482-005-8544-x; LOWE TM, 1997, NUCL ACIDS RES, V25; Mandelc S, 2009, EUR J PLANT PATHOL, V125, P159, DOI 10.1007/s10658-009-9467-6; Mardanov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107536; Martin FN, 2010, PHYTOPATHOLOGY, V100, P1231, DOI 10.1094/PHYTO-12-09-0352; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Morgenstern I, 2012, FUNGAL BIOL-UK, V116, P489, DOI 10.1016/j.funbio.2012.01.010; NCBI, 2014, ORG GEN RES DAT; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Pantou MP, 2005, FEMS MICROBIOL LETT, V245, P213, DOI 10.1016/j.femsle.2005.03.011; Radisek S, 2003, PLANT DIS, V87, P633, DOI 10.1094/PDIS.2003.87.6.633; Radisek S, 2006, EUR J PLANT PATHOL, V116, P301, DOI 10.1007/s10658-006-9061-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Seefelder S., 2009, CICH IHB IHGC INT HO, P67; Seidl MF, 2015, MOL PLANT MICROBE IN, V28, P362, DOI 10.1094/MPMI-06-14-0173-R; Sethuraman J, 2009, J MOL EVOL, V69, P372, DOI 10.1007/s00239-009-9291-9; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stone CL, 2010, MYCOLOGIA, V102, P887, DOI 10.3852/09-198; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Torriani SFF, 2014, FUNGAL GENET BIOL, V62, P34, DOI 10.1016/j.fgb.2013.11.001; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; [Universite de Montreal Centre Robert-Cedergren Bio-informatique et Genomique], 2014, RNA WEAS; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; Yoon H, 2012, J GEN APPL MICROBIOL, V58, P331; Youssar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074792; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao XQ, 2013, MICROBIOLOGYOPEN, V2, P308, DOI 10.1002/mbo3.74; 2007, EPPO B, V37, P528, DOI DOI 10.1111/J.1365-2338.2007.01160.X	64	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148525	10.1371/journal.pone.0148525	http://dx.doi.org/10.1371/journal.pone.0148525			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839950	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200143
J	Lin, LZ; Guo, LL; Zhang, WX; Cai, XB; Chen, DF; Wan, XJ				Lin, Lizhou; Guo, Lili; Zhang, Weixing; Cai, Xiaobo; Chen, Dafan; Wan, Xinjian			Novel Silicone-Coated I-125 Seeds for the Treatment of Extrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							MALIGNANT BILIARY OBSTRUCTION; BRUSH CYTOLOGY; METALLIC STENT; CANCER; MANAGEMENT; PATTERNS; QUALITY; GEL	I-125 seeds coated with titanium are considered a safe and effective interstitial brachytherapy for tumors, while the cost of I-125 seeds is a major problem for the patients implanting lots of seeds. The aim of this paper was to develop a novel silicone coating for I-125 seeds with a lower cost. In order to show the radionuclide utilization ratio, the silicone was coated onto the seeds using the electro-spinning method and the radioactivity was evaluated, then the anti-tumor efficacy of silicone I-125 seeds was compared with titanium I-125 seeds. The seeds were divided into four groups: A (control), B (pure silicone), C (silicone I-125), D (titanium I-125) at 2 Gy or 4 Gy. Their anti-tumour activity and mechanism were assessed in vitro and in vivo using a human extrahepatic cholangiocarcinoma cell line FRH-0201 and tumor-bearing BALB/c nude mice. The silicone I-125 seeds showed higher radioactivity; the rate of cell apoptosis in vitro and the histopathology in vivo demonstrated that the silicone I-125 seeds shared similar anti-tumor efficacy with the titanium I-125 seeds for the treatment of extrahepatic cholangiocarcinoma, while they have a much lower cost.	[Lin, Lizhou; Guo, Lili; Zhang, Weixing; Cai, Xiaobo; Chen, Dafan; Wan, Xinjian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200080, Peoples R China	Shanghai Jiao Tong University	Wan, XJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200080, Peoples R China.	wanxj_sh@163.com		Wan, Xinjian/0000-0002-4201-633X	Doctoral Fund of Education Administration for New Teacher [070162]	Doctoral Fund of Education Administration for New Teacher	This work was supported by Doctoral Fund of Education Administration for New Teacher (project code: 070162). The funding receiver was Xinjian Wan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2012, CANCER BIOTHER RADIO, V27, P317, DOI 10.1089/cbr.2011.0999; Chun HJ, 2010, J GASTROEN HEPATOL, V25, P234, DOI 10.1111/j.1440-1746.2009.06152.x; Daramwar PP, 2012, ANALYST, V137, P4564, DOI 10.1039/c2an35575b; Davila Jessica A., 2002, American Journal of Gastroenterology, V97, P3199; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Fanelli F, 2008, EUR RADIOL, V18, P911, DOI 10.1007/s00330-008-0852-x; Fung LCT, 1996, PERITON DIALYSIS INT, V16, P398; Han YH, 2006, ABDOM IMAGING, V31, P433, DOI 10.1007/s00261-005-8017-8; Hejna M, 1998, EUR J CANCER, V34, P977, DOI 10.1016/S0959-8049(97)10166-6; Kawada N, 2011, J GASTROEN HEPATOL, V26, P1247, DOI 10.1111/j.1440-1746.2011.06725.x; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Kim HS, 2002, GASTROINTEST ENDOSC, V55, P359, DOI 10.1067/mge.2002.121603; Kumar R, 2004, J GASTROEN HEPATOL, V19, P994, DOI 10.1111/j.1440-1746.2004.03415.x; Li G, 2013, BIOMATERIALS, V34, P9451, DOI 10.1016/j.biomaterials.2013.08.055; Liu Y, 2009, GASTROINTEST ENDOSC, V69, P1067, DOI 10.1016/j.gie.2008.08.033; Luman W, 1997, EUR J GASTROEN HEPAT, V9, P481, DOI 10.1097/00042737-199705000-00013; Ma JX, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-35; Miura Y, 2001, J Hepatobiliary Pancreat Surg, V8, P113, DOI 10.1007/s005340170032; Mulhonen V, 2009, ACTA BIOMATER, V5, P785, DOI 10.1016/j.actbio.2008.08.023; Naitoh I, 2009, J GASTROEN HEPATOL, V24, P552, DOI 10.1111/j.1440-1746.2008.05750.x; Ortner MA, 2004, PHOTODIAGN PHOTODYN, V1, P85, DOI 10.1016/S1572-1000(04)00013-4; Park SW, 2004, HEPATO-GASTROENTEROL, V51, P1612; Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E; Rumalla A, 2001, MAYO CLIN PROC, V76, P29, DOI 10.4065/76.1.29; Shinchi H, 2000, J SURG ONCOL, V75, P89, DOI 10.1002/1096-9098(200010)75:2<89::AID-JSO3>3.3.CO;2-M; Shinohara ET, 2009, INT J RADIAT ONCOL, V74, P1191, DOI 10.1016/j.ijrobp.2008.09.017; Takahashi Yutaka, 2006, Radiat Med, V24, P675, DOI 10.1007/s11604-006-0088-0; Trombetta MG, 2008, BRACHYTHERAPY, V7, P50, DOI 10.1016/j.brachy.2007.11.003; Wang JJ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-88; Wang ZM, 2010, EUR RADIOL, V20, P1786, DOI 10.1007/s00330-009-1703-0	31	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147701	10.1371/journal.pone.0147701	http://dx.doi.org/10.1371/journal.pone.0147701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840346	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200055
J	de-Magistris, T; Gracia, A				de-Magistris, Tiziana; Gracia, Azucena			Assessing Projection Bias in Consumers' Food Preferences	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; APPETITE; AUCTION; MARKETS; FUTURE; CHOICE; WOMEN	The aim of this study is to test whether projection bias exists in consumers' purchasing decisions for food products. To achieve our aim, we used a non-hypothetical experiment (i.e., experimental auction), where hungry and non-hungry participants were incentivized to reveal their willingness to pay (WTP). The results confirm the existence of projection bias when consumers made their decisions on food products. In particular, projection bias existed because currently hungry participants were willing to pay a higher price premium for cheeses than satiated ones, both in hungry and satiated future states. Moreover, participants overvalued the food product more when they were delivered in the future hungry condition than in the satiated one. Our study provides clear, quantitative and meaningful evidence of projection bias because our findings are based on economic valuation of food preferences. Indeed, the strength of this study is that findings are expressed in terms of willingness to pay which is an interpretable amount of money.	[de-Magistris, Tiziana; Gracia, Azucena] Ctr Invest & Tecnol Agroalimentaria Aragon Zarago, Unidad Econ Agroalimentaria, Zaragoza, Spain; [de-Magistris, Tiziana; Gracia, Azucena] Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain	University of Zaragoza	de-Magistris, T (corresponding author), Ctr Invest & Tecnol Agroalimentaria Aragon Zarago, Unidad Econ Agroalimentaria, Zaragoza, Spain.; de-Magistris, T (corresponding author), Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Zaragoza, Spain.	tmagistris@aragon.es	, Azucena/N-6263-2019	de Magistris, Tiziana/0000-0001-5480-183X	EU Marie Curie Project [FOODLABELS_PIOF-GA-2009-253323]	EU Marie Curie Project(European Commission)	This study has been funded by the EU Marie Curie Project, FOODLABELS_PIOF-GA-2009-253323, entitled "Do consumers value food labels? An assessment of the impact of information and personality traits on the demand for food labels."	Alfnes F, 2003, AM J AGR ECON, V85, P396, DOI 10.1111/1467-8276.t01-1-00128; Alfnes F, 2009, EUR REV AGRIC ECON, V36, P133, DOI 10.1093/erae/jbp013; Becker G., 1964, BEHAV SCI, V9, P22; Bernard John C., 2010, AGR RESOURCE EC REV, V39, P275; Bolles R.C., 1967, THEORY OF MOTIVATION; Briz T., 2015, AGR FOOD AND EC, V3, P22; Cox JC, 1996, ECON THEORY, V7, P381, DOI 10.1007/BF01213657; De Magistris T, 2015, J CONSUM AFF, V49, P457, DOI 10.1111/joca.12046; Gilbert DT, 2002, ORGAN BEHAV HUM DEC, V88, P430, DOI 10.1006/obhd.2001.2982; Hellyer NE, 2012, FOOD POLICY, V37, P232, DOI 10.1016/j.foodpol.2012.02.005; Keim NL, 1998, AM J CLIN NUTR, V68, P794, DOI 10.1093/ajcn/68.4.794; Loewenstein G, 2005, HEALTH PSYCHOL, V24, pS49, DOI 10.1037/0278-6133.24.4.S49; Loewenstein G, 2003, Q J ECON, V118, P1209, DOI 10.1162/003355303322552784; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Lusk J.L., 2005, EXPT METHODS ENV RES; Lusk JL, 2007, QUANT METH APPL ECON; Noussair C, 2004, J ECON PSYCHOL, V25, P725, DOI 10.1016/j.joep.2003.06.004; Poppitt SD, 1998, PHYSIOL BEHAV, V64, P279, DOI 10.1016/S0031-9384(98)00061-4; Read D, 1998, ORGAN BEHAV HUM DEC, V76, P189, DOI 10.1006/obhd.1998.2803; Shogren JF, 2006, ENVIRON RESOUR ECON, V34, P163, DOI 10.1007/s10640-005-3785-8; Shogren JF, 2001, J ECON BEHAV ORGAN, V46, P409, DOI 10.1016/S0167-2681(01)00165-2	21	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146308	10.1371/journal.pone.0146308	http://dx.doi.org/10.1371/journal.pone.0146308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828930	Green Published, gold			2022-12-27	WOS:000369548200007
J	Norback, D; Hashim, JH; Cai, GH; Hashim, Z; Ali, F; Bloom, E; Larsson, L				Norback, Dan; Hashim, Jamal Hisham; Cai, Gui-Hong; Hashim, Zailina; Ali, Faridah; Bloom, Erica; Larsson, Lennart			Rhinitis, Ocular, Throat and Dermal Symptoms, Headache and Tiredness among Students in Schools from Johor Bahru, Malaysia: Associations with Fungal DNA and Mycotoxins in Classroom Dust	PLOS ONE			English	Article							SICK BUILDING SYNDROME; STACHYBOTRYS-CHARTARUM; RESPIRATORY HEALTH; MASS-SPECTROMETRY; PUPILS; MOLDS; AIR; ASPERGILLUS; COMPONENTS; ALLERGENS	There are few studies on rhinitis and sick building syndrome (SBS) among students in tropical countries. We studied associations between levels of five fungal DNA sequences, two mycotoxins (sterigmatocystin and verrucarol) and cat allergen (Fel d 1) levels in schools and rhinitis and other weekly SBS symptoms in the students. Fungal DNA was measured by quantitative PCR and cat allergen by ELISA. Pupils (N = 462) from eight randomly selected schools in Johor Bahru, Malaysia participated (96%). Dust samples were collected by cotton swabs and Petri dishes exposed for one week. None of the schools had a mechanical ventilation system, but all classrooms had openable windows that were kept open during lectures and indoor CO2 levels were low (mean 492 ppm; range 380-690 ppm). Weekly nasal symptoms (rhinitis) (18.8%), ocular (11.6%), throat (11.1%), dermal symptoms, headache (20.6%) and tiredness (22.1%) were common. Total fungal DNA in swab samples was associated with rhinitis (p = 0.02), ocular symptoms (p = 0.009) and tiredness (p = 0.001). There were positive associations between Aspergillus versicolor DNA in Petri dish samples, ocular symptoms (p = 0.02) and tiredness (p = 0.001). The level of the mycotoxin verrucarol (produced by Stachybotrys chartarum) in swab samples was positively associated with tiredness (p = 0.04). Streptomyces DNA in swab samples (p = 0.03) and Petri dish samples (p = 0.03) were negatively associated with tiredness. In conclusion, total fungal contamination, measured as total fungal DNA) in the classrooms, Aspergillus versicolor and verrucarol can be risk factors for rhinitis and SBS symptoms among students in the tropical country Malaysia.	[Norback, Dan; Cai, Gui-Hong] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden; [Hashim, Jamal Hisham] United Nations Univ, Int Inst Global Hlth, Kuala Lumpur, Malaysia; [Hashim, Jamal Hisham] Natl Univ Malaysia, Dept Community Hlth, Kuala Lumpur, Malaysia; [Hashim, Zailina] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Environm & Occupat Hlth, Serdang 43400, Selangor, Malaysia; [Ali, Faridah] Johor State Hlth Dept, Primary Care Unit, Johor Baharu, Malaysia; [Bloom, Erica] IVL Swedish Environm Res Inst Ltd, Stockholm, Sweden; [Bloom, Erica; Larsson, Lennart] Lund Univ, Dept Lab Med, Div Med Microbiol, Lund, Sweden	Uppsala University; Universiti Kebangsaan Malaysia; Universiti Putra Malaysia; IVL Swedish Environmental Research Institute; Lund University	Norback, D (corresponding author), Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden.	dan.norback@medci.uu.se		Bloom, Erica/0000-0001-7893-6042	Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS) [244-2008-68]; Swedish Asthma and Allergy Association's Research Foundation [2013020-K]; Swedish International Development Agency (SIDA) [348-2004-5596]; Swedish Research Council (VR) [348-2013-6762]; Swedish Foundation for Health Care Sciences and Allergy research; IVL Swedish Environmental Research Institute Ltd	Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS); Swedish Asthma and Allergy Association's Research Foundation; Swedish International Development Agency (SIDA); Swedish Research Council (VR)(Swedish Research Council); Swedish Foundation for Health Care Sciences and Allergy research; IVL Swedish Environmental Research Institute Ltd(IVL Swedish Environmental Research Institute)	This study was supported by grants from the Swedish Council for Environmental and Agricultural Science and Spatial Planning (FORMAS) (grant nr 244-2008-68), the Swedish Asthma and Allergy Association's Research Foundation and (grant nr 2013020-K), Swedish International Development Agency (SIDA) (grant 348-2004-5596), Swedish Research Council (VR)/grant nr 348-2013-6762), and the Swedish Foundation for Health Care Sciences and Allergy research. The corresponding author was the recipient of all funding. The funders supported the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IVL Swedish Environmental Research Institute Ltd provided support in the form of salaries for authors [EB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0112-7; APTER A, 1994, J ALLERGY CLIN IMMUN, V94, P277, DOI 10.1016/0091-6749(94)90087-6; ASHRAE, 1999, VENT ACC IND AIR QUA; Bholah R, 2002, INT J ENVIRON HEAL R, V12, P93, DOI 10.1080/09603120120110095; Bloom E, 2007, APPL ENVIRON MICROB, V73, P4211, DOI 10.1128/AEM.00343-07; Bloom E, 2009, J OCCUP ENVIRON HYG, V6, P671, DOI 10.1080/15459620903252053; Brewer JH, 2013, TOXINS, V5, P605, DOI 10.3390/toxins5040605; Cai GH, 2011, PEDIAT ALLERG IMM-UK, V22, P290, DOI 10.1111/j.1399-3038.2010.01127.x; Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x; Fox A, 2005, J ENVIRON MONITOR, V7, P450, DOI 10.1039/b418038k; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Haugland RA, 2004, SYST APPL MICROBIOL, V27, P198, DOI 10.1078/072320204322881826; Hirvonen MR, 2005, INDOOR AIR, V15, P65, DOI 10.1111/j.1600-0668.2005.00345.x; HODGSON M, 1995, OCCUP MED, V10, P167; Jarvis BB, 2005, APPL MICROBIOL BIOT, V66, P367, DOI 10.1007/s00253-004-1753-9; Jarvis BB, 2003, PHYTOCHEMISTRY, V64, P53, DOI 10.1016/S0031-9422(03)00275-9; Jarvis Bruce B., 1995, Natural Toxins, V3, P10, DOI 10.1002/nt.2620030104; Johansson E, 2011, INDOOR AIR, V21, P300, DOI 10.1111/j.1600-0668.2010.00702.x; Karlsson AS, 2002, ALLERGY, V57, P164, DOI 10.1034/j.1398-9995.2002.1s3297.x; Kim JL, 2011, J KOREAN MED SCI, V26, P166, DOI 10.3346/jkms.2011.26.2.166; Kim JL, 2005, INDOOR AIR, V15, P170, DOI 10.1111/j.1600-0668.2005.00334.x; Larsson L, 2008, J ENVIRON MONITOR, V10, P301, DOI 10.1039/b718584g; Mendell MJ, 2005, INDOOR AIR, V15, P27, DOI 10.1111/j.1600-0668.2004.00320.x; Meyer HW, 2005, INDOOR AIR, V15, P17, DOI 10.1111/j.1600-0668.2005.00356.x; Mi YH, 2006, INDOOR AIR, V16, P454, DOI 10.1111/j.1600-0668.2006.00439.x; Miller JD, 2010, CHEM-BIOL INTERACT, V183, P113, DOI 10.1016/j.cbi.2009.09.023; Miller JD, 2003, MED MYCOL, V41, P271, DOI 10.1080/1369378031000137350; Norback D, 2011, J ENVIRON MONITOR, V13, P2895, DOI 10.1039/c1em10439j; Norback D, 2009, CURR OPIN ALLERGY CL, V9, P55, DOI 10.1097/ACI.0b013e32831f8f08; Peitzsch M, 2012, J ENVIRON MONITOR, V14, P2044, DOI 10.1039/c2em30195d; Raja S, 2010, ENVIRON INT, V36, P8, DOI 10.1016/j.envint.2009.09.001; Rand TG, 2011, CHEM-BIOL INTERACT, V190, P139, DOI 10.1016/j.cbi.2011.02.017; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Roussel S, 2012, INDOOR AIR, V22, P514, DOI 10.1111/j.1600-0668.2012.00781.x; Sahlberg B, 2010, SCAND J PUBLIC HEALT, V38, P232, DOI 10.1177/1403494809350517; Sahlberg B, 2009, INT ARCH OCC ENV HEA, V82, P1211, DOI 10.1007/s00420-009-0444-3; Sahlberg B, 2012, INDOOR AIR, V129, P420; Saijo Yasuaki, 2010, Environmental Health and Preventive Medicine, V15, P276, DOI 10.1007/s12199-010-0139-0; Salo PM, 2009, J ALLERGY CLIN IMMUN, V124, P185, DOI 10.1016/j.jaci.2009.05.012; Scheepers PTJ, 2003, ANN OCCUP HYG, V47, P379, DOI 10.1093/annhyg/meg036; Simoni M, 2011, PEDIAT ALLERG IMM-UK, V22, P843, DOI 10.1111/j.1399-3038.2011.01208.x; Sudakin DL, 1998, AM J IND MED, V34, P183, DOI 10.1002/(SICI)1097-0274(199808)34:2&lt;183::AID-AJIM12&gt;3.0.CO;2-R; Takaoka Motoko, 2015, Glob J Health Sci, V8, P165, DOI 10.5539/gjhs.v8n2p165; Tischer C, 2011, EUR RESPIR J, V38, P812, DOI 10.1183/09031936.00184010; Vesper SJ, 2005, LETT APPL MICROBIOL, V41, P367, DOI 10.1111/j.1472-765X.2005.01764.x; Wan GH, 1999, ARCH ENVIRON HEALTH, V54, P58, DOI 10.1080/00039899909602238; WHO Regional Office for Europe, WHO GUID IND AIR QUA; World Health Organization, 1983, WHO REG OFF EUR EURO, V78, P1; Zhang X, 2011, INDOOR AIR, V21, P462, DOI 10.1111/j.1600-0668.2011.00726.x; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112933; Zhang X, 2011, SCI TOTAL ENVIRON, V409, P5253, DOI 10.1016/j.scitotenv.2011.08.059	51	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147996	10.1371/journal.pone.0147996	http://dx.doi.org/10.1371/journal.pone.0147996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829324	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000369548200050
J	Peterson, AV; Marek, PM; Kealey, KA; Bricker, JB; Ludman, EJ; Heffner, JL				Peterson, Arthur V., Jr.; Marek, Patrick M.; Kealey, Kathleen A.; Bricker, Jonathan B.; Ludman, Evette J.; Heffner, Jaimee L.			Does Effectiveness of Adolescent Smoking-Cessation Intervention Endure Into Young Adulthood? 7-Year Follow-Up Results from a Group-Randomized Trial	PLOS ONE			English	Article							TELEPHONE COUNSELING INTERVENTION; SUBSTANCE USE; RELAPSE; ABSTINENCE; PREVENTION; DESIGN; CONSENT; HEALTH; RATES	Background The Hutchinson Study of High School Smoking was the first randomized trial to show effectiveness of a smoking cessation intervention on 6-months prolonged smoking abstinence at one year post-intervention in a large population-based sample of adolescent smokers. An important question remains: Do the positive effects from teen smoking cessation interventions seen at up to 12 months post-intervention endure into young adulthood? This study examines for the first time whether such positive early effects from teen smoking cessation intervention can endure into young adulthood in the absence of additional intervention. Methods High school smokers (n = 2,151) were proactively recruited into the trial from fifty randomly selected Washington State high schools randomized to the experimental (Motivational Interviewing + Cognitive Behavioral Skills Training telephone counseling intervention) or control (no intervention) condition. These smokers were followed to 7 years post high school to ascertain rates of six-year prolonged smoking abstinence in young adulthood. All statistical tests are two-sided. Results No evidence of intervention impact at seven years post high school was observed for the main endpoint of six-year prolonged abstinence, neither among all smokers (14.2% in the experimental condition vs. 13.1% in the control condition, difference = +1.1%, 95% confidence interval (CI) = -3.4 to 5.8, p = .61), nor among the subgroups of daily smokers and less-than-daily smokers, nor among other a priori subgroups. But, observed among males was some evidence of an intervention impact on two endpoints related to progress towards quitting: reduction in number of days smoked in the past month, and increase in the length of the longest quit attempt in the past year. Conclusions There was no evidence from this trial among adolescent smokers that positive effectiveness of the proactive telephone intervention for smoking abstinence, observed previously at one year post-intervention, was sustained for the long-term into young adulthood. In light of the positive short-term effectiveness consistently observed from this and other trials for teen smokers, together with the lack of evidence from this study that such short-term impact can endure into young adulthood, sustained interventions that continue into young adulthood should be developed and tested for long-term impact.	[Peterson, Arthur V., Jr.; Marek, Patrick M.; Kealey, Kathleen A.; Bricker, Jonathan B.; Heffner, Jaimee L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Peterson, Arthur V., Jr.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bricker, Jonathan B.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Ludman, Evette J.] Grp Hlth Res Inst, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Peterson, AV (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Peterson, AV (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	avpeters@fhcrc.org			National Cancer Institute at National Institutes of Health [R01 CA082569]; NATIONAL CANCER INSTITUTE [R01CA082569] Funding Source: NIH RePORTER	National Cancer Institute at National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute at the National Institutes of Health (grant number R01 CA082569). The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MOTIVATIONAL INTERVI; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Backinger CL, 2003, AM J HEALTH BEHAV, V27, pS170; Baer JS, 1999, J SUBST ABUSE TREAT, V17, P15, DOI 10.1016/S0740-5472(98)00072-5; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barnett E, 2012, ADDICT BEHAV, V37, P1325, DOI 10.1016/j.addbeh.2012.07.001; BIENER L, 1991, HEALTH PSYCHOL, V10, P360, DOI 10.1037/0278-6133.10.5.360; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Edgington E. S., 1987, RANDOMIZATION TESTS; ELLICKSON PL, 1989, EVALUATION REV, V13, P45, DOI 10.1177/0193841X8901300104; Fernandez E, 2006, NICOTINE TOB RES, V8, P29, DOI 10.1080/14622200500264432; Fiore MC, 2008, TREATING TOBACCO USE; GAIL MH, 1992, CONTROL CLIN TRIALS, V13, P6, DOI 10.1016/0197-2456(92)90026-V; Gilpin EA, 1997, J NATL CANCER I, V89, P572, DOI 10.1093/jnci/89.8.572; Glanz J, 2002, ALCOHOL CLIN EXP RES, V26, P1047, DOI 10.1097/01.ALC.0000019741.65567.1C; Hajek P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003999.pub4; Hawkins J, 2010, NICOTINE TOB RES, V12, P1228, DOI 10.1093/ntr/ntq175; Heckhausen J, 2010, PSYCHOL REV, V117, P32, DOI 10.1037/a0017668; Hollis JF, 2005, PEDIATRICS, V115, P981, DOI 10.1542/peds.2004-0981; Hughes JR, 2014, NICOTINE TOB RES, V16, P1190, DOI 10.1093/ntr/ntu052; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; HUNT WA, 1971, J CLIN PSYCHOL, V27, P455, DOI 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R; Jamal A., 2014, MMWR-MORBID MORTAL W, V63, P1108; Jensen CD, 2011, J CONSULT CLIN PSYCH, V79, P433, DOI 10.1037/a0023992; Kealey KA, 2007, NICOTINE TOB RES, V9, P257, DOI 10.1080/14622200601080315; Kealey KA, 2009, JNCI-J NATL CANCER I, V101, P1393, DOI 10.1093/jnci/djp318; Kirshenbaum AP, 2009, J SUBST ABUSE TREAT, V36, P8, DOI 10.1016/j.jsat.2008.04.001; Krall Elizabeth A, 2002, Nicotine Tob Res, V4, P95, DOI 10.1080/14622200110098428; Liu JM, 2007, PREV MED, V45, P215, DOI 10.1016/j.ypmed.2007.05.018; Marlatt G.A, 2005, RELAPSE PREVENTION M; Mermelstein Robin, 2002, Nicotine Tob Res, V4, P395, DOI 10.1080/1462220021000018470; Murray DM, 1998, DESIGN AND ANALYSIS; Murray RP, 2002, PREV MED, V35, P314, DOI 10.1006/pmed.2002.1087; Patnode CD, 2013, ANN INTERN MED, V158, P253, DOI 10.7326/0003-4819-158-4-201302190-00580; Pbert L, 2008, PEDIATRICS, V121, pE738, DOI 10.1542/peds.2007-1029; Peterson AV, 2009, JNCI-J NATL CANCER I, V101, P1378, DOI 10.1093/jnci/djp317; Piasecki TM, 2006, CLIN PSYCHOL REV, V26, P196, DOI 10.1016/j.cpr.2005.11.007; Piasecki TM, 2002, ADDICTION, V97, P1093, DOI 10.1046/j.1360-0443.2002.00216.x; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; SEVERSON H, 1989, PREV MED, V18, P267, DOI 10.1016/0091-7435(89)90074-1; SHIFFMAN S, 1986, ADDICT BEHAV, V11, P295, DOI 10.1016/0306-4603(86)90057-2; Simon Patricia, 2015, Curr Addict Rep, V2, P15; Spence S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006457; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stanton A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003289.pub5; THOMPSON TL, 1984, PUBLIC OPIN QUART, V48, P779, DOI 10.1086/268883; Tindle Hilary A, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2011.300186; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; VELICER WF, 1992, PSYCHOL BULL, V111, P23, DOI 10.1037/0033-2909.111.1.23; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; Wetter DW, 2004, PREV MED, V39, P1156, DOI 10.1016/j.ypmed.2004.04.028; Zhu SH, 2002, NEW ENGL J MED, V347, P1087, DOI 10.1056/NEJMsa020660; Zhu SH, 1996, J CONSULT CLIN PSYCH, V64, P202, DOI 10.1037/0022-006X.64.1.202	57	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146459	10.1371/journal.pone.0146459	http://dx.doi.org/10.1371/journal.pone.0146459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26829013	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200009
J	Pich, C; Teiti, I; Sarrabayrouse, G; Gallardo, F; Gence, R; Tilkin-Mariame, AF				Pich, Christine; Teiti, Iotefa; Sarrabayrouse, Guillaume; Gallardo, Franck; Gence, Remi; Tilkin-Mariame, Anne-Francoise			Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity	PLOS ONE			English	Article							METASTATIC MELANOMA; CD70 EXPRESSION; CELLS; BRAF; CANCER; MIGRATION; INHIBITION; INVASION; IMMUNITY; GTPASES	CD70 is a costimulatory molecule member of the Tumor Necrosis Factor family that is expressed on activated immune cells. Its ectopic expression has been described in several types of cancer cells including lymphomas, renal cell carcinomas and glioblastomas. We have recently described its expression in a part of tumor cells from the vast majority of melanoma biopsies and human melanoma cell lines, and found that CD70 expression decreased over time as the disease progressed. Here, we show that RhoA, BRAF and Mitogen Activating Protein Kinase pathways are involved in the positive transcriptional regulation of CD70 expression in melanomas. Interestingly, the clinical inhibitor of the common BRAF V600E/D variants, Vemurafenib (PLX-4032), which is currently used to treat melanoma patients with BRAF V600E/D-mutated metastatic melanomas, decreased CD70 expression in human CD70+ melanoma cell lines. This decrease was seen in melanoma cells both with and without the BRAFV600E/D mutation, although was less efficient in those lacking the mutation. But interestingly, by silencing CD70 in CD70+ melanoma cell lines we show that PLX-4032-induced melanoma cell killing and its inhibitory effect on MAPK pathway activation are unaffected by CD70 expression. Consequently, our work demonstrates that CD70 ectopic expression in melanomas is not a valuable biomarker to predict tumor cells sensitivity to BRAF V600 inhibitors.	[Pich, Christine; Teiti, Iotefa; Sarrabayrouse, Guillaume; Gence, Remi] CRCT, INSERM, UMR 1037, FR-31037 Toulouse, France; [Pich, Christine; Teiti, Iotefa; Sarrabayrouse, Guillaume; Gence, Remi; Tilkin-Mariame, Anne-Francoise] Univ Toulouse 3, FR-31062 Toulouse, France; [Gallardo, Franck] NeoVirTech, Inst Sci Vivant, FR-31106 Toulouse, France; [Tilkin-Mariame, Anne-Francoise] INSERM, IRSD, U1220, FR-31024 Toulouse, France; [Pich, Christine] Univ Lausanne, CIG, CH-1015 Lausanne, Switzerland; [Sarrabayrouse, Guillaume] Univ Hosp Vall Hebron, Digest Syst Res Unit, Passeig Vall Hebron 119-129, E-08035 Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Lausanne; Hospital Universitari Vall d'Hebron	Tilkin-Mariame, AF (corresponding author), Univ Toulouse 3, FR-31062 Toulouse, France.; Tilkin-Mariame, AF (corresponding author), INSERM, IRSD, U1220, FR-31024 Toulouse, France.	anne-francoise.tilkin@inserm.fr	Gence, Rémi/O-8961-2014	Gence, Rémi/0000-0003-0747-3540; Pich-Bavastro, Christine/0000-0002-6526-749X	Institut National de la Sante et de la Recherche Medicale; La Ligue contre le Cancer; Association pour la Recherche contre le Cancer; Ministere de l'Enseignement Superieur et de la Recherche; Institut Claudius Regaud	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ministere de l'Enseignement Superieur et de la Recherche; Institut Claudius Regaud	This work was supported by the Institut National de la Sante et de la Recherche Medicale, La Ligue contre le Cancer, Association pour la Recherche contre le Cancer, Ministere de l'Enseignement Superieur et de la Recherche, and Institut Claudius Regaud. The funder NeoVirTech provided support in the form of salaries for F Gallardo, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ades F, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/259170; Brown M, 2014, BRIT J CANCER, V110, P2099, DOI 10.1038/bjc.2014.99; Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031; Chahlavi A, 2005, CANCER RES, V65, P5428, DOI 10.1158/0008-5472.CAN-04-4395; Chinestra P, 2012, METHODS MOL BIOL, V827, P283, DOI 10.1007/978-1-61779-442-1_19; Cormary C, 2005, CANCER GENE THER, V12, P963, DOI 10.1038/sj.cgt.7700861; Denoeud J, 2011, J LEUKOCYTE BIOL, V89, P195, DOI 10.1189/jlb.0610351; Dua P, 2008, EUR J CANCER, V44, P1587, DOI 10.1016/j.ejca.2008.04.009; Flaherty L, 2014, CANCER J, V20, P18, DOI 10.1097/PPO.0000000000000024; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Garcia P, 2004, J LEUKOCYTE BIOL, V76, P263, DOI 10.1189/jlb.1003508; Grewal IS, 2008, EXPERT OPIN THER TAR, V12, P341, DOI 10.1517/14728222.12.3.341; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Jang S, 2014, CLIN PHARMACOL THER, V95, P24, DOI 10.1038/clpt.2013.197; Janjetovic Z, 2011, BRIT J CANCER, V105, P1874, DOI 10.1038/bjc.2011.458; Jilaveanu LB, 2012, HUM PATHOL, V43, P1394, DOI 10.1016/j.humpath.2011.10.014; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Lu QJ, 2005, J IMMUNOL, V174, P6212, DOI 10.4049/jimmunol.174.10.6212; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Mehnert JM, 2012, CURR ONCOL REP, V14, P449, DOI 10.1007/s11912-012-0249-5; Nolte MA, 2009, IMMUNOL REV, V229, P216, DOI 10.1111/j.1600-065X.2009.00774.x; Pereira AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101963; Pich CS G, 2015, BRIT J CANC IN PRESS; Ridley AJ, 2012, METHODS MOL BIOL, V827, P3, DOI 10.1007/978-1-61779-442-1_1; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Saldanha G, 2006, CLIN CANCER RES, V12, P4499, DOI 10.1158/1078-0432.CCR-05-2447; Sapkota B, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22890; Sarrabayrouse G, 2007, NEOPLASIA, V9, P1078, DOI 10.1593/neo.07727; Sarrabayrouse G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009043; Tilkin-Mariame AF, 2005, FASEB J, V19, P1513, DOI 10.1096/fj.04-3482fje; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039	32	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148095	10.1371/journal.pone.0148095	http://dx.doi.org/10.1371/journal.pone.0148095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828592	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200059
J	Uribe-Convers, S; Settles, ML; Tank, DC				Uribe-Convers, Simon; Settles, Matthew L.; Tank, David C.			A Phylogenomic Approach Based on PCR Target Enrichment and High Throughput Sequencing: Resolving the Diversity within the South American Species of Bartsia L. (Orobanchaceae)	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; PARTITIONING SCHEMES; MICROBIAL COMMUNITY; GENE-EXPRESSION; PLASTID GENOME; EVOLUTIONARY; CHLOROPLAST; DNA; UTILITY; PLANTS	Advances in high-throughput sequencing (HTS) have allowed researchers to obtain large amounts of biological sequence information at speeds and costs unimaginable only a decade ago. Phylogenetics, and the study of evolution in general, is quickly migrating towards using HTS to generate larger and more complex molecular datasets. In this paper, we present a method that utilizes microfluidic PCR and HTS to generate large amounts of sequence data suitable for phylogenetic analyses. The approach uses the Fluidigm Access Array System (Fluidigm, San Francisco, CA, USA) and two sets of PCR primers to simultaneously amplify 48 target regions across 48 samples, incorporating sample-specific barcodes and HTS adapters (2,304 unique amplicons per Access Array). The final product is a pooled set of amplicons ready to be sequenced, and thus, there is no need to construct separate, costly genomic libraries for each sample. Further, we present a bioinformatics pipeline to process the raw HTS reads to either generate consensus sequences (with or without ambiguities) for every locus in every sample or-more importantly-recover the separate alleles from heterozygous target regions in each sample. This is important because it adds allelic information that is well suited for coalescent-based phylogenetic analyses that are becoming very common in conservation and evolutionary biology. To test our approach and bioinformatics pipeline, we sequenced 576 samples across 96 target regions belonging to the South American clade of the genus Bartsia L. in the plant family Orobanchaceae. After sequencing cleanup and alignment, the experiment resulted in similar to 25,300bp across 486 samples for a set of 48 primer pairs targeting the plastome, and similar to 13,500bp for 363 samples for a set of primers targeting regions in the nuclear genome. Finally, we constructed a combined concatenated matrix from all 96 primer combinations, resulting in a combined aligned length of similar to 40,500bp for 349 samples.	[Uribe-Convers, Simon; Settles, Matthew L.; Tank, David C.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Uribe-Convers, Simon; Settles, Matthew L.; Tank, David C.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Uribe-Convers, Simon; Tank, David C.] Univ Idaho, Stillinger Herbarium, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Uribe-Convers, S (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Uribe-Convers, S (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.; Uribe-Convers, S (corresponding author), Univ Idaho, Stillinger Herbarium, Moscow, ID 83843 USA.	uribe.convers@gmail.com	Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	National Science Foundation [DEB-1210895, DEB-1253463]; University of Idaho; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448, P20RR016454] Funding Source: NIH RePORTER; Direct For Biological Sciences [1253463] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Idaho; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by the National Science Foundation (DEB-1210895, http://www.nsf.gov/awardsearch/showAward?AWD_ID= 1210895&HistoricalAwards=false to DCT for SUC, and DEB-1253463, http://www.nsf.gov/awardsearch/showAward?AWD_ID=1253463, to DCT) and the University of Idaho Student Grant Program to SUC. Fieldwork was supported in part by the University of Idaho Graduate Student Research Awards to SUC, by the Society of Systematic Biologists (SSB) to SUC, the Botanical Society of America (BSA) to SUC, the American Society of Plant Taxonomists (ASPT) to SUC, and the University of Idaho Stillinger Herbarium Expedition Funds to SUC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Bao SY, 2011, J HUM GENET, V56, P687, DOI [10.1038/jhg.2011.91, 10.1038/jhg.2011.62]; Bhat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039181; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Bivand R., 2015, MAPTOOLS TOOLS READI; Bogart J.P., 1980, Basic Life Sciences, V13, P341; Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; Carrothers JM, 2015, J NUTR, V145, P2379, DOI 10.3945/jn.115.211110; Chamala S, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400115; Chase MW, 1993, JSTOR, P528; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Crowl AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094199; Cruaud A, 2014, MOL BIOL EVOL, V31, P1272, DOI 10.1093/molbev/msu063; Curk F, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0152-1; Dai J, 2015, BIORESOURCE TECHNOL, V175, P23, DOI 10.1016/j.biortech.2014.10.049; Deckmyn M, MAPS DRAW GEOGRAPHIC; Dominguez MH, 2013, J IMMUNOL METHODS, V391, P133, DOI 10.1016/j.jim.2013.03.002; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Genome 10K Community of Scientists, 2009, J Hered, V100, P659, DOI 10.1093/jhered/esp086; Godden GT, 2012, PLANT ECOL DIVERS, V5, P427, DOI 10.1080/17550874.2012.745909; Gostel MR, 2015, J SYST EVOL, V53, P411, DOI 10.1111/jse.12173; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Hermann-Bank ML, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-788; Hijmans RJ, RASTER GEOGRAPHIC DA; Ilut DC, 2012, SYST BOT, V37, P7, DOI 10.1600/036364412X616576; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Judd WS, 2007, BRITTONIA, V59, P217, DOI 10.1663/0007-196X(2007)59[217:TDANSF]2.0.CO;2; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knowles LL, 2010, ESTIMATING SPECIES T; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Liang S, 2015, BIORESOURCE TECHNOL, V179, P268, DOI 10.1016/j.biortech.2014.12.032; Linnen CR, 2008, SYST BIOL, V57, P876, DOI 10.1080/10635150802580949; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Lokki J., 1980, Basic Life Sciences, V13, P277; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; Mandel JR, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300085; Marx HE, 2010, AM J BOT, V97, P1647, DOI 10.3732/ajb.1000144; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Molau U., 1990, OPERA BOT, V102, P1; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2011, INT J PLANT SCI, V172, P541, DOI 10.1086/658923; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Rambaut A., 2004, TRACER; Rannala B, 2003, GENETICS, V164, P1645; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Salamone I, 2013, AM J BOT, V100, P939, DOI 10.3732/ajb.1200624; Schmickl R, 2016, MOL ECOL RESOUR, V16, P1124, DOI 10.1111/1755-0998.12487; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; Straub SCK, 2013, GENOME BIOL EVOL, V5, P1872, DOI 10.1093/gbe/evt140; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tennessen JA, 2013, G3-GENES GENOM GENET, V3, P1341, DOI 10.1534/g3.113.006288; Tepe EJ, 2011, AM J BOT, V98, P1356, DOI 10.3732/ajb.1000516; Thiers B., INDEX HERBARIORUM GL; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Uribe-Convers S., 2014, THESIS U IDAHO; Uribe-Convers S, 2015, AM J BOT, V102, P1854, DOI 10.3732/ajb.1500229; Uribe-Convers S, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300063; Walter K, 2012, CLIN CANCER RES, V18, P2360, DOI 10.1158/1078-0432.CCR-11-2635-T; Weitemier K, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400042; WOLFE KH, 1989, J MOL EVOL, V29, P208, DOI 10.1007/BF02100204; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xi ZX, 2012, P NATL ACAD SCI USA, V109, P17519, DOI 10.1073/pnas.1205818109; Yuan YW, 2008, AM J BOT, V95, P1166, DOI 10.3732/ajb.0800133; Yuan YW, 2010, MOL PHYLOGENET EVOL, V54, P23, DOI 10.1016/j.ympev.2009.08.029; Yuan YW, 2009, NEW PHYTOL, V182, P272, DOI 10.1111/j.1469-8137.2008.02739.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP	106	57	57	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148203	10.1371/journal.pone.0148203	http://dx.doi.org/10.1371/journal.pone.0148203			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828929	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200083
J	Bourmoum, M; Charles, R; Claing, A				Bourmoum, Mohamed; Charles, Ricardo; Claing, Audrey			The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; DOWNSTREAM ACTIVATION; TYROSINE KINASE; PROTEIN; GROWTH; RECEPTOR; RAC1; MIGRATION; PATHWAYS; COMPLEX	High reactive oxygen species (ROS) levels and enhanced vascular smooth muscle cells (VSMC) proliferation are observed in numerous cardiovascular diseases. The mechanisms by which hormones such as angiotensin II (Ang II) acts to promote these cellular responses remain poorly understood. We have previously shown that the ADP-ribosylation factor 6 (ARF6), a molecular switch that coordinates intracellular signaling events can be activated by the Ang II receptor (AT(1)R). Whether this small GTP-binding protein controls the signaling events leading to ROS production and therefore Ang II-dependent VSMC proliferation, remains however unknown. Here, we demonstrate that in rat aortic VSMC, Ang II stimulation led to the subsequent activation of ARF6 and Rac1, a key regulator of NADPH oxidase activity. Using RNA interference, we showed that ARF6 is essential for ROS generation since in conditions where this GTPase was knocked down, Ang II could no longer promote superoxide anion production. In addition to regulating Rac1 activity, ARF6 also controlled expression of the NADPH oxidase 1 (Nox 1) as well as the ability of the EGFR to become transactivated. Finally, ARF6 also controlled MAPK (Erk1/2, p38 and Jnk) activation, a key pathway of VSMC proliferation. Altogether, our findings demonstrate that Ang II promotes activation of ARF6 to controls ROS production by regulating Rac1 activation and Nox1 expression. In turn, increased ROS acts to activate the MAPK pathway. These signaling events represent a new molecular mechanism by which Ang II can promote proliferation of VSMC.	[Bourmoum, Mohamed; Charles, Ricardo; Claing, Audrey] Univ Montreal, Dept Pharmacol, Fac Med, Montreal, PQ H3T 1J4, Canada	Universite de Montreal	Claing, A (corresponding author), Univ Montreal, Dept Pharmacol, Fac Med, Montreal, PQ H3T 1J4, Canada.	audrey.claing@umontreal.ca			Canadian Institutes of Health Research [MOP-79470]; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Canadian Institutes of Health Research [grant number: MOP-79470]; and the Heart and Stroke Foundation of Canada to AC. AC is a scholar of the Fonds de Recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Brewer AC, 2006, FREE RADICAL BIO MED, V40, P260, DOI 10.1016/j.freeradbiomed.2005.08.022; Cai Hua, 2007, V139, P293; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Frank GD, 2000, ENDOCRINOLOGY, V141, P3120, DOI 10.1210/en.141.9.3120; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Huckle William R., 1994, Progress in Growth Factor Research, V5, P177, DOI 10.1016/0955-2235(94)90004-3; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Knizhnik AV, 2012, J CELL BIOCHEM, V113, P360, DOI 10.1002/jcb.23362; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Kyaw M, 2001, HYPERTENS RES, V24, P251, DOI 10.1291/hypres.24.251; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Li M, 2009, CANCER-AM CANCER SOC, V115, P4959, DOI 10.1002/cncr.24550; Mifune M, 2005, J BIOL CHEM, V280, P26592, DOI 10.1074/jbc.M502906200; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Pinzar E, 2005, FEBS LETT, V579, P5100, DOI 10.1016/j.febslet.2005.08.019; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Touyz RM, 2003, CAN J PHYSIOL PHARM, V81, P159, DOI 10.1139/Y02-164; Touyz RM, 2000, PHARMACOL REV, V52, P639; Ushio-Fukai M, 1999, MOL PHARMACOL, V55, P142, DOI 10.1124/mol.55.1.142; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P19772, DOI 10.1074/jbc.273.31.19772; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Viedt C, 2000, ARTERIOSCL THROM VAS, V20, P940, DOI 10.1161/01.ATV.20.4.940; Wang ZB, 2004, J MOL CELL CARDIOL, V36, P49, DOI 10.1016/j.yjmcc.2003.09.014; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	42	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148097	10.1371/journal.pone.0148097	http://dx.doi.org/10.1371/journal.pone.0148097			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824355	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600099
J	Coudray-Meunier, C; Fraisse, A; Martin-Latil, S; Delannoy, S; Fach, P; Perelle, S				Coudray-Meunier, Coralie; Fraisse, Audrey; Martin-Latil, Sandra; Delannoy, Sabine; Fach, Patrick; Perelle, Sylvie			A Novel High-Throughput Method for Molecular Detection of Human Pathogenic Viruses Using a Nanofluidic Real-Time PCR System	PLOS ONE			English	Article							HEPATITIS-A-VIRUS; REVERSE-TRANSCRIPTION-PCR; TICK-BORNE ENCEPHALITIS; DROPLET DIGITAL PCR; DUPLEX RT-QPCR; MURINE NOROVIRUS; STOOL SPECIMENS; WATER SAMPLES; QUANTIFICATION; ASSAY	Human enteric viruses are recognized as the main causes of food-and waterborne diseases worldwide. Sensitive and quantitative detection of human enteric viruses is typically achieved through quantitative RT-PCR (RT-qPCR). A nanofluidic real-time PCR system was used to develop novel high-throughput methods for qualitative molecular detection (RT-qPCR array) and quantification of human pathogenic viruses by digital RT-PCR (RT-dPCR). The performance of high-throughput PCR methods was investigated for detecting 19 human pathogenic viruses and two main process controls used in food virology. The conventional real-time PCR system was compared to the RT-dPCR and RT-qPCR array. Based on the number of genome copies calculated by spectrophotometry, sensitivity was found to be slightly better with RT-qPCR than with RT-dPCR for 14 viruses by a factor range of from 0.3 to 1.6 log(10). Conversely, sensitivity was better with RT-dPCR than with RT-qPCR for seven viruses by a factor range of from 0.10 to 1.40 log(10). Interestingly, the number of genome copies determined by RT-dPCR was always from 1 to 2 log(10) lower than the expected copy number calculated by RT-qPCR standard curve. The sensitivity of the RT-qPCR and RT-qPCR array assays was found to be similar for two viruses, and better with RT-qPCR than with RT-qPCR array for eighteen viruses by a factor range of from 0.7 to 3.0 log(10). Conversely, sensitivity was only 0.30 log(10) better with the RT-qPCR array than with conventional RT-qPCR assays for norovirus GIV detection. Finally, the RT-qPCR array and RT-dPCR assays were successfully used together to screen clinical samples and quantify pathogenic viruses. Additionally, this method made it possible to identify co-infection in clinical samples. In conclusion, given the rapidity and potential for large numbers of viral targets, this nanofluidic RT-qPCR assay should have a major impact on human pathogenic virus surveillance and outbreak investigations and is likely to be of benefit to public health.	[Coudray-Meunier, Coralie; Fraisse, Audrey; Martin-Latil, Sandra; Perelle, Sylvie] Univ Paris Est, ANSES, Food Safety Lab, Enter Viruses Unit, 14 Rue Pierre & Marie Curie, F-94701 Maisons Alfort, France; [Delannoy, Sabine; Fach, Patrick] Univ Paris Est, ANSES, Food Safety Lab, 14 Rue Pierre & Marie Curie, F-94701 Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Perelle, S (corresponding author), Univ Paris Est, ANSES, Food Safety Lab, Enter Viruses Unit, 14 Rue Pierre & Marie Curie, F-94701 Maisons Alfort, France.	sylvie.perelle@anses.fr	Delannoy, Sabine/J-1045-2019; Martin-Latil, Sandra/GRN-8326-2022	Delannoy, Sabine/0000-0002-9208-5659; Fraisse, Audrey/0000-0001-9567-6270	ANSES	ANSES	Coralie Coudray-Meunier was a PhD student who received financial support from ANSES (Agence Nationale de Securite, Sanitaire de l'alimentation, de l'environnement et du travail).; We thank AM Roque (NRC for hepatitis A virus, France) and P Pothier (NRC for Enteric Viruses, France) for providing contaminated stools. This work is part of the thesis by Coralie Coudray-Meunier, a PhD student who received financial support from ANSES.	[Anonymous], 2013, 152161 ISOTS; [Anonymous], 2013, 152162 ISOTS; Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Chan MCW, 2006, J VIROL METHODS, V134, P146, DOI 10.1016/j.jviromet.2005.12.013; Costafreda MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05; Coudray-Meunier C, 2015, INT J FOOD MICROBIOL, V201, P17, DOI 10.1016/j.ijfoodmicro.2015.02.006; Coudray-Meunier C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-216; CROMEANS T, 1987, J MED VIROL, V22, P45, DOI 10.1002/jmv.1890220107; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Drexler JF, 2011, EMERG INFECT DIS, V17, P1544, DOI 10.3201/eid1708.101556; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Dubois E, 2006, INT J FOOD MICROBIOL, V108, P164, DOI 10.1016/j.ijfoodmicro.2005.11.007; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gibson KE, 2014, CURR OPIN VIROL, V4, P50, DOI 10.1016/j.coviro.2013.12.005; Griffin DW, 2003, CLIN MICROBIOL REV, V16, P129, DOI 10.1128/CMR.16.1.129-143.2003; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Ishii S, 2014, APPL ENVIRON MICROB, V80, P7505, DOI 10.1128/AEM.02578-14; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kaida A, 2012, JPN J INFECT DIS, V65, P430, DOI 10.7883/yoken.65.430; Kocwa-Haluch R, 2001, POL J ENVIRON STUD, V10, P485; Koo HL, 2010, DISCOV MED, V10, P61; Koopmans M, 2004, INT J FOOD MICROBIOL, V90, P23, DOI 10.1016/S0168-1605(03)00169-7; Kotwal G, 2014, CURR OPIN VIROL, V4, P37, DOI 10.1016/j.coviro.2013.12.003; Lees D, 2010, FOOD ENVIRON VIROL, V2, P146, DOI 10.1007/s12560-010-9042-5; LEMON SM, 1991, J VIROL, V65, P2056, DOI 10.1128/JVI.65.4.2056-2065.1991; Lindquist L, 2014, HAND CLINIC, V123, P531, DOI 10.1016/B978-0-444-53488-0.00025-0; Loisy F, 2005, J VIROL METHODS, V123, P1, DOI 10.1016/j.jviromet.2004.08.023; Malik YS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780752; Martin-Latil S, 2012, INT J FOOD MICROBIOL, V157, P167, DOI 10.1016/j.ijfoodmicro.2012.05.001; Martin-Latil S, 2012, FOOD MICROBIOL, V31, P246, DOI 10.1016/j.fm.2012.03.007; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; Mohamed N, 2004, J CLIN VIROL, V30, P150, DOI 10.1016/j.jcv.2003.08.016; Monpoeho S, 2000, BIOTECHNIQUES, V29, P88, DOI 10.2144/00291st03; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Nainan OV, 2006, CLIN MICROBIOL REV, V19, P63, DOI 10.1128/CMR.19.1.63-79.2006; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Pang XL, 2011, J VIROL METHODS, V172, P85, DOI 10.1016/j.jviromet.2010.12.013; Pang XLL, 2004, J MED VIROL, V72, P496, DOI 10.1002/jmv.20009; Pinto RM, 2009, APPL ENVIRON MICROB, V75, P7350, DOI 10.1128/AEM.01177-09; Racki N, 2014, ANAL BIOANAL CHEM, V406, P661, DOI 10.1007/s00216-013-7476-y; Sanchez G, 2007, LETT APPL MICROBIOL, V45, P1, DOI 10.1111/j.1472-765X.2007.02140.x; Sanders R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075296; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415; Svraka S, 2007, J CLIN MICROBIOL, V45, P1389, DOI 10.1128/JCM.02305-06; Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006; Van der Poel WHM, 2014, CURR OPIN VIROL, V4, P91, DOI 10.1016/j.coviro.2014.01.006; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Vaughan G, 2014, INFECT GENET EVOL, V21, P227, DOI 10.1016/j.meegid.2013.10.023; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Xu ZQ, 2011, J CLIN MICROBIOL, V49, P1537, DOI 10.1128/JCM.00196-10; Zlateva KT, 2011, J VIROL METHODS, V177, P174, DOI 10.1016/j.jviromet.2011.08.005	55	20	23	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147832	10.1371/journal.pone.0147832	http://dx.doi.org/10.1371/journal.pone.0147832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824897	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600065
J	Jiang, C; Liu, ZL; Wang, Y; Bian, YY; Feng, B; Weng, XS				Jiang, Chao; Liu, Zhenlei; Wang, Ying; Bian, Yanyan; Feng, Bin; Weng, Xisheng			Posterior Cruciate Ligament Retention versus Posterior Stabilization for Total Knee Arthroplasty: A Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; PROSTHESES; REPLACEMENT; SACRIFICE; FLEXION; BALANCE; MOTION; RANGE	Introduction Although being debated for many years, the superiority of posterior cruciate-retaining (CR) total knee arthroplasty (TKA) and posterior-stabilized (PS) TKA remains controversial. We compare the knee scores, post-operative knee range of motion (ROM), radiological outcomes about knee kinematic and complications between CR TKA and PS TKA. Methods Literature published up to August 2015 was searched in PubMed, Embase and Cochrane databases, and meta-analysis was performed using the software, Review Manager version 5.3. Results Totally 14 random control trials (RCTs) on this topic were included for the analysis, which showed that PS and CR TKA had no significant difference in Knee Society knee Score (KSS), pain score (KSPS), Hospital for Special Surgery score (HSS), kinematic characteristics including postoperative component alignment, tibial posterior slope and joint line, and complication rate. However, PS TKA is superior to CR TKA regarding post-operative knee range of motion (ROM) [Random Effect model (RE), Mean Difference (MD) = -7.07, 95% Confidential Interval (CI) -10.50 to -3.65, p<0.0001], improvement of ROM (Fixed Effect model (FE), MD = -5.66, 95% CI -10.79 to -0.53, p = 0.03) and femoral-tibial angle [FE, MD = 0.85, 95% CI 0.46 to 1.25, p<0.0001]. Conclusions There are no clinically relevant differences between CR and PS TKA in terms of clinical, functional, radiological outcome, and complications, while PS TKA is superior to CR TKA in	[Jiang, Chao; Liu, Zhenlei; Bian, Yanyan; Feng, Bin; Weng, Xisheng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthoped Surg, Beijing 100730, Peoples R China; [Jiang, Chao; Liu, Zhenlei; Wang, Ying; Bian, Yanyan; Feng, Bin; Weng, Xisheng] Peking Union Med Coll, Beijing 100730, Peoples R China; [Wang, Ying] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ultrasound, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Weng, XS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthoped Surg, Beijing 100730, Peoples R China.; Weng, XS (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.	xshweng@medmail.com.cn		Weng, Xisheng/0000-0002-6021-1462	Beijing Municipal Natural Science Foundation [D121100004212001]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	The research was supported in by grants from the Beijing Municipal Natural Science Foundation (D121100004212001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bercik MJ, 2013, J ARTHROPLASTY, V28, P439, DOI 10.1016/j.arth.2012.08.008; Catani F, 2004, J ARTHROPLASTY, V19, P775, DOI 10.1016/j.arth.2004.01.013; Chaudhary R, 2008, J BONE JOINT SURG AM, V90A, P2579, DOI 10.2106/JBJS.G.00995; Clark CR, 2001, CLIN ORTHOP RELAT R, P208; Conditt MA, 2004, J ARTHROPLASTY, V19, P107, DOI 10.1016/j.arth.2004.06.006; Harato K, 2008, KNEE, V15, P217, DOI 10.1016/j.knee.2007.12.007; Kim YH, 2009, J BONE JOINT SURG AM, V91A, P753, DOI 10.2106/JBJS.H.00805; Li N, 2014, KNEE SURG SPORT TR A, V22, P556, DOI 10.1007/s00167-012-2275-0; Luo SX, 2012, KNEE, V19, P246, DOI 10.1016/j.knee.2011.12.005; Maruyama S, 2004, J ARTHROPLASTY, V19, P349, DOI 10.1016/j.arth.2003.09.010; Matsumoto T, 2012, J ARTHROPLASTY, V27, P1723, DOI 10.1016/j.arth.2012.02.020; Misra AN, J BONE JOINT SURG BR, V85, P389; Nelissen RGHH, 2001, J CLIN PATHOL, V54, P381, DOI 10.1136/jcp.54.5.381; Seon JK, 2011, KNEE SURG SPORT TR A, V19, P2016, DOI 10.1007/s00167-011-1434-z; SHOJI H, 1994, CLIN ORTHOP RELAT R, P218; Straw R, 2003, J BONE JOINT SURG BR, V85B, P671, DOI 10.1302/0301-620X.85B5.13812; Swanik CB, 2004, J BONE JOINT SURG AM, V86A, P328, DOI 10.2106/00004623-200402000-00016; Tanzer M, 2002, J ARTHROPLASTY, V17, P813, DOI 10.1054/arth.2002.34814; Thomsen MG, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-127; van den Boom LGH, 2014, KNEE SURG SPORT TR A, V22, P3135, DOI 10.1007/s00167-014-3215-y; Vermesan Dinu, 2015, J Clin Med Res, V7, P171, DOI 10.14740/jocmr2048w; Verra WC, 2015, ACTA ORTHOP, V86, P195, DOI 10.3109/17453674.2014.973329; Victor J, 2005, J BONE JOINT SURG BR, V87B, P646, DOI 10.1302/0301-620X.87B5.15602; Wang Ching-Jen, 2004, Chang Gung Med J, V27, P578; Yagishita K, 2012, J ARTHROPLASTY, V27, P368, DOI 10.1016/j.arth.2011.05.008	25	41	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147865	10.1371/journal.pone.0147865	http://dx.doi.org/10.1371/journal.pone.0147865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824368	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600067
J	Schmidt, CE; Shringi, S; Besser, TE				Schmidt, Carrie E.; Shringi, Smriti; Besser, Thomas E.			Protozoan Predation of Escherichia coli O157:H7 Is Unaffected by the Carriage of Shiga Toxin-Encoding Bacteriophages	PLOS ONE			English	Article							HEMOLYTIC UREMIC SYNDROME; O157-H7; INFECTION; O157/H7; CATTLE; CALVES; VIRULENCE; DEFENSE	Escherichia coli O157:H7 is a food-borne bacterium that causes hemorrhagic diarrhea and hemolytic uremic syndrome in humans. While cattle are a known source of E. coli O157:H7 exposure resulting in human infection, environmental reservoirs may also be important sources of infection for both cattle and humans. Bacteriophage-encoded Shiga toxins (Stx) carried by E. coli O157:H7 may provide a selective advantage for survival of these bacteria in the environment, possibly through their toxic effects on grazing protozoa. To determine Stx effects on protozoan grazing, we co-cultured Paramecium caudatum, a common ciliate protozoon in cattle water sources, with multiple strains of Shiga-toxigenic E. coli O157:H7 and non-Shiga toxigenic cattle commensal E. coli. Over three days at ambient laboratory temperature, P. caudatum consistently reduced both E. coli O157:H7 and non-Shiga toxigenic E. coli populations by 1-3 log cfu. Furthermore, a wild-type strain of Shiga-toxigenic E. coli O157:H7 (EDL933) and isogenic mutants lacking the A subunit of Stx 2a, the entire Stx 2a-encoding bacteriophage, and/or the entire Stx 1-encoding bacteriophage were grazed with similar efficacy by both P. caudatum and Tetrahymena pyriformis (another ciliate protozoon). Therefore, our data provided no evidence of a protective effect of either Stx or the products of other bacteriophage genes on protozoan predation of E. coli. Further research is necessary to determine if the grazing activity of naturally-occurring protozoa in cattle water troughs can serve to decrease cattle exposure to E. coli O157:H7 and other Shiga-toxigenic E. coli.	[Schmidt, Carrie E.; Shringi, Smriti; Besser, Thomas E.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University	Schmidt, CE (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	cellis@vetmed.wsu.edu	Shringi, Smriti/AAC-9789-2020	Shringi, Smriti/0000-0001-9212-9175	USDA National Institute of Food and Agriculture [2010-04487]; ARCS Foundation; NIH Training Grant [T32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); ARCS Foundation; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Agriculture and Food Research Initiative competitive grant no. 2010-04487, from the USDA National Institute of Food and Agriculture, an NIH T32 Training Grant, and the ARCS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 1996, EPIDEMOL REV, V18, P24; Arnold JW, 2014, ENVIRON MICROBIOL, V16, P454, DOI 10.1111/1462-2920.12232; Besser TE, 2001, EPIDEMIOL INFECT, V127, P555, DOI 10.1017/S095026880100615X; Brown CA, 1997, APPL ENVIRON MICROB, V63, P27, DOI 10.1128/AEM.63.1.27-32.1997; CRAY WC, 1995, APPL ENVIRON MICROB, V61, P1586, DOI 10.1128/AEM.61.4.1586-1590.1995; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eberhart LJ, 2012, APPL ENVIRON MICROB, V78, P6592, DOI 10.1128/AEM.01067-12; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Ho NK, 2012, INFECT IMMUN, V80, P2307, DOI 10.1128/IAI.00255-12; Irino K, 2002, EMERG INFECT DIS, V8, P446, DOI 10.3201/eid0804.010490; Karnati SKR, 2003, J ANIM SCI, V81, P812; KELLY J, 1990, AM J SURG PATHOL, V14, P87, DOI 10.1097/00000478-199001000-00010; Lainhart W, 2009, J BACTERIOL, V191, P5116, DOI 10.1128/JB.00508-09; LeJeune JT, 2001, J DAIRY SCI, V84, P1856, DOI 10.3168/jds.S0022-0302(01)74626-7; Mechie SC, 1997, EPIDEMIOL INFECT, V118, P17, DOI 10.1017/S0950268896007194; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Pruimboom-Brees IM, 2000, P NATL ACAD SCI USA, V97, P10325, DOI 10.1073/pnas.190329997; Ravva SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054782; Ravva SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015671; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Sawant AA, 2011, APPL ENVIRON MICROB, V77, P2345, DOI 10.1128/AEM.03150-09; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Shringi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051572; Shringi S, 2012, INFECT IMMUN, V80, P369, DOI 10.1128/IAI.05470-11; Stolfa G, 2013, MBIO, V4, DOI 10.1128/mBio.00416-12; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	28	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147270	10.1371/journal.pone.0147270	http://dx.doi.org/10.1371/journal.pone.0147270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824472	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600020
J	Tatewaki, N; Konishi, T; Nakajima, Y; Nishida, M; Saito, M; Eitsuka, T; Sakamaki, T; Ikekawa, N; Nishida, H				Tatewaki, Naoto; Konishi, Tetsuya; Nakajima, Yuki; Nishida, Miyako; Saito, Masafumi; Eitsuka, Takahiro; Sakamaki, Toshiyuki; Ikekawa, Nobuo; Nishida, Hiroshi			Squalene Inhibits ATM-Dependent Signaling in gamma IR-Induced DNA Damage Response through Induction of Wip1 Phosphatase	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; KINASE-ACTIVITY; SCHISANDRIN B; ACTIVATES ATM; HUMAN CANCER; CHK2 KINASE; G(2) DELAY; CHECKPOINT; P53	Ataxia telangiectasia mutated (ATM) kinase plays a crucial role as a master controller in the cellular DNA damage response. Inhibition of ATM leads to inhibition of the checkpoint signaling pathway. Hence, addition of checkpoint inhibitors to anticancer therapies may be an effective targeting strategy. A recent study reported that Wip1, a protein phosphatase, dephosphorylates serine 1981 of ATM during the DNA damage response. Squalene has been proposed to complement anticancer therapies such as chemotherapy and radiotherapy; however, there is little mechanistic information supporting this idea. Here, we report the inhibitory effect of squalene on ATM-dependent DNA damage signals. Squalene itself did not affect cell viability and the cell cycle of A549 cells, but it enhanced the cytotoxicity of gamma-irradiation (gamma IR). The in vitro kinase activity of ATM was not altered by squalene. However, squalene increased Wip1 expression in cells and suppressed ATM activation in gamma IR-treated cells. Consistent with the potential inhibition of ATM by squalene, IR-induced phosphorylation of ATM effectors such as p53 (Ser15) and Chk1 (Ser317) was inhibited by cell treatment with squalene. Thus, squalene inhibits the ATM-dependent signaling pathway following DNA damage through intracellular induction of Wip1 expression.	[Tatewaki, Naoto; Konishi, Tetsuya; Nakajima, Yuki; Nishida, Miyako; Saito, Masafumi; Eitsuka, Takahiro; Nishida, Hiroshi] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan; [Sakamaki, Toshiyuki] Niigata Univ Pharm & Appl Life Sci, Dept Pharmaceut Sci, Niigata, Japan; [Ikekawa, Nobuo] Niigata Bio Res Ctr, Niigata, Japan	Niigata University; Niigata University	Nishida, H (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	wm7h-nsd@asahi-net.or.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24580203]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [S1001030]; JSPS KAKENHI [25293029]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant No. 24580203) to HN, Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (Grant No. S1001030) to HN and TK, and JSPS KAKENHI (Grant No. 25293029) to HN and Masaji Ishiguro, Niigata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Batey MA, 2013, MOL CANCER THER, V12, P959, DOI 10.1158/1535-7163.MCT-12-0707; Bracey TS, 1997, CLIN CANCER RES, V3, P1371; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Caporali S, MOL PHARM, V66, P478; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Collis SJ, 2003, CANCER RES, V63, P1550; Desai KN, 1996, CANCER LETT, V101, P93, DOI 10.1016/0304-3835(96)04122-5; Dunkern TR, 2002, MOL BIOL CELL, V13, P348, DOI 10.1091/mbc.01-05-0225; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; EIDINOFF ML, 1958, J CLIN INVEST, V37, P655, DOI 10.1172/JCI103650; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kawabe T, 2004, MOL CANCER THER, V3, P513; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; LIU GCK, 1976, J LIPID RES, V17, P38; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Luo Y, 2001, ANTICANCER RES, V21, P23; MURAKOSHI M, 1992, INT J CANCER, V52, P950, DOI 10.1002/ijc.2910520620; NAKAGAWA M, 1985, JPN J CANCER RES, V76, P315; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; On KF, 2011, MOL CANCER THER, V10, P784, DOI 10.1158/1535-7163.MCT-10-0809; POWELL SN, 1995, CANCER RES, V55, P1643; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; Shigeta T, 1999, CANCER RES, V59, P2602; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Sturgeon CM, 2007, CELL CYCLE, V6, P572, DOI 10.4161/cc.6.5.3926; Tatewaki N, 2013, J PHARMACOL SCI, V122, P138, DOI 10.1254/jphs.13048FP; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Yamamoto K, 2012, J CELL BIOL, V198, P305, DOI 10.1083/jcb.201204098; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140; Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	51	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147570	10.1371/journal.pone.0147570	http://dx.doi.org/10.1371/journal.pone.0147570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824362	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600035
J	Burguera, A; Oliver, G				Burguera, Antoni; Oliver, Gabriel			High-Resolution Underwater Mapping Using Side-Scan Sonar	PLOS ONE			English	Article							HABITAT	The goal of this study is to generate high-resolution sea floor maps using a Side-Scan Sonar(SSS). This is achieved by explicitly taking into account the SSS operation as follows. First, the raw sensor data is corrected by means of a physics-based SSS model. Second, the data is projected to the sea-floor. The errors involved in this projection are thoroughfully analysed. Third, a probabilistic SSS model is defined and used to estimate the probability of each sea-floor region to be observed. This probabilistic information is then used to weight the contribution of each SSS measurement to the map. Because of these models, arbitrary map resolutions can be achieved, even beyond the sensor resolution. Finally, a geometric map building method is presented and combined with the probabilistic approach. The resulting map is composed of two layers. The echo intensity layer holds the most likely echo intensities at each point in the sea-floor. The probabilistic layer contains information about how confident can the user or the higher control layers be about the echo intensity layer data. Experimental results have been conducted in a large subsea region.	[Burguera, Antoni; Oliver, Gabriel] Univ Illes Balears, Dept Matemat & Informat, Palma de Mallorca, Spain	Universitat de les Illes Balears	Burguera, A (corresponding author), Univ Illes Balears, Dept Matemat & Informat, Palma de Mallorca, Spain.	antoni.burguera@uib.es	Burguera, Antoni/K-5123-2014; Oliver-Codina, Gabriel/J-7749-2013	Burguera, Antoni/0000-0003-2784-2307; Oliver-Codina, Gabriel/0000-0001-6910-1940	Spanish Ministry of Economy and Competitiveness [TIN2014-58662-R, DPI2014-57746-C3-2-R]; FEDER	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission)	This work is partially supported by the Spanish Ministry of Economy and Competitiveness under contracts TIN2014-58662-R and DPI2014-57746-C3-2-R and FEDER Funding.	Blondel P., 2010, HDB SIDESCAN SONAR; Brown CJ, 2008, ESTUAR COAST SHELF S, V78, P203, DOI 10.1016/j.ecss.2007.11.026; Burguera A, 2014, P 2014 IEEE EM TECHN, P1; Burguera A, 2007, IFAC S INT AUT VEH I, V6, P49; Burguera A, 2009, AUTON ROBOT, V26, P203, DOI 10.1007/s10514-009-9108-0; CERVENKA P, 1994, MAR GEOPHYS RES, V16, P365, DOI 10.1007/BF01203973; Chang YC, 2010, J MAR SCI TECH-TAIW, V18, P785; Chen E, 2011, OCEANS 2011; Coiras E, 2007, IEEE T IMAGE PROCESS, V16, P382, DOI 10.1109/TIP.2006.888337; Elfes A., 1990, P 6 C UNC AI, P60; Fallgren M., 2011, P IEEE INT C COMM WO, P1; Hurtos N, 2014, IEEE INT CONF ROBOT, P601, DOI 10.1109/ICRA.2014.6906916; Johnson AE, 1996, UNDERWATER ROBOTS, P71; Kaeser AJ, 2013, RIVER RES APPL, V29, P634, DOI 10.1002/rra.2556; Kuc R., 2008, SPRINGER HDB ROBOTIC, P491, DOI [10.1007/978-3-540-30301-5, DOI 10.1007/978-3-540-30301-5, 10.1007/978- 3-540-30301-5_22]; LANGER D, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P2478, DOI 10.1109/ROBOT.1991.131997; Lee K, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P2908, DOI 10.1109/IROS.2008.4650882; Moreno D, 2014, P JORN AUT 2014, P1; Ojeda GY, 2004, ESTUAR COAST SHELF S, V59, P399, DOI 10.1016/j.ecss.2003.09.012; Oliver G, 2015, SIDE SCAN SONAR DATA, DOI [http://dx.doi.org/10.6084/m9.figshare.1597660, DOI 10.6084/M9.FIGSHARE.1597660]; Reed S, 2003, IEEE J OCEANIC ENG, V28, P90, DOI 10.1109/JOE.2002.808199; Singh H, 2007, SPRINGER TRAC ADV RO, V28, P430; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Thrun S, 2003, AUTON ROBOT, V15, P111, DOI 10.1023/A:1025584807625	24	31	32	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146396	10.1371/journal.pone.0146396	http://dx.doi.org/10.1371/journal.pone.0146396			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821379	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400005
J	Kim, SK; Castro, A; Kim, ES; Dinkel, AP; Liu, XY; Castro, M				Kim, Sung-Kun; Castro, Aaron; Kim, Edward S.; Dinkel, Austin P.; Liu, Xiaoyun; Castro, Miguel			Inhibitory Effect of Bridged Nucleosides on Thermus aquaticus DNA Polymerase and Insight into the Binding Interactions	PLOS ONE			English	Article							PARTICLE MESH EWALD; NUCLEIC-ACID; CRYSTAL-STRUCTURE; 2',4'-BNA(NC); MECHANISMS; NUCLEOTIDE; GROMACS	Modified nucleosides have the potential to inhibit DNA polymerases for the treatment of viral infections and cancer. With the hope of developing potent drug candidates by the modification of the 2', 4'-position of the ribose with the inclusion of a bridge, efforts were focused on the inhibition of Taq DNA polymerase using quantitative real time PCR, and the results revealed the significant inhibitory effects of 2', 4'-bridged thymidine nucleoside on the polymerase. Study on the mode of inhibition revealed the competitive mechanism with which the 2', 4'-bridged thymidine operates. With a K-i value of 9.7 +/- 1.1 mu M, the 2', 4'-bridged thymidine proved to be a very promising inhibitor. Additionally, docking analysis showed that all the nucleosides including 2', 4'-bridged thymidine were able to dock in the active site, indicating that the substrate analogs reflect a structural complementarity to the enzyme active site. The analysis also provided evidence that Asp610 was a key binding site for 2', 4'-bridged thymidine. Molecular dynamics (MD) simulations were performed to further understand the conformational variations of the binding. The root-mean-square deviation (RMSD) values for the peptide backbone of the enzyme and the nitrogenous base of the inhibitor stabilized within 0.8 and 0.2 ns, respectively. Furthermore, the MD analysis indicates substantial conformational change in the ligand (inhibitor) as the nitrogenous base rotated anticlockwise with respect to the sugar moiety, complemented by the formation of several new hydrogen bonds where Arg587 served as a pivot axis for binding formation. In conclusion, the active site inhibition of Taq DNA polymerase by 2', 4'-bridged thymidine suggests the potential of bridged nucleosides as drug candidates.	[Kim, Sung-Kun; Dinkel, Austin P.] Northeastern State Univ, Dept Nat Sci, Tahlequah, OK USA; [Castro, Aaron; Kim, Edward S.; Liu, Xiaoyun; Castro, Miguel] Biosynth Inc, Lewisville, TX USA		Kim, SK (corresponding author), Northeastern State Univ, Dept Nat Sci, Tahlequah, OK USA.	kim03@nsuok.edu	Kim, Sung-Kun/I-4193-2019	Kim, Sung-Kun/0000-0002-2325-245X	Bio-Synthesis Inc. [14-9089]	Bio-Synthesis Inc.	This work was supported by a grant from Bio-Synthesis Inc. (14-9089) to SK. AC, ESK, XL and MC are employed by Bio-Synthesis Inc. Bio-Synthesis Inc. provided support in the form of salaries for authors AC, ESK, XL and MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson VR, 2007, DRUGS, V67, P1633, DOI 10.2165/00003495-200767110-00008; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Clercq E, 2011, ANNU REV PHARMACOL, V51, P1, DOI 10.1146/annurev-pharmtox-010510-100228; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FURMAN PA, 1984, J BIOL CHEM, V259, P9575; Hari Y, 2006, BIOORGAN MED CHEM, V14, P1029, DOI 10.1016/j.bmc.2005.09.020; Havelka AM, 2007, MINI-REV MED CHEM, V7, P1035, DOI 10.2174/138955707782110196; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kim S.-K., 2015, J BIOCH MOL BIOL RES, V1, P67, DOI 10.17554/j.issn.2313-7177.2015.01.13; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Lindow M, 2012, J CELL BIOL, V199, P407, DOI 10.1083/jcb.201208082; Lundin KE, 2013, ADV GENET, V82, P47, DOI 10.1016/B978-0-12-407676-1.00002-0; Mitsuoka Y, 2009, NUCLEIC ACIDS RES, V37, P1225, DOI 10.1093/nar/gkn1062; Miyashita K, 2007, CHEM COMMUN, P3765, DOI 10.1039/b707352f; Morris Garrett M., 2008, V443, P365, DOI 10.1007/978-1-59745-177-2_19; Obika Satoshi, 2002, Nucleic Acids Res Suppl, P25; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pungitore CR, 2004, J NAT PROD, V67, P357, DOI 10.1021/np030238b; Rahman SMA, 2008, J AM CHEM SOC, V130, P4886, DOI 10.1021/ja710342q; Scatena R, 2007, AM J PHYSIOL-CELL PH, V293, pC12, DOI 10.1152/ajpcell.00314.2006; Sharma VK, 2014, RSC ADV, V4, P16618, DOI 10.1039/c3ra47841f; Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sutlovic D, 2008, ELECTROPHORESIS, V29, P1467, DOI 10.1002/elps.200700699; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watts JK, 2013, CHEM COMMUN, V49, P5618, DOI 10.1039/c3cc40340h; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p; Yamamoto T, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/707323; YARCHOAN R, 1990, ANN NY ACAD SCI, V616, P328	42	3	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147234	10.1371/journal.pone.0147234	http://dx.doi.org/10.1371/journal.pone.0147234			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820310	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528400018
J	Molina, L; Udaondo, Z; Duque, E; Fernandez, M; Bernal, P; Roca, A; de la Torre, J; Ramos, JL				Molina, Lazaro; Udaondo, Zulema; Duque, Estrella; Fernandez, Matilde; Bernal, Patricia; Roca, Amalia; de la Torre, Jesus; Luis Ramos, Juan			Specific Gene Loci of Clinical Pseudomonas putida Isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; METALLO-BETA-LACTAMASE; SECRETION SYSTEM; CYSTIC-FIBROSIS; ANTIMICROBIAL RESISTANCE; AERUGINOSA; FLUORESCENS; ACQUISITION; ADAPTATION; VIRULENCE	Pseudomonas putida are ubiquitous inhabitants of soils and clinical isolates of this species have been seldom described. Clinical isolates show significant variability in their ability to cause damage to hosts because some of them are able to modulate the host's immune response. In the current study, comparisons between the genomes of different clinical and environmental strains of P. putida were done to identify genetic clusters shared by clinical isolates that are not present in environmental isolates. We show that in clinical strains specific genes are mostly present on transposons, and that this set of genes exhibit high identity with genes found in pathogens and opportunistic pathogens. The set of genes prevalent in P. putida clinical isolates, and absent in environmental isolates, are related with survival under oxidative stress conditions, resistance against biocides, amino acid metabolism and toxin/antitoxin (TA) systems. This set of functions have influence in colonization and survival within human tissues, since they avoid host immune response or enhance stress resistance. An in depth bioinformatic analysis was also carried out to identify genetic clusters that are exclusive to each of the clinical isolates and that correlate with phenotypical differences between them, a secretion system type III-like was found in one of these clinical strains, a determinant of pathogenicity in Gram-negative bacteria.	[Molina, Lazaro; Udaondo, Zulema; Duque, Estrella; Fernandez, Matilde; de la Torre, Jesus; Luis Ramos, Juan] CSIC, Estn Expt Zaidin, Environm Protect Dept, C Prof Albareda 1, Granada, Spain; [Udaondo, Zulema; Duque, Estrella; Luis Ramos, Juan] Abengoa Res, Campus Palmas Altas, Seville, Spain; [Bernal, Patricia] Univ London Imperial Coll Sci Technol & Med, South Kensington Campus, London, England; [Roca, Amalia] Bioiliberis R&D, C Capileira 7, Granada 18210, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Imperial College London	Molina, L (corresponding author), CSIC, Estn Expt Zaidin, Environm Protect Dept, C Prof Albareda 1, Granada, Spain.	lazaro.molina@eez.csic.es	Hernandez, Amalia Roca/AAD-3048-2019; Molina, Lazaro/K-9645-2014; Bernal, Patricia/K-6399-2014; Udaondo, Zulema/ABI-7810-2020; Fernandez, Matilde/F-5980-2013; Roca, Amalia/AAB-9240-2021	Hernandez, Amalia Roca/0000-0003-2332-3112; Molina, Lazaro/0000-0002-8483-9203; Bernal, Patricia/0000-0002-6228-0496; Fernandez, Matilde/0000-0002-7064-670X; Ramos, Juan L./0000-0002-8731-7435; Fernandez, Matilde/0000-0002-5832-5161; De la Torre Zuniga, Jesus/0000-0001-8111-6299; Duque, Estrella/0000-0002-4857-8974; Udaondo, Zulema/0000-0003-3445-6842	ERANET Pathogenomics programme through the ADHERS project [BIO2008-04419-E]; Fondos FEDER from the European Union through Ministry of Economy and Competitivity of Spain [BIO2010-17227]; Bio-Iliberis RD	ERANET Pathogenomics programme through the ADHERS project; Fondos FEDER from the European Union through Ministry of Economy and Competitivity of Spain; Bio-Iliberis RD	Work in the authors' laboratories was supported by ERANET Pathogenomics programme through the ADHERS project (Ref: BIO2008-04419-E) and Fondos FEDER from the European Union through project BIO2010-17227 of the Ministry of Economy and Competitivity of Spain. Bio-Iliberis R&D provided support in the form of salary and material for Amalia Roca, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bhattacharya D., 2015, New Microbes and New Infections, V5, P5, DOI 10.1016/j.nmni.2015.02.002; Bielecki P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024235; Bossis E, 2000, AGRONOMIE, V20, P51, DOI 10.1051/agro:2000112; Butt A, 2014, BIOCHEM J, V459, P333, DOI 10.1042/BJ20140073; Choi EN, 2003, MICROBIOL-SGM, V149, P795, DOI 10.1099/mic.0.26046-0; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; Cornelissen CN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00117; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Daniels C, 2010, J BACTERIOL, V192, P2169, DOI 10.1128/JB.01129-09; Darbari VC, 2015, ANNU REV BIOCHEM, V84, P603, DOI 10.1146/annurev-biochem-062911-102821; Darling AE, 2011, BIOINFORMATICS, V27, P2756, DOI 10.1093/bioinformatics/btr451; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Di Bonito M, 2012, TRANSL MED UNISA, V3, P15; Docquier JD, 2003, ANTIMICROB AGENTS CH, V47, P1522, DOI 10.1128/AAC.47.5.1522-1528.2003; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Dutta C, 2012, CURR GENOMICS, V13, P153, DOI 10.2174/138920212799860698; Elomari M, 1997, INT J SYST BACTERIOL, V47, P846, DOI 10.1099/00207713-47-3-846; Fernandez M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00871; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; FURUTA T, 1992, J BIOL CHEM, V267, P12600; Gilarranz R, 2013, CLIN MICROBIOL INFEC, V19, pE424, DOI 10.1111/1469-0691.12248; Girerd-Genessay I, 2015, J BURN CARE RES; GRAEVENITZ AV, 1971, YALE J BIOL MED, V44, P265; Han XL, 2011, J ANTIMICROB CHEMOTH, V66, P323, DOI 10.1093/jac/dkq427; Harvey RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019650; Hobman JL, 2015, J MED MICROBIOL, V64, P471, DOI 10.1099/jmm.0.023036-0; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Hong SJ, 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.00810-15, DOI 10.1128/GEN0MEA.00810-15]; Hottes AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003617; Iacovelli V, 2014, UROLOGIA J, V81, P222, DOI 10.5301/uro.5000092; Iyer RS, 2013, ADV BIOL CHEM, V3, P564, DOI DOI 10.4236/ABC.2013.36065; JANSE JD, 1982, INT J SYST BACTERIOL, V32, P166, DOI 10.1099/00207713-32-2-166; Juan C, 2010, J ANTIMICROB CHEMOTH, V65, P474, DOI 10.1093/jac/dkp491; Kaihami GH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004442; Kim J, 2014, APPL MICROBIOL BIOT, V98, P6933, DOI 10.1007/s00253-014-5883-4; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; Kossel H, 1894, Z HYG INFEKTIONSKR, V16, P368; Kuhn S, 2015, INT J MED MICROBIOL, V305, P196, DOI 10.1016/j.ijmm.2014.12.016; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Leighton TL, 2015, ENVIRON MICROBIOL, V17, P4148, DOI 10.1111/1462-2920.12849; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Liu YL, 2014, ADV CANCER RES, V122, P69, DOI 10.1016/B978-0-12-420117-0.00002-5; LOISEAUMAROLLEAU ML, 1977, PATHOL BIOL, V25, P637; Loper JE, 1997, APPL ENVIRON MICROB, V63, P99, DOI 10.1128/AEM.63.1.99-105.1997; Mao ZJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00586-13; Marcelletti S, 2014, PHYTOPATHOLOGY, V104, P1274, DOI 10.1094/PHYTO-12-13-0344-R; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Marvig RL, 2015, FUTURE MICROBIOL, V10, P599, DOI [10.2217/FMB.15.3, 10.2217/fmb.15.3]; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Matilla MA, 2011, J BACTERIOL, V193, P1290, DOI 10.1128/JB.01281-10; Matthijs S, 2009, BIOMETALS, V22, P951, DOI 10.1007/s10534-009-9247-y; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; Mazurier S, 2015, APPL ENVIRON MICROB, V81, P2579, DOI 10.1128/AEM.04160-14; Mehrad B, 2015, CHEST, V147, P1413, DOI 10.1378/chest.14-2171; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Micek ST, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0926-5; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; Molina L, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00496-13; Molina L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081604; Munteanu A, 2015, EXTREMOPHILES, V19, P707, DOI 10.1007/s00792-015-0759-9; Nakazawa T, 2002, ENVIRON MICROBIOL, V4, P782, DOI 10.1046/j.1462-2920.2002.00310.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Ohji S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00029-14; Ottosen J, 2014, SURG CLIN N AM, V94, P1305, DOI 10.1016/j.suc.2014.09.001; Oyinloye BE, 2015, PHARMACEUTICALS-BASE, V8, P151, DOI 10.3390/ph8020151; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; Picot L, 2001, MICROBES INFECT, V3, P985, DOI 10.1016/S1286-4579(01)01462-9; Poon IKH, 2011, BLOOD, V117, P2093, DOI 10.1182/blood-2010-09-303842; Qi J, 2004, NUCLEIC ACIDS RES, V32, pW45, DOI 10.1093/nar/gkh362; Qiu X, 2009, GENOME DYNAM, V6, P126, DOI 10.1159/000235767; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Roca A, 2013, ENVIRON MICROBIOL, V15, P780, DOI 10.1111/1462-2920.12037; ROSSON RA, 1982, J BACTERIOL, V151, P1027, DOI 10.1128/JB.151.2.1027-1034.1982; Runyen-Janecky LJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00055; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Sharma PK, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0037-8; Sharma P, 2014, EXPERT REV ANTI-INFE, V12, P343, DOI 10.1586/14787210.2014.887441; Soo VWC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03186; Struelens MJ, 1998, BRIT MED J, V317, P652, DOI 10.1136/bmj.317.7159.652; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Tillett D, 2001, APPL ENVIRON MICROB, V67, P2810, DOI 10.1128/AEM.67.6.2810-2818.2001; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; Tymensen LD, 2015, J APPL MICROBIOL, V119, P263, DOI 10.1111/jam.12814; Udaondo Z, 2013, MICROB BIOTECHNOL, V6, P598, DOI 10.1111/1751-7915.12061; Udaondo Z, 2012, FEBS LETT, V586, P2932, DOI 10.1016/j.febslet.2012.07.031; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; von Tils D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00160; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wargo MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056850; Watson CM, 2014, SURG CLIN N AM, V94, P1233, DOI 10.1016/j.suc.2014.08.003; Witholt, 1992, PSEUDOMONAS MOL BIOL; Woods EJ, 2009, VET MICROBIOL, V138, P325, DOI 10.1016/j.vetmic.2009.03.023; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yadav UCS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/690545; Ye LM, 2013, BIOMETALS, V26, P561, DOI 10.1007/s10534-013-9653-z; Yomoda S, 2003, J CLIN MICROBIOL, V41, P4246, DOI 10.1128/JCM.41.9.4246-4251.2003; Yoshino Y, 2011, J INFECT CHEMOTHER, V17, P278, DOI 10.1007/s10156-010-0114-0; Yu H, 2011, J BACTERIOL, V193, P5541, DOI 10.1128/JB.05663-11	106	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147478	10.1371/journal.pone.0147478	http://dx.doi.org/10.1371/journal.pone.0147478			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820467	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400030
J	Ballesta, S; Reymond, G; Pozzobon, M; Duhamel, JR				Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Matthieu; Duhamel, Jean-Rene			Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)	PLOS ONE			English	Article							3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; OXYTOCIN CONCENTRATIONS; RHESUS-MONKEYS; ECSTASY; RELEASE; AMPHETAMINE; SEROTONIN; (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE; NOREPINEPHRINE; STEREOISOMERS	3,4-methylenedioxy-N-methyl amphetamine (MDMA) is one of the few known molecules to increase human and rodent prosocial behaviors. However, this effect has never been assessed on the social behavior of non-human primates. In our study, we subcutaneously injected three different doses of MDMA (1.0, 1.5 or 2.0mg/kg) to a group of three, socially housed, young male long-tailed macaques. More than 200 hours of behavioral data were recorded, during 68 behavioral sessions, by an automatic color-based video device that tracked the 3D positions of each animal and of a toy. This data was then categorized into 5 exclusive behaviors (resting, locomotion, foraging, social contact and object play). In addition, received and given social grooming was manually scored. Results show several significant dose-dependent behavioral effects. At 1.5mg/kg only, MDMA induces a significant increase in social grooming behavior, thus confirming the prosocial effect of MDMA in macaques. Additionally, at 1.5 and 2.0 mg/kg MDMA injection substantially decreases foraging behavior, which is consistent with the known anorexigenic effect of this compound. Furthermore, at 2.0 mg/kg MDMA injection induces an increase in locomotor behavior, which is also in accordance with its known stimulant property. Interestingly, MDMA injected at 1.0mg/kg increases the rate of object play, which might be interpreted as a decrease of the inhibition to manipulate a unique object in presence of others, or, as an increase of the intrinsic motivation to manipulate this object. Together, our results support the effectiveness of MDMA to study the complex neurobiology of primates' social behaviors.	[Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Matthieu; Duhamel, Jean-Rene] Ctr Natl Rech Sci, Ctr Neurosci Cognit, F-69675 Bron, France; [Ballesta, Sebastien; Reymond, Gilles; Pozzobon, Matthieu; Duhamel, Jean-Rene] Univ Lyon 1, Dept Biol Humaine, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ballesta, S (corresponding author), Ctr Natl Rech Sci, Ctr Neurosci Cognit, F-69675 Bron, France.; Ballesta, S (corresponding author), Univ Lyon 1, Dept Biol Humaine, F-69622 Villeurbanne, France.	sebastien.ballesta@gmail.com	Duhamel, Jean-René/M-4723-2017; Ballesta, Sebastien/AAC-7617-2022	Duhamel, Jean-René/0000-0003-0210-1027; Ballesta, Sebastien/0000-0002-7854-5735	LABEX of University de Lyon within the program "Investissement d'Avenir" [ANR-11-IDEX-0007]; Rhone-Alpes Region; Agence Nationale de la Recherche [BLAN-SVSE4-023-01, BS4-0010-01]	LABEX of University de Lyon within the program "Investissement d'Avenir"(French National Research Agency (ANR)); Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the LABEX (ANR-11-IDEX-0007) of University de Lyon within the program "Investissement d'Avenir" and by grants from the Rhone-Alpes Region and from the Agence Nationale de la Recherche (BLAN-SVSE4-023-01, BS4-0010-01) to JRD.	ALI SF, 1993, NEUROTOXICOL TERATOL, V15, P91, DOI 10.1016/0892-0362(93)90067-X; Azmitia E C, 1986, Adv Neurol, V43, P407; Ballesta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115965; Ballestaa S, 2014, J NEUROSCI METH, V234, P147, DOI 10.1016/j.jneumeth.2014.05.022; Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; BATTAGLIA G, 1988, EUR J PHARMACOL, V149, P159, DOI 10.1016/0014-2999(88)90056-8; Beaudoin-Gobert M, 2015, BRAIN, V138, P2632, DOI 10.1093/brain/awv183; BELLAROSA A, 1980, PHARMACOL BIOCHEM BE, V13, P221, DOI 10.1016/0091-3057(80)90077-5; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Brody S, 2006, BIOL PSYCHOL, V71, P312, DOI 10.1016/j.biopsycho.2005.06.008; CHAMOVE AS, 1983, MOTIV EMOTION, V7, P213, DOI 10.1007/BF00992904; CHENEY DL, 1990, COGNITION, V37, P167, DOI 10.1016/0010-0277(90)90022-C; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; Crean RD, 2006, NEUROSCIENCE, V142, P515, DOI 10.1016/j.neuroscience.2006.06.033; Dumont GJH, 2009, SOC NEUROSCI-UK, V4, P359, DOI 10.1080/17470910802649470; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Emanuele E, 2006, MED HYPOTHESES, V67, P1250, DOI 10.1016/j.mehy.2006.05.021; Fantegrossi WE, 2002, PSYCHOPHARMACOLOGY, V161, P356, DOI 10.1007/s00213-002-1021-6; Fantegrossi WE, 2008, BIOCHEM PHARMACOL, V75, P17, DOI 10.1016/j.bcp.2007.07.018; Fantegrossi WE, 2007, PSYCHOPHARMACOLOGY, V189, P471, DOI 10.1007/s00213-006-0320-8; Fone KCF, 2002, PSYCHOPHARMACOLOGY, V159, P437, DOI 10.1007/s00213-001-0931-z; Gouzoulis-Mayfrank E, 2001, HEFFTER REV PSYCHEDE, V2, P64; HABER S, 1981, J PSYCHIAT RES, V16, P23, DOI 10.1016/0022-3956(81)90010-8; Harris DS, 2002, PSYCHOPHARMACOLOGY, V162, P396, DOI 10.1007/s00213-002-1131-1; Hunt GE, 2011, BRAIN RES BULL, V86, P65, DOI 10.1016/j.brainresbull.2011.06.011; Hysek CM, 2011, CLIN PHARMACOL THER, V90, P246, DOI 10.1038/clpt.2011.78; Hysek CM, 2013, J CLIN PSYCHOPHARM, V33, P658, DOI 10.1097/JCP.0b013e3182979d32; Hysek CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036476; Hysek CM, 2013, SOC COGN AFFECT NEUR; JOHNSON MP, 1986, EUR J PHARMACOL, V132, P269, DOI 10.1016/0014-2999(86)90615-1; Kamilar-Britt P, 2015, NEUROSCI BIOBEHAV R, V57, P433, DOI 10.1016/j.neubiorev.2015.08.016; Kirkpatrick MG, 2014, PSYCHONEUROENDOCRINO, V46, P23, DOI 10.1016/j.psyneuen.2014.04.006; KUMMER H, 1991, ANIM BEHAV, V42, P529, DOI 10.1016/S0003-3472(05)80238-6; Liechti ME, 2000, NEUROPSYCHOPHARMACOL, V22, P513, DOI 10.1016/S0893-133X(99)00148-7; Liechti ME, 2001, PSYCHOPHARMACOLOGY, V154, P161, DOI 10.1007/s002130000648; Maldonado R, 2014, EUR NEUROPSYCHOPHARM; MARTEL FL, 1995, DEV PSYCHOBIOL, V28, P71, DOI 10.1002/dev.420280202; Meyer JS, 2004, DRUGS BRAIN BEHAV; Morley KC, 2000, EUR J PHARMACOL, V408, P41, DOI 10.1016/S0014-2999(00)00749-4; MOSER R, 1991, INT J PRIMATOL, V12, P217, DOI 10.1007/BF02547585; Murnane KS, 2012, HORM BEHAV, V61, P181, DOI 10.1016/j.yhbeh.2011.10.012; Murnane KS, 2010, J PHARMACOL EXP THER, V334, P642, DOI 10.1124/jpet.110.166595; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; NICHOLS DE, 1982, J MED CHEM, V25, P530, DOI 10.1021/jm00347a010; NICHOLS DE, 1986, J PSYCHOACTIVE DRUGS, V18, P305, DOI 10.1080/02791072.1986.10472362; Parrott AC, 2009, NEUROPSYCHOBIOLOGY, V60, P148, DOI 10.1159/000253551; RICAURTE GA, 1988, JAMA-J AM MED ASSOC, V260, P51, DOI 10.1001/jama.260.1.51; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P747, DOI 10.1016/0006-2952(87)90729-5; Seibert J, 2014, NEUROENDOCRINOLOGY, V100, P17, DOI 10.1159/000364879; Shively CA, 2013, PSYCHOPHARMACOLOGY B; SHULGIN AT, 1986, J PSYCHOACTIVE DRUGS, V18, P291, DOI 10.1080/02791072.1986.10472361; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Taffe MA, 2006, DRUG ALCOHOL DEPEN, V82, P276, DOI 10.1016/j.drugalcdep.2005.09.013; Thompson MR, 2009, SOC NEUROSCI-UK, V4, P60, DOI 10.1080/17470910802045042; Young SN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0375	58	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147136	10.1371/journal.pone.0147136	http://dx.doi.org/10.1371/journal.pone.0147136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840064	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200027
J	Kato, H; Ikeguchi, T				Kato, Hideyuki; Ikeguchi, Tohru			Oscillation, Conduction Delays, and Learning Cooperate to Establish Neural Competition in Recurrent Networks	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; MODEL; CONNECTIVITY; CIRCUITS; INTEGRATION; SYNCHRONY; SELECTION; PATTERNS; NEURONS; SPARSE	Specific memory might be stored in a subnetwork consisting of a small population of neurons. To select neurons involved in memory formation, neural competition might be essential. In this paper, we show that excitable neurons are competitive and organize into two assemblies in a recurrent network with spike timing-dependent synaptic plasticity (STDP) and axonal conduction delays. Neural competition is established by the cooperation of spontaneously induced neural oscillation, axonal conduction delays, and STDP. We also suggest that the competition mechanism in this paper is one of the basic functions required to organize memory-storing subnetworks into fine-scale cortical networks.	[Kato, Hideyuki] Tokyo Univ Technol, Sch Engn, Tokyo, Japan; [Ikeguchi, Tohru] Tokyo Univ Sci, Fac Engn Div 1, Tokyo 162, Japan	Tokyo University of Technology; Tokyo University of Science	Kato, H (corresponding author), Tokyo Univ Technol, Sch Engn, Tokyo, Japan.	katohdyk@stf.teu.ac.jp			Japan Society for the Promotion of Science [22-8144, 24650116, 15KT0112]; JSPS [22.8144]; Grants-in-Aid for Scientific Research [24650116] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Research Fellowships of Japan Society for the Promotion of Science (No. 22-8144) (HK), Grant-in-Aids for Challenging Exploratory Research (No. 24650116) and Grant-in-Aids for Scientific Research (C) (Generative Research Fields) (No. 15KT0112) (TI), http://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is partially supported by Research Fellowships of JSPS (No. 22.8144) for HK, and Grant-in-Aids for Challenging Exploratory Research (No. 24650116) and Grant-in-Aids for Scientific Research (C) (Generative Research Fields) (No. 15KT0112) for TI.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bhattacharya J, 2005, HUM BRAIN MAPP, V26, P1, DOI 10.1002/hbm.20104; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cateau H, 2003, NEURAL COMPUT, V15, P597, DOI 10.1162/089976603321192095; Cateau H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051909; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; DAWKINS R, 1971, NATURE, V229, P118, DOI 10.1038/229118a0; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gilson M, 2010, FRONT COMPUT NEUROSC, V4, P1, DOI DOI 10.3389/FNCOM.2010.00023; Gutig R, 2003, J NEUROSCI, V23, P3697; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iglesias J, 2005, LECT NOTES COMPUT SC, V3704, P59, DOI 10.1007/11565123_6; Iglesias J, 2007, LECT NOTES COMPUT SC, V4668, P579; Iglesias J, 2010, J PHYSIOL-PARIS, V104, P137, DOI 10.1016/j.jphysparis.2009.11.016; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kandel E., 2000, PRINCIPLES NEURAL SC; Kato H, 2008, LECT NOTES COMPUT SC, V5163, P623, DOI 10.1007/978-3-540-87536-9_64; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kozloski J, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00007; Lee S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000602; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Masuda N, 2004, NEURAL COMPUT, V16, P627, DOI 10.1162/089976604772744938; McAssey MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086526; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Mountcastle VB, 1982, THE MINDFUL BRAIN CO; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shin CW, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.045101; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Takahashi YK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051904; Tesche CD, 2013, FRONT NEURAL CIRCUIT, V7, P1; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027	58	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146044	10.1371/journal.pone.0146044	http://dx.doi.org/10.1371/journal.pone.0146044			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840529	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200006
J	Kraus, AK; Chen, J; Edenhofer, I; Ravens, I; Gaspert, A; Cippa, PE; Mueller, S; Wuthrich, RP; Segerer, S; Bernhardt, G; Fehr, T				Kraus, Anna K.; Chen, Jin; Edenhofer, Ilka; Ravens, Inga; Gaspert, Ariana; Cippa, Pietro E.; Mueller, Steffen; Wuthrich, Rudolf P.; Segerer, Stephan; Bernhardt, Guenter; Fehr, Thomas			The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation	PLOS ONE			English	Article							TUBULAR EPITHELIAL-CELLS; POLIOVIRUS RECEPTOR; IMMUNE-RESPONSES; DENDRITIC CELLS; NECTIN-2 CD112; CD226; EXPRESSION; ADHESION; MOLECULE; LIGANDS	DNAX accessory protein-1 (DNAM-1, CD226) is a co-stimulatory and adhesion molecule expressed mainly by natural killer cells and T cells. DNAM-1 and its two ligands CD112 and CD155 are important in graft-versus-host disease, but their role in solid organ transplantation is largely unknown. We investigated the relevance of this pathway in a mouse kidney transplantation model. CD112 and CD155 are constitutively expressed on renal tubular cells and strongly upregulated in acutely rejected renal allografts. In vitro DNAM-1 blockade during allogeneic priming reduced the allospecific T cell response but not the allospecific cytotoxicity against renal tubular epithelial cells. Accordingly, absence of DNAM-1 in recipient mice or absence of CD112 or CD155 in the kidney allograft did not significantly influence renal function and severity of rejection after transplantation, but led to a higher incidence of infarcts in CD112 and CD155 deficient kidney allografts. Thus, DNAM-1 blockade is not effective in preventing transplant rejection. Despite of being highly expressed, CD112 and CD155 do not appear to play a major immunogenic role in kidney transplantation. Considering the high incidence of renal infarcts in CD112 and CD155 deficient grafts, blocking these molecules might be detrimental.	[Kraus, Anna K.; Chen, Jin; Edenhofer, Ilka; Wuthrich, Rudolf P.; Segerer, Stephan; Fehr, Thomas] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Kraus, Anna K.; Chen, Jin; Edenhofer, Ilka; Cippa, Pietro E.; Wuthrich, Rudolf P.; Segerer, Stephan; Fehr, Thomas] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Ravens, Inga; Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Gaspert, Ariana] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Mueller, Steffen] SUNY Stony Brook, Dept Mol Genet & Microbiol, New York, NY USA	University of Zurich; University of Zurich; University Zurich Hospital; Hannover Medical School; University of Zurich; University Zurich Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fehr, T (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Fehr, T (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	thomas.fehr@uzh.ch	Mueller, Steffen/HGE-0738-2022; Bernhardt, Günter/F-6946-2012	Bernhardt, Günter/0000-0002-0510-2853; Cippa, Pietro/0000-0002-9507-0057; Segerer, Stephan/0000-0002-1936-9719; Mueller, Steffen/0000-0003-2660-258X	Swiss National Science Foundation [310000-121979]; Research Foundation of the University of Zurich [34171706]; Nierenstiftung Switzerland; EMDO Foundation Zurich; Else Kroener-Fresenius Foundation; Pesquisa e Desenvolvimento Humanitario Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Research Foundation of the University of Zurich; Nierenstiftung Switzerland; EMDO Foundation Zurich; Else Kroener-Fresenius Foundation; Pesquisa e Desenvolvimento Humanitario Foundation	This study was supported by the Swiss National Science Foundation (grant no. 310000-121979 to T. Fehr), the Research Foundation of the University of Zurich (grant No 34171706 to T. Fehr), the Nierenstiftung Switzerland, the EMDO Foundation Zurich, the Else Kroener-Fresenius Foundation, and the Pesquisa e Desenvolvimento Humanitario Foundation. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 1997, EXP CELL RES, V235, P374, DOI 10.1006/excr.1997.3685; Bernhardt G, 2014, NAT IMMUNOL, V15, P406, DOI 10.1038/ni.2855; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Cippa PE, 2011, TRANSPL INT, V24, P722, DOI 10.1111/j.1432-2277.2011.01272.x; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Escalante NK, 2011, ARTERIOSCL THROM VAS, V31, P1177, DOI 10.1161/ATVBAHA.111.224162; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Harris AG, 1996, AM J PHYSIOL-HEART C, V271, pH2388, DOI 10.1152/ajpheart.1996.271.6.H2388; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Kinnear G, 2013, TRANSPLANTATION, V95, P527, DOI 10.1097/TP.0b013e31826d4672; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Koyama M, 2013, BLOOD, V121, P3511, DOI 10.1182/blood-2012-07-444026; Kraus AK, 2013, TRANSPL INT, V26, P535, DOI 10.1111/tri.12070; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Pilat N, 2011, SEMIN IMMUNOL, V23, P293, DOI 10.1016/j.smim.2011.04.002; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; SCHULZE DH, 1983, P NATL ACAD SCI-BIOL, V80, P2007, DOI 10.1073/pnas.80.7.2007; Seth S, 2009, J LEUKOCYTE BIOL, V86, P91, DOI [10.1189/JLB.1208745, 10.1189/jlb.1208745]; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Starke A, 2007, NEPHRON EXP NEPHROL, V107, pE22, DOI 10.1159/000106506; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tian YH, 2010, J SURG RES, V163, pE91, DOI 10.1016/j.jss.2010.04.019; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Welsh-Bacic D, 2011, NEPHROL DIAL TRANSPL, V26, P1211, DOI 10.1093/ndt/gfq560; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147951	10.1371/journal.pone.0147951	http://dx.doi.org/10.1371/journal.pone.0147951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840537	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000369550200072
J	Wang, C; Lu, HY; Zhang, JP; He, KY; Huan, XJ				Wang, Can; Lu, Houyuan; Zhang, Jianping; He, Keyang; Huan, Xiujia			Macro-Process of Past Plant Subsistence from the Upper Paleolithic to Middle Neolithic in China: A Quantitative Analysis of Multi-Archaeobotanical Data	PLOS ONE			English	Article							WILD CEREAL-GRAINS; OHALO-II; PHYTOLITH EVIDENCE; HIGH-RESOLUTION; MONSOON RECORD; CLIMATE-CHANGE; ORIGINS; AGRICULTURE; FOOD; EXPLOITATION	Detailed studies of the long-term development of plant use strategies indicate that plant subsistence patterns have noticeably changed since the Upper Paleolithic, when humans underwent a transitional process from foraging to agriculture. This transition was best recorded in west Asia; however, information about how plant subsistence changed during this transition remains limited in China. This lack of information is mainly due to a limited availability of sufficiently large, quantified archaeobotanical datasets and a paucity of related synthetic analyses. Here, we present a compilation of extensive archaeobotanical data derived from interdisciplinary approaches, and use quantitative analysis methods to reconstruct past plant use from the Upper Paleolithic to Middle Neolithic in China. Our results show that intentional exploitation for certain targeted plants, particularly grass seeds, may be traced back to about 30,000 years ago during the Upper Paleolithic. Subsequently, the gathering of wild plants dominated the subsistence system; however, this practice gradually diminished in dominance until about 6 similar to 5 ka cal BP during the Middle Neolithic. At this point, farming based on the domestication of cereals became the major subsistence practice. Interestingly, differences in plant use strategies were detected between north and south China, with respect to (1) the proportion of certain plant taxa in assemblages, (2) the domestication rate of cereals, and (3) the type of plant subsistence practiced after the establishment of full farming. In conclusion, the transition from foraging to rice and millet agriculture in China was a slow and long-term process spanning 10s of 1000s of years, which may be analogous to the developmental paths of wheat and barley farming in west Asia.	[Wang, Can; Lu, Houyuan; Zhang, Jianping; He, Keyang; Huan, Xiujia] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China; [Wang, Can; He, Keyang; Huan, Xiujia] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lu, Houyuan; Zhang, Jianping] Chinese Acad Sci, Ctr Excellence Tibetan Plateau Earth Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Wang, C; Lu, HY (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China.; Wang, C (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Lu, HY (corresponding author), Chinese Acad Sci, Ctr Excellence Tibetan Plateau Earth Sci, Beijing 100101, Peoples R China.	wangcan@mail.iggcas.ac.cn; houyuanlu@mail.iggcas.ac.cn	Lu, houyuan/L-8661-2019; He, Keyang/ABC-9289-2020; Liu, Kam-Biu/B-4966-2012; Lu, houyuan/AAD-3100-2019; Zhang, Jianping/A-8167-2014	He, Keyang/0000-0002-6014-823X; Liu, Kam-Biu/0000-0002-0038-2198; Lu, houyuan/0000-0001-5721-6679; Zhang, Jianping/0000-0003-0815-009X; Wang, Can/0000-0003-3759-3543	National Natural Science Foundation of China [41230104]; National Science and Technology Major Project of China [2015CB953801]; Chinese Academy of Sciences [XDA05130604]; National Key Technology R&D Program of China [2013BAK08B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technology R&D Program of China(National Key Technology R&D Program)	This study was supported by the National Natural Science Foundation of China (Grant No. 41230104), the National Science and Technology Major Project of China (Grant No. 2015CB953801), the "Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences (Grant No. XDA05130604), and the National Key Technology R&D Program of China (Grant No. 2013BAK08B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby RG, 2015, J HUM EVOL, V79, P150, DOI 10.1016/j.jhevol.2014.10.014; [Anonymous], 2015, J INDO PACIFIC ARCHA, DOI [DOI 10.7152/JIPA.V35I0.14727, 10.7152/jipa.v35i0.14727]; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Bar-Yosef O, 2011, CURR ANTHROPOL, V52, pS175, DOI 10.1086/659784; Barton H, 2015, J ARCHAEOL SCI, V56, P194, DOI 10.1016/j.jas.2015.02.031; BARYOSEF O, 1989, J WORLD PREHIST, V3, P447, DOI 10.1007/BF00975111; BarYosef O, 1995, SCH AM RES, V354, P39; Bettinger R, 2009, CURR ANTHROPOL, V50, P627, DOI 10.1086/605359; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10501, DOI 10.1073/pnas.1222568110; Cohen DJ, 2011, CURR ANTHROPOL, V52, pS273, DOI 10.1086/659965; Crawford G, 2005, CURR ANTHROPOL, V46, P309, DOI 10.1086/428788; Crawford G.W., 2006, E ASIA ARCHAEOLOGY, V3, P247; Crawford GW, 2013, JIANGHAN ARCHAEOLOGY, V2, P107; [Department of Earth Sciences Sun Yat-Sen University The Peoples Government of Yingde Professional Committee on Agricultural Civilization of the Pearl River Culture Research Institute LAPCPRCRS (Lingnan Archaeological Professional Committee of the Pearl River Culture Research Society)], 2013, NIUL SIT YINGD COMPR; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Edwards DA, 1995, ANTIQUITY, V69, P769, DOI 10.1017/S0003598X00082326; [方修琦 Fang Xiuqi], 2011, [地理科学, Scientia Geographica Sinica], V31, P385; Flannery K. V., 1969, The domestication and exploitation of plants and animals., P73; FLANNERY KV, 1973, ANNU REV ANTHROPOL, V2, P271, DOI 10.1146/annurev.an.02.100173.001415; Gao Y, 2012, RELICS S, V1, P156; Ge QS, 2007, ADV ATMOS SCI, V24, P1024, DOI 10.1007/s00376-007-1024-7; Guan Y, 2014, QUATERN INT, V347, P74, DOI 10.1016/j.quaint.2014.04.007; Guan Y, 2012, CHINESE SCI BULL, V57, P379, DOI 10.1007/s11434-011-4828-x; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Henry AG, 2014, J HUM EVOL, V69, P44, DOI 10.1016/j.jhevol.2013.12.014; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Humphrey LT, 2014, P NATL ACAD SCI USA, V111, P954, DOI 10.1073/pnas.1318176111; Hunan Institute of Cultural Relics and Archaeology, 2006, PENGT BASH; Jiang LP, 2006, ANTIQUITY, V80, P355, DOI 10.1017/S0003598X00093674; Jones MK, 2009, SCIENCE, V324, P730, DOI 10.1126/science.1172082; Lee-Thorp J, 2006, YEARB PHYS ANTHROPOL, V49, P131, DOI 10.1002/ajpa.20519; Liu C, 2008, ARCHAEOBOTANY RESEAR; Liu J, 2014, CHINESE SCI BULL, V59, P3884, DOI 10.1007/s11434-014-0527-8; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Liu L, 2013, P NATL ACAD SCI USA, V110, P5380, DOI 10.1073/pnas.1217864110; Liu L, 2011, J ARCHAEOL SCI, V38, P3524, DOI 10.1016/j.jas.2011.08.015; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Nadel D, 2012, ANTIQUITY, V86, P990, DOI 10.1017/S0003598X00048201; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno DR, 2004, NATURE, V430, P670, DOI 10.1038/nature02734; Qin L., 2012, ARCHAEOBOTANICAL RES, P260; Qu TL, 2013, J ARCHAEOL RES, V21, P1, DOI 10.1007/s10814-012-9059-4; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Revedin A, 2010, P NATL ACAD SCI USA, V107, P18815, DOI 10.1073/pnas.1006993107; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Smith BD, 2001, J ARCHAEOL RES, V9, P1, DOI 10.1023/A:1009436110049; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Su B, 2009, NEW RES ORIGIN CHINE; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Torrence R., 2006, ANCIENT STARCH RES; Ungar PS, 2006, J HUM EVOL, V50, P78, DOI 10.1016/j.jhevol.2005.08.007; [万智巍 Wan Zhiwei], 2012, [第四纪研究, Quaternary Sciences], V32, P256; Wang C, 2014, QUATERNARY SCI REV, V98, P45, DOI 10.1016/j.quascirev.2014.05.015; Wang S., 2000, PROGR NATURAL SCI, V10, P325; Wang Y.Q., 2011, SICHUAN CULT RELICS, V2, P80; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Weiss E, 2004, ECON BOT, V58, pS125, DOI 10.1663/0013-0001(2004)58[S125:SWGASF]2.0.CO;2; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; Weiss E, 2008, J ARCHAEOL SCI, V35, P2400, DOI 10.1016/j.jas.2008.03.012; Wynn JG, 2013, P NATL ACAD SCI USA, V110, P10495, DOI 10.1073/pnas.1222559110; Xia Z.K., 2012, ENV ARCHAEOLOGY PRIN; Xia ZK, 2002, CHINESE SCI BULL, V47, P71, DOI 10.1360/02tb9014; Xiao JL, 2004, QUATERNARY SCI REV, V23, P1669, DOI 10.1016/j.quascirev.2004.01.005; Yan W. M., 2000, ORIGINS AGR RISE CIV, P148; Yang XY, 2014, CHINESE SCI BULL, V59, P4352, DOI 10.1007/s11434-014-0500-6; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Yang XY, 2009, SCI CHINA SER D, V52, P1164, DOI 10.1007/s11430-009-0089-9; Yasuda, 2002, ORIGINS POTTERY AGR, P157; Yuan J, 2000, ORIGINS RICE AGR POT, P31; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307; Zhang C, 2000, ORIGINS RICE AGR POT, P43; Zhang J Z, 2014, J NATL MUSEUM CHINA, V1, P6; Zhang JP, 2010, BOREAS, V39, P592, DOI 10.1111/j.1502-3885.2010.00145.x; Zhang S., 1999, ACTA ANTHROPOL SIN, V18, P193; Zhang WenXu, 1998, Acta Agronomica Sinica, V24, P416; Zhao Z, 2009, CHINESE CULTURA 1225; Zhao Z, 2010, PALEOETHNOBOTANY THE, P45; Zhao Z.J., 2004, ARCHAEOLOGY, V3, P80; Zhao Z.J., 2004, ANTIQ E ASIA; [赵志军 Zhao Zhijun], 2014, [第四纪研究, Quaternary Sciences], V34, P73; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zhao ZJ, 2010, ARCHAEOL ANTHROP SCI, V2, P99, DOI 10.1007/s12520-010-0028-x; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zhejiang Institute of Archaeology and Xiaoshan Museum, 2004, KUAH; Zheng Z., 1998, EPISODES, V21, P152, DOI DOI 10.18814/epiiugs/1998/v21i3/003	88	9	11	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148136	10.1371/journal.pone.0148136	http://dx.doi.org/10.1371/journal.pone.0148136			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840560	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200084
J	Yu, Q; Xiong, YH; Liu, JL; Wen, DL; Wu, XH; Yin, HQ				Yu, Qian; Xiong, Youhua; Liu, Jianliang; Wen, Dongling; Wu, Xiaohui; Yin, Hanqi			Transcriptome Analysis of the SL221 Cells at the Early Stage during Spodoptera litura Nucleopolyhedrovirus Infection	PLOS ONE			English	Article							IN-FIELD POPULATIONS; BIOLOGICAL-CONTROL; GENOME SEQUENCE; VIRAL TRANSPORT; PLANT-EXTRACTS; COMMON CUTWORM; APOPTOSIS; VIRUSES; BACULOVIRUSES; ANTIFEEDANT	Spodoptera litura (S. litura) is one of the most destructive agricultural pests worldwide. There is urgent need for a nuclear polyhedrosis virus that is specific to S. litura. To date, there have been no reports regarding the responses of S. litura cells to early Spodoptera litura nucleopolyhedrovirus (SpltNPV) infection due to the lack of a reference genome and transcriptome for S. litura. In this study, a cell transcriptome fromthe host S. litura was assembled and used for Illumina strand-specific RNA sequencing (RNA-seq) to generate 99180 unigenes, representing the 18 hour infection cycle. More than 2000 S. litura genes were significant differentially regulated throughout the infection. The levels of viral mRNAs began to increase dramatically at 6 hpi, and this increase continued throughout the remainder of the infection. We focused on the expression of genes related to stress responses, apoptosis, metabolic enzymes and host cell innate immune system. A small subset of genes related to host stress response, especially for 62 ones being able to annotated as enzyme, ligand and receptor genes, were observed to be specifically differentially expressed at 6 hpi. At 18 hpi, 104 unigenes were continuously significantly changing from 0 hpi to 18 hpi, considered to be viral multiplication related genes, including 3 annotated SL221 unigenes and 81 viral genes, such as tetraspanin and iap gene. This information and further studies on the regulation of host gene expression by baculovirus infection at early stage will provide the tools needed to enhance the utility of this virus as an effective insecticide.	[Yu, Qian; Xiong, Youhua; Liu, Jianliang; Wen, Dongling] Zhongkai Univ Agr & Engn, Coll Food Sci & Technol, Guangzhou 510225, Guangdong, Peoples R China; [Yin, Hanqi] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Xiaohui] Shanghai Biotechnol Corp, Shanghai 201203, Peoples R China	Zhongkai University of Agriculture & Engineering; Sun Yat Sen University	Yin, HQ (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	hanqiyincn@126.com			National Natural Science Foundation of China [31201575]; Project of outstanding young teachers in Higher Education Institutions of Guangdong Province [Yq2013096]; Deciduous fruit trees technology research institute of Guangdong Province [2015B090903082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of outstanding young teachers in Higher Education Institutions of Guangdong Province; Deciduous fruit trees technology research institute of Guangdong Province	This research was supported by the National Natural Science Foundation of China (No. 31201575), the Project of outstanding young teachers in Higher Education Institutions of Guangdong Province (No. Yq2013096) and Deciduous fruit trees technology research institute of Guangdong Province (2015B090903082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2001, J VIROL, V75, P11157, DOI 10.1128/JVI.75.22.11157-11165.2001; Ahmad M, 2007, CROP PROT, V26, P809, DOI 10.1016/j.cropro.2006.07.006; Ahrnad M, 2007, PEST MANAG SCI, V63, P1002, DOI 10.1002/ps.1430; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Baskar K., 2011, International Journal of Agricultural Technology, V7, P123; Ben-Dov IZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086856; Bernhardt R, 1996, REV PHYSIOL BIOCH P, V127, P137, DOI 10.1007/BFb0048267; Blissard GW, 2002, INSECT CELL CULTURE, P73; Bulach DM, 1999, J INVERTEBR PATHOL, V73, P59, DOI 10.1006/jipa.1998.4797; Cave Ronald D., 2000, Biocontrol News and Information, V21, p21N; Chen JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110623; Chen YR, 2014, J VIROL, V88, P13781, DOI 10.1128/JVI.02243-14; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Clem RJ, 2001, CELL DEATH DIFFER, V8, P137, DOI 10.1038/sj.cdd.4400821; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dong SB, 2014, GENE, V544, P220, DOI 10.1016/j.gene.2014.04.031; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Huang SJ, 2007, PESTIC BIOCHEM PHYS, V87, P14, DOI 10.1016/j.pestbp.2006.05.002; Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t; Kamaraj C, 2008, PARASITOL RES, V103, P325, DOI 10.1007/s00436-008-0974-8; Kamiya K, 2004, BIOL CONTROL, V31, P38, DOI 10.1016/j.biocontrol.2004.04.003; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; LIANG Q, 2008, GUANGDONG AGR SCI, V8, P028; Mallikarjuna N, 2004, J APPL ENTOMOL, V128, P321, DOI 10.1111/j.1439-0418.2004.00834.x; Maramorosch K, 2012, VIRAL INSECTICIDES B; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pan LJ, 2005, VIRUS RES, V110, P73, DOI 10.1016/j.virusres.2005.01.008; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Priyanka Bhatt, 2014, Journal of Applied and Natural Science, V6, P139; Ramakrishnan N, 1984, PESTICIDES, P18; Rhodes D, 1993, FORMULATION BIOL CON, P411; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; SMITH GE, 1978, VIROLOGY, V89, P517, DOI 10.1016/0042-6822(78)90193-9; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sun Xiu-lian, 2007, Virologica Sinica, V22, P158; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wittmann C, 2002, APPL ENVIRON MICROB, V68, P5843, DOI 10.1128/AEM.68.12.5843-5859.2002; Xiao CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094250; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Q, 2008, J GEN VIROL, V89, P1873, DOI 10.1099/vir.0.2008/001008-0; Zhang G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks196	54	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147873	10.1371/journal.pone.0147873	http://dx.doi.org/10.1371/journal.pone.0147873			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840182	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200067
J	Das, S; Sahoo, GC; Das, P; Singh, UK; Jaiswal, AK; Singh, P; Kumar, R; Kumar, R				Das, Sushmita; Sahoo, Ganesh Chandra; Das, Pradeep; Singh, Utpal Kant; Jaiswal, Anil Kumar; Singh, Prachi; Kumar, Ranjeet; Kumar, Rishikesh			Evaluating the Impact of Breastfeeding on Rotavirus Antigenemia and Disease Severity in Indian Children	PLOS ONE			English	Article							GROUP-A ROTAVIRUSES; HUMAN-MILK GLYCANS; ACUTE GASTROENTERITIS; INFECTION; DIARRHEA; PROTECTION; INFANTS; ANTIBODIES; VACCINE; LACTADHERIN	Objectives To evaluate the contribution of breastfeeding to Rotavirus (RV)-induced antigenemia and/or RNAemia and disease severity in Indian children (<2 yrs age). Methods Paired stool and serum samples were collected from (a) hospitalized infants with diarrhea (n = 145) and (b) healthy control infants without diarrhea (n = 28). Stool RV-antigen was screened in both groups by commercial rapid-test and enzyme immunoassay. The disease severity was scored and real-time-PCR was used for viral-load estimation. Serum was evaluated for RV-antigenemia by EIA and RV-RNAemia by RT-PCR. Data was stratified by age-group and breastfeeding status and compared. Results Presence of RV-antigenemia and RV-RNAemia was positively related with presence of RV in stool. Disease severity and stool viral-load was significantly associated with RV-antigenemia[(r = 0.74; CI: 0.66 to 0.84; P<0.0001, R-2 = 0.59) and (r = -0.55; CI:-0.68 to -0.39; P<0.0001, R-2 = 0.31) respectively], but not with RV-RNAemia. There was significant reduction in RV-antigenemiarate in the breast-fed group compared to non-breastfed infants, especially in 0-6 month age group (P<0.001). Non-breastfed infants were at risk for RV-antigenemia with severe disease manifestations in form of high Vesikari scores correlating with high fever, more vomiting episodes and dehydration. Conclusion RV-antigenemia was common in nonbreastfed children with severe RV-diarrhea and correlated with stool RV-load and disease severity.	[Das, Sushmita] AIIMS, Dept Microbiol, Patna, Bihar, India; [Sahoo, Ganesh Chandra; Das, Pradeep; Kumar, Ranjeet; Kumar, Rishikesh] Rajendra Mem Res Inst Med Sci ICMR, Virol Unit, Patna, Bihar, India; [Singh, Utpal Kant; Jaiswal, Anil Kumar; Singh, Prachi] Nalanda Med Coll & Hosp, Dept Paediat, Patna, Bihar, India; [Jaiswal, Anil Kumar] Patna Med Coll & Hosp, Dept Paediat, Patna, Bihar, India	All India Institute of Medical Sciences (AIIMS) Patna; Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Das, S (corresponding author), AIIMS, Dept Microbiol, Patna, Bihar, India.	sushmita.de2008@gmail.com		Kumar, Rishikesh/0000-0001-8993-4683				Asensi MT, 2006, J PEDIATR GASTR NUTR, V42, P560, DOI 10.1097/01.mpg.0000221892.59371.b3; Blutt SE, 2007, CURR OPIN GASTROEN, V23, P39, DOI 10.1097/MOG.0b013e328011829d; Blutt SE, 2007, PLOS MED, V4, P660, DOI 10.1371/journal.pmed.0040121; Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9; BRUSSOW H, 1993, J CLIN MICROBIOL, V31, P593; Civra A, 2015, J BIOL CHEM, V290, P12403, DOI 10.1074/jbc.M114.620500; Clarke E, 2015, MUCOSAL IMMUNOL, V8, P1, DOI 10.1038/mi.2014.114; CLEMENS J, 1993, PEDIATRICS, V92, P680; Fischer TK, 2005, J INFECT DIS, V192, P913, DOI 10.1086/432549; Fujita Y, 2010, JPN J INFECT DIS, V63, P83; GLASS RI, 1986, ACTA PAEDIATR SCAND, V75, P713, DOI 10.1111/j.1651-2227.1986.tb10279.x; Gomara MI, 2002, J VIROL, V76, P6596, DOI 10.1128/JVI.76.13.6596-6601.2002; Heatona PM, 2007, CLIN INFECT DIS, V45, P1618, DOI 10.1086/522997; Iturriza-Gomara M, 1999, J VIROL METHODS, V78, P93, DOI 10.1016/S0166-0934(98)00168-2; JAYASHREE S, 1988, SCAND J INFECT DIS, V20, P249, DOI 10.3109/00365548809032447; Jiang BM, 2002, CLIN INFECT DIS, V34, P1351, DOI 10.1086/340103; Kvistgaard AS, 2004, J DAIRY SCI, V87, P4088, DOI 10.3168/jds.S0022-0302(04)73551-1; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; MORRIS SS, 1994, INT J EPIDEMIOL, V23, P617, DOI 10.1093/ije/23.3.617; Morrow AL, 2005, J NUTR, V135, P1304, DOI 10.1093/jn/135.5.1304; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Morrow Ardythe L, 2004, Semin Pediatr Infect Dis, V15, P221, DOI 10.1053/j.spid.2004.07.002; Nelson EAS, 2010, LANCET, V376, P568, DOI 10.1016/S0140-6736(10)60896-3; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; Phadke SM, 2005, J NUTR, V135, P1289, DOI 10.1093/jn/135.5.1289; Phan TG, 2007, J VIROL, V81, P4645, DOI 10.1128/JVI.02342-06; Prameela K K, 2012, Malays J Nutr, V18, P103; Ramani S, 2010, CLIN INFECT DIS, V51, P1284, DOI 10.1086/657069; Ray P, 2006, J INFECT DIS, V194, P588, DOI 10.1086/505878; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Sugata K, 2008, PEDIATRICS, V122, P392, DOI 10.1542/peds.2007-2290; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	39	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146243	10.1371/journal.pone.0146243	http://dx.doi.org/10.1371/journal.pone.0146243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828823	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200005
J	Guerrero, CA; Guerrero, RA; Silva, E; Acosta, O; Barreto, E				Guerrero, Carlos A.; Guerrero, Rafael A.; Silva, Elver; Acosta, Orlando; Barreto, Emiliano			Experimental Adaptation of Rotaviruses to Tumor Cell Lines	PLOS ONE			English	Article							ONCOLYTIC VIRUS THERAPY; DNA-DAMAGE RESPONSE; HEAT-SHOCK PROTEINS; IN-VITRO; POLY(ADP-RIBOSE) POLYMERASE; N-ACETYLCYSTEINE; CANCER; INFECTION; EXPRESSION; SURFACE	A number of viruses show a naturally extended tropism for tumor cells whereas other viruses have been genetically modified or adapted to infect tumor cells. Oncolytic viruses have become a promising tool for treating some cancers by inducing cell lysis or immune response to tumor cells. In the present work, rotavirus strains TRF-41 (G5) (porcine), RRV (G3) (simian), UK (G6-P5) (bovine), Ym (G11-P9) (porcine), ECwt (murine), Wa (G1-P8), Wi61 (G9) and M69 (G8) (human), and five wild-type human rotavirus isolates were passaged multiple times in different human tumor cell lines and then combined in five different ways before additional multiple passages in tumor cell lines. Cell death caused by the tumor cell-adapted isolates was characterized using Hoechst, propidium iodide, 7-AAD, Annexin V, TUNEL, and anti-poly-(ADP ribose) polymerase (PARP) and -phospho-histone H2A. X antibodies. Multiple passages of the combined rotaviruses in tumor cell lines led to a successful infection of these cells, suggesting a gain-of-function by the acquisition of greater infectious capacity as compared with that of the parental rotaviruses. The electropherotype profiles suggest that unique tumor cell-adapted isolates were derived from reassortment of parental rotaviruses. Infection produced by such rotavirus isolates induced chromatin modifications compatible with apoptotic cell death.	[Guerrero, Carlos A.; Guerrero, Rafael A.; Silva, Elver; Acosta, Orlando] Univ Nacl Colombia, Fac Med, Dept Physiol Sci, Bogota, DC, Colombia; [Barreto, Emiliano] Univ Nacl Colombia, Inst Biotechnol, Bogota, DC, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Guerrero, CA (corresponding author), Univ Nacl Colombia, Fac Med, Dept Physiol Sci, Bogota, DC, Colombia.	caguerrerof@unal.edu.co	Barreto, Emiliano/AAB-9009-2020	Barreto, Emiliano/0000-0002-5968-6794; Guerrero Rojas, Rafael Antonio/0000-0001-8755-3385	Departamento Administrativo de Ciencia, Tecnologia e Investigacion - COLCIENCIAS [110165843297, 658-2014]; Departamento Administrativo de Ciencia, Tecnologia e Investigacion-COLCIENCIAS through Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnologia y la Innovacion, Francisco Jose de Caldas [110165843297, 658-2014]	Departamento Administrativo de Ciencia, Tecnologia e Investigacion - COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Departamento Administrativo de Ciencia, Tecnologia e Investigacion-COLCIENCIAS through Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnologia y la Innovacion, Francisco Jose de Caldas	This study was supported by a grant (No. 110165843297, 658-2014) awarded by Departamento Administrativo de Ciencia, Tecnologia e Investigacion - COLCIENCIAS to C.A. Guerrero through Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnologia y la Innovacion, Francisco Jose de Caldas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant (No. 110165843297, 658-2014) awarded by Departamento Administrativo de Ciencia, Tecnologia e Investigacion-COLCIENCIAS to CAG through Patrimonio Autonomo Fondo Nacional de Financiamiento para la Ciencia, la Tecnologia y la Innovacion, Francisco Jose de Caldas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angarita FA, 2013, TRENDS MOL MED, V19, P378, DOI 10.1016/j.molmed.2013.02.008; Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Guerrero CA, 2013, MEM I OSWALDO CRUZ, V108, P741, DOI 10.1590/0074-0276108062013011; Baker M, 2010, CURR TOP MICROBIOL, V343, P121, DOI 10.1007/82_2010_34; Ballarini F., 2010, J NUCL ACIDS, V2010, P8, DOI 350608; BASS DM, 1992, J CLIN INVEST, V90, P2313, DOI 10.1172/JCI116119; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; BROOME RL, 1993, J VIROL, V67, P2448, DOI 10.1128/JVI.67.5.2448-2455.1993; Calderon MN, 2012, INTERVIROLOGY, V55, P451, DOI 10.1159/000335262; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chaibi C, 2005, VIROLOGY, V332, P480, DOI 10.1016/j.virol.2004.11.039; CHEN D, 1993, VIROLOGY, V194, P743, DOI 10.1006/viro.1993.1315; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cuadras MA, 2003, VIROLOGY, V313, P308, DOI 10.1016/S0042-6822(03)00326-X; DELCASTILLO JR, 1991, J GEN VIROL, V72, P541, DOI 10.1099/0022-1317-72-3-541; Desselberger U, 2013, VIRUS RES, V178, P252, DOI 10.1016/j.virusres.2013.09.034; Feng N, 2009, J VIROL, V83, P6987, DOI 10.1128/JVI.00585-09; Fleming FE, 2011, J BIOL CHEM, V286, P6165, DOI 10.1074/jbc.M110.142992; Gao S, 2015, EUR J NUCL MED MOL I; GINEVSKAYA VA, 1994, ARCH VIROL, V137, P199, DOI 10.1007/BF01311188; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Goldufsky J, 2013, ONCOLYTIC VIROTHER, V2, P31, DOI 10.2147/OV.S38901; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Guerrero CA, 2002, J VIROL, V76, P4096, DOI 10.1128/JVI.76.8.4096-4102.2002; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Guerrero CA, 2014, PHARMACOTHERAPY, V34, pE333, DOI 10.1002/phar.1489; Guerrero CA, 2010, J VIROL METHODS, V168, P22, DOI 10.1016/j.jviromet.2010.04.010; Halasz P, 2010, J GEN VIROL, V91, P2007, DOI 10.1099/vir.0.018275-0; Harrington KJ, 2010, CYTOKINE GROWTH F R, V21, P91, DOI 10.1016/j.cytogfr.2010.02.006; Hemminki A, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/862925; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Isa P, 2004, VIROLOGY, V322, P370, DOI 10.1016/j.virol.2004.02.018; Jourdan N, 1997, J VIROL, V71, P8268, DOI 10.1128/JVI.71.11.8268-8278.1997; Kapikian AZ, FIELDS VIROLOGY, P1787; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Khan HA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00070; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Lee HH, 2012, INT J BIOL SCI, V8, P353, DOI 10.7150/ijbs.3157; Levine AJ, FIELDS VIROLOGY, P3; Liu RY, 2013, BIOCHEM BIOPH RES CO, V442, P171, DOI 10.1016/j.bbrc.2013.11.047; Liu TC, 2008, GENE THER, V15, P877, DOI 10.1038/gt.2008.72; Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265; Lokody I, 2014, NAT REV GENET, V15, DOI 10.1038/nrg3676; McClelland CM, 2007, BRIT J CANCER, V96, P284, DOI 10.1038/sj.bjc.6603544; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Miest TS, 2014, NAT REV MICROBIOL, V12, P23, DOI 10.1038/nrmicro3140; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Newton K, 1997, J VIROL, V71, P9458, DOI 10.1128/JVI.71.12.9458-9465.1997; Nomaguchi M, 2012, FRONT MICROBIOL, V3, P1; Patel MR, 2013, TRANSL RES, V161, P355, DOI 10.1016/j.trsl.2012.12.010; Perez JF, 1998, VIROLOGY, V252, P17, DOI 10.1006/viro.1998.9433; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Podhorecka M., 2010, J NUCL ACIDS, V2010, P1, DOI DOI 10.4061/2010/920161; Ralhan R, 1995, CLIN CANCER RES, V1, P1217; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Ruiz MC, 2005, VIROLOGY, V333, P54, DOI 10.1016/j.virol.2004.12.032; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Santana AY, 2013, ARCH VIROL, V158, P1323, DOI 10.1007/s00705-013-1626-6; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Shinderman-Maman E, 2015, ONCOGENE; Stucci S, 2015, CRIT REV ONCOL HEMAT; Takashima M, 2003, PROTEOMICS, V3, P2487, DOI 10.1002/pmic.200300621; Tanaka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096785; Teimoori A, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.10375; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; VANDENBROECKE C, 1984, ANN RECH VET, V15, P29; Virgin S, FIELDS VIROLOGY, P329; Woller N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00188; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	75	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147666	10.1371/journal.pone.0147666	http://dx.doi.org/10.1371/journal.pone.0147666			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828934	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200027
J	Kotani, O; Naeem, A; Suzuki, T; Iwata-Yoshikawa, N; Sato, Y; Nakajima, N; Hosomi, T; Tsukagoshi, H; Kozawa, K; Hasegawa, H; Taguchi, F; Shimizu, H; Nagata, N				Kotani, Osamu; Naeem, Asif; Suzuki, Tadaki; Iwata-Yoshikawa, Naoko; Sato, Yuko; Nakajima, Noriko; Hosomi, Takushi; Tsukagoshi, Hiroyuki; Kozawa, Kunihisa; Hasegawa, Hideki; Taguchi, Fumihiro; Shimizu, Hiroyuki; Nagata, Noriyo			Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse Models	PLOS ONE			English	Article							THEILERS MURINE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; SAFV GENOTYPE 3; ENCEPHALOMYOCARDITIS VIRUS; DIABETES-MELLITUS; LEADER PROTEIN; INFECTION; CHILDREN; CARDIOVIRUS; DISEASE	Objective Saffold virus (SAFV), a picornavirus, is occasionally detected in children with acute flaccid paralysis, meningitis, and cerebellitis; however, the neuropathogenicity of SAFV remains undetermined. Methods The virulence of two clinical isolates of SAFV type 3 (SAFV-3) obtained from a patient with aseptic meningitis (AM strain) and acute upper respiratory inflammation (UR strain) was analyzed in neonatal and young mice utilizing virological, pathological, and immunological methods. Results The polyproteins of the strains differed in eight amino acids. Both clinical isolates were infective, exhibited neurotropism, and were mildly neurovirulent in neonatal ddY mice. Both strains pathologically infected neural progenitor cells and glial cells, but not large neurons, with the UR strain also infecting epithelial cells. UR infection resulted in longer inflammation in the brain and spinal cord because of demyelination, while the AM strain showed more infectivity in the cerebellum in neonatal ddY mice. Additionally, young BALB/c mice sero-converted following mucosal inoculation with the UR, but not the AM, strain. Conclusions Both SAFV-3 isolates had neurotropism and mild neurovirulence but showed different cell tropisms in both neonatal and young mouse models. This animal model has the potential to recapitulate the potential neuropathogenicity of SAFV-3.	[Kotani, Osamu; Suzuki, Tadaki; Iwata-Yoshikawa, Naoko; Sato, Yuko; Nakajima, Noriko; Hasegawa, Hideki; Nagata, Noriyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Kotani, Osamu; Taguchi, Fumihiro] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Virol & Viral Infect, Tokyo, Japan; [Naeem, Asif; Shimizu, Hiroyuki] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Hosomi, Takushi] Publ Hlth Inst Kochi Prefecture, Kochi, Japan; [Tsukagoshi, Hiroyuki; Kozawa, Kunihisa] Gunma Prefectural Inst Publ Hlth & Environm Sci, Gunma, Japan; [Kotani, Osamu] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Hosomi, Takushi] Meat Inspect Ctr Kochi Prefecture, Kochi, Japan	National Institute of Infectious Diseases (NIID); Nippon Veterinary & Life Science University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Nagata, N (corresponding author), Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.	nnagata@nih.go.jp	Hasegawa, Hideki/C-7978-2014; Suzuki, Tadaki/ABH-2661-2020; Shimizu, Hiroyuki/AAU-9621-2020; Naeem, Asif/ABC-7448-2021	Shimizu, Hiroyuki/0000-0002-2987-2377; Naeem, Asif/0000-0002-2088-0629	Ministry of Education, Culture, Sports, Science, and Technology in Japan [23590554, 15K08511]; Ministry of Health, Labor, and Welfare in Japan [H23-Shinko-Ippan-007, H25-Shinko-Ippan-012]	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology in Japan (grant-in-aid for scientific research no. 23590554 and 15K08511) and the Ministry of Health, Labor, and Welfare in Japan (grant-in-aid for research on emerging and re-emerging infectious diseases, research nos. H23-Shinko-Ippan-007 and H25-Shinko-Ippan-012).	Agamanolis DP, 2003, ANN NEUROL, V54, P547, DOI 10.1002/ana.10731; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Branas P, 2015, J INFECTION, V70, P679, DOI 10.1016/j.jinf.2014.11.006; Buckwalter MR, 2011, J VIROL, V85, P6893, DOI 10.1128/JVI.00274-11; CALENOFF MA, 1990, P NATL ACAD SCI USA, V87, P978, DOI 10.1073/pnas.87.3.978; Canelli E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-64; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chiu CY, 2010, J VIROL, V84, P4407, DOI 10.1128/JVI.02536-09; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chua KB, 2011, EMERG INFECT DIS, V17, P1562, DOI 10.3201/eid1708.101380; CRAIGHEAD JE, 1968, SCIENCE, V162, P913, DOI 10.1126/science.162.3856.913; Cushing MM, 2004, AM J CLIN PATHOL, V121, P26, DOI 10.1309/G23CP54DAR1BCY8L; Czechowicz J, 2011, VECTOR-BORNE ZOONOT, V11, P367, DOI 10.1089/vbz.2010.0029; Dai XQ, 2011, J CLIN VIROL, V50, P186, DOI 10.1016/j.jcv.2010.11.004; Dal Canto Mauro C., 1996, Methods (Orlando), V10, P453, DOI 10.1006/meth.1996.0123; DALCANTO MC, 1977, AM J PATHOL, V88, P497; Delhaye S, 2004, J VIROL, V78, P4357, DOI 10.1128/JVI.78.8.4357-4362.2004; DICKINSON L, 1966, BRIT J EXP PATHOL, V47, P35; Drexler JF, 2008, EMERG INFECT DIS, V14, P1398, DOI 10.3201/eid1409.080570; Feuer R, 2003, AM J PATHOL, V163, P1379, DOI 10.1016/S0002-9440(10)63496-7; Galama J, 2011, EMERG INFECT DIS, V17, P1572, DOI 10.3201/eid1708.101953; Galama JMD, 2014, ANN CLIN TRANSL NEUR, V1, P618, DOI 10.1002/acn3.82; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Hertzler S, 2011, J VIROL, V85, P7411, DOI 10.1128/JVI.00265-11; Himeda T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-110; HUBBARD GB, 1992, LAB ANIM SCI, V42, P233; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Itagaki T, 2011, PEDIATR INFECT DIS J, V30, P680, DOI 10.1097/INF.0b013e31821608a8; Iwata-Yoshikawa N, 2014, J VIROL, V88, P8597, DOI 10.1128/JVI.00983-14; Jnaoui K, 1998, VIROLOGY, V244, P397, DOI 10.1006/viro.1998.9134; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Katano H, 2011, J MED VIROL, V83, P322, DOI 10.1002/jmv.21962; Khamrin P, 2013, INFECT GENET EVOL, V13, P339, DOI 10.1016/j.meegid.2012.11.004; Khamrin P, 2011, EMERG INFECT DIS, V17, P1150, DOI [10.3201/eid1706.101983, 10.3201/eid/1706.101983]; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Kim BS, 2001, IMMUNOL RES, V24, P121, DOI 10.1385/IR:24:2:121; Kobayashi M, 2013, J INFECTION, V66, P191, DOI 10.1016/j.jinf.2012.10.022; Kotani O, 2015, NEUROPATHOLOGY, V35, P107, DOI 10.1111/neup.12171; Kuribayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068375; Li TC, 2013, EMERG INFECT DIS, V19, P115, DOI 10.3201/eid1901.121007; Masek-Hammerman K, 2012, VET PATHOL, V49, P386, DOI 10.1177/0300985811409254; Naeem A, 2014, J GEN VIROL, V95, P1945, DOI 10.1099/vir.0.066498-0; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nielsen ACY, 2012, EMERG INFECT DIS, V18, P7, DOI 10.3201/eid1801.110725; Nix WA, 2013, J GEN VIROL, V94, P2017, DOI 10.1099/vir.0.053827-0; Oberste MS, 2009, EMERG INFECT DIS, V15, P640, DOI 10.3201/eid1504.081428; Okuwa T, 2010, MICROBIOL IMMUNOL, V54, P639, DOI 10.1111/j.1348-0421.2010.00260.x; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Onishi T, 2000, ANAT REC, V258, P384, DOI 10.1002/(SICI)1097-0185(20000401)258:4<384::AID-AR6>3.0.CO;2-U; Pallansch M, 2013, FIELDS VIROLOGY, P490; Reddacliff LA, 1997, J ZOO WILDLIFE MED, V28, P153; Ren LL, 2010, EMERG INFECT DIS, V16, P1158, DOI 10.3201/eid1607.091682; Ren LL, 2009, EMERG INFECT DIS, V15, P1509, DOI 10.3201/eid1509.081531; RODRIGUEZ M, 1983, ANN NEUROL, V13, P426, DOI 10.1002/ana.410130409; RODRIGUEZ M, 1987, CRIT REV IMMUNOL, V7, P325; RODRIGUEZ M, 1992, J VIROL, V66, P217, DOI 10.1128/JVI.66.1.217-225.1992; Stavrou S, 2011, J VIROL, V85, P7177, DOI 10.1128/JVI.00009-11; Theiler M, 1937, J EXP MED, V65, P705, DOI 10.1084/jem.65.5.705; Tsukagoshi H, 2010, JPN J INFECT DIS, V63, P378; van Pesch V, 2001, J VIROL, V75, P7811, DOI 10.1128/JVI.75.17.7811-7817.2001; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Villarreal D, 2006, MICROB PATHOGENESIS, V41, P149, DOI 10.1016/j.micpath.2006.01.009; Wang LL, 2014, INT J CLIN EXP PATHO, V7, P858; Wong KT, 2012, NEUROPATH APPL NEURO, V38, P443, DOI 10.1111/j.1365-2990.2011.01247.x; Xu ZQ, 2009, EMERG INFECT DIS, V15, P993, DOI 10.3201/eid1506.090109; Yamazaki T, 2012, J LIPID RES, V53, P2024, DOI 10.1194/jlr.M023713; Yodmeeklin A, 2015, J MED VIROL, V87, P702, DOI 10.1002/jmv.24114; YOON JW, 1980, J EXP MED, V152, P878, DOI 10.1084/jem.152.4.878; Zhang X. A., 2015, SCI REP, V5, P7704, DOI DOI 10.1038/SREP07704; Zhou L, 2000, J VIROL, V74, P1477, DOI 10.1128/JVI.74.3.1477-1485.2000; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	72	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148184	10.1371/journal.pone.0148184	http://dx.doi.org/10.1371/journal.pone.0148184			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828718	Green Published, gold			2022-12-27	WOS:000369548200080
J	Lyon, R; Correll, J; Feng, C; Bluhm, B; Shrestha, S; Shi, A; Lamour, K				Lyon, Rebecca; Correll, James; Feng, Chunda; Bluhm, Burt; Shrestha, Sandesh; Shi, Ainong; Lamour, Kurt			Population Structure of Peronospora effusa in the Southwestern United States	PLOS ONE			English	Article							DOWNY MILDEW PATHOGEN; F-SP SPINACIAE; RACE RACE-4; IDENTIFICATION	Peronospora effusa is an obligate pathogen that causes downy mildew on spinach and is considered the most economically important disease of spinach. The objective of the current research was to assess genetic diversity of known historical races and isolates collected in 2014 from production fields in Yuma, Arizona and Salinas Valley, California. Candidate neutral single nucleotide polymorphisms (SNPs) were identified by comparing sequence data from reference isolates of known races of the pathogen collected in 2009 and 2010. Genotypes were assessed using targeted sequencing on genomic DNA extracted directly from infected plant tissue. Genotyping 26 historical and 167 contemporary samples at 46 SNP loci revealed 82 unique multi-locus genotypes. The unique genotypes clustered into five groups and the majority of isolates collected in 2014 were genetically closely related, regardless of source location. The historical samples, representing several races, showed greater genetic differentiation. Overall, the SNP data indicate much of the genotypic variation found within fields was produced during asexual development, whereas overall genetic diversity may be influenced by sexual recombination on broader geographical and temporal scales.	[Lyon, Rebecca; Shrestha, Sandesh; Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Correll, James; Feng, Chunda; Bluhm, Burt] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA; [Shi, Ainong] Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Lamour, K (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	klamour@utk.edu	Shi, Ainong/L-6384-2017	Shi, Ainong/0000-0002-1066-7920; Lamour, Kurt/0000-0001-6407-8825	United States Department of Agriculture-Specialty Crop Research Initiative	United States Department of Agriculture-Specialty Crop Research Initiative	Work was completed using funds from a United States Department of Agriculture-Specialty Crop Research Initiative grant (http://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) to JC, BB, and KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANDENBERGER LP, 1992, HORTSCIENCE, V27, P1118, DOI 10.21273/HORTSCI.27.10.1118; BRANDENBERGER LP, 1991, PLANT DIS, V75, P630, DOI 10.1094/PD-75-0630; Choi YJ, 2007, MYCOL RES, V111, P381, DOI 10.1016/j.mycres.2007.02.003; Choi YJ, 2011, J MICROBIOL, V49, P1039, DOI 10.1007/s12275-011-1069-2; Corell J. C., 1990, California Agriculture, V44, P14; Correll JC, 2011, EUR J PLANT PATHOL, V129, P193, DOI 10.1007/s10658-010-9713-y; CORRELL JC, 1994, PLANT DIS, V78, P653, DOI 10.1094/PD-78-0831C; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eenink A, 1976, INT J PLANT BREEDING, V25, P713; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO , 2013, FAOSTAT FAO UN; Feng C, 2014, J APPL MICROBIOLOGY; Feng CD, 2014, PLANT DIS, V98, P145, DOI 10.1094/PDIS-04-13-0435-RE; Foss C. R, 2005, CROP PROFILE SPINACH; Hu J., 2013, PLOS ONE, V8; INABA T, 1983, PLANT DIS, V67, P1139, DOI 10.1094/PD-67-1139; Irish BM, 2007, PLANT DIS, V91, P1392, DOI 10.1094/PDIS-91-11-1392; Irish BM, 2003, PLANT DIS, V87, P567, DOI 10.1094/PDIS.2003.87.5.567; Lamour K, 2006, MYCOLOGIA, V98, P514, DOI 10.3852/mycologia.98.3.514; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lucier G, 2004, ELECT OUTLOOK REPORT; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Satou Mamoru, 2006, Journal of General Plant Pathology, V72, P193, DOI 10.1007/s10327-005-0266-4; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157	28	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148385	10.1371/journal.pone.0148385	http://dx.doi.org/10.1371/journal.pone.0148385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828428	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200096
J	Mitra, P; Gupta, ED; Sahar, T; Pandey, AK; Dangi, P; Reddy, KS; Chauhan, VS; Gaur, D				Mitra, Pallabi; Gupta, Enna Dogra; Sahar, Tajali; Pandey, Alok K.; Dangi, Poonam; Reddy, K. Sony; Chauhan, Virander Singh; Gaur, Deepak			Evidence for the Nucleo-Apical Shuttling of a Beta-Catenin Like Plasmodium falciparum Armadillo Repeat Containing Protein	PLOS ONE			English	Article							PARASITE-NEUTRALIZING ANTIBODIES; MALARIA PARASITE; EXPORT SIGNALS; ERYTHROCYTE INVASION; LEPTOMYCIN-B; BINDING; LOCALIZATION; SEQUENCE; RECEPTOR; STRAIN	Eukaryotic Armadillo (ARM) repeat proteins are multifaceted with prominent roles in cell-cell adhesion, cytoskeletal regulation and intracellular signaling among many others. One such ARM repeat containing protein, ARM Repeats Only (ARO), has recently been demonstrated in both Toxoplasma (TgARO) and Plasmodium (PfARO) parasites to be targeted to the rhoptries during the late asexual stages. TgARO has been implicated to play an important role in rhoptry positioning i.e. directing the rhoptry towards the apical end of the parasite. Here, we report for the first time that PfARO exhibits a DNA binding property and a dynamic sub-cellular localization between the nucleus (early schizont) and rhoptry (late schizont) during the different stages of the asexual blood-stage life cycle. PfARO possesses a putative nuclear export signal (NES) and the nucleo-apical shuttling was sensitive to Leptomycin B (LMB) suggesting that the nuclear export was mediated by CRM1. Importantly, PfARO specifically bound an A-T rich DNA sequence of the P. falciparum Gyrase A (PfgyrA) gene, suggesting that the DNA binding specificity of PfARO is likely due to the AT-richness of the probe. This is a novel functional characteristic that has not been reported previously for any P. falciparum ARM containing protein and suggests a putative role for PfARO in gene regulation. This study describes for the first time a conserved P. falciparum ARM repeat protein with a high degree of functional versatility.	[Mitra, Pallabi; Gupta, Enna Dogra; Sahar, Tajali; Pandey, Alok K.; Dangi, Poonam; Reddy, K. Sony; Chauhan, Virander Singh] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India; [Gaur, Deepak] Jawaharlal Nehru Univ, Sch Biotechnol, Lab Malaria & Vaccine Res, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jawaharlal Nehru University, New Delhi	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India.; Gaur, D (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, Lab Malaria & Vaccine Res, New Delhi 110067, India.	viranderschauhan@gmail.com; deepakgaur189@gmail.com	Gaur, Deepak/AAF-4379-2019; Chauhan, Virander S./K-5276-2019; Sahar, Tajali/AAI-5707-2020; Reddy, K Sony/AAR-6285-2020; Pandey, Alok Kumar/ABD-9897-2021	Gupta, Enna Dogra/0000-0003-1777-833X; Mitra, Pallabi/0000-0003-4609-3006; Reddy, K. Sony/0000-0002-8437-5250	Department of Biotechnology (DBT), Government of India; Department of Biotechnology, Ministry of Science and Technology, Government of India; Ramalingaswami fellowship contingency grant; UPEII grant from Jawaharlal Nehru University (JNU)	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Ramalingaswami fellowship contingency grant; UPEII grant from Jawaharlal Nehru University (JNU)	We thank Dr Pushkar Sharma (National Institute of Immunology, New Delhi) and Prof. Suman Dhar (Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi) for providing the antibodies against PfBip and GAPDH, respectively. We thank Dr Inderjeet Kaur at the mass spectrometry facility of the malaria group, ICGEB for technical help with the LC-MS study. We appreciate Ms Surbhi Dabral at the malaria microscopy facility for technical help in our imaging study. The assistance of Dr Alka Galav, Rakesh Kumar Singh and Ashok Das from the ICGEB animal facility is deeply appreciated. D.G is the recipient of the Ramalingaswami Fellowship from the Department of Biotechnology (DBT), Government of India.; This work was supported by the following grants of the Department of Biotechnology, Ministry of Science and Technology, Government of India: Program Support Grant to D.G. and V.S.C.; Ramalingaswami fellowship contingency grant to D.G.; as well as the UPEII grant from Jawaharlal Nehru University (JNU) to D.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Cabrera A, 2012, TRAFFIC, V13, P1335, DOI 10.1111/j.1600-0854.2012.01394.x; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chene A, 2012, NUCLEIC ACIDS RES, V40, P3066, DOI 10.1093/nar/gkr1215; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Daubenberger CA, 2000, GENE, V246, P255, DOI 10.1016/S0378-1119(00)00069-X; Deka J, 1999, ONCOGENE, V18, P5654, DOI 10.1038/sj.onc.1202944; Deshmukh AS, 2012, NUCLEIC ACIDS RES, V40, P5313, DOI 10.1093/nar/gks202; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Gupta A, 2009, EUKARYOT CELL, V8, P1341, DOI 10.1128/EC.00170-09; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639, DOI 10.7164/antibiotics.36.639; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Masuda HP, 2008, EMBO J, V27, P2746, DOI 10.1038/emboj.2008.191; Mohmmed A, 2003, MOL BIOCHEM PARASIT, V127, P199, DOI 10.1016/S0166-6851(02)00331-6; Mueller C, 2013, CELL HOST MICROBE, V13, P289, DOI 10.1016/j.chom.2013.02.001; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; Panchal M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.521; Pandey AK, 2013, INFECT IMMUN, V81, P441, DOI 10.1128/IAI.01107-12; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Reddy KS, 2015, P NATL ACAD SCI USA, V112, P1179, DOI 10.1073/pnas.1415466112; Reddy KS, 2014, INFECT IMMUN, V82, P152, DOI 10.1128/IAI.00970-13; REED RG, 1975, BIOCHEMISTRY-US, V14, P4578, DOI 10.1021/bi00692a004; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Straschil U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012901; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148446	10.1371/journal.pone.0148446	http://dx.doi.org/10.1371/journal.pone.0148446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828945	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200104
J	Sales, MAF; Lacerda, MB; Horn, BLD; de Oliveira, IAP; Schultz, CL				Sales, Marcos A. F.; Lacerda, Marcel B.; Horn, Bruno L. D.; de Oliveira, Isabel A. P.; Schultz, Cesar L.			The "chi" of the Matter: Testing the Relationship between Paleoenvironments and Three Theropod Clades	PLOS ONE			English	Article							ALCANTARA FORMATION; ISOTOPE EVIDENCE; DINOSAUR; EVOLUTION; SPINOSAURIDAE; PHYLOGENY; THAILAND; AFRICA; HABITS	The view of spinosaurs as dinosaurs of semi-aquatic habits and strongly associated with marginal and coastal habitats are deeply rooted in both scientific and popular knowledge, but it was never statistically tested. Inspired by a previous analysis of other dinosaur clades and major paleoenvironmental categories, here we present our own statistical evaluation of the association between coastal and terrestrial paleoenvironments and spinosaurids, along with other two theropod taxa: abelisaurids and carcharodontosaurids. We also included a taphonomic perspective and classified the occurrences in categories related to potential biases in order to better address our interpretations. Our main results can be summarized as follows: 1) the taxon with the largest amount of statistical evidence showing it positively associated to coastal paleoenvironments is Spinosauridae; 2) abelisaurids and carcharodontosaurids had more statistical evidence showing them positively associated with terrestrial paleoenvironments; 3) it is likely that spinosaurids also occupied spatially inland areas in a way somehow comparable at least to carcharodontosaurids; 4) abelisaurids may have been more common than the other two taxa in inland habitats.	[Sales, Marcos A. F.; Lacerda, Marcel B.; Horn, Bruno L. D.; Schultz, Cesar L.] Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Inst Geociencias, Porto Alegre, RS, Brazil; [Horn, Bruno L. D.] Serv Geol Brasil CPRM, Superintendencia Reg Recife, Pernambuco, Brazil; [de Oliveira, Isabel A. P.] INPA, Manaus, Amazonas, Brazil	Universidade Federal do Rio Grande do Sul; Institute Nacional de Pesquisas da Amazonia	Sales, MAF (corresponding author), Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Inst Geociencias, Porto Alegre, RS, Brazil.	marcos.paleo@yahoo.com.br	Schultz, Cesar/I-4127-2013	Schultz, Cesar/0000-0001-7121-0409	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [141268/2013-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Ph.D. scholarship, grant number 141268/2013-1 MAFS.	Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Astibia H, 1990, TERRA NOVA, V2, P460, DOI 10.1111/j.1365-3121.1990.tb00103.x; Bakker RT., 1986, DINOSAUR HERESIES; Behrensmeyer A.K., 1990, P232; Behrensmeyer A.K., 1991, Topics in Geobiology, V9, P291; Behrensmeyer Anna K., 2002, P297; Benton MJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000321; Benyoucef M, 2015, CRETACEOUS RES, V55, P44, DOI 10.1016/j.cretres.2015.02.002; Bittencourt JS., 2004, ARQ MUS NAC, V62, P309; Buffetaut E, 2004, NATURE, V430, P33, DOI 10.1038/430033a; BUFFETAUT E, 1989, PALAEOGEOGR PALAEOCL, V73, P77, DOI 10.1016/0031-0182(89)90046-1; Buffetaut E, 1999, PALAEOGEOGR PALAEOCL, V150, P13, DOI 10.1016/S0031-0182(99)00004-8; Buffetaut E., 2005, P INT C GEOL GEOT MI, p575 ; Buffetaut E, 2011, ORYCTOS, V10, P1; Buffetaut E, 2005, 3 ANN M EUR ASS VERT, P3; Buffetaut Eric, 2005, Acta Palaeontologica Romaniae, V5, P39; Butler RJ, 2008, NATURWISSENSCHAFTEN, V95, P1027, DOI 10.1007/s00114-008-0417-5; Canudo J.I., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P347; Canudo JI, 2009, 4 JORN INT PAL DIN E, P321; Carbone C, 2011, P ROY SOC B-BIOL SCI, V278, P2682, DOI 10.1098/rspb.2010.2497; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Churcher CS, 2001, PALAEONTOLOGY, V44, P305, DOI 10.1111/1475-4983.00181; CHURCHIER C S, 1992, Journal of Vertebrate Paleontology, V12, p23A; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; Currie PJ, 2010, CAN J EARTH SCI, V47, P1277, DOI 10.1139/E10-072; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Dalla-Vecchia FM, 1995, NATURA NASCOSTA, V11, P16; [David W.E.HONE 洪大卫], 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P19; Farlow James O., 2002, Paleontological Society Papers, V8, P251; Farlow JO, 2002, HIST BIOL, V16, P21, DOI DOI 10.1080/0891296031000154687; Fricke HC, 2008, PALEOBIOLOGY, V34, P534, DOI 10.1666/08020.1; Gates TA, 2005, PALAIOS, V20, P363, DOI 10.2110/palo.2003.p03-22; Gianechini FA, 2015, CRETACEOUS RES, V54, P1, DOI 10.1016/j.cretres.2014.11.009; Gotelli N.J., 2010, PRINCIPIOS ESTATISTI; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Horner JR, 1979, J PALEONTOL, V53; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Kellner AWA, 2011, AN ACAD BRAS CIENC, V83, P99, DOI 10.1590/S0001-37652011000100006; Kellner Alexander W.A., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P151; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Machado E. B., 2007, PALEONTOLOGIA CENARI, V1, P291; Machado E, 2008, J VERTEBR PALEONTOL, V28, p109A; Medeiros MA, 2014, J S AM EARTH SCI, V53, P50, DOI 10.1016/j.jsames.2014.04.002; Medeiros Manuel Alfredo, 2007, P413; Mo JY, 2014, ACTA GEOL SIN-ENGL, V88, P6, DOI 10.1111/1755-6724.12177; Novas F. E., 2007, PALEONTOLOGIA CENARI, P333; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; Paterson N, 2011, PLANET DINOSAUR; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; R Core Team, 2018, R LANG ENV STAT COMP; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Robert PC, 2010, INTRO MONTE CARLO ME; Scotese C.R., 2013, MAP FOLIO 73 LATE SI, V5; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Serrano-Martinez A, 2015, P GEOLOGIST ASSOC, V126, P107, DOI 10.1016/j.pgeola.2014.10.005; Smith JB, 2006, NATURWISSENSCHAFTEN, V93, P242, DOI 10.1007/s00114-006-0092-3; STERNBERG C. M., 1933, ANN AND MAG NAT HIST, V11, P231; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; Therrien F, 2005, LIFE O PAST, P179; Tortosa T, 2014, ANN PALEONTOL, V100, P63, DOI 10.1016/j.annpal.2013.10.003; Weishampel DB., 2004, DINOSAURIA; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827	74	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147031	10.1371/journal.pone.0147031	http://dx.doi.org/10.1371/journal.pone.0147031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829315	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200012
J	Vasudevan, EV; Patrick, SK; Yang, JF				Vasudevan, Erin V.; Patrick, Susan K.; Yang, Jaynie F.			Gait Transitions in Human Infants: Coping with Extremes of Treadmill Speed	PLOS ONE			English	Article							LOW SPINAL CAT; RHYTHMIC LEG MOVEMENTS; SPLIT-BELT TREADMILL; CENTER-OF-MASS; WALK-TO-RUN; INTERLIMB COORDINATION; HUMAN LOCOMOTION; BILATERAL COORDINATION; CHANGING SPEED; ADAPTATION	Spinal pattern generators in quadrupedal animals can coordinate different forms of locomotion, like trotting or galloping, by altering coordination between the limbs (interlimb coordination). In the human system, infants have been used to study the subcortical control of gait, since the cerebral cortex and corticospinal tract are immature early in life. Like other animals, human infants can modify interlimb coordination to jump or step. Do human infants possess functional neuronal circuitry necessary to modify coordination within a limb (intra-limb coordination) in order to generate distinct forms of alternating bipedal gait, such as walking and running? We monitored twenty-eight infants (7-12 months) stepping on a treadmill at speeds ranging between 0.06-2.36 m/s, and seventeen adults (22-47 years) walking or running at speeds spanning the walk-to-run transition. Six of the adults were tested with body weight support to mimic the conditions of infant stepping. We found that infants could accommodate a wide range of speeds by altering stride length and frequency, similar to adults. Moreover, as the treadmill speed increased, we observed periods of flight during which neither foot was in ground contact in infants and in adults. However, while adults modified other aspects of intralimb coordination and the mechanics of progression to transition to a running gait, infants did not make comparable changes. The lack of evidence for distinct walking and running patterns in infants suggests that the expression of different functional, alternating gait patterns in humans may require neuromuscular maturation and a period of learning post-independent walking.	[Vasudevan, Erin V.] SUNY Stony Brook, Sch Hlth Technol & Management, Rehabil Res & Movement Performance RRAMP Lab, Hlth & Rehabil Sci, Stony Brook, NY 11794 USA; [Patrick, Susan K.; Yang, Jaynie F.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada; [Yang, Jaynie F.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Patrick, Susan K.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Div Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Alberta; University of Alberta; University of Alberta	Vasudevan, EV (corresponding author), SUNY Stony Brook, Sch Hlth Technol & Management, Rehabil Res & Movement Performance RRAMP Lab, Hlth & Rehabil Sci, Stony Brook, NY 11794 USA.	erin.vasudevan@stonybrook.edu	; Vasudevan, Erin/F-7081-2017	Yang, Jaynie/0000-0002-7507-8924; Vasudevan, Erin/0000-0003-1129-3489	National Sciences and Engineering Research Council [33125006, 138181-2011]; Canadian Institutes of Health Research [MOP15130]	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Support was provided by National Sciences and Engineering Research Council 33125006 & 138181-2011 [http://www.nserc-crsng.gc.cal/] and Canadian Institutes of Health Research MOP15130 [http://www.cihr-irsc.gc.ca/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER R. M., 1995, APPL MECH REV, V48, P461, DOI [10.1115/1.3005107, DOI 10.1115/1.3005107]; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Altman J, 2001, DEV HUMAN SPINAL COR; Beres-Jones JA, 2004, BRAIN, V127, P2232, DOI 10.1093/brain/awh252; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVAGNA GA, 1963, J APPL PHYSIOL, V18, P1, DOI 10.1152/jappl.1963.18.1.1; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; CHUGANI HT, 1986, SCIENCE, V231, P840, DOI 10.1126/science.3945811; Connolly KJ, 1997, CLIN DEV MED; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; ENGLISH AW, 1982, BRAIN RES, V245, P353, DOI 10.1016/0006-8993(82)90818-6; Eyre JA, 2000, BRAIN, V123, P51, DOI 10.1093/brain/123.1.51; Fady JC, 1998, DEV BRAIN RES, V108, P111, DOI 10.1016/S0165-3806(98)00040-6; Farley CT, 1998, EXERCISE SPORT SCI R, V26, P253; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; FORSSBERG H, 1977, BRAIN RES, V132, P121, DOI 10.1016/0006-8993(77)90710-7; FORSSBERG H, 1985, EXP BRAIN RES, V57, P480; Fredriks AM, 2005, ARCH DIS CHILD, V90, P807, DOI 10.1136/adc.2004.050799; GRAMSBERGEN A, 1970, Developmental Psychobiology, V3, P267, DOI 10.1002/dev.420030407; GRILLNER S, 1979, BRAIN RES, V165, P177, DOI 10.1016/0006-8993(79)90059-3; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; HALBERTSMA JM, 1983, ACTA PHYSIOL SCAND, P1; Heng C, 2007, J NEUROSCI, V27, P8558, DOI 10.1523/JNEUROSCI.1635-07.2007; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Ivanenko YP, 2011, J APPL PHYSIOL, V110, P781, DOI 10.1152/japplphysiol.00799.2010; Labini FS, 2011, J NEUROPHYSIOL, V106, P1525, DOI 10.1152/jn.00160.2011; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Lam T, 2003, J PHYSIOL-LONDON, V553, P319, DOI 10.1113/jphysiol.2003.043984; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Minetti AE, 2001, ACTA ASTRONAUT, V49, P191, DOI 10.1016/S0094-5765(01)00098-4; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; MINETTI AE, 1994, EUR J APPL PHYSIOL O, V68, P285, DOI 10.1007/BF00571444; Muir GD, 1996, J PHYSIOL-LONDON, V493, P589, DOI 10.1113/jphysiol.1996.sp021406; Musselman KE, 2008, J NEUROPHYSIOL, V100, P2225, DOI 10.1152/jn.90532.2008; Musselman KE, 2007, J NEUROPHYSIOL, V97, P1247, DOI 10.1152/jn.00891.2006; Musselman KE, 2011, J NEUROPHYSIOL, V105, P2195, DOI 10.1152/jn.01002.2010; NILSSON J, 1985, ACTA PHYSIOL SCAND, V123, P457, DOI 10.1111/j.1748-1716.1985.tb07612.x; Ogawa T, 2015, J EXP BIOL, V218, P3192, DOI 10.1242/jeb.120865; Ogawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121951; Pang MYC, 2003, J NEUROPHYSIOL, V90, P2731, DOI 10.1152/jn.00407.2003; Pang MYC, 2001, J PHYSIOL-LONDON, V533, P617, DOI 10.1111/j.1469-7793.2001.0617a.x; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Peiper A., 1963, CEREBRAL FUNCTION IN; PIEK JP, 1994, EARLY HUM DEV, V39, P109, DOI 10.1016/0378-3782(94)90160-0; Richardson EPJ., 1982, HISTOLOGY HISTOPATHO; Rossignol S, 1996, ACTA NEUROBIOL EXP, V56, P449; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Segers V, 2006, GAIT POSTURE, V24, P247, DOI 10.1016/j.gaitpost.2005.09.006; Segers V, 2007, J EXP BIOL, V210, P578, DOI 10.1242/jeb.02693; Segers V, 2013, J EXP BIOL, V216, P3047, DOI 10.1242/jeb.087015; SMITH JL, 1983, BIRTH DEFECTS-ORIG, V19, P357; Stein PSG, 2005, J COMP PHYSIOL A, V191, P213, DOI 10.1007/s00359-004-0568-6; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336, DOI 10.2106/00004623-198062030-00004; THELEN E, 1983, DEV PSYCHOBIOL, V16, P29, DOI 10.1002/dev.420160105; THELEN E, 1987, J EXP PSYCHOL HUMAN, V13, P405, DOI 10.1037/0096-1523.13.3.405; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P211, DOI 10.1111/j.1748-1716.1987.tb08228.x; Timoszyk WK, 2002, J NEUROPHYSIOL, V88, P3108, DOI 10.1152/jn.01050.2001; Van Caekenberghe I, 2010, GAIT POSTURE, V31, P52, DOI 10.1016/j.gaitpost.2009.08.244; VANHARTESVELDT C, 1991, DEV BRAIN RES, V58, P251, DOI 10.1016/0165-3806(91)90012-8; VILLABLANCA JR, 1979, DEV PSYCHOBIOL, V12, P101, DOI 10.1002/dev.420120204; Watson RR, 2011, P ROY SOC B-BIOL SCI, V278, P2040, DOI 10.1098/rspb.2010.2022; WHITALL J, 1995, CHILD DEV, V66, P1541, DOI 10.1111/j.1467-8624.1995.tb00951.x; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yang JF, 2005, J NEUROSCI, V25, P6869, DOI 10.1523/JNEUROSCI.1765-05.2005; Yang JF, 2004, CAN J PHYSIOL PHARM, V82, P662, DOI 10.1139/Y04-070; Yang JF, 1998, J PHYSIOL-LONDON, V507, P927, DOI 10.1111/j.1469-7793.1998.927bs.x; Yang JF, DEVELOPMENTAL PSYCHO; ZELAZO PR, 1983, J MOTOR BEHAV, V15, P99; Zhong H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00112	73	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148124	10.1371/journal.pone.0148124	http://dx.doi.org/10.1371/journal.pone.0148124			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828941	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200066
J	Khor, EC; Fanshawe, B; Qi, Y; Zolotukhin, S; Kulkarni, RN; Enriquez, RF; Purtell, L; Lee, NJ; Wee, NK; Croucher, PI; Campbell, L; Herzog, H; Baldock, PA				Khor, Ee-Cheng; Fanshawe, Bruce; Qi, Yue; Zolotukhin, Sergei; Kulkarni, Rishikesh N.; Enriquez, Ronaldo F.; Purtell, Louise; Lee, Nicola J.; Wee, Natalie K.; Croucher, Peter I.; Campbell, Lesley; Herzog, Herbert; Baldock, Paul A.			Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; MINERAL DENSITY; TRANSLOCATION BREAKPOINT; BODY-COMPOSITION; SNORNA SNORD116; NEUROPEPTIDE-Y; MICE; DEFICIENCY; PATHWAYS; RECEPTOR	Prader-Willi Syndrome (PWS), a maternally imprinted disorder and leading cause of obesity, is characterised by insatiable appetite, poor muscle development, cognitive impairment, endocrine disturbance, short stature and osteoporosis. A number of causative loci have been located within the imprinted Prader-Willi Critical Region (PWCR), including a set of small non-translated nucleolar RNA's (snoRNA). Recently, micro-deletions in humans identified the snoRNA Snord116 as a critical contributor to the development of PWS exhibiting many of the classical symptoms of PWS. Here we show that loss of the PWCR which includes Snord116 in mice leads to a reduced bone mass phenotype, similar to that observed in humans. Consistent with reduced stature in PWS, PWCR KO mice showed delayed skeletal development, with shorter femurs and vertebrae, reduced bone size and mass in both sexes. The reduction in bone mass in PWCR KO mice was associated with deficiencies in cortical bone volume and cortical mineral apposition rate, with no change in cancellous bone. Importantly, while the length difference was corrected in aged mice, consistent with continued growth in rodents, reduced cortical bone formation was still evident, indicating continued osteoblastic suppression by loss of PWCR expression in skeletally mature mice. Interestingly, deletion of this region included deletion of the exclusively brain expressed Snord116 cluster and resulted in an upregulation in expression of both NPY and POMC mRNA in the arcuate nucleus. Importantly, the selective deletion of the PWCR only in NPY expressing neurons replicated the bone phenotype of PWCR KO mice. Taken together, PWCR deletion in mice, and specifically in NPY neurons, recapitulates the short stature and low BMD and aspects of the hormonal imbalance of PWS individuals. Moreover, it demonstrates for the first time, that a region encoding non-translated RNAs, expressed solely within the brain, can regulate bone mass in health and disease.	[Khor, Ee-Cheng; Fanshawe, Bruce; Kulkarni, Rishikesh N.; Enriquez, Ronaldo F.; Wee, Natalie K.; Croucher, Peter I.; Baldock, Paul A.] Garvan Inst Med Res, Bone & Mineral Res Div, Sydney, NSW, Australia; [Qi, Yue; Purtell, Louise; Lee, Nicola J.; Herzog, Herbert] Garvan Inst Med Res, Neurosci Div, Sydney, NSW, Australia; [Campbell, Lesley] Garvan Inst Med Res, Diabet & Obes Res Div, Sydney, NSW, Australia; [Lee, Nicola J.; Croucher, Peter I.; Campbell, Lesley; Herzog, Herbert; Baldock, Paul A.] Univ NSW, Sch Med Sci, Sydney, NSW, Australia; [Zolotukhin, Sergei] Univ Florida, Coll Med, Dept Pediat, Ctr Smell & Taste, Gainesville, FL USA	Garvan Institute of Medical Research; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; State University System of Florida; University of Florida	Herzog, H (corresponding author), Garvan Inst Med Res, Neurosci Div, Sydney, NSW, Australia.; Herzog, H (corresponding author), Univ NSW, Sch Med Sci, Sydney, NSW, Australia.	h.herzog@garvan.org.au	/B-2038-2013; Baldock, Paul/B-3840-2012; Wee, Natalie/AAF-2134-2019	/0000-0001-7766-6095; Croucher, Peter/0000-0002-7102-2413; , Herbert/0000-0002-1713-1029; Wee, Natalie/0000-0002-7314-2646	National Health and Medical Research Council (NHMRC) of Australia [1028882]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council (NHMRC) of Australia project grant #1028882 by providing funds for reagents.	Allison SJ, 2009, J BONE MINER RES, V24, P294, DOI [10.1359/jbmr.081013, 10.1359/JBMR.081013]; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Bervini S, 2013, FRONT NEUROENDOCRIN, V34, P107, DOI 10.1016/j.yfrne.2013.01.002; Burman P, 2001, ENDOCR REV, V22, P787, DOI 10.1210/er.22.6.787; Butler MG, 2001, AM J MED GENET, V103, P216, DOI 10.1002/ajmg.1556; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chen C, 2007, CLIN PEDIATR, V46, P580, DOI 10.1177/0009922807299314; Deal CL, 2013, J CLIN ENDOCR METAB, V98, pE1072, DOI 10.1210/jc.2012-3888; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Edouard T, 2012, J CLIN ENDOCR METAB, V97, pE275, DOI 10.1210/jc.2011-2406; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Hogler W, 2010, CLIN ENDOCRINOL, V72, P281, DOI 10.1111/j.1365-2265.2009.03686.x; Hoybye C, 2002, J CLIN ENDOCR METAB, V87, P3590, DOI 10.1210/jc.87.8.3590; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Lee NJ, 2011, BONE, V48, P461, DOI 10.1016/j.bone.2010.10.174; Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; Peters J, 2008, NAT GENET, V40, P688, DOI 10.1038/ng0608-688; Qi Y, 2015, SCI REPORTS IN PRESS; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Schule B, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-18; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Shi YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011361; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; SONTAG W, 1986, BONE, V7, P63, DOI 10.1016/8756-3282(86)90153-5; Swaab DF, 1997, ACTA PAEDIATR, V86, P50; van Mil EGAH, 2001, J PEDIATR-US, V139, P708, DOI 10.1067/mpd.2001.118399; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; van Wijngaarden RFAD, 2009, J CLIN ENDOCR METAB, V94, P3763, DOI 10.1210/jc.2009-0270; Vestergaard P, 2004, J PEDIATR-US, V144, P614, DOI 10.1016/j.jpeds.2004.01.056; Wirth J, 2001, HUM MOL GENET, V10, P201, DOI 10.1093/hmg/10.3.201; Zhang Q, 2012, INT J DEV NEUROSCI, V30, P479, DOI 10.1016/j.ijdevneu.2012.05.005; Zieba J, 2015, NEUROPEPTIDES, V53, P71, DOI 10.1016/j.npep.2015.06.009	37	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148155	10.1371/journal.pone.0148155	http://dx.doi.org/10.1371/journal.pone.0148155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824232	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600106
J	Kockott, D; Herzog, B; Reichrath, J; Keane, K; Holick, MF				Kockott, Dieter; Herzog, Bernd; Reichrath, Joerg; Keane, Kevin; Holick, Michael F.			New Approach to Develop Optimized Sunscreens that Enable Cutaneous Vitamin D Formation with Minimal Erythema Risk	PLOS ONE			English	Article							PREVENTION; SUNLIGHT	Sunscreens protect the skin against erythemal radiation (E-er). But at the same time they reduce the effective radiation dose (E-VD) responsible for the formation of previtamin D in the skin. The paper describes a calculation method for optimizing the ratio E-VD/E-er behind sunscreens e.g. with SPF 5, 15 and 30 respectively. Taking into account that a majority of people in industrialized countries suffer from a shortage in vitamin D even in summer time, the ratio E-vd/E-er is a new and important criterion for the quality of sunscreens. Furthermore the exposure time t(vd) needed per day for forming the equivalent of the recommended amount of 2000 IU of vitamin D per day for skin type 2 is estimated when sunscreens with different filter compositions are used. In vitro experiments show a significant increase of the conversion of 7-dehydrocholesterol (7-DHC) to previtamin D when exposed to artificial solar radiation behind an experimental sunscreen optimized for previtamin D production compared to a commercial sunscreen having the same SPF.	[Kockott, Dieter] UV Tech, Hanau, Germany; [Herzog, Bernd] BASF Grenzach GmbH, Grenzach Wyhlen, Germany; [Reichrath, Joerg] Univ Klinikum Saarlandes, Homburg, Germany; [Keane, Kevin; Holick, Michael F.] Boston Univ, Med Ctr, Dept Med, Endocrinol Diabet & Nutr, Boston, MA 02215 USA	BASF; Universitatsklinikum des Saarlandes; Boston University	Holick, MF (corresponding author), Boston Univ, Med Ctr, Dept Med, Endocrinol Diabet & Nutr, Boston, MA 02215 USA.	mfholick@bu.edu			Nexidus, Pty Ltd of Sydney, Australia; UVTechnik Hanau; BASF Grenzach GmbH	Nexidus, Pty Ltd of Sydney, Australia; UVTechnik Hanau; BASF Grenzach GmbH(BASF)	This project was sponsored by Nexidus, Pty Ltd of Sydney, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UVTechnik Hanau and BASF Grenzach GmbH provided support in the form of salaries for authors DK and BH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2006, OFFICIAL J EUROPEA L, V265, P39; Commission Internationale de l'Eclairage (CIE), 2006, 174 CIE, V174; Dabai NS, 2012, PHOTODERMATOL PHOTO, V28, P307, DOI 10.1111/phpp.12000; Diffey B. L., 1994, International Journal of Cosmetic Science, V16, P47, DOI 10.1111/j.1467-2494.1994.tb00082.x; Herzog B., 2008, COLLOIDS COSMETICS P, V4, P275; Herzog B, 2011, COSMET SCI TECHNOL, V62, P1; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Mason RS, 2013, ANTI-CANCER AGENT ME, V13, P83; MATSUOKA LY, 1987, J CLIN ENDOCR METAB, V64, P1165, DOI 10.1210/jcem-64-6-1165; McKinlay AF., 1987, CIE J, P83; Reichrath J, 2009, BRIT J DERMATOL, V161, P54, DOI 10.1111/j.1365-2133.2009.09450.x; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]	14	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0145509	10.1371/journal.pone.0145509	http://dx.doi.org/10.1371/journal.pone.0145509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824688	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600006
J	Maissen-Villiger, CA; Schweighauser, A; van Dorland, HA; Morel, C; Bruckmaier, RM; Zurbriggen, A; Francey, T				Maissen-Villiger, Carla A.; Schweighauser, Ariane; van Dorland, H. Anette; Morel, Claudine; Bruckmaier, Rupert M.; Zurbriggen, Andreas; Francey, Thierry			Expression Profile of Cytokines and Enzymes mRNA in Blood Leukocytes of Dogs with Leptospirosis and Its Associated Pulmonary Hemorrhage Syndrome	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR-BETA; CHRONIC ENTEROPATHIES; GENE-EXPRESSION; DISEASE; INTERROGANS; HAMSTERS; FIBROSIS; SEPSIS; KIDNEY	Background Dogs with leptospirosis show similar organ manifestations and disease course as human patients, including acute kidney injury and pulmonary hemorrhage, making this naturally-occurring infection a good animalmodel for human leptospirosis. Expression patterns of cytokines and enzymes have been correlated with disease manifestations and clinical outcome in humans and animals. The aim of this study was to describe mRNA expression of pro- and anti-inflammatory mediators in canine leptospirosis and to compare it with other renal diseases to identify patterns characterizing the disease and especially its pulmonary form. Methodology and Principal Findings The mRNA abundance of cytokines (IL-1 alpha, IL-1 beta, IL-8, IL-10, TNF-alpha, TGF-beta) and enzymes (5-LO, iNOS) was measured prospectively in blood leukocytes from 34 dogs with severe leptospirosis and acute kidney injury, including 22 dogs with leptospirosis-associated pulmonary hemorrhages. Dogs with leptospirosis were compared to 14 dogs with acute kidney injury of other origin than leptospirosis, 8 dogs with chronic kidney disease, and 10 healthy control dogs. Canine leptospirosis was characterized by high 5-LO and low TNF-alpha expression compared to other causes of acute kidney injury, although the decreased TNF-alpha expression was also seen in chronic kidney disease. Leptospirosis-associated pulmonary hemorrhage was not characterized by a specific pattern, with only mild changes noted, including increased IL-10 and decreased 5-LO expression on some days in affected dogs. Fatal outcome from pulmonary hemorrhages was associated with low TNF-alpha, high IL-1 beta, and high iNOS expression, a pattern possibly expressed also in dogs with other forms of acute kidney injury. Conclusion The patterns of cytokine and enzyme expression observed in the present study indicate a complex pro- and anti-inflammatory response to the infection with leptospires. The recognition of these signatures may be of diagnostic and prognostic relevance for affected individuals and they may indicate options for newer therapies targeting the identified pathways.	[Maissen-Villiger, Carla A.; Schweighauser, Ariane; Francey, Thierry] Univ Bern, Dept Clin Vet Med, Div Small Anim Internal Med, Vetsuisse Fac, Bern, Switzerland; [van Dorland, H. Anette; Morel, Claudine; Bruckmaier, Rupert M.] Univ Bern, Dept Clin Res & Vet Publ Hlth, Div Vet Physiol, Vetsuisse Fac, Bern, Switzerland; [Zurbriggen, Andreas] Univ Bern, Dept Clin Res & Vet Publ Hlth, Div Expt Clin Res, Vetsuisse Fac, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Francey, T (corresponding author), Univ Bern, Dept Clin Vet Med, Div Small Anim Internal Med, Vetsuisse Fac, Bern, Switzerland.	thierry.francey@vetsuisse.unibe.ch	Francey, Thierry/C-2106-2014	Francey, Thierry/0000-0002-6693-5365	Robmar Foundation for Human-Animal Bond Unrestricted grant	Robmar Foundation for Human-Animal Bond Unrestricted grant	Funded by Robmar Foundation for Human-Animal Bond (www.fondation-robmar.ch) Unrestricted grant for research in canine leptospirosis and renal replacement therapies in small animals (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ashy R, 2006, CYTOKINE, V36, P1, DOI 10.1016/j.cyto.2006.10.003; Albrecht EWJA, 2002, AM J TRANSPLANT, V2, P448, DOI 10.1034/j.1600-6143.2002.20509.x; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; [Anonymous], 2003, HUM LEPT GUID DIAGN; Baumann D, 2001, VET RADIOL ULTRASOUN, V42, P305, DOI 10.1111/j.1740-8261.2001.tb00944.x; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Beineke A, 2008, VIRAL IMMUNOL, V21, P401, DOI 10.1089/vim.2008.0043; Berg DT, 2007, J BIOL CHEM, V282, P36837, DOI 10.1074/jbc.M706909200; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CAVAILLON JM, 1992, CIRC SHOCK, V38, P145; Chierakul W, 2004, CLIN IMMUNOL, V113, P140, DOI 10.1016/j.clim.2004.08.006; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cowgill LD, 2011, NEPHROLOGY AND UROLOGY OF SMALL ANIMALS, P472; d'Andon MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002664; De Brito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071743; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029; Dumusc SD, 2014, J VET INTERN MED, V28, P1684, DOI 10.1111/jvim.12463; Fraune CK, 2013, JAVMA-J AM VET MED A, V242, P1373, DOI 10.2460/javma.242.10.1373; Funk CD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002040; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Klopfleisch R., 2010, VET MED INT, DOI DOI 10.4061/2010/928541; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kohn B, 2010, J VET INTERN MED, V24, P1277, DOI 10.1111/j.1939-1676.2010.0585.x; Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014; Lowanitchapat A, 2010, COMP IMMUNOL MICROB, V33, P423, DOI 10.1016/j.cimid.2009.05.001; Maciel EAP, 2006, ACTA TROP, V100, P256, DOI 10.1016/j.actatropica.2006.11.006; Major A, 2014, INT J ENV RES PUB HE, V11, P7242, DOI 10.3390/ijerph110707242; Marinho M, 2009, AM J TROP MED HYG, V80, P832, DOI 10.4269/ajtmh.2009.80.832; Martinez-Clemente M, 2011, CURR OPIN CLIN NUTR, V14, P347, DOI 10.1097/MCO.0b013e32834777fa; Mathis SP, 2010, J IMMUNOL, V185, P3049, DOI 10.4049/jimmunol.1001031; Matsui M, 2011, INFECT IMMUN, V79, P4480, DOI 10.1128/IAI.05727-11; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Medeiros FD, 2010, ACTA TROP, V115, P155, DOI 10.1016/j.actatropica.2010.02.016; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Monteiro APT, 2014, AM J RESP CELL MOL, V50, P87, DOI 10.1165/rcmb.2012-0525OC; Noris M, 1999, P ASSOC AM PHYSICIAN, V111, P602, DOI 10.1046/j.1525-1381.1999.99256.x; Philippart Francois, 2007, Curr Infect Dis Rep, V9, P358, DOI 10.1007/s11908-007-0056-6; Pretre G, 2011, MICROB PATHOGENESIS, V51, P203, DOI 10.1016/j.micpath.2011.03.011; Rau S, 2007, VET CLIN PATH, V36, P253, DOI 10.1111/j.1939-165X.2007.tb00220.x; Reis EAG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002457; Rizvi M, 2011, ANN TROP MED PARASIT, V105, P499, DOI 10.1179/1364859411Y.0000000041; Sauter SN, 2005, DOMEST ANIM ENDOCRIN, V29, P605, DOI 10.1016/j.domaniend.2005.04.006; Schuller S, 2015, J SMALL ANIM PRACT, V56, P159, DOI 10.1111/jsap.12328; Spichiger AC, 2005, J VET MED A, V52, P491, DOI 10.1111/j.1439-0442.2005.00770.x; Spichler AS, 2008, AM J TROP MED HYG, V79, P911, DOI 10.4269/ajtmh.2008.79.911; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Sykes JE, 2011, J VET INTERN MED, V25, P1, DOI 10.1111/j.1939-1676.2010.0654.x; Tajiki, 1997, Braz J Infect Dis, V1, P138; Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177; van de Maele I, 2008, VET REC, V163, P409, DOI 10.1136/vr.163.14.409; Vaziri ND, 2001, AM J KIDNEY DIS, V38, pS74, DOI 10.1053/ajkd.2001.27409; Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06; Vernel-Pauillac F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000582; Wada T, 2007, KIDNEY INT, V72, P269, DOI 10.1038/sj.ki.5002325; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453; Zager RA, 2009, AM J PHYSIOL-RENAL, V297, pF961, DOI 10.1152/ajprenal.00381.2009	61	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148029	10.1371/journal.pone.0148029	http://dx.doi.org/10.1371/journal.pone.0148029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824356	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528600091
J	Messias, CV; Santana-Van-Vliet, E; Lemos, JP; Moreira, OC; Cotta-de-Almeida, V; Savino, W; Mendes-da-Cruz, DA				Messias, Carolina V.; Santana-Van-Vliet, Eliane; Lemos, Julia P.; Moreira, Otacilio C.; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella Areas			Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOCYTE EGRESS; CELL-MIGRATION; PROMOTES PROLIFERATION; PERIPHERAL-BLOOD; ACTIVE MOVEMENT; IN-VITRO; KINASE 1; INVASION	Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid involved in several physiological processes including cell migration and differentiation. S1P signaling is mediated through five G protein-coupled receptors (S1P1-S1P5). S1P1 is crucial to the exit of T-lymphocytes from the thymus and peripheral lymphoid organs through a gradient of S1P. We have previously observed that T-ALL and T-LBL blasts express S1P1. Herein we analyzed the role of S1P receptors in the migratory pattern of human T-cell neoplastic blasts. S1P-triggered cell migration was directly related to S1P1 expression. T-ALL blasts expressing low levels of S1P1 mRNA (HPB-ALL) did not migrate toward S1P, whereas those expressing higher levels of S1P1 (MOLT-4, JURKAT and CEM) did migrate. The S1P ligand induced T-ALL cells chemotaxis in concentrations up to 500 nM and induced fugetaxis in higher concentrations (1000-10000 nM) through interactions with S1P1. When S1P1 was specifically blocked by the W146 compound, S1P-induced migration at lower concentrations was reduced, whereas higher concentrations induced cell migration. Furthermore, we observed that S1P/S1P1 interactions induced ERK and AKT phosphorylation, and modulation of Rac1 activity. Responding T-ALL blasts also expressed S1P3 mRNA but blockage of this receptor did not modify migratory responses. Our results indicate that S1P is involved in the migration of TALL/LBL blasts, which is dependent on S1P1 expression. Moreover, S1P concentrations in the given microenvironment might induce dose-dependent chemotaxis or fugetaxis of TALL blasts.	[Messias, Carolina V.; Santana-Van-Vliet, Eliane; Lemos, Julia P.; Cotta-de-Almeida, Vinicius; Savino, Wilson; Mendes-da-Cruz, Daniella Areas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil; [Moreira, Otacilio C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mol Biol & Endem Dis, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Mendes-da-Cruz, DA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.	daniella@ioc.fiocruz.br	Cotta-de-Almeida, Vinicius/AAC-3721-2019; Mendes-da-Cruz, Daniella A/E-7875-2016; Cotta-de-Almeida, Vinicius/G-3939-2012; Mendes-da-Cruz, Daniella/AAN-6644-2020; Moreira, Otacilio/AAS-5839-2020	Cotta-de-Almeida, Vinicius/0000-0002-6753-3480; Mendes-da-Cruz, Daniella A/0000-0003-3697-1506; Mendes-da-Cruz, Daniella/0000-0003-3697-1506; Moreira, Otacilio/0000-0002-5340-8697	CNPq; Faperj; Fiocruz; FOCEM-Mercosur	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fiocruz; FOCEM-Mercosur	This work was supported by CNPq, Faperj, Fiocruz, and FOCEM-Mercosur.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Bayerl MG, 2008, LEUKEMIA LYMPHOMA, V49, P948, DOI 10.1080/10428190801911654; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brocklyn James R Van, 2010, World J Biol Chem, V1, P307, DOI 10.4331/wjbc.v1.i10.307; Cuvillier O, 2012, M S-MED SCI, V28, P951, DOI 10.1051/medsci/20122811013; Di JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12363; EPSTEIN AL, 1974, CANCER-AM CANCER SOC, V34, P1851, DOI 10.1002/1097-0142(197412)34:6<1851::AID-CNCR2820340602>3.0.CO;2-4; Evangelisti C, 2014, ONCOTARGET, V5, P7886, DOI 10.18632/oncotarget.2318; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Forbes EM, 2012, NEURON, V74, P490, DOI 10.1016/j.neuron.2012.02.035; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Grahler MH, 2005, J IMMUNOL, V174, P1997; Guan HY, 2011, MOL ENDOCRINOL, V25, P1858, DOI 10.1210/me.2011-1048; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; He SQ, 2015, INT J CLIN EXP PATHO, V8, P5175; Iino J, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-150; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832; Lee CJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1580-7; Li MH, 2009, CANCER LETT, V276, P171, DOI 10.1016/j.canlet.2008.11.025; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Malet-Engra G, 2015, CURR BIOL, V25, P242, DOI 10.1016/j.cub.2014.11.030; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuyuki H, 2006, CELL MOL IMMUNOL, V3, P429; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Mendes-da-Cruz DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103405; MINOWADA J, 1972, J NATL CANCER I, V49, P891; MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207; Nunes J, 2012, BRIT J CANCER, V106, P909, DOI 10.1038/bjc.2012.14; Onciu M, 2009, HEMATOL ONCOL CLIN N, V23, P655, DOI 10.1016/j.hoc.2009.04.009; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Poznansky MC, 2002, J CLIN INVEST, V109, P1101, DOI 10.1172/JCI200213853; Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Tabasinezhad M, 2013, J CANCER RES THER, V9, P556, DOI 10.4103/0973-1482.126446; Tarrason G, 2011, INT IMMUNOPHARMACOL, V11, P1773, DOI 10.1016/j.intimp.2011.07.004; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Watterson K, 2003, PROG LIPID RES, V42, P344, DOI 10.1016/S0163-7827(03)00015-8; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	62	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148137	10.1371/journal.pone.0148137	http://dx.doi.org/10.1371/journal.pone.0148137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824863	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600104
J	Owino, S; Contreras-Alcantara, S; Baba, K; Tosini, G				Owino, Sharon; Contreras-Alcantara, Susana; Baba, Kenkichi; Tosini, Gianluca			Melatonin Signaling Controls the Daily Rhythm in Blood Glucose Levels Independent of Peripheral Clocks	PLOS ONE			English	Article							INSULIN-SECRETION; PLASMA-GLUCOSE; MEDIATED INFLUENCE; CIRCADIAN-RHYTHMS; FOOD-INTAKE; RECEPTORS; PINEALECTOMY; METABOLISM; IDENTIFICATION; PHARMACOLOGY	Melatonin is rhythmically secreted by both the pineal gland and retina in a circadian fashion, with its peak synthesis occurring during the night. Once synthesized, melatonin exerts its effects by binding to two specific G-protein coupled receptors-melatonin receptor type 1 (MT1) and melatonin receptor type 2(MT2). Recent studies suggest the involvement of MT1 and MT2 in the regulation of glucose homeostasis; however the ability of melatonin signaling to impart timing cues on glucose metabolism remains poorly understood. Here we report that the removal of MT1 or MT2 in mice abolishes the daily rhythm in blood glucose levels. Interestingly, removal of melatonin receptors produced small effects on the rhythmic expression patterns of clock genes within skeletal muscle, liver, and adipose tissue. Taken together, our data suggest that the loss of the daily rhythm in blood glucose observed in MT1-/- and MT2-/- mice does not occur as a consequence of 'disrupted' clocks within insulin sensitive tissues. Finally our results highlight a diurnal contribution of melatonin receptor signaling in the daily regulation of blood glucose levels.	[Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; Morehouse Sch Med, Dept Pharmacol & Toxicol, Atlanta, GA 30310 USA	Morehouse School of Medicine; Morehouse School of Medicine	Baba, K; Tosini, G (corresponding author), Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA.	bkenkichi@msm.edu; gtosini@msm.edu		tosini, gianluca/0000-0003-3645-4533	NIH; NATIONAL EYE INSTITUTE [P30EY006360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH supported the research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; Bahr I, 2012, J PINEAL RES, V53, P390, DOI 10.1111/j.1600-079X.2012.01009.x; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BOLLI GB, 1984, DIABETES, V33, P1150, DOI 10.2337/diabetes.33.12.1150; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brydon L, 1999, MOL ENDOCRINOL, V13, P2025, DOI 10.1210/me.13.12.2025; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Contreras-Alcantara S, 2010, OBESITY, V18, P1861, DOI 10.1038/oby.2010.24; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Faria JA, 2013, AM J PHYSIOL-ENDOC M, V305, pE230, DOI 10.1152/ajpendo.00094.2013; Ha E, 2006, J PINEAL RES, V41, P67, DOI 10.1111/j.1600-079X.2006.00334.x; Johnston JD, 2006, ENDOCRINOLOGY, V147, P959, DOI 10.1210/en.2005-1100; JOLIN T, 1973, HORM RES, V4, P153, DOI 10.1159/000178303; Kalsbeek A, 2014, MOL METAB, V3, P372, DOI 10.1016/j.molmet.2014.03.002; Kalsbeek A, 2010, TRENDS ENDOCRIN MET, V21, P402, DOI 10.1016/j.tem.2010.02.005; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; la Fleur SE, 2003, J NEUROENDOCRINOL, V15, P315, DOI 10.1046/j.1365-2826.2003.01019.x; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; la Fleur SE, 2001, J NEUROENDOCRINOL, V13, P1025, DOI 10.1046/j.1365-2826.2001.00717.x; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Li C, 2011, GYNECOL OBSTET INVES, V72, P130, DOI 10.1159/000323542; LIMA FB, 1994, BRAZ J MED BIOL RES, V27, P995; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; de Farias TDM, 2015, J PINEAL RES, V58, P251, DOI 10.1111/jpi.12211; Nogueira TC, 2011, ENDOCRINOLOGY, V152, P1253, DOI 10.1210/en.2010-1088; Park EJ, 2014, J PINEAL RES, V56, P97, DOI 10.1111/jpi.12102; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; PAULY JE, 1967, AM J ANAT, V120, P627, DOI 10.1002/aja.1001200312; PERET J, 1973, J NUTR, V103, P866, DOI 10.1093/jn/103.6.866; Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x; Picinato MC, 2002, J PINEAL RES, V33, P156, DOI 10.1034/j.1600-079X.2002.02903.x; Reppert SM, 2002, NATURE, P418; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Saini C, 2011, COLD SH Q B, V76, P39, DOI 10.1101/sqb.2011.76.010918; Stumpf I, 2008, J PINEAL RES, V45, P318, DOI 10.1111/j.1600-079X.2008.00593.x; TAKAHASHI K, 1976, ENDOCRINOL JAPON, V23, P417; Tosini G, 2014, BIOESSAYS, V36, P778, DOI 10.1002/bies.201400017; VANCAUTER E, 1990, HORM RES, V34, P45, DOI 10.1159/000181794; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; Von Gall C, 2005, ANN NY ACAD SCI, V1040, P508, DOI 10.1196/annals.1327.105; Vriend J, 2014, LIFE SCI, V115, P8, DOI 10.1016/j.lfs.2014.08.024; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhao Y, 2012, FEBS LETT, V586, P1306, DOI 10.1016/j.febslet.2012.03.034; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	55	35	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148214	10.1371/journal.pone.0148214	http://dx.doi.org/10.1371/journal.pone.0148214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824606	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600109
J	Sujitha, SP; Kumar, DT; Doss, CGP; Aavula, K; Ramesh, R; Lakshmanan, S; Gunasekaran, S; Anilkumar, G				Sujitha, S. P.; Kumar, D. Thirumal; Doss, C. George Priya; Aavula, K.; Ramesh, R.; Lakshmanan, S.; Gunasekaran, S.; Anilkumar, G.			DNA Repair Gene (XRCC1) Polymorphism (Arg399Gln) Associated with Schizophrenia in South Indian Population: A Genotypic and Molecular Dynamics Study	PLOS ONE			English	Article							NICOTINE DEPENDENCE; TOBACCO USE; CANCER; SUSCEPTIBILITY; SMOKING; MUTATIONS; APOPTOSIS; EXPRESSION; DISORDERS; PSYCHOSIS	This paper depicts the first report from an Indian population on the association between the variant Arg399Gln of XRCC1 locus in the DNA repair system and schizophrenia, the debilitating disease that affects 1% of the world population. Genotypic analysis of a total of 523 subjects (260 patients and 263 controls) revealed an overwhelming presence of Gln399Gln in the case subjects against the controls (P < 0.0068), indicating significant level of association of this nsSNP with schizophrenia; the Gln399 allele frequency was also perceptibly more in cases than in controls (p < 0.003; OR = 1.448). The results of the genotypic studies were further validated using pathogenicity and stability prediction analysis employing computational tools [I-Mutant Suite, iStable, PolyPhen2, SNAP, and PROVEAN], with a view toassess the magnitude of deleteriousness of the mutation. The pathogenicity analysis reveals that the nsSNP could be deleterious inasmuch as it could affect the functionality of the gene, and interfere with protein function. Molecular dynamics simulation of 60ns was performed using GROMACS to analyse structural change due to a mutation (Arg399Gln) that was never examined before. RMSD, RMSF, hydrogen bonds, radius of gyration and SASA analysis showedthe existence of asignificant difference between the native and the mutant protein. The present study gives astrong indication that the XRCC1 locus deserves serious attention, as it could be a potential candidatecontributing to the etio-pathogenesis of the disease.	[Sujitha, S. P.; Kumar, D. Thirumal; Doss, C. George Priya; Aavula, K.; Ramesh, R.; Gunasekaran, S.; Anilkumar, G.] VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Vellore 632014, Tamil Nadu, India; [Lakshmanan, S.] Govt Vellore Med Coll, Dept Psychiat, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Anilkumar, G (corresponding author), VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Vellore 632014, Tamil Nadu, India.	gopianilkumar@gmail.com	Alizadeh/AAK-1398-2021; C, George/ABE-4676-2021; Kumar, Thirumal/G-2276-2017; Aavula, Kumar/GQH-9683-2022	Kumar, Thirumal/0000-0002-5545-606X; Aavula, Kumar/0000-0002-7884-6730; gopinathan, anilkumar/0000-0001-9486-9118; C, George Priya Doss/0000-0002-5971-8290	Department of Biotechnology (DBT), Government of India [BT/ PR14216/MED/30/404/2010]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The financial support from the Department of Biotechnology (DBT), Government of India, [BT/ PR14216/MED/30/404/2010] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alderson HL, 2015, LANCET PSYCHIAT, V2, P672, DOI 10.1016/S2215-0366(15)00239-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bardia A, 2012, INFLAMM RES, V61, P359, DOI 10.1007/s00011-011-0418-2; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Catts VS, 2008, ACTA PSYCHIAT SCAND, V117, P323, DOI 10.1111/j.1600-0447.2008.01163.x; Catts VS, 2012, WORLD J BIOL PSYCHIA, V13, P114, DOI 10.3109/15622975.2011.565073; Catts VS, 2000, SCHIZOPHR RES, V41, P405, DOI 10.1016/S0920-9964(99)00077-8; Catts VS, 2006, SCHIZOPHR RES, V84, P20, DOI 10.1016/j.schres.2006.03.016; Chacko P, 2005, BREAST CANCER RES TR, V89, P15, DOI 10.1007/s10549-004-1004-x; Chen CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S5; Chen JY, 2012, NEUROIMAGE, V61, P866, DOI 10.1016/j.neuroimage.2012.03.022; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Cohen ME, 2002, SCHIZOPHR RES, V57, P139, DOI 10.1016/S0920-9964(01)00308-5; Contreras J, 2010, J NEUROGENET, V24, P83, DOI 10.3109/01677060903583994; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Derakhshandeh S, 2009, PSYCHIAT RES, V169, P186, DOI 10.1016/j.psychres.2009.03.022; Divine KK, 2001, MUTAT RES-DNA REPAIR, V461, P273, DOI 10.1016/S0921-8777(00)00059-8; Duell EJ, 2001, CANCER EPIDEM BIOMAR, V10, P217; El-Domyati MM, 2009, FERTIL STERIL, V91, P2221, DOI 10.1016/j.fertnstert.2008.03.027; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Grinshpoon A, 2005, SCHIZOPHR RES, V73, P333, DOI 10.1016/j.schres.2004.06.016; Gurillo P, 2015, LANCET PSYCHIAT, V2, P718, DOI 10.1016/S2215-0366(15)00152-2; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hodgson ME, 2010, CANCER EPIDEM BIOMAR, V19, P3055, DOI 10.1158/1055-9965.EPI-10-0877; Jarskog LF, 2005, PROG NEURO-PSYCHOPH, V29, P846, DOI 10.1016/j.pnpbp.2005.03.010; Jorgensen TJ, 2009, CANCER EPIDEM BIOMAR, V18, P346, DOI 10.1158/1055-9965.EPI-08-0659; Kaplan W, 2002, BRIEF BIOINFORM, V2, P195; Kelly C., 2000, ADV PSYCHIAT TREATME, V6, P327, DOI [10.1192/apt.6.5.37, DOI 10.1192/apt.6.5.327, DOI 10.1192/APT.6.5.327]; Korytina GF, MOLBIOL MOSK, V48, P939; LAMERDIN JE, 1995, GENOMICS, V25, P547, DOI 10.1016/0888-7543(95)80056-R; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li WQ, 2013, PROG NEURO-PSYCHOPH, V44, P290, DOI 10.1016/j.pnpbp.2013.04.003; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Melkersson K, 2009, NEUROENDOCRINOL LETT, V30, P343; Molnar S, 2010, COLLEGIUM ANTROPOL, V34, P1427; Myles N, 2012, J CLIN PSYCHIAT, V73, P468, DOI 10.4088/JCP.11r07222; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Qian Y, 2010, J NEUROL SCI, V295, P62, DOI 10.1016/j.jns.2010.05.002; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Saadat I, 2012, ARCH GYNECOL OBSTET, V286, P1459, DOI 10.1007/s00404-012-2471-7; Saadat M, 2008, PSYCHIAT RES, V157, P241, DOI 10.1016/j.psychres.2007.07.014; Saadat M, 2015, J MED BIOCHEM, V34, P409, DOI 10.2478/jomb-2014-0051; Sagud M, 2009, PSYCHIAT DANUB, V21, P371; Salin-Pascual RJ, 2003, REV INVEST CLIN, V55, P677; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider J, 2008, EXPERT REV MOL DIAGN, V8, P761, DOI 10.1586/14737159.8.6.761; Shen MR, 1998, CANCER RES, V58, P604; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sujitha SP, 2014, INDIAN J MED RES, V140, P736; Tebbs RS, 2003, DNA REPAIR, V2, P1405, DOI 10.1016/j.dnarep.2003.08.007; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Vijayan NN, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-34; Vijayan NN, 2009, J HUM GENET, V54, P538, DOI 10.1038/jhg.2009.76; Volkow ND, 2009, SCHIZOPHRENIA BULL, V35, P469, DOI 10.1093/schbul/sbp016; Weng HC, 2009, MUTAT RES-GEN TOX EN, V679, P59, DOI 10.1016/j.mrgentox.2009.07.005; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Yao J, 2015, AM J MED GENET B, V168, P1, DOI 10.1002/ajmg.b.32281; YOO HY, 1992, BIOCHEM BIOPH RES CO, V186, P900, DOI 10.1016/0006-291X(92)90831-5; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404; ZHOU ZQ, 1995, MUTAT RES LETT, V348, P111, DOI 10.1016/0165-7992(95)00053-4	67	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147348	10.1371/journal.pone.0147348	http://dx.doi.org/10.1371/journal.pone.0147348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824244	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528600026
J	Gomez-Aristizabal, A; Kim, KP; Viswanathan, S				Gomez-Aristizabal, Alejandro; Kim, Kyung-Phil; Viswanathan, Sowmya			A Systematic Study of the Effect of Different Molecular Weights of Hyaluronic Acid on Mesenchymal Stromal Cell-Mediated Immunomodulation	PLOS ONE			English	Article							REGULATORY T-CELLS; STEM-CELLS; BONE-MARROW; KNEE OSTEOARTHRITIS; CHONDROGENIC DIFFERENTIATION; INTRAARTICULAR INJECTION; MACROPHAGES; ACTIVATION; EXPRESSION; ARTHRITIS	Introduction Osteoarthritis (OA) is associated with chronic inflammation, and mesenchymal stromal cells (MSCs) have been shown to provide pain relief and reparative effects in clinical investigations. MSCs are often delivered with hyaluronic acid (HA), although the combined mechanism of action is not fully understood; we thus investigated the immunomodulatory effects of combining MSCs with different molecular weights (MW) of HA. Methods HAs with MWs of 1.6 MDa (hHA), 150 kDa or 7.5 kDa, were added to MSCs alone or MSC-immune cell co-cultures. Gene expression analyses, flow cytometry and cytokine measurements were assessed to determine the effect of HAs on the MSC interactions with immune cells. Results MSCs in the presence of HAs, in both normal and lymphocyte-conditioned medium, showed negligible changes in gene expression. While addition of hHA resulted in increased proliferation of activated lymphocytes, both in the presence and absence of MSCs, the overall combined effect was a more regulated, homeostatic one; this was supported by higher ratios of secreted IL10/IFN. and IL10/IL2, in lymphocyte cultures, than with lower MW HAs or no HA, both in the presence and absence of MSCs. In addition, examination of monocyte-derived macrophages showed an increased M2 macrophage frequency (CD14 +CD163+CD206+) in the presence of hHA, both with and without MSCs. Conclusions hHA produces a less pro-inflammatory environment than lower MW HAs. Moreover, combining hHA with MSCs has an additive effect on the MSC-mediated immunomodulation, suggestive of a more potent combination treatment modality for OA.	[Gomez-Aristizabal, Alejandro; Viswanathan, Sowmya] Toronto Western Hosp, Arthritis Program, Toronto, ON M5T 2S8, Canada; [Kim, Kyung-Phil; Viswanathan, Sowmya] Princess Margaret Canc Ctr, Cell Therapy Program, Toronto, ON, Canada; [Viswanathan, Sowmya] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Viswanathan, S (corresponding author), Toronto Western Hosp, Arthritis Program, Toronto, ON M5T 2S8, Canada.; Viswanathan, S (corresponding author), Princess Margaret Canc Ctr, Cell Therapy Program, Toronto, ON, Canada.; Viswanathan, S (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	sowmya.viswanathan@uhnresearch.ca	Viswanathan, Sowmya/N-1983-2019; Viswanathan, Sowmya/GRO-4533-2022	Viswanathan, Sowmya/0000-0002-4552-0179; Gomez-Aristizabal, Alejandro/0000-0003-0853-881X	Toronto General and Western Hospital Foundation	Toronto General and Western Hospital Foundation	This research was funded by the Toronto General and Western Hospital Foundation.; This research was funded by the Toronto General and Western Hospital Foundation. The authors wish to thank Dr. Xing-Hua Wang for providing us MSCs. We also thank Dr. Armand Keating for sharing his laboratory, Dr. Dorothy Rego for her assistance with some of the experiments and Melania Pintilie for her advice on statistical analysis.	Abumaree MH, 2013, STEM CELL REV REP, V9, P620, DOI 10.1007/s12015-013-9455-2; Adutler-Lieber S, 2013, J CARDIOVASC PHARM T, V18, P78, DOI 10.1177/1074248412453875; Al Faqeh H, 2012, EXP GERONTOL, V47, P458, DOI 10.1016/j.exger.2012.03.018; Ashford Susan, 2014, Nurse Pract, V39, P1, DOI 10.1097/01.NPR.0000445886.71205.c4; Baeva LF, 2014, J BIOMED MATER RES A, V102, P305, DOI 10.1002/jbm.a.34704; Band PA, 2015, OSTEOARTHR CARTILAGE, V23, P70, DOI 10.1016/j.joca.2014.09.017; Berenbaum F, 2012, ANN RHEUM DIS, V71, P1454, DOI 10.1136/annrheumdis-2011-200972; Blom AB, 2007, ARTHRITIS RHEUM, V56, P147, DOI 10.1002/art.22337; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; BROWN TJ, 1991, EXP PHYSIOL, V76, P125, DOI 10.1113/expphysiol.1991.sp003474; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Campo GM, 2010, INNATE IMMUN-LONDON, V16, P48, DOI 10.1177/1753425909340419; Chinnadurai R, 2014, J IMMUNOL, V192, P1491, DOI 10.4049/jimmunol.1301828; Colen S, 2012, BIODRUGS, V26, P257, DOI 10.2165/11632580-000000000-00000; DARZYNKIEWICZ Z, 1971, EXP CELL RES, V66, P113, DOI 10.1016/S0014-4827(71)80018-6; Dayan V, 2012, INTERACT CARDIOV TH, V14, P516, DOI 10.1093/icvts/ivs048; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Del Papa B, 2013, EUR J IMMUNOL, V43, P182, DOI 10.1002/eji.201242643; Duchman KR, 2014, J BONE JOINT SURG AM, V96A, P1387, DOI 10.2106/JBJS.M.01048; Dvorakova J, 2008, NEUROENDOCRINOL LETT, V29, P685; Edsman K, 2011, CARTILAGE, V2, P384, DOI 10.1177/1947603511400184; Essendoubi M, 2016, SKIN RES TECHNOL, V22, P55, DOI 10.1111/srt.12228; Fahy N, 2014, OSTEOARTHR CARTILAGE, V22, P1167, DOI 10.1016/j.joca.2014.05.021; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Fellows I, 2012, J STAT SOFTW, V49, P1; Foger N, 2000, EUR J IMMUNOL, V30, P2888; Fuchs K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.364; Gomez-Aristizabal A, 2014, RECENT PAT REGEN MED, V4, P1, DOI [10.2174/2210296504666140307010938, DOI 10.2174/2210296504666140307010938]; Hagmann S, 2013, CLIN EXP IMMUNOL, V173, P454, DOI 10.1111/cei.12122; Karatay S, 2004, ANN CLIN LAB SCI, V34, P330; Larsen NE, 2012, J BIOMED MATER RES B, V100B, P457, DOI 10.1002/jbm.b.31971; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maheu E, 2011, CLIN EXP RHEUMATOL, V29, P527; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mokbel AN, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-259; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Ottaviani RA, 2007, J BONE JOINT SURG AM, V89A, P148, DOI 10.2106/JBJS.E.01135; Petrella RJ, 2011, RHEUMATOL REP, V3, P16, DOI 10.4081/rr.2011.e4; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Sall I, 2007, POLYM DEGRAD STABIL, V92, P915, DOI 10.1016/j.polymdegradstab.2006.11.020; Sato M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3735; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shen PC, 2011, OSTEOARTHR CARTILAGE, V19, P728, DOI 10.1016/j.joca.2011.02.014; Shiedlin A, 2004, BIOMACROMOLECULES, V5, P2122, DOI 10.1021/bm0498427; Singh A, 2014, BONE JOINT RES, V3, P32, DOI 10.1302/2046-3758.32.2000187; Suhaeb AM, 2012, INDIAN J EXP BIOL, V50, P383; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Vangsness CT, 2011, BULL HOSP JT DIS, V69, P122; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Vincent Heather K, 2013, Open Orthop J, V7, P378, DOI 10.2174/1874325001307010378; Wong KL, 2013, ARTHROSCOPY, V29, P2020, DOI 10.1016/j.arthro.2013.09.074; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209	55	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147868	10.1371/journal.pone.0147868	http://dx.doi.org/10.1371/journal.pone.0147868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820314	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400051
J	Han, ZZ; Wan, JH; Deng, LM; Liu, KW				Han, Zhongzhi; Wan, Jianhua; Deng, Limiao; Liu, Kangwei			Oil Adulteration Identification by Hyperspectral Imaging Using QHM and ICA	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SUPPORT VECTOR MACHINE; PREDICTION; SPECTRA	To investigate the feasibility of identification of qualified and adulterated oil product using hyperspectral imaging(HIS) technique, a novel feature set based on quantized histogram matrix (QHM) and feature selection method using improved kernel independent component analysis (iKICA) is proposed for HSI. We use UV and Halogen excitations in this study. Region of interest(ROI) of hyperspectral images of 256 oil samples from four varieties are obtained within the spectral region of 400-720nm. Radiation indexes extracted from each ROI are used as feature vectors. These indexes are individual band radiation index (RI), difference of consecutive spectral band radiation index (DRI), ratio of consecutive spectral band radiation index (RRI) and normalized DRI (NDRI). Another set of features called quantized histogram matrix (QHM) are extracted by applying quantization on the image histogram from these features. Based on these feature sets, improved kernel independent component analysis (iKICA) is used to select significant features. For comparison, algorithms such as plus L reduce R (plusLrR), Fisher, multidimensional scaling (MDS), independent component analysis (ICA), and principle component analysis (PCA) are also used to select the most significant wavelengths or features. Support vector machine (SVM) is used as the classifier. Experimental results show that the proposed methods are able to obtain robust and better classification performance with fewer number of spectral bands and simplify the design of computer vision systems.	[Han, Zhongzhi; Deng, Limiao] Qingdao Agr Univ, Informat Coll, Qingdao, Peoples R China; [Han, Zhongzhi; Wan, Jianhua; Liu, Kangwei] China Univ Petr Huadong, Sch Geosci, Qingdao, Peoples R China	Qingdao Agricultural University; China University of Petroleum	Wan, JH (corresponding author), China Univ Petr Huadong, Sch Geosci, Qingdao, Peoples R China.	wjh66310@163.com.cn	zhongzhi, Han/M-6564-2015; Deng, Limiao/AAT-1194-2020		National Scientific Research Fund of China [31201133]	National Scientific Research Fund of China	This research was made possible by a grant from the National Scientific Research Fund of China, project 31201133.	Atas M, 2012, COMPUT ELECTRON AGR, V87, P129, DOI 10.1016/j.compag.2012.06.001; Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Berry M, 1997, DATA MINING TECHNIQU; Bonaccorsi IL, 1999, J AGR FOOD CHEM, V47, P4237, DOI 10.1021/jf990417s; Chang C.C., 2011, LIBSVM LIB SUPPORT V; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Geranian H, 2015, APPL DISCRIMINANT AN, P1; Hahn S, 2006, APPL OPTICS, V45, P8374, DOI 10.1364/AO.45.008374; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A., 2001, INDEPENDENT COMPONEN, DOI [10.1002/0471221317, DOI 10.1002/0471221317]; Jebur MN, 2015, IEEE J-STARS, V8, P674, DOI 10.1109/JSTARS.2014.2341276; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Kim M, 2000, COMPUT CHEM ENG, V24, P513, DOI 10.1016/S0098-1354(00)00522-6; Wang GQ, 2007, ANAL CHIM ACTA, V594, P101, DOI 10.1016/j.aca.2007.05.004; [王晶 Wang Jing], 2013, [海洋通报, Marine Science Bulletin], V32, P452; Wassenaar HJ, 2005, J MECH DESIGN, V127, P514, DOI 10.1115/1.1897408; Xu XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096441; Yin X, 2012, THESIS OCEAN U CHINA, P5; Zheng BJ, 2015, INT J APPL EARTH OBS, V34, P103, DOI 10.1016/j.jag.2014.07.002	19	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146547	10.1371/journal.pone.0146547	http://dx.doi.org/10.1371/journal.pone.0146547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820311	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400007
J	Kotlinski, M; Rutowicz, K; Knizewski, L; Palusinski, A; Oledzki, J; Fogtman, A; Rubel, T; Koblowska, M; Dadlez, M; Ginalski, K; Jerzmanowski, A				Kotlinski, Maciej; Rutowicz, Kinga; Knizewski, Lukasz; Palusinski, Antoni; Oledzki, Jacek; Fogtman, Anna; Rubel, Tymon; Koblowska, Marta; Dadlez, Michal; Ginalski, Krzysztof; Jerzmanowski, Andrzej			Histone H1 Variants in Arabidopsis Are Subject to Numerous Post-Translational Modifications, Both Conserved and Previously Unknown in Histones, Suggesting Complex Functions of H1 in Plants	PLOS ONE			English	Article							LINKER HISTONE; GLOBULAR DOMAIN; LYSINE PROPIONYLATION; BINDING; IDENTIFICATION; MASS; PROTEINS; GENE; PYRROLYSINE; METHYLATION	Linker histones (H1s) are conserved and ubiquitous structural components of eukaryotic chromatin. Multiple non-allelic variants of H1, which differ in their DNA/nucleosome binding properties, co-exist in animal and plant cells and have been implicated in the control of genetic programs during development and differentiation. Studies in mammals and Drosophila have revealed diverse post-translational modifications of H1s, most of which are of unknown function. So far, it is not known how this pattern compares with that of H1s from other major lineages of multicellular Eukaryotes. Here, we show that the two main H1 variants of a model flowering plant Arabidopsis thaliana are subject to a rich and diverse array of post-translational modifications. The distribution of these modifications in the H1 molecule, especially in its globular domain (GH1), resembles that occurring in mammalian H1s, suggesting that their functional significance is likely to be conserved. While the majority of modifications detected in Arabidopsis H1s, including phosphorylation, acetylation, mono and dimethylation, formylation, crotonylation and propionylation, have also been reported in H1s of other species, some others have not been previously identified in histones.	[Kotlinski, Maciej; Palusinski, Antoni; Koblowska, Marta; Jerzmanowski, Andrzej] Univ Warsaw, Fac Biol, Lab Syst Biol, Warsaw, Poland; [Rutowicz, Kinga; Oledzki, Jacek; Fogtman, Anna; Koblowska, Marta; Dadlez, Michal; Jerzmanowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Knizewski, Lukasz; Ginalski, Krzysztof] Univ Warsaw, Ctr New Technol, Lab Bioinformat & Syst Biol, Warsaw, Poland; [Rubel, Tymon] Warsaw Univ Technol, Inst Radioelect & Multimedia Technol, Warsaw, Poland; [Dadlez, Michal] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Warsaw University of Technology; University of Warsaw	Jerzmanowski, A (corresponding author), Univ Warsaw, Fac Biol, Lab Syst Biol, Warsaw, Poland.; Jerzmanowski, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	andyj@ibb.waw.pl	Rubel, Tymon/L-6861-2017	Rubel, Tymon/0000-0002-1342-414X; Fogtman, Anna/0000-0002-5331-7840; Knizewski, Lukasz/0000-0003-1882-4051; Dadlez, Michal/0000-0001-8811-5176; Kotlinski, Maciej/0000-0002-0821-077X; Koblowska, Marta/0000-0003-4497-6200; Oledzki, Jacek/0000-0002-8622-3218	University of Warsaw [BW2006, BW2007]; Polish Ministry of Science and Higher Education [PBZ-MNiI-2/1/2005]; Foundation for Polish Science; Polish National Science Centre [2011/02/A/NZ2/00014]; National Centre for Research and Development [PBS1/A9/16/2012]; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland	University of Warsaw; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Polish National Science Centre; National Centre for Research and Development(National Centre for Research & Development, Poland); Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland	Support was provided by University of Warsaw, Faculty of Biology grants BW2006 and BW2007 to M. Kotlinski, Polish Ministry of Science and Higher Education grant PBZ-MNiI-2/1/2005 to M. Koblowska, Foundation for Polish Science (TEAM), Polish National Science Centre (2011/02/A/NZ2/00014) and National Centre for Research and Development (PBS1/A9/16/2012) grants to K. Ginalski. The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by: University of Warsaw, Faculty of Biology grants BW2006 and BW2007 to M. Kotlinski, Polish Ministry of Science and Higher Education grant PBZ-MNiI-2/1/2005 to M. Koblowska, Foundation for Polish Science (TEAM), Polish National Science Centre (2011/02/A/NZ2/00014) and National Centre for Research and Development (PBS1/A9/16/2012) grants to K. Ginalski. The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaudo AM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-24; Ascenzi R, 1997, PLANT MOL BIOL, V34, P629, DOI 10.1023/A:1005886011722; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Bonet-Costa C, 2012, J PROTEOMICS, V75, P4124, DOI 10.1016/j.jprot.2012.05.034; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Cui F, 2009, NUCLEIC ACIDS RES, V37, P2818, DOI 10.1093/nar/gkp113; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Ginalski K, 2003, PROTEINS, V53, P410, DOI 10.1002/prot.10548; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; Hansen JC, 2010, J CELL PHYSIOL, V224, P289, DOI 10.1002/jcp.22150; Jerzmanowski A, 2000, PLANT BIOLOGY, V2, P586, DOI 10.1055/s-2000-16648; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Michalski A, 2012, J PROTEOME RES, V11, P5479, DOI 10.1021/pr3007045; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rutowicz K, 2015, PLANT PHYSL; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Sharma P, 1999, J BIOL CHEM, V274, P9600, DOI 10.1074/jbc.274.14.9600; She WJ, 2013, DEVELOPMENT, V140, P4008, DOI 10.1242/dev.095034; Snijders APL, 2008, J PROTEOME RES, V7, P4326, DOI 10.1021/pr800260a; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tweedie-Cullen RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036980; Villar-Garea A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001553; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Wisniewski JR, 2008, NUCLEIC ACIDS RES, V36, P570, DOI 10.1093/nar/gkm1057; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Yang SM, 2013, P NATL ACAD SCI USA, V110, P1708, DOI 10.1073/pnas.1213266110; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110; Zlatanova J, 2000, FASEB J, V14, P1697, DOI 10.1096/fj.99-0869rev	47	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147908	10.1371/journal.pone.0147908	http://dx.doi.org/10.1371/journal.pone.0147908			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820416	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000369528400052
J	Pradier, MF; Ruiz, FJR; Perez-Cruz, F				Pradier, Melanie F.; Ruiz, Francisco J. R.; Perez-Cruz, Fernando			Prior Design for Dependent Dirichlet Processes: An Application to Marathon Modeling	PLOS ONE			English	Article							SAMPLING METHODS	This paper presents a novel application of Bayesian nonparametrics (BNP) for marathon data modeling. We make use of two well-known BNP priors, the single-p dependent Dirichlet process and the hierarchical Dirichlet process, in order to address two different problems. First, we study the impact of age, gender and environment on the runners' performance. We derive a fair grading method that allows direct comparison of runners regardless of their age and gender. Unlike current grading systems, our approach is based not only on top world records, but on the performances of all runners. The presented methodology for comparison of densities can be adopted in many other applications straightforwardly, providing an interesting perspective to build dependent Dirichlet processes. Second, we analyze the running patterns of the marathoners in time, obtaining information that can be valuable for training purposes. We also show that these running patterns can be used to predict finishing time given intermediate interval measurements. We apply our models to New York City, Boston and London marathons.	[Pradier, Melanie F.; Ruiz, Francisco J. R.; Perez-Cruz, Fernando] Univ Carlos III Madrid, Signal Theory & Commun Dept, Madrid, Spain; [Pradier, Melanie F.; Ruiz, Francisco J. R.; Perez-Cruz, Fernando] Gregorio Maranon Hlth Res Inst, Madrid, Spain; [Ruiz, Francisco J. R.] Columbia Univ, Data Sci Inst, New York, NY USA	Universidad Carlos III de Madrid; Columbia University	Pradier, MF (corresponding author), Univ Carlos III Madrid, Signal Theory & Commun Dept, Madrid, Spain.; Pradier, MF (corresponding author), Gregorio Maranon Hlth Res Inst, Madrid, Spain.	melanie@tsc.uc3m.es		perez-cruz, fernando/0000-0001-8996-5076	European Union 7th Framework Programme through the Marie Curie Initial Training Network "Machine Learning for Personalized Medicine" MLPM [316861]; FPU fellowship from the Spanish Ministry of Education [AP2010-5333]; Ministerio de Economia of Spain (project "COMONSENS") [CSD2008-00010]; Ministerio de Economia of Spain (project "ALCIT") [TEC2012-38800-C03-01]; Comunidad de Madrid (project "CASI-CAM-CM") [S2013/ICE-2845]; Office of Naval Research [ONR N00014-11-1-0651]; Bell Labs Alcatel-Lucent; Ministerio de Economia of Spain (project COMPREHENSION) [TEC2012-38883-C02-01]; Comunidad de Madrid (project CASI-CAM-CM) [S2013/ICE-2845]	European Union 7th Framework Programme through the Marie Curie Initial Training Network "Machine Learning for Personalized Medicine" MLPM; FPU fellowship from the Spanish Ministry of Education(German Research Foundation (DFG)); Ministerio de Economia of Spain (project "COMONSENS"); Ministerio de Economia of Spain (project "ALCIT"); Comunidad de Madrid (project "CASI-CAM-CM")(Comunidad de Madrid); Office of Naval Research(Office of Naval Research); Bell Labs Alcatel-Lucent; Ministerio de Economia of Spain (project COMPREHENSION); Comunidad de Madrid (project CASI-CAM-CM)(Comunidad de Madrid)	The authors are grateful for financial support from the following institutions: Melanie F. Pradier is supported by the European Union 7th Framework Programme through the Marie Curie Initial Training Network "Machine Learning for Personalized Medicine" MLPM2012, Grant No. 316861 (http://mlpm.eu). Francisco J. R. Ruiz is supported by an FPU fellowship from the Spanish Ministry of Education (AP2010-5333). This work is also partially supported by the Ministerio de Economia of Spain (projects "COMONSENS", id. CSD2008-00010, and "ALCIT", id. TEC2012-38800-C03-01), by the Comunidad de Madrid (project "CASI-CAM-CM", id. S2013/ICE-2845), and by the Office of Naval Research (ONR N00014-11-1-0651). Bell Labs Alcatel-Lucent provided support in the form of salaries for author FPC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the "author contributions" section.; M. F. Pradier is supported by the European Union 7th Framework Programme through the Marie Curie Initial Training Network "Machine Learning for Personalized Medicine" MLPM2012, Grant No. 316861. F. J. R. Ruiz is supported by an FPU fellowship from the Spanish Ministry of Education (AP2010-5333). This work is also partially supported by Ministerio de Economia of Spain (projects COMPREHENSION, id. TEC2012-38883-C02-01, and ALCIT, id. TEC2012-38800-C03-01), by Comunidad de Madrid (project CASI-CAM-CM, id. S2013/ICE-2845), and by the Office of Naval Research (ONR N00014-11-1-0651).	Bishop C. M, 2006, PATTERN RECOGNITION; Casella G, 2005, SPRINGER TEXTS IN ST; Celeux G., 1998, COMPSTAT 98, P227; De Iorio M, 2004, J AM STAT ASSOC, V99, P205, DOI 10.1198/016214504000000205; Dunson DB, 2010, BAYESIAN NONPARAMETR, P223; ESCOBAR MD, 1995, J AM STAT ASSOC, V90, P577, DOI 10.2307/2291069; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Gershman SJ, 2012, J MATH PSYCHOL, V56, P1, DOI 10.1016/j.jmp.2011.08.004; Ghosh S., 2011, ADV NEURAL INFORM PR, P1476; Gorur D, 2010, J COMPUT SCI TECH-CH, V25, P653, DOI [10.1007/s11390-010-9355-8, 10.1007/s11390-010-1051-1]; Hammerling D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093800; Ishwaran H, 2001, J AM STAT ASSOC, V96, P161, DOI 10.1198/016214501750332758; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; MacEachern S., 2000, DEPENDENT DIRI UNPUB; MacEachern S, 2000, TECHNICAL REPORT; Neal RM, 2000, J COMPUT GRAPH STAT, V9, P249, DOI 10.2307/1390653; Orbanz P., 2010, ENCY MACHINE LEARNIN, P81, DOI DOI 10.1007/978-0-387-30164-866; Otranto E, 2002, ECONOMET REV, V21, P477, DOI DOI 10.1081/ETC-120015387; Pitman J, 2002, COMB PROBAB COMPUT, V11, P501, DOI 10.1017/S0963548302005163; Pitman J., 2002, COMBINATORIAL STOCHA; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ren L, 2010, J AM STAT ASSOC, V105, P458, DOI 10.1198/jasa.2009.ap08497; Ruiz FJR, 2014, J MACH LEARN RES, V15, P1215; SCHULZ R, 1988, J GERONTOL, V43, pP113, DOI 10.1093/geronj/43.5.P113; SETHURAMAN J, 1994, STAT SINICA, V4, P639; The Y W, 2004, J AM STAT ASSOC, P101; Yau C, 2011, J R STAT SOC B, V73, P37, DOI 10.1111/j.1467-9868.2010.00756.x	29	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147402	10.1371/journal.pone.0147402	http://dx.doi.org/10.1371/journal.pone.0147402			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821155	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528400025
J	Hanada, S; Iwata, S; Kishi, K; Morozumi, M; Chiba, N; Wajima, T; Takata, M; Ubukata, K				Hanada, Shigeo; Iwata, Satoshi; Kishi, Kazuma; Morozumi, Miyuki; Chiba, Naoko; Wajima, Takeaki; Takata, Misako; Ubukata, Kimiko		Invasive Pneumococcal Dis Surveill	Host Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal Disease	PLOS ONE			English	Article							AGED GREATER-THAN-OR-EQUAL-TO-65 YEARS; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; LACTATE-DEHYDROGENASE; CONJUGATE VACCINE; DRUG-RESISTANCE; RISK; BACTEREMIA; MORTALITY; SEPSIS	Background Invasive pneumococcal disease (IPD) causes considerable morbidity and mortality. We aimed to identify host factors and biomarkers associated with poor outcomes in adult patients with IPD in Japan, which has a rapidly-aging population. Methods In a large-scale surveillance study of 506 Japanese adults with IPD, we investigated the role of host factors, disease severity, biomarkers based on clinical laboratory data, treatment regimens, and bacterial factors on 28-day mortality. Results Overall mortality was 24.1%, and the mortality rate increased from 10.0% in patients aged <50 years to 33.1% in patients aged >= 80 years. Disease severity also increased 28-day mortality, from 12.5% among patients with bacteraemia without sepsis to 35.0% in patients with severe sepsis and 56.9% with septic shock. The death rate within 48 hours after admission was high at 54.9%. Risk factors for mortality identified by multivariate analysis were as follows: white blood cell (WBC) count <4000 cells/mu L (odds ratio [OR], 6.9; 95% confidence interval [CI], 3.7-12.8, p < .001); age >= 80 years (OR, 6.5; 95% CI, 2.0-21.6, p = .002); serum creatinine >= 2.0 mg/dL (OR, 4.5; 95% CI, 2.5-8.1, p < .001); underlying liver disease (OR, 3.5; 95% CI, 1.6-7.8, p = .002); mechanical ventilation (OR, 3.0; 95% CI, 1.7-5.6, p < 001); and lactate dehydrogenase >= 300 IU/L (OR, 2.4; 95% CI, 1.4-4.0, p = .001). Pneumococcal serotype and drug resistance were not associated with poor outcomes. Conclusions Host factors, disease severity, and biomarkers, especially WBC counts and serum creatinine, were more important determinants of mortality than bacterial factors.	[Hanada, Shigeo; Kishi, Kazuma] Toranomon Gen Hosp, Resp Ctr, Dept Resp Med, Tokyo, Japan; [Hanada, Shigeo; Iwata, Satoshi; Morozumi, Miyuki; Chiba, Naoko; Takata, Misako; Ubukata, Kimiko] Keio Univ, Dept Infect Dis, Sch Med, Tokyo, Japan; [Hanada, Shigeo; Kishi, Kazuma] Okinaka Mem Inst Med Res, Tokyo, Japan; [Wajima, Takeaki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Microbiol, Tokyo, Japan	Toranomon Hospital; Keio University; Tokyo University of Pharmacy & Life Sciences	Ubukata, K (corresponding author), Keio Univ, Dept Infect Dis, Sch Med, Tokyo, Japan.	ubukatak@keio.jp	ubukata, kimiko/AAE-5599-2020; Wajma, Takeaki/AAF-4743-2020	Wajma, Takeaki/0000-0001-9506-707X	Japanese Ministry of Health, Labour, and Welfare [H22-013]; Grants-in-Aid for Scientific Research [26870612] Funding Source: KAKEN	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant under the category "Research on Emerging and Re-emerging Infectious Diseases" (H22-013) from the Japanese Ministry of Health, Labour, and Welfare to K. Ubukata (http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanee SRJ, 2007, CLIN INFECT DIS, V45, P46, DOI 10.1086/518538; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Boyd AR, 2012, EXP GERONTOL, V47, P507, DOI 10.1016/j.exger.2012.04.004; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Christensen JS, 2012, EUR J CLIN MICROBIOL, V31, P2719, DOI 10.1007/s10096-012-1619-5; De Gaudio AR, 2009, CURR DRUG TARGETS, V10, P60, DOI 10.2174/138945009787122879; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Esteves F, 2014, EUR J CLIN MICROBIOL, V33, P1173, DOI 10.1007/s10096-014-2054-6; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Inamura N, 2014, J INFECT CHEMOTHER, V20, P270, DOI 10.1016/j.jiac.2014.01.001; JANOFF EN, 1992, ANN INTERN MED, V117, P314, DOI 10.7326/0003-4819-117-4-314; Kalin M, 2000, J INFECT DIS, V182, P840, DOI 10.1086/315760; Klemets P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-96; Kyaw MH, 2005, J INFECT DIS, V192, P377, DOI 10.1086/431521; Leventer-Roberts M, 2015, CLIN INFECT DIS, V60, P1472, DOI 10.1093/cid/civ096; Metlay JP, 2000, CLIN INFECT DIS, V30, P520, DOI 10.1086/313716; Naucler P, 2013, THORAX, V68, P571, DOI 10.1136/thoraxjnl-2012-203106; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Thomsen RW, 2004, DIABETES CARE, V27, P1143, DOI 10.2337/diacare.27.5.1143; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; Ubukata K, 2015, EMERG INFECT DIS, V21, P1956, DOI 10.3201/eid2111.142029; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	31	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147877	10.1371/journal.pone.0147877	http://dx.doi.org/10.1371/journal.pone.0147877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815915	Green Published, gold			2022-12-27	WOS:000369528200061
J	Aggarwal, G; Prajapati, R; Tripathy, RK; Bajaj, P; Iyengar, ARS; Sangamwar, AT; Pande, AH				Aggarwal, Geetika; Prajapati, Rameshwar; Tripathy, Rajan K.; Bajaj, Priyanka; Iyengar, A. R. Satvik; Sangamwar, Abhay T.; Pande, Abhay H.			Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192	PLOS ONE			English	Article							LACTONASE ACTIVITY; BINDING; RESIDUES	Human paraoxonase 1 (h-PON1) is a serum enzyme that can hydrolyze a variety of substrates. The enzyme exhibits anti-inflammatory, anti-oxidative, anti-atherogenic, anti-diabetic, anti-microbial and organophosphate-hydrolyzing activities. Thus, h-PON1 is a strong candidate for the development of therapeutic intervention against a variety conditions in human. However, the crystal structure of h-PON1 is not solved and the molecular details of how the enzyme hydrolyzes different substrates are not clear yet. Understanding the catalytic mechanism(s) of h-PON1 is important in developing the enzyme for therapeutic use. Literature suggests that R/Q polymorphism at position 192 in h-PON1 dramatically modulates the substrate specificity of the enzyme. In order to understand the role of the amino acid residue at position 192 of h-PON1 in its various hydrolytic activities, site-specific mutagenesis at position 192 was done in this study. The mutant enzymes were produced using Escherichia coli expression system and their hydrolytic activities were compared against a panel of substrates. Molecular dynamics simulation studies were employed on selected recombinant h-PON1 (rh-PON1) mutants to understand the effect of amino acid substitutions at position 192 on the structural features of the active site of the enzyme. Our results suggest that, depending on the type of substrate, presence of a particular amino acid residue at position 192 differentially alters the micro-environment of the active site of the enzyme resulting in the engagement of different subsets of amino acid residues in the binding and the processing of substrates. The result advances our understanding of the catalytic mechanism of h-PON1.	[Aggarwal, Geetika; Tripathy, Rajan K.; Bajaj, Priyanka; Iyengar, A. R. Satvik; Pande, Abhay H.] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Sect 67, Sas Nagar Mohali 160062, Punjab, India; [Prajapati, Rameshwar; Sangamwar, Abhay T.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Sect 67, Sas Nagar Mohali 160062, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Pande, AH (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Sect 67, Sas Nagar Mohali 160062, Punjab, India.	apande@niper.ac.in	sangamwar, abhay/AAI-2200-2020; Aggarwal, Geetika/ABD-8696-2021	Aggarwal, Geetika/0000-0002-1848-5056; Iyengar, A.R. Satvik/0000-0002-7117-349X; Bajaj, Priyanka/0000-0001-7813-3709	National Institute of Pharmaceutical Education and Research, SAS Nagar [NPLC-AHP, C0412-AHP, C0312-AHP]; CSIR, New Delhi	National Institute of Pharmaceutical Education and Research, SAS Nagar; CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the National Institute of Pharmaceutical Education and Research, SAS Nagar (NPLC-AHP and C0412-AHP and C0312-AHP). PB (CSIR-SPM-SRF) and GA (CSIR-SRF) were also supported by CSIR, New Delhi in the form of CSIR Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2002, BIOCHEM BIOPH RES CO, V290, P391, DOI 10.1006/bbrc.2001.6150; Ahn JM, 2014, MOL CELL PROTEOMICS, V13, P30, DOI 10.1074/mcp.M113.028621; Bajaj P, 2015, PROTEIN EXP IN PRESS, V2015; Bajaj P, 2014, BIOCHIMIE, V22, P210; Bajaj P, 2014, APPL BIOCHEM BIOTECH, V172, P3798, DOI 10.1007/s12010-014-0806-5; Bajaj P, 2013, PROTEIN SCI, V22, P1799, DOI 10.1002/pro.2380; Bayrak A, 2011, J CHROMATOGR B, V879, P49, DOI 10.1016/j.jchromb.2010.11.006; Ben-David M, 2015, J MOL BIOL, V427, P1359, DOI 10.1016/j.jmb.2015.01.013; Ben-David M, 2013, J MOL BIOL, V425, P1028, DOI 10.1016/j.jmb.2013.01.009; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Camps J, 2007, CLIN CHIM ACTA, V386, P114, DOI 10.1016/j.cca.2007.07.016; Camps J, 2011, ANTIMICROB AGENTS CH, V55, P1325, DOI 10.1128/AAC.01502-10; Carr RL, 2015, J TOXICOL-US, V2015, DOI 10.1155/2015/470189; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; Duysen EG, 2011, GENE THER, V18, P250, DOI 10.1038/gt.2010.136; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Ferretti G, 2010, OBESITY, V18, P1079, DOI 10.1038/oby.2009.338; Gaidukov Leonid, 2009, BMC Clin Pharmacol, V9, P18, DOI 10.1186/1472-6904-9-18; Gorl J, 2012, CHEMBIOCHEM, V13, P149, DOI 10.1002/cbic.201100576; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hu X, 2009, PROTEINS, V75, P486, DOI 10.1002/prot.22264; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2006, CHEMBIOCHEM, V7, P49, DOI 10.1002/cbic.200500334; Koren-Gluzer M, 2011, ATHEROSCLEROSIS, V219, P510, DOI 10.1016/j.atherosclerosis.2011.07.119; LADU BN, 1993, CHEM-BIOL INTERACT, V87, P25, DOI 10.1016/0009-2797(93)90022-Q; Mackness B, 2010, ADV EXP MED BIOL, V660, P143, DOI 10.1007/978-1-60761-350-3_13; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; Nachon F, 2013, CHEM-BIOL INTERACT, V206, P536, DOI 10.1016/j.cbi.2013.06.012; Olga K, 2005, BIOCHEMISTRY-US, V44, P6371; Otto TC, 2009, BIOCHEMISTRY-US, V48, P10416, DOI 10.1021/bi901161b; Pajeva IK, 2013, CHEMMEDCHEM, V8, P748, DOI 10.1002/cmdc.201200491; Prajapati R, 2014, BBA-BIOMEMBRANES, V1838, P2882, DOI 10.1016/j.bbamem.2014.07.018; Prajapati R, 2013, J COMPUT AID MOL DES, V27, P347, DOI 10.1007/s10822-013-9650-x; Rozenberg O, 2008, FREE RADICAL BIO MED, V44, P1951, DOI 10.1016/j.freeradbiomed.2008.02.012; Saeed SA, 2008, HEMODIAL INT, V12, P471, DOI 10.1111/j.1542-4758.2008.00311.x; Sanan TT, 2010, J PHYS ORG CHEM, V23, P357, DOI 10.1002/poc.1678; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Steven ZF, 2009, J MOL MODEL, V17, P97; Stevens RC, 2008, P NATL ACAD SCI USA, V105, P12780, DOI 10.1073/pnas.0805865105; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Valabhji J, 2001, CLIN SCI, V101, P659, DOI 10.1042/CS20010111; Valiyaveettil M, 2011, BIOCHEM PHARMACOL, V81, P800, DOI 10.1016/j.bcp.2010.12.024; Yamashita J, 2013, J IMMUNOL, V191, P949, DOI 10.4049/jimmunol.1201828; Yeung DT, 2005, FEBS J, V272, P2225, DOI 10.1111/j.1742-4658.2005.04646.x; Yeung DT, 2004, BBA-PROTEINS PROTEOM, V1702, P67, DOI 10.1016/j.bbapap.2004.08.002	46	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147999	10.1371/journal.pone.0147999	http://dx.doi.org/10.1371/journal.pone.0147999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829396	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200051
J	Garza, MTG; Perez, DB; Rodriguez, AV; Garcia-Gutierrez, DI; Zarate, X; Cardenas, MEC; Urraca-Botello, LI; Lopez-Chuken, UJ; Trevino-Torres, AL; Cerino-Cordoba, FD; Medina-Ruiz, P; Villarreal-Chiu, JF; Morones-Ramirez, JR				Gonzalez Garza, Maria Teresa; Barboza Perez, Daniel; Vazquez Rodriguez, Augusto; Ixcoatl Garcia-Gutierrez, Domingo; Zarate, Xristo; Cantu Cardenas, Maria Elena; Ilytch Urraca-Botello, Ludwing; Javier Lopez-Chuken, Ulrico; Ludovico Trevino-Torres, Alberto; de Jesus Cerino-Cordoba, Felipe; Medina-Ruiz, Pavel; Francisco Villarreal-Chiu, Juan; Ruben Morones-Ramirez, Jose			Metal-Induced Production of a Novel Bioadsorbent Exopolysaccharide in a Native Rhodotorula mucilaginosa from the Mexican Northeastern Region	PLOS ONE			English	Article							DYE METHYLENE-BLUE; WASTE-WATER; BASIC DYE; AQUEOUS-SOLUTION; ACTIVATED CARBON; LOW-COST; REMOVAL; ADSORPTION; BIOSORPTION; IDENTIFICATION	There is a current need to develop low-cost strategies to degrade and eliminate industrially used colorants discharged into the environment. Colorants discharged into natural water streams pose various threats, including: toxicity, degradation of aesthetics and inhibiting sunlight penetration into aquatic ecosystems. Dyes and colorants usually have complex aromatic molecular structures, which make them very stable and difficult to degrade and eliminate by conventional water treatment systems. The results in this work demonstrated that heavy metal-resistant Rhodotorula mucilaginosa strain UANL-001L isolated from the northeast region of Mexico produce an exopolysaccharide (EPS), during growth, which has colorant adsorption potential. The EPS produced was purified by precipitation and dialysis and was then physically and chemically characterized by Scanning Electron Microscopy, Fourier Transform Infrared Spectroscopy, and chemical elemental analysis. Here, the ability of the purified EPS produced to adsorb methylene blue (MB), which served as a model colorant, is studied. MB adsorption by the EPS is found to follow Langmuir Adsorption Isotherm kinetics at 25 degrees C. Further, by calculating the Langmuir constant the adsorption capabilities of the EPS produced by the Rhodotorula mucilaginosa strain UANL-001L is compared to that of other adsorbents, both, microbially produced and from agroindustrial waste. The total adsorption capacity of the EPS, from the Rhodotorula mucilaginosa strain UANL-001L, was found to be two-fold greater than the best bioadsorbents reported in the literature. Finally, apart from determining which heavy metals stimulated EPS production in the strain, the optimal conditions of pH, heavy metal concentration, and rate of agitation of the growing culture for EPS production, was determined. The EPS reported here has the potential of aiding in the efficient removal of colorants both in water treatment plants and in situ in natural water streams.	[Gonzalez Garza, Maria Teresa; Barboza Perez, Daniel; Vazquez Rodriguez, Augusto; Zarate, Xristo; Cantu Cardenas, Maria Elena; Javier Lopez-Chuken, Ulrico; Ludovico Trevino-Torres, Alberto; de Jesus Cerino-Cordoba, Felipe; Francisco Villarreal-Chiu, Juan; Ruben Morones-Ramirez, Jose] Univ Autonoma Nuevo Leon, Fac Ciencias Quim, Pedro De Alba S-N, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Ixcoatl Garcia-Gutierrez, Domingo] Univ Autonoma Nuevo Leon, Fac Ingn Mecan & Elect, Pedro De Alba S-N, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Ilytch Urraca-Botello, Ludwing; Medina-Ruiz, Pavel] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Pedro De Alba S-N, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Vazquez Rodriguez, Augusto; Ruben Morones-Ramirez, Jose] Univ Autonoma Nuevo Leon, Fac Ciencias Quim, Ctr Invest Biotecnol & Nanotoxicol, Parque Invest & Innovac Tecnol, Apodaca 66629, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Morones-Ramirez, JR (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Quim, Pedro De Alba S-N, San Nicolas De Los Garza, Nuevo Leon, Mexico.; Morones-Ramirez, JR (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Quim, Ctr Invest Biotecnol & Nanotoxicol, Parque Invest & Innovac Tecnol, Apodaca 66629, Nuevo Leon, Mexico.	morones.ruben@gmail.com	Cantú-Cárdenas, María Elena/G-8127-2018; Garcia-Gutierrez, Domingo/GVS-9431-2022; Lopez-Chuken, Ulrico/EEX-2001-2022; Villarreal-Chiu, Juan Francisco/AAH-7054-2020; Zarate, Xristo/AAH-1463-2020	Cantú-Cárdenas, María Elena/0000-0002-8898-3077; Garcia-Gutierrez, Domingo/0000-0001-6350-2161; Villarreal-Chiu, Juan Francisco/0000-0002-0419-9294; Zarate, Xristo/0000-0002-9824-3961; Lopez-Chuken, Ulrico J/0000-0002-2100-9982; Morones-Ramirez, Jose Ruben/0000-0001-7009-686X	Paicyt from the Universidad Autonoma de Nuevo Leon; PROMEP [UANL-PTC-102848]; CONACyT [221332]	Paicyt from the Universidad Autonoma de Nuevo Leon; PROMEP; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Paicyt from the Universidad Autonoma de Nuevo Leon, PROMEP grant number UANL-PTC-102848, and CONACyT basic science grant 221332 financially supported this work.	Al-Ghouti MA, 2003, J ENVIRON MANAGE, V69, P229, DOI 10.1016/j.jenvman.2003.09.005; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Campbell CK, 1999, J CLIN MICROBIOL, V37, P821, DOI 10.1128/JCM.37.3.821-823.1999; Cheng HR, 2006, BIOTECHNOL LETT, V28, P55, DOI 10.1007/s10529-005-4688-z; Chi Z, 2007, BIORESOURCE TECHNOL, V98, P1329, DOI 10.1016/j.biortech.2006.05.001; Chu W, 2000, WATER RES, V34, P3153, DOI 10.1016/S0043-1354(00)00043-9; da Silva LJ, 2014, DESALIN WATER TREAT, V52, P7878, DOI 10.1080/19443994.2013.833871; De Philippis R, 2011, APPL MICROBIOL BIOT, V92, P697, DOI 10.1007/s00253-011-3601-z; Delgado-Vargas F, 2000, CRIT REV FOOD SCI, V40, P173, DOI 10.1080/10408690091189257; Demirbas A, 2009, J HAZARD MATER, V167, P1, DOI 10.1016/j.jhazmat.2008.12.114; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Garg VK, 2004, DYES PIGMENTS, V63, P243, DOI 10.1016/j.dyepig.2004.03.005; Hameed BH, 2008, COLLOID SURFACE A, V316, P78, DOI 10.1016/j.colsurfa.2007.08.033; Hameed BH, 2007, DYES PIGMENTS, V75, P143, DOI 10.1016/j.dyepig.2006.05.039; Hameed BH, 2009, J HAZARD MATER, V162, P344, DOI 10.1016/j.jhazmat.2008.05.045; Khan TA, 2015, APPL CLAY SCI, V107, P70, DOI 10.1016/j.clay.2015.01.005; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; KRIZ J, 1994, J CHROMATOGR A, V663, P151; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; Lee JW, 2006, DYES PIGMENTS, V69, P196, DOI 10.1016/j.dyepig.2005.03.008; Lei LC, 1998, WATER RES, V32, P2753, DOI 10.1016/S0043-1354(98)00025-6; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; Mohan D, 2014, BIORESOURCE TECHNOL, V160, P191, DOI 10.1016/j.biortech.2014.01.120; Perez JAM, 2008, WORLD J MICROB BIOT, V24, P2699, DOI 10.1007/s11274-008-9800-9; Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004; Nogueira PFM, 2005, FRESHWATER BIOL, V50, P1560, DOI 10.1111/j.1365-2427.2005.01406.x; Nunes JM, 2013, ANTIMICROB AGENTS CH, V57, P382, DOI 10.1128/AAC.01647-12; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Praveen PS., 2010, INT J RES PHARM SCI, V3, P317; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Rosas-Castor JM, 2014, ENVIRON TECHNOL, V35, P1077, DOI 10.1080/09593330.2013.861022; Schnider-Keel U, 2001, APPL ENVIRON MICROB, V67, P5683, DOI 10.1128/AEM.67.12.5683-5693.2001; Shah I, 2014, BIORESOURCE TECHNOL, V160, P52, DOI 10.1016/j.biortech.2014.02.047; Sharma KP, 2007, CHEMOSPHERE, V69, P48, DOI 10.1016/j.chemosphere.2007.04.086; Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003; Talarposhti AM, 2001, WATER RES, V35, P425, DOI 10.1016/S0043-1354(00)00280-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai F-C, 2013, ADSORPTION METHYLENE; Tucker S H, 1945, J CHEM EDUC, V22, P212; Verhoef R, 2005, BIOTECHNOL BIOENG, V91, P91, DOI 10.1002/bit.20494; Verma AK, 2012, J ENVIRON MANAGE, V93, P154, DOI 10.1016/j.jenvman.2011.09.012; Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zheivot VI, 2015, MICROPOR MESOPOR MAT, V202, P57, DOI 10.1016/j.micromeso.2014.09.027; Zhou WZ, 2010, SEP PURIF TECHNOL, V76, P215, DOI 10.1016/j.seppur.2010.10.011	45	13	14	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148430	10.1371/journal.pone.0148430	http://dx.doi.org/10.1371/journal.pone.0148430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828867	gold, Green Published, Green Accepted			2022-12-27	WOS:000369548200101
J	Mizuguchi, M; Sasaki, Y; Hara, T; Higuchi, M; Tanaka, Y; Funato, N; Tanaka, N; Fujii, M; Nakamura, M				Mizuguchi, Mariko; Sasaki, Yuka; Hara, Toshifumi; Higuchi, Masaya; Tanaka, Yuetsu; Funato, Noriko; Tanaka, Nobuyuki; Fujii, Masahiro; Nakamura, Masataka			Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax	PLOS ONE			English	Article							NF-KAPPA-B; ONCOGENE PRODUCT TAX; HTLV-I TAX; CYCLE PROGRESSION; GENE-EXPRESSION; TRANSACTIVATOR GENE; SECRETORY PHENOTYPE; NUCLEAR-FACTOR; PROTEIN; ACTIVATION	Tax1 encoded by the human T-cell leukemia virus type 1 (HTLV-1) has been believed to dysregulate the expression of cellular genes involved in cell survival and mortality, leading to the development of adult T-cell leukemia (ATL). The function of Tax1 in ATL development however is still controversial, primarily because Tax1 induces cell cycle progression and apoptosis. To systemically understand cell growth phase-dependent induction of cell survival or cell death by Tax1, we established a single experimental system using an interleukin 2 (IL-2)-dependent human T-cell line Kit 225 that can be forced into resting phase by IL-2 deprivation. Introduction of Tax1 and HTLV-2 Tax (Tax2B) decreased mitochondrial activity alongside apoptosis in growing cells but not in resting cells. Cell cycle profile analysis indicated that Tax1 and Tax2B were likely to perturb the S phase in growing cells. Studies with Tax1 mutants and siRNA for NF-kappa B/RelA revealed that Tax1-mediated cell growth inhibition and apoptosis in growing Kit 225 cells depend on RelA. Interestingly, inactivation of the non-canonical NF-kappa B and p38 MAPK pathways relieved Tax1-mediated apoptosis, suggesting that the Tax1-NF-kappa B-p38 MAPK axis may be associated with apoptosis in growing cells. Inflammatory mediators such as CCL3 and CCL4, which are involved in oncogene-induced senescence (OIS), were induced by Tax1 and Tax2B in growing cells. In contrast, RelA silencing in resting cells reduced mitochondrial activity, indicating that NF-kappa B/RelA is also critical for Tax1-mediated cell survival. These findings suggest that Tax1-mediated cell survival and death depend on the cell growth phase. Both effects of Tax1 may be implicated in the long latency of HTLV-1 infection.	[Mizuguchi, Mariko; Sasaki, Yuka; Funato, Noriko; Nakamura, Masataka] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo, Japan; [Hara, Toshifumi; Higuchi, Masaya; Fujii, Masahiro] Niigata Univ, Div Virol, Grad Sch Med & Dent Sci, Niigata, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Dept Immunol, Grad Sch, Okinawa, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Fac Med, Okinawa, Japan; [Tanaka, Nobuyuki] Miyagi Canc Ctr, Res Inst, Div Canc Biol & Therapeut, Natori, Miyagi, Japan	Tokyo Medical & Dental University (TMDU); Niigata University; University of the Ryukyus; University of the Ryukyus; Miyagi Cancer Center	Nakamura, M (corresponding author), Tokyo Med & Dent Univ, Human Gene Sci Ctr, Tokyo, Japan.	naka.gene@tmd.ac.jp	Higuchi, Masaya/L-2111-2019; Funato, Noriko/AAY-5113-2020	Funato, Noriko/0000-0002-1320-3304	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arainga M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-275; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chen XL, 1997, J GEN VIROL, V78, P3277, DOI 10.1099/0022-1317-78-12-3277; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Chlichlia K, 1997, ONCOGENE, V14, P2265, DOI 10.1038/sj.onc.1201070; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; De La Fuente C, 2000, J VIROL, V74, P7270, DOI 10.1128/JVI.74.16.7270-7283.2000; de la Fuente C, 2003, MOL CELL BIOCHEM, V245, P99, DOI 10.1023/A:1022866027585; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; GESSAIN A, 1985, LANCET, V2, P407; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Hara T, 2008, CANCER SCI, V99, P1155, DOI 10.1111/j.1349-7006.2008.00798.x; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; HIRAI H, 1992, ONCOGENE, V7, P1737; Ho YK, 2012, J VIROL, V86, P9474, DOI 10.1128/JVI.00158-12; HORI T, 1987, BLOOD, V70, P1069; Iwanaga R, 2008, ONCOGENE, V27, P5635, DOI 10.1038/onc.2008.174; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; KANNAGI M, 1991, INT IMMUNOL, V3, P761, DOI 10.1093/intimm/3.8.761; KAPLAN J, 1976, AM J HEMATOL, V1, P219, DOI 10.1002/ajh.2830010206; Kawakami A, 1999, BLOOD, V94, P3847, DOI 10.1182/blood.V94.11.3847.423a24_3847_3854; Kawakami H, 2005, INT J CANCER, V115, P967, DOI 10.1002/ijc.20954; Kawata S, 2003, J VIROL, V77, P7291, DOI 10.1128/JVI.77.13.7291-7299.2003; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Lewis MJ, 2000, VIROLOGY, V271, P142, DOI 10.1006/viro.2000.0284; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liang MH, 2002, J VIROL, V76, P4022, DOI 10.1128/JVI.76.8.4022-4033.2002; Macaire H, 2012, J BIOL CHEM, V287, P21357, DOI 10.1074/jbc.M112.340992; Mahieux R, 2000, J VIROL, V74, P6866, DOI 10.1128/JVI.74.15.6866-6874.2000; Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602; Matsumoto K, 1997, J VIROL, V71, P4445, DOI 10.1128/JVI.71.6.4445-4451.1997; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Mizuguchi M, 2009, J BIOL CHEM, V284, P25501, DOI 10.1074/jbc.M109.010959; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Niinuma A, 2005, J VIROL, V79, P11925, DOI 10.1128/JVI.79.18.11925-11934.2005; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; OHTANI K, 1987, EMBO J, V6, P389, DOI 10.1002/j.1460-2075.1987.tb04767.x; OHTANI K, 1989, NUCLEIC ACIDS RES, V17, P1589, DOI 10.1093/nar/17.4.1589; OSAME M, 1986, LANCET, V1, P1031; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rivera-Walsh I, 2001, J BIOL CHEM, V276, P40385, DOI 10.1074/jbc.C100501200; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; Shoji T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-83; Sieburg M, 2004, J VIROL, V78, P10399, DOI 10.1128/JVI.78.19.10399-10409.2004; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; TANAKA Y, 1991, INT J CANCER, V48, P623, DOI 10.1002/ijc.2910480423; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Waldele K, 2006, BLOOD, V107, P4491, DOI 10.1182/blood-2005-08-3138; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Wu XW, 2013, J BIOL CHEM, V288, P36094, DOI 10.1074/jbc.M113.485029; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	72	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148217	10.1371/journal.pone.0148217	http://dx.doi.org/10.1371/journal.pone.0148217			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829041	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200086
J	Pellkofer, S; van der Heijden, MGA; Schmid, B; Wagg, C				Pellkofer, Sarah; van der Heijden, Marcel G. A.; Schmid, Bernhard; Wagg, Cameron			Soil Communities Promote Temporal Stability and Species Asynchrony in Experimental Grassland Communities	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ECOSYSTEM STABILITY; PLANT DIVERSITY; STATISTICAL INEVITABILITY; BIODIVERSITY LOSS; PRODUCTIVITY; VARIABILITY; POPULATION; MECHANISMS; MICROBES	Background Over the past two decades many studies have demonstrated that plant species diversity promotes primary productivity and stability in grassland ecosystems. Additionally, soil community characteristics have also been shown to influence the productivity and composition of plant communities, yet little is known about whether soil communities also play a role in stabilizing the productivity of an ecosystem. Methodology/Principal Findings Here we use microcosms to assess the effects of the presence of soil communities on plant community dynamics and stability over a one-year time span. Microcosms were filled with sterilized soil and inoculated with either unaltered field soil or field soil sterilized to eliminate the naturally occurring soil biota. Eliminating the naturally occurring soil biota not only resulted in lower plant productivity, and reduced plant species diversity, and evenness, but also destabilized the net aboveground productivity of the plant communities over time, which was largely driven by changes in abundance of the dominant grass Lolium perenne. In contrast, the grass and legumes contributedmore to net aboveground productivity of the plant communities in microcosms where soil biota had been inoculated. Additionally, the forbs exhibited compensatory dynamics with grasses and legumes, thus lowering temporal variation in productivity in microcosms that received the unaltered soil inocula. Overall, asynchrony among plant species was higher inmicrocosms where an unaltered soil community had been inoculated, which lead to higher temporal stability in community productivity. Conclusions/Significance Our results suggest that soil communities increase plant species asynchrony and stabilize plant community productivity by equalizing the performance among competing plant species through potential antagonistic and facilitative effects on individual plant species.	[Pellkofer, Sarah; van der Heijden, Marcel G. A.; Schmid, Bernhard; Wagg, Cameron] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Pellkofer, Sarah; van der Heijden, Marcel G. A.] Inst Sustainabil Sci, Agroscope, Plant Soil Interact, Zurich, Switzerland; [van der Heijden, Marcel G. A.] Univ Utrecht, Fac Sci, Inst Environm Biol, Plant Microbe Interact, Utrecht, Netherlands	University of Zurich; Swiss Federal Research Station Agroscope; Utrecht University	Wagg, C (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.	cameron.wagg@ieu.uzh.ch	Wagg, Cameron/O-4318-2019; Schmid, Bernhard/C-8625-2009; van der Heijden, Marcel/AAY-1593-2021; van der Heijden, Marcel G.A./H-5243-2011	Wagg, Cameron/0000-0002-9738-6901; Schmid, Bernhard/0000-0002-8430-3214; van der Heijden, Marcel/0000-0001-7040-1924	Swiss National Science Foundation [PDFMP3_137136, GAO: 6570295]; Jena Experiment (German Science Foundation (DFG)) [FOR456/1451]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Jena Experiment (German Science Foundation (DFG))(German Research Foundation (DFG))	Sarah Pellkofer was supported by the Swiss National Science Foundation grant, Project number: PDFMP3_137136, Internal Number GAO: 6570295 awarded to Marcel van der Heijden and Bernhard Schmid. Cameron Wagg was supported by the Jena Experiment (German Science Foundation (DFG) grant FOR456/1451).	Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carter DO, 2007, PEDOBIOLOGIA, V51, P295, DOI 10.1016/j.pedobi.2007.05.002; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson P., 2003, MECH MAINTENANCE SPE; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; de Mazancourt C, 2013, ECOL LETT, V16, P617, DOI 10.1111/ele.12088; De Vries FT, 2015, J ECOL, V103, P629, DOI 10.1111/1365-2745.12383; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Eisenhauer N, 2013, P NATL ACAD SCI USA, V110, P6889, DOI 10.1073/pnas.1217382110; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; FRANCIS R, 1994, PLANT SOIL, V159, P11, DOI 10.1007/BF00000091; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; HARTNETT DC, 1993, J ECOL, V81, P787, DOI 10.2307/2261676; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hendriks M, 2013, J ECOL, V101, P287, DOI 10.1111/1365-2745.12032; HETRICK BAD, 1994, ENVIRON POLLUT, V86, P171, DOI 10.1016/0269-7491(94)90188-0; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Lau JA, 2011, NEW PHYTOL, V192, P215, DOI 10.1111/j.1469-8137.2011.03790.x; Lauber K., 2018, FLORA HELVETICA; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Luescher A., 2008, BIODIVERSITY-OTTAWA, V9, P29; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Moora M, 2014, FEMS MICROBIOL ECOL, V90, P609, DOI 10.1111/1574-6941.12420; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Nyfeler D., 2008, Biodiversity and animal feed: future challenges for grassland production. Proceedings of the 22nd General Meeting of the European Grassland Federation, Uppsala, Sweden, 9-12 June 2008, P197; Polley HW, 2013, OIKOS, V122, P1275, DOI 10.1111/j.1600-0706.2013.00338.x; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Postma-Blaauw MB, 2010, ECOLOGY, V91, P460, DOI 10.1890/09-0666.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roscher C, 2011, J ECOL, V99, P1460, DOI 10.1111/j.1365-2745.2011.01875.x; Scheublin TR, 2007, J ECOL, V95, P631, DOI 10.1111/j.1365-2745.2007.01244.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Thibaut LM, 2013, ECOL LETT, V16, P140, DOI 10.1111/ele.12019; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TIWARI SC, 1988, SOIL BIOL BIOCHEM, V20, P583, DOI 10.1016/0038-0717(88)90079-X; Tsiafouli MA, 2015, GLOBAL CHANGE BIOL, V21, P973, DOI 10.1111/gcb.12752; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2; Verbruggen E, 2010, NEW PHYTOL, V186, P968, DOI 10.1111/j.1469-8137.2010.03230.x; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wagg C, 2011, ECOL LETT, V14, P1001, DOI 10.1111/j.1461-0248.2011.01666.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Yang GW, 2014, J ECOL, V102, P1072, DOI 10.1111/1365-2745.12249; ZOBEL M, 1995, FOLIA GEOBOT PHYTOTX, V30, P223, DOI 10.1007/BF02812100	65	14	15	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148015	10.1371/journal.pone.0148015	http://dx.doi.org/10.1371/journal.pone.0148015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829481	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000369548200052
J	Doran, CM; Ling, R; Byrnes, J; Crane, M; Shakeshaft, AP; Searles, A; Perez, D				Doran, Christopher M.; Ling, Rod; Byrnes, Joshua; Crane, Melanie; Shakeshaft, Anthony P.; Searles, Andrew; Perez, Donna			Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia	PLOS ONE			English	Article							PREVENTION	Public education mass media campaigns are an important intervention for influencing behaviour modifications. However, evidence on the effectiveness of such campaigns to encourage the population to reduce sun exposure is limited. This study investigates the benefits and costs of three skin cancer campaigns implemented in New South Wales from 2006-2013. This analysis uses Australian dollars (AUD) and 2010-11 as the currency and base year, respectively. Historical data on skin cancer were used to project skin cancer rates for the period 2006-2020. The expected number of skin cancer cases is derived by combining skin cancer rates, sunburn rates and relative risk of skin cancers due to sun exposure. Counterfactual estimates are based on sunburn exposure in the absence of the campaigns. Monetary values are attached to direct (treatment) and indirect (productivity) costs saved due to fewer skin cancer cases. Monetary benefits are compared with the cost of implementing the campaigns and are presented in the form of a benefit-cost ratio. Relative to the counterfactual (i.e., no campaigns) there are an estimated 13,174 fewer skin cancers and 112 averted deaths over the period 2006-2013. The net present value of these benefits is $60.17 million and the campaign cost is $15.63 million. The benefit cost ratio is 3.85, suggesting that for every $1 invested a return of $3.85 is achieved. Skin cancer public education mass media campaigns are a good investment given the likely extent to which they reduce the morbidity, mortality and economic burden of skin cancer.	[Doran, Christopher M.] Cent Queensland Univ, Sch Human Hlth & Social Sci, Brisbane, Qld, Australia; [Doran, Christopher M.; Ling, Rod; Searles, Andrew] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Byrnes, Joshua] Griffith Univ, Ctr Appl Hlth Econ, Brisbane, Qld 4111, Australia; [Crane, Melanie; Perez, Donna] Canc Inst New South Wales, Sydney, NSW, Australia; [Crane, Melanie] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Shakeshaft, Anthony P.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	Central Queensland University; Hunter Medical Research Institute; University of Newcastle; Griffith University; University of Sydney; University of New South Wales Sydney	Doran, CM (corresponding author), Cent Queensland Univ, Sch Human Hlth & Social Sci, Brisbane, Qld, Australia.; Doran, CM (corresponding author), Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia.	c.doran@cqu.edu.au	Byrnes, Josh/AAA-4387-2021; Shakeshaft, Anthony/U-4637-2017	Shakeshaft, Anthony/0000-0002-5472-0930; Searles, Andrew/0000-0002-9452-9735; Byrnes, Joshua/0000-0001-6562-711X; Crane, Melanie/0000-0002-3058-2211; ling, rod/0000-0002-6862-6363	CINSW [C12/0042]	CINSW	The research team would like to acknowledge the support and funding received from CINSW to conduct the study, Grant number C12/0042. The funder enabled access to appropriate data, assisted with the ethics application and provided comment on the final manuscript.	American Cancer Society, CANC FACTS FIG 2013; [Anonymous], 2014, WORLD CANC REP 2014; Armstrong BK, 2004, CANC PREV CANC CAUSE, V3, P89; Australian Bureau of Statistics, 2013, EST RES POP AG SEX; Australian Institute of Health and Welfare, 2012, AUSTR HLTH 2012; Australian Institute of Health and Welfare & Australasian Association of Cancer Registries, 2012, CANC AUSTR OV 2012; Cancer Council Australia, 2012, SKIN CANC FACTS FIG; Cancer Institute New South Wales, 2013, NSW CENTR CANC REG D; Dobbinson SJ, 2008, AM J PREV MED, V34, P94, DOI 10.1016/j.amepre.2007.09.024; Doran CM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2267-3; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Gordon LG, 2009, J INVEST DERMATOL, V129, P2766, DOI 10.1038/jid.2009.141; Hirst NG, 2012, VALUE HEALTH, V15, P261, DOI 10.1016/j.jval.2011.10.009; Kyle JW, 2008, PEDIATRICS, V121, pE1074, DOI 10.1542/peds.2007-1400; National Cancer Control Initiative Skin Cancer Working Group, 2003, 2002 NAT NONM SKIN C; Pollay RW, 1996, J MARKETING, V60, P1, DOI 10.2307/1251927; Reserve Bank of Australia, 2014, CASH RAT TARG; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Shih STF, 2009, PREV MED, V49, P449, DOI 10.1016/j.ypmed.2009.09.008; Tracey E, 2008, CANC NSW INCIDENCE M; Veerman L., 2010, ASSESSING COST EFFEC	21	34	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147665	10.1371/journal.pone.0147665	http://dx.doi.org/10.1371/journal.pone.0147665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824695	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600046
J	Smoothey, AF; Gray, CA; Kennelly, SJ; Masens, OJ; Peddemors, VM; Robinson, WA				Smoothey, Amy F.; Gray, Charles A.; Kennelly, Steve J.; Masens, Oliver J.; Peddemors, Victor M.; Robinson, Wayne A.			Patterns of Occurrence of Sharks in Sydney Harbour, a Large Urbanised Estuary	PLOS ONE			English	Article							JUVENILE BULL SHARKS; NEW-SOUTH-WALES; CARCHARHINUS-LEUCAS; GALEOCERDO-CUVIER; MOVEMENT PATTERNS; TIGER SHARKS; HETERODONTUS-PORTUSJACKSONI; NOTORYNCHUS-CEPEDIANUS; REPRODUCTIVE-BIOLOGY; POPULATION-STRUCTURE	Information about spatial and temporal variability in the distribution and abundance of shark-populations are required for their conservation, management and to update measures designed to mitigate human-shark interactions. However, because some species of sharks are mobile, migratory and occur in relatively small numbers, estimating their patterns of distribution and abundance can be very difficult. In this study, we used a hierarchical sampling design to examine differences in the composition of species, size-and sex-structures of sharks sampled with bottom-set longlines in three different areas with increasing distance from the entrance of Sydney Harbour, a large urbanised estuary. During two years of sampling, we obtained data for four species of sharks (Port Jackson, Heterodontus portusjack-soni; wobbegong, Orectolobus maculatus; dusky whaler, Carcharhinus obscurus and bull shark, Carcharhinus leucas). Only a few O. maculatus and C. obscurus were caught, all in the area closest to the entrance of the Harbour. O. maculatus were caught in all seasons, except summer, while C. obscurus was only caught in summer. Heterodontus portusjack-soni were the most abundant species, caught in the entrance location mostly between July to November, when water temperature was below 21.5 degrees C. This pattern was consistent across both years. C. leucas, the second most abundant species, were captured in all areas of Sydney Harbour but only in summer and autumn when water temperatures were above 23 degrees C. This study quantified, for this first time, how different species utilise different areas of Sydney Harbour, at different times of the year. This information has implications for the management of human-shark interactions, by enabling creation of education programs to modify human behaviour in times of increased risk of potentially dangerous sharks.	[Smoothey, Amy F.; Masens, Oliver J.; Peddemors, Victor M.] Sydney Inst Marine Sci, NSW Dept Primary Ind, Mosman, NSW, Australia; [Gray, Charles A.] WildFish Res, Grays Point, NSW, Australia; [Kennelly, Steve J.] IC Independent Consulting, Cronulla, NSW, Australia; [Robinson, Wayne A.] Charles Sturt Univ, Sch Environm Sci, Thurgoona, NSW, Australia	NSW Department of Primary Industries; Sydney Institute of Marine Science; Charles Sturt University	Smoothey, AF (corresponding author), Sydney Inst Marine Sci, NSW Dept Primary Ind, Mosman, NSW, Australia.	amy.smoothey@dpi.nsw.gov.au	Peddemors, Victor M/Q-4281-2016	ROBINSON, WAYNE/0000-0002-8793-7466; Peddemors, Victor/0000-0002-8743-9782; Gray, Charles/0000-0001-9939-9995	NSW Department of Primary Industries	NSW Department of Primary Industries	This study was supported by funds from NSW Department of Primary Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors can confirm that SJK is now employed by IC Independent Consulting, NSW, Australia and CAG is now employed by WildFish Research, Grays Point, NSW, Australia. Both researchers were employed by NSW Department of Primary Industries when the study was designed, data collected, initially analysed and the decision made to publish. The funders (IC Independent Consulting and WildFish Research) provided support in the form of salaries for authors (SJK & CAG, respectively), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contributions' section.	Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Barnett A, 2010, J FISH BIOL, V77, P1688, DOI 10.1111/j.1095-8649.2010.02810.x; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015464; Barnett A, 2010, MAR ECOL PROG SER, V416, P189, DOI 10.3354/meps08778; Bernal D, 2012, CRC MAR BIOL SER, P211; Broadhurst MK, 2014, GLOB ECOL CONSERV, V2, P181, DOI 10.1016/j.gecco.2014.09.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrier JC, 2004, CRC MAR BIOL SER, P269; Cavanaugh JE, 1997, STAT PROBABIL LETT, V33, P201, DOI 10.1016/S0167-7152(96)00128-9; Chapman MG, 2002, AUSTRAL ECOL, V27, P211, DOI 10.1046/j.1442-9993.2002.01172.x; Chin A, 2013, AQUAT CONSERV, V23, P468, DOI 10.1002/aqc.2349; Chin A, 2013, J FISH BIOL, V82, P1192, DOI 10.1111/jfb.12057; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Clynick B, 2002, MAR FRESHWATER RES, V53, P669, DOI 10.1071/MF00147; Clynick BG, 2008, AUSTRAL ECOL, V33, P140, DOI 10.1111/j.1442-9993.2007.01802.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Daly R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109357; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Froeschke JT, 2013, CAN J FISH AQUAT SCI, V70, P13, DOI 10.1139/cjfas-2012-0037; Gaston K.J., 1994, RARITY, P1; Gibbs L, 2015, MAR POLICY, V58, P116, DOI 10.1016/j.marpol.2015.04.014; Gibbs L, 2014, AUST GEOGR, V45, P101, DOI 10.1080/00049182.2014.899023; Grubbs RD, SHARK NURS GROUNDS G, P87; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Heithaus MR, 2008, J EXP MAR BIOL ECOL, V356, P43, DOI 10.1016/j.jembe.2007.12.013; Heithaus MR, 2007, CAN J FISH AQUAT SCI, V64, P1302, DOI 10.1139/F07-098; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00012; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2002, MAR FRESHWATER RES, V53, P543, DOI 10.1071/MF01132; Heupel MR, SHARK NURS GROUNDS G, P265; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Hutchings Pat A., 2013, Australian Zoologist, V36, P255, DOI 10.7882/AZ.2012.031; Huveneers C, 2009, AQUAT LIVING RESOUR, V22, P255, DOI 10.1051/alr/2009046; Johnston EL, 2015, MAR FRESHWATER RES, V66, P1073, DOI 10.1071/MF15159; Knip DM, 2011, MAR ECOL PROG SER, V425, P233, DOI 10.3354/meps09006; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; KOLASA J, 1991, ECOLOGICAL HETEROGEN; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lee KA, 2014, BIODIVERS CONSERV, V23, P2781, DOI 10.1007/s10531-014-0748-9; Macbeth W. G., 2009, OBSERVER BASED STUDY; Matich P, 2012, MAR ECOL PROG SER, V447, P165, DOI 10.3354/meps09497; Mayer-Pinto M, 2015, MAR FRESHWATER RES, V66, P1088, DOI 10.1071/MF15157; McCullagh P, 1989, GEN LINEAR MODELS; McPhee D, 2014, COAST MANAGE, V42, P478, DOI 10.1080/08920753.2014.942046; MORRISEY DJ, 1992, MAR ECOL PROG SER, V81, P197, DOI 10.3354/meps081197; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Neff C, 2012, COAST MANAGE, V40, P88, DOI 10.1080/08920753.2011.639867; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; Powter DM, 2008, J FISH BIOL, V72, P2615, DOI 10.1111/j.1095-8649.2008.01878.x; Powter DM, 2008, MAR FRESHWATER RES, V59, P444, DOI 10.1071/MF07096; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Smoothey AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061257; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Thompson RC, 1996, J EXP MAR BIOL ECOL, V202, P73, DOI 10.1016/0022-0981(96)00032-9; Tillett BJ, 2011, MAR FRESHWATER RES, V62, P850, DOI 10.1071/MF10271; Torres LG, 2006, HYDROBIOLOGIA, V569, P449, DOI 10.1007/s10750-006-0148-6; Underwood AJ, 1996, FRONTIERS OF POPULATION ECOLOGY, P369; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; Werry JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049796; West JG, 2011, MAR FRESHWATER RES, V62, P744, DOI 10.1071/MF10181; Williams GD, 2012, J FISH BIOL, V80, P1380, DOI 10.1111/j.1095-8649.2011.03179.x; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034; Yates P.M., 2015, ESTUAR COAST, P1	77	20	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0146911	10.1371/journal.pone.0146911	http://dx.doi.org/10.1371/journal.pone.0146911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824349	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600011
J	Suzuki, N; Bassil, E; Hamilton, JS; Inupakutika, MA; Zandalinas, SI; Tripathy, D; Luo, YT; Dion, E; Fukui, G; Kumazaki, A; Nakano, R; Rivero, RM; Verbeck, GF; Azad, RK; Blumwald, E; Mittler, R				Suzuki, Nobuhiro; Bassil, Elias; Hamilton, Jason S.; Inupakutika, Madhuri A.; Zandalinas, Sara Izquierdo; Tripathy, Deesha; Luo, Yuting; Dion, Erin; Fukui, Ginga; Kumazaki, Ayana; Nakano, Ruka; Rivero, Rosa M.; Verbeck, Guido F.; Azad, Rajeev K.; Blumwald, Eduardo; Mittler, Ron			ABA Is Required for Plant Acclimation to a Combination of Salt and Heat Stress	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; REACTIVE OXYGEN; ABSCISIC-ACID; DROUGHT STRESS; SALICYLIC-ACID; ABIOTIC STRESS; HIGH-SALINITY; H+-ATPASE; RNA-SEQ	Abiotic stresses such as drought, heat or salinity are a major cause of yield loss worldwide. Recent studies revealed that the acclimation of plants to a combination of different environmental stresses is unique and cannot be directly deduced from studying the response of plants to each of the different stresses applied individually. Here we report on the response of Arabidopsis thaliana to a combination of salt and heat stress using transcriptome analysis, physiological measurements and mutants deficient in abscisic acid, salicylic acid, jasmonic acid or ethylene signaling. Arabidopsis plants were found to be more susceptible to a combination of salt and heat stress compared to each of the different stresses applied individually. The stress combination resulted in a higher ratio of Na+/K+ in leaves and caused the enhanced expression of 699 transcripts unique to the stress combination. Interestingly, many of the transcripts that specifically accumulated in plants in response to the salt and heat stress combination were associated with the plant hormone abscisic acid. In accordance with this finding, mutants deficient in abscisic acid metabolism and signaling were found to be more susceptible to a combination of salt and heat stress than wild type plants. Our study highlights the important role abscisic acid plays in the acclimation of plants to a combination of two different abiotic stresses.	[Suzuki, Nobuhiro; Fukui, Ginga; Kumazaki, Ayana; Nakano, Ruka] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan; [Bassil, Elias; Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Mail Stop 5,1 Shields Ave, Davis, CA 95616 USA; [Hamilton, Jason S.; Inupakutika, Madhuri A.; Tripathy, Deesha; Luo, Yuting; Dion, Erin; Verbeck, Guido F.; Azad, Rajeev K.; Mittler, Ron] Univ N Texas, Coll Arts & Sci, Dept Biol Sci, 1155 Union Circle 305220, Denton, TX 76203 USA; [Zandalinas, Sara Izquierdo] Univ Jaume 1, Dept Ciencias Agrarias & Medio Nat, Campus Riu Sec, E-12071 Castellon de La Plana, Spain; [Rivero, Rosa M.] Campus Univ Espinardo, Ctr Edafol & Biol Aplicada Segura, Murcia 30100, Spain; [Azad, Rajeev K.] Univ N Texas, Dept Math, Denton, TX 76203 USA	Sophia University; University of California System; University of California Davis; University of North Texas System; University of North Texas Denton; Universitat Jaume I; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia; University of North Texas System; University of North Texas Denton	Suzuki, N (corresponding author), Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.; Mittler, R (corresponding author), Univ N Texas, Coll Arts & Sci, Dept Biol Sci, 1155 Union Circle 305220, Denton, TX 76203 USA.	n-suzuki-cs6@sophia.ac.jp; ron.mittler@unt.edu	Bassil, Elias/F-1259-2011; Verbeck, Guido/AAF-3774-2019; Blumwald, Eduardo/Y-2751-2019; Mittler, Ron/ABE-6496-2020; Zandalinas, Sara I/AAH-1075-2019; Rivero, Rosa M/A-2761-2013; Suzuki, Nobuhiro/Y-2851-2019	Bassil, Elias/0000-0001-8109-5758; Verbeck, Guido/0000-0002-3317-9911; Zandalinas, Sara I/0000-0002-1256-9371; Rivero, Rosa M/0000-0003-3880-0241; Suzuki, Nobuhiro/0000-0002-0225-1597	National Science Foundation [NSF-0431327, IOS-0639964, IOS-0743954, IOS-0820188, IOS-1353886]; University of North Texas College of Arts and Sciences; Sophia University in Japan	National Science Foundation(National Science Foundation (NSF)); University of North Texas College of Arts and Sciences; Sophia University in Japan	This paper was supported by funding from the National Science Foundation (NSF-0431327, IOS-0639964, IOS-0743954, IOS-0820188 and IOS-1353886), the University of North Texas College of Arts and Sciences, and Sophia University in Japan.	Assmann SM, 2000, PLANT CELL ENVIRON, V23, P387, DOI 10.1046/j.1365-3040.2000.00551.x; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; Caldelari D, 2011, PLANT MOL BIOL, V75, P25, DOI 10.1007/s11103-010-9701-9; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1766, DOI 10.1093/pcp/pcr121; Consales F, 2012, J EXP BOT, V63, P727, DOI 10.1093/jxb/err308; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; De Boeck HJ, 2016, NEW PHYTOL, V209, P531, DOI 10.1111/nph.13601; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Hamilton JS, 2015, J ANAL AT SPECTROM; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hu XL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00298; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; Janicka-Russak M, 2012, J PLANT PHYSIOL, V169, P1607, DOI 10.1016/j.jplph.2012.05.013; Keles Y, 2002, PLANT SCI, V163, P783, DOI 10.1016/S0168-9452(02)00213-3; Kim DH, 2013, PLANT CELL REP, V32, P1953, DOI 10.1007/s00299-013-1506-2; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Li H, 2014, PLANT CELL ENVIRON, V37, P2768, DOI 10.1111/pce.12360; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Moeder Wolfgang, 2010, Plant Signal Behav, V5, P1231, DOI 10.4161/psb.5.10.12836; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Rivero RM, 2014, PLANT CELL ENVIRON, V37, P1059, DOI 10.1111/pce.12199; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Scarpeci TE, 2008, PLANT MOL BIOL, V66, P361, DOI 10.1007/s11103-007-9274-4; Sghaier DB, 2015, J PHOTOCH PHOTOBIO B, V149, P204, DOI 10.1016/j.jphotobiol.2015.06.003; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shinde S, 2015, J EXP BOT, V66, P4001, DOI 10.1093/jxb/erv197; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Spalding EP, 1999, J GEN PHYSIOL, V113, P909, DOI 10.1085/jgp.113.6.909; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Suzuki N, 2013, PLANT CELL, V25, P3553, DOI 10.1105/tpc.113.114595; Suzuki N, 2013, J EXP BOT, V64, P253, DOI 10.1093/jxb/ers335; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Tosti N, 2006, PLANT CELL ENVIRON, V29, P1686, DOI 10.1111/j.1365-3040.2006.01542.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; VAN DER STRAETEN D, 1993, PLANT PHYSIOL, V102, P401, DOI 10.1104/pp.102.2.401; Wen XG, 2005, PLANTA, V220, P486, DOI 10.1007/s00425-004-1382-7; YALOVSKY S, 1992, J BIOL CHEM, V267, P20689; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yoon HS, 2013, J APPL GENET, V54, P129, DOI 10.1007/s13353-012-0117-x; Zhang JH, 2006, PLANT SCI, V170, P768, DOI 10.1016/j.plantsci.2005.11.009; Zhang YP, 2015, GENET MOL RES, V14, P3702, DOI 10.4238/2015.April.17.20; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	63	152	165	12	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147625	10.1371/journal.pone.0147625	http://dx.doi.org/10.1371/journal.pone.0147625			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824246	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600042
J	Margevicius, KJ; Generous, N; Abeyta, E; Althouse, B; Burkom, H; Castro, L; Daughton, A; Del Valle, SY; Fairchild, G; Hyman, JM; Kiang, R; Morse, AP; Pancerella, CM; Pullum, L; Ramanathan, A; Schlegelmilch, J; Scott, A; Taylor-McCabe, KJ; Vespignani, A; Deshpande, A				Margevicius, Kristen J.; Generous, Nicholas; Abeyta, Esteban; Althouse, Ben; Burkom, Howard; Castro, Lauren; Daughton, Ashlynn; Del Valle, Sara Y.; Fairchild, Geoffrey; Hyman, James M.; Kiang, Richard; Morse, Andrew P.; Pancerella, Carmen M.; Pullum, Laura; Ramanathan, Arvind; Schlegelmilch, Jeffrey; Scott, Aaron; Taylor-McCabe, Kirsten J.; Vespignani, Alessandro; Deshpande, Alina			The Biosurveillance Analytics Resource Directory (BARD): Facilitating the Use of Epidemiological Models for Infectious Disease Surveillance	PLOS ONE			English	Article							DECISION-MAKING; POLICY; REAL; TOOL	Epidemiological modeling for infectious disease is important for disease management and its routine implementation needs to be facilitated through better description of models in an operational context. A standardized model characterization process that allows selection or making manual comparisons of available models and their results is currently lacking. A key need is a universal framework to facilitate model description and understanding of its features. Los Alamos National Laboratory (LANL) has developed a comprehensive framework that can be used to characterize an infectious disease model in an operational context. The framework was developed through a consensus among a panel of subject matter experts. In this paper, we describe the framework, its application to model characterization, and the development of the Biosurveillance Analytics Resource Directory (BARD; http://brd.bsvgateway.org/brd/), to facilitate the rapid selection of operational models for specific infectious/communicable diseases. We offer this framework and associated database to stakeholders of the infectious disease modeling field as a tool for standardizing model description and facilitating the use of epidemiological models.	[Margevicius, Kristen J.; Generous, Nicholas; Abeyta, Esteban; Castro, Lauren; Daughton, Ashlynn; Del Valle, Sara Y.; Fairchild, Geoffrey; Taylor-McCabe, Kirsten J.; Deshpande, Alina] Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA; [Althouse, Ben] Santa Fe Inst, Santa Fe, NM 87501 USA; [Burkom, Howard] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Hyman, James M.] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Kiang, Richard] Natl Aeronaut & Space Adm, Greenbelt, MD USA; [Morse, Andrew P.] Univ Liverpool, Sch Environm Sci, Dept Geog & Planning, Liverpool L69 3BX, Merseyside, England; [Morse, Andrew P.] NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England; [Pancerella, Carmen M.] Sandia Natl Labs, Distributed Syst Res, Livermore, CA USA; [Pullum, Laura; Ramanathan, Arvind] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Schlegelmilch, Jeffrey] Columbia Univ, Earth Inst, Natl Ctr Disaster Preparedness, New York, NY USA; [Scott, Aaron] USDA APHIS Vet Serv, Sci, Technol, Anal Serv, Ft Collins, CO USA; [Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Tulane University; National Aeronautics & Space Administration (NASA); University of Liverpool; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Oak Ridge National Laboratory; Columbia University; United States Department of Agriculture (USDA); Northeastern University	Deshpande, A (corresponding author), Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA.	Deshpande_a@lanl.gov	Del Valle, Sara/AAG-5148-2021; Hyman, James M/AAF-7389-2020	Del Valle, Sara/0000-0002-0159-1952; Hyman, James M/0000-0001-5247-5794; Ramanathan, Arvind/0000-0002-1622-5488; Morse, Andrew/0000-0002-0413-2065; burkom, howard/0000-0003-0667-9467; Deshpande, Alina/0000-0003-4541-4410; Margevicius, Kristen/0000-0002-4116-8307; Vespignani, Alessandro/0000-0003-3419-4205; Pullum, Laura/0000-0001-6045-7668; Abeyta, Esteban/0000-0001-5574-4822	Defense Threat Reductions Agency - Joint Science and Technology Office [CB10007, DTRA10027-10845]; Natural Environment Research Council [NE/H003525/1, NE/H003487/1] Funding Source: researchfish; NERC [NE/H003525/1, NE/H003487/1] Funding Source: UKRI	Defense Threat Reductions Agency - Joint Science and Technology Office; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Defense Threat Reductions Agency - Joint Science and Technology Office (Grant # CB10007, DTRA10027-10845).	Akselrod Hana, 2012, J Bus Contin Emer Plan, V6, P68; Althouse BM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002912; Althouse BM, 2010, P NATL ACAD SCI USA, V107, P1696, DOI 10.1073/pnas.0906078107; [Anonymous], GLOB EP MOB MOD; Barrett Christopher L., 2008, INT C HIGH PERF COMP; Chretien JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094130, 10.1371/currents.outbreaks.3408774290b1a0f2dd7cae877c8b8ff6]; Corley CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091989; Feighner BH, 2009, MIL MED, V174, P557, DOI 10.7205/MILMED-D-04-6108; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Frieden T.R, 2011, CDC FRAMEWORK PREVEN; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Harvey N, 2007, PREV VET MED, V82, P176, DOI 10.1016/j.prevetmed.2007.05.019; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Kite-Powell A, 2010, ESSENCE USER GUIDE; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Lagergren M, 1998, EUR J OPER RES, V105, P257, DOI 10.1016/S0377-2217(97)00233-6; Lenart B, 2013, HOMELAND SEC AFF, V9, P14; Louz D, 2010, CRIT REV MICROBIOL, V36, P195, DOI 10.3109/10408411003604619; Margevicius KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083730; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226; Pfeiffer D, 2004, VET J, V167, P123, DOI 10.1016/j.tvjl.2003.09.001; Sanson RL, 1999, REV SCI TECH OIE, V18, P593, DOI 10.20506/rst.18.3.1181; Schley D., ENHANCING CONFIDENCE; Sluka JP, 2014, BIOINFORMATICS, V30, P2367, DOI 10.1093/bioinformatics/btu210; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165	29	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146600	10.1371/journal.pone.0146600	http://dx.doi.org/10.1371/journal.pone.0146600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820405	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528400008
J	Stauber, CE; Wedgworth, JC; Johnson, P; Olson, JB; Ayers, T; Elliott, M; Brown, J				Stauber, Christine E.; Wedgworth, Jessica C.; Johnson, Pauline; Olson, Julie B.; Ayers, Tracy; Elliott, Mark; Brown, Joe			Associations between Self-Reported Gastrointestinal Illness and Water System Characteristics in Community Water Supplies in Rural Alabama: A Cross-Sectional Study	PLOS ONE			English	Article							DRINKING-WATER; BOTTLED WATER; BLACK-BELT; RISK; INTERVENTION; QUALITY; HEALTH	Background Community water supplies in underserved areas of the United States may be associated with increased microbiological contamination and risk of gastrointestinal disease. Microbial and health risks affecting such systems have not been systematically characterized outside outbreak investigations. The objective of the study was to evaluate associations between self-reported gastrointestinal illnesses (GII) and household-level water supply characteristics. Methods We conducted a cross-sectional study of water quality, water supply characteristics, and GII in 906 households served by 14 small and medium-sized community water supplies in Alabama's underserved Black Belt region. Results We identified associations between respondent-reported water supply interruption and any symptoms of GII (adjusted odds ratio (aOR): 3.01, 95% confidence interval (CI) = 1.65-5.49), as well as low water pressure and any symptoms of GII (aOR: 4.51, 95% CI = 2.5-57.97). We also identified associations between measured water quality such as lack of total chlorine and any symptoms of GII (aOR: 5.73, 95% CI = 1.09-30.1), and detection of E. coli in water samples and increased reports of vomiting (aOR: 5.01, 95% CI = 1.62-15.52) or diarrhea (aOR: 7.75, 95% CI = 2.06-29.15). Conclusions Increased self-reported GII was associated with key water system characteristics as measured at the point of sampling in a cross-sectional study of small and medium water systems in rural Alabama in 2012 suggesting that these water supplies can contribute to endemic gastro-intestinal disease risks. Future studies should focus on further characterizing and managing microbial risks in systems facing similar challenges.	[Stauber, Christine E.; Ayers, Tracy] Georgia State Univ, Sch Publ Hlth, Div Environm Hlth, Atlanta, GA 30303 USA; [Wedgworth, Jessica C.; Olson, Julie B.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Johnson, Pauline; Elliott, Mark] Univ Alabama, Dept Civil Construct & Environm Engn, Tuscaloosa, AL USA; [Brown, Joe] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Wedgworth, Jessica C.] Univ West Alabama, Off Sponsored Programs, Livingston, AL USA	University System of Georgia; Georgia State University; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Tuscaloosa; University System of Georgia; Georgia Institute of Technology	Stauber, CE (corresponding author), Georgia State Univ, Sch Publ Hlth, Div Environm Hlth, Atlanta, GA 30303 USA.; Brown, J (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.	cstauber@gsu.edu; joe.brown@ce.gatech.edu	Elliott, Mark/N-1574-2019	Elliott, Mark/0000-0002-7835-0612; Ayers, Tracy/0000-0003-4140-3263	U.S. Environmental Protection Agency [R834866]	U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This publication was developed under Assistance Agreement No. R834866 awarded by the U.S. Environmental Protection Agency to the University of Alabama (PJ JB). This paper has not been formally reviewed by EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.	Albuquerque Cd, 2011, REPORT SPECIAL RAPPO; Anadu EC, 2000, J AM WATER WORKS ASS, V92, P82, DOI 10.1002/j.1551-8833.2000.tb09051.x; [Anonymous], 2007, SELECTED HLTH STATUS; Arnold BF, 2013, AM J EPIDEMIOL, V177, P361, DOI 10.1093/aje/kws281; Colford John M. Jr., 2006, Journal of Water and Health, V4, P71, DOI 10.2166/wh.2006.018; Collier SA, 2012, EPIDEMIOL INFECT, V140, P2003, DOI 10.1017/S0950268811002858; Congressional Research Service, 2014, RUR WAT SUPPL SEW SY; Craun GF, 2010, CLIN MICROBIOL REV, V23, P507, DOI 10.1128/CMR.00077-09; DeFelice NB, 2015, ENV SCI TECHNOL; Doria Miguel F., 2006, Journal of Water and Health, V4, P271, DOI 10.2166/wh.2006.0023; Egorov A, 2002, INT J ENVIRON HEAL R, V12, P221, DOI 10.1080/09603/202/000000989; Ercumen A, 2014, ENVIRON HEALTH PERSP, V122, P651, DOI 10.1289/ehp.1306912; Gargano J. W., 2015, EPIDEMIOL INFECT FIR, P1; He JJ, 2011, ENVIRON ENG SCI, V28, P693, DOI 10.1089/ees.2011.0047; Hunter PR, 2005, CLIN INFECT DIS, V40, pE32, DOI 10.1086/427750; Izenberg M, 2013, ENV JUSTICE, V6; LeChevallier Mark W., 2003, Journal of Water and Health, V1, P3; Lichtenstein B, 2007, J RURAL HEALTH, V23, P68, DOI 10.1111/j.1748-0361.2007.00126.x; Liu AG, 2005, SCI TOTAL ENVIRON, V346, P112, DOI 10.1016/j.scitotenv.2004.11.019; MacDonald Gibson J, 2015, AM J PUBLIC HEALTH, pe1; Majowicz SE, 2008, EPIDEMIOL INFECT, V136, P886, DOI 10.1017/S0950268807009375; Messner Michael, 2006, Journal of Water and Health, V4, P201, DOI 10.2166/wh.2006.024; MMWR, 2013, MMWR-MORBID MORTAL W, V62, P6; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Rust K., 1985, J OFF STAT, V1, P381; Sanspree Mary Jean, 2008, Optometry, V79, P724, DOI 10.1016/j.optm.2008.09.011; Shortridge JE, 2014, WATER RES, V53, P26, DOI 10.1016/j.watres.2014.01.013; Sobsey Mark D., 2006, Journal of Water and Health, V4, P17; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; U.S. Census, 2012, AL 2010 POP HOUS UN; Wedgworth JC, 2014, INT J ENV RES PUB HE, V11, P7376, DOI 10.3390/ijerph110707376; Wedgworth JC, 2013, WATER QUAL EXPOS HEA, V5, P69, DOI 10.1007/s12403-013-0088-0; Wimberley R. C., 2002, Southern Rural Sociology, V18, P294; World Health Organization (WHO), GUID DRINK WAT QUAL	34	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148102	10.1371/journal.pone.0148102	http://dx.doi.org/10.1371/journal.pone.0148102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820849	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400066
J	Carneiro, PP; Conceicao, J; Macedo, M; Magalhaes, V; Carvalho, EM; Bacellar, O				Carneiro, Pedro Paulo; Conceicao, Jacilara; Macedo, Michael; Magalhaes, Viviane; Carvalho, Edgar M.; Bacellar, Olivia			The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis	PLOS ONE			English	Article							MUCOSAL LEISHMANIASIS; PERITONEAL-MACROPHAGES; SUPEROXIDE-DISMUTASE; INNATE IMMUNITY; LESION SIZE; T-CELLS; RESPONSES; EXPRESSION; INFECTION; SYNTHASE	Human cutaneous leishmaniasis (CL) caused by Leishmania braziliensis, presents an exaggerated Th1 response that is associated with ulcer development. Macrophages are the primary cells infected by Leishmania parasites and both reactive oxygen species (ROS) and nitric oxide (NO) are important in the control of Leishmania by these cells. The mechanism involved in the killing of L. braziliensis is not well established. In this study, we evaluate the role of ROS and NO in the control of L. braziliensis infection by monocytes from CL patients. After in vitro infection with L. braziliensis, the oxidative burst by monocytes from CL patients was higher when compared to monocytes from healthy subjects (HS). Inhibition of the ROS pathway caused a significant decrease in the oxidative burst in L. braziliensis infected monocytes from both groups. In addition, we evaluated the intracellular expression of ROS and NO in L. braziliensis-infected monocytes. Monocytes from CL patients presented high expression of ROS after infection with L. braziliensis. The expression of NO was higher in monocytes from CL patients as compared to expression in monocytes from HS. A strong positive correlation between NO production and lesion size of CL patients was observed. The inhibition of ROS production in leishmania-infected monocytes from CL patients allowed the growth of viable promastigotes in culture supernatants. Thus, we demonstrate that while production of ROS is involved in L. braziliensis killing, NO alone is not sufficient to control infection and may contribute to the tissue damage observed in human CL.	[Carneiro, Pedro Paulo; Conceicao, Jacilara; Macedo, Michael; Magalhaes, Viviane; Carvalho, Edgar M.; Bacellar, Olivia] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Carvalho, Edgar M.; Bacellar, Olivia] CNPq MCT, INCT DT, Salvador, BA, Brazil	Universidade Federal da Bahia	Bacellar, O (corresponding author), Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.; Bacellar, O (corresponding author), CNPq MCT, INCT DT, Salvador, BA, Brazil.	olivinhaufba@gmail.com			National Institute of Health (NIH) [AI30639-20]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI030639] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (NIH) grant AI30639-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RP, 2005, AM J TROP MED HYG, V73, P79, DOI 10.4269/ajtmh.2005.73.79; Almeida TF, 2012, PARASITE IMMUNOL, V34, P492, DOI 10.1111/j.1365-3024.2012.01384.x; Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Bacellar O, 2009, J INFECT DIS, V200, P75, DOI 10.1086/599380; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; BITTENCOURT AL, 1991, MEM I OSWALDO CRUZ, V86, P51, DOI 10.1590/S0074-02761991000100009; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Cardoso TM, 2015, INFECT IMMUN, V83, P898, DOI 10.1128/IAI.02404-14; Chang HK, 2007, INFECT IMMUN, V75, P1017, DOI 10.1128/IAI.00914-06; CHANNON JY, 1984, IMMUNOLOGY, V53, P345; CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296; Nogueira NPD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025935; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Giudice A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-75; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Katara GK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001703; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Khouri R, 2014, J INFECT DIS, V210, P306, DOI 10.1093/infdis/jiu087; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kumar R, 2010, IMMUNOLOGY, V130, P193, DOI 10.1111/j.1365-2567.2009.03223.x; LIEW FY, 1990, J IMMUNOL, V145, P4306; Little JW, 2012, AMINO ACIDS, V42, P75, DOI 10.1007/s00726-010-0633-0; Machado PRL, 2007, CLIN INFECT DIS, V44, P788, DOI 10.1086/511643; Matoshvili M, 2014, Georgian Med News, P61; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Morgado FN, 2010, PARASITE IMMUNOL, V32, P285, DOI 10.1111/j.1365-3024.2009.01188.x; Novais FO, 2014, J INFECT DIS, V209, P1288, DOI 10.1093/infdis/jiu013; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; Olekhnovitch R, 2014, J CLIN INVEST, V124, P1711, DOI 10.1172/JCI72058; Passos S, 2015, J INFECT DIS, V211, P274, DOI 10.1093/infdis/jiu439; Qadoumi M, 2002, INFECT IMMUN, V70, P4638, DOI 10.1128/IAI.70.8.4638-4642.2002; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; Roy S, 2015, J CLIN IMMUNOL, V35, P56, DOI 10.1007/s10875-014-0115-3; Santos DM, 2013, NANOMED-NANOTECHNOL, V9, P985, DOI 10.1016/j.nano.2013.04.003; SASADA M, 1983, J BIOL CHEM, V258, P9631; Serarslan G, 2005, MOL CELL BIOCHEM, V280, P147, DOI 10.1007/s11010-005-8542-3; SMITH MT, 1984, BIOCHEM PHARMACOL, V33, P3109, DOI 10.1016/0006-2952(84)90619-1; Srivastava A, 2012, MOL CELL BIOCHEM, V359, P359, DOI 10.1007/s11010-011-1029-5; Srivastava S, 2013, CLIN EXP IMMUNOL, V172, P403, DOI 10.1111/cei.12074; Vieira ELM, 2013, PARASITE IMMUNOL, V35, P65, DOI 10.1111/pim.12012; Vieira MGS, 2002, MEM I OSWALDO CRUZ, V97, P979, DOI 10.1590/S0074-02762002000700009; Weinkopff T, 2013, INFECT IMMUN, V81, P1575, DOI 10.1128/IAI.01401-12; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023	47	99	98	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148084	10.1371/journal.pone.0148084	http://dx.doi.org/10.1371/journal.pone.0148084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840253	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200080
J	Chang, PJ; Lin, L; Zheng, Q; Yu, F; Yu, XY; Zhao, YY; Ding, XX; Zhu, WG; Li, J; Zhao, YE				Chang, Pingjun; Lin, Lei; Zheng, Qian; Yu, Fang; Yu, Xiaoyu; Zhao, Yinying; Ding, Xixia; Zhu, Weigen; Li, Jin; Zhao, Yun-e			An Optical Section-Assisted In Vivo Rabbit Model for Capsular Bend and Posterior Capsule Opacification Investigation	PLOS ONE			English	Article							INTRAOCULAR-LENS IMPLANTATION; CATARACT-SURGERY; COHERENCE TOMOGRAPHY; EPITHELIAL-CELLS; POLY(METHYL METHACRYLATE); EDGE DESIGN; INHIBITION; SILICONE; SHARP; EYES	Purpose To establish an optical section-assisted in vivo rabbit model for capsular bend and posterior capsule opacification (PCO) investigation. Methods A total of 10 rabbits underwent phacoemulsification surgery and intraocular lens (IOL) implantation. On the basis of the relationship between the anterior capsule and IOL, the rabbits were divided into complete overlap and incomplete overlap groups, in which six and four rabbits were included, respectively. The capsular bend optical sections were assessed using ultra-long scan depth optical coherence tomography (UL-OCT), and posterior capsule opacification was evaluated with slit lamp on postoperative day 3, 7, 14, and 28. In addition, histopathological section was used to verify the accuracy of capsular bend type captured by OCT in three rabbits. Results Based on the special animalmodel, six capsular bend types were observed, namely, anterior (A), middle (M), posterior (P), detachment (D), funnel (Fun) and furcate adhesion (Fur). On day 3, capsular bend began to form. On 14 days, the capsular bends were comprised of A, M and D types, which were almostmaintained until day 28. Histopathological section findings were consistent with optical sectioning results. In the incomplete and complete groups, the earliest PCO within the optical zone were on day 7 and 28, respectively. The incomplete group exhibited higher incidence and faster PCO on day 7 (p = 0.038) and 14 (p = 0.002). Conclusions This animal model not only mimics capsular bend evolution and PCO processes but also produces OCT optical section images equivalent to and more repeatable than histopathology, thereby providing a promising method for the further investigations of PCO.	[Chang, Pingjun; Lin, Lei; Zheng, Qian; Yu, Fang; Yu, Xiaoyu; Zhao, Yinying; Ding, Xixia; Zhu, Weigen; Li, Jin; Zhao, Yun-e] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Li, J; Zhao, YE (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	lijingerry@163.com; zye@mail.eye.ac.cn			National Natural Science Foundation of China [81170869]; Zhejiang Provincial Natural Science Foundation of China [LY13H120005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by National Natural Science Foundation of China (Grant No. 81170869 to YEZ, website: http://www.nsfc.gov.cn/) and Zhejiang Provincial Natural Science Foundation of China (Grant No. LY13H120005 to JL, website: http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6; Dawes LJ, 2008, INVEST OPHTH VIS SCI, V49, P650, DOI 10.1167/iovs.07-0586; Dawes LJ, 2013, INVEST OPHTH VIS SCI, V54, P333, DOI 10.1167/iovs.12-10425; Dick HB, 2013, J CATARACT REFR SURG, V39, P1286, DOI 10.1016/j.jcrs.2013.07.014; Hayashi H, 2002, OPHTHALMOLOGY, V109, P1427, DOI 10.1016/S0161-6420(02)01112-0; Hayashi K, 2005, OPHTHALMOLOGY, V112, P1550, DOI 10.1016/j.ophtha.2005.03.024; Hayashi K, 2001, J CATARACT REFR SURG, V27, P817, DOI 10.1016/S0886-3350(01)00787-8; KnightNanan D, 1996, J CATARACT REFR SURG, V22, P730, DOI 10.1016/S0886-3350(96)80312-9; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077864; Nagamoto T, 2003, J CATARACT REFR SURG, V29, P1605, DOI 10.1016/S0886-3350(03)00050-6; Nishi O, 1998, OPHTHALMIC SURG LAS, V29, P587; Nishi O, 2004, J CATARACT REFR SURG, V30, P2170, DOI 10.1016/j.jcrs.2004.05.022; Nishi O, 1999, J CATARACT REFR SURG, V25, P521, DOI 10.1016/S0886-3350(99)80049-2; Nishi O, 2002, J CATARACT REFR SURG, V28, P431, DOI 10.1016/S0886-3350(01)01094-X; Nishi O, 2007, J CATARACT REFR SURG, V33, P1065, DOI 10.1016/j.jcrs.2007.02.022; Sacu S, 2005, J CATARACT REFR SURG, V31, P1888, DOI 10.1016/j.jcrs.2005.03.072; Sacu S, 2005, J CATARACT REFR SURG, V31, P330, DOI 10.1016/j.jcrs.2004.04.057; Saika S, 2002, BRIT J OPHTHALMOL, V86, P1428, DOI 10.1136/bjo.86.12.1428; Shen MX, 2011, INVEST OPHTH VIS SCI, V52, P4091, DOI 10.1167/iovs.10-6507; Shen MX, 2010, EYE CONTACT LENS, V36, P73, DOI 10.1097/ICL.0b013e3181d0423e; Smith SR, 2004, AM J OPHTHALMOL, V138, P521, DOI 10.1016/j.ajo.2004.04.028; Sponer U, 2005, J CATARACT REFR SURG, V31, P595, DOI 10.1016/j.jcrs.2004.05.058; Tassignon MJ, 2007, J CATARACT REFR SURG, V33, P611, DOI 10.1016/j.jcrs.2006.12.016; Tassignon MJBR, 2002, J CATARACT REFR SURG, V28, P1182, DOI 10.1016/S0886-3350(02)01375-5; Zhao YY, 2013, AM J OPHTHALMOL, V155, P484, DOI 10.1016/j.ajo.2012.08.019	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148553	10.1371/journal.pone.0148553	http://dx.doi.org/10.1371/journal.pone.0148553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840405	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200147
J	Eng, JY; Moy, FM; Bulgiba, A				Eng, J. Y.; Moy, F. M.; Bulgiba, A.			Impact of a Workplace Health Promotion Program on Employees' Blood Pressure in a Public University	PLOS ONE			English	Article							CIGARETTE-SMOKING; WORKERS; HYPERTENSION; RISK; BMI; PRESENTEEISM; POPULATION; PREVALENCE; MANAGEMENT	Introduction Workplace health promotion is important in the prevention of non-communicable diseases among employees. Previous workplace health programs have shown benefits such as lowered disease prevalence, reduced medical costs and improved productivity. This study aims to evaluate the impact of a 6-year workplace health promotion program on employees' blood pressure in a public university. Methods In this prospective cohort study, we included 1,365 employees enrolled in the university's workplace health promotion program, a program conducted since 2008 and using data from the 2008-2013 follow-up period. Participants were permanent employees aged 35 years and above, with at least one follow up measurements and no change in antihypertensive medication during the study period. Baseline socio-demographic information was collected using a questionnaire while anthropometry measurements and resting blood pressure were collected during annual health screening. Changes in blood pressure over time were analyzed using a linear mixed model. Results The systolic blood pressure in the hypertension subgroup decreased 2.36 mmHg per year (p< 0.0001). There was also significant improvement in systolic blood pressure among the participants who were at risk of hypertension (-0.75 mmHg, p<0.001). The diastolic blood pressure among the hypertensive and at risk subgroups improved 1.76 mmHg/year (p<0.001) and 0.56 mmHg/year (p<0.001), respectively. However, there was no change in both systolic and diastolic blood pressure among participants in the healthy subgroup over the 6-year period. Conclusion This study shows that continuing participation in workplace health promotion program has the potential to improve blood pressure levels among employees.	[Eng, J. Y.; Moy, F. M.; Bulgiba, A.] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia	Universiti Malaya	Moy, FM (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia.	moyfm@ummc.edu.my	Bulgiba, Awang/B-8271-2010; Moy, Foong Ming/B-7899-2010	Bulgiba, Awang/0000-0002-5313-0445; Moy, Foong Ming/0000-0002-0306-4419	Ministry of Education High Impact Research (MoE HIR) [H-20001-E00069]; Ministry of Education High Impact Research (MoHE HIR) [H-20001-00-E000069]	Ministry of Education High Impact Research (MoE HIR); Ministry of Education High Impact Research (MoHE HIR)	The work of JY Eng and FM Moy is supported by the Ministry of Education High Impact Research (MoE HIR) grant No. H-20001-E00069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of JY Eng and FM Moy are supported by the Ministry of Education High Impact Research (MoHE HIR) grant No. H-20001-00-E000069.	Al-Safi Saafan A, 2005, Eur J Cardiovasc Nurs, V4, P286, DOI 10.1016/j.ejcnurse.2005.03.004; Alefan Q, 2009, ASIAN J PHARM CLIN R, V2, P5; Baicker K, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0626; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; Boshtam M, 2010, ARYA ATHEROSCLER, V6, P93; Burton WN, 2004, J OCCUP ENVIRON MED, V46, pS38, DOI 10.1097/01.jom.0000126687.49652.44; Carpenter KM, 2014, J OBES, V2014, DOI 10.1155/2014/414987; Caspi C, 2003, JAMA-J AM MED ASSOC, V290, P1313; Centers for Disease Control and Prevention (US) National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (US), 2010, TOB SMOK CAUS DIS BI; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Conceição Tatiana Valverde da, 2006, Arq. Bras. Cardiol., V86, P26, DOI 10.1590/S0066-782X2006000100005; Davila EP, 2012, J OCCUP ENVIRON MED, V54, P1150, DOI 10.1097/JOM.0b013e318256f675; Farrell MA, 2009, J WOMENS HEALTH, V18, P733, DOI 10.1089/jwh.2008.0871; Feng RN, 2012, J EPIDEMIOL, V22, P317, DOI 10.2188/jea.JE20110120; Fitzgerald CJ, 2012, EVOL PSYCHOL-US, V10, P770, DOI 10.1177/147470491201000502; Gates DM, 2008, J OCCUP ENVIRON MED, V50, P39, DOI 10.1097/JOM.0b013e31815d8db2; Goetzel RZ, 2010, AM J PREV MED, V38, pS223, DOI 10.1016/j.amepre.2009.10.032; Goetzel RZ, 2009, J OCCUP ENVIRON MED, V51, P487, DOI 10.1097/JOM.0b013e31819eb902; Harden A, 1999, OCCUP MED-OXFORD, V49, P540, DOI 10.1093/occmed/49.8.540; Hochart C, 2011, POPUL HEALTH MANAG, V14, P111, DOI 10.1089/pop.2010.0009; Jung H, 2012, J TELEMED TELECARE, V18, P339, DOI 10.1258/jtt.2012.120318; Leone A, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/264894; Levesque V, 2015, MED SCI SPORT EXER, V47, P1342, DOI 10.1249/MSS.0000000000000559; Li HM, 2010, BLOOD PRESSURE, V19, P92, DOI 10.3109/08037050903516300; Loeppke R, 2008, POPUL HEALTH MANAG, V11, P287, DOI 10.1089/pop.2008.0006; Lucini D, 1996, CARDIOVASC RES, V31, P633; Mark G, 2012, ANXIETY STRESS COPIN, V25, P63, DOI 10.1080/10615806.2010.548088; Maruyama C, 2010, PREV MED, V51, P11, DOI 10.1016/j.ypmed.2010.04.008; Mendez-Hernandez P, 2012, SALUD PUBLICA MEXICO, V54, P20, DOI 10.1590/s0036-36342012000100004; Ministry of Health Malaysia Institute of Public Health, 2011, NAT HLTH MORB SURV; Mohamud WNW, 2011, DIABETES RES CLIN PR, V91, P239, DOI 10.1016/j.diabres.2010.11.025; Mohd Yunus A, 2004, MAL J NUTR, V10, P6; Moy Foong Ming, 2008, Asia Pac J Public Health, V20 Suppl, P166; Muna AS, 2010, ASIAN J PHARM CLIN R, V3, P4; Nasir AS, 2013, WEIGHT REDUCING PROG; Navuluri S, 2006, J SCHOOL HEALTH, V76, P441, DOI 10.1111/j.1746-1561.2006.00138.x; Ni Mhurchu Cliona, 2010, BMC Public Health, V10, P62, DOI 10.1186/1471-2458-10-62; O'Donnell M, 2013, AM J HEALTH PROMOT, V28, pIV, DOI 10.4278/ajhp.28.1.iv; Osilla Karen Chan, 2012, Am J Manag Care, V18, pe68; Pai CW, 2009, J OCCUP ENVIRON MED, V51, P429, DOI 10.1097/JOM.0b013e3181a039a4; Pandey M R, 1999, J Indian Med Assoc, V97, P367; Papathanasiou George, 2015, Open Cardiovasc Med J, V9, P5, DOI 10.2174/1874192401509010005; Pearson-Clarke T, 2010, AM J PREV MED, V38, pS232, DOI 10.1016/j.amepre.2009.10.033; Proper KI, 2003, AM J PREV MED, V24, P218, DOI 10.1016/S0749-3797(02)00645-1; Puig-Ribera A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122474; Ragunath P., 2013, WORKPLACE HLTH PROMO; Rampal L, 2008, PUBLIC HEALTH, V122, P11, DOI 10.1016/j.puhe.2007.05.008; Rampal L, 2011, MALAYISAN J MED HLTH, V7, P10; Rampal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046365; Reidpath DD, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.14876; Rongen A, 2013, AM J PREV MED, V44, P406, DOI 10.1016/j.amepre.2012.12.007; Schulze MB, 2000, EUR J EPIDEMIOL, V16, P891, DOI 10.1023/A:1011020823807; Stanciole A, 2006, ESTIMATION EC IMPACT; Sun W, 2011, J OCCUP HEALTH, V53, P280, DOI 10.1539/joh.10-0058-OA; [World Health Organization 2013], 2013, WHODCOWHD20132; Yun MY, 2015, J HYPERTENS, V33, P266, DOI 10.1097/HJH.0000000000000410; Zoellner J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130269	57	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148307	10.1371/journal.pone.0148307	http://dx.doi.org/10.1371/journal.pone.0148307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840508	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200123
J	Jia, S; Lansdall-Welfare, T; Sudhahar, S; Carter, C; Cristianini, N				Jia, Sen; Lansdall-Welfare, Thomas; Sudhahar, Saatviga; Carter, Cynthia; Cristianini, Nello			Women Are Seen More than Heard in Online Newspapers	PLOS ONE			English	Article							FEMALE SUBJECTS; NEWS; COVERAGE	Feminist news media researchers have long contended that masculine news values shape journalists' quotidian decisions about what is newsworthy. As a result, it is argued, topics and issues traditionally regarded as primarily of interest and relevance to women are routinely marginalised in the news, while men's views and voices are given privileged space. When women do show up in the news, it is often as "eye candy," thus reinforcing women's value as sources of visual pleasure rather than residing in the content of their views. To date, evidence to support such claims has tended to be based on small-scale, manual analyses of news content. In this article, we report on findings from our large-scale, data-driven study of gender representation in online English language news media. We analysed both words and images so as to give a broader picture of how gender is represented in online news. The corpus of news content examined consists of 2,353,652 articles collected over a period of six months from more than 950 different news outlets. From this initial dataset, we extracted 2,171,239 references to named persons and 1,376,824 images resolving the gender of names and faces using automated computational methods. We found that males were represented more often than females in both images and text, but in proportions that changed across topics, news outlets and mode. Moreover, the proportion of females was consistently higher in images than in text, for virtually all topics and news outlets; women were more likely to be represented visually than they were mentioned as a news actor or source. Our large-scale, data-driven analysis offers important empirical evidence of macroscopic patterns in news content concerning the way men and women are represented.	[Jia, Sen; Lansdall-Welfare, Thomas; Sudhahar, Saatviga; Cristianini, Nello] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Carter, Cynthia] Cardiff Univ, Sch Journalism Media & Cultural Studies, Cardiff CF10 3AX, S Glam, Wales	University of Bristol; Cardiff University	Cristianini, N (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.	nello.cristianini@bristol.ac.uk		Lansdall-Welfare, Thomas/0000-0002-4246-7616; Jia, Sen/0000-0001-7104-034X	ERC; European Research Council [339365]	ERC(European Research Council (ERC)European Commission); European Research Council(European Research Council (ERC)European Commission)	Thomas Lansdall-Welfare, Saatviga Sudhahar and Nello Cristianini are supported by the ERC Advanced Grant "ThinkBIG".; A European Research Council Advanced Grant 339365 "ThinkBIG" granted to NC supported NC, TLW and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Alexa. com, 2015, AL TOP SIT CAT NEWS; Ali O, 2010, IFIP ADV INF COMM TE, V339, P162; Allan Stuart, 2004, NEWS CULTURE, V2nd; Bradski G, 2000, THE OPENCV LIB, V25; Burke C, 2008, WOMEN STUD COMMUN, V31, P395, DOI 10.1080/07491409.2008.10162548; Carter C., 1998, NEWS GENDER POWER; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Cunningham H., 2011, TEXT PROCESSING GATE; Desmond R, 2010, SEX ROLES, V62, P822, DOI 10.1007/s11199-009-9686-5; Flaounas I, 2011, P 2011 ACM SIGMOD IN, P1275, DOI [DOI 10.1145/1989323.1989474, 10.1145/1989323.1989474]; Flaounas I, 2011, PATTERN ANAL NEWS ME; Flaounas I, 2013, DIGIT JOURNAL, V1, P102, DOI 10.1080/21670811.2012.714928; Flaounas I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014243; Hall Stuart., 1978, POLICING CRISIS MUGG; Huang G. B., 2007, 0749 U MASS; Jaggar A. M., 1983, FEMINIST POLITICS HU; Jia S, 2015, PATTERN RECOGN LETT, V58, P35, DOI 10.1016/j.patrec.2015.02.006; Jones M., 2003, TR2000396314 MITS EL, V3, P2; Lansdall-Welfare Thomas, 2014, 2014 IEEE International Conference on Big Data (Big Data), P60, DOI 10.1109/BigData.2014.7004454; Macharia Sarah, 2010, WHO MAKES NEWS GLOBA; Martinson J, 2012, SEEN NOT HEARD WOMEN; Ross K, 2011, MEDIA CULT SOC, V33, P1148, DOI 10.1177/0163443711418272; Rowe D., 2004, SPORT CULTURE MEDIA, V2; Sandhaus E, 2008, NEW YORK TIMES ANNOT, V6; Shor E, 2015, AM SOCIOL REV, V80, P960, DOI 10.1177/0003122415596999; Shor E, 2014, SOC SCI QUART, V95, P1213, DOI 10.1111/ssqu.12091; Shor E, 2014, JOURNALISM STUD, V15, P759, DOI 10.1080/1461670X.2013.834149; Tuchman G., 1978, HEARTH HOME IMAGES W; Wagner Claudia, 2015, 9 INT AAAI C WEB SOC; Weninger T, 2008, INT WORKSHOP DATABAS, P23, DOI 10.1109/DEXA.2008.12	32	34	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148434	10.1371/journal.pone.0148434	http://dx.doi.org/10.1371/journal.pone.0148434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840432	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000369550200135
J	Mitchell, MD; Rice, GE; Vaswani, K; Kvaskoff, D; Peiris, HN				Mitchell, M. D.; Rice, G. E.; Vaswani, K.; Kvaskoff, D.; Peiris, H. N.			Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; ANANDAMIDE LEVELS; PRETERM BIRTH; PREGNANCY; WOMEN; MORTALITY; LABOR	An increase in intrauterine prostaglandin production is critical for the onset and progression of labor in women and indeed all mammalian species studied. Endocannabinoids can act as substrates for enzymes of the prostaglandin biosynthetic pathways and can be utilized to generate other related compounds such as prostamides. The end products are indistinguishable by radioimmunoassay. We have separated such compounds by mass spectrometry. We now show that inflammatory stimuli such as LPS and proinflammatory cytokines act differentially on these pathways in human choriodecidua and preferentially create drive through to prostaglandin end products. These findings create doubt about the interpretation of data on prostaglandin biosynthesis in intrauterine tissues from pregnant women especially in the presence of an infection. The possibility is raised that separation of these products might reduce variability in results and lead to potential uses for their measurement in the diagnosis of preterm labor.	[Mitchell, M. D.; Rice, G. E.; Vaswani, K.; Kvaskoff, D.; Peiris, H. N.] Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Kvaskoff, D.] Care of Brugger AG, Univ Heidelberg, Biochem Ctr BZH Neuenheimer Feld, Heidelberg, Germany	Royal Brisbane & Women's Hospital; University of Queensland; Ruprecht Karls University Heidelberg	Mitchell, MD (corresponding author), Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia.	murray.mitchell@uq.edu.au	Peiris, Hassendrini (Nel)/HCH-0058-2022; Kvaskoff, David/F-1010-2017; RICE, GREGORY/F-2412-2010; Peiris, Hassendrini/B-9928-2016; Mitchell, Murray/A-8639-2010	Kvaskoff, David/0000-0002-5569-7226; RICE, GREGORY/0000-0001-7177-0246; Peiris, Hassendrini/0000-0002-4685-2722; Mitchell, Murray/0000-0002-6167-7176	Therapeutics Innovation Australia-Queensland Node; National Collaborative Research Infrastructure Strategy; SmartFutures; Lalor Foundation	Therapeutics Innovation Australia-Queensland Node; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); SmartFutures; Lalor Foundation	MDM received funding from Therapeutics Innovation Australia-Queensland Node, the National Collaborative Research Infrastructure Strategy and SmartFutures. HNP was supported by The Lalor Foundation Postdoctoral Fellowship.	Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chan HW, 2013, REPRODUCTION, V146, pR101, DOI 10.1530/REP-12-0508; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; Glass M, 2005, J LIPID RES, V46, P1364, DOI 10.1194/jlr.C500006-JLR200; Habayeb OMH, 2004, J CLIN ENDOCR METAB, V89, P5482, DOI 10.1210/jc.2004-0681; Habayeb OMH, 2008, JAMA-J AM MED ASSOC, V299, P1135, DOI 10.1001/jama.299.10.1135; Keelan JA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.031; Lam PMW, 2008, ANAL BIOCHEM, V380, P195, DOI 10.1016/j.ab.2008.05.033; Li Z, 2012, AUSTR MOTHERS BABIES; Liggins G C, 1973, Recent Prog Horm Res, V29, P111; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Maccarrone M, 2002, MOL HUM REPROD, V8, P188, DOI 10.1093/molehr/8.2.188; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; Mitchell MD, 2008, AM J PHYSIOL-ENDOC M, V294, pE352, DOI 10.1152/ajpendo.00495.2007; ROMERO R, 1994, SEMIN REPROD ENDOCR, V12, P227, DOI 10.1055/s-2007-1016404; ROMERO R, 1994, PROSTAG LEUKOTR ESS, V50, P97, DOI 10.1016/0952-3278(94)90154-6; Romero R, 1996, PROSTAG LEUKOTR ESS, V54, P187, DOI 10.1016/S0952-3278(96)90015-0; Sergi M, 2013, ANAL BIOANAL CHEM, V405, P785, DOI 10.1007/s00216-012-6273-3; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; TURNBULL AC, 1981, REV PERINATAL MED, V4, P273; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371	23	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148306	10.1371/journal.pone.0148306	http://dx.doi.org/10.1371/journal.pone.0148306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840435	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200122
J	Newcombe, G; Campbell, J; Griffith, D; Baynes, M; Launchbaugh, K; Pendleton, R				Newcombe, George; Campbell, Jason; Griffith, David; Baynes, Melissa; Launchbaugh, Karen; Pendleton, Rosemary			Revisiting the Life Cycle of Dung Fungi, Including Sordaria fimicola	PLOS ONE			English	Article							ENDOPHYTES; LEAVES; FREQUENCIES; DIVERSITY	Dung fungi, such as Sordaria fimicola, generally reproduce sexually with ascospores discharged from mammalian dung after passage through herbivores. Their life cycle is thought to be obligate to dung, and thus their ascospores in Quaternary sediments have been interpreted as evidence of past mammalian herbivore activity. Reports of dung fungi as endophytes would seem to challenge the view that they are obligate to dung. However, endophyte status is controversial because surface-sterilization protocols could fail to kill dung fungus ascospores stuck to the plant surface. Thus, we first tested the ability of representative isolates of three common genera of dung fungi to affect plant growth and fecundity given that significant effects on plant fitness could not result from ascospores merely stuck to the plant surface. Isolates of S. fimicola, Preussia sp., and Sporormiella sp. reduced growth and fecundity of two of three populations of Bromus tectorum, the host from which they had been isolated. In further work with S. fimicola we showed that inoculations of roots of B. tectorum led to some colonization of above ground tissues. The same isolate of S. fimicola reproduced sexually on inoculated host plant tissues as well as in dung after passage through sheep, thus demonstrating a facultative rather than an obligate life cycle. Finally, plants inoculated with S. fimicola were not preferred by sheep; preference had been expected if the fungus were obligate to dung. Overall, these findings make us question the assumption that these fungi are obligate to dung.	[Newcombe, George; Campbell, Jason; Launchbaugh, Karen] Univ Idaho, Dept Forest Rangelands & Fire Sci, Moscow, ID 83843 USA; [Griffith, David; Baynes, Melissa] Univ Idaho, Environm Sci Program, Moscow, ID 83843 USA; [Campbell, Jason] Univ Idaho, Palouse Res Educ & Extens Ctr, Moscow, ID 83843 USA; [Griffith, David] Univ Idaho, Ctr Resilient Communities, Moscow, ID 83843 USA; [Pendleton, Rosemary] US Forest Serv, Rocky Mt Res Stn, Albuquerque, NM USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; United States Department of Agriculture (USDA); United States Forest Service	Newcombe, G (corresponding author), Univ Idaho, Dept Forest Rangelands & Fire Sci, Moscow, ID 83843 USA.	georgen@uidaho.edu	Newcombe, George/N-1650-2019	Griffith, David/0000-0001-6702-6764	U.S. Forest Service Rocky Mountain Research Station [RMRS 10-CR-11221632-182]	U.S. Forest Service Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service)	Support was provided to GN by the U.S. Forest Service Rocky Mountain Research Station in the form of grant RMRS 10-CR-11221632-182. Their website is www.fs.fed.us/rmrs. RP of the RMRS collaborated fully in all aspects of the project.	AHRENS WH, 1990, WEED SCI, V38, P452, DOI 10.1017/S0043174500056824; ANGEL K, 1975, MYCOLOGIA, V67, P63, DOI 10.2307/3758228; Baker AG, 2013, QUATERNARY SCI REV, V62, P21, DOI 10.1016/j.quascirev.2012.11.018; Baynes M, 2012, FUNGAL BIOL-UK, V116, P133, DOI 10.1016/j.funbio.2011.10.008; Bell A, 1983, DUNG FUNGI ILLUSTRAT; Botella L, 2011, FUNGAL DIVERS, V47, P9, DOI 10.1007/s13225-010-0061-1; CAIN RF, 1948, CAN J RES C, V26, P486, DOI 10.1139/cjr48c-032; CARROLL G, 1988, ECOLOGY, V69, P2, DOI 10.2307/1943154; Chambers JC, 2007, ECOL MONOGR, V77, P117, DOI 10.1890/05-1991; CHAMBERS KR, 1987, J PHYTOPATHOL, V120, P369, DOI 10.1111/j.1439-0434.1987.tb00501.x; Chen XM, 2009, J NAT PROD, V72, P1712, DOI 10.1021/np900302w; Collado J, 1996, NOVA HEDWIGIA, V63, P347; Cugny C, 2010, VEG HIST ARCHAEOBOT, V19, P391, DOI 10.1007/s00334-010-0242-6; Dewan MM, 1994, APPL SOIL ECOL, V1, P45, DOI 10.1016/0929-1393(94)90022-1; Dix NJ, 1994, FUNGAL ECOLOGY; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; Farr DF, FUNGAL DATABASES SYS; Herrera J, 2011, MICROB ECOL, V61, P239, DOI 10.1007/s00248-010-9744-0; Horie Yoshikazu, 1997, Mycoscience, V38, P287, DOI 10.1007/BF02464086; Lamb BC, 1998, GENETICS, V149, P87; Li WC, 2007, FUNGAL DIVERS, V25, P69; Luginbuhl M., 1980, Sydowia, V33, P185; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; MADRAZO GM, 1979, AM BIOL TEACH, V41, P530; Marquez SS, 2007, FUNGAL DIVERS, V27, P171; Medd RW, 2005, BIOCONTROL SCI TECHN, V15, P21, DOI 10.1080/09583150410001720635; Mosley J. C., 1996, Sheep & Goat Research Journal, V12, P74; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; PARKER AD, 1979, MYCOLOGIA, V71, P1206, DOI 10.2307/3759107; Petrini O., 1992, Sydowia, V44, P282; Petrini O, 1988, SYDOWIA, V40, P46; Popp M, 1996, J EXP BOT, V47, P1469, DOI 10.1093/jxb/47.10.1469; Preszler RW, 1996, OECOLOGIA, V108, P159, DOI 10.1007/BF00333227; Raper D, 2009, QUATERNARY RES, V71, P490, DOI 10.1016/j.yqres.2009.01.010; Richardson MJ, 2001, MYCOL RES, V105, P387, DOI 10.1017/S0953756201003884; Marquez SS, 2010, FUNGAL DIVERS, V41, P115, DOI 10.1007/s13225-009-0015-7; SCHULZ B, 1993, MYCOL RES, V97, P1447, DOI 10.1016/S0953-7562(09)80215-3; Suryanarayanan TS, 1998, CAN J MICROBIOL, V44, P1003, DOI 10.1139/cjm-44-10-1003; WICKLOW DT, 1980, MYCOLOGIA, V72, P1015, DOI 10.2307/3759740; Wood JR, 2011, QUATERNARY SCI REV, V30, P915, DOI 10.1016/j.quascirev.2011.01.007; ZAK JC, 1978, CAN J BOT, V56, P2313, DOI 10.1139/b78-279	41	18	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147425	10.1371/journal.pone.0147425	http://dx.doi.org/10.1371/journal.pone.0147425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839959	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200039
J	Tenga, A; Beard, JA; Takwi, A; Wang, YM; Chen, TS				Tenga, Alexa; Beard, Jordan A.; Takwi, Apana; Wang, Yue-Ming; Chen, Taosheng			Regulation of Nuclear Receptor Nur77 by miR-124	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CANCER CELL; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; ORPHAN RECEPTOR; STEM-CELLS; EXPRESSION; MICRORNAS; MEDULLOBLASTOMA; APOPTOSIS	The nuclear receptor Nur77 is commonly upregulated in adult cancers and has oncogenic functions. Nur77 is an immediate-early response gene that acts as a transcription factor to promote proliferation and protect cells from apoptosis. Conversely, Nur77 can translocate to the mitochondria and induce apoptosis upon treatment with various cytotoxic agents. Because Nur77 is upregulated in cancer and may have a role in cancer progression, it is of interest to understand the mechanism controlling its expression. MicroRNAs (miRNAs) are responsible for inhibiting translation of their target genes by binding to the 3'UTR and either degrading the mRNA or preventing it from being translated into protein, thereby making these non-coding endogenous RNAs vital regulators of every cellular process. Several miRNAs have been predicted to target Nur77; however, strong evidence showing the regulation of Nur77 by any miRNA is lacking. In this study, we used a luciferase reporter assay containing the 3'UTR of Nur77 to screen 296 miRNAs and found that miR-124, which is the most abundant miRNA in the brain and has a role in promoting neuronal differentiation, caused the greatest reduction in luciferase activity. Interestingly, we discovered an inverse relationship in Daoy medulloblastoma cells and undifferentiated granule neuron precursors in which Nur77 is upregulated and miR-124 is downregulated. Exogenous expression to further elevate Nur77 levels in Daoy cells increased proliferation and viability, but knocking down Nur77 via siRNA resulted in the opposite phenotype. Importantly, exogenous expression of miR-124 reduced Nur77 expression, cell viability, proliferation, and tumor spheroid size in 3D culture. In all, we have discovered miR-124 to be downregulated in instances of medulloblastoma in which Nur77 is upregulated, resulting in a proliferative state that abets cancer progression. This study provides evidence for increasing miR-124 expression as a potential therapy for cancers with elevated levels of Nur77.	[Tenga, Alexa; Beard, Jordan A.; Takwi, Apana; Wang, Yue-Ming; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Tenga, Alexa; Beard, Jordan A.; Chen, Taosheng] Univ Tennessee, Ctr Hlth Sci, Integrated Biomed Sci Program, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Chen, TS (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	taosheng.chen@stjude.org	Chen, Taosheng/I-6351-2013	Chen, Taosheng/0000-0001-6420-3809; Beard, Jordan/0000-0003-0281-1432	American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; National Institutes of Health [RO1GM086415, RO1GM110034, P30-CA21765]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086415, R01GM110034] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Lebanese Syrian Associated Charities (TC), St. Jude Children's Research Hospital (TC), and the National Institutes of Health (TC), grants RO1GM086415, RO1GM110034, & P30-CA21765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Alexopoulou AN, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2610; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anwar SL, 2013, INT J CANCER, V133, P660, DOI 10.1002/ijc.28068; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beard JA, 2015, CELL SIGNAL, V27, P257, DOI 10.1016/j.cellsig.2014.11.009; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Bras A, 2000, CELL DEATH DIFFER, V7, P262, DOI 10.1038/sj.cdd.4400653; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chen C, ENDOGENOUS CONTROLS; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; Cho SD, 2010, MOL PHARMACOL, V77, P396, DOI 10.1124/mol.109.061143; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Hu LH, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0054-z; Hu Y, 2015, MOL CANCER RES, V13, P281, DOI 10.1158/1541-7786.MCR-14-0230; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kotchetkov R, 2005, INT J ONCOL, V27, P1029; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee SO, 2012, ONCOGENE, V31, P3265, DOI 10.1038/onc.2011.504; Lee SO, 2014, MOL CANCER RES, V12, P527, DOI 10.1158/1541-7786.MCR-13-0567; Lee SO, 2011, EXPERT OPIN THER TAR, V15, P195, DOI 10.1517/14728222.2011.547481; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin PC, 2008, J NEUROCHEM, V106, P1017, DOI 10.1111/j.1471-4159.2008.05432.x; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Maruoka H, 2010, J BIOCHEM, V148, P93, DOI 10.1093/jb/mvq036; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mazuy C, 2013, FEBS LETT, V587, P3883, DOI 10.1016/j.febslet.2013.10.024; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Mondanizadeh M, 2015, J CELL BIOCHEM, V116, P943, DOI 10.1002/jcb.25045; Mu XM, 2003, J BIOL CHEM, V278, P42840, DOI 10.1074/jbc.M305594200; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Murray MJ, 2015, CANCER EPIDEM BIOMAR, V24, P350, DOI 10.1158/1055-9965.EPI-14-0669; Packer RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1419, DOI 10.1001/archneur.65.11.1419; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2013, NEURO-ONCOLOGY, V15, P83, DOI 10.1093/neuonc/nos281; Smoll NR, 2012, CANCER-AM CANCER SOC, V118, P1313, DOI 10.1002/cncr.26387; Stephen Safe KK, 2011, NUCL RECEPT SIGNAL, V9; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; To SKY, 2012, EXPERT OPIN THER TAR, V16, P573, DOI 10.1517/14728222.2012.680958; Tomioka T, 2014, NEUROSCI RES, V88, P39, DOI 10.1016/j.neures.2014.07.009; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Tricoli James V, 2007, Cancer Res, V67, P4553, DOI 10.1158/0008-5472.CAN-07-0563; Ueda Y, 1999, AM J RESP CELL MOL, V20, P1319, DOI 10.1165/ajrcmb.20.6.3577; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; [Washington University St. Jude Childrens Research Hospital], 2014, PED CANC GEN PROJ; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Xu WW, 2012, NEUROSCI LETT, V529, P12, DOI 10.1016/j.neulet.2012.09.025; Yoo YG, 2007, ONCOGENE, V26, P3823, DOI 10.1038/sj.onc.1210149; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng FY, 2009, CANCER LETT, V284, P157, DOI 10.1016/j.canlet.2009.04.016; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	77	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148433	10.1371/journal.pone.0148433	http://dx.doi.org/10.1371/journal.pone.0148433			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840408	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200134
J	Duarte, DA; Papadimitriou, A; Gilbert, RE; Thai, K; Zhang, YL; Rosales, MAB; de Faria, JBL; de Faria, JML				Duarte, Diego A.; Papadimitriou, Alexandros; Gilbert, Richard E.; Thai, Kerri; Zhang, Yanling; Rosales, Mariana A. B.; Lopes de Faria, Jose B.; Lopes de Faria, Jacqueline M.			Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SIRT1; DEGENERATION; MECHANISMS; TARGET; GROWTH; DAMAGE	Bone marrow-derived cells were demonstrated to improve organ function, but the lack of cell retention within injured organs suggests that the protective effects are due to factors released by the cells. Herein, we tested cell therapy using early outgrowth cells (EOCs) or their conditioned media (CM) to protect the retina of diabetic animal models (type 1 and type 2) and assessed the mechanisms by in vitro study. Control and diabetic (db/db) mice (8 weeks of age) were randomized to receive a unique intravenous injection of 5x10(5)EOCs or 0.25 ml thrice weekly tail-vein injections of 10x concentrated CM and Wystar Kyoto rats rendered diabetic were randomized to receive 0.50 ml thrice weekly tail-vein injections of 10x concentrated CM. Four weeks later, the animals were euthanized and the eyes were enucleated. Rat retinal Muller cells (rMCs) were exposed for 24 h to high glucose (HG), combined or not with EOC-conditioned medium (EOC-CM) from db/m EOC cultures. Diabetic animals showed increase in diabetic retinopathy (DR) and oxidative damage markers; the treatment with EOCs or CM infusions significantly reduced this damage and re-established the retinal function. In rMCs exposed to diabetic milieu conditions (HG), the presence of EOC-CM reduced reactive oxygen species production by modulating the NADPH-oxidase 4 system, thus upregulating SIRT1 activity and deacetylating Lys-310-p65-NF.B, decreasing GFAP and VEGF expressions. The antioxidant capacity of EOC-CM led to the prevention of carbonylation and nitrosylation posttranslational modifications on the SIRT1 molecule, preserving its activity. The pivotal role of SIRT1 on the mode of action of EOCs or their CM was also demonstrated on diabetic retina. These findings suggest that EOCs are effective as a form of systemic delivery for preventing the early molecular markers of DR and its conditioned medium is equally protective revealing a novel possibility for cell-free therapy for the treatment of DR.	[Duarte, Diego A.; Papadimitriou, Alexandros; Rosales, Mariana A. B.; Lopes de Faria, Jose B.; Lopes de Faria, Jacqueline M.] State Univ Campinas UNICAMP, Fac Med Sci, Renal Pathophysiol Lab, Invest Diabet Complicat, Campinas, SP, Brazil; [Gilbert, Richard E.; Thai, Kerri; Zhang, Yanling] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li KaShing Knowledge Inst, Toronto, ON, Canada	Universidade Estadual de Campinas; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	de Faria, JML (corresponding author), State Univ Campinas UNICAMP, Fac Med Sci, Renal Pathophysiol Lab, Invest Diabet Complicat, Campinas, SP, Brazil.	jmlfaria@fcm.unicamp.br	de faria, jose b lopes/C-2752-2012; de Faria, Jose B. Lopes/M-7198-2019; de Faria, Jacqueline M Lopes/B-3851-2013; Rosales, Mariana A B/K-7965-2014	de faria, jose b lopes/0000-0003-2373-5539; de Faria, Jose B. Lopes/0000-0003-2373-5539; de Faria, Jacqueline M Lopes/0000-0002-4783-4665; Rosales, Mariana A B/0000-0001-8042-0483	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57560-0, 2010/11514-7, 2013/04331-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants 2008/57560-0, 2010/11514-7, J.B.L. F.; 2013/04331-1, J.M.L.F.) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). D.A.D. and A.P. received a scholarship from FAPESP, and M.A.M.R from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio M, 2008, CURR PHARM DESIGN, V14, P2651, DOI 10.2174/138161208786264052; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Duarte DA, 2015, J NUTR BIOCHEM, V26, P64, DOI 10.1016/j.jnutbio.2014.09.003; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Kawamoto Atsuhiko, 2002, Cardiovasc Radiat Med, V3, P221, DOI 10.1016/S1522-1865(03)00082-9; Kitada M, 2010, J DIABETES INVEST, V1, P77, DOI 10.1111/j.2040-1124.2010.00018.x; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Papadimitriou A, 2014, CELL PHYSIOL BIOCHEM, V34, P1260, DOI 10.1159/000366336; Rahman I, 2012, PREV MED, V54, pS20, DOI 10.1016/j.ypmed.2011.11.014; REICHENBACH A, 1986, NEUROSCI LETT, V71, P125, DOI 10.1016/0304-3940(86)90545-8; Santos JM, 2011, CURR PHARM BIOTECHNO, V12, P352; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Siqueira RC, 2011, RETINA-J RET VIT DIS, V31, P1207, DOI 10.1097/IAE.0b013e3181f9c242; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wei XF, 2009, AM J PHYSIOL-RENAL, V296, pF427, DOI 10.1152/ajprenal.90536.2008; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yuen DA, 2013, STEM CELLS, V31, P2408, DOI 10.1002/stem.1502; Yuen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009543; Zhang YL, 2012, DIABETES, V61, P2114, DOI 10.2337/db11-1365; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zheng Y, 1922, INDIAN J OPHTHALMOL, V60, P428	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0147978	10.1371/journal.pone.0147978	http://dx.doi.org/10.1371/journal.pone.0147978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26836609	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548500005
J	Wanlapakorn, N; Ngaovithunvong, V; Thongmee, T; Vichaiwattana, P; Vongpunsawad, S; Poovorawan, Y				Wanlapakorn, Nasamon; Ngaovithunvong, Varisara; Thongmee, Thanunrat; Vichaiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong			Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; DIPHTHERIA; SEROEPIDEMIOLOGY; IMMUNIZATION; ADULTS	Despite the high coverage of prophylactic vaccine against Bordetella pertussis infection in many countries for more than three decades, pertussis remains a common vaccine-preventable disease. Infections have been detected more commonly in countries using acellular pertussis vaccine in their Expanded Program of Immunization. Thailand implemented a routine infant immunization program with whole-cell pertussis vaccine in 1977, and since 1992, the national vaccine policy has offered a five-dose whole-cell pertussis vaccine for children given at the ages of 2, 4, 6, 18, and 48 months. This study aimed to investigate the seroprevalence of antibodies to pertussis toxin among healthy people across all ages to determine the level of whole-cell vaccine-induced immunity in the population, and to identify which age group should be targeted for a booster dose. The lowest seronegative rate and highest geometric mean concentrations were found in the 0-10 years age group, corresponding to their recent pertussis vaccination. The proportion of people with undetectable IgG level was prominent, starting after 11 years of age onwards. Now that a reduced-dose pertussis vaccine with fewer adverse effects is available, a booster dose during adolescence should be considered in order to reduce the incidence of pertussis disease. Further studies exploring how long the reduced-dose pertussis vaccine can provide protective immunity against pertussis disease when administered to adults and adolescents should also be performed.	[Wanlapakorn, Nasamon; Ngaovithunvong, Varisara; Thongmee, Thanunrat; Vichaiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok 10330, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728	National Research University Project; Office of Higher Education Commission [WCU001-HR-57, WCU007-HR-57, WCU-58-006-HR]; National Research Council of Thailand (NRCT); Research Chair Grant from the National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of Thailand Research Fund [DPG5480002]; Siam Cement Group; MK Restaurant Company Limited	National Research University Project; Office of Higher Education Commission(Office of Higher Education Commission (OHEC)); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Research Chair Grant from the National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of Thailand Research Fund; Siam Cement Group; MK Restaurant Company Limited	This work was supported by The National Research University Project, Office of Higher Education Commission (WCU001-HR-57, WCU007-HR-57, and WCU-58-006-HR), the National Research Council of Thailand (NRCT), the Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), the Outstanding Professor of Thailand Research Fund (DPG5480002), Siam Cement Group, and MK Restaurant Company Limited. All grants were given to Professor Yong Poovorawan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATIONAL DISEASE SUR; Bureau of Epidemiology Department of Disease Control Ministry of Public Health Thailand, ANNUAL EPIDEMIOLOGIC; Centers for Disease Control and Prevention, 2014 PROVISIONAL PER; Centers for Disease Control and Prevention, MMWR; Cherry JD, 1996, J INFECT DIS, V174, pS259, DOI 10.1093/infdis/174.Supplement_3.S259; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Lugauer S, 2002, EUR J PEDIATR, V161, P142, DOI 10.1007/s00431-001-0893-5; McGirr A, 2015, PEDIATRICS, V135, P331, DOI 10.1542/peds.2014-1729; Rendi-Wagner P, 2010, VACCINE, V28, P3285, DOI 10.1016/j.vaccine.2010.02.104; Riolo MA, 2015, P NATL ACAD SCI USA, V112, pE472, DOI 10.1073/pnas.1415573112; Ronn PF, 2014, EPIDEMIOL INFECT, V142, P729, DOI 10.1017/S0950268813002446; Shamsizadeh A, 2014, E MEDITERR HEALTH J, V20, P623, DOI 10.26719/2014.20.10.623; Snapp Barbara, 2013, Adv Neonatal Care, V13, P103, DOI 10.1097/ANC.0b013e318285f918; Syed MA, 2012, JCPSP-J COLL PHYSICI, V22, P677, DOI 10.2012/JCPSP.677678; Tharmaphornpilas P, 2001, J INFECT DIS, V184, P1035, DOI 10.1086/323453; Urwyler P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-397; Wanlapakorn N, 2014, SE ASIAN J TROP MED, V45, P1132; World Health Organization, IMMUNIZATION VACCINE; World Health Organization, WHO GLOBAL AND REGIO; Zhang Q, 2011, J INFECTION, V63, P441, DOI 10.1016/j.jinf.2011.07.018	22	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2016	11	2							e0148338	10.1371/journal.pone.0148338	http://dx.doi.org/10.1371/journal.pone.0148338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NO	26837004	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548500007
J	Markus, NM; Hasel, P; Qiu, J; Bell, KFS; Heron, S; Kind, PC; Dando, O; Simpson, TI; Hardingham, GE				Markus, Nora M.; Hasel, Philip; Qiu, Jing; Bell, Karen F. S.; Heron, Samuel; Kind, Peter C.; Dando, Owen; Simpson, T. Ian; Hardingham, Giles E.			Expression of mRNA Encoding Mcu and Other Mitochondrial Calcium Regulatory Genes Depends on Cell Type, Neuronal Subtype, and Ca2+ Signaling	PLOS ONE			English	Article							NMDA RECEPTOR-ACTIVITY; ESSENTIAL COMPONENT; NUCLEAR CA2+; GENOME-WIDE; MICU1; UNIPORTER; PROTEIN; TRANSCRIPTION; MEMBRANE; STRESS	Uptake of Ca2+ into the mitochondrial matrix controls cellular metabolism and survival-death pathways. Several genes are implicated in controlling mitochondrial Ca2+ uptake (mitochondrial calcium regulatory genes, MCRGs), however, less is known about the factors which influence their expression level. Here we have compared MCRG mRNA expression, in neural cells of differing type (cortical neurons vs. astrocytes), differing neuronal subtype (CA3 vs. CA1 hippocampus) and in response to Ca2+ influx, using a combination of qPCR and RNA-seq analysis. Of note, we find that the Mcu-regulating Micu gene family profile differs substantially between neurons and astrocytes, while expression of Mcu itself is markedly different between CA3 and CA1 regions in the adult hippocampus. Moreover, dynamic control of MCRG mRNA expression in response to membrane depolarization-induced Ca2+ influx is also apparent, resulting in repression of Letm1, as well as Mcu. Thus, the mRNA expression profile of MCRGs is not fixed, which may cause differences in the coupling between cytoplasmic and mitochondrial Ca2+, as well as diversity of mitochondrial Ca2+ uptake mechanisms.	[Markus, Nora M.; Hasel, Philip; Qiu, Jing; Bell, Karen F. S.; Heron, Samuel; Kind, Peter C.; Hardingham, Giles E.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Heron, Samuel; Simpson, T. Ian] Univ Edinburgh, Sch Informat, Edinburgh EH8 9AB, Midlothian, Scotland; [Kind, Peter C.; Dando, Owen] Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med, Ctr Brain Dev & Repair, Bangalore 560065, Karnataka, India	University of Edinburgh; University of Edinburgh; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Hardingham, GE (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	Giles.Hardingham@ed.ac.uk	Qiu, Jing/GQH-8027-2022; Simpson, Ian/AAG-8830-2021	Simpson, Ian/0000-0003-0495-7187; Hasel, Philip/0000-0003-4378-3685; Dando, Owen/0000-0002-6269-6408; Hardingham, Giles/0000-0002-7629-5314; Kind, Peter/0000-0002-4256-9639	Medical Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council; MRC [G0902044] Funding Source: UKRI; Medical Research Council [1292847, G0902044] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, the Wellcome Trust, and the Biotechnology and Biological Sciences Research Council.	Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Baxter PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7761; Baxter PS, 2011, J NEUROCHEM, V118, P365, DOI 10.1111/j.1471-4159.2011.07330.x; Bell KF, 2011, P NATL ACAD SCI USA, V108, pE1, DOI 10.1073/pnas.1015229108; Bell KFS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8066; Bell KFS, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/689524; Bell KFS, 2011, ANTIOXID REDOX SIGN, V14, P1467, DOI 10.1089/ars.2010.3567; Bell KFS, 2011, CURR OPIN NEUROBIOL, V21, P299, DOI 10.1016/j.conb.2011.01.002; Bilican B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085932; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Chen M, 2011, ACTA BIOCH BIOPH SIN, V43, P822, DOI 10.1093/abbs/gmr075; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; Csordas G, 2012, MOL CELL ENDOCRINOL, V353, P109, DOI 10.1016/j.mce.2011.11.011; De Stefani D, 2015, BIOCH BIOPHYS ACTA; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Gupta K, 2012, CELL DEATH DIFFER, V19, P779, DOI 10.1038/cdd.2011.154; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2011, ANTIOXID REDOX SIGN, V14, P1421, DOI 10.1089/ars.2010.3573; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hardingham NR, 2007, J NEUROPHYSIOL, V97, P2965, DOI 10.1152/jn.01352.2006; Hasel P, 2014, BIOCH BIOPHYS ACTA; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoffman NE, 2014, MOL BIOL CELL, V25, P936, DOI 10.1091/mbc.E13-08-0502; Jakob R, 2014, NEUROSCI LETT, V575, P7, DOI 10.1016/j.neulet.2014.05.026; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kamer KJ, 2014, EMBO REP, V15, P299, DOI 10.1002/embr.201337946; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Mallilankaraman K, 2015, NAT CELL BIOL, V17, P953, DOI 10.1038/ncb3202; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; Newrzella D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-370; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Puddifoot C, 2012, J NEUROSCI, V32, P6995, DOI 10.1523/JNEUROSCI.6407-11.2012; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Vais H, 2015, CELL METAB, V22, P533, DOI 10.1016/j.cmet.2015.09.015; Wahl AS, 2009, NEUROSCIENCE, V158, P344, DOI 10.1016/j.neuroscience.2008.06.018; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wilde GJC, 1997, J NEUROCHEM, V69, P883; Wyllie DJA, 2013, NEUROPHARMACOLOGY, V74, P4, DOI 10.1016/j.neuropharm.2013.01.016; Yang G, 2000, BRAIN RES, V870, P195, DOI 10.1016/S0006-8993(00)02319-2; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	68	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148164	10.1371/journal.pone.0148164	http://dx.doi.org/10.1371/journal.pone.0148164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828201	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200075
J	McHaffie, SL; Hastie, ND; Chau, YY				McHaffie, Sophie L.; Hastie, Nicholas D.; Chau, You-Ying			Effects of CreER(T2), 4-OH Tamoxifen, and Gender on CFU-F Assays	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; CRE RECOMBINASE; MESENCHYMAL PROGENITORS; ALKALINE-PHOSPHATASE; DIFFERENTIATION; POPULATIONS; RALOXIFENE; STRAINS; SURFACE	Gene function in stem cell maintenance is often tested by inducing deletion via the Cre-loxP system. However, controls for Cre and other variables are frequently not included. Here we show that when cultured in the presence of 4-OH tamoxifen, bone and marrow cells containing the CreER(T2) construct have a reduced colony forming ability. Inactive CreER(T2) recombinase, however, has the opposite effect. Young female marrow cells containing the inactive CreER(T2) construct grew more colonies than cells lacking the construct altogether. Young female control marrow cells (i.e., negative for CreER(T2)) also produced significantly greater colony numbers when cultured with 4-OH tamoxifen, compared with the ethanol vehicle control. In conclusion, we report that the use of the Cre-loxP system is inadvisable in combination with CFU-F assays, and that appropriate controls should be in place to extend the future use of Cre-loxP in alternate assays.	[McHaffie, Sophie L.; Hastie, Nicholas D.; Chau, You-Ying] Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Chau, You-Ying] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Chau, YY (corresponding author), Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh, Midlothian, Scotland.; Chau, YY (corresponding author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	You-Ying.Chau@igmm.ed.ac.uk		McHaffie, Sophie/0000-0002-9088-2646	Medical Research Council; MRC [MC_PC_U127527180] Funding Source: UKRI; Medical Research Council [MC_PC_U127527180] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is funded by a Medical Research Council core grant.	Antoniou ES, 2004, SHOCK, V22, P415, DOI 10.1097/01.shk.0000142185.88094.88; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Brake Rachael L, 2004, Genet Mol Res, V3, P456; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780; ISHIKAWA Y, 1988, EUR J HAEMATOL, V40, P126; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Liu SG, 2014, J BONE MINER RES, V29, P1141, DOI 10.1002/jbmr.2120; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Michael H, 2007, BRIT J PHARMACOL, V151, P384, DOI 10.1038/sj.bjp.0707232; Miki Y, 2009, J STEROID BIOCHEM, V113, P281, DOI 10.1016/j.jsbmb.2009.01.010; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Ohishi M, 2012, AM J PATHOL, V180, P811, DOI 10.1016/j.ajpath.2011.10.028; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Penfornis P, 2011, METHODS MOL BIOL, V698, P11, DOI 10.1007/978-1-60761-999-4_2; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Ratajczak MZ, 2004, FOLIA HISTOCHEM CYTO, V42, P139; Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Siclari VA, 2013, BONE, V53, P575, DOI 10.1016/j.bone.2012.12.013; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Solchaga LA, 2011, METHODS MOL BIOL, V698, P253, DOI 10.1007/978-1-60761-999-4_20; Sreekala C, 2005, PLANT CELL REP, V24, P86, DOI 10.1007/s00299-004-0909-5; Srivastava V, 2003, PLANT MOL BIOL, V52, P661, DOI 10.1023/A:1024839617490; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; VANSTRAALEN JP, 1991, CLIN CHIM ACTA, V201, P27, DOI 10.1016/0009-8981(91)90021-4; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064	37	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148105	10.1371/journal.pone.0148105	http://dx.doi.org/10.1371/journal.pone.0148105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828722	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200061
J	Wu, ML; Liu, CZ; Joiner, WJ				Wu, Meilin; Liu, Clifford Z.; Joiner, William J.			Structural Analysis and Deletion Mutagenesis Define Regions of QUIVER/SLEEPLESS that Are Responsible for Interactions with Shaker-Type Potassium Channels and Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PHARMACOLOGICAL CHAPERONE; ALPHA-BUNGAROTOXIN; PROTEINS; NEUROTOXINS; ACTIVATION; MECHANISMS; FAMILY; DOMAIN; CELLS	Ly6 proteins are endogenous prototoxins found in most animals. They show striking structural and functional parallels to snake a-neurotoxins, including regulation of ion channels and cholinergic signaling. However, the structural contributions of Ly6 proteins to regulation of effector molecules is poorly understood. This question is particularly relevant to the Ly6 protein QUIVER/SLEEPLESS (QVR/SSS), which has previously been shown to suppress excitability and synaptic transmission by upregulating potassium (K) channels and downregulating nicotinic acetylcholine receptors (nAChRs) in wake-promoting neurons to facilitate sleep in Drosophila. Using deletion mutagenesis, co-immunoprecipitations, ion flux assays, surface labeling and confocal microscopy, we demonstrate that only loop 2 is required for many of the previously described properties of SSS in transfected cells, including interactions with K channels and nAChRs. Collectively our data suggest that QVR/SSS, and by extension perhaps other Ly6 proteins, target effector molecules using limited protein motifs. Mapping these motifs may be useful in rational design of drugs that mimic or suppress Ly6-effector interactions to modulate nervous system function.	[Wu, Meilin; Joiner, William J.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Liu, Clifford Z.] Univ Calif San Diego, Marshall Coll, UCSD Undergrad Program, La Jolla, CA 92093 USA; [Joiner, William J.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Joiner, WJ (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Joiner, WJ (corresponding author), Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA.	wjoiner@ucsd.edu		Liu, Clifford/0000-0003-1783-299X	National Institute of Neurological Disorders and Stroke/National Institutes of Health [NS072431]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by National Institute of Neurological Disorders and Stroke/National Institutes of Health grant # NS072431 to WJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt KB, 2009, J LEUKOCYTE BIOL, V85, P55, DOI 10.1189/jlb.0507305; Adeyo O, 2015, BR J DERMATOL; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Bresson-Mazet C, 2008, CELL PROLIFERAT, V41, P726, DOI 10.1111/j.1365-2184.2008.00554.x; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Dean T, 2011, J NEUROSCI, V31, P11387, DOI 10.1523/JNEUROSCI.0502-11.2011; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Holmes RS, 2012, 3 BIOTECH, V2, P37, DOI 10.1007/s13205-011-0026-4; Kiguchi N, 2012, NEUROCHEM INT, V61, P1212, DOI 10.1016/j.neuint.2012.09.001; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Loertscher R, 2002, TRANSPL IMMUNOL, V9, P93, DOI 10.1016/S0966-3274(02)00013-8; Long KK, 2011, FASEB J, V25, P1156, DOI 10.1096/fj.10-170308; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Plengpanich W, 2014, J BIOL CHEM, V289, P19491, DOI 10.1074/jbc.M114.558528; Puddifoot CA, 2015, J NEUROSCI, V35, P3420, DOI 10.1523/JNEUROSCI.3630-14.2015; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Tirosh Y, 2013, TOXINS, V5, P1314, DOI 10.3390/toxins5071314; Tsetlin VI, 2015, TRENDS PHARMACOL SCI, V36, P109, DOI 10.1016/j.tips.2014.11.003; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang JW, 2010, J NEUROGENET, V24, P67, DOI 10.3109/01677061003746341; Wang JW, 2000, J NEUROSCI, V20, P5958, DOI 10.1523/JNEUROSCI.20-16-05958.2000; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Wu ML, 2015, J BIOL CHEM, V290, P24509, DOI 10.1074/jbc.M115.647248; Wu ML, 2014, CURR BIOL, V24, P621, DOI 10.1016/j.cub.2014.02.026	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148215	10.1371/journal.pone.0148215	http://dx.doi.org/10.1371/journal.pone.0148215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828958	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200085
J	Balinda, SN; Ondoa, P; Obuku, EA; Kliphuis, A; Egau, I; Bronze, M; Kasambula, L; Schuurman, R; Spieker, N; de Wit, TFR; Kityo, C				Balinda, Sheila N.; Ondoa, Pascale; Obuku, Ekwaro A.; Kliphuis, Aletta; Egau, Isaac; Bronze, Michelle; Kasambula, Lordwin; Schuurman, Rob; Spieker, Nicole; de Wit, Tobias F. Rinke; Kityo, Cissy		ART-A Consortium	Clinical Evaluation of an Affordable Qualitative Viral Failure Assay for HIV Using Dried Blood Spots in Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; DRUG-RESISTANCE; CHILDREN; STRATEGIES; COUNTRIES; PLASMA; ADULTS	Background WHO recommends regular viral load (VL) monitoring of patients on antiretroviral therapy (ART) for timely detection of virological failure, prevention of acquired HIV drug resistance (HIVDR) and avoiding unnecessary switching to second-line ART. However, the cost and complexity of routine VL testing remains prohibitive in most resource limited settings (RLS). We evaluated a simple, low-cost, qualitative viral-failure assay (VFA) on dried blood spots (DBS) in three clinical settings in Uganda. Methods We conducted a cross-sectional diagnostic accuracy study in three HIV/AIDS treatment centres at the Joint Clinical Research Centre in Uganda. The VFA employs semi-quantitative detection of HIV-1 RNA amplified from the LTR gene. We used paired dry blood spot (DBS) and plasma with the COBASAmpliPrep/COBASTaqMan, Roche version 2 (VLref) as the reference assay. We used the VFA at two thresholds of viral load, (>5,000 or >1,000 copies/ml). Results 496 paired VFA and VLref results were available for comparative analysis. Overall, VFA demonstrated 78.4% sensitivity, (95% CI: 69.7%-87.1%), 93% specificity (95% CI: 89.7%-96.4%), 89.3% accuracy (95% CI: 85%-92%) and an agreement kappa = 0.72 as compared to the VLref. The predictive values of positivity and negativity among patients on ART for >12 months were 72.7% and 99.3%, respectively. Conclusions VFA allowed 89% of correct classification of VF. Only 11% of the patients were misclassified with the potential of unnecessary or late switch to second-line ART. Our findings present an opportunity to roll out simple and affordable VLmonitoring for HIV-1 treatment in RLS.	[Balinda, Sheila N.; Obuku, Ekwaro A.; Egau, Isaac; Kasambula, Lordwin; Kityo, Cissy] Joint Clin Res Ctr, POB 10005, Kampala, Uganda; [Ondoa, Pascale; de Wit, Tobias F. Rinke] Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, Trinity C Bldg,Pietersbergweg 17, NL-1105 BM Amsterdam, Netherlands; [Kliphuis, Aletta; Spieker, Nicole] PharmAccess Int, Trinity Bldg C Pietersbergweg 17, NL-1105 BM Amsterdam, Netherlands; [Bronze, Michelle] Univ Witwatersrand, Wits Hlth Consortium, 1 Jan Smuts Ave,Braamfontein 2000, Johannesburg, South Africa; [Schuurman, Rob] Univ Med Ctr Utrecht, POB 80125, NL-3508 TC Utrecht, Netherlands	Joint Clinic Research Center - United Arab Emirates; University of Amsterdam; Academic Medical Center Amsterdam; University of Witwatersrand; Utrecht University; Utrecht University Medical Center	Balinda, SN (corresponding author), Joint Clin Res Ctr, POB 10005, Kampala, Uganda.	sbalinda@jcrc.org.ug	Schuurman, Rob/M-4687-2019; Obuku, Ekwaro A./H-4988-2011	Schuurman, Rob/0000-0002-0060-9831; 	Netherlands Organization for Scientific Research for Global Development (NWO/WOTRO) under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty-related Diseases (NACCAP) [W.07.05.204.00]	Netherlands Organization for Scientific Research for Global Development (NWO/WOTRO) under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty-related Diseases (NACCAP)	This research was supported by a grant from the Netherlands Organization for Scientific Research for Global Development (NWO/WOTRO) under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty-related Diseases (NACCAP) given to TRW, for Amsterdam Institute of Global Health & Development under the terms of Grant Award Number-W.07.05.204.00.	Aitken SC, 2013, J CLIN MICROBIOL, V51, P1899, DOI 10.1128/JCM.03305-12; Aitken SC, 2013, J CLIN MICROBIOL, V51, P1757, DOI 10.1128/JCM.00118-13; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bossuyt PM, 2003, CROAT MED J, V44, P639; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Dodd R, 2010, HEALTH POLICY PLANN, V25, P363, DOI 10.1093/heapol/czq014; Fryatt R, 2010, LANCET, V375, P419, DOI 10.1016/S0140-6736(09)61833-X; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hamers RL, 2012, INT J EPIDEMIOL, V41, P43, DOI 10.1093/ije/dyq192; Hamers RL, 2009, ANTIVIR THER, V14, P619; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; Medecins Sans Frontieres, 2013, LOW CAN WE GO PRIC H; Palumbo PE, 1998, JAMA-J AM MED ASSOC, V279, P756, DOI 10.1001/jama.279.10.756; Rutherford GW, 2014, AIDS, V28, pS161, DOI 10.1097/QAD.0000000000000236; Sigaloff KCE, 2013, AIDS RES HUM RETROV, V29, P925, DOI [10.1089/aid.2012.0218, 10.1089/AID.2012.0218]; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Tucker JD, 2014, AIDS, V28, pS151, DOI 110.1097/QAD.0000000000000230; UNAIDS, 2015, AIDS CHANG EV MDG 6; World Bank, 2013, GROSS DOM PROD 2013	20	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0145110	10.1371/journal.pone.0145110	http://dx.doi.org/10.1371/journal.pone.0145110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824465	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600004
J	Meyer, CA; Singh, R; Jones, MT; Yu, CG; Power, RF; Geddes, JW				Meyer, Carolyn A.; Singh, Ranjana; Jones, Mackenzie T.; Yu, Chen-Guang; Power, Ronan F.; Geddes, James W.			Dietary Supplementation with Organoselenium Accelerates Recovery of Bladder Expression, but Does Not Improve Locomotor Function, following Spinal Cord Injury	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; PARKINSONS-DISEASE; TISSUE RETENTION; OXIDATIVE DAMAGE; SELENOPROTEIN-P; RATING-SCALE; CELL-DEATH; IN-VITRO; SELENIUM; BRAIN	Selenium is an essential element required for activity of several antioxidant enzymes, including glutathione peroxidase. Because of the critical role of the antioxidant system in responding to traumatic events, we hypothesized that dietary selenium supplementation would enhance neuroprotection in a rodent model of spinal cord injury. Rats were maintained on either a control or selenium-enriched diet prior to, and following, injury. Dietary selenium supplementation, provided as selenized yeast added to normal rat chow, resulted in a doubling of selenium levels in the spinal cord. Dietary selenium reduced the time required for recovery of bladder function following thoracic spinal cord injury. However, this was not accompanied by improvement in locomotor function or tissue sparing.	[Meyer, Carolyn A.; Singh, Ranjana; Jones, Mackenzie T.; Yu, Chen-Guang; Geddes, James W.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Meyer, Carolyn A.; Singh, Ranjana; Geddes, James W.] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA; [Power, Ronan F.] Alltech, Ctr Anim Nutrigen & Appl Anim Nutr, Nicholasville, KY USA	University of Kentucky; University of Kentucky	Geddes, JW (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA.; Geddes, JW (corresponding author), Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA.	jgeddes@uky.edu		Jones, Mackenzie/0000-0001-9286-505X	NIH [T32 NS07789, P30 NS051220]; Kentucky Spinal Cord and Head Injury Research Trust; Admiral Sheeley Endowment for Spinal Cord and Brain Injury Research; Alltech Inc. (Nicholasville, KY); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS051220] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust; Admiral Sheeley Endowment for Spinal Cord and Brain Injury Research; Alltech Inc. (Nicholasville, KY); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CAM was supported by NIH T32 NS07789 and the research was supported by NIH P30 NS051220, the Kentucky Spinal Cord and Head Injury Research Trust, and the Admiral Sheeley Endowment for Spinal Cord and Brain Injury Research (JWG). Alltech Inc. (Nicholasville, KY) provided support in the form of salary for RFP and animal diets, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.A.M. was supported by NIH T32 NS07789 and the research was supported by NIH P30 NS051220, the Kentucky Spinal Cord and Head Injury Research Trust, and the Admiral Sheeley Endowment for Spinal Cord and Brain Injury Research (J.W.G). We thank Dr. Richard Kryscio for assistance with the statistical analysis. Alltech Inc. (Nicholasville, KY) provided support in the form of salary for R.F.P and animal diets, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; Bellinger FP, 2012, J PARKINSON DIS, V2, P115, DOI 10.3233/JPD-2012-11052; Bierla K, 2012, TRAC-TREND ANAL CHEM, V41, P122, DOI 10.1016/j.trac.2012.08.006; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; BURK RF, 1972, J NUTR, V102, P1049, DOI 10.1093/jn/102.8.1049; Center N. S. C. I. S., 2013, SPIN CORD INJ FACTS; Chen XB, 2015, EUR REV MED PHARMACO, V19, P4434; DAWSON DA, 1995, NEUROSCI LETT, V185, P65, DOI 10.1016/0304-3940(94)11226-9; Ellwanger JH, 2015, NUTRITION, V31, P359, DOI 10.1016/j.nut.2014.07.004; Ferrero SL, 2015, J NEUROTRAUM, V32, P200, DOI 10.1089/neu.2013.3247; Griffiths JC, 2006, INT J TOXICOL, V25, P465, DOI 10.1080/10915810600959626; Grulova I, 2013, SPINE J, V13, P1881, DOI 10.1016/j.spinee.2013.06.073; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; Kjell J, 2014, SPINAL CORD, V52, P186, DOI 10.1038/sc.2013.166; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Lovell MA, 2009, FREE RADICAL BIO MED, V46, P1527, DOI 10.1016/j.freeradbiomed.2009.03.008; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Nuttall KL, 2006, ANN CLIN LAB SCI, V36, P409; Ogawa A, 1999, CEREBROVASC DIS, V9, P112, DOI 10.1159/000015908; Ozsoy O, 2012, RESTOR NEUROL NEUROS, V30, P363, DOI 10.3233/RNN-2012-110203; PARNHAM MJ, 1987, INT J TISSUE REACT, V9, P45; PROHASKA JR, 1977, BIOCHEM BIOPH RES CO, V76, P437, DOI 10.1016/0006-291X(77)90744-6; PROHASKA JR, 1976, J NEUROCHEM, V27, P1379, DOI 10.1111/j.1471-4159.1976.tb02619.x; Pruss H, 2011, BRAIN PATHOL, V21, P652, DOI 10.1111/j.1750-3639.2011.00488.x; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; SALBE AD, 1990, J NUTR, V120, P207, DOI 10.1093/jn/120.2.207; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sharp KG, 2014, EXP NEUROL, V254, P1, DOI 10.1016/j.expneurol.2013.12.019; Song KD, 2013, ANIM SCI J, V84, P238, DOI [10.1111/j.1740-0929.2012.01060.x, 10.1111/j.17]; SPALLHOLZ JE, 1994, FREE RADICAL BIO MED, V17, P45, DOI 10.1016/0891-5849(94)90007-8; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vinceti M, 2013, NEUROTOXICOLOGY, V38, P25, DOI 10.1016/j.neuro.2013.05.016; Wrobel JK, 2013, NUTR CANCER, V65, P563, DOI 10.1080/01635581.2013.775315; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Yip PK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-6	46	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147716	10.1371/journal.pone.0147716	http://dx.doi.org/10.1371/journal.pone.0147716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824231	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600050
J	Montes-Rodriguez, IM; Rivera, LE; Lopez-Garriga, J; Cadilla, CL				Montes-Rodriguez, Ingrid M.; Rivera, Linda E.; Lopez-Garriga, Juan; Cadilla, Carmen L.			Characterization and Expression of the Lucina pectinata Oxygen and Sulfide Binding Hemoglobin Genes	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS MITES; MULTIPLE SEQUENCE ALIGNMENT; NONVERTEBRATE GLOBIN GENES; MOLLUSK ANADARA-TRAPEZIA; AMINO-ACID-SEQUENCE; DEEP-SEA CLAM; MESSENGER-RNA; CODAKIA-ORBICULARIS; BACTERIA SYMBIOSIS; MAMMALIAN GENOMES	The clam Lucina pectinata lives in sulfide-rich muds and houses intracellular symbiotic bacteria that need to be supplied with hydrogen sulfide and oxygen. This clam possesses three hemoglobins: hemoglobin I (HbI), a sulfide-reactive protein, and hemoglobin II (HbII) and III (HbIII), which are oxygen-reactive. We characterized the complete gene sequence and promoter regions for the oxygen reactive hemoglobins and the partial structure and promoters of the HbI gene from Lucina pectinata. We show that HbI has two mRNA variants, where the 5' end had either a sequence of 96 bp (long variant) or 37 bp (short variant). The gene structure of the oxygen reactive Hbs is defined by having 4-exons/3-introns with conservation of intron location at B12.2 and G7.0 and the presence of pre-coding introns, while the partial gene structure of HbI has the same intron conservation but appears to have a 5-exon/4-intron structure. A search for putative transcription factor binding sites (TFBSs) was done with the promoters for HbII, HbIII, HbI short and HbI long. The HbII, HbIII and HbI long promoters showed similar predicted TFBSs. We also characterized MITE-like elements in the HbI and HbII gene promoters and intronic regions that are similar to sequences found in other mollusk genomes. The gene expression levels of the clam Hbs, from sulfide-rich and sulfide-poor environments showed a significant decrease of expression in the symbiont-containing tissue for those clams in a sulfide-poor environment, suggesting that the sulfide concentration may be involved in the regulation of these proteins. Gene expression evaluation of the two HbI mRNA variants indicated that the longer variant is expressed at higher levels than the shorter variant in both environments.	[Montes-Rodriguez, Ingrid M.; Lopez-Garriga, Juan] Univ Puerto Rico, Arts & Sci Fac, Dept Chem, Mayaguuez Campus,POB 9019, Mayaguez, PR 00681 USA; [Rivera, Linda E.; Cadilla, Carmen L.] Univ Puerto Rico, Sch Med, Dept Biochem, Med Sci Campus,POB 365067, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Cadilla, CL (corresponding author), Univ Puerto Rico, Sch Med, Dept Biochem, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.	carmen.cadilla@upr.edu			National Institute on Minority Health and Health Disparities RCMI grant [G12 MD007600]; National Institute of General Medical Sciences from the National Institutes of Health [P20GM103475, R25GM061838, R25 GM088023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM088023, P20GM103475, R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587, G12MD007600] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities RCMI grant; National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funds from National Institute on Minority Health and Health Disparities RCMI grant G12 MD007600, National Institute of General Medical Sciences - Awards Number P20GM103475 and R25GM061838 to CLC and R25 GM088023 to JLG from the National Institutes of Health supported this work. IMMR and LER received support from grants R25 GM088023 and R25GM061838, respectively.	ALLEN JA, 1958, PHILOS T R SOC B, V241, P421, DOI 10.1098/rstb.1958.0010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antommattei-Perez FM, 1999, J PROTEIN CHEM, V18, P831, DOI 10.1023/A:1020623011363; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Bailey TL, 1994, C INT SYST MOL BIOL, P28; Bailly X, 2005, J INORG BIOCHEM, V99, P142, DOI 10.1016/j.jinorgbio.2004.10.012; Balkwill GD, 2009, BIOCHEMISTRY-US, V48, P11487, DOI 10.1021/bi901420k; Berezikov E, 2005, NUCLEIC ACIDS RES, V33, pW447, DOI 10.1093/nar/gki378; Berezikov Eugene, 2007, V395, P437; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Brodie R, 2004, BIOINFORMATICS, V20, P279, DOI 10.1093/bioinformatics/btg406; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cardazzo B, 2003, MOL BIOL EVOL, V20, P2034, DOI 10.1093/molbev/msg213; Caro A, 2009, APPL ENVIRON MICROB, V75, P3304, DOI 10.1128/AEM.02659-08; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chen Jiongjiong, 2012, Mob Genet Elements, V2, P127; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Jesus-Bonilla W, 2006, J BIOL INORG CHEM, V11, P334, DOI 10.1007/s00775-006-0082-0; Dewilde S, 1998, J BIOL CHEM, V273, P13583, DOI 10.1074/jbc.273.22.13583; Duan ZJ, 2002, P NATL ACAD SCI USA, V99, P5509, DOI 10.1073/pnas.072084499; Duplessis MR, 2004, APPL ENVIRON MICROB, V70, P4144, DOI 10.1128/AEM.70.7.4144-4150.2004; Fattash I, 2013, GENOME, V56, P475, DOI 10.1139/gen-2012-0174; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fossat N, 2014, EMBO REP, V15, P903, DOI 10.15252/embr.201438450; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Gavira JA, 2006, ACTA CRYSTALLOGR F, V62, P196, DOI 10.1107/S1744309106002648; Gavira JA, 2008, J BIOL CHEM, V283, P9414, DOI 10.1074/jbc.M705026200; GIBSON QH, 1989, J BIOL CHEM, V264, P100; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hardison R, 1998, J EXP BIOL, V201, P1099; Hardison R, 2001, CLIN MANAGEMENT, P1; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Heyn P, 2015, BIOESSAYS, V37, P148, DOI 10.1002/bies.201400138; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kawano K, 2003, CELL MOL LIFE SCI, V60, P1952, DOI 10.1007/s00018-003-3184-7; KRAUS DW, 1990, J BIOL CHEM, V265, P16043; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; KRAUS DW, 1995, AM ZOOL, V35, P112; Krebs S, 2009, ANAL BIOCHEM, V387, P136, DOI 10.1016/j.ab.2008.12.020; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Lechaire JP, 2006, BIOL CELL, V98, P163, DOI 10.1042/BC20040502; LEWIN R, 1984, SCIENCE, V226, P328, DOI 10.1126/science.226.4672.328; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; MCDONALD JF, 1993, CURR OPIN GENET DEV, V3, P855, DOI 10.1016/0959-437X(93)90005-A; MOENS L, 1992, FEBS LETT, V312, P105, DOI 10.1016/0014-5793(92)80915-4; Moucadel V, 2007, NUCLEIC ACIDS RES, V35, P1947, DOI 10.1093/nar/gkm062; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; NAITO Y, 1991, P NATL ACAD SCI USA, V88, P6672, DOI 10.1073/pnas.88.15.6672; Nassif NT, 1996, GENE, V183, P225, DOI 10.1016/S0378-1119(96)00564-1; Nicholas HB, 2002, BIOTECHNIQUES, V32, P572, DOI 10.2144/02323rv01; Nicholas KB, 1997, GENEDOC TOOL EDITING, P14; Oki N, 2008, GENES GENET SYST, V83, P321, DOI 10.1266/ggs.83.321; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Palavicini JP, 2012, J BIOL CHEM, V287, P17754, DOI 10.1074/jbc.M112.366005; Pietri R, 2005, BBA-PROTEINS PROTEOM, V1747, P195, DOI 10.1016/j.bbapap.2004.11.005; Pietri R, 2006, BBA-PROTEINS PROTEOM, V1764, P758, DOI 10.1016/j.bbapap.2005.11.006; Rivera L, 2008, GENE, V410, P122, DOI 10.1016/j.gene.2007.12.005; Rizzi M, 1996, J MOL BIOL, V258, P1, DOI 10.1006/jmbi.1996.0228; RIZZI M, 1994, J MOL BIOL, V244, P86, DOI 10.1006/jmbi.1994.1706; Rosenthal JJC, 2015, J EXP BIOL, V218, P1812, DOI 10.1242/jeb.119065; Ruiz-Martinez CR, 2009, ACTA CRYSTALLOGR F, V65, P25, DOI 10.1107/S1744309108038542; Satovic E, 2013, GENOME BIOL EVOL, V5, P2549, DOI 10.1093/gbe/evt202; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; SHERMAN DR, 1992, P NATL ACAD SCI USA, V89, P11696, DOI 10.1073/pnas.89.24.11696; Silfa E, 1998, BIOSPECTROSCOPY, V4, P311, DOI 10.1002/(SICI)1520-6343(1998)4:5<311::AID-BSPY3>3.0.CO;2-T; Sobczak K, 2002, J BIOL CHEM, V277, P17349, DOI 10.1074/jbc.M109162200; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; Suzuki T, 2000, INT J BIOCHEM CELL B, V32, P1205, DOI 10.1016/S1357-2725(00)00054-6; Taylor JD, 2000, GEOL SOC SPEC PUBL, V177, P207, DOI 10.1144/GSL.SP.2000.177.01.12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; TITCHEN DA, 1991, BIOCHIM BIOPHYS ACTA, V1089, P61, DOI 10.1016/0167-4781(91)90085-Z; Torres-Mercado E, 2003, J PROTEIN CHEM, V22, P683, DOI 10.1023/B:JOPC.0000008734.44356.b7; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041; VINOGRADOV SN, 1992, COMP BIOCHEM PHYS B, V103, P759, DOI 10.1016/0305-0491(92)90193-U; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160	89	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147977	10.1371/journal.pone.0147977	http://dx.doi.org/10.1371/journal.pone.0147977			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824233	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600082
J	Nishinaka, H; Nakane, J; Nagata, T; Imai, A; Kuroki, N; Sakikawa, N; Omori, M; Kuroda, O; Hirabayashi, N; Igarashi, Y; Hashimoto, K				Nishinaka, Hirofumi; Nakane, Jun; Nagata, Takako; Imai, Atsushi; Kuroki, Noriomi; Sakikawa, Noriko; Omori, Mayu; Kuroda, Osamu; Hirabayashi, Naotsugu; Igarashi, Yoshito; Hashimoto, Kenji			Neuropsychological Impairment and Its Association with Violence Risk in Japanese Forensic Psychiatric Patients: A Case-Control Study	PLOS ONE			English	Article							IOWA GAMBLING TASK; QUALITY-OF-LIFE; DECISION-MAKING; MENTAL-ILLNESS; NEUROCOGNITIVE DEFICITS; AFFECTIVE-DISORDERS; ALCOHOL DEPENDENCE; THERAPEUTIC DRUGS; SCHIZOPHRENIA; PSYCHOPATHY	Background In Japan, the legislation directing treatment of offenders with psychiatric disorders was enacted in 2005. Neuropsychological impairment is highly related to functional outcomes in patients with psychiatric disorders, and several studies have suggested an association between neuropsychological impairment and violent behaviors. However, there have been no studies of neuropsychological impairment in forensic patients covered by the Japanese legislation. This study is designed to examine the neuropsychological characteristics of forensic patients in comparison to healthy controls and to assess the relationship between neuropsychological impairment and violence risk. Methods Seventy-one forensic patients with psychiatric disorders and 54 healthy controls (matched by age, gender, and education) were enrolled. The CogState Battery (CSB) consisting of eight cognitive domains, the Iowa Gambling Task (IGT) to test emotion-based decision making, and psychological measures of violence risk including psychopathy were used. Results Forensic patients exhibited poorer performances on all CSB subtests and the IGT than controls. For each group, partial correlational analyses indicated that poor IGT performance was related to psychopathy, especially antisocial behavior. In forensic patients, the CSB composite score was associated with risk factors for future violent behavior, including stress and noncompliance with remediation attempts. Conclusion Forensic patients with psychiatric disorders exhibit a wide range of neuropsychological impairments, and these findings suggest that neuropsychological impairment may increase the risk of violent behavior. Therefore, the treatment of neuropsychological impairment in forensic patients with psychiatric disorders is necessary to improve functional outcomes as well as to prevent violence.	[Nishinaka, Hirofumi; Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan; [Nakane, Jun] Natl Hosp Org Shimofusa Psychiat, Med Ctr, Chiba, Japan; [Nagata, Takako; Omori, Mayu; Hirabayashi, Naotsugu] Natl Ctr Neurol & Psychiat, Dept Psychiat, Tokyo, Japan; [Imai, Atsushi; Kuroki, Noriomi; Sakikawa, Noriko; Kuroda, Osamu] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Japan; [Igarashi, Yoshito] Chiba Univ, Div Law & Psychiat, Ctr Forens Mental Hlth, Chiba, Japan	Chiba University; National Center for Neurology & Psychiatry - Japan; Chiba University	Hashimoto, K (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Kuroki, Noriomi/AAY-4720-2020; Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439; Kuroki, Noriomi/0000-0003-1281-9307				ADAMS JJ, 1990, J NERV MENT DIS, V178, P253, DOI 10.1097/00005053-199004000-00006; Barkataki I, 2005, SCHIZOPHR RES, V74, P1, DOI 10.1016/j.schres.2004.08.001; Barry D, 2008, BRAIN COGNITION, V66, P243, DOI 10.1016/j.bandc.2007.09.001; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bellani M, 2009, EPIDEMIOL PSICHIAT S, V18, P104, DOI 10.1017/S1121189X0000097X; Beszterczey S, 2013, NEUROPSYCHOLOGY, V27, P491, DOI 10.1037/a0033162; Brevers D, 2014, ALCOHOL CLIN EXP RES, V38, P1924, DOI 10.1111/acer.12447; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Colpaert K, 2013, EUR ADDICT RES, V19, P173, DOI 10.1159/000343098; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dean AC, 2013, PERS INDIV DIFFER, V54, P272, DOI 10.1016/j.paid.2012.09.009; Dolan MC, 2009, BIOL PSYCHIAT, V66, P570, DOI 10.1016/j.biopsych.2009.03.019; Fioravanti M, 2005, NEUROPSYCHOL REV, V15, P73, DOI 10.1007/s11065-005-6254-9; Fond G, 2013, EUR ARCH PSY CLIN N, V263, P249, DOI 10.1007/s00406-012-0330-y; Fujii DE, 2004, SCHIZOPHR RES, V69, P67, DOI 10.1016/S0920-9964(03)00122-1; Fujii DEM, 2005, PSYCHIAT SERV, V56, P711, DOI 10.1176/appi.ps.56.6.711; Fullam R, 2006, PERS INDIV DIFFER, V40, P1591, DOI 10.1016/j.paid.2006.01.003; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hanson KL, 2008, DRUG ALCOHOL DEPEN, V96, P99, DOI 10.1016/j.drugalcdep.2008.02.003; Hansson L, 2006, ACTA PSYCHIAT SCAND, V113, P46, DOI 10.1111/j.1600-0447.2005.00717.x; Hare RD., 2003, MANUAL REVISED PSYCH, V2; Hashimoto K, 2015, CURR PHARM DESIGN, V21, P3797, DOI 10.2174/1381612821666150605111345; Hashimoto K, 2014, EXPERT OPIN THER TAR, V18, P1049, DOI 10.1517/14728222.2014.934225; Hashimoto K, 2013, EUR ARCH PSY CLIN N, V263, P367, DOI 10.1007/s00406-013-0399-y; Jaeger J, 2006, PSYCHIAT RES, V145, P39, DOI 10.1016/j.psychres.2005.11.011; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Krakowski M, 1997, J NEUROPSYCH CLIN N, V9, P549; Kugo A, 2006, PSYCHIAT RES, V144, P49, DOI 10.1016/j.psychres.2005.06.012; Link BG, 1998, ARCH GEN PSYCHIAT, V55, P403, DOI 10.1001/archpsyc.55.5.403; Losel F, 2004, J ABNORM PSYCHOL, V113, P522, DOI 10.1037/0021-843X.113.4.522; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuzawa D, 2015, PROG NEURO-PSYCHOPH, V57, P52, DOI 10.1016/j.pnpbp.2014.10.007; McCleery A, 2006, SCHIZOPHR RES, V88, P187, DOI 10.1016/j.schres.2006.06.040; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Mitchell DGV, 2002, NEUROPSYCHOLOGIA, V40, P2013, DOI 10.1016/S0028-3932(02)00056-8; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Naudts K, 2006, SCHIZOPHRENIA BULL, V32, P562, DOI 10.1093/schbul/sbj036; Niitsu T, 2012, CURR PHARM DESIGN, V18, P875, DOI 10.2174/138161212799436476; Nuechterlein KH, 2011, SCHIZOPHRENIA BULL, V37, pS33, DOI 10.1093/schbul/sbr084; Palmer BW, 2005, ARCH GEN PSYCHIAT, V62, P726, DOI 10.1001/archpsyc.62.7.726; RASMUSSEN K, 1995, PSYCHOL CRIME LAW, V2, P119, DOI 10.1080/10683169508409770; Ritsner M, 2000, J CLIN PSYCHIAT, V61, P880, DOI 10.4088/JCP.v61n1113; Scheurich A, 2005, CURR OPIN PSYCHIATR, V18, P319, DOI 10.1097/01.yco.0000165602.36671.de; Sevy S, 2007, SCHIZOPHR RES, V92, P74, DOI 10.1016/j.schres.2007.01.005; Silver H, 2005, J CLIN PSYCHIAT, V66, P300, DOI 10.4088/JCP.v66n0305; Sohn JS, 2010, ASIA PACIFIC J POLIC, V8, P49; Stefanopoulou E, 2009, INT REV PSYCHIATR, V21, P336, DOI 10.1080/09540260902962149; Takahashi T, 2014, NEUROENDOCRINOL LETT, V35, P510; TOPLAK ME, 2010, DECISION MAKING COGN, V30, P562; Webster C.D., 1997, HCR 20 ASSESSING RIS; Weiss FM, 2012, SIENTIFICA, V2012, DOI [10.6064/2012/158646, DOI 10.6064/2012/158646]; Yoshida T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020469; Yoshida T, 2012, CURR PSYCHIATRY REV, V8, P140, DOI 10.2174/1573400511208020140; Zhou JS, 2016, AUST NZ J PSYCHIAT, V50, P33, DOI 10.1177/0004867415585580	56	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148354	10.1371/journal.pone.0148354	http://dx.doi.org/10.1371/journal.pone.0148354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824701	Green Published, gold			2022-12-27	WOS:000369528600118
J	Raoufy, MR; Ghafari, T; Darooei, R; Nazari, M; Mahdaviani, SA; Eslaminejad, AR; Almasnia, M; Gharibzadeh, S; Mani, AR; Hajizadeh, S				Raoufy, Mohammad Reza; Ghafari, Tara; Darooei, Reza; Nazari, Milad; Mahdaviani, Seyed Alireza; Eslaminejad, Ali Reza; Almasnia, Mehdi; Gharibzadeh, Shahriar; Mani, Ali R.; Hajizadeh, Sohrab			Classification of Asthma Based on Nonlinear Analysis of Breathing Pattern	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; AIRWAY-OBSTRUCTION; FACE RECOGNITION; ALLERGIC-ASTHMA; RESPIRATORY IMPEDANCE; SPARSE REPRESENTATION; FLUCTUATION ANALYSIS; APPROXIMATE ENTROPY; NONATOPIC ASTHMA; SAMPLE ENTROPY	Normal human breathing exhibits complex variability in both respiratory rhythm and volume. Analyzing such nonlinear fluctuations may provide clinically relevant information in patients with complex illnesses such as asthma. We compared the cycle-by-cycle fluctuations of inter-breath interval (IBI) and lung volume (LV) among healthy volunteers and patients with various types of asthma. Continuous respiratory datasets were collected from forty age-matched men including 10 healthy volunteers, 10 patients with controlled atopic asthma, 10 patients with uncontrolled atopic asthma, and 10 patients with uncontrolled non-atopic asthma during 60 min spontaneous breathing. Complexity of breathing pattern was quantified by calculating detrended fluctuation analysis, largest Lyapunov exponents, sample entropy, and cross-sample entropy. The IBI as well as LV fluctuations showed decreased long-range correlation, increased regularity and reduced sensitivity to initial conditions in patients with asthma, particularly in uncontrolled state. Our results also showed a strong synchronization between the IBI and LV in patients with uncontrolled asthma. Receiver operating characteristic (ROC) curve analysis showed that nonlinear analysis of breathing pattern has a diagnostic value in asthma and can be used in differentiating uncontrolled from controlled and non-atopic from atopic asthma. We suggest that complexity analysis of breathing dynamics may represent a novel physiologic marker to facilitate diagnosis and management of patients with asthma. However, future studies are needed to increase the validity of the study and to improve these novel methods for better patient management.	[Raoufy, Mohammad Reza; Hajizadeh, Sohrab] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Ghafari, Tara] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Darooei, Reza] Tarbiat Modares Univ, Fac Elect & Comp Engn, Dept Biomed Engn, Tehran, Iran; [Nazari, Milad] Sharif Univ Technol, Fac Elect Engn, Tehran, Iran; [Mahdaviani, Seyed Alireza] Shahid Beheshti Univ Med Sci, NRITLD, Pediat Resp Dis Res Ctr, Tehran, Iran; [Eslaminejad, Ali Reza] Shahid Beheshti Univ Med Sci, NRITLD, Tracheal Dis Res Ctr, Tehran, Iran; [Almasnia, Mehdi] Shahid Beheshti Univ Med Sci, NRITLD, Chron Resp Dis Res Ctr, Tehran, Iran; [Gharibzadeh, Shahriar] Amirkabir Univ Technol, Fac Biomed Engn, Dept Bioelect, Tehran, Iran; [Mani, Ali R.] UCL, Div Med, London, England	Tarbiat Modares University; Shahid Beheshti University Medical Sciences; Tarbiat Modares University; Sharif University of Technology; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Amirkabir University of Technology; University of London; University College London	Raoufy, MR; Hajizadeh, S (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.	raoufy@modares.ac.ir; hajezads@modares.ac.ir	mahdaviani, alireza/G-3256-2017; Darooei, Reza/CAF-6976-2022; eslaminejad, alireza/G-3239-2017; Mani, Alireza/H-3236-2015; Raoufy, Mohammad Reza/M-7809-2017	mahdaviani, alireza/0000-0001-6224-4797; eslaminejad, alireza/0000-0002-8788-4544; Mani, Alireza/0000-0003-0830-2022; gharibzadeh, shahriar/0000-0002-9604-8433; hajizadeh, sohrab/0000-0001-7920-6949; Raoufy, Mohammad Reza/0000-0002-9292-8564; Nazari, Milad/0000-0002-5008-5159; Ghafari, Tara/0000-0002-5178-8702	Tarbiat Modares University	Tarbiat Modares University	This work was supported by grants from the Tarbiat Modares University to M.R. Raoufy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARBANEL HDI, 1993, REV MOD PHYS, V65, P1331, DOI 10.1103/RevModPhys.65.1331; Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Basyigit I, 2004, MEDIAT INFLAMM, V13, P285, DOI 10.1080/09629350400003118; Bonham AC, 2001, ENVIRON HEALTH PERSP, V109, P573, DOI 10.2307/3454672; Cernelc M, 2002, J APPL PHYSIOL, V92, P1817, DOI 10.1152/japplphysiol.00675.2001; Chen CY, 2001, J ALLERGY CLIN IMMUN, V108, P557; Chen SD, 2008, NEUROSCI LETT, V440, P87, DOI 10.1016/j.neulet.2008.03.092; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Dames KK, 2014, RESP PHYSIOL NEUROBI, V192, P39, DOI 10.1016/j.resp.2013.12.004; Deng WH, 2012, IEEE T PATTERN ANAL, V34, P1864, DOI 10.1109/TPAMI.2012.30; Engoren M, 1998, CRIT CARE MED, V26, P1817, DOI 10.1097/00003246-199811000-00021; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Frey U, 2008, LANCET, V372, P1088, DOI 10.1016/S0140-6736(08)61450-6; Frey U, 2011, J APPL PHYSIOL, V110, P1723, DOI 10.1152/japplphysiol.01297.2010; Gonem S, 2012, EUR RESPIR J, V40, P1156, DOI 10.1183/09031936.00228611; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Irvin CG, 2003, EUR RESPIR J, V22, P3, DOI 10.1183/09031936.03.00035703; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Jain M, 2011, CURR SCI INDIA, V101, P1435; Kaminsky DA, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0505-x; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kohlboeck G, 2013, PEDIAT ALLERG IMM-UK, V24, P230, DOI 10.1111/pai.12056; Kuusela TA, 2002, AM J PHYSIOL-HEART C, V282, pH773, DOI 10.1152/ajpheart.00559.2001; Lefevre GR, 1996, AM J RESP CRIT CARE, V154, P1567, DOI 10.1164/ajrccm.154.5.8912782; Lin MJ, 2014, NEUROSCI LETT, V563, P22, DOI 10.1016/j.neulet.2014.01.023; Lu CY, 2013, J VIS COMMUN IMAGE R, V24, P111, DOI 10.1016/j.jvcir.2012.05.003; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895; Muskulus M, 2010, J APPL PHYSIOL, V109, P1582, DOI 10.1152/japplphysiol.01414.2009; Nhlbi. and Prevention Program Expert Panel, 2007, CHILDREN, V120, pS94, DOI [10.1016/j.jaci.2007.09.029, DOI 10.1016/J.JACI.2007.09.029]; Peng CK, 2002, ANN BIOMED ENG, V30, P683, DOI 10.1114/1.1481053; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PINCUS SM, 1994, MATH BIOSCI, V122, P161, DOI 10.1016/0025-5564(94)90056-6; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; RACKEMANN FM, 1947, AM J MED, V3, P601, DOI 10.1016/0002-9343(47)90204-0; Raoufy MR, 2013, RESPIROLOGY, V18, P108, DOI 10.1111/j.1440-1843.2012.02251.x; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Seely AJE, 2014, CRIT CARE, V18, DOI 10.1186/cc13822; Shim E, 2015, ALLERGY ASTHMA IMMUN, V7, P339, DOI 10.4168/aair.2015.7.4.339; Shirazi AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072854; Suki B, 2002, AM J RESP CRIT CARE, V166, P133, DOI 10.1164/rccm.200202-152PP; Suki B, 2010, J APPL PHYSIOL, V109, P1571, DOI 10.1152/japplphysiol.01102.2010; Thamrin C, 2009, J APPL PHYSIOL, V106, P753, DOI 10.1152/japplphysiol.91588.2008; Valenza Gaetano, 2012, Front Neuroeng, V5, P3, DOI 10.3389/fneng.2012.00003; Veiga J, 2012, MED BIOL ENG COMPUT, V50, P1249, DOI 10.1007/s11517-012-0957-x; Veiga J, 2011, J APPL PHYSIOL, V111, P412, DOI 10.1152/japplphysiol.00267.2011; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Walsh GM, 2003, J ENDOCRINOL, V178, P37, DOI 10.1677/joe.0.1780037; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wu HT, 2014, IEEE T BIO-MED ENG, V61, P736, DOI 10.1109/TBME.2013.2288497; Yeragani VK, 2002, NEUROPSYCHOBIOLOGY, V46, P111, DOI 10.1159/000066388; Yin J, 2012, NEUROCOMPUTING, V77, P120, DOI 10.1016/j.neucom.2011.08.018; Zhang T, 2007, EXP PHYSIOL, V92, P659, DOI 10.1113/expphysiol.2007.037150	58	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147976	10.1371/journal.pone.0147976	http://dx.doi.org/10.1371/journal.pone.0147976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824900	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600081
J	Roussis, IM; Guille, M; Myers, FA; Scarlett, GP				Roussis, Ioannis M.; Guille, Matthew; Myers, Fiona A.; Scarlett, Garry P.			RNA Whole-Mount In situ Hybridisation Proximity Ligation Assay (rISH-PLA), an Assay for Detecting RNA-Protein Complexes in Intact Cells	PLOS ONE			English	Article							LOCKED NUCLEIC-ACID; BINDING PROTEINS; MESSENGER-RNA; XENOPUS; LOCALIZATION; MICRORNAS; LNA; TRANSCRIPTION; RECOGNITION; ELEMENT	Techniques for studying RNA-protein interactions have lagged behind those for DNA-protein complexes as a consequence of the complexities associated with working with RNA. Here we present a method for the modification of the existing In Situ Hybridisation-Proximity Ligation Assay (ISH-PLA) protocol to adapt it to the study of RNA regulation (rISH-PLA). As proof of principle we used the well-characterised interaction of the Xenopus laevis Staufen RNA binding protein with Vg1 mRNA, the complex of which co-localises to the vegetal pole of Xenopus oocytes. The applicability of both the Stau1 antibody and the Locked Nucleic Acid probe (LNA) recognising Vg1 mRNA were independently validated by whole-mount Immunohistochemistry and whole-mount in situ hybridisation assays respectively prior to combining them in the rISH-PLA assay. The rISH-PLA assay allows the identification of a given RNA-protein complex at subcellular and single cell resolution, thus avoiding the lack of spatial resolution and sensitivity associated with assaying heterogenous cell populations from which conventional RNA-protein interaction detection techniques suffer. This technique will be particularly usefully for studying the activity of RNA binding proteins (RBPs) in complex mixtures of cells, for example tissue sections or whole embryos.	[Roussis, Ioannis M.; Guille, Matthew; Myers, Fiona A.; Scarlett, Garry P.] Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England	University of Portsmouth	Myers, FA; Scarlett, GP (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England.	fiona.myers@port.ac.uk; garry.scarlett@port.ac.uk		Myers, Fiona/0000-0001-5568-1817; Guille, Matthew/0000-0001-6865-4519; Scarlett, Garry/0000-0001-8338-2398	Biochemical Society: Eric Reid Fund Methodology grant; University of Portsmouth; Biotechnology and Biological Sciences Research Council [BB/K019988/1] Funding Source: researchfish; BBSRC [BB/K019988/1] Funding Source: UKRI	Biochemical Society: Eric Reid Fund Methodology grant; University of Portsmouth; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biochemical Society: Eric Reid Fund Methodology grant and the University of Portsmouth: Internal funding.	Allison R, 2004, RNA, V10, P1751, DOI 10.1261/rna.7450204; Bheda P, 2014, TRENDS CELL BIOL, V24, P712, DOI 10.1016/j.tcb.2014.08.010; Bilinski SM, 2010, METHODS, V51, P11, DOI 10.1016/j.ymeth.2009.12.003; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DALE L, 1993, EMBO J, V12, P4471, DOI 10.1002/j.1460-2075.1993.tb06136.x; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Goljanek-Whysall K, 2014, DEVELOPMENT, V141, P3378, DOI 10.1242/dev.108787; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Guille M, 1999, ZEBRAFISH; Joseph EM, 1998, DEVELOPMENT, V125, P2677; Kechavarzi B, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r14; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Lewis RA, 2004, MECH DEVELOP, V121, P101, DOI 10.1016/j.mod.2003.09.009; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Llewellyn KJ, 2009, BBA-GENE REGUL MECH, V1789, P675, DOI 10.1016/j.bbagrm.2009.07.007; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; MOWRY KL, 1992, SCIENCE, V255, P991, DOI 10.1126/science.1546297; Myers FA, 2001, J BIOL CHEM, V276, P20197, DOI 10.1074/jbc.M009472200; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Rosa A, 2015, LONG NONCODING RNA R; Scarlett GP, 2004, J BIOL CHEM, V279, P52447, DOI 10.1074/jbc.M406107200; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Szabo L, 2015, GENOME BIOL, V16, DOI [10.1186/s13059-015-0690-5, 10.1186/s13059-016-1123-9]; Tallafuss A, 2014, CURR GENOMICS, V15, P278, DOI 10.2174/1389202915666140602230106; THOMSEN GH, 1993, CELL, V74, P433, DOI 10.1016/0092-8674(93)80045-G; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Van Assche E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00141; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; Yoon YJ, 2004, DEVELOPMENT, V131, P3035, DOI 10.1242/dev.01170; Zhao WM, 2001, EMBO J, V20, P2315, DOI 10.1093/emboj/20.9.2315	40	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147967	10.1371/journal.pone.0147967	http://dx.doi.org/10.1371/journal.pone.0147967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824753	Green Published, gold			2022-12-27	WOS:000369528600079
J	Whittle, S; Vijayakumar, N; Dennison, M; Schwartz, O; Simmons, JG; Sheeber, L; Allen, NB				Whittle, Sarah; Vijayakumar, Nandita; Dennison, Meg; Schwartz, Orli; Simmons, Julian G.; Sheeber, Lisa; Allen, Nicholas B.			Observed Measures of Negative Parenting Predict Brain Development during Adolescence	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; COGNITIVE-DEVELOPMENT; EXECUTIVE FUNCTIONS; EMOTION REGULATION; LATE CHILDHOOD; MATTER VOLUME; MATURATION; DISORDERS; CHILDREN; BEHAVIOR	Limited attention has been directed toward the influence of non-abusive parenting behaviour on brain structure in adolescents. It has been suggested that environmental influences during this period are likely to impact the way that the brain develops over time. The aim of this study was to investigate the association between aggressive and positive parenting behaviors on brain development from early to late adolescence, and in turn, psychological and academic functioning during late adolescence, using a multi-wave longitudinal design. Three hundred and sixty seven magnetic resonance imaging (MRI) scans were obtained over three time points from 166 adolescents (11-20 years). At the first time point, observed measures of maternal aggressive and positive behaviors were obtained. At the final time point, measures of psychological and academic functioning were obtained. Results indicated that a higher frequency of maternal aggressive behavior was associated with alterations in the development of right superior frontal and lateral parietal cortical thickness, and of nucleus accumbens volume, in males. Development of the superior frontal cortex in males mediated the relationship between maternal aggressive behaviour and measures of late adolescent functioning. We suggest that our results support an association between negative parenting and adolescent functioning, which may be mediated by immature or delayed brain maturation.	[Whittle, Sarah; Vijayakumar, Nandita; Dennison, Meg; Schwartz, Orli; Simmons, Julian G.; Allen, Nicholas B.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Whittle, Sarah; Simmons, Julian G.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic, Australia; [Whittle, Sarah; Dennison, Meg; Simmons, Julian G.] Melbourne Hlth, Melbourne, Vic, Australia; [Dennison, Meg] Univ Melbourne, Dept Psychiat, Australian Ctr Posttraumat Mental Hlth, Melbourne, Vic, Australia; [Sheeber, Lisa] Oregon Res Inst, Eugene, OR 97403 USA; [Allen, Nicholas B.] Univ Melbourne, Natl Ctr Excellence Youth Mental Hlth, Orygen, Melbourne, Vic, Australia; [Allen, Nicholas B.] Univ Oregon, Eugene, OR 97403 USA	University of Melbourne; University of Melbourne; University of Melbourne; Oregon Research Institute; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Oregon	Whittle, S (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.; Whittle, S (corresponding author), Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic, Australia.; Whittle, S (corresponding author), Melbourne Hlth, Melbourne, Vic, Australia.	swhittle@unimelb.edu.au	Vijayakumar, Nandita/ABE-1215-2020; Schwartz, Orli/ABD-3996-2021; Whittle, Sarah/I-2200-2014	Vijayakumar, Nandita/0000-0002-5622-9547; Simmons, Julian G./0000-0002-7228-1847; Allen, Nicholas/0000-0002-1086-6639; Whittle, Sarah/0000-0003-3145-1528; Schwartz, Orli/0000-0001-7634-3737	National Health and Medical Research Council (NHMRC, Australia) [350241, 1007716]; Australian Research Council (ARC) [DP0878136]; Colonial Foundation	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Colonial Foundation	This research was supported by grants from the Colonial Foundation, the National Health and Medical Research Council (NHMRC, Australia, Program Grant 350241; Career Development Fellowship ID: 1007716 to SW) and the Australian Research Council (ARC, Discovery Grant DP0878136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P409, DOI 10.1111/j.1469-7610.2010.02281.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Capaldi DM., 1992, J EARLY ADOLESCENCE, V12, P153, DOI 10.1177/0272431692012002002; Cauffman E, 2005, CRIMINOLOGY, V43, P133, DOI 10.1111/j.0011-1348.2005.00005.x; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Ducharme S, 2013, CEREB CORTEX; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Frye RE, 2010, J INT NEUROPSYCH SOC, V16, P784, DOI 10.1017/S1355617710000585; Goto Y, 2008, TRENDS NEUROSCI, V31, P552, DOI 10.1016/j.tins.2008.08.002; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hops H., 1995, LIVING FAMILY ENV LI; Howell BR, 2014, DEV PSYCHOBIOL, V56, P1735, DOI 10.1002/dev.21237; Jones FL, 2001, WORK EMPLOY SOC, V15, P539, DOI 10.1177/09500170122119147; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Lee KH, 2014, SOCIAL COGNITIVE AFF; Luby JL, 2012, P NATL ACAD SCI USA, V109, P2854, DOI 10.1073/pnas.1118003109; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; McLaughlin KA, 2014, NEUROSCI BIOBEHAV R, V47, P578, DOI 10.1016/j.neubiorev.2014.10.012; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Moriceau S, 2006, NAT NEUROSCI, V9, P1004, DOI 10.1038/nn1733; Oldehinkel AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1757, DOI 10.1016/j.neubiorev.2010.10.013; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao H, 2010, NEUROIMAGE, V49, P1144, DOI 10.1016/j.neuroimage.2009.07.003; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; Schaie KW, 1994, 3 DEV DESIGNS REVISI; Schneider S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.113; Schwartz OS, 2014, CLIN PSYCHOL SCI, V2, P272, DOI 10.1177/2167702613505531; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shaw DS, 1997, PRECURSORS CORRELATE; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sheeber LB, 2007, J ABNORM PSYCHOL, V116, P144, DOI 10.1037/0021-843X.116.1.144; Spera C, 2005, EDUC PSYCHOL REV, V17, P120, DOI 10.1007/s10648-005-3950-1; Tamnes CK, 2010, NEUROPSYCHOLOGIA, V48, P2496, DOI 10.1016/j.neuropsychologia.2010.04.024; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; Tupler LA, 2006, BIOL PSYCHIAT, V59, P523, DOI 10.1016/j.biopsych.2005.08.007; van Hasselt FN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037820; Vijayakumar N, 2014, DEV COGN NEUROS-NETH, V9, P30, DOI 10.1016/j.dcn.2013.12.002; Walsh ND, 2014, NEUROIMAGE-CLIN, V4, P308, DOI 10.1016/j.nicl.2014.01.001; Whittle S, 2009, SOCIAL COGNITIVE AFF; Whittle S, 2014, DEV COGN NEUROS-NETH, V8, P7, DOI 10.1016/j.dcn.2013.10.006; Yap MBH, 2007, CLIN CHILD FAM PSYCH, V10, P180, DOI 10.1007/s10567-006-0014-0; Yap MBH, 2011, DEV PSYCHOPATHOL, V23, P267, DOI 10.1017/S0954579410000787	53	63	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147774	10.1371/journal.pone.0147774	http://dx.doi.org/10.1371/journal.pone.0147774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824348	Green Published, gold			2022-12-27	WOS:000369528600059
J	Wu, YH; Yu, YQ; Zhao, TC; Wang, SB; Fu, YL; Qi, Y; Yang, G; Yao, WW; Su, YY; Ma, Y; Shi, JP; Jiang, J; Kou, CG				Wu, Yanhua; Yu, Yaqin; Zhao, Tiancheng; Wang, Shibin; Fu, Yingli; Qi, Yue; Yang, Guang; Yao, Wenwang; Su, Yingying; Ma, Yue; Shi, Jieping; Jiang, Jing; Kou, Changgui			Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome	PLOS ONE			English	Article							APOLIPOPROTEIN A1/C3/A5 HAPLOTYPES; PLASMA-LIPID LEVELS; ALCOHOL-CONSUMPTION; TRIGLYCERIDE LEVELS; DAIRY CONSUMPTION; A5 GENE; PREVALENCE; RISK; ASSOCIATION; DISEASE	Objective The present study investigated the prevalence and risk factors for Metabolic syndrome. We evaluated the association between single nucleotide polymorphisms (SNPs) in the apolipoprotein APOA1/C3/A4/A5 gene cluster and the MetS risk and analyzed the interactions of environmental factors and APOA1/C3/A4/A5 gene cluster polymorphisms with MetS. Methods A study on the prevalence and risk factors for MetS was conducted using data from a large cross-sectional survey representative of the population of Jilin Province situated in northeastern China. A total of 16,831 participations were randomly chosen by multistage stratified cluster sampling of residents aged from 18 to 79 years in all nine administrative areas of the province. Environmental factors associated with MetS were examined using univariate and multivariate logistic regression analyses based on the weighted sample data. A subsample of 1813 survey subjects who met the criteria for MetS patients and 2037 controls from this case-control study were used to evaluate the association between SNPs and MetS risk. Genomic DNA was extracted from peripheral blood lymphocytes, and SNP genotyping was determined by MALDI-TOF-MS. The associations between SNPs and MetS were examined using a case-control study design. The interactions of environmental factors and APOA1/C3/A4/A5 gene cluster polymorphisms with MetS were assessed using multivariate logistic regression analysis. Results The overall adjusted prevalence of MetS was 32.86% in Jilin province. The prevalence of MetS in men was 36.64%, which was significantly higher than the prevalence in women (29.66%). MetS was more common in urban areas (33.86%) than in rural areas (31.80%). The prevalence of MetS significantly increased with age (OR = 8.621, 95% CI = 6.594-11.272). Mental labor (OR = 1.098, 95% CI = 1.008-1.195), current smoking (OR = 1.259, 95% CI = 1.108-1.429), excess salt intake (OR = 1.252, 95% CI = 1.149-1.363), and a fruit and dairy intake less than 2 servings a week were positively associated with MetS (P<0.05). A family history of diabetes (OR = 1.630, 95% CI = 1.484-1.791), cardiovascular disease or cerebral diseases (OR = 1.297, 95% CI = 1.211-1.389) was associated with MetS. APOA1 rs670, APOA5 rs662799 and rs651821 revealed significant differences in genotype distributions between the MetS patients and control subjects. The minor alleles of APOA1 rs670, APOA5 rs662799 and rs651821, and APOA5 rs2075291 were associated with MetS (P<0.0016). APOA1 rs5072 and APOC3 rs5128, APOA5 rs651821 and rs662799 were in strong linkage disequilibrium to each other with r(2) greater than 0.8. Five haplotypes were associated with an increased risk of MetS (OR = 1.23, 1.58, 1.80, 1.90, and 1.98). When we investigated the interactions of environmental factors and APOA1/C3/A4/A5 gene cluster gene polymorphisms, we found that APOA5 rs662799 had interactions with tobacco use and alcohol consumption (P-GE<0.05). Conclusions There was a high prevalence of MetS in the northeast of China. Male gender, increasing age, mental labor, family history of diabetes, cardiovascular disease or cerebral diseases, current smoking, excess salt intake, fruit and dairy intake less than 2 servings a week, and drinking were associated with MetS. The APOA1/C3/A4/A5 gene cluster was associated with MetS in the Han Chinese. APOA5 rs662799 had interactions with the environmental factors associated with MetS.	[Wu, Yanhua; Yu, Yaqin; Wang, Shibin; Fu, Yingli; Qi, Yue; Yang, Guang; Yao, Wenwang; Su, Yingying; Ma, Yue; Shi, Jieping; Kou, Changgui] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin Province, Peoples R China; [Wu, Yanhua; Jiang, Jing] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China; [Zhao, Tiancheng] Jilin Univ, China Japan Union Hosp, Dept Endoscopy Ctr, Changchun 130021, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Kou, CG (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin Province, Peoples R China.; Jiang, J (corresponding author), Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China.	jiangjing19702000@jlu.edu.cn; koucg@jlu.edu.cn	SHI, JIE/GXG-3394-2022	Yang, Guang/0000-0002-4335-2618; Rao, Wenwang/0000-0002-3514-3082; Wu, Yanhua/0000-0002-9920-3486	scientific research foundation of Jilin Provincial Health Department, China [2011Z116]; Jilin Provincial Health Department; Chinese Jilin Provincial Center for Disease Control and Prevention	scientific research foundation of Jilin Provincial Health Department, China; Jilin Provincial Health Department; Chinese Jilin Provincial Center for Disease Control and Prevention	This research was supported by grant 2011Z116 from the scientific research foundation of Jilin Provincial Health Department, China.; We are grateful to the Jilin Provincial Health Department and the Chinese Jilin Provincial Center for Disease Control and Prevention for supporting our project.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; BAI H, 1995, HUM GENET, V95, P102; Chen BD, 2010, CLIN CHIM ACTA, V411, P705, DOI 10.1016/j.cca.2010.01.038; CHEN M, 1994, J LIPID RES, V35, P1918; Cheng TO, 2007, INT J CARDIOL, V116, P257, DOI 10.1016/j.ijcard.2006.04.050; Chhabra S, 2005, DIS MARKERS, V21, P169, DOI 10.1155/2005/195078; Chhabra S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-9; Chien KL, 2008, CLIN CHIM ACTA, V390, P56, DOI 10.1016/j.cca.2007.12.014; Coban N, 2014, CLIN CHIM ACTA, V431, P244, DOI 10.1016/j.cca.2014.01.017; De Franca E, 2005, BRAZ J MED BIOL RES, V38, P535, DOI 10.1590/S0100-879X2005000400006; DECODA Study Grp, 2007, DIABETES RES CLIN PR, V76, P57, DOI 10.1016/j.diabres.2006.07.020; Ding Y.C., 2012, MATH PROBL ENG, V2012, P1, DOI DOI 10.1155/2012/509420; Dodani S, 2012, DIS MARKERS, V32, P9, DOI [10.3233/DMA-2012-0856, 10.1155/2012/868029]; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Fumeron F, 2011, DIABETES CARE, V34, P813, DOI 10.2337/dc10-1772; Garelnabi M, 2013, CLIN BIOCHEM, V46, P12, DOI 10.1016/j.clinbiochem.2012.09.007; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; Gu YL, 2014, ENDOCRINE, V45, P454, DOI 10.1007/s12020-013-0020-1; Heng CK, 2001, PEDIATR RES, V49, P514, DOI 10.1203/00006450-200104000-00013; Hosseini-Esfahani F, 2015, BRIT J NUTR, V113, P644, DOI 10.1017/S0007114514003687; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Janczura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133750; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; Kazlauskiene L, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0096-2; Komurcu-Bayrak E, 2008, CLIN CHEM LAB MED, V46, P778, DOI 10.1515/CCLM.2008.161; Korea Health Industry Development Institute, 2005, 3 KOR NAT HLTH NUTR; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; Li JB, 2010, J INT MED RES, V38, P1142, DOI 10.1177/147323001003800343; Liu L, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0080-8; Liu ZK, 2010, ATHEROSCLEROSIS, V208, P427, DOI 10.1016/j.atherosclerosis.2009.08.013; Ma X, 2013, EUR J CLIN NUTR, V67, P518, DOI 10.1038/ejcn.2013.24; Mar R, 2004, CIRC RES, V94, P993, DOI 10.1161/01.RES.0000124922.61830.F0; Mattei J, 2011, NUTR METAB CARDIOVAS, V21, P862, DOI 10.1016/j.numecd.2010.02.024; Mohammadi SG, 2015, INT J ENDOCRINOL MET, V13, DOI 10.5812/ijem.25201v2; Moreno R, 2006, ATHEROSCLEROSIS, V189, P163, DOI 10.1016/j.atherosclerosis.2005.11.029; Mosley M.A., 2013, FOOD NUTR SCI, V4, P56, DOI [10.4236/fns.2013.41009, DOI 10.4236/FNS.2013.41009]; Office for the Sixth Population Census of Jilin Province Jilin Provincial Bureau of Statistics, 2012, TABULATION ON THE 20; Olivieri O, 2003, J LIPID RES, V44, P2374, DOI 10.1194/jlr.M300253-JLR200; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Qi L, 2007, ATHEROSCLEROSIS, V192, P204, DOI 10.1016/j.atherosclerosis.2006.05.006; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Rudkowska I, 2013, BRIT J NUTR, V109, P953, DOI 10.1017/S0007114512002231; Ruidavets J.-B., 2002, Journal of Epidemiology and Community Health, V56, P24, DOI 10.1136/jech.56.1.24; Salamone F, 2010, NEW ENGL J MED, V363, P194; Shim Unjin, 2014, Genomics & Informatics, V12, P195, DOI 10.5808/GI.2014.12.4.195; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Son KY, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0111-5; Song KH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/585134; STEINMETZ A, 1985, J BIOL CHEM, V260, P2258; Steuenson JE, 2012, METABOLISM, V61, P1582, DOI 10.1016/j.metabol.2012.04.010; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; Volcik KA, 2008, ANN EPIDEMIOL, V18, P101, DOI 10.1016/j.annepidem.2007.07.103; Wang SB, 2015, ASIA-PAC J PUBLIC HE, V27, P394, DOI 10.1177/1010539514551200; Wang W, 2010, J INT MED RES, V38, P150, DOI 10.1177/147323001003800117; Xu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056216; Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035; Yin JH, 2012, CLIN ENDOCRINOL, V76, P802, DOI 10.1111/j.1365-2265.2011.04198.x; Yin RX, 2013, ALCOHOL CLIN EXP RES, V37, P234, DOI 10.1111/j.1530-0277.2012.01918.x; Yin RX, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-140; Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008	65	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147946	10.1371/journal.pone.0147946	http://dx.doi.org/10.1371/journal.pone.0147946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824674	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600078
J	Sole, R; Amor, DR; Valverde, S				Sole, Ricard; Amor, Daniel R.; Valverde, Sergi			On Singularities and Black Holes in Combination-Driven Models of Technological Innovation Networks	PLOS ONE			English	Article							EVOLUTION; POPULATION	It has been suggested that innovations occur mainly by combination: the more inventions accumulate, the higher the probability that new inventions are obtained from previous designs. Additionally, it has been conjectured that the combinatorial nature of innovations naturally leads to a singularity: at some finite time, the number of innovations should diverge. Although these ideas are certainly appealing, no general models have been yet developed to test the conditions under which combinatorial technology should become explosive. Here we present a generalised model of technological evolution that takes into account two major properties: the number of previous technologies needed to create a novel one and how rapidly technology ages. Two different models of combinatorial growth are considered, involving different forms of ageing. When long-range memory is used and thus old inventions are available for novel innovations, singularities can emerge under some conditions with two phases separated by a critical boundary. If the ageing has a characteristic time scale, it is shown that no singularities will be observed. Instead, a "black hole" of old innovations appears and expands in time, making the rate of invention creation slow down into a linear regime.	[Sole, Ricard; Amor, Daniel R.; Valverde, Sergi] Univ Pompeu Fabra, ICREA Complex Syst Lab, Barcelona, Spain; [Sole, Ricard; Amor, Daniel R.; Valverde, Sergi] CSIC UPF, Inst Biol Evolut, Barcelona, Spain; [Sole, Ricard] Santa Fe Inst, Santa Fe, NM 87501 USA	ICREA; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; The Santa Fe Institute	Sole, R (corresponding author), Univ Pompeu Fabra, ICREA Complex Syst Lab, Barcelona, Spain.; Sole, R (corresponding author), CSIC UPF, Inst Biol Evolut, Barcelona, Spain.; Sole, R (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	ricard.sole@upf.edu	Valverde, Sergi/J-3275-2012; Solé, Ricard/I-3379-2015; Amor, Daniel R./AAB-4591-2021	Valverde, Sergi/0000-0002-2150-9610; R. Amor, Daniel/0000-0003-4659-330X; Sole, Ricard/0000-0001-6974-1008	Fundacion Botin; Spanish Ministry of Economy and Competitiveness [FIS2013-44674-P]; FEDER; Santa Fe Institute; ICREA Funding Source: Custom	Fundacion Botin; Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission); Santa Fe Institute; ICREA(ICREA)	This work was supported by the Fundacion Botin and by the Spanish Ministry of Economy and Competitiveness, Grant FIS2013-44674-P and FEDER and by the Santa Fe Institute, where most of this work was done. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur B.W., 2009, NATURE TECHNOLOGY WH; Arthur WB, 2006, COMPLEXITY, V11, P23, DOI 10.1002/cplx.20130; Basalla G., 1989, EVOLUTION TECHNOLOGY; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P7, DOI 10.1007/BF00420631; Eldredge N., 2011, EVOLUTION ED OUTREAC, V4, P364, DOI [10.1007/s12052-011-0356-z, DOI 10.1007/S12052-011-0356-Z]; FOERSTER HV, 1960, SCIENCE, V132, P1291; Hanel R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036117; Hanel R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036110; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Johansen A, 2001, PHYSICA A, V294, P465, DOI 10.1016/S0378-4371(01)00105-4; Johnson S., 2010, GOOD IDEAS COME NATU; Kauffman S., 1995, HOME UNIVERSE SEARCH; Kelly K., 2010, WHAT TECHNOLOGY WANT; Kurzweil R., 2005, SINGULARITY IS NEAR; McNerney J, 2011, P NATL ACAD SCI USA, V108, P9008, DOI 10.1073/pnas.1017298108; Nagi B., 2011, J TECH FORECAST SOC, V73, P1061; Nagy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052669; Sahal D., 1981, PATTERNS TECHNOLOGIC; Schuster P, 2006, COMPLEXITY, V11, P9, DOI 10.1002/cplx.20132; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Shao ZG, 2006, J PHYS A-MATH GEN, V39, P2035, DOI 10.1088/0305-4470/39/9/004; Sole R., 2011, PHASE TRANSITIONS; Sole R. V., 2002, Complexity, V8, P20, DOI 10.1002/cplx.10055; Sole RV, 2013, COMPLEXITY, V18, P15, DOI 10.1002/cplx.21436; Sood V, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.178701; Temkin I, 2007, CURR ANTHROPOL, V48, P146, DOI 10.1086/510463; Thurner S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/075029; Trajtenberg M, 2003, PATENTS CITATIONS IN; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046118; Weitzman ML, 1998, Q J ECON, V113, P331, DOI 10.1162/003355398555595; Youn HJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0272	35	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146180	10.1371/journal.pone.0146180	http://dx.doi.org/10.1371/journal.pone.0146180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821277	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528400004
J	Choi, E; Choi, KH; Park, SM; Shin, D; Joh, HK; Cho, EY				Choi, Eunjoo; Choi, Kyung-Hyun; Park, Sang Min; Shin, Doosup; Joh, Hee-Kyung; Cho, Eunyoung			The Benefit of Bone Health by Drinking Coffee among Korean Postmenopausal Women: A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys	PLOS ONE			English	Article							MINERAL DENSITY; ESTROGENIC ACTIVITY; CALCIUM-METABOLISM; CAFFEINE INTAKE; ALCOHOL INTAKE; ELDERLY-WOMEN; RISK-FACTORS; CONSUMPTION; ASSOCIATION; FRACTURE	Purpose Although the concern about coffee-associated health problems is increasing, the effect of coffee on osteoporosis is still conflicting. This study aimed to determine the relationship between coffee consumption and bone health in Korean postmenopausal women. Methods A population-based, cross-sectional study was performed using a nationally representative sample of the Korean general population. All 4,066 postmenopausal women (mean age 62.6 years) from the fourth and fifth Korean National Health and Nutrition Examination Survey (2008-2011), who completed the questionnaire about coffee consumption and had data of dual-energy X-ray absorptiometry (DXA) examination. Bone mineral density (BMD) was measured using DXA at the femoral neck and lumbar spine and osteoporosis was defined by World Health Organization T-score criteria in addition to self-report of current anti-osteoporotic medication use. Results After adjusting for various demographic and lifestyle confounders (including hormonal factors), subjects in the highest quartile of coffee intake had 36% lower odds for osteoporosis compared to those in the lowest quartile (Adjusted odds ratio [aOR] = 0.64; 95% confidence interval [CI], 0.43-0.95; P for trend = 0.015). This trend was consistent in osteoporosis of lumbar spine and femoral neck (aOR = 0.65 and 0.55; P for trend = 0.026 and 0.003, respectively). In addition, age-and body mass index (BMI)-adjusted BMD of the femoral neck and lumbar spine increased with higher coffee intake (P for trend = 0.019 and 0.051, respectively). Conclusions Coffee consumption may have protective benefits on bone health in Korean postmenopausal women in moderate amount. Further, prospective studies are required to confirm this association.	[Choi, Eunjoo; Park, Sang Min] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, 101 Daehak Ro, Seoul 110744, South Korea; [Choi, Kyung-Hyun] Dongnam Inst Radiol & Med Sci, Ctr Hlth Promot & Canc Prevent, Jwadong Gil 40, Busan 619953, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, 28 Yunkeon Dong, Seoul 110744, South Korea; [Shin, Doosup] Seoul Natl Univ Hosp, Dept Educ & Res, 101 Daehak Ro, Seoul 110744, South Korea; [Joh, Hee-Kyung] Seoul Natl Univ, Coll Med, Dept Med, 28 Yunkeon Dong, Seoul 110744, South Korea; [Joh, Hee-Kyung] Seoul Natl Univ, Hlth Serv Ctr, Dept Family Med, Seoul 152742, South Korea; [Cho, Eunyoung] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, 339 Eddy St, Providence, RI 02903 USA	Seoul National University (SNU); Seoul National University Hospital; Korea Institute of Radiological & Medical Sciences; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brown University	Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, 101 Daehak Ro, Seoul 110744, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 28 Yunkeon Dong, Seoul 110744, South Korea.	smpark.snuh@gmail.com	Cho, Eunyoung/AAV-4469-2020; Park, Sang Min/V-9194-2019	Cho, Eunyoung/0000-0001-6594-2582; Joh, Hee-Kyung/0000-0003-3854-7012; Shin, Doosup/0000-0003-4960-5732				Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001; Arlot ME, 1997, J BONE MINER RES, V12, P683, DOI 10.1359/jbmr.1997.12.4.683; Atalar E, 2009, RHEUMATOL INT, V29, P1025, DOI 10.1007/s00296-008-0768-4; Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1; BARGERLUX MJ, 1995, J CLIN ENDOCR METAB, V80, P406, DOI 10.1210/jc.80.2.406; Carbone LD, 2003, J BONE MINER RES, V18, P1795, DOI 10.1359/jbmr.2003.18.10.1795; Cauley JA, 2005, OSTEOPOROSIS INT, V16, P1525, DOI 10.1007/s00198-005-1866-8; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Date C, 2005, J EPIDEMIOL, V15, pS9, DOI 10.2188/jea.15.S9; Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925; FELSON DT, 1995, AM J EPIDEMIOL, V142, P485, DOI 10.1093/oxfordjournals.aje.a117664; Forsmo S, 2001, OSTEOPOROSIS INT, V12, P222, DOI 10.1007/s001980170133; Gallus S, 2002, ANN EPIDEMIOL, V12, P202, DOI 10.1016/S1047-2797(01)00304-0; Ganry O, 2000, AM J EPIDEMIOL, V151, P773, DOI 10.1093/oxfordjournals.aje.a010277; Hallstrom H, 2006, OSTEOPOROSIS INT, V17, P1055, DOI 10.1007/s00198-006-0109-y; Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95, DOI 10.1093/ajcn/84.1.95; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; HARRIS SS, 1994, AM J CLIN NUTR, V60, P573, DOI 10.1093/ajcn/60.4.573; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HASLING C, 1992, J NUTR, V122, P1119, DOI 10.1093/jn/122.5.1119; Holvik K., 2003, NORSK EPIDEMIOLOGI, V13, P177; Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11; Kim JY, 2006, BIOFACTORS, V26, P17, DOI 10.1002/biof.5520260103; KITTS DD, 1987, J TOXICOL ENV HEALTH, V20, P37, DOI 10.1080/15287398709530960; Lee DR, 2014, BONE, V63, P20, DOI 10.1016/j.bone.2014.02.007; Lee KW, 2013, NEUROTHERAPEUTICS, V10, P143, DOI 10.1007/s13311-012-0165-2; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lloyd T, 2000, J AM COLL NUTR, V19, P256, DOI 10.1080/07315724.2000.10718924; MASSEY LK, 1993, J NUTR, V123, P1611, DOI 10.1093/jn/123.9.1611; NILAS L, 1988, EUR J CLIN INVEST, V18, P529, DOI 10.1111/j.1365-2362.1988.tb01052.x; Ososki AL, 2003, PHYTOTHER RES, V17, P845, DOI 10.1002/ptr.1364; Rapuri PB, 2001, AM J CLIN NUTR, V74, P694; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Schliep KC, 2012, AM J CLIN NUTR, V95, P488, DOI 10.3945/ajcn.111.021287; Shin CS, 2010, BONE, V47, P378, DOI 10.1016/j.bone.2010.03.017; Stanford BD, 2010, J AM WATER WORKS ASS, V102, P55; Tang QY, 2006, HISTOCHEM CELL BIOL, V125, P215, DOI 10.1007/s00418-005-0062-4; United States Department of Agriculture, 2013, COFF WORLD MARK TRAD; Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244; 박형무, 2010, Obstetrics & Gynecology Science, V53, P152	43	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147762	10.1371/journal.pone.0147762	http://dx.doi.org/10.1371/journal.pone.0147762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816211	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200048
J	Abdin, E; Ong, C; Chong, SA; Vaingankar, JA; Subramaniam, M				Abdin, Edimansyah; Ong, Clarissa; Chong, Siow Ann; Vaingankar, Janhavi Ajit; Subramaniam, Mythily			Days Out of Role Due to Mental and Physical Conditions: Results from the Singapore Mental Health Study	PLOS ONE			English	Article							DISORDERS; BURDEN; COSTS; ORGANIZATION; COMORBIDITY; POPULATION; PREVALENCE; DISABILITY; INFORMATION; DEPRESSION	Objective The aim of the current study was to evaluate the relative contributions of mental and physical conditions to days out of role among adults aged 18 years and above in Singapore. Methods The Singapore Mental Health Study was a cross-sectional epidemiological survey of a nationally representative sample of residents aged 18 years or older. Diagnosis of mental disorders was established using the Composite International Diagnostic Interview; while chronic physical conditions were established using a checklist. Days out of role were assessed using a WHO Disability Assessment Schedule item. Multivariate regression analyses were used to estimate individual-level and societal-level effects of disorders. Results Overall, 8.7% of respondents reported at least one day out of role, with a mean of 5.8 days. The most disabling conditions at the individual level were cancer (118.9 additional days), cardiovascular diseases (93.5), and bipolar disorder (71.0). At the societal level, cardiovascular diseases contributed the highest population attributable risk proportion (45%), followed by cancer (39.3%), and hypertension (13.5%). Conclusions Mental and physical conditions are linked to significant losses in productivity for society as well as role disability for individuals, underscoring the need to enhance prevention and intervention efforts to increase overall productivity and improve individual functioning.	[Abdin, Edimansyah; Ong, Clarissa; Chong, Siow Ann; Vaingankar, Janhavi Ajit; Subramaniam, Mythily] Inst Mental Hlth, Div Res, Singapore, Singapore		Abdin, E (corresponding author), Inst Mental Hlth, Div Res, Singapore, Singapore.	edimansyah_abdin@imh.com.sg	Abdin, Edimansyah/E-6451-2011	Abdin, Edimansyah/0000-0002-1016-3298; Ong, Clarissa W./0000-0002-2318-5453	Singapore Millennium Foundation; Ministry of Health, Singapore	Singapore Millennium Foundation; Ministry of Health, Singapore	This study was supported by funding from the Singapore Millennium Foundation and the Ministry of Health, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo R, 2013, J MENT HEALTH POLICY, V16, P151; Al-Hamzawi AO, 2014, J PSYCHIATR RES, V53, P23, DOI 10.1016/j.jpsychires.2014.02.006; Alonso J, 2011, MOL PSYCHIATR, V16, P1234, DOI 10.1038/mp.2010.101; Alonso J, 2011, PSYCHOL MED, V41, P873, DOI 10.1017/S0033291710001212; Andrade LH, 2013, CLINICS, V68, P1392, DOI 10.6061/clinics/2013(11)02; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Chatterji P, 2011, J HEALTH ECON, V30, P858, DOI 10.1016/j.jhealeco.2011.06.006; Chong SA, 2012, ANN ACAD MED SINGAP, V41, P105; Chong SA, 2012, ANN ACAD MED SINGAP, V41, P49; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hansen H, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-39; Hilbe J.M., 2014, MODELING COUNT DATA; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Mall S, 2015, SOC PSYCH PSYCH EPID, V50, P461, DOI 10.1007/s00127-014-0941-x; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Parker G, 2001, SOC PSYCH PSYCH EPID, V36, P287, DOI 10.1007/s001270170046; Phua HP, 2009, SINGAP MED J, V50, P468; Ryder AG, 2008, J ABNORM PSYCHOL, V117, P300, DOI 10.1037/0021-843X.117.2.300; Schofield DJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-72; Smit F, 2006, J MENT HEALTH POLICY, V9, P193; Stuhldreher N, 2014, J AFFECT DISORDERS, V165, P87, DOI 10.1016/j.jad.2014.04.039; Subramaniam M, 2014, GEN HOSP PSYCHIAT, V36, P375, DOI 10.1016/j.genhosppsych.2014.03.002; Subramaniam M, 2013, COMPR PSYCHIAT, V54, P381, DOI 10.1016/j.comppsych.2012.10.004; Subramaniam M, 2012, INT J METH PSYCH RES, V21, P149, DOI 10.1002/mpr.1351; Von Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009	31	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148248	10.1371/journal.pone.0148248	http://dx.doi.org/10.1371/journal.pone.0148248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840741	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200111
J	Ruiz, JD; Quackenboss, JJ; Tulve, NS				Ruiz, Jazmin Del Carmen; Quackenboss, James J.; Tulve, Nicolle S.			Contributions of a Child's Built, Natural, and Social Environments to Their General Cognitive Ability: A Systematic Scoping Review	PLOS ONE			English	Review							LOW-BIRTH-WEIGHT; 1ST 3 YEARS; POLYUNSATURATED FATTY-ACIDS; PRENATAL ALCOHOL EXPOSURE; BLOOD LEAD CONCENTRATIONS; IN-UTERO EXPOSURE; POLYCYCLIC AROMATIC-HYDROCARBONS; CUMULATIVE RISK-ASSESSMENT; WATER ARSENIC EXPOSURE; BODY-MASS INDEX	The etiology of a child's cognitive ability is complex, with research suggesting that it is not attributed to a single determinant or even a defined period of exposure. Rather, cognitive development is the product of cumulative interactions with the environment, both negative and positive, over the life course. The aim of this systematic scoping review was to collate evidence associated with children's cognitive health, including inherent factors as well as chemical and non-chemical stressors from the built, natural, and social environments. Three databases were used to identify recent epidemiological studies (2003-2013) that examined exposure factors associated with general cognitive ability in children. Over 100 factors were evaluated from 258 eligible studies. We found that recent literature mainly assessed the hypothesized negative effects of either inherent factors or chemical exposures present in the physical environment. Prenatal growth, sleep health, lead and water pollutants showed consistent negative effects. Of the few studies that examined social stressors, results consistently showed cognitive development to be influenced by both positive and negative social interactions at home, in school or the community. Among behavioral factors related to diet and lifestyle choices of the mother, breastfeeding was the most studied, showing consistent positive associations with cognitive ability. There were mostly inconsistent results for both chemical and non-chemical stressors. The majority of studies utilized traditional exposure assessments, evaluating chemical and non-chemical stressors separately. Collective evidence from a limited number of studies revealed that cumulative exposure assessment that incorporates multiple chemical and non-chemical stressors over the life course may unravel the variability in effect on cognitive development and help explain the inconsistencies across studies. Future research examining the interactions of multiple stressors within a child's total environment, depicting a more real-world exposure, will aid in understanding the cumulative effects associated with a child's ability to learn.	[Ruiz, Jazmin Del Carmen] Oak Ridge Inst Sci & Educ, Res Participat Program, Oak Ridge, TN USA; [Ruiz, Jazmin Del Carmen; Tulve, Nicolle S.] US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Off Res & Dev, Durham, NC USA; [Quackenboss, James J.] US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Off Res & Dev, Las Vegas, NV 89193 USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; United States Environmental Protection Agency	Ruiz, JD (corresponding author), Oak Ridge Inst Sci & Educ, Res Participat Program, Oak Ridge, TN USA.; Ruiz, JD (corresponding author), US EPA, Human Exposure & Atmospher Sci Div, Natl Exposure Res Lab, Off Res & Dev, Durham, NC USA.	jaz13ruiz@gmail.com			U.S. Environmental Protection Agency, Office of Research and Development, National Exposure Research Laboratory, Human Exposure and Atmospheric Sciences Division, Exposure Measurements and Analysis Branch	U.S. Environmental Protection Agency, Office of Research and Development, National Exposure Research Laboratory, Human Exposure and Atmospheric Sciences Division, Exposure Measurements and Analysis Branch	This project was supported by an appointment to the Internship/Research Participation Program at the U.S. Environmental Protection Agency, Office of Research and Development, National Exposure Research Laboratory, Human Exposure and Atmospheric Sciences Division, Exposure Measurements and Analysis Branch, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy and EPA. It has been subjected to Agency administrative review and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.	Agency for Toxic Substances and Disease Registry U. S. Department of Health and Human Services. Syracuse Research Corporation, 2007, TOX PROF ARS; Agency for Toxic Substances Registry, 2012, TOX PROF MANG; Agency for Toxic Substances Registry, 2003, TOX PROF FLUOR HYDR; Alati R, 2008, PEDIATR RES, V64, P659, DOI 10.1203/PDR.0b013e318187cc31; Albers EM, 2010, INFANT BEHAV DEV, V33, P401, DOI 10.1016/j.infbeh.2010.04.004; Alvarez-Pedrerol M, 2007, CLIN ENDOCRINOL, V66, P890, DOI 10.1111/j.1365-2265.2007.02871.x; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Bahena-Medina LA, 2011, J EXPO SCI ENV EPID, V21, P609, DOI 10.1038/jes.2011.25; Arantani Y., 2011, RACIAL GAPS EARLY CH; Arendt RE, 2004, J DEV BEHAV PEDIATR, V25, P83, DOI 10.1097/00004703-200404000-00002; Axelrad DA, 2007, ENVIRON HEALTH PERSP, V115, P609, DOI 10.1289/ehp.9303; Bakker EC, 2003, EUR J CLIN NUTR, V57, P89, DOI 10.1038/sj.ejcn.1601506; Banerjee PN, 2007, INFANT BEHAV DEV, V30, P479, DOI 10.1016/j.infbeh.2006.12.001; Barrigas C, 2012, J BIOSOC SCI, V44, P165, DOI 10.1017/S0021932011000538; Begega A, 2010, PSICOTHEMA, V22, P648; Bennett DS, 2008, DEV PSYCHOL, V44, P919, DOI 10.1037/0012-1649.44.4.919; Bergman K, 2010, BIOL PSYCHIAT, V67, P1026, DOI 10.1016/j.biopsych.2010.01.002; Beyerlein A, 2010, AM J CLIN NUTR, V92, P585, DOI 10.3945/ajcn.2009.29116; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P1189, DOI 10.1289/ehp.1003185; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P138, DOI 10.1289/ehp.1002321; Bourke R, 2011, SLEEP MED, V12, P489, DOI 10.1016/j.sleep.2010.11.010; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Buckhalt JA, 2007, CHILD DEV, V78, P213, DOI 10.1111/j.1467-8624.2007.00993.x; Busch AL, 2010, ATTACH HUM DEV, V12, P505, DOI 10.1080/14616734.2010.504542; Cabrera NJ, 2011, CHILD DEV, V82, P1985, DOI 10.1111/j.1467-8624.2011.01667.x; Calhoun SL, 2012, SLEEP, V35, P627, DOI 10.5665/sleep.1818; Calhoun SL, 2009, J CLIN SLEEP MED, V5, P228; Campbell JM, 2008, J PEDIATR PSYCHOL, V33, P999, DOI 10.1093/jpepsy/jsm138; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Cao Y, 2010, NEUROTOXICOLOGY, V31, P1, DOI 10.1016/j.neuro.2009.10.017; Cao Y, 2009, ENVIRON HEALTH PERSP, V117, P1580, DOI 10.1289/ehp.0900765; Carlo WA, 2012, J PEDIATR-US, V160, P781, DOI 10.1016/j.jpeds.2011.10.007; Chambers B., 2010, EFFECTIVE EARLY CHIL; Chan WS, 2010, HYPERTENS PREGNANCY, V29, P271, DOI 10.3109/10641950902777705; Chao HR, 2011, PEDIATR RES, V70, P596, DOI 10.1203/PDR.0b013e3182320b9b; Chatzi L, 2012, PUBLIC HEALTH NUTR, V15, P1728, DOI 10.1017/S1368980012000067; Chaudhari Sudha, 2004, Indian Pediatr, V41, P121; Chen AM, 2005, ENVIRON HEALTH PERSP, V113, P597, DOI 10.1289/ehp.7625; Chevrier J, 2011, J THROID RES, V2011, DOI 10.4061/2011/426427; Chiodo LM, 2009, ALCOHOL CLIN EXP RES, V33, P634, DOI 10.1111/j.1530-0277.2008.00878.x; Chiodo LM, 2004, NEUROTOXICOL TERATOL, V26, P359, DOI 10.1016/j.ntt.2004.01.010; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; Cooke RWI, 2003, ARCH DIS CHILD, V88, P482, DOI 10.1136/adc.88.6.482; Cory-Slechta DA, 2010, TOXICOL SCI, V117, P427, DOI 10.1093/toxsci/kfq221; Craig WY, 2012, J CLIN ENDOCR METAB, V97, pE22, DOI 10.1210/jc.2011-1772; Cserjesi R, 2012, PEDIATRICS, V130, pE838, DOI 10.1542/peds.2011-2079; Cummins SK, 2001, PEDIATR CLIN N AM, V48, P1241, DOI 10.1016/S0031-3955(05)70372-2; Davidson PW, 2008, NEUROTOXICOLOGY, V29, P767, DOI 10.1016/j.neuro.2008.06.001; Davidson PW, 2006, NEUROTOXICOL TERATOL, V28, P529, DOI 10.1016/j.ntt.2006.06.002; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Garcia CD, 2009, NUTR NEUROSCI, V12, P13, DOI 10.1179/147683009X388913; DePrince AP, 2009, CHILD ABUSE NEGLECT, V33, P353, DOI 10.1016/j.chiabu.2008.08.002; Deroma L, 2013, INT J HYG ENVIR HEAL, V216, P486, DOI 10.1016/j.ijheh.2013.02.004; Doherty G., 1997, ZERO 6 BASIS SCH REA, V1st; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; El-khayat Hamed, 2007, Pak J Biol Sci, V10, P1773, DOI 10.3923/pjbs.2007.1773.1781; Emancipator JL, 2006, ARCH PEDIAT ADOL MED, V160, P203, DOI 10.1001/archpedi.160.2.203; Emond AM, 2007, PEDIATRICS, V120, pe1051, DOI 10.1542/peds.2006-2295; Engel SM, 2011, ENVIRON HEALTH PERSP, V119, P1182, DOI 10.1289/ehp.1003183; Engle PL, 1996, SOC SCI MED, V43, P621, DOI 10.1016/0277-9536(96)00110-4; Eriksen HLF, 2012, BJOG-INT J OBSTET GY, V119, P1191, DOI 10.1111/j.1471-0528.2012.03394.x; Eriksen HLF, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/945196; Escobar GJ, 2007, J PEDIATR-US, V151, P127, DOI 10.1016/j.jpeds.2007.03.009; Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828; Eskenazi B, 2006, PEDIATRICS, V118, P233, DOI 10.1542/peds.2005-3117; Eskenazi B, 2013, ENVIRON HEALTH PERSP, V121, P257, DOI 10.1289/ehp.1205597; Eskenazi B, 2010, ENVIRON HEALTH PERSP, V118, P1775, DOI 10.1289/ehp.1002234; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Evans J, 2012, J CHILD PSYCHOL PSYC, V53, P632, DOI 10.1111/j.1469-7610.2011.02513.x; Feldman R, 2005, PEDIATRICS, V115, P443, DOI 10.1542/peds.2004-1137; Ferguson KT, 2013, INT J PSYCHOL, V48, P437, DOI 10.1080/00207594.2013.804190; Fishbein D, 2009, CHILD MALTREATMENT, V14, P299, DOI 10.1177/1077559508326355; Forns J, 2012, GAC SANIT, V26, P397, DOI 10.1016/j.gaceta.2011.10.011; Forns J, 2012, SCI TOTAL ENVIRON, V432, P338, DOI 10.1016/j.scitotenv.2012.06.012; Forns J, 2012, ENVIRON INT, V45, P72, DOI 10.1016/j.envint.2012.04.009; Frank DA, 2005, NEUROTOXICOL TERATOL, V27, P15, DOI 10.1016/j.ntt.2004.09.003; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Freire C, 2010, EUR J ENDOCRINOL, V163, P901, DOI 10.1530/EJE-10-0495; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; Freire C, 2010, ENVIRON RES, V110, P96, DOI 10.1016/j.envres.2009.10.005; Gaily E, 2004, NEUROLOGY, V62, P28, DOI 10.1212/WNL.62.1.28; Galbally M, 2011, AUST NZ J PSYCHIAT, V45, P393, DOI 10.3109/00048674.2010.549995; Gale CR, 2008, J CHILD PSYCHOL PSYC, V49, P1061, DOI 10.1111/j.1469-7610.2008.01908.x; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Gale CR, 2009, J CHILD PSYCHOL PSYC, V50, P816, DOI 10.1111/j.1469-7610.2008.02029.x; Gascon M, 2012, ENVIRON HEALTH PERSP, V120, P1760, DOI 10.1289/ehp.1205266; Gascon M, 2011, ENVIRON INT, V37, P605, DOI 10.1016/j.envint.2010.12.005; Gee GC, 2004, ENVIRON HEALTH PERSP, V112, P1645, DOI 10.1289/ehp.7074; Geiger A, 2010, DEV PSYCHOL, V46, P949, DOI 10.1037/a0019679; Goldschmidt L, 2008, J AM ACAD CHILD PSY, V47, P254, DOI 10.1097/chi.0b013e318160b3f0; Gomez-Sanchiz M, 2004, CLIN PEDIATR, V43, P753, DOI 10.1177/000992280404300811; Gomez-Sanchiz M, 2003, CLIN PEDIATR, V42, P35, DOI 10.1177/000992280304200106; Gordon N, 1998, Eur J Paediatr Neurol, V2, P1, DOI 10.1016/1090-3798(98)01000-1; Gottlieb DJ, 2004, J PEDIATR-US, V145, P458, DOI 10.1016/j.jpeds.2004.05.039; Grosse SD, 2002, ENVIRON HEALTH PERSP, V110, P563, DOI 10.1289/ehp.02110563; Gruber R, 2010, SLEEP MED, V11, P289, DOI 10.1016/j.sleep.2009.09.007; Gunnell D, 2005, PEDIATRICS, V116, pE681, DOI 10.1542/peds.2004-2390; Gustafsson PA, 2004, ACTA PAEDIATR, V93, P1280, DOI 10.1080/08035250410033123; Guxens M, 2012, ENVIRON HEALTH PERSP, V120, P144, DOI 10.1289/ehp.1103469; Guxens M, 2011, PEDIATRICS, V128, pE880, DOI 10.1542/peds.2010-1633; Hamadani JD, 2011, INT J EPIDEMIOL, V40, P1593, DOI 10.1093/ije/dyr176; Hamadani JD, 2010, INT J EPIDEMIOL, V39, P1206, DOI 10.1093/ije/dyp369; Han WJ, 2005, CHILD DEV, V76, P137, DOI 10.1111/j.1467-8624.2005.00835.x; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Henn BC, 2012, ENVIRON HEALTH PERSP, V120, P126, DOI 10.1289/ehp.1003300; Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Herbstman JB, 2010, ENVIRON HEALTH PERSP, V118, P712, DOI 10.1289/ehp.0901340; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hillemeier MM, 2011, MATERN CHILD HLTH J, V15, P1001, DOI 10.1007/s10995-010-0656-x; Hinkle SN, 2012, INT J OBESITY, V36, P1312, DOI 10.1038/ijo.2012.143; Horton MK, 2012, NEUROTOXICOL TERATOL, V34, P534, DOI 10.1016/j.ntt.2012.07.004; Horton MK, 2011, PEDIATRICS, V127, pE699, DOI 10.1542/peds.2010-0133; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; Huang PC, 2012, ENVIRON INT, V40, P88, DOI 10.1016/j.envint.2011.10.011; Huizink AC, 2003, J CHILD PSYCHOL PSYC, V44, P810, DOI 10.1111/1469-7610.00166; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Jackman AR, 2012, SLEEP MED, V13, P621, DOI 10.1016/j.sleep.2012.01.013; Jacobson JL, 2008, J PEDIATR-US, V152, P356, DOI 10.1016/j.jpeds.2007.07.008; Jacobson SW, 2004, ALCOHOL CLIN EXP RES, V28, P1732, DOI 10.1097/01.ALC.0000145691.81233.FA; Jedrychowski W, 2007, ENVIRON INT, V33, P1057, DOI 10.1016/j.envint.2007.06.001; Jedrychowski W, 2006, ANN EPIDEMIOL, V16, P439, DOI 10.1016/j.annepidem.2005.06.059; Jedrychowski W, 2012, EUR J PEDIATR, V171, P151, DOI 10.1007/s00431-011-1507-5; Jedrychowski W, 2011, PHYSIOL BEHAV, V104, P989, DOI 10.1016/j.physbeh.2011.06.019; Jedrychowski W, 2009, EARLY HUM DEV, V85, P503, DOI 10.1016/j.earlhumdev.2009.04.006; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Juarez PD, 2014, INT J ENV RES PUB HE, V11, P12866, DOI 10.3390/ijerph111212866; Julvez J, 2009, ALLERGY, V64, P1279, DOI 10.1111/j.1398-9995.2009.01987.x; Julvez J, 2007, INT J EPIDEMIOL, V36, P825, DOI 10.1093/ije/dym107; Julvez J, 2013, EPIDEMIOLOGY, V24, P150, DOI 10.1097/EDE.0b013e318276ccd3; Julvez J, 2011, ENVIRON HEALTH PERSP, V119, P1429, DOI 10.1289/ehp.1003172; Julvez J, 2009, PAEDIATR PERINAT EP, V23, P199, DOI 10.1111/j.1365-3016.2009.01032.x; Jurewicz J, 2013, ANN AGR ENV MED, V20, P465; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Kaemingk KL, 2003, J INT NEUROPSYCH SOC, V9, P1016, DOI 10.1017/S1355617703970056; Kennedy JD, 2004, PEDIATR PULM, V37, P330, DOI 10.1002/ppul.10453; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1222, DOI 10.1111/j.1471-0528.2012.03395.x; Kilbride HW, 2004, PEDIATRICS, V113, P742, DOI 10.1542/peds.113.4.742; Kim Y, 2013, NEUROTOXICOLOGY, V35, P15, DOI 10.1016/j.neuro.2012.11.006; Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178; Kim Y, 2009, NEUROTOXICOLOGY, V30, P564, DOI 10.1016/j.neuro.2009.03.012; Koenen KC, 2003, DEV PSYCHOPATHOL, V15, P297, DOI 10.1017/S0954579403000166; Kohler MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007343; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Kolobe THA, 2004, PHYS THER, V84, P439, DOI 10.1093/ptj/84.5.439; Koutra K, 2013, SOC PSYCH PSYCH EPID, V48, P1335, DOI 10.1007/s00127-012-0636-0; Koutra K, 2012, INFANT BEHAV DEV, V35, P48, DOI 10.1016/j.infbeh.2011.09.005; Lacour M., 2011, ED RES REV, V6, P522; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Laslo-Baker D, 2004, ARCH PEDIAT ADOL MED, V158, P956, DOI 10.1001/archpedi.158.10.956; Lederman SA, 2008, ENVIRON HEALTH PERSP, V116, P1085, DOI 10.1289/ehp.10831; Lee BE, 2011, ENVIRON RES, V111, P539, DOI 10.1016/j.envres.2011.02.014; Lewis AS, 2011, INT J ENV RES PUB HE, V8, P2020, DOI 10.3390/ijerph8062020; Lewis MW, 2004, AM J DRUG ALCOHOL AB, V30, P299, DOI 10.1081/ADA-120037380; Lewis SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049407; Li XM, 2004, PEDIATRICS, V113, P1715, DOI 10.1542/peds.113.6.1715; Li Y, 2010, CLIN ENDOCRINOL, V72, P825, DOI 10.1111/j.1365-2265.2009.03743.x; Liu JH, 2014, J ENVIRON HEALTH, V76, P130; Llop S, 2012, AM J EPIDEMIOL, V175, P451, DOI 10.1093/aje/kwr328; Loman MM, 2009, J DEV BEHAV PEDIATR, V30, P426, DOI 10.1097/DBP.0b013e3181b1fd08; Lovasi GS, 2011, AM J PUBLIC HEALTH, V101, P63, DOI 10.2105/AJPH.2009.168419; Lowe J, 2010, INFANT BEHAV DEV, V33, P629, DOI 10.1016/j.infbeh.2010.07.016; Lucchini RG, 2012, ENVIRON RES, V118, P65, DOI 10.1016/j.envres.2012.08.003; Lugo-Gil J, 2008, CHILD DEV, V79, P1065, DOI 10.1111/j.1467-8624.2008.01176.x; Lynch CD, 2012, REPROD TOXICOL, V34, P451, DOI 10.1016/j.reprotox.2012.04.013; Mackner LM, 2003, J CHILD PSYCHOL PSYC, V44, P743, DOI 10.1111/1469-7610.00160; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Meldrum SJ, 2012, EARLY HUM DEV, V88, P567, DOI 10.1016/j.earlhumdev.2011.12.032; Mendez MA, 2009, PUBLIC HEALTH NUTR, V12, P1702, DOI 10.1017/S1368980008003947; Menezes JA, 2011, ENVIRON RES, V111, P156, DOI 10.1016/j.envres.2010.09.006; Messinger DS, 2004, PEDIATRICS, V113, P1677, DOI 10.1542/peds.113.6.1677; Miano S, 2011, CLIN NEUROPHYSIOL, V122, P311, DOI 10.1016/j.clinph.2010.06.019; Min MYO, 2009, NEUROTOXICOL TERATOL, V31, P225, DOI 10.1016/j.ntt.2009.03.002; Morales E, 2008, ENVIRON HEALTH PERSP, V116, P1581, DOI 10.1289/ehp.11303; Morales E, 2012, PEDIATRICS, V130, pE913, DOI 10.1542/peds.2011-3289; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Morales E, 2009, INT J EPIDEMIOL, V38, P690, DOI 10.1093/ije/dyp141; Morrow CE, 2006, DEV NEUROPSYCHOL, V30, P905, DOI 10.1207/s15326942dn3003_8; Munck P, 2010, ACTA PAEDIATR, V99, P359, DOI 10.1111/j.1651-2227.2009.01589.x; Munck P, 2012, PEDIATRICS, V129, P503, DOI 10.1542/peds.2011-1566; Murcia M, 2011, AM J EPIDEMIOL, V173, P804, DOI 10.1093/aje/kwq424; Nair P, 2008, AMBUL PEDIATR, V8, P154, DOI 10.1016/j.ambp.2008.02.002; Najman JM, 2009, J PEDIATR-US, V154, P284, DOI 10.1016/j.jpeds.2008.08.052; Nakajima S, 2006, ENVIRON HEALTH PERSP, V114, P773, DOI 10.1289/ehp.8614; Nelson S, 2004, J DEV BEHAV PEDIATR, V25, P1, DOI 10.1097/00004703-200402000-00001; Nepomnyaschy L, 2012, MATERN CHILD HLTH J, V16, P1612, DOI 10.1007/s10995-011-0853-2; Northstone K, 2012, J EPIDEMIOL COMMUN H, V66, P624, DOI 10.1136/jech.2010.111955; Nulman I, 2004, Arch Womens Ment Health, V7, P173; Nulman I, 2012, AM J PSYCHIAT, V169, P1165, DOI 10.1176/appi.ajp.2012.11111721; Nulman I, 2009, J PEDIATR-US, V155, P45, DOI 10.1016/j.jpeds.2009.02.005; O'Callaghan FV, 2007, EARLY HUM DEV, V83, P115, DOI 10.1016/j.earlhumdev.2006.05.011; Odd DE, 2009, LANCET, V373, P1615, DOI 10.1016/S0140-6736(09)60244-0; Odd DE, 2012, DEV MED CHILD NEUROL, V54, P704, DOI 10.1111/j.1469-8749.2012.04315.x; Orchinik LJ, 2011, J INT NEUROPSYCH SOC, V17, P1067, DOI 10.1017/S135561771100107X; Park HY, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-51; Park HY, 2009, ENVIRON HEALTH PERSP, V117, P1600, DOI 10.1289/ehp.0900611; Pawlas N, 2012, NEUROTOXICOLOGY, V33, P37, DOI 10.1016/j.neuro.2011.10.012; Pears K, 2005, J DEV BEHAV PEDIATR, V26, P112, DOI 10.1097/00004703-200504000-00006; Perera FP, 2007, ENVIRON HEALTH PERSP, V115, P1497, DOI 10.1289/ehp.10144; Perera FP, 2006, ENVIRON HEALTH PERSP, V114, P1287, DOI 10.1289/ehp.9084; Perera FP, 2013, PEDIATRICS, V132, pE1284, DOI 10.1542/peds.2012-3844; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Piaget J., 2008, PSYCHOL CHILD; Pilsner JR, 2010, AM J CLIN NUTR, V92, P226, DOI 10.3945/ajcn.2009.28839; Piteo AM, 2012, EARLY HUM DEV, V88, P651, DOI 10.1016/j.earlhumdev.2012.01.013; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Puertas R, 2010, NEUROTOXICOLOGY, V31, P154, DOI 10.1016/j.neuro.2009.09.009; Raikes H, 2006, CHILD DEV, V77, P924, DOI 10.1111/j.1467-8624.2006.00911.x; Raman Vijaya, 2010, Indian J Psychiatry, V52, P360, DOI 10.4103/0019-5545.74313; Rauh VA, 2004, NEUROTOXICOL TERATOL, V26, P373, DOI 10.1016/j.ntt.2004.01.002; Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Reardon SF, 2011, WHITHER OPPORTUNITY?: RISING INEQUALITY, SCHOOLS, AND CHILDREN'S LIFE CHANCES, P91; Rebagliato M, 2013, AM J EPIDEMIOL, V177, P944, DOI 10.1093/aje/kws333; Ribas-Fito N, 2003, PEDIATRICS, V111, pE580, DOI 10.1542/peds.111.5.e580; Ribas-Fito N, 2007, AM J EPIDEMIOL, V166, P1198, DOI 10.1093/aje/kwm207; Ribas-Fito N, 2006, AM J EPIDEMIOL, V164, P955, DOI 10.1093/aje/kwj299; Richardson GA, 2008, NEUROTOXICOL TERATOL, V30, P96, DOI 10.1016/j.ntt.2007.12.006; Riojas-Rodriguez H, 2010, ENVIRON HEALTH PERSP, V118, P1465, DOI 10.1289/ehp.0901229; Rocha-Amador D, 2007, CAD SAUDE PUBLICA, V23, pS579, DOI 10.1590/S0102-311X2007001600018; Roze E, 2009, ENVIRON HEALTH PERSP, V117, P1953, DOI 10.1289/ehp.0901015; Saxena S, 2012, J NEUROSCI RURAL PRA, V3, P144, DOI 10.4103/0976-3147.98213; Schermann L, 2004, ACTA PAEDIATR, V93, P1619, DOI 10.1080/08035250410023386; Schnaas L, 2006, ENVIRON HEALTH PERSP, V114, P791, DOI 10.1289/ehp.8552; Seraj B, 2012, J Dent (Tehran), V9, P221; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Sexton K, 2011, AM J PUBLIC HEALTH, V101, pS81, DOI 10.2105/AJPH.2011.300118; Shivaprakash P K, 2011, J Indian Soc Pedod Prev Dent, V29, P117, DOI 10.4103/0970-4388.84683; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Shy CG, 2011, B ENVIRON CONTAM TOX, V87, P643, DOI 10.1007/s00128-011-0422-9; Signore C, 2008, AM J CLIN NUTR, V87, P896, DOI 10.1093/ajcn/87.4.896; Silva RDR, 2012, J PEDIAT-BRAZIL, V88, P149, DOI 10.2223/JPED.2176; Singer LT, 2004, JAMA-J AM MED ASSOC, V291, P2448, DOI 10.1001/jama.291.20.2448; Singer LT, 2012, PEDIATRICS, V130, P407, DOI 10.1542/peds.2012-0666; Singer LT, 2012, NEUROTOXICOL TERATOL, V34, P303, DOI 10.1016/j.ntt.2012.02.001; Slykerman RF, 2005, EARLY HUM DEV, V81, P815, DOI 10.1016/j.earlhumdev.2005.05.005; Smith LM, 2011, NEUROTOXICOL TERATOL, V33, P176, DOI 10.1016/j.ntt.2010.10.004; Smithers LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058904; Smithers LG, 2012, EUR J EPIDEMIOL, V27, P525, DOI 10.1007/s10654-012-9715-5; Solon O, 2008, J PEDIATR-US, V152, P237, DOI 10.1016/j.jpeds.2007.09.008; Soria-Pastor S, 2009, PEDIATRICS, V124, pE1161, DOI 10.1542/peds.2009-0244; Stewart PW, 2008, ENVIRON HEALTH PERSP, V116, P1416, DOI 10.1289/ehp.11058; Stewart PW, 2012, NEUROTOXICOL TERATOL, V34, P96, DOI 10.1016/j.ntt.2011.11.003; Stewart PW, 2003, NEUROTOXICOL TERATOL, V25, P11, DOI 10.1016/S0892-0362(02)00320-3; Strina A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-5; Suglia SF, 2008, AM J EPIDEMIOL, V167, P280, DOI 10.1093/aje/kwm308; Sunyer J, 2010, ENVIRON RES, V110, P733, DOI 10.1016/j.envres.2010.07.005; Surkan PJ, 2008, NEUROTOXICOLOGY, V29, P278, DOI 10.1016/j.neuro.2007.11.006; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; Sutter-Dallay AL, 2011, EUR PSYCHIAT, V26, P484, DOI 10.1016/j.eurpsy.2010.05.004; Sylva K, 2011, BRIT J DEV PSYCHOL, V29, P18, DOI 10.1348/026151010X533229; Tamis-LeMonda CS, 2004, CHILD DEV, V75, P1806, DOI 10.1111/j.1467-8624.2004.00818.x; Tellez-Rojo MM, 2006, PEDIATRICS, V118, pE323, DOI 10.1542/peds.2005-3123; Thomas SV, 2007, EPILEPSIA, V48, P2234; Thompson WW, 2007, NEW ENGL J MED, V357, P1281, DOI 10.1056/NEJMoa071434; Tofail F, 2012, EUR J CLIN NUTR, V66, P237, DOI 10.1038/ejcn.2011.165; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; Tong SL, 2006, J PAEDIATR CHILD H, V42, P98, DOI 10.1111/j.1440-1754.2006.00805.x; Torres-Sanchez L, 2007, ENVIRON HEALTH PERSP, V115, P435, DOI 10.1289/ehp.9566; Torres-Sanchez L, 2013, ENVIRON HEALTH PERSP, V121, P263, DOI 10.1289/ehp.1205034; Torres-Sanchez L, 2009, NEUROTOXICOLOGY, V30, P1162, DOI 10.1016/j.neuro.2009.08.010; Tozzi AE, 2012, DEV MED CHILD NEUROL, V54, P843, DOI 10.1111/j.1469-8749.2012.04319.x; United States Environmental Protection Agency (US EPA), 2006, FRAM ASS HLTH RISK E; Veldwijk J, 2011, OBESITY FACTS, V4, P264, DOI 10.1159/000331015; Virgolini MB, 2008, NEUROTOXICOLOGY, V29, P812, DOI 10.1016/j.neuro.2008.03.003; von Ehrenstein OS, 2009, AM J EPIDEMIOL, V170, P1388, DOI 10.1093/aje/kwp296; von Ehrenstein OS, 2007, EPIDEMIOLOGY, V18, P44, DOI 10.1097/01.ede.0000248900.65613.a9; Vrijheid M, 2012, EPIDEMIOLOGY, V23, P23, DOI 10.1097/EDE.0b013e31823a4023; Vrijheid M, 2010, EPIDEMIOLOGY, V21, P259, DOI 10.1097/EDE.0b013e3181cb41e0; Waisbren SE, 2003, PEDIATRICS, V112, P1544; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Wang SX, 2007, ENVIRON HEALTH PERSP, V115, P643, DOI 10.1289/ehp.9270; Wang S, 2010, ANN HUM GENET, V74, P46, DOI 10.1111/j.1469-1809.2009.00550.x; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wasserman GA, 2007, ENVIRON HEALTH PERSP, V115, P285, DOI 10.1289/ehp.9501; Wasserman GA, 2011, NEUROTOXICOLOGY, V32, P450, DOI 10.1016/j.neuro.2011.03.009; Watson GE, 2012, NEUROTOXICOLOGY, V33, P1511, DOI 10.1016/j.neuro.2012.10.001; Watson GE, 2011, J AM DENT ASSOC, V142, P1283, DOI 10.14219/jada.archive.2011.0114; Whitehouse AJO, 2012, PAEDIATR PERINAT EP, V26, P101, DOI 10.1111/j.1365-3016.2011.01257.x; Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705; Wilhelm M, 2008, MUTAT RES-REV MUTAT, V659, P83, DOI 10.1016/j.mrrev.2007.11.002; Willford JA, 2006, ALCOHOL CLIN EXP RES, V30, P1051, DOI 10.1111/j.1530-0277.2006.00119.x; Williams FLR, 2013, J CLIN ENDOCR METAB, V98, P829, DOI 10.1210/jc.2012-3572; Williamson DL, 2005, CAN J PUBLIC HEALTH, V96, P13, DOI 10.1007/BF03404006; Wright RJ, 2009, CURR OPIN PEDIATR, V21, P222, DOI 10.1097/MOP.0b013e3283292629; Wu BTF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043448; Yang S, 2012, INT J EPIDEMIOL, V41, P1086, DOI 10.1093/ije/dys071; Yang S, 2011, INT J EPIDEMIOL, V40, P1215, DOI 10.1093/ije/dyr094; Yumoto C, 2008, CHILD DEV, V79, P1761, DOI 10.1111/j.1467-8624.2008.01224.x; Zhou SJ, 2007, NUTRITION, V23, P236, DOI 10.1016/j.nut.2006.12.011	294	22	22	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147741	10.1371/journal.pone.0147741	http://dx.doi.org/10.1371/journal.pone.0147741			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26840411	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200057
J	Zhang, Y; Cheng, JJ; Hua, XL; Yu, MJ; Xu, CD; Zhang, F; Xu, JR; Wu, HW				Zhang, Ying; Cheng, Jiejun; Hua, Xiaolan; Yu, Mingji; Xu, Chengdong; Zhang, Feng; Xu, Jianrong; Wu, Huawei			Can Spectral CT Imaging Improve the Differentiation between Malignant and Benign Solitary Pulmonary Nodules?	PLOS ONE			English	Article							DUAL-ENERGY CT; IODINATED CONTRAST MATERIAL; PRIMARY HUMAN CARCINOMAS; INITIAL-EXPERIENCE; MICROVASCULAR BED; LUNG NODULES; ENHANCEMENT; MULTICENTER; MORPHOLOGY; LESIONS	Purpose To quantitatively assess the value of dual-energy CT (DECT) in differentiating malignancy and benignity of solitary pulmonary nodules. Materials and Methods Sixty-three patients with solitary pulmonary nodules detected by CT plain scan underwent contrast enhanced CT scans in arterial phase (AP) and venous phase (VP) with spectral imaging mode for tumor type differentiation. The Gemstone Spectral Imaging (GSI) viewer was used for image display and data analysis. Region of interest was placed on the relatively homogeneous area of the nodule to measure iodine concentration (IC) on iodinebased material decomposition images and CT numbers on monochromatic image sets to generate spectral HU curve. Normalized IC (NIC), slope of the spectral HU curve (lambda(HU)) and net CT number enhancement on 70keV images were calculated. The two-sample t-test was used to compare quantitative parameters. Receiver operating characteristic curves were generated to calculate sensitivity and specificity. Results There were 63 nodules, with 37 malignant nodules (59%) and 26 benign nodules (41%). NIC,lambda(HU) and net CT number enhancement on 70keV images for malignant nodules were all greater than those of benign nodules. NIC and lambda(HU) had intermediate to high performances to differentiate malignant nodules from benign ones with the areas under curve of 0.89 and 0.86 respectively in AP, 0.96 and 0.89 respectively in VP. Using 0.30 as a threshold value for NIC in VP, one could obtain sensitivity of 93.8% and specificity of 85.7% for differentiating malignant from benign solitary pulmonary nodules. These values were statistically higher than the corresponding values of 74.2% and 53.8% obtained with the conventional CT number enhancement. Conclusions DECT imaging with GSI mode provides more promising value in quantitative way for distinguishing malignant nodules from benign ones than CT enhancement numbers.	[Zhang, Ying; Cheng, Jiejun; Hua, Xiaolan; Yu, Mingji; Xu, Chengdong; Zhang, Feng; Xu, Jianrong; Wu, Huawei] Shanghai Jiao Tong Univ, Dept Radiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wu, HW (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China.	Huaweiwu26@163.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X	Shanghai Municipal Health Bureau [20124176]; Shanghai Municipal Science and Technology Commission [14411968100]	Shanghai Municipal Health Bureau; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported in part by a research project of Shanghai Municipal Health Bureau (20124176) and Shanghai Municipal Science and Technology Commission (14411968100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chae EJ, 2008, RADIOLOGY, V249, P671, DOI 10.1148/radiol.2492071956; Chae EJ, 2010, J THORAC IMAG, V25, P301, DOI 10.1097/RTI.0b013e3181e16232; De Cecco CN, 2012, AM J ROENTGENOL, V199, pS98, DOI 10.2214/AJR.12.9207; Erasmus JJ, 2000, RADIOGRAPHICS, V20, P43, DOI 10.1148/radiographics.20.1.g00ja0343; Fornaro J, 2011, INSIGHTS IMAGING, V2, P149, DOI 10.1007/s13244-010-0057-0; Goodsitt MM, 2009, MED PHYS, V36, P3107, DOI 10.1118/1.3148536; Hou WS, 2015, ACAD RADIOL, V22, P337, DOI 10.1016/j.acra.2014.10.004; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Knoss N, 2011, EUR J RADIOL, V80, pE516, DOI 10.1016/j.ejrad.2010.11.001; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Patel BN, 2013, CLIN RADIOL, V68, P148, DOI 10.1016/j.crad.2012.06.108; Schaefer JF, 2004, RADIOLOGY, V232, P544, DOI 10.1148/radiol.2322030515; Simons D, 2014, EUR RADIOL, V24, P930, DOI 10.1007/s00330-013-3087-4; SWENSEN SJ, 1992, RADIOLOGY, V182, P343, DOI 10.1148/radiology.182.2.1732947; Swensen SJ, 2000, RADIOLOGY, V214, P81, DOI 10.1148/radiology.214.1.r00ja2681; Swensen SJ, 2000, RADIOLOGY, V214, P73, DOI 10.1148/radiology.214.1.r00ja1473; Swensen SJ, 1996, RADIOLOGY, V201, P447, DOI 10.1148/radiology.201.2.8888239; SWENSEN SJ, 1995, RADIOLOGY, V194, P393, DOI 10.1148/radiology.194.2.7824716; Truong MT, 2014, RADIOGRAPHICS, V34, P1658, DOI 10.1148/rg.346130092; Wang GL, 2014, J COMPUT ASSIST TOMO, V38, P77, DOI 10.1097/RCT.0b013e3182a21633; Winer-Muram HT, 2006, RADIOLOGY, V239, P34, DOI 10.1148/radiol.2391050343; ZERHOUNI EA, 1986, RADIOLOGY, V160, P319, DOI 10.1148/radiology.160.2.3726107; Zhang MM, 1997, RADIOLOGY, V205, P471, DOI 10.1148/radiology.205.2.9356631; ZIELINSKI KW, 1984, PATHOL RES PRACT, V178, P369, DOI 10.1016/S0344-0338(84)80029-1; ZIELINSKI KW, 1984, PATHOL RES PRACT, V178, P243, DOI 10.1016/S0344-0338(84)80106-5	26	46	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147537	10.1371/journal.pone.0147537	http://dx.doi.org/10.1371/journal.pone.0147537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840459	Green Published, Green Submitted, gold			2022-12-27	WOS:000369550200044
J	Gaucher, S; Boutron, I; Marchand-Maillet, F; Baron, G; Douard, R; Bethoux, JP				Gaucher, Sonia; Boutron, Isabelle; Marchand-Maillet, Florence; Baron, Gabriel; Douard, Richard; Bethoux, Jean-Pierre		AMBUPROG Grp Investigators	Assessment of a Standardized Pre-Operative Telephone Checklist Designed to Avoid Late Cancellation of Ambulatory Surgery: The AMBUPROG Multicenter Randomized Controlled Trial	PLOS ONE			English	Article							SYSTEM; IMPACT	Objectives To assess the impact of a standardized pre-operative telephone checklist on the rate of late cancellations of ambulatory surgery (AMBUPROG trial). Design Multicenter, two-arm, parallel-group, open-label randomized controlled trial. Setting 11 university hospital ambulatory surgery units in Paris, France. Participants Patients scheduled for ambulatory surgery and able to be reached by telephone. Intervention A 7-item checklist designed to prevent late cancellation, available in five languages and two versions (for children and adults), was administered between 7 and 3 days before the planned date of surgery, by an automated phone system or a research assistant. The control group received standard management alone. Main Outcome Measures Rate of cancellation on the day of surgery or the day before. Results The study population comprised 3900 patients enrolled between November 2012 and September 2013: 1950 patients were randomized to the checklist arm and 1950 patients to the control arm. The checklist was administered to 68.8% of patients in the intervention arm, 1002 by the automated phone system and 340 by a research assistant. The rate of late cancellation did not differ significantly between the checklist and control arms (109 (5.6%) vs. 113 (5.8%), adjusted odds ratio [95% confidence interval] = 0.91 [0.65-1.29], (p = 0.57)). Checklist administration revealed that 355 patients (28.0%) had not undergone tests ordered by the surgeon or anesthetist, and that 254 patients (20.0%) still had questions concerning the fasting state. Conclusions A standardized pre-operative telephone checklist did not avoid late cancellations of ambulatory surgery but enabled us to identify several frequent causes.	[Gaucher, Sonia; Boutron, Isabelle; Douard, Richard; Bethoux, Jean-Pierre] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Gaucher, Sonia; Bethoux, Jean-Pierre] Hop Cochin, Hop Univ Paris Ctr, AP HP, Serv Chirurg Gen Plast & Ambulatoire, 27 Rue Faubourg St Jacques, F-75674 Paris, France; [Boutron, Isabelle; Baron, Gabriel] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Boutron, Isabelle; Baron, Gabriel] INSERM, Sorbonne Paris Cite Ctr CRESS, UMR Epidemiol & Stat 1153, METHODS Team, Paris, France; [Marchand-Maillet, Florence] Hop St Antoine, Hop Univ Paris Est, AP HP, Unite Chirurg Ambulatoire,Pole Digestif Anesthesi, F-75571 Paris, France; [Douard, Richard] Hop Europeen Georges Pompidou, Serv Chirurg Gen & Digest, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Gaucher, S (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Gaucher, S (corresponding author), Hop Cochin, Hop Univ Paris Ctr, AP HP, Serv Chirurg Gen Plast & Ambulatoire, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	sonia.gaucher@aphp.fr	Douard, Richard/ABD-2202-2020	Douard, Richard/0000-0001-7841-5140; Boutron, Isabelle/0000-0002-5263-6241	French Ministry of health	French Ministry of health	The AMBUPROG study was funded by the French Ministry of health (Preqhos 2011 grant).	Argo JL, 2009, AM J SURG, V198, P600, DOI 10.1016/j.amjsurg.2009.07.005; Basson MD, 2006, ANESTHESIOLOGY, V104, P826, DOI 10.1097/00000542-200604000-00029; Basu S, 2001, ANN ROY COLL SURG, V83, P329; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Dimitriadis PA, 2013, INT J SURG, V11, P1126, DOI 10.1016/j.ijsu.2013.09.002; Downer SR, 2005, MED J AUSTRALIA, V183, P366, DOI 10.5694/j.1326-5377.2005.tb07085.x; Ferschl MB, 2005, ANESTHESIOLOGY, V103, P855, DOI 10.1097/00000542-200510000-00025; Haufler Kimberly, 2011, AORN J, V94, P19, DOI 10.1016/j.aorn.2010.12.024; Hovlid E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-154; Huang J, 2002, INTERNET J ANESTH, V7; Jimenez A, 2006, J AMBUL SURG, V12, P199; Knox M, 2009, SURG-J R COLL SURG E, V7, P76, DOI 10.1016/S1479-666X(09)80019-X; Moher D, 2012, J CLIN EPIDEMIOL, V65, P351, DOI 10.1016/j.jclinepi.2011.10.006; PATEL RI, 1992, ANESTH ANALG, V75, P258; Pollard JB, 1999, ANESTH ANALG, V89, P502, DOI 10.1097/00000539-199908000-00048; Rai MR, 2003, ANAESTHESIA, V58, P692, DOI 10.1046/j.1365-2044.2003.03189_3.x; Rymaruk Sophy, 2011, J Perioper Pract, V21, P337; Sanjay P, 2007, J Health Organ Manag, V21, P54, DOI 10.1108/14777260710732268; Singhal R, 2014, J Perioper Pract, V24, P70; Tung A, 2010, ANESTH ANALG, V111, P749, DOI 10.1213/ANE.0b013e3181e661e8; Xue Wei, 2013, J Anesth Clin Res, V4, P314	22	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147194	10.1371/journal.pone.0147194	http://dx.doi.org/10.1371/journal.pone.0147194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829478	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200014
J	Reichhardt, MP; Jarva, H; Lokki, AI; Laivuori, H; Vuorela, P; Loimaranta, V; Glasner, A; Siwetz, M; Huppertz, B; Meri, S				Reichhardt, Martin Parnov; Jarva, Hanna; Lokki, Anna Inkeri; Laivuori, Hannele; Vuorela, Piia; Loimaranta, Vuokko; Glasner, Andreas; Siwetz, Monika; Huppertz, Berthold; Meri, Seppo		FINNPEC Study Grp	The Salivary Scavenger and Agglutinin (SALSA) in Healthy and Complicated Pregnancy	PLOS ONE			English	Article							MALIGNANT BRAIN-TUMORS; SURFACTANT PROTEIN-D; EXTRACELLULAR-MATRIX; AMNIOTIC-FLUID; LECTIN PATHWAY; HUMAN PLACENTA; PREECLAMPSIA; COMPLEMENT; DMBT1; MOLECULE	Pre-eclampsia is a leading cause of maternal and perinatal morbidity and mortality worldwide. The etiology is not clear, but an immune attack towards components of placenta or fetus has been indicated. This involves activation of the complement system in the placenta. We have previously described the presence of the complement-regulating protein salivary scavenger and agglutinin (SALSA) in amniotic fluid. In this study we investigated the potential role of SALSA in pregnancy by analyzing its presence in amniotic fluid and placental tissue during healthy and complicated pregnancies. SALSA levels in amniotic fluid increased during pregnancy. Before 20 weeks of gestation the levels were slightly higher in patients who later developed pre-eclampsia than in gestation age-matched controls. In the placenta of pre-eclamptic patients syncytial damage is often followed by the formation of fibrinoid structures. SALSA was found clustered into these fibrinoid structures in partial co-localization with complement C1q and fibronectin. In vitro analysis showed direct protein binding of SALSA to fibronectin. SALSA binds also to fibrin/fibrinogen but did not interfere with the blood clotting process in vitro. Thus, in addition to antimicrobial defense and epithelial differentiation, the data presented here suggest that SALSA, together with fibronectin and C1q, may be involved in the containment of injured placental structures into fibrinoids.	[Reichhardt, Martin Parnov; Jarva, Hanna; Lokki, Anna Inkeri; Meri, Seppo] Univ Helsinki, Fac Med, Res Programs Unit, Immunobiol Res Program, Helsinki, Finland; [Reichhardt, Martin Parnov; Jarva, Hanna; Lokki, Anna Inkeri; Meri, Seppo] Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Helsinki, Finland; [Jarva, Hanna; Meri, Seppo] Helsinki Univ Hosp Lab HUSLAB, Helsinki, Finland; [Lokki, Anna Inkeri; Laivuori, Hannele] Univ Helsinki, Med Genet, Helsinki, Finland; [Lokki, Anna Inkeri; Laivuori, Hannele; Vuorela, Piia] Helsinki Univ Hosp, Helsinki, Finland; [Laivuori, Hannele; Vuorela, Piia] Univ Helsinki, Obstet & Gynecol, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Vuorela, Piia] Porvoo Hosp, Obstet & Gynecol, Porvoo, Finland; [Loimaranta, Vuokko] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Glasner, Andreas] Femina Med Ctr, Graz, Austria; [Siwetz, Monika; Huppertz, Berthold] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Huppertz, Berthold] Med Univ Graz, Org Unit Res Infrastruct, Biobank Graz, Graz, Austria	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Turku; Medical University of Graz; Medical University of Graz	Reichhardt, MP; Meri, S (corresponding author), Univ Helsinki, Fac Med, Res Programs Unit, Immunobiol Res Program, Helsinki, Finland.; Reichhardt, MP; Meri, S (corresponding author), Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Helsinki, Finland.; Meri, S (corresponding author), Helsinki Univ Hosp Lab HUSLAB, Helsinki, Finland.	martin.reichhardt@helsinki.fi; seppo.meri@helsinki.fi	Laivuori, Hannele/F-2953-2011; Lokki, A. Inkeri/H-4783-2019; Kere, Juha/A-9179-2008; Huppertz, Berthold/I-2331-2019	Laivuori, Hannele/0000-0003-3212-7826; Lokki, A. Inkeri/0000-0003-4397-8415; Kere, Juha/0000-0003-1974-0271; Huppertz, Berthold/0000-0003-4814-2158; Parnov Reichhardt, Martin/0000-0001-5345-5103; Kivinen, Katja/0000-0002-1135-7625; Jarva, Hanna/0000-0002-9154-354X; Loimaranta, Vuokko/0000-0002-6873-2270; Meri, Seppo/0000-0001-9142-501X	Helsingin Yliopisto [212/51/2011]; Sigrid Juselius saatio [18032015]; Signe ja Ane Gyllenbergin saatio [14052014]; Stockman foundation [05092014]; Varsinais-Suomi rahasto [85121924]; Helsinki University Hospital Funds [TYH2011205]	Helsingin Yliopisto; Sigrid Juselius saatio; Signe ja Ane Gyllenbergin saatio; Stockman foundation; Varsinais-Suomi rahasto; Helsinki University Hospital Funds	This work was supported by Helsingin Yliopisto: (www.helsinki.fi) [Grant number: 212/51/2011 (HJ)], Sigrid Juselius saatio: (http://www.sigridjuselius.fi/foundation) [Grant number: 18032015 (SM)], Signe ja Ane Gyllenbergin saatio: (http:gyllenbergs.fi/fi/) [Grant number: 14052014 (SM)], the Stockman foundation: Postal address: Tempelgatan 1 A 17, 00100 Helsinki, Finland [Grant number: 05092014 (SM)], Varsinais-Suomi rahasto: (https://skr.fi/fi/rahastot/varsinais-suomen-rahasto) [Grant number: 85121924 (VL)], and Helsinki University Hospital Funds: (http://www.hus.fi/en/Pages/default.aspx) [Grant number: TYH2011205 (PV)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates SM, 2005, CIRCULATION, V112, pE53, DOI 10.1161/CIRCULATIONAHA.104.478222; BOACKLE RJ, 1993, MOL IMMUNOL, V30, P309, DOI 10.1016/0161-5890(93)90059-K; Buurma A, 2012, HYPERTENSION, V60, P1332, DOI 10.1161/HYPERTENSIONAHA.112.194324; CADROY Y, 1993, BRIT J OBSTET GYNAEC, V100, P416, DOI 10.1111/j.1471-0528.1993.tb15264.x; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V11, P362, DOI 10.1080/713605565; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Flierman R, 2007, IMMUNOBIOLOGY, V212, P363, DOI 10.1016/j.imbio.2006.11.005; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Hay ED, 1995, ACTA ANAT, V154, P8; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794; Kang W, 2002, CLIN EXP IMMUNOL, V130, P449, DOI 10.1046/j.1365-2249.2002.01992.x; Kaufmann P, 1996, ANN ANAT, V178, P485, DOI 10.1016/S0940-9602(96)80102-6; Leito JTD, 2011, MOL IMMUNOL, V49, P185, DOI 10.1016/j.molimm.2011.08.010; Lokki AI, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00312; Lynch AM, 2010, PLACENTA, V31, P561, DOI 10.1016/j.placenta.2010.03.010; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; MALHOTRA R, 1994, IMMUNOLOGY, V82, P439; Meri S, 1998, VOX SANG, V74, P291, DOI 10.1111/j.1423-0410.1998.tb05434.x; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Mollenhauer J, 2001, CANCER RES, V61, P8880; Mollenhauer J, 2000, CANCER RES, V60, P1704; Muller H, 2013, CARDIOVASC PATHOL, V22, P195, DOI 10.1016/j.carpath.2012.10.006; Muller H, 2012, ARTERIOSCL THROM VAS, V32, P442, DOI 10.1161/ATVBAHA.111.239830; Muller H, 2009, J THORAC CARDIOV SUR, V138, P725, DOI 10.1016/j.jtcvs.2009.05.021; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; NELSON DM, 1990, AM J PATHOL, V136, P855; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Reichhardt MP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00205; Reichhardt MP, 2014, J IMMUNOL, V193, P5240, DOI 10.4049/jimmunol.1401631; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; ROMERO R, 1989, AM J PERINAT, V6, P32, DOI 10.1055/s-2007-999540; Rose SL, 2005, J BIOMED MATER RES A, V72A, P269, DOI 10.1002/jbm.a.30222; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Rossez Y, 2011, BIOCHIMIE, V93, P593, DOI 10.1016/j.biochi.2010.12.002; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020; Schulz BL, 2002, BIOCHEM J, V366, P511, DOI 10.1042/BJ20011876; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439; Vijayakumar S, 2006, J CELL SCI, V119, P4797, DOI 10.1242/jcs.03269; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2	48	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147867	10.1371/journal.pone.0147867	http://dx.doi.org/10.1371/journal.pone.0147867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828433	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200039
J	Shrestha, R; Pant, ND; Ganga, GC; Thapa, S; Neupane, B; Shah, Y; Gautam, I; Pandey, BD				Shrestha, Rojina; Pant, Narayan Dutt; Ganga, G. C.; Thapa, Srinivas; Neupane, Biswas; Shah, Yogendra; Gautam, Ishan; Pandey, Basu Dev			Serological and Entomological Study of Dengue in Dang and Chitwan Districts of Nepal	PLOS ONE			English	Article							LARVAE; VIRUS	A descriptive cross-sectional study was carried out among 264 suspected dengue patients in two districts (Dang and Chitwan) of Nepal from June 2013 to November 2013. The anti-dengue IgM positivity was found to be (51/264) 19.31% by capture ELISA, of which 21 (41.2%) were male and 30 (58.8%) were female. Symptoms of seropositive cases were fever, anorexia, nausea, headache, retro-orbital pain, skin rashes, and myalgia. Hematological features like thrombocytopenia and leucopenia were found to be significantly associated with the dengue fever (DF). Discarded tires were found as the commonest breeding habitats for the dengue vectors. Higher sero-positivity was recorded from the area having higher Breteau index (BI). The pH, chloride ion concentration and the salinity of the water from breeding habitats were found to be ranging from 6.9+/-0.82 to 8, 103.33+/-17.52 mg/L to 140.65 mg/L, and 0.19+/-0.032 ppt to 0.25 ppt respectively. This study may be helpful for the health authorities and public health workers for early diagnosis of DF and for the improved preventive measures to be adopted in the epidemic and possible epidemic areas.	[Shrestha, Rojina; Ganga, G. C.; Thapa, Srinivas] Dept Microbiol, Trichandra Multiple Campus, Kathmandu, Nepal; [Pant, Narayan Dutt] Grande Int Hosp, Dept Microbiol, Kathmandu, Nepal; [Neupane, Biswas; Shah, Yogendra; Pandey, Basu Dev] Everest Int Clin & Res Ctr, Kathmandu, Nepal; [Gautam, Ishan] Tribhuvan Univ, Inst Sci & Technol, Nat Hist Museum, Kathmandu, Nepal	Tribhuvan University; Institute of Science & Technology (IoST) - Nepal	Pant, ND (corresponding author), Grande Int Hosp, Dept Microbiol, Kathmandu, Nepal.	ndpant1987@gmail.com	Shah, Yogendra/AAU-7395-2020	Shah, Yogendra/0000-0002-0820-4556				Bijaya Gaire, 2014, Dengue Bulletin, V38, P96; BRADLEY TJ, 1987, ANNU REV ENTOMOL, V32, P439, DOI 10.1146/annurev.en.32.010187.002255; Clark TM, 2004, J EXP BIOL, V207, P2297, DOI 10.1242/jeb.01021; Collins DL, 1970, AM MOSQ CONTROL ASS, V5, P190; de Souza LJ, 2013, BRAZ J INFECT DIS, V17, P27, DOI 10.1016/j.bjid.2012.08.020; Epidemiology and Disease Control Division (EDCD), 2008, ANN REP 2006 2007; Glenn SS, 2012, DENGUE B, P26; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gupta BP, 2013, INT J APPL SCI BIOTE, V1, P224; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Honda S, 2009, AM J TROP MED HYG, V80, P841, DOI 10.4269/ajtmh.2009.80.841; Khan H, 2011, GOMAL J MED SCI, V9, P143; Mahilum MM, 2005, J VECTOR ECOL, V30, P277; Nguyen H, 2010, AM J PHYSIOL-REG I, V299, pR762, DOI 10.1152/ajpregu.00745.2009; Organization WH, 2009, DENG GUID DIAGN TRAT; Pancharoen C, 2001, J MED ASS THAI, V85, P25; Pandey BD, 2008, EMERG INFECT DIS, V14, P514, DOI 10.3201/eid1403.070473; Pandey Basu Dev, 2004, Nepal Med Coll J, V6, P157; Poudel A, 2012, Nepal Med Coll J, V14, P114; Sah OP, 2009, J NEPAL HLTH RES COU, V7, P29; SHAH Y, 2012, INT J INFECT MICROBI, V1, P58; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Singh R. K., 2008, Journal of Vector Borne Diseases, V45, P170; Umar A., 2008, INT J PURE APPL SCI, V2, P58; World Health Organisation, 2011, WAT SAMPL AND AN; World Health Organization, 2012, DENG SEV DENG	28	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147953	10.1371/journal.pone.0147953	http://dx.doi.org/10.1371/journal.pone.0147953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828951	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200046
J	Soans, RE; Lim, DC; Keenan, BT; Pack, AI; Shackleford, JA				Soans, Rajath E.; Lim, Diane C.; Keenan, Brendan T.; Pack, Allan I.; Shackleford, James A.			Automated Protein Localization of Blood Brain Barrier Vasculature in Brightfield IHC Images	PLOS ONE			English	Article							TRANSPORTERS; RECEPTORS; DELIVERY; TISSUE; PERMEABILITY; EXPRESSION; PROTEOMICS; SIRNA	In this paper, we present an objective method for localization of proteins in blood brain barrier (BBB) vasculature using standard immunohistochemistry (IHC) techniques and bright-field microscopy. Images from the hippocampal region at the BBB are acquired using bright-field microscopy and subjected to our segmentation pipeline which is designed to automatically identify and segment microvessels containing the protein glucose transporter 1 (GLUT1). Gabor filtering and k-means clustering are employed to isolate potential vascular structures within cryosectioned slabs of the hippocampus, which are subsequently subjected to feature extraction followed by classification via decision forest. The false positive rate (FPR) of microvessel classification is characterized using synthetic and non-synthetic IHC image data for image entropies ranging between 3 and 8 bits. The average FPR for synthetic and non-synthetic IHC image data was found to be 5.48% and 5.04%, respectively.	[Soans, Rajath E.; Shackleford, James A.] Drexel Univ, Dept Elect Engn, Philadelphia, PA 19104 USA; [Lim, Diane C.; Pack, Allan I.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Keenan, Brendan T.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA	Drexel University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Shackleford, JA (corresponding author), Drexel Univ, Dept Elect Engn, Philadelphia, PA 19104 USA.	shack@drexel.edu	Soans, Rajath/GOG-8978-2022	Soans, Rajath/0000-0002-2579-1510; Pack, Allan/0000-0002-2879-0484; Shackleford, James/0000-0002-7987-651X	NIH [T32HL07713, K12 HL090021, HL094307]; American Sleep Medicine Foundation [ASMF 56-PA-10]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007713, P01HL094307, K12HL090021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Sleep Medicine Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants T32HL07713 and K12 HL090021; American Sleep Medicine Foundation (Physician Scientist Training Award), ASMF 56-PA-10; and NIH grant HL094307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2012, DRUG METAB DISPOS, V40, P1164, DOI 10.1124/dmd.112.044719; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Criminisi A., 2011, MSRTR2011114, V5, P12; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; DILLENCOURT MB, 1992, J ACM, V39, P253, DOI 10.1145/128749.128750; Haghighat Mohammad, 2013, Computer Analysis of Images and Patterns. 15th International Conference, CAIP 2013. Proceedings: LNCS 8048, P440, DOI 10.1007/978-3-642-40246-3_55; Hawkins BT, 2005, AM J PHYSIOL-HEART C, V289, pH212, DOI 10.1152/ajpheart.01210.2004; Hoshi Y, 2013, J PHARM SCI-US, V102, P3343, DOI 10.1002/jps.23575; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Nicklay JJ, 2013, ANAL CHEM, V85, P7191, DOI 10.1021/ac400902h; Steven RT, 2013, ANAL BIOANAL CHEM, V405, P4719, DOI 10.1007/s00216-013-6899-9; Sturm RM, 2013, ANAL METHODS-UK, V5, P1623, DOI 10.1039/c3ay26067d; Swinehart D., 1962, J CHEM ED, V39, DOI [10.1021/ed039p333, DOI 10.1021/ED039P333]; Ting CY, 2012, BIOMATERIALS, V33, P704, DOI 10.1016/j.biomaterials.2011.09.096; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Yousif S, 2007, BRAIN RES, V1134, P1, DOI 10.1016/j.brainres.2006.11.089; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	23	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148411	10.1371/journal.pone.0148411	http://dx.doi.org/10.1371/journal.pone.0148411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828723	Green Published, gold			2022-12-27	WOS:000369548200099
J	Thieme, S; Muhldorfer, K; Luschow, D; Hafez, HM				Thieme, Susann; Muehldorfer, Kristin; Lueschow, Doerte; Hafez, Hafez M.			Molecular Characterization of the Recently Emerged Poultry Pathogen Ornithobacterium rhinotracheale by Multilocus Sequence Typing	PLOS ONE			English	Article							GENETIC DIVERSITY; CHICKENS; SCHEME; INFECTION; IDENTIFICATION	Ornithobacterium rhinotracheale (ORT) is an economically important bacterial pathogen of turkeys and chickens worldwide. Since its first detection, a variety of typing methods have been used to gain basic knowledge about the bacterial population structure, an issue that still needs to be addressed. Serological characterization revealed at least 18 different serotypes (A-R) with ORT of serotype A to be predominate among poultry. This study aimed to establish a multilocus sequence typing (MLST) scheme for ORT that could easily be used by other laboratories and allows for worldwide comparison of sequence data. For this purpose, 87 ORT strains from different poultry hosts, geographical origins, years of isolation and serotypes were included in the analysis to identify correlations. Fourteen different sequence types (ST) were found. The most common ST1 was identified in 40 ORT strains from turkeys and chickens on 4 continents and in 3 different European countries. Together with ST9, both STs represented over three quarters (77%) of ORT strains used in the MLST analysis and included strains of frequently cross-reacting ORT serotypes A, E and I. Nine STs were only represented by one ORT strain and might indicate possible avian host, disease or serotype-specific relationships. In contrast, discrepancies between serotype and phylogenetic relatedness were clearly demonstrated by ORT strains that belonged to identical serotypes but differed in their ST. The overall identified low genetic diversity among strains isolated from turkeys and chickens independent of host and geographical origins suggests that ORT has only recently been introduced into domestic poultry and dispersed worldwide.	[Thieme, Susann; Muehldorfer, Kristin; Lueschow, Doerte; Hafez, Hafez M.] Free Univ Berlin, Inst Poultry Dis, Berlin, Germany; [Muehldorfer, Kristin] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany	Free University of Berlin; Leibniz Institut fur Zoo und Wildtierforschung	Thieme, S (corresponding author), Free Univ Berlin, Inst Poultry Dis, Berlin, Germany.	Susann.Thieme@fu-berlin.de		Langforth, Susann/0000-0001-8037-8481				Amonsin A, 1997, J CLIN MICROBIOL, V35, P2894, DOI 10.1128/JCM.35.11.2894-2898.1997; Canal CW, 2005, RES VET SCI, V78, P225, DOI 10.1016/j.rvsc.2004.10.003; Chin R. P., 2013, DIS POULTRY, P828; Coffey TJ, 2006, APPL ENVIRON MICROB, V72, P1420, DOI 10.1128/AEM.72.2.1420-1428.2006; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hafez H. M., 2002, International Journal of Poultry Science, V1, P114; Hafez Hafez Mohamed, 2010, Avian Dis, V54, P161, DOI 10.1637/9008-080309-Case.1; Hafez HM, 1999, AVIAN DIS, V43, P1, DOI 10.2307/1592755; Hafez HM, 1993, INT C POULTR DIS; Han JE, 2013, NEW MICROBIOL, V36, P395; Hung AL, 2001, AVIAN DIS, V45, P999, DOI 10.2307/1592880; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Leroy-Setrin S, 1998, LETT APPL MICROBIOL, V26, P189, DOI 10.1046/j.1472-765X.1998.00315.x; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Marien M, 2005, AVIAN PATHOL, V34, P204, DOI 10.1080/03079450500096414; Numee S, 2012, AVIAN DIS, V56, P654, DOI 10.1637/10079-021412-Reg.1; Ozbey G, 2005, VET MED-CZECH, V50, P526, DOI 10.17221/5660-VETMED; Pan Q, 2012, AVIAN DIS, V56, P680, DOI 10.1637/10109-030112-Reg.1; Pan Q, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-104; Popp C, 2003, THESIS FREIE U BERLI; Ruiz-Garbajosa P, 2006, J CLIN MICROBIOL, V44, P2220, DOI 10.1128/JCM.02596-05; Sakai E, 2000, VET REC, V146, P502, DOI 10.1136/vr.146.17.502; Schuijffel DF, 2005, INFECT IMMUN, V73, P6812, DOI 10.1128/IAI.73.10.6812-6821.2005; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Subaaharan S, 2010, VET MICROBIOL, V141, P354, DOI 10.1016/j.vetmic.2010.01.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai HJ, 2006, AVIAN DIS, V50, P502, DOI 10.1637/7527-031906R.1; Van Empel P, 1998, THESIS U UTRECHT; van Veen L, 2004, AVIAN DIS, V48, P233, DOI 10.1637/7012; VANDAMME P, 1994, INT J SYST BACTERIOL, V44, P24, DOI 10.1099/00207713-44-1-24; vanEmpel P, 1996, AVIAN DIS, V40, P858, DOI 10.2307/1592310; vanEmpel P, 1997, J CLIN MICROBIOL, V35, P418, DOI 10.1128/JCM.35.2.418-421.1997; Waldow K, 2009, THESIS FREIE U BERLI; Welchman DD, 2013, AVIAN PATHOL, V42, P171, DOI 10.1080/03079457.2013.778387	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148158	10.1371/journal.pone.0148158	http://dx.doi.org/10.1371/journal.pone.0148158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829551	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200073
J	Volkmann, RA; Fanger, CM; Anderson, DR; Sirivolu, VR; Paschetto, K; Gordon, E; Virginio, C; Gleyzes, M; Buisson, B; Steidl, E; Mierau, SB; Fagiolini, M; Menniti, FS				Volkmann, Robert A.; Fanger, Christopher M.; Anderson, David R.; Sirivolu, Venkata Ramana; Paschetto, Kathy; Gordon, Earl; Virginio, Caterina; Gleyzes, Melanie; Buisson, Bruno; Steidl, Esther; Mierau, Susanna B.; Fagiolini, Michela; Menniti, Frank S.			MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; GRIN2A MUTATIONS; ANTAGONISTS; EXPRESSION; METAPLASTICITY; SCHIZOPHRENIA; DIVERSITY; EPILEPSY; APHASIA; NR2A	GluN2A is the most abundant of the GluN2 NMDA receptor subunits in the mammalian CNS. Physiological and genetic evidence implicate GluN2A-containing receptors in susceptibility to autism, schizophrenia, childhood epilepsy and neurodevelopmental disorders such as Rett Syndrome. However, GluN2A-selective pharmacological probes to explore the therapeutic potential of targeting these receptors have been lacking. Here we disclose a novel series of pyrazine-containing GluN2A antagonists exemplified byMPX-004 (5-(((3-chloro-4-fluorophenyl) sulfonamido) methyl)-N-((2-methylthiazol-5-yl) methyl) pyrazine-2-carboxamide) and MPX007 (5-(((3-fluoro-4-fluorophenyl) sulfonamido) methyl)-N-((2-methylthiazol-5-yl) methyl) methylpyrazine-2-carboxamide). MPX-004 and MPX-007 inhibit GluN2A-containing NMDA receptors expressed in HEK cells with IC(50)s of 79 nM and 27 nM, respectively. In contrast, at concentrations that completely inhibited GluN2A activity these compounds have no inhibitory effect on GluN2B or GluN2D receptor-mediated responses in similar HEK cell-based assays. Potency and selectivity were confirmed in electrophysiology assays in Xenopus oocytes expressing GluN2A-D receptor subtypes. Maximal concentrations of MPX-004 and MPX-007 inhibited similar to 30% of the whole-cell current in rat pyramidal neurons in primary culture and MPX-004 inhibited similar to 60% of the total NMDA receptor-mediated EPSP in rat hippocampal slices. GluN2A-selectivity at native receptors was confirmed by the finding that MPX-004 had no inhibitory effect on NMDA receptor mediated synaptic currents in cortical slices from GRIN2A knock out mice. Thus, MPX-004 and MPX-007 offer highly selective pharmacological tools to probe GluN2A physiology and involvement in neuropsychiatric and developmental disorders.	[Volkmann, Robert A.; Fanger, Christopher M.; Anderson, David R.; Menniti, Frank S.] Mnemosyne Pharmaceut Inc Luc Therapeut, 400 Technol Sq, Cambridge, MA 02139 USA; [Sirivolu, Venkata Ramana] Jubilant Biosys Ltd, 96 Ind Suburb 2nd Stage, Bangalore 560022, Karnataka, India; [Paschetto, Kathy; Gordon, Earl] Jubilant Discovery Serv Inc, 365 Phoenixville Pike, Malvern, PA 19355 USA; [Virginio, Caterina] Aptuit Med Res Ctr, Via Fleming 4, I-37135 Verona, Italy; [Gleyzes, Melanie; Buisson, Bruno; Steidl, Esther] Domaine St Hilaire, Neuroserv, 595 Rue Pierre Berthier,CS 30531, F-13593 Aix En Provence 03, France; [Mierau, Susanna B.; Fagiolini, Michela] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA	Jubilant Biosys Limited; Harvard University; Boston Children's Hospital	Menniti, FS (corresponding author), Mnemosyne Pharmaceut Inc Luc Therapeut, 400 Technol Sq, Cambridge, MA 02139 USA.	mennitifs@gmail.com		fagiolini, michela/0000-0003-2807-803X; Menniti, Frank/0000-0003-2612-9534; Mierau, Susanna/0000-0002-1220-6423; Fanger, Christopher/0000-0002-8268-9053	Mnemosyne Pharmaceuticals Inc.; Rett Syndrome Research Trust	Mnemosyne Pharmaceuticals Inc.; Rett Syndrome Research Trust	This work was funded by Mnemosyne Pharmaceuticals Inc. who provided support in the form of salaries for authors RAV, CMF, FSM, and DRA. These authors participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript as part of their duties as Mnemosyne employees. VRS, KP, EG, CV, MG, RB, and ES are employees of Jubilant Biosys Limited, Jubilant Discovery Services, Inc., Aptuit Medicines Research Centre, and Neuroservice. Each of these authors participated in the research under contract between their respective employers and Mnemosyne Pharmaceuticals. The work of SBM and MF was funded by a grant from the Rett Syndrome Research Trust. These authors participated in the study design, data collection and analysis, and preparation of the manuscript, but did not participate in the decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson DR, 2015, US Patent, Patent No. [20,150,141,433, 20150141433]; Barnby G, 2005, AM J HUM GENET, V76, P950, DOI 10.1086/430454; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bettini E, 2010, J PHARMACOL EXP THER, V335, P636, DOI 10.1124/jpet.110.172544; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy SG, 2004, SCI STKE, V2004, P16; Dupuis DS, 2005, BASIC CLIN PHARMACOL, V96, P123, DOI 10.1111/j.1742-7843.2005.pto960206.x; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Edman S, 2012, NEUROPHARMACOLOGY, V63, P441, DOI 10.1016/j.neuropharm.2012.04.027; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gardoni F, 2012, NEUROBIOL AGING, V33, P2138, DOI 10.1016/j.neurobiolaging.2011.06.019; Gipson CD, 2013, P NATL ACAD SCI USA, V110, P9124, DOI 10.1073/pnas.1220591110; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Hallett PJ, 2005, NEUROPHARMACOLOGY, V48, P503, DOI 10.1016/j.neuropharm.2004.11.008; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Hansen KB, 2012, J NEUROSCI, V32, P6197, DOI 10.1523/JNEUROSCI.5757-11.2012; Hansen KB, 2010, J PHARMACOL EXP THER, V333, P650, DOI 10.1124/jpet.110.166256; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI 10.1016/j.brainresbull.2010.04.006; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Layton ME, 2006, CURR TOP MED CHEM, V6, P697, DOI 10.2174/156802606776894447; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Mierau SB, 2016, BIOL PSYCHIAT, V79, P746, DOI 10.1016/j.biopsych.2015.05.018; Monaghan DT, 2012, NEUROCHEM INT, V61, P581, DOI 10.1016/j.neuint.2012.01.004; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1038/sj.npp.1380292; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Small D, GLUTAMATE RECEPTOR P, P27; Soares C, 2013, J NEUROSCI, V33, P14975, DOI 10.1523/JNEUROSCI.3109-13.2013; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; Steidl EM, 2006, BRAIN RES, V1096, P70, DOI 10.1016/j.brainres.2006.04.034; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wu F, 2013, MOL CELL NEUROSCI, V52, P9, DOI 10.1016/j.mcn.2012.10.001; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zhou Q, 2013, NEUROPHARMACOLOGY, V74, P69, DOI 10.1016/j.neuropharm.2013.03.030	56	37	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148129	10.1371/journal.pone.0148129	http://dx.doi.org/10.1371/journal.pone.0148129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829109	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200068
J	Esponda, F; Huerta, K; Guerrero, VM				Esponda, Fernando; Huerta, Kael; Guerrero, Victor M.			A Statistical Approach to Provide Individualized Privacy for Surveys	PLOS ONE			English	Article							RANDOMIZED-RESPONSE	In this paper we propose an instrument for collecting sensitive data that allows for each participant to customize the amount of information that she is comfortable revealing. Current methods adopt a uniform approach where all subjects are afforded the same privacy guarantees; however, privacy is a highly subjective property with intermediate points between total disclosure and non-disclosure: each respondent has a different criterion regarding the sensitivity of a particular topic. The method we propose empowers respondents in this respect while still allowing for the discovery of interesting findings through the application of well-known inferential procedures.	[Esponda, Fernando] Inst Tecnol Autonomo Mexico, Dept Comp Sci, Mexico City, DF, Mexico; [Huerta, Kael; Guerrero, Victor M.] Inst Tecnol Autonomo Mexico, Dept Stat, Mexico City, DF, Mexico	Instituto Tecnologico Autonomo de Mexico; Instituto Tecnologico Autonomo de Mexico	Esponda, F (corresponding author), Inst Tecnol Autonomo Mexico, Dept Comp Sci, Mexico City, DF, Mexico.	fernando.esponda@itam.mx	Guerrero, Victor M./G-1986-2019	Guerrero, Victor M./0000-0003-2184-5216	Asociacion Mexican de Cultura A.C.	Asociacion Mexican de Cultura A.C.	This work was supported by Asociacion Mexican de Cultura A.C.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; [Anonymous], 1997, GRAPHIC UCG VISUALIZ; Aoki S., 2012, Proceedings of the 2012 IEEE 1st International Conference on Cloud Networking (CLOUDNET 2012), P158, DOI 10.1109/CloudNet.2012.6483674; Aoki S, 2014, IEICE T COMMUN, VE97B, P721, DOI 10.1587/transcom.E97.B.721; Bao YF, 2014, STAT PROBABIL LETT, V89, P31, DOI 10.1016/j.spl.2014.02.011; Bao YF, 2013, STAT PROBABIL LETT, V83, P551, DOI 10.1016/j.spl.2012.10.032; Basharat I., 2012, INT J COMPUT APPL, V47, P28, DOI [10.5120/7242-0218, DOI 10.5120/7242-0218]; Ben Othman Sofiene, 2013, International Journal of Mobile Network Design and Innovation, V5, P28, DOI 10.1504/IJMNDI.2013.057146; Chaudhuri A., 2013, INDIRECT QUESTIONING, DOI DOI 10.1007/978-3-642-36276-7; Chaudhuri A., 1988, RANDOMIZED RESPONSE; Di Pietro R, 2011, COMPUT COMMUN, V34, P515, DOI 10.1016/j.comcom.2010.05.014; Droitcour J, 2001, P ANN M AM STAT ASS, P1; Esponda F, 2009, STAT PROBABIL LETT, V79, P2456, DOI 10.1016/j.spl.2009.08.019; Feigenbaum J, 2004, EU WORKSH SEC MULT C; Glynn AN, 2013, PUBLIC OPIN QUART, V77, P159, DOI 10.1093/poq/nfs070; Groat MM, 2012, INT CONF PERVAS COMP, P144, DOI 10.1109/PerCom.2012.6199861; Krumm J, 2009, PERS UBIQUIT COMPUT, V13, P391, DOI 10.1007/s00779-008-0212-5; KULIK L, 2009, ACM SIGSPATIAL SPECI, V1, P9; Machanavajjhala A., 2006, P 22 INT C DAT ENG I, P24, DOI DOI 10.1109/ICDE.2006.1; Mun M, 2010, P 6 INT C, P17; RAGHAVARAO D, 1979, J ROY STAT SOC B MET, V41, P40; Ran Liu, 2015, Advances in Swarm and Computational Intelligence. 6th International Conference, ICSI 2015 held in conjunction with the Second BRICS Congress, CCI 2015. Proceedings: LNCS 9141, P151, DOI 10.1007/978-3-319-20472-7_17; Schneier B., 1994, APPL CRYPTOGRAPHY PR; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Trappmann M, 2013, J SURVEY STAT METHOD; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137	26	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147314	10.1371/journal.pone.0147314	http://dx.doi.org/10.1371/journal.pone.0147314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824758	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600023
J	Hsiao, SM; Lin, HH; Kuo, HC				Hsiao, Sheng-Mou; Lin, Ho-Hsiung; Kuo, Hann-Chorng			Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome	PLOS ONE			English	Article							BOTULINUM-A TOXIN; IDIOPATHIC DETRUSOR OVERACTIVITY; URINARY-INCONTINENCE; OUTLET OBSTRUCTION; URGENCY SEVERITY; SYMPTOMS; P2X(3)	Objectives To analyze the predictors of therapeutic efficacy after intravesical botulinum toxin A injection for overactive bladder syndrome (OAB) refractory to antimuscarinic therapy. Methods All consecutively OAB patients, who visited the urologic outpatient clinics of a medical center and refractory to antimuscarinic treatment, were prospectively enrolled. All enrolled patients received intravesical injection of 100 U onabotulinumtoxinA (Botox). The Global Response Assessment (GRA) score >= 2 at 3 months after Botox injection was defined as a successful treatment, otherwise failed. Results Overall, 89 patients received intravesical injection. Eighty patients, including 42 men and 38 women, had received follow-up at 3 months. The overall success rate was 63.8%. The global response assessment, urgency severity score, urgency, urgency urinary incontinence and frequency episodes, and functional bladder capacity improved after treatment. However, post-void residual volume (PVR) increased, and voiding efficiency (VE) decreased after treatment. Female gender (odds ratio = 3.75) was the only independent factor associated with the success. Female gender (coefficient = 0.74), low baseline overactive bladder symptoms score (coefficient = -0.12) and the presence of OAB-wet (coefficient = 0.79) were independent factors associated with therapeutic efficacy (i.e., GRA score). VE (odds ratio = 0.062) was the only predictor for a large PVR at 3 months. The optimum cutoff value of VE was <87% with the area under the ROC curve being 0.64 (sensitivity = 63.8%, specificity = 57.1%). Conclusions The therapeutic effects of Botox can persist till 6 months after treatment. Female gender, low overactive bladder symptoms score and OAB-wet are associated better therapeutic efficacy, and low baseline VE is associated with large PVR. These findings can serve as an initial guide or assist in consultation regarding the treatment of OAB patients with Botox injection.	[Hsiao, Sheng-Mou] Far Eastern Mem Hosp, Dept Obstet & Gynecol, New Taipei, Taiwan; [Lin, Ho-Hsiung] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.; Kuo, HC (corresponding author), Tzu Chi Univ, Hualien, Taiwan.	hck@tzuchi.com.tw		LIN, HO-HSIUNG/0000-0001-7370-9545				Abrams P, 1999, BJU INT, V84, P14; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Apostolidis A, 2005, J UROLOGY, V174, P977, DOI 10.1097/01.ju.0000169481.42259.54; Brubaker L, 2008, J UROLOGY, V180, P217, DOI 10.1016/j.juro.2008.03.028; Chapple CR, 2000, UROLOGY, V55, P33, DOI 10.1016/S0090-4295(99)00492-6; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Hsiao SM, 2014, NEUROUROL URODYNAM, V33, P331, DOI 10.1002/nau.22394; Jiang YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091609, 10.1371/journal.pone.0093563, 10.1371/journal.pone.0105989]; Kessler TM, 2005, NEUROUROL URODYNAM, V24, P231, DOI 10.1002/nau.20105; Kuo HC, 2012, J FORMOS MED ASSOC, V111, P386, DOI 10.1016/j.jfma.2011.05.014; Kuo HC, 2011, NEUROUROL URODYNAM, V30, P1497, DOI 10.1002/nau.21132; Kuo HC, 2005, UROLOGY, V66, P1005, DOI 10.1016/j.urology.2005.05.047; Kuo HC, 2004, UROLOGY, V63, P868, DOI 10.1016/j.urology.2003.12.007; Kuo HC, 2005, UROLOGY, V66, P94, DOI 10.1016/j.urology.2005.02.002; Makovey I, 2011, NEUROUROL URODYNAM, V30, P1538, DOI 10.1002/nau.21150; Nixon A, 2005, J UROLOGY, V174, P604, DOI 10.1097/01.ju.0000165461.38088.7b; Osborn DJ, 2015, NEUROUROL URODYNAM, V34, P675, DOI 10.1002/nau.22642; Popat R, 2005, J UROLOGY, V174, P984, DOI 10.1097/01.ju.0000169480.43557.31; Rajkumar GN, 2005, BJU INT, V96, P848, DOI 10.1111/j.1464-410X.2005.05725.x; RESNICK NM, 1987, JAMA-J AM MED ASSOC, V257, P3076, DOI 10.1001/jama.257.22.3076; Sahai A, 2007, J UROLOGY, V177, P2231, DOI 10.1016/j.juro.2007.01.130; Sievert KD, 2014, INT J CLIN PRACT, V68, P1246, DOI 10.1111/ijcp.12443; SIMPSON LL, 1980, J PHARMACOL EXP THER, V212, P16; Wagg A, 2012, BJU INT, V110, P1767, DOI 10.1111/j.1464-410X.2012.11023.x; Werner M, 2005, AM J OBSTET GYNECOL, V192, P1735, DOI 10.1016/j.ajog.2004.11.052; Yiangou Y, 2001, BJU INT, V87, P774, DOI 10.1046/j.1464-410x.2001.02190.x	26	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147137	10.1371/journal.pone.0147137	http://dx.doi.org/10.1371/journal.pone.0147137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824901	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600017
J	Miller, RB; Sadek, A; Rodriguez, A; Iannuzzi, M; Giai, C; Senko, JM; Monty, CN				Miller, Robert Bertram, II; Sadek, Anwar; Rodriguez, Alvaro; Iannuzzi, Mariano; Giai, Carla; Senko, John M.; Monty, Chelsea N.			Use of an Electrochemical Split Cell Technique to Evaluate the Influence of Shewanella oneidensis Activities on Corrosion of Carbon Steel	PLOS ONE			English	Article							MICROBIOLOGICALLY INFLUENCED CORROSION; MICROBIAL IRON RESPIRATION; DESULFOVIBRIO-VULGARIS; MILD-STEEL; INHIBITION; BACTERIA; BIOFILM; 304-STAINLESS-STEEL	Microbially induced corrosion (MIC) is a complex problem that affects various industries. Several techniques have been developed to monitor corrosion and elucidate corrosion mechanisms, including microbiological processes that induce metal deterioration. We used zero resistance ammetry (ZRA) in a split chamber configuration to evaluate the effects of the facultatively anaerobic Fe(III) reducing bacterium Shewanella oneidensis MR-1 on the corrosion of UNS G10180 carbon steel. We show that activities of S. oneidensis inhibit corrosion of steel with which that organism has direct contact. However, when a carbon steel coupon in contact with S. oneidensis was electrically connected to a second coupon that was free of biofilm (in separate chambers of the split chamber assembly), ZRA-based measurements indicated that current moved from the S. oneidensis-containing chamber to the cell-free chamber. This electron transfer enhanced the O-2 reduction reaction on the coupon deployed in the cell free chamber, and consequently, enhanced oxidation and corrosion of that electrode. Our results illustrate a novel mechanism for MIC in cases where metal surfaces are heterogeneously covered by biofilms.	[Miller, Robert Bertram, II; Senko, John M.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Miller, Robert Bertram, II; Senko, John M.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Sadek, Anwar; Rodriguez, Alvaro; Iannuzzi, Mariano; Monty, Chelsea N.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Giai, Carla; Senko, John M.] Univ Akron, Dept Geosci, Akron, OH 44325 USA; [Iannuzzi, Mariano; Giai, Carla] Gen Elect, Eyvind Lyches Vei 10,POB 423, NO-1338 Sandvika, Norway	University System of Ohio; University of Akron; University System of Ohio; University of Akron; University System of Ohio; University of Akron; University System of Ohio; University of Akron; General Electric	Monty, CN (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	cm78@uakron.edu	Iannuzzi, Mariano/A-6548-2016	Iannuzzi, Mariano/0000-0001-9202-3696	US Department of Defense Office of Corrosion Policy and Oversight; US Air Force Academy [FY11-TCC 9, FY12-TCC4]	US Department of Defense Office of Corrosion Policy and Oversight(United States Department of Defense); US Air Force Academy(United States Department of Defense)	This work was supported by the US Department of Defense Office of Corrosion Policy and Oversight and the US Air Force Academy (FY11-TCC 9 and FY12-TCC4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Shewanella oneidensis MR-1 was provided by Dr. Yuri Gorby (Rensselaer Polytechnic Institute). This work was supported by the US Department of Defense Office of Corrosion Policy and Oversight and the US Air Force Academy (FY11-TCC 9 and FY12-TCC4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAbbas FM, 2013, INT BIODETER BIODEGR, V78, P34, DOI 10.1016/j.ibiod.2012.10.014; [Anonymous], 2014, E155809 ASTM; [Anonymous], 2017, G103 ASTM; Baron D, 2009, J BIOL CHEM, V284, P28865, DOI 10.1074/jbc.M109.043455; Beech I.B., 2014, UNDERSTANDING BIOCOR, P33; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Belkaid S, 2012, RES CHEM INTERMEDIAT, V38, P2309, DOI 10.1007/s11164-012-0547-4; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Brennenstuhl AM, 1994, AM SOC TEST MATER, P15; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Chen YJ, 2015, CORROS SCI, V90, P89, DOI 10.1016/j.corsci.2014.09.016; Cote C, 2015, CORROS SCI, V94, P104, DOI 10.1016/j.corsci.2015.01.044; Cottis RA, 2000, NEW TRENDS ELECTROCH, P247; DAUMAS S, 1988, CORROS SCI, V28, P1041, DOI 10.1016/0010-938X(88)90100-X; Davis J.R., 2000, CORROSION UNDERSTAND; De Windt W, 2003, ENVIRON MICROBIOL, V5, P1192, DOI 10.1046/j.1462-2920.2003.00527.x; Dong ZH, 2011, CORROS SCI, V53, P2978, DOI 10.1016/j.corsci.2011.05.041; Dubiel M, 2002, APPL ENVIRON MICROB, V68, P1440, DOI 10.1128/AEM.68.3.1440-1445.2002; Dzierzewicz Z, 1997, RES MICROBIOL, V148, P785, DOI 10.1016/S0923-2508(97)82454-0; Enning D, 2014, APPL ENVIRON MICROB, V80, P1226, DOI 10.1128/AEM.02848-13; Flemming HC, 1996, MICROBIALLY INFLUENCED CORROSION OF MATERIALS, P5; FORD T, 1990, ADV MICROB ECOL, V11, P231; He Z, 2009, ENERG ENVIRON SCI, V2, P215, DOI 10.1039/b814914c; Iannuzzi M, 2007, ELECTROCHIM ACTA, V52, P4032, DOI 10.1016/j.electacta.2006.11.019; Ismail KM, 1999, ELECTROCHIM ACTA, V44, P4685, DOI 10.1016/S0013-4686(99)00218-2; Herrera LK, 2009, INT BIODETER BIODEGR, V63, P891, DOI 10.1016/j.ibiod.2009.06.003; Kip N, 2015, ISME J, V9, P542, DOI 10.1038/ismej.2014.169; Koch G. H., 2002, FHWARD01156, DOI DOI 10.1097/JCE.0B013E3181FB9A65; Lee AK, 2003, APPL MICROBIOL BIOT, V62, P134, DOI 10.1007/s00253-003-1314-7; Lenhart TR, 2014, BIOFOULING, V30, P823, DOI 10.1080/08927014.2014.931379; Li XX, 2015, CORROS SCI, V90, P331, DOI 10.1016/j.corsci.2014.10.028; Lin J, 2015, J BASIC MICROB, V55, P1; Little B, 1998, BIODEGRADATION, V9, P1, DOI 10.1023/A:1008264313065; Little BJ, 2013, RECENT PATENTS MAT S, V6, P20; Little BJ, 2011, NRLPP7303100367; Little BJ., 2007, MICROBIOLOGICALLY IN; MANSFELD F, 1991, CORROS SCI, V32, P247, DOI 10.1016/0010-938X(91)90072-W; Mansfeld F, 2003, MATER CORROS, V54, P489, DOI 10.1002/maco.200390111; MANSFELD F, 1993, J ELECTROCHEM SOC, V140, P2205, DOI 10.1149/1.2220796; McLean JS, 2010, ENVIRON SCI TECHNOL, V44, P2721, DOI 10.1021/es903043p; Moradi M, 2015, ELECTROCHEM COMMUN, V51, P64, DOI 10.1016/j.elecom.2014.12.007; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Pastore T, 2011, MATER CORROS, V62, P187, DOI 10.1002/maco.201005789; Potekhina JS, 1999, APPL MICROBIOL BIOT, V52, P639, DOI 10.1007/s002530051571; Rutala W.A., 2019, GUIDELINE DISINFECTI; Stadler R, 2008, ELECTROCHIM ACTA, V54, P91, DOI 10.1016/j.electacta.2008.04.082; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Suflita JM, 2014, UNDERSTANDING BIOCOR, V313; Tanner RS, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P69; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Venzlaff H, 2013, CORROS SCI, V66, P88, DOI 10.1016/j.corsci.2012.09.006; Videla HA, 2005, INT MICROBIOL, V8, P169; Wang HB, 2012, WATER RES, V46, P1070, DOI 10.1016/j.watres.2011.12.001; Xu CM, 2007, MAT SCI ENG A-STRUCT, V443, P235, DOI 10.1016/j.msea.2006.08.110; Xu DK, 2013, CORROS SCI, V77, P385, DOI 10.1016/j.corsci.2013.07.044; Yuan SJ, 2007, COLLOID SURFACE B, V59, P87, DOI 10.1016/j.colsurfb.2007.04.020; Zhang PY, 2015, BIOELECTROCHEMISTRY, V101, P14, DOI 10.1016/j.bioelechem.2014.06.010; Zuo R, 2007, APPL MICROBIOL BIOT, V76, P1245, DOI 10.1007/s00253-007-1130-6	59	11	11	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147899	10.1371/journal.pone.0147899	http://dx.doi.org/10.1371/journal.pone.0147899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824529	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528600069
J	Nakada, S; Ogasawara, R; Kawada, S; Maekawa, T; Ishii, N				Nakada, Satoshi; Ogasawara, Riki; Kawada, Shigeo; Maekawa, Takahiro; Ishii, Naokata			Correlation between Ribosome Biogenesis and the Magnitude of Hypertrophy in Overloaded Skeletal Muscle	PLOS ONE			English	Article							REGENERATING RAT-LIVER; RESISTANCE EXERCISE; PROTEIN-SYNTHESIS; STRUCTURAL PROTEINS; GENE-EXPRESSION; INDUCED GROWTH; RNA SYNTHESIS; TIME-COURSE; YOUNG MEN; ACTIVATION	External loads applied to skeletal muscle cause increases in the protein translation rate, which leads to muscle hypertrophy. Although some studies have demonstrated that increases in the capacity and efficiency of translation are involved in this process, it remains unclear how these two factors are related to the magnitude of muscle hypertrophy. The present study aimed to clarify the roles played by the capacity and efficiency of translation in muscle hypertrophy. We used an improved synergist ablation in which the magnitude of compensatory hypertrophy could be controlled by partial removal of synergist muscles. Male rats were assigned to four groups in which the plantaris muscle was unilaterally subjected to weak (WK), moderate (MO), middle (MI), and strong (ST) overloading by four types of synergist ablation. Fourteen days after surgery, the weight of the plantaris muscle per body weight increased by 8%, 22%, 32% and 45%, in the WK, MO, MI and ST groups, respectively. Five days after surgery, 18+28S rRNA content (an indicator of translational capacity) increased with increasing overload, with increases of 1.8-fold (MO), 2.2-fold (MI), and 2.5-fold (ST), respectively, relative to non-overloaded muscle (NL) in the WK group. rRNA content showed a strong correlation with relative muscle weight measured 14 days after surgery (r = 0.98). The phosphorylated form of p70S6K (a positive regulator of translational efficiency) showed a marked increase in the MO group, but no further increase was observed with further increase in overload (increases of 22.6-fold (MO), 17.4-fold (MI), and 18.2-fold (ST), respectively, relative to NL in the WK group). These results indicate that increases in ribosome biogenesis at the early phase of overloading are strongly dependent on the amount of overloading, and may play an important role in increasing the translational capacity for further gain of muscular size.	[Nakada, Satoshi; Ogasawara, Riki; Maekawa, Takahiro; Ishii, Naokata] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Kawada, Shigeo] Teikyo Univ, Fac Med Technol, Dept Sport & Med Sci, Tokyo 173, Japan	University of Tokyo; Teikyo University	Nakada, S (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	s.nakada.d@gmail.com	Ogasawara, Riki/AAD-7221-2020; 理紀, 小笠原/HGC-1855-2022	Ogasawara, Riki/0000-0002-2600-1613; Nakada, Satoshi/0000-0003-0453-4969	JSPS KAKENHI Grant [15H03078]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 15H03078.	Adams GR, 2002, AM J PHYSIOL-CELL PH, V283, pC1182, DOI 10.1152/ajpcell.00173.2002; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Chaillou T, 2014, J CELL PHYSIOL, V229, P1584, DOI 10.1002/jcp.24604; Chaillou T, 2013, J APPL PHYSIOL, V115, P1065, DOI 10.1152/japplphysiol.00611.2013; Chaillou T, 2012, AM J PHYSIOL-REG I, V302, pR643, DOI 10.1152/ajpregu.00262.2011; CSIBI A, 2010, PLOS ONE, V5; Figueiredo VC, 2015, AM J PHYSIOL-ENDOC M; GOLDBERG AL, 1968, J CELL BIOL, V36, P653, DOI 10.1083/jcb.36.3.653; Goodfellow SJ, 2006, EMBO J, V25, P1522, DOI 10.1038/sj.emboj.7601040; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Granneman S, 2007, CURR BIOL, V17, pR415, DOI 10.1016/j.cub.2007.04.011; Hannan RD, 1996, J BIOL CHEM, V271, P3213, DOI 10.1074/jbc.271.6.3213; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Mayhew DL, 2011, J PHYSIOL-LONDON, V589, P3023, DOI 10.1113/jphysiol.2010.202432; Mitchell CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078636; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Miyazaki M, 2011, J PHYSIOL-LONDON, V589, P1831, DOI 10.1113/jphysiol.2011.205658; Nader GA, 2014, J APPL PHYSIOL, V116, P693, DOI 10.1152/japplphysiol.01366.2013; Nader GA, 2002, CLIN ORTHOP RELAT R, pS178, DOI 10.1097/01.blo.0000031979.92980.2e; Nader GA, 2005, AM J PHYSIOL-CELL PH, V289, pC1457, DOI 10.1152/ajpcell.00165.2005; Ochi E, 2010, J SPORT SCI MED, V9, P170; Ogasawara R, 2013, J APPL PHYSIOL, V114, P934, DOI 10.1152/japplphysiol.01161.2012; Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949; Phillips SM, 2009, APPL PHYSIOL NUTR ME, V34, P403, DOI 10.1139/H09-042; Roy RR, 1999, J APPL PHYSIOL, V87, P634, DOI 10.1152/jappl.1999.87.2.634; TAMAKI T, 1995, PHYSIOL BEHAV, V57, P913, DOI 10.1016/0031-9384(94)00359-D; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; TSURUGI K, 1972, EUR J BIOCHEM, V29, P585, DOI 10.1111/j.1432-1033.1972.tb02025.x; TSURUGI K, 1972, EUR J BIOCHEM, V25, P117, DOI 10.1111/j.1432-1033.1972.tb01675.x; van der Meer SFT, 2011, ANN ANAT, V193, P56, DOI 10.1016/j.aanat.2010.08.004; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weigl LG, 2012, CURR OPIN PHARMACOL, V12, P377, DOI 10.1016/j.coph.2012.02.017; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Zhang Z, 2013, J MOL CELL CARDIOL, V59, P139, DOI 10.1016/j.yjmcc.2013.03.006	36	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147284	10.1371/journal.pone.0147284	http://dx.doi.org/10.1371/journal.pone.0147284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824605	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600021
J	Brans, E; de Graaf, JS; Munzebrock, AVE; Bessem, B; Reininga, IHF				Brans, Erwin; de Graaf, Joost S.; Munzebrock, Arvid V. E.; Bessem, Bram; Reininga, Inge H. F.			Cross-Cultural Adaptation and Validation of the Dutch Version of the Hip and Groin Outcome Score (HAGOS-NL)	PLOS ONE			English	Article							FUNCTION ASSESSMENT QUESTIONNAIRE; CHRONIC PAIN; COPENHAGEN HIP; HERNIA REPAIR; CORE OUTCOMES; HEALTH SURVEY; QUALITY; RELIABILITY; AGREEMENT; VALIDITY	Background Valid and reliable questionnaires to assess hip and groin pain are lacking. The Hip and Groin Outcome Score (HAGOS) is a valid and reliable self-reported measure to assess symptoms, activity limitations, participation restrictions and quality of life of persons with hip and/or groin complaints. The purpose of this study was to translate and cross-culturally adapt the HAGOS into Dutch (HAGOS-NL), and to evaluate its internal consistency, validity and reliability. Methods Translation and cross-cultural adaption of the Dutch version of the HAGOS (HAGOS-NL) was performed according to international guidelines. The study population consisted of 178 adult patients who had undergone groin hernia repair surgery in the previous year. All respondents filled in the HAGOS-NL, the SF-36, and the SMFA-NL for determining construct validity of the HAGOS-NL. To determine reliability, 81 respondents filled in the HAGOS-NL after a time interval of two weeks. Results Factor analysis confirmed the original six-factor solution of the HAGOS. Internal consistency was good for all the subscales of the HAGOS-NL. High correlations were observed between the HAGOS-NL and the SF-36 and SMFA-NL, indicating good construct validity. The HAGOS-NL showed high reliability, except for the subscale Participation in Physical Activities which was moderate. Conclusions The HAGOS was successfully translated and cross-culturally adapted from English into Dutch (HAGOS-NL). This study shows that the HAGOS-NL is a valid and reliable instrument for the assessment of functional status and health-related quality of life in patients with groin complaints.	[Brans, Erwin; de Graaf, Joost S.; Munzebrock, Arvid V. E.] Med Ctr Leeuwarden, Dept Surg, Leeuwarden, Netherlands; [Munzebrock, Arvid V. E.; Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, NL-9713 AV Groningen, Netherlands; [Brans, Erwin; Bessem, Bram] Univ Groningen, Univ Med Ctr Groningen, Ctr Sports Med, NL-9713 AV Groningen, Netherlands	Medical Center Leeuwarden; University of Groningen; University of Groningen	Brans, E (corresponding author), Med Ctr Leeuwarden, Dept Surg, Leeuwarden, Netherlands.; Brans, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Sports Med, NL-9713 AV Groningen, Netherlands.	Erwin.brans@ZNB.nl	de Graaf, Joost/C-5364-2012; Reininga, Inge H.F./H-4250-2013	de Graaf, Joost/0000-0002-8781-7368; Reininga, Inge H.F./0000-0003-1341-845X				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bitzer EM, 2008, HERNIA, V12, P407, DOI 10.1007/s10029-008-0364-2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bollen KA, 1989, STRUCTURAL EQUATIONS; Burney RE, 1997, J AM COLL SURGEONS, V185, P509, DOI 10.1016/S1072-7515(97)00108-7; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Clay L, 2012, LANGENBECK ARCH SURG, V397, P1219, DOI 10.1007/s00423-012-0932-x; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Jonge PVH, 2008, HERNIA, V12, P561, DOI 10.1007/s10029-008-0412-y; de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479, DOI 10.1017/S0266462301107038; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Devlin N, GETTING MOST OUT PRO; Franneby U, 2008, BRIT J SURG, V95, P488, DOI 10.1002/bjs.6014; Loos M J A, 2007, Hernia, V11, P169, DOI 10.1007/s10029-007-0196-5; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Poobalan AS, 2003, CLIN J PAIN, V19, P48, DOI 10.1097/00002508-200301000-00006; Reininga IHF, 2012, INJURY, V43, P726, DOI 10.1016/j.injury.2011.07.013; Staerkle RF, 2011, BRIT J SURG, V98, P148, DOI 10.1002/bjs.7236; Swiontkowski MF, 1999, J BONE JOINT SURG AM, V81A, P1245, DOI 10.2106/00004623-199909000-00006; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thomee R, 2014, KNEE SURG SPORT TR A, V22, P835, DOI 10.1007/s00167-013-2721-7; Thorborg K, 2011, BRIT J SPORT MED, V45, P478, DOI 10.1136/bjsm.2010.080937; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	28	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148119	10.1371/journal.pone.0148119	http://dx.doi.org/10.1371/journal.pone.0148119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GF	26821266	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400069
J	Chang, EYC; Chang, YC; Shun, CT; Tien, YW; Tsai, SH; Hee, SW; Chen, IJ; Chuang, LM				Chang, Emily Yun-Chia; Chang, Yi-Cheng; Shun, Chia-Tung; Tien, Yu-Wen; Tsai, Shu-Huei; Hee, Siow-Wey; Chen, Ing-Jung; Chuang, Lee-Ming			Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE(2)	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CANCER-CELLS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; PPAR-GAMMA; UP-REGULATION; CYSTINE/GLUTAMATE ANTIPORTER; COLORECTAL-CANCER; CARCINOMA GROWTH; APOPTOSIS; PATHWAY	Prostaglandin reductase 2 (PTGR2) is the enzyme that catalyzes 15-keto-PGE(2), an endogenous PPAR gamma ligand, into 13,14-dihydro-15-keto-PGE(2). Previously, we have reported a novel oncogenic role of PTGR2 in gastric cancer, where PTGR2 was discovered to modulate ROS-mediated cell death and tumor transformation. In the present study, we demonstrated the oncogenic potency of PTGR2 in pancreatic cancer. First, we observed that the majority of the human pancreatic ductal adenocarcinoma tissues was stained positive for PTGR2 expression but not in the adjacent normal parts. In vitro analyses showed that silencing of PTGR2 expression enhanced ROS production, suppressed pancreatic cell proliferation, and promoted cell death through increasing 15-keto-PGE(2). Mechanistically, silencing of PTGR2 or addition of 15-keto-PGE(2) suppressed the expressions of solute carrier family 7 member 11 (xCT) and cystathionine gamma-lyase (CTH), two important providers of intracellular cysteine for the generation of glutathione (GSH), which is widely accepted as the first-line antioxidative defense. The oxidative stress-mediated cell death after silencing of PTGR2 or addition of 15-keto-PGE(2) was further abolished after restoring intracellular GSH concentrations and cysteine supply by N-acetyl-L-cysteine and 2-Mercaptomethanol. Our data highlight the therapeutic potential of targeting PTGR2/15-keto-PGE(2) for pancreatic cancer.	[Chang, Emily Yun-Chia; Chang, Yi-Cheng; Hee, Siow-Wey; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chang, Yi-Cheng] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Chang, Yi-Cheng] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chang, Yi-Cheng] Natl Taiwan Univ Hosp, Ctr Obes Life Style & Metab Surg, Taipei, Taiwan; [Shun, Chia-Tung] Natl Taiwan Univ Hosp, Dept Forens Med & Pathol, Taipei, Taiwan; [Tien, Yu-Wen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Surg, Coll Med, Taipei 10764, Taiwan; [Tsai, Shu-Huei] BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Chen, Ing-Jung; Chuang, Lee-Ming] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10764, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Dept Med, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; British Columbia Cancer Agency; National Taiwan University; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10764, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Dept Med, Coll Med, Taipei 10764, Taiwan.	leeming@ntu.edu.tw	Chang, Yi-cheng/O-1334-2018; Chuang, Lee-Ming/AAF-3324-2019; Chen, Ing-Jung/AAX-7312-2020; Shun, Chia-Tung/M-1400-2019; Chen, Ing-Jung/AAX-7324-2020	Chang, Yi-cheng/0000-0002-8077-5011; Chen, Ing-Jung/0000-0003-3951-129X; Chen, Ing-Jung/0000-0003-3951-129X; TIEN, YU-WEN/0000-0002-9126-2705; CHUANG, LEE-MING/0000-0003-0978-2662; SHUN, CHIA-TUNG/0000-0002-0468-4468	National Science Council of Taiwan [NSC 100-2314-B-002 -068 -MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was done with a grant (NSC 100-2314-B-002 -068 -MY3) from the National Science Council of Taiwan (https://www.most.gov.tw/), and it did not require any external funding. LMC received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostoli AJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0347-8; Chandel NS, 2014, BIOCH PHARM; Chang EYC, 2012, AM J PATHOL, V181, P1316, DOI 10.1016/j.ajpath.2012.07.006; Chen YX, 2003, WORLD J GASTROENTERO, V9, P2149; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Chu JS, 2003, MOL CANCER THER, V2, P1; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Clay CE, 2002, J LIPID RES, V43, P1818, DOI 10.1194/jlr.M200224-JLR200; Dai L, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-30; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Ding YF, 2005, CARCINOGENESIS, V26, P65, DOI 10.1093/carcin/bgh277; Dong YW, 2009, WORLD J GASTROENTERO, V15, P441, DOI 10.3748/wjg.15.441; Eibl G, 2005, CANCER RES, V65, P982; Eibl G, 2008, PPAR RES, V2008, DOI 10.1155/2008/326915; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Frank B, 2011, CARCINOGENESIS, V32, P190, DOI 10.1093/carcin/bgq231; Fujiki K, 2014, ARCH TOXICOL, V88, P403, DOI 10.1007/s00204-013-1129-y; Fujiwara N, 2015, CANCER RES, V75, P3890, DOI 10.1158/0008-5472.CAN-15-0257; Fulzele SV, 2007, ANTI-CANCER DRUG, V18, P65, DOI 10.1097/CAD.0b013e3280101006; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; Goicoechea SM, 2013, ONCOGENE; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guo WJ, 2011, CANCER LETT, V312, P55, DOI 10.1016/j.canlet.2011.07.024; Hourihan JM, 2013, ANTIOXID REDOX SIGN, V19, P465, DOI 10.1089/ars.2012.4944; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Konturek PC, 2004, J PHARMACOL SCI, V96, P134, DOI 10.1254/jphs.FPJ04016X; Kristiansen G, 2006, CLIN CANCER RES, V12, P6444, DOI 10.1158/1078-0432.CCR-06-0834; Lalier L, 2011, CELL DEATH DIFFER, V18, P528, DOI 10.1038/cdd.2010.128; Larsson K, 2015, P NATL ACAD SCI USA, V112, P8070, DOI 10.1073/pnas.1424355112; Lee ZW, 2014, BIOCHEM J, V460, P425, DOI 10.1042/BJ20131434; Leikam C, 2014, ONCOGENE, V33, P771, DOI 10.1038/onc.2012.641; Leikam C, 2013, ONCOGENE; Leung WK, 2004, GUT, V53, P331, DOI 10.1136/gut.2003.021105; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Li LY, 2001, J BIOL CHEM, V276, P38152; Lim JC, 2011, EXP EYE RES, V92, P162, DOI 10.1016/j.exer.2010.05.007; Linher-Melville K, 2015, MOL CELL BIOCHEM, V405, P205, DOI 10.1007/s11010-015-2412-4; Liu B, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0260-7; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Lo M, 2010, CURR ONCOL, V17, P9; Lu D, 2014, ONCOGENE, V33, P1101, DOI 10.1038/onc.2013.69; Lu DD, 2013, J BIOL CHEM, V288, P19484, DOI 10.1074/jbc.M113.453886; Luo S, 2015, BIOCHEM BIOPH RES CO, V462, P85, DOI 10.1016/j.bbrc.2015.04.023; Ma MZ, 2015, CANCER LETT, V368, P88, DOI 10.1016/j.canlet.2015.07.031; Ma XM, 2009, WORLD J GASTROENTERO, V15, P3874, DOI 10.3748/wjg.15.3874; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Min KW, 2012, TOXICOL APPL PHARM, V263, P225, DOI 10.1016/j.taap.2012.06.014; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Omura N, 2010, MOL CANCER RES, V8, P821, DOI 10.1158/1541-7786.MCR-09-0336; Pazienza V, 2012, PPAR RES, V2012, DOI 10.1155/2012/560846; Pazienza V, 2012, PPAR RES, V2012, DOI 10.1155/2012/461784; Pham H, 2010, PANCREAS, V39, P332, DOI 10.1097/MPA.0b013e3181baecbe; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Sabatino L, 2014, WORLD J GASTROENTERO, V20, P7137, DOI 10.3748/wjg.v20.i23.7137; Shiozaki A, 2014, J GASTROENTEROL, V49, P853, DOI 10.1007/s00535-013-0847-5; Simons AL, 2009, J ONCOL, V2009, DOI 10.1155/2009/519563; Srivastava N, 2014, CELL METAB, V20, P650, DOI 10.1016/j.cmet.2014.08.003; Stravodimou A, 2012, PPAR RES, V2012, DOI 10.1155/2012/367450; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Thiel A, 2009, CLIN CANCER RES, V15, P4572, DOI 10.1158/1078-0432.CCR-08-2518; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tseng-Rogenski S, 2010, AM J PATHOL, V176, P1462, DOI 10.2353/ajpath.2010.090875; Tsujie M, 2003, EXP CELL RES, V289, P143, DOI 10.1016/S0014-4827(03)00263-5; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5; Wu YH, 2008, STRUCTURE, V16, P1714, DOI 10.1016/j.str.2008.09.007; Yamaue H, 2013, CANCER CHEMOTHER PHA; Yang Y, 2013, J RECEPT SIG TRANSD, V33, P14, DOI 10.3109/10799893.2012.752003; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Yin Peng, 2012, Cell Signal, V24, P1229, DOI 10.1016/j.cellsig.2012.02.003; Yip-Schneider MT, 2000, CARCINOGENESIS, V21, P139, DOI 10.1093/carcin/21.2.139; Zhang Y, 2015, INT J ONCOL, V46, P175, DOI 10.3892/ijo.2014.2709	76	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147390	10.1371/journal.pone.0147390	http://dx.doi.org/10.1371/journal.pone.0147390			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820738	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400022
J	Cheng, TS; Loy, SL; Cheung, YB; Chan, JKY; Tint, MT; Godfrey, KM; Gluckman, PD; Kwek, K; Saw, SM; Chong, YS; Lee, YS; Yap, F; Lek, N				Cheng, Tuck Seng; Loy, See Ling; Cheung, Yin Bun; Chan, Jerry Kok Yen; Tint, Mya Thway; Godfrey, Keith M.; Gluckman, Peter D.; Kwek, Kenneth; Saw, Seang Mei; Chong, Yap-Seng; Lee, Yung Seng; Yap, Fabian; Lek, Ngee		Growing Singapore Towards Hlth Out	Singaporean Mothers' Perception of Their Three-year-old Child's Weight Status: A Cross-Sectional Study	PLOS ONE			English	Article							PARENTS PERCEPTIONS; OBESITY; OVERWEIGHT; CONSEQUENCES; PREVALENCE; DISEASE; RISKS	Objective Inaccurate parental perception of their child's weight status is commonly reported in Western countries. It is unclear whether similar misperception exists in Asian populations. This study aimed to evaluate the ability of Singaporean mothers to accurately describe their three-year-old child's weight status verbally and visually. Methods At three years post-delivery, weight and height of the children were measured. Body mass index (BMI) was calculated and converted into actual weight status using International Obesity Task Force criteria. The mothers were blinded to their child's measurements and asked to verbally and visually describe what they perceived was their child's actual weight status. Agreement between actual and described weight status was assessed using Cohen's Kappa statistic (kappa). Results Of 1237 recruited participants, 66.4% (n = 821) with complete data on mothers' verbal and visual perceptions and children's anthropometric measurements were analysed. Nearly thirty percent of the mothers were unable to describe their child's weight status accurately. In verbal description, 17.9% under-estimated and 11.8% over-estimated their child's weight status. In visual description, 10.4% under-estimated and 19.6% over-estimated their child's weight status. Many mothers of underweight children over-estimated (verbal 51.6%; visual 88.8%), and many mothers of overweight and obese children under-estimated (verbal 82.6%; visual 73.9%), their child's weight status. In contrast, significantly fewer mothers of normal-weight children were inaccurate (verbal 16.8%; visual 8.8%). Birth order (p< 0.001), maternal (p = 0.004) and child's weight status (p< 0.001) were associated with consistently inaccurate verbal and visual descriptions. Conclusions Singaporean mothers, especially those of underweight and overweight children, may not be able to perceive their young child's weight status accurately. To facilitate prevention of childhood obesity, educating parents and caregivers about their child's weight status is needed.	[Cheng, Tuck Seng; Yap, Fabian; Lek, Ngee] KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore; [Loy, See Ling; Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore; [Cheung, Yin Bun] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Cheung, Yin Bun] Univ Tampere, Dept Int Hlth, FIN-33101 Tampere, Finland; [Chan, Jerry Kok Yen; Yap, Fabian; Lek, Ngee] Duke NUS Med Sch, Singapore, Singapore; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry Kok Yen; Chong, Yap-Seng] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117548, Singapore; [Godfrey, Keith M.] Univ Southampton, MRC Life Course Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Gluckman, Peter D.; Chong, Yap-Seng; Lee, Yung Seng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yap, Fabian] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117548, Singapore	KK Women's & Children's Hospital; KK Women's & Children's Hospital; National University of Singapore; Tampere University; National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Auckland; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); KK Women's & Children's Hospital; National University of Singapore; National University of Singapore	Lek, N (corresponding author), KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore.; Lek, N (corresponding author), Duke NUS Med Sch, Singapore, Singapore.	lek.ngee@singhealth.com.sg	Henry, Christiani Jeyakumar/AHB-2632-2022; Tint, Mya-Thway/HGU-1202-2022; Lee, Yung Seng/F-2169-2014; Loy, SeeLing/AGW-6714-2022; Qiu, Anqi/H-2267-2011; Hsu, Chin-ying/E-7855-2016	Henry, Christiani Jeyakumar/0000-0002-1602-0140; Lee, Yung Seng/0000-0002-1253-0557; Qiu, Anqi/0000-0002-0215-6338; Amutha, Chinnaiah/0000-0003-1395-2089; TINT, Mya Thway/0000-0002-9548-7186; LAU, Ivy Yee-Man/0000-0003-0036-2477; Chong, Yap Seng/0000-0002-7232-8473; Shek, Lynette/0000-0001-9064-8983; Kapur, Jeevesh/0000-0002-5696-0233; Cheng, Tuck Seng/0000-0003-4442-7332; Richmond, Jenny/0000-0002-5808-4249; Godfrey, Keith/0000-0002-4643-0618; BISWAS, ARIJIT/0000-0002-3311-2135; Yap, Fabian/0000-0003-1083-7958; Hsu, Chin-ying/0000-0001-7367-3204; Tan, Kok Hian/0000-0003-1945-0266	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union's Seventh Framework Programme (FP7), project EarlyNutrition [289346]; Ministry of Health's National Medical Research Council, Singapore [NMRC/CSA/043/2012]; MRC [MC_U147585827, G0400491, MC_U147585819, MC_UU_12011/4, MC_UP_A620_1017] Funding Source: UKRI; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Medical Research Council [MC_U147585819, MC_UP_A620_1014, U1475000001, MC_UU_12011/1, MC_U147585824, G0400491, MC_UU_12011/4, MC_U147585827, MC_UP_A620_1017] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085, NF-SI-0515-10042] Funding Source: researchfish	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme(National Research Foundation, Singapore); Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union's Seventh Framework Programme (FP7), project EarlyNutrition; Ministry of Health's National Medical Research Council, Singapore(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore- NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014. Additional funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre and by the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement no289346. JKYC received salary support from the Ministry of Health's National Medical Research Council, Singapore (NMRC/CSA/043/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binkin N, 2013, NUTR METAB CARDIOVAS, V23, P410, DOI 10.1016/j.numecd.2011.09.006; Chen S, 2014, ASIA PAC J CLIN NUTR, V23, P452, DOI 10.6133/apjcn.2014.23.3.14; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Golan M, 2004, NUTR REV, V62, P39, DOI 10.1111/j.1753-4887.2004.tb00005.x; Hager ER, 2012, ARCH PEDIAT ADOL MED, V166, P417, DOI 10.1001/archpediatrics.2011.1900; Hager ER, 2010, OBESITY, V18, P397, DOI 10.1038/oby.2009.293; Lee YS, 2009, ANN ACAD MED SINGAP, V38, P75; Lundahl A, 2014, PEDIATRICS, V133, pE689, DOI 10.1542/peds.2013-2690; Mareno N, 2014, J ADV NURS, V70, P34, DOI 10.1111/jan.12143; McMullen S, 2014, P NUTR SOC, V73, P389, DOI 10.1017/S0029665114000111; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Pwint MK, 2013, ANN ACAD MED SINGAP, V42, P66; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Soh SE, 2014, INT J EPIDEMIOL, V43, P1401, DOI 10.1093/ije/dyt125; Souto-Gallardo MC, 2011, ARCH LATINOAM NUTR, V61, P382; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Warschburger P, 2009, PEDIATRICS, V124, pE60, DOI 10.1542/peds.2008-1845; Wen X, 2011, CHILD CARE HLTH DEV, V37, P343, DOI 10.1111/j.1365-2214.2010.01166.x; World Health Organization, 2008, WHO CHILD GROWTH STA; Yilmaz R, 2013, NUTR HOSP, V28, P741, DOI 10.3305/nh.2013.28.3.6358	26	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147563	10.1371/journal.pone.0147563	http://dx.doi.org/10.1371/journal.pone.0147563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820665	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528400032
J	Zhang, JT; Weng, ZH; Tsang, KS; Tsang, LL; Chan, HC; Jiang, XH				Zhang, Jie Ting; Weng, Zhi Hui; Tsang, Kam Sze; Tsang, Lai Ling; Chan, Hsiao Chang; Jiang, Xiao Hua			MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells	PLOS ONE			English	Article							N-MYC; NEURONAL DIFFERENTIATION; TARGETED DISRUPTION; NERVOUS-SYSTEM; NEUROBLASTOMA; EXPRESSION; PHOX2B; GENE; TRANSCRIPTION; NEUROGENESIS	The biologic studies of human neural crest stem cells (hNCSCs) are extremely challenging due to the limited source of hNCSCs as well as ethical and technical issues surrounding isolation of early human embryonic tissues. On the other hand, vast majority of studies on MycN have been conducted in human tumor cells, thus, the role of MycN in normal human neural crest development is completely unknown. In the present study, we determined the role of MycN in hNCSCs isolated from in vitro-differentiating human embryonic stem cells (hESCs). For the first time, we show that suppression of MycN in hNCSCs inhibits cell growth and cell cycle progression. Knockdown of MycN in hNCSCs increases the expression of Cdkn1a, Cdkn2a and Cdkn2b, which encodes the cyclin-dependent kinases p21(CIP1), p16(INK4a) and p15(INK4b). In addition, MycN is involved in the regulation of human sympathetic neurogenesis, as knockdown of MycN enhances the expression of key transcription factors involved in sympathetic neuron differentiation, including Phox2a, Phox2b, Mash1, Hand2 and Gata3. We propose that unlimited source of hNCSCs provides an invaluable platform for the studies of human neural crest development and diseases.	[Zhang, Jie Ting; Weng, Zhi Hui; Tsang, Lai Ling; Chan, Hsiao Chang; Jiang, Xiao Hua] Chinese Univ Hong Kong, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China; [Tsang, Kam Sze] Chinese Univ Hong Kong, Fac Med, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Hsiao Chang; Jiang, Xiao Hua] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Jiang, XH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China.; Jiang, XH (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	xjiang@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016; jiang, cynthia xiaohua/F-7580-2017	jiang, cynthia xiaohua/0000-0002-7372-4961	University Grants Committee [466710]; National Natural Science Foundation of China (NSFC) [81272548]; Health and Medical Research Fund (HMRF) [01120056]	University Grants Committee; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Health and Medical Research Fund (HMRF)	This research was supported by University Grants Committee (General Research Fund, No. 466710), National Natural Science Foundation of China (NSFC, No. 81272548) and Health and Medical Research Fund (HMRF, No. 01120056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Basu S, 2009, P NATL ACAD SCI USA, V106, P1433, DOI 10.1073/pnas.0804863106; Benetatos L, 2014, CELL MOL LIFE SCI, V71, P257, DOI 10.1007/s00018-013-1426-x; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Corvetta D, 2013, J BIOL CHEM, V288, P8332, DOI 10.1074/jbc.M113.454280; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Hurlin Peter J., 2005, Birth Defects Research, V75, P340, DOI 10.1002/bdrc.20059; Itahana Koji, 2010, Epigenomics, V2, P610; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; O'Rahilly R, 1999, TERATOLOGY, V60, P39, DOI 10.1002/(SICI)1096-9926(199907)60:1<39::AID-TERA11>3.0.CO;2-I; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pei DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003533; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; SAWAI S, 1993, DEVELOPMENT, V117, P1445; SAWAI S, 1990, MOL CELL BIOL, V10, P2017, DOI 10.1128/MCB.10.5.2017; SAWAI S, 1991, NEW BIOL, V3, P861; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tiveron MC, 1996, J NEUROSCI, V16, P7649; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermark UK, 2011, SEMIN CANCER BIOL, V21, P256, DOI 10.1016/j.semcancer.2011.08.001	36	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0148062	10.1371/journal.pone.0148062	http://dx.doi.org/10.1371/journal.pone.0148062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26815535	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528200071
J	Deshpande, D; Kethireddy, S; Janero, DR; Amiji, MM				Deshpande, Dipti; Kethireddy, Sravani; Janero, David R.; Amiji, Mansoor M.			Therapeutic Efficacy of an omega-3-Fatty Acid-Containing 17-beta Estradiol Nano-Delivery System against Experimental Atherosclerosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MUSCLE-CELL PHENOTYPES; EXPRESSION IN-VIVO; CARDIOVASCULAR-DISEASE; DIETARY FLAXSEED; NANOEMULSION SYSTEM; NITRIC-OXIDE; ESTROGEN; PREVENTION; 17-BETA-ESTRADIOL	Atherosclerosis and its consequences remain prevalent clinical challenges throughout the world. Initiation and progression of atherosclerosis involves a complex, dynamic interplay among inflammation, hyperlipidemia, and endothelial dysfunction. A multicomponent treatment approach targeted for delivery within diseased vessels could prove beneficial in treating atherosclerosis. This study was undertaken to evaluate the multimodal effects of a novel omega-3-fatty acid-rich, 17-beta-estradiol (17-beta E)-loaded, CREKA-peptide-modified nanoemulsion system on experimental atherosclerosis. In vitro treatment of cultured human aortic endothelial cells (ECs) with the 17-beta E-loaded, CREKA-peptide-modified nanoemulsion system increased cellular nitrate/ nitrite, indicating improved nitric oxide formation. In vivo, systemic administration of this nanoemulsion system to apolipoprotein-E knock out (ApoE(-/-)) mice fed a high-fat diet significantly improved multiple parameters related to the etiology and development of occlusive atherosclerotic vasculopathy: lesion area, circulating plasma lipid levels, and expression of aortic-wall inflammatory markers. These salutary effects were attributed selectively to the 17-beta E and/or omega-3 polyunsaturated fatty acid components of the nano-delivery system. At therapeutic doses, the 17-beta E-loaded, CREKA-peptide modified nanoemulsion system appeared to be biocompatible in that it elicited no apparent adverse/toxic effects, as indexed by body weight, plasma alanine aminotransferase/aspartate aminotransferase levels, and liver and kidney histopathology. The study demonstrates the therapeutic potential of a novel, 17-beta E-loaded, CREKA-peptide-modified nanoemulsion system against atherosclerosis in a multimodal fashion by reducing lesion size, lowering the levels of circulating plasma lipids and decreasing the gene expression of inflammatory markers associated with the disease.	[Deshpande, Dipti; Kethireddy, Sravani; Janero, David R.; Amiji, Mansoor M.] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Janero, David R.] Northeastern Univ, Ctr Drug Discovery, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Amiji, Mansoor M.] King Abdulaziz Univ, Fac Pharm, Jeddah 21413, Saudi Arabia	Northeastern University; Northeastern University; King Abdulaziz University	Amiji, MM (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA.; Amiji, MM (corresponding author), King Abdulaziz Univ, Fac Pharm, Jeddah 21413, Saudi Arabia.	m.amiji@neu.edu	kethireddy, sravani/J-8511-2019; Deshpande, Dipti/L-2523-2019; Amiji, Mansoor M/AAK-1531-2020	Amiji, Mansoor M/0000-0001-6170-881X				Barton M, 2013, CURR OPIN LIPIDOL, V24, P214, DOI 10.1097/MOL.0b013e3283613a94; Bassett CMC, 2009, APPL PHYSIOL NUTR ME, V34, P965, DOI 10.1139/H09-087; Binsalamah ZM, 2012, EXPERT REV CARDIOVAS, V10, P805, DOI [10.1586/erc.12.41, 10.1586/ERC.12.41]; Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022; Brown WV, 2011, J CLIN LIPIDOL, V5, P424, DOI 10.1016/j.jacl.2011.09.006; Casula M, 2013, ATHEROSCLEROSIS SUPP, V14, P243, DOI 10.1016/S1567-5688(13)70005-9; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; Deshpande D, 2014, J CONTROL RELEASE, V180, P117, DOI 10.1016/j.jconrel.2014.02.009; Deshpande D, 2013, NANOMED-NANOTECHNOL, V9, P885, DOI 10.1016/j.nano.2013.02.007; Deshpande DD, 2011, EXPERT OPIN BIOL TH, V11, P1637, DOI 10.1517/14712598.2011.625007; Dimitrow PP, 2009, MINI-REV MED CHEM, V9, P1030, DOI 10.2174/138955709788922638; Duckles SP, 2010, PFLUG ARCH EUR J PHY, V459, P841, DOI 10.1007/s00424-010-0797-1; Dupasquier CMC, 2006, AM J PHYSIOL-HEART C, V291, pH2987, DOI 10.1152/ajpheart.01179.2005; Dupasquier CMC, 2007, AM J PHYSIOL-HEART C, V293, pH2394, DOI 10.1152/ajpheart.01104.2006; Durst R, 2009, GENET TEST MOL BIOMA, V13, P583, DOI 10.1089/gtmb.2009.0048; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Francis AA, 2013, AM J PHYSIOL-HEART C, V304, pH1743, DOI 10.1152/ajpheart.00606.2012; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Godin B, 2010, TRENDS PHARMACOL SCI, V31, P199, DOI 10.1016/j.tips.2010.01.003; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hamzah J, 2011, P NATL ACAD SCI USA, V108, P7154, DOI 10.1073/pnas.1104540108; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Janero DR, 2014, EXPERT OPIN PHARMACO, V15, P5, DOI 10.1517/14656566.2014.852538; Jawien J, 2012, CURR PHARM BIOTECHNO, V13, P2435, DOI 10.2174/1389201011208062435; Jayagopal A, 2010, CURR ATHEROSCLER REP, V12, P209, DOI 10.1007/s11883-010-0106-7; Jin RC, 2010, J BLOOD MED, V1, P147; Kaul S, 2004, J AM COLL CARDIOL, V43, P461, DOI 10.1016/j.jacc.2003.11.010; Kim KH, 2014, MOL CELL ENDOCRINOL, V389, P65, DOI 10.1016/j.mce.2014.02.001; Kitagawa K, 2002, ATHEROSCLEROSIS, V160, P305, DOI 10.1016/S0021-9150(01)00587-1; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Komesaroff PA, 2001, HYPERTENSION, V38, P1011, DOI 10.1161/hy1101.095006; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; LI HM, 1995, J CLIN INVEST, V95, P122, DOI 10.1172/JCI117628; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Madigan M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00174; Makinen PI, 2013, CURR OPIN LIPIDOL, V24, P116, DOI 10.1097/MOL.0b013e32835da13c; Meng J, 2012, CURR DRUG METAB, V13, P1123, DOI 10.2174/138920012802850056; Meyer MR, 2006, HYPERTENSION, V47, P1019, DOI 10.1161/01.HYP.0000223064.62762.0b; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Napoli C, 2006, NITRIC OXIDE-BIOL CH, V15, P265, DOI 10.1016/j.niox.2006.03.011; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Palmieri D, 2014, ANGIOLOGY, V65, P17, DOI 10.1177/0003319713477909; Pervin S, 1998, ARTERIOSCL THROM VAS, V18, P1575, DOI 10.1161/01.ATV.18.10.1575; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Psarros C, 2012, NANOMED-NANOTECHNOL, V8, pS59, DOI 10.1016/j.nano.2012.05.006; Rizos EC, 2013, EUR J PHARMACOL, V706, P1, DOI 10.1016/j.ejphar.2013.02.050; Rodriguez-Leyva D, 2010, CAN J CARDIOL, V26, P489, DOI 10.1016/S0828-282X(10)70455-4; Ryu SK, 2009, J CARDIOVASC TRANSL, V2, P240, DOI 10.1007/s12265-009-9105-x; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Valenzuela P, 2012, NANOMED-NANOTECHNOL, V8, pS83, DOI 10.1016/j.nano.2012.05.008; Volcik KA, 2009, CLIN CHEM, V55, P1076, DOI 10.1373/clinchem.2008.119487; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xu SP, 2014, REDOX BIOL, V2, P642, DOI 10.1016/j.redox.2014.04.004; Yeap BB, 2014, J AM MED DIR ASSOC, V15, P326, DOI 10.1016/j.jamda.2013.12.004; Yu SS, 2011, WIRES NANOMED NANOBI, V3, P620, DOI 10.1002/wnan.158	62	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147337	10.1371/journal.pone.0147337	http://dx.doi.org/10.1371/journal.pone.0147337			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840601	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200033
J	Vigors, S; O'Doherty, JV; Kelly, AK; O'Shea, CJ; Sweeney, T				Vigors, Stafford; O'Doherty, John V.; Kelly, Alan K.; O'Shea, Cormac J.; Sweeney, Torres			The Effect of Divergence in Feed Efficiency on the Intestinal Microbiota and the Intestinal Immune Response in Both Unchallenged and Lipopolysaccharide Challenged Ileal and Colonic Explants	PLOS ONE			English	Article							GASTROINTESTINAL FERMENTATION; PIGS; QUANTIFICATION; NUTRITION; INFECTION; EMISSIONS; BACTERIA; AMMONIA; SYSTEM; TRACT	Feed efficiency is an important trait in pig production, with evidence to suggest that the efficiencies of a variety of biological systems contribute to variation in this trait. Little work has been conducted on the contribution of the intestinal innate immune response to divergence in feed efficiency. Hence, the objective of this study was to examine select bacterial populations and gene expression profiles of a range of targets relating to gut health and immunity in the intestine of pigs phenotypically divergent in feed efficiency in: a) the basal state; and (b) following an ex-vivo lipopolysaccharide (LPS) challenge of ileal and colonic tissue. Male pigs (initial BW22.4 kg (SD = 2.03)) were fed a standard finishing diet for the final 43 days prior to slaughter to evaluate feed intake and growth for the purpose of calculating residual feed intake (RFI). On day 115, 16 animals (average weight 85 kg, SEM 2.8 kg), designated high RFI (HRFI) and low RFI (LRFI) were slaughtered. The LRFI pigs had increased lactobacillus spp. in the caecum compared to HRFI pigs (P < 0.05). RFI groups did not differ in the expression of the measured genes involved in the innate immune system in the basal ileal or colonic tissues (P > 0.10). Interestingly, there was an interaction between RFI and LPS for the cytokines IL-8, IL-1, IL-6, TNF-alpha, Interferon-gamma (IFN-gamma) and SOCS3, with the LRFI group having consistently lower gene expression in the colon following the LPS challenge, compared to the HRFI group. The lower gene expression of SOCS and cytokines following an ex vivo LPS challenge supports the theory that a possible energy saving mechanism exists in the intestinal innate immune response to an immune challenge in more feed efficient pigs.	[Vigors, Stafford; O'Doherty, John V.; Kelly, Alan K.] Natl Univ Ireland Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland; [Sweeney, Torres] Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland; [O'Shea, Cormac J.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University College Dublin; University College Dublin; University of Sydney	Sweeney, T (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland.	john.vodoherty@ucd.ie	O'Doherty, John/AAS-7261-2021; O'Shea, Cormac/U-7635-2019	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X; Vigors, Stafford/0000-0002-9304-2925; O'Shea, Cormac/0000-0002-1797-1941	Earth and Natural Sciences Doctoral Studies Programme under programme for Research in Third-Level Institutions; European Regional Development Fund	Earth and Natural Sciences Doctoral Studies Programme under programme for Research in Third-Level Institutions; European Regional Development Fund(European Commission)	This study was funded under the Earth and Natural Sciences Doctoral Studies Programme, which is funded under the programme for Research in Third-Level Institutions and co-funded under the European Regional Development Fund.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Canny GO, 2008, INFECT IMMUN, V76, P3360, DOI 10.1128/IAI.00187-08; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cotter PF, 2006, POULTRY SCI, V85, P435, DOI 10.1093/ps/85.3.435; Dunkelberger JR, 2015, LIVEST SCI, V177, P132, DOI 10.1016/j.livsci.2015.04.014; Han GQ, 2012, MOL BIOL REP, V39, P1869, DOI 10.1007/s11033-011-0932-x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Johnson R.W., 2012, FEED EFFICIENCY SWIN, P211; JOHNSON RW, 1994, J ANIM SCI, V72, P309, DOI 10.2527/1994.722309x; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Klasing KC, 2007, BRIT POULTRY SCI, V48, P525, DOI 10.1080/00071660701671336; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; LINKAMSTER H, 1994, FEMS IMMUNOL MED MIC, V10, P55, DOI 10.1111/j.1574-695X.1994.tb00011.x; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091091; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lynch MB, 2008, ANIMAL, V2, P425, DOI 10.1017/S1751731107001267; Madara JL, 1989, MONOGR PATHOL, P306; Mair KH, 2014, DEV COMP IMMUNOL, V45, P321, DOI 10.1016/j.dci.2014.03.022; Mani V, 2013, J ANIM SCI, V91, P2141, DOI 10.2527/jas.2012-6053; McKay DM, 1999, GUT, V44, P283, DOI 10.1136/gut.44.2.283; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; O'Shea CJ, 2012, J ANIM SCI, V90, P3848, DOI 10.2527/jas.2011-4461; O'Shea CJ, 2010, J ANIM SCI, V88, P1411, DOI 10.2527/jas.2009-2115; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Rakhshandeh A, 2012, J ANIM SCI, V90, P233, DOI 10.2527/jas.53976; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; Richards JD, 2005, CAN J ANIM SCI, V85, P421, DOI 10.4141/A05-049; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schierack P, 2007, MICROBIOL-SGM, V153, P3830, DOI 10.1099/mic.0.2007/010173-0; Vaughan EE, 1999, CURR OPIN BIOTECH, V10, P505, DOI 10.1016/S0958-1669(99)00018-X; Vigors S, 2014, ADSA ASAS CSAS JOINT	34	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148145	10.1371/journal.pone.0148145	http://dx.doi.org/10.1371/journal.pone.0148145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840831	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200086
J	Junaid, M; Almuqri, EA; Liu, JJ; Zhang, HJ				Junaid, Muhammad; Almuqri, Eman Abdullah; Liu, Junjun; Zhang, Houjin			Analyses of the Binding between Water Soluble C60 Derivatives and Potential Drug Targets through a Molecular Docking Approach	PLOS ONE			English	Article							PARTICLE MESH EWALD; LUMAZINE SYNTHASE; ALZHEIMERS-DISEASE; FULLERENE DERIVATIVES; POLYHYDROXYLATED C-60; N-MYRISTOYLTRANSFERASE; GLUTAMATE RACEMASE; CRYSTAL-STRUCTURE; MODEL; INHIBITORS	Fullerene C60, a unique sphere-shaped molecule consisting of carbon, has been proved to have inhibitory effects on many diseases. However, the applications of C60 in medicine have been severely hindered by its complete insolubility in water and low solubility in almost all organic solvents. In this study, the water-soluble C60 derivatives and the C60 binding protein's structures were collected from the literature. The selected proteins fall into several groups, including acetylcholinesterase, glutamate racemase, inosine monophosphate dehydrogenase, lumazine synthase, human estrogen receptor alpha, dihydrofolate reductase and N-myristoyltransferase. The C60 derivatives were docked into the binding sites in the proteins. The binding affinities of the C60 derivatives were calculated. The bindings between proteins and their known inhibitors or native ligands were also characterized in the same way. The results show that C60 derivatives form good interactions with the binding sites of different protein targets. In many cases, the binding affinities of C60 derivatives are better than those of known inhibitors and native ligands. This study demonstrates the interaction patterns of C60 derivatives and their binding partners, which will have good impact on the fullerene-based drug discovery.	[Junaid, Muhammad; Almuqri, Eman Abdullah; Zhang, Houjin] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Houjin] Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China; [Liu, Junjun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, HJ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China.; Zhang, HJ (corresponding author), Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China.	hjzhang@hust.edu.cn	Junaid, Dr. Muhammad/ABF-9669-2021		National Key Basic Research Program of China [2013CB933900]	National Key Basic Research Program of China(National Basic Research Program of China)	This work is financially supported by National Key Basic Research Program of China (No. 2013CB933900).	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Anderson RE, 2013, DALTON T, V42, P2186, DOI 10.1039/c2dt32523c; Babic T, 1999, J NEUROL NEUROSUR PS, V67, P558, DOI 10.1136/jnnp.67.4.558; Bacher A, 2001, VITAM HORM, V61, P1; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; BECKER L, 1993, J ORG CHEM, V58, P7630, DOI 10.1021/jo00079a002; BENSASSON RV, 1994, J PHYS CHEM-US, V98, P3492, DOI 10.1021/j100064a035; Bobylev AG, 2011, ORG BIOMOL CHEM, V9, P5714, DOI 10.1039/c1ob05067b; Bosi S, 2003, BIOORG MED CHEM LETT, V13, P4437, DOI 10.1016/j.bmcl.2003.09.016; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Braun T, 1997, FULLERENE SCI TECHN, V5, P615, DOI 10.1080/15363839708015912; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; BUGG TDH, 1992, NAT PROD REP, V9, P199, DOI 10.1039/np9920900199; Cai XQ, 2008, J NEUROSCI RES, V86, P3622, DOI 10.1002/jnr.21805; Calvaresi M, 2010, ACS NANO, V4, P2283, DOI 10.1021/nn901809b; Case D., 2015, AMBER, V14; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; CHIANG LY, 1992, J AM CHEM SOC, V114, P10154, DOI 10.1021/ja00052a010; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434; Dugan LL, 1996, NEUROBIOL DIS, V3, P129, DOI 10.1006/nbdi.1996.0013; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fischer M, 2003, J MOL BIOL, V326, P783, DOI 10.1016/S0022-2836(02)01473-0; Fisher SL, 2008, MICROB BIOTECHNOL, V1, P345, DOI 10.1111/j.1751-7915.2008.00031.x; FRIEDMAN SH, 1993, J AM CHEM SOC, V115, P6506, DOI 10.1021/ja00068a005; GALLO KA, 1993, BIOCHEMISTRY-US, V32, P3991, DOI 10.1021/bi00066a020; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Goncalves AD, 2016, J BIOMOL STRUCT DYN, V34, P1307, DOI 10.1080/07391102.2015.1077345; Gottwald, 1999, Expert Opin Investig Drugs, V8, P1673, DOI 10.1517/13543784.8.10.1673; GREGORET LM, 1991, PROTEINS, V9, P99, DOI 10.1002/prot.340090204; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Harer SL, 2014, J PHARM BIOALLIED SC, V6, P285, DOI 10.4103/0975-7406.142962; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HOWARD JB, 1991, NATURE, V352, P139, DOI 10.1038/352139a0; Hu Z, 2012, CHEM-BIOL INTERACT, V195, P86, DOI 10.1016/j.cbi.2011.11.003; HUNGERBUHLER H, 1993, J AM CHEM SOC, V115, P3386, DOI 10.1021/ja00061a070; HWANG KC, 1992, J AM CHEM SOC, V114, P9705, DOI 10.1021/ja00050a086; Hwang KY, 1999, NAT STRUCT BIOL, V6, P422; Jensen AW, 1996, BIOORGAN MED CHEM, V4, P767, DOI 10.1016/0968-0896(96)00081-8; Jin H, 2000, J NEUROSCI RES, V62, P600, DOI 10.1002/1097-4547(20001115)62:4<600::AID-JNR15>3.0.CO;2-F; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARFUNKEL HR, 1992, J COMPUT AID MOL DES, V6, P521, DOI 10.1007/BF00130402; Kelly CA, 1997, BRIT MED J, V314, P693, DOI 10.1136/bmj.314.7082.693; KOSHLAND DE, 1991, SCIENCE, V254, P1705, DOI 10.1126/science.254.5039.1705; Kozlikova B, 2014, BIOINFORMATICS, V30, P2684, DOI 10.1093/bioinformatics/btu364; KROTO HW, 1991, CHEM REV, V91, P1213, DOI 10.1021/cr00006a005; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lam T, 2014, J MED CHEM, V57, P651, DOI 10.1021/jm401204g; Lu LH, 1998, BRIT J PHARMACOL, V123, P1097, DOI 10.1038/sj.bjp.0701722; McKenna MT, 1997, J MED CHEM, V40, P3516; Morgunova E, 2005, BIOCHEMISTRY-US, V44, P2746, DOI 10.1021/bi047848a; Morgunova E, 2007, J BIOL CHEM, V282, P17231, DOI 10.1074/jbc.M701724200; Morgunova E, 2006, FEBS J, V273, P4790, DOI 10.1111/j.1742-4658.2006.05481.x; Moussa F, 1996, FULLERENE SCI TECHN, V4, P21, DOI 10.1080/10641229608001534; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Oliveira AA, 2011, J BIOMOL STRUCT DYN, V29, P351, DOI 10.1080/07391102.2011.10507390; Prosise GL, 2002, J BIOL CHEM, V277, P50654, DOI 10.1074/jbc.M208330200; Puig E, 2005, J CHEM THEORY COMPUT, V1, P737, DOI 10.1021/ct049881g; Roberts AJ, 2014, BIOCHEM J, V459, P323, DOI 10.1042/BJ20131033; Russo P, 2013, CURR MED CHEM, V20, P976; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samal S, 2000, CHEM COMMUN, P1101, DOI 10.1039/b000710m; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; Scott LJ, 2000, DRUGS, V60, P1095, DOI 10.2165/00003495-200060050-00008; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; SIJBESMA R, 1993, J AM CHEM SOC, V115, P6510, DOI 10.1021/ja00068a006; Sivaraman N, 2001, J CHEM INF COMP SCI, V41, P1067, DOI 10.1021/ci010003a; SRINIVAS R, 1993, J AM SOC MASS SPECTR, V4, P894, DOI 10.1016/1044-0305(93)87007-Y; Tagmatarchis N., 2001, Mini-Reviews in Medicinal Chemistry, V1, P339, DOI 10.2174/1389557013406693; TANNER ME, 1993, BIOCHEMISTRY-US, V32, P3998, DOI 10.1021/bi00066a021; Tate EW, 2014, PARASITOLOGY, V141, P37, DOI 10.1017/S0031182013000450; TEBBE FN, 1992, SCIENCE, V256, P822, DOI 10.1126/science.256.5058.822; TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064; Troshina OA, 2007, ORG BIOMOL CHEM, V5, P2783, DOI 10.1039/b705331b; Tsai MC, 1997, J PHARM PHARMACOL, V49, P438, DOI 10.1111/j.2042-7158.1997.tb06821.x; WALSH CT, 1989, J BIOL CHEM, V264, P2393; Whalen KL, 2010, ACS MED CHEM LETT, V1, P9, DOI 10.1021/ml900005b; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]; Wu J, 2007, J BIOL CHEM, V282, P22185, DOI 10.1074/jbc.M702696200; Xie NZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137113; Xu MM, 2015, CRIT REV EUKAR GENE, V25, P259, DOI 10.1615/CritRevEukaryotGeneExpr.2015013978; YAMAKOSHI YN, 1994, J CHEM SOC CHEM COMM, P517, DOI 10.1039/c39940000517; Zhang XF, 2003, J MOL BIOL, V328, P167, DOI 10.1016/S0022-2836(03)00186-4; Zhang You-wen, 2014, Yaoxue Xuebao, V49, P285; Zhou CS, 2011, CHEM COMMUN, V47, P2982, DOI 10.1039/c0cc04919k; Zwanzig R., 1973, J STAT PHYS, V9, P215, DOI DOI 10.1007/BF01008729	92	22	22	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147761	10.1371/journal.pone.0147761	http://dx.doi.org/10.1371/journal.pone.0147761			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829126	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200031
J	Lorenz, S; Bhattacharyya, M; Feiler, C; Rape, M; Kuriyan, J				Lorenz, Sonja; Bhattacharyya, Moitrayee; Feiler, Christian; Rape, Michael; Kuriyan, John			Crystal Structure of a Ube2S-Ubiquitin Conjugate	PLOS ONE			English	Article							UBIQUITIN CHAIN ELONGATION; E3 LIGASE; MECHANISM; ENZYME; REVEALS; ACTIVATION; INSIGHTS; COMPLEX; INHIBITION; PROMOTE	Protein ubiquitination occurs through the sequential formation and reorganization of specific protein-protein interfaces. Ubiquitin-conjugating (E2) enzymes, such as Ube2S, catalyze the formation of an isopeptide linkage between the C-terminus of a "donor" ubiquitin and a primary amino group of an "acceptor" ubiquitin molecule. This reaction involves an intermediate, in which the C-terminus of the donor ubiquitin is thioester-bound to the active site cysteine of the E2 and a functionally important interface is formed between the two proteins. A docked model of a Ube2S-donor ubiquitin complex was generated previously, based on chemical shift mapping by NMR, and predicted contacts were validated in functional studies. We now present the crystal structure of a covalent Ube2S-ubiquitin complex. The structure contains an interface between Ube2S and ubiquitin in trans that resembles the earlier model in general terms, but differs in detail. The crystallographic interface is more hydrophobic than the earlier model and is stable in molecular dynamics (MD) simulations. Remarkably, the docked Ube2S-donor complex converges readily to the configuration seen in the crystal structure in 3 out of 8 MD trajectories. Since the crystallographic interface is fully consistent with mutational effects, this indicates that the structure provides an energetically favorable representation of the functionally critical Ube2S-donor interface.	[Lorenz, Sonja; Bhattacharyya, Moitrayee; Rape, Michael; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Lorenz, Sonja; Bhattacharyya, Moitrayee; Rape, Michael; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Lorenz, Sonja; Feiler, Christian] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Rape, Michael; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Wurzburg; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Kuriyan, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Lorenz, Sonja/AAL-4499-2020	Lorenz, Sonja/0000-0002-9639-2381; Rape, Michael/0000-0003-4849-6343	Leukemia and Lymphoma Society [LLS 5509-11]; Emmy Noether Program of the German Research Foundation [LO 2003/1-1]; Human Frontiers Science Program [LT000002/2013]; NHI [NIGMS]; Howard Hughes Medical Institute	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Emmy Noether Program of the German Research Foundation(German Research Foundation (DFG)); Human Frontiers Science Program(Human Frontier Science Program); NHI [NIGMS]; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported in part by the Leukemia and Lymphoma Society [grant number LLS 5509-11 (to SL)], the Emmy Noether Program of the German Research Foundation [grant number LO 2003/1-1 (to SL)], the Human Frontiers Science Program [grant number LT000002/2013 (to MB)], and an NHI RO1 grant [NIGMS (to MR)]. JK and MR are funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chen ZD, 1998, NUCLEIC ACIDS RES, V26, P1126, DOI 10.1093/nar/26.4.1126; Cohen I, 2015, P NATL ACAD SCI USA, V112, pE625, DOI 10.1073/pnas.1415621112; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Grishin AM, 2014, STRUCTURE, V22, P878, DOI 10.1016/j.str.2014.04.010; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Huang H, 2014, NAT CHEM BIOL, V10, P156, DOI [10.1038/NCHEMBIO.1412, 10.1038/nchembio.1412]; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lorenz S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-65; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Page RC, 2012, BIOCHEMISTRY-US, V51, P4175, DOI 10.1021/bi300058m; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	51	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147550	10.1371/journal.pone.0147550	http://dx.doi.org/10.1371/journal.pone.0147550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828794	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200024
J	Rao, Q; You, A; Guo, ZL; Zuo, BF; Gao, XJ; Zhang, T; Du, Z; Wu, CX; Yin, HF				Rao, Quan; You, Abin; Guo, Zhenglong; Zuo, Bingfeng; Gao, Xianjun; Zhang, Ti; Du, Zhi; Wu, Chenxuan; Yin, HaiFang			Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models	PLOS ONE			English	Article							TUMOR-GROWTH; NUDE-MICE; TRANSITION; LIVER; LUNG	Mouse models are commonly used for studying hepatocellular carcinoma (HCC) biology and exploring new therapeutic interventions. Currently three main modalities of HCC mouse models have been extensively employed in pre-clinical studies including chemically induced, transgenic and transplantation models. Among them, transplantation models are preferred for evaluating in vivo drug efficacy in pre-clinical settings given the short latency, uniformity in size and close resemblance to tumors in patients. However methods used for establishing orthotopic HCC transplantation mouse models are diverse and fragmentized without a comprehensive comparison. Here, we systemically evaluate four different approaches commonly used to establish HCC mice in preclinical studies, including intravenous, intrasplenic, intrahepatic inoculation of tumor cells and intrahepatic tissue implantation. Four parameters-the latency period, take rates, pathological features and metastatic rates-were evaluated side-by-side. 100% take rates were achieved in liver with intrahepatic, intrasplenic inoculation of tumor cells and intrahepatic tissue implantation. In contrast, no tumor in liver was observed with intravenous injection of tumor cells. Intrahepatic tissue implantation resulted in the shortest latency with 0.5cm (longitudinal diameter) tumors found in liver two weeks after implantation, compared to 0.1cm for intrahepatic inoculation of tumor cells. Approximately 0.1cm tumors were only visible at 4 weeks after intrasplenic inoculation. Uniform, focal and solitary tumors were formed with intrahepatic tissue implantation whereas multinodular, dispersed and non-uniform tumors produced with intrahepatic and intrasplenic inoculation of tumor cells. Notably, metastasis became visible in liver, peritoneum and mesenterium at 3 weeks post-implantation, and lung metastasis was visible after 7 weeks. T cell infiltration was evident in tumors, resembling the situation in HCC patients. Our study demonstrated that orthotopic HCC mouse models established via intrahepatic tissue implantation authentically reflect clinical manifestations in HCC patients pathologically and immunologically, suggesting intrahepatic tissue implantation is a preferable approach for establishing orthotopic HCC mouse models.	[Rao, Quan; You, Abin; Guo, Zhenglong; Zuo, Bingfeng; Gao, Xianjun; Yin, HaiFang] Tianjin Med Univ, Dept Cell Biol, Qixiangtai Rd, Tianjin 300070, Peoples R China; [Rao, Quan; You, Abin; Guo, Zhenglong; Zuo, Bingfeng; Gao, Xianjun; Yin, HaiFang] Tianjin Med Univ, Res Ctr Basic Med Sci, Qixiangtai Rd, Tianjin 300070, Peoples R China; [Rao, Quan; Du, Zhi; Wu, Chenxuan] Tianjin Med Univ, Cent Clin Coll 3, Jintang Rd, Tianjin 300170, Peoples R China; [You, Abin; Zhang, Ti] Tianjin Med Univ, Tianjin Canc Hosp, Huanhu West Rd, Tianjin 300000, Peoples R China; [Du, Zhi] Tianjin Med Univ, Cent Hosp 3, Inst Hepatobiliary Dis, Dept Hepatobiliary Surg,Key Lab Artificial Cell, Jintang Rd, Tianjin 300170, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yin, HF (corresponding author), Tianjin Med Univ, Dept Cell Biol, Qixiangtai Rd, Tianjin 300070, Peoples R China.; Yin, HF (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Qixiangtai Rd, Tianjin 300070, Peoples R China.; Wu, CX (corresponding author), Tianjin Med Univ, Cent Clin Coll 3, Jintang Rd, Tianjin 300170, Peoples R China.	haifangyin@tmu.edu.cn; chenxuanw@aliyun.com			Chinese National Basic Research Program (973) [2012CBA01305, 2012CB932503]; National Natural Science Foundation of China [81273420, 81501531, 81361128013]; Research Fund for the Doctoral Program of Higher Education of China [20111202110002]	Chinese National Basic Research Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by Chinese National Basic Research Program (973) (no. 2012CBA01305, 2012CB932503), National Natural Science Foundation of China (grant no. 81273420, 81501531, and 81361128013), and Research Fund for the Doctoral Program of Higher Education of China (no. 20111202110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Foster JR, 2005, TOXICOL PATHOL, V33, P63, DOI 10.1080/01926230590890196; Gao YS, 2004, WORLD J GASTROENTERO, V10, P3107; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Kang JH, 2009, VET J, V181, P336, DOI 10.1016/j.tvjl.2008.04.001; Kim J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12315; Leenders MWH, 2008, WORLD J GASTROENTERO, V14, P6915, DOI 10.3748/wjg.14.6915; LeveilleWebster CR, 1996, CLIN CANCER RES, V2, P695; Li JF, 2011, CANCER BIOL THER, V12, P737, DOI 10.4161/cbt.12.8.16442; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Lin SB, 2012, LIVER CANCER, V1, P144, DOI 10.1159/000343828; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048075; Markowitz GJ, 2015, SCI BULL, V60, P762, DOI 10.1007/s11434-015-0772-5; Okubo H, 2007, J GASTROEN HEPATOL, V22, P423, DOI 10.1111/j.1440-1746.2006.04520.x; Sun FX, 1996, INT J CANCER, V66, P239, DOI 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.3.CO;2-G; Terada T, 2013, INT J CLIN EXP PATHO, V6, P816; Wang BF, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-43; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Zhao GJ, 2012, WORLD J GASTROENTERO, V18, P7087, DOI 10.3748/wjg.v18.i47.7087; Zhou X, 2014, TUMOR BIOL, V35, P12561, DOI 10.1007/s13277-014-2576-7	21	9	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148263	10.1371/journal.pone.0148263	http://dx.doi.org/10.1371/journal.pone.0148263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824903	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600113
J	Suo, QH; Zhang, DM				Suo, Qinghui; Zhang, Daming			Psychological Differences toward Pedestrian Red Light Crossing between University Students and Their Peers	PLOS ONE			English	Article							ULTRA-ORTHODOX; BEHAVIOR; DRIVER; MODEL	Based on our site investigation conducted in 2013, we found that the pedestrian red light crossing at the midblock connecting the campus of Southwest University and living area was low, where most of pedestrians are university students and staff. This paper reports a supplementary work applying the Theory of Planned Behaviour (TPB) to identify any psychological differences toward pedestrian red light crossing between university students and their peers. Three social groups participated in the investigation. The first group is the university students in Grade one (Group 1), the other two groups are their previous senior middle school classmates who are now working full time (Group 2) or who are now out of work and school (Group 3). The statistical results indicated The TPB components accounted for 42.9%, 55.3% and 55.4% of the variance of red signal crossing intention for Group 1, Group 2 and Group 3 in the depicted road crossing scenario. The data also showed that there are obvious differences among the participants' responses to "refrain from crossing" between university students and others, and the subsequent regression analysis revealed the ability to "refrain from crossing" played the most important role in the intention of red light crossing in the depicted scenario.	[Suo, Qinghui; Zhang, Daming] Southwest Univ, Sch Engn & Technol, Chongqing 400715, Peoples R China	Southwest University - China	Suo, QH (corresponding author), Southwest Univ, Sch Engn & Technol, Chongqing 400715, Peoples R China.	suo@swu.edu.cn		suo, qinghui/0000-0003-2064-2687	Chongqing Science and Technology Commission [CSTC, 20011BB6016]; Southwest University [SWU111005]	Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC); Southwest University(Southwest University - China)	This work was supported by Chongqing Science and Technology Commission [grant number CSTC, 20011BB6016](URL:http://wkj.cq.gov.cn/); and Southwest University [grant number SWU111005] (url:www.swu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2015, HEALTH PSYCHOL REV, V9, P131, DOI 10.1080/17437199.2014.883474; Andrws BR, 1903, AM J PSYCHOL, V14, P121, DOI 10.2307/1412711; [Anonymous], 2002, TRANSP RES F, DOI DOI 10.1016/S1369-8478(02)00015-3; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bernhoft IM, 2008, TRANSPORT RES F-TRAF, V11, P83, DOI 10.1016/j.trf.2007.08.004; Cinnamon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021063; Evans D, 1998, HEALTH EDUC RES, V13, P481, DOI 10.1093/her/13.4.481-a; Guo HW, 2011, TRAFFIC INJ PREV, V12, P96, DOI 10.1080/15389588.2010.518652; Guo RY, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/11/118903; Guo RY, 2015, J SYSTEMS SCI COMPLE; Hamed MM, 2001, SAFETY SCI, V38, P63, DOI 10.1016/S0925-7535(00)00058-8; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Morris J., 2012, THEORIES MODELS BEHA; Rosenbloom T, 2006, SOC BEHAV PERSONAL, V34, P113, DOI 10.2224/sbp.2006.34.2.113; Rosenbloom T, 2004, TRANSPORT RES F-TRAF, V7, P395, DOI 10.1016/j.trf.2004.10.004; Rosenbloom T, 2011, ACCIDENT ANAL PREV, V43, P2010, DOI 10.1016/j.aap.2011.05.019; Rosenbloom T, 2009, TRANSPORT RES F-TRAF, V12, P389, DOI 10.1016/j.trf.2009.05.002; Rosenbloom T, 2008, ACCIDENT ANAL PREV, V40, P1919, DOI 10.1016/j.aap.2008.08.004; Simpson G, 2003, ACCIDENT ANAL PREV, V35, P787, DOI 10.1016/S0001-4575(02)00081-7; Simsekoglu O, 2015, TRAFFIC INJ PREV, V16, P84, DOI 10.1080/15389588.2014.880785; Sun K., 1993, J GANG RES, V1, P39; Tang TQ, 2011, INT J MOD PHYS B, V25, P4471, DOI 10.1142/S0217979211059462; Tang TQ, 2012, TRANSPORT RES C-EMER, V22, P1, DOI 10.1016/j.trc.2011.11.005; Taubman-Ben-Ari O, 2012, TRANSPORT RES F-TRAF, V15, P188, DOI 10.1016/j.trf.2011.12.005; Tiwari G, 2007, TRANSPORT RES F-TRAF, V10, P77, DOI 10.1016/j.trf.2006.06.002; Tom A, 2011, ACCIDENT ANAL PREV, V43, P1794, DOI 10.1016/j.aap.2011.04.012; Torgler B, 2006, J ECON BEHAV ORGAN, V61, P81, DOI 10.1016/j.jebo.2004.10.007; Wang WH, 2011, INT J CRASHWORTHINES, V16, P1, DOI 10.1080/13588265.2010.491715; World Health Organization (WHO), 2013, PED SAF ROAD SAF MAN; Xu YS, 2013, ACCIDENT ANAL PREV, V50, P811, DOI 10.1016/j.aap.2012.07.007; Yang JG, 2006, TRANSPORT RES A-POL, V40, P280, DOI 10.1016/j.tra.2005.08.001; Zhou RG, 2009, ACCIDENT ANAL PREV, V41, P491, DOI 10.1016/j.aap.2009.01.007; Zhuang XL, 2014, ACCIDENT ANAL PREV, V70, P235, DOI 10.1016/j.aap.2013.12.015	34	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148000	10.1371/journal.pone.0148000	http://dx.doi.org/10.1371/journal.pone.0148000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824667	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600086
J	Beklemisheva, VR; Perelman, PL; Lemskaya, NA; Kulemzina, AI; Proskuryakova, AA; Burkanov, VN; Graphodatsky, AS				Beklemisheva, Violetta R.; Perelman, Polina L.; Lemskaya, Natalya A.; Kulemzina, Anastasia I.; Proskuryakova, Anastasia A.; Burkanov, Vladimir N.; Graphodatsky, Alexander S.			The Ancestral Carnivore Karyotype As Substantiated by Comparative Chromosome Painting of Three Pinnipeds, the Walrus, the Steller Sea Lion and the Baikal Seal (Pinnipedia, Carnivora)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; BANDING PATTERNS; EVOLUTION; INTERRELATIONSHIPS; HOMOPLASY; HEMIPLASY; ORIGIN; CAT; DOG; MAP	Karyotype evolution in Carnivora is thoroughly studied by classical and molecular cytogenetics and supplemented by reconstructions of Ancestral Carnivora Karyotype (ACK). However chromosome painting information from two pinniped families (Odobenidae and Otariidae) is noticeably missing. We report on the construction of the comparative chromosome map for species from each of the three pinniped families: the walrus (Odobenus rosmarus, Odobenidae-monotypic family), near threatened Steller sea lion (Eumetopias jubatus, Otariidae) and the endemic Baikal seal (Pusa sibirica, Phocidae) using combination of human, domestic dog and stone marten whole-chromosome painting probes. The earliest karyological studies of Pinnipedia showed that pinnipeds were characterized by a pronounced karyological conservatism that is confirmed here with species from Phocidae, Otariidae and Odobenidae sharing same low number of conserved human autosomal segments (32). Chromosome painting in Pinnipedia and comparison with non-pinniped carnivore karyotypes provide strong support for refined structure of ACK with 2n = 38. Constructed comparative chromosome maps show that pinniped karyotype evolution was characterized by few tandem fusions, seemingly absent inversions and slow rate of genome rearrangements (less then one rearrangement per 10 million years). Integrative comparative analyses with published chromosome painting of Phoca vitulina revealed common cytogenetic signature for Phoca/Pusa branch and supports Phocidae and Otaroidea (Otariidae/Odobenidae) as sister groups. We revealed rearrangements specific for walrus karyotype and found the chromosomal signature linking together families Otariidae and Odobenidae. The Steller sea lion karyotype is the most conserved among three studied species and differs from the ACK by single fusion. The study underlined the strikingly slow karyotype evolution of the Pinnipedia in general and the Otariidae in particular.	[Beklemisheva, Violetta R.; Perelman, Polina L.; Lemskaya, Natalya A.; Kulemzina, Anastasia I.; Proskuryakova, Anastasia A.; Graphodatsky, Alexander S.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Dept Comparat Genom, Novosibirsk, Russia; [Burkanov, Vladimir N.] Russian Acad Sci, Far East Branch, Pacific Geog Inst, Dept Higher Vertebrates Ecol,Kamchatka Branch, Petropavlovsk Kamchatski, Russia; [Burkanov, Vladimir N.] NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Perelman, Polina L.; Proskuryakova, Anastasia A.; Graphodatsky, Alexander S.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; National Oceanic Atmospheric Admin (NOAA) - USA; Novosibirsk State University	Beklemisheva, VR (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Dept Comparat Genom, Novosibirsk, Russia.	bekl@mcb.nsc.ru	Perelman, Polina/N-8088-2015; Kulemzina, Anastasia I/N-8554-2015; Proskuryakova, Anastasiya/N-8059-2015; Graphodatsky, Alexander/B-4922-2010; Perelman, Polina/AAD-9030-2019; Beklemisheva, Violetta R./N-9532-2015; Lemskaya, Natalya A./N-5609-2015; Burkanov, Vladimir/C-3116-2012	Perelman, Polina/0000-0002-0982-5100; Graphodatsky, Alexander/0000-0002-8282-1085; Perelman, Polina/0000-0002-0982-5100; Lemskaya, Natalya/0000-0002-3682-6125; Kulemzina, Anastasia/0000-0002-6791-5120; Burkanov, Vladimir/0000-0002-0129-7884	Russian Foundation for Basic Research [14-04-00467, 15-04-00962, 15-29-02384]; Molecular and Cell Biology of RAS	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cell Biology of RAS	This work was supported by Russian Foundation for Basic Research (https://kias.rfbr.ru): project 14-04-00467 to VRB; project 15-04-00962 to ASG; project 15-29-02384 to ASG and the Research grant of the Molecular and Cell Biology of RAS to ASG.	[Anonymous], 1999, WALKERS MAMMALS WORL; ARNASON U, 1970, HEREDITAS-GENETISK A, V64, P237; ARNASON U, 1972, HEREDITAS-GENETISK A, V70, P113; ARNASON U, 1974, HEREDITAS, V76, P179; ARNASON U, 1977, HEREDITAS, V87, P227; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Bielec PE, 1998, CYTOGENET CELL GENET, V81, P18, DOI 10.1159/000015002; Bininda-Emonds ORP, 2000, EVOLUTION, V54, P1011; Breen M, 1999, GENOMICS, V61, P145, DOI 10.1006/geno.1999.5947; Cavagna P, 2000, MAMM GENOME, V11, P866, DOI 10.1007/s003350010172; DUTRILLAUX B, 1983, CYTOGENET CELL GENET, V35, P200, DOI 10.1159/000131867; FAY FH, 1967, CAN J ZOOLOG, V45, P773, DOI 10.1139/z67-088; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; Ferguson-Smith MA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0125-8; FergusonSmith MA, 1997, EUR J HUM GENET, V5, P253, DOI 10.1159/000484775; Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198; Fronicke L, 1997, CHROMOSOMA, V106, P108; Graphodatsky A, 2001, CYTOGENET CELL GENET, V92, P243, DOI 10.1159/000056911; Graphodatsky A.S., 1989, P95; GRAPHODATSKY AS, 1987, GENETIKA+, V23, P93; Graphodatsky AS, 2000, CYTOGENET CELL GENET, V88, P296, DOI 10.1159/000015513; Hameister H, 1997, CHROMOSOME RES, V5, P5, DOI 10.1023/A:1018433200553; Jones KE, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0285-5; Kellogg ME, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-6; Kulemzina AI, 2009, CHROMOSOME RES, V17, P419, DOI 10.1007/s10577-009-9032-3; MITCHELL E, 1967, SYST ZOOL, V16, P350, DOI 10.2307/2412158; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; Nash WG, 1998, CYTOGENET CELL GENET, V83, P182, DOI 10.1159/000015176; Nash WG, 2001, CYTOGENET CELL GENET, V95, P210, DOI 10.1159/000059348; Nash WG, 2006, ATLAS MAMMALIAN CHRO, P537; Nash WG, 2006, ATLAS MAMMALIAN CHRO, P445; Nash WG, 2008, J HERED, V99, P241, DOI 10.1093/jhered/esm130; Nie W, 2012, HEREDITY, V108, P17, DOI 10.1038/hdy.2011.107; Nie WH, 2002, CHROMOSOME RES, V10, P209, DOI 10.1023/A:1015292005631; OBRIEN SJ, 1982, SCIENCE, V216, P257, DOI 10.1126/science.7063884; Perelman PL, 2012, CYTOGENET GENOME RES, V137, P174, DOI 10.1159/000341389; Perelman PL, 2008, CHROMOSOME RES, V16, P1215, DOI 10.1007/s10577-008-1270-2; Robinson TJ, 2008, P NATL ACAD SCI USA, V105, P14477, DOI 10.1073/pnas.0807433105; Robinson TJ, 2011, SYST BIOL, V60, P439, DOI 10.1093/sysbio/syr045; ROBINSON TJ, 1979, CYTOGENET CELL GENET, V23, P157, DOI 10.1159/000131321; Ruiz-Herrera A, 2012, HEREDITY, V108, P28, DOI 10.1038/hdy.2011.102; Sato JJ, 2006, ZOOL SCI, V23, P125, DOI 10.2108/zsj.23.125; SEABRIGH.M, 1971, LANCET, V2, P971; STANYON R, 1991, B ZOOL, V58, P81, DOI 10.1080/11250009109355732; Tian Y, 2004, CHROMOSOME RES, V12, P55, DOI 10.1023/B:CHRO.0000009299.59969.fa; Trifonov VA, 2012, CYTOGENET GENOME RES, V137, P208, DOI 10.1159/000339900; Vorontsov N, 1969, MAMMALS EVOLUTION KA, P23; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WURSTERHILL DH, 1982, CYTOGENET CELL GENET, V34, P178, DOI 10.1159/000131806; WURSTERHILL DH, 1975, CYTOGENET CELL GENET, V15, P306, DOI 10.1159/000130528; WURSTERHILL DH, 1973, J MAMMAL, V54, P753, DOI 10.2307/1378975; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; Yang FT, 2004, CHROMOSOM T, V14, P215; Yu L, 2011, SYST BIOL, V60, P175, DOI 10.1093/sysbio/syq090	55	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147647	10.1371/journal.pone.0147647	http://dx.doi.org/10.1371/journal.pone.0147647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821159	Green Published, gold			2022-12-27	WOS:000369528400036
J	Benedeti, PD; Paulino, PVR; Marcondes, MI; Maciel, IFS; da Silva, MC; Faciola, AP				Benedeti, Pedro Del Bianco; Rodrigues Paulino, Pedro Veiga; Marcondes, Marcos Inacio; Smith Maciel, Ivan Franca; da Silva, Matheus Custodio; Faciola, Antonio Pinheiro			Partial Replacement of Ground Corn with Glycerol in Beef Cattle Diets: Intake, Digestibility, Performance, and Carcass Characteristics	PLOS ONE			English	Article							CRUDE GLYCERIN; MEAT QUALITY; RUMINAL FERMENTATION; GROWTH-PERFORMANCE; RUMEN FERMENTATION; TRAITS; METABOLITES; ULTRASOUND; INCLUSION; BLOOD	The objective of this study was to evaluate the effects of replacing dry ground corn with crude glycerol on intake, apparent digestibility, performance, and carcass characteristics of finishing beef bulls. A completely randomized block design experiment with 25 d for adaptation and 100 d for data collection was conducted, in which 3,640 Nellore bulls (367 +/- 36.8 kg; 18 +/- 3 mo) were blocked by body weight and assigned to 20 pens. Bulls were randomly assigned to one of four treatments: 0, 5, 10, and 15% (dry matter basis) of crude glycerol in the diet. Initially, 20 bulls were slaughtered to serve as a reference to estimate initial empty body weight, which allowed for carcass gain calculation. Bulls were weighed at the beginning, at two-thirds, and at the end of the experiment for performance calculations. Carcass measurements were obtained by ultrasound. Fecal output was estimated using indigestible neutral detergent fiber as an internal marker. Data were analyzed using the mixed procedures in SAS 9.2 (SAS Institute Inc., Cary, NC). Intake of dry matter, organic matter, and neutral detergent fiber decreased linearly (P < 0.05) with crude glycerol inclusion. However, crude glycerol levels did not affect (P > 0.05) intakes of crude protein, non-fiber carbohydrates, and total digestible nutrients. Digestibility of dry matter, organic matter, neutral detergent fiber, and total digestible nutrients increased quadratically (P < 0.05) with the inclusion of crude glycerol in the diet. Crude glycerol inclusion did not change the intake of digestible dry matter, average daily gain, final body weight, carcass gain, carcass dressing, gain-to-feed ratio, Longissimus thoracis muscle area, and back and rump fat thicknesses (P > 0.05). These results suggest that crude glycerol may be included in finishing beef diets at levels up to 15% without impairing performance and carcass characteristics.	[Benedeti, Pedro Del Bianco; Marcondes, Marcos Inacio; Smith Maciel, Ivan Franca; da Silva, Matheus Custodio] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Rodrigues Paulino, Pedro Veiga] Cargill Anim Nutr Nutron, Campinas, SP, Brazil; [Faciola, Antonio Pinheiro] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA	Universidade Federal de Vicosa; Nevada System of Higher Education (NSHE); University of Nevada Reno	Faciola, AP (corresponding author), Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA.	afaciola@cabnr.unr.edu	Del Bianco Benedeti, Pedro/C-3120-2016; Faciola, Antonio/U-4800-2018; Faciola, Antonio/AAF-3865-2019; Marcondes, Marcos/AAH-7553-2020	Del Bianco Benedeti, Pedro/0000-0003-2515-8974; Faciola, Antonio/0000-0003-0935-6233; Faciola, Antonio/0000-0003-0935-6233; Marcondes, Marcos/0000-0003-4843-2809	National Council for Scientific and Technological Development (CNPq); Granol Industria Comercio e Exportacao S.A.	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Granol Industria Comercio e Exportacao S.A.	The National Council for Scientific and Technological Development (CNPq) provided graduate scholarship to Pedro Del Bianco Benedeti. Granol Industria Comercio e Exportacao S.A. provided financial support to cover expenses related to animals, feed, and management. These funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or manuscript preparation. At the time of this study Dr. Pedro Veiga Rodrigues Paulino held a faculty position at the Federal University of Vicosa, he is currently employed by Cargill Animal Nutrition / Nutron. Cargill Animal Nutrition / Nutron did not play a role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Allen MS, 2000, J DAIRY SCI, V83, P1598, DOI 10.3168/jds.S0022-0302(00)75030-2; ANP, 2014, PROD NAC BIOD PURO B; AOAC, 2005, AOAC OFFICIAL METHOD, V18th ed.; Araujo FRC, 2003, THESIS U CALIFORNIA; Barton L, 2013, LIVEST SCI, V155, P53, DOI 10.1016/j.livsci.2013.04.010; Benedeti PD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143201; BERGMAN EN, 1968, AM J PHYSIOL, V215, P874; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BERGNER H, 1995, ARCH ANIM NUTR, V48, P245, DOI 10.1080/17450399509381845; BRASIL, 1997, REG INSP IND SAN PRO; Brasil, 2004, SIST BRAS CLASS CARC; BRUNGARDT VH, 1963, J ANIM SCI, V22, P177, DOI 10.2527/jas1963.221177x; van Cleef EHCB, 2014, REV BRAS ZOOTECN, V43, P86, DOI 10.1590/S1516-35982014000200006; DeFrain JM, 2004, J DAIRY SCI, V87, P4195, DOI 10.3168/jds.S0022-0302(04)73564-X; Detmann E, 2010, ARQ BRAS MED VET ZOO, V62, P980, DOI 10.1590/S0102-09352010000400030; DiLorenzo N, 2010, J ANIM SCI, V88, pE123, DOI 10.2527/jas.2009-2362; DONKIN S., 2008, REV BRAS ZOOTECN, V37, P280, DOI DOI 10.1590/S1516-35982008001300032; Egea M, 2014, MEAT SCI, V98, P673, DOI 10.1016/j.meatsci.2014.06.034; Eiras CE, 2014, ANIM FEED SCI TECH, V197, P222, DOI 10.1016/j.anifeedsci.2014.07.004; Eiras CE, 2014, MEAT SCI, V96, P930, DOI 10.1016/j.meatsci.2013.10.002; Francozo MC, 2013, BRAZ ARCH BIOL TECHN, V56, P327, DOI 10.1590/S1516-89132013000200019; Greiner SP, 2003, J ANIM SCI, V81, P1736; Gunn P. J., 2011, Professional Animal Scientist, V27, P283; Hales KE, 2015, J ANIM SCI, V93, P348, DOI 10.2527/jas.2014-8075; Hales KE, 2013, J ANIM SCI, V91, P4277, DOI 10.2527/jas.2013-6341; Hales KE, 2013, J ANIM SCI, V91, P3875, DOI 10.2527/jas.2012-5944; Herring WO, 1998, J ANIM SCI, V76, P364; Hess B, 2009, J ANIM SCI S2, V86, P392; HUHTANEN P, 1994, ANIM FEED SCI TECH, V48, P211, DOI 10.1016/0377-8401(94)90173-2; Lage JF, 2014, MEAT SCI, V96, P1158, DOI 10.1016/j.meatsci.2013.10.027; Mach N, 2009, J ANIM SCI, V87, P632, DOI 10.2527/jas.2008-0987; Millen DD, 2009, J ANIM SCI, V87, P3427, DOI 10.2527/jas.2009-1880; Monnerat J. P. I. S., 2013, ENERGY PROTEIN METAB, V134, P97, DOI [10.3920/978-90-8686-781-3, DOI 10.3920/978-90-8686-781-3]; NRC (National Research Council), 2000, NUTR REQ BEEF CATTL, DOI DOI 10.17226/19014; Parsons GL, 2009, J ANIM SCI, V87, P653, DOI 10.2527/jas.2008-1053; Pyatt NA, 2007, J ANIM SCI, V85, P412; Ramos MH, 2012, J ANIM SCI, V90, P892, DOI 10.2527/jas.2011-4099; REMOND B, 1993, ANIM FEED SCI TECH, V41, P121, DOI 10.1016/0377-8401(93)90118-4; Robinson PH, 2006, ANIM FEED SCI TECH, V129, P1, DOI 10.1016/j.anifeedsci.2006.05.011; ROGER V, 1992, CURR MICROBIOL, V25, P197, DOI 10.1007/BF01570719; Schroder A., 1999, INT RAP C GOSF REG I, P241; Shin JH, 2012, J DAIRY SCI, V95, P4006, DOI 10.3168/jds.2011-5121; Trabue S, 2007, J AGR FOOD CHEM, V55, P7043, DOI 10.1021/jf071076i; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang C, 2009, LIVEST SCI, V121, P15, DOI 10.1016/j.livsci.2008.05.010; Wilson D, 1998, BEEF RES REPORT	47	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148224	10.1371/journal.pone.0148224	http://dx.doi.org/10.1371/journal.pone.0148224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820725	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528400077
J	Vejdemo, S; Horberg, T				Vejdemo, Susanne; Horberg, Thomas			Semantic Factors Predict the Rate of Lexical Replacement of Content Words	PLOS ONE			English	Article							FREQUENCY; CONCRETE; ENGLISH; RATINGS; EVOLUTION; AGE	The rate of lexical replacement estimates the diachronic stability of word forms on the basis of how frequently a proto-language word is replaced or retained in its daughter languages. Lexical replacement rate has been shown to be highly related to word class and word frequency. In this paper, we argue that content words and function words behave differently with respect to lexical replacement rate, and we show that semantic factors predict the lexical replacement rate of content words. For the 167 content items in the Swadesh list, data was gathered on the features of lexical replacement rate, word class, frequency, age of acquisition, synonyms, arousal, imageability and average mutual information, either from published databases or gathered from corpora and lexica. A linear regression model shows that, in addition to frequency, synonyms, senses and imageability are significantly related to the lexical replacement rate of content words-in particular the number of synonyms that a word has. The model shows no differences in lexical replacement rate between word classes, and outperforms a model with word class and word frequency predictors only.	[Vejdemo, Susanne; Horberg, Thomas] Stockholm Univ, Dept Linguist, S-10691 Stockholm, Sweden	Stockholm University	Vejdemo, S (corresponding author), Stockholm Univ, Dept Linguist, S-10691 Stockholm, Sweden.	susanne@ling.su.se	Hörberg, Thomas/ABG-2256-2021	Hörberg, Thomas/0000-0003-0897-8911				[Anonymous], REGRESSION MODELLING, DOI DOI 10.1200/JCO.2017.76.1155; [Anonymous], 1994, WORDS MIND INTRO MEN; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Brown K, 2006, ENCY LANGUAGE LINGUI, P455, DOI DOI 10.1016/B0-08-044854-2/01092-0; Brown K, 2006, ENCY LANGUAGE LINGUI, P452; Brysbaert M, 2014, BEHAV RES METHODS, V46, P904, DOI 10.3758/s13428-013-0403-5; Bybee Joan L., 2007, FREQUENCY USE ORG LA, DOI DOI 10.1093/ACPROF:OSO/9780195301571.001.0001; Calude AS, 2011, PHILOS T R SOC B, V366, P1101, DOI 10.1098/rstb.2010.0315; Canty A, 2013, BOOT BOOTSTRAP R S P; Cortese MJ, 2004, BEHAV RES METH INS C, V36, P384, DOI 10.3758/BF03195585; Crutch SJ, 2005, BRAIN, V128, P615, DOI 10.1093/brain/awh349; Curtin J, 2014, LMSUPPORT SUPPORT LI; Dahl Osten, 2004, GROWTH MAINTENANCE L; Diaz MT, 2009, BRAIN RES, V1282, P38, DOI 10.1016/j.brainres.2009.05.043; Dyen I, 1992, INDOEUROPEAN CLASSIF; Fellbaum C., 1999, WORDNET ELECT LEXICA; Grzega J, 2004, ONOMASIOLOGY ONLINE, V5, P15; Gude JA, 2009, WILDLIFE BIOL, V15, P352, DOI 10.2981/08-057; Hills TT, 2015, COGNITION, V143, P87, DOI 10.1016/j.cognition.2015.06.009; Holzknecht KA, 1988, LANG LINGUIST MELANE, P43; Ingemann T, 2011, SYNONYMORDBOG; Ingram JCL, 2007, CAMB TEXTBK LINGUIST, P1; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; Kleparski Grzegorz A., 1997, THEORY PRACTICE HIST; KROLL JF, 1986, J EXP PSYCHOL LEARN, V12, P92, DOI 10.1037/0278-7393.12.1.92; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Ladd DR, 2015, ANNU REV LINGUIST, V1; Lindberg CA, 2012, POCKET OXFORD AMERIC, DOI DOI 10.1093/ACREF/9780195301694.001.0001; Martensson F, 2011, ACTA NEUROBIOL EXP, V71, P455; Monaghan P, 2014, COGNITION, V133, P530, DOI 10.1016/j.cognition.2014.08.007; Munte TF, 2001, NEUROPSYCHOLOGIA, V39, P91, DOI 10.1016/S0028-3932(00)00095-6; Osgood C.E., 1957, MEASUREMENT MEANING; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Paivio A, 1971, IMAGERY VERBAL PROCE; Perani D, 1999, BRAIN, V122, P2337, DOI 10.1093/brain/122.12.2337; Pinker S, 1994, NY TIMES        0403; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Spitzer M., 1999, MIND NET MODELS LEAR; Traugott Elizabeth C., 2002, REGULARITY SEMANTIC; Vejdemo S, 2010, P WIGL 2010 WISC; Vigliocco G., 2007, OXFORD HDB PSYCHOLIN, P195, DOI [https://doi.org/10.1093/oxfordhb/9780198568971.001.0001, DOI 10.1093/OXFORDHB/9780198568971.013.0012, DOI 10.1093/OXFORDHB/9780198568971.001.0001]; Walter G, 2000, BONNIERS SYNONYMORDB; Warriner AB, 2013, BEHAV RES METHODS; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zalizniak AA, 2012, LINGUISTICS, V50, P633, DOI 10.1515/ling-2012-0020	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147924	10.1371/journal.pone.0147924	http://dx.doi.org/10.1371/journal.pone.0147924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GF	26820737	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528400055
J	Daut, EF; Lahodny, G; Peterson, MJ; Ivanek, R				Daut, Elizabeth F.; Lahodny, Glenn, Jr.; Peterson, Markus J.; Ivanek, Renata			Interacting Effects of Newcastle Disease Transmission and Illegal Trade on a Wild Population of White-Winged Parakeets in Peru: A Modeling Approach	PLOS ONE			English	Article							DOUBLE-CRESTED CORMORANTS; EXOTIC BIRDS; POSTFLEDGING SURVIVAL; INTERNATIONAL-TRADE; SOUTHERN-CALIFORNIA; INFECTIOUS-DISEASE; HEALTH EVALUATION; PSITTACINE BIRDS; RACING PIGEONS; HERD-IMMUNITY	Illegal wildlife-pet trade can threaten wildlife populations directly from overharvest, but also indirectly as a pathway for introduction of infectious diseases. This study evaluated consequences of a hypothetical introduction of Newcastle disease (ND) into a wild population of Peru's most trafficked psittacine, the white-winged parakeet (Brotogeris versicolurus), through release of infected confiscated individuals. We developed two mathematical models that describe ND transmission and the influence of illegal harvest in a homogeneous (model 1) and age-structured population of parakeets (model 2). Infection transmission dynamics and harvest were consistent for all individuals in model 1, which rendered it mathematically more tractable compared to the more complex, age-structured model 2 that separated the host population into juveniles and adults. We evaluated the interaction of ND transmission and harvest through changes in the basic reproduction number (R-0) and short-term host population dynamics. Our findings demonstrated that ND introduction would likely provoke considerable disease-related mortality, up to 24% population decline in two years, but high harvest rates would dampen the magnitude of the outbreak. Model 2 produced moderate differences in disease dynamics compared to model 1 (R-0 = 3.63 and 2.66, respectively), but highlighted the importance of adult disease dynamics in diminishing the epidemic potential. Therefore, we suggest that future studies should use a more realistic, age-structured model. Finally, for the presumptive risk that illegal trade of white-winged parakeets could introduce ND into wild populations, our results suggest that while high harvest rates may have a protective effect on the population by reducing virus transmission, the combined effects of high harvest and disease-induced mortality may threaten population survival. These results capture the complexity and consequences of the interaction between ND transmission and harvest in a wild parrot population and highlight the importance of preventing illegal trade.	[Daut, Elizabeth F.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Schubot Exot Bird Hlth Ctr, College Stn, TX USA; [Lahodny, Glenn, Jr.] Texas A&M Univ, Dept Math, College Stn, TX 77843 USA; [Peterson, Markus J.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Lahodny, Glenn, Jr.; Ivanek, Renata] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA; [Daut, Elizabeth F.] Natl Socioenvironm Synth Ctr, Annapolis, MD USA; [Ivanek, Renata] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas El Paso; Texas A&M University System; Texas A&M University College Station; Cornell University	Daut, EF (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Schubot Exot Bird Hlth Ctr, College Stn, TX USA.; Daut, EF (corresponding author), Natl Socioenvironm Synth Ctr, Annapolis, MD USA.	edaut@sesync.org	Ivanek, Renata/B-9005-2009	Ivanek, Renata/0000-0001-6348-4709; Peterson, Markus/0000-0001-6145-0134	Applied Biodiversity Science NSF-IGERT 727 program; Department of Veterinary Pathobiology; Schubot Exotic Bird Health Center 728 at Texas AM University; Direct For Biological Sciences [1639145] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	Applied Biodiversity Science NSF-IGERT 727 program; Department of Veterinary Pathobiology; Schubot Exotic Bird Health Center 728 at Texas AM University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	E. Daut is grateful 726 for the financial and academic support provided by Applied Biodiversity Science NSF-IGERT 727 program, the Department of Veterinary Pathobiology, and the Schubot Exotic Bird Health Center 728 at Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 2004, TECHNOLOGY REV NEWCA; Alexander Dennis J., 2009, P19, DOI 10.1007/978-88-470-0826-7_2; ALEXANDER DJ, 1986, VET REC, V118, P424, DOI 10.1136/vr.118.15.424; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Apanius V, 1980, AVIAN GROWTH DEV EVO, P203; AWAN MA, 1994, AVIAN PATHOL, V23, P405, DOI 10.1080/03079459408419012; Barman L. R., 2010, Bangladesh Veterinarian, V27, P56; Begazo AJ, 1989, THESIS U NACL AGRARI; Beissinger S.R., 1992, P73; Beissinger S.R., 2001, CONSERVATION EXPLOIT, P182; BEISSINGER SR, 1991, AUK, V108, P982; Bennett EL, 2011, ORYX, V45, P476, DOI 10.1017/S003060531000178X; Birdlife International, 2014, SPEC FACTSH BROT VER; BirdLife International, 2012, OV THREAT MAN LARG C; BirdLife International, 2014, COUNTR PROF; BirdLife International, 2015, BIRDLIFE DAT ZON; Brooks-Moizer F, 2009, AVIAN INFLUENZA H5N1; Brooks-Pollock E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008479; BRUNINGFANN C, 1992, J AM VET MED ASSOC, V201, P1709; Burger Joanna, 2003, Acta Ethologica, V6, P23; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butron O, 2010, J WILDLIFE DIS, V46, P718, DOI 10.7589/0090-3558-46.3.718; Cantu J. C. G., 2007, ILLEGAL PARROT TRADE; Carrasco AOT, 2009, TROP ANIM HEALTH PRO, V41, P1325, DOI 10.1007/s11250-009-9318-7; Chng SCL, 2015, MARKET EXTINCTION IN; Choisy M, 2006, P ROY SOC B-BIOL SCI, V273, P2025, DOI 10.1098/rspb.2006.3554; Chukwudi OE, 2012, PAK VET J, V32, P354; Clarke RV, 2013, J EXP CRIMINOL, V9, P333, DOI 10.1007/s11292-013-9177-0; Clubb SL, 1980, OUTBREAK VISCEROTROP, P105; Collar N. J., 2000, International Zoo Yearbook, V37, P21, DOI 10.1111/j.1748-1090.2000.tb00704.x; Cox WA, 2014, J WILDLIFE MANAGE, V78, P183, DOI 10.1002/jwmg.670; Alves RRD, 2010, HUM ECOL, V38, P147, DOI 10.1007/s10745-009-9295-5; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Daut EF, 2015, THESIS TEXAS A M U; Daut EF, 2015, J NAT CONSERV, V27, P44, DOI 10.1016/j.jnc.2015.06.005; Daut EF, 2015, J NAT CONSERV, V24, P72, DOI 10.1016/j.jnc.2014.10.005; Deem SL, 2005, J ZOO WILDLIFE MED, V36, P598, DOI 10.1638/04094.1; Denadai J., 2010, International Journal of Poultry Science, V9, P765; Diel DG, 2012, J CLIN MICROBIOL, V50, P378, DOI 10.1128/JCM.06018-11; Drews C, 2001, SOC ANIM, V9, P107, DOI 10.1163/156853001753639233; Dube C., 2007, C OIE, P13; Eniang EE, 2008, ETHIOPIAN J ENV STUD, V1, P68, DOI DOI 10.4314/EJESM.V1I2.41583; ERICKSON GA, 1980, AVIAN DIS, V24, P257, DOI 10.2307/1589785; ERICKSON GA, 1977, AVIAN DIS, V21, P642, DOI 10.2307/1589424; ERICKSON GA, 1978, AM J VET RES, V39, P105; Ferrer R, 2008, REV INVESTIG VET PER, V19, P67; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Forshaw JM, 1989, CANARY WINGED PARAKE, P528; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Galetti Mauro, 1997, Ararajuba, V5, P115; Gastanaga M, 2011, BIRD CONSERV INT, V21, P76, DOI 10.1017/S0959270910000249; GILARDI KVK, 1995, J WILDLIFE DIS, V31, P523, DOI 10.7589/0090-3558-31.4.523; Gilbert M, 2012, BIOL CONSERV, V153, P10, DOI 10.1016/j.biocon.2012.04.024; Godoy SN, 2010, J AVIAN MED SURG, V24, P199, DOI 10.1647/2009-029.1; Gomes GF, 2012, EFFORTS COMBAT WILDL, DOI [10.5772/48351, DOI 10.5772/48351]; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; Gonzalez Medina OE, 2004, ECOLOGIA AVES URBANA; GOODMAN BB, 1988, AVIAN DIS, V32, P713, DOI 10.2307/1590989; Grausgruber VW, 1972, WIENER TIERARZTLICHE, V59, P353; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heisey DM, 2006, ECOLOGY, V87, P2356, DOI 10.1890/0012-9658(2006)87[2356:TFOGFM]2.0.CO;2; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; Herrera M, 2007, BIRD CONSERV INT, V17, P295, DOI 10.1017/S0959270907000858; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Hines Nichole L, 2012, Vet Med Int, V2012, P708216, DOI 10.1155/2012/708216; HIRAI K, 1981, JPN J VET SCI, V43, P557; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hoque MA, 2012, PREV VET MED, V103, P49, DOI 10.1016/j.prevetmed.2011.08.013; Hosseini PR, 2004, P ROY SOC B-BIOL SCI, V271, P2569, DOI 10.1098/rspb.2004.2938; Hudson P., 2002, ECOLOGY WILDLIFE DIS; HUGHJONES M, 1973, J HYG-CAMBRIDGE, V71, P325, DOI 10.1017/S0022172400022786; Ivanek R, 2009, APPL ENVIRON MICROB, V75, P5893, DOI 10.1128/AEM.02757-08; Jepson P, 2009, ORYX, V43, P364, DOI 10.1017/S0030605309990251; Jibril AH, 2014, ISRN EPIDEMIOLOGY, V2014, P1, DOI DOI 10.1155/2014/513961; JIMENEZ I, 2004, ORNITOLOGIA COLOMBIA, V2, P53; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; JOHNSON DC, 1986, AVIAN DIS, V30, P813, DOI 10.2307/1590590; Johnston J, 1992, COMPUTER MODELLING E, P46; Kaleta E. F., 1988, Newcastle disease., P197; Kapczynski DR, 2006, AVIAN DIS, V50, P336, DOI 10.1637/7479-112905R.1; Karesh W. B., 2012, Animal health and biodiversity: preparing for the future. Compendium of the OIE Global Conference on Wildlife, Paris, France, 23-25 February 2011, P51; KARESH WB, 1995, J ZOO WILDLIFE MED, V26, P2; Karesh WB, 1997, J ZOO WILDLIFE MED, V28, P368; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kinde H, 2005, AVIAN DIS, V49, P195, DOI 10.1637/7229-062704R; Kuiken T, 1998, J WILDLIFE DIS, V34, P457, DOI 10.7589/0090-3558-34.3.457; Kuiken T, 1998, AVIAN PATHOL, V27, P541, DOI 10.1080/03079459808419381; Kuiken T, 1999, WATERBIRDS, V22, P333, DOI 10.2307/1522109; Lande Russell, 2001, Conservation Biology Series (Cambridge), V6, P67; Leighton Frederick A., 2007, P3; Levinson M, 1987, INT WILDLIFE MAGAZIN, V17, P48; Li XX, 2009, VET MICROBIOL, V136, P226, DOI 10.1016/j.vetmic.2008.11.002; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LINDSEY GD, 1994, J FIELD ORNITHOL, V65, P76; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Lung NP, 1996, AM J VET RES, V57, P1162; Marini MA, 2005, CONSERV BIOL, V19, P665, DOI 10.1111/j.1523-1739.2005.00706.x; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nekaris KAI, 2010, AM J PRIMATOL, V72, P877, DOI 10.1002/ajp.20842; Nijman V, 2012, HERPETOL J, V22, P83; Nilsson G, 1985, IMPORTATION BIRDS US, V2; Alves RRN, 2013, BIRD CONSERV INT, V23, P53, DOI 10.1017/S095927091200010X; OIE, 2015, WORLD AN HLTH INF DA; Oraby T, 2014, J THEOR BIOL, V340, P50, DOI 10.1016/j.jtbi.2013.09.003; Pain DJ, 2006, ANIM CONSERV, V9, P322, DOI 10.1111/j.1469-1795.2006.00040.x; PANIGRAHY B, 1993, AVIAN DIS, V37, P254, DOI 10.2307/1591484; PAREDE L, 1990, AVIAN DIS, V34, P803, DOI 10.2307/1591366; PEARSON GL, 1975, J AM VET MED ASSOC, V167, P610; Pearson GL, 1976, TECHNIQUES ISOLATION, P61; Powell LL, 2009, BIOTROPICA, V41, P279, DOI 10.1111/j.1744-7429.2009.00514.x; Ricklefs RE, 2000, CONDOR, V102, P9, DOI 10.1650/0010-5422(2000)102[0009:DDEOAT]2.0.CO;2; Rios L., 2008, REPORTE SITUACIONAL; RITCHIE BW, 1992, AM J VET RES, V53, P1512; Roldan-Clara B, 2014, ETHNOBIOL CONSERV, V3, DOI 10.15451/ec2014-10-3.5-1-18; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; ROWLEY I, 1983, AUST WILDLIFE RES, V10, P329; RSPCA, 2006, ITS TIM STOP WING IT; Rupiper DJ, 1998, J AVIAN MED SURG, V12, P70; Salinas-Melgoza A, 2007, J WILDLIFE MANAGE, V71, P43, DOI 10.2193/2005-646; Sandercock BK, 2002, J APPL STAT, V29, P589, DOI 10.1080/02664760120108818; Schat K. A., 2013, AVIAN IMMUNOLOGY, V2nd; Schulenberg T.S., 2007, BIRDS PERU REVISED U, P18; Shepherd Chris R., 2006, BirdingASIA, V5, P16; Shepherd CR, 2012, ENDANGER SPECIES RES, V11, P201; Shroads CV, 1974, STUDIES POPULATION C; Regueira RFS, 2012, BIOL CONSERV, V149, P16, DOI 10.1016/j.biocon.2012.02.009; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Spradbrow P, 2005, WORLD POULTRY SCI J, V61, P47, DOI 10.1079/WPS200441; Sung YH, 2013, CONSERV BIOL, V27, P1421, DOI 10.1111/cobi.12102; The Poultry Site, 2009, NEWC DIS BACK PER; Therneau T. M., 2014, PACKAGE RPART; Thomsen JB, 1992, PERCEPTIONS CONSERVA; Tieguhong JC, 2006, COMMODITY CHAIN ANAL; Tossas Adrianne G., 2012, Journal of Caribbean Ornithology, V25, P1; United States Department of Agriculture, 2014, NEWC DIS RESP PLAN R; van Boven M, 2008, AVIAN PATHOL, V37, P1, DOI 10.1080/03079450701772391; van den Berg T, 2009, REV SCI TECH OIE, V28, P93; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vayssieres MP, 2000, J VEG SCI, V11, P679, DOI 10.2307/3236575; VICKERS ML, 1979, AVIAN DIS, V23, P70, DOI 10.2307/1589673; WALKER JW, 1973, AVIAN DIS, V17, P486, DOI 10.2307/1589147; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326; Wonham MJ, 2004, P ROY SOC B-BIOL SCI, V271, P501, DOI 10.1098/rspb.2003.2608; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P123; World Parrot Trust, 2004, DEADL NEWC DIS DISC; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Young AM, 2012, ANIM CONSERV, V15, P28, DOI 10.1111/j.1469-1795.2011.00477.x; Zhang L, 2008, BIODIVERS CONSERV, V17, P1493, DOI 10.1007/s10531-008-9358-8	158	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147517	10.1371/journal.pone.0147517	http://dx.doi.org/10.1371/journal.pone.0147517			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816214	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200036
J	Aso, K; Tsuruhara, A; Takagaki, K; Oki, K; Ota, M; Nose, Y; Tanemura, H; Urushihata, N; Sasanuma, J; Sano, M; Hirano, A; Aso, R; McGhee, JR; Fujihashi, K				Aso, Kazuyoshi; Tsuruhara, Akitoshi; Takagaki, Kentaro; Oki, Katsuyuki; Ota, Megumi; Nose, Yasuhiro; Tanemura, Hideki; Urushihata, Naoki; Sasanuma, Jinichi; Sano, Masayuki; Hirano, Atsuyuki; Aso, Rio; McGhee, Jerry R.; Fujihashi, Kohtaro			Adipose-Derived Mesenchymal Stem Cells Restore Impaired Mucosal Immune Responses in Aged Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NALT DENDRITIC CELLS; T-CELLS; CROHNS-DISEASE; LYMPHORETICULAR TISSUE; ORAL TOLERANCE; TH2 CELLS; IN-VITRO	It has been shown that adipose-derived mesenchymal stem cells (AMSCs) can differentiate into adipocytes, chondrocytes and osteoblasts. Several clinical trials have shown the ability of AMSCs to regenerate these differentiated cell types. Age-associated dysregulation of the gastrointestinal (GI) immune system has been well documented. Our previous studies showed that impaired mucosal immunity in the GI tract occurs earlier during agingthan is seen in the systemic compartment. In this study, we examined the potential of AMSCs to restore the GI mucosal immune system in aged mice. Aged (>18 mo old) mice were adoptively transferred with AMSCs. Two weeks later, mice were orally immunized with ovalbumin (OVA) plus cholera toxin (CT) three times at weekly intervals. Seven days after the final immunization, when fecal extract samples and plasma were subjected to OVA-and CT-B-specific ELISA, elevated levels of mucosal secretory IgA (SIgA) and plasma IgG antibody (Ab) responses were noted in aged mouse recipients. Similar results were also seen aged mice which received AMSCs at one year of age. When cytokine production was examined, OVA-stimulated Peyer's patch CD4(+) T cells produced increased levels of IL-4. Further, CD4+ T cells from the lamina propria revealed elevated levels of IL-4 and IFN-gamma production. In contrast, aged mice without AMSC transfer showed essentially no OVA-or CT-B-specific mucosal SIgA or plasma IgG Ab or cytokine responses. Of importance, fecal extracts from AMSC transferred aged mice showed neutralization activity to CT intoxication. These results suggest that AMSCs can restore impaired mucosal immunity in the GI tract of aged mice.	[Aso, Kazuyoshi; Tsuruhara, Akitoshi; Aso, Rio; McGhee, Jerry R.; Fujihashi, Kohtaro] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL USA; [Takagaki, Kentaro; Oki, Katsuyuki; Ota, Megumi; Nose, Yasuhiro; Tanemura, Hideki; Urushihata, Naoki] BioMimet Sympathies Inc, Tokyo, Japan; [Sasanuma, Jinichi] Shinyurigaoka Gen Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Sano, Masayuki; Hirano, Atsuyuki] Sunfield Clin, Koto Ku, Tokyo, Japan	University of Alabama System; University of Alabama Birmingham	Fujihashi, K (corresponding author), Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL USA.	kohtarof@uab.edu		Ota, Megumi/0000-0002-6222-4830; Takagaki, Kentaro/0000-0001-8085-6201	BioMimetics Sympathies Inc.	BioMimetics Sympathies Inc.	This work is supported by funding provided by BioMimetics Sympathies Inc. (http://www.bm-s.biz) to Dr. Kohtaro Fujihashi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asanuma H, 2012, VACCINE, V30, P803, DOI 10.1016/j.vaccine.2011.10.093; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Casiraghi F, 2013, CURR OPIN ORGAN TRAN, V18, P51, DOI 10.1097/MOT.0b013e32835c5016; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Effros RB, 2003, IMMUNOL ALLERGY CLIN, V23, P41, DOI 10.1016/S0889-8561(02)00055-3; Effros RB, 2007, VACCINE, V25, P599, DOI 10.1016/j.vaccine.2006.08.032; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; Figueroa FE, 2012, BIOL RES, V45, P269, DOI 10.4067/S0716-97602012000300008; Forbes GM, 2014, CLIN GASTROENTEROL H, V12, P64, DOI 10.1016/j.cgh.2013.06.021; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Fukuiwa T, 2008, VACCINE, V26, P4849, DOI 10.1016/j.vaccine.2008.06.091; Fukuyama Y, 2012, BIOCHEM BIOPH RES CO, V418, P6, DOI 10.1016/j.bbrc.2011.12.046; Fukuyama Y, 2011, J IMMUNOL, V186, P2454, DOI 10.4049/jimmunol.1002837; Garcia-Olmo D, 2008, EXPERT OPIN BIOL TH, V8, P1417, DOI 10.1517/14712598.8.9.1417 ; Gardner EM, 2006, VACCINE, V24, P1609, DOI 10.1016/j.vaccine.2005.09.058; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Hagiwara Y, 2003, J IMMUNOL, V170, P1754, DOI 10.4049/jimmunol.170.4.1754; Ho MSH, 2015, J CELL PHYSIOL, V230, P2606, DOI 10.1002/jcp.25028; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kato H, 2003, INT IMMUNOL, V15, P145, DOI 10.1093/intimm/dxg011; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kim MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072544; Knyazev OV, 2013, B EXP BIOL MED+, V156, P139, DOI 10.1007/s10517-013-2297-8; Koga T, 2000, J IMMUNOL, V165, P5352, DOI 10.4049/jimmunol.165.9.5352; Kong QF, 2009, J NEUROIMMUNOL, V207, P83, DOI 10.1016/j.jneuroim.2008.12.005; Kovaiou Rania D., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000221; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Larbi A., 2013, AGING HLTH, V9, P35, DOI [10.2217/ahe.12.78, DOI 10.2217/AHE.12.78]; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; Lee PH, 2012, ANN NEUROL, V72, P32, DOI 10.1002/ana.23612; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu SY, 2012, CELL IMMUNOL, V278, P35, DOI 10.1016/j.cellimm.2012.06.010; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516; Okahashi N, 1996, INFECT IMMUN, V64, P1516, DOI 10.1128/IAI.64.5.1516-1525.1996; Perez-Simon JA, 2011, HAEMATOL-HEMATOL J, V96, P1072, DOI 10.3324/haematol.2010.038356; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Sato S, 2015, GERONTOLOGY, V61, P336, DOI 10.1159/000368897; Sekine S, 2008, J IMMUNOL, V180, P8126, DOI 10.4049/jimmunol.180.12.8126; TAGUCHI T, 1990, J IMMUNOL, V145, P68; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; TAYLOR LD, 1992, IMMUNOLOGY, V75, P614; Tobita M, 2013, CYTOTHERAPY, V15, P1517, DOI 10.1016/j.jcyt.2013.05.007; Tobita M, 2011, DISCOV MED, V11, P160; Tokuhara D, 2010, P NATL ACAD SCI USA, V107, P8794, DOI 10.1073/pnas.0914121107; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Wang DD, 2013, CELL TRANSPLANT, V22, P2267, DOI [10.3727/096368911X582769c, 10.3727/096368911X582769]; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138	67	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148185	10.1371/journal.pone.0148185	http://dx.doi.org/10.1371/journal.pone.0148185			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840058	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200092
J	Bonfill, X; Osorio, D; Sola, I; Pijoan, JI; Balasso, V; Quintana, MJ; Puig, T; Bolibar, I; Urrutia, G; Zamora, J; Emparanza, JI; de la Camara, AG; Ferreira-Gonzalez, I				Bonfill, Xavier; Osorio, Dimelza; Sola, Ivan; Ignacio Pijoan, Jose; Balasso, Valentina; Jesus Quintana, Maria; Puig, Teresa; Bolibar, Ignasi; Urrutia, Gerard; Zamora, Javier; Ignacio Emparanza, Jose; Gomez de la Camara, Agustin; Ferreira-Gonzalez, Ignacio			DianaHealth.com, an On-Line Database Containing Appraisals of the Clinical Value and Appropriateness of Healthcare Interventions: Database Development and Retrospective Analysis	PLOS ONE			English	Article							MEDICAL OVERUSE; REDUCE; UK	Objective To describe the development of a novel on-line database aimed to serve as a source of information concerning healthcare interventions appraised for their clinical value and appropriateness by several initiatives worldwide, and to present a retrospective analysis of the appraisals already included in the database. Methods and Findings Database development and a retrospective analysis. The database DianaHealth.com is already on-line and it is regularly updated, independent, open access and available in English and Spanish. Initiatives are identified in medical news, in article references, and by contacting experts in the field. We include appraisals in the form of clinical recommendations, expert analyses, conclusions from systematic reviews, and original research that label any health care intervention as low-value or inappropriate. We obtain the information necessary to classify the appraisals according to type of intervention, specialties involved, publication year, authoring initiative, and key words. The database is accessible through a search engine which retrieves a list of appraisals and a link to the website where they were published. DianaHealth.com also provides a brief description of the initiatives and a section where users can report new appraisals or suggest new initiatives. From January 2014 to July 2015, the on-line database included 2940 appraisals from 22 initiatives: eleven campaigns gathering clinical recommendations from scientific societies, five sets of conclusions from literature review, three sets of recommendations from guidelines, two collections of articles on low clinical value in medical journals, and an initiative of our own. Conclusions We have developed an open access on-line database of appraisals about healthcare interventions considered of low clinical value or inappropriate. DianaHealth.com could help physicians and other stakeholders make better decisions concerning patient care and healthcare systems sustainability. Future efforts should be focused on assessing the impact of these appraisals in the clinical practice.	[Bonfill, Xavier; Osorio, Dimelza; Sola, Ivan; Balasso, Valentina; Jesus Quintana, Maria; Puig, Teresa; Bolibar, Ignasi; Urrutia, Gerard] Iberoamer Cochrane Ctr, Inst Biomed Res IIB St Pau, Clin Epidemiol & Publ Hlth, Barcelona, Spain; [Bonfill, Xavier; Sola, Ivan; Ignacio Pijoan, Jose; Urrutia, Gerard; Zamora, Javier; Ignacio Emparanza, Jose; Gomez de la Camara, Agustin; Ferreira-Gonzalez, Ignacio] CIBERESP, Madrid, Spain; [Bonfill, Xavier; Sola, Ivan; Jesus Quintana, Maria; Puig, Teresa; Bolibar, Ignasi; Urrutia, Gerard] Univ Autonoma Barcelona, Fac Med, E-08193 Barcelona, Spain; [Osorio, Dimelza] Univ Tecnol Equinoccial, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador; [Ignacio Pijoan, Jose] UICEC BioCruces SCReN, Unidad Epidemiol Clin & Soporte Metodol, Baracaldo, Spain; [Zamora, Javier] IRYCIS, Hosp Univ Ramon y Cajal, Unidad Bioestadist Clin, Madrid, Spain; [Ignacio Emparanza, Jose] BioDonostia, Hosp Univ Donostia, Unidad Epidemiol Clin, San Sebastian, Spain; [Gomez de la Camara, Agustin] Hosp Univ 12 Octubre, Unidad Invest Clin, Madrid, Spain; [Ferreira-Gonzalez, Ignacio] Hosp Univ Vall dHebron, Dept Cardiol, Barcelona, Spain; [Osorio, Dimelza; Ferreira-Gonzalez, Ignacio] Vall dHebron Inst Recerca VHIR, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona; Hospital Universitario Ramon y Cajal; Instituto de Investigacion Sanitaria Biodonostia; Hospital Universitario 12 de Octubre; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Osorio, D (corresponding author), Iberoamer Cochrane Ctr, Inst Biomed Res IIB St Pau, Clin Epidemiol & Publ Hlth, Barcelona, Spain.; Osorio, D (corresponding author), Univ Tecnol Equinoccial, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador.; Osorio, D (corresponding author), Vall dHebron Inst Recerca VHIR, Barcelona, Spain.	dimelza@cochrane.es	de la Camara, Agustin Gomez/S-7123-2018; Zamora, Javier/B-1722-2009; Zamora, Javier/AEO-0608-2022; Ferreira-Gonzalez, Ignacio/K-9939-2017; Osorio, Dimelza/D-1595-2018	Zamora, Javier/0000-0003-4901-588X; Zamora, Javier/0000-0003-4901-588X; Osorio, Dimelza/0000-0001-6166-647X; Bonfill Cosp, Xavier/0000-0003-1530-3509	EpiClin Programme of the Consorcio de Investigacion Biomedica de Epidemiologia y Salud Publica CIBERESP, a public institution from the Instituto de Salud Carlos III; Hospital Ramon y Cajal; Hospital 12 de Octubre; Hospital Universitario de Donostia; Hospital Universitario Cruces; Universidad Miguel Hernandez; Hospital Universitario Vall d'Hebron	EpiClin Programme of the Consorcio de Investigacion Biomedica de Epidemiologia y Salud Publica CIBERESP, a public institution from the Instituto de Salud Carlos III; Hospital Ramon y Cajal(Spanish Government); Hospital 12 de Octubre; Hospital Universitario de Donostia; Hospital Universitario Cruces; Universidad Miguel Hernandez; Hospital Universitario Vall d'Hebron	This project received financial support from the EpiClin Programme of the Consorcio de Investigacion Biomedica de Epidemiologia y Salud Publica CIBERESP, a public institution from the Instituto de Salud Carlos III aiming to support research in Epidemiology and Public Health in Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project is led by a research group from the Clinical Epidemiology Department of the Hospital de Sant Pau and the Iberoamerican Cochrane Centre, based in Barcelona, Spain. They have had the support of other associated partners pertaining to CIBERESP: Hospital Ramon y Cajal, Hospital 12 de Octubre, Hospital Universitario de Donostia, Hospital Universitario Cruces, Universidad Miguel Hernandez, Hospital Universitario Vall d'Hebron.	American College of Radiology, ACR APPR CRIT; [Anonymous], TOO MUCH MED; [Anonymous], US PREV SERV TASK FO; [Anonymous], 2015, REV PRESCRIRE, V35, P144; AQA Alliance, 2009, AQA PRINC APPR CRIT; Association of the Scientific Medical Societies in Germany, CHOOS WIS TOG; Bodenheimer T, 2005, ANN INTERN MED, V143, P26, DOI 10.7326/0003-4819-143-1-200507050-00007; CASCADE PN, 1994, RADIOLOGY, V192, pA50; ChoosingWiselyAustralia.org.au, NPS MEDICINEWISE CHO; Elshaug AG, 2012, MED J AUSTRALIA, V197, P556, DOI 10.5694/mja12.11083; Garner S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4519; Gaspoz JM, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14125; Greene RA, 2008, HEALTH AFFAIR, V27, pW250, DOI 10.1377/hlthaff.27.4.w250; Hurley R, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4289; Katz MH, 2014, JAMA INTERN MED, V174, P1076, DOI 10.1001/jamainternmed.2014.1101; Lown Institute, RIGHTCARE ALL; Malhotra A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2308; Morgan DJ, 2015, JAMA INTERN MED, V175, P120, DOI 10.1001/jamainternmed.2014.5444; National Institute for Health and Care Excellence, SAVINGS AND PRODUCTI; Pearson Steven, 2007, J Health Serv Res Policy, V12, P160; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Rightcare.nhs.uk, NAT HLTH SERV RIGH T; Slow Medicine, FAR PIU NONS FAR MEG; Sociedad Espanola de Radiologia Medica (SERAM), REC NO HAC; The Canadian Task Force for Preventive Health Care, CTFPHC GUID; The JAMA Network, LESS IS MOR COLL; Thomson S., 2009, ADDRESSING FINANCIAL; Tokuda Y, 2015, J GEN FAM MED, V16, P3, DOI 10.14442/general.16.3; Toussaint B, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3325; Vernero S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4703; WHO Regional Office for Europe, 2009, WHO WORKSH KOBL GERM	32	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147943	10.1371/journal.pone.0147943	http://dx.doi.org/10.1371/journal.pone.0147943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840451	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200071
J	Homaira, N; Luby, SP; Hossain, K; Islam, K; Ahmed, M; Rahman, M; Rahman, Z; Paul, RC; Bhuiyan, MU; Brooks, WA; Sohel, BM; Banik, KC; Widdowson, MA; Willby, M; Rahman, M; Bresee, J; Ramirez, KS; Azziz-Baumgartner, E				Homaira, Nusrat; Luby, Stephen P.; Hossain, Kamal; Islam, Kariul; Ahmed, Makhdum; Rahman, Mustafizur; Rahman, Ziaur; Paul, Repon C.; Bhuiyan, Mejbah Uddin; Brooks, W. Abdullah; Sohel, Badrul Munir; Banik, Kajal Chandra; Widdowson, Marc-Alain; Willby, Melisa; Rahman, Mahmudur; Bresee, Joseph; Ramirez, Katharine-Sturm; Azziz-Baumgartner, Eduardo			Respiratory Viruses Associated Hospitalization among Children Aged < 5 Years in Bangladesh: 2010-2014	PLOS ONE			English	Article							SYNCYTIAL VIRUS; CHILDHOOD DEATHS; INFLUENZA; INFECTIONS; PNEUMONIA; COST; IMMUNIZATION; PROPHYLAXIS; RHINOVIRUS; RISK	Background We combined hospital-based surveillance and health utilization survey data to estimate the incidence of respiratory viral infections associated hospitalization among children aged <5 years in Bangladesh. Methods Surveillance physicians collected respiratory specimens from children aged <5 years hospitalized with respiratory illness and residing in the primary hospital catchment areas. We tested respiratory specimens for respiratory syncytial virus, parainfluenza viruses, human metapneumovirus, influenza, adenovirus and rhinoviruses using rRT-PCR. During 2013, we conducted a health utilization survey in the primary catchment areas of the hospitals to determine the proportion of all hospitalizations for respiratory illness among children aged <5 years at the surveillance hospitals during the preceding 12 months. We estimated the respiratory virus-specific incidence of hospitalization by dividing the estimated number of hospitalized children with a laboratory confirmed infection with a respiratory virus by the population aged <5 years of the catchment areas and adjusted for the proportion of children who were hospitalized at the surveillance hospitals. Results We estimated that the annual incidence per 1000 children (95% CI) of all cause associated respiratory hospitalization was 11.5 (10-12). The incidences per 1000 children (95% CI) per year for respiratory syncytial virus, parainfluenza, adenovirus, human metapneumovirus and influenza infections were 3(2-3), 0.5(0.4-0.8), 0.4 (0.3-0.6), 0.4 (0.3-0.6), and 0.4 (0.3-0.6) respectively. The incidences per 1000 children (95%CI) of rhinovirus-associated infections among hospitalized children were 5 (3-7), 2 (1-3), 1 (0.6-2), and 3 (2-4) in 2010, 2011, 2012 and 2013, respectively. Conclusion Our data suggest that respiratory viruses are associated with a substantial burden of hospitalization in children aged <5 years in Bangladesh.	[Homaira, Nusrat; Luby, Stephen P.; Hossain, Kamal; Islam, Kariul; Ahmed, Makhdum; Rahman, Mustafizur; Rahman, Ziaur; Paul, Repon C.; Bhuiyan, Mejbah Uddin; Brooks, W. Abdullah; Sohel, Badrul Munir; Banik, Kajal Chandra; Ramirez, Katharine-Sturm; Azziz-Baumgartner, Eduardo] Icddr B, Dhaka, Bangladesh; [Luby, Stephen P.; Widdowson, Marc-Alain; Willby, Melisa; Bresee, Joseph; Ramirez, Katharine-Sturm; Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Brooks, W. Abdullah] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ, Baltimore, MD USA; [Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Homaira, N (corresponding author), Icddr B, Dhaka, Bangladesh.	nhomaira@icddrb.org	Bhuiyan, Mejbah/AAY-1238-2020; Homaira, Nusrat/U-4526-2019; Islam/AAO-8937-2020; Bhuiyan, Mejbah/ABG-4827-2020; Brooks, W. Abdullah/AAD-3876-2021; Ahmed, Makhdum/D-2615-2012	Bhuiyan, Mejbah/0000-0002-8274-6265; Brooks, W. Abdullah/0000-0001-9871-5546; Ahmed, Makhdum/0000-0002-0772-8710; Islam, Mdkariul/0000-0003-4085-7159; Homaira, Nusrat/0000-0003-3341-7964; Luby, Stephen/0000-0001-5385-899X	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta [1U01CI000628-01, 1U01CI000628-04]; US CDC [1U01CI000628-04]; National Center for Preparedness, Detection, and Control of Infectious Diseases [U01CI000628] Funding Source: NIH RePORTER	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta; US CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Preparedness, Detection, and Control of Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta under the co-operative agreement numbers 1U01CI000628-01 and 1U01CI000628-04. Co-authors SPL, MAW, MW, JB, KSR and EAB who work for the funding body were also involved in designing and analyzing of the study.; icddr,b is grateful for the commitment of CDC to its research efforts. US CDC gave financial support for this study (cooperative agreement 1U01CI000628-04). The authors would like to thank all the study participants and the surveillance hospitals for their contribution in the study. We gratefully acknowledge the relentless effort of the field staff involved in data collection and compilation. We also acknowledge the contribution of Dean D. Erdman for the design of the primers and probes for the laboratory testing of the study. We are also very grateful to Diana DiazGranados for her help with editing of the manuscript.	Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; AUSINA V, 1988, EUR J CLIN MICROBIOL, V7, P343, DOI 10.1007/BF01962334; Banerjee S, 2007, J CLIN VIROL, V38, P70, DOI 10.1016/j.jcv.2006.07.003; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Centers for Disease Control and Prevention (CDC), 2009, PROTOCOL OF REALTIME; Clara W, 2012, B WORLD HEALTH ORGAN, V90, P756, DOI 10.2471/BLT.11.098202; Connor E, 1997, PEDIATRICS, V99, P93; Englund JA, 2003, VACCINE, V21, P3460, DOI 10.1016/S0264-410X(03)00351-7; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Gurley ES, 2010, CLIN INFECT DIS, V50, P1084, DOI 10.1086/651265; Saborio GG, 2014, EMERG INFECT DIS, V20, P878, DOI 10.3201/eid2005.131775; Halder AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008145; Haque F, 2012, INT J INFECT DIS, V16, pE866, DOI 10.1016/j.ijid.2012.07.016; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; Haynes LM, 2013, J INFECT DIS, V208, pS177, DOI 10.1093/infdis/jit512; Henrickson Kelly J, 1998, Semin Pediatr Infect Dis, V9, P217, DOI 10.1016/S1045-1870(98)80035-6; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Joffe S, 1999, PEDIATRICS, V104, P419, DOI 10.1542/peds.104.3.419; KORPPI M, 1993, EUR J PEDIATR, V152, P24, DOI 10.1007/BF02072512; Miller EK, 2013, J CLIN VIROL, V57, P291, DOI 10.1016/j.jcv.2013.04.015; Mitra S, 2004, BANGLADESH DEMOGRAPH; Montes A, 2005, VACCINE, V23, P4302, DOI 10.1016/j.vaccine.2005.04.006; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nasreen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089978; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Simoes EAF, 2007, J PEDIATR-US, V151, P34, DOI 10.1016/j.jpeds.2007.02.032; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Smyth A, 2002, BRIT MED BULL, V61, P247, DOI 10.1093/bmb/61.1.247; van Benten I, 2003, PEDIAT ALLERG IMM-UK, V14, P363, DOI 10.1034/j.1399-3038.2003.00064.x; WALKER TA, 1994, PEDIATR CLIN N AM, V41, P1365; WANG D, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI DOI 10.1099/vir.0.82282-0; Warren-Gash C., 2012, INFLUENZA OTHER RESP, DOI 10.111/Irv.12015; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Weber MW, 1999, INT J EPIDEMIOL, V28, P157, DOI 10.1093/ije/28.1.157; Weinberg GA, 2013, J CLIN VIROL, V57, P254, DOI 10.1016/j.jcv.2013.03.016; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	50	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147982	10.1371/journal.pone.0147982	http://dx.doi.org/10.1371/journal.pone.0147982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840782	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200074
J	Huang, WC; Ke, MW; Cheng, CC; Chiou, SH; Wann, SR; Shu, CW; Chiou, KR; Tseng, CJ; Pan, HW; Mar, GY; Liu, CP				Huang, Wei-Chun; Ke, Meng-Wei; Cheng, Chin-Chang; Chiou, Shih-Hwa; Wann, Shue-Ren; Shu, Chih-Wen; Chiou, Kuan-Rau; Tseng, Ching-Jiunn; Pan, Hung-Wei; Mar, Guang-Yuan; Liu, Chun-Peng			Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension	PLOS ONE			English	Article							INFLAMMATION; ALPHA-1-ANTITRYPSIN; INTERLEUKIN-6; INHIBITION; SURVIVAL; PROTEIN; FETUIN; MODEL; MICE	Pulmonary arterial hypertension (PAH) is characterized by progressive increases in vascular resistance and the remodeling of pulmonary arteries. The accumulation of inflammatory cells in the lung and elevated levels of inflammatory cytokines in the bloodstream suggest that inflammation may play a role in PAH. In this study, the benefits of induced pluripotent stem cells (iPSCs) and iPSC-conditioned medium (iPSC CM) were explored in monocrotaline (MCT)-induced PAH rats. We demonstrated that both iPSCs and iPSC CM significantly reduced the right ventricular systolic pressure and ameliorated the hypertrophy of the right ventricle in MCT-induced PAH rats in models of both disease prevention and disease reversal. In the prevention of MCT-induced PAH, iPSC-based therapy led to the decreased accumulation of inflammatory cells and down-regulated the expression of the IL-1 beta, IL-6, IL-12 alpha, IL-12 beta, IL-23 and IFN gamma genes in lung specimens, which implied that iPSC-based therapy may be involved in the regulation of inflammation. NF-kappa B signaling is essential to the inflammatory cascade, which is activated via the phosphorylation of the NF-kappa B molecule. Using the chemical inhibitor specifically blocked the phosphorylation of NF-kappa B, and in vitro assays of cultured human M1 macrophages implied that the anti-inflammation effect of iPSC-based therapy may contribute to the disturbance of NF-kappa B activation. Here, we showed that iPSC-based therapy could restore the hemodynamic function of right ventricle with benefits for preventing the ongoing inflammation in the lungs of MCT-induced PAH rats by regulating NF-kappa B phosphorylation.	[Huang, Wei-Chun; Ke, Meng-Wei; Cheng, Chin-Chang; Chiou, Kuan-Rau; Mar, Guang-Yuan; Liu, Chun-Peng] Kaohsiung Vet Gen Hosp, Cardiovasc Med Ctr, Kaohsiung, Taiwan; [Huang, Wei-Chun; Cheng, Chin-Chang; Chiou, Kuan-Rau; Liu, Chun-Peng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Wei-Chun; Cheng, Chin-Chang] Fooyin Univ, Dept Phys Therapy, Kaohsiung, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Educ & Res, Taipei, Taiwan; [Shu, Chih-Wen; Tseng, Ching-Jiunn; Pan, Hung-Wei] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Wann, Shue-Ren] Kaohsiung Vet Gen Hosp, Dept Emergency, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Fooyin University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital	Liu, CP (corresponding author), Kaohsiung Vet Gen Hosp, Cardiovasc Med Ctr, Kaohsiung, Taiwan.; Liu, CP (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.; Wann, SR (corresponding author), Kaohsiung Vet Gen Hosp, Dept Emergency, Kaohsiung, Taiwan.	srwann@vghks.gov.tw; wchuanglulu.photo@gmail.com	Shu, Chih-Wen/AAE-9652-2019	Shu, Chih-Wen/0000-0002-7774-0002	Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan [VGHKS 102-058, 103-053, 103-121, 103-124, 102-054]; National Science Council, Taiwan [NSC 101-2314-13-075B-008, MOST-103-2314-B-075B-003]	Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Grant No. VGHKS 102-058, 103-053, 103-121, 103-124, 102-054, and National Science Council, Taiwan, NSC 101-2314-13-075B-008, MOST-103-2314-B-075B-003.	Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Dorronsoro A, 2013, J NEUROSCI RES, V91, P1440, DOI [10.1002/jnr.23267PMID:23996632, DOI 10.1002/JNR.23267]; Ehlers MR, 2014, BIOL CHEM, V395, P1187, DOI 10.1515/hsz-2014-0161; Fang IM, 2014, J OCUL PHARMACOL TH, V30, P757, DOI 10.1089/jop.2014.0020; Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599; Gangneux C, 2003, NUCLEIC ACIDS RES, V31, P5957, DOI 10.1093/nar/gkg788; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; Ho WJ, 2014, ACTA CARDIOL SIN, V30, P236; Hsu CH, 2014, ACTA CARDIOL SIN, V30, P401; Hsu CH, 2012, ACTA CARDIOL SIN, V28, P267; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Jodele S, 2013, BIOL BLOOD MARROW TR, V19, P202, DOI 10.1016/j.bbmt.2012.08.022; Johnson JL, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/276457; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Keogh AM, 2009, J AM COLL CARDIOL, V54, pS67, DOI 10.1016/j.jacc.2009.04.016; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li L, 2014, HYPERTENSION, V63, P1260, DOI 10.1161/HYPERTENSIONAHA.114.03220; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066760; Lockett AD, 2013, AM J RESP CELL MOL, V49, P143, DOI 10.1165/rcmb.2012-0515OC; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Morin C, 2014, AM J PHYSIOL-HEART C, V307, pH574, DOI 10.1152/ajpheart.00814.2013; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Ogulur I, 2014, INT IMMUNOPHARMACOL, V22, P31, DOI 10.1016/j.intimp.2014.06.011; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Ormiston ML, 2010, AM J RESP CELL MOL, V43, P546, DOI 10.1165/rcmb.2009-0152OC; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Reel B, 2011, BRIT J PHARMACOL, V163, P1679, DOI 10.1111/j.1476-5381.2011.01298.x; Ruiter G, 2013, EUR RESPIR J, V42, P553, DOI 10.1183/09031936.00012313; Sahara M, 2007, CIRCULATION, V115, P509, DOI 10.1161/CIRCULATIONAHA.106.655837; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tatarishvili J, 2014, RESTOR NEUROL NEUROS, V32, P547, DOI 10.3233/RNN-140404; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Voelkel NF, 2004, CARDIOL CLIN, V22, P343, DOI 10.1016/j.ccl.2004.04.010; Voelkel NF, 2002, CRIT CARE MED, V30, pS251, DOI 10.1097/00003246-200205001-00013; Wang H, 2014, INT IMMUNOPHARMACOL, V22, P31; Woltje M, 2006, J MOL ENDOCRINOL, V36, P261, DOI 10.1677/jme.1.02001; Yang KY, 2011, CHEST, V140, P1243, DOI 10.1378/chest.11-0539; Zhang ZH, 2012, EXP THER MED, V4, P839, DOI 10.3892/etm.2012.691; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	56	17	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0142476	10.1371/journal.pone.0142476	http://dx.doi.org/10.1371/journal.pone.0142476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840075	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200001
J	Jia, TT; Ogawa, Y; Miura, M; Ito, O; Kohzuki, M				Jia, Tiantian; Ogawa, Yoshiko; Miura, Misa; Ito, Osamu; Kohzuki, Masahiro			Music Attenuated a Decrease in Parasympathetic Nervous System Activity after Exercise	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; POWER SPECTRAL-ANALYSIS; RATE RECOVERY; ORTHOSTATIC INTOLERANCE; BLOOD-PRESSURE; NEURAL-CONTROL; HYPOTENSION; MECHANISMS; INTERVAL; RESERVE	Music and exercise can both affect autonomic nervous system activity. However, the effects of the combination of music and exercise on autonomic activity are poorly understood. Additionally, it remains unknown whether music affects post-exercise orthostatic tolerance. The aim of this study was to evaluate the effects of music on autonomic nervous system activity in orthostatic tolerance after exercise. Twenty-six healthy graduate students participated in four sessions in a random order on four separate days: a sedentary session, a music session, a bicycling session, and a bicycling with music session. Participants were asked to listen to their favorite music and to exercise on a cycle ergometer. We evaluated autonomic nervous system activity before and after each session using frequency analysis of heart rate variability. High frequency power, an index of parasympathetic nervous system activity, was significantly increased in the music session. Heart rate was increased, and high frequency power was decreased, in the bicycling session. There was no significant difference in high frequency power before and after the bicycling with music session, although heart rate was significantly increased. Additionally, both music and exercise did not significantly affect heart rate, systolic blood pressure or also heart rate variability indices in the orthostatic test. These data suggest that music increased parasympathetic activity and attenuated the exercise-induced decrease in parasympathetic activity without altering the orthostatic tolerance after exercise. Therefore, music may be an effective approach for improving post-exercise parasympathetic reactivation, resulting in a faster recovery and a reduction in cardiac stress after exercise.	[Jia, Tiantian; Ogawa, Yoshiko; Ito, Osamu; Kohzuki, Masahiro] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 980, Japan; [Miura, Misa] Tsukuba Univ Technol, Natl Univ Corp, Course Phys Therapy, Fac Hlth Sci, Tsukuba, Ibaraki, Japan	Tohoku University; Tsukuba University of Technology	Ogawa, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 980, Japan.	yoshikogawa@med.tohoku.ac.jp	äæ, çä/L-4382-2019	Ito, Osamu/0000-0001-7583-5270				Adams V, 2008, FRONT BIOSCI-LANDMRK, V13, P302, DOI 10.2741/2680; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Billman GE, 1985, J APPL PHYSL BETHESD, V2002, P446, DOI DOI 10.1152/JAPPLPHYSI0L.00874.2001; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buchheit M, 2006, AM J PHYSIOL-HEART C, V291, pH451, DOI 10.1152/ajpheart.00008.2006; Camm AJ, 1996, CIRCULATION, V93, P1043; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; da Silva SAF, 2014, INT CARDIOVASC RES J, V8, P105; Eckberg DL, 1998, CIRCULATION, V98, P2643; Fu Q, 2004, CIRCULATION, V110, P2931, DOI 10.1161/01.CIR.0000146384.91715.B5; Goldberger JJ, 2001, CIRCULATION, V103, P1977; Halliwill J R, 2001, Exerc Sport Sci Rev, V29, P65, DOI 10.1097/00003677-200104000-00005; Houle MS, 1999, AM J PHYSIOL-HEART C, V276, pH215, DOI 10.1152/ajpheart.1999.276.1.H215; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; KENNEY MJ, 1993, HYPERTENSION, V22, P653, DOI 10.1161/01.HYP.22.5.653; Knight WEJ, 2001, J MUSIC THER, V38, P254, DOI 10.1093/jmt/38.4.254; Koelsch S, 2015, EUR HEART J, V36, P3043, DOI 10.1093/eurheartj/ehv430; Kon H, 2006, INT HEART J, V47, P867, DOI 10.1536/ihj.47.867; Krabs RU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126224; Kubo M, 1996, J JAPAN BIOMUSIC ASS, V13, P126; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lucas SJE, 2008, J APPL PHYSIOL, V105, P213, DOI 10.1152/japplphysiol.00175.2008; Macor F, 1996, INT J SPORTS MED, V17, P175, DOI 10.1055/s-2007-972828; Mikutta CA, 2013, PSYCHOPHYSIOLOGY, V50, P909, DOI 10.1111/psyp.12071; Murrell CJ, 2011, EUR J APPL PHYSIOL, V111, P469, DOI 10.1007/s00421-010-1671-8; Ogoh S, 2003, J PHYSIOL-LONDON, V551, P601, DOI 10.1113/jphysiol.2003.046029; Orini M, 2010, MED BIOL ENG COMPUT, V48, P423, DOI 10.1007/s11517-010-0592-3; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Peng SM, 2009, J ALTERN COMPLEM MED, V15, P53, DOI 10.1089/acm.2008.0243; Pomeranz B., 1985, CNS NEUROSCI THER, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; SAVIN WM, 1982, J APPL PHYSIOL, V53, P1572, DOI 10.1152/jappl.1982.53.6.1572; Sumi K, 2006, SCAND J MED SCI SPOR, V16, P314, DOI 10.1111/j.1600-0838.2005.00492.x; Suzuki Shigehiro, 2008, Journal of Physiological Anthropology, V27, P325, DOI 10.2114/jpa2.27.325; Terziotti P, 2001, EUR J APPL PHYSIOL, V84, P187, DOI 10.1007/s004210170003; Urakawa K, 2005, TOHOKU J EXP MED, V206, P213, DOI 10.1620/tjem.206.213; VICTOR RG, 1987, J APPL PHYSIOL, V63, P2558, DOI 10.1152/jappl.1987.63.6.2558; Willie CK, 2013, EUR J APPL PHYSIOL, V113, P1597, DOI 10.1007/s00421-012-2578-3; Yamashita S, 2006, J SPORT MED PHYS FIT, V46, P425	42	18	18	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148648	10.1371/journal.pone.0148648	http://dx.doi.org/10.1371/journal.pone.0148648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840532	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200150
J	Pascoe, S; Tobin, R; Windle, J; Cannard, T; Marshall, N; Kabir, Z; Flint, N				Pascoe, Sean; Tobin, Renae; Windle, Jill; Cannard, Toni; Marshall, Nadine; Kabir, Zobaidul; Flint, Nicole			Developing a Social, Cultural and Economic Report Card for a Regional Industrial Harbour	PLOS ONE			English	Article							MULTICRITERIA DECISION-ANALYSIS; WEIGHT ELICITATION METHODS; BAYESIAN NETWORK; RESOURCE-MANAGEMENT; ECOSYSTEM SERVICES; QUALITY; ALLOCATION; FRAMEWORK; BENEFITS; FISHERY	Report cards are increasingly used to provide ongoing snap-shots of progress towards specific ecosystem health goals, particularly in coastal regions where planners need to balance competing demands for coastal resources from a range of industries. While most previous report cards focus on the biophysical components of the system, there is a growing interest in including the social and economic implications of ecosystem management to provide a greater social-ecological system understanding. Such a report card was requested on the Gladstone Harbour area in central Queensland, Australia. Gladstone Harbour adjoins the southern Great Barrier Reef, and is also a major industrial and shipping port. Balancing social, economic and environmental interests is therefore of great concern to the regional managers. While environmental benchmarking procedures are well established within Australia (and elsewhere), a method for assessing social and economic performance of coastal management is generally lacking. The key aim of this study was to develop and pilot a system for the development of a report card relating to appropriate cultural, social and economic objectives. The approach developed uses a range of multicriteria decision analysis methods to assess and combine different qualitative and quantitative measures, including the use of Bayesian Belief Networks to combine the different measures and provide an overall quantitative score for each of the key management objectives. The approach developed is readily transferable for purposes of similar assessments in other regions.	[Pascoe, Sean; Cannard, Toni] CSIRO Oceans & Atmosphere, Brisbane, Qld, Australia; [Tobin, Renae] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Tobin, Renae] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Windle, Jill; Kabir, Zobaidul; Flint, Nicole] Cent Queensland Univ, Sch Business & Law, Rockhampton, Qld 4702, Australia; [Marshall, Nadine] CSIRO Land & Water, Townsville, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; James Cook University; Central Queensland University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Pascoe, S (corresponding author), CSIRO Oceans & Atmosphere, Brisbane, Qld, Australia.	sean.pascoe@csiro.au	Marshall, Nadine/D-9339-2011; Cannard, Toni/AAA-8521-2019; Flint, Nicole/AAJ-8538-2021; Cannard, Toni M/D-8005-2012; Pascoe, Sean/D-9710-2011	Marshall, Nadine/0000-0003-4463-3558; Flint, Nicole/0000-0003-4331-4109; Cannard, Toni M/0000-0003-4254-8683; Pascoe, Sean/0000-0001-6581-2649	Gladstone Healthy Harbour Partnership [ISP005]	Gladstone Healthy Harbour Partnership	This work was supported by Gladstone Healthy Harbour Partnership, ISP005 (http://rc.ghhp.org.au/) to SP, RT, and JW. The funders had commissioned previous studies that identified objectives and preliminary indicators that were used in this analysis. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BARBER W E, 1990, North American Journal of Fisheries Management, V10, P365, DOI 10.1577/1548-8675(1990)010<0365:TIOGOA>2.3.CO;2; Bottomley PA, 2000, J MARKETING RES, V37, P508, DOI 10.1509/jmkr.37.4.508.18794; Bottomley PA, 2001, OMEGA-INT J MANAGE S, V29, P553, DOI 10.1016/S0305-0483(01)00044-5; Cannard T, 2012, EST COAST SCI ASS C, P1; Carroll C, 2012, MAR POLLUT BULL, V65, P136, DOI 10.1016/j.marpolbul.2011.11.022; Chapman D., 1996, WATER QUALITY ASSESS, P59, DOI [10.4324/noe0419216001, DOI 10.4324/NOE0419216001]; Christianson JB, 2010, J GEN INTERN MED, V25, P1235, DOI 10.1007/s11606-010-1438-2; Curtin R, 2010, MAR POLICY, V34, P821, DOI 10.1016/j.marpol.2010.01.003; Diener E., 2006, APPL RES QUAL LIFE, DOI [10.1007/s11482-006-9007-x, DOI 10.1007/S10902-006-9000-Y, DOI 10.1007/S11482-006-9007-X]; Dill DD, 2005, HIGH EDUC, V49, P495, DOI 10.1007/s10734-004-1746-8; Drescher LS, 2014, INT J CONSUM STUD, V38, P217, DOI 10.1111/ijcs.12086; Estevez RA, 2013, DIVERS DISTRIB, V19, P608, DOI 10.1111/ddi.12058; Gladstone Ports Corporation, 2013, ANN REP 2012 13; Grabowski DC, 2011, HEALTH SERV RES, V46, P1698, DOI 10.1111/j.1475-6773.2011.01298.x; Greer L., 2013, GUIDANCE SELECTION S; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hayashi K, 2000, EUR J OPER RES, V122, P486, DOI 10.1016/S0377-2217(99)00249-0; Hayes N., 2007, IMPACT ASSESS PROJ A, V25, P209, DOI [10.3152/146155107x227126, DOI 10.3152/146155107X227126]; Heilman P, 1997, APPL MATH COMPUT, V83, P173, DOI 10.1016/S0096-3003(96)00168-3; HUYLENBROEK GV, 1992, EUROPEAN REV AGR EC, V19, P237, DOI DOI 10.1093/erae/19.2.237; Jacquet J, 2010, ORYX, V44, P45, DOI 10.1017/S0030605309990470; Koschke L, 2012, ECOL INDIC, V21, P54, DOI 10.1016/j.ecolind.2011.12.010; Leigh C, 2013, WATER-SUI, V5, P780, DOI 10.3390/w5020780; Lipton D, 2003, ESTUARIES, V26, P310, DOI 10.1007/BF02695969; Little LR, 2004, ENVIRON MODELL SOFTW, V19, P27, DOI 10.1016/S1364-8152(03)00100-2; Liu S, 2013, J ENVIRON MANAGE, V129, P92, DOI 10.1016/j.jenvman.2013.06.047; Marshall N. A., 2013, SOCIAL EC LONG TERM; McCann RK, 2006, CAN J FOREST RES, V36, P3053, DOI 10.1139/X06-238; McIntosh E. J., 2014, GLADSTONE HARBOUR RE; Naranjo-Madrigal H, 2015, MAR POLICY, V62, P102, DOI 10.1016/j.marpol.2015.09.003; Nolan MA, 2012, LOCAL ECON, V27, P403, DOI 10.1177/0269094212437834; Overton JM, 2013, AMBIO, V42, P100, DOI 10.1007/s13280-012-0342-x; Pascoe S, 2014, PILOTING SOCIAL CULT; Pascoe S, 2014, OCEAN COAST MANAGE, V98, P1, DOI 10.1016/j.ocecoaman.2014.05.014; Pascoe S, 2013, MAR POLICY, V37, P115, DOI 10.1016/j.marpol.2012.02.016; Pollino CA, 2007, ENVIRON MODELL SOFTW, V22, P1140, DOI 10.1016/j.envsoft.2006.03.006; Roberts R., 2002, J MULTI-CRITERIA DEC, V11, P291, DOI [10.1002/mcda.320, DOI 10.1002/mcda.320, DOI 10.1002/MCDA.320]; Saaty TL., 1980, ANAL HIERARCHY PROCE; Sheppard SRJ, 2005, FOREST ECOL MANAG, V207, P171, DOI 10.1016/j.foreco.2004.10.032; Sutton SG, 2009, ENVIRON CONSERV, V36, P245, DOI 10.1017/S0376892909990270; Tobin RC, 2010, 9 J COOK U FISH FISH; Triantafillos L, 2014, FRDC REPORT PROJECT; van Putten I, 2013, MAR POLICY, V37, P96, DOI 10.1016/j.marpol.2012.04.001; Wang JJ, 2009, RENEW SUST ENERG REV, V13, P2263, DOI 10.1016/j.rser.2009.06.021; Yang M, 2011, INT J ENV RES PUB HE, V8, P1368, DOI 10.3390/ijerph8051368	46	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148271	10.1371/journal.pone.0148271	http://dx.doi.org/10.1371/journal.pone.0148271			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9OF	26839949	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000369550200117
J	Su, RN; Wang, C; Feng, H; Lin, L; Liu, XY; Wei, YM; Yang, HX				Su, Rina; Wang, Chen; Feng, Hui; Lin, Li; Liu, Xinyue; Wei, Yumei; Yang, Huixia			Alteration in Expression and Methylation of IGF2/H19 in Placenta and Umbilical Cord Blood Are Associated with Macrosomia Exposed to Intrauterine Hyperglycemia	PLOS ONE			English	Article							GROWTH-FACTOR 2; DNA METHYLATION; EPIGENETIC CHANGES; IMPRINTED GENES; FETAL-GROWTH; IGF-II; BIRTH; SUSCEPTIBILITY; PREGNANCIES; MODULATOR	Objective Macrosomia is one of the most common complications in gestational diabetes mellitus. Insulin-like growth factor 2 and H19 are two of the imprinted candidate genes that are involved in fetal growth and development. Change in methylation at differentially methylated region of the insulin-like growth factor 2 and H19 has been proved to be an early event related to the programming of metabolic profile, including macrosomia and small for gestational age in offspring. Here we hypothesize that alteration in methylation at differentially methylated region of the insulin-like growth factor 2 and H19 is associated with macrosomia induced by intrauterine hyperglycemia. Results The expression of insulin-like growth factor 2 is significant higher in gestational diabetes mellitus group (GDM group) compared to normal glucose tolerance group (NGT group) both in umbilical cord blood and placenta, while the expression of H19 is significant lower in GDM group in umbilical cord blood. The expression of insulin-like growth factor 2 is significant higher in normal glucose tolerance with macrosomia group (NGT-M) compared to normal glucose tolerance with normal birthweight group (NGT-NBW group) both in placenta and umbilical cord blood. A model with interaction term of gene expression of IGF2 and H19 found that IGF2 and the joint action of IGF2 and H19 in placenta showed significantly relationship with GDM/NGT and GDM-NBW/NGT-NBW. A borderline significant association was seen among IGF2 and H19 in cord blood and GDM-M/NGT-M. The methylation level at different CpG sites of insulin-like growth factor 2 and H19 in umbilical cord blood was also significantly different among groups. Based on the multivariable linear regression analysis, the methylation of the insulin-like growth factor 2 / H19 is closely related to birth weight and intrauterine hyperglycemia. Conclusions We confirmed the existence of alteration in DNA methylation in umbilical cord blood exposed to intrauterine hyperglycemia and reported a functional role in regulating gene associated with insulin-like growth factor 2/H19. Both of these might be the underlying pathogenesis of macrosomia. We also provided the evidence of strong associations between methylation of insulin-like growth factor 2/H19 and macrosomia induced by intrauterine hyperglycemia.	[Su, Rina; Wang, Chen; Feng, Hui; Lin, Li; Wei, Yumei; Yang, Huixia] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Liu, Xinyue] Univ Florida, Coll Pharm, Pharmaceut Outcomes & Policy, Gainesville, FL 32611 USA	Peking University; State University System of Florida; University of Florida	Wei, YM; Yang, HX (corresponding author), Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	weiyumei1982@126.com; yanghuixia688@sina.com		YANG, HUIXIA/0000-0001-9913-2721; Yang, Huixia/0000-0001-8954-2102	National Natural Science Foundation of China [81341020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81341020).	Algar EM, 2007, CANCER RES, V67, P2360, DOI 10.1158/0008-5472.CAN-06-3383; Allard C, 2015, EPIGENETICS-US, V10, P342, DOI 10.1080/15592294.2015.1029700; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Burris HH, 2013, EPIGENOMICS-UK, V5, P271, DOI [10.2217/EPI.13.24, 10.2217/epi.13.24]; Chatterjee A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0674-5; Chen DQ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0108-3; Claycombe KJ, 2013, J NUTR, V143, P1533, DOI 10.3945/jn.113.178038; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Court F, 2013, HUM MUTAT, V34, P595, DOI 10.1002/humu.22276; Ding GL, 2012, DIABETES, V61, P1133, DOI 10.2337/db11-1314; Finer S, 2015, HUM MOL GENET, V24, P3021, DOI 10.1093/hmg/ddv013; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; Hoyo C, 2012, CANCER CAUSE CONTROL, V23, P635, DOI 10.1007/s10552-012-9932-y; Huang RC, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-21; Ideraabdullah FY, 2014, HUM MOL GENET, V23, P6246, DOI 10.1093/hmg/ddu344; Koukoura O, 2011, INT J MOL MED, V28, P481, DOI 10.3892/ijmm.2011.754; LaRocca J, 2014, ENVIRON RES, V133, P396, DOI 10.1016/j.envres.2014.04.032; Manderson JG, 2002, DIABETOLOGIA, V45, P991, DOI 10.1007/s00125-002-0865-y; Mpondo BCT, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0169-7; Ornoy A, 2015, BIRTH DEFECTS RES C, V105, P53, DOI 10.1002/bdrc.21090; Parretti E, 2001, DIABETES CARE, V24, P1319, DOI 10.2337/diacare.24.8.1319; Perkins E, 2012, J PEDIATR-US, V161, P31, DOI 10.1016/j.jpeds.2012.01.015; Petry CJ, 2011, DIABETES, V60, P3090, DOI 10.2337/db11-0689; Shao WJ, 2008, COMPARATIVE MED, V58, P341; Sireesha M, 2009, J DIABETES, V1, P118, DOI 10.1111/j.1753-0407.2009.00025.x; St-Pierre J, 2012, EPIGENETICS-US, V7, P1125, DOI 10.4161/epi.21855; Suliman SGL, 2009, DIABETES, V58, P2954, DOI 10.2337/db09-0787; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Xie T, 2008, ENDOCRINOLOGY, V149, P2443, DOI 10.1210/en.2007-1458; Yang HX, 2012, CHINESE MED J-PEKING, V125, P1212, DOI 10.3760/cma.j.issn.0366-6999.2012.07.004; Zhang SL, 2015, J PEDIATR ENDOCR MET, V28, P613, DOI 10.1515/jpem-2014-0269; Zhu WW, 2013, DIABETES CARE, V36, P586, DOI 10.2337/dc12-1157	33	45	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148399	10.1371/journal.pone.0148399	http://dx.doi.org/10.1371/journal.pone.0148399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840070	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200131
J	Barb, JJ; Oler, AJ; Kim, HS; Chalmers, N; Wallen, GR; Cashion, A; Munson, PJ; Ames, NJ				Barb, Jennifer J.; Oler, Andrew J.; Kim, Hyung-Suk; Chalmers, Natalia; Wallen, Gwenyth R.; Cashion, Ann; Munson, Peter J.; Ames, Nancy J.			Development of an Analysis Pipeline Characterizing Multiple Hypervariable Regions of 16S rRNA Using Mock Samples	PLOS ONE			English	Article							CLINICAL MICROBIOLOGY; DIVERSITY; SEQUENCES; IDENTIFICATION; PERFORMANCE; BACTERIA; PRIMERS	Objectives There is much speculation on which hypervariable region provides the highest bacterial specificity in 16S rRNA sequencing. The optimum solution to prevent bias and to obtain a comprehensive view of complex bacterial communities would be to sequence the entire 16S rRNA gene; however, this is not possible with second generation standard library design and short-read next-generation sequencing technology. Methods This paper examines a new process using seven hypervariable or V regions of the 16S rRNA (six amplicons: V2, V3, V4, V6-7, V8, and V9) processed simultaneously on the Ion Torrent Personal Genome Machine (Life Technologies, Grand Island, NY). Four mock samples were amplified using the 16S Ion Metagenomics Kit (TM) (Life Technologies) and their sequencing data is subjected to a novel analytical pipeline. Results Results are presented at family and genus level. The Kullback-Leibler divergence (D-KL), a measure of the departure of the computed from the nominal bacterial distribution in the mock samples, was used to infer which region performed best at the family and genus levels. Three different hypervariable regions, V2, V4, and V6-7, produced the lowest divergence compared to the known mock sample. The V9 region gave the highest (worst) average D-KL while the V4 gave the lowest (best) average D-KL. In addition to having a high D-KL, the V9 region in both the forward and reverse directions performed the worst finding only 17% and 53% of the known family level and 12% and 47% of the genus level bacteria, while results from the forward and reverse V4 region identified all 17 family level bacteria. Conclusions The results of our analysis have shown that our sequencing methods using 6 hypervariable regions of the 16S rRNA and subsequent analysis is valid. This method also allowed for the assessment of how well each of the variable regions might perform simultaneously. Our findings will provide the basis for future work intended to assess microbial abundance at different time points throughout a clinical protocol.	[Barb, Jennifer J.; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bldg 10, Bethesda, MD 20892 USA; [Oler, Andrew J.] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kim, Hyung-Suk; Cashion, Ann] NINR, NIH, Bethesda, MD 20892 USA; [Chalmers, Natalia] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Wallen, Gwenyth R.; Ames, Nancy J.] NIH, Ctr Clin, Dept Nursing, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Barb, JJ (corresponding author), NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bldg 10, Bethesda, MD 20892 USA.	barbj@mail.nih.gov	Natalia I. Chalmers, MHSc/AAI-6870-2021	Barb, Jennifer/0000-0003-3022-0154	NIH; Clinical Center and NIH; National Institute of Nursing Research; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000277, ZIACT000266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [ZIANR000030, ZIANR000015] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Center and NIH; National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by the Intramural Research Program of NIH, Clinical Center and NIH, National Institute of Nursing Research.	[Anonymous], 2014, BBMAP ALIGNER DNA RN; [Anonymous], 2014, 16 RRNA SEQ INT RES; [Anonymous], 2014, BEI RESOURCES; Birtel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125356; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Dassi E, 2014, J BIOTECHNOL, V190, P30, DOI 10.1016/j.jbiotec.2014.03.024; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ghyselinck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071360; Guo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076185; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He Y, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-208; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Li J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0316-1; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-17; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Mosher JJ, 2014, J MICROBIOL METH, V104, P59, DOI 10.1016/j.mimet.2014.06.012; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Pylro VS, 2014, MICROB ECOL, V67, P237, DOI 10.1007/s00248-013-0302-4; Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Tanner A, 1994, Periodontol 2000, V5, P26, DOI 10.1111/j.1600-0757.1994.tb00017.x; Toma I, 2014, J CLIN MICROBIOL, V52, P3913, DOI 10.1128/JCM.01678-14; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x	46	73	74	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148047	10.1371/journal.pone.0148047	http://dx.doi.org/10.1371/journal.pone.0148047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829716	Green Submitted, gold, Green Published			2022-12-27	WOS:000369548200055
J	Chin, WY; Choi, EPH; Wan, EYF				Chin, Weng Yee; Choi, Edmond P. H.; Wan, Eric Y. F.			Trajectory Pathways for Depressive Symptoms and Their Associated Factors in a Chinese Primary Care Cohort by Growth Mixture Modelling	PLOS ONE			English	Article							HONG-KONG; RISK-FACTORS; DISORDERS; NUMBER; CRITERION; SELECTION; OUTCOMES; VERSION; PHQ-9; AGE	Background The naturalistic course for patients suffering from depressive disorders can be quite varied. Whilst some remit with little or no intervention, others may suffer a more prolonged course of symptoms. The aim of this study was to identify trajectory patterns for depressive symptoms in a Chinese primary care cohort and their associated factors. Methods and Results A 12-month cohort study was conducted. Patients recruited from 59 primary care clinics across Hong Kong were screened for depressive symptoms using the Centre for Epidemiologic Studies Depression Scale (CES-D) and monitored over 12 months using the Patient Health Questionnaire-9 items (PHQ-9) administered at 12, 26 and 52 weeks. 721 subjects were included for growth mixture modelling analysis. Using Akaike Information Criterion, Bayesian Information Criterion, Entropy and Lo-Mendell-Rubin adjusted likelihood ratio test, a seven-class trajectory path model was identified. Over 12 months, three trajectory groups showed improvement in depressive symptoms, three remained static, whilst one deteriorated. A mild severity of depressive symptoms with gradual improvement was the most prevalent trajectory identified. Multivariate, multinomial regression analysis was used to identify factors associated with each trajectory. Risk factors associated with chronicity included: female gender; not married; not in active employment; presence of multiple chronic disease co-morbidities; poor self-rated general health; and infrequent health service use. Conclusions Whilst many primary care patients may initially present with a similar severity of depressive symptoms, their course over 12 months can be quite heterogeneous. Although most primary care patients improve naturalistically over 12 months, many do not remit and it is important for doctors to be able to identify those who are at risk of chronicity. Regular follow-up and greater treatment attention is recommended for patients at risk of chronicity.	[Chin, Weng Yee; Wan, Eric Y. F.] Univ Hong Kong, Dept Family Med & Primary Care, Ap Lei Chau Clin, 3-F,161 Main St, Hong Kong, Hong Kong, Peoples R China; [Choi, Edmond P. H.] Univ Hong Kong, Sch Nursing, 4-F William MW Mong Block 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chin, WY (corresponding author), Univ Hong Kong, Dept Family Med & Primary Care, Ap Lei Chau Clin, 3-F,161 Main St, Hong Kong, Hong Kong, Peoples R China.	chinwy@hku.hk	Choi, Edmond/H-4187-2019; Choi, Edmond/HDN-8462-2022	Choi, Edmond/0000-0001-9062-3540; 	Hong Kong Food and Health Bureau's Commissioned Research on Mental Health Policy and Service grant [SMH-27]	Hong Kong Food and Health Bureau's Commissioned Research on Mental Health Policy and Service grant	This work was supported by the Hong Kong Food and Health Bureau's Commissioned Research on Mental Health Policy and Service grant reference no. SMH-27.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; [Anonymous], 2009, RELATING LATENT CLAS; Asparouhov T, 2014, STRUCT EQU MODELING, V21, P329, DOI 10.1080/10705511.2014.915181; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brendgen M, 2005, J ABNORM CHILD PSYCH, V33, P579, DOI 10.1007/s10802-005-6739-2; Brendgen M, 2010, DEV PSYCHOL, V46, P491, DOI 10.1037/a0017413; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Cheng C., 2007, J ESTHET RESTOR DENT, V29, P381, DOI [DOI 10.1016/J.JAD.2013.07.014, 10.1016/j.jad.2013.07.014]; Cheung CK, 1998, J PSYCHOL, V132, P169, DOI 10.1080/00223989809599157; Chin WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135131; Chin WY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006730; Chin WY, 2015, FAM PRACT, V32, P288, DOI 10.1093/fampra/cmv009; Chin WY, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-30; Chin WY, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-129; Cui XJ, 2008, AM J GERIAT PSYCHIAT, V16, P406, DOI 10.1097/JGP.0b013e3181693264; Dunn LB, 2011, HEALTH PSYCHOL, V30, P683, DOI 10.1037/a0024366; Elliott P, 2005, J TRAUMA STRESS, V18, P303, DOI 10.1002/jts.20041; Gaynes BN, 2002, J NERV MENT DIS, V190, P799, DOI 10.1097/00005053-200212000-00001; Gilchrist G, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-28; Gunn J, 2013, J AFFECT DISORDERS, V148, P338, DOI 10.1016/j.jad.2012.12.021; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Interian A, 2011, GEN HOSP PSYCHIAT, V33, P94, DOI 10.1016/j.genhosppsych.2010.12.001; Jorm AF, 2005, PSYCHOL MED, V35, P1253, DOI 10.1017/S0033291705004976; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lam CL, 1999, HONG KONG PRACTITION, V21, P460; Lam ETP, 2013, J EVAL CLIN PRACT, V19, P200, DOI 10.1111/j.1365-2753.2011.01800.x; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Magnil M, 2013, SCAND J PRIM HEALTH, V31, P20, DOI 10.3109/02813432.2012.757074; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RAMASWAMY V, 1993, MARKET SCI, V12, P103, DOI 10.1287/mksc.12.1.103; Rhebergen D, 2012, PSYCHOL MED, V42, P1383, DOI 10.1017/S0033291711002509; Rubin D. B., 2004, MULTIPLE IMPUTATION; Russo A, 2007, J GERIATR PSYCH NEUR, V20, P131, DOI 10.1177/0891988707301865; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Thompson C, 2001, BRIT J PSYCHIAT, V179, P317, DOI 10.1192/bjp.179.4.317; Tofighi D, 2008, ADVANCES IN LATENT VARIABLE MIXTURE MODELS, P317; Tolvanen A., 2007, LATENT GROWTH MIXTUR; Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025; Vuorilehto M, 2005, PSYCHOL MED, V35, P673, DOI 10.1017/S0033291704003770; Wood BM, 2010, PAIN MED, V11, P1780, DOI 10.1111/j.1526-4637.2010.01005.x; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	49	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147775	10.1371/journal.pone.0147775	http://dx.doi.org/10.1371/journal.pone.0147775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26829330	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200033
J	Fan, LL; Li, HJ; Niu, YW; Chen, QH				Fan, Linlin; Li, Hongji; Niu, Yongwu; Chen, Qihe			Characterization and Inducing Melanoma Cell Apoptosis Activity of Mannosylerythritol Lipids-A Produced from Pseudozyma aphidis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; GLYCOLIPID BIOSURFACTANTS; CANDIDA-ANTARCTICA; DIFFERENTIATION; DEATH; CALCIUM; YEAST; BETA; MITOCHONDRION	Mannosylerythritol lipids (MELs) are natural glycolipid biosurfactants which have potential applications in the fields of food, cosmetic and medicine. In this study, MELs were produced from vegetable oil by Pseudozyma aphidis. Their structural data through LC/MS, GC/MS and NMR analysis revealed that MEL-A with two acetyls was the major compound and the identified homologs of MEL-A contained a length of C8 to C14 fatty acid chains. This glycolipid exhibited a surface tension of 27.69 mN/m at a critical micelle concentration (CMC), self-assembling into particles in the water solution. It was observed to induce cell growth-inhibition and apoptosis of B16 melanoma cells in a dose-dependent manner, as well as cause cell cycle arrest at the S phase. Further quantitative RT-PCR analysis and western blotting revealed an increasing tendency of both mRNA and protein expressions of Caspase-12, CHOP, GRP78 and Caspase-3, and a down-regulation of protein Bcl-2. Combined with the up regulation of signaling IRE1 and ATF6, it can be speculated that MEL-A-induced B16 melanoma cell apoptosis was associated with the endoplasmic reticulum stress (ERS).	[Fan, Linlin; Li, Hongji; Niu, Yongwu; Chen, Qihe] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Qihe] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, QH (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Chen, QH (corresponding author), Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	chenqh@zju.edu.cn	Chen, QiHe/G-4425-2012	Chen, QiHe/0000-0003-3862-4356	Zhejiang Provincial Natural Science Foundation of China [LR13C200002];  [LY12C20009]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); 	The study was based upon work funded by Zhejiang Provincial Natural Science Foundation of China under Grant No. LR13C200002, and another foundation under Grant No. LY12C20009. The authors are very grateful for the support.	Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Arutchelvi JI, 2008, J IND MICROBIOL BIOT, V35, P1559, DOI 10.1007/s10295-008-0460-4; Buckley BJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1298, DOI 10.1152/ajpcell.1997.273.4.C1298; Dai K, 2009, CURR OPIN COLLOID IN, V14, P315, DOI [10.1016/j.cocis.2009.05.009, DOI 10.1016/J.COCIS.2009.05.009]; Dubey KV, 2012, BIORESOURCE TECHNOL, V126, P368, DOI 10.1016/j.biortech.2012.05.024; Fan LL, 2014, CARBOHYD RES, V392, P1, DOI 10.1016/j.carres.2014.04.013; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Imura T, 2006, CHEM-EUR J, V12, P2434, DOI 10.1002/chem.200501199; Imura T, 2007, LANGMUIR, V23, P1659, DOI 10.1021/la0620814; Isoda H, 1997, LIPIDS, V32, P263, DOI 10.1007/s11745-997-0033-0; Isoda H, 1997, CYTOTECHNOLOGY, V25, P191, DOI 10.1023/A:1007982909932; Kim HS, 1999, APPL MICROBIOL BIOT, V52, P713, DOI 10.1007/s002530051583; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kitamoto D, 1998, BIOTECHNOL LETT, V20, P813, DOI 10.1023/A:1005347022247; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P31, DOI 10.1080/00021369.1990.10869918; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Morita Y, 2011, BBA-GEN SUBJECTS, V1810, P1302, DOI 10.1016/j.bbagen.2011.07.002; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Onghena M, 2011, ANAL BIOANAL CHEM, V400, P1263, DOI 10.1007/s00216-011-4741-9; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Rau U, 2005, APPL MICROBIOL BIOT, V66, P551, DOI 10.1007/s00253-004-1672-9; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Takahashi M, 2012, J OLEO SCI, V61, P457, DOI 10.5650/jos.61.457; Wakamatsu Y, 2001, EUR J BIOCHEM, V268, P374, DOI 10.1046/j.1432-1033.2001.01887.x; Wang HMD, 2014, J AGR FOOD CHEM, V62, P1057, DOI 10.1021/jf403730z; Yu MD, 2015, CARBOHYD RES, V407, P63, DOI 10.1016/j.carres.2014.12.012; Zhao XX, 1999, CANCER RES, V59, P482; Zhao XX, 2001, J BIOL CHEM, V276, P39903, DOI 10.1074/jbc.M010281200	36	27	28	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148198	10.1371/journal.pone.0148198	http://dx.doi.org/10.1371/journal.pone.0148198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828792	gold, Green Published			2022-12-27	WOS:000369548200081
J	Gao, ZZ; Li, LA; Meng, YG				Gao, Zhenzhen; Li, Li'an; Meng, Yuanguang			A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma	PLOS ONE			English	Article							TUMOR MORCELLATION; SURGICAL-PROCEDURE; LEIOMYOSARCOMA; PROGNOSIS; OUTCOMES; SURGERY; MYOMAS	Laparoscopic myomectomy is a minimally invasive, conservative surgical approach commonly used for the treatment of uterine fibroids. However, there is a lack of effective means to distinguish the nature of uterine tumors prior to surgery. The impact of fibroid morcellation during laparoscopic surgery on the dissemination of cancerous uterine fibroids and long-term survival of patients has gained increasing attention. A retrospective cohort study was conducted to analyze the impact of different surgical approaches on recurrence-free survival (RFS) and overall survival (OS) in patients with a postoperative pathological diagnosis of uterine sarcoma at a single medical center. Patients who underwent the first surgery for uterine fibroids (confined to the uterus) and had a postoperative pathological diagnosis of uterine sarcoma were selected in the Chinese PLA General Hospital from January 2005 to January 2014. Based on the use of fibroid morcellation, the subjects were divided into fibroid morcellation (FM) and total hysterectomy (TH, non-morcellation) groups. Follow-up outcomes, including RFS and OS times, were observed. In total, 59 patients were included, with 30 cases in the FM group and 29 cases in the TH group. There were no significant differences in RFS and OS time between the two groups (RFS: P = 0.16, OS: P = 0.09). Multivariate correlation analysis showed that the impact of a higher grade level on RFS and OS was nearly 2-fold the impact of a lower grade level (RFS: P = 0.04, odds ratio (OR) = 1.97; OS: P = 0.03, OR = 2.29). Intraoperative morcellation, postoperative adjuvant therapy, age, tumor size, FIGO stage, and surgical approach were not risk factors affecting RFS and OS. Fibroid morcellation during laparoscopic surgery (including laparoscopic, transvaginal and transabdominal approaches) had no significant impact on RFS and OS time in patients. However, the 5-year RFS and OS rates were both lower in the FM group than in the TH group. Grade level was a significant risk factor for the prognosis of patients with uterine sarcoma.	[Gao, Zhenzhen] Gen Hosp Armed Police Forces, Dept Obstet & Gynecol, Beijing, Peoples R China; [Li, Li'an; Meng, Yuanguang] Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital	Li, LA; Meng, YG (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing 100853, Peoples R China.	llapla@163.com; meng6512@vip.sina.com						[Anonymous], NY TIMES; Anupama R, 2011, J MINIM INVAS GYN, V18, P386, DOI 10.1016/j.jmig.2011.01.014; Bogani G, 2015, GYNECOL ONCOL, V137, P167, DOI 10.1016/j.ygyno.2014.11.011; Bojahr B, 2006, J MINIM INVAS GYN, V13, P183, DOI 10.1016/j.jmig.2006.01.010; Einarsson JI, 2014, J MINIM INVAS GYN, V21, P951, DOI 10.1016/j.jmig.2014.04.010; Fukunishi H, 2007, INT J GYNECOL CANCER, V17, P724, DOI 10.1111/j.1525-1438.2007.00818.x; George S, 2014, CANCER-AM CANCER SOC, V120, P3154, DOI 10.1002/cncr.28844; HARLOW BL, 1986, J NATL CANCER I, V76, P399; Kido A, 2003, RADIOGRAPHICS, V23, P1423, DOI 10.1148/rg.236035033; Larrain D, 2010, J MINIM INVAS GYN, V17, P719, DOI 10.1016/j.jmig.2010.05.013; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Leung F, 2009, GYNECOL OBSTET FERTI, V37, P109, DOI 10.1016/j.gyobfe.2008.09.022; Morice P, 2003, EUR J GYNAECOL ONCOL, V24, P237; OLAH KS, 1992, BRIT J OBSTET GYNAEC, V99, P590, DOI 10.1111/j.1471-0528.1992.tb13827.x; Park JY, 2011, ANN SURG ONCOL, V18, P3453, DOI 10.1245/s10434-011-1751-y; Park JY, 2011, GYNECOL ONCOL, V122, P255, DOI 10.1016/j.ygyno.2011.04.021; PARKER WH, 1994, OBSTET GYNECOL, V83, P414; Perri T, 2009, INT J GYNECOL CANCER, V19, P257, DOI 10.1111/IGC.0b013e31819a1f8f; Siedhoff MT, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.03.006; van Dongen H, 2008, J MINIM INVAS GYN, V15, P466, DOI 10.1016/j.jmig.2008.02.002; Yanazume S, 2012, J OBSTET GYNAECOL RE, V38, P875, DOI 10.1111/j.1447-0756.2011.01784.x	21	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148050	10.1371/journal.pone.0148050	http://dx.doi.org/10.1371/journal.pone.0148050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828206	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200056
J	Isakov, A; Holcomb, A; Glowacki, L; Christakis, NA				Isakov, Alexander; Holcomb, Amelia; Glowacki, Luke; Christakis, Nicholas A.			Modeling the Role of Networks and Individual Differences in Inter-Group Violence	PLOS ONE			English	Article							COOPERATION; POPULATION; AGGRESSION; CONFLICT; WARFARE; PATTERN	There is significant heterogeneity within and between populations in their propensity to engage in conflict. Most research has neglected the role of within-group effects in social networks in contributing to between-group violence and focused instead on the precursors and consequences of violence, or on the role of between-group ties. Here, we explore the role of individual variation and of network structure within a population in promoting and inhibiting group violence towards other populations. Motivated by ethnographic observations of collective behavior in a small-scale society, we describe a model with differentiated roles for individuals embedded within friendship networks. Using a simple model based on voting-like dynamics, we explore several strategies for influencing group-level behavior. When we consider changing population level attitude changes and introducing control nodes separately, we find that a particularly effective control strategy relies on exploiting network degree. We also suggest refinements to our model such as tracking fine-grained information spread dynamics that can lead to further enrichment in using evolutionary game theory models for sociological phenomena.	[Isakov, Alexander] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Holcomb, Amelia] Yale Univ, Dept Math, New Haven, CT 06520 USA; [Glowacki, Luke] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Glowacki, Luke] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Yale Inst Network Sci, New Haven, CT USA	Harvard University; Yale University; Harvard University; Harvard University; Yale University; Yale University; Yale University	Christakis, NA (corresponding author), Yale Univ, Dept Sociol, New Haven, CT USA.; Christakis, NA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.; Christakis, NA (corresponding author), Yale Univ, Yale Inst Network Sci, New Haven, CT USA.	nicholas.christakis@yale.edu			Star Family Foundation; Wenner-Gren Foundation; Department of Defense, Air Force Office of Scientific Research [FA9550-11-C-0028]; National Defense Science and Engineering Graduate Fellowship [32 CFR 168a]	Star Family Foundation; Wenner-Gren Foundation; Department of Defense, Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Defense Science and Engineering Graduate Fellowship	This work was supported by grants from the Star Family Foundation and the Wenner-Gren Foundation (http://www.wennergren.org/). A. I. was supported under FA9550-11-C-0028 awarded by the Department of Defense, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a (http://www.wpafb.af.mil/afrl/afosr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Boster JS, 2003, ETHOS, V31, P471, DOI 10.1525/eth.2003.31.4.471; Collins H., 2009, VIOLENCE MICROSOCIOL; Gelfand M, 2012, PHILOS T R SOC B, V367, P692, DOI 10.1098/rstb.2011.0304; Glowacki L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0010; Glowacki L, 2015, P NATL ACAD SCI USA, V112, P348, DOI 10.1073/pnas.1412287112; Glowacki L, 2013, HUM NATURE-INT BIOS, V24, P444, DOI 10.1007/s12110-013-9178-8; Isakov A, 2012, DYN GAMES APPL, V2, P97, DOI 10.1007/s13235-011-0020-9; Johnson N, 2011, SCIENCE, V333, P81, DOI 10.1126/science.1205068; Keeley LH., 1996, WAR CIVILIZATION; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Labianca G, 1998, ACAD MANAGE J, V41, P55, DOI 10.2307/256897; Lim M, 2007, SCIENCE, V317, P1540, DOI 10.1126/science.1142734; Macfarlan SJ, 2014, P NATL ACAD SCI USA, V111, P16662, DOI 10.1073/pnas.1418639111; McDoom OS, 2014, J CONFLICT RESOLUT, V58, P865, DOI 10.1177/0022002713484282; NELSON RE, 1989, ACAD MANAGE J, V32, P377, DOI 10.2307/256367; Page-Gould E, 2012, SOC PSYCHOL PERS SCI, V3, P462, DOI 10.1177/1948550611426937; Papachristos AV, 2015, SOC SCI MED, V125, P139, DOI 10.1016/j.socscimed.2014.01.056; Papachristos AV, 2014, AM J PUBLIC HEALTH, V104, P143, DOI 10.2105/AJPH.2013.301441; Papachristos AV, 2009, AM J SOCIOL; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pinker S., 2011, BETTER ANGELS OUR NA; Rand DG, 2014, P NATL ACAD SCI USA, V111, P17093, DOI 10.1073/pnas.1400406111; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Robarchek Clayton, 1998, WAORANI CONTEXTS VIO; Roithmayr D, 2015, GAMES           0603, DOI [10.3390/g6020124, DOI 10.3390/G6020124]; Sood V, 2005, PHYS REV LETT, DOI [10.1103/ PhysRevLett.947178701, DOI 10.1103/PHYSREVLETT.947178701]; von Rueden C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WIESSNER P, 2010, YOUTHS ELDERS WAGES; Wiessner P, 2012, SCIENCE, V337, P1651, DOI 10.1126/science.1221685	33	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148314	10.1371/journal.pone.0148314	http://dx.doi.org/10.1371/journal.pone.0148314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9NL	26828362	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200095
J	Liu, YW; Xie, SJ; Yu, JJ				Liu, Yuwei; Xie, Shaojun; Yu, Jingjuan			Genome-Wide Analysis of the Lysine Biosynthesis Pathway Network during Maize Seed Development	PLOS ONE			English	Article							DIHYDRODIPICOLINATE SYNTHASE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; ASPARTATE-KINASE; RNA-SEQ; PROTEIN; COEXPRESSION; REVEALS; FRAMEWORK; TOOL	Lysine is one of the most limiting essential amino acids for humans and livestock. The nutritional value of maize (Zea mays L.) is reduced by its poor lysine content. To better understand the lysine biosynthesis pathway in maize seed, we conducted a genome-wide analysis of the genes involved in lysine biosynthesis. We identified lysine biosynthesis pathway genes (LBPGs) and investigated whether a diaminopimelate pathway variant exists in maize. We analyzed two genes encoding the key enzyme dihydrodipicolinate synthase, and determined that they contribute differently to lysine synthesis during maize seed development. A coexpression network of LBPGs was constructed using RNA-sequencing data from 21 developmental stages of B73 maize seed. We found a large set of genes encoding ribosomal proteins, elongation factors and zein proteins that were coexpressed with LBPGs. The coexpressed genes were enriched in cellular metabolism terms and protein related terms. A phylogenetic analysis of the LBPGs from different plant species revealed different relationships. Additionally, six transcription factor (TF) families containing 13 TFs were identified as the Hub TFs of the LBPGs modules. Several expression quantitative trait loci of LBPGs were also identified. Our results should help to elucidate the lysine biosynthesis pathway network in maize seed.	[Liu, Yuwei; Xie, Shaojun; Yu, Jingjuan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	China Agricultural University	Yu, JJ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	yujj@cau.edu.cn	Xie, Shaojun/H-3162-2019	Xie, Shaojun/0000-0002-6719-9814	National Transgenic Major Program of China [2014ZX08003-002, 2013ZX08003-002, 2011ZX08003-002]	National Transgenic Major Program of China	This work was supported by the National Transgenic Major Program of China (grant no. 2014ZX08003-002, 2013ZX08003-002 and 2011ZX08003-002).; We thank Jian Chen (China Agricultural University, Prof. Jinsheng Lai's laboratory) for providing eight stages B73 maize seeds. We thank Fei Yi (China Agricultural University, Prof. Jingjuan Yu's laboratory) for useful discussions. This work was supported by the National Transgenic Major Program of China (grant no. 2014ZX08003-002, 2013ZX08003-002 and2011ZX08003-002).	Agarwal P, 2011, BIOESSAYS, V33, P189, DOI 10.1002/bies.201000107; Angelovici R, 2009, PLANT PHYSIOL, V151, P2058, DOI 10.1104/pp.109.145631; ARRUDA P, 1983, PHYTOCHEMISTRY, V22, P2687, DOI 10.1016/S0031-9422(00)97673-8; Atkinson SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038318; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; BRIGHT SWJ, 1983, CRC CR REV PLANT SCI, V1, P49, DOI 10.1080/07352688309382171; BrinchPedersen H, 1996, PLANT MOL BIOL, V32, P611, DOI 10.1007/BF00020202; Broun P, 2004, CURR OPIN PLANT BIOL, V7, P202, DOI 10.1016/j.pbi.2004.01.013; Chen J, 2014, PLANT PHYSL; Clark TJ, 2015, PLANT PHYSIOL, V168, P1512, DOI 10.1104/pp.15.00364; Craciun A, 2000, FEBS LETT, V487, P234, DOI 10.1016/S0014-5793(00)02303-6; DASILVA WJ, 1979, PHYTOCHEMISTRY, V18, P1803, DOI 10.1016/0031-9422(79)83056-3; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; DiLeo MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026683; FALCO SC, 1995, BIO-TECHNOL, V13, P577, DOI 10.1038/nbt0695-577; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; GALILI G, 1995, PLANT CELL, V7, P899, DOI 10.2307/3870045; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Griffin MDW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040318; HABBEN JE, 1995, P NATL ACAD SCI USA, V92, P8640, DOI 10.1073/pnas.92.19.8640; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; Huang SS, 2005, PLANT BIOTECHNOL J, V3, P555, DOI 10.1111/j.1467-7652.2005.00146.x; Hudson AO, 2006, PLANT PHYSIOL, V140, P292, DOI 10.1104/pp.105.072629; Jones-Held S, 2012, FUNCT PLANT BIOL, V39, P1058, DOI 10.1071/FP12169; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KARCHI H, 1994, P NATL ACAD SCI USA, V91, P2577, DOI 10.1073/pnas.91.7.2577; Kroj T, 2003, DEVELOPMENT, V130, P6065, DOI 10.1242/dev.00814; KWON T, 1995, J PLANT PHYSIOL, V146, P615, DOI 10.1016/S0176-1617(11)81923-1; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Ledwidge R, 1999, BIOCHEMISTRY-US, V38, P3019, DOI 10.1021/bi982574a; Li CB, 2015, PLANT CELL, V27, P532, DOI 10.1105/tpc.114.134858; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li ZS, 1998, PLANT CELL, V10, P383, DOI 10.1105/tpc.10.3.383; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Mena M, 1998, PLANT J, V16, P53, DOI 10.1046/j.1365-313x.1998.00275.x; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PERL A, 1992, PLANT MOL BIOL, V19, P815, DOI 10.1007/BF00027077; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song JT, 2004, PLANT CELL, V16, P353, DOI 10.1105/tpc.019372; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team RC, 2005, R LANG ENV STAT COMP; Varisi VA, 2007, PLANT SCI, V173, P458, DOI 10.1016/j.plantsci.2007.07.007; Vauterin M, 1999, PLANT MOL BIOL, V39, P695, DOI 10.1023/A:1006132428623; Velasco AM, 2002, J MOL EVOL, V55, P445, DOI 10.1007/s00239-002-2340-2; Verdier J, 2008, PLANT CELL PHYSIOL, V49, P1263, DOI 10.1093/pcp/pcn116; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEINBERGER S, 1970, J BACTERIOL, V101, P323, DOI 10.1128/JB.101.1.323-324.1970; WENKO LK, 1985, PLANT MOL BIOL, V4, P197, DOI 10.1007/BF02418236; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yohannes T, 1999, CURR PLANT SCI BIOT, V36, P617; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	82	4	5	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148287	10.1371/journal.pone.0148287	http://dx.doi.org/10.1371/journal.pone.0148287			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829553	Green Published, gold			2022-12-27	WOS:000369548200092
J	Vuong, J; Collard, JM; Whaley, MJ; Bassira, I; Seidou, I; Diarra, S; Ouedraogo, RT; Kambire, D; Taylor, TH; Sacchi, C; Mayer, LW; Wang, X				Vuong, Jeni; Collard, Jean-Marc; Whaley, Melissa J.; Bassira, Issaka; Seidou, Issaka; Diarra, Seydou; Ouedraogo, Rasmata T.; Kambire, Dinanibe; Taylor, Thomas H., Jr.; Sacchi, Claudio; Mayer, Leonard W.; Wang, Xin			Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; CHILDREN YOUNGER; IDENTIFICATION; HAEMOPHILUS; BURDEN; ASSAYS; TESTS; BLOOD	Neisseria meningitidis (Nm), Haemophilus influenzae (Hi), and Streptococcus pneumoniae (Sp) are the lead causes of bacterial meningitis. Detection of these pathogens from clinical specimens using traditional real-time PCR (rt-PCR) requires DNA extraction to remove the PCR inhibitors prior to testing, which is time consuming and labor intensive. In this study, five species-specific (Nm-sodC and -ctrA, Hi-hpd# 1 and -hpd#3 and Sp-lytA) and six serogroup- specific rt-PCR tests (A, B, C, W, X, Y) targeting Nm capsular genes were evaluated in the two direct rt-PCR methods using PerfeCTa and 5x Omni that do not require DNA extraction. The sensitivity and specify of the two direct rt-PCR methods were compared to TaqMan traditional rt-PCR, the current standard rt-PCR method for the detection of meningitis pathogens. The LLD for all 11 rt-PCR tests ranged from 6,227 to 272,229 CFU/ml for TaqMan, 1,824-135,982 for 5x Omni, and 168-6,836 CFU/ml for PerfeCTa. The diagnostic sensitivity using TaqMan ranged from 89.2%-99.6%, except for NmB-csb, which was 69.7%. For 5x Omni, the sensitivity varied from 67.1% to 99.8%, with three tests below 90%. The sensitivity of these tests using PerfeCTa varied from 89.4% to 99.8%. The specificity ranges of the 11 tests were 98.0-99.9%, 97.5-99.9%, and 92.9-99.9% for TaqMan, 5x Omni, and PerfeCTa, respectively. PerfeCTa direct rt-PCR demonstrated similar or better sensitivity compared to 5x Omni direct rt-PCR or TaqMan traditional rt-PCR. Since the direct rt-PCR method does not require DNA extraction, it reduces the time and cost for processing CSF specimens, increases testing throughput, decreases the risk of cross-contamination, and conserves precious CSF. The direct rt-PCR method will be beneficial to laboratories with high testing volume.	[Vuong, Jeni; Whaley, Melissa J.; Taylor, Thomas H., Jr.; Mayer, Leonard W.; Wang, Xin] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA USA; [Collard, Jean-Marc] Sci Inst Publ Hlth, Brussels, Belgium; [Collard, Jean-Marc; Bassira, Issaka; Seidou, Issaka] Ctr Rech Med & Sanit, Niamey, Niger; [Diarra, Seydou] Inst Natl Rech Sante Publ, Bamako, Mali; [Ouedraogo, Rasmata T.; Kambire, Dinanibe] Ctr Hosp Univ Pediat Charles De Gaulle, Ouagadougou, Burkina Faso; [Sacchi, Claudio] Adolfo Lutz Inst, Sao Paulo, Brazil	Centers for Disease Control & Prevention - USA; Instituto Adolfo Lutz	Wang, X (corresponding author), Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA USA.	gqe8@cdc.gov	Collard, Jean-Marc/Q-2342-2019	Collard, Jean-Marc/0000-0002-1490-3978				AKANE A, 1994, J FORENSIC SCI, V39, P362; Baughman AL, 2008, CLIN VACCINE IMMUNOL, V15, P106, DOI 10.1128/CVI.00223-07; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; LASCOLEA LJ, 1984, J CLIN MICROBIOL, V19, P187, DOI 10.1128/JCM.19.2.187-190.1984; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; Norskov-Lauritsen N, 2014, CLIN MICROBIOL REV, V27, P214, DOI 10.1128/CMR.00103-13; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	15	53	54	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147765	10.1371/journal.pone.0147765	http://dx.doi.org/10.1371/journal.pone.0147765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829233	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200032
J	AbdulAzeez, S; Borgio, JF				AbdulAzeez, Sayed; Borgio, J. Francis			In-Silico Computing of the Most Deleterious nsSNPs in HBA1 Gene	PLOS ONE			English	Article							HUMAN HEMOGLOBIN-VARIANTS; THALASSEMIA MUTATIONS; STABILIZING RESIDUES; SWISS-MODEL; PROTEIN; ALPHA; DATABASE; PREDICTION; SERVER; ENVIRONMENT	Background alpha-Thalassemia (alpha-thal) is a genetic disorder caused by the substitution of single amino acid or large deletions in the HBA1 and/or HBA2 genes. Method Using modern bioinformatics tools as a systematic in-silico approach to predict the deleterious SNPs in the HBA1 gene and its significant pathogenic impact on the functions and structure of HBA1 protein was predicted. Results and Discussion A total of 389 SNPs in HBA1 were retrieved from dbSNP database, which includes: 201 non-coding synonymous (nsSNPs), 43 human active SNPs, 16 intronic SNPs, 11 mRNA 30' UTR SNPs, 9 coding synonymous SNPs, 9 5' UTR SNPs and other types. Structural homology-based method (PolyPhen) and sequence homology-based tool (SIFT), SNPs&Go, PROVEAN and PANTHER revealed that 2.4% of the nsSNPs are pathogenic. Conclusions A total of 5 nsSNPs (G60V, K17M, K17T, L92F and W15R) were predicted to be responsible for the structural and functional modifications of HBA1 protein. It is evident from the deep comprehensive in-silico analysis that, two nsSNPs such as G60Vand W15R in HBA1 are highly deleterious. These "2 pathogenic nsSNPs" can be considered for wet-lab confirmatory analysis.	[AbdulAzeez, Sayed; Borgio, J. Francis] Univ Dammam, IRMC, Dammam, Saudi Arabia	Imam Abdulrahman Bin Faisal University	Borgio, JF (corresponding author), Univ Dammam, IRMC, Dammam, Saudi Arabia.	borgiomicro@gmail.com	Sayed, Abdulazeez/I-6770-2019; Sayed, Abdul Azeez/A-3234-2015; Borgio, J Francis/P-5586-2014; Azeez, Syed Abdul/AAE-3876-2020	Sayed, Abdulazeez/0000-0002-9763-9446; Sayed, Abdul Azeez/0000-0002-9763-9446; Borgio, J Francis/0000-0001-7199-1540; 				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akhtar MS, 2013, HEMOGLOBIN, V37, P65, DOI 10.3109/03630269.2012.753510; Al-Nafie AN, 2015, BLOOD CELL MOL DIS, V55, P27, DOI 10.1016/j.bcmd.2015.03.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borgio JF, 2015, SAUDI MED J, V36, P1271, DOI 10.15537/smj.2015.11.12704; Borgio JF, 2014, BLOOD CELL MOL DIS, V53, P199, DOI 10.1016/j.bcmd.2014.07.001; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Chen JJ, 2009, CURR PROTEOMICS, V6, P228, DOI 10.2174/157016409789973734; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Doss CGP, 2012, APPL TRANSL GENOM, V1, P37, DOI 10.1016/j.atg.2012.06.002; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han JH, 2006, STRUCTURE, V14, P935, DOI 10.1016/j.str.2006.01.016; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Khafizov K, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2794-y; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Knudsen B, 2001, P NATL ACAD SCI USA, V98, P14512, DOI 10.1073/pnas.251526398; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Piel FB, 2014, NEW ENGL J MED, V371, P1908, DOI 10.1056/NEJMra1404415; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tiwari Abhishek, 2007, In Silico Biology, V7, P651; Varfolomeev SD, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1099, DOI 10.1023/A:1020907122341; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366	40	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147702	10.1371/journal.pone.0147702	http://dx.doi.org/10.1371/journal.pone.0147702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824843	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600048
J	Bowsher, AW; Ali, R; Harding, SA; Tsai, CJ; Donovan, LA				Bowsher, Alan W.; Ali, Rifhat; Harding, Scott A.; Tsai, Chung-Jui; Donovan, Lisa A.			Evolutionary Divergences in Root Exudate Composition among Ecologically-Contrasting Helianthus Species	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; AMINO-ACID-UPTAKE; ORGANIC-ACIDS; LUPINUS-ALBUS; MORPHOLOGICAL PLASTICITY; MECHANICAL IMPEDANCE; MISSING VALUES; RHIZOSPHERE; PLANT; SOIL	Plant roots exude numerous metabolites into the soil that influence nutrient availability. Although root exudate composition is hypothesized to be under selection in low fertility soils, few studies have tested this hypothesis in a phylogenetic framework. In this study, we examined root exudates of three pairs of Helianthus species chosen as phylogenetically-independent contrasts with respect to native soil nutrient availability. Under controlled environmental conditions, seedlings were grown to the three-leaf-pair stage, then transferred to either high or low nutrient treatments. After five days of nutrient treatments, we used gas chromatography-mass spectrometry for analysis of root exudates, and detected 37 metabolites across species. When compared in the high nutrient treatment, species native to low nutrient soils exhibited overall higher exudation than their sister species native to high nutrient soils in all three species pairs, providing support for repeated evolutionary shifts in response to native soil fertility. Species native to low nutrient soils and those native to high nutrient soils responded similarly to low nutrient treatments with increased exudation of organic acids (fumaric, citric, malic acids) and glucose, potentially as a mechanism to enhance nutrition acquisition. However, species native to low nutrient soils also responded to low nutrient treatments with a larger decrease in exudation of amino acids than species native to high nutrient soils in all three species pairs. This indicates that species native to low nutrient soils have evolved a unique sensitivity to changes in nutrient availability for some, but not all, root exudates. Overall, these repeated evolutionary divergences between species native to low nutrient soils and those native to high nutrient soils provide evidence for the adaptive value of root exudation, and its plasticity, in contrasting soil environments.	[Bowsher, Alan W.; Donovan, Lisa A.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Ali, Rifhat] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Harding, Scott A.; Tsai, Chung-Jui] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Harding, Scott A.; Tsai, Chung-Jui] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bowsher, AW (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	bowsher@uga.edu	Donovan, Lisa A/H-4754-2016	Donovan, Lisa A/0000-0001-9814-0666	National Science Foundation [IOS-1122842]; Sigma Xi the Scientific Research Society; Georgia Research Alliance-Haynes Forest Biotechnology Endowment; Direct For Biological Sciences [1122842] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Sigma Xi the Scientific Research Society; Georgia Research Alliance-Haynes Forest Biotechnology Endowment; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation IOS-1122842 to LAD (www.nsf.gov), a Grant-in-aid of Research from Sigma Xi the Scientific Research Society to AWB (https://www.sigmaxi.org), and the Georgia Research Alliance-Haynes Forest Biotechnology Endowment to CJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; [Anonymous], 2007, NUTR CYCLING TERREST; [Anonymous], 2005, MINERAL NUTR PLANTS; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Babushok VI, 2007, J CHROMATOGR A, V1157, P414, DOI 10.1016/j.chroma.2007.05.044; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; BARBER DA, 1974, NEW PHYTOL, V73, P39, DOI 10.1111/j.1469-8137.1974.tb04604.x; BOEUFTREMBLAY V, 1995, PLANT SOIL, V172, P279, DOI 10.1007/BF00011330; BOWEN GD, 1969, PLANT SOIL, V30, P139, DOI 10.1007/BF01885274; Bowsher AW, 2015, J PLANT NUTR SOIL SC, V178, P776, DOI 10.1002/jpln.201400521; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Cesco S, 2010, PLANT SOIL, V329, P1, DOI 10.1007/s11104-009-0266-9; Condit R, 2013, P NATL ACAD SCI USA, V110, P5064, DOI 10.1073/pnas.1218042110; Coudun C, 2006, J BIOGEOGR, V33, P1750, DOI 10.1111/j.1365-2699.2005.01443.x; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Craine JM, 2013, FUNCT ECOL, V27, P833, DOI 10.1111/1365-2435.12081; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Denton MD, 2007, NEW PHYTOL, V173, P592, DOI 10.1111/j.1469-8137.2006.01956.x; Dijkstra FA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00216; DINKELAKER B, 1989, PLANT CELL ENVIRON, V12, P285, DOI 10.1111/j.1365-3040.1989.tb01942.x; Dodge Y., 1985, ANALYSIS OF EXPERIME; Dray S, 2015, PLANT ECOL, V216, P657, DOI 10.1007/s11258-014-0406-z; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fransen B, 1998, OECOLOGIA, V115, P351, DOI 10.1007/s004420050527; Frost CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044467; GARDNER WK, 1983, PLANT SOIL, V70, P107, DOI 10.1007/BF02374754; GERKE J, 1994, Z PFLANZ BODENKUNDE, V157, P289, DOI 10.1002/jpln.19941570408; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Grime J. P., 1979, Plant strategies and vegetation processes.; Grime J. P., 1994, EXPLOITATION ENV HET, P1; Groleau-Renaud V, 1998, PLANT SOIL, V201, P231, DOI 10.1023/A:1004316416034; Gromski PS, 2014, METABOLITES, V4, P433, DOI 10.3390/metabo4020433; Haase S, 2007, SOIL BIOL BIOCHEM, V39, P2208, DOI 10.1016/j.soilbio.2007.03.014; HARVEY PH, 1991, NATURE, V351, P619, DOI 10.1038/351619a0; HEISER C B JR, 1969, Memoirs of the Torrey Botanical Club, V22, P1; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Jeong ML, 2004, PLANT PHYSIOL, V136, P3364, DOI 10.1104/pp.104.044776; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Johnson JF, 1996, PLANT PHYSIOL, V112, P31, DOI 10.1104/pp.112.1.31; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; JONES DL, 1994, PLANT SOIL, V166, P247, DOI 10.1007/BF00008338; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kane NC, 2013, MOL ECOL RESOUR, V13, P10, DOI 10.1111/1755-0998.12023; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kuzyakov Y, 2001, SOIL BIOL BIOCHEM, V33, P1915, DOI 10.1016/S0038-0717(01)00117-1; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lambers H, 2013, AM J BOT, V100, P263, DOI 10.3732/ajb.1200474; Lesuffleur F, 2010, PLANT SOIL, V333, P191, DOI 10.1007/s11104-010-0334-1; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; MARSCHNER H, 1986, Z PFLANZ BODENKUNDE, V149, P441, DOI 10.1002/jpln.19861490408; Mason CM, 2015, EVOLUTION, V69, P2705, DOI 10.1111/evo.12768; Meier CL, 2009, J ECOL, V97, P941, DOI 10.1111/j.1365-2745.2009.01537.x; Moe LA, 2013, AM J BOT, V100, P1692, DOI 10.3732/ajb.1300033; MOGHIMI A, 1978, SOIL BIOL BIOCHEM, V10, P277, DOI 10.1016/0038-0717(78)90022-6; Neumann G, 1999, PLANT SOIL, V211, P121, DOI 10.1023/A:1004380832118; Neumann G, 2001, RHIZOSPHERE BIOCH OR, P23; Nicotra AB, 2002, OECOLOGIA, V130, P136, DOI 10.1007/s004420100788; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; Pearse SJ, 2007, NEW PHYTOL, V173, P181, DOI 10.1111/j.1469-8137.2006.01897.x; Persson J, 2002, PLANTA, V215, P639, DOI 10.1007/s00425-002-0786-5; Pineda-Garcia F, 2011, PLANT CELL ENVIRON, V34, P1536, DOI 10.1111/j.1365-3040.2011.02351.x; Raupp FM, 2013, J AGR FOOD CHEM, V61, P10481, DOI 10.1021/jf402392e; Rengel Z, 2002, PLANT SOIL, V245, P59, DOI 10.1023/A:1020646011229; Roelofs RFR, 2001, PLANT CELL ENVIRON, V24, P891, DOI 10.1046/j.1365-3040.2001.00741.x; Shi SJ, 2011, FEMS MICROBIOL ECOL, V77, P600, DOI 10.1111/j.1574-6941.2011.01150.x; SHUM HY, 1995, IEEE T PATTERN ANAL, V17, P854, DOI 10.1109/34.406651; Stephens JD, 2015, AM J BOT, V102, P910, DOI 10.3732/ajb.1500031; Strom L, 1997, OIKOS, V80, P459, DOI 10.2307/3546618; TYLER G, 1995, ANN BOT-LONDON, V75, P75, DOI 10.1016/S0305-7364(05)80011-3; van der Krift TAJ, 2001, SOIL BIOL BIOCHEM, V33, P2115, DOI 10.1016/S0038-0717(01)00145-6; Veneklaas EJ, 2003, PLANT SOIL, V248, P187, DOI 10.1023/A:1022367312851; von Wiren N, 2000, PLANT J, V21, P167, DOI 10.1046/j.1365-313x.2000.00665.x; Wouterlood M, 2004, NEW PHYTOL, V162, P745, DOI 10.1111/j.1469-8137.2004.01070.x; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xue LJ, 2013, PLANT CELL, V25, P2714, DOI 10.1105/tpc.113.112839	80	26	27	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148280	10.1371/journal.pone.0148280	http://dx.doi.org/10.1371/journal.pone.0148280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824236	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528600114
J	Kurkowiak, M; Zietkiewicz, E; Greber, A; Voelkel, K; Wojda, A; Pogorzelski, A; Witt, M				Kurkowiak, Malgorzata; Zietkiewicz, Ewa; Greber, Agnieszka; Voelkel, Katarzyna; Wojda, Alina; Pogorzelski, Andrzej; Witt, Michal			ZMYND10 - Mutation Analysis in Slavic Patients with Primary Ciliary Dyskinesia	PLOS ONE			English	Article							NITRIC-OXIDE MEASUREMENTS; OUTER DYNEIN ARMS; CHILDREN; NASAL; PREDICTION; LRRC6; INNER; AGE	Primary ciliary dyskinesia (PCD) is a rare recessive disease with a prevalence of 1/10,000; its symptoms are caused by a kinetic dysfunction of motile cilia in the respiratory epithelium, flagella in spermatozoids, and primary cilia in the embryonic node. PCD is genetically heterogeneous: genotyping the already known PCD-related genes explains the genetic basis in 60-65% of the cases, depending on the population. While identification of new genes involved in PCD pathogenesis remains crucial, the search for new, population-specific mutations causative for PCD is equally important. The Slavs remain far less characterized in this respect compared to West European populations, which significantly limits diagnostic capability. The main goal of this study was to characterize the profile of causative genetic defects in one of the PCD-causing genes, ZMYND10, in the cohort of PCD patients of Slavic origin. The study was carried out using biological material from 172 unrelated PCD individuals of Polish origin, with no causative mutation found in nine major PCD genes. While none of the previously described mutations was found using the HRM-based screening, a novel frameshift mutation (c.367delC) in ZMYND10, unique for Slavic PCD population, was found in homozygous state in two unrelated PCD patients. Immunofluorescence analysis confirmed the absence of outer and inner dynein arms from the ciliary axoneme, consistent with the already published ZMYND10-mutated phenotype; cDNA analysis revealed the lack of ZMYND10 mRNA, indicating nonsense-mediated decay of the truncated transcript.	[Kurkowiak, Malgorzata; Zietkiewicz, Ewa; Greber, Agnieszka; Voelkel, Katarzyna; Wojda, Alina; Witt, Michal] Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland; [Kurkowiak, Malgorzata; Witt, Michal] Int Inst Mol & Cell Biol, Warsaw, Poland; [Pogorzelski, Andrzej] Inst TB & Lung Dis, Dept Pneumol & Cyst Fibrosis, Rabka Zdroj, Poland; [Kurkowiak, Malgorzata] Med Univ Warsaw, Dept Immunol, Ctr Biostruct, Warsaw, Poland	Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Medical University of Warsaw	Kurkowiak, M; Zietkiewicz, E (corresponding author), Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland.; Kurkowiak, M (corresponding author), Int Inst Mol & Cell Biol, Warsaw, Poland.; Kurkowiak, M (corresponding author), Med Univ Warsaw, Dept Immunol, Ctr Biostruct, Warsaw, Poland.	mszczepaniak86@gmail.com; zietkiee@man.poznan.pl	Zietkiewicz, Ewa/ABP-3539-2022	Witt, Michal/0000-0003-1729-4159; Zietkiewicz, Ewa/0000-0003-2437-5088; Kurkowiak, Malgorzata/0000-0002-4968-7136	Foundation for Polish Science; National Research Center [2011/01/B/NZ4/04840, 2014/13/B/NZ2/03858]; European Union Seventh Framework Programme (FP7) funds (BESTCILIA) [305404]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Research Center(National Research Centre (NRC)); European Union Seventh Framework Programme (FP7) funds (BESTCILIA)	The study was supported by grants from the Foundation for Polish Science to MK (International PhD Projects Programme), from the National Research Center to EZ (2011/01/B/NZ4/04840 and 2014/13/B/NZ2/03858), as well as from the European Union Seventh Framework Programme (FP7/2007-2013) funds to MW (BESTCILIA - grant agreement no. 305404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Boon M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-11; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059436; Karadag B, 1999, EUR RESPIR J, V13, P1402, DOI 10.1034/j.1399-3003.1999.13f28.x; Kharitonov S, 1997, EUR RESPIR J, V10, P1683, DOI 10.1183/09031936.97.10071683; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Kuehni CE, 2010, EUR RESPIR J, V36, P1248, DOI 10.1183/09031936.00001010; Kurkowiak M, 2015, J MED GENET, V52, P1, DOI 10.1136/jmedgenet-2014-102755; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Shoemark A, 2009, RESP MED, V103, P700, DOI 10.1016/j.rmed.2008.12.004; Stillwell PC, 2011, PEDIAT ALLER IMM PUL, V24, P191, DOI 10.1089/ped.2011.0099; Struben VMD, 2005, EUR RESPIR J, V26, P453, DOI 10.1183/09031936.05.00015205; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wodehouse T, 2003, EUR RESPIR J, V21, P43, DOI 10.1183/09031936.03.00305503; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zhao Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03032	20	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148067	10.1371/journal.pone.0148067	http://dx.doi.org/10.1371/journal.pone.0148067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824761	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600095
J	Pervaiz, T; Jia, HF; Haider, MS; Cheng, Z; Cui, MJ; Wang, MQ; Cui, LW; Wang, X; Fang, JG				Pervaiz, Tariq; Jia Haifeng; Haider, Muhammad Salman; Cheng, Zhang; Cui, Mengjie; Wang, Mengqi; Cui, Liwen; Wang, Xicheng; Fang, Jinggui			Transcriptomic Analysis of Grapevine (cv. Summer Black) Leaf, Using the Illumina Platform	PLOS ONE			English	Article							GENE-EXPRESSION; TERPENOID METABOLISM; BERRY DEVELOPMENT; PLANT; BIOSYNTHESIS; SYNTHASE; PATHWAY; PROTEIN; GROWTH; LIGHT	Proceeding to illumina sequencing, determining RNA integrity numbers for poly RNA were separated from each of the four developmental stages of cv. Summer Black leaves by using Illumina HiSeq (TM) 2000. The sums of 272,941,656 reads were generated from vitis vinifera leaf at four different developmental stages, with more than 27 billion nucleotides of the sequence data. At each growth stage, RNA samples were indexed through unique nucleic acid identifiers and sequenced. KEGG annotation results depicted that the highest number of transcripts in 2,963 (2Avs4A) followed by 1Avs4A (2,920), and 3Avs4A (2,294) out of 15,614 (71%) transcripts were recorded. In comparison, a total of 1,532 transcripts were annotated in GOs, including Cellular component, with the highest number in "Cell part" 251 out of 353 transcripts (71.1%), followed by intracellular organelle 163 out of 353 transcripts (46.2%), while in molecular function and metabolic process 375 out of 525 (71.4%) transcripts, multicellular organism process 40 out of 525 (7.6%) transcripts in biological process were most common in 1Avs2A. While in case of 1Avs3A, cell part 476 out of 662 transcripts (71.9%), and membrane-bounded organelle 263 out of 662 transcripts (39.7%) were recorded in Cellular component. In the grapevine transcriptome, during the initial stages of leaf development 1Avs2A showed single transcript was down-regulated and none of them were up-regulated. While in comparison of 1A to 3A showed one up-regulated (photosystem II reaction center protein C) and one down regulated (conserved gene of unknown function) transcripts, during the hormone regulating pathway namely SAUR-like auxin-responsive protein family having 2 up-regulated and 7 down-regulated transcripts, phytochrome-associated protein showed 1 up-regulated and 9 down-regulated transcripts, whereas genes associated with the Leucine-rich repeat protein kinase family protein showed 7 up-regulated and 1 down-regulated transcript, meanwhile Auxin Resistant 2 has single up-regulated transcript in second developmental stage, although 3 were down-regulated at lateral growth stages (3A and 4A). In the present study, 489 secondary metabolic pathways related genes were identified during leaf growth, which mainly includes alkaloid (40), anthocyanins (21), Diterpenoid (144), Monoterpenoid (90) and Flavonoids (93). Quantitative real-time PCR was applied to validate 10 differentially expressed transcripts patterns from flower, leaf and fruit metabolic pathways at different growth stages.	[Pervaiz, Tariq; Jia Haifeng; Haider, Muhammad Salman; Cheng, Zhang; Cui, Mengjie; Wang, Mengqi; Cui, Liwen; Fang, Jinggui] Nanjing Agr Univ, Coll Hort, Key Lab Genet & Fruit Dev, Nanjing 210095, Jiangsu, Peoples R China; [Wang, Xicheng] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Fang, JG (corresponding author), Nanjing Agr Univ, Coll Hort, Key Lab Genet & Fruit Dev, Nanjing 210095, Jiangsu, Peoples R China.	fanggg@njau.edu.cn	Pervaiz, Tariq/AFK-5705-2022; Salman, Haider Muhammad/Y-6129-2018; pervaiz, tariq/GMW-6618-2022; Pervaiz, Tariq/AAG-4135-2022	Salman, Haider Muhammad/0000-0002-4674-4254; pervaiz, tariq/0000-0001-9834-9355; Fang, Jinggui/0000-0003-1975-2715	Important National Science and technology Specific Projects [2012FY110100-3]; Jiangsu Agricultural science and technology innovation fund [CX(14) 2097]; Natural Science Foundation of China, NSFC [31361140358]	Important National Science and technology Specific Projects; Jiangsu Agricultural science and technology innovation fund; Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the Important National Science and technology Specific Projects (No. 2012FY110100-3) and Jiangsu Agricultural science and technology innovation fund (CX(14) 2097), Natural Science Foundation of China, NSFC (No. 31361140358).	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Boucher RC, 1999, J PHYSIOL-LONDON, V516, P631, DOI 10.1111/j.1469-7793.1999.0631u.x; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; BROWN RH, 1975, CROP SCI, V15, P681, DOI 10.2135/cropsci1975.0011183X001500050020x; Connan S, 2011, AQUAT TOXICOL, V104, P1, DOI 10.1016/j.aquatox.2011.03.016; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; De Vos D, 2012, J EXP BOT, V63, P3325, DOI 10.1093/jxb/ers037; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; FERREIRA RB, 1987, PLANT PHYSIOL, V83, P869, DOI 10.1104/pp.83.4.869; Figueiredo A, 2008, J EXP BOT, V59, P3371, DOI 10.1093/jxb/ern187; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Guenot B, 2012, PLANT PHYSIOL, V159, P1501, DOI 10.1104/pp.112.200402; Kalve S, 2014, FRONT PLANT SCI, P5; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krishnamurthy A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25761; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucker J, 2004, PHYTOCHEMISTRY, V65, P2649, DOI 10.1016/j.phytochem.2004.08.017; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Melidou M, 2005, FREE RADICAL BIO MED, V39, P1591, DOI 10.1016/j.freeradbiomed.2005.08.009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murakami A, 1997, PLANT CELL PHYSIOL, V38, P188, DOI 10.1093/oxfordjournals.pcp.a029151; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Ohara K, 2003, J EXP BOT, V54, P2635, DOI 10.1093/jxb/erg300; Ojeda H, 1999, VITIS, V38, P145; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Prasad MNV, 2001, PLANT SCI, V161, P881, DOI 10.1016/S0168-9452(01)00478-2; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ritter A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-116; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; TANAKA Y, 1989, PLANT PHYSIOL, V90, P1403, DOI 10.1104/pp.90.4.1403; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Upadhyay S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-746; VIRO M, 1980, PLANTA, V150, P41, DOI 10.1007/BF00385613; Vivier MA, 2002, TRENDS BIOTECHNOL, V20, P472, DOI 10.1016/S0167-7799(02)02058-9; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; WANG JL, 1992, PLANT CELL, V4, P173, DOI 10.1105/tpc.4.2.173; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	53	17	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147369	10.1371/journal.pone.0147369	http://dx.doi.org/10.1371/journal.pone.0147369			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824474	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528600028
J	McIntyre, LA; Moher, D; Fergusson, DA; Sullivan, KJ; Mei, SHJ; Lalu, M; Marshall, J; Mcleod, M; Griffin, G; Grimshaw, J; Turgeon, A; Avey, MT; Rudnicki, MA; Jazi, M; Fishman, J; Stewart, DJ				McIntyre, Lauralyn A.; Moher, David; Fergusson, Dean A.; Sullivan, Katrina J.; Mei, Shirley H. J.; Lalu, Manoj; Marshall, John; Mcleod, Malcolm; Griffin, Gilly; Grimshaw, Jeremy; Turgeon, Alexis; Avey, Marc T.; Rudnicki, Michael A.; Jazi, Mazen; Fishman, Jason; Stewart, Duncan J.		Canadian Critical Care Translation	Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review	PLOS ONE			English	Review							STEM-CELLS; BONE-MARROW; INTRAPULMONARY DELIVERY; BACTERIAL CLEARANCE; CLINICAL-TRIALS; ADIPOSE-TISSUE; TRANSPLANTATION; SEPSIS; LIPOPOLYSACCHARIDE; INFLAMMATION	The Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical condition that is associated with a 30-40% risk of death, and significant long term morbidity for those who survive. Mesenchymal stromal cells (MSC) have emerged as a potential novel treatment as in pre-clinical models they have been shown to modulate inflammation (a major pathophysiological hallmark of ARDS) while enhancing bacterial clearance and reducing organ injury and death. A systematic search of MEDLINE, EMBASE, BIOSIS and Web of Science was performed to identify pre-clinical studies that examined the efficacy MSCs as compared to diseased controls for the treatment of Acute Lung Injury (ALI) (the pre-clinical correlate of human ARDS) on mortality, a clinically relevant outcome. We assessed study quality and pooled results using random effect meta-analysis. A total of 54 publications met our inclusion criteria of which 17 (21 experiments) reported mortality and were included in the meta-analysis. Treatment with MSCs, as compared to controls, significantly decreased the overall odds of death in animals with ALI (Odds Ratio 0.24, 95% Confidence Interval 0.18-0.34, I-2 8%). Efficacy was maintained across different types of animal models and means of ALI induction; MSC origin, source, route of administration and preparation; and the clinical relevance of the model (timing of MSC administration, administration of fluids and or antibiotics). Reporting of standard MSC characterization for experiments that used human MSCs and risks of bias was generally poor, and although not statistically significant, a funnel plot analysis for overall mortality suggested the presence of publication bias. The results from our meta-analysis support that MSCs substantially reduce the odds of death in animal models of ALI but important reporting elements were sub optimal and limit the strength of our conclusions.	[McIntyre, Lauralyn A.; Rudnicki, Michael A.] Univ Ottawa, Dept Med, Div Crit Care, Ottawa, ON, Canada; [McIntyre, Lauralyn A.; Moher, David; Fergusson, Dean A.; Sullivan, Katrina J.; Mei, Shirley H. J.; Lalu, Manoj; Griffin, Gilly; Grimshaw, Jeremy; Avey, Marc T.; Rudnicki, Michael A.; Stewart, Duncan J.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [McIntyre, Lauralyn A.; Moher, David; Fergusson, Dean A.; Grimshaw, Jeremy] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Lalu, Manoj] Univ Ottawa, Dept Anesthesiol, Ottawa, ON, Canada; [Marshall, John] Univ Toronto, Dept Surg & Crit Care Med, Keenan Res Ctr, Li Ka Shing Knowledge Inst,St Michael Hosp, Toronto, ON, Canada; [Mcleod, Malcolm] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Moher, David; Grimshaw, Jeremy] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Turgeon, Alexis; Fishman, Jason] Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, Quebec City, PQ, Canada; [Turgeon, Alexis] Hop Enfants Jesus, CHU Quebec, CHU Quebec Res Ctr, Populat Hlth & Optimal Hlth Practice Res Unit Tra, Quebec City, PQ, Canada; [Rudnicki, Michael A.; Stewart, Duncan J.] Univ Ottawa, Dept Cell & Mol Med, Ottawa, ON, Canada; [Jazi, Mazen] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Edinburgh; University of Ottawa; Laval University; Laval University; University of Ottawa; University of Ottawa	McIntyre, LA (corresponding author), Univ Ottawa, Dept Med, Div Crit Care, Ottawa, ON, Canada.; McIntyre, LA (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.; McIntyre, LA (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	lmcintyre@ohri.ca	McIntyre, Lauralyn/AAR-7710-2021; Moher, David/I-3408-2019; Macleod, Malcolm Robert/B-2052-2010	McIntyre, Lauralyn/0000-0001-7421-1407; Moher, David/0000-0003-2434-4206; Macleod, Malcolm Robert/0000-0001-9187-9839; Rudnicki, Michael/0000-0002-3866-5249; Fergusson, Dean/0000-0002-3389-2485; Mei, Shirley/0000-0003-4727-1177; Avey, Marc/0000-0002-8696-3232	Canadian Institutes of Health Research Knowledge Synthesis Grant [KRS126596]; Division of Critical Care at the Ottawa Hospital; University Research Chair; UK NC3Rs [NC/L000970/1]; Northern Therapeutics	Canadian Institutes of Health Research Knowledge Synthesis Grant(Canadian Institutes of Health Research (CIHR)); Division of Critical Care at the Ottawa Hospital; University Research Chair; UK NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Northern Therapeutics	This systematic review was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) Knowledge Synthesis Grant (KRS126596) and by the Division of Critical Care at the Ottawa Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DM is supported by a University Research Chair. MRM is supported by the UK NC3Rs (grant NC/L000970/1). Northern Therapeutics provided support in the form of salaries for authors [DS and SM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bi LK, 2010, PROG BIOCHEM BIOPHYS, V37, P678, DOI 10.3724/SP.J.1206.2010.00107; Chang CL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-244; Chen SC, 2012, J SURG RES, V178, P81, DOI 10.1016/j.jss.2012.01.039; Chen Wen, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P21; Chien MH, 2012, CRIT CARE MED, V40, P1245, DOI 10.1097/CCM.0b013e31823bc89a; Curley GF, 2013, ANESTHESIOLOGY, V118, P924, DOI 10.1097/ALN.0b013e318287ba08; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gao P, 2013, INT J MOL MED, V31, P1313, DOI 10.3892/ijmm.2013.1328; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Gotts JE, 2011, CRIT CARE CLIN, V27, P719, DOI 10.1016/j.ccc.2011.04.004; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Gupta N, 2012, THORAX, V67, P533, DOI 10.1136/thoraxjnl-2011-201176; Hackam DG, 2007, BMJ-BRIT MED J, V334, P163, DOI 10.1136/bmj.39104.362951.80; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hannoush EJ, 2013, SURGERY, V153, P44, DOI 10.1016/j.surg.2012.06.020; Hannoush EJ, 2011, J TRAUMA, V71, P283, DOI 10.1097/TA.0b013e318222f380; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Huang Yang, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P645; Huang Y, 2011, CLIN TOXICOL, V49, P298, DOI 10.3109/15563650.2011.566882; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Islam MN, 2011, AM J RESP CRIT CARE, V183; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kim ES, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-108; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Leblond AL, 2009, HUM GENE THER, V20, P1329, DOI 10.1089/hum.2009.035; Lee SH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-16; Li J, 2012, J ASIA TEFL, V9, P1, DOI 10.1186/1476-9255-9-33; Liang ZX, 2011, CHINESE MED J-PEKING, V124, P2715, DOI 10.3760/cma.j.issn.0366-6999.2011.17.027; Lim R, 2013, RESPIRATION, V85, P332, DOI 10.1159/000343078; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maron-Gutierrez T, 2013, CRIT CARE MED, V41, pE319, DOI 10.1097/CCM.0b013e31828a663e; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Qin ZH, 2012, J CELL MOL MED, V16, P2745, DOI 10.1111/j.1582-4934.2012.01597.x; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Shin S, 2013, INT J MED SCI, V10, P8, DOI 10.7150/ijms.5385; Song L, 2012, J CELL MOL MED, V16, P376, DOI 10.1111/j.1582-4934.2011.01326.x; Stevens A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3804; Sun CK, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-118; Sun J, 2011, CELL PHYSIOL BIOCHEM, V27, P587, DOI 10.1159/000329980; Tai Wen-Lin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P283; Thomson Reuters, 2008, THOMSON REUTERS; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Wang L, 2012, MOL MED REP, V6, P287, DOI 10.3892/mmr.2012.922; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wu H, 2012, J INT PHARM RES, V39, P425; Wu QY, 2012, HEPATO-GASTROENTEROL, V59, P965, DOI 10.5754/hge12094; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Xu YL, 2012, CHINESE MED J-PEKING, V125, P2012, DOI 10.3760/cma.j.issn.0366-6999.2012.11.031; Yagi H, 2010, CELL TRANSPLANT, V19, P823, DOI 10.3727/096368910X508942; Yagi H, 2010, MOL THER, V18, P1857, DOI 10.1038/mt.2010.155; Yang B, 2013, CYTOTHERAPY, V15, P154, DOI 10.1016/j.jcyt.2012.11.007; Yang Huang, 2013, BMC Emerg Med, V13 Suppl 1, pS5, DOI 10.1186/1471-227X-13-S1-S5; Yilmaz S, 2013, STEM CELL REV REP, V9, P80, DOI 10.1007/s12015-012-9395-2; [张峰 Zhang Feng], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P5225; Zhang SJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt161; Zhao F, 2008, TRANSPL P, V40, P1700, DOI 10.1016/j.transproceed.2008.01.080; Zhao F.M., 2008, AEROSPACE MAT TECHNO, V1, P1, DOI DOI 10.1128/JCM.00105-11; Zhao YJ, 2013, INT IMMUNOPHARMACOL, V15, P246, DOI 10.1016/j.intimp.2012.12.008; Zhu F, 2010, WORLD J EMERG MED, V1, P224; Zhu Feng, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P18; Zhu Feng, 2010, Zhonghua Shao Shang Za Zhi, V26, P360	73	85	88	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147170	10.1371/journal.pone.0147170	http://dx.doi.org/10.1371/journal.pone.0147170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821255	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528400015
J	Ochoa, E; Iriondo, M; Manzano, C; Fullaondo, A; Villar, I; Ruiz-Irastorza, G; Zubiaga, AM; Estonba, A				Ochoa, Eguzkine; Iriondo, Mikel; Manzano, Carmen; Fullaondo, Asier; Villar, Irama; Ruiz-Irastorza, Guillermo; Zubiaga, Ana M.; Estonba, Andone			LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CORONARY-ARTERY-DISEASE; AUTOIMMUNE-DISEASES; VALINE/LEUCINE(247) POLYMORPHISM; FAMILIAL HYPERCHOLESTEROLEMIA; RECEPTOR GENE; FACTOR-V; EXPRESSION; ATHEROSCLEROSIS; ANTICARDIOLIPIN	Introduction The identification of the genetic risk factors that could discriminate non-thrombotic from thrombotic antiphospholipid antibodies (aPLA) carriers will improve prognosis of these patients. Several human studies have shown the presence of aPLAs associated with atherosclerotic plaque, which is a known risk factor for thrombosis. Hence, in order to determine the implication of atherosclerosis in the risk of developing thrombosis in aPLA positive patients, we performed a genetic association study with 3 candidate genes, APOH, LDLR and PCSK9. Material & Methods For genetic association study we analyzed 190 aPLA carriers -100 with non-thrombotic events and 90 with thrombotic events-and 557 healthy controls. Analyses were performed by chi(2) test and were corrected by false discovery rate. To evaluate the functional implication of the newly established susceptibility loci, we performed expression analyses in 86 aPLA carrier individuals (43 with thrombotic manifestations and 43 without it) and in 45 healthy controls. Results Our results revealed significant associations after correction in SNPs located in LDLR gene with aPLA carriers and thrombotic aPLA carriers, when compared with healthy controls. The most significant association in LDLR gene was found between SNP rs129083082 and aPLA carriers in recessive model (adjusted P-value = 2.55 x 10(-3); OR = 2.18; 95% CI = 1.49-3.21). Furthermore, our work detected significant allelic association after correction between thrombotic aPLA carriers and healthy controls in SNP rs562556 located in PCSK9 gene (adjusted P-value = 1.03 x 10(-2); OR = 1.60; 95% CI = 1.24-2.06). Expression level study showed significantly decreased expression level of LDLR gene in aPLA carriers (P-value < 0.0001; 95% CI 0.16-2.10; SE 0.38-1.27) in comparison to the control group. Discussion Our work has identified LDLR gene as a new susceptibility gene associated with the development of thrombosis in aPLA carriers, describing for the first time the deregulation of LDLR expression in individuals with aPLAs. Besides, thrombotic aPLA carriers also showed significant association with PCSK9 gene, a regulator of LDLR plasma levels. These results highlight the importance of atherosclerotic processes in the development of thrombosis in patients with aPLA.	[Ochoa, Eguzkine; Iriondo, Mikel; Manzano, Carmen; Fullaondo, Asier; Zubiaga, Ana M.; Estonba, Andone] Univ Basque Country UPV EHU, Sch Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Villar, Irama; Ruiz-Irastorza, Guillermo] Hosp Univ Cruces, BioCruces Hlth Res Inst, Serv Internal Med, Autoimmune Dis Res Unit, Baracaldo, Spain	University of Basque Country; Hospital Universitario Cruces	Zubiaga, AM; Estonba, A (corresponding author), Univ Basque Country UPV EHU, Sch Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	ana.zubiaga@ehu.eus; andone.estonba@ehu.eus	Fullaondo, Asier/L-2848-2019; Iriondo, Mikel/AAA-7997-2019; zubiaga, ana/S-3457-2019; Ruiz-Irastorza, Guillermo/P-7058-2014; Fullaondo, Asier/G-7131-2019; Ochoa, Eguzkine/AAO-5639-2020	Fullaondo, Asier/0000-0001-5387-4762; Iriondo, Mikel/0000-0001-7835-0041; zubiaga, ana/0000-0002-2132-9708; Ruiz-Irastorza, Guillermo/0000-0001-7788-1043; Fullaondo, Asier/0000-0001-5387-4762; Ochoa, Eguzkine/0000-0002-1506-9065; Estonba, Andone/0000-0003-2851-5201; Manzano, Carmen/0000-0002-8261-0608	Basque Government [Etortek IE09-256, Saiotek S-PE10UN82, Plan +Euskadi 09UE09+/57, Saiotek-PE08UN73, Saiotek-PE09UN64]; University of the Basque Country [UFI 11/20]	Basque Government(Basque Government); University of the Basque Country	Support was provided by the Basque Government (www.euskadi.eus/) Etortek IE09-256, Saiotek S-PE10UN82, Plan +Euskadi 09UE09+/57, Saiotek-PE08UN73 and Saiotek-PE09UN64; and by the University of the Basque Country (www.ehu.eus/) UFI 11/20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001043; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernales I, 2008, GENES IMMUN, V9, P38, DOI 10.1038/sj.gene.6364443; Bertolaccini ML, 2001, THROMB HAEMOSTASIS, V85, P198, DOI 10.1055/s-0037-1615676; Biggioggero M, 2010, AUTOIMMUN REV, V9, pA299, DOI 10.1016/j.autrev.2009.11.013; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Cardenas-Roldan J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-73; Chamorro AJ, 2012, AUTOIMMUN REV, V11, P705, DOI 10.1016/j.autrev.2011.12.006; DelPapa N, 1997, ARTHRITIS RHEUM-US, V40, P551; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Folsom AR, 2009, ATHEROSCLEROSIS, V202, P211, DOI 10.1016/j.atherosclerosis.2008.03.009; Full LE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2631; Galli M, 2000, BRIT J HAEMATOL, V108, P865, DOI 10.1046/j.1365-2141.2000.01964.x; George J, 1999, CIRCULATION, V99, P2227, DOI 10.1161/01.CIR.99.17.2227; GOLDSTEIN JL, 1979, ANNU REV GENET, V13, P259, DOI 10.1146/annurev.ge.13.120179.001355; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hamid C, 2007, ANN RHEUM DIS, V66, P1000, DOI 10.1136/ard.2006.063909; Harris EN, 2002, LUPUS, V11, P269, DOI 10.1191/0961203302lu202cr; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Hochberg Y. B. a. Y., 1995, J R STAT SOC B, V57, P12; Kenet G, 2000, STROKE, V31, P1283, DOI 10.1161/01.STR.31.6.1283; Levy Y, 2006, LUPUS, V15, P784, DOI 10.1177/0961203306071004; Levy Zohar, 2003, Eur J Intern Med, V14, P479, DOI 10.1016/j.ejim.2003.08.010; Linsel-Nitschke P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002986; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM-US, V54, P301, DOI 10.1002/art.21549; Lopez-Pedrera C, 2008, ARTHRITIS RHEUM-US, V58, P2835, DOI 10.1002/art.23756; Martinelli N, 2010, BLOOD, V116, P5688, DOI 10.1182/blood-2010-03-277079; Matsuura Eiji, 2009, Curr Rheumatol Rep, V11, P61; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Potti A, 2006, BLOOD, V107, P1391, DOI 10.1182/blood-2005-07-2669; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Sebastiani GD, 2003, LUPUS, V12, P560, DOI 10.1191/0961203303lu402oa; Sene D, 2009, REV MED INTERNE, V30, P135, DOI 10.1016/j.revmed.2008.05.020; Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092; Stanic AK, 2006, P NATL ACAD SCI USA, V103, P7018, DOI 10.1073/pnas.0602311103; Swadzba J, 2006, LUPUS, V15, P218, DOI 10.1191/0961203306lu2288oa; Tincani A, 2001, THROMB HAEMOSTASIS, V86, P575; Vazquez-Del Mercado M, 2007, SCAND J RHEUMATOL, V36, P206, DOI 10.1080/03009740601089648; Vega-Ostertag Mariano E, 2007, Curr Rheumatol Rep, V9, P190, DOI 10.1007/s11926-007-0031-0; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wisloff F, 2002, THROMB RES, V108, P263, DOI 10.1016/S0049-3848(02)00400-0; Wong RCW, 2004, THROMB RES, V114, P559, DOI 10.1016/j.thromres.2004.06.002; Yasuda S, 2005, ARTHRITIS RHEUM-US, V52, P212, DOI 10.1002/art.20741; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	50	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146990	10.1371/journal.pone.0146990	http://dx.doi.org/10.1371/journal.pone.0146990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820623	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400010
J	Gouse, H; Magidson, JF; Burnhams, W; Remmert, JE; Myers, B; Joska, JA; Carrico, AW				Gouse, Hetta; Magidson, Jessica F.; Burnhams, Warren; Remmert, Jocelyn E.; Myers, Bronwyn; Joska, John A.; Carrico, Adam W.			Implementation of Cognitive-Behavioral Substance Abuse Treatment in Sub-Saharan Africa: Treatment Engagement and Abstinence at Treatment Exit	PLOS ONE			English	Article							CONTINGENCY MANAGEMENT; ACCESS	Aims This study documented the treatment cascade for engagement in care and abstinence at treatment exit as well as examined correlates of these outcomes for the first certified Matrix Model (R) substance abuse treatment site in Sub-Saharan Africa. Design This retrospective chart review conducted at a resource-limited community clinic in Cape Town, South Africa, assessed treatment readiness and substance use severity at treatment entry as correlates of the number of sessions attended and biologically confirmed abstinence at treatment exit among 986 clients who initiated treatment from 2009-2014. Socio-demographic and clinical correlates of treatment outcomes were examined using logistic regression, modeling treatment completion and abstinence at treatment exit separately. Results Of the 2,233 clients who completed screening, approximately 44% (n = 986) initiated treatment. Among those who initiated treatment, 45% completed at least four group sessions, 30% completed early recovery skills training (i.e., at least eight group sessions), and 13% completed the full 16-week program. Approximately half (54%) of clients who provided a urine sample had negative urine toxicology results for any substance at treatment exit. Higher motivation at treatment entry was independently associated with greater odds of treatment completion and negative urine toxicology results at treatment exit. Conclusions Findings provide initial support for the successful implementation the Matrix Model in a resource-limited setting. Motivational enhancement interventions could support treatment initiation, promote sustained engagement in treatment, and achieve better treatment outcomes.	[Gouse, Hetta; Joska, John A.] HIV Mental Hlth Res Unit, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Magidson, Jessica F.; Remmert, Jocelyn E.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Magidson, Jessica F.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Burnhams, Warren] City Cape Town Hlth, Subst Abuse, Cape Town, South Africa; [Myers, Bronwyn] South African Med Res Council, Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa; [Carrico, Adam W.] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; South African Medical Research Council; University of California System; University of California San Francisco	Gouse, H (corresponding author), HIV Mental Hlth Res Unit, Dept Psychiat & Mental Hlth, Cape Town, South Africa.	hetta.gouse@uct.ac.za	Myers, Bronwyn/AAT-7788-2021; Gouse, Hetta/H-1461-2015	Myers, Bronwyn/0000-0003-0235-6716; Gouse, Hetta/0000-0001-7885-8363; Joska, John/0000-0003-4260-1181	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH093310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA041901] Funding Source: NIH RePORTER; NIDA NIH HHS [K23 DA041901] Funding Source: Medline; NIMH NIH HHS [T32 MH093310] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ali R, 2002, ADDICTION, V97, P1183; [Anonymous], 1995, INTENSIVE OUTPATIENT; [Anonymous], 2015, WORLD DRUG REP 2015; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Carney T, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-25; City of Cape Town, 2010, TAFELSIG MATRIX TREA; Dada Sp, 2012, MONITORING ALCOHOL D, P1; Epstein DH, 2003, PSYCHOL ADDICT BEHAV, V17, P73, DOI 10.1037/0893-164X.17.1.73; Loveland D, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-41; Marinelli-Casey P, 2002, PSYCHIATR SERV, V53, P984, DOI 10.1176/appi.ps.53.8.984; Miller WR, 1996, PSYCHOL ADDICT BEHAV, V10, P81, DOI 10.1037/0893-164X.10.2.81; Myers B, 2008, TECHNICAL REPORT; Myers B, 2008, INT J SOC WELF, V17, P156, DOI 10.1111/j.1468-2397.2007.00546.x; Myers B, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-177; Myers B, 2012, SAMJ S AFR MED J, V102, P667, DOI 10.7196/SAMJ.5990; Myers BJ, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-28; Pasche S, 2015, INT J MENT HEALTH AD, V13, P322, DOI 10.1007/s11469-014-9537-7; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; Rawson RA, 2006, ADDICTION, V101, P267, DOI 10.1111/j.1360-0443.2006.01312.x; RAWSON RA, 1995, J SUBST ABUSE TREAT, V12, P117, DOI 10.1016/0740-5472(94)00080-B; Rawson RA, 2004, ADDICTION, V99, P708, DOI 10.1111/j.1360-0443.2004.00707.x; SHOPTAW S, 1994, J ADDICT DIS, V13, P129; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2013, TREATM EP DAT SET TE	23	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0147900	10.1371/journal.pone.0147900	http://dx.doi.org/10.1371/journal.pone.0147900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GD	26816208	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528200062
J	Pelechrinis, K; Wei, D				Pelechrinis, Konstantinos; Wei, Dong			VA-Index: Quantifying Assortativity Patterns in Networks with Multidimensional Nodal Attributes	PLOS ONE			English	Article								Network connections have been shown to be correlated with structural or external attributes of the network vertices in a variety of cases. Given the prevalence of this phenomenon network scientists have developed metrics to quantify its extent. In particular, the assortativity coefficient is used to capture the level of correlation between a single-dimensional attribute (categorical or scalar) of the network nodes and the observed connections, i.e., the edges. Nevertheless, in many cases a multi-dimensional, i.e., vector feature of the nodes is of interest. Similar attributes can describe complex behavioral patterns (e.g., mobility) of the network entities. To date little attention has been given to this setting and there has not been a general and formal treatment of this problem. In this study we develop a metric, the vector assortativity index (VA-index for short), based on network randomization and (empirical) statistical hypothesis testing that is able to quantify the assortativity patterns of a network with respect to a vector attribute. Our extensive experimental results on synthetic network data show that the VA-index outperforms a baseline extension of the assortativity coefficient, which has been used in the literature to cope with similar cases. Furthermore, the VA-index can be calibrated (in terms of parameters) fairly easy, while its benefits increase with the (co-) variance of the vector elements, where the baseline systematically over(under) estimate the true mixing patterns of the network.	[Pelechrinis, Konstantinos; Wei, Dong] Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pelechrinis, K (corresponding author), Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA USA.	kpele@pitt.edu	Pelechrinis, Konstantinos/ACX-4835-2022; Wei, Dong/AAO-7518-2020	Pelechrinis, Konstantinos/0000-0002-6443-3935; Wei, Dong/0000-0003-0693-0295	Army Research Office [W911NF-15-1-0599]	Army Research Office	This work was supported by Army Research Office (W911NF-15-1-0599) (KP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Block P, 2014, NETW SCI, V2, P189, DOI 10.1017/nws.2014.17; CATANIA JA, 1992, AM J PUBLIC HEALTH, V82, P284, DOI 10.2105/AJPH.82.2.284; Crandall David, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; ERDOS P, 1960, B INT STATIST INST, V38, P343; FISHER L, 1971, BIOMETRIKA, V58, P91, DOI 10.2307/2334320; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Kim Myunghwan, 2012, ARXIV12054546, P1719; Kleinberg J, 2002, ADV NEUR IN, V14, P431; Lauw HW, 2010, IEEE INTERNET COMPUT, V14, P15, DOI 10.1109/MIC.2010.25; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Moody J, 2001, AM J SOCIOL, V107, P679, DOI 10.1086/338954; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Pelechrinis K, ECML PKDD 2012; Pelechrinis K, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0188-2; Scellato S, 2011, P 17 ACM SIGKDD INT, P1046, DOI DOI 10.1145/2020408.2020575; Sun Y, 2012, ACM SIGKDD EXPLORATI; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581; Zhang K, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P271, DOI 10.1145/2566486.2567990; Zhao K, 2010, LECT NOTES COMPUT SC, V6007, P265, DOI 10.1007/978-3-642-12079-4_33	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146188	10.1371/journal.pone.0146188	http://dx.doi.org/10.1371/journal.pone.0146188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816262	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000369528200010
J	Ahmad, T; Desai, N; Wilson, F; Schulte, P; Dunning, A; Jacoby, D; Allen, L; Fiuzat, M; Rogers, J; Felker, GM; O'Connor, C; Patel, CB				Ahmad, Tariq; Desai, Nihar; Wilson, Francis; Schulte, Phillip; Dunning, Allison; Jacoby, Daniel; Allen, Larry; Fiuzat, Mona; Rogers, Joseph; Felker, G. Michael; O'Connor, Christopher; Patel, Chetan B.			Clinical Implications of Cluster Analysis-Based Classification of Acute Decompensated Heart Failure and Correlation with Bedside Hemodynamic Profiles	PLOS ONE			English	Article							SEX-DIFFERENCES; MORTALITY; TRIAL; ASSOCIATION; PHENOTYPES; MORBIDITY; OUTCOMES; REGISTRY; PROGRAM; ESCAPE	Background Classification of acute decompensated heart failure (ADHF) is based on subjective criteria that crudely capture disease heterogeneity. Improved phenotyping of the syndrome may help improve therapeutic strategies. Objective To derive cluster analysis-based groupings for patients hospitalized with ADHF, and compare their prognostic performance to hemodynamic classifications derived at the bedside. Methods We performed a cluster analysis on baseline clinical variables and PAC measurements of 172 ADHF patients from the ESCAPE trial. Employing regression techniques, we examined associations between clusters and clinically determined hemodynamic profiles (warm/cold/ wet/dry). We assessed association with clinical outcomes using Cox proportional hazards models. Likelihood ratio tests were used to compare the prognostic value of cluster data to that of hemodynamic data. Results We identified four advanced HF clusters: 1) male Caucasians with ischemic cardiomyopathy, multiple comorbidities, lowest B-type natriuretic peptide (BNP) levels; 2) females with non-ischemic cardiomyopathy, few comorbidities, most favorable hemodynamics; 3) young African American males with non-ischemic cardiomyopathy, most adverse hemodynamics, advanced disease; and 4) older Caucasians with ischemic cardiomyopathy, concomitant renal insufficiency, highest BNP levels. There was no association between clusters and bedside-derived hemodynamic profiles (p = 0.70). For all adverse clinical outcomes, Cluster 4 had the highest risk, and Cluster 2, the lowest. Compared to Cluster 4, Clusters 1-3 had 45-70% lower risk of all-cause mortality. Clusters were significantly associated with clinical outcomes, whereas hemodynamic profiles were not. Conclusions By clustering patients with similar objective variables, we identified four clinically relevant phenotypes of ADHF patients, with no discernable relationship to hemodynamic profiles, but distinct associations with adverse outcomes. Our analysis suggests that ADHF classification using simultaneous considerations of etiology, comorbid conditions, and biomarker levels, may be superior to bedside classifications.	[Ahmad, Tariq; Desai, Nihar; Jacoby, Daniel] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Wilson, Francis] Yale Univ, Sch Med, Program Translat Med, New Haven, CT USA; [Schulte, Phillip] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Dunning, Allison; Fiuzat, Mona; Rogers, Joseph; Felker, G. Michael; Patel, Chetan B.] Duke Clin Res Inst, Durham, NC USA; [Allen, Larry] Univ Colorado, Dept Med, Div Cardiol, Denver, CO 80202 USA; [Rogers, Joseph; Felker, G. Michael; Patel, Chetan B.] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [O'Connor, Christopher] Inova Heart & Vasc Inst, Falls Church, VA USA	Yale University; Yale University; Mayo Clinic; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Duke University; Inova Fairfax Hospital	Ahmad, T (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.	tariq.ahmad@yale.edu	Felker, Michael/AAX-2288-2021; Allen, Larry/AAI-1323-2020; Ahamed, Tariq/E-8985-2016	Felker, Gary/0000-0002-5931-1239; Ahamed, Tariq/0000-0002-4525-0738; Wilson, Francis Perry/0000-0002-2633-2412	Daland Fellowship in Clinical Investigation; National Heart, Lung, and Blood Institute (NHLBI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097201] Funding Source: NIH RePORTER	Daland Fellowship in Clinical Investigation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Ahmad received support from the Daland Fellowship in Clinical Investigation. The ESCAPE trial was funded by grants from the National Heart, Lung, and Blood Institute (NHLBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2014, J AM COLL CARDIOL, V64, P1765, DOI 10.1016/j.jacc.2014.07.979; Allen LA, 2008, J CARD FAIL, V14, P661, DOI 10.1016/j.cardfail.2008.05.004; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Bergau L, 2014, J ELECTROCARDIOL, V47, P869, DOI 10.1016/j.jelectrocard.2014.08.007; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Costanzo MR, 2008, AM HEART J, V155, P339, DOI 10.1016/j.ahj.2007.10.020; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Echols MR, 2006, J CARD FAIL, V12, P684, DOI 10.1016/j.cardfail.2006.08.003; Erro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070244; Felker GM, 2010, CIRC-HEART FAIL, V3, P314, DOI 10.1161/CIRCHEARTFAILURE.109.893222; FORRESTER JS, 1976, NEW ENGL J MED, V295, P1356, DOI 10.1056/NEJM197612092952406; Hamid JS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-364; Katz AM, 2008, CIRC-HEART FAIL, V1, P63, DOI 10.1161/CIRCHEARTFAILURE.108.772756; Krumholz HM, 2014, HEALTH AFFAIR, V33, P1163, DOI 10.1377/hlthaff.2014.0053; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mehra MR, 2014, HEART FAIL CLIN, V10, pIX, DOI 10.1016/j.hfc.2014.02.001; Nohria A, 2002, JAMA-J AM MED ASSOC, V287, P628, DOI 10.1001/jama.287.5.628; O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030; O'Meara E, 2007, CIRCULATION, V115, P3111, DOI 10.1161/CIRCULATIONAHA.106.673442; Shah MR, 2001, J CARD FAIL, V7, P105, DOI 10.1054/jcaf.2001.24131; Shah SJ, 2015, CIRCULATION, V131, P269, DOI 10.1161/CIRCULATIONAHA.114.010637; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Stevenson LW, 2008, J AM COLL CARDIOL, V52, P1702, DOI 10.1016/j.jacc.2008.08.028; Taylor AL, 2005, AM J CARDIOL, V96, p44I, DOI 10.1016/j.amjcard.2005.07.033; Yancy C, 2013, CIRCULATION, V2013, P6, DOI DOI 10.1016/J.JACC.2013.05.020; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	26	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0145881	10.1371/journal.pone.0145881	http://dx.doi.org/10.1371/journal.pone.0145881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840410	gold, Green Submitted, Green Published			2022-12-27	WOS:000369550200004
J	Huang, Q; Chen, YP; Wang, RW; Cheng, S; Evans, JD				Huang, Qiang; Chen, Yan Ping; Wang, Rui Wu; Cheng, Shang; Evans, Jay D.			Host-Parasite Interactions and Purifying Selection in a Microsporidian Parasite of Honey Bees	PLOS ONE			English	Article							NOSEMA CERANAE MICROSPORIDIA; APIS-MELLIFERA; PARASITOPHOROUS VACUOLE; APOPTOSIS; INFECTIONS; PROTEIN; GENOME; MITOCHONDRIA; PACKAGE; SINGLE	To clarify the mechanisms of Nosema ceranae parasitism, we deep-sequenced both honey bee host and parasite mRNAs throughout a complete 6-day infection cycle. By time-series analysis, 1122 parasite genes were significantly differently expressed during the reproduction cycle, clustering into 4 expression patterns. We found reactive mitochondrial oxygen species modulator 1 of the host to be significantly down regulated during the entire infection period. Our data support the hypothesis that apoptosis of honey bee cells was suppressed during infection. We further analyzed genome-wide genetic diversity of this parasite by comparing samples collected from the same site in 2007 and 2013. The number of SNP positions per gene and the proportion of non-synonymous substitutions per gene were significantly reduced over this time period, suggesting purifying selection on the parasite genome and supporting the hypothesis that a subset of N. ceranae strains might be dominating infection.	[Huang, Qiang; Wang, Rui Wu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Huang, Qiang; Chen, Yan Ping; Evans, Jay D.] ARS, USDA, Bee Res Lab, BARC East Bldg 306, Beltsville, MD 20705 USA; [Wang, Rui Wu] Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Peoples R China; [Cheng, Shang] Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; United States Department of Agriculture (USDA); Northwestern Polytechnical University	Huang, Q (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China.; Huang, Q; Evans, JD (corresponding author), ARS, USDA, Bee Res Lab, BARC East Bldg 306, Beltsville, MD 20705 USA.; Wang, RW (corresponding author), Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Peoples R China.	qiang-huang@live.com; Jay.Evans@ars.usda.gov	Evans, Jay/C-8408-2012	Evans, Jay/0000-0002-0036-4651	United States Department of Agriculture-National Institute of Food and Agriculture [2014-67013-21784]	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was supported by the United States Department of Agriculture-National Institute of Food and Agriculture- 2014-67013-21784.r We thank Dawn Lopez, Michele Hamilton, and Margaret Mulhern for technical support. We appreciate Jiajie Sun and Lingyang Xu for statistical support. The work is supported by USDA-NIFA grant 2014-67013-21784 and USDA-NIFA had no role in study design, analysis, and publication of the work.	Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Bohne W, 2011, INT J MED MICROBIOL, V301, P395, DOI 10.1016/j.ijmm.2011.04.006; Burri L, 2006, P NATL ACAD SCI USA, V103, P15916, DOI 10.1073/pnas.0604109103; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; del Aguila C, 2006, INT J PARASITOL, V36, P869, DOI 10.1016/j.ijpara.2006.04.002; Dussaubat C, 2013, J INVERTEBR PATHOL, V113, P42, DOI 10.1016/j.jip.2013.01.002; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Elsik CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-86; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fokin SI, 2008, J EUKARYOT MICROBIOL, V55, P214, DOI 10.1111/j.1550-7408.2008.00322.x; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Fries I, 2006, J APICULT RES, V45, P230; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gisder S, 2011, ENVIRON MICROBIOL, V13, P404, DOI 10.1111/j.1462-2920.2010.02346.x; Gomez-Moracho T, 2015, INFECT GENET EVOL, V31, P87, DOI 10.1016/j.meegid.2015.01.002; Gomez-Moracho T, 2014, PARASITOLOGY, V141, P475, DOI 10.1017/S0031182013001790; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2013, ENV MICROBIOL REP, V5, P530, DOI 10.1111/1758-2229.12059; Holt HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-799; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Huang SK, 2014, J ECON ENTOMOL, V107, P54, DOI 10.1603/EC13213; Kurze C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140174; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Li Z, 2014, PLOS ONE, P9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Pelin A, 2015, ENV MICROBIOL; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scanlon M, 1999, J EUKARYOT MICROBIOL, V46, p34S; Scanlon M, 2004, J EUKARYOT MICROBIOL, V51, P81, DOI 10.1111/j.1550-7408.2004.tb00166.x; Schwarz RS, 2013, DEV COMP IMMUNOL, V40, P300, DOI 10.1016/j.dci.2013.03.010; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Wu JH, 2006, BIOCHIMIE, V88, P201, DOI 10.1016/j.biochi.2005.07.007	43	18	27	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147549	10.1371/journal.pone.0147549	http://dx.doi.org/10.1371/journal.pone.0147549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840596	Green Submitted, gold, Green Published			2022-12-27	WOS:000369550200045
J	Rawski, M; Kieronczyk, B; Dlugosz, J; Swiatkiewicz, S; Jozefiak, D				Rawski, Mateusz; Kieronczyk, Bartosz; Dlugosz, Jakub; Swiatkiewicz, Sylwester; Jozefiak, Damian			Dietary Probiotics Affect Gastrointestinal Microbiota, Histological Structure and Shell Mineralization in Turtles	PLOS ONE			English	Article							AKKERMANSIA-MUCINIPHILA; OLIGONUCLEOTIDE PROBES; INTESTINAL MICROFLORA; SALMONELLA-ENTERICA; BACTERIAL GROUPS; PERFORMANCE; HEALTH; REPTILES; TORTOISES; RESPONSES	Probiotics are widely used in nutrition, and their mode of action is intensively studied in mammals and birds; however, it is almost unknown in reptiles. In the present study, Trachemys scripta scripta and Sternotherus odoratus were used to assess the effects of dietary probiotics on chelonian gastrointestinal tract microecology. In the first, 20-week experiment, 40 young T. s. scripta were randomly distributed to four experimental groups: 1st, (CON)-with no additives; 2nd, (SSPA) with Bacillus subtilis PB6; 3rd, (MSP)-with multiple strain probiotic; and 4th, (SSPB) with Bacillus subtilis C-3102. The first study has shown that SSPA and MSP decreased the numbers of total bacteria, Enterobacteriace, Staphylococcus sp. and Streptococcus sp. excreted to water and increased the villous height and mucosa thickness in duodenum. SSPB improved the duodenal microstructure; however, it also increased numbers of kanamycin and vancomycin resistant bacteria, Staphylococcus sp. and Streptococcus sp., in water. In the second, 52-week experiment, 30 S. odoratus were randomly assigned to three dietary treatments. CON, SSPA and MSP groups. The MSP preparation increased the body weight gain, crude ash, Ca and P share in the turtles' shells. Both probiotics affected duodenal histomorphology. SSPA decreased the villous height, while MSP increased the villous height and mucosa thickness, and decreased the crypt depth. SSPA decreased the concentrations of bacteria excreted to water. In the case of intestinal microbiota, bacteria suppressing effects were observed in the case of both probiotics. MSP increased the number of Bifidobacterium sp. and Lactobacillus sp./Enteroccoccus sp., and decreased the number of Clostridium perfringens and Campylobacter sp. in the small intestine. In the large intestine it lowered, amongst others, Bacteroides-Pervotella cluster, Clostridium leptum subgroup and Clostridium perfringens numbers. The above-mentioned results suggest that probiotics are useful in turtle nutrition due to their positive effects on growth performance, shell mineralization, duodenal histomorphology and microbiota.	[Rawski, Mateusz; Kieronczyk, Bartosz; Dlugosz, Jakub; Jozefiak, Damian] Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland; [Swiatkiewicz, Sylwester] Natl Res Inst Anim Prod, Dept Anim Nutr & Feed Sci, Balice, Poland	Poznan University of Life Sciences; National Research Institute of Animal Production	Jozefiak, D (corresponding author), Poznan Univ Life Sci, Dept Anim Nutr & Feed Management, Poznan, Poland.	damjo@up.poznan.pl	Swiatkiewicz, Sylwester/H-4807-2011; Swiatkiewicz, Sylwester/O-9967-2019; Kierończyk, Bartosz/I-8760-2019; Swiatkiewicz, Sylwester/K-1623-2019	Swiatkiewicz, Sylwester/0000-0001-8330-2159; Kierończyk, Bartosz/0000-0001-6006-117X; Swiatkiewicz, Sylwester/0000-0001-8330-2159; Rawski, Mateusz/0000-0001-8734-724X; Jozefiak, Damian/0000-0002-6606-7975	National Science Center (Poland) [NCN PRELUDIUM: UMO-2013/11/N/NZ9/04624]	National Science Center (Poland)	The current study was supported by the following grant: NCN PRELUDIUM: UMO-2013/11/N/NZ9/04624, financed by National Science Center (Poland).	Alloui MN, 2013, ANN ANIM SCI, V13, P17, DOI 10.2478/v10220-012-0055-x; AYASAN T, 2006, INT J POULT SCI, V5, P776, DOI DOI 10.3923/IJPS.2006.776.779; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; CONGDON JD, 1994, AM ZOOL, V34, P397; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Dicks LMT, 2010, BENEF MICROBES, V1, P11, DOI 10.3920/BM2009.0012; Ebani VV, 2005, RES VET SCI, V78, P117, DOI 10.1016/j.rvsc.2004.08.002; Fallani M, 2006, J MICROBIOL METH, V67, P150, DOI 10.1016/j.mimet.2006.03.010; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; FRAZER NB, 1991, ECOLOGY, V72, P2218, DOI 10.2307/1941572; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gaertner JP, 2008, J WILDLIFE DIS, V44, P519, DOI 10.7589/0090-3558-44.2.519; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Geue L, 2002, VET MICROBIOL, V84, P79, DOI 10.1016/S0378-1135(01)00437-0; GIBBONS J.W, 1990, LIFE HIST ECOLOGY SL; Gong SP, 2014, SCI TOTAL ENVIRON, V468, P28, DOI 10.1016/j.scitotenv.2013.08.025; Guban J, 2006, POULTRY SCI, V85, P2186, DOI 10.1093/ps/85.12.2186; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Harris JR, 2010, CLIN INFECT DIS, V50, P554, DOI 10.1086/649932; Hoby S, 2010, J NUTR, V140, P1923, DOI 10.3945/jn.110.120998; JACKSON OF, 1980, J SMALL ANIM PRACT, V21, P409, DOI 10.1111/j.1748-5827.1980.tb01269.x; Jeong JS, 2014, POULTRY SCI, V93, P3097, DOI 10.3382/ps.2014-04086; Jin LZ, 1997, WORLD POULTRY SCI J, V53, P351, DOI 10.1079/WPS19970028; Jozefiak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085347; Jozefiak D, 2013, ANN ANIM SCI, V13, P449, DOI 10.2478/aoas-2013-0031; Keenan SW, 2013, SCI REP-UK, V3, DOI 10.1038/srep02877; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P6425, DOI 10.1128/AEM.68.12.6425-6428.2002; Leary S, 2013, AVMA GUIDELINES EUTH; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068772; Lei GYZHZ, 2010, CHINESE J ANIMAL NUT, V1, P42; Lei XJ, 2015, ASIAN AUSTRAL J ANIM, V28, P239, DOI 10.5713/ajas.14.0330; Mader D. R., 2005, REPTILE MED SURG; Mali I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139053; Mali I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086478; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Marubashi T, 2013, J APPL ANIMAL NUTR, V1, P1; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; Montalban-Arques A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00512; Parvaneh K, 2014, SCI WORLD J, DOI 10.1155/2014/595962; Pees M, 2013, EUROSURVEILLANCE, V18; Rawski M, 2014, ANN ANIM SCI, V14, P573, DOI 10.2478/aoas-2014-0037; Revy R, 2004, ANIM FEED SCI TECH, V116, P93, DOI 10.1016/j.anifeedsci.2004.04.003; SAS Institute, 2011, SAS IML 9 3 US GUID; Schmid MW, 2005, INT J FOOD MICROBIOL, V105, P245, DOI 10.1016/j.ijfoodmicro.2005.04.012; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shamoto K, 2000, POULTRY SCI, V79, P718, DOI 10.1093/ps/79.5.718; Shi HT, 2008, ORYX, V42, P147, DOI 10.1017/S0030605308000562; Shi HT, 2007, CONSERV BIOL, V21, P5, DOI 10.1111/j.1523-1739.2006.00622_2.x; Swiatkiewicz S, 2010, ACTA AGR SCAND A-AN, V60, P125, DOI 10.1080/09064702.2010.482593; Swiatkiewicz Sylwester, 2007, Medycyna Weterynaryjna, V63, P1291; Teo AY, 2007, J APPL POULTRY RES, V16, P296, DOI 10.1093/japr/16.3.296; Timmerman HM, 2004, INT J FOOD MICROBIOL, V96, P219, DOI 10.1016/j.ijfoodmicro.2004.05.012; Willemsen RE, 2002, HERPETOL J, V12, P105; Zajac M, 2011, MED WETER, V67, P376; Zhang X, 2014, AQUACULT NUTR, V20, P667, DOI 10.1111/anu.12128	63	27	29	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147859	10.1371/journal.pone.0147859	http://dx.doi.org/10.1371/journal.pone.0147859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828367	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200038
J	Yang, Y; Liu, YL				Yang, Yi; Liu, Yuanli			Iterative Approximation of Basic Belief Assignment Based on Distance of Evidence	PLOS ONE			English	Article							DEMPSTER-SHAFER THEORY; TOTAL UNCERTAINTY	In the theory of belief functions, the approximation of a basic belief assignment (BBA) is for reducing the high computational cost especially when large number of focal elements are available. In traditional BBA approximation approaches, a focal element's own characteristics such as the mass assignment and the cardinality, are usually used separately or jointly as criteria for the removal of focal elements. Besides the computational cost, the distance between the original BBA and the approximated one is also concerned, which represents the loss of information in BBA approximation. In this paper, an iterative approximation approach is proposed based on maximizing the closeness, i.e., minimizing the distance between the approximated BBA in current iteration and the BBA obtained in the previous iteration, where one focal element is removed in each iteration. The iteration stops when the desired number of focal elements is reached. The performance evaluation approaches for BBA approximations are also discussed and used to compare and evaluate traditional BBA approximations and the newly proposed one in this paper, which include traditional time-based way, closeness-based way and new proposed ones. Experimental results and related analyses are provided to show the rationality and efficiency of our proposed new BBA approximation.	[Yang, Yi; Liu, Yuanli] Xi An Jiao Tong Univ, Sch Aerosp, SKLSVMS, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Yang, Y (corresponding author), Xi An Jiao Tong Univ, Sch Aerosp, SKLSVMS, Xian 710049, Shaanxi, Peoples R China.	jiafeiyy@mail.xjtu.edu.cn			Grant for State Key Program for Basic Research of China [2013CB329405]; National Natural Science Foundation [61573275, 61203222]; Science and technology project of Shaanxi Province [2013KJXX-46]; Specialized Research Fund for the Doctoral Program of Higher Education [20120201120036]; Fundamental Research Funds for the Central Universities [xjj2014122]	Grant for State Key Program for Basic Research of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and technology project of Shaanxi Province; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Grant for State Key Program for Basic Research of China (973) No. 2013CB329405, National Natural Science Foundation (No. 61573275, No. 61203222), Science and technology project of Shaanxi Province (No. 2013KJXX-46), Specialized Research Fund for the Doctoral Program of Higher Education (20120201120036), and Fundamental Research Funds for the Central Universities (xjj2014122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan J, 2008, INT J GEN SYST, V37, P733, DOI 10.1080/03081070802082486; Barnett JA, 2008, STUD FUZZ SOFT COMP, V219, P197; Bauer M, 1996, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P73; Bouchard M, 2013, INT J APPROX REASON, V54, P615, DOI 10.1016/j.ijar.2013.01.006; Burger T, 2010, P 1 INT WORKSH THEOR; Burger T, 2012, ADV INTEL SOFT COMPU, V164, P145; Denoeux T, 2001, INT J UNCERTAIN FUZZ, V9, P437, DOI 10.1016/S0218-4885(01)00088-0; Destercke S, 2012, ADV INTEL SOFT COMPU, V164, P153; Dezert J, 2012, ADV INTEL SOFT COMPU, V164, P275; Grabisch M., 1999, PROC 1 INT S IMPRECI, P158; Han DQ, 2015, 2015 18TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION (FUSION), P428; HARMANEC D, 1994, INT J GEN SYST, V22, P405, DOI 10.1080/03081079408935225; Jousselme AL, 2006, IEEE T SYST MAN CY A, V36, P890, DOI 10.1109/TSMCA.2005.853483; Joussleme A.-L., 2001, Information Fusion, V2, P91, DOI 10.1016/S1566-2535(01)00026-4; KENNES R, 1992, IEEE T SYST MAN CYB, V22, P201, DOI 10.1109/21.148425; Klir GJ, 2008, IEEE T SYST MAN CY A, V38, P995, DOI 10.1109/TSMCA.2008.923066; Laamari W, 2015, LECT NOTES ARTIF INT, V9310, P234, DOI 10.1007/978-3-319-23540-0_16; Lowrance JD, 2008, STUD FUZZ SOFT COMP, V219, P419; Myers J. L., 2010, RES DESIGN STAT ANAL; SHAFER G, 1987, ARTIF INTELL, V33, P271, DOI 10.1016/0004-3702(87)90040-3; Shafer G., 1976, MATH THEORY EVIDENCE, V1; Shah Harsheel R, 2015, THESIS MISSOURI U SC; Smarandache F, 2009, ADV APPL DSMT INFORM, V3, DOI [10.5281/zenodo.8791, DOI 10.5281/ZENODO.8791]; Smarandache F., 2015, ADV APPL DSMT INFORM, V4; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; Smets P, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P612; TESSEM B, 1993, ARTIF INTELL, V61, P315, DOI 10.1016/0004-3702(93)90072-J; Yang Y, 2013, CHINESE J AERONAUT, V26, P993, DOI 10.1016/j.cja.2013.04.061	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147799	10.1371/journal.pone.0147799	http://dx.doi.org/10.1371/journal.pone.0147799			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829403	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200034
J	Achouiti, A; de Vos, AF; van 't Veer, C; Florquin, S; Tanck, MW; Nawroth, PP; Bierhaus, A; van der Poll, T; van Zoelen, MAD				Achouiti, Ahmed; de Vos, Alex F.; van 't Veer, Cornelis; Florquin, Sandrine; Tanck, Michael W.; Nawroth, Peter P.; Bierhaus, Angelika; van der Poll, Tom; van Zoelen, Marieke A. D.			Receptor for Advanced Glycation End Products (RAGE) Serves a Protective Role during Klebsiella pneumoniae - Induced Pneumonia	PLOS ONE			English	Article							ACUTE LUNG INJURY; VENTILATOR-ASSOCIATED PNEUMONIA; COMMUNITY-ACQUIRED PNEUMONIA; MOBILITY GROUP BOX-1; HOST-DEFENSE; PNEUMOCOCCAL PNEUMONIA; EXPERIMENTAL-MODELS; LIPOTEICHOIC ACID; IMMUNE-RESPONSE; SEVERE SEPSIS	Klebsiella species is the second most commonly isolated gram-negative organism in sepsis and a frequent causative pathogen in pneumonia. The receptor for advanced glycation end products (RAGE) is expressed on different cell types and plays a key role in diverse inflammatory responses. We here aimed to investigate the role of RAGE in the host response to Klebsiella (K.) pneumoniae pneumonia and intransally inoculated rage gene deficient (RAGE(-/-)) and normal wild-type (Wt) mice with K. pneumoniae. Klebsiella pneumonia resulted in an increased pulmonary expression of RAGE. Furthermore, the high-affinity RAGE ligand high mobility group box-1 was upregulated during K. pneumoniae pneumonia. RAGE deficiency impaired host defense as reflected by a worsened survival, increased bacterial outgrowth and dissemination in RAGE(-/-) mice. RAGE(-/-) neutrophils showed a diminished phagocytosing capacity of live K. pneumoniae in vitro. Relative toWt mice, RAGE(-/-) mice demonstrated similar lung inflammation, and slightly elevated-if any-cytokine and chemokine levels and unchanged hepatocellular injury. In addition, RAGE(-/-) mice displayed an unaltered response to intranasally instilled Klebsiella lipopolysaccharide (LPS) with respect to pulmonary cell recruitment and local release of cytokines and chemokines. These data suggest that (endogenous) RAGE protects against K. pneumoniae pneumonia. Also, they demonstrate that RAGE contributes to an effective antibacterial defense during K. pneumoniae pneumonia, at least partly via its participation in the phagocytic properties of professional granulocytes. Additionally, our results indicate that RAGE is not essential for the induction of a local and systemic inflammatory response to either intact Klebsiella or Klebsiella LPS.	[Achouiti, Ahmed; de Vos, Alex F.; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Achouiti, Ahmed; de Vos, Alex F.; van 't Veer, Cornelis; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, CEMM, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Tanck, Michael W.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Nawroth, Peter P.; Bierhaus, Angelika] Heidelberg Univ, Dept Internal Med & Clin Chem, Heidelberg, Germany; [van Zoelen, Marieke A. D.] North Shore Long Isl Univ Hosp, Feinstein Inst Med Res, Lab Biomed Sci, Manhassat, NY USA; [van Zoelen, Marieke A. D.] Univ Med Ctr Utrecht, Div Internal Med & Infect Dis, Utrecht, Netherlands; [van Zoelen, Marieke A. D.] Univ Med Ctr Utrecht, LTI, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Ruprecht Karls University Heidelberg; Northwell Health; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Zoelen, MAD (corresponding author), North Shore Long Isl Univ Hosp, Feinstein Inst Med Res, Lab Biomed Sci, Manhassat, NY USA.	M.A.D.vanZoelen@umcutrecht.nl		Florquin, Sandrine/0000-0002-9676-1722; Tanck, Michael/0000-0001-9828-4459	Netherlands Organisation for Scientific Research (NWO); Clinical Research Talent Fellowship grant from the UMCU; Deutsche Forschungsgemeinschaft [SFB405]; IDSA/ID-week International Investigator Award	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Clinical Research Talent Fellowship grant from the UMCU; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IDSA/ID-week International Investigator Award	This work was supported by a VENI grant in the field of biomedical sciences from the Netherlands Organisation for Scientific Research (NWO) and by a Clinical Research Talent Fellowship grant from the UMCU, both to MADvZ, and by a grant from the Deutsche Forschungsgemeinschaft (SFB405 to PPN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been awarded with the IDSA/ID-week International Investigator Award 2012 (to dr. M.A.D. van Zoelen).	BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Christaki E, 2012, CURR OPIN INFECT DIS, V25, P304, DOI 10.1097/QCO.0b013e3283519b82; Christaki E, 2011, SHOCK, V35, P492, DOI 10.1097/SHK.0b013e31820b2e1c; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Foell DMD, 2013, AM J RESPIR CRIT CAR; Friggeri A, 2011, J IMMUNOL, V186, P6191, DOI 10.4049/jimmunol.1004134; Fuellen G, 2003, TRENDS IMMUNOL, V24, P622, DOI 10.1016/j.it.2003.10.004; Giamarellou H, 2005, CLIN MICROBIOL INFEC, V11, P1, DOI 10.1111/j.1469-0691.2005.01160.x; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Kang CI, 2011, J INFECTION, V62, P26, DOI 10.1016/j.jinf.2010.10.010; Knapp S, 2005, SHOCK, V24, P12, DOI 10.1097/01.shk.0000191385.41689.f3; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Kollef MH, 2005, CHEST, V128, P2706, DOI 10.1378/chest.128.4.2706; Leemans JC, 2002, AM J RESP CRIT CARE, V165, P1445, DOI 10.1164/rccm.2106045; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Liu R, 2009, ACTA MED OKAYAMA, V63, P203; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Ramsgaard L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020132; Renckens R, 2007, BLOOD, V109, P1593, DOI 10.1182/blood-2006-05-025197; Rijneveld AW, 2004, BLOOD, V103, P1702, DOI 10.1182/blood-2002-05-1380; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Strieter RM, 2003, CURR OPIN INFECT DIS, V16, P193, DOI 10.1097/00001432-200306000-00002; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; van Zoelen MA, 2010, CRIT CARE MED; van Zoelen MAD, 2008, SHOCK, V29, P441, DOI 10.1097/SHK.0b013e318157eddd; van Zoelen MAD, 2007, CRIT CARE MED, V35, P2799, DOI 10.1097/01.CCM.0000287588.69000.97; van Zoelen MAD, 2009, VIROLOGY, V391, P265, DOI 10.1016/j.virol.2009.05.032; van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; van Zoelen MA, 2011, CRIT CARE, V15, DOI 10.1186/cc9990; VANDERWINDT GJ, 2010, EUR RESP J; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wiersinga WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003494; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Zen K, 2007, J IMMUNOL, V178, P2483, DOI 10.4049/jimmunol.178.4.2483	50	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0141000	10.1371/journal.pone.0141000	http://dx.doi.org/10.1371/journal.pone.0141000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824892	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528600001
J	Brose, LS; McEwen, A				Brose, Leonie S.; McEwen, Andy			Neighbourhood Deprivation and Outcomes of Stop Smoking Support - An Observational Study	PLOS ONE			English	Article							NICOTINE REPLACEMENT THERAPY; QUITTING SMOKING; CESSATION SERVICES; LEVEL; INEQUALITIES; PREDICTORS; SMOKERS; HEALTH; IMPACT; DISADVANTAGE	Background Rates of smoking and smoking cessation vary with socio-economic status. The objectives were to assess the association between neighbourhood deprivation, completion of treatment to support quit attempts and success of quit attempts-while taking into account other predictors of outcome. Methods 555,744 quit attempts supported by English Stop Smoking Services in 2009-2012 were linked to the Index of Multiple Deprivation (IMD) 2010 ranks for the clients' neighbourhood and split into deciles relative to the national IMD. Logistic regressions tested the association between neighbourhood deprivation and completion (4-week follow-up) of treatment and biochemically validated success (expired-air carbon monoxide <10ppm) while adjusting for demographics and intervention characteristics. Sensitivity analyses assessed subsamples: first supported attempts (n = 364,397), those with recorded cigarette dependence (n = 98,659) and completed treatment (n = 416,436). Results Higher neighbourhood deprivation was associated with reduced completion (ORadj = 0.949, 95% CI: 0.947 to 0.951) and success (ORadj = 0.957, 95% CI: 0.955 to 0.959). Results of sensitivity analyses were consistent with those of the main analysis. Conclusions Neighbourhood deprivation was associated with small but consistent reductions in completion and success of evidence-based interventions. These associations were not explained	[Brose, Leonie S.] Kings Coll London, Natl Addict Ctr, London WC2R 2LS, England; [Brose, Leonie S.] Kings Coll London, UK Ctr Tobacco & Alcohol Studies, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [McEwen, Andy] UCL, Natl Ctr Smoking Cessat & Training, London, England; [McEwen, Andy] UCL, Canc Res UK Hlth Behav Res Ctr, London, England	University of London; King's College London; University of London; King's College London; University of London; University College London; Cancer Research UK; University of London; University College London	Brose, LS (corresponding author), Kings Coll London, Natl Addict Ctr, London WC2R 2LS, England.; Brose, LS (corresponding author), Kings Coll London, UK Ctr Tobacco & Alcohol Studies, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England.	leonie.brose@kcl.ac.uk	Brose, Leonie S./H-6690-2019		Medical Research Council; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; National Institute for Health Research under the UK Clinical Research Collaboration [MR/K023195/1]; Medical Research Council [MR/K023195/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research under the UK Clinical Research Collaboration; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Leonie Brose is a member of the UK Centre for Tobacco & Alcohol Studies, a UK Clinical Research Collaboration Public Health Research: Centre of Excellence. Funding from the Medical Research Council, British Heart Foundation, Cancer Research UK, Economic and Social Research Council and the National Institute for Health Research under the auspices of the UK Clinical Research Collaboration is gratefully acknowledged (MR/K023195/1). The authors received no specific funding for this work and the funders played no role in the study design, collection, analysis and interpretation of the data, in the writing of the manuscript and in the decision to submit this manuscript for publication.	[Anonymous], 2011, ENGLISH INDICES DEPR; Bauld L, 2003, TOB CONTROL, V12, P296, DOI 10.1136/tc.12.3.296; Bauld L., 2011, TOBACCO CONTROL INEQ; Bauld L, 2007, TOB CONTROL, V16, P400, DOI 10.1136/tc.2007.021626; Brose LS, 2013, MAYO CLIN PROC, V88, P226, DOI 10.1016/j.mayocp.2012.11.013; Brown T, 2014, EUR J PUBLIC HEALTH, V24, P551, DOI 10.1093/eurpub/cku065; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Chandola T, 2004, ADDICTION, V99, P770, DOI 10.1111/j.1360-0443.2004.00756.x; Chesterman J, 2005, ADDICTION, V100, P36, DOI 10.1111/j.1360-0443.2005.01026.x; Department of Health, 2012, LOC STOP SMOK SERV; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Field A, 2013, DISCOVERING STAT USI; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Herd N, 2009, ADDICTION, V104, P2088, DOI 10.1111/j.1360-0443.2009.02732.x; Hiscock R, 2013, ADDICT BEHAV, V38, P2787, DOI 10.1016/j.addbeh.2013.07.010; Hiscock R, 2011, J PUBLIC HEALTH-UK, V33, P39, DOI 10.1093/pubmed/fdq097; Hitchman SC, 2014, PSYCHOL ADDICT BEHAV, V28, P1144, DOI 10.1037/a0036483; Kleinschmidt I, 1995, J EPIDEMIOL COMMUN H, V49, pS72, DOI 10.1136/jech.49.Suppl_2.S72; Kotz D, 2009, TOB CONTROL, V18, P43, DOI 10.1136/tc.2008.025981; Lakshman R, 2011, J PUBLIC HEALTH-UK, V33, P234, DOI 10.1093/pubmed/fdq072; Lam TH, 2005, PSYCHOPHARMACOLOGY, V177, P400, DOI 10.1007/s00213-004-1971-y; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; NHS choices, 2015, HELP HLTH COSTS; NHS Information Centre: [The Health and Social Care Information Centre), 2012, STAT NHS STOP SMOK S; Office for National Statistics, 2014, DO SMOK RAT VAR MOR; Partos TR, 2012, DRUG ALCOHOL REV, V31, P653, DOI 10.1111/j.1465-3362.2012.00427.x; Reid JL, 2010, NICOTINE TOB RES, V12, pS20, DOI 10.1093/ntr/ntq051; Schaap MM, 2008, TOB CONTROL, V17, P248, DOI 10.1136/tc.2007.024265; Shohaimi S, 2003, J EPIDEMIOL COMMUN H, V57, P270, DOI 10.1136/jech.57.4.270; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub2; The National Health Service (NHS) Information Centre, 2010, STAT NHS STOP SMOK S; Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, 2007, Nicotine Tob Res, V9 Suppl 4, pS555, DOI 10.1080/14622200701673480; Turrell G, 2012, DRUG ALCOHOL REV, V31, P645, DOI 10.1111/j.1465-3362.2012.00452.x; Vangeli E, 2011, ADDICTION, V106, P2110, DOI 10.1111/j.1360-0443.2011.03565.x; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4921; Zhou XL, 2009, ADDICT BEHAV, V34, P365, DOI 10.1016/j.addbeh.2008.11.013	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148194	10.1371/journal.pone.0148194	http://dx.doi.org/10.1371/journal.pone.0148194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824352	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600107
J	Gwak, SJ; Yun, Y; Yoon, DH; Kim, KN; Ha, Y				Gwak, So-Jung; Yun, Yeomin; Yoon, Do Heum; Kim, Keung Nyun; Ha, Yoon			Therapeutic Use of 3 beta-[N-(N ',N '-Dimethylaminoethane) Carbamoyl] Cholesterol-Modified PLGA Nanospheres as Gene Delivery Vehicles for Spinal Cord Injury	PLOS ONE			English	Article							BIODEGRADABLE NANOPARTICLES; CATIONIC LIPOSOME; LOCAL-DELIVERY; PLASMID DNA; STEM-CELLS; IN-VITRO; FORMULATION; RECOVERY; ACID); TRANSPLANTATION	Gene delivery holds therapeutic promise for the treatment of neurological diseases and spinal cord injury. Although several studies have investigated the use of non-viral vectors, such as polyethylenimine (PEI), their clinical value is limited by their cytotoxicity. Recently, biodegradable poly (lactide-co-glycolide) (PLGA) nanospheres have been explored as non-viral vectors. Here, we show that modification of PLGA nanospheres with 3 beta-[N-(N',N'-dimethylaminoethane) carbamoyl] cholesterol (DC-Chol) enhances gene transfection efficiency. PLGA/DC-Chol nanospheres encapsulating DNA were prepared using a double emulsion-solvent evaporation method. PLGA/DC-Chol nanospheres were less cytotoxic than PEI both in vitro and in vivo. DC-Chol modification improved the uptake of nanospheres, thereby increasing their transfection efficiency in mouse neural stem cells in vitro and rat spinal cord in vivo. Also, transgene expression induced by PLGA nanospheres was higher and longer-lasting than that induced by PEI. In a rat model of spinal cord injury, PLGA/DC-Chol nanospheres loaded with vascular endothelial growth factor gene increased angiogenesis at the injury site, improved tissue regeneration, and resulted in better recovery of locomotor function. These results suggest that DC-Chol-modified PLGA nanospheres could serve as therapeutic gene delivery vehicles for spinal cord injury.	[Gwak, So-Jung; Yun, Yeomin; Yoon, Do Heum; Kim, Keung Nyun; Ha, Yoon] Yonsei Univ, Coll Med, Dept Neurosurg, Spine & Spinal Cord Inst, Seoul 120749, South Korea; [Gwak, So-Jung] Clemson Univ, Dept Bioengn, Clemson, SC USA	Yonsei University; Yonsei University Health System; Clemson University	Ha, Y (corresponding author), Yonsei Univ, Coll Med, Dept Neurosurg, Spine & Spinal Cord Inst, Seoul 120749, South Korea.	HAYOON@yuhs.ac		Yoon, Do Heum/0000-0003-1452-5724	Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C0916]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9C6065075]; ICT R&D program of MSIP/IITP [R0190-15-2072]	Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; ICT R&D program of MSIP/IITP	This work was supported by the Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C0916), Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9C6065075) and the ICT R&D program of MSIP/IITP. [R0190-15-2072].	Ajmani PS, 1999, NEUROCHEM RES, V24, P699, DOI 10.1023/A:1021012727796; Asasutjarit R, 2007, PHARM RES-DORDR, V24, P1098, DOI 10.1007/s11095-007-9234-3; Benfer M, 2012, EUR J PHARM BIOPHARM, V80, P247, DOI 10.1016/j.ejpb.2011.10.021; Blits B, 2006, J NEUROTRAUM, V23, P508, DOI 10.1089/neu.2006.23.508; Cohen H, 2000, GENE THER, V7, P1896, DOI 10.1038/sj.gt.3301318; Cristiano RJ, 1998, ANTICANCER RES, V18, P3241; Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Federici T, 2006, MUSCLE NERVE, V33, P302, DOI 10.1002/mus.20439; Frampton AR, 2005, GENE THER, V12, P891, DOI 10.1038/sj.gt.3302545; Gao J, 2010, BIOMATERIALS, V31, P2655, DOI 10.1016/j.biomaterials.2009.11.112; GAO X, 1991, BIOCHEM BIOPH RES CO, V179, P280, DOI 10.1016/0006-291X(91)91366-K; Griesenbach U, 2010, BIOMATERIALS, V31, P2665, DOI 10.1016/j.biomaterials.2009.12.005; Gwak SJ, 2008, BIOTECHNOL LETT, V30, P1177, DOI 10.1007/s10529-008-9676-7; Jensen DK, 2012, J CONTROL RELEASE, V157, P141, DOI 10.1016/j.jconrel.2011.08.011; Jeon O, 2007, J DRUG TARGET, V15, P190, DOI 10.1080/10611860601143479; Kang SW, 2008, BIOMATERIALS, V29, P1109, DOI 10.1016/j.biomaterials.2007.11.004; Kim IS, 2005, INT J PHARMACEUT, V298, P255, DOI 10.1016/j.ijpharm.2005.04.017; Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077; Kumar MNVR, 2004, BIOMATERIALS, V25, P1771, DOI 10.1016/j.biomaterials.2003.08.069; Lemmouchi Y, 1998, BIOMATERIALS, V19, P1827, DOI 10.1016/S0142-9612(98)00074-X; Mandel RJ, 1997, P NATL ACAD SCI USA, V94, P14083, DOI 10.1073/pnas.94.25.14083; Ning GZ, 2013, REGEN MED, V8, P271, DOI [10.2217/RME.13.26, 10.2217/rme.13.26]; Nishikawa M, 2000, GENE THER, V7, P548, DOI 10.1038/sj.gt.3301140; Oh JS, 2012, NEUROREPORT, V23, P277, DOI 10.1097/WNR.0b013e3283505ae2; Oh J, 2012, NEUROREPORT, V23, P658, DOI 10.1097/WNR.0b013e3283555d1b; Oudega M, 2012, CELL TISSUE RES, V349, P269, DOI 10.1007/s00441-012-1440-6; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016; Ren H, 2014, BIOMATERIALS, V35, P6585, DOI 10.1016/j.biomaterials.2014.04.042; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Wen XJ, 2006, BIOMATERIALS, V27, P3800, DOI 10.1016/j.biomaterials.2006.02.036; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485; Yi F, 2006, J CLIN PHARM THER, V31, P43, DOI 10.1111/j.1365-2710.2006.00702.x; Zhang XY, 2011, RECENT ADVANCE IN STATISTICS APPLICATION AND RELATED AREAS, PTS 1 AND 2, P148	38	22	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147389	10.1371/journal.pone.0147389	http://dx.doi.org/10.1371/journal.pone.0147389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824765	gold, Green Published, Green Submitted			2022-12-27	WOS:000369528600031
J	Wicherts, JM				Wicherts, Jelte M.			Peer Review Quality and Transparency of the Peer-Review Process in Open Access and Subscription Journals	PLOS ONE			English	Article							BIBLIOMETRIC INDICATORS	Background Recent controversies highlighting substandard peer review in Open Access (OA) and traditional (subscription) journals have increased the need for authors, funders, publishers, and institutions to assure quality of peer-review in academic journals. I propose that transparency of the peer-review process may be seen as an indicator of the quality of peer-review, and develop and validate a tool enabling different stakeholders to assess transparency of the peer-review process. Methods and Findings Based on editorial guidelines and best practices, I developed a 14-item tool to rate transparency of the peer-review process on the basis of journals' websites. In Study 1, a random sample of 231 authors of papers in 92 subscription journals in different fields rated transparency of the journals that published their work. Authors' ratings of the transparency were positively associated with quality of the peer-review process but unrelated to journal's impact factors. In Study 2, 20 experts on OA publishing assessed the transparency of established (non-OA) journals, OA journals categorized as being published by potential predatory publishers, and journals from the Directory of Open Access Journals (DOAJ). Results show high reliability across items (alpha =.91) and sufficient reliability across raters. Ratings differentiated the three types of journals well. In Study 3, academic librarians rated a random sample of 140 DOAJ journals and another 54 journals that had received a hoax paper written by Bohannon to test peer-review quality. Journals with higher transparency ratings were less likely to accept the flawed paper and showed higher impact as measured by the h5 index from Google Scholar. Conclusions The tool to assess transparency of the peer-review process at academic journals shows promising reliability and validity. The transparency of the peer-review process can be seen as an indicator of peer-review quality allowing the tool to be used to predict academic quality in new journals.	[Wicherts, Jelte M.] Tilburg Univ, Dept Methodol & Stat, Tilburg Sch Behav Sci, NL-5000 LE Tilburg, Netherlands	Tilburg University	Wicherts, JM (corresponding author), Tilburg Univ, Dept Methodol & Stat, Tilburg Sch Behav Sci, NL-5000 LE Tilburg, Netherlands.	j.m.wicherts@uvt.nl	Wicherts, Jelte M./A-2664-2008	Wicherts, Jelte M./0000-0003-2415-2933	Netherlands Organisation for Research [016.125.385]	Netherlands Organisation for Research	This work was funded by VIDI Grant no. 016.125.385 from the Netherlands Organisation for Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P., 2022, PUBLISHING PERSPECTI; Beall J., 2010, CHARLESTON ADVISOR, V12, P50, DOI [DOI 10.5260/CHARA.12.1.50, 10.5260/chara.12.1.50]; Beall J., 2009, CHARLESTON ADVISOR, V11, P29; Beall J., 2011, CHARLESTON ADVISOR, V12, P39, DOI [10.5260/chara.12.4.39, DOI 10.5260/CHARA.12.4.39]; Beall J., 2012, CHARLESTON ADVISOR, V13, P5, DOI [10.5260/chara.13.4.5.2, DOI 10.5260/CHARA.13.4.5]; Beall J, 2012, NATURE, V489, P179, DOI 10.1038/489179a; Black N, 1998, JAMA-J AM MED ASSOC, V280, P231, DOI 10.1001/jama.280.3.231; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Bornmann L, 2010, PLOS ONE, V12; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P229, DOI 10.1001/jama.280.3.229; Costas R, 2012, DEV INDICATORS UNPUB; Enserink M, 2012, SCIENCE, V338, P1018, DOI 10.1126/science.338.6110.1018; Gallo SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106474; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; Ho RCM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-74; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2786, DOI 10.1001/jama.287.21.2786; Juznic P, 2010, SCIENTOMETRICS, V85, P429, DOI 10.1007/s11192-010-0230-8; Kingsley DA, 2015, COMMUNICATIONS ASS I, V37, P14; Laakso M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-124; Mulligan A, 2013, J AM SOC INF SCI TEC, V64, P132, DOI 10.1002/asi.22798; Rinia EJ, 1998, RES POLICY, V27, P95, DOI 10.1016/S0048-7333(98)00026-2; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Solomon DJ, 2013, J INFORMETR, V7, P642, DOI 10.1016/j.joi.2013.03.008; van den Besselaar P, 2007, PERFORMANCE PREDICTO; Van Noorden R., 2014, NATURE, DOI [10.1038/nature.2014.14763, DOI 10.1038/NATURE.2014.14763]; Van Noorden R, 2013, NATURE, V495, P426, DOI 10.1038/495426a; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; vanRaan AFJ, 1996, SCIENTOMETRICS, V36, P397, DOI 10.1007/BF02129602; Weber EJ, 2002, JAMA-J AM MED ASSOC, V287, P2790, DOI 10.1001/jama.287.21.2790; Wicherts JM, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00020	30	75	79	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147913	10.1371/journal.pone.0147913	http://dx.doi.org/10.1371/journal.pone.0147913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824759	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600071
J	Elfving, K; Shakely, D; Andersson, M; Baltzell, K; Ali, AS; Bachelard, M; Falk, KI; Ljung, A; Msellem, MI; Omar, RS; Parola, P; Xu, WP; Petzold, M; Trollfors, B; Bjorkman, A; Lindh, M; Martensson, A				Elfving, Kristina; Shakely, Deler; Andersson, Maria; Baltzell, Kimberly; Ali, Abdullah S.; Bachelard, Marc; Falk, Kerstin I.; Ljung, Annika; Msellem, Mwinyi I.; Omar, Rahila S.; Parola, Philippe; Xu, Weiping; Petzold, Max; Trollfors, Birger; Bjorkman, Anders; Lindh, Magnus; Martensson, Andreas			Acute Uncomplicated Febrile Illness in Children Aged 2-59 months in Zanzibar - Aetiologies, Antibiotic Treatment and Outcome	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; MALARIA; PNEUMONIA; BURDEN; MANAGEMENT; SYMPTOMS; VIRUSES; FEVER; KENYA	Background Despite the fact that a large proportion of children with fever in Africa present at primary health care facilities, few studies have been designed to specifically study the causes of uncomplicated childhood febrile illness at this level of care, especially in areas like Zanzibar that has recently undergone a dramatic change from high to low malaria transmission. Methods We prospectively studied the aetiology of febrile illness in 677 children aged 2-59 months with acute uncomplicated fever managed by IMCI (Integrated Management of Childhood Illness) guidelines in Zanzibar, using point-of-care tests, urine culture, blood-PCR, chest Xray (CXR) of IMCI-pneumonia classified patients, and multiple quantitative (q) PCR investigations of nasopharyngeal (NPH) (all patients) and rectal (GE) swabs (diarrhoea patients). For comparison, we also performed NPH and GE qPCR analyses in 167 healthy community controls. Final fever diagnoses were retrospectively established based on all clinical and laboratory data. Clinical outcome was assessed during a 14-day follow-up. The utility of IMCI for identifying infections presumed to require antibiotics was evaluated. Findings NPH-qPCR and GE-qPCR detected >= 1 pathogen in 657/672 (98%) and 153/164 (93%) of patients and 158/166 (95%) and 144/165 (87%) of controls, respectively. Overall, 57% (387/677) had IMCI-pneumonia, but only 12% (42/342) had CXR-confirmed pneumonia. Two patients were positive for Plasmodium falciparum. Respiratory syncytial virus (24.5%), influenza A/B (22.3%), rhinovirus (10.5%) and group-A streptococci (6.4%), CXR-confirmed pneumonia (6.2%), Shigella (4.3%) were the most common viral and bacterial fever diagnoses, respectively. Blood-PCR conducted in a sub-group of patients (n = 83) without defined fever diagnosis was negative for rickettsiae, chikungunya, dengue, Rift Valley fever and West Nile viruses. Antibiotics were prescribed to 500 (74%) patients, but only 152 (22%) had an infection retrospectively considered to require antibiotics. Clinical outcome was generally good. However, two children died. Only 68 (11%) patients remained febrile on day 3 and three of them had verified fever on day 14. An additional 29 (4.5%) children had fever relapse on day 14. Regression analysis determined C-reactive Protein (CRP) as the only independent variable significantly associated with CXR-confirmed pneumonia. Conclusions This is the first study on uncomplicated febrile illness in African children that both applied a comprehensive laboratory panel and a healthy control group. A majority of patients had viral respiratory tract infection. Pathogens were frequently detected by qPCR also in asymptomatic children, demonstrating the importance of incorporating controls in fever aetiology studies. The precision of IMCI for identifying infections requiring antibiotics was low.	[Elfving, Kristina; Andersson, Maria; Ljung, Annika; Lindh, Magnus] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Elfving, Kristina; Bachelard, Marc; Trollfors, Birger] Univ Gothenburg, Dept Paediat, Gothenburg, Sweden; [Shakely, Deler; Xu, Weiping; Bjorkman, Anders; Martensson, Andreas] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Malaria Res, Stockholm, Sweden; [Shakely, Deler] Kungalv Hosp, Dept Med, Kungalv, Sweden; [Baltzell, Kimberly] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA; [Ali, Abdullah S.; Msellem, Mwinyi I.; Omar, Rahila S.] Minist Hlth, Zanzibar Malaria Eliminat Programme, Zanzibar, Tanzania; [Falk, Kerstin I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Parola, Philippe] Aix Marseille Univ, Fac Med, WHO Collaborat Ctr Rickettsioses & Other Arthropo, UM63, Marseille, France; [Petzold, Max] Univ Gothenburg, Akad Stat, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden; [Martensson, Andreas] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Martensson, Andreas] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth Unit IMCH, Uppsala, Sweden	University of Gothenburg; University of Gothenburg; Karolinska Institutet; University of California System; University of California San Francisco; Karolinska Institutet; UDICE-French Research Universities; Aix-Marseille Universite; University of Gothenburg; Uppsala University; Uppsala University	Elfving, K (corresponding author), Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden.; Elfving, K (corresponding author), Univ Gothenburg, Dept Paediat, Gothenburg, Sweden.	kristina.elfving@vgregion.se	Parola, Philippe/AAY-4346-2021	Parola, Philippe/0000-0002-1061-1927; Elfving, Kristina/0000-0003-4477-8765	ACT Consortium through Bill and Melinda Gates Foundation	ACT Consortium through Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the ACT Consortium through an award from Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, POCKET BOOK HOSP CAR; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Castro AV, 2005, INDIAN PEDIATR, V42, P773; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Colvin JM, 2012, PEDIATRICS, V130, pE1455, DOI 10.1542/peds.2012-1391; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Elfving K, 2014, J CLIN MICROBIOL; English M, 2008, PLOS MED, V5, P1665, DOI 10.1371/journal.pmed.0050241; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Fuller JA, 2013, J MED VIROL, V85, P924, DOI 10.1002/jmv.23455; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Kerkhof E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090847; Kotloff KL, 2013, LANCET; Laxminarayan R, 2015, LANCET; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4; Mahende C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104197; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Puumalainen T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-95; Senn N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090990; Shakely D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072912; Sokhna C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001999; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Waitumbi JN, 2010, AM J TROP MED HYG, V83, P1010, DOI 10.4269/ajtmh.2010.10-0174; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9	33	48	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0146054	10.1371/journal.pone.0146054	http://dx.doi.org/10.1371/journal.pone.0146054			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821179	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528400003
J	Muller, L; Meyer, M; Bauer, RN; Zhou, HB; Zhang, HT; Jones, S; Robinette, C; Noah, TL; Jaspers, I				Mueller, Loretta; Meyer, Megan; Bauer, Rebecca N.; Zhou, Haibo; Zhang, Hongtao; Jones, Shannon; Robinette, Carole; Noah, Terry L.; Jaspers, Ilona			Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study	PLOS ONE			English	Article							BRAUN-TYPE LIPOPROTEINS; NASAL EPITHELIAL-CELLS; SULFORAPHANE; VACCINES; SMOKERS; CANCER; ISOTHIOCYANATE; EXPRESSION; INDUCTION; INFECTION	Enhancing antiviral host defense responses through nutritional supplementation would be an attractive strategy in the fight against influenza. Using inoculation with live attenuated influenza virus (LAIV) as an infection model, we have recently shown that ingestion of sulforaphane-containing broccoli sprout homogenates (BSH) reduces markers of viral load in the nose. To investigate the systemic effects of short-term BSH supplementation in the context of LAIV-inoculation, we examined peripheral blood immune cell populations in non-smoking subjects from this study, with a particular focus on NK cells. We carried out a randomized, double-blinded, placebo-controlled study measuring the effects of BSH (N = 13) or placebo (alfalfa sprout homogenate, ASH; N = 16) on peripheral blood mononuclear cell responses to a standard nasal vaccine dose of LAIV in healthy volunteers. Blood was drawn prior to (day-1) and post (day2, day21) LAIV inoculation and analyzed for neutrophils, monocytes, macrophages, T cells, NKT cells, and NK cells. In addition, NK cells were enriched, stimulated, and assessed for surface markers, intracellular markers, and cytotoxic potential by flow cytometry. Overall, LAIV significantly reduced NKT (day2 and day21) and T cell (day2) populations. LAIV decreased NK cell CD56 and CD158b expression, while significantly increasing CD16 expression and cytotoxic potential (on day2). BSH supplementation further increased LAIV-induced granzyme B production (day2) in NK cells compared to ASH and in the BSH group granzyme B levels appeared to be negatively associated with influenza RNA levels in nasal lavage fluid cells. We conclude that nasal influenza infection may induce complex changes in peripheral blood NK cell activation, and that BSH increases virus-induced peripheral blood NK cell granzyme B production, an effect that may be important for enhanced antiviral defense responses.	[Mueller, Loretta; Bauer, Rebecca N.; Jones, Shannon; Robinette, Carole; Noah, Terry L.; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA; [Mueller, Loretta] Univ Childrens Hosp Basel, Basel, Switzerland; [Meyer, Megan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Bauer, Rebecca N.] Stanford Univ, Dept Pediat Allergy & Immunol, Stanford, CA 94305 USA; [Zhou, Haibo; Zhang, Hongtao] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Noah, Terry L.; Jaspers, Ilona] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Basel; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jaspers, I (corresponding author), Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA.; Jaspers, I (corresponding author), Univ N Carolina, Dept Pediat, Chapel Hill, NC USA.	Ilona-Jaspers@med.unc.edu	ZHOU, Haibo/M-7373-2017; Jaspers, Ilona/AAZ-5035-2020		NIH [R01 HL095163]; Swiss National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES013611, T32ES007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH R01 HL095163. Loretta Muller was supported by a personal grant from the Swiss National Science Foundation.	Amin PJ, 2015, LIFE SCI, V126, P19, DOI 10.1016/j.lfs.2015.01.026; Broder K., 2009, Morbidity and Mortality Weekly Report, V58, P1351; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; Dinkova-Kostova AT, 2007, CANCER EPIDEM BIOMAR, V16, P847, DOI 10.1158/1055-9965.EPI-06-0934; Dou YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121258; Egner PA, 2014, CANCER PREV RES, V7, P813, DOI 10.1158/1940-6207.CAPR-14-0103; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; Fan X, 2013, AM J PHYSIOL-LUNG C, V305, P1267, DOI 10.1152/ajplung.00288.2012; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; He XS, 2008, J INFECT DIS, V197, P803, DOI 10.1086/528804; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Heber D, 2014, FOOD FUNCT, V5, P35, DOI 10.1039/c3fo60277j; Horvath KM, 2012, CLIN IMMUNOL, V142, P232, DOI 10.1016/j.clim.2011.12.013; Horvath KM, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-102; Jaspers I, 2010, AM J RESP CELL MOL, V43, P368, DOI 10.1165/rcmb.2009-0254OC; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; Meyer M, 2013, RESP MED, V107, P472, DOI 10.1016/j.rmed.2012.11.006; Muller L, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-16; Muller L, 2013, AM J PHYSIOL-LUNG C, V304, pL332, DOI 10.1152/ajplung.00256.2012; Nielsen CH, 2010, PLANTA MED, V76, P1802, DOI 10.1055/s-0030-1250043; Noah TL, 2011, ENVIRON HEALTH PERSP, V119, P78, DOI 10.1289/ehp.1002258; Noah TL, 2014, PLOS ONE, V9; Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383; Peng H, 2014, CLIN REV ALLERG IMMU, V47, P119, DOI 10.1007/s12016-013-8400-0; Pugh ND, 2008, INT IMMUNOPHARMACOL, V8, P1023, DOI 10.1016/j.intimp.2008.03.007; Pugh ND, 2015, PHYTOMEDICINE, V22, P271, DOI 10.1016/j.phymed.2014.12.006; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Rudenko L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087962; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Thejass P, 2006, IMMUNOPHARM IMMUNOT, V28, P443, DOI 10.1080/08923970600928049; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wu CC, 2013, MOL CARCINOGEN, V52, P946, DOI 10.1002/mc.21926	36	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147742	10.1371/journal.pone.0147742	http://dx.doi.org/10.1371/journal.pone.0147742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820305	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528400040
J	Rouch, JD; Scott, A; Lei, NY; Solorzano-Vargas, RS; Wang, JF; Hanson, EM; Kobayashi, M; Lewis, M; Stelzner, MG; Dunn, JCY; Eckmann, L; Martin, MG				Rouch, Joshua D.; Scott, Andrew; Lei, Nan Ye; Solorzano-Vargas, R. Sergio; Wang, Jiafang; Hanson, Elaine M.; Kobayashi, Masae; Lewis, Michael; Stelzner, Matthias G.; Dunn, James C. Y.; Eckmann, Lars; Martin, Martin G.			Development of Functional Microfold (M) Cells from Intestinal Stem Cells in Primary Human Enteroids	PLOS ONE			English	Article							EPITHELIAL M-CELLS; PATCH M-CELLS; NF-KAPPA-B; MESENCHYMAL TRANSITION; TRANSEPITHELIAL TRANSPORT; MOUSE INTESTINE; PEYERS-PATCHES; IN-VITRO; DIFFERENTIATION; EXPRESSION	Background & Aims Intestinal microfold (M) cells are specialized epithelial cells that act as gatekeepers of luminal antigens in the intestinal tract. They play a critical role in the intestinal mucosal immune response through transport of viruses, bacteria and other particles and antigens across the epithelium to immune cells within Peyer's patch regions and other mucosal sites. Recent studies in mice have demonstrated that M cells are generated from Lgr5+ intestinal stem cells (ISCs), and that infection with Salmonella enterica serovar Typhimurium increases M cell formation. However, it is not known whether and how these findings apply to primary human small intestinal epithelium propagated in an in vitro setting. Methods Human intestinal crypts were grown as monolayers with growth factors and treated with recombinant RANKL, and assessed for mRNA transcripts, immunofluorescence and uptake of microparticles and S. Typhimurium. Results Functional M cells were generated by short-term culture of freshly isolated human intestinal crypts in a dose-and time-dependent fashion. RANKL stimulation of the monolayer cultures caused dramatic induction of the M cell-specific markers, SPIB, and Glycoprotein-2 (GP2) in a process primed by canonical WNT signaling. Confocal microscopy demonstrated a pseudopod phenotype of GP2-positive M cells that preferentially take up microparticles. Furthermore, infection of the M cell-enriched cultures with the M cell-tropic enteric pathogen, S. Typhimurium, led to preferential association of the bacteria with M cells, particularly at lower inoculum sizes. Larger inocula caused rapid induction of M cells. Conclusions Human intestinal crypts containing ISCs can be cultured and differentiate into an epithelial layer with functional M cells with characteristic morphological and functional properties. This study is the first to demonstrate that M cells can be induced to form from primary human intestinal epithelium, and that S. Typhimurium preferentially infect these cells in an in vitro setting. We anticipate that this model can be used to generate large numbers of M cells for further functional studies of these key cells of intestinal immune induction and their impact on controlling enteric pathogens and the intestinal microbiome.	[Rouch, Joshua D.; Scott, Andrew; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Surg, Div Pediat Surg, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Lei, Nan Ye; Kobayashi, Masae; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn, Los Angeles, CA USA; [Solorzano-Vargas, R. Sergio; Wang, Jiafang; Martin, Martin G.] Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol & Nutr, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Solorzano-Vargas, R. Sergio; Wang, Jiafang; Martin, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Hanson, Elaine M.; Eckmann, Lars] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lewis, Michael] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol, Los Angeles, CA USA; [Stelzner, Matthias G.] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Surg, Los Angeles, CA USA; [Martin, Martin G.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Martin, MG (corresponding author), Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol & Nutr, Mattel Childrens Hosp, Los Angeles, CA 90024 USA.; Martin, MG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.; Martin, MG (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA.	mmartin@mednet.ucla.edu	Solorzano-Vargas, R Sergio/D-4869-2016; Martín, María/HDL-9512-2022	Dunn, James/0000-0002-6826-7065	Intestinal Stem Cell Consortium - National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases [DK085535]; NIDDK [DK083762, DK083319]; California Institute for Regenerative Medicine [RT2-01985]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085535, R01DK083762, P30DK041301] Funding Source: NIH RePORTER	Intestinal Stem Cell Consortium - National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intestinal Stem Cell Consortium (https://iscc.coh.org), a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases (DK085535); and other grants from NIDDK (DK083762, and DK083319), and the California Institute for Regenerative Medicine (RT2-01985).	AMERONGEN HM, 1992, ANN NY ACAD SCI, V664, P18, DOI 10.1111/j.1749-6632.1992.tb39745.x; AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760; APTER FM, 1993, INFECT IMMUN, V61, P5279, DOI 10.1128/IAI.61.12.5279-5285.1993; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Desai MP, 1996, PHARMACEUT RES, V13, P1838, DOI 10.1023/A:1016085108889; Ermak TH, 1998, ADV DRUG DELIVER REV, V34, P261, DOI 10.1016/S0169-409X(98)00043-X; FANTINI J, 1991, P NATL ACAD SCI USA, V88, P9297, DOI 10.1073/pnas.88.20.9297; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gonzalez-Hernandez MB, 2014, J VIROL, V88, P6934, DOI 10.1128/JVI.00204-14; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; Jabaji Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107814; Jabaji Z, 2013, TISSUE ENG PART C-ME, V19, P961, DOI [10.1089/ten.tec.2012.0710, 10.1089/ten.TEC.2012.0710]; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563; Kobayashi A, 2013, MUCOSAL IMMUNOL, V6, P1027, DOI 10.1038/mi.2012.141; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018083; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Odero-Marah VA, 2008, CELL RES, V18, P858, DOI 10.1038/cr.2008.84; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Tahoun A, 2012, CELL HOST MICROBE, V12, P645, DOI 10.1016/j.chom.2012.10.009; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; WALKER RI, 1988, CAN J MICROBIOL, V34, P1142, DOI 10.1139/m88-201; Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	37	51	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148216	10.1371/journal.pone.0148216	http://dx.doi.org/10.1371/journal.pone.0148216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820624	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400076
J	Stadlbauer, V; Haselgrubler, R; Lanzerstorfer, P; Plochberger, B; Borgmann, D; Jacak, J; Winkler, SM; Schroder, K; Hoglinger, O; Weghuber, J				Stadlbauer, Verena; Haselgruebler, Renate; Lanzerstorfer, Peter; Plochberger, Birgit; Borgmann, Daniela; Jacak, Jaroslaw; Winkler, Stephan M.; Schroeder, Klaus; Hoeglinger, Otmar; Weghuber, Julian			Biomolecular Characterization of Putative Antidiabetic Herbal Extracts	PLOS ONE			English	Article							PORTULACA-OLERACEA L.; HYPOGLYCEMIC ACTIVITY; GLUCOSE-UPTAKE; ADIPOCYTE DIFFERENTIATION; GLUT4 TRANSLOCATION; INSULIN-RESISTANCE; MEDICINAL-PLANTS; CELL-SURFACE; PURSLANE; OBESITY	Induction of GLUT4 translocation in the absence of insulin is considered a key concept to decrease elevated blood glucose levels in diabetics. Due to the lack of pharmaceuticals that specifically increase the uptake of glucose from the blood circuit, application of natural compounds might be an alternative strategy. However, the effects and mechanisms of action remain unknown for many of those substances. For this study we investigated extracts prepared from seven different plants, which have been reported to exhibit anti-diabetic effects, for their GLUT4 translocation inducing properties. Quantitation of GLUT4 translocation was determined by total internal reflection fluorescence (TIRF) microscopy in insulin sensitive CHO-K1 cells and adipocytes. Two extracts prepared from purslane (Portulaca oleracea) and tindora (Coccinia grandis) were found to induce GLUT4 translocation, accompanied by an increase of intracellular glucose concentrations. Our results indicate that the PI3K pathway is mainly responsible for the respective translocation process. Atomic force microscopy was used to prove complete plasma membrane insertion. Furthermore, this approach suggested a compound mediated distribution of GLUT4 molecules in the plasma membrane similar to insulin stimulated conditions. Utilizing a fluorescent actin marker, TIRF measurements indicated an impact of purslane and tindora on actin remodeling as observed in insulin treated cells. Finally, in-ovo experiments suggested a significant reduction of blood glucose levels under tindora and purslane treated conditions in a living organism. In conclusion, this study confirms the anti-diabetic properties of tindora and purslane, which stimulate GLUT4 translocation in an insulin-like manner.	[Stadlbauer, Verena; Haselgruebler, Renate; Lanzerstorfer, Peter; Hoeglinger, Otmar; Weghuber, Julian] Univ Appl Sci Upper Austria, Wels, Austria; [Plochberger, Birgit; Jacak, Jaroslaw] Univ Appl Sci Upper Austria, Linz, Austria; [Borgmann, Daniela; Winkler, Stephan M.] Univ Appl Sci Upper Austria, Hagenberg, Austria; [Schroeder, Klaus] BioMed Zet Life Sci GmbH, Linz, Austria; [Plochberger, Birgit] Vienna Univ Technol, A-1040 Vienna, Austria	Technische Universitat Wien	Weghuber, J (corresponding author), Univ Appl Sci Upper Austria, Wels, Austria.	julian.weghuber@fh-wels.at	Jacak, Jarosław/AAM-9987-2021	Jacak, Jarosław/0000-0002-4989-1276; Lanzerstorfer, Peter/0000-0003-4512-7964	Austrian Research Promotion Agency (FFG) [850681]; University of Applied Sciences Upper Austria Basic Funding initiative; federal state auf Upper Austria; BioMed zet Life Science GmbH	Austrian Research Promotion Agency (FFG); University of Applied Sciences Upper Austria Basic Funding initiative; federal state auf Upper Austria; BioMed zet Life Science GmbH	This work was funded by the Austrian Research Promotion Agency (FFG; project number 850681) and University of Applied Sciences Upper Austria Basic Funding initiative (project GlucoSTAR). BioMed zet Life Science GmbH is funded by the federal state auf Upper Austria. BioMed zet Life Science GmbH provided support in the form of salaries for author KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Almqvist N, 2004, BIOPHYS J, V86, P1753, DOI 10.1016/S0006-3495(04)74243-5; Bouderba S, 2014, J DIABETES, V6, P184, DOI 10.1111/1753-0407.12083; Bunkrongcheap R, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-88; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; El-Sayed MIK, 2011, J ETHNOPHARMACOL, V137, P643, DOI 10.1016/j.jep.2011.06.020; Esmaillzadeh A, 2015, J RES MED SCI, V20, P47; Gu JF, 2015, J ETHNOPHARMACOL, V161, P214, DOI 10.1016/j.jep.2014.12.002; He YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110711; Heyman L, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/403041; Huyen VTT, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/765383; Jacak J, 2015, MICROSC MICROANAL, V21, P826, DOI 10.1017/S1431927615013513; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Jung CH, 2015, NUTRIENTS, V7, P4851, DOI 10.3390/nu7064851; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kar A, 2003, J ETHNOPHARMACOL, V84, P105, DOI 10.1016/S0378-8741(02)00144-7; Kroll DJ, 2007, INTEGR CANCER THER, V6, P110, DOI 10.1177/1534735407301825; Lanzerstorfer P, 2015, FEBS J, V282, P987, DOI 10.1111/febs.13213; Lanzerstorfer P, 2014, BRIT J PHARMACOL, V171, P5237, DOI 10.1111/bph.12845; Lee AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/741824; Lee JO, 2015, J CELL BIOCHEM, V116, P1401, DOI 10.1002/jcb.25100; Li YM, 2012, PLANTA MED, V78, P1549, DOI 10.1055/s-0032-1315041; Lim Chun-Yan, 2014, Bioarchitecture, V4, P210, DOI 10.1080/19490992.2015.1031949; Liu LX, 2000, J CHROMATOGR A, V893, P207, DOI 10.1016/S0021-9673(00)00747-0; Lokman EF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/120572; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Megalli S, 2006, J PHARM PHARM SCI, V9, P281; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Mozaffari-Khosravi H, 2014, COMPLEMENT THER MED, V22, P9, DOI 10.1016/j.ctim.2013.12.017; Munasinghe MAAK, 2011, EXP DIABETES RES, DOI 10.1155/2011/978762; Naowaboot J, 2012, AM J CHINESE MED, V40, P163, DOI 10.1142/S0192415X12500139; Norberg A, 2004, J BIOL CHEM, V279, P41361, DOI 10.1074/jbc.M403435200; OMARAALWALA TR, 1991, J AM OIL CHEM SOC, V68, P198, DOI 10.1007/BF02657769; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P320, DOI 10.1016/S2221-1691(12)60032-X; Prabhakar PK, 2011, THER ADV ENDOCRINOL, V2, P103, DOI 10.1177/2042018811411356; Purintrapiban J, 2006, BIOL PHARM BULL, V29, P1995, DOI 10.1248/bpb.29.1995; Qin ZY, 2012, J BIOENERG BIOMEMBR, V44, P579, DOI 10.1007/s10863-012-9460-1; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SHIBIB BA, 1993, BIOCHEM J, V292, P267, DOI 10.1042/bj2920267; SIMOPOULOS AP, 1992, J AM COLL NUTR, V11, P374; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Stefanut MN, 2013, PLANT FOOD HUM NUTR, V68, P378, DOI 10.1007/s11130-013-0380-y; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Turmelle YP, 2006, FASEB J, V20, P2609, DOI 10.1096/fj.06-6511fje; Ueda M, 2010, FOOD FUNCT, V1, P167, DOI 10.1039/c0fo00105h; Vijayakumar MV, 2010, J BIOSCIENCES, V35, P525, DOI 10.1007/s12038-010-0060-0; Vijayakumar MV, 2005, BRIT J PHARMACOL, V146, P41, DOI 10.1038/sj.bjp.0706312; Weghuber J, 2011, BBA-BIOMEMBRANES, V1808, P2581, DOI 10.1016/j.bbamem.2011.06.007; Yoshiyama Y, 2005, BIOL PHARM BULL, V28, P1986, DOI 10.1248/bpb.28.1986; Zhan TZ, 2011, J CELL BIOCHEM, V112, P849, DOI 10.1002/jcb.22984; Zhang Z, 1993, J SHANXI U NATURAL S, V16, P307; Zidan Y, 2014, PHYTOMEDICINE, V21, P1504, DOI 10.1016/j.phymed.2014.07.010	55	14	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148109	10.1371/journal.pone.0148109	http://dx.doi.org/10.1371/journal.pone.0148109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820984	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528400067
J	Winham, DM; Florian, TLA; Thompson, SV				Winham, Donna M.; Florian, Traci L. Armstrong; Thompson, Sharon V.			Low-Income US Women Under-informed of the Specific Health Benefits of Consuming Beans	PLOS ONE			English	Article							LEGUME CONSUMPTION; DIET QUALITY; GLYCEMIC RESPONSE; HEART-DISEASE; RISK; ACCULTURATION; BEHAVIORS; HISPANICS; ADHERENCE; RICE	Background Bean consumption can reduce chronic disease risk and improve nutrition status. Consumer knowledge of bean health benefits could lead to increased intakes. Low-income women have poorer health and nutrition, but their level of knowledge about bean health benefits is unknown. Beans are a familiar food of reasonable cost in most settings and are cultural staples for Hispanics and other ethnicities. Study objectives were to assess awareness of bean health benefits among low-income women, and to evaluate any differences by acculturation status for Hispanic women in the Southwestern United States. Methods A convenience sample of 406 primarily Mexican-origin (70%) low-income women completed a survey on knowledge of bean health benefits and general food behaviors. Principal components analysis of responses identified two summary scale constructs representing "bean health benefits" and "food behaviors." Acculturation level was the main independent variable in chi-square or ANOVA. Results survey completion rate was 86% (406/471). Most women agreed or strongly agreed that beans improved nutrition (65%) and were satiating (62%). Over 50% answered `neutral' to statements that beans could lower LDL cholesterol (52%), control blood glucose (56%) or reduce cancer risk (56%), indicating indifference or possible lack of knowledge about bean health benefits. There were significant differences by acculturation for beliefs that beans aid weight loss and intestinal health. Scores on the bean health benefits scale, but not the food behavior scale, also differed by acculturation. Conclusions Limited resource women have a favorable view of the nutrition value of beans, but the majority did not agree or disagreed with statements about bean health benefits. Greater efforts to educate low-income women about bean health benefits may increase consumption and improve nutrition.	[Winham, Donna M.] Iowa State Univ, Food Sci & Human Nutr, Ames, IA USA; [Florian, Traci L. Armstrong] Univ Arizona, Cooperat Extens Maricopa Cty, Phoenix, AZ USA; [Thompson, Sharon V.] Univ Illinois, Food Sci & Human Nutr, Urbana, IL USA	Iowa State University; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign	Winham, DM (corresponding author), Iowa State Univ, Food Sci & Human Nutr, Ames, IA USA.	dwinham@iastate.edu	Winham, Donna/B-2091-2014	Winham, Donna/0000-0003-3924-2560	United States Dry Bean Council, Nutrition Science [0020]	United States Dry Bean Council, Nutrition Science	This work was supported by the United States Dry Bean Council, Nutrition Science 0020, http://www.usdrybeans.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizona Department of Health Services, WIC NEEDS ASS; Bazzano LA, 2011, NUTR METAB CARDIOVAS, V21, P94, DOI 10.1016/j.numecd.2009.08.012; Bazzano LA, 2001, ARCH INTERN MED, V161, P2573, DOI 10.1001/archinte.161.21.2573; Beydoun MA, 2008, PREV MED, V46, P145, DOI 10.1016/j.ypmed.2007.06.016; CABAN A, 2008, DIABETES SPECTRUM, V21, P120, DOI DOI 10.2337/DIASPECT.21.2.120; Centers for Disease Control and Prevention, 2011, NAT DIAB FAT SHEET N; Darmadi-Blackberry I, 2004, ASIA PAC J CLIN NUTR, V13, P217; Desrochers N, 2001, CAN J DIET PRACT RES, V62, P193; Field AP, 2010, DISCOVERING STAT USI; Finley JW, 2007, J NUTR, V137, P2391, DOI 10.1093/jn/137.11.2391; Hiza HAB, 2013, J ACAD NUTR DIET, V113, P297, DOI 10.1016/j.jand.2012.08.011; Hutchins AM, 2012, BRIT J NUTR, V108, pS52, DOI 10.1017/S0007114512000761; Jimenez-Cruz A, 2006, NUTR HOSP, V21, P353; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lanza E, 2006, J NUTR, V136, P1896, DOI 10.1093/jn/136.7.1896; Lichtenstein AH, 2002, J LIPID RES, V43, P264; Macartney Suzanne, 2013, AM COMMUNITY SURVEY; Marin G, 1996, HISPANIC J BEHAV SCI, V18, P297, DOI 10.1177/07399863960183002; Martinez AD, 2013, ETHNIC HEALTH, V18, P115, DOI 10.1080/13557858.2012.698254; Mattei J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0109-9; Mattei J, 2014, HEALTH BEHAV POLICY, V1, P38, DOI 10.14485/HBPR.1.1.5; Mattei J, 2011, AM J CLIN NUTR, V94, P869, DOI 10.3945/ajcn.111.013219; Mitchell DC, 2009, J AM DIET ASSOC, V109, P909, DOI 10.1016/j.jada.2009.02.029; Purdue University, 2012, EXP FOOD NUTR ED PRO; Rodriguez CJ, 2014, CIRCULATION, V130, P593, DOI 10.1161/CIR.0000000000000071; Rose D, 2007, J NUTR EDUC BEHAV, V39, P226, DOI 10.1016/j.jneb.2007.04.180; Russell J., 2014, Journal of Nutrition & Intermediary Metabolism, V1, P18, DOI 10.1016/j.jnim.2014.10.059; Rustveld LO, 2009, PATIENT PREFER ADHER, V3, P123; Slawson DL, 2013, J ACAD NUTR DIET, V113, P972, DOI 10.1016/j.jand.2013.05.005; Smith WE, 2005, J AM DIET ASSOC, V105, P404, DOI 10.1016/j.jada.2004.12.005; Thompson SV, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-23; U.S. Department of Agriculture Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; United States Department of Agriculture, 2010, WIC FOOD PACK TIM CH; United States Department of Health and Human Services, 2011, 2011 HHS POV GUID, V72, P3147; [University of Arizona Maricopa County Cooperative Extension], 2011, MAR COUNT SUMM AD PA; *US DEP HHS USDA, 2005, DIET GUID AM; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM; Vijan S, 2005, DIABETIC MED, V22, P32, DOI 10.1111/j.1464-5491.2004.01342.x; Wiig K, 2009, PUBLIC HEALTH NUTR, V12, P1726, DOI 10.1017/S1368980008004102; Winham D., 2008, Nutrition Today, V43, P201, DOI 10.1097/01.NT.0000303354.21347.45; Winham DM, 2007, J AM COLL NUTR, V26, P243, DOI 10.1080/07315724.2007.10719607; Winham DM, 2010, J HUNGER ENVIRON NUT, V5, P498, DOI 10.1080/19320248.2010.527280; Winham DM, 2009, AM J LIFESTYLE MED, V3, p64S, DOI 10.1177/1559827609335552; Zambrana RE, 2001, J HEALTH CARE POOR U, V12, P20	45	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147592	10.1371/journal.pone.0147592	http://dx.doi.org/10.1371/journal.pone.0147592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820889	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400034
J	Zhang, ML; Sun, YH; Chen, LQ; Cai, CF; Qiao, F; Du, ZY; Li, EC				Zhang, Meiling; Sun, Yuhong; Chen, Liqiao; Cai, Chunfang; Qiao, Fang; Du, Zhenyu; Li, Erchao			Symbiotic Bacteria in Gills and Guts of Chinese Mitten Crab (Eriocheir sinensis) Differ from the Free-Living Bacteria in Water	PLOS ONE			English	Article							SP NOV.; MICROBIOTA; COMMUNITIES; FISH; DIVERSITY; DECAPODA; PACIFIC; NUMBER	Aquatic animals have a close relationship with water, but differences in their symbiotic bacteria and the bacterial composition in water remains unclear. Wild or domestic Chinese mitten crabs (Eriocheir sinensis) and the water in which they live were collected from four sampling sites in Jiangsu and Shanghai, China. Bacterial composition in water, gills or guts of E. sinensis, were compared by high-throughput sequencing using 16S rRNA genes. Analysis of >660,000 sequences indicated that bacterial diversity was higher in water than in gills or guts. Tenericutes and Proteobacteria were dominant phyla in guts, while Actinobacteria, Proteobacteria and Bacteroidetes were dominant in gills and water. Non-metric multidimensional scaling analysis indicated that microbiota from gills, guts or water clearly separated into three groups, suggesting that crabs harbor a more specific microbial community than the water in which they live. The dominant OTUs in crab gut were related to Mycoplasmataceae, which were low in abundance in gills, showing that, like mammals, crabs have body-site specific microbiota. OTUs related to Ilumatobacter and Albimonas, which are commonly present in sediment and seawater, were dominant in gills but almost absent from the sampled water. Considering E. sinensis are bottom-dwelling crustacean and they mate in saline water or seawater, behavior and life cycle of crabs may play an important role in shaping the symbiotic bacterial pattern. This study revealed the relationship between the symbiotic bacteria of Chinese mitten crab and their habitat, affording information on the assembly factors of commensal bacteria in aquatic animals.	[Zhang, Meiling; Sun, Yuhong; Chen, Liqiao; Qiao, Fang; Du, Zhenyu; Li, Erchao] E China Normal Univ, Lab Aquaculture Nutr & Environm Hlth, Sch Life Sci, Shanghai 200241, Peoples R China; [Cai, Chunfang] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China	East China Normal University; Soochow University - China	Zhang, ML; Li, EC (corresponding author), E China Normal Univ, Lab Aquaculture Nutr & Environm Hlth, Sch Life Sci, Shanghai 200241, Peoples R China.	mlzhang@bio.ecnu.edu.cn; ecli@bio.ecnu.edu.cn	Zhang, Meiling/AEQ-4299-2022	Chen, Liqiao/0000-0003-0138-7828; LI, Erchao/0000-0001-8495-2241; Du, Zhen-Yu/0000-0001-6581-5313	Special Fund for Agro-scientific Research in the Public Interest [201003020, 201203065]; National Natural Science Foundation of China [31472291, 31172422]; National 'Twelfth Five-Year' Plan for Science & Technology Support [2012BAD25B03]; National Basic Research Program (973Program) [2014CB138803]; Shanghai Technology System for Chinese Mitten-handed Crab Industry; Shanghai University Knowledge Service Platform Shanghai Ocean University Aquatic Animal Breeding Center [ZF1206]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 'Twelfth Five-Year' Plan for Science & Technology Support; National Basic Research Program (973Program)(National Basic Research Program of China); Shanghai Technology System for Chinese Mitten-handed Crab Industry; Shanghai University Knowledge Service Platform Shanghai Ocean University Aquatic Animal Breeding Center	This research was supported by grants from the Special Fund for Agro-scientific Research in the Public Interest (Nos. 201003020, 201203065), the National Natural Science Foundation of China (Nos. 31472291, 31172422), the National 'Twelfth Five-Year' Plan for Science & Technology Support (2012BAD25B03), the National Basic Research Program (973Program, No. 2014CB138803), Shanghai Technology System for Chinese Mitten-handed Crab Industry, and Shanghai University Knowledge Service Platform Shanghai Ocean University Aquatic Animal Breeding Center (ZF1206).	Bakke I, 2015, ENVIRON MICROBIOL, V17, P3914, DOI 10.1111/1462-2920.12888; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chen XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123990; Dittel AI, 2009, J EXP MAR BIOL ECOL, V374, P79, DOI 10.1016/j.jembe.2009.04.012; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Goffredi SK, 2014, MOL ECOL, V23, P1457, DOI 10.1111/mec.12439; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Larsen A, 2013, FEMS MICROBIOL ECOL, V85, P483, DOI 10.1111/1574-6941.12136; Leone FA, 2015, COMP BIOCHEM PHYS B, V186, P59, DOI 10.1016/j.cbpb.2015.04.010; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li GW, 2013, INT J SYST EVOL MICR, V63, P3597, DOI 10.1099/ijs.0.049742-0; Matsumoto A, 2013, INT J SYST EVOL MICR, V63, P3404, DOI 10.1099/ijs.0.047316-0; Meisterhans G, 2016, MICROB ECOL, V71, P194, DOI 10.1007/s00248-015-0662-z; Miyake S, 2015, MOL ECOL, V24, P656, DOI 10.1111/mec.13050; Mouchet MA, 2012, FEMS MICROBIOL ECOL, V79, P568, DOI 10.1111/j.1574-6941.2011.01241.x; O'Connor RM, 2014, P NATL ACAD SCI USA, V111, pE5096, DOI 10.1073/pnas.1413110111; Rudnick D, 2005, BIOL INVASIONS, V7, P333, DOI 10.1007/s10530-004-2286-y; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Tan SJ, 2015, FISH SHELLFISH IMMUN, V43, P264, DOI 10.1016/j.fsi.2014.12.034; Wei YM, 2015, ENVIRON SCI POLLUT R, V22, P12605, DOI 10.1007/s11356-015-4534-3; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181; Zhang ML, 2014, AQUACULTURE, V434, P449, DOI 10.1016/j.aquaculture.2014.09.008	34	60	65	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148135	10.1371/journal.pone.0148135	http://dx.doi.org/10.1371/journal.pone.0148135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820139	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528400072
J	Zhang, YN; Vernooij, F; Ibrahim, I; Ooi, S; Gijsberts, CM; Schoneveld, AH; Sen, KW; den Ruijter, HM; Timmers, L; Richards, AM; Jong, CT; Mazlan, I; Wang, JW; Lam, CSP; de Kleijn, DPV				Zhang, Ya-Nan; Vernooij, Flora; Ibrahim, Irwani; Ooi, Shirley; Gijsberts, Crystel M.; Schoneveld, Arjan H.; Sen, Kuan Win; den Ruijter, Hester M.; Timmers, Leo; Richards, Arthur Mark; Jong, Chun Tzen; Mazlan, Ibrahim; Wang, Jiong-Wei; Lam, Carolyn S. P.; de Kleijn, Dominique P. V.			Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; MYOCARDIAL-INFARCTION; ENDOTHELIAL MICROPARTICLES; CARDIOVASCULAR EVENTS; C1 INHIBITOR; CYSTATIN-C; DYSFUNCTION; DISEASE; RISK; DIAGNOSIS	Background SerpinF2, SerpinG1, CystatinC and CD14 are involved in inflammatory processes and plasma extracellular vesicle (EV) -levels of these proteins have been reported to be associated with systemic vascular events. Evidence is accumulating that inflammatory processes may play a pivotal role both in systemic vascular events and in heart failure. Therefore, we studied the association between plasma extracellular vesicle SerpinF2-, SerpinG1-, CystatinC and CD14-levels and the occurrence of acute heart failure in patients. Methods and Result Extracellular vesicle protein levels of SerpinG1, SerpinF2, CystatinC and CD14 were measured in an observational study of 404 subjects presenting with dysponea at the emergency department (4B-cohort). Plasma extracellular vesicles were precipitated in a total extracellular vesicles (TEX)-fraction and in separate LDL- and HDL-subfractions. Extracellular vesicle protein levels were measured with a quantitative immune assay in all 3 precipitates. Out of 404 subjects, 141 (35%) were diagnosed with acutely decompensated heart failure. After correction for confounders (including comorbidities and medications), levels of CD14 in the HDL-fraction (OR 1.53, p = 0.01), SerpinF2 in the TEX-and LDL-fraction (ORs respectively 0.71 and 0.65, p<0.05) and SerpinG1 in the TEX-fraction (OR 1.55, p = 0.004) were statistically significantly related to heart failure. Furthermore, extracellular vesicle CD14- and SerpinF2-levels were significantly higher in heart failure patients with preserved ejection fraction than in those with reduced ejection fraction. Conclusion Extracellular vesicle levels of CD14, SerpinG1 and SerpinF2 are associated with the occurrence of heart failure in subjects suspected for acute heart failure, suggesting common underlying pathophysiological mechanisms for heart failure and vascular events.	[Zhang, Ya-Nan; Vernooij, Flora; Gijsberts, Crystel M.; Jong, Chun Tzen; Mazlan, Ibrahim; Wang, Jiong-Wei; de Kleijn, Dominique P. V.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117548, Singapore; [Zhang, Ya-Nan; Vernooij, Flora; Richards, Arthur Mark; Jong, Chun Tzen; Mazlan, Ibrahim; Wang, Jiong-Wei; de Kleijn, Dominique P. V.] Natl Univ Heart Ctr Singapore, Cardiovasc Res Inst, Singapore, Singapore; [Zhang, Ya-Nan; Vernooij, Flora; Richards, Arthur Mark; Jong, Chun Tzen; Mazlan, Ibrahim; Wang, Jiong-Wei; de Kleijn, Dominique P. V.] Natl Univ Hlth Syst Singapore, Singapore, Singapore; [Ibrahim, Irwani; Ooi, Shirley; Sen, Kuan Win] Natl Univ Hlth Syst, Dept Emergency Med, Singapore, Singapore; [Gijsberts, Crystel M.; Schoneveld, Arjan H.; den Ruijter, Hester M.; Timmers, Leo; de Kleijn, Dominique P. V.] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Timmers, Leo; de Kleijn, Dominique P. V.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Richards, Arthur Mark] Univ Otago, Christchurch Heart Inst, Christchurch, New Zealand; [Lam, Carolyn S. P.] Duke Natl Univ Singapore, Singapore Gen Hosp, Natl Heart Ctr Singapore, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Otago; National Heart Centre Singapore; National University of Singapore; Singapore General Hospital	de Kleijn, DPV (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117548, Singapore.; de Kleijn, DPV (corresponding author), Natl Univ Heart Ctr Singapore, Cardiovasc Res Inst, Singapore, Singapore.; de Kleijn, DPV (corresponding author), Natl Univ Hlth Syst Singapore, Singapore, Singapore.; de Kleijn, DPV (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.; de Kleijn, DPV (corresponding author), Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands.	surdvp@nus.edu.sg	Lam, Carolyn SP/ABD-6810-2021; Wang, Jiong-Wei/AAW-9118-2021; Kuan, Win Sen/I-7684-2018	Lam, Carolyn SP/0000-0003-1903-0018; Wang, Jiong-Wei/0000-0001-7986-6082; Kuan, Win Sen/0000-0002-2134-7842; BIN MAZLAN, Stephane Muhammad Ibrahim/0000-0002-7636-8456; den Ruijter, Hester/0000-0001-9762-014X; Ibrahim, Irwani/0000-0001-6831-8742	National University of Singapore; National Medical Research Council Centre; Queen of Hearts program Dutch Heart Foundation [2013T084]; National Medical Research Council CS-IRG; ATTRaCT SPF grant; KNAW strategic grant	National University of Singapore(National University of Singapore); National Medical Research Council Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Queen of Hearts program Dutch Heart Foundation; National Medical Research Council CS-IRG(National Medical Research Council, Singapore); ATTRaCT SPF grant; KNAW strategic grant	This study is partly supported by a start up grant National University of Singapore to Dominique PV de Kleijn; National Medical Research Council Centre Grant (http://www.nmrc.gov.sg/content/nmrc_internet/home.html) to Dominique PV de Kleijn, Arthur Mark Richards, Carolyn SP Lam; Queen of Hearts program Dutch Heart Foundation (https://www.hartstichting.nl/) 2013T084 to Hester M den Ruijter and Dominique PV de Kleijn; National Medical Research Council CS-IRG (http://www.nmrc.gov.sg/content/nmrc_internet/home/grant/compgrants/irg11.html) to Carolyn SP Lam and Dominique PV de Kleijn; ATTRaCT SPF grant (http://www.a-star.edu.sg/Awards-Scholarship/Overview.aspx) to Arthur Mark Richards, Dominique PV de Kleijn, Carolyn SP Lam; KNAW strategic grant (https://www.knaw.nl/en) to Dominique PV de Kleijn.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Allaire J, 2011, R US C USER 2011 AUG; Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Anker SD, 1997, AM J CARDIOL, V79, P1426, DOI 10.1016/S0002-9149(97)00159-8; [Anonymous], 1970, RAPID METHOD ISOLATI; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Beemath A, 2006, AM J CARDIOL, V98, P793, DOI 10.1016/j.amjcard.2006.03.064; Berezin AE, 2014, INT CARDIOVASC RES J, V8, P116; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; Hoog VC, 2013, EUR HEART J-ACUTE CA, V2, P53, DOI 10.1177/2048872612471212; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Emmens RW, 2016, CARDIOVASC PATHOL, V25, P33, DOI 10.1016/j.carpath.2015.09.006; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; FRANCIS RB, 1985, NEPHRON, V39, P325; Gijsberts CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132278; Glezeva N, 2015, J CARD FAIL, V21, P167, DOI 10.1016/j.cardfail.2014.11.004; Grodin JL, 2015, AM J MED, V128, P276, DOI 10.1016/j.amjmed.2014.09.029; Hubacek JA, 1999, CIRCULATION; Kanhai D, 2013, ADIPOSITY ADIPOCYTOK, V115; Kanhai DA, 2013, INT J CARDIOL, V168, P2358, DOI 10.1016/j.ijcard.2013.01.231; Kruger Stefan, 2005, Eur J Intern Med, V16, P345, DOI 10.1016/j.ejim.2005.01.010; Lam CSP, 2011, CIRCULATION, V124, P24, DOI 10.1161/CIRCULATIONAHA.110.979203; Lonez C, 2015, CELL MOL LIFE SCI, V72, P3971, DOI 10.1007/s00018-015-1915-1; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lu FX, 2013, CARDIOVASC PATHOL, V22, P75, DOI 10.1016/j.carpath.2012.05.003; Lu WB, 2015, INT HEART J, V56, P22, DOI 10.1536/ihj.14-174; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Matsuno H, 2002, BLOOD, V100, P2487, DOI 10.1182/blood-2001-12-0251; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Nozaki T, 2010, EUR J HEART FAIL, V12, P1223, DOI 10.1093/eurjhf/hfq145; Nozaki T, 2009, J AM COLL CARDIOL, V54, P601, DOI 10.1016/j.jacc.2009.05.022; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; RCore Team, 2020, R LANG ENV STAT COMP; Richards M, 2013, JACC-HEART FAIL, V1, P192, DOI 10.1016/j.jchf.2013.02.004; Schuliga M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/437695; Shah RV, 2012, AM HEART J, V164, P862, DOI 10.1016/j.ahj.2012.08.019; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Timmers L, 2009, CIRC RES, V104, P699, DOI 10.1161/CIRCRESAHA.108.189746; Travaglino F, 2014, AM J EMERG MED, V32, P334, DOI 10.1016/j.ajem.2013.12.045; Tschope C, 2012, HERZ, V37, P875, DOI 10.1007/s00059-012-3719-5; Wang JW, 2013, NETH HEART J, V21, P467, DOI 10.1007/s12471-013-0462-3; World Health Organization, 2011, SER FERR CONC ASS IR; Yeo TJ, 2014, EUR J HEART FAIL, V16, P1125, DOI 10.1002/ejhf.161; Zhang J, 2008, BIOCHEM BIOPH RES CO, V366, P579, DOI 10.1016/j.bbrc.2007.12.011	51	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148073	10.1371/journal.pone.0148073	http://dx.doi.org/10.1371/journal.pone.0148073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820481	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400063
J	Davis, MA; Douglas, MR; Collyer, ML; Douglas, ME				Davis, Mark A.; Douglas, Marlis R.; Collyer, Michael L.; Douglas, Michael E.			Deconstructing a Species-Complex: Geometric Morphometric and Molecular Analyses Define Species in the Western Rattlesnake (Crotalus viridis)	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; CHARACTER DISPLACEMENT; NEOGENE VICARIANCE; SEXUAL-DIMORPHISM; MORPHOLOGY; SHAPE; DIVERGENCE; EVOLUTION; DIVERSIFICATION; VIPERIDAE	Morphological data are a conduit for the recognition and description of species, and their acquisition has recently been broadened by geometric morphometric (GM) approaches that co-join the collection of digital data with exploratory 'big data' analytics. We employed this approach to dissect the Western Rattlesnake (Crotalus viridis) species-complex in North America, currently partitioned by mitochondrial (mt) DNA analyses into eastern and western lineages (two and seven subspecies, respectively). The GM data (i.e., 33 dorsal and 50 lateral head landmarks) were gleaned from 2,824 individuals located in 10 museum collections. We also downloaded and concatenated sequences for six mtDNA genes from the NCBI GenBank database. GM analyses revealed significant head shape differences attributable to size and subspecies-designation (but not their interactions). Pairwise shape distances among subspecies were significantly greater than those derived from ancestral character states via squared-change parsimony, with the greatest differences separating those most closely related. This, in turn, suggests the potential for historic character displacement as a diversifying force in the complex. All subspecies, save one, were significantly differentiated in a Bayesian discriminant function analysis (DFA), regardless of whether our priors were uniform or informative (i.e., mtDNA data). Finally, shape differences among sister-clades were significantly greater than expected by chance alone under a Brownian model of evolution, promoting the hypothesis that selection rather than drift was the driving force in the evolution of the complex. Lastly, we combine head shape and mtDNA data so as to derived an integrative taxonomy that produced robust boundaries for six OTUs (operational taxonomic units) of the C. viridis complex. We suggest these boundaries are concomitant with species-status and subsequently provide a relevant nomenclature for its recognition and representation.	[Davis, Mark A.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Douglas, Marlis R.; Douglas, Michael E.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Collyer, Michael L.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Arkansas System; University of Arkansas Fayetteville; Western Kentucky University	Davis, MA (corresponding author), Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	davis63@illinois.edu	Douglas, Michael/T-1761-2019	Davis, Mark/0000-0001-9034-9430; Douglas, Michael/0000-0001-9670-7825				Adams DC, 1999, EVOL ECOL RES, V1, P959; Adams DC, 2015, EVOLUTION, V69, P823, DOI 10.1111/evo.12596; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Anderson CG, 2012, HERPETOL MONOGR, V26, P19, DOI 10.1655/HERPMONOGRAPHS-D-11-00012.1; Ashton KG, 2001, MOL PHYLOGENET EVOL, V21, P176, DOI 10.1006/mpev.2001.1013; Avise J, 2004, MOL MARKERS NATURAL; Barlow KE, 1997, P ROY SOC B-BIOL SCI, V264, P1695, DOI 10.1098/rspb.1997.0235; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Bookstein FL, 1996, PROCEEDINGS OF THE IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, P279, DOI 10.1109/MMBIA.1996.534080; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bookstein FL, 1997, 1997 INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, PROCEEDINGS, P110, DOI 10.1109/SMA.1997.634888; Bookstein FL, 1997, LECT NOTES COMPUTER, V1230, p[33, 15]; BRATTSTROM BH, 1967, COPEIA, P188; Bryson RW, 2012, MOL PHYLOGENET EVOL, V62, P447, DOI 10.1016/j.ympev.2011.10.014; Charlesworth D, 2010, HEREDITY, V105, P509, DOI 10.1038/hdy.2010.14; Collyer ML, 2015, HEREDITY, V115, P357, DOI 10.1038/hdy.2014.75; Corlett RT, 2015, TRENDS ECOL EVOL, V30, P36, DOI 10.1016/j.tree.2014.10.007; Coyne J.A., 2004, SPECIATION; Crother BI, 2012, HERPETOLOGICAL CIRCU, P1; Davis M, 2012, THESIS U ILLINOIS UR; Davis MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131067; Douglas ME, 2007, COPEIA, P920, DOI 10.1643/0045-8511(2007)7[920:GCBMAN]2.0.CO;2; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Douglas Michael E., 2002, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst C.H., 2003, SNAKES US CANADA; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Giribet G, 2010, ACTA ZOOL-STOCKHOLM, V91, P11, DOI 10.1111/j.1463-6395.2009.00420.x; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grismer L. Lee, 2001, Bulletin Southern California Academy of Sciences, V100, P12; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hampton PM, 2013, J MORPHOL, V247, P194, DOI [10.1002/jmor.20087, DOI 10.1002/JM0R.20087]; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Henderson RW, 2013, BIOL J LINN SOC, V109, P466, DOI 10.1111/bij.12052; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Holman, 2000, FOSSIL SNAKES N AM O; Holycross AT, 2007, BIOL CONSERV, V134, P142, DOI 10.1016/j.biocon.2006.07.020; Hopken MW, 2013, MOL ECOL, V22, P956, DOI 10.1111/mec.12156; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Kaliontzopoulou A, 2008, BIOL J LINN SOC, V93, P111; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; KLAUBER LAURENCE M., 1935, TRANS SUN DIEGO SOC NAT HIST, V8, P75; Klauber LM, 1949, T SAN DIEGO SOC NAT, V11, P161; Klauber LM, 1956, RATTLESNAKES THEIR H; Kozak KH, 2005, EVOLUTION, V59, P2000; Lamar W.W., 2004, VENOMOUS REPTILES W, VII; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Mallet J, 2001, J EVOLUTION BIOL, V14, P887, DOI 10.1046/j.1420-9101.2001.00342.x; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Margres MJ, 2015, MOL ECOL, V24, P3405, DOI 10.1111/mec.13240; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Martins EP, 1999, AM NAT, V153, P448, DOI 10.1086/303188; Meik JM, 2012, BIOL J LINN SOC, V106, P633, DOI 10.1111/j.1095-8312.2012.01881.x; Nenadic O, 2003, BARC INT C CORR AN R; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pante E, 2015, SYST BIOL, V64, P152, DOI 10.1093/sysbio/syu083; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PATTERSON C, 1993, ANNU REV ECOL SYST, V24, P153; Perkins SL, 2011, PARASITOLOGY, V138, P1664, DOI 10.1017/S0031182011000679; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Pook CE, 2000, MOL PHYLOGENET EVOL, V15, P269, DOI 10.1006/mpev.1999.0756; Quinn HR, 1987, THESIS U HOUSTON; R Core Team, 2019, R LANG ENV STAT COMP; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rohlf FJ., 2002, MORPHOLOGY SHAPE PHY; Rohlf FJ., 2006, TPSDIG VERSION 2 10; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruane S, 2015, ZOOL J LINN SOC-LOND, V174, P394, DOI 10.1111/zoj.12245; Runemark A, 2015, ECOLOGY, V96, P2077, DOI 10.1890/14-1996.1; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schroer K, 2015, EVOLUTION, V69, P1630, DOI 10.1111/evo.12672; SHINE R, 1991, AM NAT, V138, P103, DOI 10.1086/285207; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 1997, CONSERV BIOL, V11, P1289, DOI 10.1046/j.1523-1739.1997.96254.x; Stebbins R.C., 1985, FIELD GUIDE W REPTIL, V2nd; Sullivan BK, 2014, COPEIA, P519, DOI 10.1643/CG-13-140; Thompson D. W., 1917, GROWTH FORM; Vincent SE, 2009, J EVOLUTION BIOL, V22, P1203, DOI 10.1111/j.1420-9101.2009.01739.x; Vincent SE, 2004, J ZOOL, V264, P53, DOI 10.1017/S0952836904005503; WILLIAMS BK, 1983, ECOLOGY, V64, P1283, DOI 10.2307/1937836; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	94	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2016	11	1							e0146166	10.1371/journal.pone.0146166	http://dx.doi.org/10.1371/journal.pone.0146166			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GD	26816132	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528200009
J	Black, C; Collen, B; Johnston, D; Hart, T				Black, Caitlin; Collen, Ben; Johnston, Daniel; Hart, Tom			Why Huddle? Ecological Drivers of Chick Aggregations in Gentoo Penguins, Pygoscelis papua, across Latitudes	PLOS ONE			English	Article								Aggregations of young animals are common in a range of endothermic and ectothermic species, yet the adaptive behavior may depend on social circumstance and local conditions. In penguins, many species form aggregations (aka. creches) for a variety of purposes, whilst others have never been observed exhibiting this behavior. Those that do form aggregations do so for three known benefits: 1) reduced thermoregulatory requirements, 2) avoidance of unrelated-adult aggression, and 3) lower predation risk. In gentoo penguins, Pygoscelis papua, chick aggregations are known to form during the post-guard period, yet the cause of these aggregations is poorly understood. Here, for the first time, we study aggregation behavior in gentoo penguins, examining four study sites along a latitudinal gradient using time-lapse cameras to examine the adaptive benefit of aggregations to chicks. Our results support the idea that aggregations of gentoo chicks decrease an individual's energetic expenditure when wet, cold conditions are present. However, we found significant differences in aggregation behavior between the lowest latitude site, Maiviken, South Georgia, and two of the higher latitude sites on the Antarctic Peninsula, suggesting this behavior may be colony specific. We provide strong evidence that more chicks aggregate and a larger number of aggregations occur on South Georgia, while the opposite occurs at Petermann Island in Antarctica. Future studies should evaluate multiple seabird colonies within one species before generalizing behaviors based on one location, and past studies may need to be re-evaluated to determine whether chick aggregation and other behaviors are in fact exhibited species-wide.	[Black, Caitlin; Hart, Tom] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Collen, Ben] UCL, Ctr Biodivers & Environm Res, London, England; [Johnston, Daniel] British Antarctic Survey, King Edward Point Res Stn, London, England	University of Oxford; University of London; University College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Black, C (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	caitlin.black@lincoln.ox.ac.uk	Collen, Ben/F-2543-2016	Collen, Ben/0000-0003-2564-4243; Black, Caitlin/0000-0001-9591-3571	Darwin Initiative [DPLUS002]; Foreign and Commonwealth Office; Quark Expeditions Ltd.; Exodus Travel Ltd.; Natural Environment Research Council [bas010011] Funding Source: researchfish; NERC [bas010011] Funding Source: UKRI	Darwin Initiative; Foreign and Commonwealth Office; Quark Expeditions Ltd.; Exodus Travel Ltd.; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Darwin Initiative (DPLUS002; https://www.gov.uk/government/groups/the-darwin-initiative) awarded to TH and BC, the Foreign and Commonwealth Office (https://www.gov.uk/government/organisations/foreign-commonwealth-office), Quark Expeditions Ltd., (http://www.quarkexpeditions.com/en), and Exodus Travel Ltd., (www.exodustravels.com) awarded to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Aytar Y., 2012, ANNOTATION TOOL; Barbosa A, 2007, POLAR BIOL, V30, P1239, DOI 10.1007/s00300-007-0284-0; Barbosa A, 2012, POLAR BIOL, V35, P725, DOI 10.1007/s00300-011-1117-8; Barbosa A, 2011, POLAR BIOL, V34, P1621, DOI 10.1007/s00300-011-1000-7; BARRE H, 1984, J COMP PHYSIOL, V154, P317, DOI 10.1007/BF02464413; BEAL KG, 1978, AUK, V95, P195; Bost C.-A., 1990, P85; BOST CA, 1991, IBIS, V133, P14, DOI 10.1111/j.1474-919X.1991.tb04804.x; Chesalin M, 2009, MARINE ECOLOGICAL J, VVIII, P5; DAVIS LS, 1982, NEW ZEAL J ZOOL, V9, P279, DOI 10.1080/03014223.1982.10423856; de Leon A, 2002, POLAR BIOL, V25, P355, DOI 10.1007/s00300-001-0350-y; EVANS RM, 1984, CAN J ZOOL, V62, P814, DOI 10.1139/z84-118; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Janes DN, 1997, PHYSIOL ZOOL, V70, P237, DOI 10.1086/639586; Lawless RM, 2001, J THERM BIOL, V26, P555, DOI 10.1016/S0306-4565(00)00049-8; Le Bohec C, 2005, ANIM BEHAV, V70, P527, DOI 10.1016/j.anbehav.2004.11.012; Lowen J., 2011, ANTARCTIC WILDLIFE V; Lynch HJ, 2010, POLAR BIOL, V33, P493, DOI 10.1007/s00300-009-0726-y; Lynch Heather J., 2008, Marine Ornithology, V36, P83; Martin J, 2006, BEHAV ECOL SOCIOBIOL, V60, P778, DOI 10.1007/s00265-006-0221-1; MESERVEY WR, 1976, AUK, V93, P177; Newbery KB, 2009, COLD REG SCI TECHNOL, V55, P47, DOI 10.1016/j.coldregions.2008.06.001; Penney R. L., 1968, Antarctic Research Series Washington, V12, P83; Penteriani V, 2003, POLAR BIOL, V26, P538, DOI 10.1007/s00300-003-0517-9; Pettingill Jr O. S., 1960, WILSON B, V72, P212; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; R Core Development Team, 2013, R LANG ENV STAT COMP; SEDDON PJ, 1991, AUK, V108, P548, DOI 10.2307/4088094; SMITH SM, 1972, CONDOR, V74, P478, DOI 10.2307/1365903; TAYLOR JRE, 1985, J COMP PHYSIOL B, V155, P615, DOI 10.1007/BF00694453; Trathan PN, 2008, BIOL CONSERV, V141, P3019, DOI 10.1016/j.biocon.2008.09.006; van Heezik Y, 1992, J FIELD ORNITHOL, P90; Venables WN., 2002, MODERN APPL STAT S 4; WILLIAMS TD, 1991, POLAR BIOL, V11, P197; Wilson D, 2009, AUK, V126, P688, DOI 10.1525/auk.2009.9709	36	17	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0145676	10.1371/journal.pone.0145676	http://dx.doi.org/10.1371/journal.pone.0145676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840252	Green Published, gold, Green Accepted			2022-12-27	WOS:000369550200002
J	Lv, X; Xia, L; Ge, DY; Wen, ZX; Qu, YH; Lu, L; Yang, QS				Lv, Xue; Xia, Lin; Ge, Deyan; Wen, Zhixin; Qu, Yanhua; Lu, Liang; Yang, Qisen			Continental Refugium in the Mongolian Plateau during Quaternary Glacial Oscillations: Phylogeography and Niche Modelling of the Endemic Desert Hamster, Phodopus roborovskii	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION; MOLECULAR PHYLOGENY; CYTOCHROME-B; CLIMATE; DIVERSIFICATION; EVOLUTION; SEQUENCE; NEUTRALITY; DIVERSITY; INFERENCE	The Mongolian Plateau (MP), which is situated in the interior of Asia and possesses a typical continental climate, experienced harsh climatic conditions during the Quaternary glacial fluctuations. Although these events likely had huge impacts on the local animal populations, the current effects have hardly been explored. To investigate whether the MP supported a refugium along an oceanic-continental gradient (ROCG), and whether this refugium was glacial or interglacial, we investigated the demographic and phylogeographic history of an endemic mammal species, the desert hamster Phodopus roborovskii. We reconstructed the demographic variation, the phylogeographic diffusion, and modelled the potential habitat during historical periods. The genetic diversity in the MP was the highest among all the localities, and the MP was a suitable habitat throughout the modelled historical periods. A phylogeographic diffusion analysis emphasized the importance of the MP as the centre of origin, preservation and spread for P. roborovskii. The homogeneous landscape provided the opportunity for a wide gene flow, which resulted in low resolution of the phylogenetic relationships. Moreover, P. roborovskii was favoured by the interglacial condition, with both its demographical and geographical ranges expanded within the interglacial periods. The range variation from the Last Glacial Maximum to the current condition reflects a distinct longitudinal shift, while both ranges largely contracted from that of the Last Interglacial. Our results support that the MP served as a refugium and spread centre for P. roborovskii during the Quaternary climate fluctuations. The interglacial expansion and the longitudinal shifts highlighted the important effects of precipitations on the distribution range of species adapted to arid and semi-arid during glacial oscillations.	[Lv, Xue; Xia, Lin; Ge, Deyan; Wen, Zhixin; Qu, Yanhua; Yang, Qisen] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Lv, Xue] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Lu, Liang] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Yang, QS (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China.	yangqs@ioz.ac.cn	Ge, Deyan/AAU-7240-2020; 葛, 德燕/ABB-3018-2021	Wen, Zhixin/0000-0002-8300-4845; Ge, Deyan/0000-0001-8230-8647	Natural Science Foundation of China [31372177]; Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences [Y352D81405]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences	The work was supported by the following: Natural Science Foundation of China (http://www.nsfc.gov.cn): 31372177; and the Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences (http://www.anisys.ioz.cas.cn/): Y352D81405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bao WD, 2002, FOLIA ZOOL, V51, P9; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bouckaert RR, 2015, PHYLOGEOGRAPHY DIFFU; Chen, 1997, QUAT SCI, V2, P158; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Drummond AJ, 2012, BAYESIAN INFERENCE S, P1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FLINT V. E., 1961, BYULL MOSKOV OBSHCHESTVA ISPYTAT PRIRODY OTDEL BIOL, V66, P57; Fu YX, 1997, GENETICS, V147, P915; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Guo P, 2011, J BIOGEOGR, V38, P2326, DOI 10.1111/j.1365-2699.2011.02566.x; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, IUCN RED LIST THREAT; Jin LY, 2012, CLIM DYNAM, V38, P1577, DOI 10.1007/s00382-011-1086-1; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lanier HC, 2013, J BIOGEOGR, V40, P466, DOI 10.1111/jbi.12035; Lascoux M, 2010, MOL ECOL, V19, P1075, DOI 10.1111/j.1365-294X.2010.04547.x; Lebedev VS, 2007, ZOOL SCR, V36, P547, DOI 10.1111/j.1463-6409.2007.00300.x; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li Y, 2012, PALAEOGEOGR PALAEOCL, V365, P263, DOI 10.1016/j.palaeo.2012.09.032; Lu HY, 2013, CHINESE SCI BULL, V58, P2775, DOI 10.1007/s11434-013-5919-7; MADDISON DR, 2000, MACCLADE 4; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Martinez-Freiria F, 2015, DIVERS DISTRIB, V21, P331, DOI 10.1111/ddi.12265; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Mescherskii IG, 2011, BIOL BULL+, V38, P82, DOI 10.1134/S1062359011010080; Meschersky IG, 2012, PHYLOGEOGRAPHY UNPUB; Meshchersky I G, 2009, Dokl Biol Sci, V424, P35; Neumann K, 2006, MOL PHYLOGENET EVOL, V39, P135, DOI 10.1016/j.ympev.2006.01.010; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Qu YH, 2005, MOL ECOL, V14, P1767, DOI 10.1111/j.1365-294X.2005.02528.x; Rambaut A, 2007, TRACER V 1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ricanova S, 2013, MOL ECOL, V22, P4256, DOI 10.1111/mec.12382; Ross Patricia D., 1994, Mammalian Species, V459, P1; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sakka H, 2010, BIOL J LINN SOC, V100, P797, DOI 10.1111/j.1095-8312.2010.01477.x; Shan WJ, 2011, CHINESE SCI BULL, V56, P1370, DOI 10.1007/s11434-011-4460-9; Shi CM, 2013, MOL ECOL, V22, P1700, DOI 10.1111/mec.12205; Shi YF, 2009, ANN GLACIOL, V50, P1, DOI 10.3189/172756410790595831; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Su ZH, 2013, BIOL J LINN SOC, V109, P757, DOI 10.1111/bij.12088; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang LZ, 2010, J BIOGEOGR, V37, P657, DOI 10.1111/j.1365-2699.2009.02232.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang L, 2012, QUATERNARY SCI REV, V32, P131, DOI 10.1016/j.quascirev.2011.11.003; Wang W, 2013, EARTH-SCI REV, V122, P38, DOI 10.1016/j.earscirev.2013.03.005; Wang WJ, 2013, J BIOGEOGR, V40, P1156, DOI 10.1111/jbi.12055; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wiens JJ, 2013, EVOLUTION, V67, P1715, DOI 10.1111/evo.12053; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yi CL, 2005, QUATERNARY SCI, V05, P609; Zhang QA, 2010, MOL PHYLOGENET EVOL, V57, P1091, DOI 10.1016/j.ympev.2010.10.003	66	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148182	10.1371/journal.pone.0148182	http://dx.doi.org/10.1371/journal.pone.0148182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839955	gold, Green Published, Green Submitted			2022-12-27	WOS:000369550200091
J	Tagliarolo, M; McQuaid, CD				Tagliarolo, Morgana; McQuaid, Christopher D.			Field Measurements Indicate Unexpected, Serious Underestimation of Mussel Heart Rates and Thermal Tolerance by Laboratory Studies	PLOS ONE			English	Article							IN-SITU; PERNA-PERNA; INTERTIDAL MUSSELS; BODY TEMPERATURES; GENETIC-STRUCTURE; CARDIAC ACTIVITY; CARCINUS-MAENAS; WAVE EXPOSURE; PHYSIOLOGY; ECOLOGY	Attempts to predict the response of species to long-term environmental change are generally based on extrapolations from laboratory experiments that inevitably simplify the complex interacting effects that occur in the field. We recorded heart rates of two genetic lineages of the brown mussel Perna perna over a full tidal cycle in-situ at two different sites in order to evaluate the cardiac responses of the two genetic lineages present on the South African coast to temperature and the immersion/ emersion cycle. "Robomussel" temperature loggers were used to monitor thermal conditions at the two sites over one year. Comparison with live animals showed that robomussels provided a good estimate of mussel body temperatures. A significant difference in estimated body temperatures was observed between the sites and the results showed that, under natural conditions, temperatures regularly approach or exceed the thermal limits of P. perna identified in the laboratory. The two P. perna lineages showed similar tidal and diel patterns of heart rate, with higher cardiac activity during daytime immersion and minimal values during daytime emersion. Comparison of the heart rates measured in the field with data previously measured in the laboratory indicates that laboratory results seriously underestimate heart rate activity, by as much as 75%, especially during immersion. Unexpectedly, field estimates of body temperatures indicated an ability to tolerate temperatures considered lethal on the basis of laboratory measurements. This suggests that the interaction of abiotic conditions in the field does not necessarily raise vulnerability to high temperatures.	[Tagliarolo, Morgana; McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Tagliarolo, Morgana] Univ KwaZulu Natal, Sch Life Sci, Biol Sci Bldg,Westville Campus, ZA-4000 Durban, South Africa	Rhodes University; University of Kwazulu Natal	Tagliarolo, M (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Biol Sci Bldg,Westville Campus, ZA-4000 Durban, South Africa.	morgana.tagliarolo@gmail.com	Tagliarolo, Morgana/H-6303-2019; McQuaid, Christopher/AAT-3725-2020	Tagliarolo, Morgana/0000-0002-9659-4565; McQuaid, Christopher/0000-0002-3473-8308	Rhodes University post doctoral fellowship; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	Rhodes University post doctoral fellowship; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This work was supported by a Rhodes University post doctoral fellowship, South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation.	Aagaard A, 1996, MAR BIOL, V125, P765, DOI 10.1007/BF00349259; Bozinovic F, 2015, ECOL EVOL, V5, P1025, DOI 10.1002/ece3.1403; Burnett NP, 2013, LIMNOL OCEANOGR-METH, V11, P91, DOI 10.4319/lom.2013.11.91; COLEMAN N, 1971, Journal of Experimental Marine Biology and Ecology, V7, P295, DOI 10.1016/0022-0981(71)90011-6; Cunha RL, 2014, ECOL EVOL, V4, P2070, DOI 10.1002/ece3.1033; Depledge MH, 1996, MAR BIOL, V126, P313, DOI 10.1007/BF00347455; Fitzhenry T, 2004, MAR BIOL, V145, P339, DOI 10.1007/s00227-004-1318-6; Gudimov A V, 2009, Dokl Biol Sci, V427, P335; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2008, MAR ECOL PROG SER, V371, P37, DOI 10.3354/meps07711; HELM MM, 1967, COMP BIOCHEM PHYSIOL, V21, P171, DOI 10.1016/0010-406X(67)90126-0; Helmuth B, 2002, INTEGR COMP BIOL, V42, P837, DOI 10.1093/icb/42.4.837; Helmuth B, 2009, INTEGR COMP BIOL, V42, P771; Hicks DW, 2002, MAR BIOL, V140, P1167, DOI 10.1007/s00227-002-0787-8; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; LANGTON RW, 1977, MAR BIOL, V41, P53, DOI 10.1007/BF00390581; Lathlean JA, 2011, MAR ECOL PROG SER, V439, P83, DOI 10.3354/meps09317; Lima FP, 2009, LIMNOL OCEANOGR-METH, V7, P347, DOI 10.4319/lom.2009.7.347; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; MARSHALL DJ, 1994, J EXP MAR BIOL ECOL, V179, P1, DOI 10.1016/0022-0981(94)90013-2; MARSHALL DJ, 1993, J EXP MAR BIOL ECOL, V171, P225, DOI 10.1016/0022-0981(93)90005-9; Nicastro KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047382; Nicastro Katy R., 2010, BMC Ecology, V10, P17, DOI 10.1186/1472-6785-10-17; Nicholson S, 2002, J EXP MAR BIOL ECOL, V267, P207, DOI 10.1016/S0022-0981(01)00362-8; Petes LE, 2008, OECOLOGIA, V156, P671, DOI 10.1007/s00442-008-1018-x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Santini G, 1999, PHYSIOL BIOCHEM ZOOL, V72, P198, DOI 10.1086/316656; Santini G, 2000, MAR BIOL, V137, P291, DOI 10.1007/s002270000339; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Styrishave B, 2003, MAR FRESHW BEHAV PHY, V36, P161, DOI 10.1080/10236240310001603215; Tagliarolo M, 2015, MAR ECOL PROG SER, V535, P145, DOI 10.3354/meps11434; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; TSUCHIYA M, 1983, J EXP MAR BIOL ECOL, V66, P101, DOI 10.1016/0022-0981(83)90032-1; Williams EE, 1996, J EXP BIOL, V199, P1587; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135; Zardi GI, 2011, OECOLOGIA, V165, P947, DOI 10.1007/s00442-010-1788-9	36	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146341	10.1371/journal.pone.0146341	http://dx.doi.org/10.1371/journal.pone.0146341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840775	Green Submitted, Green Published, gold			2022-12-27	WOS:000369550200008
J	Xie, J; Li, RR; Li, S; Ran, XQ; Wang, JF; Jiang, JC; Zhao, PJ				Xie, Jian; Li, Rongrong; Li, Sheng; Ran, Xueqin; Wang, Jiafu; Jiang, Jicai; Zhao, Pengju			Identification of Copy Number Variations in Xiang and Kele Pigs	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; SNP GENOTYPING ARRAYS; GENOME-WIDE DETECTION; GENETIC DIVERSITY; STRUCTURAL VARIATION; RECEPTOR GENES; KIT-LIGAND; POLYMORPHISM; EXPRESSION; SEQUENCE	Xiang and Kele pigs are two well-known local Chinese pig breeds that possess rich genetic resources and have enormous economic and scientific value. We performed a comprehensive genomic analysis of the copy number variations (CNVs) in these breeds. CNVs are one of the most important forms of genomic variation and have profound effects on phenotypic variation. In this study, PorcineSNP60 genotyping data from 98 Xiang pigs and 22 Kele pigs were used to identify CNVs. In total, 172 candidate CNV regions (CNVRs) were identified, ranging from 3.19 kb to 8175.26 kb and covering 80.41 Mb of the pig genome. Approximately 56.40% (97/172) of the CNVRs overlapped with those identified in seven previous studies, and 43.60% (75/172) of the identified CNVRs were novel. Of the identified CNVRs, 82 (47 gain, 33 loss, and two gain-loss events that covered 4.58 Mb of the pig genome) were found only in a Xiang population with a large litter size. In contrast, 13 CNVRs (8 gain and 5 loss events) were unique to a Xiang population with small litter sizes, and 30 CNVRs (14 loss and 16 gain events) were unique to Kele pigs. The CNVRs span approximately 660 annotated Sus scrofa genes that are significantly enriched for specific biological functions, such as sensory perception, cognition, reproduction, ATP biosynthetic processes, and neurological processes. Many CNVR-associated genes, particularly the genes involved in reproductive traits, differed between the Xiang populations with large and small litter sizes, and these genes warrant further investigation due to their importance in determining the reproductive performance of Xiang pigs. Our results provide meaningful information about genomic variation, which may be useful in future assessments of the associations between CNVs and important phenotypes in Xiang and Kele pigs to ultimately help protect these rare breeds.	[Xie, Jian; Li, Rongrong; Li, Sheng; Wang, Jiafu] Guizhou Univ, Inst Agrobioengn, Guiyang 550003, Peoples R China; [Xie, Jian; Li, Rongrong; Li, Sheng; Wang, Jiafu] Guizhou Univ, Coll Life Sci, Guiyang 550003, Peoples R China; [Ran, Xueqin] Guizhou Univ, Coll Anim Sci, Guiyang 550003, Peoples R China; [Jiang, Jicai; Zhao, Pengju] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Guizhou University; Guizhou University; Guizhou University; China Agricultural University	Wang, JF (corresponding author), Guizhou Univ, Inst Agrobioengn, Guiyang 550003, Peoples R China.; Wang, JF (corresponding author), Guizhou Univ, Coll Life Sci, Guiyang 550003, Peoples R China.; Ran, XQ (corresponding author), Guizhou Univ, Coll Anim Sci, Guiyang 550003, Peoples R China.	rxueq@aliyun.com; jfwang@gzu.edu.cn		Jiang, Jicai/0000-0001-6890-7539	National High Technology Research and Development Program (863 Program) [2013AA102503]; Guizhou Agricultural Science and Technology research projects [NY[2013]3073]; Guizhou Province Science and Technology Innovation Team Building Special (Guizhou Branch of talent team) [2009-4006]; Guizhou University "undergraduate teaching project" [BKJX2012007]; Innovation Funds of Guizhou University [2015009]; Guizhou University [BKJX2012007]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Guizhou Agricultural Science and Technology research projects; Guizhou Province Science and Technology Innovation Team Building Special (Guizhou Branch of talent team); Guizhou University "undergraduate teaching project"; Innovation Funds of Guizhou University; Guizhou University	The present paper was funded by the National High Technology Research and Development Program (863 Program) issue (2013AA102503); Guizhou Agricultural Science and Technology research projects (NY[2013]3073); Guizhou Province Science and Technology Innovation Team Building Special (Guizhou Branch of talent team 2009-4006); Guizhou University "undergraduate teaching project" (BKJX2012007). The authors thank the Congjiang Xiang Pig Development and Management Office for helping with the sample collection.; This study was funded by the National High Technology Research and Development Program (863 Program), grant 2013AA102503, (http://www.most.gov.cn/bszn/new/863/jbxx/), the Guizhou Agricultural Science and Technology research projects (NY[2013]3073), (http://kjt.gzst.gov.cn), the Innovation Funds of Guizhou University (2015009)(http://www.gzu.edu.cn/), the Guizhou Province Science and Technology Innovation Team Building Special (Guizhou Branch of talent team 2009-4006) and the Guizhou University "undergraduate teaching project" (BKJX2012007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amills M, 2010, ORIGIN GENETIC DIVER; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Beaudet AL, 2014, NAT GENET, V46, P1046, DOI 10.1038/ng.3106; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cookingham LM, 2015, J ASSIST REPROD GEN, V32, P737, DOI 10.1007/s10815-015-0447-9; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dong K, 2015, ANIM GENET, V46, P101, DOI 10.1111/age.12247; Driancourt MA, 2000, REV REPROD, V5, P143, DOI 10.1530/revreprod/5.3.143; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fernandez AI, 2014, ANIM GENET, V45, P357, DOI 10.1111/age.12137; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fontanesi L, 2011, GENOMICS, V97, P158, DOI 10.1016/j.ygeno.2010.11.005; Fowler KE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-784; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43; Gazave E, 2011, GENOME RES, V21, P1626, DOI 10.1101/gr.117242.110; Ghosh S, 2014, COPY NUMBER VARIATIO, DOI [10.1371/journal.pgen.1004712, DOI 10.1371/JOURNAL.PGEN.1004712]; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Giuffra E, 2000, ORIGIN DOMESTIC PIG; Graubert TA, 2007, HIGH RESOLUTION MAP; Grimmond S, 2000, HUM MOL GENET, V9, P1553, DOI 10.1093/hmg/9.10.1553; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jiang JC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-85; Joyce IM, 1999, DEV BIOL, V214, P342, DOI 10.1006/dbio.1999.9437; Kim JH, 2012, BIOINFORMATICS, V28, P1790, DOI 10.1093/bioinformatics/bts239; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li SJ, 2004, J ANIM SCI, V82, P368; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu JS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-229; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Ming T, 2013, BMC GENOMICS, V14; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nozawa M, 2008, CYTOGENET GENOME RES, V123, P263, DOI 10.1159/000184716; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; Paudel Y, 2015, BMC GENOMICS, V16, P1; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Phelan JK, 2001, HUM MUTAT, V18, P472, DOI 10.1002/humu.1225; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shozu M, 2005, J MOL ENDOCRINOL, V35, P343, DOI 10.1677/jme.1.01735; Smyk M, 2007, HUM GENET, V122, P63, DOI 10.1007/s00439-007-0373-8; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Talseth-Palmer BA, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-10; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walters KA, 2010, HUMAN REPROD UPDATE, pq3; Wang J, 2015, IMPROVED DETECTION C, V5; Wang Jiying, 2013, PLoS One, V8, pe68683, DOI 10.1371/journal.pone.0068683; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang Y, 2014, ANAL GENOME WIDE COP, DOI [10.1371/journal.pone.0106780, DOI 10.1371/JOURNAL.PONE.0106780]; Wen YL, 2013, J COMPUT BIOL, V20, P514, DOI 10.1089/cmb.2011.0102; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Yang HS, 2012, MOL BIOL REP, V39, P1887, DOI 10.1007/s11033-011-0934-8; Yi GQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-962; Yung Y, 2010, MOL CELL ENDOCRINOL, V328, P104, DOI 10.1016/j.mce.2010.07.019; Zhang CY, 2011, CURR GENOMICS, V12, P138, DOI 10.2174/138920211795564386	73	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0148565	10.1371/journal.pone.0148565	http://dx.doi.org/10.1371/journal.pone.0148565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840413	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200148
J	Dziadek, B; Brzostek, A; Grzybowski, M; Fol, M; Krupa, A; Kryczka, J; Plocinski, P; Kurdowska, A; Dziadek, J				Dziadek, Bozena; Brzostek, Anna; Grzybowski, Marcin; Fol, Marek; Krupa, Agnieszka; Kryczka, Jakub; Plocinski, Przemyslaw; Kurdowska, Anna; Dziadek, Jaroslaw			Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; L-HOMOCYSTEINE HYDROLASE; EPITHELIAL-CELLS; INFECTED MONOCYTES; GROWTH-FACTOR; BINDING; EXPRESSION; PATHWAY; ALPHA; IL-8	Mycobacterium tuberculosis is an extremely successful intracellular pathogen that has evolved a broad spectrum of pathogenic mechanisms that enable its manipulation of host defense elements and its survival in the hostile environment inside phagocytes. Cellular influx into the site of mycobacterial entry is mediated by a variety of chemokines, including interleukin-8 (IL-8), and the innate cytokine network is critical for the development of an adaptive immune response and infection control. Using affinity chromatography, liquid chromatography electrospray ionization tandem mass spectrometry and surface plasmon resonance techniques, we identified M. tuberculosis AtsG arylsulphatase, bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyl transferase (GlmU) and S-adenosyl-L-homocysteine hydrolase (SahH) as the pathogen proteins that bind to human IL-8. The interactions of all of the identified proteins (AtsG, GlmU and SahH) with IL-8 were characterized by high binding affinity with K-D values of 6.83x10(-6) M, 5.24x10(-6) M and 7.14x10(-10) M, respectively. Furthermore, the construction of Mtb mutant strains overproducing AtsG, GlmU or SahH allowed determination of the contribution of these proteins to mycobacterial entry into human neutrophils. The significantly increased number of intracellularly located bacilli of the overproducing M. tuberculosis mutant strains compared with those of "wild-type" M. tuberculosis and the binding interaction of AtsG, GlmU and SahH proteins with human IL-8 may indicate that these proteins participate in the modulation of the early events of infection with tubercle bacilli and could affect pathogen attachment to target cells.	[Dziadek, Bozena; Grzybowski, Marcin] Univ Lodz, Fac Biol & Environm Protect, Dept Immunoparasitol, PL-90131 Lodz, Poland; [Brzostek, Anna; Krupa, Agnieszka; Kryczka, Jakub; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Fol, Marek] Univ Lodz, Fac Biol & Environm Protect, Dept Immunol & Infect Biol, PL-90131 Lodz, Poland; [Kurdowska, Anna] Univ Texas Tyler, Hlth Sci Ctr, Dept Cellular & Mol Biol, Tyler, TX 75799 USA; [Plocinski, Przemyslaw] Polish Acad Sci, Inst Biochem & Biophys, Lab RNA Biol & Funct Genom, Warsaw, Poland	University of Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Dziadek, J (corresponding author), Polish Acad Sci, Inst Med Biol, Lodz, Poland.	jdziadek@cbm.pan.pl	Płociński, Przemysław A/S-5587-2017	Płociński, Przemysław A/0000-0002-6623-3494; Krupa, Agnieszka/0000-0003-1303-4608; /0000-0002-5197-7538; Fol, Marek/0000-0002-8041-1920; Dziadek, Jaroslaw/0000-0003-1427-884X; Kryczka, Jakub/0000-0002-5719-4139; Dziadek, Bozena/0000-0002-4942-7385	National Science Centre, Poland [UMO-2011/01/M/NZ6/01764]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre (UMO-2011/01/M/NZ6/01764), Poland for JD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUZEID C, 1988, INFECT IMMUN, V56, P3046, DOI 10.1128/IAI.56.12.3046-3051.1988; Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; Ameixa C, 2002, INFECT IMMUN, V70, P4743, DOI 10.1128/IAI.70.8.4743-4746.2002; Bartlomiejczyk MA, 2014, CLIN EXP IMMUNOL, V178, P310, DOI 10.1111/cei.12416; Bermudez LE, 1996, INFECT IMMUN, V64, P2917, DOI 10.1128/IAI.64.8.2917-2922.1996; Boggaram V, 2013, J BIOL CHEM, V288, P25500, DOI 10.1074/jbc.M112.448217; Byrd TF, 1997, J CLIN INVEST, V99, P2518, DOI 10.1172/JCI119436; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Corrales RM, 2013, BIOCHEM BIOPH RES CO, V430, P858, DOI 10.1016/j.bbrc.2012.11.038; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; DENIS M, 1992, CELL IMMUNOL, V141, P182, DOI 10.1016/0008-8749(92)90137-E; DENIS M, 1991, CAN J MICROBIOL, V37, P479, DOI 10.1139/m91-080; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Ferguson JS, 1999, J IMMUNOL, V163, P312; FRIEDLAND JS, 1995, CLIN EXP IMMUNOL, V100, P233; Fronseca JD, 2015, INT J INFECT DIS, V32, P94, DOI [10.1016/j.ijid.2015.01.014, DOI 10.1016/J.IJID.2015.01.014]; Fudala R, 2007, AM J PHYSIOL-LUNG C, V293, pL364, DOI 10.1152/ajplung.00179.2006; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hall-Stoodley L, 2006, INFECT IMMUN, V74, P3587, DOI 10.1128/IAI.01644-05; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Heinz Christian, 2003, Methods Mol Biol, V228, P139, DOI 10.1385/1-59259-400-X:139; Hilda JN, 2014, HUM IMMUNOL, V75, P914, DOI 10.1016/j.humimm.2014.06.020; HIRSCH CS, 1994, J INFECT DIS, V170, P1229, DOI 10.1093/infdis/170.5.1229; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Hossain MM, 2009, J BIOCHEM, V146, P767, DOI 10.1093/jb/mvp141; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jansen HJ, 1999, J MED MICROBIOL, V48, P551, DOI 10.1099/00222615-48-6-551; Jones SA, 1997, J BIOL CHEM, V272, P16166, DOI 10.1074/jbc.272.26.16166; Kisich KO, 2002, INFECT IMMUN, V70, P4591, DOI 10.1128/IAI.70.8.4591-4599.2002; Krupa A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124762; LEE J, 1992, J BIOL CHEM, V267, P16283; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Migliori GB, 2007, EUROSURVEILLANCE, V12; Miranda MS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139127; Mougous JD, 2002, CHEM BIOL, V9, P767, DOI 10.1016/S1074-5521(02)00175-8; Mueller-Ortiz SL, 2001, INFECT IMMUN, V69, P7501, DOI 10.1128/IAI.69.12.7501-7511.2001; Neufert C, 2001, J IMMUNOL, V167, P1542, DOI 10.4049/jimmunol.167.3.1542; Nibbering PH, 2014, HUM IMMUNOL, V75, P914; Parida SK, 2015, J INTERN MED, V277, P388, DOI 10.1111/joim.12264; Pasula R, 1997, AM J RESP CELL MOL, V17, P209, DOI 10.1165/ajrcmb.17.2.2469; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Poirier V, 2012, MICROBES INFECT, V14, P1211, DOI 10.1016/j.micinf.2012.07.001; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Reddy MCM, 2008, PROTEIN SCI, V17, P2134, DOI 10.1110/ps.038125.108; Sadek MI, 1998, AM J RESP CELL MOL, V19, P513, DOI 10.1165/ajrcmb.19.3.2815; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Schlorke D, 2012, CARBOHYD RES, V356, P196, DOI 10.1016/j.carres.2012.02.025; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sidobre S, 2000, J BIOL CHEM, V275, P2415, DOI 10.1074/jbc.275.4.2415; Singhal N, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-14; Sogi KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065080; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Troegeler A, 2015, PLOS ONE, V14, P1; Velayati AA, 2013, INT J CLIN EXP MED, V6, P307; WHO, 2015, TUBERCULOSIS; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702	62	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148030	10.1371/journal.pone.0148030	http://dx.doi.org/10.1371/journal.pone.0148030			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829648	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200054
J	Zhao, ZL; Wang, CD; Lai, JH				Zhao, Zhi-Lin; Wang, Chang-Dong; Lai, Jian-Huang			AUI&GIV: Recommendation with Asymmetric User Influence and Global Importance Value	PLOS ONE			English	Article								The user-based collaborative filtering (CF) algorithm is one of the most popular approaches for making recommendation. Despite its success, the traditional user-based CF algorithm suffers one serious problem that it only measures the influence between two users based on their symmetric similarities calculated by their consumption histories. It means that, for a pair of users, the influences on each other are the same, which however may not be true. Intuitively, an expert may have an impact on a novice user but a novice user may not affect an expert at all. Besides, each user may possess a global importance factor that affects his/her influence to the remaining users. To this end, in this paper, we propose an asymmetric user influence model to measure the directed influence between two users and adopt the PageRank algorithm to calculate the global importance value of each user. And then the directed influence values and the global importance values are integrated to deduce the final influence values between two users. Finally, we use the final influence values to improve the performance of the traditional user-based CF algorithm. Extensive experiments have been conducted, the results of which have confirmed that both the asymmetric user influence model and global importance value play key roles in improving recommendation accuracy, and hence the proposed method significantly outperforms the existing recommendation algorithms, in particular the user-based CF algorithm on the datasets of high rating density.	[Zhao, Zhi-Lin; Wang, Chang-Dong; Lai, Jian-Huang] Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou 510275, Guangdong, Peoples R China; [Lai, Jian-Huang] Guangdong Key Lab Informat Secur Technol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wang, CD (corresponding author), Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou 510275, Guangdong, Peoples R China.	changdongwang@hotmail.com			National Natural Science Foundation of China [61502543, 61573387]; Guangdong Natural Science Funds for Distinguished Young Scholar; PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China [2014A030310180]; GuangZhou Program [201508010032]; CCF-Tencent Open Research Fund; Pilot Program of SYSU-CMU Shunde International Joint Research Institute; Undergraduate Innovation Program of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholar; PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of China (NSFC)); GuangZhou Program; CCF-Tencent Open Research Fund; Pilot Program of SYSU-CMU Shunde International Joint Research Institute; Undergraduate Innovation Program of Sun Yat-sen University	This work was supported by National Natural Science Foundation of China (No. 61502543 and No. 61573387), Guangdong Natural Science Funds for Distinguished Young Scholar, the PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China (2014A030310180), GuangZhou Program (No. 201508010032), CCF-Tencent Open Research Fund, Pilot Program of SYSU-CMU Shunde International Joint Research Institute, and Undergraduate Innovation Program of Sun Yat-sen University. The funders had no role in study design.	Banerjee Somnath, 2008, WWW, P1135; Bin Wang, 2013, 2013 5th International Conference on Intelligent Human-Machine Systems and Cybernetics (IHMSC 2013), P449, DOI 10.1109/IHMSC.2013.254; Bourquard T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018541; Canny J., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P238, DOI 10.1145/564376.564419; Chen W, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P892; Davidson J, 2010, P 4 ACM C REC SYST, P293, DOI DOI 10.1145/1864708.1864770; Gan M, 2014, PLOS ONE, P1; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Goldberg K, 2001, INFORM RETRIEVAL, V4, P133, DOI 10.1023/A:1011419012209; Hannon J., 2010, P 4 ACM C REC SYST R, P199, DOI DOI 10.1145/1864708.1864746; Jannach D, 2013, RECOMMENDER SYSTEMS; Kim BM, 2006, J INTELL INF SYST, V27, P79, DOI 10.1007/s10844-006-8771-2; Laureti P, 2006, EUROPHYS LETT, V75, P1006, DOI 10.1209/epl/i2006-10204-8; Lemire D, 2005, SIAM PROC S, P471; Li Sa, 2011, Proceedings of the 2011 International Conference on Business Computing and Global Informatization (BCGIn 2011), P645, DOI 10.1109/BCGIn.2011.170; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu B, 2010, PROCEEDINGS OF THE RECSYS'2010 ACM CHALLENGE ON CONTEXT-AWARE MOVIE RECOMMENDATION (CAMRA2010), P53, DOI 10.1145/1869652.1869661; Liu J, 2012, APPL COMPUT REV, V12, P48, DOI 10.1145/2432546.2432550; liu Jiali, 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1016/J.CCLET.2014.06.001; Lu J., 2013, J MACH LEARN RES, P325; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; Millan M, 2007, LECT NOTES COMPUT SC, V4881, P663; Nakamura Atsuyoshi., 2015, P ASIAN C MACHINE LE, P315; Onuma K, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P657; Osmanli ON, 2010, SINGULAR VALUE DECOM, P1; Paterek A., 2007, P KDD CUP WORKSH, V2007, P5, DOI DOI 10.1145/1557019.1557072; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Pirasteh P, 2015, EXPLOITING MATRIX FA, P1; Ren J, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/58007; Ricci F., 2011, P 2011 ACM C REC SYS, P301, DOI DOI 10.1145/2043932.2043988; Ricci F., 2011, INTRO RECOMMENDER SY; Salakhutdinov R., 2007, P 24 INT C MACH LEAR, P1; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Shi Y, 2014, ACM COMPUT SURV, V47, DOI 10.1145/2556270; Wang J., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P501, DOI 10.1145/1148170.1148257; Xiang L, 2012, PRACICE RECOMMENDATI; Yang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030093; Yin B, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P771, DOI 10.1145/2567948.2579237; Yu C, 2006, 2006 ICEC: EIGHTH INTERNATIONAL CONFERENCE ON ELECTRONIC COMMERCE, PROCEEDINGS, P574; Zhang JB, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON NETWORK INFRASTRUCTURE AND DIGITAL CONTENT, PROCEEDINGS, P414, DOI 10.1109/ICNIDC.2009.5360986; Zhou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065906	45	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147944	10.1371/journal.pone.0147944	http://dx.doi.org/10.1371/journal.pone.0147944			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828803	gold, Green Submitted, Green Published			2022-12-27	WOS:000369548200043
J	Senzaki, S; Masuda, T; Takada, A; Okada, H				Senzaki, Sawa; Masuda, Takahiko; Takada, Akira; Okada, Hiroyuki			The Communication of Culturally Dominant Modes of Attention from Parents to Children: A Comparison of Canadian and Japanese Parent-Child Conversations during a Joint Scene Description Task	PLOS ONE			English	Article							CONTEXT-SENSITIVITY; SOCIAL EXPLANATION; YOUNG-CHILDREN; FACIAL EMOTION; PERCEPTION; AMERICAN; REPRODUCTION; STORIES; MOTHERS; STEREOTYPES	Previous findings have indicated that, when presented with visual information, North American undergraduate students selectively attend to focal objects, whereas East Asian undergraduate students are more sensitive to background information. However, little is known about how these differences are driven by culture and socialization processes. In this study, two experiments investigated how young children and their parents used culturally unique modes of attention (selective vs. context sensitive attention). We expected that children would slowly learn culturally unique modes of attention, and the experience of communicating with their parents would aid the development of such modes of attention. Study 1 tested children's solitary performance by examining Canadian and Japanese children's (4-6 vs. 7-9 years old) modes of attention during a scene description task, whereby children watched short animations by themselves and then described their observations. The results confirmed that children did not demonstrate significant cross-cultural differences in attention during the scene description task while working independently, although results did show rudimentary signs of culturally unique modes of attention in this task scenario by age 9. Study 2 examined parent-child (4-6 and 7-9 years old) dyads using the same task. The results indicated that parents communicated to their children differently across cultures, replicating attentional differences among undergraduate students in previous cross-cultural studies. Study 2 also demonstrated that children's culturally unique description styles increased significantly with age. The descriptions made by the older group (7-9 years old) showed significant cross-cultural variances in attention, while descriptions among the younger group (4-6 years old) did not. The significance of parental roles in the development of culturally unique modes of attention is discussed in addition to other possible facilitators of this developmental process.	[Senzaki, Sawa] Univ Wisconsin, Dept Human Dev & Psychol, Green Bay, WI 54302 USA; [Masuda, Takahiko] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Takada, Akira] Kyoto Univ, Grad Sch Asian & African Area Studies, Kyoto, Japan; [Okada, Hiroyuki] Tamagawa Univ, Grad Sch Brain Sci, Tokyo, Japan	University of Wisconsin System; University of Alberta; Kyoto University	Senzaki, S (corresponding author), Univ Wisconsin, Dept Human Dev & Psychol, Green Bay, WI 54302 USA.	senzakis@uwgb.edu	Okada, HIroyuki/AAN-8999-2020	Takada, Akira/0000-0002-0549-026X	Alberta Innovates Scholarship [200801188]; SSHRC [410-2007-382]; Grants-in-Aid for Scientific Research [25330176] Funding Source: KAKEN	Alberta Innovates Scholarship; SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Alberta Innovates Scholarship (200801188) to SS (http://www.albertatechfutures.ca), SSHRC grant (410-2007-382) to TM (http://www.sshrc-crsh.gc.ca/homeaccueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Sandra Wiebe, Miki Kodama, and members of Culture and Cognition Lab and the Alberta Behavior and Cognitive Development Lab at University of Alberta for their support at various stages of this project. We also thank Dr. Qi Wang, Dr. Kimberly Noels, and Dr. Elena Nicoladis for their valuable comments on the earlier drafts. Finally, we thank all the parents and children who participated in our study. This work was partly supported by an Alberta Innovates Scholarship (200801188) awarded to Sawa Senzaki and a SSHRC grant (410-2007- 382) awarded to Takahiko Masuda.	Bartlett F. C, 1932, REMEMBERING A STUDY; BJORKLUND DF, 1981, CHILD DEV, V52, P888; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Bruner J., 1995, 43 JOINT ATTENTION I; Bruner J, 1983, CHILDS TALK LEARNING; Bruner J. S., 1990, ACTS MEANING; Calero CI, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00281; Callaghan Tara, 2011, Monogr Soc Res Child Dev, V76, pvii, DOI 10.1111/j.1540-5834.2011.00603.x; Chavajay P, 1999, DEV PSYCHOL, V35, P1079, DOI 10.1037/0012-1649.35.4.1079; Cheung CSS, 2011, CHILD DEV, V82, P932, DOI 10.1111/j.1467-8624.2011.01582.x; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cole M., 1996, DEV CHILDREN; de la Ossa JL, 2001, INT J BEHAV DEV, V25, P176, DOI 10.1080/01650250042000168; Deacon T., 1997, SYMBOLIC SPECIES; Diamond A., 2006, LIFESPAN COGNITION M, P70, DOI [10.1093/acprof:oso/9780195169539.003.0006, DOI 10.1093/ACPROF:OSO/9780195169539.003.0006]; Duff Patricia A., 2011, HDB LANGUAGE SOCIALI, P564, DOI [10.1002/9781444342901.ch24, DOI 10.1002/9781444342901.CH24, 10.1002/9781444342901, DOI 10.1002/9781444342901]; Duffy S, 2009, J EXP CHILD PSYCHOL, V102, P351, DOI 10.1016/j.jecp.2008.06.006; Ellis MV, 1999, COUNS PSYCHOL, V27, P552, DOI 10.1177/0011000099274004; FERNALD A, 1993, CHILD DEV, V64, P637; FLAVELL JH, 1970, COGNITIVE PSYCHOL, V1, P324, DOI 10.1016/0010-0285(70)90019-8; Frick A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00386; GATHERCOLE SE, 1994, MEM COGNITION, V22, P201, DOI 10.3758/BF03208891; GAUVAIN M, 1989, DEV PSYCHOL, V25, P139, DOI 10.1037/0012-1649.25.1.139; GAUVAIN M, 1992, INT J BEHAV DEV, V15, P377, DOI 10.1177/016502549201500306; Gauvain M., 2001, THE SOCIAL CONTEXT O; Greenfield PM, 2003, ANNU REV PSYCHOL, V54, P461, DOI 10.1146/annurev.psych.54.101601.145221; Henry LA, 1996, INT J BEHAV DEV, V19, P177, DOI 10.1080/016502596386018; Imada T, 2013, DEVELOPMENTAL SCI, V16, P198, DOI 10.1111/desc.12016; Imada T, 2012, PERS SOC PSYCHOL B, V38, P114, DOI 10.1177/0146167211421938; Ishii K, 2014, PERS SOC PSYCHOL B, V40, P175, DOI 10.1177/0146167213508151; Ito K, 2013, PERS SOC PSYCHOL B, V39, P763, DOI 10.1177/0146167213481387; Ji LJ, 2008, PERS SOC PSYCHOL B, V34, P613, DOI 10.1177/0146167207313935; Ji LJ, 2000, J PERS SOC PSYCHOL, V78, P943, DOI 10.1037/0022-3514.78.5.943; Kashima Y, 2000, PERS SOC PSYCHOL B, V26, P594, DOI 10.1177/0146167200267007; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Kitayama S, 1999, COHERENCE OF PERSONALITY, P242; Kuwabara M, 2012, J EXP CHILD PSYCHOL, V113, P20, DOI 10.1016/j.jecp.2012.04.009; Kuwabara M, 2011, J COGN DEV, V12, P502, DOI 10.1080/15248372.2011.554927; Li L. M. W., 2015, INVESTIGATION OF THE; Lyons A, 2003, J PERS SOC PSYCHOL, V85, P989, DOI 10.1037/0022-3514.85.6.989; Lyons A, 2001, SOC COGNITION, V19, P372, DOI 10.1521/soco.19.3.372.21470; Masuda T, 2006, COGNITIVE SCI, V30, P381, DOI 10.1207/s15516709cog0000_63; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Masuda T., 2015, CULTURE AND EMOTION; Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365; Masuda T, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00072; Mesoudi A, 2004, EVOLUTION, V58, P1; Mesoudi A., 2011, CULTURAL EVOLUTION H, V6, P20; Mesoudi A, 2008, PHILOS T R SOC B, V363, P3489, DOI 10.1098/rstb.2008.0129; MILLER JG, 1984, J PERS SOC PSYCHOL, V46, P961; MILLER JG, 1986, DEV PSYCHOL, V22, P514, DOI 10.1037/0012-1649.22.4.514; Miller P. J., 2013, ADVANCES IN CULTURE, V4; Miller PJ, 2012, MONOGR SOC RES CHILD, V77, P77, DOI 10.1111/j.1540-5834.2011.00646.x; Moore C., 1995, JOINT ATTENTION ITS; Nand K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01041; Nelson K., 1981, SOCIAL COGNITIVE DEV, P97; Nisbett R., 2003, THE GEOGRAPHY OF THO; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; RADZISZEWSKA B, 1991, DEV PSYCHOL, V27, P381, DOI 10.1037/0012-1649.27.3.381; Rai RS, 2004, J EXP CHILD PSYCHOL, V89, P112, DOI 10.1016/j.jecp.2004.05.003; Richerson P. J., 2005, NOT BY GENES ALONE H; ROGOFF B, 1993, MONOGR SOC RES CHILD, V58, pR5; Rogoff B, 2003, THE CULTURAL NATURE; Senzaki S, 2014, COGNITIVE SCI, V38, P1493, DOI 10.1111/cogs.12118; Senzaki S, 2014, J CROSS CULT PSYCHOL, V45, P1297, DOI 10.1177/0022022114537704; SHWEDER RA, 1991, THINKING THROUGH CUL; Tomasello M, 2009, WHY WE COOPERATE, P1; Tomasello M., 1999, THE CULTURAL ORIGINS; Tsai JL, 2007, PERS SOC PSYCHOL B, V33, P17, DOI 10.1177/0146167206292749; Uskul AK, 2008, P NATL ACAD SCI USA, V105, P8552, DOI 10.1073/pnas.0803874105; Vygotsky L. S., 1978, MIND SOC DEV HIGHER; Vygotsky L.S., 1987, COLLECTED WORKS LS V, P43; Wang Q, 2000, MEMORY, V8, P159, DOI 10.1080/096582100387588; Wang Q, 2001, COGNITIVE DEV, V16, P693, DOI 10.1016/S0885-2014(01)00055-7; Witkin H. A., 1975, JOURNAL OF CROSS CUL, V6, P2; WITKIN HA, 1977, PSYCHOL BULL, V84, P661, DOI 10.1037/0033-2909.84.4.661; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x	79	44	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147199	10.1371/journal.pone.0147199	http://dx.doi.org/10.1371/journal.pone.0147199			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GH	26824241	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600018
J	Webb, HE; Bugarel, M; den Bakker, HC; Nightingale, KK; Granier, SA; Scott, HM; Loneragan, GH				Webb, Hattie E.; Bugarel, Marie; den Bakker, Henk C.; Nightingale, Kendra K.; Granier, Sophie A.; Scott, H. Morgan; Loneragan, Guy H.			Carbapenem-Resistant Bacteria Recovered from Faeces of Dairy Cattle in the High Plains Region of the USA	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; SPREAD; PRODUCERS; EVOLUTION; SEQUENCE; GENES	Objective A study was conducted to recover carbapenem-resistant bacteria from the faeces of dairy cattle and identify the underlying genetic mechanisms associated with reduced phenotypic susceptibility to carbapenems. Methods One hundred and fifty-nine faecal samples from dairy cattle were screened for carbapenem- resistant bacteria. Phenotypic screening was conducted on two media containing ertapenem. The isolates from the screening step were characterised via disk diffusion, Modified Hodge, and Carba NP assays. Carbapenem-resistant bacteria and carbapenemase-producing isolates were subjected to Gram staining and biochemical testing to include Gram-negative bacilli. Whole genome sequencing was performed on bacteria that exhibited either a carbapenemase-producing phenotype or were not susceptible to ertapenem and were presumptively Enterobacteriaceae. Results Of 323 isolates collected from the screening media, 28 were selected for WGS; 21 of which were based on a carbapenemase-producing phenotype and 7 were presumptively Enterobacteriaceae and not susceptible to ertapenem. Based on analysis of WGS data, isolates included: 3 Escherichia coli harbouring blaCMY-2 and truncated ompF genes; 8 Aeromonas harbouring blacphA-like genes; 1 Acinetobacter baumannii harbouring a novel blaOXA gene (blaOXA-497); and 6 Pseudomonas with conserved domains of various carbapenemase-producing genes. Conclusions Carbapenem resistant bacteria appear to be rare in cattle. Nonetheless, carbapenem-resistant bacteria were detected across various genera and were found to harbour a variety of mechanisms conferring reduced susceptibility. The development and dissemination of carbapenem-resistant bacteria in livestock would have grave implications for therapeutic treatment options in human medicine; thus, continued monitoring of carbapenem susceptibility among enteric bacteria of livestock is warranted.	[Webb, Hattie E.; Bugarel, Marie; den Bakker, Henk C.; Nightingale, Kendra K.; Loneragan, Guy H.] Texas Tech Univ, Dept Anim & Food Sci, Int Ctr Food Ind Excellence, Lubbock, TX 79409 USA; [Granier, Sophie A.] Paris Est Univ, ANSES, Lab Food Safety, Antimicrobial Resistance Unit, Maisons Alfort, France; [Scott, H. Morgan] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX USA	Texas Tech University System; Texas Tech University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Securite Aliments; Ecole Nationale Veterinaire d'Alfort (ENVA); Texas A&M University System; Texas A&M University College Station	Loneragan, GH (corresponding author), Texas Tech Univ, Dept Anim & Food Sci, Int Ctr Food Ind Excellence, Lubbock, TX 79409 USA.	guy.loneragan@ttu.edu	Scott, Harvey/ABC-9935-2020; Webb, Hattie/L-4072-2015; Granier, Sophie A./H-6796-2019; Bakker, Henk den/AAF-8282-2020	Scott, Harvey/0000-0002-0538-5961; Webb, Hattie/0000-0002-1190-7930; Granier, Sophie A./0000-0001-9676-2402; 	United States Department of Agriculture (USDA); National Institutes of Food and Agriculture; National Integrated Food Safety Initiative award [2011-51110-31081, 2010-51110-21083]; National Antimicrobial Resistance Monitoring System (USDA Agricultural Research Service project) [0204-41510-001-47G]; Texas Tech University; ANSES through the Chateaubriand Fellowship program; Houston Livestock Show and Rodeo	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); National Institutes of Food and Agriculture; National Integrated Food Safety Initiative award; National Antimicrobial Resistance Monitoring System (USDA Agricultural Research Service project); Texas Tech University; ANSES through the Chateaubriand Fellowship program; Houston Livestock Show and Rodeo	This work was supported in part by the United States Department of Agriculture (USDA), National Institutes of Food and Agriculture, National Integrated Food Safety Initiative award numbers 2011-51110-31081 and 2010-51110-21083, and the National Antimicrobial Resistance Monitoring System (USDA Agricultural Research Service project number 0204-41510-001-47G). In addition, we also thank the Embassy of France in the US for sponsoring research collaborations between Texas Tech University and ANSES through the Chateaubriand Fellowship program as well as the Houston Livestock Show and Rodeo for the graduate student assistantship.	Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Benedict MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-8; Bush K, 2013, J INFECT CHEMOTHER, V19, P549, DOI 10.1007/s10156-013-0640-7; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Centers for Disease Control and Prevention (CDC), ANT RES THREATS US A; Clinical and Laboratory Standards (CLSI), 2013, PERF STAND ANT SUSC; Clinical and Laboratory Standards Institute, 2010, METH ANT DIL DISK SU, V2rd; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dortet L, 2015, J ANTIMICROB CHEMOTH; *ECDC, ANT RES SURV EUR 201; EFSA, 2013, EFSA J, V11; European Commission, 2013, COMM IMPL DEC MON RE; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P478, DOI 10.1093/jac/dks393; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P3198, DOI 10.1128/AAC.49.8.3198-3202.2005; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Kochar S, 2009, INFECT CONT HOSP EP, V30, P447, DOI 10.1086/596734; Livermore D, 2007, J ANTIMICROB CHEMOTH, V60, pI59, DOI 10.1093/jac/dkm160; Livermore DM, 2001, ANTIMICROB AGENTS CH, V45, P1860, DOI 10.1128/AAC.45.6.1860-1867.2001; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; Low AS, 2001, MOL MICROBIOL, V42, P619, DOI 10.1046/j.1365-2958.2001.02647.x; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Nordmann P, 2012, J CLIN MICROBIOL, V50, P2761, DOI 10.1128/JCM.06477-11; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; OIE, OIE LIST ANT AG VET; Poirel L, 2004, J CLIN MICROBIOL, V42, P3831, DOI 10.1128/JCM.42.8.3831-3833.2004; Poirel L, 2014, J ANTIMICROB CHEMOTH, V69, P2007, DOI [10.1093/jac/dku054, 10.1093/jac/dku323]; Poirel L, 2012, EMERG INFECT DIS, V18, P523, DOI 10.3201/eid1803.111330; Pournaras S, 2010, J ANTIMICROB CHEMOTH, V65, P1319, DOI 10.1093/jac/dkq124; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Ribeiro VB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/139305; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; ROSSOLINI GM, 1995, ANTIMICROB AGENTS CH, V39, P346, DOI 10.1128/AAC.39.2.346; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Smet A, 2012, J ANTIMICROB CHEMOTH, V67, P3009, DOI 10.1093/jac/dks311; Tacao M, 2015, MICROB DRUG RESIST, V21, P497, DOI 10.1089/mdr.2015.0072; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Wang T, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-111; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang WJ, 2013, J ANTIMICROB CHEMOTH, V68, P1681, DOI 10.1093/jac/dkt066	50	45	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147363	10.1371/journal.pone.0147363	http://dx.doi.org/10.1371/journal.pone.0147363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824353	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600027
J	Zhang, Y; Shan, JL; Liu, XM; Li, F; Guan, K; Sun, TS				Zhang, Yang; Shan, Jian-Lin; Liu, Xiu-Mei; Li, Fang; Guan, Kai; Sun, Tian-Sheng			Comparison of the Dynesys Dynamic Stabilization System and Posterior Lumbar Interbody Fusion for Lumbar Degenerative Disease	PLOS ONE			English	Article							NEUTRALIZATION SYSTEM; ADJACENT SEGMENTS; SPINAL STENOSIS; FOLLOW-UP	Background There have been few studies comparing the clinical and radiographic outcomes between the Dynesys dynamic stabilization system and posterior lumbar interbody fusion (PLIF). The objective of this study is to compare the clinical and radiographic outcomes of Dynesys and PLIF for lumbar degenerative disease. Methods Of 96 patients with lumbar degenerative disease included in this retrospectively analysis, 46 were treated with the Dynesys system and 50 underwent PLIF from July 2008 to March 2011. Clinical and radiographic outcomes were evaluated. We also evaluated the occurrence of radiographic and symptomatic adjacent segment degeneration (ASD). Results The mean follow-up time in the Dynesys group was 53.6 +/- 5.3 months, while that in the PLIF group was 55.2 +/- 6.8 months. At the final follow-up, the Oswestry disability index and visual analogue scale score were significantly improved in both groups. The range of motion (ROM) of stabilized segments in Dynesys group decreased from 7.1 +/- 2.2 degrees to 4.9 +/- 2.2 degrees (P < 0.05), while that of in PLIF group decreased from 7.3 +/- 2.3 degrees to 0 degrees (P < 0.05). The ROM of the upper segments increased significantly in both groups at the final follow-up, the ROM was higher in the PLIF group. There were significantly more radiographic ASDs in the PLIF group than in the Dynesys group. The incidence of complications was comparable between groups. Conclusions Both Dynesys and PLIF can improve the clinical outcomes for lumbar degenerative disease. Compared to PLIF, Dynesys stabilization partially preserves the ROM of the stabilized segments, limits hypermobility in the upper adjacent segment, and may prevent the occurrence of ASD.	[Zhang, Yang; Shan, Jian-Lin; Liu, Xiu-Mei; Li, Fang; Guan, Kai; Sun, Tian-Sheng] Beijing Army Gen Hosp, Dept Orthoped, Beijing 100700, Peoples R China		Li, F (corresponding author), Beijing Army Gen Hosp, Dept Orthoped, Beijing 100700, Peoples R China.	fangl6722@163.com		Sun, Tiansheng/0000-0002-4053-7297	Youth Project of the "Twelfth Five-year Plan" for Medical Science Development of PLA [13QNP010]	Youth Project of the "Twelfth Five-year Plan" for Medical Science Development of PLA	This study was funded by the Youth Project of the "Twelfth Five-year Plan" for Medical Science Development of PLA (13QNP010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandjiwala J, 2011, EUR SPINE J, V20, P1951, DOI 10.1007/s00586-011-1917-0; Beastall J, 2007, SPINE, V32, P685, DOI 10.1097/01.brs.0000257578.44134.fb; Cakir B, 2009, SPINE, V34, P1287, DOI 10.1097/BRS.0b013e3181a136ab; Dakhil-Jerew F, 2009, EUR SPINE J, V18, P1486, DOI 10.1007/s00586-009-1071-0; Fay LY, 2013, CLIN NEUROL NEUROSUR, V115, P535, DOI 10.1016/j.clineuro.2012.05.036; Haddad B, 2013, ACTA ORTHOP BELG, V79, P97; Hikata T, 2014, J SPINAL DISORD TECH, V27, P70, DOI 10.1097/BSD.0b013e31824e5292; Hu Yong, 2011, Orthop Surg, V3, P167, DOI 10.1111/j.1757-7861.2011.00142.x; Kim CH, 2011, J SPINAL DISORD TECH, V24, P60, DOI 10.1097/BSD.0b013e3181d4eb44; Ko CC, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1052; Kumar A, 2008, SPINE, V33, P2909, DOI 10.1097/BRS.0b013e31818bdca7; Lee MJ, 2010, J AM ACAD ORTHOP SUR, V18, P581, DOI 10.5435/00124635-201010000-00001; Lee SE, 2008, J KOREAN NEUROSURG S, V43, P221, DOI 10.3340/jkns.2008.43.5.221; Legaye J, 2005, REV CHIR ORTHOP, V91, P542, DOI 10.1016/S0035-1040(05)84444-7; Schaeren S, 2008, SPINE, V33, pE636, DOI 10.1097/BRS.0b013e31817d2435; Schmoelz W, 2003, J SPINAL DISORD TECH, V16, P418, DOI 10.1097/00024720-200308000-00015; Stoll TM, 2002, EUR SPINE J, V11, pS170, DOI 10.1007/s00586-002-0438-2; Tsutsumimoto T, 2009, SPINE, V34, P1923, DOI 10.1097/BRS.0b013e3181a9d28e; Vaga S, 2009, EUR SPINE J, V18, pS40, DOI 10.1007/s00586-009-0996-7; Welch William C, 2007, Neurosurg Focus, V22, pE8; Wilsa MS, 2011, SEMIN SPINE SURG, V23, P266; Yu SW, 2012, ACTA ORTHOP BELG, V78, P230; Yu SW, 2012, ARCH ORTHOP TRAUM SU, V132, P583, DOI 10.1007/s00402-012-1460-4; Zhang Y, 2013, CHINESE J BONE JOINT, V2, P308	24	13	25	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0148071	10.1371/journal.pone.0148071	http://dx.doi.org/10.1371/journal.pone.0148071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824851	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600096
J	Bai, Y; Chen, SL; Laurson, KR; Kim, YW; Saint-Maurice, PF; Welk, GJ				Bai, Yang; Chen, Senlin; Laurson, Kelly R.; Kim, Youngwon; Saint-Maurice, Pedro F.; Welk, Gregory J.			The Associations of Youth Physical Activity and Screen Time with Fatness and Fitness: The 2012 NHANES National Youth Fitness Survey	PLOS ONE			English	Article							CARDIOMETABOLIC RISK-FACTORS; SEDENTARY BEHAVIOR; CARDIORESPIRATORY FITNESS; HEALTH INDICATORS; CHILDREN; ADIPOSITY; MODERATE; OBESITY; INTENSITY; ADOLESCENTS	The purpose of the study is to examine the associations of youth physical activity and screen time with weight status and cardiorespiratory fitness in children and adolescents, separately, utilizing a nationally representative sample. A total of 1,113 participants (692 children aged 6-11 yrs; 422 adolescents aged 12-15 yrs) from the 2012 NHANES National Youth Fitness Survey. Participants completed physical activity and screen time questionnaires, and their body mass index and cardiorespiratory fitness (adolescents only) were assessed. Adolescents completed additional physical activity questions to estimate daily MET minutes. Children not meeting the screen time guideline had 1.69 times the odds of being overweight/obese compared to those meeting the screen time guideline, after adjusting for physical activity and other control variables. Among adolescent, screen time was significantly associated with being overweight/obese (odds ratio = 1.82, 95% confidence interval: 1.06-3.15), but the association attenuated toward the borderline of being significant after controlling for physical activity. Being physically active was positively associated with cardiorespiratory fitness, independent of screen time among adolescents. In joint association analysis, children who did not meet physical activity nor screen time guidelines had 2.52 times higher odds of being overweight/obese than children who met both guidelines. Adolescents who did not meet the screen time guideline had significantly higher odds ratio of being overweight/obese regardless of meeting the physical activity guideline. Meeting the physical activity guideline was also associated with cardiorespiratory fitness regardless of meeting the screen time guideline in adolescents. Screen time is a stronger factor than physical activity in predicting weight status in both children and adolescents, and only physical activity is strongly associated with cardiorespiratory fitness in adolescents.	[Bai, Yang; Chen, Senlin; Saint-Maurice, Pedro F.; Welk, Gregory J.] Iowa State Univ, Dept Kinesiol, Ames, IA USA; [Laurson, Kelly R.] Illinois State Univ, Sch Kinesiol & Recreat, Normal, IL 61761 USA; [Kim, Youngwon] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	Iowa State University; Illinois State University; University of Cambridge	Bai, Y (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA USA.	ybai@iastate.edu		Saint-Maurice, Pedro F./0000-0002-8752-2340	MRC [MC_U106179473, MC_UU_12015/3] Funding Source: UKRI; Medical Research Council [MC_UU_12015/3, MC_U106179473] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Borrud L, 2014, VITA HLTH STAT, V2; Chaput JP, 2012, PEDIATR OBES, V7, P251, DOI 10.1111/j.2047-6310.2011.00028.x; Chaput JP, 2013, APPL PHYSIOL NUTR ME, V38, P477, DOI 10.1139/apnm-2012-0382; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Costigan SA, 2013, J ADOLESCENT HEALTH, V52, P382, DOI 10.1016/j.jadohealth.2012.07.018; Denton SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061073; Ekelund U, 2014, P NUTR SOC, V73, P319, DOI 10.1017/S0029665114000019; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Fulton JE, 2009, AM J PREV MED, V37, pS40, DOI 10.1016/j.amepre.2009.04.010; Hardy LL, 2009, AM J PREV MED, V36, P120, DOI 10.1016/j.amepre.2008.09.034; Hay J, 2012, ARCH PEDIAT ADOL MED, V166, P1022, DOI 10.1001/archpediatrics.2012.1028; Herman KM, 2014, PREV MED, V60, P115, DOI 10.1016/j.ypmed.2013.12.029; Herrick Kirsten A, 2014, NCHS Data Brief, P1; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Huang Jeannie S, 2011, BMC Res Notes, V4, P29, DOI 10.1186/1756-0500-4-29; Jago R, 2008, PREV MED, V47, P525, DOI 10.1016/j.ypmed.2008.07.016; Kriska A, 2013, PEDIATRICS, V131, pE850, DOI 10.1542/peds.2012-0620; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Kwon S, 2013, J PEDIATR-US, V162, P1169, DOI 10.1016/j.jpeds.2012.11.071; Laurson KR, 2008, J PEDIATR-US, V153, P209, DOI 10.1016/j.jpeds.2008.02.042; Liao Y, 2014, OBES REV, V15, P159, DOI 10.1111/obr.12112; Maher CA, 2013, OBESITY, V21, pE730, DOI 10.1002/oby.20430; Marques A, 2015, MED SCI SPORT EXER, V47, P575, DOI 10.1249/MSS.0000000000000426; Miller SA, 2008, INT J PEDIATR OBES, V3, P168, DOI 10.1080/17477160801915935; Mitchell JA, 2009, OBESITY, V17, P1596, DOI 10.1038/oby.2009.42; Moore JB, 2013, J SPORT SCI, V31, P1520, DOI 10.1080/02640414.2013.793378; Morrow JR, 2013, AM J PREV MED, V44, P439, DOI 10.1016/j.amepre.2013.01.008; Parikh T, 2011, SPORTS MED, V41, P477, DOI 10.2165/11588750-000000000-00000; Pate RR, 2013, OBES REV, V14, P645, DOI 10.1111/obr.12035; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Rundle A, 2012, AM J EPIDEMIOL, V176, P986, DOI 10.1093/aje/kws187; Santos R, 2014, BRIT J SPORT MED, V48, P1508, DOI 10.1136/bjsports-2012-091610; Saunders TJ, 2014, CAN J DIABETES, V38, P53, DOI 10.1016/j.jcjd.2013.08.266; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Trilk JL, 2013, MED SCI SPORT EXER, V45, P722, DOI 10.1249/MSS.0b013e31827aa875; Tucker JS, 2014, J PHYS ACT HEALTH, V11, P1006, DOI 10.1123/jpah.2011-0431; Welk GJ, 2011, AM J PREV MED, V41, pS111, DOI 10.1016/j.amepre.2011.07.007; Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436	43	55	55	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148038	10.1371/journal.pone.0148038	http://dx.doi.org/10.1371/journal.pone.0148038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820144	gold, Green Submitted, Green Published			2022-12-27	WOS:000369528400061
J	Castejon, C; Barros-Zulaica, N; Nunez, A				Castejon, Carlos; Barros-Zulaica, Natali; Nunez, Angel			Control of Somatosensory Cortical Processing by Thalamic Posterior Medial Nucleus: A New Role of Thalamus in Cortical Function	PLOS ONE			English	Article							PYRAMIDAL NEURONS; BARREL CORTEX; LAYER-I; ELECTRICAL-STIMULATION; SENSORY INFORMATION; GABAERGIC NEURONS; PREFRONTAL CORTEX; CEREBRAL-CORTEX; TUFT DENDRITES; GABA RELEASE	Current knowledge of thalamocortical interaction comes mainly from studying lemniscal thalamic systems. Less is known about paralemniscal thalamic nuclei function. In the vibrissae system, the posterior medial nucleus (POm) is the corresponding paralemniscal nucleus. POm neurons project to L1 and L5A of the primary somatosensory cortex (S1) in the rat brain. It is known that L1 modifies sensory-evoked responses through control of intracortical excitability suggesting that L1 exerts an influence on whisker responses. Therefore, thalamocortical pathways targeting L1 could modulate cortical firing. Here, using a combination of electrophysiology and pharmacology in vivo, we have sought to determine how POm influences cortical processing. In our experiments, single unit recordings performed in urethane-anesthetized rats showed that POm imposes precise control on the magnitude and duration of supra-and infragranular barrel cortex whisker responses. Our findings demonstrated that L1 inputs from POm imposed a time and intensity dependent regulation on cortical sensory processing. Moreover, we found that blocking L1 GABAergic inhibition or blocking P/Q-type Ca2+ channels in L1 prevents POm adjustment of whisker responses in the barrel cortex. Additionally, we found that POm was also controlling the sensory processing in S2 and this regulation was modulated by corticofugal activity from L5 in S1. Taken together, our data demonstrate the determinant role exerted by the POm in the adjustment of somatosensory cortical processing and in the regulation of cortical processing between S1 and S2. We propose that this adjustment could be a thalamocortical gain regulation mechanism also present in the processing of information between cortical areas.	[Castejon, Carlos; Barros-Zulaica, Natali; Nunez, Angel] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain	Autonomous University of Madrid	Nunez, A (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain.	angel.nunez@uam.es	Nuñez, Angel/Y-9137-2019	Nuñez, Angel/0000-0002-8013-4812	Ministerio de Economia y Competitividad [BFU2012-36107]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by a grant from Ministerio de Economia y Competitividad (BFU2012-36107).	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; Ahissar E, 2001, Prog Brain Res, V130, P75; Ahissar E, 2015, CEREB CORTEX, V25, P845, DOI 10.1093/cercor/bht296; [Anonymous], 2004, RAT NERVOUS SYSTEM; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Atencio CA, 2014, J NEUROPHYSIOL, V111, P1077, DOI 10.1152/jn.00749.2012; Barros-Zulaica N, 2014, NEUROSCIENCE, V281, P178, DOI 10.1016/j.neuroscience.2014.09.057; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; Bokor H, 2008, J NEUROSCI, V28, P5169, DOI 10.1523/JNEUROSCI.0490-08.2008; Bragin A, 1997, J NEUROSCI, V17, P2567; BULLIER J, 1988, EXP BRAIN RES, V70, P90; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Castro-Alamancos MA, 2002, J NEUROPHYSIOL, V87, P946, DOI 10.1152/jn.00426.2001; Castro-Alamancos MA, 1999, J NEUROSCI, V19, part. no.; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Chakrabarti S, 2008, J NEUROPHYSIOL, V100, P50, DOI 10.1152/jn.90327.2008; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Chu ZG, 2003, J NEUROSCI, V23, P96; Clasca F, 2012, EUR J NEUROSCI, V35, P1524, DOI 10.1111/j.1460-9568.2012.08033.x; Cottam JCH, 2009, J NEUROPHYSIOL, V102, P9, DOI 10.1152/jn.00290.2009; Cruikshank SJ, 2012, J NEUROSCI, V32, P17813, DOI 10.1523/JNEUROSCI.3231-12.2012; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; Dilgen J, 2013, J NEUROPHYSIOL, V110, P221, DOI 10.1152/jn.00531.2012; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Frangeul L, 2014, EUR J NEUROSCI, V39, P1455, DOI 10.1111/ejn.12524; Gambino F, 2014, NATURE, V515, P116, DOI 10.1038/nature13664; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Groh A, 2014, CEREB CORTEX, V24, P3167, DOI 10.1093/cercor/bht173; Guillery RW, 2011, BRAIN RES REV, V66, P205, DOI 10.1016/j.brainresrev.2010.08.001; Guillery RW, 2005, PROG BRAIN RES, V149, P235, DOI 10.1016/S0079-6123(05)49017-2; Haidarliu S, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.004.2008; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; JACQUIN MF, 1989, J COMP NEUROL, V282, P24, DOI 10.1002/cne.902820104; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Jones E G, 1998, Adv Neurol, V77, P49; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Killackey HP, 2003, J NEUROSCI, V23, P7381; Kubota Y, 2014, CURR OPIN NEUROBIOL, V26, P7, DOI 10.1016/j.conb.2013.10.003; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lee AJ, 2014, CEREB CORTEX; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Masri R, 2008, J NEUROPHYSIOL, V100, P681, DOI 10.1152/jn.01322.2007; Masri R, 2012, ADV EXP MED BIOL, V760, P74; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; Nunez A, 2012, J NEUROPHYSIOL, V108, P1656, DOI 10.1152/jn.00156.2012; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pezze M, 2014, J NEUROSCI, V34, P7931, DOI 10.1523/JNEUROSCI.3450-13.2014; Pierret T, 2000, J NEUROSCI, V20, P7455; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; PRIETO JJ, 1994, J COMP NEUROL, V344, P349, DOI 10.1002/cne.903440304; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rose HJ, 2001, NEUROSCIENCE, V106, P331, DOI 10.1016/S0306-4522(01)00282-2; Rossignol E, 2013, ANN NEUROL, V74, P209, DOI 10.1002/ana.23913; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Salling MC, 2014, J NEUROPHYSIOL, V112, P1169, DOI 10.1152/jn.00714.2013; Sewards TV, 2002, BRAIN RES BULL, V58, P243, DOI 10.1016/S0361-9230(02)00783-9; Sherman SM, 2012, CURR OPIN NEUROBIOL, V22, P575, DOI 10.1016/j.conb.2012.03.005; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Shlosberg D, 2006, J NEUROPHYSIOL, V96, P3170, DOI 10.1152/jn.00520.2006; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Sitnikova E Yu, 2010, Neurosci Behav Physiol, V40, P325, DOI 10.1007/s11055-010-9259-7; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Swadlow HA, 1998, J NEUROSCI METH, V79, P131, DOI 10.1016/S0165-0270(97)00176-3; Theyel BB, 2010, NAT NEUROSCI, V13, P84, DOI 10.1038/nn.2449; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Veinante P, 2000, J COMP NEUROL, V420, P233, DOI 10.1002/(SICI)1096-9861(20000501)420:2<233::AID-CNE6>3.0.CO;2-T; Veinante P, 1999, J NEUROSCI, V19, P5085; Viaene AN, 2011, P NATL ACAD SCI USA, V108, P18156, DOI 10.1073/pnas.1114828108; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; WINER JA, 1989, NEUROSCIENCE, V33, P499, DOI 10.1016/0306-4522(89)90402-8; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257; Wright N, 2010, J NEUROPHYSIOL, V103, P709, DOI 10.1152/jn.00560.2009; Yang JW, 2013, CEREB CORTEX, V23, P1299, DOI 10.1093/cercor/bhs103; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zaitsev AV, 2007, J NEUROPHYSIOL, V97, P3567, DOI 10.1152/jn.01293.2006; Zhou FM, 1996, J NEUROPHYSIOL, V76, P651, DOI 10.1152/jn.1996.76.2.651; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004	95	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148169	10.1371/journal.pone.0148169	http://dx.doi.org/10.1371/journal.pone.0148169			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820514	Green Submitted, gold, Green Published			2022-12-27	WOS:000369528400075
J	Krueger, AS; Munck, C; Dantas, G; Church, GM; Galagan, J; Lehar, J; Sommer, MOA				Krueger, Andrew S.; Munck, Christian; Dantas, Gautam; Church, George M.; Galagan, James; Lehar, Joseph; Sommer, Morten O. A.			Simulating Serial-Target Antibacterial Drug Synergies Using Flux Balance Analysis	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; COMBINATION; CONSTRAINT; MODELS; METABOLISM; GROWTH; RECONSTRUCTION; RESISTANCE	Flux balance analysis (FBA) is an increasingly useful approach for modeling the behavior of metabolic systems. However, standard FBA modeling of genetic knockouts cannot predict drug combination synergies observed between serial metabolic targets, even though such synergies give rise to some of the most widely used antibiotic treatments. Here we extend FBA modeling to simulate responses to chemical inhibitors at varying concentrations, by diverting enzymatic flux to a waste reaction. This flux diversion yields very similar qualitative predictions to prior methods for single target activity. However, we find very different predictions for combinations, where flux diversion, which mimics the kinetics of competitive metabolic inhibitors, can explain serial target synergies between metabolic enzyme inhibitors that we confirmed in Escherichia coli cultures. FBA flux diversion opens the possibility for more accurate genome-scale predictions of drug synergies, which can be used to suggest treatments for infections and other diseases.	[Krueger, Andrew S.; Galagan, James; Lehar, Joseph] Boston Univ, 44 Cummington St, Boston, MA 02215 USA; [Munck, Christian; Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO USA; [Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Galagan, James] Cambridge Ctr, Broad Inst, Cambridge, MA USA	Boston University; Technical University of Denmark; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lehar, J (corresponding author), Boston Univ, 44 Cummington St, Boston, MA 02215 USA.; Sommer, MOA (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.	jlehar@bu.edu; msom@bio.dtu.dk		church, george/0000-0001-6232-9969; Dantas, Gautam/0000-0003-0455-8370; Sommer, Morten Otto Alexander/0000-0003-4005-5674; Galagan, James/0000-0003-0542-3291	Lundbeck Foundation; EU FP7-Health Program Evotar [282004]; Lundbeck Foundation [R140-2013-13496, R77-2010-6772] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517, NNF14OC0011335, NNF13SA0006019, NNF13SA0009311] Funding Source: researchfish; NNF Center for Biosustainability [Bacterial Synthetic Biology] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); EU FP7-Health Program Evotar; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	MOAS acknowledges funding from The Lundbeck Foundation (www.lundbeckfonden.com) and EU FP7-Health Program Evotar (282004) (www.cordis.europa.eu/fp7/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENBAUM MC, 1985, J THEOR BIOL, V114, P413, DOI 10.1016/S0022-5193(85)80176-4; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brandes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036947; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; CHRISTOPHERSON RI, 1983, EUR J BIOCHEM, V134, P331, DOI 10.1111/j.1432-1033.1983.tb07571.x; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Cottarel G, 2007, TRENDS BIOTECHNOL, V25, P547, DOI 10.1016/j.tibtech.2007.09.004; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Federowicz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004264; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fischbach MA, 2011, CURR OPIN MICROBIOL, V14, P519, DOI 10.1016/j.mib.2011.08.003; Gelius-Dietrich G, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-125; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Imielinski M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-40; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Thiele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045635; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994	45	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147651	10.1371/journal.pone.0147651	http://dx.doi.org/10.1371/journal.pone.0147651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26821252	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400037
J	Kniel, N; Bender, S; Witte, K				Kniel, Nina; Bender, Stefanie; Witte, Klaudia			Sex-Specific Audience Effect in the Context of Mate Choice in Zebra Finches	PLOS ONE			English	Article							TAENIOPYGIA-GUTTATA; PUBLIC INFORMATION; SPERM COMPETITION; MATING PREFERENCES; JAPANESE-QUAIL; MALES; PAIR; BEHAVIOR; ADJUST; COLOR	Animals observing conspecifics during mate choice can gain additional information about potential mates. However, the presence of an observer, if detected by the observed individuals, can influence the nature of the behavior of the observed individuals, called audience effect. In zebra finches (Taeniopygia guttata castanotis), domesticated males show an audience effect during mate choice. However, whether male and female descendants of the wild form show an audience effect during mate choice is unknown. Therefore, we conducted an experiment where male and female focal birds could choose between two distinctive phenotypes of the opposite sex, an artificially adorned stimulus bird with a red feather on the forehead and an unadorned stimulus bird, two times consecutively, once without an audience and once with an audience bird (same sex as test bird). Males showed an audience effect when an audience male was present and spent more time with adorned and less time with unadorned females compared to when there was no audience present. The change in time spent with the respective stimulus females was positively correlated with the time that the audience male spent in front of its cage close to the focal male. Females showed no change in mate choice when an audience female was present, but their motivation to associate with both stimulus males decreased. In a control for mate-choice consistency there was no audience in either test. Here, both focal females and focal males chose consistently without a change in choosing motivation. Our results showed that there is an audience effect on mate choice in zebra finches and that the response to a same-sex audience was sex-specific.	[Kniel, Nina; Bender, Stefanie; Witte, Klaudia] Univ Siegen, Res Grp Ecol & Behav Biol, Inst Biol, Dept Biol & Chem, D-57068 Siegen, Germany	Universitat Siegen	Kniel, N (corresponding author), Univ Siegen, Res Grp Ecol & Behav Biol, Inst Biol, Dept Biol & Chem, D-57068 Siegen, Germany.	kniel@biologie.uni-siegen.de		Kniel, Nina/0000-0002-0858-3912	"Hochschulinterne Forschungsoforderung (HIFF)" of the University of Siegen; University of Siegen	"Hochschulinterne Forschungsoforderung (HIFF)" of the University of Siegen; University of Siegen	This work was supported by the "Hochschulinterne Forschungsoforderung (HIFF)" of the University of Siegen. NK was supported by a Ph.D. scholarship of the University of Siegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy M, 2008, ANIM BEHAV, V76, P971, DOI 10.1016/j.anbehav.2008.03.023; Auld HL, 2015, BEHAV ECOL SOCIOBIOL, V69, P1191, DOI 10.1007/s00265-015-1933-x; BALTZ AP, 1994, ANIM BEHAV, V47, P460, DOI 10.1006/anbe.1994.1061; Baltz AP, 1997, ANIM BEHAV, V53, P1017, DOI 10.1006/anbe.1996.0354; Bierbach D, 2011, BIOL LETTERS, V7, P349, DOI 10.1098/rsbl.2010.0982; Birkhead TR, 2010, EMU, V110, P189, DOI 10.1071/MU09086; BIRKHEAD TR, 1990, BEHAV ECOL SOCIOBIOL, V27, P315, DOI 10.1007/BF00164002; BIRKHEAD TR, 1993, J REPROD FERTIL, V99, P593; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1985, AUK, V102, P647, DOI 10.1093/auk/102.3.647; Burley N., 1985, Ornithological Monographs, P22; Burley NT, 1998, AM NAT, V152, P792, DOI 10.1086/286209; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Doucet SM, 2004, CAN J ZOOL, V82, P1, DOI 10.1139/Z03-210; Drullion D, 2008, BEHAV ECOL SOCIOBIOL, V63, P269, DOI 10.1007/s00265-008-0658-5; Dubois F, 2007, ANIM BEHAV, V74, P1785, DOI 10.1016/j.anbehav.2007.03.023; Dubois F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043697; Dzieweczynski TL, 2014, ETHOLOGY, V120, P855, DOI 10.1111/eth.12255; Dzieweczynski TL, 2012, ANIM BEHAV, V83, P1219, DOI 10.1016/j.anbehav.2012.02.013; Fitzsimmons LP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0449; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; HECTOR ACK, 1989, ANIM BEHAV, V38, P262, DOI 10.1016/S0003-3472(89)80088-0; Hoi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032806; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hoysak DJ, 2007, ETHOLOGY, V113, P1007, DOI 10.1111/j.1439-0310.2007.01413.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jones KM, 2001, ANIM BEHAV, V62, P1021, DOI 10.1006/anbe.2001.1843; Kniel N, 2015, BEHAV ECOL, V26, P647, DOI 10.1093/beheco/aru241; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Leaver LA, 2007, ANIM COGN, V10, P23, DOI 10.1007/s10071-006-0026-7; Leboucher G, 2004, ANIM BEHAV, V68, P957, DOI 10.1016/j.anbehav.2003.12.011; Makowicz AM, 2010, BEHAVIOUR, V147, P1657, DOI 10.1163/000579510X528206; Matessi G, 2005, BEHAVIOUR, V142, P507, DOI 10.1163/1568539054012010; Matos Ricardo J., 2005, P63, DOI 10.1017/CBO9780511610363.006; Matos RJ, 2002, BEHAVIOUR, V139, P1211, DOI 10.1163/15685390260437344; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; Monaghan P, 1996, P ROY SOC B-BIOL SCI, V263, P1183, DOI 10.1098/rspb.1996.0173; Nobel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053865; Ophir AG, 2005, J COMP PSYCHOL, V119, P3, DOI 10.1037/0735-7036.119.1.3; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Overduin-De Vries AM, 2012, AM J PRIMATOL, V74, P217, DOI 10.1002/ajp.21988; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Plath M, 2007, BEHAV ECOL, V18, P680, DOI 10.1093/beheco/arm030; Plath Martin, 2008, Communicative & Integrative Biology, V1, P199; Plath M, 2009, BEHAV ECOL SOCIOBIOL, V63, P381, DOI 10.1007/s00265-008-0672-7; Plenge M, 2000, BEHAVIOUR, V137, P741, DOI 10.1163/156853900502321; Price AC, 2006, ETHOLOGY, V112, P22, DOI 10.1111/j.1439-0310.2006.01142.x; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Schlupp I, 1997, BEHAV ECOL, V8, P104, DOI 10.1093/beheco/8.1.104; Simons MJP, 2011, BEHAV ECOL, V22, P755, DOI 10.1093/beheco/arr043; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V258, P267, DOI 10.1098/rspb.1994.0172; Swaddle JP, 2005, P ROY SOC B-BIOL SCI, V272, P1053, DOI 10.1098/rspb.2005.3054; Tachon G, 1999, J INSECT BEHAV, V12, P533, DOI 10.1023/A:1020970908541; Townsend Simon, 2009, Communicative & Integrative Biology, V2, P282; Ung D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022686; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Westneat DF, 2000, ANIM BEHAV, V59, P467, DOI 10.1006/anbe.1999.1341; Williams TH, 2010, ETHOLOGY, V116, P1038, DOI 10.1111/j.1439-0310.2010.01816.x; Witte K, 1999, BEHAV ECOL, V10, P15, DOI 10.1093/beheco/10.1.15; Witte K, 2000, ETHOLOGY, V106, P349, DOI 10.1046/j.1439-0310.2000.00558.x; Witte K, 2003, ANIM BEHAV, V65, P195, DOI 10.1006/anbe.2002.2009; Witte K, 2011, FISH COGNITION BEHAV, P85; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; Wong BBM, 2009, BEHAV ECOL, V20, P278, DOI 10.1093/beheco/arp010; Wronski T, 2012, BEHAV ECOL, V23, P551, DOI 10.1093/beheco/arr223; Zann R. A., 1996, ZEBRA FINCHES SYNTHE; Ziege M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-17	77	7	7	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0147130	10.1371/journal.pone.0147130	http://dx.doi.org/10.1371/journal.pone.0147130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26839957	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200026
J	Wang, M; Moran, AE; Liu, J; Coxson, PG; Penko, J; Goldman, L; Bibbins-Domingo, K; Zhao, D				Wang, Miao; Moran, Andrew E.; Liu, Jing; Coxson, Pamela G.; Penko, Joanne; Goldman, Lee; Bibbins-Domingo, Kirsten; Zhao, Dong			Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study	PLOS ONE			English	Article							TARGETED FOOD TAXES; BLOOD-PRESSURE; MAGNESIUM SUPPLEMENTATION; POTASSIUM EXCRETION; URINARY SODIUM; HEART-DISEASE; METAANALYSIS; REDUCTION; HEALTH; RISK	Objectives To estimate the effects of achieving China's national goals for dietary salt (NaCl) reduction or implementing culturally-tailored dietary salt restriction strategies on cardiovascular disease (CVD) prevention. Methods The CVD Policy Model was used to project blood pressure lowering and subsequent downstream prevented CVD that could be achieved by population-wide salt restriction in China. Outcomes were annual CVD events prevented, relative reductions in rates of CVD incidence and mortality, quality-adjusted life-years (QALYs) gained, and CVD treatment costs saved. Results Reducing mean dietary salt intake to 9.0 g/day gradually over 10 years could prevent approximately 197 000 incident annual CVD events [95% uncertainty interval (UI): 173 000-219 000], reduce annual CVD mortality by approximately 2.5% (2.2-2.8%), gain 303 000 annual QALYs (278 000-329 000), and save approximately 1.4 billion international dollars (Int$) in annual CVD costs (Int$; 1.2-1.6 billion). Reducing mean salt intake to 6.0 g/day could approximately double these benefits. Implementing cooking salt-restriction spoons could prevent 183 000 fewer incident CVD cases (153 000-215 000) and avoid Int$ 1.4 billion in CVD treatment costs annually (1.2-1.7 billion). Implementing a cooking salt substitute strategy could lead to approximately three times the health benefits of the saltrestriction spoon program. More than three-quarters of benefits from any dietary salt reduction strategy would be realized in hypertensive adults. Conclusion China could derive substantial health gains from implementation of population-wide dietary salt reduction policies. Most health benefits from any dietary salt reduction program would be realized in adults with hypertension.	[Wang, Miao; Liu, Jing; Zhao, Dong] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing Anzhen Hosp, Beijing, Peoples R China; [Moran, Andrew E.] Columbia Univ, Dept Med, Div Gen Med, New York, NY USA; [Coxson, Pamela G.; Penko, Joanne; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA USA; [Goldman, Lee] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA	Capital Medical University; Columbia University; University of California System; University of California San Francisco; Columbia University	Zhao, D (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing Anzhen Hosp, Beijing, Peoples R China.	deezhao@vip.sina.com	Zhao, D/AAX-5040-2021		National Program on Key Basic Research Project of China [2012CB517806]; National Science & Technology Pillar Program [2011BAI09B01, 2011BAI11B03]; Capital Health Research and Development of Special [2011-1005-01]; Mentored Career Development Award from the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health [K08HL089675]; University of California Pacific Rim Research Program; Beijing Talents Fund [2014000021469G232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Science & Technology Pillar Program; Capital Health Research and Development of Special; Mentored Career Development Award from the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health; University of California Pacific Rim Research Program(University of California System); Beijing Talents Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the National Program on Key Basic Research Project of China (contract 2012CB517806, http://program.most.gov.cn) and the National Science & Technology Pillar Program during the 12th Five-Year Plan Period (contracts 2011BAI09B01 and 2011BAI11B03, http://program.most.gov.cn) to Dr. Zhao, the Capital Health Research and Development of Special (contract 2011-1005-01, http://www.bjhbkj.com) to Dr. Liu, Mentored Career Development Award (contract K08HL089675, http://www.nhlbi.nih.gov) from the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health to Dr. Moran, a University of California Pacific Rim Research Program (http://www.ucsf.edu) grant to Dr. Bibbins-Domingo, and the Beijing Talents Fund (contract 2014000021469G232, http://bjrcgz.gov.cn) to Dr. Wang. The sponsors of this study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2014, LANCET, DOI DOI 10.1016/S0140-6736(14)60616-4; Chen JJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/658925; Chinese Center for Disease Control and Prevention, 2013, SALT INT LEV WAS REL; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ge K, 2011, ASIA PAC J CLIN NUTR, V20, P439; Geleijnse JM, 2003, J HUM HYPERTENS, V17, P471, DOI 10.1038/sj.jhh.1001575; Gillespie DOS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127927; Gu DF, 2008, AM J HYPERTENS, V21, P265, DOI 10.1038/ajh.2007.59; Gu DF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001860; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; He J, 2004, ETHNIC DIS, V14, P260; Hendriksen MAH, 2014, AM J CLIN NUTR, V99, P446, DOI 10.3945/ajcn.113.062018; [胡继宏 Hu Jihong], 2014, [中华高血压杂志, Chinese Journal of Hypertension], V22, P42; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3; Kass L, 2012, EUR J CLIN NUTR, V66, P411, DOI 10.1038/ejcn.2012.4; Li N, 2013, AM HEART J, V166, P815, DOI 10.1016/j.ahj.2013.07.009; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Ministry of Health of the Peoples Republic of China, 2011, CHIN HLTH STAT YB 20; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; The Peoples Republic of China National Health and Family Planning Commission, 2012, CHIN NAT PLAN NCD PR; Wang M, 2015, GLOB HEART, V10, P291, DOI 10.1016/j.gheart.2014.10.009; Wang MA, 2014, CIRC-CARDIOVASC QUAL, V7, P78, DOI 10.1161/CIRCOUTCOMES.113.000674; Wang Y, 2015, EUR J PREV CARDIOL, V22, P380, DOI 10.1177/2047487313516563; World Health Organization, 2014, WORLD HLTH STAT 2013; Xi B, 2014, LANCET, V383, P1128, DOI 10.1016/S0140-6736(14)60567-5; Zhai F., 2006, REPORT CHINESE NATL; Zhang Ji-Guo, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P310; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807	40	15	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2016	11	2							e0146820	10.1371/journal.pone.0146820	http://dx.doi.org/10.1371/journal.pone.0146820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9OF	26840409	Green Published, gold, Green Submitted			2022-12-27	WOS:000369550200017
J	Martos-Sitcha, JA; Mancera, JM; Calduch-Giner, JA; Yufera, M; Martinez-Rodriguez, G; Perez-Sanchez, J				Antonio Martos-Sitcha, Juan; Miguel Mancera, Juan; Alvar Calduch-Giner, Josep; Yufera, Manuel; Martinez-Rodriguez, Gonzalo; Perez-Sanchez, Jaume			Unraveling the Tissue-Specific Gene Signatures of Gilthead Sea Bream (Sparus aurata L.) after Hyper- and Hypo-Osmotic Challenges	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TIME-COURSE; ENERGY-METABOLISM; FUNDULUS-HETEROCLITUS; OPERCULAR EPITHELIUM; ARGININE VASOTOCIN; RAINBOW-TROUT; UDP-GLUCURONOSYLTRANSFERASE; OREOCHROMIS-MOSSAMBICUS; OSMOREGULATORY RESPONSE	A custom microarray was used for the transcriptomic profiling of liver, gills and hypothalamus in response to hypo-(38% -> 5%) or hyper-(38% -> 55%) osmotic challenges (7 days after salinity transfer) in gilthead sea bream (Sparus aurata) juveniles. The total number of differentially expressed genes was 777. Among them, 341 and 310 were differentially expressed in liver after hypo-and hyper-osmotic challenges, respectively. The magnitude of changes was lower in gills and hypothalamus with around 131 and 160 responsive genes in at least one osmotic stress condition, respectively. Regardless of tissue, a number of genes were equally regulated in either hypo-and hyper-osmotic challenges: 127 out of 524 in liver, 11 out of 131 in gills and 19 out of 160 in hypothalamus. In liver and gills, functional analysis of differentially expressed genes recognized two major clusters of overlapping canonical pathways that were mostly related to "Energy Metabolism" and "Oxidative Stress". The later cluster was represented in all the analyzed tissues, including the hypothalamus, where differentially expressed genes related to "Cell and tissue architecture" were also over-represented. Overall the response for "Energy Metabolism" was the up-regulation, whereas for oxidative stress-related genes the type of response was highly dependent of tissue. These results support common and different osmoregulatory responses in the three analyzed tissues, helping to load new allostatic conditions or even to return to basal levels after hypo-or hyper-osmotic challenges according to the different physiological role of each tissue.	[Antonio Martos-Sitcha, Juan; Yufera, Manuel; Martinez-Rodriguez, Gonzalo] CSIC, Inst Ciencias Marinas Andalucia ICMAN, E-11519 Puerto Real, Cadiz, Spain; [Antonio Martos-Sitcha, Juan; Miguel Mancera, Juan] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEI MAR, E-11519 Puerto Real, Cadiz, Spain; [Alvar Calduch-Giner, Josep; Perez-Sanchez, Jaume] CSIC, IATS, Nutrigen & Fish Growth Endocrinol Grp, E-12595 Ribera De Cabanes, Castellon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Martos-Sitcha, JA (corresponding author), CSIC, Inst Ciencias Marinas Andalucia ICMAN, E-11519 Puerto Real, Cadiz, Spain.; Martos-Sitcha, JA (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEI MAR, E-11519 Puerto Real, Cadiz, Spain.	juanantonio.sitcha@icman.csic.es	Yufera, Manuel/E-1309-2011; Calduch-Giner, Josep/AAY-1475-2021; sanchez, jaume perez/K-3231-2014; MARTINEZ-RODRIGUEZ, GONZALO/A-2564-2009; Sánchez, Jaume Pérez/AAJ-6628-2021; Martos-Sitcha, Juan Antonio/L-6140-2014	Calduch-Giner, Josep/0000-0003-3124-5986; sanchez, jaume perez/0000-0003-2506-1523; MARTINEZ-RODRIGUEZ, GONZALO/0000-0003-3379-580X; Sánchez, Jaume Pérez/0000-0003-2506-1523; Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; Yufera, Manuel/0000-0003-2999-4611	Spanish Ministry of Economic Affairs and Competitiveness (MINECO); FEDER/ERDF [AGL2013-48835-C2-1-R, CDS2007-00002]; Spanish Ministry of Economic Affairs and Competitiveness (MINECO) [FJCI-2014-20161]	Spanish Ministry of Economic Affairs and Competitiveness (MINECO); FEDER/ERDF; Spanish Ministry of Economic Affairs and Competitiveness (MINECO)	This research was funded by the Spanish Ministry of Economic Affairs and Competitiveness (MINECO) with FEDER/ERDF contribution by projects AGL2013-48835-C2-1-R to JMM and AQUAGENOMICS (CDS2007-00002) to MY and JPS. JAMS is supported by a Post-Doctoral contract (Juan de la Cierva-formacion, Reference FJCI-2014-20161) from Spanish Ministry of Economic Affairs and Competitiveness (MINECO).	ANKLEY GT, 1986, AQUAT TOXICOL, V9, P91, DOI 10.1016/0166-445X(86)90016-0; Martos-Sitcha JA, 2015, COMP BIOCHEM PHYS A, V182, P93, DOI 10.1016/j.cbpa.2014.12.027; Martos-Sitcha JA, 2013, GEN COMP ENDOCR, V193, P221, DOI 10.1016/j.ygcen.2013.07.017; Arjona FJ, 2007, COMP BIOCHEM PHYS A, V148, P413, DOI 10.1016/j.cbpa.2007.05.026; Benedito-Palos L, 2010, J ANIM SCI, V88, P1759, DOI 10.2527/jas.2009-2564; Benedito-Palos L, 2014, GENE, V547, P34, DOI 10.1016/j.gene.2014.05.073; Bermejo-Nogales A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122889; Bermejo-Nogales A, 2014, GEN COMP ENDOCR, V205, P305, DOI 10.1016/j.ygcen.2014.04.016; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Calduch-Giner JA, 2014, MAR BIOTECHNOL, V16, P423, DOI 10.1007/s10126-014-9562-3; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; Calduch-Giner JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-193; Cuesta A, 2005, FISH SHELLFISH IMMUN, V18, P255, DOI 10.1016/j.fsi.2004.07.009; Davey GC, 2011, MOL IMMUNOL, V48, P2102, DOI 10.1016/j.molimm.2011.07.003; Edwards SL, 2013, FISH PHYSIOL, V32, P1, DOI 10.1016/B978-0-12-396951-4.00001-3; Evans DH, 2008, AM J PHYSIOL-REG I, V295, pR704, DOI 10.1152/ajpregu.90337.2008; Evans David H., 1993, P315; Evans DH, 2004, AM J PHYSIOL-REG I, V286, pR560, DOI 10.1152/ajpregu.00281.2003; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Evans TG, 2008, J EXP BIOL, V211, P3636, DOI 10.1242/jeb.022160; Ferraresso S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-580; Finnson KW, 1997, COMP BIOCHEM PHYS C, V117, P193, DOI 10.1016/S0742-8413(96)00231-9; Finnson KW, 1996, GEN COMP ENDOCR, V101, P145, DOI 10.1006/gcen.1996.0016; Fiol DF, 2007, FEBS J, V274, P5790, DOI 10.1111/j.1742-4658.2007.06099.x; Frische EW, 2010, DEV BIOL, V340, P1, DOI 10.1016/j.ydbio.2009.12.043; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George Stephen G., 1994, P37; Gregorio SF, 2013, J EXP BIOL, V216, P470, DOI 10.1242/jeb.073742; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Henry RP, 2003, COMP BIOCHEM PHYS A, V136, P243, DOI 10.1016/S1095-6433(03)00113-2; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; Holmes W. N., 1969, P1; Kalujnaia S, 2007, PHYSIOL GENOMICS, V31, P385, DOI 10.1152/physiolgenomics.00059.2007; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kelly SP, 1999, ZOOL SCI, V16, P505, DOI 10.2108/zsj.16.505; Klaren PHM, 2007, GEN COMP ENDOCR, V152, P215, DOI 10.1016/j.ygcen.2007.02.010; Kleszczynska A, 2006, COMP BIOCHEM PHYS A, V145, P268, DOI 10.1016/j.cbpa.2006.06.037; KNOWLES AF, 1971, J BIOL CHEM, V246, P2672; Kulczykowska E, 2002, REV FISH BIOL FISHER, V11, P321; Kulczykowska E, 1998, EXP PHYSIOL, V83, P809, DOI 10.1113/expphysiol.1998.sp004161; KULCZYKOWSKA E, 1995, REV FISH BIOL FISHER, V5, P96, DOI 10.1007/BF01103367; Kultz D, 2001, COMP BIOCHEM PHYS B, V129, P821, DOI 10.1016/S1096-4959(01)00395-5; Laiz-Carrion R, 2005, AQUACULTURE, V250, P849, DOI 10.1016/j.aquaculture.2005.05.021; Laiz-Carrion R, 2005, J EXP ZOOL PART A, V303A, P563, DOI 10.1002/jez.a.183; Lam SH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-921; Lin CH, 2004, J EXP ZOOL PART A, V301A, P85, DOI 10.1002/jez.a.20007; Lionetto MG, 1998, COMP BIOCHEM PHYS A, V120, P89, DOI 10.1016/S1095-6433(98)10014-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Olmeda JF, 2009, COMP BIOCHEM PHYS A, V152, P486, DOI 10.1016/j.cbpa.2008.12.003; Maetz J., 1974, Biochemical biophys Perspect mar Biol, V1, P1; Mancera JM, 2002, GEN COMP ENDOCR, V129, P95, DOI 10.1016/S0016-6480(02)00522-1; Marshall WS, 1999, J EXP BIOL, V202, P1535; Marshall WS, 2005, J EXP BIOL, V208, P1063, DOI 10.1242/jeb.01491; Marshall WS, 2002, J EXP ZOOL, V293, P264, DOI 10.1002/jez.10127; Martos-Sitcha JA, 2014, GEN COMP ENDOCR, V197, P5, DOI 10.1016/j.ygcen.2013.11.026; Martos-Sitcha JA, 2014, COMP BIOCHEM PHYS A, V177, P49, DOI 10.1016/j.cbpa.2014.07.021; McCormick SD, 2013, FISH PHYSIOL, V32, P1; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; NEUWELT EA, 1987, J NEURO-ONCOL, V4, P195, DOI 10.1007/BF00150611; RAPOPORT SI, 1988, ANN NEUROL, V24, P677, DOI 10.1002/ana.410240513; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Salem M, 2005, COMP BIOCHEM PHYS B, V140, P63, DOI 10.1016/j.cbpc.2004.09.007; Sangiao-Alvarellos S, 2005, J EXP BIOL, V208, P4291, DOI 10.1242/jeb.01900; Sangiao-Alvarellos S, 2003, AM J PHYSIOL-REG I, V285, pR897, DOI 10.1152/ajpregu.00161.2003; Sarropoulou E, 2005, PHYSIOL GENOMICS, V23, P182, DOI 10.1152/physiolgenomics.00139.2005; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Soengas JL, 2002, COMP BIOCHEM PHYS B, V131, P271, DOI 10.1016/S1096-4959(02)00022-2; Soengas Jose L., 2007, P277; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; Takei Y, 2013, FISH PHYSIOL, V32, P69, DOI 10.1016/B978-0-12-396951-4.00003-7; Tanaka M, 2006, J HYPERTENS, V24, P489, DOI 10.1097/01.hjh.0000209985.66853.1e; Tang CH, 2014, FISH PHYSIOL BIOCHEM, V40, P1533, DOI 10.1007/s10695-014-9946-3; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Teles M, 2013, MAR BIOTECHNOL, V15, P104, DOI 10.1007/s10126-012-9467-y; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Vieira FA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-490; Wilson JM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P237, DOI 10.1086/341817; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Yong JHA, 2013, FRONT PHYSIOL, P1	85	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0148113	10.1371/journal.pone.0148113	http://dx.doi.org/10.1371/journal.pone.0148113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828928	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200064
J	Beckensteiner, J; Kaplan, DM; Potts, WM; Santos, CV; O'Farrell, MR				Beckensteiner, Jennifer; Kaplan, David M.; Potts, Warren M.; Santos, Carmen V.; O'Farrell, Michael R.			Data-Limited Population-Status Evaluation of Two Coastal Fishes in Southern Angola Using Recreational Catch Length-Frequency Data	PLOS ONE			English	Article							BENGUELA FRONTAL ZONE; MARINE PROTECTED AREA; STOCK-ASSESSMENT; MATERNAL-AGE; LIFE-HISTORY; MANAGEMENT; FLUCTUATIONS; RECRUITMENT; SELECTION; SURVIVAL	Excessive truncation of a population's size structure is often identified as an important deleterious effect of exploitation, yet the effect on population persistence of size-structure truncation caused by exploitation is often not quantified due to data limitations. In this study, we estimate changes in eggs per recruit (EPR)using annual length-frequency samples over a 9 year period to assess persistence of the two most important recreational fishes in southern Angola: west coast dusky kob (Argyrosomus coronus) and leerfish (Lichia amia). Using a length-and age-structured model, we improve on an existing method to fit this type of model to length-frequency data and estimate EPR. The objectives of the methodological changes are to add flexibility and robustness to the approach for assessing population status in data-limited situations. Results indicate that dusky kob presents very low levels of EPR (5%-10% of the per recruit reproductive capacity in the absence of fishing) in 2013, whereas large inter-annual variability in leerfish estimates suggest caution must be applied when drawing conclusions about its exploitation status. Using simulated length frequency data with known parameter values, we demonstrate that recruitment decline due to overexploitation leads to overestimation of EPR values. Considering the low levels of EPR estimated for the study species, recruitment limitation is not impossible and true EPR values may be even lower than our estimates. It is, therefore, likely that management action, such as the creation of Marine Protected Areas, is needed to reconstitute the west coast dusky kob population.	[Beckensteiner, Jennifer; Kaplan, David M.] IRD, Ctr Rech Halieut Mediterraneenne & Trop, UMR EME 212, Sete, France; [Beckensteiner, Jennifer; Kaplan, David M.] Virginia Inst Marine Sci, Coll William & Mary, Dept Fisheries, Gloucester Point, VA 23062 USA; [Potts, Warren M.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [Santos, Carmen V.] FCUAN, Luanda, Angola; [O'Farrell, Michael R.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [O'Farrell, Michael R.] SW Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA USA	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; William & Mary; Virginia Institute of Marine Science; Rhodes University; University of California System; University of California Davis; National Oceanic Atmospheric Admin (NOAA) - USA	Beckensteiner, J (corresponding author), IRD, Ctr Rech Halieut Mediterraneenne & Trop, UMR EME 212, Sete, France.; Beckensteiner, J (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Dept Fisheries, Gloucester Point, VA 23062 USA.	jbeckensteiner@vims.edu	Santos, Carmen Van-Dúnem/O-1778-2014; Kaplan, David/G-5230-2010	Santos, Carmen Van-Dúnem/0000-0003-0643-5462; Kaplan, David/0000-0001-6087-359X; Beckensteiner, Jennifer/0000-0002-3811-6506	AMPED project from French National Research Agency (ANR), Systerra Programme [ANR-08-STRA-03]; National Research Foundation [66957]; National Research Foundations Knowledge Field Development South African Biosystems Initiative [74457]	AMPED project from French National Research Agency (ANR), Systerra Programme(French National Research Agency (ANR)); National Research Foundation; National Research Foundations Knowledge Field Development South African Biosystems Initiative	JB and DMK were supported by the AMPED project (www.amped.ird.fr) through a grant from the French National Research Agency (ANR), Systerra Programme, grant number ANR-08-STRA-03. WP and CVS were supported by the National Research Foundation under grant number 66957 and by the National Research Foundations Knowledge Field Development South African Biosystems Initiative under grant number 74457. This work was performed in part using computational facilities at the College of William and Mary which were provided with the assistance of the National Science Foundation, the Virginia Port Authority, Sun Microsystems, and Virginia's Commonwealth Technology Research Fund.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Barnes JI, 2004, DIR ENV AFF MINIST E; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Beverton RJH, 1957, FISH INVESTIG SER 2, V19; Brodziak J, 2012, WORKSH METH EST TOT; Brouwer SL, 2005, FISH B-NOAA, V103, P258; Clark WG, 2002, N AM J FISH MANAGE, V22, P251, DOI 10.1577/1548-8675(2002)022<0251:FRTYL>2.0.CO;2; Duarte A, 2005, LMRAFSE0301B; FAO, 2007, ANG FISH COUNTR PROF, P17; Gedamke T, 2006, T AM FISH SOC, V135, P476, DOI 10.1577/T05-153.1; Griffiths M. H., 1995, CONTRIBUTION TAXONOM; HILBORN R, 1993, CAN J FISH AQUAT SCI, V50, P874, DOI 10.1139/f93-100; Hordyk A, 2015, ICES J MAR SCI, V72, P217, DOI 10.1093/icesjms/fsu004; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; Hutchings JA, 1996, CAN J FISH AQUAT SCI, V53, P943, DOI 10.1139/f96-097; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Jennings S., 2001, MARINE FISHERIES ECO; John HC, 2001, J MARINE SYST, V28, P91, DOI 10.1016/S0924-7963(00)00085-3; Kaplan DM, 2009, ECOL APPL, V19, P433, DOI 10.1890/07-1705.1; Klaer NL, 2012, FISH RES, V134, P42, DOI 10.1016/j.fishres.2012.08.010; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lennert-Cody CE, 2010, FISH RES, V102, P323, DOI 10.1016/j.fishres.2009.11.014; Maunder MN, 2013, FISH RES, V142, P61, DOI 10.1016/j.fishres.2012.07.025; Maunder MN, 2011, FISH RES, V109, P311, DOI 10.1016/j.fishres.2011.02.018; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Monteiro PMS, 2008, DEEP-SEA RES PT I, V55, P435, DOI 10.1016/j.dsr.2007.12.010; Moussa SZ, 2002, APPRAISAL REPORT ART, P58; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; O'Farrell MR, 2006, CAN J FISH AQUAT SCI, V63, P2249, DOI 10.1139/F06-130; O'Farrell MR, 2006, ECOL APPL, V16, P977, DOI 10.1890/1051-0761(2006)016[0977:ETSONR]2.0.CO;2; O'Farrell MR, 2005, CAN J FISH AQUAT SCI, V62, P1626, DOI 10.1139/F05-064; Pauly D, 2001, CAN J FISH AQUAT SCI, V58, P51, DOI 10.1139/cjfas-58-1-51; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Potts WM, 2008, AFR J MAR SCI, V30, P113, DOI 10.2989/AJMS.2008.30.1.11.461; Potts WM, 2010, AFR J MAR SCI, V32, P247, DOI 10.2989/1814232X.2010.501567; Potts WM, 2009, FISHERIES MANAG ECOL, V16, P14, DOI 10.1111/j.1365-2400.2008.00617.x; Potts WM, 2014, GLOBAL CHANGE BIOL, V20, P2765, DOI 10.1111/gcb.12612; Quinn TJI, 1999, BIOL RESOUR MANAG SE; Reboulet AM, 1999, BIRD STUDY, V46, P148; Rouyer T, 2012, ECOL LETT, V15, P658, DOI 10.1111/j.1461-0248.2012.01781.x; Sadovy Y, 2003, FISH FISH, V4, P86, DOI 10.1046/j.1467-2979.2003.00104.x; Sampson DB, 2011, CAN J FISH AQUAT SCI, V68, P1077, DOI 10.1139/F2011-044; SCHNUTE J, 1980, CAN J FISH AQUAT SCI, V37, P1337, DOI 10.1139/f80-172; Schnute JT, 2007, ICES J MAR SCI, V64, P218, DOI 10.1093/icesjms/fsl024; SHEPHERD JG, 1982, J CONSEIL, V40, P67; SISSENWINE MP, 1987, CAN J FISH AQUAT SCI, V44, P913, DOI 10.1139/f87-110; Stenseth NC, 2008, NATURE, V452, P825, DOI 10.1038/452825a; Stewart IJ, 2015, ICES J MAR SCI, V72, P2187, DOI 10.1093/icesjms/fsv061; Thorson JT, 2015, ICES J MAR SCI, V72, P1245, DOI 10.1093/icesjms/fsu213; Thorson JT, 2015, ICES J MAR SCI, V72, P178, DOI 10.1093/icesjms/fst211; Thorson JT, 2014, CAN J FISH AQUAT SCI, V71, P973, DOI 10.1139/cjfas-2013-0645; Van der Elst RP, 1993, BIOL STATUS GARRICK, P28; Veitch JA, 2006, INT J REMOTE SENS, V27, P987, DOI 10.1080/01431160500127914; Veitch J, 2010, J PHYS OCEANOGR, V40, P1942, DOI 10.1175/2010JPO4382.1; Vincenzi S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003828	57	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147834	10.1371/journal.pone.0147834	http://dx.doi.org/10.1371/journal.pone.0147834			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829489	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200035
J	Forat, S; Huettel, B; Reinhardt, R; Fimmers, R; Haidl, G; Denschlag, D; Olek, K				Forat, Sophia; Huettel, Bruno; Reinhardt, Richard; Fimmers, Rolf; Haidl, Gerhard; Denschlag, Dominik; Olek, Klaus			Methylation Markers for the Identification of Body Fluids and Tissues from Forensic Trace Evidence	PLOS ONE			English	Article							COLLABORATIVE EDNAP EXERCISE; RNA/DNA CO-ANALYSIS; DNA METHYLATION; SEMEN; STAINS; BLOOD; RNA; GENOME; CANCER; SALIVA	The identification of body fluids is an essential tool for clarifying the course of events at a criminal site. The analytical problem is the fact that the biological material has been very often exposed to detrimental exogenous influences. Thereby, the molecular substrates used for the identification of the traces may become degraded. So far, most protocols utilize cell specific proteins or RNAs. Instead of measuring these more sensitive compounds this paper describes the application of the differential DNA-methylation. As a result of two genome wide screenings with the Illumina HumanMethylation BeadChips 27 and 450k we identified 150 candidate loci revealing differential methylation with regard to the body fluids venous blood, menstrual blood, vaginal fluid, saliva and sperm. Among them we selected 9 loci as the most promising markers. For the final determination of the methylation degree we applied the SNuPE-method. Because the degree of methylation might be modified by various endogenous and exogenous factors, we tested each marker with approximately 100 samples of each target fluid in a validation study. The stability of the detection procedure is proved in various simulated forensic surroundings according to standardized conditions. We studied the potential influence of 12 relatively common tumors on the methylation of the 9 markers. For this purpose the target fluids of 34 patients have been analysed. Only the cervix carcinoma might have an remarkable effect because impairing the signal of both vaginal markers. Using the Illumina MiSeq device we tested the potential influence of cis acting sequence variants on the methylation degree of the 9 markers in the specific body fluid DNA of 50 individuals. For 4 marker loci we observed such an influence either by sole SNPs or haplotypes. The identification of each target fluid is possible in arbitrary mixtures with the remaining four body fluids. The sensitivity of the individual body fluid tests is in the same range as for the forensic STR-analysis. It is the first forensic body fluid protocol which considers the exogenic and endogenic parameters potentially interfering with the true results.	[Forat, Sophia; Olek, Klaus] Lab Abstammungsbegutachtungen GmbH, Rheinbach, Germany; [Huettel, Bruno; Reinhardt, Richard] Max Planck Genome Ctr Cologne, Inst Breeding Res, Cologne, Germany; [Fimmers, Rolf] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Haidl, Gerhard] Univ Bonn, Dept Dermatol, Androl Unit, Bonn, Germany; [Denschlag, Dominik] Dept OB GYN Hochtaunuskliniken Bad Homburg, Bad Homburg, Germany	Max Planck Society; University of Bonn; University of Bonn	Forat, S; Olek, K (corresponding author), Lab Abstammungsbegutachtungen GmbH, Rheinbach, Germany.	forats@web.de; olek@lfa-gmbh.de		Reinhardt, Richard/0000-0001-9376-2132	ZIM project [KU2117901AJ8.]	ZIM project	SF was supported in part by ZIM project Nr. KU2117901AJ8.	ALLEN SM, 1995, J IMMUNOASSAY, V16, P297, DOI 10.1080/15321819508013564; An JH, 2013, INT J LEGAL MED, V127, P35, DOI 10.1007/s00414-012-0719-1; Barfield RT, 2014, GENET EPIDEMIOL, V38, P231, DOI 10.1002/gepi.21789; Baron U, 2006, EPIGENETICS-US, V1, P55, DOI 10.4161/epi.1.1.2643; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fiegl H, 2007, DIS MARKERS, V23, P89, DOI 10.1155/2007/293138; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frumkin D, 2011, FORENSIC SCI INT-GEN, V5, P517, DOI 10.1016/j.fsigen.2010.12.001; Haas C, 2014, FORENSIC SCI INT-GEN, V8, P203, DOI 10.1016/j.fsigen.2013.09.009; Haas C, 2013, FORENSIC SCI INT-GEN, V7, P230, DOI 10.1016/j.fsigen.2012.10.011; Haas C, 2012, FORENSIC SCI INT-GEN, V6, P70, DOI 10.1016/j.fsigen.2011.02.004; Haas C, 2011, FORENSIC SCI INT-GEN, V5, P21, DOI 10.1016/j.fsigen.2010.01.003; Haas C, 2009, FORENSIC SCI INT-GEN, V3, P80, DOI 10.1016/j.fsigen.2008.11.003; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; James SH, 2003, IDENTIFICATION BIOL; Juusola J, 2007, J FORENSIC SCI, V52, P1252, DOI 10.1111/j.1556-4029.2007.00550.x; Larue BL, 2013, INT J LEGAL MED, V127, P299, DOI 10.1007/s00414-012-0760-0; Lee HY, 2015, FORENSIC SCI INT-GEN, V17, P17, DOI 10.1016/j.fsigen.2015.03.002; Lee HY, 2012, INT J LEGAL MED, V126, P55, DOI 10.1007/s00414-011-0569-2; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Santucci KA, 1999, PEDIATRICS, V104, P1342, DOI 10.1542/peds.104.6.1342; Sato I, 2007, INT J LEGAL MED, V121, P315, DOI 10.1007/s00414-006-0084-z; Setzer M, 2008, J FORENSIC SCI, V53, P296, DOI 10.1111/j.1556-4029.2007.00652.x; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; van den Berge M, 2014, FORENSIC SCI INT-GEN, V10, P40, DOI 10.1016/j.fsigen.2014.01.006; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	31	41	42	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147973	10.1371/journal.pone.0147973	http://dx.doi.org/10.1371/journal.pone.0147973			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829227	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200049
J	Mouttet, D; Lae, M; Caly, M; Gentien, D; Carpentier, S; Peyro-Saint-Paul, H; Vincent-Salomon, A; Rouzier, R; Sigal-Zafrani, B; Sastre-Garau, X; Reyal, F				Mouttet, D.; Lae, M.; Caly, M.; Gentien, D.; Carpentier, S.; Peyro-Saint-Paul, H.; Vincent-Salomon, A.; Rouzier, R.; Sigal-Zafrani, B.; Sastre-Garau, X.; Reyal, F.			Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant (TM) Microarray Based Assay	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; GENOMIC GRADE INDEX; CENTRAL LABORATORIES; HORMONE-RECEPTORS; HISTOLOGIC GRADE; MOLECULAR-BASIS; EXPRESSION; PROGNOSIS; CHEMOTHERAPY; SIGNATURES	Background Hormone receptor status and HER2 status are of critical interest in determining the prognosis of breast cancer patients. Their status is routinely assessed by immunohistochemistry (IHC). However, it is subject to intra-laboratory and inter-laboratory variability. The aim of our study was to compare the estrogen receptor, progesterone receptor and HER2 status as determined by the MapQuant (TM) test to the routine immuno-histochemical tests in early stage invasive breast cancer in a large comprehensive cancer center. Patients and Methods We retrospectively studied 163 invasive early-stage breast carcinoma with standard IHC status. The genomic status was determined using the MapQuant (TM) test providing the genomic grade index. Results We found only 4 tumours out of 161 (2.5%) with discrepant IHC and genomic results concerning ER status. The concordance rate between the two methods was 97.5% and the Cohen's Kappa coefficient was 0.89. Comparison between the MapQuant (TM) PR status and the PR IHC status gave more discrepancies. The concordance rate between the two methods was 91.4% and the Cohen's Kappa coefficient was 0.74. The HER2 MapQuant (TM) test was classified as "undetermined" in 2 out of 163 cases (1.2%). One HER2 IHC-negative tumour was found positive with a high HER2 MapQuant (TM) genomic score. The concordance rate between the two methods was 99.3% and the Cohen's Kappa coefficient was 0.86. Conclusion Our results show that the MapQuant (TM) assay, based on mRNA expression assay, provides an objective and quantitative assessment of Estrogen receptor, Progesterone receptor and HER2 status in invasive breast cancer.	[Mouttet, D.; Rouzier, R.; Reyal, F.] Inst Curie, Dept Surg, Paris, France; [Reyal, F.] Inst Curie, Dept Translat Res, Residual Tumor & Response Treatment Team, Paris, France; [Lae, M.; Caly, M.; Vincent-Salomon, A.; Sigal-Zafrani, B.; Sastre-Garau, X.] Inst Curie, Dept Tumor Biol, Paris, France; [Gentien, D.] Inst Curie, Dept Translat Res, Paris, France; [Carpentier, S.; Peyro-Saint-Paul, H.] Marseille SA, QIAGEN, Marseille, SA, Australia	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.; Reyal, F (corresponding author), Inst Curie, Dept Translat Res, Residual Tumor & Response Treatment Team, Paris, France.	fabien.reyal@curie.fr	Gentien, David/L-7757-2017; Gentien, David/O-9356-2019; Rouzier, Roman/G-2953-2018	Gentien, David/0000-0001-8317-5188; Sastre-Garau, Xavier/0000-0001-5992-2083; Rouzier, Roman/0000-0002-8167-6808	QIAGEN	QIAGEN	The authors received no specific funding for this work. Authors SC and HP are employed by QIAGEN. QIAGEN provided support in the form of research material (Affymetrix arrays) and salaries for authors SC and HP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allred DC, 2008, J CLIN ONCOL, V26, P2433, DOI 10.1200/JCO.2007.15.7800; Arihiro K, 2007, AM J CLIN PATHOL, V127, P356, DOI 10.1309/4D1A04NCDK96WFY7; Badve SS, 2008, J CLIN ONCOL, V26, P2473, DOI 10.1200/JCO.2007.13.6424; Baehner FL, 2010, J CLIN ONCOL, V28, P4300, DOI 10.1200/JCO.2009.24.8211; Chebil G, 2003, ACTA ONCOL, V42, P43, DOI 10.1080/02841860300672; Chowdhury Nilotpal, 2011, Patholog Res Int, V2011, P890938, DOI 10.4061/2011/890938; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dobbe E, 2008, AM J HEALTH-SYST PH, V65, P23, DOI 10.2146/ajhp060352; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Ignatiadis M, 2008, PATHOBIOLOGY, V75, P104, DOI 10.1159/000123848; Ignatiadis M, 2007, PHARMACOGENOMICS, V8, P101, DOI 10.2217/14622416.8.1.101; Lacroix-Triki M, 2006, EUR J CANCER, V42, P2946, DOI 10.1016/j.ejca.2006.06.020; Liedtke C, 2009, J CLIN ONCOL, V27, P3185, DOI 10.1200/JCO.2008.18.5934; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Marchionni L, 2008, ANN INTERN MED, V148, P358, DOI 10.7326/0003-4819-148-5-200803040-00208; Marchionni Luigi, 2007, Evid Rep Technol Assess (Full Rep), P1; Metzger O, 2011, CRIT REV ONCOL HEMAT, V77, P21, DOI 10.1016/j.critrevonc.2010.01.011; Mudduwa Lakmini, 2009, Indian J Med Sci, V63, P21; Naoi Y, 2011, CANCER-AM CANCER SOC, V117, P472, DOI 10.1002/cncr.25626; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; Penault-Llorca F, 2010, ANN PATHOL, V30, P357, DOI 10.1016/j.annpat.2010.07.001; Perez EA, 2006, J CLIN ONCOL, V24, P3032, DOI 10.1200/JCO.2005.03.4744; Reddy JC, 2006, CLIN BREAST CANCER, V7, P153, DOI 10.3816/CBC.2006.n.025; Reyal F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035184; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Roepman P, 2009, CLIN CANCER RES, V15, P7003, DOI 10.1158/1078-0432.CCR-09-0449; Romond EH, 2012, J CLIN ONCOL; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	33	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0146474	10.1371/journal.pone.0146474	http://dx.doi.org/10.1371/journal.pone.0146474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829108	Green Published, Green Submitted, gold			2022-12-27	WOS:000369548200010
J	Tamura, K; Kawabayashi, T; Shikanai, T; Hara-Nishimura, I				Tamura, Kentaro; Kawabayashi, Takenori; Shikanai, Toshiharu; Hara-Nishimura, Ikuko			Decreased Expression of a Gene Caused by a T-DNA Insertion in an Adjacent Gene in Arabidopsis	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; TRIPLE-A-SYNDROME; WD-REPEAT PROTEIN; ARTIFICIAL MICRORNAS; RIBOSOMAL-PROTEINS; REVERSE GENETICS; THALIANA; MUTAGENESIS; IDENTIFICATION; COLLECTION	ALADIN is a component of the nuclear pore complex in higher eukaryotes. An Arabidopsis knockout line that had a T-DNA insertion in the ALADIN gene was defective in plant growth and thylakoid development and had reduced photosynthetic activity resulting from lower chlorophyll accumulation. The mutation appeared to decrease the level of chloroplast RuBisCO subunits and PSBA and PGL35 proteins. Unexpectedly, the T-DNA insertion in the ALADIN gene decreased the expression of the neighboring gene PSRP5, which functions in translation in chloroplasts. The mutant phenotype was rescued by expressing PSRP5, but not by expressing ALADIN. The abnormal phenotypes were also detected in an artificial microRNA (amiRNA)-mediated PSRPS5 knockdown, but not in an amiRNA-mediated ALADIN knockdown line. Thus, users of T-DNA insertions should be aware that a T-DNA insertion in one gene can have effects on the expression of neighboring genes.	[Tamura, Kentaro; Kawabayashi, Takenori; Shikanai, Toshiharu; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Kyoto University	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Kyoto, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp	Tamura, Kentaro/AAU-2354-2021; kawabayashi, takenori/E-2201-2016; Shikanai, Toshiharu/AAK-9112-2020	Tamura, Kentaro/0000-0001-7387-2211; 	Japan Society for the Promotion of Science (JSPS) [15K14545, 26711017, 15H05776, 22000014]; Grants-in-Aid for Scientific Research [22000014] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research to K.T. [nos. 15K14545 (https://kaken.nii ac.jp/d/p/15K14545.en.html) and 26711017 (https://kaken.nii.ac.jp/d/p/26711017.en.html)] and to I.H.N. [no. 15H05776 (https://kaken.nii.ac.jp/d/p/15H05776.en.html)], and a Grant-in-Aid for Specially Promoted Research to I.H.N. [no. 22000014 (https://kaken.nii.ac.jp/d/p/22000014.en.html)] from the Japan Society for the Promotion of Science (JSPS).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; AzpirozLeehan R, 1997, TRENDS GENET, V13, P152, DOI 10.1016/S0168-9525(97)01094-9; Bagga R, 2000, NUCLEIC ACIDS RES, V28, P2541, DOI 10.1093/nar/28.13.2541; Barton MC, 1997, P NATL ACAD SCI USA, V94, P7257, DOI 10.1073/pnas.94.14.7257; Braud C, 2012, PLANT PHYSIOL, V160, P823, DOI 10.1104/pp.112.202192; GHEYSEN G, 1990, GENE, V94, P155, DOI 10.1016/0378-1119(90)90382-2; Goto C, 2014, PLANT CELL, V26, P2143, DOI 10.1105/tpc.113.122168; Handschug K, 2001, HUM MOL GENET, V10, P283, DOI 10.1093/hmg/10.3.283; Hirano M, 2006, P NATL ACAD SCI USA, V103, P2298, DOI 10.1073/pnas.0505598103; Huebner A, 2006, MOL CELL BIOL, V26, P1879, DOI 10.1128/MCB.26.5.1879-1887.2006; Huebner A, 2004, ENDOCR RES, V30, P891, DOI 10.1081/ERC-200044138; LARKIN JC, 1993, PLANT CELL, V5, P1739, DOI 10.1105/tpc.5.12.1739; Lin D, 2015, PLANT BIOLOGY, V17, P599, DOI 10.1111/plb.12271; MacGregor DR, 2013, PLANT CELL, V25, P4391, DOI 10.1105/tpc.113.114959; Nacry P, 1998, GENETICS, V149, P641; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Parry G, 2006, PLANT CELL, V18, P1590, DOI 10.1105/tpc.106.041566; Romani I, 2012, PLANT J, V72, P922, DOI 10.1111/tpj.12000; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shikanai T, 1999, PLANT CELL PHYSIOL, V40, P1134, DOI 10.1093/oxfordjournals.pcp.a029498; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Tamura K, 2013, J EXP BOT, V64, P823, DOI 10.1093/jxb/ers258; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Tax FE, 2001, PLANT PHYSIOL, V126, P1527, DOI 10.1104/pp.126.4.1527; Thole V, 2012, J EXP BOT, V63, P567, DOI 10.1093/jxb/err333; Tiller N, 2012, PLANT J, V69, P302, DOI 10.1111/j.1365-313X.2011.04791.x; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wang NL, 2013, MOL PLANT, V6, P596, DOI 10.1093/mp/sss142; Woody ST, 2007, J PLANT RES, V120, P157, DOI 10.1007/s10265-006-0048-x	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147911	10.1371/journal.pone.0147911	http://dx.doi.org/10.1371/journal.pone.0147911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828726	gold, Green Published, Green Submitted			2022-12-27	WOS:000369548200042
J	Tang, JJ; Zou, YJ; Ash, J; Zhang, S; Liu, F; Wang, YH				Tang, Jinjun; Zou, Yajie; Ash, John; Zhang, Shen; Liu, Fang; Wang, Yinhai			Travel Time Estimation Using Freeway Point Detector Data Based on Evolving Fuzzy Neural Inference System	PLOS ONE			English	Article							EXTENDED KALMAN FILTER; C-MEANS; IMPUTATION; ALGORITHM; NETWORKS	Travel time is an important measurement used to evaluate the extent of congestion within road networks. This paper presents a new method to estimate the travel time based on an evolving fuzzy neural inference system. The input variables in the system are traffic flow data (volume, occupancy, and speed) collected from loop detectors located at points both upstream and downstream of a given link, and the output variable is the link travel time. A first order Takagi-Sugeno fuzzy rule set is used to complete the inference. For training the evolving fuzzy neural network (EFNN), two learning processes are proposed: (1) a K-means method is employed to partition input samples into different clusters, and a Gaussian fuzzy membership function is designed for each cluster to measure the membership degree of samples to the cluster centers. As the number of input samples increases, the cluster centers are modified and membership functions are also updated; (2) a weighted recursive least squares estimator is used to optimize the parameters of the linear functions in the Takagi-Sugeno type fuzzy rules. Testing datasets consisting of actual and simulated data are used to test the proposed method. Three common criteria including mean absolute error (MAE), root mean square error (RMSE), and mean absolute relative error (MARE) are utilized to evaluate the estimation performance. Estimation results demonstrate the accuracy and effectiveness of the EFNN method through comparison with existing methods including: multiple linear regression (MLR), instantaneous model (IM), linear model (LM), neural network (NN), and cumulative plots (CP).	[Tang, Jinjun; Zhang, Shen] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin 150001, Peoples R China; [Tang, Jinjun; Ash, John; Wang, Yinhai] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Zou, Yajie] Tongji Univ, Minist Educ, Key Lab Rd & Traff Engn, Shanghai 201804, Peoples R China; [Liu, Fang] Inner Mongolia Agr Univ, Sch Energy & Transportat Engn, Hohhot 010018, Peoples R China	Harbin Institute of Technology; University of Washington; University of Washington Seattle; Tongji University; Inner Mongolia Agricultural University	Wang, YH (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	yinhai@uw.edu	Wang, Yinhai/B-5396-2012	Wang, Yinhai/0000-0002-4180-5628	National Natural Science Foundation of China [51138003, 51329801]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was funded in part by the National Natural Science Foundation of China (grant nos. 51138003 and 51329801). This research was also funded in part by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydilek IB, 2013, INFORM SCIENCES, V233, P25, DOI 10.1016/j.ins.2013.01.021; Bachmann C, 2013, TRANSPORT RES C-EMER, V26, P33, DOI 10.1016/j.trc.2012.07.003; Bhaskar A, 2010, INT J INTELL TRANSP, V8, P151, DOI 10.1007/s13177-010-0012-y; Bhaskar A, 2009, TRANSPORT RES REC, P41, DOI 10.3141/2121-05; Brockfeld E., 2007, P 11 WCTR C BERK CA, P24; Cherrett T, 2002, J OPER RES SOC, V53, P610, DOI 10.1057/palgrave.jors.2601348; Cherrett T, 2001, P I CIVIL ENG-TRANSP, V147, P23; Cheu RL, 2002, COMPUT-AIDED CIV INF, V17, P53, DOI 10.1111/1467-8667.00252; Coifman B, 2001, TRANSPORT RES A-POL, V35, P863, DOI 10.1016/S0965-8564(00)00028-8; Cortes CE, 2002, TRANSPORT RES REC, P181, DOI 10.3141/1802-20; Daganzo C. F., 1997, FUNDAMENTALS TRANSPO; Demsar J, 2006, J MACH LEARN RES, V7, P1; Gastaldi M, 2014, TRANSPORT RES C-EMER, V47, P86, DOI 10.1016/j.trc.2014.06.002; Goodwin G, 1984, ADAPTIVE FILTERING P; Haghani A., 2010, J TRANSPORTATION RES, V2160, P60, DOI DOI 10.3141/2160-07; Hegyi A., 2006, 2006 IEEE INT TRANSP; Hellinga B, 2008, TRANSPORT RES C-EMER, V16, P768, DOI 10.1016/j.trc.2008.04.002; Hofleitner A, 2012, IEEE T INTELL TRANSP, V13, P1679, DOI 10.1109/TITS.2012.2200474; Hong J, 2007, 2007 IEEE INTELLIGENT VEHICLES SYMPOSIUM, VOLS 1-3, P1030; Hsia T. C., 1977, SYSTEM IDENTIFICATIO; Jenelius E, 2013, TRANSPORT RES B-METH, V53, P64, DOI 10.1016/j.trb.2013.03.008; Kasabov N., 1998, Proceedings of the 5th International Conference on Soft Computing and Information/Intelligent Systems. Methodologies for the Conception, Design and Application of Soft Computing, P271; Kasabov N, 2001, IEEE T SYST MAN CY B, V31, P902, DOI 10.1109/3477.969494; Kasabov NK, 2002, IEEE T FUZZY SYST, V10, P144, DOI 10.1109/91.995117; Kim S., 2007, INT J MULTIMEDIA UBI, V2, P67; Kloot G., 1999, P 6 WORLD C ITS TOR; Kwon J, 2000, TRANSPORT RES REC, P120, DOI 10.3141/1717-15; Li RM, 2006, J TRANSP ENG, V132, P540, DOI 10.1061/(ASCE)0733-947X(2006)132:7(540); Liu H., 2007, P 86 ANN M TRANSP RE; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Martchouk M, 2011, J TRANSP ENG, V137, P697, DOI 10.1061/(ASCE)TE.1943-5436.0000253; Messelodi S, 2009, EXPERT SYST APPL, V36, P4213, DOI 10.1016/j.eswa.2008.04.008; Naranjo JE, 2012, IEEE T INTELL TRANSP, V13, P107, DOI 10.1109/TITS.2011.2180377; Newell G. F, 1982, APPL QUEUING THEORY; Rouphil N. M., 1993, ADVANCE WORKING PAPE, V21; Shin C., 1998, P 5 WORLD C ITS SEOU; Sisiopiku V.P., 1994, TRANSPORT RES REC, V1457, P166; Srinivasan Karthik K., 1996, TRANSPORT RES REC, V1537, P15, DOI [10.3141/1537-03, DOI 10.3141/1537-03]; Tampere Chris M. J., 2007, 2007 IEEE Intelligent Transportation Systems Conference, P209, DOI 10.1109/ITSC.2007.4357755; Tang JJ, 2015, TRANSPORT RES C-EMER, V51, P29, DOI 10.1016/j.trc.2014.11.003; van Lint JWC, 2003, TRANSPORT RES REC, P41, DOI 10.3141/1855-05; Wang YB, 2005, TRANSPORT RES B-METH, V39, P141, DOI 10.1016/j.trb.2004.03.003; Wang YB, 2007, TRANSPORT SCI, V41, P167, DOI 10.1287/trsc.1070.0194; Wang YB, 2008, TRANSPORT RES A-POL, V42, P1340, DOI 10.1016/j.tra.2008.06.001; Wasson JS, 2008, ITE J, V78, P20; Wei C.H., 2003, TRANSPORTATION PLANN, VVol. 32, P651; Yuan YF, 2012, IEEE T INTELL TRANSP, V13, P59, DOI 10.1109/TITS.2011.2178837; Zhang M, 1998, ESTIMATING ARTERIAL; Zheng FF, 2013, TRANSPORT RES C-EMER, V31, P145, DOI 10.1016/j.trc.2012.04.007	49	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0147263	10.1371/journal.pone.0147263	http://dx.doi.org/10.1371/journal.pone.0147263			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26829639	Green Published, gold, Green Submitted			2022-12-27	WOS:000369548200016
J	Wu, W; Huo, XC; Zhao, XQ; Liao, XL; Wang, CJ; Pan, YS; Wang, YL; Wang, YJ				Wu, Wei; Huo, Xiaochuan; Zhao, Xingquan; Liao, Xiaoling; Wang, Chunjuan; Pan, Yuesong; Wang, Yilong; Wang, Yongjun		TIMS-CHINA Investigators	Relationship between Blood Pressure and Outcomes in Acute Ischemic Stroke Patients Administered Lytic Medication in the TIMS-China Study	PLOS ONE			English	Article							ANTIHYPERTENSIVE THERAPY; CLINICAL-OUTCOMES; TRIAL; IMPLEMENTATION; THROMBOLYSIS; HYPERTENSION; ASSOCIATION; PREVALENCE	Objective Increased blood pressure (BP) management following acute ischemic stroke (AIS) remains controversial. This study aimed to identify the association between BP and clinical outcomes in AIS patients administered lytic medication in the TIMS-China (thrombolysis implementation and monitor of acute ischemic stroke in China) database. Methods The sample comprised 1128 patients hospitalized within 4.5 hours (h) of AIS for intravenous recombinant tissue plasminogen activator (i.v. rt-PA) thrombolysis. Systolic BP (SBP) and diastolic BP (DBP) at baseline, 2 h and 24 h after treatment, and changes from baseline were analyzed. The study outcomes comprised a favorable outcome (modified Rankin Scale 0-1 at 90 days) and symptomatic intracerebral hemorrhage (SICH), analyzed using logistic regression, with low BP as the reference group. Results Lower BP (baseline, 2 h, and 24 h) was beneficial in AIS patients and significantly related to a favorable outcome (P<0.05). A substantial BP decrease at 24 h after rt-PA thrombolysis was significantly associated with a favorable outcome compared with a moderate BP decrease (P = 0.0298). A SBP > 160 mmHg 2 h after rt-PA thrombolysis was significantly associated with SICH compared with a SBP < 140 mmHg (P = 0.0238). An increase or no change (> 25 mmHg) in SBP was significantly associated with SICH (P = 0.002) compared with a small SBP decrease (1-9 mmHg). Conclusions This study provides novel evidence that lower BP within the first 24 h is associated with a more favorable outcome and less frequent SICH in AIS patients administered lytic medication. Routine BP-lowering treatment should be considered in AIS patients following lytic medication.	[Wu, Wei; Huo, Xiaochuan; Zhao, Xingquan; Liao, Xiaoling; Wang, Chunjuan; Pan, Yuesong; Wang, Yilong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wu, Wei] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan China & Braian Sci Res Inst, Jinan 250100, Peoples R China	Capital Medical University; Shandong University	Wang, YL; Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yilong528@aliyun.com; yongjunwang1962@gmail.com	Pan, Yuesong/AAI-6303-2020	Pan, Yuesong/0000-0003-3082-6789; Wang, Shaoshi/0000-0003-2547-0247; Xu, An-Ding/0000-0003-3154-0985				Ahmed N, 2009, STROKE, V40, P2442, DOI 10.1161/STROKEAHA.109.548602; Aslanyan S, 2003, STROKE, V34, P2420, DOI 10.1161/01.STR.0000091233.04524.0C; Bath PMW, 2015, LANCET, V385, P617, DOI 10.1016/S0140-6736(14)61121-1; BRITTON M, 1986, STROKE, V17, P861, DOI 10.1161/01.STR.17.5.861; Chao AC, 2010, STROKE, V41, P885, DOI 10.1161/STROKEAHA.109.575605; Christensen H, 2002, ACTA NEUROL SCAND, V106, P142, DOI 10.1034/j.1600-0404.2002.01356.x; Daskalopoulou SS, 2015, CAN J CARDIOL, V31, P549, DOI 10.1016/j.cjca.2015.02.016; Ishitsuka K, 2014, HYPERTENSION, V63, P54, DOI 10.1161/HYPERTENSIONAHA.113.02189; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Keezer MR, 2008, CEREBROVASC DIS, V25, P202, DOI 10.1159/000113857; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Liao XL, 2013, CNS NEUROSCI THER, V19, P43, DOI 10.1111/cns.12031; Lyerly MJ, 2014, J STROKE CEREBROVASC, V23, P855, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.019; Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f; Powers WJ, 2015, STROKE, DOI DOI 10.1161/STR.0000000000000074; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Sare GM, 2009, STROKE, V40, P2098, DOI 10.1161/STROKEAHA.108.539155; Stead LG, 2005, NEUROLOGY, V65, P1179, DOI 10.1212/01.wnl.0000180939.24845.22; Vemmos KN, 2004, J INTERN MED, V255, P257, DOI 10.1046/j.1365-2796.2003.01291.x; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Yong M, 2008, STROKE, V39, P366, DOI 10.1161/STROKEAHA.107.492330	21	28	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2016	11	2							e0144260	10.1371/journal.pone.0144260	http://dx.doi.org/10.1371/journal.pone.0144260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9NL	26828609	Green Submitted, Green Published, gold			2022-12-27	WOS:000369548200002
J	Ann, SH; Singh, GB; Lim, KH; Koo, BK; Shin, ES				Ann, Soe Hee; Singh, Gillian Balbir; Lim, Kyung Hun; Koo, Bon-Kwon; Shin, Eun-Seok			Anatomical and Physiological Changes after Paclitaxel-Coated Balloon for Atherosclerotic De Novo Coronary Lesions: Serial IVUS-VH and FFR Study	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND; STENT RESTENOSIS; ELUTING STENT; ANGIOPLASTY; MULTICENTER; PREVENTION	Aims To assess the serial changes of de novo coronary lesions treated with paclitaxel-coated balloon (PCB) using intravascular ultrasound virtual histology (IVUS-VH) and fractional flow reserve (FFR). Method and Results This prospective observational study enrolled 27 patients with coronary artery disease treated with PCB who underwent coronary angiography, IVUS-VH and FFR before, immediately after intervention and at 9 months. 28 de novo lesions were successfully treated with PCB. Angiographic late luminal loss was 0.02 +/- 0.27mm. Mean vessel and lumen areas showed increase at 9 months (12.0 +/- 3.5mm(2) to 13.2 +/- 3.9mm(2), p <0.001; and 5.4 +/- 1.2mm(2) to 6.5 +/- 1.8mm(2), p <0.001, respectively). Although mean plaque area was unchanged (6.6 +/- 2.6mm(2) to 6.6 +/- 2.4mm(2), p = 0.269), percent atheroma volume decreased significantly (53.4 +/- 7.9% to 49.5 +/- 6.4%, p = 0.002). The proportion of plaque compositions including fibrous, fibrofatty, dense calcium and necrotic core by IVUS-VH was unchanged at 9 months. The FFR of the treated lesion was 0.71 +/- 0.13 pre-procedure, 0.87 +/- 0.06 post-procedure and 0.84 +/- 0.06 at follow-up. Conclusions De novo coronary lesions treated with PCB showed persistent anatomical and physiological patency with plaque redistribution and vessel remodeling without chronic elastic recoil or plaque compositional change during follow-up.	[Ann, Soe Hee; Singh, Gillian Balbir; Lim, Kyung Hun; Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan 680749, South Korea; [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea	University of Ulsan; Ulsan University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Shin, ES (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan 680749, South Korea.	sesim1989@gmail.com						Axel DI, 1997, CIRCULATION, V96, P636; Cortese B, 2012, INT J CARDIOL, V161, P4, DOI 10.1016/j.ijcard.2011.08.855; Costa MA, 2001, HEART, V85, P73, DOI 10.1136/heart.85.1.73; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Gray WA, 2010, CIRCULATION, V121, P2672, DOI 10.1161/CIRCULATIONAHA.110.936922; Kubo T, 2010, J AM COLL CARDIOL, V55, P1590, DOI 10.1016/j.jacc.2009.07.078; Latib A, 2012, J AM COLL CARDIOL, V60, P2473, DOI 10.1016/j.jacc.2012.09.020; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Okura H, 2002, AM HEART J, V144, P323, DOI 10.1067/mhj.2002.122282; Rittger H, 2012, J AM COLL CARDIOL, V59, P1377, DOI 10.1016/j.jacc.2012.01.015; Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064; ROUBIN GS, 1988, CIRCULATION, V78, P557, DOI 10.1161/01.CIR.78.3.557; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Scheller B, 2013, CLIN RES CARDIOL, V102, P469, DOI 10.1007/s00392-013-0556-3; Speck U, 2012, CIRC-CARDIOVASC INTE, V5, P392, DOI 10.1161/CIRCINTERVENTIONS.111.967794; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; TALLEY JD, 1988, CIRCULATION, V77, P820, DOI 10.1161/01.CIR.77.4.820; Waksman R, 2013, EUROINTERVENTION, V9, P613, DOI 10.4244/EIJV9I5A98; Zeymer U, 2014, HEART, V100, P311, DOI 10.1136/heartjnl-2013-304881	24	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147057	10.1371/journal.pone.0147057	http://dx.doi.org/10.1371/journal.pone.0147057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824602	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600013
J	Gallant, JL; Viljoen, AJ; van Helden, PD; Wiid, IJF				Gallant, James L.; Viljoen, Albertus J.; van Helden, Paul D.; Wiid, Ian J. F.			Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress	PLOS ONE			English	Article							OXIDATIVE STRESS; PHAGOLYSOSOMAL PH; TUBERCULOSIS; SYNTHETASE; METABOLISM; GROWTH; AMMONIA; ANAPLEROSIS; INHIBITION; SOLUTES	We recently reported on our success to generate deletion mutants of the genes encoding glutamate dehydrogenase (GDH) and glutamine oxoglutarate aminotransferase (GOGAT) in M. bovis BCG, despite their in vitro essentiality in M. tuberculosis. We could use these mutants to delineate the roles of GDH and GOGAT in mycobacterial nitrogen metabolism by using M. bovis BCG as a model for M. tuberculosis specifically. Here, we extended our investigation towards the involvement of GDH and GOGAT in other aspects of M. bovis BCG physiology, including the use of glutamate as a carbon source and resistance to known phagosomal stresses, as well as in survival inside macrophages. We find that gdh is indispensable for the utilization of glutamate as a major carbon source, in low pH environments and when challenged with nitric oxide. On the other hand, the gltBD mutant had increased viability under low pH conditions and was unaffected by a challenge with nitric oxide. Strikingly, GDH was required to sustain M. bovis BCG during infection of both murine RAW 264.7 and bone-marrow derived and macrophages, while GOGAT was not. We conclude that the catabolism of glutamate in slow growing mycobacteria may be a crucial function during infection of macrophage cells and demonstrate a novel requirement for M. bovis BCG GDH in the protection against acidic and nitrosative stress. These results provide strong clues on the role of GDH in intracellular survival of M. tuberculosis, in which the essentiality of the gdh gene complicates knock out studies making the study of the role of this enzyme in pathogenesis difficult.	[Gallant, James L.; van Helden, Paul D.; Wiid, Ian J. F.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,SA MRC Ctr T, Cape Town, South Africa; [Viljoen, Albertus J.] Univ Montpellier, Ctr Etud Agents Pathogenes & Biotechnol Sante, Ctr Natl Rech Sci FRE 3689, 1919 Route Mende, F-34059 Montpellier, France	National Research Foundation - South Africa; Stellenbosch University; Universite de Montpellier	Gallant, JL (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res,SA MRC Ctr T, Cape Town, South Africa.	jgallant@sun.ac.za	Viljoen, Albertus/O-6794-2019	Viljoen, Albertus/0000-0001-8949-7401	NRF/MRC; Harry Crossley Foundation; NRF-DAAD; L'Infectionpole Sud	NRF/MRC; Harry Crossley Foundation; NRF-DAAD; L'Infectionpole Sud	JG would like to acknowledge the NRF/MRC for financial assistance through the Allied Health Scholarship. AV would like to acknowledge the Harry Crossley Foundation, the NRF-DAAD and L'Infectionpole Sud for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearson BL, 2009, MICROBIOL-SGM, V155, P805, DOI 10.1099/mic.0.022905-0; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Cheung Y. W., 2011, Hong Kong Medical Journal, V17, P32; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; DeJesus MA, 2013, BIOINFORMATICS, V29, P695, DOI 10.1093/bioinformatics/btt043; EDSON NL, 1951, BACTERIOL REV, V15, P147, DOI 10.1128/MMBR.15.3.147-182.1951; Gising J, 2012, J MED CHEM, V55, P2894, DOI 10.1021/jm201212h; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Goude R, 2004, APPL ENVIRON MICROB, V70, P6535, DOI 10.1128/AEM.70.11.6535-6541.2004; Gouzy A, 2014, NAT REV MICROBIOL, V12, P729, DOI 10.1038/nrmicro3349; Gouzy A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003928; Gouzy A, 2013, NAT CHEM BIOL, V9, P674, DOI [10.1038/NCHEMBIO.1355, 10.1038/nchembio.1355]; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Harth G, 1999, J EXP MED, V189, P1425, DOI 10.1084/jem.189.9.1425; Harth G, 2003, INFECT IMMUN, V71, P456, DOI 10.1128/IAI.71.1.456-464.2003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kosenko E, 1997, FREE RADICAL RES, V27, P637, DOI 10.3109/10715769709097867; LUNDBORG M, 1992, ENVIRON HEALTH PERSP, V97, P153, DOI 10.2307/3431345; LYON RH, 1967, J BACTERIOL, V94, P92, DOI 10.1128/JB.94.1.92-100.1967; Maksymiuk C, 2015, P NATL ACAD SCI USA, V112, pE5834, DOI 10.1073/pnas.1510932112; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nilsson MT, 2009, J MOL BIOL, V393, P504, DOI 10.1016/j.jmb.2009.08.028; Nordqvist A, 2012, MEDCHEMCOMM, V3, P620, DOI 10.1039/c2md00310d; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; NYBERG K, 1992, ENVIRON HEALTH PERSP, V97, P149, DOI 10.2307/3431344; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Odell LR, 2009, BIOORG MED CHEM LETT, V19, P4790, DOI 10.1016/j.bmcl.2009.06.045; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rhee KY, 2011, TRENDS MICROBIOL, V19, P307, DOI 10.1016/j.tim.2011.03.008; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Saum SH, 2006, J BACTERIOL, V188, P6808, DOI 10.1128/JB.00781-06; Schultz C, 2007, APPL MICROBIOL BIOT, V76, P691, DOI 10.1007/s00253-007-0933-9; Sinha AK, 2015, COMP BIOCHEM PHYS C, V174, P21, DOI 10.1016/j.cbpc.2015.06.002; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; Ventura M, 2013, MOL MICROBIOL, V90, P356, DOI 10.1111/mmi.12368; Viljoen AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084452; WHO, GLOB TUB REP 2014; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yang W, 2010, J FRESHWATER ECOL, V25, P297, DOI 10.1080/02705060.2010.9665080	45	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147706	10.1371/journal.pone.0147706	http://dx.doi.org/10.1371/journal.pone.0147706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824899	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528600049
J	Naber, SK; Matthijsse, SM; Rozemeijer, K; Penning, C; de Kok, IMCM; van Ballegooijen, M				Naber, Steffie K.; Matthijsse, Suzette M.; Rozemeijer, Kirsten; Penning, Corine; de Kok, Inge M. C. M.; van Ballegooijen, Marjolein			Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; HPV-16/18 AS04-ADJUVANTED VACCINE; CROSS-PROTECTIVE EFFICACY; RISK HUMAN-PAPILLOMAVIRUS; OF-STUDY ANALYSIS; INTRAEPITHELIAL NEOPLASIA; QUADRIVALENT VACCINE; IMPACT; WOMEN; INFECTION	Background Vaccination against the oncogenic human papillomavirus (HPV) types 16 and 18 will reduce the prevalence of these types, thereby also reducing cervical cancer risk in unvaccinated women. This (measurable) herd effect will be limited at first, but is expected to increase over time. At a certain herd immunity level, tailoring screening to vaccination status may no longer be worth the additional effort. Moreover, uniform screening may be the only viable option. We therefore investigated at what level of herd immunity it is cost-effective to also reduce screening intensity in unvaccinated women. Methods We used the MISCAN-Cervix model to determine the optimal screening strategy for a pre-vaccination population and for vaccinated women (similar to 80% decreased risk), assuming a willingness- to-pay of (sic)50,000 per quality-adjusted life year gained. We considered HPV testing, cytology testing and co-testing and varied the start age of screening, the screening interval and the number of lifetime screens. We then calculated the incremental cost-effectiveness ratio (ICER) of screening unvaccinated women with the strategy optimized to the pre-vaccination population as compared to with the strategy optimized to vaccinated women, assuming different herd immunity levels. Results Primary HPV screening with cytology triage was the optimal strategy, with 8 lifetime screens for the pre-vaccination population and 3 for vaccinated women. The ICER of screening unvaccinated women 8 times instead of 3 was (sic)28,085 in the absence of herd immunity. At around 50% herd immunity, the ICER reached (sic)50,000. Conclusion From a herd immunity level of 50% onwards, screening intensity based on the pre-vaccination risk level becomes cost-ineffective for unvaccinated women. Reducing the screening intensity of uniform screening may then be considered.	[Naber, Steffie K.; Matthijsse, Suzette M.; Rozemeijer, Kirsten; Penning, Corine; de Kok, Inge M. C. M.; van Ballegooijen, Marjolein] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Naber, SK (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	s.naber@erasmusmc.nl	Naber, Steffie/A-9758-2015	Naber, Steffie/0000-0001-8357-1738				Accetta G, 2010, J MED SCREEN, V17, P181, DOI 10.1258/jms.2010.010019; [Anonymous], 1985, HOSP DIAGN STAT 1963; [Anonymous], 2013, STATLINE DATABASE; Berkhof J, 2005, INT J CANCER, V115, P268, DOI 10.1002/ijc.20846; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Brotherton JML, 2013, MED J AUSTRALIA, V199, P614, DOI 10.5694/mja13.10272; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Burger EA, 2012, BRIT J CANCER, V106, P1571, DOI 10.1038/bjc.2012.94; Casparie M, 2007, CELL ONCOL, V29, P19; Castanon A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001585; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Coupe VMH, 2008, BRIT J CANCER, V98, P646, DOI 10.1038/sj.bjc.6604162; Coupe VMH, 2012, VACCINE, V30, P1813, DOI 10.1016/j.vaccine.2012.01.001; Dempsey AF, 2009, ANN EPIDEMIOL, V19, P531, DOI 10.1016/j.annepidem.2009.03.011; Diaz M, 2010, EUR J CANCER, V46, P2973, DOI 10.1016/j.ejca.2010.06.016; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; European Centre for Disease Prevention and Control, 2012, INTRODUCTION OF HPV; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goldhaber-Fiebert JD, 2008, JNCI-J NATL CANCER I, V100, P308, DOI 10.1093/jnci/djn019; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; HABBEMA JDF, 1985, COMPUT METH PROG BIO, V20, P79, DOI 10.1016/0169-2607(85)90048-3; Heinonen A, 2013, EUR J OBSTET GYN R B, V169, P387, DOI 10.1016/j.ejogrb.2013.03.033; Herzog TJ, 2007, GYNECOL ONCOL, V107, P572, DOI 10.1016/j.ygyno.2007.09.019; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lenselink CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003743; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Netherlands Cancer Registry, 2012, CERV CANC INC ON YEA; Netherlands Cancer Registry, 2012, STAG DISTR SURV CERV; Nobbenhuis MAE, 2001, LANCET, V358, P1782, DOI 10.1016/S0140-6736(01)06809-X; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; US Food and Drug Administration, 2014, FDA APPR GARD 9 PREV; Van Ballegooijen M, 2006, EFFECTEN KOSTEN BEVO; van Lier EA, 2015, IMMUNISATION COVERAG; van Rosmalen J, 2012, BJOG-INT J OBSTET GY, V119, P699, DOI 10.1111/j.1471-0528.2011.03228.x; van 't Schurink-van 't Klooster TM, 2011, 2100120012011 NAT I; VANBALLEGOOIJEN M, 1998, EFFECTS COSTS CERVIC; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	53	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0145548	10.1371/journal.pone.0145548	http://dx.doi.org/10.1371/journal.pone.0145548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824771	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600007
J	Tran, NN; Pham, TT; Ozawa, K; Nishijo, M; Anh, T; Nguyet, N; Tran, TQ; Luong, VH; Tran, AH; Phan, VHA; Nakai, A; Nishino, Y; Nishijo, H				Nghi Ngoc Tran; Tai The Pham; Ozawa, Kyoko; Nishijo, Muneko; Anh Thi; Nguyet Nguyen; Tuong Quy Tran; Luong Van Hoang; Anh Hai Tran; Vu Huy Anh Phan; Nakai, Akio; Nishino, Yoshikazu; Nishijo, Hisao			Impacts of Perinatal Dioxin Exposure on Motor Coordination and Higher Cognitive Development in Vietnamese Preschool Children: A Five-Year Follow-Up	PLOS ONE			English	Article							BREAST-MILK; MATERNAL EXPOSURE; AUTISM; PCBS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; SKILLS; NEURODEVELOPMENT; PERFORMANCE; BEHAVIOR; MOTHERS	Dioxin concentrations remain elevated in the environment and in humans residing near former US Air Force bases in South Vietnam. Our previous epidemiological studies showed adverse effects of dioxin exposure on neurodevelopment for the first 3 years of life. Subsequently, we extended the follow-up period and investigated the influence of perinatal dioxin exposure on neurodevelopment, including motor coordination and higher cognitive ability, in preschool children. Presently, we investigated 176 children in a hot spot of dioxin contamination who were followed up from birth until 5 years old. Perinatal dioxin exposure levels were estimated by measuring dioxin levels in maternal breast milk. Dioxin toxicity was evaluated using two indices; toxic equivalent (TEQ)-polychlorinated dibenzo-p-dioxins/furans (PCDDs/Fs) and concentration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Coordinated movements, including manual dexterity, aiming and catching, and balance, were assessed using the Movement Assessment Battery for Children, Second Edition (Movement ABC-2). Cognitive ability was assessed using the nonverbal index (NVI) of the Kaufman Assessment Battery for Children, Second Edition (KABC-II). In boys, total test and balance scores of Movement ABC-2 were significantly lower in the high TEQ-PCDDs/Fs group compared with the moderate and low exposure groups. NVI scores and the pattern reasoning subscale of the KABC-II indicating planning ability were also significantly lower in the high TCDD exposure group compared with the low exposure group of boys. However, in girls, no significant differences in Movement ABC-2 and KABC-II scores were found among the different TEQ-PCDDs/Fs and TCDD exposure groups. Furthermore, in high risk cases, five boys and one girl highly exposed to TEQ-PCDDs/Fs and TCDD had double the risk for difficulties in both neurodevelopmental skills. These results suggest differential impacts of TEQ-PCDDs/Fs and TCDD exposure on motor coordination and higher cognitive ability, respectively. Moreover, high TEQ-PCDDs/Fs exposure combined with high TCDD exposure may increase autistic traits combined with developmental coordination disorder.	[Nghi Ngoc Tran; Nishijo, Muneko; Nishino, Yoshikazu] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan; [Nghi Ngoc Tran; Nguyet Nguyen; Tuong Quy Tran] Vietnam Govt, Minist Hlth, Hanoi, Vietnam; [Tai The Pham; Luong Van Hoang; Anh Hai Tran] Vietnam Mil Med Univ, Biomed & Pharmaceut Res Ctr, Hanoi, Vietnam; [Ozawa, Kyoko; Nishijo, Hisao] Toyama Univ, Syst Emot Sci, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan; [Vu Huy Anh Phan] Dong Nai Gen Hosp, Bien Hoa City, Dong Nai Provin, Vietnam; [Nakai, Akio] Hyogo Rehabil Ctr Hosp, Dept Pediat Neurol, Hyogo Childrens Sleep & Dev Med Res Ctr, Nishi Ku, 1070 Akebono, Kobe, Hyogo 6512181, Japan	Kanazawa Medical University; University of Toyama	Nishijo, M (corresponding author), Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	ni-koei@kanazawa-med.ac.jp	Nakai, Akio/AAE-1124-2020		Japan Society for the Promotion of Science Asian Core Program; Ministry of Education, Science, Sports and Culture [25305024, 25290005]; Challenging Exploratory Research [15K15244]	Japan Society for the Promotion of Science Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (25305024) and (25290005) and Challenging Exploratory Research (15K15244). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program and the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (25305024) and (25290005) and Challenging Exploratory Research (15K15244). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament K, 2015, J AUTISM DEV DISORD, V45, P742, DOI 10.1007/s10803-014-2229-0; Araki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109039; Augustowska K, 2003, REPRODUCTION, V126, P681, DOI 10.1530/rep.0.1260681; Endo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050741; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Green D, 2009, DEV MED CHILD NEUROL, V51, P311, DOI 10.1111/j.1469-8749.2008.03242.x; Hatfield Consultants Office of the National Steering Committee 33 MONRE, 2009, COMPR ASS DIOX CONT; Haugen AC, 2015, J DEV ORIG HLTH DIS, V6, P55, DOI 10.1017/S2040174414000580; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Hill EL, 2006, NEUROPSYCHOLOGIA, V44, P2822, DOI 10.1016/j.neuropsychologia.2006.06.007; Jansiewicz EM, 2006, J AUTISM DEV DISORD, V36, P613, DOI 10.1007/s10803-006-0109-y; Kakeyama M, 2014, ARCH TOXICOL, V88, P789, DOI 10.1007/s00204-013-1161-y; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; Nguyen MN, 2013, TOXICOLOGY, V314, P125, DOI 10.1016/j.tox.2013.09.005; Neugebauer J, 2015, INT J HYG ENVIR HEAL, V218, P153, DOI 10.1016/j.ijheh.2014.09.005; Neurodevelopmental disorders work group, 2013, DIAGN STAT MAN MENT; Nguyen ATN, 2013, ENVIRON HEALTH INSIG, V7, P1, DOI 10.4137/EHI.S10346; Nishijo M, 2014, MOL PSYCHIATR, V19, P1220, DOI 10.1038/mp.2014.18; Nishijo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040273; Papadopoulos N, 2012, AUTISM, V16, P627, DOI 10.1177/1362361311418692; Pellicano E, 2010, CHILD DEV, V81, P1400, DOI 10.1111/j.1467-8624.2010.01481.x; Tai PT, 2013, OCCUP ENVIRON MED, V70, P656, DOI 10.1136/oemed-2012-101021; Tai PT, 2011, ENVIRON SCI TECHNOL, V45, P6625, DOI 10.1021/es201666d; Roze E, 2009, ENVIRON HEALTH PERSP, V117, P1953, DOI 10.1289/ehp.0901015; Schaafsma SM, 2014, FRONT NEUROENDOCRIN, V35, P255, DOI 10.1016/j.yfrne.2014.03.006; Schellart NAM, 2008, CLIN NEUROPHYSIOL, V119, P1486, DOI 10.1016/j.clinph.2008.03.002; Stellman JM, 2003, ENVIRON HEALTH PERSP, V111, P321, DOI 10.1289/ehp.5755; Pham TT, 2015, SCI TOTAL ENVIRON, V536, P575, DOI 10.1016/j.scitotenv.2015.07.055; ten Tusscher GW, 2014, SCI TOTAL ENVIRON, V491, P235, DOI 10.1016/j.scitotenv.2014.02.100; Todaka T, 2010, CHEMOSPHERE, V78, P185, DOI 10.1016/j.chemosphere.2009.09.047; Nghi TN, 2015, ENVIRON SCI TECHNOL, V49, P5732, DOI 10.1021/es506211p; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; van Ede KI, 2014, ARCH TOXICOL, V88, P637, DOI 10.1007/s00204-013-1186-2; Vreugdenhil HJI, 2002, ENVIRON HEALTH PERSP, V110, pA593, DOI 10.1289/ehp.021100593; Whyatt CP, 2012, J AUTISM DEV DISORD, V42, P1799, DOI 10.1007/s10803-011-1421-8; Winneke G, 2014, ENVIRON HEALTH PERSP, V122, P292, DOI 10.1289/ehp.1306533; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS286, DOI 10.1016/j.chemosphere.2006.05.118	37	36	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2016	11	1							e0147655	10.1371/journal.pone.0147655	http://dx.doi.org/10.1371/journal.pone.0147655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GH	26824471	Green Published, gold, Green Submitted			2022-12-27	WOS:000369528600044
J	Etchells, PJ; Gage, SH; Rutherford, AD; Munafo, MR				Etchells, Peter J.; Gage, Suzanne H.; Rutherford, Adam D.; Munafo, Marcus R.			Prospective Investigation of Video Game Use in Children and Subsequent Conduct Disorder and Depression Using Data from the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							AGGRESSIVE-BEHAVIOR; MEDIA VIOLENCE; ASSOCIATION; ADOLESCENTS; COMPETITION; EXPOSURE; FAMILY; PLAY; LINK	There is increasing public and scientific concern regarding the long-term behavioural effects of video game use in children, but currently little consensus as to the nature of any such relationships. We investigated the relationship between video game use in children, degree of violence in games, and measures of depression and a 6-level banded measure of conduct disorder. Data from the Avon Longitudinal Study of Parents and Children were used. A 3-level measure of game use at age 8/9 years was developed, taking into account degree of violence based on game genre. Associations with conduct disorder and depression, measured at age 15, were investigated using ordinal logistic regression, adjusted for a number of potential confounders. Shoot-em-up games were associated with conduct disorder bands, and with a binary measure of conduct disorder, although the strength of evidence for these associations was weak. A sensitivity analysis comparing those who play competitive games to those who play shoot-em-ups found weak evidence supporting the hypothesis that it is violence rather than competitiveness that is associated with conduct disorder. However this analysis was underpowered, and we cannot rule out the possibility that increasing levels of competition in games may be just as likely to account for the observed associations as violent content. Overall game exposure as indicated by number of games in a household was not related to conduct disorder, nor was any association found between shoot-em-up video game use and depression.	[Etchells, Peter J.] Bath Spa Univ, Sch Soc Enterprise & Environm, Bath, Avon, England; [Etchells, Peter J.; Gage, Suzanne H.; Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, 12a Priory Rd, Bristol, Avon, England; [Gage, Suzanne H.; Munafo, Marcus R.] Univ Bristol, MRC Integrat Epidemiol Unit, 12a Priory Rd, Bristol, Avon, England; [Gage, Suzanne H.; Munafo, Marcus R.] Univ Bristol, UK Ctr Tobacco & Alcohol Studies, 12a Priory Rd, Bristol, Avon, England; [Rutherford, Adam D.] UCL, UCL Div Biosci Genet Evolut & Environm, Gower St, London, England	Bath Spa University; University of Bristol; University of Bristol; University of Bristol; University of London; University College London	Etchells, PJ (corresponding author), Bath Spa Univ, Sch Soc Enterprise & Environm, Bath, Avon, England.; Etchells, PJ (corresponding author), Univ Bristol, Sch Expt Psychol, 12a Priory Rd, Bristol, Avon, England.	p.etchells@bathspa.ac.uk	Munafo, Marcus/AAE-2306-2020	Munafo, Marcus/0000-0002-4049-993X; Etchells, Peter/0000-0002-6642-7918	Medical Research Council [MC_UU_12013/6, G9815508, MC_PC_15018] Funding Source: Medline; Wellcome Trust [102215] Funding Source: Medline; MRC [MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [1046634] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adachi PJC, 2013, J YOUTH ADOLESCENCE, V42, P1090, DOI 10.1007/s10964-013-9952-2; Adachi PJC, 2011, PSYCHOL VIOLENCE, V1, P259, DOI 10.1037/a0024908; Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 2004, J ADOLESCENCE, V27, P113, DOI 10.1016/j.adolescence.2003.10.009; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Bushman BJ, 2015, PSYCHOL POP MEDIA CU, V4, P200, DOI 10.1037/ppm0000046; Consortium of Scholars, 2013, SCHOL OP STAT APA TA; Engelhardt CR, 2015, PSYCHOL SCI, V26, P1187, DOI 10.1177/0956797615583038; Etchells P., 2014, GUARDIAN; Ewoldsen DR, 2012, CYBERPSYCH BEH SOC N, V15, P277, DOI 10.1089/cyber.2011.0308; Ferguson CJ, 2008, CRIM JUSTICE BEHAV, V35, P311, DOI 10.1177/0093854807311719; Ferguson CJ, 2012, J PSYCHIATR RES, V46, P141, DOI 10.1016/j.jpsychires.2011.10.014; Ferguson CJ, 2010, REV GEN PSYCHOL, V14, P68, DOI 10.1037/a0018941; Ferguson CJ, 2009, J PEDIATR-US, V155, P904, DOI 10.1016/j.jpeds.2009.06.021; Ferguson CJ, 2009, J PEDIATR-US, V154, P759, DOI 10.1016/j.jpeds.2008.11.033; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greitemeyer T, 2009, J EXP SOC PSYCHOL, V45, P896, DOI 10.1016/j.jesp.2009.04.005; Hasan Y, 2013, J EXP SOC PSYCHOL, V49, P224, DOI 10.1016/j.jesp.2012.10.016; Hasan Y, 2012, J EXP SOC PSYCHOL, V48, P953, DOI 10.1016/j.jesp.2011.12.019; Ivory JD, 2015, PSYCHOL POP MEDIA CU, V4, P222, DOI 10.1037/ppm0000056; Odgers CL, 2007, ARCH GEN PSYCHIAT, V64, P476, DOI 10.1001/archpsyc.64.4.476; Parkes A, 2013, ARCH DIS CHILD, V98, P341, DOI 10.1136/archdischild-2011-301508; Primack BA, 2009, ARCH GEN PSYCHIAT, V66, P181, DOI 10.1001/archgenpsychiatry.2008.532; Przybylski AK, 2009, PERS SOC PSYCHOL B, V35, P243, DOI 10.1177/0146167208327216; Strasburger VC, 2007, PEDIATRICS, V119, pE1398, DOI 10.1542/peds.2007-0083; Wechsler D., 1992, WECHSLER INTELLIGENC; Willoughby T, 2012, DEV PSYCHOL, V48, P1044, DOI 10.1037/a0026046	30	31	30	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147732	10.1371/journal.pone.0147732	http://dx.doi.org/10.1371/journal.pone.0147732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DC9GF	26820149	Green Published, Green Accepted, gold			2022-12-27	WOS:000369528400039
J	Li, DL; Yang, XY; Zhang, Z; Wang, ZX; Qi, X; Ruan, YH; Zhou, YH; Li, CR; Luo, FJ; Lau, JTF				Li, Dongliang; Yang, Xueying; Zhang, Zheng; Wang, Zixin; Qi, Xiao; Ruan, Yuhua; Zhou, Yunhua; Li, Chunrong; Luo, Fengji; Lau, Joseph T. F.			Incidence of Co-Infections of HIV, Herpes Simplex Virus Type 2 and Syphilis in a Large Cohort of Men Who Have Sex with Men in Beijing, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; GENITAL ULCER DISEASE; VIRAL LOAD; CLINICAL-MANIFESTATIONS; RISK-FACTORS; IMMUNODEFICIENCY; INFECTION; PREVALENCE; CELL; ASSOCIATION	Background The HIV-epidemic among MSM in China has worsened. In this key population, prevalence of HSV-2 and syphilis infection and co-infection with HIV is high. Methods A longitudinal study was conducted (n = 962) in Beijing, China, with three overlapping cohorts (n = 857, 757 and 760) consisting of MSM that were free from pairs of infections of concern (i. e. HIV-HSV-2, HIV-syphilis, HSV-2-syphilis) at baseline to estimate incidence of HIV, HSV-2, syphilis, and those of co-infection. Results The incidence of HIV, HSV-2 and syphilis in the overall cohort was 3.90 (95% CI = 2.37, 5.43), 7.87 (95% CI = 5.74, 10.00) and 6.06 (95% CI = 4.18, 7.94) cases per 100 personyears (PYs), respectively. The incidence of HIV-HSV-2, HIV-Syphilis and HSV-2-Syphilis co-infections was 0.30 (95% CI = 0.29, 0.88), 1.02 (95% CI = 0.13, 2.17) and 1.41 (95% CI: 0.04, 2.78) cases per 100 PYs, respectively, in the three sub-cohorts constructed for this study. Conclusions The incidence of HIV, HSV-2 and syphilis was very high and those of their co-infections were relatively high. Such co-infections have negative impacts on the HIV/STI epidemics. Prevention practices need to take such co-infections into account.	[Li, Dongliang; Yang, Xueying; Zhang, Zheng; Qi, Xiao; Luo, Fengji] Chaoyang Ctr Dis Control & Prevent, Beijing, Peoples R China; [Yang, Xueying; Wang, Zixin; Li, Chunrong; Lau, Joseph T. F.] Chinese Univ Hong Kong SAR, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Ruan, Yuhua] Chinese Ctr Dis Control & Prevent China CDC, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control SKLID, Beijing, Peoples R China; [Zhou, Yunhua] Soochow Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Suzhou, Jiangsu, Peoples R China	Chinese University of Hong Kong; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Soochow University - China	Luo, FJ (corresponding author), Chaoyang Ctr Dis Control & Prevent, Beijing, Peoples R China.; Lau, JTF (corresponding author), Chinese Univ Hong Kong SAR, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	lfj67773666@126.com; jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022	Li, Chunrong/0000-0002-5128-0132	Ministry of Science and Technology of China [2012ZX10004-904]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	Funding for this study was provided by Ministry of Science and Technology of China (2012ZX10004-904).	Amaratunge BC, 2010, CLIN EXP OPHTHALMOL, V38, P68, DOI 10.1111/j.1442-9071.2010.02203.x; [Anonymous], 2008, DEP HLTH HUMAN SERVI, V1; Bergamini M, 2013, J Prev Med Hyg, V54, P114; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chesson HW, 2005, SEX TRANSM DIS, V32, P265, DOI 10.1097/01.olq.0000162359.75509.9c; Chow EPF, 2013, AIDS BEHAV, V17, P2387, DOI 10.1007/s10461-012-0300-4; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Chun Helen M, 2013, J Sex Transm Dis, V2013, P176459, DOI 10.1155/2013/176459; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; de Almeida SM, 2010, J NEUROVIROL, V16, P6, DOI 10.3109/13550280903514776; Diaz JJ, 1996, NATURE, V379, P273, DOI 10.1038/379273a0; Ding YY, 2016, SEX TRANSM INFECT, V92, P76, DOI 10.1136/sextrans-2014-051975; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Ghanem KG, 2008, CLIN INFECT DIS, V47, P258, DOI 10.1086/589295; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Huang DY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/174870; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jarzebowski W, 2012, ARCH INTERN MED, V172, P1237, DOI 10.1001/archinternmed.2012.2706; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; KUCERA LS, 1990, AIDS RES HUM RETROV, V6, P641, DOI 10.1089/aid.1990.6.641; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2013, AIDS BEHAV, V17, P1395, DOI 10.1007/s10461-012-0244-8; Li Chun-mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P126; Li DL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001829; Li HC, 2015, INT J STD AIDS, V26, P13, DOI 10.1177/0956462414528309; Meng XJ, 2013, SEX HEALTH, V10, P211, DOI 10.1071/SH12093; Moriuchi M, 2000, VIROLOGY, V278, P534, DOI 10.1006/viro.2000.0667; MUSHER DM, 1990, ANN INTERN MED, V113, P872, DOI 10.7326/0003-4819-113-11-872; Nasio JM, 1996, INT J STD AIDS, V7, P410, DOI 10.1258/0956462961918374; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Norman P., 1996, PREDICTING HLTH BEHA, P197; NORRIS SA, 1988, J INFECT DIS, V157, P209, DOI 10.1093/infdis/157.1.209; Palo G, 2001, Herpes, V8, P50; Prabhakar P, 2012, SEX TRANSM DIS, V39, P906, DOI 10.1097/OLQ.0b013e3182663e22; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Rodrigues J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-39; Rompalo AM, 2001, SEX TRANSM DIS, V28, P448, DOI 10.1097/00007435-200108000-00004; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; SAFRIN S, 1991, AIDS, V5, P1107, DOI 10.1097/00002030-199109000-00008; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; Su YZ, 2011, THESIS; Tan Darrell H S, 2009, Can J Infect Dis Med Microbiol, V20, pe1; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Wu ZY, 2009, WHO M MSM GEN; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Yin YP, 2012, SEX TRANSM DIS, V39, P354, DOI 10.1097/OLQ.0b013e318244aef0	54	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0147422	10.1371/journal.pone.0147422	http://dx.doi.org/10.1371/journal.pone.0147422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26820145	Green Published, Green Submitted, gold			2022-12-27	WOS:000369528400028
J	Wang, C; Lin, X; Li, L; Lin, SJ				Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie			Differential Growth Responses of Marine Phytoplankton to Herbicide Glyphosate	PLOS ONE			English	Article							DISSOLVED ORGANIC PHOSPHORUS; TRANSPORTER GENE PHND; FRESH-WATER POND; PSEUDOMONAS SP; ACUTE TOXICITY; ROUNDUP; LIMITATION; COMMUNITY; IMPACT; DEGRADATION	Glyphosate is a globally popular herbicide to kill weeds and its wide applications may lead to accumulation in coastal oceans as a source of phosphorus (P) nutrient or growth inhibitor of phytoplankton. We studied the physiological effects of glyphosate on fourteen species representing five major coastal phytoplankton phyla (haptophyta, bacillariophyta, dinoflagellata, raphidophyta, and chlorophyta). Based on growth responses to different concentrations of glyphosate under contrasting dissolved inorganic phosphorus (DIP) conditions, we found that phytoplankton species could be classified into five groups. Group I (Emiliania huxleyi, Skeletonema costatum, Phaeodactylum tricornutum) could utilize glyphosate as sole P-source to support growth in axenic culture, but in the presence of DIP, they were inhibited by both 36-mu M and 360-mu M glyphosate. Group II (Karenia mikimotoi, Prorocentrum minimum, Dunaliella tertiolecta, Symbiodinium sp., Heterosigma akashiwo and Alexandrium catenella) could not utilize glyphosate as sole P-source to support growth, and in the presence of DIP growth was not affected by 36-mu M but inhibited by 360-mu M glyphosate. Glyphosate consistently enhanced growth of Group III (Isochrysis galbana) and inhibited Group IV (Thalassiosira weissflogii, Thalassiosira pseudonana and Chattonella marina) regardless of DIP condition. Group V (Amphidinium carterae) exhibited no measurable response to glyphosate regardless of DIP condition. This grouping is not congruent with the phylogenetic relationships of the phytoplankton species suggesting functional differentiation driven by environmental pressure. We conclude that glyphosate could be used as P-source by some species while is toxic to some other species and yet has no effects on others. The observed differential effects suggest that the continued use of glyphosate and increasing concentration of this herbicide in the coastal waters will likely exert significant impact on coastal marine phytoplankton community structure.	[Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, Coll Ocean & Marine Biodivers, Xiamen, Fujian, Peoples R China; [Wang, Cong; Lin, Xin; Li, Ling; Lin, Senjie] Xiamen Univ, Global Change Res Ctr, Xiamen, Fujian, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Xiamen University; Xiamen University; Xiamen University; University of Connecticut	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Xiamen Univ, Coll Ocean & Marine Biodivers, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Xiamen Univ, Global Change Res Ctr, Xiamen, Fujian, Peoples R China.; Lin, SJ (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016	CHEN, SHYR-CHYR/0000-0002-5858-3013; LIU, KAO-LANG/0000-0003-4100-8909; WANG, CHIH-HUNG/0000-0003-0802-7825; WU, YAO-MING/0000-0002-1720-7863; YANG, JUSTIN CHENG-TA/0000-0001-8256-2477; LIEN, WAN-CHING/0000-0001-9448-5093	National Natural Science Foundation of China (NSFC) [41176091, 41330959]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC), 41176091 and 41330959. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1978, CAN J BOT, V56, P2196, DOI 10.1139/b78-263; Annett R, 2014, J APPL TOXICOL, V34, P458, DOI 10.1002/jat.2997; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arunakumara K. K. I. U., 2013, African Journal of Microbiology Research, V7, P4084; Baylis AD, 2000, PEST MANAG SCI, V56, P299, DOI 10.1002/(SICI)1526-4998(200004)56:4<299::AID-PS144>3.0.CO;2-K; BERNER T, 1989, J PHYCOL, V25, P70, DOI 10.1111/j.0022-3646.1989.00070.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BOWMER KH, 1982, PESTIC SCI, V13, P623, DOI 10.1002/ps.2780130609; Busse MD, 2001, SOIL BIOL BIOCHEM, V33, P1777, DOI 10.1016/S0038-0717(01)00103-1; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; DICK RE, 1995, APPL MICROBIOL BIOT, V43, P545, DOI 10.1007/BF00218464; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Duke SO, 2011, J AGR FOOD CHEM, V59, P5835, DOI 10.1021/jf102704x; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Edge CB, 2013, SCI TOTAL ENVIRON, V444, P145, DOI 10.1016/j.scitotenv.2012.11.045; FENG JC, 1990, J AGR FOOD CHEM, V38, P1118, DOI 10.1021/jf00094a046; Fiori E, 2014, AQUAT TOXICOL, V147, P112, DOI 10.1016/j.aquatox.2013.12.014; FOLMAR LC, 1979, ARCH ENVIRON CON TOX, V8, P269, DOI 10.1007/BF01056243; Forlani G, 2008, PLANT CELL PHYSIOL, V49, P443, DOI 10.1093/pcp/pcn021; Forlani G, 2015, NEW PHYTOL, V205, P160, DOI 10.1111/nph.13022; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; Giesy JP, 2000, REV ENVIRON CONTAM T, V167, P35; Gimsing AL, 2004, APPL SOIL ECOL, V27, P233, DOI 10.1016/j.apsoil.2004.05.007; GOLDSBOROUGH LG, 1989, ARCH ENVIRON CON TOX, V18, P537, DOI 10.1007/BF01055020; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; HERNANDO F, 1989, J PLANT PHYSIOL, V134, P26, DOI 10.1016/S0176-1617(89)80197-X; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hove-Jensen B, 2014, MICROBIOL MOL BIOL R, V78, P176, DOI 10.1128/MMBR.00040-13; Ilikchyan IN, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00135; Ilikchyan IN, 2009, ENVIRON MICROBIOL, V11, P1314, DOI 10.1111/j.1462-2920.2009.01869.x; Kamlow M, 2013, THESIS NORWEGIAN U S; Karl DM, 2000, NATURE, V406, P31, DOI 10.1038/35017683; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; KREUTZWEISER DP, 1989, B ENVIRON CONTAM TOX, V42, P331, DOI 10.1007/BF01699957; Kryuchkova YV, 2014, MICROBIOL RES, V169, P99, DOI 10.1016/j.micres.2013.03.002; Krzysko-Lupicka T, 2008, CHEMOSPHERE, V71, P1386, DOI 10.1016/j.chemosphere.2007.11.006; Labry C, 2002, J PLANKTON RES, V24, P97, DOI 10.1093/plankt/24.2.97; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; LeGresley M, 2010, COUNTING CHAMBER MET; Lin X, 2011, J PHYCOL, V47, P1110, DOI 10.1111/j.1529-8817.2011.01038.x; Lipok J, 2010, ECOTOX ENVIRON SAFE, V73, P1681, DOI 10.1016/j.ecoenv.2010.08.017; LIU CM, 1991, APPL ENVIRON MICROB, V57, P1799, DOI 10.1128/AEM.57.6.1799-1804.1991; Ma J, 2003, B ENVIRON CONTAM TOX, V71, P594, DOI 10.1007/s00128-003-8521-x; MITCHELL DG, 1987, B ENVIRON CONTAM TOX, V39, P1028, DOI 10.1007/BF01689594; Modesto KA, 2010, CHEMOSPHERE, V81, P781, DOI 10.1016/j.chemosphere.2010.07.005; Mohr S, 2008, ENVIRON POLLUT, V152, P530, DOI 10.1016/j.envpol.2007.07.010; Mohr S, 2007, AQUAT TOXICOL, V82, P73, DOI 10.1016/j.aquatox.2007.02.001; MOORE JK, 1983, APPL ENVIRON MICROB, V46, P316, DOI 10.1128/AEM.46.2.316-320.1983; Nandula V. K., 2005, Outlooks on Pest Management, V16, P183, DOI 10.1564/16aug11; ORRETT K, 1987, LIMNOL OCEANOGR, V32, P383, DOI 10.4319/lo.1987.32.2.0383; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Perez GL, 2007, ECOL APPL, V17, P2310, DOI 10.1890/07-0499.1; Peruzzo PJ, 2008, ENVIRON POLLUT, V156, P61, DOI 10.1016/j.envpol.2008.01.015; PIPKE R, 1988, APPL ENVIRON MICROB, V54, P1293, DOI 10.1128/AEM.54.5.1293-1296.1988; PIPKE R, 1987, EUR J BIOCHEM, V165, P267, DOI 10.1111/j.1432-1033.1987.tb11437.x; QUINN JP, 1989, APPL MICROBIOL BIOT, V31, P283, DOI 10.1007/BF00258410; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Sandrini JZ, 2013, AQUAT TOXICOL, V130, P171, DOI 10.1016/j.aquatox.2013.01.006; Saxton MA, 2011, J GREAT LAKES RES, V37, P683, DOI 10.1016/j.jglr.2011.07.004; Schaffer JD, 2004, B ENVIRON CONTAM TOX, V72, P1032, DOI 10.1007/s00128-004-0347-7; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SCHULZ A, 1985, FEMS MICROBIOL LETT, V28, P297, DOI 10.1111/j.1574-6968.1985.tb00809.x; SERVIZI JA, 1987, B ENVIRON CONTAM TOX, V39, P15, DOI 10.1007/BF01691783; Shi XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071232; Stachowski-Haberkorn S, 2008, AQUAT TOXICOL, V89, P232, DOI 10.1016/j.aquatox.2008.07.004; Stalikas CD, 2001, J CHROMATOGR A, V907, P1, DOI 10.1016/S0021-9673(00)01009-8; Sun YY, 2009, BIOTECHNOL BIOPROC E, V14, P225, DOI 10.1007/s12257-008-0013-8; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Suzumura M, 1998, LIMNOL OCEANOGR, V43, P1553, DOI 10.4319/lo.1998.43.7.1553; TALBOT HW, 1984, CURR MICROBIOL, V10, P255, DOI 10.1007/BF01577137; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963; Vendrell E, 2009, B ENVIRON CONTAM TOX, V82, P538, DOI 10.1007/s00128-009-9674-z; Vera MS, 2010, ECOTOXICOLOGY, V19, P710, DOI 10.1007/s10646-009-0446-7; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; Webster TMU, 2014, ENVIRON SCI TECHNOL, V48, P1271, DOI 10.1021/es404258h; Winer BJ, 1971, STAT PRINCIPLES EXPT; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	84	118	126	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151633	10.1371/journal.pone.0151633	http://dx.doi.org/10.1371/journal.pone.0151633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26985828	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300099
J	Wang, CH; Wu, CY; Yang, JCT; Lien, WC; Wang, HP; Liu, KL; Wu, YM; Chen, SC				Wang, Chih-Hung; Wu, Cheng-Yi; Yang, Justin Cheng-Ta; Lien, Wan-Ching; Wang, Hsiu-Po; Liu, Kao-Lang; Wu, Yao-Ming; Chen, Shyr-Chyr			Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center	PLOS ONE			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; SURGICAL-PATIENTS; MANAGEMENT; DIAGNOSIS; BRIDGE; TRIAL; BILE	Background Percutaneous cholecystostomy tube (PCT) has been effectively used for the treatment of acute cholecystitis (AC) for patients unsuitable for early cholecystectomy. This retrospective study investigated the recurrence rate after successful PCT treatment and factors associated with recurrence. Methods We reviewed patients treated with PCT for AC from October 2004 through December 2013. Patients with successful PCT treatment were those who were free from persistent PCT drainage. We used multivariable logistic regression analysis sequentially to identify factors associated with each outcome. Results The study included 184 patients (mean age: 70.1 years). The average duration for parenteral antibiotics was 14.4 days and 20.0 days for PCT drainage. The one-year recurrence rate was 9.2% (17/184) with most recurrences occurring within two months (6.5%, 12/184) of the procedure. Complicated cholecystitis (odds ratio [OR]: 4.67; 95% confidence interval [CI]: 1.44-15.70; P = 0.01) and PCT drainage duration >32 days (OR: 4.92; 95% CI: 1.03-23.53; P = 0.05) positively correlated with one-year recurrence; parenteral antibiotics duration > 10 days (OR: 0.21; 95% CI: 0.05-0.68; P = 0.01) was inversely associated with one-year recurrence. Conclusions The recurrence rate was low for patients after successful PCT treatment. Predictors for recurrence included the severity of initial AC and subsequently provided treatments.	[Wang, Chih-Hung; Wu, Cheng-Yi; Chen, Shyr-Chyr] Natl Taiwan Univ, Dept Emergency Med, Taipei 10764, Taiwan; [Wang, Chih-Hung; Wu, Cheng-Yi; Yang, Justin Cheng-Ta; Wang, Hsiu-Po; Liu, Kao-Lang; Wu, Yao-Ming; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, Justin Cheng-Ta; Liu, Kao-Lang] Natl Taiwan Univ, Dept Med Imaging, Taipei 10764, Taiwan; [Lien, Wan-Ching] Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsinchu, Taiwan; [Lien, Wan-Ching] Natl Taiwan Univ, Hsinchu, Taiwan; [Wang, Hsiu-Po] Natl Taiwan Univ, Dept Internal Med, Taipei 10764, Taiwan; [Wu, Yao-Ming] Natl Taiwan Univ, Dept Surg, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Lien, WC (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Hsinchu, Taiwan.; Lien, WC (corresponding author), Natl Taiwan Univ, Hsinchu, Taiwan.	wanchinglien@ntu.edu.tw	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016	CHEN, SHYR-CHYR/0000-0002-5858-3013; LIU, KAO-LANG/0000-0003-4100-8909; WANG, CHIH-HUNG/0000-0003-0802-7825; WU, YAO-MING/0000-0002-1720-7863; YANG, JUSTIN CHENG-TA/0000-0001-8256-2477; LIEN, WAN-CHING/0000-0001-9448-5093				Browning P D, 1993, J Vasc Interv Radiol, V4, P531, DOI 10.1016/S1051-0443(93)71915-6; Chang YR, 2014, SURGERY, V155, P615, DOI 10.1016/j.surg.2013.12.026; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chok KSH, 2010, ANZ J SURG, V80, P280, DOI 10.1111/j.1445-2197.2009.05105.x; Crnich CJ, 2012, INFECT DIS CLIN N AM, V26, P143, DOI 10.1016/j.idc.2011.09.007; Davis CA, 1999, ARCH SURG-CHICAGO, V134, P727, DOI 10.1001/archsurg.134.7.727; de Mestral C, 2013, J TRAUMA ACUTE CARE, V74, P175, DOI 10.1097/TA.0b013e31827890e1; Decker G, 2001, ACTA CHIR BELG, V101, P294; Gomi H, 2013, J HEPATO-BIL-PAN SCI, V20, P60, DOI 10.1007/s00534-012-0572-0; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Hatjidakis AA, 1998, CARDIOVASC INTER RAD, V21, P36, DOI 10.1007/s002709900208; HOUGHTON PWJ, 1985, BRIT J SURG, V72, P220, DOI 10.1002/bjs.1800720327; HUBER DF, 1983, AM J SURG, V146, P719, DOI 10.1016/0002-9610(83)90326-4; Kiviniemi H, 1998, INT SURG, V83, P299; Kortram K, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-7; Leveau P, 2008, SCAND J GASTROENTERO, V43, P593, DOI 10.1080/00365520701851673; Li M, 2013, AM SURGEON, V79, P524; MARGIOTTA SJ, 1988, AM SURGEON, V54, P34; McGillicuddy EA, 2012, BRIT J SURG, V99, P1254, DOI 10.1002/bjs.8836; Miura F, 2013, J HEPATO-BIL-PAN SCI, V20, P47, DOI 10.1007/s00534-012-0563-1; MORRIS CR, 1952, SURGERY, V32, P673; Okamoto K, 2013, J HEPATO-BIL-PAN SCI, V20, P55, DOI 10.1007/s00534-012-0562-2; Pessaux P, 2001, SURG LAPARO ENDO PER, V11, P252, DOI 10.1097/00129689-200108000-00005; RADDER RW, 1980, DIAGN IMAGING, V49, P330; ROSLYN JJ, 1980, AM J SURG, V140, P126, DOI 10.1016/0002-9610(80)90428-6; Sanjay P, 2013, HPB, V15, P511, DOI 10.1111/j.1477-2574.2012.00610.x; Smith TJ, 2013, ANN SURG, V257, P1112, DOI 10.1097/SLA.0b013e318274779c; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; VANDERLINDEN W, 1970, AM J SURG, V120, P7, DOI 10.1016/S0002-9610(70)80133-7; Venara A, 2014, J VISC SURG, V151, P435, DOI 10.1016/j.jviscsurg.2014.06.003; Wang CH, 2014, WORLD J SURG, V38, P347, DOI 10.1007/s00268-013-2311-3; WERBEL GB, 1989, ARCH SURG-CHICAGO, V124, P782; Winbladh A, 2009, HPB, V11, P183, DOI 10.1111/j.1477-2574.2009.00052.x; Wise JN, 2005, AM J ROENTGENOL, V184, P1647, DOI 10.2214/ajr.184.5.01841647; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Zerem E, 2014, SURG LAPARO ENDO PER, V24, P187, DOI 10.1097/SLE.0b013e31828fa45e	36	118	126	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2016	11	1							e0148017	10.1371/journal.pone.0148017	http://dx.doi.org/10.1371/journal.pone.0148017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GF	26985828	Green Submitted, Green Published, gold			2022-12-27	WOS:000369528400058
